Citrus Sinensis ID: 001658
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
ID ![]() | Alignment graph ![]() | Length ![]() |
Definition ![]() |
RBH(Q2H) ![]() |
RBH(H2Q) ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 1036 | 2.2.26 [Sep-21-2011] | |||||||
| C0LGH2 | 1032 | Probable LRR receptor-lik | yes | no | 0.987 | 0.991 | 0.631 | 0.0 | |
| C0LGH3 | 1033 | Probable LRR receptor-lik | no | no | 0.975 | 0.978 | 0.646 | 0.0 | |
| C0LGG8 | 1038 | Probable LRR receptor-lik | no | no | 0.895 | 0.894 | 0.431 | 0.0 | |
| C0LGG9 | 1035 | Probable LRR receptor-lik | no | no | 0.930 | 0.931 | 0.420 | 0.0 | |
| C0LGE0 | 1014 | Probable LRR receptor-lik | no | no | 0.887 | 0.906 | 0.418 | 0.0 | |
| C0LGN2 | 1020 | Probable leucine-rich rep | no | no | 0.896 | 0.910 | 0.423 | 0.0 | |
| C0LGG7 | 953 | Probable LRR receptor-lik | no | no | 0.809 | 0.880 | 0.422 | 0.0 | |
| Q9FXF2 | 1021 | Probable LRR receptor-lik | no | no | 0.833 | 0.845 | 0.403 | 1e-178 | |
| Q9ASQ6 | 1019 | Probable LRR receptor-lik | no | no | 0.880 | 0.894 | 0.417 | 1e-177 | |
| O23081 | 665 | Cysteine-rich receptor-li | no | no | 0.327 | 0.509 | 0.446 | 2e-83 |
| >sp|C0LGH2|Y1561_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g56130 OS=Arabidopsis thaliana GN=At1g56130 PE=1 SV=2 | Back alignment and function desciption |
|---|
Score = 1340 bits (3468), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 657/1041 (63%), Positives = 809/1041 (77%), Gaps = 18/1041 (1%)
Query: 2 LRRSLPPVSGFALCFVCLFVHFCLCQAQNRTQATTDPNEVRALNSIFQQWRISARQGQWN 61
+RRS P + + F+C+ + Q+QN+T ATT P+E RALNSIF W+I A + +WN
Sbjct: 4 IRRS-PCLLLLIIWFMCIAGSVQVVQSQNQTGATTHPDEARALNSIFAAWKIQAPR-EWN 61
Query: 62 RSGDPCTGAALDDSIVFDNTDYNPFIKCDCSSQNGTVCHITQLKVYALNVVGVIPDELWN 121
SG+ C+GAA+D S++ N YNP IKCDCS QN T+C IT +KVYA++VVG IP ELW
Sbjct: 62 ISGELCSGAAIDASVLDSNPAYNPLIKCDCSFQNSTICRITNIKVYAIDVVGPIPPELWT 121
Query: 122 LTSLFNLNLGQNYLTGPLSPSVGNLTAMQYLNLAINALSGELPKELGQLTELLILGIGTN 181
LT L NLNLGQN LTG L P++GNLT MQ++ INALSG +PKE+G LT+L +LGI +N
Sbjct: 122 LTYLTNLNLGQNVLTGSLPPAIGNLTRMQWMTFGINALSGPVPKEIGLLTDLRLLGISSN 181
Query: 182 NFSGPLPSELGSLSKLQELYIDSAGVSGEIPSSFANLQSLTKWWASDTRLTGRIPDFIGN 241
NFSG +P E+G +KLQ++YIDS+G+SG IP SFANL L + W +D +T +IPDFIG+
Sbjct: 182 NFSGSIPDEIGRCTKLQQMYIDSSGLSGRIPLSFANLVQLEQAWIADLEVTDQIPDFIGD 241
Query: 242 WSKLTALRFQGNSFNGPIPSSFSNLTSVTELRISDLSNGSSKLAFIRDMKSLSILELRNN 301
W+KLT LR G +GPIPSSFSNLTS+TELR+ D+S+GSS L FI+DMKSLS+L LRNN
Sbjct: 242 WTKLTTLRIIGTGLSGPIPSSFSNLTSLTELRLGDISSGSSSLDFIKDMKSLSVLVLRNN 301
Query: 302 NISDSIPSNIGEYRSLQHLDLSFNNLGGSIPDSLFNLSSLTHLFLGNNKLNGTLPARKSP 361
N++ +IPS IGE+ SL+ +DLSFN L G IP SLFNLS LTHLFLGNN LNG+ P +K+
Sbjct: 302 NLTGTIPSTIGEHSSLRQVDLSFNKLHGPIPASLFNLSQLTHLFLGNNTLNGSFPTQKTQ 361
Query: 362 LLLNIDVSYNNLQGNLPSWINGQQNLQINLVANNLTIRSSDNSVLPRGLICLQRNFPCNR 421
L N+DVSYN+L G+LPSW++ +L++NLVANN T+ DN VLP GL CLQ+NFPCNR
Sbjct: 362 SLRNVDVSYNDLSGSLPSWVS-LPSLKLNLVANNFTLEGLDNRVLP-GLNCLQKNFPCNR 419
Query: 422 GYAIYADFAIKSGGPQIRSSNGVVYERDNATLGPATYYVTDSNKWGVSNVGLFTGSNNPQ 481
G IY+DF+I GGP+ RS G ++ER++ GPA+++V+ +W S+VGLF GS+N
Sbjct: 420 GKGIYSDFSINCGGPEKRSVTGALFEREDEDFGPASFFVSAGQRWAASSVGLFAGSSNNI 479
Query: 482 YKSSSLSQFTNTLDSELFQTARLSASSLRYYGLGLENGNYTVLLQFAEMAILDTNR--WE 539
Y ++S SQF NTLDSELFQ+ARLSASS+RYYGLGLENG YTV LQFAE+ IL + W+
Sbjct: 480 YIATSQSQFVNTLDSELFQSARLSASSVRYYGLGLENGGYTVTLQFAEIQILGSTSTTWK 539
Query: 540 SLGRRVFDVYIQGNRVLKDFDIKREAGGVSKRAIQREIKTRVSENYLEIHLFWAGKGTCC 599
LGRR FD+Y+QG V KDFD++R AG + RA+QR K VSEN+LE+HLFWAGKGTCC
Sbjct: 540 GLGRRRFDIYVQGRLVEKDFDVRRTAGDSTVRAVQRVYKANVSENHLEVHLFWAGKGTCC 599
Query: 600 VPAQGTYGPSISAIRVTPDFTPTV-RPPKEKDNNRTGLIVGIVVGVGVATFLSVLAIFCI 658
+P QG YGP ISA+ TPDFTPTV P K NRTG IVG++VGVG+ + L+ + +F I
Sbjct: 600 IPIQGAYGPLISAVSATPDFTPTVANKPPSKGKNRTGTIVGVIVGVGLLSILAGVVMFTI 659
Query: 659 VRRRKRPQHDDDEELLGMDARPYTFSYAELKTATENFSPSNKLGEGGFGPVYKGKLGDGR 718
+RRKR + DDEELLGMD +PY F+Y+ELK+AT++F PSNKLGEGGFGPVYKG L DGR
Sbjct: 660 RKRRKR--YTDDEELLGMDVKPYIFTYSELKSATQDFDPSNKLGEGGFGPVYKGNLNDGR 717
Query: 719 AIAVKQLSVASRQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLVYEYLENKSLDQ 778
+AVK LSV SRQGK QFVAEI IS+V HRNLVKL+GCC EG R+LVYEYL N SLDQ
Sbjct: 718 VVAVKLLSVGSRQGKGQFVAEIVAISSVLHRNLVKLYGCCFEGEHRMLVYEYLPNGSLDQ 777
Query: 779 ALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDF 838
ALFG ++L LDW+TRYEIC GVARGL YLHEE+ VRI+HRDVKASN+LLD+ LVP+ISDF
Sbjct: 778 ALFGDKTLHLDWSTRYEICLGVARGLVYLHEEASVRIVHRDVKASNILLDSRLVPQISDF 837
Query: 839 GLAKLYDDKKTHISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRPNSDPS 898
GLAKLYDDKKTHISTRVAGTIGYLAPEYAMRGHLTEKTDV+AFGV+ALE VSGRPNSD +
Sbjct: 838 GLAKLYDDKKTHISTRVAGTIGYLAPEYAMRGHLTEKTDVYAFGVVALELVSGRPNSDEN 897
Query: 899 LDEEKLYLLEWAWHLHENNQEIELADPKLIEFNEEEVKRLIGVALLCTQTLPSLRPSMSR 958
L+EEK YLLEWAW+LHE +++IEL D KL +FN EE KR+IG+ALLCTQT +LRP MSR
Sbjct: 898 LEEEKKYLLEWAWNLHEKSRDIELIDDKLTDFNMEEAKRMIGIALLCTQTSHALRPPMSR 957
Query: 959 VVAMLCGDMEVSTVTAKPGYLTDWKFDDITSFVRTDEATKGTDTSHYTSSSSTSIVAEAE 1018
VVAML GD+E+ VT+KPGY++DW+FDD T + K DT+ Y S S+VA
Sbjct: 958 VVAMLSGDVEIGDVTSKPGYVSDWRFDDTTGSSLSGFQIK--DTTGY----SMSLVAPGS 1011
Query: 1019 HLS---RNGKPLLHDLVGEGR 1036
+S + KP+L + EGR
Sbjct: 1012 EISPRDSDFKPMLGSKINEGR 1032
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|C0LGH3|Y5614_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g56140 OS=Arabidopsis thaliana GN=At1g56140 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 1328 bits (3438), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 665/1028 (64%), Positives = 803/1028 (78%), Gaps = 17/1028 (1%)
Query: 16 FVCLFVHFCLCQAQNRTQATTDPNEVRALNSIFQQWRISARQGQWNRSGDPCTGAALDDS 75
F+C F + +AQNRT ATT P+E ALNSIF WRI A + +WN SG+ C+GAA+D S
Sbjct: 16 FLCNFGPVYVVRAQNRTGATTHPDEALALNSIFAAWRIRAPR-EWNISGELCSGAAIDAS 74
Query: 76 IVFDNTDYNPFIKCDCSSQNGTVCHITQLKVYALNVVGVIPDELWNLTSLFNLNLGQNYL 135
++ N YNP IKCDCS +N T+C IT +KVYA+ VVG IP +LW L L NLNLGQN L
Sbjct: 75 VLDSNPAYNPLIKCDCSFENSTICRITNIKVYAMEVVGSIPQQLWTLEYLTNLNLGQNVL 134
Query: 136 TGPLSPSVGNLTAMQYLNLAINALSGELPKELGQLTELLILGIGTNNFSGPLPSELGSLS 195
TG L P++GNLT M+++ INALSG +PKE+G LT+L +L I +NNFSG +P E+G +
Sbjct: 135 TGSLPPALGNLTRMRWMTFGINALSGPIPKEIGLLTDLRLLSISSNNFSGSIPDEIGRCT 194
Query: 196 KLQELYIDSAGVSGEIPSSFANLQSLTKWWASDTRLTGRIPDFIGNWSKLTALRFQGNSF 255
KLQ++YIDS+G+SG +P SFANL L + W +D LTG+IPDFIG+W+KLT LR G
Sbjct: 195 KLQQIYIDSSGLSGGLPVSFANLVELEQAWIADMELTGQIPDFIGDWTKLTTLRILGTGL 254
Query: 256 NGPIPSSFSNLTSVTELRISDLSNGSSKLAFIRDMKSLSILELRNNNISDSIPSNIGEYR 315
+GPIP+SFSNLTS+TELR+ D+SNG+S L FI+DMKSLSIL LRNNN++ +IPSNIGEY
Sbjct: 255 SGPIPASFSNLTSLTELRLGDISNGNSSLEFIKDMKSLSILVLRNNNLTGTIPSNIGEYS 314
Query: 316 SLQHLDLSFNNLGGSIPDSLFNLSSLTHLFLGNNKLNGTLPARKSPLLLNIDVSYNNLQG 375
SL+ LDLSFN L G+IP SLFNL LTHLFLGNN LNG+LP +K L N+DVSYN+L G
Sbjct: 315 SLRQLDLSFNKLHGTIPASLFNLRQLTHLFLGNNTLNGSLPTQKGQSLSNVDVSYNDLSG 374
Query: 376 NLPSWINGQQNLQINLVANNLTIRSSDNSVLPRGLICLQRNFPCNRGYAIYADFAIKSGG 435
+LPSW++ NL +NLVANN T+ DN VL GL CLQ+NFPCNRG IY+DF+I GG
Sbjct: 375 SLPSWVS-LPNLNLNLVANNFTLEGLDNRVLS-GLNCLQKNFPCNRGKGIYSDFSINCGG 432
Query: 436 PQIRSSNGVVYERDNATLGPATYYVTDSNKWGVSNVGLFTGSNNPQYKSSSLSQFTNTLD 495
P+IRS V+ER++ LGPA++ V+ +W S+VGLF GS+N Y S+S SQF NTLD
Sbjct: 433 PEIRSVTEAVFEREDEDLGPASFVVSAGQRWAASSVGLFAGSSNNIYISTSQSQFVNTLD 492
Query: 496 SELFQTARLSASSLRYYGLGLENGNYTVLLQFAEMAIL--DTNRWESLGRRVFDVYIQGN 553
SELFQ+ARLSASSLRYYGLGLENG YTV LQFAE+ IL +N W LGRR FD+Y+QG
Sbjct: 493 SELFQSARLSASSLRYYGLGLENGGYTVTLQFAEIQILGSTSNTWRGLGRRRFDIYVQGR 552
Query: 554 RVLKDFDIKREAGGVSKRAIQREIKTRVSENYLEIHLFWAGKGTCCVPAQGTYGPSISAI 613
V KDFD++R AG + RA+QRE K VS+N+LEIHLFWAGKGTCC+P QG YGP ISA+
Sbjct: 553 LVEKDFDVRRTAGDSTVRAVQREYKANVSQNHLEIHLFWAGKGTCCIPIQGAYGPLISAV 612
Query: 614 RVTPDFTPTV--RPPKEKDNNRTGLIVGIVVGVGVATFLSVLAIFCIVRRRKRPQHDDDE 671
TPDFTPTV RPP K + TG IVG++VGVG+ + +S + IF I +RRKR + DDE
Sbjct: 613 GATPDFTPTVGNRPPS-KGKSMTGTIVGVIVGVGLLSIISGVVIFIIRKRRKR--YTDDE 669
Query: 672 ELLGMDARPYTFSYAELKTATENFSPSNKLGEGGFGPVYKGKLGDGRAIAVKQLSVASRQ 731
E+L MD +PYTF+Y+ELK+AT++F PSNKLGEGGFGPVYKGKL DGR +AVK LSV SRQ
Sbjct: 670 EILSMDVKPYTFTYSELKSATQDFDPSNKLGEGGFGPVYKGKLNDGREVAVKLLSVGSRQ 729
Query: 732 GKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLVYEYLENKSLDQALFGQRSLTLDWA 791
GK QFVAEI ISAVQHRNLVKL+GCC EG RLLVYEYL N SLDQALFG+++L LDW+
Sbjct: 730 GKGQFVAEIVAISAVQHRNLVKLYGCCYEGEHRLLVYEYLPNGSLDQALFGEKTLHLDWS 789
Query: 792 TRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHI 851
TRYEIC GVARGL YLHEE+R+RI+HRDVKASN+LLD+ LVPK+SDFGLAKLYDDKKTHI
Sbjct: 790 TRYEICLGVARGLVYLHEEARLRIVHRDVKASNILLDSKLVPKVSDFGLAKLYDDKKTHI 849
Query: 852 STRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAW 911
STRVAGTIGYLAPEYAMRGHLTEKTDV+AFGV+ALE VSGRPNSD +L++EK YLLEWAW
Sbjct: 850 STRVAGTIGYLAPEYAMRGHLTEKTDVYAFGVVALELVSGRPNSDENLEDEKRYLLEWAW 909
Query: 912 HLHENNQEIELADPKLIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVAMLCGDMEVST 971
+LHE +E+EL D +L EFN EE KR+IG+ALLCTQT +LRP MSRVVAML GD+EVS
Sbjct: 910 NLHEKGREVELIDHQLTEFNMEEGKRMIGIALLCTQTSHALRPPMSRVVAMLSGDVEVSD 969
Query: 972 VTAKPGYLTDWKFDDITSFVRTDEATKGTDTSHYTSSSSTSIVAEAEHLS---RNGKPLL 1028
VT+KPGYLTDW+FDD T+ + + T S S TS VA +S + +P+L
Sbjct: 970 VTSKPGYLTDWRFDDTTASSISGFPLRNTQASE----SFTSFVAPRSEISPRNNDARPML 1025
Query: 1029 HDLVGEGR 1036
+ EGR
Sbjct: 1026 GAQMNEGR 1033
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGG8|Y5343_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g53430 OS=Arabidopsis thaliana GN=At1g53430 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 742 bits (1916), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 422/977 (43%), Positives = 592/977 (60%), Gaps = 49/977 (5%)
Query: 14 LCFVCLFVHFCLCQAQNRTQATTDPNEVRALNSIFQQW--------RISARQGQWNRSGD 65
+ +V L + CL + Q + +EV+ L +IF++ R S WN
Sbjct: 10 VVYVLLLIFVCLENFGSNAQLLPE-DEVQTLRTIFRKLQNQTVNIERTSCSDQNWN---- 64
Query: 66 PCTGAALDDSIVFDNTDYNPF--IKCDCSSQNGTVCHITQLKVYALNVVGVIPDELWNLT 123
V ++ +P I CDC+ +VC +T +++ + ++ G+ P E NLT
Sbjct: 65 ----------FVVESASNSPTSNITCDCTFNASSVCRVTNIQLKSFSLPGIFPPEFGNLT 114
Query: 124 SLFNLNLGQNYLTGPLSPSVGNLTAMQYLNLAINALSGELPKELGQLTELLILGIGTNNF 183
L ++L +N+L G + P+ + ++ L++ N LSG P +LG +T L + + TN F
Sbjct: 115 RLREIDLSRNFLNGTI-PTTLSQIPLEILSVIGNRLSGPFPPQLGDITTLTDVNLETNLF 173
Query: 184 SGPLPSELGSLSKLQELYIDSAGVSGEIPSSFANLQSLTKWWASDTRLTGRIPDFIGNWS 243
+GPLP LG+L L+EL + + +G+IP S +NL++LT++ L+G+IPDFIGNW+
Sbjct: 174 TGPLPRNLGNLRSLKELLLSANNFTGQIPESLSNLKNLTEFRIDGNSLSGKIPDFIGNWT 233
Query: 244 KLTALRFQGNSFNGPIPSSFSNLTSVTELRISDLSNGSSKLAF--IRDMKSLSILELRNN 301
L L QG S GPIP S SNLT++TELRI+DL G + +F +R++ + L LRN
Sbjct: 234 LLERLDLQGTSMEGPIPPSISNLTNLTELRITDL-RGQAAFSFPDLRNLMKMKRLVLRNC 292
Query: 302 NISDSIPSNIGEYRSLQHLDLSFNNLGGSIPDSLFNLSSLTHLFLGNNKLNGTLPARKSP 361
I IP IG L+ LDLS N L G IPD+ NL + +FL NN L G +P
Sbjct: 293 LIRGPIPEYIGSMSELKTLDLSSNMLTGVIPDTFRNLDAFNFMFLNNNSLTGPVPQFIIN 352
Query: 362 LLLNIDVSYNNLQGNLPSWINGQQNLQINLVANNLTIRSSDNSVLPRGLICLQRNFPCNR 421
N+D+S NN P ++ Q L +NL+++ ++ +DNSV CL+ PC
Sbjct: 353 SKENLDLSDNNFTQ--PPTLSCNQ-LDVNLISSYPSV--TDNSVQ----WCLREGLPCPE 403
Query: 422 GYAIYADFAIKSGGPQIRSSNGVVYERDNATLGPATYYVTDSNKWGVSNVGLFTGSNNPQ 481
A + I GG +++ Y D + G +T+ S +WG S+ G++ G +
Sbjct: 404 D-AKQSSLFINCGGSRLKIGKDT-YTDDLNSRGQSTFSSV-SERWGYSSSGVWLGKEDAG 460
Query: 482 YKSSSLSQFTNTLDSELFQTARLSASSLRYYGLGLENGNYTVLLQFAEMAILDTNRWESL 541
Y ++ N E ++TARLS SL+YYGL L G+Y + L FAE+ + + SL
Sbjct: 461 YLATDRFNLINGSTPEYYKTARLSPQSLKYYGLCLRRGSYKLQLHFAEIMFSNDQTFNSL 520
Query: 542 GRRVFDVYIQGNRVLKDFDIKREAGGVSKRAIQREIKTRVSENYLEIHLFWAGKGTCCVP 601
GRR+FD+Y+QGN + +DF+I AGGV K I++ +V+ + LEIHL W GKGT +P
Sbjct: 521 GRRIFDIYVQGNLLERDFNIAERAGGVGKPFIRQIDGVQVNGSTLEIHLQWTGKGTNVIP 580
Query: 602 AQGTYGPSISAIRVTPDFTPTVRPPKEKDNNRTGLIVGIVVGVGVATFLSVLAIFCIVRR 661
+G YGP ISAI +TP+F P G + GIV+ L VL I +
Sbjct: 581 TRGVYGPLISAITITPNFKVDTGKPLSN-----GAVAGIVIAACAVFGLLVLVILRLTGY 635
Query: 662 RKRPQHDDDEELLGMDARPYTFSYAELKTATENFSPSNKLGEGGFGPVYKGKLGDGRAIA 721
+ D++EEL G+D + +F+ ++K AT NF P NK+GEGGFGPVYKG L DG IA
Sbjct: 636 LGGKEVDENEELRGLDLQTGSFTLKQIKRATNNFDPENKIGEGGFGPVYKGVLADGMTIA 695
Query: 722 VKQLSVASRQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLVYEYLENKSLDQALF 781
VKQLS S+QG +FV EI ISA+QH NLVKL+GCCIEG E LLVYEYLEN SL +ALF
Sbjct: 696 VKQLSSKSKQGNREFVTEIGMISALQHPNLVKLYGCCIEGKELLLVYEYLENNSLARALF 755
Query: 782 G--QRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFG 839
G ++ L LDW+TR +IC G+A+GLAYLHEESR++I+HRD+KA+NVLLD L KISDFG
Sbjct: 756 GTEKQRLHLDWSTRNKICIGIAKGLAYLHEESRLKIVHRDIKATNVLLDLSLNAKISDFG 815
Query: 840 LAKLYDDKKTHISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRPNSDPSL 899
LAKL DD+ THISTR+AGTIGY+APEYAMRG+LT+K DV++FGV+ LE VSG+ N++
Sbjct: 816 LAKLNDDENTHISTRIAGTIGYMAPEYAMRGYLTDKADVYSFGVVCLEIVSGKSNTNYRP 875
Query: 900 DEEKLYLLEWAWHLHENNQEIELADPKL-IEFNEEEVKRLIGVALLCTQTLPSLRPSMSR 958
EE +YLL+WA+ L E +EL DP L F+++E R++ +ALLCT P+LRP MS
Sbjct: 876 KEEFVYLLDWAYVLQEQGSLLELVDPDLGTSFSKKEAMRMLNIALLCTNPSPTLRPPMSS 935
Query: 959 VVAMLCGDMEVSTVTAK 975
VV+ML G ++V K
Sbjct: 936 VVSMLEGKIKVQPPLVK 952
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGG9|Y5344_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g53440 OS=Arabidopsis thaliana GN=At1g53440 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 742 bits (1915), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 427/1015 (42%), Positives = 616/1015 (60%), Gaps = 51/1015 (5%)
Query: 17 VCLFVHFCLCQAQNRTQATTDPNEVRALNSIFQQW--------RISARQGQWNRSGDPCT 68
+ L + CL + Q + +EV+ L +IF++ R S +WN
Sbjct: 11 LLLIIFICLDIFGSNAQLLPE-DEVQTLRTIFRKLQNQTVNIERTSCLDRKWN------- 62
Query: 69 GAALDDSIVFDNTDYNPF--IKCDCSSQNGTVCHITQLKVYALNVVGVIPDELWNLTSLF 126
V ++T P I CDC+ +VC +T +++ N+ G+IP E NLT L
Sbjct: 63 -------FVAESTSKLPTSNITCDCTFNASSVCRVTNIQLRGFNLRGIIPPEFGNLTRLT 115
Query: 127 NLNLGQNYLTGPLSPSVGNLTAMQYLNLAINALSGELPKELGQLTELLILGIGTNNFSGP 186
++L N+L+G + P+ + ++ L + N LSG P +LGQ+T L + + +N F+G
Sbjct: 116 EIDLVLNFLSGTI-PTTLSQIPLEILAVTGNRLSGPFPPQLGQITTLTDVIMESNLFTGQ 174
Query: 187 LPSELGSLSKLQELYIDSAGVSGEIPSSFANLQSLTKWWASDTRLTGRIPDFIGNWSKLT 246
LP LG+L L+ L I S ++G IP S +NL++LT + L+G+IPDFIGNW++L
Sbjct: 175 LPPNLGNLRSLKRLLISSNNITGRIPESLSNLKNLTNFRIDGNSLSGKIPDFIGNWTRLV 234
Query: 247 ALRFQGNSFNGPIPSSFSNLTSVTELRISDLSNGSSKLAFIRDMKSLSILELRNNNISDS 306
L QG S GPIP+S SNL ++TELRI+DL +S +++M ++ L LRN I +
Sbjct: 235 RLDLQGTSMEGPIPASISNLKNLTELRITDLRGPTSPFPDLQNMTNMERLVLRNCLIREP 294
Query: 307 IPSNIGEYRS-LQHLDLSFNNLGGSIPDSLFNLSSLTHLFLGNNKLNGTLPARKSPLLLN 365
IP IG + L+ LDLS N L G+IPD+ +L++ ++L NN L G +P N
Sbjct: 295 IPEYIGTSMTMLKLLDLSSNMLNGTIPDTFRSLNAFNFMYLNNNSLTGPVPQFILDSKQN 354
Query: 366 IDVSYNNLQGNLPSWINGQQNLQINLVANNLTIRSSDNSVLPRGLICLQRNFPCNRGYAI 425
ID+SYNN P ++ Q L +NL+++ ++ ++NSV CL+++ PC G A
Sbjct: 355 IDLSYNNFTQ--PPTLSCNQ-LDVNLISSYPSV--TNNSVQ----WCLRKDLPC-PGDAH 404
Query: 426 YADFAIKSGGPQIRSSNGVVYERDNATLGPATYYVTDSNKWGVSNVGLFTGSNNPQYKSS 485
++ I GG +++ Y D G +T+ S +WG S+ G + G++ Y ++
Sbjct: 405 HSSLFINCGGNRLKVDKDE-YADDLNKRGASTFSSV-SERWGYSSSGAWLGNDGATYLAT 462
Query: 486 SLSQFTNTLDSELFQTARLSASSLRYYGLGLENGNYTVLLQFAEMAILDTNRWESLGRRV 545
N E ++TARL++ SL+YYGL + G+Y V L FAE+ + + SLGRR+
Sbjct: 463 DTFNLINESTPEYYKTARLASQSLKYYGLCMRRGSYKVQLYFAEIMFSNDQTYSSLGRRL 522
Query: 546 FDVYIQGNRVLKDFDIKREAGGVSKRAIQREIKTRVSENYLEIHLFWAGKGTCCVPAQGT 605
FD+Y+QG + +DF+I + AGGV K +++ + +V+ + LEIHL W GKGT +P +G
Sbjct: 523 FDIYVQGILLERDFNIAQRAGGVGKPFLRQVDEVQVNGSTLEIHLKWTGKGTNVIPTRGV 582
Query: 606 YGPSISAIRVTPDFTPTVRPPKEKDNNRTGLIVGIVVGVGVATFLSVLAIFCIVRRRKRP 665
YGP ISAI VTP+F P G++ GIV+ VA L VL I +
Sbjct: 583 YGPLISAITVTPNFKVDTGKPLSN-----GVVAGIVIAACVAFGLLVLVILRLTGYLGGK 637
Query: 666 QHDDDEELLGMDARPYTFSYAELKTATENFSPSNKLGEGGFGPVYKGKLGDGRAIAVKQL 725
+ D++EEL G+D + +F+ ++K AT NF P NK+GEGGFGPVYKG L DG IAVKQL
Sbjct: 638 EVDENEELRGLDLQTGSFTLKQIKRATNNFDPENKIGEGGFGPVYKGVLADGMTIAVKQL 697
Query: 726 SVASRQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLVYEYLENKSLDQALFG--Q 783
S S+QG +FV EI ISA+QH NLVKL+GCCIEG E LLVYEYLEN SL +ALFG +
Sbjct: 698 SSKSKQGNREFVTEIGMISALQHPNLVKLYGCCIEGKELLLVYEYLENNSLARALFGTEK 757
Query: 784 RSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKL 843
+ L LDW+TR ++C G+A+GLAYLHEESR++I+HRD+KA+NVLLD L KISDFGLAKL
Sbjct: 758 QRLHLDWSTRNKVCIGIAKGLAYLHEESRLKIVHRDIKATNVLLDLSLNAKISDFGLAKL 817
Query: 844 YDDKKTHISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEK 903
+++ THISTR+AGTIGY+APEYAMRG+LT+K DV++FGV+ LE VSG+ N++ EE
Sbjct: 818 DEEENTHISTRIAGTIGYMAPEYAMRGYLTDKADVYSFGVVCLEIVSGKSNTNYRPKEEF 877
Query: 904 LYLLEWAWHLHENNQEIELADPKL-IEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVAM 962
+YLL+WA+ L E +EL DP L F+++E R++ +ALLCT P+LRP MS VV+M
Sbjct: 878 IYLLDWAYVLQEQGSLLELVDPDLGTSFSKKEAMRMLNIALLCTNPSPTLRPPMSSVVSM 937
Query: 963 LCGDMEVSTVTAK----PGYLTDWKFDDITSFVRTDEATKGTDTSHYTSSSSTSI 1013
L G ++V K P +F + + E+ T T + SS+S+
Sbjct: 938 LQGKIKVQPPLVKREADPSGSAAMRFKALEHLSQDSESQVSTYTRNKEHKSSSSM 992
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGE0|Y1765_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g07650 OS=Arabidopsis thaliana GN=At1g07650 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 698 bits (1801), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 400/956 (41%), Positives = 582/956 (60%), Gaps = 37/956 (3%)
Query: 40 EVRALNSIFQQWRISARQGQWNRSGDPCTGAALDDSIVFDNTDYNPFIKCDCS--SQNGT 97
EVRAL I ++ + W+ + DPC+G + + I CDCS QN +
Sbjct: 34 EVRALKEIGKKLG----KKDWDFNKDPCSGEGTWIVTTYTTKGFESNITCDCSFLPQNSS 89
Query: 98 VCHITQLKVYALNVVGVIPDELWNLTSLFNLNLGQNYLTGPLSPSVGNLTAMQYLNLAIN 157
CH+ ++ + + N+ G++P E L L L+L +N LTG + ++ ++ L+ N
Sbjct: 90 -CHVIRIALKSQNLTGIVPPEFSKLRHLKVLDLSRNSLTGSIPKEWASMR-LEDLSFMGN 147
Query: 158 ALSGELPKELGQLTELLILGIGTNNFSGPLPSELGSLSKLQELYIDSAGVSGEIPSSFAN 217
LSG PK L +LT L L + N FSGP+P ++G L L++L++ S +G +
Sbjct: 148 RLSGPFPKVLTRLTMLRNLSLEGNQFSGPIPPDIGQLVHLEKLHLPSNAFTGPLTEKLGL 207
Query: 218 LQSLTKWWASDTRLTGRIPDFIGNWSKLTALRFQGNSFNGPIPSSFSNLTSVTELRISDL 277
L++LT SD TG IPDFI NW+++ L+ G +GPIPSS S+LTS+T+LRISDL
Sbjct: 208 LKNLTDMRISDNNFTGPIPDFISNWTRILKLQMHGCGLDGPIPSSISSLTSLTDLRISDL 267
Query: 278 SNGSSKLAFIRDMKSLSILELRNNNISDSIPSNIGEYRSLQHLDLSFNNLGGSIPDSLFN 337
S +++++S+ L LR I IP IG+ + L+ LDLSFN L G IP S N
Sbjct: 268 GGKPSSFPPLKNLESIKTLILRKCKIIGPIPKYIGDLKKLKTLDLSFNLLSGEIPSSFEN 327
Query: 338 LSSLTHLFLGNNKLNGTLPARKSPLLLNIDVSYNNL--QGNLPSWINGQQNLQINLVANN 395
+ ++L NKL G +P N+DVS+NN + ++PS N V +N
Sbjct: 328 MKKADFIYLTGNKLTGGVPNYFVERNKNVDVSFNNFTDESSIPSH-------DCNRVTSN 380
Query: 396 LTIRSSDNSVLPRGLICLQRNFPC--NRGYAIYADFAIKSGGPQIRSSNGVVYERDNATL 453
L + + +G C + PC + Y +Y + I GG +++ + Y+ D+
Sbjct: 381 LVESFALGNKSHKGSTCFLQRMPCVHPKRYHLYKLY-INCGGGEVKVDKEITYQADDEPK 439
Query: 454 GPATYYVTDSNKWGVSNVGLFTGSNNP--QYKSSSLSQFTNTLDSE---LFQTARLSASS 508
G + Y + + +W +S+ G F +++ +Y + S+ + S L++TAR+S S
Sbjct: 440 GASMYVLGANKRWALSSTGNFMDNDDDADEYTVQNTSRLSVNASSPSFGLYRTARVSPLS 499
Query: 509 LRYYGLGLENGNYTVLLQFAEMAILDTNRWESLGRRVFDVYIQGNRVLKDFDIKREAGGV 568
L YYG+ L NGNYTV L FAE+ D N SLG+R+FD+Y+Q V+K+F+I+ A G
Sbjct: 500 LTYYGICLGNGNYTVNLHFAEIIFTDDNTLYSLGKRLFDIYVQDQLVIKNFNIQEAARG- 558
Query: 569 SKRAIQREIKTRVSENYLEIHLFWAGKGTCCVPAQGTYGPSISAIRVTPDFTPTVRPPKE 628
S + I + V+++ L+I L WAGKGT +P +G YGP ISAI V P+F +PP
Sbjct: 559 SGKPIIKSFLVNVTDHTLKIGLRWAGKGTTGIPIRGVYGPMISAISVEPNF----KPPVY 614
Query: 629 KDNNRTGLIVGIVVGVGVATFLSVLAIFCIVRRRKRPQHDDDEELLGMDARPYTFSYAEL 688
D L VG+ V ++ +F +++R ++D D+EL G+D + TF+ ++
Sbjct: 615 YDTKDIILKVGVPVAAATLLLFIIVGVFW---KKRRDKNDIDKELRGLDLQTGTFTLRQI 671
Query: 689 KTATENFSPSNKLGEGGFGPVYKGKLGDGRAIAVKQLSVASRQGKSQFVAEIATISAVQH 748
K AT+NF + K+GEGGFG VYKG+L +G+ IAVKQLS SRQG +FV EI ISA+QH
Sbjct: 672 KAATDNFDVTRKIGEGGFGSVYKGELSEGKLIAVKQLSAKSRQGNREFVNEIGMISALQH 731
Query: 749 RNLVKLHGCCIEGAERLLVYEYLENKSLDQALFGQRS---LTLDWATRYEICSGVARGLA 805
NLVKL+GCC+EG + +LVYEYLEN L +ALFG+ L LDW+TR +I G+A+GL
Sbjct: 732 PNLVKLYGCCVEGNQLILVYEYLENNCLSRALFGKDESSRLKLDWSTRKKIFLGIAKGLT 791
Query: 806 YLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVAGTIGYLAPE 865
+LHEESR++I+HRD+KASNVLLD DL KISDFGLAKL DD THISTR+AGTIGY+APE
Sbjct: 792 FLHEESRIKIVHRDIKASNVLLDKDLNAKISDFGLAKLNDDGNTHISTRIAGTIGYMAPE 851
Query: 866 YAMRGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEIELADP 925
YAMRG+LTEK DV++FGV+ALE VSG+ N++ E+ +YLL+WA+ L E +EL DP
Sbjct: 852 YAMRGYLTEKADVYSFGVVALEIVSGKSNTNFRPTEDFVYLLDWAYVLQERGSLLELVDP 911
Query: 926 KLI-EFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVAMLCGDMEVSTVTAKPGYLT 980
L +++EEE ++ VAL+CT P+LRP+MS+VV+++ G + + + P + T
Sbjct: 912 TLASDYSEEEAMLMLNVALMCTNASPTLRPTMSQVVSLIEGKTAMQELLSDPSFST 967
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGN2|Y3148_ARATH Probable leucine-rich repeat receptor-like serine/threonine-protein kinase At3g14840 OS=Arabidopsis thaliana GN=LRR-RLK PE=1 SV=1 | Back alignment and function description |
|---|
Score = 697 bits (1799), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 412/972 (42%), Positives = 579/972 (59%), Gaps = 43/972 (4%)
Query: 14 LCFVCLFVHFCLCQAQNRTQATTDPNEVRALNSIFQQWRISARQGQWNRSGDPCTGAALD 73
L F F+ + + + AT EV AL S+ + ++ WN S DPC +
Sbjct: 7 LLFTYYFIVSLILFSDFVSSATLPKEEVDALQSV----ATALKKSNWNFSVDPCDETLSE 62
Query: 74 DSIVFDNT--DYNPFIKCDCSSQNGTVCHITQLKVYALNVVGVIPDELWNLTSLFNLNLG 131
N + + C+CSS +CH+T + + A ++ G +P +L L L L+L
Sbjct: 63 GGWRNPNAAKGFEDAVTCNCSS---VICHVTNIVLKAQDLQGSLPTDLSGLPFLQELDLT 119
Query: 132 QNYLTGPLSPSVGNLTAMQYLNLAI--NALSGELPKELGQLTELLILGIGTNNFSGPLPS 189
+NYL G + P G A LN+++ N +SG +PKELG LT L L + N SG +P
Sbjct: 120 RNYLNGSIPPEWG---ASSLLNISLLGNRISGSIPKELGNLTTLSGLVLEYNQLSGKIPP 176
Query: 190 ELGSLSKLQELYIDSAGVSGEIPSSFANLQSLTKWWASDTRLTGRIPDFIGNWSKLTALR 249
ELG+L L+ L + S +SGEIPS+FA L +LT SD + TG IPDFI NW L L
Sbjct: 177 ELGNLPNLKRLLLSSNNLSGEIPSTFAKLTTLTDLRISDNQFTGAIPDFIQNWKGLEKLV 236
Query: 250 FQGNSFNGPIPSSFSNLTSVTELRISDLSNGSSKLAFIRDMKSLSILELRNNNISDSIPS 309
Q + GPIPS+ L ++T+LRI+DLS S +R+M S+ L LRN N++ +P+
Sbjct: 237 IQASGLVGPIPSAIGLLGTLTDLRITDLSGPESPFPPLRNMTSMKYLILRNCNLTGDLPA 296
Query: 310 NIGEYRSLQHLDLSFNNLGGSIPDSLFNLSSLTHLFLGNNKLNGTLPARKSPLLLNIDVS 369
+G+ R L++LDLSFN L G IP + LS + ++ +N LNG +P+ ID++
Sbjct: 297 YLGQNRKLKNLDLSFNKLSGPIPATYSGLSDVDFIYFTSNMLNGQVPSWMVDQGDTIDIT 356
Query: 370 YNNLQGNLPSWINGQQNLQINLVANNLTIRSSDNSVLPRGLICLQRNFPCNRGYAIYADF 429
YNN + Q +N ++ + ++++S + CL + + C + +
Sbjct: 357 YNNFSKDKTEEC---QQKSVNTFSSTSPLVANNSS----NVSCLSK-YTCPK---TFYGL 405
Query: 430 AIKSGGPQIRSSNGVVYERDNATLGPATYYVTDSNKWGVSNVGLF-----TGSNNPQYKS 484
I GG +I +SN Y+ D T YY N W SN G F T + ++ +
Sbjct: 406 HINCGGNEI-TSNETKYDAD--TWDTPGYY-DSKNGWVSSNTGNFLDDDRTNNGKSKWSN 461
Query: 485 SSLSQFTNT-LDSELFQTARLSASSLRYYGLGLENGNYTVLLQFAEMAILDTNRWESLGR 543
SS + TN+ +D L+ ARLSA SL Y L L GNYTV L FAE+ + N + +LGR
Sbjct: 462 SSELKITNSSIDFRLYTQARLSAISLTYQALCLGKGNYTVNLHFAEIMFNEKNMYSNLGR 521
Query: 544 RVFDVYIQGNRVLKDFDIKREAGGVSKRAIQREIKTRVSENYLEIHLFWAGKGTCCVPAQ 603
R FD+Y+QG R +KDF+I EA GV K A+ ++ V+ LEI L WAGKGT +P +
Sbjct: 522 RYFDIYVQGKREVKDFNIVDEAKGVGK-AVVKKFPVMVTNGKLEIRLQWAGKGTQAIPVR 580
Query: 604 GTYGPSISAIRVTPDFTPTVRPPKEKDNNRTGLIVGIVVGVGVATFLSVLAIFCIVRRRK 663
G YGP ISA+ V PDF P + P + + + + FL VL I I+ R
Sbjct: 581 GVYGPLISAVSVDPDFIPP-KEPGTGTGGGSSVGTVVGSVIASTVFL-VLLIGGILWWRG 638
Query: 664 --RPQHDDDEELLGMDARPYTFSYAELKTATENFSPSNKLGEGGFGPVYKGKLGDGRAIA 721
RP+ +++ +D + +FS ++K AT+NF P+NK+GEGGFGPV+KG + DG IA
Sbjct: 639 CLRPKSQMEKDFKNLDFQISSFSLRQIKVATDNFDPANKIGEGGFGPVHKGIMTDGTVIA 698
Query: 722 VKQLSVASRQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLVYEYLENKSLDQALF 781
VKQLS S+QG +F+ EIA ISA+QH +LVKL+GCC+EG + LLVYEYLEN SL +ALF
Sbjct: 699 VKQLSAKSKQGNREFLNEIAMISALQHPHLVKLYGCCVEGDQLLLVYEYLENNSLARALF 758
Query: 782 G--QRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFG 839
G + + L+W R +IC G+ARGLAYLHEESR++I+HRD+KA+NVLLD +L PKISDFG
Sbjct: 759 GPQETQIPLNWPMRQKICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKELNPKISDFG 818
Query: 840 LAKLYDDKKTHISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRPNSDPSL 899
LAKL +++ THISTRVAGT GY+APEYAMRGHLT+K DV++FGV+ALE V G+ N+
Sbjct: 819 LAKLDEEENTHISTRVAGTYGYMAPEYAMRGHLTDKADVYSFGVVALEIVHGKSNTSSRS 878
Query: 900 DEEKLYLLEWAWHLHENNQEIELADPKL-IEFNEEEVKRLIGVALLCTQTLPSLRPSMSR 958
+ YLL+W L E N +E+ DP+L ++N++E +I + +LCT P RPSMS
Sbjct: 879 KADTFYLLDWVHVLREQNTLLEVVDPRLGTDYNKQEALMMIQIGMLCTSPAPGDRPSMST 938
Query: 959 VVAMLCGDMEVS 970
VV+ML G V+
Sbjct: 939 VVSMLEGHSTVN 950
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGG7|Y1534_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g53420 OS=Arabidopsis thaliana GN=At1g53420 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 654 bits (1688), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 378/894 (42%), Positives = 516/894 (57%), Gaps = 55/894 (6%)
Query: 89 CDCSSQNGTVCHITQLKVYALNVVGVIPDELWNLTSLFNLNLGQNYLTGPLSPSVGNLTA 148
C+ SS I++ + N+ G +P EL L L ++L +NYL G + P G L
Sbjct: 54 CEVSSTGNEWSTISR-NLKRENLQGSLPKELVGLPLLQEIDLSRNYLNGSIPPEWGVLPL 112
Query: 149 MQYLNLAINALSGELPKELGQLTELLILGIGTNNFSGPLPSELGSLSKLQELYIDSAGVS 208
+ L N L+G +PKE G +T L L + N SG LP ELG+L +Q++ + S +
Sbjct: 113 VNIWLLG-NRLTGPIPKEFGNITTLTSLVLEANQLSGELPLELGNLPNIQQMILSSNNFN 171
Query: 209 GEIPSSFANLQSLTKWWASDTRLTGRIPDFIGNWSKLTALRFQGNSFNGPIPSSFSNLTS 268
GEIPS+FA L +L + SD +L+G IPDFI W+KL L Q + GPIP + ++L
Sbjct: 172 GEIPSTFAKLTTLRDFRVSDNQLSGTIPDFIQKWTKLERLFIQASGLVGPIPIAIASLVE 231
Query: 269 VTELRISDLSNGSSKLAFIRDMKSLSILELRNNNISDSIPSNIGEYRSLQHLDLSFNNLG 328
+ +LRISDL+ S +R++K + L LRN N++ +P +G+ S + LDLSFN L
Sbjct: 232 LKDLRISDLNGPESPFPQLRNIKKMETLILRNCNLTGDLPDYLGKITSFKFLDLSFNKLS 291
Query: 329 GSIPDSLFNLSSLTHLFLGNNKLNGTLPARKSPLLLNIDVSYNNLQGNLPSWINGQQNLQ 388
G+IP++ NL +++ N LNG++P ID+SYNN
Sbjct: 292 GAIPNTYINLRDGGYIYFTGNMLNGSVPDWMVNKGYKIDLSYNNF--------------- 336
Query: 389 INLVANNLTIRSSDNSVLPRGLICLQRN-FPCNRGYAIYADF---AIKSGGPQIRSSNGV 444
SV P +C N C R Y F I GG ++ S NG
Sbjct: 337 ---------------SVDPTNAVCKYNNVLSCMRNYQCPKTFNALHINCGGDEM-SINGT 380
Query: 445 VYERDNATLGPATYYVTDSNKWGVSNVGLFTGSNNPQYKSS--SLSQFTNTLDSELFQTA 502
+YE D + Y N W +NVG+F + + + S S N +D L+ A
Sbjct: 381 IYESDKYDRLESWY--ESRNGWFSNNVGVFVDDKHVPERVTIESNSSELNVVDFGLYTQA 438
Query: 503 RLSASSLRYYGLGLENGNYTVLLQFAEMAILDTNRWESLGRRVFDVYIQGNRVLKDFDIK 562
R+SA SL YY L LENGNY V L FAE+ N ++SLGRR FD+YIQ +KDF+I
Sbjct: 439 RISAISLTYYALCLENGNYNVNLHFAEIMFNGNNNYQSLGRRFFDIYIQRKLEVKDFNIA 498
Query: 563 REAGGVSKRAIQREIKTRVSENYLEIHLFWAGKGTCCVPAQGTYGPSISAIRVTPDFTPT 622
+EA V I + + + LEI L+WAG+GT +P + YGP ISAI V P+
Sbjct: 499 KEAKDVGNVVI-KTFPVEIKDGKLEIRLYWAGRGTTVIPKERVYGPLISAISVDSSVNPS 557
Query: 623 VRPPKEKDNNRTGLIVGIVVGVGVATFLSVLAIFCIVRRRK--RPQHDDDEELLGMDARP 680
R + TG + +VV + + V +F + ++ R + +++ ++
Sbjct: 558 PR-----NGMSTGTLHTLVV---ILSIFIVFLVFGTLWKKGYLRSKSQMEKDFKSLELMI 609
Query: 681 YTFSYAELKTATENFSPSNKLGEGGFGPVYKGKLGDGRAIAVKQLSVASRQGKSQFVAEI 740
+FS ++K AT NF +N++GEGGFGPVYKGKL DG IAVKQLS S+QG +F+ EI
Sbjct: 610 ASFSLRQIKIATNNFDSANRIGEGGFGPVYKGKLFDGTIIAVKQLSTGSKQGNREFLNEI 669
Query: 741 ATISAVQHRNLVKLHGCCIEGAERLLVYEYLENKSLDQALFG--QRSLTLDWATRYEICS 798
ISA+ H NLVKL+GCC+EG + LLVYE++EN SL +ALFG + L LDW TR +IC
Sbjct: 670 GMISALHHPNLVKLYGCCVEGGQLLLVYEFVENNSLARALFGPQETQLRLDWPTRRKICI 729
Query: 799 GVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVAGT 858
GVARGLAYLHEESR++I+HRD+KA+NVLLD L PKISDFGLAKL ++ THISTR+AGT
Sbjct: 730 GVARGLAYLHEESRLKIVHRDIKATNVLLDKQLNPKISDFGLAKLDEEDSTHISTRIAGT 789
Query: 859 IGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQ 918
GY+APEYAMRGHLT+K DV++FG++ALE V GR N YL++W L E N
Sbjct: 790 FGYMAPEYAMRGHLTDKADVYSFGIVALEIVHGRSNKIERSKNNTFYLIDWVEVLREKNN 849
Query: 919 EIELADPKL-IEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVAMLCGDMEVST 971
+EL DP+L E+N EE +I +A++CT + P RPSMS VV ML G V
Sbjct: 850 LLELVDPRLGSEYNREEAMTMIQIAIMCTSSEPCERPSMSEVVKMLEGKKMVEV 903
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FXF2|RKF1_ARATH Probable LRR receptor-like serine/threonine-protein kinase RFK1 OS=Arabidopsis thaliana GN=RKF1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 626 bits (1615), Expect = e-178, Method: Compositional matrix adjust.
Identities = 365/905 (40%), Positives = 533/905 (58%), Gaps = 42/905 (4%)
Query: 87 IKCDCSSQNGTVCHITQLKVYALNVVGVIPDELWNLTSLFNLNLGQNYLTGPLSPSVGNL 146
I+C+CS N T CH+ + N+ G +P ++ L L ++L NY+ G L P
Sbjct: 88 IECECSPTNDTDCHVVKFAFKDHNLPGTLP-QIVKLPYLREIDLAYNYINGTL-PREWAS 145
Query: 147 TAMQYLNLAINALSGELPKELGQLTELLILGIGTNNFSGPLPSELGSLSKLQELYIDSAG 206
+ + +++L +N LSGE+PKE G + L L + +N FSG +P ELG+L L++L + S
Sbjct: 146 SNLTFISLLVNRLSGEIPKEFGN-SSLTYLDLESNAFSGTIPQELGNLVHLKKLLLSSNK 204
Query: 207 VSGEIPSSFANLQSLTKWWASDTRLTGRIPDFIGNWSKLTALRFQGNSFNGPIPSSFSNL 266
++G +P+S A LQ++T + +D +L+G IP +I NW +L L + GPIPS S L
Sbjct: 205 LTGTLPASLARLQNMTDFRINDLQLSGTIPSYIQNWKQLERLEMIASGLTGPIPSVISVL 264
Query: 267 TSVTELRISDLSNGSSKLAFIRDMKSLSILELRNNNISDSIPSNIGEYRSLQHLDLSFNN 326
+++ LRISD+ ++++ L+ + L+N NIS IP+ + + L+ LDLSFN
Sbjct: 265 SNLVNLRISDIRGPVQPFPSLKNVTGLTKIILKNCNISGQIPTYLSHLKELETLDLSFNK 324
Query: 327 LGGSIPDSLFNLSSLTHLFLGNNKLNGTLPARKSPLLLNIDVSYNNLQGNLPSWINGQQN 386
L G IP S +L + L N L G P + +D+SYNNL+ P + N
Sbjct: 325 LVGGIP-SFAQAENLRFIILAGNMLEGDAPDELLRDGITVDLSYNNLKWQSPESRACRPN 383
Query: 387 LQINLVANNLTIRSSDNSVLPRGLICLQRNFPCNRGYAIYADFAIKSGGPQI---RSSNG 443
+ +NL T + LP C+ ++F C R + + GG +
Sbjct: 384 MNLNLNLFQSTSTKKSSKFLP----CI-KDFKCPRYSSC---LHVNCGGSDMYVKEKKTK 435
Query: 444 VVYERD-NATLGPATYYVTDSNKWGVSNVGLFTGSNNPQYKSSSLSQFTNTLD-SELFQT 501
+YE D N G A Y++ WG S+ G F NN ++++ + F + S+L+++
Sbjct: 436 ELYEGDGNVEGGAAKYFLKPDANWGFSSTGDFMDDNN--FQNTRFTMFVPASNQSDLYKS 493
Query: 502 ARLSASSLRYYGLGLENGNYTVLLQFAEMAILDTNRWESLGRRVFDVYIQGNRVLKDFDI 561
AR++ SL Y+ LENGNYT+ L FAE+ + + LGRR+FD+YIQ V KDF+I
Sbjct: 494 ARIAPVSLTYFHACLENGNYTINLDFAEIRFTNDENYNRLGRRLFDIYIQEKLVAKDFNI 553
Query: 562 KREAGGVSKRAIQREIKTRVSENYLEIHLFWAGKGTCCVPAQGTYGPSISAIRVTPDFTP 621
EA G ++ I + + V+ ++L I L WAGKGT +P +G YGP ISAI + D P
Sbjct: 554 MDEAKG-AQTPIIKPLTAYVTNHFLTIRLSWAGKGTTRIPTRGVYGPIISAISIVSDSKP 612
Query: 622 TVRPPKEKDNNRTGLIVGIVVGVGVAT------FLSVLAIFCIVRRRKRPQHDDDEELLG 675
RP +TG+ G + +G+ L L I + R R + D EE L
Sbjct: 613 CERP-------KTGMSPGAYIAIGIGAPCLIIFILGFLWICGCLPRCGRQRKDPYEEELP 665
Query: 676 MDARPYTFSYAELKTATENFSPSNKLGEGGFGPVYKGKLGDGRAIAVKQLSVASRQGKSQ 735
TF+ ++K AT++F+P+NK+GEGGFG V+KG L DGR +AVKQLS SRQG +
Sbjct: 666 SG----TFTLRQIKFATDDFNPTNKIGEGGFGAVFKGVLADGRVVAVKQLSSKSRQGNRE 721
Query: 736 FVAEIATISAVQHRNLVKLHGCCIEGAERLLVYEYLENKSLDQALFG--QRSLTLDWATR 793
F+ EI IS +QH NLVKLHG C+E A+ LL YEY+EN SL ALF + + +DW TR
Sbjct: 722 FLNEIGAISCLQHPNLVKLHGFCVERAQLLLAYEYMENNSLSSALFSPKHKQIPMDWPTR 781
Query: 794 YEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHIST 853
++IC G+A+GLA+LHEES ++ +HRD+KA+N+LLD DL PKISDFGLA+L +++KTHIST
Sbjct: 782 FKICCGIAKGLAFLHEESPLKFVHRDIKATNILLDKDLTPKISDFGLARLDEEEKTHIST 841
Query: 854 RVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHL 913
+VAGTIGY+APEYA+ G+LT K DV++FGVL LE V+G NS+ + + LLE+A
Sbjct: 842 KVAGTIGYMAPEYALWGYLTFKADVYSFGVLVLEIVAGITNSNFMGAGDSVCLLEFANEC 901
Query: 914 HENNQEIELADPKL-IEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVAMLCGDMEVSTV 972
E+ +++ D +L E + +E + +I VAL+C+ P+ RP MS VVAML G V
Sbjct: 902 VESGHLMQVVDERLRPEVDRKEAEAVIKVALVCSSASPTDRPLMSEVVAMLEGLYPVPES 961
Query: 973 TAKPG 977
T PG
Sbjct: 962 T--PG 964
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ASQ6|Y1972_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g29720 OS=Arabidopsis thaliana GN=RFK1 PE=2 SV=3 | Back alignment and function description |
|---|
Score = 622 bits (1605), Expect = e-177, Method: Compositional matrix adjust.
Identities = 409/980 (41%), Positives = 553/980 (56%), Gaps = 68/980 (6%)
Query: 62 RSGDPCTGAALDDSIVFD---NTDYNPFIKCDCSSQNGTVCHITQLKVYALNVVGVIPDE 118
R DPC+ L D N D N I CDCS N T+C IT+L + +++ G +P E
Sbjct: 54 RDEDPCSSKTLKIIQEVDFVPNLDINNTIGCDCSFNNNTICRITELALKTMSLRGKLPPE 113
Query: 119 LWNLTSLFNLNLGQNYLTGPLSPSVGNLTAMQYLNLAINALSGELPKELGQLTELLILGI 178
L L L ++ L +NYL+G + + + +++ N LSG LP L L LG+
Sbjct: 114 LTKLPYLKSIELCRNYLSGTIPMEWAKMAYLTSISVCANNLSGNLPAGLQNFKNLTFLGV 173
Query: 179 GTNNFSGPLPSELGSLSKLQELYIDSAGVSGEIPSSFANLQSLTKWWASDTRLTGRIPDF 238
N FSGP+P ELG+L+ L L + S +G +P + A L +L + D TG IP +
Sbjct: 174 EGNQFSGPIPDELGNLTSLTGLELASNKFTGILPGTLARLVNLERVRICDNNFTGIIPAY 233
Query: 239 IGNWSKLTALRFQGNSFNGPIPSSFSNLTSVTELRISDLSNGSSKLAFIRDMKSLSILEL 298
IGNW++L L + GPIP + L ++ EL +SD + G + K L L L
Sbjct: 234 IGNWTRLQKLHLYASGLTGPIPDAVVRLENLLELSLSD-TTGIKSFPNLSS-KGLKRLIL 291
Query: 299 RNNNISDSIPSNIGEYRSLQHLDLSFNNLGGSIPDSLFNLSSLTHLFLGNNKLNGTLPAR 358
RN +S IPS I L+ LDLSFN L G I + N +++L N L+G +
Sbjct: 292 RNVGLSGPIPSYIWNLTDLKILDLSFNKLNG-IVQGVQNPPK--NIYLTGNLLSGNI--- 345
Query: 359 KSPLLLN----IDVSYNNLQGNLPSWINGQQN------LQINLVANNLTIRSSDNSVLPR 408
+S LLN ID+SYNN SW + Q Q + NNLT
Sbjct: 346 ESGGLLNSQSYIDLSYNNF-----SWSSSCQKGSTINTYQSSYSKNNLT----------- 389
Query: 409 GLICLQRNFPCNRGYAIYADF-AIKSGGPQ--IRSSNG-VVYERDNATLGPATYYVTDSN 464
GL C + Y F I GG + IR+S G + Y+ DN+ A SN
Sbjct: 390 GLPPCAVPANCKK----YQRFLHINCGGEEVSIRNSLGKITYQTDNSRQTNAA-----SN 440
Query: 465 K----WGVSNVGLFTGSNNPQYKSSSLSQFTNTLD-SELFQTARLSASSLRYYGLGLENG 519
+ WGVSN G FT N+ + + + T + D +L++TAR SA SL YY LENG
Sbjct: 441 QQFDYWGVSNTGDFTDDNSDHDEYYTSTNLTLSGDYPDLYKTARRSALSLVYYAFCLENG 500
Query: 520 NYTVLLQFAEMAILDTNRWESLGRRVFDVYIQGNRVLKDFDIKREAGGVSKRAIQREIKT 579
NY V L F E+ D + LGRR+FDVY+QG L+DF+I +EA G K I +EI
Sbjct: 501 NYNVKLHFMEIQFSDKEVYSRLGRRIFDVYVQGKLFLRDFNINKEANGNMKPVI-KEINA 559
Query: 580 RVSENYLEIHLFWAGKGTCCVPAQGTYGPSISAIRVTPDFTPTVRPPKEKDNNRTGLIVG 639
V+ + LEI L+WAGKGT +P +G YGP ISAI + P K K + + LI+G
Sbjct: 560 TVTNHMLEIRLYWAGKGTTLIPKRGNYGPLISAISLCHSQEPLCGVEKTKHHIKYPLILG 619
Query: 640 IVVGVGVATFLSVLAIFCIVRR-RKRPQHDDDEELLGMDARPYTFSYAELKTATENFSPS 698
G + +LA+ R +R + + +L + FS+ +L+TAT NF +
Sbjct: 620 ---ASGALVTIVLLAVGIYARGIYRRDNNRRERDLRAQGLQTVCFSWRQLQTATNNFDQA 676
Query: 699 NKLGEGGFGPVYKGKLGDGRAIAVKQLSVASRQGKSQFVAEIATISAVQHRNLVKLHGCC 758
NKLGEGGFG V+KG+L DG IAVKQLS S QG +FV EI IS + H NLVKL+GCC
Sbjct: 677 NKLGEGGFGSVFKGELSDGTIIAVKQLSSKSSQGNREFVNEIGMISGLNHPNLVKLYGCC 736
Query: 759 IEGAERLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHR 818
+E + LLVYEY+EN SL ALFGQ SL LDWA R +IC G+ARGL +LH+ S +R++HR
Sbjct: 737 VERDQLLLVYEYMENNSLALALFGQNSLKLDWAARQKICVGIARGLEFLHDGSAMRMVHR 796
Query: 819 DVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVAGTIGYLAPEYAMRGHLTEKTDV 878
D+K +NVLLD DL KISDFGLA+L++ + THIST+VAGTIGY+APEYA+ G LTEK DV
Sbjct: 797 DIKTTNVLLDTDLNAKISDFGLARLHEAEHTHISTKVAGTIGYMAPEYALWGQLTEKADV 856
Query: 879 FAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEIELADPKLI-EFNEEEVKR 937
++FGV+A+E VSG+ N+ + + + L+ WA L + +E+ D L EFN E R
Sbjct: 857 YSFGVVAMEIVSGKSNTKQQGNADSVSLINWALTLQQTGDILEIVDRMLEGEFNRSEAVR 916
Query: 938 LIGVALLCTQTLPSLRPSMSRVVAMLCGDMEVSTVTAKPG-YLTDW---KFDDITSFVRT 993
+I VAL+CT + PSLRP+MS V ML G++E++ V + PG Y DW K DI + +
Sbjct: 917 MIKVALVCTNSSPSLRPTMSEAVKMLEGEIEITQVMSDPGIYGHDWSISKLRDIDT--HS 974
Query: 994 DEATKG-TDTSHYTSSSSTS 1012
+T G TD + T SS S
Sbjct: 975 SSSTSGVTDQTTTTMKSSVS 994
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O23081|CRK41_ARATH Cysteine-rich receptor-like protein kinase 41 OS=Arabidopsis thaliana GN=CRK41 PE=3 SV=2 | Back alignment and function description |
|---|
Score = 311 bits (796), Expect = 2e-83, Method: Compositional matrix adjust.
Identities = 156/349 (44%), Positives = 224/349 (64%), Gaps = 10/349 (2%)
Query: 625 PPKEKDNNRTGLIVGIVVGVGVATFLSVLAIFCIVRRRK----RPQHDDDEELLGMDARP 680
P + N++ +I+ V V ++V F + R R+ R + D EEL+ DA+
Sbjct: 270 PDPKPGNDKVKIIIATVCSVIGFAIIAVFLYFFMTRNRRTAKQRHEGKDLEELMIKDAQL 329
Query: 681 YTFSYAELKTATENFSPSNKLGEGGFGPVYKGKLGDGRAIAVKQLSVASRQGKSQFVAEI 740
+ ++ AT +FS N+LGEGGFG VYKG L G IAVK+LS+ S QG ++F+ E+
Sbjct: 330 LQLDFDTIRLATNDFSRDNQLGEGGFGAVYKGVLDYGEEIAVKRLSMKSGQGDNEFINEV 389
Query: 741 ATISAVQHRNLVKLHGCCIEGAERLLVYEYLENKSLDQALF-GQRSLTLDWATRYEICSG 799
+ ++ +QHRNLV+L G C++G ER+L+YE+ +N SLD +F R + LDW TRY I SG
Sbjct: 390 SLVAKLQHRNLVRLLGFCLQGEERILIYEFFKNTSLDHYIFDSNRRMILDWETRYRIISG 449
Query: 800 VARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYD---DKKTHISTRVA 856
VARGL YLHE+SR +I+HRD+KASNVLLD + PKI+DFG+AKL+D +T +++VA
Sbjct: 450 VARGLLYLHEDSRFKIVHRDMKASNVLLDDAMNPKIADFGMAKLFDTDQTSQTRFTSKVA 509
Query: 857 GTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHEN 916
GT GY+APEYAM G + KTDVF+FGVL LE + G+ N+ ++ L+LL + W
Sbjct: 510 GTYGYMAPEYAMSGEFSVKTDVFSFGVLVLEIIKGKKNNWSPEEDSSLFLLSYVWKSWRE 569
Query: 917 NQEIELADPKLIEF--NEEEVKRLIGVALLCTQTLPSLRPSMSRVVAML 963
+ + + DP L+E +E+ + I + LLC Q RP+M+ VV ML
Sbjct: 570 GEVLNIVDPSLVETIGVSDEIMKCIHIGLLCVQENAESRPTMASVVVML 618
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
Close Homologs in the Non-Redundant Database Detected by BLAST 
Original result of BLAST against Nonredundant Database
GI ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 1036 | ||||||
| 224096626 | 1036 | predicted protein [Populus trichocarpa] | 0.986 | 0.986 | 0.719 | 0.0 | |
| 359485959 | 1028 | PREDICTED: probable LRR receptor-like se | 0.978 | 0.986 | 0.719 | 0.0 | |
| 225447810 | 1031 | PREDICTED: probable LRR receptor-like se | 0.971 | 0.975 | 0.717 | 0.0 | |
| 255544644 | 1016 | ATP binding protein, putative [Ricinus c | 0.977 | 0.997 | 0.720 | 0.0 | |
| 296081493 | 2193 | unnamed protein product [Vitis vinifera] | 0.956 | 0.451 | 0.725 | 0.0 | |
| 449444258 | 1122 | PREDICTED: probable LRR receptor-like se | 0.984 | 0.909 | 0.690 | 0.0 | |
| 359485957 | 1031 | PREDICTED: probable LRR receptor-like se | 0.939 | 0.943 | 0.727 | 0.0 | |
| 356523547 | 1029 | PREDICTED: probable LRR receptor-like se | 0.988 | 0.995 | 0.682 | 0.0 | |
| 356526421 | 1034 | PREDICTED: probable LRR receptor-like se | 0.990 | 0.992 | 0.687 | 0.0 | |
| 15223460 | 1032 | putative LRR receptor-like serine/threon | 0.987 | 0.991 | 0.631 | 0.0 |
| >gi|224096626|ref|XP_002310677.1| predicted protein [Populus trichocarpa] gi|222853580|gb|EEE91127.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1527 bits (3954), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 740/1029 (71%), Positives = 869/1029 (84%), Gaps = 7/1029 (0%)
Query: 12 FALCFVCLFVHFCLCQAQNRTQATTDPNEVRALNSIFQQWRISARQGQWNRSGDPCTGAA 71
AL FVC+ + QAQN+TQATTDP+E RALNSIFQQW ISA QWN SGD C+GAA
Sbjct: 11 LALSFVCIIGLAAIAQAQNQTQATTDPDEARALNSIFQQWSISANTNQWNTSGDVCSGAA 70
Query: 72 LDDSIVFDNTDYNPFIKCDCSSQNGTVCHITQLKVYALNVVGVIPDELWNLTSLFNLNLG 131
S DNTD+NPFIKCDC+ NGT C IT LKVYA++V+G+IPDELW+L L NLNLG
Sbjct: 71 TGASPTIDNTDFNPFIKCDCTFLNGTTCRITALKVYAIDVIGLIPDELWSLKYLTNLNLG 130
Query: 132 QNYLTGPLSPSVGNLTAMQYLNLAINALSGELPKELGQLTELLILGIGTNNFSGPLPSEL 191
QNYLTG LSPS+GNLT MQYL + INALSGELPKELGQLT+L + G G+NNF+G LPS L
Sbjct: 131 QNYLTGNLSPSIGNLTRMQYLTIGINALSGELPKELGQLTDLRVFGFGSNNFNGSLPSAL 190
Query: 192 GSLSKLQELYIDSAGVSGEIPSSFANLQSLTKWWASDTRLTGRIPDFIGNWSKLTALRFQ 251
G+L KL+++Y DS+GVSGEIP++FANLQ+L WASD LTGRIPDFIGNWSKLT+LRF+
Sbjct: 191 GNLVKLEQIYFDSSGVSGEIPTTFANLQNLATVWASDNELTGRIPDFIGNWSKLTSLRFE 250
Query: 252 GNSFNGPIPSSFSNLTSVTELRISDLSNGSSKLAFIRDMKSLSILELRNNNISDSIPSNI 311
GN+F GPIPS FSNLT++T+LRISDLS+G S L FI++MKSLSIL LRN+NIS SIPS I
Sbjct: 251 GNAFEGPIPSVFSNLTNLTDLRISDLSDGGSSLEFIKNMKSLSILMLRNDNISASIPSYI 310
Query: 312 GEYRSLQHLDLSFNNLGGSIPDSLFNLSSLTHLFLGNNKLNGTLPARKSPLLLNIDVSYN 371
GE++SL LDLSFNN+ G IPDSLFNLSSLT+LFLGNNKLNGTLPA KS LLN+DVSYN
Sbjct: 311 GEFQSLTQLDLSFNNIEGQIPDSLFNLSSLTYLFLGNNKLNGTLPATKSSRLLNVDVSYN 370
Query: 372 NLQGNLPSWINGQQNLQINLVANNLTIRSSDNSVLPRGLICLQRNFPCNRGYAIYADFAI 431
NL G PSW++ + NL++NLVANN T+ +S+ S LP L CLQRNFPCNRG IY+ F I
Sbjct: 371 NLAGGFPSWVS-ETNLELNLVANNFTVVASNLSGLPSRLNCLQRNFPCNRGSPIYSQFGI 429
Query: 432 KSGGPQIRSSNGVVYERDNATLGPATYYVTDSNKWGVSNVGLFTGSNNPQYKSSSLSQFT 491
K GGP+I SSN V++ERDN +L A+YYV+D++ +GVSN G F+GSN+PQY +SS SQFT
Sbjct: 430 KCGGPEITSSNRVLFERDNTSLAAASYYVSDTSTFGVSNTGYFSGSNDPQYTTSSSSQFT 489
Query: 492 NTLDSELFQTARLSASSLRYYGLGLENGNYTVLLQFAEMAILDTNRWESLGRRVFDVYIQ 551
NTLDSELFQT+RLSASSLRYYGLGLENGNYT+ +QF E I + W+SLGRRVFDVYIQ
Sbjct: 490 NTLDSELFQTSRLSASSLRYYGLGLENGNYTITIQFTESVIFQGSTWKSLGRRVFDVYIQ 549
Query: 552 GNRVLKDFDIKREAGGVSKRAIQREIKTRVSENYLEIHLFWAGKGTCCVPAQGTYGPSIS 611
G+RVLKDFDI++ AGG+ +A+QRE K +V+ENYL+IH FWAGKGTCC+PAQGTYGPS+S
Sbjct: 550 GSRVLKDFDIQKAAGGIMNQAVQREFKVQVTENYLDIHFFWAGKGTCCIPAQGTYGPSVS 609
Query: 612 AIRVTPDFTPTVR---PPKEKDNNRTGLIVGIVVGVGVATFLSVLAIFCIVRRRKRPQHD 668
AI PDFTPTV P ++K NRTGLI GIVVGVG+ FL V A+F VRRRK ++
Sbjct: 610 AINAIPDFTPTVSNKLPSEKKKKNRTGLIAGIVVGVGIVGFLLVFAVF-FVRRRKGQSNN 668
Query: 669 DDEELLGMDARPYTFSYAELKTATENFSPSNKLGEGGFGPVYKGKLGDGRAIAVKQLSVA 728
D EE LG+DARPYTFSY ELKTATE+FS +NKLGEGGFGPV+KGKL DGR IAVKQLS+A
Sbjct: 669 DFEEFLGIDARPYTFSYGELKTATEDFSSANKLGEGGFGPVFKGKLNDGRVIAVKQLSIA 728
Query: 729 SRQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLVYEYLENKSLDQALFGQRSLTL 788
S QGK+QF+AEIATISAVQHRNLVKL+GCCIEGA RLLVYEYLENKSLDQA+FG++SL L
Sbjct: 729 SHQGKTQFIAEIATISAVQHRNLVKLYGCCIEGANRLLVYEYLENKSLDQAVFGEQSLNL 788
Query: 789 DWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKK 848
DW TRY+IC GVARGLAYLHEESR+RI+HRDVKASN+LLD +L+PKISDFGLAKLYDDKK
Sbjct: 789 DWPTRYDICLGVARGLAYLHEESRIRIVHRDVKASNILLDFNLIPKISDFGLAKLYDDKK 848
Query: 849 THISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLE 908
THISTRVAGTIGYLAPEYAMRGHLTEK DVFAFGV+ALE +SGRPNSD SL+ EK+YLLE
Sbjct: 849 THISTRVAGTIGYLAPEYAMRGHLTEKADVFAFGVVALEIISGRPNSDTSLETEKIYLLE 908
Query: 909 WAWHLHENNQEIELADPKLIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVAMLCGDME 968
WAW LHENN+++EL D +L EFNEEEV RLIGVALLCTQT P+LRPSMSRV+AML GD+E
Sbjct: 909 WAWDLHENNRQVELVDSRLSEFNEEEVNRLIGVALLCTQTAPTLRPSMSRVIAMLSGDIE 968
Query: 969 VSTVTAKPGYLTDWKFDDITSFVRTDEATKGTDTSHYTSSSSTSIVAEAEHLSRNG-KPL 1027
V++VT+KPGYLTDWKFDD ++++ +D+AT+ +DTSHY SS+ TS+V + LS P+
Sbjct: 969 VNSVTSKPGYLTDWKFDDTSTYM-SDDATRASDTSHYNSSTRTSLVNNPKDLSPTATDPI 1027
Query: 1028 LHDLVGEGR 1036
L D +G+GR
Sbjct: 1028 LRDTIGQGR 1036
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359485959|ref|XP_002267672.2| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At1g56130-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1498 bits (3877), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 750/1042 (71%), Positives = 852/1042 (81%), Gaps = 28/1042 (2%)
Query: 6 LPPVSGFALCFVCLF-------VHFCLCQAQNRTQATTDPNEVRALNSIFQQWRISARQG 58
+P + FV L+ H Q+ ATTDP+EV LNSIFQQW ISA
Sbjct: 4 MPGAQSVSWVFVALYGVYVIGLFHAAAAQS-TEANATTDPSEVTILNSIFQQWGISASN- 61
Query: 59 QWNRSGDPCTGAALDDSIVFDNTDYNPFIKCDCSSQNGTVCHITQLKVYALNVVGVIPDE 118
+WN SG+PCTGAALD + + NP IKCDCS N + CHITQLKVYAL+VVG IPDE
Sbjct: 62 EWNTSGEPCTGAALDSADI-----KNPGIKCDCSYDNASTCHITQLKVYALDVVGAIPDE 116
Query: 119 LWNLTSLFNLNLGQNYLTGPLSPSVGNLTAMQYLNLAINALSGELPKELGQLTELLILGI 178
LWNLT L NLNLGQNYLTG LS S+GNLT+MQYL+L INALSGELPKELGQLT+L +
Sbjct: 117 LWNLTFLTNLNLGQNYLTGSLSASIGNLTSMQYLSLGINALSGELPKELGQLTDLRSIAF 176
Query: 179 GTNNFSGPLPSELGSLSKLQELYIDSAGVSGEIPSSFANLQSLTKWWASDTRLTGRIPDF 238
GTNNFSG LPSELG+L KL++LY DS+G+SG+IPS+FANLQSLT WASD LTG IPDF
Sbjct: 177 GTNNFSGSLPSELGNLVKLEQLYFDSSGLSGDIPSTFANLQSLTTVWASDNELTGNIPDF 236
Query: 239 IGNWSKLTALRFQGNSFNGPIPSSFSNLTSVTELRISDLSNGSSK-LAFIRDMKSLSILE 297
IGNWSKLT LR QGNSF G IPSSFSNLTS+T+LRISD+SNGSS L FI+DMKSLS L
Sbjct: 237 IGNWSKLTVLRLQGNSFEGSIPSSFSNLTSLTDLRISDISNGSSSSLEFIKDMKSLSTLI 296
Query: 298 LRNNNISDSIPSNIGEYRSLQHLDLSFNNLGGSIPDSLFNLSSLTHLFLGNNKLNGTLPA 357
+RNNNISD+IPSNIGEY SL LDLSFNNL G +P+SLFNLS LT+LFLGNN+L G+LP+
Sbjct: 297 IRNNNISDAIPSNIGEYGSLTQLDLSFNNLSGQLPESLFNLSQLTYLFLGNNQLTGSLPS 356
Query: 358 RKSPLLLNIDVSYNNLQGNLPSWINGQQNLQINLVANNLTIRSSDNSVLPRGLICLQRNF 417
+KS LLNID+SYN L G+ PSW++ ++NLQ+NLVANN T+ SS++SVLP GL CLQ+NF
Sbjct: 357 QKSTSLLNIDLSYNGLSGSFPSWVD-EENLQLNLVANNFTLDSSNSSVLPSGLNCLQQNF 415
Query: 418 PCNRGYAIYADFAIKSGGPQIRSSNGVVYERDNATLGPATYYVTDSNKWGVSNVGLFTGS 477
PCNRG IY +FAIK GGPQI SS+ +V+ERDN TLGPATYYVTD N+W VSNVGLF+GS
Sbjct: 416 PCNRGSGIYYNFAIKCGGPQITSSDQIVFERDNETLGPATYYVTDENRWAVSNVGLFSGS 475
Query: 478 NNPQYKSSSLSQFTNTLDSELFQTARLSASSLRYYGLGLENGNYTVLLQFAEMAILDTNR 537
NNPQY S+S SQFTNTLDSELFQTAR+SA SLRYYGLGLENGNYT+ LQFAE AI+++N
Sbjct: 476 NNPQYTSTSSSQFTNTLDSELFQTARISAGSLRYYGLGLENGNYTLTLQFAETAIVNSNS 535
Query: 538 WESLGRRVFDVYIQGNRVLKDFDIKREAGGVSKRAIQREIKTRVSENYLEIHLFWAGKGT 597
W+SLGRRVFDVYIQG+ VLKDFDI++EAGGVS +A+++E +V ENY+EIHLFWAGKGT
Sbjct: 536 WKSLGRRVFDVYIQGDLVLKDFDIRKEAGGVSFQAVKKEFTAQVLENYIEIHLFWAGKGT 595
Query: 598 CCVPAQGTYGPSISAIRVTPDFTPTVR--PPKEKDNNRTGLIVGIVVGVGVATFLSVLAI 655
CCVPAQGTYGPSISAI TPDF PTV P K NRTGLIVGI VG+GV FLSV A+
Sbjct: 596 CCVPAQGTYGPSISAISATPDFEPTVSNTAPNGK-KNRTGLIVGIAVGLGVVCFLSVFAL 654
Query: 656 FCIVRRRKRPQHDDDEELLGMDARPYTFSYAELKTATENFSPSNKLGEGGFGPVYKGKLG 715
+ V RRK+P + DEELLGMDARPYTFSYAELK AT +FSPSNKLGEGGFGPVYKG L
Sbjct: 655 YYFVLRRKKPSENQDEELLGMDARPYTFSYAELKNATGDFSPSNKLGEGGFGPVYKGTLS 714
Query: 716 DGRAIAVKQLSVASRQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLVYEYLENKS 775
DGR +AVKQLSVAS QGK QFVAEIATISAVQHRNLVKL+GCCIEG R LVYEYLENKS
Sbjct: 715 DGRVVAVKQLSVASHQGKKQFVAEIATISAVQHRNLVKLYGCCIEGVNRSLVYEYLENKS 774
Query: 776 LDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKI 835
LDQALFG SL LDW TRY+IC GVARGLAYLHEESRVRI+HRDVKASN+LLD PKI
Sbjct: 775 LDQALFGNGSLDLDWPTRYDICLGVARGLAYLHEESRVRIVHRDVKASNILLDYHRNPKI 834
Query: 836 SDFGLAKLYDDKKTHISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRPNS 895
SDFGLAKLYDD KTHISTRVAGTIGYLAPEYAMRGHLTEK DVF FGV+ALE VSGRPNS
Sbjct: 835 SDFGLAKLYDDTKTHISTRVAGTIGYLAPEYAMRGHLTEKADVFGFGVVALEIVSGRPNS 894
Query: 896 DPSLDEEKLYLLEWAWHLHENNQEIELADPKLIEFNEEEVKRLIGVALLCTQTLPSLRPS 955
D SL+EEK YLLEWAW LHENN EIEL D +L EF+EEE +R+IGVALLCTQT P+LRP
Sbjct: 895 DTSLEEEKTYLLEWAWQLHENNHEIELVDSRLSEFSEEEARRMIGVALLCTQTSPTLRPP 954
Query: 956 MSRVVAMLCGDMEVSTVTAKPGYLTDWKFDDITSFVRTDEATKGTDTSHYTSSSSTSIVA 1015
MSR VAML GD+EVS VT KPGYLTDWKF+D +SF+ ++ SH+ SS+S S+ A
Sbjct: 955 MSRAVAMLSGDIEVSRVTTKPGYLTDWKFNDASSFM--------SENSHFNSSTSISMAA 1006
Query: 1016 EAEHLSRNG-KPLLHDLVGEGR 1036
+A+ K +H+++GEGR
Sbjct: 1007 DADRSPVTATKTKIHEIIGEGR 1028
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225447810|ref|XP_002267129.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At1g56130 [Vitis vinifera] gi|296081492|emb|CBI20015.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1478 bits (3826), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 742/1034 (71%), Positives = 849/1034 (82%), Gaps = 28/1034 (2%)
Query: 13 ALCFVCLFVHFCLCQAQN-RTQATTDPNEVRALNSIFQQWRISARQGQWNRSGDPCTGAA 71
ALC V + F + AQ ATTDP+EVR LNSIFQQW ISA QWN SG+PCTGAA
Sbjct: 16 ALCSVYVIGLFHIAVAQTTEANATTDPSEVRVLNSIFQQWGISASN-QWNTSGEPCTGAA 74
Query: 72 LDDSIVFDNTDYNPFIKCDCSSQNGTVCHITQLKVYALNVVGVIPDELWNLTSLFNLNLG 131
+D + + D++DYNP IKCDCS N + CHITQLKVYAL+VVGVIPDELWNLT L NLNLG
Sbjct: 75 IDSTSI-DSSDYNPGIKCDCSYDNASTCHITQLKVYALDVVGVIPDELWNLTFLTNLNLG 133
Query: 132 QNYLTGPLSPSVGNLTAMQYLNLAINALSGELPKELGQLTELLILGIGTNNFSGPLPSEL 191
QNYLTGPLS S+GNLT+MQYL++ INALSGELPKELGQLT+L L GTNNFSG LPSE+
Sbjct: 134 QNYLTGPLSASIGNLTSMQYLSMGINALSGELPKELGQLTDLRSLAFGTNNFSGSLPSEI 193
Query: 192 GSLSKLQELYIDSAGVSGEIPSSFANLQSLTKWWASDTRLTGRIPDFIGNWSKLTALRFQ 251
G+L KL++LY DS+GVSGEIPS+FANLQSLT WASD LTG IPDFIGNWSKLT LR Q
Sbjct: 194 GNLVKLEQLYFDSSGVSGEIPSTFANLQSLTTVWASDNELTGNIPDFIGNWSKLTVLRLQ 253
Query: 252 GNSFNGPIPSSFSNLTSVTELRISDLSNGSSK-LAFIRDMKSLSILELRNNNISDSIPSN 310
GNSF G IPSSFSNLTS+T+L +SD+SN SS L FI+DMK LS L LRNNNISDSIPSN
Sbjct: 254 GNSFEGAIPSSFSNLTSLTDLMVSDISNASSSSLEFIKDMKLLSTLVLRNNNISDSIPSN 313
Query: 311 IGEYRSLQHLDLSFNNLGGSIPDSLFNLSSLTHLFLGNNKLNGTLPARKSPLLLNIDVSY 370
IGEY SL LDLSFNNL G +P+SLFNLS L+ LFLGNN+L GTLP+ KS LLNID+SY
Sbjct: 314 IGEYGSLTQLDLSFNNLSGQLPESLFNLSQLSLLFLGNNQLTGTLPSLKSTSLLNIDLSY 373
Query: 371 NNLQGNLPSWINGQQNLQINLVANNLTIRSSDNSVLPRGLICLQRNFPCNRGYAIYADFA 430
N L G+ PSW++ ++NLQ+NLVANN T+ SS++SVLP GL CLQ+NFPCN+G IY +FA
Sbjct: 374 NGLSGSFPSWVD-EENLQLNLVANNFTLDSSNSSVLPSGLNCLQQNFPCNKGSGIYYNFA 432
Query: 431 IKSGGPQIRSSNGVVYERDNATLGPATYYVTDSNKWGVSNVGLFTGSNNPQYKSSSLSQF 490
IK GGPQI SS+ +V+ERDN TLGPATYYVTD+N+W VSNVGLF+GSNNPQY S S SQF
Sbjct: 433 IKCGGPQITSSDQIVFERDNETLGPATYYVTDTNRWAVSNVGLFSGSNNPQYTSRSSSQF 492
Query: 491 TNTLDSELFQTARLSASSLRYYGLGLENGNYTVLLQFAEMAILDTNRWESLGRRVFDVYI 550
TNTLDSELFQTAR+SA SLRYYGLGLENGNY + LQFAE AI+++N W+SLGRRVFD+YI
Sbjct: 493 TNTLDSELFQTARISAGSLRYYGLGLENGNYNLTLQFAETAIVNSNSWKSLGRRVFDIYI 552
Query: 551 QGNRVLKDFDIKREAGGVSKRAIQREIKTRVSENYLEIHLFWAGKGTCCVPAQGTYGPSI 610
QG+ VLKDFDI++EAGGVS +A+++E +V ENY+EIHLFWAGK TCCVPAQGTYGPSI
Sbjct: 553 QGDLVLKDFDIRKEAGGVSFQAVKKEFTAQVLENYIEIHLFWAGKRTCCVPAQGTYGPSI 612
Query: 611 SAIRVTPDFTPTV--RPPKEKDNNRTGLIVGIVVGVGVATFLSVLAIFCIVRRRKRPQHD 668
SAI TP+F PTV P K N TGLIVGI V +G+ FL+V +++ V RRK+P +
Sbjct: 613 SAISATPNFEPTVPNTAPNGK-KNWTGLIVGIAVALGLVCFLAVFSVYYFVLRRKKPYEN 671
Query: 669 DDEELLGMDARPYTFSYAELKTATENFSPSNKLGEGGFGPVYKGKLGDGRAIAVKQLSVA 728
DEELLGMDARPYTFSYAELK AT +FSPSNKLGEGGFGPVYKG L DGR +AVKQLSV+
Sbjct: 672 QDEELLGMDARPYTFSYAELKNATGDFSPSNKLGEGGFGPVYKGTLSDGRVVAVKQLSVS 731
Query: 729 SRQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLVYEYLENKSLDQALFGQRSLTL 788
S QGK+QFV EIATISAVQHRNLVKL+GCCIEG R LVYEYLENKSLDQALFG+ +L L
Sbjct: 732 SHQGKNQFVTEIATISAVQHRNLVKLYGCCIEGVNRSLVYEYLENKSLDQALFGEGNLDL 791
Query: 789 DWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKK 848
W TRY+IC GVARGLAYLHEESR+RI+HRDVKASN+LLD L PKISDFGLAKLYDD K
Sbjct: 792 VWPTRYDICLGVARGLAYLHEESRLRIVHRDVKASNILLDYYLNPKISDFGLAKLYDDTK 851
Query: 849 THISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLE 908
THISTRVAGTIGYLAPEYAMRGHLTEK DVF FGV+ALE VSGRPNSD SL+EEK YLLE
Sbjct: 852 THISTRVAGTIGYLAPEYAMRGHLTEKADVFGFGVVALEIVSGRPNSDTSLEEEKTYLLE 911
Query: 909 WAWHLHENNQEIELADPKLIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVAMLCGDME 968
WAW LHE N+EIEL D +L EF+EEE +R+IGVALLCTQT P+LRP MSRVVAML GD+E
Sbjct: 912 WAWQLHETNREIELVDSRLSEFSEEEARRMIGVALLCTQTSPTLRPPMSRVVAMLSGDIE 971
Query: 969 VSTVTAKPGYLTDWKFDDITSFVRTDEATKGTDTSHYTSSSSTSIVAEAEHLSRNGKPL- 1027
VS VT KPGYLTDWKF+D++SF+ S + +S SI E + R+ PL
Sbjct: 972 VSRVTTKPGYLTDWKFNDVSSFM-----------SENSDLNSPSISMEVD---RDSSPLT 1017
Query: 1028 -----LHDLVGEGR 1036
LH+++GEGR
Sbjct: 1018 VNKTELHEIIGEGR 1031
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255544644|ref|XP_002513383.1| ATP binding protein, putative [Ricinus communis] gi|223547291|gb|EEF48786.1| ATP binding protein, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 1475 bits (3819), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 749/1039 (72%), Positives = 857/1039 (82%), Gaps = 26/1039 (2%)
Query: 1 MLRRSLPPVSGFALCFVCLFVHFCLCQAQNRTQATTDPNEVRALNSIFQQWRISARQGQW 60
MLR S PV L VC+ VH AQN+TQAT DP+E RALNSIF+QW ISA Q QW
Sbjct: 1 MLRDSFLPV--LLLYAVCVAVH-----AQNQTQATIDPDEGRALNSIFEQWGISAAQSQW 53
Query: 61 NRSGDPCTGAALDDSIVFDNTDYNPFIKCDCSSQNGTVCHITQLKVYALNVVGVIPDELW 120
N SG+ C+GAAL S D+ YNPFIKCDCS NGT CHIT LKV+A++VVGV+PDEL
Sbjct: 54 NISGELCSGAALGTSPTIDDQAYNPFIKCDCSDNNGTTCHITALKVFAIDVVGVLPDEL- 112
Query: 121 NLTSLFNLNLGQNYLTGPLSPSVGNLTAMQYLNLAINALSGELPKELGQLTELLILGIGT 180
NLGQN+LTG LSPS+GNLT MQYLN IN+LSGELPKELG LT+L +G G+
Sbjct: 113 --------NLGQNFLTGNLSPSIGNLTRMQYLNFGINSLSGELPKELGLLTDLRSIGFGS 164
Query: 181 NNFSGPLPSELGSLSKLQELYIDSAGVSGEIPSSFANLQSLTKWWASDTRLTGRIPDFIG 240
NNFSGPLPSELG+ ++L ++Y DS+GVSGEIP +FANL+++ WASD LTGRIPDFIG
Sbjct: 165 NNFSGPLPSELGNCTRLDQIYFDSSGVSGEIPPTFANLRNMVTVWASDNELTGRIPDFIG 224
Query: 241 NWSKLTALRFQGNSFNGPIPSSFSNLTSVTELRISDLSNGSSKLAFIRDMKSLSILELRN 300
NWSKL LR +GNSF GPIPS+ SNL+S+TELRIS LSNGSS LAFIRDM SL++L LRN
Sbjct: 225 NWSKLATLRLEGNSFEGPIPSALSNLSSLTELRISGLSNGSSSLAFIRDMTSLTVLVLRN 284
Query: 301 NNISDSIPSNIGEYRSLQHLDLSFNNLGGSIPDSLFNLSSLTHLFLGNNKLNGTLPARKS 360
NNISDSIPSNIG+Y++L LDLSFNN+ G IP+ LFNLS L+ LFLGNNKL+G LPA+KS
Sbjct: 285 NNISDSIPSNIGDYQNLTQLDLSFNNITGQIPEPLFNLSKLSFLFLGNNKLDGPLPAQKS 344
Query: 361 PLLLNIDVSYNNLQGNLPSWINGQQNLQINLVANNLTIRSSDNSVLPRGLICLQRNFPCN 420
L NIDVSYNNL G+ PSW++ QNLQ+NLVANN I S++SVLP GL CLQRNFPC
Sbjct: 345 SSLQNIDVSYNNLSGSFPSWVS-DQNLQVNLVANNFIIDLSNSSVLPSGLNCLQRNFPCI 403
Query: 421 RGYAIYADFAIKSGGPQIRSSNGVVYERDNATLGPATYYVTDSNKWGVSNVGLFTGSNNP 480
RG +Y+ FA K GGPQI SSN +VYERDN TLGPA YYVT +++WGVSNVG FTGS+NP
Sbjct: 404 RGPPVYSQFAAKCGGPQITSSNNIVYERDNETLGPAAYYVTGTSRWGVSNVGYFTGSSNP 463
Query: 481 QYKSSSLSQFTNTLDSELFQTARLSASSLRYYGLGLENGNYTVLLQFAEMAILDTNRWES 540
QY + S SQFTNTLDSELFQTAR+SASSLRYYGLGLENGNYTV LQFAE+ I D N W S
Sbjct: 464 QYIAFSSSQFTNTLDSELFQTARVSASSLRYYGLGLENGNYTVNLQFAEIVIEDGNTWRS 523
Query: 541 LGRRVFDVYIQGNRVLKDFDIKREAGGVSKRAIQREIKTRVSENYLEIHLFWAGKGTCCV 600
LGRRVFD+Y+QGN VLKDFDIK+EAGGVSK ++R +VSENYLEIHLFWAGKGTCC+
Sbjct: 524 LGRRVFDIYVQGNLVLKDFDIKKEAGGVSKLPVERSFTAQVSENYLEIHLFWAGKGTCCI 583
Query: 601 PAQGTYGPSISAIRVTPDFTPTVR---PPKEKDNNRTGLIVGIVVGVGVATFLSVLAIFC 657
P QGTYGPSISAI TPDF PTV P +KD RTGL+VGIVVGV +FL V IF
Sbjct: 584 PFQGTYGPSISAISATPDFIPTVSNILPTSKKD--RTGLVVGIVVGV-GISFLLVFVIFF 640
Query: 658 IVRRRKRPQHDDDEELLGMDARPYTFSYAELKTATENFSPSNKLGEGGFGPVYKGKLGDG 717
+V+RRKR DDEELLG++A TFSYAELKTATE+FSP+NKLGEGGFGPVYKGKL DG
Sbjct: 641 VVQRRKRKNTYDDEELLGIEAD--TFSYAELKTATEDFSPANKLGEGGFGPVYKGKLNDG 698
Query: 718 RAIAVKQLSVASRQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLVYEYLENKSLD 777
R IAVKQLSVAS QGKSQFV EIATISAVQHRNLVKLHGCCIEG RLLVYEYLENKSLD
Sbjct: 699 RVIAVKQLSVASHQGKSQFVTEIATISAVQHRNLVKLHGCCIEGYNRLLVYEYLENKSLD 758
Query: 778 QALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISD 837
QALFG+ +L LDW TRY+IC GVARGLAYLHEESR+RI+HRDVKASN+LLD+DL+PKISD
Sbjct: 759 QALFGETNLNLDWQTRYDICLGVARGLAYLHEESRLRIVHRDVKASNILLDSDLIPKISD 818
Query: 838 FGLAKLYDDKKTHISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRPNSDP 897
FGLAKLYDDKKTHISTRVAGTIGYLAPEYAMRGHLTEK DVFAFGV+ LE +SGRPNSD
Sbjct: 819 FGLAKLYDDKKTHISTRVAGTIGYLAPEYAMRGHLTEKADVFAFGVVVLELISGRPNSDS 878
Query: 898 SLDEEKLYLLEWAWHLHENNQEIELADPKLIEFNEEEVKRLIGVALLCTQTLPSLRPSMS 957
SL+EEK+YLLEWAW+LHENN+E+EL D KL +F+EEEV RL VALLCTQT P+LRPSMS
Sbjct: 879 SLEEEKIYLLEWAWYLHENNRELELVDVKLSDFSEEEVIRLTRVALLCTQTSPNLRPSMS 938
Query: 958 RVVAMLCGDMEVSTVTAKPGYLTDWKFDDITSFVRTDEATKGTDTSHYTSSSSTSIVAEA 1017
RVVAM+ GD EV +V++KPGYLT WKFDD ++F D TKGTDTS Y SS+ST++VA+A
Sbjct: 939 RVVAMVSGDTEVGSVSSKPGYLTGWKFDD-STFTSDDNVTKGTDTSFYDSSTSTTMVADA 997
Query: 1018 EHLSRNGKPLLHDLVGEGR 1036
+ + +P+L +++GEGR
Sbjct: 998 KQPELSTRPILSEIIGEGR 1016
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|296081493|emb|CBI20016.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1473 bits (3814), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 743/1024 (72%), Positives = 842/1024 (82%), Gaps = 33/1024 (3%)
Query: 16 FVCLFVHFCLCQAQNRTQATTDPNEVRALNSIFQQWRISARQGQWNRSGDPCTGAALDDS 75
+V H Q+ ATTDP+EV LNSIFQQW ISA +WN SG+PCTGAALD +
Sbjct: 87 YVIGLFHAAAAQS-TEANATTDPSEVTILNSIFQQWGISASN-EWNTSGEPCTGAALDSA 144
Query: 76 IVFDNTDYNPFIKCDCSSQNGTVCHITQLKVYALNVVGVIPDELWNLTSLFNLNLGQNYL 135
+ NP IKCDCS N + CHITQLKVYAL+VVG IPDELWNLT L NLNLGQNYL
Sbjct: 145 DI-----KNPGIKCDCSYDNASTCHITQLKVYALDVVGAIPDELWNLTFLTNLNLGQNYL 199
Query: 136 TGPLSPSVGNLTAMQYLNLAINALSGELPKELGQLTELLILGIGTNNFSGPLPSELGSLS 195
TG LS S+GNLT+MQYL+L INALSGELPKELGQLT+L + GTNNFSG LPSELG+L
Sbjct: 200 TGSLSASIGNLTSMQYLSLGINALSGELPKELGQLTDLRSIAFGTNNFSGSLPSELGNLV 259
Query: 196 KLQEL----------YIDSAGVSGEIPSSFANLQSLTKWWASDTRLTGRIPDFIGNWSKL 245
KL++L Y DS+G+SG+IPS+FANLQSLT WASD LTG IPDFIGNWSKL
Sbjct: 260 KLEQLICCYCLTNQCYFDSSGLSGDIPSTFANLQSLTTVWASDNELTGNIPDFIGNWSKL 319
Query: 246 TALRFQGNSFNGPIPSSFSNLTSVTELRISDLSNGSSK-LAFIRDMKSLSILELRNNNIS 304
T LR QGNSF G IPSSFSNLTS+T+LRISD+SNGSS L FI+DMKSLS L +RNNNIS
Sbjct: 320 TVLRLQGNSFEGSIPSSFSNLTSLTDLRISDISNGSSSSLEFIKDMKSLSTLIIRNNNIS 379
Query: 305 DSIPSNIGEYRSLQHLDLSFNNLGGSIPDSLFNLSSLTHLFLGNNKLNGTLPARKSPLLL 364
D+IPSNIGEY SL LDLSFNNL G +P+SLFNLS LT+LFLGNN+L G+LP++KS LL
Sbjct: 380 DAIPSNIGEYGSLTQLDLSFNNLSGQLPESLFNLSQLTYLFLGNNQLTGSLPSQKSTSLL 439
Query: 365 NIDVSYNNLQGNLPSWINGQQNLQINLVANNLTIRSSDNSVLPRGLICLQRNFPCNRGYA 424
NID+SYN L G+ PSW++ ++NLQ+NLVANN T+ SS++SVLP GL CLQ+NFPCNRG
Sbjct: 440 NIDLSYNGLSGSFPSWVD-EENLQLNLVANNFTLDSSNSSVLPSGLNCLQQNFPCNRGSG 498
Query: 425 IYADFAIKSGGPQIRSSNGVVYERDNATLGPATYYVTDSNKWGVSNVGLFTGSNNPQYKS 484
IY +FAIK GGPQI SS+ +V+ERDN TLGPATYYVTD N+W VSNVGLF+GSNNPQY S
Sbjct: 499 IYYNFAIKCGGPQITSSDQIVFERDNETLGPATYYVTDENRWAVSNVGLFSGSNNPQYTS 558
Query: 485 SSLSQFTNTLDSELFQTARLSASSLRYYGLGLENGNYTVLLQFAEMAILDTNRWESLGRR 544
+S SQFTNTLDSELFQTAR+SA SLRYYGLGLENGNYT+ LQFAE AI+++N W+SLGRR
Sbjct: 559 TSSSQFTNTLDSELFQTARISAGSLRYYGLGLENGNYTLTLQFAETAIVNSNSWKSLGRR 618
Query: 545 VFDVYIQGNRVLKDFDIKREAGGVSKRAIQREIKTRVSENYLEIHLFWAGKGTCCVPAQG 604
VFDVYIQG+ VLKDFDI++EAGGVS +A+++E +V ENY+EIHLFWAGKGTCCVPAQG
Sbjct: 619 VFDVYIQGDLVLKDFDIRKEAGGVSFQAVKKEFTAQVLENYIEIHLFWAGKGTCCVPAQG 678
Query: 605 TYGPSISAIRVTPDFTPTVR--PPKEKDNNRTGLIVGIVVGVGVATFLSVLAIFCIVRRR 662
TYGPSISAI TPDF PTV P K NRTGLIVGI VG+GV FLSV A++ V RR
Sbjct: 679 TYGPSISAISATPDFEPTVSNTAPNGK-KNRTGLIVGIAVGLGVVCFLSVFALYYFVLRR 737
Query: 663 KRPQHDDDEELLGMDARPYTFSYAELKTATENFSPSNKLGEGGFGPVYKGKLGDGRAIAV 722
K+P + DEELLGMDARPYTFSYAELK AT +FSPSNKLGEGGFGPVYKG L DGR +AV
Sbjct: 738 KKPSENQDEELLGMDARPYTFSYAELKNATGDFSPSNKLGEGGFGPVYKGTLSDGRVVAV 797
Query: 723 KQLSVASRQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLVYEYLENKSLDQALFG 782
KQLSVAS QGK QFVAEIATISAVQHRNLVKL+GCCIEG R LVYEYLENKSLDQALFG
Sbjct: 798 KQLSVASHQGKKQFVAEIATISAVQHRNLVKLYGCCIEGVNRSLVYEYLENKSLDQALFG 857
Query: 783 Q--RSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGL 840
+ SL LDW TRY+IC GVARGLAYLHEESRVRI+HRDVKASN+LLD PKISDFGL
Sbjct: 858 KGNGSLDLDWPTRYDICLGVARGLAYLHEESRVRIVHRDVKASNILLDYHRNPKISDFGL 917
Query: 841 AKLYDDKKTHISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRPNSDPSLD 900
AKLYDD KTHISTRVAGTIGYLAPEYAMRGHLTEK DVF FGV+ALE VSGRPNSD SL+
Sbjct: 918 AKLYDDTKTHISTRVAGTIGYLAPEYAMRGHLTEKADVFGFGVVALEIVSGRPNSDTSLE 977
Query: 901 EEKLYLLEWAWHLHENNQEIELADPKLIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVV 960
EEK YLLEWAW LHENN EIEL D +L EF+EEE +R+IGVALLCTQT P+LRP MSR V
Sbjct: 978 EEKTYLLEWAWQLHENNHEIELVDSRLSEFSEEEARRMIGVALLCTQTSPTLRPPMSRAV 1037
Query: 961 AMLCGDMEVSTVTAKPGYLTDWKFDDITSFVRTDEATKGTDTSHYTSSSSTSIVAEAEHL 1020
AML GD+EVS VT KPGYLTDWKF+D +SF+ ++ SH+ SS+S S+ A+A+ L
Sbjct: 1038 AMLSGDIEVSRVTTKPGYLTDWKFNDASSFM--------SENSHFNSSTSISMAADAD-L 1088
Query: 1021 SRNG 1024
++N
Sbjct: 1089 AKNA 1092
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449444258|ref|XP_004139892.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At1g56130-like [Cucumis sativus] gi|449493071|ref|XP_004159184.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At1g56130-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 1429 bits (3698), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 711/1030 (69%), Positives = 843/1030 (81%), Gaps = 10/1030 (0%)
Query: 12 FALCFVCLFVHFCLC--QAQNRTQATTDPNEVRALNSIFQQWRISARQGQWNRSGDPCTG 69
F LC + V + QAQN Q TDP++ RALNS+F+QWRISA G WN SG+ C+G
Sbjct: 98 FVLCAIVSIVSHLIVSSQAQNSPQPITDPDQARALNSVFRQWRISAPSGAWNISGNLCSG 157
Query: 70 AALDDSIVFD-NTDYNPFIKCDCSSQNGTVCHITQLKVYALNVVGVIPDELWNLTSLFNL 128
A+D + D N + NP IKCDCS+ T C ITQL VYA+NVVGV+P ELW LTSL L
Sbjct: 158 RAVDTTTPIDTNGNLNPLIKCDCSANGSTTCLITQLHVYAMNVVGVLPPELWTLTSLTYL 217
Query: 129 NLGQNYLTGPLSPSVGNLTAMQYLNLAINALSGELPKELGQLTELLILGIGTNNFSGPLP 188
L QN+LTG LS S+G L+ ++ L+L INALSGELPKELG L++L +L G+NNFSGPLP
Sbjct: 218 KLDQNFLTGTLSSSIGALSELRTLSLGINALSGELPKELGSLSKLELLAFGSNNFSGPLP 277
Query: 189 SELGSLSKLQELYIDSAGVSGEIPSSFANLQSLTKWWASDTRLTGRIPDFIGNWSKLTAL 248
SELG+LS L+ELYIDS+GVSG IP SF+ L++L WASD TGRIPDFIGNW++LT+L
Sbjct: 278 SELGNLSVLRELYIDSSGVSGGIPPSFSRLRNLQIVWASDNEFTGRIPDFIGNWTRLTSL 337
Query: 249 RFQGNSFNGPIPSSFSNLTSVTELRISDLSNGSSKLAFIRDMKSLSILELRNNNISDSIP 308
RFQGNSF GPIPS+FSNLTS+TELRI DLSNGSS LAFI M SL+IL LRNNNI+ SIP
Sbjct: 338 RFQGNSFTGPIPSTFSNLTSLTELRIGDLSNGSSSLAFISKMTSLTILVLRNNNITGSIP 397
Query: 309 SNIGEYRSLQHLDLSFNNLGGSIPDSLFNLSSLTHLFLGNNKLNGTLPARKSPLLLNIDV 368
SNIGE+R L LDLSFNNL G IP SLF+LSSL+HL LGNNKLNGTLP +KS LLNID+
Sbjct: 398 SNIGEFRRLAQLDLSFNNLTGEIPSSLFSLSSLSHLILGNNKLNGTLPTQKSVSLLNIDL 457
Query: 369 SYNNLQGNLPSWINGQQNLQINLVANNLTIRSSDNSVLPRGLICLQRNFPCNRGYAIYAD 428
SYN+L G+ P+WI+ Q+NLQ+NLVAN TI SS++ VLP GL CLQRNFPCNRG +Y+D
Sbjct: 458 SYNDLSGSFPAWID-QENLQLNLVANIFTIESSNSRVLPSGLNCLQRNFPCNRGRPLYSD 516
Query: 429 FAIKSGGPQIRSSNGVVYERDNATLGPATYYVTDSNKWGVSNVGLFTGSNNPQYKSSSLS 488
F IK GGPQIRSS+GV++ER+N LGPATY+VT+S +W VSN G FTG++NP Y +S++S
Sbjct: 517 FGIKCGGPQIRSSSGVLFERENMALGPATYFVTESQRWAVSNTGYFTGTSNPNYTASTMS 576
Query: 489 QFTNTLDSELFQTARLSASSLRYYGLGLENGNYTVLLQFAEMAILDTNRWESLGRRVFDV 548
QF+NTL+SELFQT R+SASSLRYYGLGLENGNYTV L FAE+A ++N W+SLGRR+FD+
Sbjct: 577 QFSNTLESELFQTQRISASSLRYYGLGLENGNYTVNLHFAEIAFPNSNTWQSLGRRLFDI 636
Query: 549 YIQGNRVLKDFDIKREAGGVSKRAIQREIKTRVSENYLEIHLFWAGKGTCCVPAQGTYGP 608
YIQGNRVL++FDI++EAGG S A+ R V+EN+LEIHLFWAGKGTCC+P QG +GP
Sbjct: 637 YIQGNRVLQNFDIRKEAGG-SFLALTRNFTAEVTENFLEIHLFWAGKGTCCIPRQGDFGP 695
Query: 609 SISAIRVTPDFTPTVR--PPKEKDNNRTGLIVGIVVGVGVATFLSVLAIFCIVRRRKRPQ 666
++SAI TP+F PTV PP K RTGLIVG+VVG+G FL V A+F +V+RRKR +
Sbjct: 696 AVSAISATPNFVPTVSNVPPTTKVT-RTGLIVGLVVGLGSVFFLIVGAVFFVVQRRKRRR 754
Query: 667 HDDDEELLGMDARPYTFSYAELKTATENFSPSNKLGEGGFGPVYKGKLGDGRAIAVKQLS 726
+DEELLG+D RPYTFSY+EL+ AT +F+ SNKLGEGGFGPVYKG L DGR +AVKQLS
Sbjct: 755 AYEDEELLGIDIRPYTFSYSELRDATNDFNSSNKLGEGGFGPVYKGTLNDGRVVAVKQLS 814
Query: 727 VASRQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLVYEYLENKSLDQALFGQRSL 786
VAS QGKSQFVAEIATISAVQHRNLVKL+GCCIE +RLLVYE+LENKSLDQ+LFGQ+
Sbjct: 815 VASHQGKSQFVAEIATISAVQHRNLVKLYGCCIEADKRLLVYEFLENKSLDQSLFGQKHF 874
Query: 787 TLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDD 846
+DW TR+EIC GVARGL YLHEESR+RI+HRDVKASN+LLD +L+PKISDFGLAKLYDD
Sbjct: 875 VIDWPTRFEICVGVARGLTYLHEESRLRIVHRDVKASNILLDGNLIPKISDFGLAKLYDD 934
Query: 847 KKTHISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYL 906
KKTHISTRVAGTIGYLAPEYAMRGHLTEK DVF FGV+ALE VSGRPNSDPSLD++K+YL
Sbjct: 935 KKTHISTRVAGTIGYLAPEYAMRGHLTEKADVFGFGVVALEIVSGRPNSDPSLDQDKIYL 994
Query: 907 LEWAWHLHENNQEIELADPKLIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVAMLCGD 966
LEWAW+LHENN E+E+ D L EF +EEVKR+IGVALLCTQT P LRPSMSRVVAML GD
Sbjct: 995 LEWAWYLHENNCELEMVDSALSEFRKEEVKRVIGVALLCTQTSPGLRPSMSRVVAMLSGD 1054
Query: 967 MEVSTVTAKPGYLTDWKFDDITSFVRTDEATKGTDTSHYTSSSSTSIVAEAEHLSRNGKP 1026
+EV+TVT+KPGYLTDWKF+DITSF+ T +T+ DT Y S+SS SI+ + +P
Sbjct: 1055 IEVATVTSKPGYLTDWKFEDITSFIDT-PSTEEPDTGRYASTSS-SIIDTKRSPANPSEP 1112
Query: 1027 LLHDLVGEGR 1036
+L L+GEGR
Sbjct: 1113 MLRGLLGEGR 1122
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359485957|ref|XP_002267620.2| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At1g56130-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1425 bits (3688), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 715/983 (72%), Positives = 818/983 (83%), Gaps = 10/983 (1%)
Query: 13 ALCFVCLFVHFCLCQAQN-RTQATTDPNEVRALNSIFQQWRISARQGQWNRSGDPCTGAA 71
ALC V + F + AQ ATTDP+EVR LNSIF+QW ISA QW G+PCTGAA
Sbjct: 16 ALCSVYVTGLFHIAAAQTTEANATTDPSEVRVLNSIFRQWGISASS-QWRTIGEPCTGAA 74
Query: 72 LDDSIVFDNTDYNPFIKCDCSSQNGTVCHITQLKVYALNVVGVIPDELWNLTSLFNLNLG 131
+D + + D+ DYN IKCDCS N + CHITQLKVYAL+VVGVIPDELWNLT L +LNLG
Sbjct: 75 IDSTSI-DSADYNFGIKCDCSYDNASTCHITQLKVYALDVVGVIPDELWNLTFLTSLNLG 133
Query: 132 QNYLTGPLSPSVGNLTAMQYLNLAINALSGELPKELGQLTELLILGIGTNNFSGPLPSEL 191
QNYLTGPLS S+GNLT+MQYL+L INALSGELPKELGQLT+L GTNNFSG LPSE+
Sbjct: 134 QNYLTGPLSASIGNLTSMQYLSLGINALSGELPKELGQLTDLRSFAFGTNNFSGSLPSEI 193
Query: 192 GSLSKLQELYIDSAGVSGEIPSSFANLQSLTKWWASDTRLTGRIPDFIGNWSKLTALRFQ 251
G+L KL++LY DS+GVSGEIPS+FANLQSLT WASD LTG IPDFIGNWSKLT LR Q
Sbjct: 194 GNLVKLEQLYFDSSGVSGEIPSTFANLQSLTIVWASDNELTGNIPDFIGNWSKLTVLRLQ 253
Query: 252 GNSFNGPIPSSFSNLTSVTELRISDLSNGSSK-LAFIRDMKSLSILELRNNNISDSIPSN 310
GNSF GPIPSSFSNLTS+T+LR+SD+SN SS L FI++MK LS L LRNNNISDSIPSN
Sbjct: 254 GNSFEGPIPSSFSNLTSLTDLRVSDISNASSSSLEFIKNMKLLSTLVLRNNNISDSIPSN 313
Query: 311 IGEYRSLQHLDLSFNNLGGSIPDSLFNLSSLTHLFLGNNKLNGTLPARKSPLLLNIDVSY 370
IGEY SL LDLSFNNL G +P+SLFNLS LT+LFLGNN+L GTLP+ KS LLNID+SY
Sbjct: 314 IGEYGSLTQLDLSFNNLSGQLPESLFNLSQLTYLFLGNNQLTGTLPSLKSTSLLNIDLSY 373
Query: 371 NNLQGNLPSWINGQQNLQINLVANNLTIRSSDNSVLPRGLICLQRNFPCNRGYAIYADFA 430
N L G+ PSW++ ++NLQ+NLVANN T+ SS++SVLP GL CLQ+NFPCNRG IY +FA
Sbjct: 374 NGLSGSFPSWVD-EENLQLNLVANNFTLDSSNSSVLPSGLNCLQQNFPCNRGSGIYYNFA 432
Query: 431 IKSGGPQIRSSNGVVYERDNATLGPATYYVTDSNKWGVSNVGLFTGSNNPQYKSSSLSQF 490
IK GGPQI SS+ +V+ERD+ TLGPATYYVTD+N+W SNVG F+GSNN SSSL F
Sbjct: 433 IKCGGPQITSSDQIVFERDSETLGPATYYVTDTNRWAFSNVGKFSGSNNYTSTSSSL--F 490
Query: 491 TNTLDSELFQTARLSASSLRYYGLGLENGNYTVLLQFAEMAILDTNRWESLGRRVFDVYI 550
TNTLDSELFQTAR+SA SLRYYGLGL+NGNYT+ LQFAE AI+++N W++LGRRVFD+YI
Sbjct: 491 TNTLDSELFQTARISAGSLRYYGLGLKNGNYTLTLQFAETAIVNSNSWKTLGRRVFDIYI 550
Query: 551 QGNRVLKDFDIKREAGGVSKRAIQREIKTRVSENYLEIHLFWAGKGTCCVPAQGTYGPSI 610
QG+ +LKDFDI++EAGGVS +A+++E +V ENY+EIHLFWAGKGTCCVPAQGTYGPSI
Sbjct: 551 QGDLILKDFDIRKEAGGVSFQAVKKEFTAQVLENYIEIHLFWAGKGTCCVPAQGTYGPSI 610
Query: 611 SAIRVTPDFTPTV--RPPKEKDNNRTGLIVGIVVGVGVATFLSVLAIFCIVRRRKRPQHD 668
SAI TP+F PTV P K +RTGLIVGI V +G+ FL+V +++ V RRK+P +
Sbjct: 611 SAISATPNFEPTVPNTAPNGK-KHRTGLIVGIAVALGLVCFLAVFSVYYFVLRRKKPYEN 669
Query: 669 DDEELLGMDARPYTFSYAELKTATENFSPSNKLGEGGFGPVYKGKLGDGRAIAVKQLSVA 728
DEELLGM+ARPYTFSYAELK AT +FSPSNKLGEGGFGPVYKG L DGR +AVKQLSV+
Sbjct: 670 QDEELLGMEARPYTFSYAELKNATGDFSPSNKLGEGGFGPVYKGTLSDGRVVAVKQLSVS 729
Query: 729 SRQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLVYEYLENKSLDQALFGQRSLTL 788
S QGK+QFV EI TISAVQHRNLVKL+GCCIEG R LVYEYLENKSLDQALFG+ +L L
Sbjct: 730 SHQGKNQFVTEIKTISAVQHRNLVKLYGCCIEGVNRSLVYEYLENKSLDQALFGEGNLDL 789
Query: 789 DWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKK 848
W TRY+IC GVARGLAYLHEESR+RI+HRDVKASN+LLD L PKISDFGLAKLYDD K
Sbjct: 790 VWQTRYDICLGVARGLAYLHEESRLRIVHRDVKASNILLDYYLNPKISDFGLAKLYDDTK 849
Query: 849 THISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLE 908
THISTRVAGTIGYLAPEYAMRGHLTEK DVF FGV+ALE VSGRPNSD SL+EEK YLLE
Sbjct: 850 THISTRVAGTIGYLAPEYAMRGHLTEKADVFGFGVVALEIVSGRPNSDTSLEEEKTYLLE 909
Query: 909 WAWHLHENNQEIELADPKLIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVAMLCGDME 968
WAW LHE N E+EL D L EF+EEE R+IGVALLCTQT P+LRP MS VVAML GD+E
Sbjct: 910 WAWQLHETNCELELVDSGLSEFSEEEATRMIGVALLCTQTSPTLRPPMSHVVAMLSGDIE 969
Query: 969 VSTVTAKPGYLTDWKFDDITSFV 991
VS VT KPGYLTDWKF+D +SF+
Sbjct: 970 VSRVTTKPGYLTDWKFNDASSFM 992
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356523547|ref|XP_003530399.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At1g56130-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1416 bits (3665), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 710/1041 (68%), Positives = 840/1041 (80%), Gaps = 17/1041 (1%)
Query: 1 MLRRSLPPVSGFALCFVCLFVHFCLCQAQNRTQATTDPNEVRALNSIFQQWRISARQGQW 60
M R L V FAL V+ Q+ N ATTDP+E RALNSIF++W I A W
Sbjct: 1 MARCILSHVLAFALVAALSLVNVAQSQSAN---ATTDPSEARALNSIFKKWDILANPTHW 57
Query: 61 NRSGDPCTGAALDDSIVFDNTDYNPFIKCDCSSQNGTVCHITQLKVYALNVVGVIPDELW 120
N SG+ CTG A+D S++ D+T +NP IKCDCS N T C IT LKVYA++VVG IP+ELW
Sbjct: 58 NISGELCTGRAIDTSLI-DDTTFNPLIKCDCSYDNRTTCRITALKVYAMSVVGTIPEELW 116
Query: 121 NLTSLFNLNLGQNYLTGPLSPSVGNLTAMQYLNLAINALSGELPKELGQLTELLILGIGT 180
LT L NLNLGQNYLTG L PS+ NLT +QYL+L IN +SGELPKELG LTEL +L G+
Sbjct: 117 TLTYLTNLNLGQNYLTGSLPPSIENLTRLQYLSLGINNISGELPKELGNLTELKLLAFGS 176
Query: 181 NNFSGPLPSELGSLSKLQELYIDSAGVSGEIPSSFANLQSLTKWWASDTRLTGRIPDFIG 240
N F G LPSELG L+ L+E++ DS+G+SG IPS+FANL++L + WASDT LTG+IPDFIG
Sbjct: 177 NKFRGSLPSELGKLTNLEEIHFDSSGISGLIPSTFANLRNLKQVWASDTELTGKIPDFIG 236
Query: 241 NWSKLTALRFQGNSFNGPIPSSFSNLTSVTELRISDLSNGSSKLAFIRDMKSLSILELRN 300
NWSKL +LRFQGNSFNG IPSSFSNL+S+TELRI+ LSNGSS L F+R+MKSL+ILEL+N
Sbjct: 237 NWSKLQSLRFQGNSFNGSIPSSFSNLSSLTELRITGLSNGSSSLEFLRNMKSLTILELKN 296
Query: 301 NNISDSIPSNIGEYRSLQHLDLSFNNLGGSIPDSLFNLSSLTHLFLGNNKLNGTLPARKS 360
NNIS IPS IGE +L LDLSFNN+ G S+FNLSSL+ LFLGNNK NGTLP +KS
Sbjct: 297 NNISGLIPSTIGELHNLNQLDLSFNNITGQNLGSIFNLSSLSFLFLGNNKFNGTLPMQKS 356
Query: 361 PLLLNIDVSYNNLQGNLPSWINGQQNLQINLVANNLTIRSSDNSVLPRGLICLQRNFPCN 420
P L+NID+SYN+L G+LP W+N + NLQ+NLVANNL + S+ LP GL CLQ+ FPCN
Sbjct: 357 PSLVNIDLSYNDLSGSLPPWVN-EPNLQLNLVANNLDV--SNAGGLPIGLNCLQKKFPCN 413
Query: 421 RGYAIYADFAIKSGGPQIRSSNGVVYERDNATLGPATYYVTDSNKWGVSNVGLFTGSNNP 480
+G Y+DFAIK GG QIRS++G+VYE DN TLGPATY+VTD+N+W VSNVGLF GS+NP
Sbjct: 414 QGVGRYSDFAIKGGGNQIRSADGIVYEMDNQTLGPATYFVTDANRWAVSNVGLFAGSSNP 473
Query: 481 QYKSSSLSQFTNTLDSELFQTARLSASSLRYYGLGLENGNYTVLLQFAEMAILDTNR-WE 539
YKS +QF T++ ELFQTARLSASSLRYYGLGLENG Y + LQFAE AILD+NR WE
Sbjct: 474 VYKSFVPNQFAGTVNPELFQTARLSASSLRYYGLGLENGFYNITLQFAETAILDSNRTWE 533
Query: 540 SLGRRVFDVYIQGNRVLKDFDIKREAGGVSKRAIQREIKTRVSENYLEIHLFWAGKGTCC 599
SLGRRVFD+YIQG RVLKDFDI++EAGG+S RAIQR+ + V+ENYLEIHLFWAGKGTCC
Sbjct: 534 SLGRRVFDIYIQGTRVLKDFDIQKEAGGISYRAIQRQFRFEVTENYLEIHLFWAGKGTCC 593
Query: 600 VPAQGTYGPSISAIRVTPDFTPTV--RPPKEKDNNRTGLIVGIVVGVGVATFLSVLAIFC 657
+P QGTYGP I AI PDF PTV +PP +NN GLI+GIV GVGV + LS+ AIF
Sbjct: 594 IPTQGTYGPLIQAIHAIPDFIPTVSNKPPSSSNNN-IGLILGIVFGVGVVSVLSIFAIFY 652
Query: 658 IVRRRKRPQHDDDEELLGMDARPYTFSYAELKTATENFSPSNKLGEGGFGPVYKGKLGDG 717
I+RRR+ + DD++ELLG+D +PYTFSY+ELK AT +F+ NKLGEGGFGPVYKG L DG
Sbjct: 653 IIRRRR--RRDDEKELLGIDTKPYTFSYSELKNATNDFNHENKLGEGGFGPVYKGTLNDG 710
Query: 718 RAIAVKQLSVASRQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLVYEYLENKSLD 777
RAIAVKQLSV S QGKSQF+ EIATISAVQHRNLVKL+GCCIEG++RLLVYEYLENKSLD
Sbjct: 711 RAIAVKQLSVGSHQGKSQFITEIATISAVQHRNLVKLYGCCIEGSKRLLVYEYLENKSLD 770
Query: 778 QALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISD 837
QALFG + LTL+W+TRY+IC GVARGL YLHEESR+RI+HRDVKASN+LLD +L+PKISD
Sbjct: 771 QALFG-KCLTLNWSTRYDICLGVARGLTYLHEESRLRIVHRDVKASNILLDYELIPKISD 829
Query: 838 FGLAKLYDDKKTHISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRPNSDP 897
FGLAKLYDDKKTHIST VAGTIGYLAPEYAMRG LTEK DVF+FGV+ALE VSGRPNSD
Sbjct: 830 FGLAKLYDDKKTHISTGVAGTIGYLAPEYAMRGLLTEKADVFSFGVVALELVSGRPNSDS 889
Query: 898 SLDEEKLYLLEWAWHLHENNQEIELADPKLIEFNEEEVKRLIGVALLCTQTLPSLRPSMS 957
SL+ EK+YLLEWAW LHE N I+L D +L EFNEEEVKR++G+ LLCTQT P+LRPSMS
Sbjct: 890 SLEGEKVYLLEWAWQLHEKNCIIDLVDDRLSEFNEEEVKRIVGIGLLCTQTSPTLRPSMS 949
Query: 958 RVVAMLCGDMEVSTVTAKPGYLTDWKFDDITSFVRTDEATKGTDTSHYTSSSSTSIVAEA 1017
RVVAML GD+EV TV +KPGYL+DWKF+D++SF+ E KG+DTS+ SS STS++
Sbjct: 950 RVVAMLSGDIEVGTVPSKPGYLSDWKFEDVSSFMTGIE-IKGSDTSYQNSSGSTSMMGGV 1008
Query: 1018 EHLSRN--GKPLLHDLVGEGR 1036
++ KP+L + + EGR
Sbjct: 1009 DYYPPRDVSKPILKEALREGR 1029
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356526421|ref|XP_003531816.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At1g56130-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1362 bits (3526), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 718/1044 (68%), Positives = 848/1044 (81%), Gaps = 18/1044 (1%)
Query: 1 MLRRSLPPVSGFALCF-VCLFVHFCL---CQAQNRTQATTDPNEVRALNSIFQQWRISAR 56
M R L V FAL +C+F CL QAQ+ ATTDP+E RALNSIF +W I A
Sbjct: 1 MARCILSHVLAFALVAGLCVFS--CLVNVAQAQS-ANATTDPSEARALNSIFSKWDILAN 57
Query: 57 QGQWNRSGDPCTGAALDDSIVFDNTDYNPFIKCDCSSQNGTVCHITQLKVYALNVVGVIP 116
QWN S + C+G A+D + D+T +NPFIKCDCS + T C IT LKVYA+++VG IP
Sbjct: 58 PTQWNISSELCSGRAIDATTTIDDTTFNPFIKCDCSYDSRTTCRITALKVYAMSIVGTIP 117
Query: 117 DELWNLTSLFNLNLGQNYLTGPLSPSVGNLTAMQYLNLAINALSGELPKELGQLTELLIL 176
+ELW LT L NLNLGQNYLTG L P++GNLT MQYL++ IN SGELPKELG LTEL L
Sbjct: 118 EELWTLTYLTNLNLGQNYLTGSLPPNIGNLTRMQYLSIGINNFSGELPKELGNLTELRSL 177
Query: 177 GIGTNNFSGPLPSELGSLSKLQELYIDSAGVSGEIPSSFANLQSLTKWWASDTRLTGRIP 236
G+N F G LPSELG L+ L+++Y DS+G+SG IPS+FANL++L ASDT LTG+IP
Sbjct: 178 AFGSNKFRGSLPSELGKLTNLEQIYFDSSGISGPIPSTFANLKNLLHVGASDTELTGKIP 237
Query: 237 DFIGNWSKLTALRFQGNSFNGPIPSSFSNLTSVTELRISDLSNGSSKLAFIRDMKSLSIL 296
DFIGNWSKL LRFQGNSFNG IPSSFSNL+S+TELRIS LSNGSS L F+R+MKSL+IL
Sbjct: 238 DFIGNWSKLQTLRFQGNSFNGSIPSSFSNLSSLTELRISGLSNGSSSLEFLRNMKSLTIL 297
Query: 297 ELRNNNISDSIPSNIGEYRSLQHLDLSFNNLGGSIPDSLFNLSSLTHLFLGNNKLNGTLP 356
ELRNNNIS SI S IGE +L LDLSFNN+ G S+FNLSSLT+LFLGNNK NGTLP
Sbjct: 298 ELRNNNISGSISSTIGELHNLNQLDLSFNNITGQNLGSIFNLSSLTYLFLGNNKFNGTLP 357
Query: 357 ARKSPLLLNIDVSYNNLQGNLPSWINGQQNLQINLVANNLTIRSSDNSVLPRGLICLQRN 416
+KS L+NID+SYN+L G+LPSW+N + NLQ+NLVANNL + S+ S LP GL CLQ+N
Sbjct: 358 MQKSSSLVNIDLSYNDLSGSLPSWVN-EPNLQLNLVANNLDV--SNASGLPIGLNCLQKN 414
Query: 417 FPCNRGYAIYADFAIKSGGPQIRSSNGVVYERDNATLGPATYYVTDSNKWGVSNVGLFTG 476
FPCN+G Y+DFAIK GG QIRS++G+VYE DN TLGPATY+VTD+N+W +SNVGLFTG
Sbjct: 415 FPCNQGIGRYSDFAIKCGGNQIRSADGIVYEMDNQTLGPATYFVTDANRWAISNVGLFTG 474
Query: 477 SNNPQYKSSSLSQFTNTLDSELFQTARLSASSLRYYGLGLENGNYTVLLQFAEMAILDTN 536
S+NP YKS +QFT T++SELFQTARLSASSLRYYGLGLENG Y + LQFAE AILD+
Sbjct: 475 SSNPVYKSFVSNQFTGTVNSELFQTARLSASSLRYYGLGLENGFYNITLQFAETAILDST 534
Query: 537 R-WESLGRRVFDVYIQGNRVLKDFDIKREAGGVSKRAIQREIKTRVSENYLEIHLFWAGK 595
R WESLGRRVFD+YIQG RVLKDFDI++EAGG+S +AIQR+ + V+ENYLEIHLFWAGK
Sbjct: 535 RSWESLGRRVFDIYIQGTRVLKDFDIQKEAGGISYKAIQRQFRFEVTENYLEIHLFWAGK 594
Query: 596 GTCCVPAQGTYGPSISAIRVTPDFTPTV-RPPKEKDNNRTGLIVGIVVGVGVATFLSVLA 654
GTCC+P QGTYGP I AI PDF PTV P +NN GLI+GIV+GVGV + LS+ A
Sbjct: 595 GTCCIPTQGTYGPLIQAIHAIPDFIPTVSNKPPSSNNNNIGLILGIVLGVGVVSVLSIFA 654
Query: 655 IFCIVRRRKRPQHDDDEELLGMDARPYTFSYAELKTATENFSPSNKLGEGGFGPVYKGKL 714
IFCI+RRR+ + DD++ELLG+D +PYTFSY+ELK AT +F+ NKLGEGGFGPVYKG L
Sbjct: 655 IFCIIRRRR--RRDDEKELLGIDTKPYTFSYSELKNATNDFNLENKLGEGGFGPVYKGTL 712
Query: 715 GDGRAIAVKQLSVASRQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLVYEYLENK 774
DGR IAVKQLSV S QGKSQF+ EIATISAVQHRNLVKL+GCCIEG++RLLVYEYLENK
Sbjct: 713 NDGRVIAVKQLSVGSHQGKSQFITEIATISAVQHRNLVKLYGCCIEGSKRLLVYEYLENK 772
Query: 775 SLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPK 834
SLDQALFG + LTL+W+TRY+IC GVARGL YLHEESR+RI+HRDVKASN+LLD +L+PK
Sbjct: 773 SLDQALFG-KCLTLNWSTRYDICLGVARGLTYLHEESRLRIVHRDVKASNILLDYELIPK 831
Query: 835 ISDFGLAKLYDDKKTHISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRPN 894
ISDFGLAKLYDDKKTHIST VAGTIGYLAPEYAMRGHLTEK DVF+FGV+ALE VSGRPN
Sbjct: 832 ISDFGLAKLYDDKKTHISTGVAGTIGYLAPEYAMRGHLTEKADVFSFGVVALELVSGRPN 891
Query: 895 SDPSLDEEKLYLLEWAWHLHENNQEIELADPKLIEFNEEEVKRLIGVALLCTQTLPSLRP 954
SD SL+ EK+YLLEWAW LHE N I+L D +L EFNEEEVKR++G+ALLCTQT P+LRP
Sbjct: 892 SDSSLEGEKVYLLEWAWQLHEKNCIIDLVDDRLSEFNEEEVKRVVGIALLCTQTSPTLRP 951
Query: 955 SMSRVVAMLCGDMEVSTVTAKPGYLTDWKFDDITSFVRTDEATKGTDTSHYTSSSSTSIV 1014
SMSRVVAML GD+EVSTVT+KPGYL+DWKF+D++SF+ E KG+DT++ SS STS++
Sbjct: 952 SMSRVVAMLSGDIEVSTVTSKPGYLSDWKFEDVSSFMTGIE-IKGSDTNYQNSSGSTSMM 1010
Query: 1015 AEAEHLSRN--GKPLLHDLVGEGR 1036
++ S KP+L + + EGR
Sbjct: 1011 GGVDYYSPRDVSKPILKETLWEGR 1034
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|15223460|ref|NP_176009.1| putative LRR receptor-like serine/threonine-protein kinase [Arabidopsis thaliana] gi|263711285|sp|C0LGH2.2|Y1561_ARATH RecName: Full=Probable LRR receptor-like serine/threonine-protein kinase At1g56130; Flags: Precursor gi|332195226|gb|AEE33347.1| putative LRR receptor-like serine/threonine-protein kinase [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 1340 bits (3468), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 657/1041 (63%), Positives = 809/1041 (77%), Gaps = 18/1041 (1%)
Query: 2 LRRSLPPVSGFALCFVCLFVHFCLCQAQNRTQATTDPNEVRALNSIFQQWRISARQGQWN 61
+RRS P + + F+C+ + Q+QN+T ATT P+E RALNSIF W+I A + +WN
Sbjct: 4 IRRS-PCLLLLIIWFMCIAGSVQVVQSQNQTGATTHPDEARALNSIFAAWKIQAPR-EWN 61
Query: 62 RSGDPCTGAALDDSIVFDNTDYNPFIKCDCSSQNGTVCHITQLKVYALNVVGVIPDELWN 121
SG+ C+GAA+D S++ N YNP IKCDCS QN T+C IT +KVYA++VVG IP ELW
Sbjct: 62 ISGELCSGAAIDASVLDSNPAYNPLIKCDCSFQNSTICRITNIKVYAIDVVGPIPPELWT 121
Query: 122 LTSLFNLNLGQNYLTGPLSPSVGNLTAMQYLNLAINALSGELPKELGQLTELLILGIGTN 181
LT L NLNLGQN LTG L P++GNLT MQ++ INALSG +PKE+G LT+L +LGI +N
Sbjct: 122 LTYLTNLNLGQNVLTGSLPPAIGNLTRMQWMTFGINALSGPVPKEIGLLTDLRLLGISSN 181
Query: 182 NFSGPLPSELGSLSKLQELYIDSAGVSGEIPSSFANLQSLTKWWASDTRLTGRIPDFIGN 241
NFSG +P E+G +KLQ++YIDS+G+SG IP SFANL L + W +D +T +IPDFIG+
Sbjct: 182 NFSGSIPDEIGRCTKLQQMYIDSSGLSGRIPLSFANLVQLEQAWIADLEVTDQIPDFIGD 241
Query: 242 WSKLTALRFQGNSFNGPIPSSFSNLTSVTELRISDLSNGSSKLAFIRDMKSLSILELRNN 301
W+KLT LR G +GPIPSSFSNLTS+TELR+ D+S+GSS L FI+DMKSLS+L LRNN
Sbjct: 242 WTKLTTLRIIGTGLSGPIPSSFSNLTSLTELRLGDISSGSSSLDFIKDMKSLSVLVLRNN 301
Query: 302 NISDSIPSNIGEYRSLQHLDLSFNNLGGSIPDSLFNLSSLTHLFLGNNKLNGTLPARKSP 361
N++ +IPS IGE+ SL+ +DLSFN L G IP SLFNLS LTHLFLGNN LNG+ P +K+
Sbjct: 302 NLTGTIPSTIGEHSSLRQVDLSFNKLHGPIPASLFNLSQLTHLFLGNNTLNGSFPTQKTQ 361
Query: 362 LLLNIDVSYNNLQGNLPSWINGQQNLQINLVANNLTIRSSDNSVLPRGLICLQRNFPCNR 421
L N+DVSYN+L G+LPSW++ +L++NLVANN T+ DN VLP GL CLQ+NFPCNR
Sbjct: 362 SLRNVDVSYNDLSGSLPSWVS-LPSLKLNLVANNFTLEGLDNRVLP-GLNCLQKNFPCNR 419
Query: 422 GYAIYADFAIKSGGPQIRSSNGVVYERDNATLGPATYYVTDSNKWGVSNVGLFTGSNNPQ 481
G IY+DF+I GGP+ RS G ++ER++ GPA+++V+ +W S+VGLF GS+N
Sbjct: 420 GKGIYSDFSINCGGPEKRSVTGALFEREDEDFGPASFFVSAGQRWAASSVGLFAGSSNNI 479
Query: 482 YKSSSLSQFTNTLDSELFQTARLSASSLRYYGLGLENGNYTVLLQFAEMAILDTNR--WE 539
Y ++S SQF NTLDSELFQ+ARLSASS+RYYGLGLENG YTV LQFAE+ IL + W+
Sbjct: 480 YIATSQSQFVNTLDSELFQSARLSASSVRYYGLGLENGGYTVTLQFAEIQILGSTSTTWK 539
Query: 540 SLGRRVFDVYIQGNRVLKDFDIKREAGGVSKRAIQREIKTRVSENYLEIHLFWAGKGTCC 599
LGRR FD+Y+QG V KDFD++R AG + RA+QR K VSEN+LE+HLFWAGKGTCC
Sbjct: 540 GLGRRRFDIYVQGRLVEKDFDVRRTAGDSTVRAVQRVYKANVSENHLEVHLFWAGKGTCC 599
Query: 600 VPAQGTYGPSISAIRVTPDFTPTV-RPPKEKDNNRTGLIVGIVVGVGVATFLSVLAIFCI 658
+P QG YGP ISA+ TPDFTPTV P K NRTG IVG++VGVG+ + L+ + +F I
Sbjct: 600 IPIQGAYGPLISAVSATPDFTPTVANKPPSKGKNRTGTIVGVIVGVGLLSILAGVVMFTI 659
Query: 659 VRRRKRPQHDDDEELLGMDARPYTFSYAELKTATENFSPSNKLGEGGFGPVYKGKLGDGR 718
+RRKR + DDEELLGMD +PY F+Y+ELK+AT++F PSNKLGEGGFGPVYKG L DGR
Sbjct: 660 RKRRKR--YTDDEELLGMDVKPYIFTYSELKSATQDFDPSNKLGEGGFGPVYKGNLNDGR 717
Query: 719 AIAVKQLSVASRQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLVYEYLENKSLDQ 778
+AVK LSV SRQGK QFVAEI IS+V HRNLVKL+GCC EG R+LVYEYL N SLDQ
Sbjct: 718 VVAVKLLSVGSRQGKGQFVAEIVAISSVLHRNLVKLYGCCFEGEHRMLVYEYLPNGSLDQ 777
Query: 779 ALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDF 838
ALFG ++L LDW+TRYEIC GVARGL YLHEE+ VRI+HRDVKASN+LLD+ LVP+ISDF
Sbjct: 778 ALFGDKTLHLDWSTRYEICLGVARGLVYLHEEASVRIVHRDVKASNILLDSRLVPQISDF 837
Query: 839 GLAKLYDDKKTHISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRPNSDPS 898
GLAKLYDDKKTHISTRVAGTIGYLAPEYAMRGHLTEKTDV+AFGV+ALE VSGRPNSD +
Sbjct: 838 GLAKLYDDKKTHISTRVAGTIGYLAPEYAMRGHLTEKTDVYAFGVVALELVSGRPNSDEN 897
Query: 899 LDEEKLYLLEWAWHLHENNQEIELADPKLIEFNEEEVKRLIGVALLCTQTLPSLRPSMSR 958
L+EEK YLLEWAW+LHE +++IEL D KL +FN EE KR+IG+ALLCTQT +LRP MSR
Sbjct: 898 LEEEKKYLLEWAWNLHEKSRDIELIDDKLTDFNMEEAKRMIGIALLCTQTSHALRPPMSR 957
Query: 959 VVAMLCGDMEVSTVTAKPGYLTDWKFDDITSFVRTDEATKGTDTSHYTSSSSTSIVAEAE 1018
VVAML GD+E+ VT+KPGY++DW+FDD T + K DT+ Y S S+VA
Sbjct: 958 VVAMLSGDVEIGDVTSKPGYVSDWRFDDTTGSSLSGFQIK--DTTGY----SMSLVAPGS 1011
Query: 1019 HLS---RNGKPLLHDLVGEGR 1036
+S + KP+L + EGR
Sbjct: 1012 EISPRDSDFKPMLGSKINEGR 1032
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST 
Original result of BLAST against Gene Ontology (AMIGO)
ID ![]() |
Alignment graph ![]() |
Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 1036 | ||||||
| TAIR|locus:2205250 | 1032 | AT1G56130 [Arabidopsis thalian | 0.964 | 0.968 | 0.615 | 0.0 | |
| TAIR|locus:2205260 | 1047 | AT1G56120 [Arabidopsis thalian | 0.876 | 0.867 | 0.506 | 3e-227 | |
| TAIR|locus:2203718 | 1035 | AT1G53440 [Arabidopsis thalian | 0.840 | 0.841 | 0.434 | 1.2e-184 | |
| TAIR|locus:2019317 | 969 | AT1G29730 [Arabidopsis thalian | 0.299 | 0.319 | 0.562 | 1.6e-160 | |
| TAIR|locus:2203847 | 1021 | RKF1 "receptor-like kinase in | 0.838 | 0.851 | 0.388 | 3.1e-154 | |
| TAIR|locus:2009630 | 953 | AT1G53420 [Arabidopsis thalian | 0.819 | 0.890 | 0.385 | 3.3e-143 | |
| TAIR|locus:2019367 | 1078 | AT1G29740 [Arabidopsis thalian | 0.803 | 0.771 | 0.394 | 4.3e-141 | |
| TAIR|locus:2017923 | 390 | AT1G16670 [Arabidopsis thalian | 0.319 | 0.848 | 0.526 | 3.3e-86 | |
| TAIR|locus:2026097 | 628 | SERK2 "somatic embryogenesis r | 0.352 | 0.581 | 0.414 | 9.3e-82 | |
| TAIR|locus:2095334 | 393 | AT3G09010 [Arabidopsis thalian | 0.280 | 0.740 | 0.528 | 4.1e-81 |
| TAIR|locus:2205250 AT1G56130 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 3229 (1141.7 bits), Expect = 0., P = 0.
Identities = 625/1016 (61%), Positives = 762/1016 (75%)
Query: 27 QAQNRTQATTDPNEVRALNSIFQQWRISARQGQWNRSGDPCTGAALDDSIVFDNTDYNPF 86
Q+QN+T ATT P+E RALNSIF W+I A + +WN SG+ C+GAA+D S++ N YNP
Sbjct: 28 QSQNQTGATTHPDEARALNSIFAAWKIQAPR-EWNISGELCSGAAIDASVLDSNPAYNPL 86
Query: 87 IKCDCSSQNGTVCHITQLKVYALNVVGVIPDELWNLTSLFNLNLGQNYLTGPLSPSVGNL 146
IKCDCS QN T+C IT +KVYA++VVG IP ELW LT L NLNLGQN LTG L P++GNL
Sbjct: 87 IKCDCSFQNSTICRITNIKVYAIDVVGPIPPELWTLTYLTNLNLGQNVLTGSLPPAIGNL 146
Query: 147 TAMQYLNLAINALSGELPKELGQLTELLILGIGTNNFXXXXXXXXXXXXXXQELYIDSAG 206
T MQ++ INALSG +PKE+G LT+L +LGI +NNF Q++YIDS+G
Sbjct: 147 TRMQWMTFGINALSGPVPKEIGLLTDLRLLGISSNNFSGSIPDEIGRCTKLQQMYIDSSG 206
Query: 207 VSGEIPSSFANLQSLTKWWASDTRLTGRIPDFIGNWSKLTALRFQGNSFNGPIPSSFSNL 266
+SG IP SFANL L + W +D +T +IPDFIG+W+KLT LR G +GPIPSSFSNL
Sbjct: 207 LSGRIPLSFANLVQLEQAWIADLEVTDQIPDFIGDWTKLTTLRIIGTGLSGPIPSSFSNL 266
Query: 267 TSVTELRISDLSNGSSKLAFIRDMKSLSILELRXXXXXXXXXXXXGEYRSLQHLDLSFNN 326
TS+TELR+ D+S+GSS L FI+DMKSLS+L LR GE+ SL+ +DLSFN
Sbjct: 267 TSLTELRLGDISSGSSSLDFIKDMKSLSVLVLRNNNLTGTIPSTIGEHSSLRQVDLSFNK 326
Query: 327 LGGSIPDSLFNLSSLTHLFLGNNKLNGTLPARKSPLLLNIDVSYNNLQGNLPSWINGQQN 386
L G IP SLFNLS LTHLFLGNN LNG+ P +K+ L N+DVSYN+L G+LPSW++ +
Sbjct: 327 LHGPIPASLFNLSQLTHLFLGNNTLNGSFPTQKTQSLRNVDVSYNDLSGSLPSWVS-LPS 385
Query: 387 LQINLVANNLTIRSSDNSVLPRGLICLQRNFPCNRGYAIYADFAIKSGGPQIRSSNGVVY 446
L++NLVANN T+ DN VLP GL CLQ+NFPCNRG IY+DF+I GGP+ RS G ++
Sbjct: 386 LKLNLVANNFTLEGLDNRVLP-GLNCLQKNFPCNRGKGIYSDFSINCGGPEKRSVTGALF 444
Query: 447 ERDNATLGPATYYVTDSNKWGVSNVGLFTGSNNPQYKSSSLSQFTNTLDSELFQTARLSA 506
ER++ GPA+++V+ +W S+VGLF GS+N Y ++S SQF NTLDSELFQ+ARLSA
Sbjct: 445 EREDEDFGPASFFVSAGQRWAASSVGLFAGSSNNIYIATSQSQFVNTLDSELFQSARLSA 504
Query: 507 SSLRYYGLGLENGNYTVLLQFAEMAILDTNR--WESLGRRVFDVYIQGNRVLKDFDIKRE 564
SS+RYYGLGLENG YTV LQFAE+ IL + W+ LGRR FD+Y+QG V KDFD++R
Sbjct: 505 SSVRYYGLGLENGGYTVTLQFAEIQILGSTSTTWKGLGRRRFDIYVQGRLVEKDFDVRRT 564
Query: 565 AGGVSKRAIQREIKTRVSENYLEIHLFWAGKGTCCVPAQGTYGPSISAIRVTPDFTPTV- 623
AG + RA+QR K VSEN+LE+HLFWAGKGTCC+P QG YGP ISA+ TPDFTPTV
Sbjct: 565 AGDSTVRAVQRVYKANVSENHLEVHLFWAGKGTCCIPIQGAYGPLISAVSATPDFTPTVA 624
Query: 624 -RPPKEKDNNRTGLXXXXXXXXXXATFLSVLAIFCIVRRRKRPQHDDDEELLGMDARPYT 682
+PP K NRTG + L+ + +F I +RRKR + DDEELLGMD +PY
Sbjct: 625 NKPPS-KGKNRTGTIVGVIVGVGLLSILAGVVMFTIRKRRKR--YTDDEELLGMDVKPYI 681
Query: 683 FSYAELKTATENFSPSNKLGEGGFGPVYKGKLGDGRAIAVKQLSVASRQGKSQFVAEIAT 742
F+Y+ELK+AT++F PSNKLGEGGFGPVYKG L DGR +AVK LSV SRQGK QFVAEI
Sbjct: 682 FTYSELKSATQDFDPSNKLGEGGFGPVYKGNLNDGRVVAVKLLSVGSRQGKGQFVAEIVA 741
Query: 743 ISAVQHRNLVKLHGCCIEGAERLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVAR 802
IS+V HRNLVKL+GCC EG R+LVYEYL N SLDQALFG ++L LDW+TRYEIC GVAR
Sbjct: 742 ISSVLHRNLVKLYGCCFEGEHRMLVYEYLPNGSLDQALFGDKTLHLDWSTRYEICLGVAR 801
Query: 803 GLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVAGTIGYL 862
GL YLHEE+ VRI+HRDVKASN+LLD+ LVP+ISDFGLAKLYDDKKTHISTRVAGTIGYL
Sbjct: 802 GLVYLHEEASVRIVHRDVKASNILLDSRLVPQISDFGLAKLYDDKKTHISTRVAGTIGYL 861
Query: 863 APEYAMRGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEIEL 922
APEYAMRGHLTEKTDV+AFGV+ALE VSGRPNSD +L+EEK YLLEWAW+LHE +++IEL
Sbjct: 862 APEYAMRGHLTEKTDVYAFGVVALELVSGRPNSDENLEEEKKYLLEWAWNLHEKSRDIEL 921
Query: 923 ADPKLIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVAMLCGDMEVSTVTAKPGYLTDW 982
D KL +FN EE KR+IG+ALLCTQT +LRP MSRVVAML GD+E+ VT+KPGY++DW
Sbjct: 922 IDDKLTDFNMEEAKRMIGIALLCTQTSHALRPPMSRVVAMLSGDVEIGDVTSKPGYVSDW 981
Query: 983 KFDDITSFVRTDEATKGXXXXXXXXXXXXXIVAEAEHLSRNG--KPLLHDLVGEGR 1036
+FDD T + G + +E R+ KP+L + EGR
Sbjct: 982 RFDDTTG-----SSLSGFQIKDTTGYSMSLVAPGSEISPRDSDFKPMLGSKINEGR 1032
|
|
| TAIR|locus:2205260 AT1G56120 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2193 (777.0 bits), Expect = 3.0e-227, P = 3.0e-227
Identities = 481/949 (50%), Positives = 614/949 (64%)
Query: 103 QLKVYALNVV-GVIPDELWNLTSLFNLNLGQNYLTGPLSPSVGNLTAMQYLNLAINALSG 161
Q + +N + G IP E+ LT L L + N +G L +G+ T +Q + + + LSG
Sbjct: 125 QWMTFGINALSGPIPKEIGLLTDLRLLGISSNNFSGSLPAEIGSCTKLQQMYIDSSGLSG 184
Query: 162 ELPKELGQLTELLILGIGTNNFXXXXXXXXXXXXXXQELYIDSAGVSGEIPSSFANLQSL 221
+P EL + I L I G+SG IPSSF+NL +L
Sbjct: 185 GIPLSFANFVELEVAWIMDVELTGRIPDFIGFWTKLTTLRILGTGLSGPIPSSFSNLIAL 244
Query: 222 TKWWASDTRLTGRIPDFIGNWSKLTALRFQGNSFNGPIPSSFSNLTSVTELRISDLSNGS 281
T+ D DFI + L+ L + N+ G IPS+ TS+ ++ +S
Sbjct: 245 TELRLGDISNGSSSLDFIKDMKSLSVLVLRNNNLTGTIPSTIGGYTSLQQVDLSFNKLHG 304
Query: 282 SKLAFIRDMKSLSILELRXXXXXXXXXXXXGEYRSLQHLDLSFNNLGGSIPDSLFNLSSL 341
A + ++ L+ L L G+ SL +LD+S+N+L GS+P S +L L
Sbjct: 305 PIPASLFNLSRLTHLFLGNNTLNGSLPTLKGQ--SLSNLDVSYNDLSGSLP-SWVSLPDL 361
Query: 342 THLFLGNNKLNGTLPARKSPLLLNIDVSYNNLQGNLPSWI---NGQQNLQINLVANNLTI 398
+ NN TL + +L + N N I N + QI N+
Sbjct: 362 KLNLVANNF---TLEGLDNRVLSGLHCLQKNFPCNRGEGICKCNKKIPSQIMFSMLNVQT 418
Query: 399 RSSDNSVLPRGLICLQRNFPCNRGYAI-----YADFAIKSGGPQIRSSNGVVYERDNATL 453
++VL L++N C + +AI Y +F+I GGP+IRS +G ++E+++A L
Sbjct: 419 YGQGSNVL------LEKN--CFKTFAIDWCLDY-NFSINCGGPEIRSVSGALFEKEDADL 469
Query: 454 GPATYYVTDSNKWGVSNVGLFTGSNNPQYKSSSLSQFTNTLDSELFQTARLSASSLRYYG 513
GPA++ V+ + +W S+VG F GS+N Y ++SL+QF NT+DSELFQ+ARLSASSLRYYG
Sbjct: 470 GPASFVVSAAKRWAASSVGNFAGSSNNIYIATSLAQFINTMDSELFQSARLSASSLRYYG 529
Query: 514 LGLENGNYTVLLQFAEMAILDTNRWESLGRRVFDVYIQGNRVLKDFDIKREAGGVSKRAI 573
LGLENG YTV LQFAE+ I +N W+ +GRR F++Y+QG V KDFDI+R AGG S RA+
Sbjct: 530 LGLENGGYTVTLQFAEVQIEGSNSWKGIGRRRFNIYVQGRLVEKDFDIRRTAGGSSVRAV 589
Query: 574 QREIKTRVSENYLEIHLFWAGKGTCCVPAQGTYGPSISAIRVTPDFTPTV--RPPKEKDN 631
QRE KT VSEN+LE+HLFWAGKGTCC+P QG YGP I+A+ TPDFTPTV RPP K
Sbjct: 590 QREYKTNVSENHLEVHLFWAGKGTCCIPIQGAYGPLIAAVSATPDFTPTVANRPPS-KGK 648
Query: 632 NRTGLXXXXXXXXXXATFLSVLA--IFCIVRRRKRPQHDDDEELLGMDARPYTFSYAELK 689
+RTG LS+ A + ++R+R++P + DDEE+L MD +PYTF+Y+ELK
Sbjct: 649 SRTG---TIVGVIVGVGLLSIFAGVVILVIRKRRKP-YTDDEEILSMDVKPYTFTYSELK 704
Query: 690 TATENFSPSNKLGEGGFGPVYKGKLGDGRAIAVKQLSVASRQGKSQFVAEIATISAVQHR 749
AT++F SNKLGEGGFG VYKG L DGR +AVKQLS+ SRQGK QFVAEI IS+V HR
Sbjct: 705 NATQDFDLSNKLGEGGFGAVYKGNLNDGREVAVKQLSIGSRQGKGQFVAEIIAISSVLHR 764
Query: 750 NLVKLHGCCIEGAERLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHE 809
NLVKL+GCC EG RLLVYEYL N SLDQALFG +SL LDW+TRYEIC GVARGL YLHE
Sbjct: 765 NLVKLYGCCFEGDHRLLVYEYLPNGSLDQALFGDKSLHLDWSTRYEICLGVARGLVYLHE 824
Query: 810 ESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVAGTIGYLAPEYAMR 869
E+ VRIIHRDVKASN+LLD++LVPK+SDFGLAKLYDDKKTHISTRVAGTIGYLAPEYAMR
Sbjct: 825 EASVRIIHRDVKASNILLDSELVPKVSDFGLAKLYDDKKTHISTRVAGTIGYLAPEYAMR 884
Query: 870 GHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEIELADPKLIE 929
GHLTEKTDV+AFGV+ALE VSGR NSD +L+E K YLLEWAW+LHE N+++EL D +L E
Sbjct: 885 GHLTEKTDVYAFGVVALELVSGRKNSDENLEEGKKYLLEWAWNLHEKNRDVELIDDELSE 944
Query: 930 FNEEEVKRLIGVALLCTQTLPSLRPSMSRVVAMLCGDMEVSTVTAKPGYLTDWKFDDITS 989
+N EEVKR+IG+ALLCTQ+ +LRP MSRVVAML GD EV+ T+KPGYLTD FDD TS
Sbjct: 945 YNMEEVKRMIGIALLCTQSSYALRPPMSRVVAMLSGDAEVNDATSKPGYLTDCTFDDTTS 1004
Query: 990 FVRTDEATKGXXXXXXXXXXXXXIVAEAEHLSRNG--KPLLHDLVGEGR 1036
++ TK I E R+G KP++ + EGR
Sbjct: 1005 SSFSNFQTKDTSFSTSF------IAPGPEMPLRDGESKPMVGFKIKEGR 1047
|
|
| TAIR|locus:2203718 AT1G53440 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1791 (635.5 bits), Expect = 1.2e-184, P = 1.2e-184
Identities = 388/893 (43%), Positives = 554/893 (62%)
Query: 87 IKCDCSSQNGTVCHITQLKVYALNVVGVIPDELWNLTSLFNLNLGQNYLTGPLSPSVGNL 146
I CDC+ +VC +T +++ N+ G+IP E NLT L ++L N+L+G + ++ +
Sbjct: 76 ITCDCTFNASSVCRVTNIQLRGFNLRGIIPPEFGNLTRLTEIDLVLNFLSGTIPTTLSQI 135
Query: 147 TAMQYLNLAINALSGELPKELGQLTELLILGIGTNNFXXXXXXXXXXXXXXQELYIDSAG 206
++ L + N LSG P +LGQ+T L + + +N F + L I S
Sbjct: 136 P-LEILAVTGNRLSGPFPPQLGQITTLTDVIMESNLFTGQLPPNLGNLRSLKRLLISSNN 194
Query: 207 VSGEIPSSFANLQSLTKWWASDTRLTGRIPDFIGNWSKLTALRFQGNSFNGPIPSSFSNL 266
++G IP S +NL++LT + L+G+IPDFIGNW++L L QG S GPIP+S SNL
Sbjct: 195 ITGRIPESLSNLKNLTNFRIDGNSLSGKIPDFIGNWTRLVRLDLQGTSMEGPIPASISNL 254
Query: 267 TSVTELRISDLSNGSSKLAFIRDMKSLSILELRXXXXXXXXXXXXGEYRS-LQHLDLSFN 325
++TELRI+DL +S +++M ++ L LR G + L+ LDLS N
Sbjct: 255 KNLTELRITDLRGPTSPFPDLQNMTNMERLVLRNCLIREPIPEYIGTSMTMLKLLDLSSN 314
Query: 326 NLGGSIPDSLFNLSSLTHLFLGNNKLNGTLPARKSPLLLNIDVSYNNLQGNLPSWINGQQ 385
L G+IPD+ +L++ ++L NN L G +P NID+SYNN P ++ Q
Sbjct: 315 MLNGTIPDTFRSLNAFNFMYLNNNSLTGPVPQFILDSKQNIDLSYNNF--TQPPTLSCNQ 372
Query: 386 NLQINLVANNLTIRSSDNSVLPRGLICLQRNFPCNRGYAIYADFAIKSGGPQIRSSNGVV 445
L +NL+++ ++ ++NSV CL+++ PC G A ++ I GG +++
Sbjct: 373 -LDVNLISSYPSV--TNNSVQ----WCLRKDLPCP-GDAHHSSLFINCGGNRLKVDKDE- 423
Query: 446 YERDNATLGPATYYVTDSNKWGVSNVGLFTGSNNPQYKSSSLSQFTNTLDSELFQTARLS 505
Y D G +T+ S +WG S+ G + G++ Y ++ N E ++TARL+
Sbjct: 424 YADDLNKRGASTFSSV-SERWGYSSSGAWLGNDGATYLATDTFNLINESTPEYYKTARLA 482
Query: 506 ASSLRYYGLGLENGNYTVLLQFAEMAILDTNRWESLGRRVFDVYIQGNRVLKDFDIKREA 565
+ SL+YYGL + G+Y V L FAE+ + + SLGRR+FD+Y+QG + +DF+I + A
Sbjct: 483 SQSLKYYGLCMRRGSYKVQLYFAEIMFSNDQTYSSLGRRLFDIYVQGILLERDFNIAQRA 542
Query: 566 GGVSKRAIQREIKTRVSENYLEIHLFWAGKGTCCVPAQGTYGPSISAIRVTPDFTPTVRP 625
GGV K +++ + +V+ + LEIHL W GKGT +P +G YGP ISAI VTP+F V
Sbjct: 543 GGVGKPFLRQVDEVQVNGSTLEIHLKWTGKGTNVIPTRGVYGPLISAITVTPNFK--VDT 600
Query: 626 PKEKDNNRTGLXXXXXXXXXXATFLSVLAIFCIVRRRKRPQHDDDEELLGMDARPYTFSY 685
K N G+ A L VL I + + D++EEL G+D + +F+
Sbjct: 601 GKPLSN---GVVAGIVIAACVAFGLLVLVILRLTGYLGGKEVDENEELRGLDLQTGSFTL 657
Query: 686 AELKTATENFSPSNKLGEGGFGPVYKGKLGDGRAIAVKQLSVASRQGKSQFVAEIATISA 745
++K AT NF P NK+GEGGFGPVYKG L DG IAVKQLS S+QG +FV EI ISA
Sbjct: 658 KQIKRATNNFDPENKIGEGGFGPVYKGVLADGMTIAVKQLSSKSKQGNREFVTEIGMISA 717
Query: 746 VQHRNLVKLHGCCIEGAERLLVYEYLENKSLDQALFG--QRSLTLDWATRYEICSGVARG 803
+QH NLVKL+GCCIEG E LLVYEYLEN SL +ALFG ++ L LDW+TR ++C G+A+G
Sbjct: 718 LQHPNLVKLYGCCIEGKELLLVYEYLENNSLARALFGTEKQRLHLDWSTRNKVCIGIAKG 777
Query: 804 LAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVAGTIGYLA 863
LAYLHEESR++I+HRD+KA+NVLLD L KISDFGLAKL +++ THISTR+AGTIGY+A
Sbjct: 778 LAYLHEESRLKIVHRDIKATNVLLDLSLNAKISDFGLAKLDEEENTHISTRIAGTIGYMA 837
Query: 864 PEYAMRGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEIELA 923
PEYAMRG+LT+K DV++FGV+ LE VSG+ N++ EE +YLL+WA+ L E +EL
Sbjct: 838 PEYAMRGYLTDKADVYSFGVVCLEIVSGKSNTNYRPKEEFIYLLDWAYVLQEQGSLLELV 897
Query: 924 DPKL-IEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVAMLCGDMEVSTVTAK 975
DP L F+++E R++ +ALLCT P+LRP MS VV+ML G ++V K
Sbjct: 898 DPDLGTSFSKKEAMRMLNIALLCTNPSPTLRPPMSSVVSMLQGKIKVQPPLVK 950
|
|
| TAIR|locus:2019317 AT1G29730 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 885 (316.6 bits), Expect = 1.6e-160, Sum P(2) = 1.6e-160
Identities = 176/313 (56%), Positives = 230/313 (73%)
Query: 672 ELLGMDARPYTFSYAELKTATENFSPSNKLGEGGFGPVYKGKLGDGRAIAVKQLSVASRQ 731
+L G D R +FS +LK AT +F P NK+GEGGFG VYKG+L DG IAVK+LS S Q
Sbjct: 617 KLKGPDLRTGSFSLRQLKVATNDFDPLNKIGEGGFGSVYKGRLPDGTLIAVKKLSSKSHQ 676
Query: 732 GKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLVYEYLENKSLDQALFGQRS-LTLDW 790
G +FV EI I+ +QH NLVKL+GCC+E + LLVYEYLEN L ALF RS L L+W
Sbjct: 677 GNKEFVNEIGMIACLQHPNLVKLYGCCVEKNQLLLVYEYLENNCLSDALFAGRSCLKLEW 736
Query: 791 ATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTH 850
TR++IC G+ARGLA+LHE+S V+IIHRD+K +NVLLD DL KISDFGLA+L++D ++H
Sbjct: 737 GTRHKICLGIARGLAFLHEDSAVKIIHRDIKGTNVLLDKDLNSKISDFGLARLHEDNQSH 796
Query: 851 ISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLY-LLEW 909
I+TRVAGTIGY+APEYAMRGHLTEK DV++FGV+A+E VSG+ N+ + D+E LL+W
Sbjct: 797 ITTRVAGTIGYMAPEYAMRGHLTEKADVYSFGVVAMEIVSGKSNAKYTPDDECCVGLLDW 856
Query: 910 AWHLHENNQEIELADPKLIE-FNEEEVKRLIGVALLCTQTLPSLRPSMSRVVAMLCGDME 968
A+ L + E+ DP+L F+ E +R+I V+LLC +LRP+MS+VV ML G+ E
Sbjct: 857 AFVLQKKGDIAEILDPRLEGMFDVMEAERMIKVSLLCANKSSTLRPNMSQVVKMLEGETE 916
Query: 969 VSTVTAKPGYLTD 981
+ + + PG +D
Sbjct: 917 IEQIISDPGVYSD 929
|
|
| TAIR|locus:2203847 RKF1 "receptor-like kinase in flowers 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1504 (534.5 bits), Expect = 3.1e-154, P = 3.1e-154
Identities = 349/899 (38%), Positives = 511/899 (56%)
Query: 87 IKCDCSSQNGTVCHITQLKVYALNVVGVIPDELWNLTSLFNLNLGQNYLTGPLSPSVGNL 146
I+C+CS N T CH+ + N+ G +P ++ L L ++L NY+ G L P
Sbjct: 88 IECECSPTNDTDCHVVKFAFKDHNLPGTLP-QIVKLPYLREIDLAYNYINGTL-PREWAS 145
Query: 147 TAMQYLNLAINALSGELPKELGQLTELLILGIGTNNFXXXXXXXXXXXXXXQELYIDSAG 206
+ + +++L +N LSGE+PKE G + L L + +N F ++L + S
Sbjct: 146 SNLTFISLLVNRLSGEIPKEFGN-SSLTYLDLESNAFSGTIPQELGNLVHLKKLLLSSNK 204
Query: 207 VSGEIPSSFANLQSLTKWWASDTRLTGRIPDFIGNWSKLTALRFQGNSFNGPIPSSFSNL 266
++G +P+S A LQ++T + +D +L+G IP +I NW +L L + GPIPS S L
Sbjct: 205 LTGTLPASLARLQNMTDFRINDLQLSGTIPSYIQNWKQLERLEMIASGLTGPIPSVISVL 264
Query: 267 TSVTELRISDLSNGSSKLAFIRDMKSLSILELRXXXXXXXXXXXXGEYRSLQHLDLSFNN 326
+++ LRISD+ ++++ L+ + L+ + L+ LDLSFN
Sbjct: 265 SNLVNLRISDIRGPVQPFPSLKNVTGLTKIILKNCNISGQIPTYLSHLKELETLDLSFNK 324
Query: 327 LGGSIPDSLFNLSSLTHLFLGNNKLNGTLPARKSPLLLNIDVSYNNLQGNLPSWINGQQN 386
L G IP S +L + L N L G P + +D+SYNNL+ P + N
Sbjct: 325 LVGGIP-SFAQAENLRFIILAGNMLEGDAPDELLRDGITVDLSYNNLKWQSPESRACRPN 383
Query: 387 LQINLVANNLTIRSSDNSVLPRGLICLQRNFPCNRGYAIYADFAIKSGGPQI---RSSNG 443
+ +NL T + LP C+ ++F C R Y+ + + GG +
Sbjct: 384 MNLNLNLFQSTSTKKSSKFLP----CI-KDFKCPR-YS--SCLHVNCGGSDMYVKEKKTK 435
Query: 444 VVYERD-NATLGPATYYVTDSNKWGVSNVGLFTGSNNPQYKSSSLSQFTNTLD-SELFQT 501
+YE D N G A Y++ WG S+ G F NN ++++ + F + S+L+++
Sbjct: 436 ELYEGDGNVEGGAAKYFLKPDANWGFSSTGDFMDDNN--FQNTRFTMFVPASNQSDLYKS 493
Query: 502 ARLSASSLRYYGLGLENGNYTVLLQFAEMAILDTNRWESLGRRVFDVYIQGNRVLKDFDI 561
AR++ SL Y+ LENGNYT+ L FAE+ + + LGRR+FD+YIQ V KDF+I
Sbjct: 494 ARIAPVSLTYFHACLENGNYTINLDFAEIRFTNDENYNRLGRRLFDIYIQEKLVAKDFNI 553
Query: 562 KREAGGVSKRAIQREIKTRVSENYLEIHLFWAGKGTCCVPAQGTYGPSISAIRVTPDFTP 621
EA G ++ I + + V+ ++L I L WAGKGT +P +G YGP ISAI + D P
Sbjct: 554 MDEAKG-AQTPIIKPLTAYVTNHFLTIRLSWAGKGTTRIPTRGVYGPIISAISIVSDSKP 612
Query: 622 TVRPPKEKDNNRTGLXXXXXXXXXXATFLSVLAIFCIVRRRKRPQHDDDEELLGMDARPY 681
RP K + + L L I + R R + D EE L
Sbjct: 613 CERP-KTGMSPGAYIAIGIGAPCLIIFILGFLWICGCLPRCGRQRKDPYEEELPSG---- 667
Query: 682 TFSYAELKTATENFSPSNKLGEGGFGPVYKGKLGDGRAIAVKQLSVASRQGKSQFVAEIA 741
TF+ ++K AT++F+P+NK+GEGGFG V+KG L DGR +AVKQLS SRQG +F+ EI
Sbjct: 668 TFTLRQIKFATDDFNPTNKIGEGGFGAVFKGVLADGRVVAVKQLSSKSRQGNREFLNEIG 727
Query: 742 TISAVQHRNLVKLHGCCIEGAERLLVYEYLENKSLDQALFG--QRSLTLDWATRYEICSG 799
IS +QH NLVKLHG C+E A+ LL YEY+EN SL ALF + + +DW TR++IC G
Sbjct: 728 AISCLQHPNLVKLHGFCVERAQLLLAYEYMENNSLSSALFSPKHKQIPMDWPTRFKICCG 787
Query: 800 VARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVAGTI 859
+A+GLA+LHEES ++ +HRD+KA+N+LLD DL PKISDFGLA+L +++KTHIST+VAGTI
Sbjct: 788 IAKGLAFLHEESPLKFVHRDIKATNILLDKDLTPKISDFGLARLDEEEKTHISTKVAGTI 847
Query: 860 GYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQE 919
GY+APEYA+ G+LT K DV++FGVL LE V+G NS+ + + LLE+A E+
Sbjct: 848 GYMAPEYALWGYLTFKADVYSFGVLVLEIVAGITNSNFMGAGDSVCLLEFANECVESGHL 907
Query: 920 IELADPKLI-EFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVAMLCGDMEVSTVTAKPG 977
+++ D +L E + +E + +I VAL+C+ P+ RP MS VVAML G V T PG
Sbjct: 908 MQVVDERLRPEVDRKEAEAVIKVALVCSSASPTDRPLMSEVVAMLEGLYPVPEST--PG 964
|
|
| TAIR|locus:2009630 AT1G53420 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1400 (497.9 bits), Expect = 3.3e-143, P = 3.3e-143
Identities = 344/893 (38%), Positives = 483/893 (54%)
Query: 93 SQNGTVCHITQLKVYALNV-VGVIPDEL---WNLTSLFNLNLGQNYLTGPLSPSVGNLTA 148
+Q G + + N+ + V P E+ N S + NL + L G L + L
Sbjct: 29 TQEGEAFKVVLTTLKKTNIDLNVDPCEVSSTGNEWSTISRNLKRENLQGSLPKELVGLPL 88
Query: 149 MQYLNLAINALSGELPKELGQLTELLILGIGTNNFXXXXXXXXXXXXXXQELYIDSAGVS 208
+Q ++L+ N L+G +P E G L + I +G N L +++ +S
Sbjct: 89 LQEIDLSRNYLNGSIPPEWGVLPLVNIWLLG-NRLTGPIPKEFGNITTLTSLVLEANQLS 147
Query: 209 GEIPSSFANLQSLTKWWASDTRLTGRIPDFIGNWSKLTALRFQGNSFNGPIPSSFSNLTS 268
GE+P NL ++ + S G IP + L R N +G IP T
Sbjct: 148 GELPLELGNLPNIQQMILSSNNFNGEIPSTFAKLTTLRDFRVSDNQLSGTIPDFIQKWTK 207
Query: 269 VTELRI--SDLSNGSS-KLAFIRDMKSLSILELRXXXXXXXXXXXXGEYRSLQHLDLSFN 325
+ L I S L +A + ++K L I +L + ++ L L
Sbjct: 208 LERLFIQASGLVGPIPIAIASLVELKDLRISDLNGPESPFPQLR---NIKKMETLILRNC 264
Query: 326 NLGGSIPDSLFNLSSLTHLFLGNNKLNGTLPARKSPLLLN--IDVSYNNLQGNLPSWING 383
NL G +PD L ++S L L NKL+G +P L I + N L G++P W+
Sbjct: 265 NLTGDLPDYLGKITSFKFLDLSFNKLSGAIPNTYINLRDGGYIYFTGNMLNGSVPDWMVN 324
Query: 384 QQNLQINLVANNLTIRSSDNSVLPRGLICLQRNFPCNRGY-AIYADFAIKSGGPQIRSSN 442
+ +I+L NN ++ ++ ++ RN+ C + + A++ I GG ++ S N
Sbjct: 325 K-GYKIDLSYNNFSVDPTNAVCKYNNVLSCMRNYQCPKTFNALH----INCGGDEM-SIN 378
Query: 443 GVVYERDNATLGPATYYVTDSNKWGVSNVGLFTGSNN-PQYKS-SSLSQFTNTLDSELFQ 500
G +YE D + Y N W +NVG+F + P+ + S S N +D L+
Sbjct: 379 GTIYESDKYDRLESWY--ESRNGWFSNNVGVFVDDKHVPERVTIESNSSELNVVDFGLYT 436
Query: 501 TARLSASSLRYYGLGLENGNYTVLLQFAEMAILDTNRWESLGRRVFDVYIQGNRVLKDFD 560
AR+SA SL YY L LENGNY V L FAE+ N ++SLGRR FD+YIQ +KDF+
Sbjct: 437 QARISAISLTYYALCLENGNYNVNLHFAEIMFNGNNNYQSLGRRFFDIYIQRKLEVKDFN 496
Query: 561 IKREAGGVSKRAIQREIKTRVSENYLEIHLFWAGKGTCCVPAQGTYGPSISAIRVTPDFT 620
I +EA V I + + + LEI L+WAG+GT +P + YGP ISAI V
Sbjct: 497 IAKEAKDVGNVVI-KTFPVEIKDGKLEIRLYWAGRGTTVIPKERVYGPLISAISVDSSVN 555
Query: 621 PTVRPPKEKDNNRTGLXXXXXXXXXXATFLSVLAIFCIVRR--RK---RPQHDDDEELLG 675
P+ R + TG LS+ +F + +K R + +++
Sbjct: 556 PSPR-----NGMSTG------TLHTLVVILSIFIVFLVFGTLWKKGYLRSKSQMEKDFKS 604
Query: 676 MDARPYTFSYAELKTATENFSPSNKLGEGGFGPVYKGKLGDGRAIAVKQLSVASRQGKSQ 735
++ +FS ++K AT NF +N++GEGGFGPVYKGKL DG IAVKQLS S+QG +
Sbjct: 605 LELMIASFSLRQIKIATNNFDSANRIGEGGFGPVYKGKLFDGTIIAVKQLSTGSKQGNRE 664
Query: 736 FVAEIATISAVQHRNLVKLHGCCIEGAERLLVYEYLENKSLDQALFG--QRSLTLDWATR 793
F+ EI ISA+ H NLVKL+GCC+EG + LLVYE++EN SL +ALFG + L LDW TR
Sbjct: 665 FLNEIGMISALHHPNLVKLYGCCVEGGQLLLVYEFVENNSLARALFGPQETQLRLDWPTR 724
Query: 794 YEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHIST 853
+IC GVARGLAYLHEESR++I+HRD+KA+NVLLD L PKISDFGLAKL ++ THIST
Sbjct: 725 RKICIGVARGLAYLHEESRLKIVHRDIKATNVLLDKQLNPKISDFGLAKLDEEDSTHIST 784
Query: 854 RVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHL 913
R+AGT GY+APEYAMRGHLT+K DV++FG++ALE V GR N YL++W L
Sbjct: 785 RIAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVHGRSNKIERSKNNTFYLIDWVEVL 844
Query: 914 HENNQEIELADPKL-IEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVAMLCG 965
E N +EL DP+L E+N EE +I +A++CT + P RPSMS VV ML G
Sbjct: 845 REKNNLLELVDPRLGSEYNREEAMTMIQIAIMCTSSEPCERPSMSEVVKMLEG 897
|
|
| TAIR|locus:2019367 AT1G29740 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1380 (490.8 bits), Expect = 4.3e-141, P = 4.3e-141
Identities = 344/871 (39%), Positives = 470/871 (53%)
Query: 135 LTGPLSPSVGNLTAMQYLNLAINALSGELPKELGQLTELLILGIGTNNFXXXXXXXXXXX 194
L G L P L +++++L N L G +P E L L + + N
Sbjct: 110 LPGRLPPEFSKLRYLEFIDLCRNYLYGSIPMEWASLPYLKSISVCANRLTGDIPKGLGKF 169
Query: 195 XXXQELYIDSAGVSGEIPSSFANLQSLTKWWASDTRLTGRIPDFIGNWSKLTALRFQGNS 254
+L +++ SG IP NL +L S +L G +P + KLT LRF N
Sbjct: 170 INLTQLGLEANQFSGTIPKELGNLVNLEGLAFSSNQLVGGVPKTLARLKKLTNLRFSDNR 229
Query: 255 FNGPIPSSFSNLTSVTELRISDLSNGSSKLAFIRDMKSLSILELRXXXXXXXXXXX-XGE 313
NG IP NL+ + L + ++G + ++++LR
Sbjct: 230 LNGSIPEFIGNLSKLQRLEL--YASGLKDPIPYSIFRLENLIDLRISDTAAGLGQVPLIT 287
Query: 314 YRSLQHLDLSFNNLGGSIPDSLFNLSSLTHLFLGNNKLNGTLPARKSPLLLNIDVSYNNL 373
+SL+ L L NL G IP SL++L +L L L N+L G +PA S ++ N L
Sbjct: 288 SKSLKFLVLRNMNLTGPIPTSLWDLPNLMTLDLSFNRLTGEVPADASAPKYTY-LAGNML 346
Query: 374 QGNLPSWINGQQNLQINLVANNLTIRSS---DNSV----LPRGLICLQRNFPC---NRGY 423
G + S + I+L NN T S N++ R L R PC N
Sbjct: 347 SGKVESGPFLTASTNIDLSYNNFTWSQSCKERNNINTYASSRSTNSLTRLLPCSAINLCQ 406
Query: 424 AIYADFAIKSGGPQ--IRSSNG-VVYERDNATL-GPATYYVTDSNKWGVSNVGLFTGS-- 477
I GGP I +S G +YE DN L G AT Y WG SN G F
Sbjct: 407 NYNRSLHINCGGPDVTIENSRGRFLYEGDNYGLTGSATNYY--GKNWGFSNTGDFMDDAI 464
Query: 478 NNPQYKSSSLSQFTNTLDSELFQTARLSASSLRYYGLGLENGNYTVLLQFAEMAILDTNR 537
Y SS S + +L+Q AR S SL Y+ + ENG+Y V L FAE+ D
Sbjct: 465 TEDTYTVSSESAVSAKYP-DLYQNARRSPLSLAYFAICFENGSYNVKLHFAEIQFSDEEP 523
Query: 538 WESLGRRVFDVYIQGNRVLKDFDIKREAGGVSKRAIQREIKTRVSENYLEIHLFWAGKGT 597
+ L +RVF++Y+QG + +DF I+ EA G K I +E+ T V++N LEI L+WAGKGT
Sbjct: 524 FSRLAKRVFNIYVQGKLIWEDFSIREEANGTHKEVI-KEVNTTVTDNTLEIRLYWAGKGT 582
Query: 598 CCVPAQGTYGPSISAIRVTPDF-----TPTVRPPKEKDNNRTGLXXXXXXXXXXATFLSV 652
+P +G YG ISAI V P P P K ++ LS
Sbjct: 583 TIIPKRGNYGSLISAISVCPSSESECGVPVQIHPVTKQQHKQRKYHLILGIAALIVSLSF 642
Query: 653 LAIFCIVRRRKRPQHDDDEELLGMDARPYTFSYAELKTATENFSPSNKLGEGGFGPVYKG 712
L + + R D ++ G +FS +LK AT++F+P NK+GEGGFG VYKG
Sbjct: 643 LILGALYWRICVSNADGEKR--G------SFSLRQLKVATDDFNPLNKIGEGGFGSVYKG 694
Query: 713 KLGDGRAIAVKQLSVASRQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLVYEYLE 772
+L +G IAVK+LS S QG +F+ EI I+ +QH NLVKL+GCC+E + LLVYEYLE
Sbjct: 695 RLPNGTLIAVKKLSSKSCQGNKEFINEIGIIACLQHPNLVKLYGCCVEKTQLLLVYEYLE 754
Query: 773 NKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLV 832
N L ALFG+ L LDW TR++IC G+ARGLA+LHE+S V+IIHRD+K +N+LLD DL
Sbjct: 755 NNCLADALFGRSGLKLDWRTRHKICLGIARGLAFLHEDSAVKIIHRDIKGTNILLDKDLN 814
Query: 833 PKISDFGLAKLYDDKKTHISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGR 892
KISDFGLA+L++D ++HI+TRVAGTIGY+APEYAMRGHLTEK DV++FGV+A+E VSG+
Sbjct: 815 SKISDFGLARLHEDDQSHITTRVAGTIGYMAPEYAMRGHLTEKADVYSFGVVAMEIVSGK 874
Query: 893 PNSDPSLDEEKLY-LLEWAWHLHENNQEIELADPKLIE-FNEEEVKRLIGVALLCTQTLP 950
N++ + D E LL+WA+ L + E+ DPKL F+ E +R+I V+LLC+ P
Sbjct: 875 SNANYTPDNECCVGLLDWAFVLQKKGAFDEILDPKLEGVFDVMEAERMIKVSLLCSSKSP 934
Query: 951 SLRPSMSRVVAMLCGDMEVSTVTAKPGYLTD 981
+LRP+MS VV ML G+ E+ + + PG D
Sbjct: 935 TLRPTMSEVVKMLEGETEIEEIISDPGAYGD 965
|
|
| TAIR|locus:2017923 AT1G16670 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 862 (308.5 bits), Expect = 3.3e-86, P = 3.3e-86
Identities = 180/342 (52%), Positives = 231/342 (67%)
Query: 663 KRPQHDDDEELLGMDARPYTFSYAELKTATENFSPSNKLGEGGFGPVYKGKLGDGRAIAV 722
+R + D E+ +D + Y E++ AT++FS NK+GEGGFG VYKG L DG+ A+
Sbjct: 10 RREATEVDGEIAAID-NVKIYKYREIRQATDDFSAENKIGEGGFGSVYKGCLKDGKLAAI 68
Query: 723 KQLSVASRQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLVYEYLENKSLDQALFG 782
K LS SRQG +F+ EI IS +QH NLVKL+GCC+EG R+LVY +LEN SLD+ L
Sbjct: 69 KVLSAESRQGVKEFLTEINVISEIQHENLVKLYGCCVEGNHRILVYNFLENNSLDKTLLA 128
Query: 783 ---QRS-LTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDF 838
RS + DW++R IC GVA+GLA+LHEE R IIHRD+KASN+LLD L PKISDF
Sbjct: 129 GGYTRSGIQFDWSSRANICVGVAKGLAFLHEEVRPHIIHRDIKASNILLDKYLSPKISDF 188
Query: 839 GLAKLYDDKKTHISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRPNSDPS 898
GLA+L TH+STRVAGTIGYLAPEYA+RG LT K D+++FGVL +E VSGR N +
Sbjct: 189 GLARLMPPNMTHVSTRVAGTIGYLAPEYAVRGQLTRKADIYSFGVLLMEIVSGRSNKNTR 248
Query: 899 LDEEKLYLLEWAWHLHENNQEIELADPKLIE-FNEEEVKRLIGVALLCTQTLPSLRPSMS 957
L E YLLE AW L+E N+ ++L D L F+ EE R + + LLCTQ P LRPSMS
Sbjct: 249 LPTEYQYLLERAWELYERNELVDLVDSGLNGVFDAEEACRYLKIGLLCTQDSPKLRPSMS 308
Query: 958 RVVAMLCGDMEVS-TVTAKPGYLTDWKFDDITSFVRTDEATK 998
VV +L G+ ++ ++PG ++D F D+ VR ATK
Sbjct: 309 TVVRLLTGEKDIDYKKISRPGLISD--FMDLK--VRGPVATK 346
|
|
| TAIR|locus:2026097 SERK2 "somatic embryogenesis receptor-like kinase 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 659 (237.0 bits), Expect = 9.3e-82, Sum P(2) = 9.3e-82
Identities = 158/381 (41%), Positives = 208/381 (54%)
Query: 599 CVPAQGTYGPSISAIRVTPDFTPTVRPPKEKDNNRTGLXXXXXXXXXXATFLSVLAIFCI 658
C P P P F P P + TG F + F
Sbjct: 205 CGPVTSRPCPGSPPFSPPPPFIPPPIVPTPGGYSATGAIAGGVAAGAALLFAAPALAFAW 264
Query: 659 VRRRKR-------PQHDDDEELLGMDARPYTFSYAELKTATENFSPSNKLGEGGFGPVYK 711
RRRK P +D E LG R FS EL+ AT++FS N LG GGFG VYK
Sbjct: 265 WRRRKPQEFFFDVPAEEDPEVHLGQLKR---FSLRELQVATDSFSNKNILGRGGFGKVYK 321
Query: 712 GKLGDGRAIAVKQLSVASRQG-KSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLVYEY 770
G+L DG +AVK+L G + QF E+ IS HRNL++L G C+ ERLLVY Y
Sbjct: 322 GRLADGTLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPY 381
Query: 771 LENKSLDQALFGQ--RSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLD 828
+ N S+ L + L L W+ R +I G ARGL+YLH+ +IIHRDVKA+N+LLD
Sbjct: 382 MANGSVASCLRERPPSQLPLAWSIRQQIALGSARGLSYLHDHCDPKIIHRDVKAANILLD 441
Query: 829 ADLVPKISDFGLAKLYDDKKTHISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALET 888
+ + DFGLA+L D K TH++T V GTIG++APEY G +EKTDVF +G++ LE
Sbjct: 442 EEFEAVVGDFGLARLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLEL 501
Query: 889 VSGRPNSDPS--LDEEKLYLLEWAWHLHENNQEIELADPKL-IEFNEEEVKRLIGVALLC 945
++G+ D + +++ + LL+W L + + L DP L + E EV++LI VALLC
Sbjct: 502 ITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQSNYTEAEVEQLIQVALLC 561
Query: 946 TQTLPSLRPSMSRVVAMLCGD 966
TQ+ P RP MS VV ML GD
Sbjct: 562 TQSSPMERPKMSEVVRMLEGD 582
|
|
| TAIR|locus:2095334 AT3G09010 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 814 (291.6 bits), Expect = 4.1e-81, P = 4.1e-81
Identities = 156/295 (52%), Positives = 205/295 (69%)
Query: 671 EELLGMDARPYTFSYAELKTATENFSPSNKLGEGGFGPVYKGKLGDGRAIAVKQLSVASR 730
EE+ + R FSY L++AT++F P+N++G GG+G V+KG L DG +AVK LS S+
Sbjct: 24 EEICTNNVR--VFSYNSLRSATDSFHPTNRIGGGGYGVVFKGVLRDGTQVAVKSLSAESK 81
Query: 731 QGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLVYEYLENKSLDQALFGQRS--LTL 788
QG +F+ EI IS + H NLVKL GCCIEG R+LVYEYLEN SL L G RS + L
Sbjct: 82 QGTREFLTEINLISNIHHPNLVKLIGCCIEGNNRILVYEYLENNSLASVLLGSRSRYVPL 141
Query: 789 DWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKK 848
DW+ R IC G A GLA+LHEE ++HRD+KASN+LLD++ PKI DFGLAKL+ D
Sbjct: 142 DWSKRAAICVGTASGLAFLHEEVEPHVVHRDIKASNILLDSNFSPKIGDFGLAKLFPDNV 201
Query: 849 THISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLE 908
TH+STRVAGT+GYLAPEYA+ G LT+K DV++FG+L LE +SG ++ + +E + L+E
Sbjct: 202 THVSTRVAGTVGYLAPEYALLGQLTKKADVYSFGILVLEVISGNSSTRAAFGDEYMVLVE 261
Query: 909 WAWHLHENNQEIELADPKLIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVAML 963
W W L E + +E DP+L +F +EV R I VAL CTQ RP+M +V+ ML
Sbjct: 262 WVWKLREERRLLECVDPELTKFPADEVTRFIKVALFCTQAAAQKRPNMKQVMEML 316
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries 
Original result of BLAST against SWISS-PROT
ID ![]() | Name ![]() | Annotated EC number ![]() | Identity ![]() | Query coverage ![]() | Hit coverage ![]() | RBH(Q2H) ![]() | RBH(H2Q) ![]() |
| C0LGH2 | Y1561_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.6311 | 0.9874 | 0.9912 | yes | no |
EC Number Prediction by Ezypred Server 
Original result from Ezypred Server
Fail to connect to Ezypred Server
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING 
Original result from the STRING server
| Your Input: | |||||||||||
| fgenesh4_pm.C_LG_VII000290 | hypothetical protein (1036 aa) | ||||||||||
(Populus trichocarpa) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against CDD database part I
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 1036 | |||
| pfam11721 | 164 | pfam11721, Malectin, Di-glucose binding within end | 1e-61 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 9e-51 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 2e-49 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 5e-49 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 4e-47 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 8e-45 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 2e-43 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-43 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 5e-43 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-42 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 1e-38 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-38 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 3e-35 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-33 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 3e-32 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 1e-31 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 2e-30 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 7e-30 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 3e-29 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 1e-28 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-28 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 5e-28 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 1e-27 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 3e-27 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 4e-27 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 5e-27 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 2e-26 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 2e-26 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 2e-26 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 4e-26 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 1e-25 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 1e-25 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 2e-25 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 2e-25 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 3e-25 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 2e-24 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 2e-24 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 2e-24 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 5e-24 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 1e-23 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 2e-23 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 3e-23 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 9e-23 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 1e-22 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 1e-22 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 2e-22 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 2e-22 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 3e-22 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 3e-22 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 3e-22 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 4e-22 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 4e-22 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 9e-22 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 9e-22 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 1e-21 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 1e-21 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 1e-21 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 1e-21 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 2e-21 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 2e-21 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 2e-21 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-21 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 7e-21 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 7e-21 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 8e-21 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 1e-20 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 1e-20 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 2e-20 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 2e-20 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 3e-20 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 4e-20 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 4e-20 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 4e-20 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 4e-20 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 4e-20 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 5e-20 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 6e-20 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 6e-20 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 7e-20 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 1e-19 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 1e-19 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 1e-19 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 1e-19 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 1e-19 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 1e-19 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 2e-19 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 3e-19 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 3e-19 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 3e-19 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 3e-19 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 3e-19 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 4e-19 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 4e-19 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 4e-19 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 7e-19 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 1e-18 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 1e-18 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 1e-18 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 2e-18 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 2e-18 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 4e-18 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 4e-18 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 5e-18 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 5e-18 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 6e-18 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 7e-18 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 7e-18 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 8e-18 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-17 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 1e-17 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 1e-17 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 1e-17 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 2e-17 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 2e-17 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 2e-17 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 2e-17 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 2e-17 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 2e-17 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 3e-17 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 3e-17 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 3e-17 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 4e-17 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 4e-17 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 5e-17 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 5e-17 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 6e-17 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 6e-17 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 7e-17 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 7e-17 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 1e-16 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 1e-16 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 1e-16 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 1e-16 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 1e-16 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-16 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 2e-16 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 2e-16 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 2e-16 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 2e-16 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 2e-16 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 2e-16 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 3e-16 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 3e-16 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 4e-16 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 5e-16 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 6e-16 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 6e-16 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 7e-16 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 1e-15 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 1e-15 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 1e-15 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 2e-15 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 2e-15 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 2e-15 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 2e-15 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 3e-15 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 3e-15 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 4e-15 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 4e-15 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 5e-15 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 5e-15 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 7e-15 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 9e-15 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 2e-14 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 3e-14 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 3e-14 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 5e-14 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 5e-14 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 6e-14 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 6e-14 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 8e-14 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 9e-14 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 1e-13 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 1e-13 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 1e-13 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 1e-13 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 1e-13 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 2e-13 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 2e-13 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 2e-13 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 2e-13 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 3e-13 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 3e-13 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 4e-13 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 4e-13 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 5e-13 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 5e-13 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 5e-13 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 6e-13 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 7e-13 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 7e-13 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 1e-12 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 1e-12 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 1e-12 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 2e-12 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 2e-12 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 3e-12 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 3e-12 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 3e-12 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 3e-12 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 3e-12 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 3e-12 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 3e-12 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 4e-12 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 5e-12 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 5e-12 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 5e-12 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 7e-12 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 7e-12 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 8e-12 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-11 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 1e-11 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 1e-11 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 1e-11 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 1e-11 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 2e-11 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 2e-11 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 2e-11 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 2e-11 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 2e-11 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 2e-11 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 2e-11 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 2e-11 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 3e-11 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 5e-11 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 6e-11 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 7e-11 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 7e-11 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 1e-10 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 1e-10 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 1e-10 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 1e-10 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 1e-10 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 1e-10 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 1e-10 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 2e-10 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 2e-10 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 2e-10 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 3e-10 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 3e-10 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 4e-10 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 4e-10 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 4e-10 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 4e-10 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 4e-10 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 6e-10 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 6e-10 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 7e-10 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 8e-10 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 8e-10 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 1e-09 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 1e-09 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 2e-09 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 2e-09 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 2e-09 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 2e-09 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 4e-09 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 4e-09 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 4e-09 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 5e-09 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 5e-09 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 6e-09 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 6e-09 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 6e-09 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 8e-09 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 9e-09 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 1e-08 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 1e-08 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 1e-08 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 1e-08 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-08 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 3e-08 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 3e-08 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 4e-08 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 4e-08 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 4e-08 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-07 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 1e-07 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 1e-07 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 1e-07 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 1e-07 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 2e-07 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 2e-07 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 2e-07 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 2e-07 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 2e-07 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 3e-07 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 3e-07 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 3e-07 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 5e-07 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 7e-07 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 9e-07 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 1e-06 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 1e-06 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 1e-06 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 1e-06 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 2e-06 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 2e-06 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 3e-06 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 4e-06 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 5e-06 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 6e-06 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 6e-06 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 7e-06 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 1e-05 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 2e-05 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 2e-05 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 2e-05 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 3e-05 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 3e-05 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 3e-05 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 4e-05 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 8e-05 | |
| cd00116 | 319 | cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo | 9e-05 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 9e-05 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 1e-04 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 2e-04 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 2e-04 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 2e-04 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 4e-04 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 4e-04 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 4e-04 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 4e-04 | |
| cd00116 | 319 | cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo | 6e-04 | |
| COG3642 | 204 | COG3642, COG3642, Mn2+-dependent serine/threonine | 0.003 | |
| PRK09605 | 535 | PRK09605, PRK09605, bifunctional UGMP family prote | 0.004 | |
| pfam12799 | 43 | pfam12799, LRR_4, Leucine Rich repeats (2 copies) | 0.004 | |
| PHA03265 | 402 | PHA03265, PHA03265, envelope glycoprotein D; Provi | 0.004 |
| >gnl|CDD|221187 pfam11721, Malectin, Di-glucose binding within endoplasmic reticulum | Back alignment and domain information |
|---|
Score = 206 bits (527), Expect = 1e-61
Identities = 88/187 (47%), Positives = 104/187 (55%), Gaps = 27/187 (14%)
Query: 429 FAIKSGGPQIRSSNGVVYERDNA-TLGPATYYVTDSNKWGVSNVGLFTGSNNPQYKSSSL 487
AI GGP+ S+G+ YE D T G A YYV+D+N
Sbjct: 3 LAINCGGPEHTDSDGITYEADTYFTGGSADYYVSDTNG---------------------S 41
Query: 488 SQFTNTLDSELFQTARLSASSLRYYGLGLENGNYTVLLQFAEMAILDTNRWESLGRRVFD 547
S T D EL+QT R S SS YY LENGNYTV+L FAE+ + LGRRVFD
Sbjct: 42 SSIAGTTDPELYQTERYSPSSFSYYIPCLENGNYTVILHFAEIYFGED----GLGRRVFD 97
Query: 548 VYIQGNRVLKDFDIKREAGGVSKRAIQREIKTRVSENYLEIHLFWAGKGTCCVPAQGTYG 607
VY+QG VLKDFDI EAGG K A + I V++ LEIH +WAGKGT +P +G YG
Sbjct: 98 VYVQGKLVLKDFDIVAEAGGKGKTAHKEYIPVTVTDGTLEIHFYWAGKGTLLIPFRGVYG 157
Query: 608 -PSISAI 613
P ISAI
Sbjct: 158 NPKISAI 164
|
Malectin is a membrane-anchored protein of the endoplasmic reticulum that recognises and binds Glc2-N-glycan. It carries a signal peptide from residues 1-26, a C-terminal transmembrane helix from residues 255-274, and a highly conserved central part of approximately 190 residues followed by an acidic, glutamate-rich region. Carbohydrate-binding is mediated by the four aromatic residues, Y67, Y89, Y116, and F117 and the aspartate at D186. NMR-based ligand-screening studies has shown binding of the protein to maltose and related oligosaccharides, on the basis of which the protein has been designated "malectin", and its endogenous ligand is found to be Glc2-high-mannose N-glycan. Length = 164 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 179 bits (457), Expect = 9e-51
Identities = 94/282 (33%), Positives = 131/282 (46%), Gaps = 38/282 (13%)
Query: 699 NKLGEGGFGPVYKGKL----GDGRAIAVKQL-SVASRQGKSQFVAEIATISAVQHRNLVK 753
KLGEG FG VYKGKL G +AVK L AS + + F+ E + + H N+V+
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 754 LHGCCIEGAERLLVYEYLENKSLDQALFGQRSL-------TLDWATRYEICSGVARGLAY 806
L G C E LV EY+E L L R + TL +A+G+ Y
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120
Query: 807 LHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVAGT---IGYLA 863
L + +HRD+ A N L+ DLV KISDFGL++ D + G I ++A
Sbjct: 121 LAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKT--GGKLPIRWMA 175
Query: 864 PEYAMRGHLTEKTDVFAFGVLALETVS--GRPNSDPSLDEEKLYLLEWAWHLHENNQEIE 921
PE G T K+DV++FGVL E + P S +E +LE +L + +
Sbjct: 176 PESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEE----VLE---YLRKGYR--- 225
Query: 922 LADPKLIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVAML 963
L P+ +E+ L+ L C Q P RP+ S +V L
Sbjct: 226 LPKPEYC---PDELYELM---LSCWQLDPEDRPTFSELVERL 261
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 175 bits (447), Expect = 2e-49
Identities = 72/191 (37%), Positives = 96/191 (50%), Gaps = 10/191 (5%)
Query: 700 KLGEGGFGPVYKGKLGD-----GRAIAVKQL-SVASRQGKSQFVAEIATISAVQHRNLVK 753
KLGEG FG VYKGKL +AVK L AS Q +F+ E + + H N+VK
Sbjct: 6 KLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVK 65
Query: 754 LHGCCIEGAERLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRV 813
L G C E +V EY+E L L + L + +ARG+ YL +
Sbjct: 66 LLGVCTEEEPLYIVMEYMEGGDLLSYL-RKNRPKLSLSDLLSFALQIARGMEYLESK--- 121
Query: 814 RIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVAGTIGYLAPEYAMRGHLT 873
IHRD+ A N L+ +LV KISDFGL++ D + I ++APE G T
Sbjct: 122 NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESLKEGKFT 181
Query: 874 EKTDVFAFGVL 884
K+DV++FGVL
Sbjct: 182 SKSDVWSFGVL 192
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 174 bits (444), Expect = 5e-49
Identities = 71/191 (37%), Positives = 95/191 (49%), Gaps = 9/191 (4%)
Query: 700 KLGEGGFGPVYKGKLGDG-----RAIAVKQL-SVASRQGKSQFVAEIATISAVQHRNLVK 753
KLGEG FG VYKG L +AVK L AS Q +F+ E + + H N+VK
Sbjct: 6 KLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVK 65
Query: 754 LHGCCIEGAERLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRV 813
L G C E ++V EY+ L L R L + +ARG+ YL +
Sbjct: 66 LLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESK--- 122
Query: 814 RIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVAGTIGYLAPEYAMRGHLT 873
IHRD+ A N L+ +LV KISDFGL++ D + I ++APE G T
Sbjct: 123 NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESLKEGKFT 182
Query: 874 EKTDVFAFGVL 884
K+DV++FGVL
Sbjct: 183 SKSDVWSFGVL 193
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 167 bits (425), Expect = 4e-47
Identities = 69/191 (36%), Positives = 100/191 (52%), Gaps = 9/191 (4%)
Query: 701 LGEGGFGPVYKGK-LGDGRAIAVKQLSVASRQG-KSQFVAEIATISAVQHRNLVKLHGCC 758
LGEGGFG VY + G+ +A+K + + + EI + + H N+VKL+G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 759 IEGAERLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHR 818
+ LV EY E SL L + L I + GL YLH IIHR
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLK-ENEGKLSEDEILRILLQILEGLEYLHSN---GIIHR 116
Query: 819 DVKASNVLLDAD-LVPKISDFGLAKLYDDKKTHISTRVAGTIGYLAPE-YAMRGHLTEKT 876
D+K N+LLD+D K++DFGL+KL K+ + T V GT Y+APE +G+ +EK+
Sbjct: 117 DLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIV-GTPAYMAPEVLLGKGYYSEKS 175
Query: 877 DVFAFGVLALE 887
D+++ GV+ E
Sbjct: 176 DIWSLGVILYE 186
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 162 bits (412), Expect = 8e-45
Identities = 85/273 (31%), Positives = 129/273 (47%), Gaps = 29/273 (10%)
Query: 700 KLGEGGFGPVYKGKL-----GDGRAIAVKQLSV-ASRQGKSQFVAEIATISAVQHRNLVK 753
KLGEG FG VYKG L G +AVK L AS + + +F+ E + + + H N+V+
Sbjct: 6 KLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVR 65
Query: 754 LHGCCIEGAERLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRV 813
L G C +G +V EY+ L L + L ++ +A+G+ YL
Sbjct: 66 LLGVCTQGEPLYIVTEYMPGGDLLDFL-RKHGEKLTLKDLLQMALQIAKGMEYLES---K 121
Query: 814 RIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVAGT-IGYLAPEYAMRGHL 872
+HRD+ A N L+ +LV KISDFGL++ + + I ++APE G
Sbjct: 122 NFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESLKDGKF 181
Query: 873 TEKTDVFAFGVLALETVSG--RPNSDPSLDEEKLYLLEWAWHLHENNQEIELADPKLIEF 930
T K+DV++FGVL E + +P S +E +LE L + + L P+
Sbjct: 182 TSKSDVWSFGVLLWEIFTLGEQPYPGMSNEE----VLE---LLEDGYR---LPRPENC-- 229
Query: 931 NEEEVKRLIGVALLCTQTLPSLRPSMSRVVAML 963
+E+ L+ L C P RP+ S +V L
Sbjct: 230 -PDELYELM---LQCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 158 bits (401), Expect = 2e-43
Identities = 66/199 (33%), Positives = 104/199 (52%), Gaps = 13/199 (6%)
Query: 699 NKLGEGGFGPVYKGK-LGDGRAIAVKQLSVASRQGK-SQFVAEIATISAVQHRNLVKLHG 756
KLGEG FG VY + G+ +A+K + + + + EI + ++H N+V+L+
Sbjct: 5 EKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYD 64
Query: 757 CCIEGAERLLVYEYLENKSLDQALFGQRSLTLDWATRY--EICSGVARGLAYLHEESRVR 814
+ + LV EY E L L + L+ D A Y +I S L YLH +
Sbjct: 65 VFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSA----LEYLHSK---G 117
Query: 815 IIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVAGTIGYLAPEYAMRGHLTE 874
I+HRD+K N+LLD D K++DFGLA+ D ++T V GT Y+APE + +
Sbjct: 118 IVHRDLKPENILLDEDGHVKLADFGLARQLDP-GEKLTTFV-GTPEYMAPEVLLGKGYGK 175
Query: 875 KTDVFAFGVLALETVSGRP 893
D+++ GV+ E ++G+P
Sbjct: 176 AVDIWSLGVILYELLTGKP 194
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 170 bits (433), Expect = 3e-43
Identities = 107/311 (34%), Positives = 165/311 (53%), Gaps = 29/311 (9%)
Query: 113 GVIPDELWNLTSLFNLNLGQNYLTGPLSPSVGNLTAMQYLNLAINALSGELPKELGQLTE 172
G IP+++ + +SL L+LG N L G + S+ NLT++++L LA N L G++P+ELGQ+
Sbjct: 154 GEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKS 213
Query: 173 LLILGIGTNNFSGPLPSELGSLSKLQELYIDSAGVSGEIPSSFANLQSLTKWWASDTRLT 232
L + +G NN SG +P E+G L+ L L + ++G IPSS NL++L + +L+
Sbjct: 214 LKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLS 273
Query: 233 GRIPDFIGNWSKLTALRFQGNSFNGPIPSSFSNLTSVTELRI-SDLSNGSSKLAFIRDMK 291
G IP I + KL +L NS +G IP L ++ L + S+ G +A + +
Sbjct: 274 GPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVA-LTSLP 332
Query: 292 SLSILELRNNNISDSIPSNIGEYRSLQHLDLSFNNLGGSIPDSLFNLSSLTHLFLGNNKL 351
L +L+L +N S IP N+G++ +L LDLS NNL G IP+ L + +L L L +N L
Sbjct: 333 RLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSL 392
Query: 352 NGTLPAR--------------------------KSPLLLNIDVSYNNLQGNLPSWINGQQ 385
G +P K PL+ +D+S NNLQG + S
Sbjct: 393 EGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMP 452
Query: 386 NLQ-INLVANN 395
+LQ ++L N
Sbjct: 453 SLQMLSLARNK 463
|
Length = 968 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 157 bits (399), Expect = 5e-43
Identities = 78/237 (32%), Positives = 110/237 (46%), Gaps = 12/237 (5%)
Query: 700 KLGEGGFGPVYKGK-LGDGRAIAVKQLSVASR--QGKSQFVAEIATISAVQHRNLVKLHG 756
KLG G FG VYK K G G+ +AVK L S + EI + + H N+V+L
Sbjct: 6 KLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLID 65
Query: 757 CCIEGAERLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRII 816
+ LV EY E L L R L +I + RGL YLH II
Sbjct: 66 AFEDKDHLYLVMEYCEGGDLFDYLS--RGGPLSEDEAKKIALQILRGLEYLHSN---GII 120
Query: 817 HRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVAGTIGYLAPE-YAMRGHLTEK 875
HRD+K N+LLD + V KI+DFGLAK + ++T V GT Y+APE K
Sbjct: 121 HRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFV-GTPWYMAPEVLLGGNGYGPK 179
Query: 876 TDVFAFGVLALETVSGRP--NSDPSLDEEKLYLLEWAWHLHENNQEIELADPKLIEF 930
DV++ GV+ E ++G+P + + LD+ +L L + + + +
Sbjct: 180 VDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWSSGSEEAKDL 236
|
Length = 260 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 168 bits (426), Expect = 2e-42
Identities = 112/315 (35%), Positives = 163/315 (51%), Gaps = 28/315 (8%)
Query: 110 NVVGVIPDELWNLTSLFNLNLGQNYLTGPLSPSVGNLTAMQYLNLAINALSGELPKELGQ 169
N+ G IP L NL +L L L QN L+GP+ PS+ +L + L+L+ N+LSGE+P+ + Q
Sbjct: 247 NLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQ 306
Query: 170 LTELLILGIGTNNFSGPLPSELGSLSKLQELYIDSAGVSGEIPSSFANLQSLTKWWASDT 229
L L IL + +NNF+G +P L SL +LQ L + S SGEIP + +LT S
Sbjct: 307 LQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTN 366
Query: 230 RLTGRIPDFIGNWSKLTALRFQGNSFNGPIPSSFSNLTSVTELRISD------LSNGSSK 283
LTG IP+ + + L L NS G IP S S+ +R+ D L + +K
Sbjct: 367 NLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTK 426
Query: 284 LAFIR------------------DMKSLSILELRNNNISDSIPSNIGEYRSLQHLDLSFN 325
L + DM SL +L L N +P + G R L++LDLS N
Sbjct: 427 LPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGSKR-LENLDLSRN 485
Query: 326 NLGGSIPDSLFNLSSLTHLFLGNNKLNGTLPARKSPL--LLNIDVSYNNLQGNLPSWING 383
G++P L +LS L L L NKL+G +P S L+++D+S+N L G +P+ +
Sbjct: 486 QFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSE 545
Query: 384 QQNL-QINLVANNLT 397
L Q++L N L+
Sbjct: 546 MPVLSQLDLSQNQLS 560
|
Length = 968 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 144 bits (365), Expect = 1e-38
Identities = 67/202 (33%), Positives = 107/202 (52%), Gaps = 11/202 (5%)
Query: 695 FSPSNKLGEGGFGPVYKGK-LGDGRAIAVKQLSVASRQGKSQFVAEIATISAVQHRNLVK 753
F K+G+GGFG VYK + G+ +A+K + + S++ K + + EI + +H N+VK
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVK 61
Query: 754 LHGCCIEGAERLLVYEYLENKSLDQAL-FGQRSLTLDW-ATRYEICSGVARGLAYLHEES 811
+G ++ E +V E+ SL L ++LT A +C + +GL YLH
Sbjct: 62 YYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAY---VCKELLKGLEYLHSN- 117
Query: 812 RVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVAGTIGYLAPEYAMRGH 871
IIHRD+KA+N+LL +D K+ DFGL+ D K + GT ++APE
Sbjct: 118 --GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTM--VGTPYWMAPEVINGKP 173
Query: 872 LTEKTDVFAFGVLALETVSGRP 893
K D+++ G+ A+E G+P
Sbjct: 174 YDYKADIWSLGITAIELAEGKP 195
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 155 bits (393), Expect = 2e-38
Identities = 101/302 (33%), Positives = 153/302 (50%), Gaps = 42/302 (13%)
Query: 121 NLTSLFNLNLGQNYLTGPLSPSVGNLTAMQYLNLAINALSGELPKELGQLT-ELLILGIG 179
N + + +++L ++G +S ++ L +Q +NL+ N LSG +P ++ + L L +
Sbjct: 67 NSSRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLS 126
Query: 180 TNNFSGPLPSELGSLSKLQELYIDSAGVSGEIPS---SFANLQSLTKWWASDTRLTGRIP 236
NNF+G +P GS+ L+ L + + +SGEIP+ SF++L+ L L G+IP
Sbjct: 127 NNNFTGSIPR--GSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLD---LGGNVLVGKIP 181
Query: 237 DFIGNWSKLTALRFQGNSFNGPIPSSFSNLTSVTELRISDLSNGSSKLAFIRDMKSLSIL 296
+ + N + L L N G IP MKSL +
Sbjct: 182 NSLTNLTSLEFLTLASNQLVGQIPRELGQ------------------------MKSLKWI 217
Query: 297 ELRNNNISDSIPSNIGEYRSLQHLDLSFNNLGGSIPDSLFNLSSLTHLFLGNNKLNGTLP 356
L NN+S IP IG SL HLDL +NNL G IP SL NL +L +LFL NKL+G +P
Sbjct: 218 YLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIP 277
Query: 357 ARKSPL--LLNIDVSYNNLQGNLPSWINGQQNLQI-NLVANNLTIRSSDNSVLPRGLICL 413
L L+++D+S N+L G +P + QNL+I +L +NN T + +P L L
Sbjct: 278 PSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGK------IPVALTSL 331
Query: 414 QR 415
R
Sbjct: 332 PR 333
|
Length = 968 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 134 bits (340), Expect = 3e-35
Identities = 66/214 (30%), Positives = 103/214 (48%), Gaps = 27/214 (12%)
Query: 694 NFSPSNKLGEGGFGPVYKGKLGD-GRAIAVKQLSVASRQGK--SQFVAEIATISAVQHRN 750
++ LG G FG VY D G +AVK + ++ + EI +S++QH N
Sbjct: 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPN 60
Query: 751 LVKLHGCCIEGAER-LLVY-EYLENKSLDQAL--FGQ------RSLTLDWATRYEICSGV 800
+V+ +G + + L ++ EY+ SL L FG+ R T +
Sbjct: 61 IVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQ----------I 110
Query: 801 ARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTR-VAGTI 859
GLAYLH I+HRD+K +N+L+D+D V K++DFG AK D +T T V GT
Sbjct: 111 LEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTP 167
Query: 860 GYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRP 893
++APE D+++ G +E +G+P
Sbjct: 168 YWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKP 201
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 139 bits (353), Expect = 1e-33
Identities = 99/294 (33%), Positives = 159/294 (54%), Gaps = 12/294 (4%)
Query: 110 NVVGVIPDELWNLT-SLFNLNLGQNYLTGPLSPSVGNLTAMQYLNLAINALSGELPKELG 168
+ G IPD+++ + SL LNL N TG + G++ ++ L+L+ N LSGE+P ++G
Sbjct: 104 QLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPR--GSIPNLETLDLSNNMLSGEIPNDIG 161
Query: 169 QLTELLILGIGTNNFSGPLPSELGSLSKLQELYIDSAGVSGEIPSSFANLQSLTKW-WAS 227
+ L +L +G N G +P+ L +L+ L+ L + S + G+IP ++SL KW +
Sbjct: 162 SFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSL-KWIYLG 220
Query: 228 DTRLTGRIPDFIGNWSKLTALRFQGNSFNGPIPSSFSNLTSVTELRI--SDLSNGSSKLA 285
L+G IP IG + L L N+ GPIPSS NL ++ L + + LS
Sbjct: 221 YNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSI 280
Query: 286 FIRDMKSLSILELRNNNISDSIPSNIGEYRSLQHLDLSFNNLGGSIPDSLFNLSSLTHLF 345
F ++ L L+L +N++S IP + + ++L+ L L NN G IP +L +L L L
Sbjct: 281 F--SLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQ 338
Query: 346 LGNNKLNGTLPAR--KSPLLLNIDVSYNNLQGNLPSWINGQQNL-QINLVANNL 396
L +NK +G +P K L +D+S NNL G +P + NL ++ L +N+L
Sbjct: 339 LWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSL 392
|
Length = 968 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 126 bits (317), Expect = 3e-32
Identities = 64/199 (32%), Positives = 102/199 (51%), Gaps = 6/199 (3%)
Query: 693 ENFSPSNKLGEGGFGPVYKGKLGDGRAIAVKQLSVASRQGKSQFVAEIATISAVQHRNLV 752
E F+ KLG G FG V++G + +A+K L + F E+ + ++H++L+
Sbjct: 6 EEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLI 65
Query: 753 KLHGCCIEGAERLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESR 812
L C G ++ E +E SL L L A+ ++ VA G+AYL E+
Sbjct: 66 SLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQ-- 123
Query: 813 VRIIHRDVKASNVLLDADLVPKISDFGLAKLY-DDKKTHISTRVAGTIGYLAPEYAMRGH 871
IHRD+ A N+L+ DLV K++DFGLA+L +D ++ + APE A G
Sbjct: 124 -NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIP--YKWTAPEAASHGT 180
Query: 872 LTEKTDVFAFGVLALETVS 890
+ K+DV++FG+L E +
Sbjct: 181 FSTKSDVWSFGILLYEMFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 1e-31
Identities = 73/207 (35%), Positives = 109/207 (52%), Gaps = 17/207 (8%)
Query: 694 NFSPSNKLGEGGFGPVYKG-KLGDGRAIAVKQLSVA--SRQGKSQFVAEIATISAVQHRN 750
N+ + +G G FG VYKG L G +A+KQ+S+ + + EI + ++H N
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 751 LVKLHGCCIEGAERLLVYEYLENKSLDQAL--FGQRSLTLDWATRYEICSGVARGLAYLH 808
+VK G ++ EY EN SL Q + FG +L Y V +GLAYLH
Sbjct: 61 IVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESL--VAVY--VYQVLQGLAYLH 116
Query: 809 EESRVRIIHRDVKASNVLLDADLVPKISDFGLA-KLYDDKKTHISTRVAGTIGYLAPE-Y 866
E+ +IHRD+KA+N+L D V K++DFG+A KL D K V GT ++APE
Sbjct: 117 EQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD--DASVVGTPYWMAPEVI 171
Query: 867 AMRGHLTEKTDVFAFGVLALETVSGRP 893
M G + +D+++ G +E ++G P
Sbjct: 172 EMSGA-STASDIWSLGCTVIELLTGNP 197
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 120 bits (304), Expect = 2e-30
Identities = 72/215 (33%), Positives = 109/215 (50%), Gaps = 16/215 (7%)
Query: 701 LGEGGFGPVYKGKLGDGRAIAVKQLSVASRQGKSQFVAEIATISAVQHRNLVKLHGCCIE 760
+G+G FG V G G+ +AVK L S F+AE + ++ ++H NLV+L G ++
Sbjct: 14 IGKGEFGDVMLGDY-RGQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQ 71
Query: 761 GAERLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDV 820
G +V EY+ SL L + + A + V G+ YL E+ +HRD+
Sbjct: 72 GNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEK---NFVHRDL 128
Query: 821 KASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVAGTIGYLAPEYAMRGHLTEKTDVFA 880
A NVL+ DLV K+SDFGLAK + + S ++ + + APE + K+DV++
Sbjct: 129 AARNVLVSEDLVAKVSDFGLAK--EASQGQDSGKLP--VKWTAPEALREKKFSTKSDVWS 184
Query: 881 FGVLALETVS-GR-PNSDPSLDE-----EKLYLLE 908
FG+L E S GR P L + EK Y +E
Sbjct: 185 FGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYRME 219
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 7e-30
Identities = 80/283 (28%), Positives = 129/283 (45%), Gaps = 34/283 (12%)
Query: 698 SNKLGEGGFGPVYKGKL-----GDGRAIAVKQLSVAS-RQGKSQFVAEIATISAVQHRNL 751
+LGEG FG V + G +AVK L+ + Q +S F EI + + H N+
Sbjct: 9 IKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENI 68
Query: 752 VKLHGCCIEGAER--LLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHE 809
VK G C + R L+ EYL + SL L R ++ S + +G+ YL
Sbjct: 69 VKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRD-QINLKRLLLFSSQICKGMDYLGS 127
Query: 810 ESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVAGT--IGYLAPEYA 867
+ R IHRD+ A N+L++++ + KISDFGLAK+ + K + + G I + APE
Sbjct: 128 Q---RYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECL 184
Query: 868 MRGHLTEKTDVFAFGVLALETVS-GRPNSDPSLDEEKLYLLEWAWHLHENNQEIELADPK 926
+ +DV++FGV E + G P+ P + ++ + + E
Sbjct: 185 RTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLE------- 237
Query: 927 LIEFNE---------EEVKRLIGVALLCTQTLPSLRPSMSRVV 960
L++ E +EV L+ LC + P RPS + ++
Sbjct: 238 LLKEGERLPRPPSCPDEVYDLM---KLCWEAEPQDRPSFADLI 277
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 3e-29
Identities = 70/196 (35%), Positives = 103/196 (52%), Gaps = 9/196 (4%)
Query: 700 KLGEGGFGPVYKGKLGDGRAIAVKQLSVASRQGKSQFVAEIATISAVQHRNLVKLHGCCI 759
KLG G FG V+ G +AVK L + ++ F+ E + ++H LV+L+ C
Sbjct: 13 KLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEA-FLQEAQIMKKLRHDKLVQLYAVCS 71
Query: 760 EGAERLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRD 819
E +V EY+ SL L L ++ + +A G+AYL ESR IHRD
Sbjct: 72 EEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYL--ESR-NYIHRD 128
Query: 820 VKASNVLLDADLVPKISDFGLAKLYDDKK--THISTRVAGTIGYLAPEYAMRGHLTEKTD 877
+ A N+L+ +LV KI+DFGLA+L +D + + I + APE A G T K+D
Sbjct: 129 LAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFP--IKWTAPEAANYGRFTIKSD 186
Query: 878 VFAFGVLALETVS-GR 892
V++FG+L E V+ GR
Sbjct: 187 VWSFGILLTEIVTYGR 202
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 1e-28
Identities = 52/206 (25%), Positives = 97/206 (47%), Gaps = 21/206 (10%)
Query: 699 NKLGEGGFGPVYKGK-LGDGRAIAVKQLSVA--SRQGKSQFVAEIATISAVQHRNLVKLH 755
++G+G FG VY + DG+ +K++ ++ S + + + E+ + + H N++K +
Sbjct: 6 KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYY 65
Query: 756 GCCIEGAERLLVYEYLENKSLDQAL----FGQRSLT----LDWATRYEICSGVARGLAYL 807
E + +V EY + L Q + + LDW ++C L YL
Sbjct: 66 ESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFV--QLCLA----LKYL 119
Query: 808 HEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVAGTIGYLAPEYA 867
H +I+HRD+K N+ L ++ + K+ DFG++K+ T V GT YL+PE
Sbjct: 120 HSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVV-GTPYYLSPELC 175
Query: 868 MRGHLTEKTDVFAFGVLALETVSGRP 893
K+D+++ G + E + +
Sbjct: 176 QNKPYNYKSDIWSLGCVLYELCTLKH 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 123 bits (309), Expect = 2e-28
Identities = 81/266 (30%), Positives = 127/266 (47%), Gaps = 25/266 (9%)
Query: 100 HITQLKVYALNVVGVIPDELWNLTSLFNLNLGQNYLTGPLSPSVGNLTAMQYLNLAINAL 159
++T L + N+ G IP+ L + +LF L L N L G + S+G +++ + L N+
Sbjct: 357 NLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSF 416
Query: 160 SGELPKELGQLTELLILGIGTNNFSGPLPSELGSLSKLQELYIDSAGVSGEIPSSFANLQ 219
SGELP E +L + L I NN G + S + LQ L + G +P SF + +
Sbjct: 417 SGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGS-K 475
Query: 220 SLTKWWASDTRLTGRIPDFIGNWSKLTALRFQGNSFNGPIPSSFSNLTSVTELRISDLSN 279
L S + +G +P +G+ S+L L+ N +G IP S+
Sbjct: 476 RLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSC------------- 522
Query: 280 GSSKLAFIRDMKSLSILELRNNNISDSIPSNIGEYRSLQHLDLSFNNLGGSIPDSLFNLS 339
K L L+L +N +S IP++ E L LDLS N L G IP +L N+
Sbjct: 523 -----------KKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVE 571
Query: 340 SLTHLFLGNNKLNGTLPARKSPLLLN 365
SL + + +N L+G+LP+ + L +N
Sbjct: 572 SLVQVNISHNHLHGSLPSTGAFLAIN 597
|
Length = 968 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 5e-28
Identities = 68/200 (34%), Positives = 98/200 (49%), Gaps = 16/200 (8%)
Query: 701 LGEGGFGPVYK-GKLGDGRAIAVKQLS---VASRQGKSQFVAEIATISAVQHRNLVKLHG 756
LG+G FG V K G+ A+K L + R+ + E +S + H +VKLH
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLH- 59
Query: 757 CCIEGAERL-LVYEYLENKSLDQALFGQRSLTLDWATRY--EICSGVARGLAYLHEESRV 813
+ E+L LV EY L L + + + A Y EI L YLH +
Sbjct: 60 YAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLA----LEYLH---SL 112
Query: 814 RIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVAGTIGYLAPEYAMRGHLT 873
II+RD+K N+LLDAD K++DFGLAK + + +T GT YLAPE +
Sbjct: 113 GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNT-FCGTPEYLAPEVLLGKGYG 171
Query: 874 EKTDVFAFGVLALETVSGRP 893
+ D ++ GVL E ++G+P
Sbjct: 172 KAVDWWSLGVLLYEMLTGKP 191
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 1e-27
Identities = 76/270 (28%), Positives = 123/270 (45%), Gaps = 30/270 (11%)
Query: 692 TENFSPSNKLGEGGFGPVYKGK-LGDGRAIAVKQLSVASRQGKSQFVAEIATISAVQHRN 750
E + K+GEG G VYK G+ +A+K++ + Q K + EI + +H N
Sbjct: 18 RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRK-QNKELIINEILIMKDCKHPN 76
Query: 751 LVKLHGCCIEGAERLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEE 810
+V + + G E +V EY++ SL + Q + ++ +C V +GL YLH
Sbjct: 77 IVDYYDSYLVGDELWVVMEYMDGGSLTDIIT-QNFVRMNEPQIAYVCREVLQGLEYLH-- 133
Query: 811 SRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVAGTIGYLAPEYAMRG 870
+IHRD+K+ N+LL D K++DFG A +K+ ++ V GT ++APE R
Sbjct: 134 -SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVV-GTPYWMAPEVIKRK 191
Query: 871 HLTEKTDVFAFGVLALETVSGRPNSDPSLDE---EKLYLL--EWAWHLHENNQEIELADP 925
K D+++ G++ +E G P P L E L+L+ + L + E P
Sbjct: 192 DYGPKVDIWSLGIMCIEMAEGEP---PYLREPPLRALFLITTKGIPPL----KNPEKWSP 244
Query: 926 KLIEFNEEEVKRLIGVALLCTQTLPSLRPS 955
+ +F C P RPS
Sbjct: 245 EFKDFLN-----------KCLVKDPEKRPS 263
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 3e-27
Identities = 70/238 (29%), Positives = 112/238 (47%), Gaps = 32/238 (13%)
Query: 698 SNKLGEGGFGPVYKGKLGDGRAIAVKQLSVASRQG---KSQFVAEIATISAVQHRNLVKL 754
++G G FG V+ G + R +A+K + R+G + F+ E + + H LV+L
Sbjct: 9 VQEIGSGQFGLVWLGYWLEKRKVAIKTI----REGAMSEEDFIEEAQVMMKLSHPKLVQL 64
Query: 755 HGCCIEGAERLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVR 814
+G C E + LV+E++E+ L L QR T +C V G+AYL +
Sbjct: 65 YGVCTERSPICLVFEFMEHGCLSDYLRAQRGK-FSQETLLGMCLDVCEGMAYLESSN--- 120
Query: 815 IIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVAGTIGYLAPEYAMRGHLTE 874
+IHRD+ A N L+ + V K+SDFG+ + D + ST + + +PE +
Sbjct: 121 VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSS 180
Query: 875 KTDVFAFGVLALETVS-------GRPNSD-------------PSLDEEKLY-LLEWAW 911
K+DV++FGVL E S R NS+ P L + +Y L++ W
Sbjct: 181 KSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYKPRLASQSVYELMQHCW 238
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 4e-27
Identities = 67/213 (31%), Positives = 101/213 (47%), Gaps = 29/213 (13%)
Query: 701 LGEGGFGPVYKGKL------GDGRAIAVKQLS-VASRQGKSQFVAEIATISAVQHRNLVK 753
LGEG FG V+ G+ D +AVK L AS + F E ++ QH N+VK
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72
Query: 754 LHGCCIEGAERLLVYEYLENKSLDQAL------------FGQRSLTLDWATRYEICSGVA 801
+G C EG ++V+EY+E+ L++ L L + +I +A
Sbjct: 73 FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132
Query: 802 RGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVAGT--- 858
G+ YL + +HRD+ N L+ DLV KI DFG+++ D T RV G
Sbjct: 133 SGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSR---DVYTTDYYRVGGHTML 186
Query: 859 -IGYLAPEYAMRGHLTEKTDVFAFGVLALETVS 890
I ++ PE M T ++DV++FGV+ E +
Sbjct: 187 PIRWMPPESIMYRKFTTESDVWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (278), Expect = 5e-27
Identities = 64/195 (32%), Positives = 95/195 (48%), Gaps = 13/195 (6%)
Query: 701 LGEGGFGPVYKGKLGDGRAIAVKQLSVASRQG---KSQFVAEIATISAVQHRNLVKLHGC 757
LG G FG V+ GK +A+K + R+G + F+ E + + H NLV+L+G
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMI----REGAMSEDDFIEEAKVMMKLSHPNLVQLYGV 67
Query: 758 CIEGAERLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIH 817
C + +V EY+ N L L ++ L ++CS V + YL IH
Sbjct: 68 CTKQRPIFIVTEYMANGCLLNYLRERKGK-LGTEWLLDMCSDVCEAMEYLESNG---FIH 123
Query: 818 RDVKASNVLLDADLVPKISDFGLAK-LYDDKKTHISTRVAGTIGYLAPEYAMRGHLTEKT 876
RD+ A N L+ D V K+SDFGLA+ + DD+ T S + + PE + K+
Sbjct: 124 RDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTS-SQGTKFPVKWAPPEVFDYSRFSSKS 182
Query: 877 DVFAFGVLALETVSG 891
DV++FGVL E S
Sbjct: 183 DVWSFGVLMWEVFSE 197
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 2e-26
Identities = 59/200 (29%), Positives = 95/200 (47%), Gaps = 18/200 (9%)
Query: 700 KLGEGGFGPVYKG-KLGDGRAIAVKQLSVASRQGKSQFVAEIATISAVQHRNLVKLHGCC 758
KLGEG +G VYK G+ +A+K + V + + EI+ + +VK +G
Sbjct: 10 KLGEGSYGSVYKAIHKETGQVVAIKVVPVEE--DLQEIIKEISILKQCDSPYIVKYYGSY 67
Query: 759 IEGAERLLVYEYLENKS-LDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIH 817
+ + +V EY S D + + TL I +GL YLH + IH
Sbjct: 68 FKNTDLWIVMEYCGAGSVSD--IMKITNKTLTEEEIAAILYQTLKGLEYLH---SNKKIH 122
Query: 818 RDVKASNVLLDADLVPKISDFGLA-KL---YDDKKTHISTRVAGTIGYLAPEYAMRGHLT 873
RD+KA N+LL+ + K++DFG++ +L + T V GT ++APE
Sbjct: 123 RDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNT-----VIGTPFWMAPEVIQEIGYN 177
Query: 874 EKTDVFAFGVLALETVSGRP 893
K D+++ G+ A+E G+P
Sbjct: 178 NKADIWSLGITAIEMAEGKP 197
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 2e-26
Identities = 66/202 (32%), Positives = 108/202 (53%), Gaps = 7/202 (3%)
Query: 694 NFSPSNKLGEGGFGPVYKG-KLGDGRAIAVKQ--LSVASRQGKSQFVAEIATISAVQHRN 750
+F NK+G+G FG V+K + D R A+KQ LS +R+ + + + E ++ +
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSY 60
Query: 751 LVKLHGCCIEGAERLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEE 810
+++ + ++ + +V EY EN L + L QR L + + GLA+LH +
Sbjct: 61 IIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSK 120
Query: 811 SRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVAGTIGYLAPEYAMRG 870
+I+HRD+K+ N+ LDA KI D G+AKL D T+ + + GT YL+PE
Sbjct: 121 ---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSD-NTNFANTIVGTPYYLSPELCEDK 176
Query: 871 HLTEKTDVFAFGVLALETVSGR 892
EK+DV+A GV+ E +G+
Sbjct: 177 PYNEKSDVWALGVVLYECCTGK 198
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 2e-26
Identities = 61/205 (29%), Positives = 96/205 (46%), Gaps = 14/205 (6%)
Query: 698 SNKLGEGGFGPVYKG-KLGDGRAIAVKQLSVASRQGKS--QFVAEIATISAVQHRNLVKL 754
NK+G G FG VY L G +AVK++ + K+ + E+ + ++H NLVK
Sbjct: 5 GNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKY 64
Query: 755 HGCCIEGAERLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVR 814
+G + + + EY +L++ L R L Y + + GLAYLH
Sbjct: 65 YGVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTL--QLLEGLAYLHSH---G 119
Query: 815 IIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVAGTIG---YLAPEYAMRGH 871
I+HRD+K +N+ LD + V K+ DFG A + T + V G Y+APE G
Sbjct: 120 IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGK 179
Query: 872 LTEK---TDVFAFGVLALETVSGRP 893
D+++ G + LE +G+
Sbjct: 180 GKGHGRAADIWSLGCVVLEMATGKR 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 4e-26
Identities = 59/197 (29%), Positives = 106/197 (53%), Gaps = 12/197 (6%)
Query: 701 LGEGGFGPVYKGKLG----DGRAIAVKQL-SVASRQGKSQFVAEIATISAVQHRNLVKLH 755
+G G FG V +G+L +A+K L + +S + + F+ E + + H N+++L
Sbjct: 12 IGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLE 71
Query: 756 GCCIEGAERLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRI 815
G + +++ EY+EN SLD+ L + + G+A G+ YL S +
Sbjct: 72 GVVTKSRPVMIITEYMENGSLDKFL-RENDGKFTVGQLVGMLRGIASGMKYL---SEMNY 127
Query: 816 IHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVAGTIG--YLAPEYAMRGHLT 873
+HRD+ A N+L++++LV K+SDFGL++ +D + +T+ G I + APE T
Sbjct: 128 VHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTK-GGKIPIRWTAPEAIAYRKFT 186
Query: 874 EKTDVFAFGVLALETVS 890
+DV++FG++ E +S
Sbjct: 187 SASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 1e-25
Identities = 63/210 (30%), Positives = 103/210 (49%), Gaps = 30/210 (14%)
Query: 701 LGEGGFGPVYKG---KLGDGRAI--AVKQLSVAS-RQGKSQFVAEIATISAVQHRNLVKL 754
LG G FG VYKG G+ I A+K L + + + + E +++V H ++V+L
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74
Query: 755 HGCCIEGAERLLVYEYLENKSLD------QALFGQRSLTLDWATRYEICSGVARGLAYLH 808
G C+ ++ L+ + + L + G + L L+W + +A+G++YL
Sbjct: 75 LGICL-SSQVQLITQLMPLGCLLDYVRNHKDNIGSQYL-LNWCVQ------IAKGMSYLE 126
Query: 809 EESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVAG---TIGYLAPE 865
E R++HRD+ A NVL+ KI+DFGLAKL D + G I ++A E
Sbjct: 127 E---KRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEY--HAEGGKVPIKWMALE 181
Query: 866 YAMRGHLTEKTDVFAFGVLALE--TVSGRP 893
+ T K+DV+++GV E T +P
Sbjct: 182 SILHRIYTHKSDVWSYGVTVWELMTFGAKP 211
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 1e-25
Identities = 64/194 (32%), Positives = 105/194 (54%), Gaps = 6/194 (3%)
Query: 700 KLGEGGFGPVYKGKLGDGRAIAVKQLSVASRQGKSQFVAEIATISAVQHRNLVKLHGCCI 759
KLG+G FG V+ G +A+K L + ++ F+ E + ++H LV+L+
Sbjct: 13 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAVVS 71
Query: 760 EGAERLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRD 819
E +V EY+ SL L G+ L ++ + +A G+AY+ R+ +HRD
Sbjct: 72 E-EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRD 127
Query: 820 VKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVAGTIGYLAPEYAMRGHLTEKTDVF 879
++A+N+L+ +LV K++DFGLA+L +D + I + APE A+ G T K+DV+
Sbjct: 128 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 187
Query: 880 AFGVLALE-TVSGR 892
+FG+L E T GR
Sbjct: 188 SFGILLTELTTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 2e-25
Identities = 62/194 (31%), Positives = 101/194 (52%), Gaps = 5/194 (2%)
Query: 700 KLGEGGFGPVYKGKLGDGRAIAVKQLSVASRQGKSQFVAEIATISAVQHRNLVKLHGCCI 759
KLG G FG V++G + +AVK L + K F+AE + ++H L++L+ C
Sbjct: 13 KLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPK-DFLAEAQIMKKLRHPKLIQLYAVCT 71
Query: 760 EGAERLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRD 819
+V E ++ SL + L G L ++ + VA G+AYL ++ IHRD
Sbjct: 72 LEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQN---YIHRD 128
Query: 820 VKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVAGTIGYLAPEYAMRGHLTEKTDVF 879
+ A NVL+ + + K++DFGLA++ + I + APE A+ + K+DV+
Sbjct: 129 LAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIKSDVW 188
Query: 880 AFGVLALETVS-GR 892
+FG+L E V+ GR
Sbjct: 189 SFGILLTEIVTYGR 202
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 109 bits (271), Expect = 2e-25
Identities = 80/282 (28%), Positives = 124/282 (43%), Gaps = 22/282 (7%)
Query: 694 NFSPSNKLGEGGFGPVYKGKLGDGRAIAVKQLSVA---SRQGKSQFVAEIATISAVQH-R 749
++ KLGEG FG VY + D + +A+K L+ + +F+ EI ++++ H
Sbjct: 1 SYRILRKLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58
Query: 750 NLVKLHGCCIEGAERLLVYEYLENKSLDQAL-FGQRSLTLDWATRYEICSGVARGLAYLH 808
N+VKL+ + LV EY++ SL+ L R L + I + + L YLH
Sbjct: 59 NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH 118
Query: 809 EESRVRIIHRDVKASNVLLDADL-VPKISDFGLAKLYDDKKTHISTR-----VAGTIGYL 862
+ IIHRD+K N+LLD D V K+ DFGLAKL D + S GT GY+
Sbjct: 119 SK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYM 175
Query: 863 APEYAM---RGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQE 919
APE + + + +D+++ G+ E ++G P P E+ +
Sbjct: 176 APEVLLGLSLAYASSSSDIWSLGITLYELLTGLP---PFEGEKNSSATSQTLKIILELPT 232
Query: 920 IELADPKLIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVA 961
LA P E K + P R S S ++
Sbjct: 233 PSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLS 274
|
Length = 384 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 3e-25
Identities = 59/206 (28%), Positives = 104/206 (50%), Gaps = 29/206 (14%)
Query: 700 KLGEGGFGPVYKGKL-GDGRAIAVKQLSVASR-QGKSQFVAEIATISAVQHRNLVKLHGC 757
LG+G G VYK + G+ A+K++ V + + Q + E+ T+ + + +VK +G
Sbjct: 8 VLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGA 67
Query: 758 CIEGAERLLVYEYLENKSLDQAL-----FGQRSLTLDWATRYEICSGVARGLAYLHEESR 812
+ E +V EY++ SL L + L I + +GL YLH ++
Sbjct: 68 FYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAY-------IARQILKGLDYLH--TK 118
Query: 813 VRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVAGTIGYLAPE------Y 866
IIHRD+K SN+L+++ KI+DFG++K+ ++ +T V GT+ Y++PE Y
Sbjct: 119 RHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFV-GTVTYMSPERIQGESY 177
Query: 867 AMRGHLTEKTDVFAFGVLALETVSGR 892
+ D+++ G+ LE G+
Sbjct: 178 SY------AADIWSLGLTLLECALGK 197
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 103 bits (260), Expect = 2e-24
Identities = 62/226 (27%), Positives = 100/226 (44%), Gaps = 31/226 (13%)
Query: 693 ENFSPSNKLGEGGFGPVYKGKL-GDGRAIAVKQLSVA--SRQGKSQFVA-EIATISAV-Q 747
++F +GEG F V K + A+K L ++ K ++V E ++ +
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNG 60
Query: 748 HRNLVKLHGCCIEGAERL-LVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAY 806
H ++KL+ + E L V EY N L Q + SL TR+ + + L Y
Sbjct: 61 HPGIIKLY-YTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKC-TRF-YAAEILLALEY 117
Query: 807 LHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVA---------- 856
LH IIHRD+K N+LLD D+ KI+DFG AK+ D + S +
Sbjct: 118 LH---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEK 174
Query: 857 ---------GTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRP 893
GT Y++PE + +D++A G + + ++G+P
Sbjct: 175 NRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKP 220
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 75/231 (32%), Positives = 102/231 (44%), Gaps = 30/231 (12%)
Query: 691 ATENFSPSNKLGEGGFGPVYKGKL----GDGR--AIAVKQL-SVASRQGKSQFVAEIATI 743
++ + LG G FG VY+G GD +AVK L S Q +S F+ E +
Sbjct: 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIM 63
Query: 744 SAVQHRNLVKLHGCCIEGAERLLVYEYLENKSLDQALFGQR-------SLTLDWATRYEI 796
S H+N+V+L G E R ++ E + L L R SLT+
Sbjct: 64 SKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTM--KDLLFC 121
Query: 797 CSGVARGLAYLHEESRVRIIHRDVKASNVLLD---ADLVPKISDFGLAK-LYDDKKTHIS 852
VA+G YL E IHRD+ A N LL V KI+DFG+A+ +Y
Sbjct: 122 ARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKG 178
Query: 853 TRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVS-------GRPNSD 896
R I ++ PE + G T KTDV++FGVL E S GR N +
Sbjct: 179 GRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQE 229
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 2e-24
Identities = 65/201 (32%), Positives = 102/201 (50%), Gaps = 6/201 (2%)
Query: 693 ENFSPSNKLGEGGFGPVYKGKLGDGRAIAVKQLSVASRQGKSQFVAEIATISAVQHRNLV 752
E KLG G FG V+ G +A+K L S F+AE + +QH LV
Sbjct: 6 ETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMS-PEAFLAEANLMKQLQHPRLV 64
Query: 753 KLHGCCIEGAERLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESR 812
+L+ + ++ EY+EN SL L + L ++ + +A G+A++ ++
Sbjct: 65 RLYAV-VTQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKN- 122
Query: 813 VRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVAGTIGYLAPEYAMRGHL 872
IHRD++A+N+L+ L KI+DFGLA+L +D + I + APE G
Sbjct: 123 --YIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTF 180
Query: 873 TEKTDVFAFGVLALETVS-GR 892
T K+DV++FG+L E V+ GR
Sbjct: 181 TIKSDVWSFGILLTEIVTYGR 201
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 5e-24
Identities = 65/202 (32%), Positives = 107/202 (52%), Gaps = 17/202 (8%)
Query: 700 KLGEGGFGPVYKGK-LGDGRAIAVKQLSVASRQGK--SQFVAEIATISAVQHRNLVKLHG 756
++GEG G V+K K G +A+K++++ +G +Q + EI + A QH +VKL
Sbjct: 7 RIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLD 66
Query: 757 CCIEGAERLLVYEYLENKSLDQALFG-QRSLTLDWATRY--EICSGVARGLAYLHEESRV 813
G+ +LV EY+ + L + L +R L Y + +G+AY+H
Sbjct: 67 VFPHGSGFVLVMEYMPS-DLSEVLRDEERPLPEAQVKSYMRMLL----KGVAYMHAN--- 118
Query: 814 RIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVAGTIGYLAPE--YAMRGH 871
I+HRD+K +N+L+ AD V KI+DFGLA+L+ +++ + + T Y APE Y R
Sbjct: 119 GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGAR-K 177
Query: 872 LTEKTDVFAFGVLALETVSGRP 893
D++A G + E ++G P
Sbjct: 178 YDPGVDLWAVGCIFAELLNGSP 199
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 1e-23
Identities = 74/211 (35%), Positives = 105/211 (49%), Gaps = 26/211 (12%)
Query: 701 LGEGGFGPVYKGK----LGDGRA---IAVKQLSV-ASRQGKSQFVAEIATISAVQHRNLV 752
LG G FG VY+G LG G +AVK L A+ Q K +F+ E +S H N+V
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62
Query: 753 KLHGCCIEGAERLLVYEYLENKSLDQALFGQRSLT-----LDWATRYEICSGVARGLAYL 807
KL G C+ + ++ E +E L L R L +IC VA+G YL
Sbjct: 63 KLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYL 122
Query: 808 HEESRVRIIHRDVKASNVLL-----DADLVPKISDFGLAK-LYDDKKTHISTRVAGTIG- 860
++ IHRD+ A N L+ DAD V KI DFGLA+ +Y K + G +
Sbjct: 123 E---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIY--KSDYYRKEGEGLLPV 177
Query: 861 -YLAPEYAMRGHLTEKTDVFAFGVLALETVS 890
++APE + G T ++DV++FGVL E ++
Sbjct: 178 RWMAPESLLDGKFTTQSDVWSFGVLMWEILT 208
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 63/203 (31%), Positives = 94/203 (46%), Gaps = 21/203 (10%)
Query: 699 NKLGEGGFGPVYKGKL----GDGRAIAVKQLSV-ASRQGKSQFVAEIATISAVQHRNLVK 753
+LG G FG V KG G +AVK L GK +F+ E + ++ + H +V+
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVR 60
Query: 754 LHGCCIEGAERLLVYEYLENKSLDQALFGQRSLT----LDWATRYEICSGVARGLAYLHE 809
L G C +G +LV E L + L +R + + A + VA G+AYL
Sbjct: 61 LIGVC-KGEPLMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQ------VAMGMAYLES 113
Query: 810 ESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVAGT--IGYLAPEYA 867
+HRD+ A NVLL KISDFG+++ + AG + + APE
Sbjct: 114 ---KHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECI 170
Query: 868 MRGHLTEKTDVFAFGVLALETVS 890
G + K+DV+++GV E S
Sbjct: 171 NYGKFSSKSDVWSYGVTLWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 3e-23
Identities = 69/230 (30%), Positives = 101/230 (43%), Gaps = 26/230 (11%)
Query: 699 NKLGEGGFGPVYKGK-LGDGRAIAVKQLSVASRQGKSQFVA-EIATISAVQHRNLVKLHG 756
+G G VY L + +A+K++ + Q + E+ +S H N+VK +
Sbjct: 7 EVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYT 66
Query: 757 CCIEGAERLLVYEYLENKS-LDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRI 815
+ G E LV YL S LD LD A + V +GL YLH +
Sbjct: 67 SFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQ--- 123
Query: 816 IHRDVKASNVLLDADLVPKISDFGL-AKLYD--DKKTHISTRVAGTIGYLAPEYAMRGH- 871
IHRD+KA N+LL D KI+DFG+ A L D D+ + GT ++APE + H
Sbjct: 124 IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHG 183
Query: 872 LTEKTDVFAFGVLALETVSGRP----------------NSDPSLDEEKLY 905
K D+++FG+ A+E +G N PSL+ Y
Sbjct: 184 YDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADY 233
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 98.6 bits (246), Expect = 9e-23
Identities = 79/269 (29%), Positives = 124/269 (46%), Gaps = 42/269 (15%)
Query: 701 LGEGGFGPVYKG-KLGDGRAIAVKQLSVASRQGKSQFVA-----EIATISAVQHRNLVKL 754
LG G FG VY+G L DG AVK++S+A Q EIA +S +QH N+V+
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 755 HGCCIEGAERLLVY-EYLENKSLDQAL--FGQRSLTLDWATRYEICSGVAR----GLAYL 807
G E + L ++ E + SL + L +G + + R GL YL
Sbjct: 68 LGTEREE-DNLYIFLELVPGGSLAKLLKKYG--------SFPEPVIRLYTRQILLGLEYL 118
Query: 808 HEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVAGTIGYLAPEYA 867
H+ +HRD+K +N+L+D + V K++DFG+AK + S G+ ++APE
Sbjct: 119 HDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKS--FKGSPYWMAPEVI 173
Query: 868 MR-GHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEIELADPK 926
+ G D+++ G LE +G+P P E + + + + + P
Sbjct: 174 AQQGGYGLAADIWSLGCTVLEMATGKP---PWSQLEGVAAV---FKIGRSK-----ELPP 222
Query: 927 LIEFNEEEVKRLIGVALLCTQTLPSLRPS 955
+ + +E K I L C Q PSLRP+
Sbjct: 223 IPDHLSDEAKDFI---LKCLQRDPSLRPT 248
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 98.6 bits (245), Expect = 1e-22
Identities = 64/204 (31%), Positives = 101/204 (49%), Gaps = 11/204 (5%)
Query: 700 KLGEGGFGPVYKGKLGDGRAIAVKQLSVASRQGKSQFVAEIATISAVQHRNLVKLHGCCI 759
KLG G FG V+ G + +AVK L + ++ F+ E + +QH LV+L+
Sbjct: 13 KLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQA-FLEEANLMKTLQHDKLVRLYAVVT 71
Query: 760 EGAERLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRD 819
+ ++ EY+ SL L + + + +A G+AY+ R IHRD
Sbjct: 72 KEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE---RKNYIHRD 128
Query: 820 VKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVAGTIGYLAPEYAMRGHLTEKTDVF 879
++A+NVL+ L+ KI+DFGLA++ +D + I + APE G T K+DV+
Sbjct: 129 LRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVW 188
Query: 880 AFGVLALETVS-------GRPNSD 896
+FG+L E V+ G NSD
Sbjct: 189 SFGILLYEIVTYGKIPYPGMSNSD 212
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 98.5 bits (245), Expect = 1e-22
Identities = 67/194 (34%), Positives = 102/194 (52%), Gaps = 6/194 (3%)
Query: 700 KLGEGGFGPVYKGKLGDGRAIAVKQLSVASRQGKSQFVAEIATISAVQHRNLVKLHGCCI 759
KLG G FG V+ G +AVK L + +S F+ E + ++H LV+L+
Sbjct: 13 KLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPES-FLEEAQIMKKLRHDKLVQLYAVVS 71
Query: 760 EGAERLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRD 819
E +V EY+ SL L L ++ + VA G+AY+ R+ IHRD
Sbjct: 72 E-EPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIE---RMNYIHRD 127
Query: 820 VKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVAGTIGYLAPEYAMRGHLTEKTDVF 879
++++N+L+ LV KI+DFGLA+L +D + I + APE A+ G T K+DV+
Sbjct: 128 LRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 187
Query: 880 AFGVLALETVS-GR 892
+FG+L E V+ GR
Sbjct: 188 SFGILLTELVTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 98.0 bits (244), Expect = 2e-22
Identities = 72/218 (33%), Positives = 100/218 (45%), Gaps = 23/218 (10%)
Query: 701 LGEGGFGPV--YK---GKLGDGRAIAVKQL-SVASRQGKSQFVAEIATISAVQHRNLVKL 754
LGEG FG V Y G G +AVK L +Q S + EI + + H N+VK
Sbjct: 12 LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKY 71
Query: 755 HGCCIEGAER--LLVYEYLENKSLDQALFGQRSLTLDWATRY--EICSGVARGLAYLHEE 810
GCC E + L+ EY+ SL L + L L + +IC G+AYLH +
Sbjct: 72 KGCCSEQGGKGLQLIMEYVPLGSLRDYL-PKHKLNLAQLLLFAQQIC----EGMAYLHSQ 126
Query: 811 SRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVAGT--IGYLAPEYAM 868
IHRD+ A NVLLD D + KI DFGLAK + + R G + + A E
Sbjct: 127 ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLK 183
Query: 869 RGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYL 906
+ +DV++FGV E ++ + D K +
Sbjct: 184 ENKFSYASDVWSFGVTLYELLT---HCDSKQSPPKKFE 218
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 97.3 bits (242), Expect = 2e-22
Identities = 68/235 (28%), Positives = 105/235 (44%), Gaps = 28/235 (11%)
Query: 700 KLGEGGFGPVYKGKLGDGRAIAVKQLSVASRQGKSQFVAEIATISAVQHRNLVKLHGCCI 759
+LG G FG V GK +A+K + S + +F+ E + + H LV+L+G C
Sbjct: 11 ELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCT 69
Query: 760 EGAERLLVYEYLENKSLDQALF-GQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHR 818
+ +V EY+ N L L + + E+C V G+AYL ES+ + IHR
Sbjct: 70 KQRPIYIVTEYMSNGCLLNYLREHGKRFQP--SQLLEMCKDVCEGMAYL--ESK-QFIHR 124
Query: 819 DVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVAGTIGYLAPEYAMRGHLTEKTDV 878
D+ A N L+D K+SDFGL++ D + S + + PE + + K+DV
Sbjct: 125 DLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLYSKFSSKSDV 184
Query: 879 FAFGVL--------------------ALETVSGRPNSDPSLDEEKLYLLEWA-WH 912
+AFGVL + G P L EK+Y + ++ WH
Sbjct: 185 WAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYRPHLASEKVYAIMYSCWH 239
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 97.2 bits (242), Expect = 3e-22
Identities = 74/265 (27%), Positives = 122/265 (46%), Gaps = 25/265 (9%)
Query: 699 NKLGEGGFGPVYKGKLGD-GRAIAVKQLSVASRQGKSQFVAEIATISAVQHRNLVKLHGC 757
+KLG G +G VY+G +AVK L + + + +F+ E A + ++H NLV+L G
Sbjct: 12 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGV 70
Query: 758 CIEGAERLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIH 817
C ++ E++ +L L ++ + + ++ + YL E + IH
Sbjct: 71 CTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYL--EKK-NFIH 127
Query: 818 RDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVAGT---IGYLAPEYAMRGHLTE 874
RD+ A N L+ + + K++DFGL++L T AG I + APE +
Sbjct: 128 RDLAARNCLVGENHLVKVADFGLSRLMTGD---TYTAHAGAKFPIKWTAPESLAYNKFSI 184
Query: 875 KTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEIELADPKLIEFNEEE 934
K+DV+AFGVL E + + P +D ++Y L E +E P E +
Sbjct: 185 KSDVWAFGVLLWEIATYGMSPYPGIDLSQVY------ELLEKGYRME--RP---EGCPPK 233
Query: 935 VKRLIGVALLCTQTLPSLRPSMSRV 959
V L+ C Q PS RPS + +
Sbjct: 234 VYELM---RACWQWNPSDRPSFAEI 255
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 98.3 bits (244), Expect = 3e-22
Identities = 69/235 (29%), Positives = 117/235 (49%), Gaps = 15/235 (6%)
Query: 693 ENFSPSNKLGEGGFGPVYKGK-LGDGRAIAVKQLSVASRQGKSQFVAEIATISAVQHRNL 751
+ ++ K+G+G G V+ + G+ +A+KQ+++ + K + EI + +++ N+
Sbjct: 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNI 78
Query: 752 VKLHGCCIEGAERLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEES 811
V + G E +V EYL SL + +D A +C + L +LH
Sbjct: 79 VNFLDSFLVGDELFVVMEYLAGGSLTDVV---TETCMDEAQIAAVCRECLQALEFLHAN- 134
Query: 812 RVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVAGTIGYLAPEYAMRGH 871
++IHRD+K+ NVLL D K++DFG +++ ST V GT ++APE R
Sbjct: 135 --QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKA 191
Query: 872 LTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEIELADPK 926
K D+++ G++A+E V G P P L+E L L +L N EL +P+
Sbjct: 192 YGPKVDIWSLGIMAIEMVEGEP---PYLNENPLRAL----YLIATNGTPELQNPE 239
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 96.8 bits (241), Expect = 3e-22
Identities = 63/194 (32%), Positives = 97/194 (50%), Gaps = 6/194 (3%)
Query: 700 KLGEGGFGPVYKGKLGDGRAIAVKQLSVASRQG-KSQFVAEIATISAVQHRNLVKLHGCC 758
K+G+G FG VYKG L +AVK K +F+ E + H N+VKL G C
Sbjct: 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC 61
Query: 759 IEGAERLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHR 818
++ +V E + SL L +++ L ++ A G+ YL ES+ IHR
Sbjct: 62 VQKQPIYIVMELVPGGSLLTFLRKKKN-RLTVKKLLQMSLDAAAGMEYL--ESK-NCIHR 117
Query: 819 DVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVAGT-IGYLAPEYAMRGHLTEKTD 877
D+ A N L+ + V KISDFG+++ + +S + I + APE G T ++D
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSESD 177
Query: 878 VFAFGVLALETVSG 891
V+++G+L ET S
Sbjct: 178 VWSYGILLWETFSL 191
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 97.7 bits (243), Expect = 4e-22
Identities = 69/227 (30%), Positives = 111/227 (48%), Gaps = 15/227 (6%)
Query: 700 KLGEGGFGPVYKG-KLGDGRAIAVKQLSVASRQGKSQFVAEIATISAVQHRNLVKLHGCC 758
K+G+G G VY + G+ +A+KQ+++ + K + EI + +H N+V
Sbjct: 26 KIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSY 85
Query: 759 IEGAERLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHR 818
+ G E +V EYL SL + +D +C + L +LH ++IHR
Sbjct: 86 LVGDELWVVMEYLAGGSLTDVV---TETCMDEGQIAAVCRECLQALEFLHSN---QVIHR 139
Query: 819 DVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVAGTIGYLAPEYAMRGHLTEKTDV 878
D+K+ N+LL D K++DFG +++ ST V GT ++APE R K D+
Sbjct: 140 DIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKVDI 198
Query: 879 FAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEIELADP 925
++ G++A+E V G P P L+E L A +L N EL +P
Sbjct: 199 WSLGIMAIEMVEGEP---PYLNENPLR----ALYLIATNGTPELQNP 238
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 97.4 bits (243), Expect = 4e-22
Identities = 57/213 (26%), Positives = 102/213 (47%), Gaps = 40/213 (18%)
Query: 700 KLGEGGFGPVYKGK-LGDGRAIAVKQLSVASRQG--KSQFVAEIATISAVQHRNLVKLHG 756
K+GEG +G VYK + G +A+K++ + + EI + + H N++KL
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLD 65
Query: 757 CCIEGAERLLVYEYLE----------NKSLDQALFGQRSLTLDWATRYEICSGVARGLAY 806
+ LV+E+++ + L ++L +S Y++ +GLA+
Sbjct: 66 VFRHKGDLYLVFEFMDTDLYKLIKDRQRGLPESLI--KSYL------YQLL----QGLAF 113
Query: 807 LHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKK---TH-ISTRVAGTIGYL 862
H I+HRD+K N+L++ + V K++DFGLA+ + TH + TR Y
Sbjct: 114 CH---SHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTR-----WYR 165
Query: 863 APE--YAMRGHLTEKTDVFAFGVLALETVSGRP 893
APE +G+ + D+++ G + E +S RP
Sbjct: 166 APELLLGDKGY-STPVDIWSVGCIFAELLSRRP 197
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 95.9 bits (238), Expect = 9e-22
Identities = 64/194 (32%), Positives = 103/194 (53%), Gaps = 6/194 (3%)
Query: 700 KLGEGGFGPVYKGKLGDGRAIAVKQLSVASRQGKSQFVAEIATISAVQHRNLVKLHGCCI 759
KLG+G FG V+ G +A+K L + ++ F+ E + ++H LV L+
Sbjct: 13 KLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEA-FLQEAQIMKKLRHDKLVPLYAVVS 71
Query: 760 EGAERLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRD 819
E +V E++ SL L L ++ + +A G+AY+ R+ IHRD
Sbjct: 72 E-EPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIE---RMNYIHRD 127
Query: 820 VKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVAGTIGYLAPEYAMRGHLTEKTDVF 879
++A+N+L+ +LV KI+DFGLA+L +D + I + APE A+ G T K+DV+
Sbjct: 128 LRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 187
Query: 880 AFGVLALETVS-GR 892
+FG+L E V+ GR
Sbjct: 188 SFGILLTELVTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 95.9 bits (238), Expect = 9e-22
Identities = 73/272 (26%), Positives = 122/272 (44%), Gaps = 21/272 (7%)
Query: 693 ENFSPSNKLGEGGFGPVYKGKLGDGRAIAVKQLSVASRQGKSQFVAEIATISAVQHRNLV 752
E+ KLG G FG V+ +AVK + S F+AE + +QH LV
Sbjct: 6 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLV 64
Query: 753 KLHGCCIEGAERLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESR 812
KLH + ++ E++ SL L + + +A G+A++ + +
Sbjct: 65 KLHAV-VTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN- 122
Query: 813 VRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVAGTIGYLAPEYAMRGHL 872
IHRD++A+N+L+ A LV KI+DFGLA++ +D + I + APE G
Sbjct: 123 --YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSF 180
Query: 873 TEKTDVFAFGVLALETVS-GRPNSDPSLDEEKLYLLEWAWHLHENNQEIELADPKLIEFN 931
T K+DV++FG+L +E V+ GR + E + LE + +
Sbjct: 181 TIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPR---------------P 225
Query: 932 EEEVKRLIGVALLCTQTLPSLRPSMSRVVAML 963
E + L + + C + P RP+ + ++L
Sbjct: 226 ENCPEELYNIMMRCWKNRPEERPTFEYIQSVL 257
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 95.8 bits (238), Expect = 1e-21
Identities = 67/214 (31%), Positives = 111/214 (51%), Gaps = 21/214 (9%)
Query: 701 LGEGGFGPVYKGKLG-DGR---AIAVKQLSVA-SRQGKSQFVAEIATISAVQHRNLVKLH 755
+G G FG V++G L GR A+A+K L + + + F++E + + H N+++L
Sbjct: 13 IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLE 72
Query: 756 GCCIEGAERLLVYEYLENKSLDQALFGQ----RSLTLDWATRYEICSGVARGLAYLHEES 811
G + +++ EY+EN +LD+ L S L R G+A G+ YL + +
Sbjct: 73 GVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLR-----GIAAGMKYLSDMN 127
Query: 812 RVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVAGTIG--YLAPEYAMR 869
V HRD+ A N+L++++L K+SDFGL+++ +D T G I + APE
Sbjct: 128 YV---HRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAY 184
Query: 870 GHLTEKTDVFAFGVLALETVS--GRPNSDPSLDE 901
T +DV++FG++ E +S RP D S E
Sbjct: 185 RKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHE 218
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 95.6 bits (238), Expect = 1e-21
Identities = 65/207 (31%), Positives = 110/207 (53%), Gaps = 15/207 (7%)
Query: 694 NFSPSNKLGEGGFGPVYKGK-LGDGRAIAVKQ--LSVASRQGKSQFVAEIATISAVQHRN 750
+F KLG+G +G VYK K L D + A+K+ L S++ + V EI +++V H N
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60
Query: 751 LVKLHGCCIEGAERLLVYEYLENKSLDQALFGQ----RSLTLDWATRYEICSGVARGLAY 806
++ ++G + +V EY L +A+ + + + R I + RGL
Sbjct: 61 IISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFI--QLLRGLQA 118
Query: 807 LHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVAGTIGYLAPEY 866
LHE+ +I+HRD+K++N+LL A+ + KI D G++K+ KK T++ GT Y+APE
Sbjct: 119 LHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVL--KKNMAKTQI-GTPHYMAPEV 172
Query: 867 AMRGHLTEKTDVFAFGVLALETVSGRP 893
+ K+D+++ G L E + P
Sbjct: 173 WKGRPYSYKSDIWSLGCLLYEMATFAP 199
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 96.3 bits (240), Expect = 1e-21
Identities = 78/286 (27%), Positives = 128/286 (44%), Gaps = 46/286 (16%)
Query: 701 LGEGGFGPVYKG------KLGDGRAIAVKQL-SVASRQGKSQFVAEIATISAV-QHRNLV 752
LGEG FG V K + +AVK L A+ + S V+E+ + + +H+N++
Sbjct: 20 LGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNII 79
Query: 753 KLHGCCIEGAERLLVYEYLENKSLDQALFGQRSLTLDWA-----------TRYEICS--- 798
L G C + +V EY + +L L +R + T+ ++ S
Sbjct: 80 NLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAY 139
Query: 799 GVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDD----KKTHISTR 854
VARG+ +L S+ + IHRD+ A NVL+ D V KI+DFGLA+ +KT T
Sbjct: 140 QVARGMEFL--ASK-KCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKT---TN 193
Query: 855 VAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLH 914
+ ++APE T ++DV++FGVL E + + P + E+L+
Sbjct: 194 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELF--------- 244
Query: 915 ENNQEIELADPKLIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVV 960
+ +E + E L + C +PS RP+ ++V
Sbjct: 245 KLLKEGYRMEKPQNCTQE-----LYHLMRDCWHEVPSQRPTFKQLV 285
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 96.3 bits (239), Expect = 1e-21
Identities = 68/235 (28%), Positives = 115/235 (48%), Gaps = 15/235 (6%)
Query: 693 ENFSPSNKLGEGGFGPVYKG-KLGDGRAIAVKQLSVASRQGKSQFVAEIATISAVQHRNL 751
+ ++ K+G+G G VY + G+ +A+KQ+++ + K + EI + ++ N+
Sbjct: 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNI 78
Query: 752 VKLHGCCIEGAERLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEES 811
V + G E +V EYL SL + +D +C + L +LH
Sbjct: 79 VNYLDSYLVGDELWVVMEYLAGGSLTDVV---TETCMDEGQIAAVCRECLQALDFLHSN- 134
Query: 812 RVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVAGTIGYLAPEYAMRGH 871
++IHRD+K+ N+LL D K++DFG +++ ST V GT ++APE R
Sbjct: 135 --QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKA 191
Query: 872 LTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEIELADPK 926
K D+++ G++A+E V G P P L+E L L +L N EL +P+
Sbjct: 192 YGPKVDIWSLGIMAIEMVEGEP---PYLNENPLRAL----YLIATNGTPELQNPE 239
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 95.6 bits (238), Expect = 2e-21
Identities = 80/288 (27%), Positives = 122/288 (42%), Gaps = 36/288 (12%)
Query: 693 ENFSPSNKLGEGGFGPVYKGKL------GDGRAIAVKQL-SVASRQGKSQFVAEIATISA 745
N LG G FG V+ K G + VK L +S+F E+
Sbjct: 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRK 64
Query: 746 VQHRNLVKLHGCCIEGAERLLVYEYLENKSLDQALFGQRSLT-------LDWATRYEICS 798
+ H+N+V+L G C E ++ EY + L Q L +S L + +C+
Sbjct: 65 LSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCT 124
Query: 799 GVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAK-LYDDKKTHISTRVAG 857
+A G+ +L S R +HRD+ A N L+ + K+S L+K +Y+ + + +
Sbjct: 125 QIALGMDHL---SNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALI- 180
Query: 858 TIGYLAPEYAMRGHLTEKTDVFAFGVLALE--TVSGRPNSDPSLDEEKLYLLEWAWHLHE 915
+ +LAPE + K+DV++FGVL E T P S DEE L L+
Sbjct: 181 PLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLS-DEEVLNRLQ------- 232
Query: 916 NNQEIELADPKLIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVAML 963
++EL P E RL + C P RPS S +V+ L
Sbjct: 233 -AGKLELPVP------EGCPSRLYKLMTRCWAVNPKDRPSFSELVSAL 273
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 95.4 bits (237), Expect = 2e-21
Identities = 59/208 (28%), Positives = 99/208 (47%), Gaps = 23/208 (11%)
Query: 700 KLGEGGFGPVYKGKLG------DGRAIAVKQLSVASRQGKSQFVAEIATISAVQHRNLVK 753
+LGEG FG V+ + D +AVK L AS + F E ++ +QH+++V+
Sbjct: 12 ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVR 71
Query: 754 LHGCCIEGAERLLVYEYLENKSLDQALF-------------GQRSLTLDWATRYEICSGV 800
+G C EG L+V+EY+ + L++ L L I S +
Sbjct: 72 FYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQI 131
Query: 801 ARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAK-LYDDKKTHISTRVAGTI 859
A G+ YL + + +HRD+ N L+ LV KI DFG+++ +Y + R I
Sbjct: 132 ASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 188
Query: 860 GYLAPEYAMRGHLTEKTDVFAFGVLALE 887
++ PE + T ++D+++FGV+ E
Sbjct: 189 RWMPPESILYRKFTTESDIWSFGVVLWE 216
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 95.2 bits (237), Expect = 2e-21
Identities = 69/210 (32%), Positives = 101/210 (48%), Gaps = 15/210 (7%)
Query: 701 LGEGGFGPVYKGK---LGD--GRAIAVKQLSVASRQGKSQFVAEIATISAVQHRNLVKLH 755
LG+G FG V + L D G +AVK+L ++ + F EI + ++QH N+VK
Sbjct: 12 LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYK 71
Query: 756 GCCIEGAER--LLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRV 813
G C R LV EYL SL L R LD S + +G+ YL +
Sbjct: 72 GVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRE-RLDHRKLLLYASQICKGMEYLGSK--- 127
Query: 814 RIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVAGT--IGYLAPEYAMRGH 871
R +HRD+ N+L++++ KI DFGL K+ K + R G I + APE
Sbjct: 128 RYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESK 187
Query: 872 LTEKTDVFAFGVLALE--TVSGRPNSDPSL 899
+ +DV++FGV+ E T S + S P+
Sbjct: 188 FSVASDVWSFGVVLYELFTYSDKSCSPPAE 217
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 3e-21
Identities = 87/338 (25%), Positives = 152/338 (44%), Gaps = 29/338 (8%)
Query: 636 LIVGIVVGVGVATFLSVLAIFCIVRRR----KRPQHDDDE-ELLGMDARPYTFSYAELKT 690
+ +G + L I R KR +++D EL D++ + S +
Sbjct: 630 FYITCTLGAFLVLALVAFGFVFIRGRNNLELKRVENEDGTWELQFFDSK-VSKSIT-IND 687
Query: 691 ATENFSPSNKLGEGGFGPVYKGK-LGDGRAIAVKQLSVASRQGKSQFVAEIATISAVQHR 749
+ N + G G YKGK + +G VK++ S +EIA + +QH
Sbjct: 688 ILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEI----NDVNSIPSSEIADMGKLQHP 743
Query: 750 NLVKLHGCCIEGAERLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHE 809
N+VKL G C L++EY+E K+L + L L W R +I G+A+ L +LH
Sbjct: 744 NIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN-----LSWERRRKIAIGIAKALRFLHC 798
Query: 810 ESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLY-DDKKTHISTRVAGTIGYLAPEYAM 868
++ ++ +++D P + L L D K IS+ Y+APE
Sbjct: 799 RCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTDTKCFISS------AYVAPETRE 851
Query: 869 RGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEIELADPKL- 927
+TEK+D++ FG++ +E ++G+ +D ++EWA + + + DP +
Sbjct: 852 TKDITEKSDIYGFGLILIELLTGKSPADAEFGVHG-SIVEWARYCYSDCHLDMWIDPSIR 910
Query: 928 --IEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVAML 963
+ N+ E+ ++ +AL CT T P+ RP + V+ L
Sbjct: 911 GDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTL 948
|
Length = 968 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 93.9 bits (233), Expect = 7e-21
Identities = 63/202 (31%), Positives = 100/202 (49%), Gaps = 22/202 (10%)
Query: 701 LGEGGFGPVYKG---KLGDGRAIAVKQLSVASRQGKSQFVA---EIATISAVQHRNLVKL 754
LG G FG V+KG GD I V ++ R G+ F + + ++ H +V+L
Sbjct: 15 LGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRL 74
Query: 755 HGCCIEGAERLLVYEYLENKSLDQALFGQR-----SLTLDWATRYEICSGVARGLAYLHE 809
G C GA LV + SL + R L+W C +A+G+ YL E
Sbjct: 75 LGIC-PGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNW------CVQIAKGMYYLEE 127
Query: 810 ESRVRIIHRDVKASNVLLDADLVPKISDFGLAK-LYDDKKTHISTRVAGTIGYLAPEYAM 868
R++HR++ A N+LL +D + +I+DFG+A LY D K + + I ++A E +
Sbjct: 128 H---RMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESIL 184
Query: 869 RGHLTEKTDVFAFGVLALETVS 890
G T ++DV+++GV E +S
Sbjct: 185 FGRYTHQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 94.5 bits (235), Expect = 7e-21
Identities = 73/270 (27%), Positives = 122/270 (45%), Gaps = 35/270 (12%)
Query: 695 FSPSNKLGEGGFGPVYKGK-LGDGRAIAVKQLSVASRQGKSQF---VAEIATISAVQHRN 750
F+ ++G G FG VY + + +A+K++S + +Q ++ + E+ + ++H N
Sbjct: 17 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPN 76
Query: 751 LVKLHGCCIEGAERLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEE 810
++ GC + LV EY + D ++ L IC G +GLAYLH
Sbjct: 77 TIEYKGCYLREHTAWLVMEYCLGSASDILEVHKKPLQEVEIA--AICHGALQGLAYLHSH 134
Query: 811 SRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVAGTIGYLAPE--YAM 868
R IHRD+KA N+LL K++DFG A L + + GT ++APE AM
Sbjct: 135 ER---IHRDIKAGNILLTEPGTVKLADFGSASLVSPANSFV-----GTPYWMAPEVILAM 186
Query: 869 -RGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEIELADPKL 927
G K DV++ G+ +E +P P + + L +H+ +N+ P L
Sbjct: 187 DEGQYDGKVDVWSLGITCIELAERKP---PLFNMNAMSAL---YHIAQNDS------PTL 234
Query: 928 --IEFNEEEVKRLIGVALLCTQTLPSLRPS 955
++++ C Q +P RPS
Sbjct: 235 SSNDWSDY----FRNFVDSCLQKIPQDRPS 260
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 93.6 bits (232), Expect = 8e-21
Identities = 78/307 (25%), Positives = 136/307 (44%), Gaps = 46/307 (14%)
Query: 694 NFSPSNKLGEGGFGPVYKGKL------GDGRAIAVKQLSVASRQGKSQFVAEIATISAVQ 747
N +LGEG FG V+ + D +AVK L AS + F E ++ +Q
Sbjct: 6 NIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQ 65
Query: 748 HRNLVKLHGCCIEGAERLLVYEYLENKSLDQALF-----------GQRSLTLDWATRYEI 796
H ++VK +G C+EG ++V+EY+++ L++ L G R L + I
Sbjct: 66 HEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHI 125
Query: 797 CSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAK-LYDDKKTHISTRV 855
+A G+ YL + +HRD+ N L+ +L+ KI DFG+++ +Y +
Sbjct: 126 AQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHT 182
Query: 856 AGTIGYLAPEYAMRGHLTEKTDVFAFGVLALE--TVSGRPNSDPSLDEEKLYLLEWAWHL 913
I ++ PE M T ++DV++ GV+ E T +P W+
Sbjct: 183 MLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQP-----------------WYQ 225
Query: 914 HENNQEIE-LADPKLIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVAMLCGDMEVSTV 972
NN+ IE + ++++ K + + L C Q P +R ++ + ++L +
Sbjct: 226 LSNNEVIECITQGRVLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLL-----QNLA 280
Query: 973 TAKPGYL 979
A P YL
Sbjct: 281 KASPVYL 287
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 92.4 bits (230), Expect = 1e-20
Identities = 57/193 (29%), Positives = 86/193 (44%), Gaps = 15/193 (7%)
Query: 700 KLGEGGFGPVYKGK----LGDGRAIAVKQLSVASRQGKSQ-FVAEIATISAVQHRNLVKL 754
KLG+G FG V +G+ G +AVK L F+ E A + ++ H NL++L
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61
Query: 755 HGCCIEGAERLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVR 814
+G + ++V E SL L +T + +A G+ YL + R
Sbjct: 62 YGVVLT-HPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESK---R 117
Query: 815 IIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHIST----RVAGTIGYLAPEYAMRG 870
IHRD+ A N+LL +D KI DFGL + + H +V + APE
Sbjct: 118 FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVP--FAWCAPESLRTR 175
Query: 871 HLTEKTDVFAFGV 883
+ +DV+ FGV
Sbjct: 176 TFSHASDVWMFGV 188
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 93.3 bits (232), Expect = 1e-20
Identities = 62/214 (28%), Positives = 106/214 (49%), Gaps = 13/214 (6%)
Query: 693 ENFSPSNKLGEGGFGPVYKG-KLGDGRAIAVKQLSVASRQGKSQFVAEIATISAVQHRNL 751
K+GEG G V GR +AVK++ + +Q + E+ + QH N+
Sbjct: 19 SYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNI 78
Query: 752 VKLHGCCIEGAERLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEES 811
V+++ + G E +V E+LE +L + R AT +C V + L++LH +
Sbjct: 79 VEMYSSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAT---VCLAVLKALSFLHAQ- 134
Query: 812 RVRIIHRDVKASNVLLDADLVPKISDFGL-AKLYDDKKTHISTRVAGTIGYLAPEYAMRG 870
+IHRD+K+ ++LL +D K+SDFG A++ + S + GT ++APE R
Sbjct: 135 --GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKS--LVGTPYWMAPEVISRL 190
Query: 871 HLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKL 904
+ D+++ G++ +E V G P P +E L
Sbjct: 191 PYGTEVDIWSLGIMVIEMVDGEP---PYFNEPPL 221
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 92.9 bits (230), Expect = 2e-20
Identities = 66/235 (28%), Positives = 115/235 (48%), Gaps = 15/235 (6%)
Query: 693 ENFSPSNKLGEGGFGPVYKG-KLGDGRAIAVKQLSVASRQGKSQFVAEIATISAVQHRNL 751
+ ++ K+G+G G VY + G+ +A++Q+++ + K + EI + ++ N+
Sbjct: 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNI 79
Query: 752 VKLHGCCIEGAERLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEES 811
V + G E +V EYL SL + +D +C + L +LH
Sbjct: 80 VNYLDSYLVGDELWVVMEYLAGGSLTDVV---TETCMDEGQIAAVCRECLQALEFLHSN- 135
Query: 812 RVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVAGTIGYLAPEYAMRGH 871
++IHRD+K+ N+LL D K++DFG +++ ST V GT ++APE R
Sbjct: 136 --QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKA 192
Query: 872 LTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEIELADPK 926
K D+++ G++A+E + G P P L+E L L +L N EL +P+
Sbjct: 193 YGPKVDIWSLGIMAIEMIEGEP---PYLNENPLRAL----YLIATNGTPELQNPE 240
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 92.0 bits (229), Expect = 2e-20
Identities = 71/283 (25%), Positives = 129/283 (45%), Gaps = 41/283 (14%)
Query: 701 LGEGGFGPVYKG------KLGDGRAIAVKQLSV-ASRQGKSQFVAEIATISAVQHRNLVK 753
LG+G FG VY+G K +A+K ++ AS + + +F+ E + + ++V+
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 754 LHGCCIEGAERLLVYEYLENKSLDQALFGQRS----------LTLDWATRYEICSGVARG 803
L G G L+V E + L L +R TL ++ + +A G
Sbjct: 74 LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKF--IQMAAEIADG 131
Query: 804 LAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAK-LYDDKKTHISTRVAGTIGYL 862
+AYL + + +HRD+ A N ++ DL KI DFG+ + +Y+ + + ++
Sbjct: 132 MAYLAAK---KFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 188
Query: 863 APEYAMRGHLTEKTDVFAFGVLALE--TVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEI 920
APE G T K+DV++FGV+ E T++ +P S +E +++
Sbjct: 189 APESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVI------------- 235
Query: 921 ELADPKLIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVAML 963
D ++ E +L+ + +C Q P +RP+ +V+ L
Sbjct: 236 ---DGGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSL 275
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 92.4 bits (229), Expect = 3e-20
Identities = 61/207 (29%), Positives = 106/207 (51%), Gaps = 13/207 (6%)
Query: 689 KTATENFSPSNKLGEGGFGPVYKGKLG-DGRAIAVKQLSVASRQGKSQFVAEIATISAVQ 747
++ EN+ K+GEG G V + GR +AVK + + +Q + E+ + Q
Sbjct: 20 RSLLENYI---KIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQ 76
Query: 748 HRNLVKLHGCCIEGAERLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYL 807
H+N+V+++ + G E ++ E+L+ +L + R AT +C V + L YL
Sbjct: 77 HQNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQTRLNEEQIAT---VCESVLQALCYL 133
Query: 808 HEESRVRIIHRDVKASNVLLDADLVPKISDFGL-AKLYDDKKTHISTRVAGTIGYLAPEY 866
H + +IHRD+K+ ++LL D K+SDFG A++ D S + GT ++APE
Sbjct: 134 HSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS--LVGTPYWMAPEV 188
Query: 867 AMRGHLTEKTDVFAFGVLALETVSGRP 893
R + D+++ G++ +E V G P
Sbjct: 189 ISRTPYGTEVDIWSLGIMVIEMVDGEP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 91.3 bits (227), Expect = 4e-20
Identities = 78/283 (27%), Positives = 127/283 (44%), Gaps = 40/283 (14%)
Query: 692 TENFSPSNKLGEGGFGPVYKGK-LGDGRAIAVKQLSV---ASRQGKSQFVAEIATISAVQ 747
NF K+G+G F VYK L DGR +A+K++ + + + + EI + +
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 748 HRNLVKLHGCCIEGAERLLVYEYLENKSL---------DQALFGQRSLTLDWATRYEICS 798
H N++K IE E +V E + L + L +R++ W ++CS
Sbjct: 61 HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTI---WKYFVQLCS 117
Query: 799 GVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVAGT 858
L ++H + RI+HRD+K +NV + A V K+ D GL + + K T + V GT
Sbjct: 118 A----LEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GT 169
Query: 859 IGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQ 918
Y++PE K+D+++ G L E + + S D+ LY L +
Sbjct: 170 PYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQ--SPFYGDKMNLYSL---------CK 218
Query: 919 EIELAD--PKLIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRV 959
+IE D P + EE++ L+ C P RP +S V
Sbjct: 219 KIEKCDYPPLPADHYSEELRDLVSR---CINPDPEKRPDISYV 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 91.0 bits (226), Expect = 4e-20
Identities = 61/204 (29%), Positives = 94/204 (46%), Gaps = 21/204 (10%)
Query: 701 LGEGGFGPVYKGK-LGDGRAIAVKQLSVASRQGKSQFVAEIATISAVQHRNLVKLHGCCI 759
LG+G +G VY + L IA+K++ + EIA S ++HRN+V+ G
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDS 75
Query: 760 EGAERLLVYEYLENKSLDQAL------FGQRSLTLDWATRYEICSGVARGLAYLHEESRV 813
E + E + SL L T+ + T+ + GL YLH+
Sbjct: 76 ENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQ-----ILEGLKYLHDN--- 127
Query: 814 RIIHRDVKASNVLLDA-DLVPKISDFGLAKLYDDKKTHISTRVAGTIGYLAPE---YAMR 869
+I+HRD+K NVL++ V KISDFG +K T GT+ Y+APE R
Sbjct: 128 QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTET-FTGTLQYMAPEVIDKGPR 186
Query: 870 GHLTEKTDVFAFGVLALETVSGRP 893
G+ D+++ G +E +G+P
Sbjct: 187 GY-GAPADIWSLGCTIVEMATGKP 209
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.5 bits (228), Expect = 4e-20
Identities = 57/209 (27%), Positives = 100/209 (47%), Gaps = 27/209 (12%)
Query: 699 NKLGEGGFGPVYKGK-LGDGRAIAVKQLSVAS-RQGKSQFVA-EIATISAVQHRNLVKLH 755
++GEG +G VYK + G +A+K++ + + ++G EI + ++H N+V+L
Sbjct: 5 AQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLK 64
Query: 756 GCCIEGAER--LLVYEYLENKSLD-QALFGQRSLTLDWATRYEICSGVARGLAYLHEESR 812
+ +V+EY+++ D L + + + GL YLH
Sbjct: 65 EIVTSKGKGSIYMVFEYMDH---DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLH---S 118
Query: 813 VRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHIST-RVAGTIGYLAPE------ 865
I+HRD+K SN+L++ D V K++DFGLA+ Y + + T RV T+ Y PE
Sbjct: 119 NGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI-TLWYRPPELLLGAT 177
Query: 866 -YAMRGHLTEKTDVFAFGVLALETVSGRP 893
Y + D+++ G + E G+P
Sbjct: 178 RY------GPEVDMWSVGCILAELFLGKP 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 91.2 bits (227), Expect = 4e-20
Identities = 57/210 (27%), Positives = 98/210 (46%), Gaps = 22/210 (10%)
Query: 699 NKLGEGGFGPVYKGK-LGDGRAIAVKQLSVA--SRQGKSQFVAEIATISAVQHRNLVKLH 755
+G+G FG V K + DG+ + K++ + + K Q V+E+ + ++H N+V+ +
Sbjct: 6 ETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYY 65
Query: 756 GCCIEGAERLL--VYEYLENKSLDQALFGQRSLTLD--------WATRYEICSGVARGLA 805
I+ + + L V EY E L Q + Q+ W ++ L
Sbjct: 66 DRIIDRSNQTLYIVMEYCEGGDLAQLI--QKCKKERKYIEEEFIWRILTQLL----LALY 119
Query: 806 YLH--EESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVAGTIGYLA 863
H + ++HRD+K +N+ LDA+ K+ DFGLAK+ + T V GT Y++
Sbjct: 120 ECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYV-GTPYYMS 178
Query: 864 PEYAMRGHLTEKTDVFAFGVLALETVSGRP 893
PE EK+D+++ G L E + P
Sbjct: 179 PEQLNHMSYDEKSDIWSLGCLIYELCALSP 208
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.1 bits (227), Expect = 4e-20
Identities = 61/205 (29%), Positives = 102/205 (49%), Gaps = 10/205 (4%)
Query: 695 FSPSNKLGEGGFGPVYKG-KLGDGRAIAVKQLSVASRQGKSQFVA-EIATISAVQHRNLV 752
F+ +G+G FG VYK + +A+K + + + + + + EI +S + +
Sbjct: 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYIT 62
Query: 753 KLHGCCIEGAERLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESR 812
K +G ++G++ ++ EY S L + LD I V GL YLHEE
Sbjct: 63 KYYGSFLKGSKLWIIMEYCGGGSCLDLL---KPGKLDETYIAFILREVLLGLEYLHEE-- 117
Query: 813 VRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVAGTIGYLAPEYAMRGHL 872
IHRD+KA+N+LL + K++DFG++ + +T V GT ++APE +
Sbjct: 118 -GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFV-GTPFWMAPEVIKQSGY 175
Query: 873 TEKTDVFAFGVLALETVSGR-PNSD 896
EK D+++ G+ A+E G P SD
Sbjct: 176 DEKADIWSLGITAIELAKGEPPLSD 200
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 90.7 bits (225), Expect = 5e-20
Identities = 61/200 (30%), Positives = 104/200 (52%), Gaps = 17/200 (8%)
Query: 701 LGEGGFGPVYKGKLG-DGR---AIAVKQLSVA-SRQGKSQFVAEIATISAVQHRNLVKLH 755
+G G FG V G+L G+ +A+K L + + + F++E + + H N++ L
Sbjct: 12 IGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71
Query: 756 GCCIEGAERLLVYEYLENKSLDQALF---GQRSLTLDWATRYEICSGVARGLAYLHEESR 812
G + ++V EY+EN SLD L GQ ++ + G+A G+ YL +
Sbjct: 72 GVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVI----QLVGMLRGIASGMKYLSDMGY 127
Query: 813 VRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVAGTIG--YLAPEYAMRG 870
V HRD+ A N+L++++LV K+SDFGL+++ +D T G I + APE
Sbjct: 128 V---HRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYR 184
Query: 871 HLTEKTDVFAFGVLALETVS 890
T +DV+++G++ E +S
Sbjct: 185 KFTSASDVWSYGIVMWEVMS 204
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 90.9 bits (225), Expect = 6e-20
Identities = 77/272 (28%), Positives = 128/272 (47%), Gaps = 28/272 (10%)
Query: 693 ENFSPSNKLGEGGFGPVYKGKLGDGRA---IAVKQLSVASRQGKSQFVA-EIATISAVQH 748
E F+ ++G+G FG V+KG D R +A+K + + + + + + EI +S
Sbjct: 4 ELFTKLERIGKGSFGEVFKGI--DNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDS 61
Query: 749 RNLVKLHGCCIEGAERLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLH 808
+ K +G ++G + ++ EYL S AL R+ D + + +GL YLH
Sbjct: 62 PYVTKYYGSYLKGTKLWIIMEYLGGGS---ALDLLRAGPFDEFQIATMLKEILKGLDYLH 118
Query: 809 EESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVAGTIGYLAPEYAM 868
E + IHRD+KA+NVLL K++DFG+A D + +T V GT ++APE
Sbjct: 119 SEKK---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIQ 174
Query: 869 RGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEIELADPKLI 928
+ K D+++ G+ A+E G P P+ D + +L + + +NN P L
Sbjct: 175 QSAYDSKADIWSLGITAIELAKGEP---PNSDMHPMRVL---FLIPKNNP------PTLT 222
Query: 929 EFNEEEVKRLIGVALLCTQTLPSLRPSMSRVV 960
+ K I C PS RP+ ++
Sbjct: 223 GEFSKPFKEFIDA---CLNKDPSFRPTAKELL 251
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 90.0 bits (223), Expect = 6e-20
Identities = 68/217 (31%), Positives = 111/217 (51%), Gaps = 20/217 (9%)
Query: 700 KLGEGGFGPVYKGKLGDGRAIAVKQLSV-ASRQGKSQFVAEIATISAVQHRNLVKLHGCC 758
+GEG FG V +G+ G+ +AVK + + Q F+ E A ++ + H+NLV+L G
Sbjct: 13 IIGEGEFGAVLQGEY-TGQKVAVKNIKCDVTAQA---FLEETAVMTKLHHKNLVRLLGVI 68
Query: 759 IEGAERLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHR 818
+ +V E + +L L + + + VA G+ YL ES+ +++HR
Sbjct: 69 LHNG-LYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYL--ESK-KLVHR 124
Query: 819 DVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVAGTIGYLAPEYAMRGHLTEKTDV 878
D+ A N+L+ D V K+SDFGLA++ ++++ + + APE + K+DV
Sbjct: 125 DLAARNILVSEDGVAKVSDFGLARV--GSMGVDNSKLP--VKWTAPEALKHKKFSSKSDV 180
Query: 879 FAFGVLALETVS-GR-PNSDPSLDE-----EKLYLLE 908
+++GVL E S GR P SL E EK Y +E
Sbjct: 181 WSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRME 217
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 90.3 bits (224), Expect = 7e-20
Identities = 65/212 (30%), Positives = 110/212 (51%), Gaps = 21/212 (9%)
Query: 701 LGEGGFGPVYKGKLG-DGRA---IAVKQLSVA-SRQGKSQFVAEIATISAVQHRNLVKLH 755
+G G FG V +G+L G+ +A+K L + + + F++E + + H N++ L
Sbjct: 12 IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71
Query: 756 GCCIEGAERLLVYEYLENKSLDQALF---GQRSLTLDWATRYEICSGVARGLAYLHEESR 812
G + +++ E++EN +LD L GQ ++ + G+A G+ YL E +
Sbjct: 72 GVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVI----QLVGMLRGIAAGMKYLSEMNY 127
Query: 813 VRIIHRDVKASNVLLDADLVPKISDFGLAK-LYDDKKTHISTRVAG---TIGYLAPEYAM 868
V HRD+ A N+L++++LV K+SDFGL++ L DD T G I + APE
Sbjct: 128 V---HRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIA 184
Query: 869 RGHLTEKTDVFAFGVLALETVS--GRPNSDPS 898
T +DV+++G++ E +S RP D S
Sbjct: 185 YRKFTSASDVWSYGIVMWEVMSYGERPYWDMS 216
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.4 bits (225), Expect = 1e-19
Identities = 60/190 (31%), Positives = 99/190 (52%), Gaps = 33/190 (17%)
Query: 695 FSPSNKLGEGGFGPVYKGK-LGDGRAIAVKQLSV-ASRQGKSQF-VAEIAT---ISAVQH 748
+ ++GEG +G VYK + L GR +A+K++ V S +G + EIA + + +H
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEH 60
Query: 749 RNLVKL----HGCCIEGAERL-LVYEYLENKSLDQALFGQR-------SLTLDWATRYEI 796
N+V+L HG + +L LV+E+++ D A + + T+ R ++
Sbjct: 61 PNIVRLLDVCHGPRTDRELKLTLVFEHVDQ---DLATYLSKCPKPGLPPETIKDLMR-QL 116
Query: 797 CSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHIS-TRV 855
GV +LH RI+HRD+K N+L+ +D KI+DFGLA++Y ++ T V
Sbjct: 117 LRGVD----FLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLARIYSF---EMALTSV 166
Query: 856 AGTIGYLAPE 865
T+ Y APE
Sbjct: 167 VVTLWYRAPE 176
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.8 bits (226), Expect = 1e-19
Identities = 65/224 (29%), Positives = 104/224 (46%), Gaps = 46/224 (20%)
Query: 700 KLGEGGFGPVYKGKL---GDGRAIAVKQL--SVASRQGKSQ-FVAEIATISAVQHRNLVK 753
+G G +G VYK K DG+ A+K+ G SQ EIA + ++H N+V
Sbjct: 7 CIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVS 66
Query: 754 LHGCCIEGAERL--LVYEYLE--------------NKSLDQALFGQRSLTLDWATRYEIC 797
L +E A++ L+++Y E S+ ++ +SL ++I
Sbjct: 67 LVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMV--KSLL------WQIL 118
Query: 798 SGVARGLAYLHEESRVRIIHRDVKASNVLLDADL----VPKISDFGLAKLYDD--KKTHI 851
+GV YLH ++HRD+K +N+L+ + V KI D GLA+L++ K
Sbjct: 119 NGV----HYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLAD 171
Query: 852 STRVAGTIGYLAPEYAMRG--HLTEKTDVFAFGVLALETVSGRP 893
V TI Y APE + G H T+ D++A G + E ++ P
Sbjct: 172 LDPVVVTIWYRAPELLL-GARHYTKAIDIWAIGCIFAELLTLEP 214
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.7 bits (223), Expect = 1e-19
Identities = 59/206 (28%), Positives = 97/206 (47%), Gaps = 23/206 (11%)
Query: 699 NKLGEGGFGPVYKGK-LGDGRAIAVKQLSVASRQGKSQFVAEIATISAVQHRNLVKLHGC 757
++G G +G VYK + + G +A+K + + EI+ + +H N+V G
Sbjct: 9 QRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGS 68
Query: 758 CIEGAERLLVYEYLENKSLDQALFGQRSLTLDWATRYEI---CSGVARGLAYLHEESRVR 814
+ + +V EY SL +T + +I C +GLAYLHE +
Sbjct: 69 YLRRDKLWIVMEYCGGGSLQDIY----QVTRGPLSELQIAYVCRETLKGLAYLHETGK-- 122
Query: 815 IIHRDVKASNVLLDADLVPKISDFGLAKLYDD----KKTHISTRVAGTIGYLAPEYA--- 867
IHRD+K +N+LL D K++DFG++ +K+ I GT ++APE A
Sbjct: 123 -IHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFI-----GTPYWMAPEVAAVE 176
Query: 868 MRGHLTEKTDVFAFGVLALETVSGRP 893
+G K D++A G+ A+E +P
Sbjct: 177 RKGGYDGKCDIWALGITAIELAELQP 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 89.9 bits (223), Expect = 1e-19
Identities = 64/218 (29%), Positives = 98/218 (44%), Gaps = 31/218 (14%)
Query: 701 LGEGGFGPVYKGK-LG-----DGRAIAVKQLSV-ASRQGKSQFVAEIATISAVQHRNLVK 753
+G+G FG V++ + G +AVK L AS ++ F E A ++ H N+VK
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72
Query: 754 LHGCCIEGAERLLVYEYLENKSLDQ--------------------ALFGQRSLTLDWATR 793
L G C G L++EY+ L++ G L L +
Sbjct: 73 LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132
Query: 794 YEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLA-KLYDDKKTHIS 852
I VA G+AYL E + +HRD+ N L+ ++V KI+DFGL+ +Y S
Sbjct: 133 LCIAKQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKAS 189
Query: 853 TRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVS 890
A I ++ PE T ++DV+A+GV+ E S
Sbjct: 190 ENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 227
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 1e-19
Identities = 58/209 (27%), Positives = 100/209 (47%), Gaps = 24/209 (11%)
Query: 700 KLGEGGFGPVYKGK------LGDGRAIAVKQLSVASRQGKSQFVAEIATISAVQHRNLVK 753
+LGEG FG V+ + D +AVK L + + F E ++ +QH ++VK
Sbjct: 12 ELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVK 71
Query: 754 LHGCCIEGAERLLVYEYLENKSLDQALFG--------------QRSLTLDWATRYEICSG 799
+G C +G ++V+EY+++ L++ L Q L + I S
Sbjct: 72 FYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQ 131
Query: 800 VARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAK-LYDDKKTHISTRVAGT 858
+A G+ YL + +HRD+ N L+ A+L+ KI DFG+++ +Y +
Sbjct: 132 IASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLP 188
Query: 859 IGYLAPEYAMRGHLTEKTDVFAFGVLALE 887
I ++ PE M T ++DV++FGV+ E
Sbjct: 189 IRWMPPESIMYRKFTTESDVWSFGVILWE 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 89.9 bits (224), Expect = 1e-19
Identities = 61/204 (29%), Positives = 101/204 (49%), Gaps = 17/204 (8%)
Query: 699 NKLGEGGFGPVYKGK-LGDGRAIAVKQLSVASRQGKSQ---FVA--EIATISAVQHRNLV 752
KLGEG + VYK + GR +A+K++ + R+ F A EI + ++H N++
Sbjct: 6 KKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNII 65
Query: 753 KLHGCCIEGAERLLVYEYLENKSLD-QALFGQRSLTLDWATRYEICSGVARGLAYLHEES 811
L + LV+E++E D + + +S+ L A RGL YLH
Sbjct: 66 GLLDVFGHKSNINLVFEFMET---DLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNW 122
Query: 812 RVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVAGTIGYLAPE--YAMR 869
I+HRD+K +N+L+ +D V K++DFGLA+ + ++ +V T Y APE + R
Sbjct: 123 ---ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVV-TRWYRAPELLFGAR 178
Query: 870 GHLTEKTDVFAFGVLALETVSGRP 893
H D+++ G + E + P
Sbjct: 179 -HYGVGVDMWSVGCIFAELLLRVP 201
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 2e-19
Identities = 60/206 (29%), Positives = 102/206 (49%), Gaps = 11/206 (5%)
Query: 700 KLGEGGFGPV-YKGKLGDGRAIAVKQLSVASRQGKSQFVAEIATISAVQHRNLVKLHGCC 758
K+GEG G V + G+ +AVK++ + +Q + E+ + H N+V ++
Sbjct: 29 KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSY 88
Query: 759 IEGAERLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHR 818
+ G E +V E+LE +L + R AT +C V R L+YLH + +IHR
Sbjct: 89 LVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAT---VCLSVLRALSYLHNQG---VIHR 142
Query: 819 DVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVAGTIGYLAPEYAMRGHLTEKTDV 878
D+K+ ++LL +D K+SDFG K+ + GT ++APE R + D+
Sbjct: 143 DIKSDSILLTSDGRIKLSDFGFCAQV-SKEVPKRKSLVGTPYWMAPEVISRLPYGTEVDI 201
Query: 879 FAFGVLALETVSGRPNSDPSLDEEKL 904
++ G++ +E + G P P +E L
Sbjct: 202 WSLGIMVIEMIDGEP---PYFNEPPL 224
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 3e-19
Identities = 63/219 (28%), Positives = 106/219 (48%), Gaps = 32/219 (14%)
Query: 700 KLGEGGFGPVYKGK-------LGDGRA--------IAVKQL-SVASRQGKSQFVAEIATI 743
KLGEG FG V+ + LG+G +AVK L + ++ ++ F+ EI +
Sbjct: 12 KLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIM 71
Query: 744 SAVQHRNLVKLHGCCIEGAERLLVYEYLENKSLDQALFGQRSL-----------TLDWAT 792
S +++ N+++L G C+ ++ EY+EN L+Q L QR + ++ A
Sbjct: 72 SRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFL-SQREIESTFTHANNIPSVSIAN 130
Query: 793 RYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAK-LYDDKKTHI 851
+ +A G+ YL + + +HRD+ N L+ KI+DFG+++ LY I
Sbjct: 131 LLYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRI 187
Query: 852 STRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVS 890
R I ++A E + G T +DV+AFGV E +
Sbjct: 188 QGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 88.7 bits (220), Expect = 3e-19
Identities = 70/220 (31%), Positives = 110/220 (50%), Gaps = 38/220 (17%)
Query: 701 LGEGGFGPVYKG-KLGDGRAIAVKQLSV----ASRQGKSQ------FVAEIATISAVQHR 749
+G+G +G VY + G +AVKQ+ + A R Q +EI T+ + H
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68
Query: 750 NLVKLHGCCIEGAERLLVY-EYLENKSLDQAL--FGQ------RSLTLDWATRYEICSGV 800
N+V+ G E L ++ EY+ S+ L +G+ R T V
Sbjct: 69 NIVQYLGF-ETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFT----------EQV 117
Query: 801 ARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHIS-TRVAGTI 859
GLAYLH + I+HRD+KA N+L+DAD + KISDFG++K DD + + G++
Sbjct: 118 LEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSV 174
Query: 860 GYLAPE--YAMRGHLTEKTDVFAFGVLALETVSG-RPNSD 896
++APE ++ + K D+++ G + LE +G RP SD
Sbjct: 175 FWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSD 214
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 88.4 bits (219), Expect = 3e-19
Identities = 60/194 (30%), Positives = 92/194 (47%), Gaps = 11/194 (5%)
Query: 700 KLGEGGFGPVYKGKLGDGRAIAVKQLSVASRQG---KSQFVAEIATISAVQHRNLVKLHG 756
+LG G FG V+ GK +A+K A +G + F+ E + + H LV+L+G
Sbjct: 11 ELGSGQFGVVHLGKWRAQIKVAIK----AINEGAMSEEDFIEEAKVMMKLSHPKLVQLYG 66
Query: 757 CCIEGAERLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRII 816
C + +V E++EN L L QR L +C V G+ YL S I
Sbjct: 67 VCTQQKPLYIVTEFMENGCLLNYL-RQRQGKLSKDMLLSMCQDVCEGMEYLERNS---FI 122
Query: 817 HRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVAGTIGYLAPEYAMRGHLTEKT 876
HRD+ A N L+ + V K+SDFG+ + D + S+ + + PE + K+
Sbjct: 123 HRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKS 182
Query: 877 DVFAFGVLALETVS 890
DV++FGVL E +
Sbjct: 183 DVWSFGVLMWEVFT 196
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 88.5 bits (219), Expect = 3e-19
Identities = 76/281 (27%), Positives = 129/281 (45%), Gaps = 34/281 (12%)
Query: 694 NFSPSNKLGEGGFGPVYKGK-LGDGRAIAVKQLSV---ASRQGKSQFVAEIATISAVQHR 749
NF K+G G F VY+ L DG +A+K++ + + ++ + EI + + H
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62
Query: 750 NLVKLHGCCIEGAERLLVYEYLENKSLDQALF---GQRSLTLD---WATRYEICSGVARG 803
N++K + IE E +V E + L + + Q+ L + W ++CS
Sbjct: 63 NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCS----- 117
Query: 804 LAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVAGTIGYLA 863
A H SR R++HRD+K +NV + A V K+ D GL + + K T + V GT Y++
Sbjct: 118 -ALEHMHSR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMS 174
Query: 864 PEYAMRGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEIELA 923
PE K+D+++ G L E + + S D+ LY L ++IE
Sbjct: 175 PERIHENGYNFKSDIWSLGCLLYEMAALQ--SPFYGDKMNLYSL---------CKKIEQC 223
Query: 924 D--PKLIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVAM 962
D P + EE+++L+ +C P RP ++ V +
Sbjct: 224 DYPPLPSDHYSEELRQLVN---MCINPDPEKRPDITYVYDV 261
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 89.1 bits (221), Expect = 3e-19
Identities = 63/212 (29%), Positives = 101/212 (47%), Gaps = 25/212 (11%)
Query: 701 LGEGGFGPVYKGKL------GDGRAIAVKQL-SVASRQGKSQFVAEIATISAVQHRNLVK 753
LGEG FG VYKG+L ++A+K L A + + +F E +S +QH N+V
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72
Query: 754 LHGCCIEGAERLLVYEYLENKSLDQALF--------------GQRSLTLDWATRYEICSG 799
L G C + +++EYL + L + L +LD + I
Sbjct: 73 LLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQ 132
Query: 800 VARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKL-YDDKKTHISTRVAGT 858
+A G+ YL S +HRD+ A N L+ L KISDFGL++ Y + ++
Sbjct: 133 IAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLP 189
Query: 859 IGYLAPEYAMRGHLTEKTDVFAFGVLALETVS 890
+ ++ PE + G T ++D+++FGV+ E S
Sbjct: 190 VRWMPPEAILYGKFTTESDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 4e-19
Identities = 59/208 (28%), Positives = 103/208 (49%), Gaps = 10/208 (4%)
Query: 700 KLGEGGFGPVYKGKL-GDGRAIAVKQLSVASRQGKSQFVAEIATISAVQHRNLVKLHGCC 758
K+GEG G V + G+ +AVK++ + +Q + E+ + QH N+V+++
Sbjct: 27 KIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 86
Query: 759 IEGAERLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHR 818
+ G E +V E+LE +L + R A +C V + L+ LH + +IHR
Sbjct: 87 LVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAA---VCLAVLKALSVLHAQG---VIHR 140
Query: 819 DVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVAGTIGYLAPEYAMRGHLTEKTDV 878
D+K+ ++LL D K+SDFG K+ + GT ++APE R + D+
Sbjct: 141 DIKSDSILLTHDGRVKLSDFGFCAQV-SKEVPRRKSLVGTPYWMAPELISRLPYGPEVDI 199
Query: 879 FAFGVLALETVSGRPN--SDPSLDEEKL 904
++ G++ +E V G P ++P L K+
Sbjct: 200 WSLGIMVIEMVDGEPPYFNEPPLKAMKM 227
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 88.6 bits (220), Expect = 4e-19
Identities = 58/210 (27%), Positives = 94/210 (44%), Gaps = 20/210 (9%)
Query: 693 ENFSPSNKLGEGGFGPVYKGKL-GDGRAIAVKQLSVASRQG-KSQFVAEIATISAVQHRN 750
E ++LGEG G V K +L G A+K ++ + Q + E+ + +
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPY 60
Query: 751 LVKLHGCCIEGAERLL--VYEYLENKSLDQALFGQRSLTLDWATRY--EICSGVARGLAY 806
+VK +G ++ + + EY E SLD + + +I V +GL+Y
Sbjct: 61 IVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSY 120
Query: 807 LHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVAGT-IG---YL 862
LH +IIHRD+K SN+LL K+ DFG++ + +AGT G Y+
Sbjct: 121 LHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSG-------ELVNSLAGTFTGTSFYM 170
Query: 863 APEYAMRGHLTEKTDVFAFGVLALETVSGR 892
APE + +DV++ G+ LE R
Sbjct: 171 APERIQGKPYSITSDVWSLGLTLLEVAQNR 200
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.3 bits (219), Expect = 4e-19
Identities = 62/214 (28%), Positives = 106/214 (49%), Gaps = 24/214 (11%)
Query: 701 LGEGGFGPVYKGK-LGDGRAIAVKQLSVASRQGK-SQFVAEIATISAVQH---RNLVKLH 755
+G G +G VY+GK + GR +A+K +++ + S E+A +S ++ N+ K +
Sbjct: 9 IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYY 68
Query: 756 GCCIEGAERLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVAR----GLAYLHEES 811
G ++G ++ EY E S+ R+L + S + R L Y+H
Sbjct: 69 GSYLKGPRLWIIMEYAEGGSV-------RTLMKAGPIAEKYISVIIREVLVALKYIH--- 118
Query: 812 RVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVAGTIGYLAPEYAMRGH 871
+V +IHRD+KA+N+L+ K+ DFG+A L + + ST V GT ++APE G
Sbjct: 119 KVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFV-GTPYWMAPEVITEGK 177
Query: 872 LTE-KTDVFAFGVLALETVSGRPNSDPSLDEEKL 904
+ K D+++ G+ E +G P P D +
Sbjct: 178 YYDTKADIWSLGITIYEMATGNP---PYSDVDAF 208
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.5 bits (218), Expect = 7e-19
Identities = 58/183 (31%), Positives = 90/183 (49%), Gaps = 27/183 (14%)
Query: 695 FSPSNKLGEGGFGPVYKGK-LGDGRAIAVKQLSVASRQGK------SQFVAEIATISAVQ 747
+ KLGEG +G VYK + G +A+K++ R S + EI+ + ++
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKI----RLDNEEEGIPSTALREISLLKELK 56
Query: 748 HRNLVKLHGCCIEGAERLLVYEYLEN---KSLDQALFGQRSLTLDWATR--YEICSGVAR 802
H N+VKL + LV+EY + K LD+ L+ + Y++ R
Sbjct: 57 HPNIVKLLDVIHTERKLYLVFEYCDMDLKKYLDKR---PGPLSPNLIKSIMYQLL----R 109
Query: 803 GLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVAGTIGYL 862
GLAY H RI+HRD+K N+L++ D V K++DFGLA+ + + V T+ Y
Sbjct: 110 GLAYCH---SHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVV-TLWYR 165
Query: 863 APE 865
APE
Sbjct: 166 APE 168
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 88.5 bits (219), Expect = 1e-18
Identities = 94/340 (27%), Positives = 154/340 (45%), Gaps = 65/340 (19%)
Query: 701 LGEGGFGPVY--------KGKLGDGRAIAVKQLSV-ASRQGKSQFVAEIATISAV-QHRN 750
LGEG FG V K K +AVK L A+ + S V+E+ + + +H+N
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79
Query: 751 LVKLHGCCIEGAERLLVYEYLENKSLDQALFGQRSLTLDWATRYEICS------------ 798
++ L G C + ++ EY +L + L +R +D++ ++ C
Sbjct: 80 IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYS--FDTCKLPEEQLTFKDLV 137
Query: 799 ----GVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDD----KKTH 850
VARG+ YL + + IHRD+ A NVL+ D V KI+DFGLA+ + KKT
Sbjct: 138 SCAYQVARGMEYLASQ---KCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKT- 193
Query: 851 ISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWA 910
T + ++APE T ++DV++FGVL E + + P + E+L+ L
Sbjct: 194 --TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKL--- 248
Query: 911 WHLHENNQEIELADPKLIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVAMLCGDME-V 969
L E ++ + A+ L + C +PS RP+ ++V D++ V
Sbjct: 249 --LKEGHRMDKPANC---------THELYMIMRECWHAVPSQRPTFKQLVE----DLDRV 293
Query: 970 STVTAKPGYLTDWKFDDITSFVRTDEATKGTDTSHYTSSS 1009
TVT+ YL D++ V ++ + G S + SS
Sbjct: 294 LTVTSTDEYL------DLS--VPFEQYSPGCPDSPSSCSS 325
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 87.3 bits (216), Expect = 1e-18
Identities = 76/287 (26%), Positives = 128/287 (44%), Gaps = 47/287 (16%)
Query: 701 LGEGGFGPVYKGKLGD--GRA----IAVKQLSVASRQGK-SQFVAEIATISAVQHRNLVK 753
LGEG FG V K GRA +AVK L + + ++E + V H +++K
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67
Query: 754 LHGCCIEGAERLLVYEYLENKSLDQAL-------------FGQRSLTLDWATRYEICS-- 798
L+G C + LL+ EY + SL L G R+ + +
Sbjct: 68 LYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMG 127
Query: 799 -------GVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAK-LYDDKKTH 850
++RG+ YL E ++++HRD+ A NVL+ KISDFGL++ +Y++
Sbjct: 128 DLISFAWQISRGMQYLAE---MKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYV 184
Query: 851 ISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWA 910
++ + ++A E T ++DV++FGVL E V+ N P + E+L
Sbjct: 185 KRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERL------ 238
Query: 911 WHLHENNQEIELADPKLIEFNEEEVKRLIGVALLCTQTLPSLRPSMS 957
++L + +E + EE+ L+ L C + P RP+ +
Sbjct: 239 FNLLKTGYRMERPEN-----CSEEMYNLM---LTCWKQEPDKRPTFA 277
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 1e-18
Identities = 62/192 (32%), Positives = 95/192 (49%), Gaps = 7/192 (3%)
Query: 701 LGEGGFGPVYKGKLGDGRAIAVKQLSVASRQG-KSQFVAEIATISAVQHRNLVKLHGCCI 759
LG+G FG V+KG L D +AVK Q K +F++E + H N+VKL G C
Sbjct: 3 LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCT 62
Query: 760 EGAERLLVYEYLENKSLDQALFGQR-SLTLDWATRYEICSGVARGLAYLHEESRVRIIHR 818
+ +V E + L ++ L ++ + A G+AYL ++ IHR
Sbjct: 63 QRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFAL--DAAAGMAYLESKN---CIHR 117
Query: 819 DVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVAGTIGYLAPEYAMRGHLTEKTDV 878
D+ A N L+ + V KISDFG+++ DD S I + APE G + ++DV
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSESDV 177
Query: 879 FAFGVLALETVS 890
+++G+L ET S
Sbjct: 178 WSYGILLWETFS 189
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 85.8 bits (213), Expect = 2e-18
Identities = 61/214 (28%), Positives = 100/214 (46%), Gaps = 29/214 (13%)
Query: 699 NKLGEGGFGPVYKGK-LGDGRAIAVKQLSVASRQGK-SQFVAEIATISAVQHRNLVKLHG 756
+LG G G V K G+ +AVK + + + Q + E+ + +V +G
Sbjct: 7 GELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYG 66
Query: 757 CCIEGAERLLVYEYLENKSLDQAL------FGQRSLTLDWATRYEICSGVARGLAYLHEE 810
+ + EY++ SLD+ L +R L +I V +GL YLHE
Sbjct: 67 AFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILG-------KIAVAVLKGLTYLHE- 118
Query: 811 SRVRIIHRDVKASNVLLDADLVPKISDFGLA-KLYDDK-KTHISTRVAGTIGYLAPEYAM 868
+ +IIHRDVK SN+L+++ K+ DFG++ +L + KT GT Y+APE
Sbjct: 119 -KHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTF-----VGTSSYMAPERIQ 172
Query: 869 RGHLTEKTDVFAFGVLALETVSGR-----PNSDP 897
+ K+D+++ G+ +E +GR N P
Sbjct: 173 GNDYSVKSDIWSLGLSLIELATGRFPYPPENDPP 206
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 86.0 bits (213), Expect = 2e-18
Identities = 63/201 (31%), Positives = 90/201 (44%), Gaps = 19/201 (9%)
Query: 701 LGEGGFGPVYKGKLGD-GRAIAVKQLS---VASRQGKSQFVAEIATISAVQHRNLVKLHG 756
LG+GGFG V ++ G+ A K+L + R+G+ + E + V R +V L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 757 CCIEGAERLLVYEYLENKSLDQALF--GQRSLTLDWATRY--EICSGVARGLAYLHEESR 812
+ LV + L ++ G+ A Y +I G L +LH+
Sbjct: 61 AFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICG----LEHLHQR-- 114
Query: 813 VRIIHRDVKASNVLLDADLVPKISDFGLA-KLYDDKKTHISTRVAGTIGYLAPEYAMRGH 871
RI++RD+K NVLLD +ISD GLA +L KK AGT GY+APE
Sbjct: 115 -RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGR---AGTPGYMAPEVLQGEV 170
Query: 872 LTEKTDVFAFGVLALETVSGR 892
D FA G E ++GR
Sbjct: 171 YDFSVDWFALGCTLYEMIAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 4e-18
Identities = 61/218 (27%), Positives = 101/218 (46%), Gaps = 21/218 (9%)
Query: 693 ENFSPSNKLGEGGFGPVYKG----KLGDGRAIAVKQLSVASRQGKSQ-FVAEIATISAVQ 747
E+ + +GEG FG VY+G + A+AVK + + F+ E +
Sbjct: 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFD 65
Query: 748 HRNLVKLHGCCIEGAERLL--VYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLA 805
H ++VKL G E ++ + E +S Q +LD A+ ++ LA
Sbjct: 66 HPHIVKLIGVITENPVWIVMELAPLGELRSYLQ----VNKYSLDLASLILYSYQLSTALA 121
Query: 806 YLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVAGTIGYLAPE 865
YL ES+ R +HRD+ A NVL+ + K+ DFGL++ +D+ + +++ I ++APE
Sbjct: 122 YL--ESK-RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPE 178
Query: 866 YAMRGHLTEKTDVFAFGVLALETVS-------GRPNSD 896
T +DV+ FGV E + G N+D
Sbjct: 179 SINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNND 216
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 4e-18
Identities = 68/218 (31%), Positives = 117/218 (53%), Gaps = 15/218 (6%)
Query: 694 NFSPSNKLGEGGFGPVYKGK-LGDGRAIAVKQLSVASRQGK-SQFVAEIATISAVQHRNL 751
NF KLGEG + VYKG+ G +A+K++ + + +G S + EI+ + ++H N+
Sbjct: 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENI 60
Query: 752 VKLHGCCIEGAERLLVYEYLEN---KSLDQALFGQRSLTLDWATRYEICSGVARGLAYLH 808
V+LH + +LV+EY++ K +D G R LD T + +G+A+ H
Sbjct: 61 VRLHDVIHTENKLMLVFEYMDKDLKKYMD--THGVRG-ALDPNTVKSFTYQLLKGIAFCH 117
Query: 809 EESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVAGTIGYLAPEYAM 868
E R++HRD+K N+L++ K++DFGLA+ + S V T+ Y AP+ +
Sbjct: 118 EN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV-TLWYRAPDVLL 173
Query: 869 RGHLTEKT--DVFAFGVLALETVSGRPNSDPSLDEEKL 904
G T T D+++ G + E ++GRP + +E++L
Sbjct: 174 -GSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQL 210
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 5e-18
Identities = 74/239 (30%), Positives = 119/239 (49%), Gaps = 42/239 (17%)
Query: 701 LGEGGFGPVY--------KGKLGDGRAIAVKQLS-VASRQGKSQFVAEIATISAV-QHRN 750
LGEG FG V K K + +AVK L A+ + S V+E+ + + +H+N
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82
Query: 751 LVKLHGCCIEGAERLLVYEYLENKSLDQALFGQRSLTLDWATRYEI-------------- 796
++ L G C + ++ EY +L + L +R ++++ Y+I
Sbjct: 83 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYS--YDIARVPDEQMTFKDLV 140
Query: 797 -CS-GVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDD----KKTH 850
C+ VARG+ YL + + IHRD+ A NVL+ + V KI+DFGLA+ ++ KKT
Sbjct: 141 SCTYQVARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKT- 196
Query: 851 ISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALE--TVSGRPNSDPSLDEEKLYLL 907
T + ++APE T ++DV++FGVL E T+ G P P + E+L+ L
Sbjct: 197 --TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY--PGIPVEELFKL 251
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 5e-18
Identities = 65/207 (31%), Positives = 106/207 (51%), Gaps = 10/207 (4%)
Query: 693 ENFSPSNKLGEGGFGPVYKGKLGDGR-AIAVKQLSVASRQGKSQFVA-EIATISAVQHRN 750
E F+ ++G+G FG VYKG + +A+K + + + + + + EI +S
Sbjct: 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 63
Query: 751 LVKLHGCCIEGAERLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEE 810
+ + +G ++G + ++ EYL S AL + L+ I + +GL YLH E
Sbjct: 64 ITRYYGSYLKGTKLWIIMEYLGGGS---ALDLLKPGPLEETYIATILREILKGLDYLHSE 120
Query: 811 SRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVAGTIGYLAPEYAMRG 870
R IHRD+KA+NVLL K++DFG+A D + +T V GT ++APE +
Sbjct: 121 ---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIKQS 176
Query: 871 HLTEKTDVFAFGVLALETVSGR-PNSD 896
K D+++ G+ A+E G PNSD
Sbjct: 177 AYDFKADIWSLGITAIELAKGEPPNSD 203
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 84.6 bits (209), Expect = 6e-18
Identities = 69/210 (32%), Positives = 106/210 (50%), Gaps = 21/210 (10%)
Query: 701 LGEGGFGPVYKG--KLGDGRA--IAVKQLSV-ASRQGKSQFVAEIATISAVQHRNLVKLH 755
LG G FG + +G KL R +A+ L S + + F+AE T+ H N+V+L
Sbjct: 13 LGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLE 72
Query: 756 GCCIEGAERLLVYEYLENKSLDQALF---GQRSLTLDWATRYEICSGVARGLAYLHEESR 812
G G ++V EY+ N +LD L GQ L + G+A G+ YL E
Sbjct: 73 GVITRGNTMMIVTEYMSNGALDSFLRKHEGQ----LVAGQLMGMLPGLASGMKYLSE--- 125
Query: 813 VRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVAG--TIGYLAPEYAMRG 870
+ +H+ + A VL+++DLV KIS F +L +DK I T ++G + + APE
Sbjct: 126 MGYVHKGLAAHKVLVNSDLVCKISGFR--RLQEDKSEAIYTTMSGKSPVLWAAPEAIQYH 183
Query: 871 HLTEKTDVFAFGVLALETVS--GRPNSDPS 898
H + +DV++FG++ E +S RP D S
Sbjct: 184 HFSSASDVWSFGIVMWEVMSYGERPYWDMS 213
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 84.6 bits (209), Expect = 7e-18
Identities = 55/208 (26%), Positives = 100/208 (48%), Gaps = 20/208 (9%)
Query: 699 NKLGEGGFGPVYKGKLGDGRAIAVKQLSV------ASRQGKSQFVAEIATISAVQHRNLV 752
LG+G +G VY G G+ IAVKQ+ + A+ + + E+ + +++H N+V
Sbjct: 6 EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65
Query: 753 KLHGCCIEGAERLLVYEYLENKSLDQAL--FGQRSLTLDWATRYEICSGVARGLAYLHEE 810
+ G C++ + E++ S+ L FG L +Y + G+AYLH
Sbjct: 66 QYLGTCLDDNTISIFMEFVPGGSISSILNRFG--PLPEPVFCKYT--KQILDGVAYLHNN 121
Query: 811 SRVRIIHRDVKASNVLLDADLVPKISDFGLAKLY-----DDKKTHISTRVAGTIGYLAPE 865
++HRD+K +NV+L + + K+ DFG A+ +++ + GT ++APE
Sbjct: 122 C---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPE 178
Query: 866 YAMRGHLTEKTDVFAFGVLALETVSGRP 893
K+D+++ G E +G+P
Sbjct: 179 VINESGYGRKSDIWSIGCTVFEMATGKP 206
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 84.0 bits (208), Expect = 7e-18
Identities = 62/279 (22%), Positives = 117/279 (41%), Gaps = 34/279 (12%)
Query: 694 NFSPSNKLGEGGFGP--VYKGKLGDGRAIAVKQLSVASRQGKSQFVA--EIATISAVQHR 749
++ P LG+G FG +Y+ + D + K++++ K + A EI +S +QH
Sbjct: 1 HYIPIRVLGKGAFGEATLYR-RTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHP 59
Query: 750 NLVKLHGCCIEGAERLLVYEYLENKSLDQALFGQRSLTLD-----WATRYEICSGVARGL 804
N++ + ++ L+ EY +L + Q+ + W ++I S V+
Sbjct: 60 NIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYL-FQIVSAVS--- 115
Query: 805 AYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVAGTIGYLAP 864
Y+H+ I+HRD+K N+ L + K+ DFG++K+ + + T V GT Y++P
Sbjct: 116 -YIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAET-VVGTPYYMSP 170
Query: 865 EYAMRGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEIELAD 924
E K+D++A G + E ++ + D + L + + N +
Sbjct: 171 ELCQGVKYNFKSDIWALGCVLYELLTLKRTFDAT------NPLNLVVKIVQGNYTPVV-- 222
Query: 925 PKLIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVAML 963
LI + Q P RP+ V+
Sbjct: 223 -------SVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 84.7 bits (210), Expect = 8e-18
Identities = 66/221 (29%), Positives = 104/221 (47%), Gaps = 35/221 (15%)
Query: 700 KLGEGGFGPVY------------KGKLGDGRA-----IAVKQLSV-ASRQGKSQFVAEIA 741
KLGEG FG V+ K + A +AVK L AS + F+ E+
Sbjct: 12 KLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVK 71
Query: 742 TISAVQHRNLVKLHGCCIEGAERLLVYEYLENKSLDQALFGQR-----------SLTLDW 790
+S + N+ +L G C ++ EY+EN L+Q L Q+ S +L +
Sbjct: 72 ILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFL--QKHVAETSGLACNSKSLSF 129
Query: 791 ATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAK-LYDDKKT 849
+T + + +A G+ YL ES +HRD+ N L+ + KI+DFG+++ LY
Sbjct: 130 STLLYMATQIASGMRYL--ESL-NFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYY 186
Query: 850 HISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVS 890
+ R I ++A E + G T K+DV+AFGV E ++
Sbjct: 187 RVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 88.4 bits (219), Expect = 1e-17
Identities = 71/259 (27%), Positives = 112/259 (43%), Gaps = 58/259 (22%)
Query: 113 GVIPDELWNLTSLFNLNLGQNYLTGPLSPSVGNLTAMQYLNLAINALSGELPKELGQLTE 172
G +P E L ++ L++ N L G ++ ++ ++Q L+LA N G LP G
Sbjct: 418 GELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGS-KR 476
Query: 173 LLILGIGTNNFSGPLPSELGSLSKLQELYIDSAGVSGEIPSSFANLQSLTKWWASDTRLT 232
L L + N FSG +P +LGSLS+L +L + +SGEIP ++ + L S +L+
Sbjct: 477 LENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLS 536
Query: 233 GRIPDFIGNWSKLTALRFQGNSFNGPIPSSFSNLTSVTELRISDLSNGSSKLAFIRDMKS 292
G+IP SFS +M
Sbjct: 537 GQIPA------------------------SFS------------------------EMPV 548
Query: 293 LSILELRNNNISDSIPSNIGEYRSLQHLDLSFNNLGGSIPDS----LFNLSSLT--HLFL 346
LS L+L N +S IP N+G SL +++S N+L GS+P + N S++
Sbjct: 549 LSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLC 608
Query: 347 GNNKLNGTLPAR---KSPL 362
G + +G P + K+P
Sbjct: 609 GGDTTSGLPPCKRVRKTPS 627
|
Length = 968 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 84.1 bits (208), Expect = 1e-17
Identities = 59/209 (28%), Positives = 99/209 (47%), Gaps = 30/209 (14%)
Query: 701 LGEGGFGPVYKGKL----GDGRAIAVKQLSVA--SRQGKSQFVAEIATISAVQHRNLVKL 754
LGEG FG V +G+L G +AVK + + + +F++E A + H N++KL
Sbjct: 7 LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKL 66
Query: 755 HGCCIEGAER------LLVYEYLENKSLDQALFGQR------SLTLDWATRYEICSGVAR 802
G C E + +++ ++++ L L R L L ++ + +A
Sbjct: 67 IGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMV--DIAL 124
Query: 803 GLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLA-KLYDD---KKTHISTRVAGT 858
G+ YL S IHRD+ A N +L D+ ++DFGL+ K+Y ++ I+
Sbjct: 125 GMEYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKM---P 178
Query: 859 IGYLAPEYAMRGHLTEKTDVFAFGVLALE 887
+ ++A E T K+DV+AFGV E
Sbjct: 179 VKWIAIESLADRVYTSKSDVWAFGVTMWE 207
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 1e-17
Identities = 58/221 (26%), Positives = 105/221 (47%), Gaps = 19/221 (8%)
Query: 701 LGEGGFGPVYKGKLGDGRAI---AVKQLSVA--SRQGKSQFVAEIATISAVQHRNLVKLH 755
LGEG FG V +G+L +I AVK + +A +R F++E + H N+++L
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 756 GCCIEGAER------LLVYEYLENKSLDQALF----GQRSLTLDWATRYEICSGVARGLA 805
G C++ E +++ ++++ L L G L + + +A G+
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126
Query: 806 YLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVAGT-IGYLAP 864
YL S IHRD+ A N +L+ ++ ++DFGL+K + + R+A + ++A
Sbjct: 127 YL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAI 183
Query: 865 EYAMRGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLY 905
E T K+DV++FGV E + P ++ ++Y
Sbjct: 184 ESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIY 224
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 84.6 bits (209), Expect = 1e-17
Identities = 60/219 (27%), Positives = 102/219 (46%), Gaps = 31/219 (14%)
Query: 700 KLGEGGFGPVY-----------------KGKLGDGRAIAVKQL-SVASRQGKSQFVAEIA 741
KLGEG FG V+ +AVK L A++ ++ F+ EI
Sbjct: 12 KLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIK 71
Query: 742 TISAVQHRNLVKLHGCCIEGAERLLVYEYLENKSLDQALFGQR---------SLTLDWAT 792
+S ++ N+++L CI ++ EY+EN L+Q L +T+ ++T
Sbjct: 72 IMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYST 131
Query: 793 RYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAK-LYDDKKTHI 851
+ + +A G+ YL S + +HRD+ N L+ + KI+DFG+++ LY I
Sbjct: 132 LIFMATQIASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRI 188
Query: 852 STRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVS 890
R I +++ E + G T +DV+AFGV E ++
Sbjct: 189 QGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.6 bits (207), Expect = 2e-17
Identities = 60/205 (29%), Positives = 98/205 (47%), Gaps = 23/205 (11%)
Query: 701 LGEGGFGPVYKGKLGD-GRAIAVKQLSVASRQGKSQFVAEIATISAVQHRNLVKLHGCCI 759
LG+G FG VYK + + G A K + + S + F+ EI +S +H N+V L+
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72
Query: 760 EGAERLLVYEYLENKSLDQALFG-QRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHR 818
+ ++ E+ + +LD + +R LT RY +C + L +LH ++IHR
Sbjct: 73 YENKLWILIEFCDGGALDSIMLELERGLTEPQ-IRY-VCRQMLEALNFLHSH---KVIHR 127
Query: 819 DVKASNVLLDADLVPKISDFGL-AKLYDDKKTHISTRVAGTIGYLAPEYAMRGHLTE--- 874
D+KA N+LL D K++DFG+ AK + T + GT ++APE E
Sbjct: 128 DLKAGNILLTLDGDVKLADFGVSAKNKSTLQKR-DTFI-GTPYWMAPEVVA----CETFK 181
Query: 875 ------KTDVFAFGVLALETVSGRP 893
K D+++ G+ +E P
Sbjct: 182 DNPYDYKADIWSLGITLIELAQMEP 206
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 2e-17
Identities = 61/194 (31%), Positives = 94/194 (48%), Gaps = 12/194 (6%)
Query: 701 LGEGGFGPVYKGKLGDGRAIAVKQLSVASRQGKSQFVAEIATISAVQHRNLVKLHGCCIE 760
+G+G FG V LGD R V + + F+AE + ++ ++H NLV+L G +E
Sbjct: 14 IGKGEFGDVM---LGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE 70
Query: 761 GAERL-LVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRD 819
L +V EY+ SL L + L + V + YL + +HRD
Sbjct: 71 EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRD 127
Query: 820 VKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVAGTIGYLAPEYAMRGHLTEKTDVF 879
+ A NVL+ D V K+SDFGL K + T + ++ + + APE + K+DV+
Sbjct: 128 LAARNVLVSEDNVAKVSDFGLTK--EASSTQDTGKLP--VKWTAPEALREKKFSTKSDVW 183
Query: 880 AFGVLALETVS-GR 892
+FG+L E S GR
Sbjct: 184 SFGILLWEIYSFGR 197
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.7 bits (208), Expect = 2e-17
Identities = 59/208 (28%), Positives = 99/208 (47%), Gaps = 30/208 (14%)
Query: 700 KLGEGGFGPVYKGK-LGDGRAIAVKQLSVASRQGKSQF--------VAEIATISAVQ-HR 749
+LG+G FG VY + G +A+K++ K +F + E+ ++ + H
Sbjct: 6 QLGDGTFGSVYLARNKETGELVAIKKM-------KKKFYSWEECMNLREVKSLRKLNEHP 58
Query: 750 NLVKLHGCCIEGAERLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHE 809
N+VKL E E V+EY+E +L Q + ++ + I + +GLA++H
Sbjct: 59 NIVKLKEVFRENDELYFVFEYMEG-NLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIH- 116
Query: 810 ESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTH---ISTRVAGTIGYLAPEY 866
+ HRD+K N+L+ V KI+DFGLA+ + + +STR Y APE
Sbjct: 117 --KHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTDYVSTR-----WYRAPEI 169
Query: 867 AMR-GHLTEKTDVFAFGVLALETVSGRP 893
+R + D++A G + E + RP
Sbjct: 170 LLRSTSYSSPVDIWALGCIMAELYTLRP 197
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 84.2 bits (208), Expect = 2e-17
Identities = 84/301 (27%), Positives = 140/301 (46%), Gaps = 52/301 (17%)
Query: 693 ENFSPSNKLGEGGFGPVYKGK-LGDGR-------AIAVKQLS-VASRQGKSQFVAEIATI 743
+ LGEG FG V + + G + +AVK L A+ + + ++E+ +
Sbjct: 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELM 71
Query: 744 SAV-QHRNLVKLHGCCIEGAERLLVYEYLENKSLDQALFGQRSLTLDWA----------- 791
+ +H+N++ L G C + ++ EY +L + L +R D+
Sbjct: 72 KLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQL 131
Query: 792 TRYEICS---GVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDD-- 846
+ ++ S VARG+ YL ESR R IHRD+ A NVL+ D V KI+DFGLA+ D
Sbjct: 132 SFKDLVSCAYQVARGMEYL--ESR-RCIHRDLAARNVLVTEDNVMKIADFGLARGVHDID 188
Query: 847 --KKTHISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALE--TVSGRPNSDPSLDEE 902
KKT + R+ + ++APE T ++DV++FG+L E T+ G P P + E
Sbjct: 189 YYKKTS-NGRLP--VKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPY--PGIPVE 243
Query: 903 KLYLLEWAWHLHENNQEIELADPKLIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVAM 962
+L+ L L E ++ ++ L + C +P+ RP+ ++V
Sbjct: 244 ELFKL-----LREGHR---------MDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEA 289
Query: 963 L 963
L
Sbjct: 290 L 290
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 84.0 bits (208), Expect = 2e-17
Identities = 65/210 (30%), Positives = 101/210 (48%), Gaps = 20/210 (9%)
Query: 694 NFSPSNKLGEGGFGPVYKGK-LGDGRAIAVKQLSV-ASRQGKS-QFVAEIATISAVQHRN 750
F N++GEG +G VY+ + G +A+K++ + R G + EI + ++H N
Sbjct: 8 EFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPN 67
Query: 751 LVKLHGCCIEGAERL----LVYEYLENKSLDQA-LFGQRSLTLDWATRYEICSGVARGLA 805
+V+L + + L LV EY E D A L + + + RGL
Sbjct: 68 IVELKEVVV--GKHLDSIFLVMEYCEQ---DLASLLDNMPTPFSESQVKCLMLQLLRGLQ 122
Query: 806 YLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVAGTIGYLAPE 865
YLHE IIHRD+K SN+LL KI+DFGLA+ Y ++ +V T+ Y APE
Sbjct: 123 YLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVV-TLWYRAPE 178
Query: 866 --YAMRGHLTEKTDVFAFGVLALETVSGRP 893
+ T D++A G + E ++ +P
Sbjct: 179 LLLGCTTY-TTAIDMWAVGCILAELLAHKP 207
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 83.2 bits (205), Expect = 2e-17
Identities = 77/272 (28%), Positives = 126/272 (46%), Gaps = 28/272 (10%)
Query: 693 ENFSPSNKLGEGGFGPVYKGKLGDGRA---IAVKQLSVASRQGKSQFVA-EIATISAVQH 748
E F+ K+G+G FG V+KG D R +A+K + + + + + + EI +S
Sbjct: 4 ELFTKLEKIGKGSFGEVFKGI--DNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDS 61
Query: 749 RNLVKLHGCCIEGAERLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLH 808
+ K +G ++ + ++ EYL S AL LD I + +GL YLH
Sbjct: 62 PYVTKYYGSYLKDTKLWIIMEYLGGGS---ALDLLEPGPLDETQIATILREILKGLDYLH 118
Query: 809 EESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVAGTIGYLAPEYAM 868
E + IHRD+KA+NVLL K++DFG+A D + +T V GT ++APE
Sbjct: 119 SEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIK 174
Query: 869 RGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEIELADPKLI 928
+ K D+++ G+ A+E G P +L+ ++ + + +NN P +
Sbjct: 175 QSAYDSKADIWSLGITAIELAKGEP------PHSELHPMKVLFLIPKNN-------PPTL 221
Query: 929 EFNEEEVKRLIGVALLCTQTLPSLRPSMSRVV 960
E N K L C PS RP+ ++
Sbjct: 222 EGNYS--KPLKEFVEACLNKEPSFRPTAKELL 251
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 83.0 bits (205), Expect = 3e-17
Identities = 62/207 (29%), Positives = 97/207 (46%), Gaps = 20/207 (9%)
Query: 701 LGEGGFGPVYKG-KLGDGRAIAVKQ--LSVASRQGKSQFVA-------EIATISAVQHRN 750
+G G FG VY G G +AVKQ L S K + + EIA + +QH N
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 751 LVKLHGCCIEGAERLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEE 810
+V+ G ++ + EY+ S+ AL + + +GL YLH
Sbjct: 68 IVQYLGSSLDADHLNIFLEYVPGGSV-AALLNNYG-AFEETLVRNFVRQILKGLNYLHNR 125
Query: 811 SRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVA-----GTIGYLAPE 865
IIHRD+K +N+L+D KISDFG++K + T A G++ ++APE
Sbjct: 126 G---IIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPE 182
Query: 866 YAMRGHLTEKTDVFAFGVLALETVSGR 892
+ T K D+++ G L +E ++G+
Sbjct: 183 VVKQTSYTRKADIWSLGCLVVEMLTGK 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.7 bits (205), Expect = 3e-17
Identities = 58/205 (28%), Positives = 104/205 (50%), Gaps = 23/205 (11%)
Query: 700 KLGEGGFGPVYKGK-LGDGRAIAVKQLSVASR-QG-KSQFVAEIATISAVQHRNLVKLHG 756
K+GEG +G VYK + G +A+K++ + + +G S + EI+ + + H N+V+L
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLD 65
Query: 757 CCIEGAERLLVYEYLE---NKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRV 813
+ LV+E+L+ K +D + L + Y++ +G+AY H S
Sbjct: 66 VVHSENKLYLVFEFLDLDLKKYMDSSPLTGLDPPLIKSYLYQLL----QGIAYCH--SH- 118
Query: 814 RIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVAG----TIGYLAPEYAMR 869
R++HRD+K N+L+D + K++DFGLA+ + + R T+ Y APE +
Sbjct: 119 RVLHRDLKPQNLLIDREGALKLADFGLARAFG-----VPVRTYTHEVVTLWYRAPEILLG 173
Query: 870 G-HLTEKTDVFAFGVLALETVSGRP 893
+ D+++ G + E V+ RP
Sbjct: 174 SRQYSTPVDIWSIGCIFAEMVNRRP 198
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 82.4 bits (204), Expect = 3e-17
Identities = 69/256 (26%), Positives = 107/256 (41%), Gaps = 22/256 (8%)
Query: 694 NFSPSNKLGEGGFGPVYKGKLGDGR-----AIAVKQLSVASRQGKSQFVAEIATISAVQH 748
+F +G+G FG V + D + KQ V ++ E + + H
Sbjct: 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVL-NERRILQELNH 59
Query: 749 RNLVKLHGCCIEGAERLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLH 808
LV L + LV + L L L + + + ++ IC + L YLH
Sbjct: 60 PFLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEE-QVKFWICE-IVLALEYLH 117
Query: 809 EESRVRIIHRDVKASNVLLDADLVPKISDFGLA-KLYDDKKTHISTRVAGTIGYLAPEYA 867
+ IIHRD+K N+LLD I+DF +A K+ D T T +GT GY+APE
Sbjct: 118 SK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLT---TSTSGTPGYMAPEVL 171
Query: 868 MRGHLTEKTDVFAFGVLALETVSGR---PNSDPSLDEEKLYLLEWAWHLHENNQEIELAD 924
R + D ++ GV A E + G+ ++ ++ E A L+ E D
Sbjct: 172 CRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYPATWSTEAID 231
Query: 925 --PKLIEFNEEEVKRL 938
KL+E + + KRL
Sbjct: 232 AINKLLERDPQ--KRL 245
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 82.2 bits (203), Expect = 4e-17
Identities = 60/211 (28%), Positives = 109/211 (51%), Gaps = 30/211 (14%)
Query: 701 LGEGGFGPVYKGK-LGDGRAIAVKQLS----VASRQGK--SQFVAEIATISAVQHRNLVK 753
LG G F Y+ + + G +AVKQ++ +S Q + EI ++ + H ++++
Sbjct: 8 LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIR 67
Query: 754 LHGCCIEGAERLLVYEYLENKSLDQAL--FG--QRSLTLDWATRYEICSGVARGLAYLHE 809
+ G E + L E++ S+ L +G + ++ +++ + RGL+YLHE
Sbjct: 68 MLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINY------TEQLLRGLSYLHE 121
Query: 810 ESRVRIIHRDVKASNVLLDA---DLVPKISDFGLAKLYDDKKT---HISTRVAGTIGYLA 863
+IIHRDVK +N+L+D+ L +I+DFG A K T ++ GTI ++A
Sbjct: 122 N---QIIHRDVKGANLLIDSTGQRL--RIADFGAAARLAAKGTGAGEFQGQLLGTIAFMA 176
Query: 864 PEYAMRGHLTEKT-DVFAFGVLALETVSGRP 893
PE +RG ++ DV++ G + +E + +P
Sbjct: 177 PE-VLRGEQYGRSCDVWSVGCVIIEMATAKP 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 82.1 bits (203), Expect = 4e-17
Identities = 86/275 (31%), Positives = 131/275 (47%), Gaps = 37/275 (13%)
Query: 701 LGEGGFGPVYKGKL--GDGRAI--AVKQLS-VASRQGKSQFVAEIATISAVQHRNLVKLH 755
+G+G FG VY G L DG+ I AVK L+ + + QF+ E + H N++ L
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLL 62
Query: 756 GCCI--EGAERLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSG--VARGLAYLHEES 811
G C+ EG+ L+V Y+++ L + RS T + + I G VA+G+ YL +
Sbjct: 63 GICLPSEGSP-LVVLPYMKHGDLRNFI---RSETHNPTVKDLIGFGLQVAKGMEYLASK- 117
Query: 812 RVRIIHRDVKASNVLLDADLVPKISDFGLAK-LYDDK--KTHISTRVAGTIGYLAPEYAM 868
+ +HRD+ A N +LD K++DFGLA+ +YD + H T + ++A E
Sbjct: 118 --KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQ 175
Query: 869 RGHLTEKTDVFAFGVLALE--TVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEIELADPK 926
T K+DV++FGVL E T P D + +YLL Q L P
Sbjct: 176 TQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLL----------QGRRLLQP- 224
Query: 927 LIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVA 961
E+ + L V L C P +RP+ S +V+
Sbjct: 225 --EYCPDP---LYEVMLSCWHPKPEMRPTFSELVS 254
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 82.2 bits (203), Expect = 5e-17
Identities = 71/246 (28%), Positives = 110/246 (44%), Gaps = 28/246 (11%)
Query: 699 NKLGEGGFGPVYKGKLGDGRAIA---VKQL-SVASRQGKSQFVAEIATISAVQHRNLVKL 754
+++G G FG V G+ G + A VK+L + A+ + F+ E+ + H N+++
Sbjct: 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQC 60
Query: 755 HGCCIEGAERLLVYEYLENKSLDQALFGQR---SLTLDWATRYEICSGVARGLAYLHEES 811
G CIE LLV E+ L L R + + VA GL +LH
Sbjct: 61 LGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH--- 117
Query: 812 RVRIIHRDVKASNVLLDADLVPKISDFGLA-KLYDDKKTHISTRVAGTIGYLAPEYAMRG 870
+ IH D+ N L ADL KI D+GLA + Y + A + +LAPE
Sbjct: 118 QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIR 177
Query: 871 H-------LTEKTDVFAFGVLALE--TVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEIE 921
T+K+++++ GV E T + +P D S DE+ L + E Q+I+
Sbjct: 178 GQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLS-DEQVL-----KQVVRE--QDIK 229
Query: 922 LADPKL 927
L P+L
Sbjct: 230 LPKPQL 235
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 82.6 bits (204), Expect = 5e-17
Identities = 66/220 (30%), Positives = 112/220 (50%), Gaps = 20/220 (9%)
Query: 693 ENFSPSNKLGEGGFGPVYKGK-LGDGRAIAVKQLSVASR-QG-KSQFVAEIATISAVQHR 749
+ + K+GEG +G VYK + IA+K++ + +G S + EI+ + +QH
Sbjct: 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHG 61
Query: 750 NLVKLHGCCIEGAERL-LVYEYLE---NKSLDQALFGQRSLTLDWATRYEICSGVARGLA 805
N+V+L + +RL LV+EYL+ K +D + ++ L Y+I RG+A
Sbjct: 62 NIVRLQDV-VHSEKRLYLVFEYLDLDLKKHMDSSPDFAKNPRLIKTYLYQIL----RGIA 116
Query: 806 YLHEESRVRIIHRDVKASNVLLDADL-VPKISDFGLAKLYDDKKTHISTRVAGTIGYLAP 864
Y H R++HRD+K N+L+D K++DFGLA+ + + V T+ Y AP
Sbjct: 117 YCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVV-TLWYRAP 172
Query: 865 EYAMRG-HLTEKTDVFAFGVLALETVSGRP--NSDPSLDE 901
E + H + D+++ G + E V+ +P D +DE
Sbjct: 173 EILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDE 212
|
Length = 294 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 6e-17
Identities = 62/209 (29%), Positives = 96/209 (45%), Gaps = 16/209 (7%)
Query: 693 ENFSPSNKLGEGGFGPVYK------GKLGDGRAIAVKQL-SVASRQGKSQFVAEIATISA 745
N S LG G FG V + K +AVK L A + ++E+ +S
Sbjct: 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSH 94
Query: 746 V-QHRNLVKLHGCCIEGAERLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGL 804
+ H N+V L G C G L++ EY L L +R L VA+G+
Sbjct: 95 LGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGM 154
Query: 805 AYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHI---STRVAGTIGY 861
A+L ++ IHRD+ A NVLL + KI DFGLA+ + ++ + R+ + +
Sbjct: 155 AFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLP--VKW 209
Query: 862 LAPEYAMRGHLTEKTDVFAFGVLALETVS 890
+APE T ++DV+++G+L E S
Sbjct: 210 MAPESIFNCVYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 6e-17
Identities = 75/294 (25%), Positives = 121/294 (41%), Gaps = 60/294 (20%)
Query: 701 LGEGGFGPVYKGKLGDGRA--IAVKQLSV---ASRQGKSQ-------FVAEIATI-SAVQ 747
LG G FG VYK + + +A+K+++V A + K + V+E+ I ++
Sbjct: 8 LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67
Query: 748 HRNLVKLHGCCIEGAERLLVYEYLENKSLDQAL---------FGQRSLTLDWATRYEICS 798
H N+V+ + +E +V + +E L + F + + W ++
Sbjct: 68 HPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERI---WNIFVQMV- 123
Query: 799 GVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVAGT 858
L YLH+E R I+HRD+ +N++L D I+DFGLAK + T V GT
Sbjct: 124 ---LALRYLHKEKR--IVHRDLTPNNIMLGEDDKVTITDFGLAK--QKQPESKLTSVVGT 176
Query: 859 IGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQ 918
I Y PE EK DV+AFG + + + +P + N
Sbjct: 177 ILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPP------------------FYSTNM 218
Query: 919 EIELADPKLIEFNEEEVK------RLIGVALLCTQTLPSLRPSMSRVVAMLCGD 966
+ LA K++E E + + V C RP + +V AM D
Sbjct: 219 -LSLA-TKIVEAVYEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAM-ISD 269
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 7e-17
Identities = 59/208 (28%), Positives = 98/208 (47%), Gaps = 21/208 (10%)
Query: 695 FSPSNKLGEGGFGPVYKGKLGDGRA---IAVKQLSVASRQGKSQF---VAEIATISAVQH 748
F+ ++G G FG VY + D R +A+K++S + +Q ++ + E+ + ++H
Sbjct: 27 FTDLREIGHGSFGAVYFAR--DVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKH 84
Query: 749 RNLVKLHGCCIEGAERLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLH 808
N ++ GC + LV EY + D L L I G +GLAYLH
Sbjct: 85 PNSIEYKGCYLREHTAWLVMEYCLGSASD--LLEVHKKPLQEVEIAAITHGALQGLAYLH 142
Query: 809 EESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVAGTIGYLAPEYAM 868
+ +IHRD+KA N+LL K++DFG A + + + GT ++APE +
Sbjct: 143 SHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASPANSFV-----GTPYWMAPEVIL 194
Query: 869 ---RGHLTEKTDVFAFGVLALETVSGRP 893
G K DV++ G+ +E +P
Sbjct: 195 AMDEGQYDGKVDVWSLGITCIELAERKP 222
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 7e-17
Identities = 58/207 (28%), Positives = 101/207 (48%), Gaps = 19/207 (9%)
Query: 695 FSPSNKLGEGGFGPVYKGK-LGDGRAIAVKQLSVASRQGKSQF---VAEIATISAVQHRN 750
FS ++G G FG VY + + + +A+K++S + +Q ++ + E+ + ++H N
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 751 LVKLHGCCIEGAERLLVYEYLENKSLDQALFGQRSLT-LDWATRYEICSGVARGLAYLHE 809
++ GC + LV EY + D ++ L ++ A + G +GLAYLH
Sbjct: 77 TIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAA---VTHGALQGLAYLHS 133
Query: 810 ESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVAGTIGYLAPEYAM- 868
+ +IHRDVKA N+LL + K+ DFG A + + GT ++APE +
Sbjct: 134 HN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFV-----GTPYWMAPEVILA 185
Query: 869 --RGHLTEKTDVFAFGVLALETVSGRP 893
G K DV++ G+ +E +P
Sbjct: 186 MDEGQYDGKVDVWSLGITCIELAERKP 212
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.2 bits (201), Expect = 1e-16
Identities = 61/223 (27%), Positives = 99/223 (44%), Gaps = 24/223 (10%)
Query: 688 LKTATENFSPSNKLGEGGFGPVYKGKLGD-GRAIAVKQLSVASRQGKSQFVAEIATISAV 746
L T F +GEG +G VYK + G+ +A+K + + + + + E +
Sbjct: 1 LPDPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDE-EEEIKEEYNILRKY 59
Query: 747 -QHRNLVKLHGC------CIEGAERLLVYEYLENKS---LDQALFGQ-RSLTLDWATRYE 795
H N+ +G + LV E S L + L + + L +W Y
Sbjct: 60 SNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIA-Y- 117
Query: 796 ICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRV 855
I RGLAYLHE ++IHRD+K N+LL + K+ DFG++ D +T +
Sbjct: 118 ILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFI 174
Query: 856 AGTIGYLAPE-----YAMRGHLTEKTDVFAFGVLALETVSGRP 893
GT ++APE ++DV++ G+ A+E G+P
Sbjct: 175 -GTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKP 216
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 82.0 bits (203), Expect = 1e-16
Identities = 52/169 (30%), Positives = 83/169 (49%), Gaps = 12/169 (7%)
Query: 690 TATENFSPSNKLGEGGFGPVYKG-KLGDGRAIAVKQLSVASRQGKSQFVA--EIATISAV 746
+ ++ KLGEG FG VYK ++ GR +A+K++ + + + A EI + +
Sbjct: 5 SKLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKL 64
Query: 747 QHRNLVKLHGCCIE-----GAERLLVYEYLENKSLDQA-LFGQRSLTLDWATRYEICSGV 800
+H N+V L +E +R VY D + L S+ L + +
Sbjct: 65 KHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQL 124
Query: 801 ARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKT 849
G+ YLHE I+HRD+KA+N+L+D + KI+DFGLA+ YD
Sbjct: 125 LEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLARPYDGPPP 170
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 81.3 bits (201), Expect = 1e-16
Identities = 61/221 (27%), Positives = 111/221 (50%), Gaps = 24/221 (10%)
Query: 694 NFSPSNKLGEGGFGPVYKGK-LGDGRAIAVKQLSVASRQG--KSQFVAEIATISAVQHRN 750
+++ K+GEG +G VYKG+ G+ +A+K++ + S + S + EI+ + +QH N
Sbjct: 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPN 60
Query: 751 LVKLHGCCIEGAERLLVYEYLE---NKSLDQALFGQRSLTLDWATRYEICSGVARGLAYL 807
+V L ++ + L++E+L K LD GQ +D + +G+ +
Sbjct: 61 IVCLQDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQ---YMDAELVKSYLYQILQGILFC 117
Query: 808 HEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRV----AGTIGYLA 863
H R++HRD+K N+L+D V K++DFGLA+ + I RV T+ Y A
Sbjct: 118 H---SRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFG-----IPVRVYTHEVVTLWYRA 169
Query: 864 PEYAMRGHL-TEKTDVFAFGVLALETVSGRP--NSDPSLDE 901
PE + + D+++ G + E + +P + D +D+
Sbjct: 170 PEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQ 210
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 82.6 bits (204), Expect = 1e-16
Identities = 62/214 (28%), Positives = 97/214 (45%), Gaps = 43/214 (20%)
Query: 699 NKLGEGGFGPVYKGK-LGDGRAIAVKQL------SVASRQGKSQFVAEIATISAVQHRNL 751
N++G G G VYK GR A+K + +V + Q EI + V H N+
Sbjct: 80 NRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTV-----RRQICREIEILRDVNHPNV 134
Query: 752 VKLHGCCIEGAERLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEES 811
VK H E ++ E+++ SL+ D A + + G+AYLH
Sbjct: 135 VKCHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQFLADVARQ------ILSGIAYLH--- 185
Query: 812 RVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVAGTIGYLAPE------ 865
R I+HRD+K SN+L+++ KI+DFG++++ ++ V GTI Y++PE
Sbjct: 186 RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSV-GTIAYMSPERINTDL 244
Query: 866 -------YAMRGHLTEKTDVFAFGVLALETVSGR 892
YA D+++ GV LE GR
Sbjct: 245 NHGAYDGYA--------GDIWSLGVSILEFYLGR 270
|
Length = 353 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 80.7 bits (200), Expect = 1e-16
Identities = 62/205 (30%), Positives = 95/205 (46%), Gaps = 27/205 (13%)
Query: 701 LGEGGFGPVYKGKL-GDGRAIAVKQLS----VASRQGKSQFVAEIATISAVQHRNLVKLH 755
LG GGFG V K+ R A+K + V + Q + +E + H +VKL+
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQE-HIFSEKEILEECNHPFIVKLY 59
Query: 756 GCCIEGAERLLVYEYLENKSL-----DQALFGQRSLTLDWATRYEICSGVARGLAYLHEE 810
+ ++ EY L D+ LF ++ R+ + V YLH
Sbjct: 60 RTFKDKKYIYMLMEYCLGGELWTILRDRGLFD------EYTARF-YIACVVLAFEYLHNR 112
Query: 811 SRVRIIHRDVKASNVLLDADLVPKISDFGLAK-LYDDKKTHISTRVAGTIGYLAPEYAM- 868
II+RD+K N+LLD++ K+ DFG AK L +KT T GT Y+APE +
Sbjct: 113 G---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTW--TFC-GTPEYVAPEIILN 166
Query: 869 RGHLTEKTDVFAFGVLALETVSGRP 893
+G+ D ++ G+L E ++GRP
Sbjct: 167 KGY-DFSVDYWSLGILLYELLTGRP 190
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 84.1 bits (208), Expect = 1e-16
Identities = 61/186 (32%), Positives = 94/186 (50%), Gaps = 31/186 (16%)
Query: 36 TDPNEVRALNSIFQQWRISARQGQWNRSGDPC-------TGAALDDSIVFDNTDYNPFIK 88
T EV AL ++ + R G WN GDPC +GA FD+T FI
Sbjct: 369 TLLEEVSALQTLKSSLGLPLRFG-WN--GDPCVPQQHPWSGA----DCQFDSTKGKWFID 421
Query: 89 CDCSSQNGTVCHITQLKVYALNVVGVIPDELWNLTSLFNLNLGQNYLTGPLSPSVGNLTA 148
G L+ G IP+++ L L ++NL N + G + PS+G++T+
Sbjct: 422 GLGLDNQG-------LR-------GFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITS 467
Query: 149 MQYLNLAINALSGELPKELGQLTELLILGIGTNNFSGPLPSELGS--LSKLQELYIDSAG 206
++ L+L+ N+ +G +P+ LGQLT L IL + N+ SG +P+ LG L + + D+AG
Sbjct: 468 LEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDNAG 527
Query: 207 VSGEIP 212
+ G IP
Sbjct: 528 LCG-IP 532
|
Length = 623 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 2e-16
Identities = 72/236 (30%), Positives = 116/236 (49%), Gaps = 36/236 (15%)
Query: 701 LGEGGFGPVY--------KGKLGDGRAIAVKQL-SVASRQGKSQFVAEIATISAV-QHRN 750
LGEG FG V K K +AVK L S A+ + S ++E+ + + +H+N
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85
Query: 751 LVKLHGCCIEGAERLLVYEYLENKSLDQALFGQRSLTLDWA-----------TRYEICS- 798
++ L G C + ++ EY +L + L +R +++ + ++ S
Sbjct: 86 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSC 145
Query: 799 --GVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAK---LYDDKKTHIST 853
VARG+ YL + + IHRD+ A NVL+ D V KI+DFGLA+ D K +
Sbjct: 146 AYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 202
Query: 854 RVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALE--TVSGRPNSDPSLDEEKLYLL 907
R+ + ++APE T ++DV++FGVL E T+ G P P + E+L+ L
Sbjct: 203 RLP--VKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY--PGVPVEELFKL 254
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 81.3 bits (201), Expect = 2e-16
Identities = 63/215 (29%), Positives = 95/215 (44%), Gaps = 22/215 (10%)
Query: 701 LGEGGFGPV----YKGKLGDGRAIAV--KQLSVASRQGKSQFVAEIATISAVQHRNLVKL 754
LG+G FG V KG + A+ V K + + + + A +H L +L
Sbjct: 3 LGKGSFGKVLLAELKGT-DELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQL 61
Query: 755 HGCCIEGAERL-LVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRV 813
H C + +RL V EY+ L + A Y + GL +LHE
Sbjct: 62 H-SCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAE--IVLGLQFLHERG-- 116
Query: 814 RIIHRDVKASNVLLDADLVPKISDFGLAK---LYDDKKTHISTRVAGTIGYLAPEYAMRG 870
II+RD+K NVLLD++ KI+DFG+ K L ++ GT Y+APE
Sbjct: 117 -IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVT----TSTFCGTPDYIAPEILSYQ 171
Query: 871 HLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLY 905
D +A GVL E ++G+ + DE++L+
Sbjct: 172 PYGPAVDWWALGVLLYEMLAGQSPFEGD-DEDELF 205
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 2e-16
Identities = 71/272 (26%), Positives = 120/272 (44%), Gaps = 35/272 (12%)
Query: 693 ENFSPSNKLGEGGFGPVY-KGKLGDGRAIAVKQLSVASRQGKSQF---VAEIATISAVQH 748
E F +++G G FG VY +AVK++S + +Q ++ + E+ + ++H
Sbjct: 21 EIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKH 80
Query: 749 RNLVKLHGCCIEGAERLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLH 808
N ++ GC ++ LV EY + D L L I G +GLAYLH
Sbjct: 81 PNTIEYKGCYLKEHTAWLVMEYCLGSASD--LLEVHKKPLQEVEIAAITHGALQGLAYLH 138
Query: 809 EESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVAGTIGYLAPEYAM 868
+ +IHRD+KA N+LL K++DFG A + + GT ++APE +
Sbjct: 139 SHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSSPANSFV-----GTPYWMAPEVIL 190
Query: 869 ---RGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEIELADP 925
G K DV++ G+ +E +P P + + L +H+ +N D
Sbjct: 191 AMDEGQYDGKVDVWSLGITCIELAERKP---PLFNMNAMSAL---YHIAQN-------DS 237
Query: 926 KLIEFNE--EEVKRLIGVALLCTQTLPSLRPS 955
++ NE + + + C Q +P RP+
Sbjct: 238 PTLQSNEWTDSFRGFVD---YCLQKIPQERPA 266
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.4 bits (199), Expect = 2e-16
Identities = 67/253 (26%), Positives = 109/253 (43%), Gaps = 31/253 (12%)
Query: 700 KLGEGGFGPVYKGKLGD-GRAIAVKQLSVA--SRQGKSQFVAEIATISAVQHRNLVKLHG 756
+GEG +G V K + G +A+K+ + K + E+ + ++H N+V L
Sbjct: 8 VVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKE 67
Query: 757 CCIEGAERLLVYEYLENKSLDQALFGQRSLTLDWATR---YEICSGVARGLAYLHEESRV 813
LV+EY+E L+ L D A R +++ + +AY H
Sbjct: 68 AFRRKGRLYLVFEYVERTLLELLEASPGGLPPD-AVRSYIWQLL----QAIAYCH---SH 119
Query: 814 RIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVAGTIGYLAPE----YAMR 869
IIHRD+K N+L+ V K+ DFG A+ + T T Y APE
Sbjct: 120 NIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTNY 179
Query: 870 GHLTEKTDVFAFGVLALETVSGRP--NSDPSLDEEKLYLLEWAW-HLHENNQEIELADP- 925
G + DV+A G + E + G P D +D+ LYL++ L ++QE+ ++P
Sbjct: 180 G---KPVDVWAIGCIMAELLDGEPLFPGDSDIDQ--LYLIQKCLGPLPPSHQELFSSNPR 234
Query: 926 ----KLIEFNEEE 934
E ++ E
Sbjct: 235 FAGVAFPEPSQPE 247
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 80.7 bits (199), Expect = 2e-16
Identities = 61/227 (26%), Positives = 106/227 (46%), Gaps = 39/227 (17%)
Query: 700 KLGEGGFGPVYKGKLGD---------------GRA--IAVKQLSV-ASRQGKSQFVAEIA 741
KLGEG FG V+ ++ + GR +AVK L A++ ++ F+ E+
Sbjct: 12 KLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVK 71
Query: 742 TISAVQHRNLVKLHGCCIEGAERLLVYEYLENKSLDQALFGQR----------------- 784
+S ++ N+++L G C++ ++ EY+EN L+Q L
Sbjct: 72 ILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHC 131
Query: 785 SLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAK-L 843
+ +++ + +A G+ YL S + +HRD+ N L+ +L KI+DFG+++ L
Sbjct: 132 LPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADFGMSRNL 188
Query: 844 YDDKKTHISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVS 890
Y I R I ++A E + G T +DV+AFGV E +
Sbjct: 189 YAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILM 235
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 2e-16
Identities = 75/278 (26%), Positives = 121/278 (43%), Gaps = 34/278 (12%)
Query: 694 NFSPSNKLGEGGFGPVYKGK-LGDGRAIAVKQLSV---ASRQGKSQFVAEIATISAVQHR 749
NF K+G G F VY+ L D + +A+K++ + + + V EI + + H
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62
Query: 750 NLVKLHGCCIEGAERLLVYEYLENKSLDQALF---GQRSLTLD---WATRYEICSGVARG 803
N++K IE E +V E + L Q + Q+ L + W ++CS V
Sbjct: 63 NVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVE-- 120
Query: 804 LAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVAGTIGYLA 863
H SR R++HRD+K +NV + A V K+ D GL + + K T + V GT Y++
Sbjct: 121 ----HMHSR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMS 174
Query: 864 PEYAMRGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEIELA 923
PE K+D+++ G L E + +K+ L Q+IE
Sbjct: 175 PERIHENGYNFKSDIWSLGCLLYEMAA----LQSPFYGDKMNLFSLC-------QKIEQC 223
Query: 924 D--PKLIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRV 959
D P E E+++ L+ +C P RP + V
Sbjct: 224 DYPPLPTEHYSEKLRELVS---MCIYPDPDQRPDIGYV 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 3e-16
Identities = 57/206 (27%), Positives = 101/206 (49%), Gaps = 15/206 (7%)
Query: 694 NFSPSNKLGEGGFGPVYKGK-LGDGRAIAVKQ--LSVASRQGKSQFVAEIATISAVQHRN 750
NF K+GEG +G VYK + G +A+K+ L + S + EI+ + + H N
Sbjct: 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 60
Query: 751 LVKLHGCCIEGAERLLVYEYLEN---KSLDQALFGQRSLTLDWATRYEICSGVARGLAYL 807
+VKL + LV+E+L K +D + L L + +++ G+A +
Sbjct: 61 IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLA----FC 116
Query: 808 HEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVAGTIGYLAPEYA 867
H R++HRD+K N+L++ + K++DFGLA+ + + V T+ Y APE
Sbjct: 117 HSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEIL 172
Query: 868 M-RGHLTEKTDVFAFGVLALETVSGR 892
+ + + D+++ G + E V+ R
Sbjct: 173 LGCKYYSTAVDIWSLGCIFAEMVTRR 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 79.6 bits (197), Expect = 3e-16
Identities = 65/206 (31%), Positives = 94/206 (45%), Gaps = 26/206 (12%)
Query: 704 GGFGPVY---KGKLGDGRAIAVKQLSVASRQGKSQF---VAEIATISAVQHRNLVKLHGC 757
G +G V+ K GD A+K + A K+Q + E +S Q +VKL+
Sbjct: 4 GAYGRVFLAKKKSTGD--IYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLY-Y 60
Query: 758 CIEGAERL-LVYEYLENKSLDQALFGQRSLTLDWATRY--EICSGVARGLAYLHEESRVR 814
+G + L LV EYL L L SL D A Y EI L YLH
Sbjct: 61 SFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEI----VLALEYLH---SNG 113
Query: 815 IIHRDVKASNVLLDADLVPKISDFGLAK--LYDDKKTHIST-----RVAGTIGYLAPEYA 867
IIHRD+K N+L+D++ K++DFGL+K L + R+ GT Y+APE
Sbjct: 114 IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVI 173
Query: 868 MRGHLTEKTDVFAFGVLALETVSGRP 893
+ ++ D ++ G + E + G P
Sbjct: 174 LGQGHSKTVDWWSLGCILYEFLVGIP 199
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 4e-16
Identities = 58/202 (28%), Positives = 95/202 (47%), Gaps = 15/202 (7%)
Query: 701 LGEGGFGPVYKGKLGD-GRAIAVKQ-----LSVASRQGKSQFVAEIATISAVQHRNLVKL 754
LG+G FG VY D GR +AVKQ S +++ + EI + +QH +V+
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQY 69
Query: 755 HGCCIEGAERLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVR 814
+GC + + EY+ S+ L +LT +Y + G+ YLH
Sbjct: 70 YGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYT--RQILEGVEYLH---SNM 124
Query: 815 IIHRDVKASNVLLDADLVPKISDFGLAKLYDD---KKTHISTRVAGTIGYLAPEYAMRGH 871
I+HRD+K +N+L D+ K+ DFG +K T + + V GT +++PE
Sbjct: 125 IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKS-VTGTPYWMSPEVISGEG 183
Query: 872 LTEKTDVFAFGVLALETVSGRP 893
K DV++ G +E ++ +P
Sbjct: 184 YGRKADVWSVGCTVVEMLTEKP 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 5e-16
Identities = 71/278 (25%), Positives = 122/278 (43%), Gaps = 41/278 (14%)
Query: 700 KLGEGGFGPVYKGKL-----GDGRAIAVKQLS-VASRQGKSQFVAEIATISAVQHRNLVK 753
+LGE FG +YKG L + +A+K L + + Q +F E + ++ + H N+V
Sbjct: 12 ELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVC 71
Query: 754 LHGCCIEGAERLLVYEYLENKSLDQALF---------------GQRSLTLDWATRYEICS 798
L G + +++EYL L + L G +LD I
Sbjct: 72 LLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAI 131
Query: 799 GVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAK-LYDDKKTHISTRVAG 857
+A G+ YL S +H+D+ A N+L+ L KISD GL++ +Y + +
Sbjct: 132 QIAAGMEYL---SSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLL 188
Query: 858 TIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENN 917
I ++ PE M G + +D+++FGV+ E S + L+ ++ N
Sbjct: 189 PIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS--------------FGLQ-PYYGFSNQ 233
Query: 918 QEIELADPK-LIEFNEEEVKRLIGVALLCTQTLPSLRP 954
+ IE+ + L+ +E+ R+ + C Q PS RP
Sbjct: 234 EVIEMVRKRQLLPCSEDCPPRMYSLMTECWQEGPSRRP 271
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 6e-16
Identities = 63/207 (30%), Positives = 107/207 (51%), Gaps = 24/207 (11%)
Query: 701 LGEGGFGPVYKGK-LGDGRAI----AVKQLS-VASRQGKSQFVAEIATISAVQHRNLVKL 754
LG G FG VYKG + +G + A+K L+ + +F+ E ++++ H +LV+L
Sbjct: 15 LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 74
Query: 755 HGCCIEGAERLLVYEYLENKSLDQALFGQR-----SLTLDWATRYEICSGVARGLAYLHE 809
G C+ +L V + + + L + + L L+W C +A+G+ YL E
Sbjct: 75 LGVCLSPTIQL-VTQLMPHGCLLDYVHEHKDNIGSQLLLNW------CVQIAKGMMYLEE 127
Query: 810 ESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYD-DKKTHISTRVAGTIGYLAPEYAM 868
R++HRD+ A NVL+ + KI+DFGLA+L + D+K + + I ++A E
Sbjct: 128 R---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIH 184
Query: 869 RGHLTEKTDVFAFGVLALE--TVSGRP 893
T ++DV+++GV E T G+P
Sbjct: 185 YRKFTHQSDVWSYGVTIWELMTFGGKP 211
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 79.1 bits (196), Expect = 6e-16
Identities = 64/199 (32%), Positives = 95/199 (47%), Gaps = 17/199 (8%)
Query: 701 LGEGGFGPVYKGKLGD-GRAIAVKQLS----VASRQGKSQFVAEIATISAVQHRNLVKLH 755
LG G FG V + G+ A+K LS V +Q + E + +++H LV L+
Sbjct: 9 LGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQ-VEHVLNEKRILQSIRHPFLVNLY 67
Query: 756 GCCIEGAERLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRI 815
G + + LV EY+ L L A Y + V L YLH I
Sbjct: 68 GSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFY--AAQVVLALEYLHSLD---I 122
Query: 816 IHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVAGTIGYLAPEYAM-RGHLTE 874
++RD+K N+LLD+D KI+DFG AK +T+ + GT YLAPE + +G+ +
Sbjct: 123 VYRDLKPENLLLDSDGYIKITDFGFAK-RVKGRTYT---LCGTPEYLAPEIILSKGY-GK 177
Query: 875 KTDVFAFGVLALETVSGRP 893
D +A G+L E ++G P
Sbjct: 178 AVDWWALGILIYEMLAGYP 196
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 7e-16
Identities = 53/205 (25%), Positives = 97/205 (47%), Gaps = 22/205 (10%)
Query: 694 NFSPSNKLGEGGFGPVY--KGKLGDGRAIAVKQLSVASRQGKSQFVA--EIATISAVQHR 749
+ K+GEG FG +Y K K D +K++ + K + + E+ ++ ++H
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAKS-DSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHP 59
Query: 750 NLVKLHGCCIEGAERLLVYEYLENKSLDQALFGQRSL------TLDWATRYEICSGVARG 803
N+V E +V EY + L + + QR + L W + ++ G
Sbjct: 60 NIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQ------ISLG 113
Query: 804 LAYLHEESRVRIIHRDVKASNVLLDAD-LVPKISDFGLAKLYDDKKTHISTRVAGTIGYL 862
L ++H+ +I+HRD+K+ N+ L + +V K+ DFG+A+ +D ++ GT YL
Sbjct: 114 LKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLND-SMELAYTCVGTPYYL 169
Query: 863 APEYAMRGHLTEKTDVFAFGVLALE 887
+PE KTD+++ G + E
Sbjct: 170 SPEICQNRPYNNKTDIWSLGCVLYE 194
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 1e-15
Identities = 60/218 (27%), Positives = 105/218 (48%), Gaps = 12/218 (5%)
Query: 687 ELKTATENFSPSNKLGEGGFGPVYKGKLGDGRAIAVKQLSVASRQG--KSQFVAEIATIS 744
ELK ++F ++LG G G V K + I ++L + ++Q + E+ +
Sbjct: 1 ELKD--DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLH 58
Query: 745 AVQHRNLVKLHGCCIEGAERLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGL 804
+V +G E + E+++ SLDQ L + + + + I V RGL
Sbjct: 59 ECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSI--AVLRGL 116
Query: 805 AYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVAGTIGYLAP 864
AYL E+ + I+HRDVK SN+L+++ K+ DFG++ D ++ GT Y++P
Sbjct: 117 AYLREKHQ--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MANSFVGTRSYMSP 171
Query: 865 EYAMRGHLTEKTDVFAFGVLALETVSGR-PNSDPSLDE 901
E H + ++D+++ G+ +E GR P P E
Sbjct: 172 ERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKE 209
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 1e-15
Identities = 63/219 (28%), Positives = 110/219 (50%), Gaps = 11/219 (5%)
Query: 693 ENFSPSNKLGEGGFGPVYKG--KLGDGRAIAVKQLSVASRQGKS-QFVAEIATISAVQHR 749
E + KLGEG + V+KG KL + +A+K++ + +G + E++ + ++H
Sbjct: 6 ETYIKLEKLGEGTYATVFKGRSKLTEN-LVALKEIRLEHEEGAPCTAIREVSLLKDLKHA 64
Query: 750 NLVKLHGCCIEGAERLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHE 809
N+V LH LV+EYL+ K L Q + ++ + + + RGLAY H
Sbjct: 65 NIVTLHDIVHTDKSLTLVFEYLD-KDLKQYMDDCGNIMSMHNVKIFLYQ-ILRGLAYCH- 121
Query: 810 ESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVAGTIGYLAPEYAM- 868
R +++HRD+K N+L++ K++DFGLA+ S V T+ Y P+ +
Sbjct: 122 --RRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV-TLWYRPPDVLLG 178
Query: 869 RGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLL 907
+ + D++ G + E SGRP S E++L+L+
Sbjct: 179 SSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLI 217
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 1e-15
Identities = 66/203 (32%), Positives = 101/203 (49%), Gaps = 18/203 (8%)
Query: 701 LGEGGFGPVYKGKLGDG----RAIAVKQLSVAS--RQGK--SQFVAEIATISAVQHRNLV 752
LG+GG+G V++ + G + A+K L A+ R K + AE + AV+H +V
Sbjct: 4 LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIV 63
Query: 753 KLHGCCIEGAERLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESR 812
L G + L+ EYL L L + D A Y S ++ L +LH++
Sbjct: 64 DLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFY--LSEISLALEHLHQQG- 120
Query: 813 VRIIHRDVKASNVLLDADLVPKISDFGLAK--LYDDKKTHISTRVAGTIGYLAPEYAMRG 870
II+RD+K N+LLDA K++DFGL K +++ TH GTI Y+APE MR
Sbjct: 121 --IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHT---FCGTIEYMAPEILMRS 175
Query: 871 HLTEKTDVFAFGVLALETVSGRP 893
+ D ++ G L + ++G P
Sbjct: 176 GHGKAVDWWSLGALMYDMLTGAP 198
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 78.0 bits (192), Expect = 2e-15
Identities = 64/204 (31%), Positives = 101/204 (49%), Gaps = 22/204 (10%)
Query: 701 LGEGGFGPV----YKGKLGD--GRAIAVKQLSVASRQGKS-QFVAEIATISAVQHRNLVK 753
LGEG FG V Y + GD G +AVK L S EI + + H N+VK
Sbjct: 12 LGEGHFGKVELCRYDPE-GDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVK 70
Query: 754 LHGCCIEGAER--LLVYEYLENKSLDQALFGQRS-LTLDWATRY--EICSGVARGLAYLH 808
G C E L+ E+L + SL + L ++ + L +Y +IC +G+ YL
Sbjct: 71 YKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQIC----KGMDYLG 126
Query: 809 EESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTR--VAGTIGYLAPEY 866
SR + +HRD+ A NVL++++ KI DFGL K + K + + + + + + APE
Sbjct: 127 --SR-QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPEC 183
Query: 867 AMRGHLTEKTDVFAFGVLALETVS 890
++ +DV++FGV E ++
Sbjct: 184 LIQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 77.8 bits (192), Expect = 2e-15
Identities = 79/284 (27%), Positives = 130/284 (45%), Gaps = 39/284 (13%)
Query: 700 KLGEGGFGPVYKGKLGD-GRAIAVKQL--SVASRQGKSQFVAEIATISAVQHRNLVKLHG 756
+GEG +G V K K + G+ +A+K+ S + K + EI + ++H NLV L
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIE 67
Query: 757 CCIEGAERLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRII 816
LV+E++++ LD + LD + + + RG+ + H + II
Sbjct: 68 VFRRKKRLYLVFEFVDHTVLDD--LEKYPNGLDESRVRKYLFQILRGIEFCHSHN---II 122
Query: 817 HRDVKASNVLLDADLVPKISDFGLAK-------LYDDKKTHISTRVAGTIGYLAPEYAMR 869
HRD+K N+L+ V K+ DFG A+ +Y D +++TR Y APE +
Sbjct: 123 HRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTD---YVATR-----WYRAPELLVG 174
Query: 870 GHLTEK-TDVFAFGVLALETVSGRPNSDPSLDEEKLY-LLEWAWHLHENNQEI------- 920
+ D++A G L E ++G P D ++LY +++ +L +QEI
Sbjct: 175 DTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLF 234
Query: 921 ---ELADPKLIEFNEEEVKRLIGVAL----LCTQTLPSLRPSMS 957
L + K IE E+ +L G+ L C + P RPS S
Sbjct: 235 AGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSS 278
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 2e-15
Identities = 61/198 (30%), Positives = 94/198 (47%), Gaps = 13/198 (6%)
Query: 700 KLGEGGFGPVYKG---KLGDGRAIAVKQLSVASRQG--KSQFVAEIATISAVQHRNLVKL 754
+LG G FG V KG + +AVK L + K + + E + + + +V++
Sbjct: 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRM 61
Query: 755 HGCCIEGAERLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVR 814
G C E +LV E E L++ L + +T T E+ V+ G+ YL E +
Sbjct: 62 IGIC-EAESWMLVMELAELGPLNKFLQKNKHVTEKNIT--ELVHQVSMGMKYLEETN--- 115
Query: 815 IIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVAGT--IGYLAPEYAMRGHL 872
+HRD+ A NVLL KISDFGL+K + + + G + + APE
Sbjct: 116 FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKF 175
Query: 873 TEKTDVFAFGVLALETVS 890
+ K+DV++FGVL E S
Sbjct: 176 SSKSDVWSFGVLMWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 2e-15
Identities = 63/206 (30%), Positives = 105/206 (50%), Gaps = 30/206 (14%)
Query: 701 LGEGGFGPVYKGK-LGDGRAI----AVKQL-SVASRQGKSQFVAEIATISAVQHRNLVKL 754
LG G FG VYKG + DG + A+K L S + + + E ++ V + +L
Sbjct: 15 LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRL 74
Query: 755 HGCCIEGAERLL--------VYEYL-ENKSLDQALFGQRSLTLDWATRYEICSGVARGLA 805
G C+ +L+ + +Y+ ENK G + L L+W C +A+G++
Sbjct: 75 LGICLTSTVQLVTQLMPYGCLLDYVRENKDR----IGSQDL-LNW------CVQIAKGMS 123
Query: 806 YLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYD-DKKTHISTRVAGTIGYLAP 864
YL E VR++HRD+ A NVL+ + KI+DFGLA+L D D+ + + I ++A
Sbjct: 124 YLEE---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMAL 180
Query: 865 EYAMRGHLTEKTDVFAFGVLALETVS 890
E + T ++DV+++GV E ++
Sbjct: 181 ESILHRRFTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 3e-15
Identities = 64/219 (29%), Positives = 108/219 (49%), Gaps = 11/219 (5%)
Query: 693 ENFSPSNKLGEGGFGPVYKG--KLGDGRAIAVKQLSVASRQGKS-QFVAEIATISAVQHR 749
E + +KLGEG + VYKG KL D +A+K++ + +G + E++ + ++H
Sbjct: 6 ETYIKLDKLGEGTYATVYKGRSKLTDN-LVALKEIRLEHEEGAPCTAIREVSLLKDLKHA 64
Query: 750 NLVKLHGCCIEGAERLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHE 809
N+V LH LV+EYL+ K L Q L + ++ + RGL Y H
Sbjct: 65 NIVTLHDIIHTEKSLTLVFEYLD-KDLKQYLDDCGNS-INMHNVKLFLFQLLRGLNYCH- 121
Query: 810 ESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVAGTIGYLAPEYAM- 868
R +++HRD+K N+L++ K++DFGLA+ S V T+ Y P+ +
Sbjct: 122 --RRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV-TLWYRPPDILLG 178
Query: 869 RGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLL 907
+ + D++ G + E +GRP S EE+L+ +
Sbjct: 179 STDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFI 217
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 3e-15
Identities = 72/288 (25%), Positives = 132/288 (45%), Gaps = 35/288 (12%)
Query: 700 KLGEGGFGPVYKGKLGD---GRA---IAVKQLS-VASRQGKSQFVAEIATISAVQHRNLV 752
+LG+G FG VY+G D G A +AVK ++ AS + + +F+ E + + ++V
Sbjct: 13 ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 72
Query: 753 KLHGCCIEGAERLLVYEYLENKSLDQALFGQRSLTLDWATR--------YEICSGVARGL 804
+L G +G L+V E + + L L R + R ++ + +A G+
Sbjct: 73 RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 132
Query: 805 AYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAK-LYDDKKTHISTRVAGTIGYLA 863
AYL+ + + +HRD+ A N ++ D KI DFG+ + +Y+ + + ++A
Sbjct: 133 AYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMA 189
Query: 864 PEYAMRGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEIELA 923
PE G T +D+++FGV+ E S L E + N Q ++
Sbjct: 190 PESLKDGVFTTSSDMWSFGVVLWEITS---------------LAEQPYQGLSNEQVLKFV 234
Query: 924 -DPKLIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVAMLCGDMEVS 970
D ++ + +R+ + +C Q P +RP+ +V +L D+ S
Sbjct: 235 MDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPS 282
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 4e-15
Identities = 68/262 (25%), Positives = 116/262 (44%), Gaps = 36/262 (13%)
Query: 701 LGEGGFGPVYKGKLGD-GRAIAVKQLSVASRQGKSQFVAEIATISAVQHRNLVKLHGCCI 759
LG G G V+ D + +AVK++ + Q + EI I + H N+VK++
Sbjct: 13 LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLG 72
Query: 760 EGAERL--------------LVYEYLEN---KSLDQALFGQRSLTLDWATRYEICSGVAR 802
L +V EY+E L+Q + L Y++ R
Sbjct: 73 PSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHARL---FMYQLL----R 125
Query: 803 GLAYLHEESRVRIIHRDVKASNVLLDA-DLVPKISDFGLAKLYD---DKKTHISTRVAGT 858
GL Y+H + ++HRD+K +NV ++ DLV KI DFGLA++ D K ++S + T
Sbjct: 126 GLKYIHSAN---VLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLV-T 181
Query: 859 IGYLAPEYAMR-GHLTEKTDVFAFGVLALETVSGRP--NSDPSLDEEKLYLLEWAWHLHE 915
Y +P + + T+ D++A G + E ++G+P L++ +L L E
Sbjct: 182 KWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVREE 241
Query: 916 NNQEIELADPKLIEFNEEEVKR 937
+ E+ P + + E +R
Sbjct: 242 DRNELLNVIPSFVRNDGGEPRR 263
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 4e-15
Identities = 63/212 (29%), Positives = 108/212 (50%), Gaps = 30/212 (14%)
Query: 695 FSPSNKLGEGGFGPVYKGK-LGDGRAI----AVKQLSVA-SRQGKSQFVAEIATISAVQH 748
F LG G FG VYKG + +G + A+K+L A S + + + E +++V +
Sbjct: 9 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 68
Query: 749 RNLVKLHGCCIEGAERLL--------VYEYL-ENKSLDQALFGQRSLTLDWATRYEICSG 799
++ +L G C+ +L+ + +Y+ E+K G + L L+W C
Sbjct: 69 PHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDN----IGSQYL-LNW------CVQ 117
Query: 800 VARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYD-DKKTHISTRVAGT 858
+A+G+ YL E R++HRD+ A NVL+ KI+DFGLAKL D+K + +
Sbjct: 118 IAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVP 174
Query: 859 IGYLAPEYAMRGHLTEKTDVFAFGVLALETVS 890
I ++A E + T ++DV+++GV E ++
Sbjct: 175 IKWMALESILHRIYTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 5e-15
Identities = 56/200 (28%), Positives = 97/200 (48%), Gaps = 19/200 (9%)
Query: 700 KLGEGGFG-PVYKGKLGDGRAIAVKQLSVASRQGKSQFVA--EIATISAVQHRNLVKLHG 756
K+GEG FG + DG+ +K+++++ K + + E+A +S ++H N+V+
Sbjct: 7 KIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQE 66
Query: 757 CCIEGAERLLVYEYLENKSLDQALFGQRSL------TLDWATRYEICSGVARGLAYLHEE 810
E +V +Y E L + + QR + LDW +IC LA H
Sbjct: 67 SFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFV--QIC------LALKHVH 118
Query: 811 SRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVAGTIGYLAPEYAMRG 870
R +I+HRD+K+ N+ L D K+ DFG+A++ + ++ GT YL+PE
Sbjct: 119 DR-KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNS-TVELARTCIGTPYYLSPEICENR 176
Query: 871 HLTEKTDVFAFGVLALETVS 890
K+D++A G + E +
Sbjct: 177 PYNNKSDIWALGCVLYEMCT 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 5e-15
Identities = 68/201 (33%), Positives = 98/201 (48%), Gaps = 19/201 (9%)
Query: 701 LGEGGFGPVYKGKL-GDGRAIAVKQLS---VASRQGKSQFVAEIATISAVQHRNLVKLHG 756
LG+GGFG V ++ G+ A K+L + R+G+S + E + V R +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSL-A 66
Query: 757 CCIEGAERL-LVYEYLENKSLDQALF--GQRSLTLDWATRY--EICSGVARGLAYLHEES 811
E + L LV + L ++ G+ A Y EIC G L LH+E
Sbjct: 67 YAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCG----LEDLHQE- 121
Query: 812 RVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVAGTIGYLAPEYAMRGH 871
RI++RD+K N+LLD +ISD GLA + +T I RV GT+GY+APE
Sbjct: 122 --RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT-IKGRV-GTVGYMAPEVVKNER 177
Query: 872 LTEKTDVFAFGVLALETVSGR 892
T D +A G L E ++G+
Sbjct: 178 YTFSPDWWALGCLLYEMIAGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 7e-15
Identities = 61/204 (29%), Positives = 98/204 (48%), Gaps = 17/204 (8%)
Query: 701 LGEGGFGPVYKG-KLGDGRAIAVKQL-----SVASRQGKSQFVAEIATISAVQHRNLVKL 754
LG+G FG VY + GR +A KQ+ S + + S EI + +QH +V+
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQY 69
Query: 755 HGCCIEGAERLLV--YEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESR 812
+GC + AE+ L EY+ S+ L +LT +Y + G++YLH
Sbjct: 70 YGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYT--RQILEGMSYLHSN-- 125
Query: 813 VRIIHRDVKASNVLLDADLVPKISDFGLAKLYDD---KKTHISTRVAGTIGYLAPEYAMR 869
I+HRD+K +N+L D+ K+ DFG +K T I + V GT +++PE
Sbjct: 126 -MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRS-VTGTPYWMSPEVISG 183
Query: 870 GHLTEKTDVFAFGVLALETVSGRP 893
K DV++ G +E ++ +P
Sbjct: 184 EGYGRKADVWSLGCTVVEMLTEKP 207
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 9e-15
Identities = 70/243 (28%), Positives = 116/243 (47%), Gaps = 24/243 (9%)
Query: 700 KLGEGGFGPVYKGKLGDG---RAIAVKQLSV-ASRQGKSQFVAEIATISAVQHRNLVKLH 755
++G G FG V G++ G + VK+L V AS Q + +F+ E ++QH NL++
Sbjct: 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCL 61
Query: 756 GCCIEGAERLLVYEYLENKSLDQALFGQR---SLTLDWATRYEICSGVARGLAYLHEESR 812
G C E LLV E+ L L R +T D T + +A GL +LH+ +
Sbjct: 62 GQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN- 120
Query: 813 VRIIHRDVKASNVLLDADLVPKISDFGLAKL-YDDKKTHISTRVAGTIGYLAPEYA--MR 869
IH D+ N LL ADL KI D+GL+ Y + ++ + ++APE +
Sbjct: 121 --FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVH 178
Query: 870 GHL-----TEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEIELAD 924
G+L T++++V++ GV E L +E++ + + E Q+++L
Sbjct: 179 GNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVL----TYTVRE--QQLKLPK 232
Query: 925 PKL 927
P+L
Sbjct: 233 PRL 235
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 2e-14
Identities = 57/220 (25%), Positives = 108/220 (49%), Gaps = 22/220 (10%)
Query: 693 ENFSPSNKLGEGGFGPVYKGK--LGDGRAIAVKQLSVASRQ-----GKSQFVAEIATISA 745
+ + ++GEG +G V+K + GR +A+K++ V + + + VA + +
Sbjct: 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLET 60
Query: 746 VQHRNLVKLHGCC-IEGAER----LLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGV 800
+H N+V+L C + +R LV+E+++ + L L + T ++ +
Sbjct: 61 FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQL 119
Query: 801 ARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVAGTIG 860
RGL +LH R++HRD+K N+L+ + K++DFGLA++Y + T V T+
Sbjct: 120 LRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM--ALTSVVVTLW 174
Query: 861 YLAPEYAMRGHLTEKTDVFAFGVLALETVSGRP----NSD 896
Y APE ++ D+++ G + E +P +SD
Sbjct: 175 YRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD 214
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 3e-14
Identities = 71/266 (26%), Positives = 113/266 (42%), Gaps = 27/266 (10%)
Query: 700 KLGEGGFGPVYKGKL-GDGRAIAVKQL-SVASRQGKSQFVAEIATISAVQHRNLVKLHGC 757
++G G FG V+ G+L D +AVK K++F+ E + H N+V+L G
Sbjct: 2 RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 61
Query: 758 CIEGAERLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIH 817
C + +V E ++ L ++ A G+ YL ES+ IH
Sbjct: 62 CTQKQPIYIVMELVQGGDF-LTFLRTEGPRLKVKELIQMVENAAAGMEYL--ESK-HCIH 117
Query: 818 RDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVAGT----IGYLAPEYAMRGHLT 873
RD+ A N L+ V KISDFG+++ +D + G + + APE G +
Sbjct: 118 RDLAARNCLVTEKNVLKISDFGMSREEEDG---VYASTGGMKQIPVKWTAPEALNYGRYS 174
Query: 874 EKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEIELADPKLIEFNEE 933
++DV++FG+L E S +L ++ Q + L P+L +
Sbjct: 175 SESDVWSFGILLWEAFSLGAVPYANLSNQQTR--------EAIEQGVRLPCPELC---PD 223
Query: 934 EVKRLIGVALLCTQTLPSLRPSMSRV 959
V RL+ C + P RPS S V
Sbjct: 224 AVYRLM---ERCWEYDPGQRPSFSTV 246
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 3e-14
Identities = 59/204 (28%), Positives = 93/204 (45%), Gaps = 19/204 (9%)
Query: 700 KLGEGGFGPVYKGKLGD-GRAIAVKQLSVASRQGKSQFVAEIATISAVQHRNLVKLHGCC 758
+LG+G FG VYK K + G A K + S + ++ EI ++ H +VKL G
Sbjct: 19 ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAF 78
Query: 759 IEGAERLLVYEYLENKSLDQALFGQRSLTLDWATRYE----ICSGVARGLAYLHEESRVR 814
+ ++ E+ ++D + L LD IC + L YLH +
Sbjct: 79 YWDGKLWIMIEFCPGGAVDAIM-----LELDRGLTEPQIQVICRQMLEALQYLHSM---K 130
Query: 815 IIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVAGTIGYLAPEYAMRGHLTE 874
IIHRD+KA NVLL D K++DFG++ + K GT ++APE M + +
Sbjct: 131 IIHRDLKAGNVLLTLDGDIKLADFGVSA-KNVKTLQRRDSFIGTPYWMAPEVVMCETMKD 189
Query: 875 -----KTDVFAFGVLALETVSGRP 893
K D+++ G+ +E P
Sbjct: 190 TPYDYKADIWSLGITLIEMAQIEP 213
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 5e-14
Identities = 62/198 (31%), Positives = 89/198 (44%), Gaps = 21/198 (10%)
Query: 704 GGFGPVYKG-KLGDGRAIAVKQLSVASRQGKSQFVAEIA--TISAVQHR--NLVKLHGCC 758
G FG VY K G A+K L + K+Q A I +Q + KL+
Sbjct: 7 GAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSF 66
Query: 759 IEGAERLLVYEYLEN---KSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRI 815
LV EYL SL + L G L DWA +Y + V G+ LH+ I
Sbjct: 67 QSKDYLYLVMEYLNGGDCASLIKTLGG---LPEDWAKQY--IAEVVLGVEDLHQRG---I 118
Query: 816 IHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVAGTIGYLAPEYAMRGHLTEK 875
IHRD+K N+L+D K++DFGL++ + K + GT YLAPE + +
Sbjct: 119 IHRDIKPENLLIDQTGHLKLTDFGLSRNGLENK-----KFVGTPDYLAPETILGVGDDKM 173
Query: 876 TDVFAFGVLALETVSGRP 893
+D ++ G + E + G P
Sbjct: 174 SDWWSLGCVIFEFLFGYP 191
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 5e-14
Identities = 66/217 (30%), Positives = 95/217 (43%), Gaps = 24/217 (11%)
Query: 693 ENFSPSNKLGEGGFGPVYKG---KLGDGRAIAVKQL-SVASRQGKSQFVAEIATISAV-Q 747
E+ + +GEG FG V + K G A+K L AS F E+ + +
Sbjct: 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGH 61
Query: 748 HRNLVKLHGCCIEGAERLLVYEYLENKSLDQALFGQRSLTLDWATRYE------------ 795
H N++ L G C + EY +L L R L D A E
Sbjct: 62 HPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQL 121
Query: 796 --ICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHIST 853
S VA G+ YL E+ + IHRD+ A NVL+ +L KI+DFGL++ +
Sbjct: 122 LQFASDVATGMQYLSEK---QFIHRDLAARNVLVGENLASKIADFGLSRGEEVYVKKTMG 178
Query: 854 RVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVS 890
R+ + ++A E T K+DV++FGVL E VS
Sbjct: 179 RLP--VRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 6e-14
Identities = 60/218 (27%), Positives = 108/218 (49%), Gaps = 9/218 (4%)
Query: 693 ENFSPSNKLGEGGFGPVYKGKLG-DGRAIAVKQLSVASRQGKS-QFVAEIATISAVQHRN 750
E + +KLGEG + V+KG+ +A+K++ + +G + E++ + ++H N
Sbjct: 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHAN 64
Query: 751 LVKLHGCCIEGAERLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEE 810
+V LH LV+EYL++ L Q L +L + + + RGL+Y H+
Sbjct: 65 IVTLHDIIHTERCLTLVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQ-LLRGLSYCHKR 122
Query: 811 SRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVAGTIGYLAPEYAM-R 869
+I+HRD+K N+L++ K++DFGLA+ S V T+ Y P+ +
Sbjct: 123 ---KILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV-TLWYRPPDVLLGS 178
Query: 870 GHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLL 907
+ D++ G + E +GRP S +E+L+L+
Sbjct: 179 TEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLI 216
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 6e-14
Identities = 53/186 (28%), Positives = 94/186 (50%), Gaps = 27/186 (14%)
Query: 698 SNKLGEGGFGPVYKGK-LGDGRAIAVKQLSVASRQGKSQF----VAEIATISAVQHRNLV 752
K+G+G FG V+K + + +A+K++ + + K F + EI + ++H N+V
Sbjct: 17 LAKIGQGTFGEVFKARHKKTKQIVALKKVLMENE--KEGFPITALREIKILQLLKHENVV 74
Query: 753 KLHGCCIEGAER--------LLVYEYLENKSLDQA-LFGQRSLTLDWATRYEICSGVARG 803
L C A LV+E+ E+ D A L +++ + ++ + G
Sbjct: 75 NLIEICRTKATPYNRYKGSFYLVFEFCEH---DLAGLLSNKNVKFTLSEIKKVMKMLLNG 131
Query: 804 LAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLY----DDKKTHISTRVAGTI 859
L Y+H R +I+HRD+KA+N+L+ D + K++DFGLA+ + + K + RV T+
Sbjct: 132 LYYIH---RNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVV-TL 187
Query: 860 GYLAPE 865
Y PE
Sbjct: 188 WYRPPE 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 8e-14
Identities = 69/230 (30%), Positives = 94/230 (40%), Gaps = 51/230 (22%)
Query: 701 LGEGGFGPV----YKGKLGDGRAIAVKQLSVASRQGKSQFVAE-------------IATI 743
LG G FG V YK G A+K L K + T
Sbjct: 7 LGRGHFGKVLLAEYKKT---GELYAIKAL-------KKGDIIARDEVESLMCEKRIFETA 56
Query: 744 SAVQHRNLVKLHGCCIEGAERL-LVYEYLENKSL----DQALFGQRSLTLDWATRYEICS 798
++ +H LV L C + + + V EY L +F + A Y C
Sbjct: 57 NSERHPFLVNLF-ACFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEPR-----AVFYAAC- 109
Query: 799 GVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAK---LYDDKKTHISTRV 855
V GL YLHE +I++RD+K N+LLD + KI+DFGL K + D+ ST
Sbjct: 110 -VVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRT---ST-F 161
Query: 856 AGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLY 905
GT +LAPE T D + GVL E + G P DEE+++
Sbjct: 162 CGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGES-PFPGDDEEEVF 210
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 9e-14
Identities = 58/206 (28%), Positives = 99/206 (48%), Gaps = 18/206 (8%)
Query: 701 LGEGGFGPVYKGK-LGDGRAIAVKQLSVASRQGKSQFVAEIATISAV-QHRNLVKLHGCC 758
+G G +G VYKG+ + G+ A+K + V + + + EI + HRN+ +G
Sbjct: 14 VGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE-EEEIKQEINMLKKYSHHRNIATYYGAF 72
Query: 759 IEGA------ERLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESR 812
I+ + LV E+ S+ + + TL IC + RGL++LH+
Sbjct: 73 IKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH-- 130
Query: 813 VRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVAGTIGYLAPEYAMRGHL 872
++IHRD+K NVLL + K+ DFG++ D +T + GT ++APE
Sbjct: 131 -KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-GTPYWMAPEVIACDEN 188
Query: 873 TE-----KTDVFAFGVLALETVSGRP 893
+ K+D+++ G+ A+E G P
Sbjct: 189 PDATYDFKSDLWSLGITAIEMAEGAP 214
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 1e-13
Identities = 53/195 (27%), Positives = 94/195 (48%), Gaps = 11/195 (5%)
Query: 701 LGEGGFGPVY--KGKLGDGRAIAVKQLSVASRQGKSQFVA--EIATISAVQHRNLVKLHG 756
+G G FG V+ + K D + + +KQ+ V + A E + + H N+++ +
Sbjct: 8 VGRGAFGIVHLCRRK-ADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYE 66
Query: 757 CCIEGAERLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRII 816
+E ++V EY +L + + + + LD T + L ++H + I+
Sbjct: 67 NFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKL---IL 123
Query: 817 HRDVKASNVLLDA-DLVPKISDFGLAKLYDDKKTHISTRVAGTIGYLAPEYAMRGHLTEK 875
HRD+K N+LLD +V KI DFG++K+ K + V GT Y++PE +K
Sbjct: 124 HRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK--AYTVVGTPCYISPELCEGKPYNQK 181
Query: 876 TDVFAFGVLALETVS 890
+D++A G + E S
Sbjct: 182 SDIWALGCVLYELAS 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 1e-13
Identities = 60/208 (28%), Positives = 99/208 (47%), Gaps = 22/208 (10%)
Query: 701 LGEGGFGPVYKGK-LGDGRAIAVKQLSVASRQGKSQFVAEIATISAV-QHRNLVKLHGCC 758
+G G +G VYKG+ + G+ A+K + V + + + EI + HRN+ +G
Sbjct: 24 VGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDE-EEEIKLEINMLKKYSHHRNIATYYGAF 82
Query: 759 IEGA------ERLLVYEYLENKSLDQALFGQRSLTL--DWATRYEICSGVARGLAYLHEE 810
I+ + + LV E+ S+ + + L DW IC + RGLA+LH
Sbjct: 83 IKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAY--ICREILRGLAHLHAH 140
Query: 811 SRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVAGTIGYLAPEYAMRG 870
++IHRD+K NVLL + K+ DFG++ D +T + GT ++APE
Sbjct: 141 ---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-GTPYWMAPEVIACD 196
Query: 871 HLTEKT-----DVFAFGVLALETVSGRP 893
+ T D+++ G+ A+E G P
Sbjct: 197 ENPDATYDYRSDIWSLGITAIEMAEGAP 224
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 1e-13
Identities = 61/212 (28%), Positives = 100/212 (47%), Gaps = 17/212 (8%)
Query: 693 ENFSPSNKLGEGGFGPVYKGKLGD-GRAIAVKQL-----SVASRQGKSQFVAEIATISAV 746
N+ LG G FG VY D GR +AVKQ+ S + + + EI + +
Sbjct: 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNL 61
Query: 747 QHRNLVKLHGCCIEGAERLL--VYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGL 804
+H +V+ +GC + E+ L EY+ S+ L +LT + RY + +G+
Sbjct: 62 RHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYT--RQILQGV 119
Query: 805 AYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDD---KKTHISTRVAGTIGY 861
+YLH I+HRD+K +N+L D+ K+ DFG +K T I + V GT +
Sbjct: 120 SYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKS-VTGTPYW 175
Query: 862 LAPEYAMRGHLTEKTDVFAFGVLALETVSGRP 893
++PE K DV++ +E ++ +P
Sbjct: 176 MSPEVISGEGYGRKADVWSVACTVVEMLTEKP 207
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 1e-13
Identities = 64/224 (28%), Positives = 104/224 (46%), Gaps = 29/224 (12%)
Query: 689 KTATENFSPSNKLGEGGFGPVYKGKLGD-GRAIAVKQLSVASRQGKSQF----VAEIATI 743
K + F ++GEG +G VYK + D G +A+K+ V K F + EI +
Sbjct: 3 KRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKK--VRLDNEKEGFPITAIREIKIL 60
Query: 744 SAVQHRNLVKLHGCCIEGAERL----------LVYEYLENKSLDQALFGQRSLTLDWATR 793
+ HRN+V L + + L LV+EY+ D L G L +
Sbjct: 61 RQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYM-----DHDLMGLLESGLVHFSE 115
Query: 794 YEICSGVAR---GLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTH 850
I S + + GL Y H+++ +HRD+K SN+LL+ K++DFGLA+LY+ +++
Sbjct: 116 DHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESR 172
Query: 851 ISTRVAGTIGYLAPEYAM-RGHLTEKTDVFAFGVLALETVSGRP 893
T T+ Y PE + DV++ G + E + +P
Sbjct: 173 PYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKP 216
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 1e-13
Identities = 60/198 (30%), Positives = 92/198 (46%), Gaps = 13/198 (6%)
Query: 701 LGEGGFGPVYKGKLGD-GRAIAVKQLS---VASRQGKSQFVAEIATISAVQHRNLVKLHG 756
LG+GGFG V ++ + G+ A K+L + + G+ + E + V +V L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60
Query: 757 CCIEGAERLLVYEYLENKSLDQALF--GQRSLTLDWATRYEICSGVARGLAYLHEESRVR 814
LV + L ++ G+R L ++ Y + + G+ +LH +
Sbjct: 61 AFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYS--AQITCGILHLHS---MD 115
Query: 815 IIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVAGTIGYLAPEYAMRGHLTE 874
I++RD+K NVLLD ++SD GLA D KT T+ AGT GY+APE +
Sbjct: 116 IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT--ITQRAGTNGYMAPEILKEEPYSY 173
Query: 875 KTDVFAFGVLALETVSGR 892
D FA G E V+GR
Sbjct: 174 PVDWFAMGCSIYEMVAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 2e-13
Identities = 58/204 (28%), Positives = 98/204 (48%), Gaps = 17/204 (8%)
Query: 701 LGEGGFGPVYKGKLGD-GRAIAVKQL-----SVASRQGKSQFVAEIATISAVQHRNLVKL 754
LG+G FG VY D GR +AVKQ+ S + + + EI + + H +V+
Sbjct: 10 LGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQY 69
Query: 755 HGCCIEGAERLL--VYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESR 812
+GC + ER L E++ S+ L +LT + +Y + G++YLH
Sbjct: 70 YGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYT--RQILEGVSYLHSN-- 125
Query: 813 VRIIHRDVKASNVLLDADLVPKISDFGLAKLYDD---KKTHISTRVAGTIGYLAPEYAMR 869
I+HRD+K +N+L D+ K+ DFG +K T + + V GT +++PE
Sbjct: 126 -MIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKS-VTGTPYWMSPEVISG 183
Query: 870 GHLTEKTDVFAFGVLALETVSGRP 893
K D+++ G +E ++ +P
Sbjct: 184 EGYGRKADIWSVGCTVVEMLTEKP 207
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 2e-13
Identities = 66/290 (22%), Positives = 126/290 (43%), Gaps = 35/290 (12%)
Query: 689 KTATENFSPSNKLGEGGFGPVYKG------KLGDGRAIAVKQLS-VASRQGKSQFVAEIA 741
+ A E + S +LG+G FG VY+G K +A+K ++ AS + + +F+ E +
Sbjct: 2 EVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS 61
Query: 742 TISAVQHRNLVKLHGCCIEGAERLLVYEYLENKSLDQALFGQRSLTLDWATR-------- 793
+ ++V+L G +G L++ E + L L R + +
Sbjct: 62 VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKM 121
Query: 794 YEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAK-LYDDKKTHIS 852
++ +A G+AYL+ + +HRD+ A N ++ D KI DFG+ + +Y+
Sbjct: 122 IQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKG 178
Query: 853 TRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWH 912
+ + +++PE G T +DV++FGV+ E + L E +
Sbjct: 179 GKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT---------------LAEQPYQ 223
Query: 913 LHENNQEIELA-DPKLIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVA 961
N Q + + L++ + L + +C Q P +RPS +++
Sbjct: 224 GMSNEQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIIS 273
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 2e-13
Identities = 63/200 (31%), Positives = 102/200 (51%), Gaps = 18/200 (9%)
Query: 701 LGEGGFGPVY--KGKLGD--GRAIAVKQLSVASRQGKSQFVA--EIATISAVQHRNLVKL 754
LG+G FG V+ + G G+ A+K L A+ + + + E ++ V H +VKL
Sbjct: 4 LGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKL 63
Query: 755 HGCCIEGAERLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVR 814
H + L+ ++L L L + T + Y + +A L +LH +
Sbjct: 64 HYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFY--LAELALALDHLH---SLG 118
Query: 815 IIHRDVKASNVLLDADLVPKISDFGLAK--LYDDKKTHISTRVAGTIGYLAPEYAMR-GH 871
II+RD+K N+LLD + K++DFGL+K + +KK + GT+ Y+APE R GH
Sbjct: 119 IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAY---SFCGTVEYMAPEVVNRRGH 175
Query: 872 LTEKTDVFAFGVLALETVSG 891
T+ D ++FGVL E ++G
Sbjct: 176 -TQSADWWSFGVLMFEMLTG 194
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 2e-13
Identities = 62/209 (29%), Positives = 97/209 (46%), Gaps = 24/209 (11%)
Query: 701 LGEGGFGPVYKGKL-GDGRAI--AVKQLS-VASRQGKSQFVAEIATISAV-QHRNLVKLH 755
+GEG FG V K ++ DG + A+K++ AS+ F E+ + + H N++ L
Sbjct: 15 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 74
Query: 756 GCCIEGAERLLVYEYLENKSLDQALFGQRSL--------------TLDWATRYEICSGVA 801
G C L EY + +L L R L TL + VA
Sbjct: 75 GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 134
Query: 802 RGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVAGTIGY 861
RG+ YL S+ + IHRD+ A N+L+ + V KI+DFGL++ + R+ + +
Sbjct: 135 RGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLP--VRW 189
Query: 862 LAPEYAMRGHLTEKTDVFAFGVLALETVS 890
+A E T +DV+++GVL E VS
Sbjct: 190 MAIESLNYSVYTTNSDVWSYGVLLWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 3e-13
Identities = 81/270 (30%), Positives = 127/270 (47%), Gaps = 10/270 (3%)
Query: 139 LSPSVGNLTAMQYLNLAINALSGELPKELGQLTELLILGIGTNNFSGPLPSELGSL-SKL 197
S ++ NL + L+L +N L + EL +LT L L + NN + +P +G L S L
Sbjct: 85 GSENLLNLLPLPSLDLNLNRLRSNIS-ELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNL 142
Query: 198 QELYIDSAGVSGEIPSSFANLQSLTKWWASDTRLTGRIPDFIGNWSKLTALRFQGNSFNG 257
+EL + + +PS NL +L S L+ +P + N S L L GN +
Sbjct: 143 KELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKIS- 199
Query: 258 PIPSSFSNLTSVTELRISDLSNGSSKLAFIRDMKSLSILELRNNNISDSIPSNIGEYRSL 317
+P L+++ EL +S+ S + + ++K+LS LEL NN + D +P +IG +L
Sbjct: 200 DLPPEIELLSALEELDLSNNSIIELLSS-LSNLKNLSGLELSNNKLED-LPESIGNLSNL 257
Query: 318 QHLDLSFNNLGGSIPDSLFNLSSLTHLFLGNNKLNGTLPARKSPLLLNIDVSYNNLQGNL 377
+ LDLS N + S SL +L++L L L N L+ LP LLL + L
Sbjct: 258 ETLDLSNNQI--SSISSLGSLTNLRELDLSGNSLSNALPLIALLLLLLELLLNLLLTLKA 315
Query: 378 PSWINGQQNLQINLVANNLTIRSSDNSVLP 407
L N+++N T S+L
Sbjct: 316 LELKLNSILLNNNILSNGETSSPEALSILE 345
|
Length = 394 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 3e-13
Identities = 42/108 (38%), Positives = 62/108 (57%), Gaps = 9/108 (8%)
Query: 800 VARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAK--LYDDKKTHISTRVAG 857
+A GL +LH + II+RD+K NV+LDA+ KI+DFG+ K ++ K T G
Sbjct: 110 IAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRT---FCG 163
Query: 858 TIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLY 905
T Y+APE + D +AFGVL E ++G+P D DE++L+
Sbjct: 164 TPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFD-GEDEDELF 210
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 4e-13
Identities = 62/223 (27%), Positives = 105/223 (47%), Gaps = 32/223 (14%)
Query: 700 KLGEGGFGPVYKGKLGD-GRAIAVKQLSVASRQG---KSQFVAEIATISAVQHRNLVKLH 755
K+GEG +G V+K + + G+ +A+K+ V S K + EI + ++H NLV L
Sbjct: 8 KIGEGSYGVVFKCRNRETGQIVAIKKF-VESEDDPVIKKIALREIRMLKQLKHPNLVNLI 66
Query: 756 GCCIEGAERL-LVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVR 814
+L LV+EY ++ L++ + + +I + + + H+ +
Sbjct: 67 EV-FRRKRKLHLVFEYCDHTVLNE--LEKNPRGVPEHLIKKIIWQTLQAVNFCHKHN--- 120
Query: 815 IIHRDVKASNVLLDADLVPKISDFGLAKL---YDDKKT-HISTRVAGTIGYLAPEYAMRG 870
IHRDVK N+L+ K+ DFG A++ D T +++TR Y APE
Sbjct: 121 CIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATR-----WYRAPEL---- 171
Query: 871 HLTEKT------DVFAFGVLALETVSGRPNSDPSLDEEKLYLL 907
L T DV+A G + E ++G+P D ++LYL+
Sbjct: 172 -LVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLI 213
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 4e-13
Identities = 58/206 (28%), Positives = 98/206 (47%), Gaps = 21/206 (10%)
Query: 700 KLGEGGFGPVYKGKLGDGRAIAVKQLSVASRQGKSQ----FVAEIATISAVQHR----NL 751
+LG G FG V KG + KQ+ VA + K++ E+ + + H+ +
Sbjct: 2 ELGSGNFGCVKKGVY----KMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYI 57
Query: 752 VKLHGCCIEGAERLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEES 811
V++ G C E +LV E L++ L G++ + + E+ V+ G+ YL ++
Sbjct: 58 VRMIGVC-EAEALMLVMEMASGGPLNKFLSGKKD-EITVSNVVELMHQVSMGMKYLEGKN 115
Query: 812 RVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVAGT--IGYLAPEYAMR 869
+HRD+ A NVLL KISDFGL+K ++ R AG + + APE
Sbjct: 116 ---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINF 172
Query: 870 GHLTEKTDVFAFGVLALETVS--GRP 893
+ ++DV+++G+ E S +P
Sbjct: 173 RKFSSRSDVWSYGITMWEAFSYGQKP 198
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 5e-13
Identities = 57/197 (28%), Positives = 91/197 (46%), Gaps = 15/197 (7%)
Query: 700 KLGEGGFGPVY-----KGKLGDGRAIAVKQLSVASRQGKSQFVA--EIATISAVQHRNLV 752
+LG+G FG VY K + R +K++ V A E +S + H +V
Sbjct: 7 RLGKGSFGTVYLVKDKKAVAEE-RLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIV 65
Query: 753 KLHGCCIEGAERLLVYEYLENKSLDQAL--FGQRSLTLDWATRYEICSGVARGLAYLHEE 810
K H +E ++ EY E + LD L TL E + G+ Y+H+
Sbjct: 66 KFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR 125
Query: 811 SRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVAGTIGYLAPEYAMRG 870
RI+HRD+KA N+ L +L+ KI DFG+++L ++T GT Y++PE
Sbjct: 126 ---RILHRDLKAKNIFLKNNLL-KIGDFGVSRLLMG-SCDLATTFTGTPYYMSPEALKHQ 180
Query: 871 HLTEKTDVFAFGVLALE 887
K+D+++ G + E
Sbjct: 181 GYDSKSDIWSLGCILYE 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 5e-13
Identities = 55/202 (27%), Positives = 98/202 (48%), Gaps = 17/202 (8%)
Query: 700 KLGEGGFGPVYKGK-LGDGRAIAVKQLSVASR-QG-KSQFVAEIATISAVQHRNLVKLHG 756
K+GEG +G V+K K +A+K++ + +G S + EI + ++H+N+V+L+
Sbjct: 7 KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYD 66
Query: 757 CCIEGAERLLVYEYLENKSLDQAL---FGQRSLTLDWATRYEICSGVARGLAYLHEESRV 813
+ LV+EY DQ L F + +D + +GLA+ H
Sbjct: 67 VLHSDKKLTLVFEYC-----DQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSH--- 118
Query: 814 RIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVAGTIGYLAPEYAMRGHL- 872
++HRD+K N+L++ + K++DFGLA+ + S V T+ Y P+ L
Sbjct: 119 NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVV-TLWYRPPDVLFGAKLY 177
Query: 873 TEKTDVFAFG-VLALETVSGRP 893
+ D+++ G + A +GRP
Sbjct: 178 STSIDMWSAGCIFAELANAGRP 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 5e-13
Identities = 72/247 (29%), Positives = 109/247 (44%), Gaps = 30/247 (12%)
Query: 701 LGEGGFGPVYKGKL-GDGRAIAVKQLS----VASRQGKSQFVAEIATISAVQHRNLVKLH 755
LG+G FG V+ +L G + A+K L + + V + A +H L L+
Sbjct: 3 LGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLY 62
Query: 756 GCCIEGAERLL-VYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVR 814
C + E L V EYL L + L AT Y + + GL +LH +
Sbjct: 63 -CTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFY--AAEIICGLQFLHSKG--- 116
Query: 815 IIHRDVKASNVLLDADLVPKISDFGLAK--LYDDKKTHISTRVAGTIGYLAPEYAMRGHL 872
I++RD+K N+LLD D KI+DFG+ K + D KT GT Y+APE +
Sbjct: 117 IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKT---CTFCGTPDYIAPEILLGQKY 173
Query: 873 TEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEIELADPKLIEFNE 932
D ++FGVL E + G+ + DEE+L+ Q I + +P +
Sbjct: 174 NTSVDWWSFGVLLYEMLIGQ-SPFHGHDEEELF------------QSIRMDNPCYPRWLT 220
Query: 933 EEVKRLI 939
E K ++
Sbjct: 221 REAKDIL 227
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 6e-13
Identities = 58/204 (28%), Positives = 93/204 (45%), Gaps = 19/204 (9%)
Query: 700 KLGEGGFGPVYKGKLGDGRAIAV-KQLSVASRQGKSQFVAEIATISAVQHRNLVKLHGCC 758
+LG+G FG VYK + + +A K + S + ++ EI +++ H N+VKL
Sbjct: 12 ELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 71
Query: 759 IEGAERLLVYEYLENKSLDQALFG-QRSLTLDWATRYEICSGVARGLAYLHEESRVRIIH 817
++ E+ ++D + +R LT +C L YLHE +IIH
Sbjct: 72 YYENNLWILIEFCAGGAVDAVMLELERPLTEPQIR--VVCKQTLEALNYLHEN---KIIH 126
Query: 818 RDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVAGTIG---YLAPEYAMRGHLTE 874
RD+KA N+L D K++DFG++ K T R IG ++APE M +
Sbjct: 127 RDLKAGNILFTLDGDIKLADFGVSA----KNTRTIQRRDSFIGTPYWMAPEVVMCETSKD 182
Query: 875 -----KTDVFAFGVLALETVSGRP 893
K DV++ G+ +E P
Sbjct: 183 RPYDYKADVWSLGITLIEMAQIEP 206
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.8 bits (174), Expect = 7e-13
Identities = 64/258 (24%), Positives = 101/258 (39%), Gaps = 44/258 (17%)
Query: 693 ENFSPSNKLGEGGFGPVYKGKLGDGRAI-AVKQL--SVASRQGKSQFV-AEIATISAVQH 748
++F +G G FG V+ + D + A+K L S ++ + V AE ++
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADS 60
Query: 749 RNLVKLHGCCIEGAERL-LVYEYLENKSLDQALFGQRSLTLDWATRY--EICSGVARGLA 805
+VKL+ + E L LV EY+ L L + + A Y E+ LA
Sbjct: 61 PWIVKLY-YSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELV------LA 113
Query: 806 YLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKT---------------- 849
L ++ IHRD+K N+L+DAD K++DFGL K + K
Sbjct: 114 -LDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDN 172
Query: 850 ------------HISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGR-PNSD 896
+ GT Y+APE + D ++ GV+ E + G P
Sbjct: 173 VLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYS 232
Query: 897 PSLDEEKLYLLEWAWHLH 914
+L E ++ W L
Sbjct: 233 DTLQETYNKIINWKESLR 250
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 7e-13
Identities = 65/203 (32%), Positives = 94/203 (46%), Gaps = 21/203 (10%)
Query: 701 LGEGGFGPVYKGKL-GDGRAIAVKQL---SVASRQGKSQFVAE--IATISAVQHRNLVKL 754
LG+G FG V +L G A+K L + + E I ++A +H L L
Sbjct: 3 LGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAA-KHPFLTAL 61
Query: 755 HGCCIEGAERLL-VYEYLENKSLDQALFG-QRSLTLDWATRYEICSGVARGLAYLHEESR 812
H CC + +RL V EY+ L +F QRS D + V L +LH
Sbjct: 62 H-CCFQTKDRLFFVMEYVNGGDL---MFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHG- 116
Query: 813 VRIIHRDVKASNVLLDADLVPKISDFGLAK--LYDDKKTHISTRVAGTIGYLAPEYAMRG 870
+I+RD+K N+LLDA+ K++DFG+ K + + T T GT Y+APE
Sbjct: 117 --VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTT---TTFCGTPDYIAPEILQEL 171
Query: 871 HLTEKTDVFAFGVLALETVSGRP 893
D +A GVL E ++G+P
Sbjct: 172 EYGPSVDWWALGVLMYEMMAGQP 194
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 1e-12
Identities = 54/205 (26%), Positives = 100/205 (48%), Gaps = 10/205 (4%)
Query: 701 LGEGGFGPVYKGK-LGDGRAIAVKQLSV-ASRQGKSQFVAEIATISAVQHRNLVKLHGCC 758
LG G G V K K + G +A K + + A + Q + E+ + + +V +G
Sbjct: 13 LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAF 72
Query: 759 IEGAERLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHR 818
+ + E+++ SLD+ + ++ + I V GL YL+ R I+HR
Sbjct: 73 LNENNICMCMEFMDCGSLDRIYKKGGPIPVEILGK--IAVAVVEGLTYLYNVHR--IMHR 128
Query: 819 DVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVAGTIGYLAPEYAMRGHLTEKTDV 878
D+K SN+L+++ K+ DFG++ + I+ GT Y++PE G T K+DV
Sbjct: 129 DIKPSNILVNSRGQIKLCDFGVS---GELINSIADTFVGTSTYMSPERIQGGKYTVKSDV 185
Query: 879 FAFGVLALETVSGR-PNSDPSLDEE 902
++ G+ +E G+ P + ++D++
Sbjct: 186 WSLGISIIELALGKFPFAFSNIDDD 210
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 1e-12
Identities = 58/215 (26%), Positives = 97/215 (45%), Gaps = 22/215 (10%)
Query: 689 KTATENFSPSNKLGEGGFGPVYKG-KLGDGRAIAVKQLSVASRQGKSQFVAEIATISAVQ 747
+ ++ ++G G +G VYK L G AVK + + S EI + +
Sbjct: 5 RNPQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECK 64
Query: 748 HRNLVKLHGCCIEGAERLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYL 807
H N+V G + + + EY SL Q ++ + Y +C +GLAYL
Sbjct: 65 HCNIVAYFGSYLSREKLWICMEYCGGGSL-QDIYHVTGPLSELQIAY-VCRETLQGLAYL 122
Query: 808 HEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVA------GTIGY 861
H + + +HRD+K +N+LL + K++DFG+A I+ +A GT +
Sbjct: 123 HSKGK---MHRDIKGANILLTDNGDVKLADFGVA-------AKITATIAKRKSFIGTPYW 172
Query: 862 LAPEYAM---RGHLTEKTDVFAFGVLALETVSGRP 893
+APE A G + D++A G+ A+E +P
Sbjct: 173 MAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQP 207
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 1e-12
Identities = 56/211 (26%), Positives = 99/211 (46%), Gaps = 19/211 (9%)
Query: 695 FSPSNKLGEGGFGPVYKGK-LGDGRAIAVKQLSVASRQ-----GKSQFVAEIATISAVQH 748
+ P ++G G +G VYK + G +A+K + V + + + VA + + A H
Sbjct: 2 YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDH 61
Query: 749 RNLVKLHGCCI-----EGAERLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARG 803
N+V+L C + LV+E+++ + L L L T ++ RG
Sbjct: 62 PNIVRLMDVCATSRTDRETKVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRG 120
Query: 804 LAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHIS-TRVAGTIGYL 862
L +LH I+HRD+K N+L+ + K++DFGLA++Y ++ T V T+ Y
Sbjct: 121 LDFLHAN---CIVHRDLKPENILVTSGGQVKLADFGLARIY---SCQMALTPVVVTLWYR 174
Query: 863 APEYAMRGHLTEKTDVFAFGVLALETVSGRP 893
APE ++ D+++ G + E +P
Sbjct: 175 APEVLLQSTYATPVDMWSVGCIFAEMFRRKP 205
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 69.2 bits (170), Expect = 2e-12
Identities = 63/219 (28%), Positives = 111/219 (50%), Gaps = 36/219 (16%)
Query: 693 ENFSPSNKLGEGGFGPVYKGK-LGDGRAIAVKQLSVASRQGKSQF----VAEIATISAVQ 747
+ + N++ EG +G VY+ + G +A+K+L + + K F + EI + +Q
Sbjct: 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKM--EKEKEGFPITSLREINILLKLQ 62
Query: 748 HRNLVKLH----GCCIEGAERLLVYEYLEN--KSLDQAL---FGQ---RSLTLDWATRYE 795
H N+V + G ++ + +V EY+E+ KSL + + F Q + L L +
Sbjct: 63 HPNIVTVKEVVVGSNLD--KIYMVMEYVEHDLKSLMETMKQPFLQSEVKCLML------Q 114
Query: 796 ICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRV 855
+ SGVA +LH+ I+HRD+K SN+LL+ + KI DFGLA+ Y T++
Sbjct: 115 LLSGVA----HLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPY-TQL 166
Query: 856 AGTIGYLAPEYAM-RGHLTEKTDVFAFGVLALETVSGRP 893
T+ Y APE + + D+++ G + E ++ +P
Sbjct: 167 VVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKP 205
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 2e-12
Identities = 72/285 (25%), Positives = 118/285 (41%), Gaps = 41/285 (14%)
Query: 698 SNKLGEGGFGPVYKGKLGDG-----RAIAVKQLS-VASRQGKSQFVAEIATISAVQHRNL 751
S+ L EG FG ++ G L D + VK + AS + + E + + H+N+
Sbjct: 11 SDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNI 70
Query: 752 VKLHGCCIEGAERLLVYE----------YLENKSLDQALFGQRSLTLDWATRYEICSGVA 801
+ + CIE E V +L+ L +A Q T + +A
Sbjct: 71 LPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLV---HMAIQIA 127
Query: 802 RGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAK-LYDDKKTHISTRVAGTIG 860
G++YLH + +IH+D+ A N ++D +L KI+D L++ L+ + +
Sbjct: 128 CGMSYLH---KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVK 184
Query: 861 YLAPEYAMRGHLTEKTDVFAFGVLALE--TVSGRPNSDPSLDEEKLYLLEWAWHLHENNQ 918
++A E + + +DV++FGVL E T+ P + E YL +
Sbjct: 185 WMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKD---------- 234
Query: 919 EIELADPKLIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVAML 963
LA P I +E L V C P RPS S++V L
Sbjct: 235 GYRLAQP--INCPDE----LFAVMACCWALDPEERPSFSQLVQCL 273
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 3e-12
Identities = 60/213 (28%), Positives = 100/213 (46%), Gaps = 27/213 (12%)
Query: 695 FSPSNKLGEGGFGPVYKGK-LGDGRAIAVKQLS------VASRQGKSQFVAEIATISAVQ 747
P +G G FG V+ DG+ +A+K++ V+ ++ E+ + +
Sbjct: 2 VEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKR----VFRELKMLCFFK 57
Query: 748 HRNLVK----LHGCCIEGAERLLVYEYLENKSLDQALFGQRSLTLDWAT--RYEICSGVA 801
H N++ L I+ E + V L L + + + L+ D Y+I
Sbjct: 58 HDNVLSALDILQPPHIDPFEEIYVVTELMQSDLHKIIVSPQPLSSDHVKVFLYQIL---- 113
Query: 802 RGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYD-DKKTHISTRVAGTIG 860
RGL YLH I+HRD+K N+L++++ V KI DFGLA++ + D+ H++ V T
Sbjct: 114 RGLKYLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVV-TQY 169
Query: 861 YLAPEYAMRG-HLTEKTDVFAFGVLALETVSGR 892
Y APE M H T D+++ G + E + R
Sbjct: 170 YRAPEILMGSRHYTSAVDIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 68.2 bits (166), Expect = 3e-12
Identities = 61/209 (29%), Positives = 97/209 (46%), Gaps = 24/209 (11%)
Query: 701 LGEGGFGPVYKGKLG-DGRAI--AVKQL-SVASRQGKSQFVAEIATISAV-QHRNLVKLH 755
+GEG FG V K ++ DG + A+K++ AS+ F E+ + + H N++ L
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62
Query: 756 GCCIEGAERLLVYEYLENKSLDQALFGQRSLTLDWATRYE--------------ICSGVA 801
G C L EY + +L L R L D A + VA
Sbjct: 63 GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 122
Query: 802 RGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVAGTIGY 861
RG+ YL ++ + IHRD+ A N+L+ + V KI+DFGL++ + R+ + +
Sbjct: 123 RGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLP--VRW 177
Query: 862 LAPEYAMRGHLTEKTDVFAFGVLALETVS 890
+A E T +DV+++GVL E VS
Sbjct: 178 MAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 3e-12
Identities = 66/235 (28%), Positives = 104/235 (44%), Gaps = 28/235 (11%)
Query: 693 ENFSPSNKLGEGGFGPVYKGKLGDGRA-IAVKQLSVAS--RQGKSQFV-AEIATISAVQH 748
++ +G G FG V+ + A+K +++ R + Q V E + V H
Sbjct: 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSH 60
Query: 749 RNLVKLHGCCIEGAERLL--VYEYLENKSLDQALFGQRSLTLDWATRY--EICSGVARGL 804
+++L E +R L + EY+ L L + Y EI L
Sbjct: 61 PFIIRLF--WTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCA----L 114
Query: 805 AYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVAGTIGYLAP 864
YLH + I++RD+K N+LLD + K++DFG AK D+ + + GT YLAP
Sbjct: 115 EYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR----TWTLCGTPEYLAP 167
Query: 865 E-YAMRGHLTEKTDVFAFGVLALETVSGRP---NSDPSLDEEKLYL--LEWAWHL 913
E +GH + D +A G+L E + G P + +P EK+ LE+ HL
Sbjct: 168 EVIQSKGH-NKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFPRHL 221
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 67.8 bits (165), Expect = 3e-12
Identities = 53/215 (24%), Positives = 99/215 (46%), Gaps = 22/215 (10%)
Query: 689 KTATENFSPSNKLGEGGFGPVYKGK-LGDGRAIAVKQLSVASRQGKSQFVAEIATISAVQ 747
+ E+F ++G G +G VYK + + G A+K + + + + EI + +
Sbjct: 5 RNPQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCK 64
Query: 748 HRNLVKLHGCCIEGAERLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYL 807
H N+V G + + + E+ SL Q ++ + Y + +GL YL
Sbjct: 65 HSNIVAYFGSYLRRDKLWICMEFCGGGSL-QDIYHVTGPLSESQIAY-VSRETLQGLYYL 122
Query: 808 HEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVA------GTIGY 861
H + + +HRD+K +N+LL + K++DFG++ I+ +A GT +
Sbjct: 123 HSKGK---MHRDIKGANILLTDNGHVKLADFGVS-------AQITATIAKRKSFIGTPYW 172
Query: 862 LAPEYAM---RGHLTEKTDVFAFGVLALETVSGRP 893
+APE A +G + D++A G+ A+E +P
Sbjct: 173 MAPEVAAVERKGGYNQLCDIWAVGITAIELAELQP 207
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 3e-12
Identities = 59/221 (26%), Positives = 109/221 (49%), Gaps = 12/221 (5%)
Query: 687 ELKTATENFSPSNKLGEGGFGPVYK-GKLGDGRAIAVKQLSVASRQG-KSQFVAEIATIS 744
ELK ++F ++LG G G V+K G +A K + + + ++Q + E+ +
Sbjct: 1 ELKD--DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLH 58
Query: 745 AVQHRNLVKLHGCCIEGAERLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGL 804
+V +G E + E+++ SLDQ L +++ + ++ V +GL
Sbjct: 59 ECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL--KKAGRIPEQILGKVSIAVIKGL 116
Query: 805 AYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVAGTIGYLAP 864
YL E+ + I+HRDVK SN+L+++ K+ DFG++ D ++ GT Y++P
Sbjct: 117 TYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MANSFVGTRSYMSP 171
Query: 865 EYAMRGHLTEKTDVFAFGVLALETVSGR-PNSDPSLDEEKL 904
E H + ++D+++ G+ +E GR P P E +L
Sbjct: 172 ERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELEL 212
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 3e-12
Identities = 41/125 (32%), Positives = 69/125 (55%), Gaps = 9/125 (7%)
Query: 769 EYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLD 828
E+++ SLDQ L + + + I V RGL YL E+ +I+HRDVK SN+L++
Sbjct: 79 EHMDGGSLDQVLKKAGRIPENILGKISIA--VLRGLTYLREK--HKIMHRDVKPSNILVN 134
Query: 829 ADLVPKISDFGLA-KLYDDKKTHISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALE 887
+ K+ DFG++ +L D ++ GT Y++PE H T ++D+++ G+ +E
Sbjct: 135 SRGEIKLCDFGVSGQLIDS----MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVE 190
Query: 888 TVSGR 892
GR
Sbjct: 191 MAIGR 195
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 3e-12
Identities = 64/200 (32%), Positives = 95/200 (47%), Gaps = 19/200 (9%)
Query: 701 LGEGGFGPVYKGKL-GDGRAIAVKQLS---VASRQGKSQFVAEIATIS-AVQHRNLVKLH 755
LG+G FG V +L GR AVK L + + E +S A H L +L+
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLY 62
Query: 756 GCCIEGAERLL-VYEYLENKSLDQALFG-QRSLTLDWATRYEICSGVARGLAYLHEESRV 813
CC + +RL V E++ L +F Q+S D A + + L +LH++
Sbjct: 63 -CCFQTPDRLFFVMEFVNGGDL---MFHIQKSRRFDEARARFYAAEITSALMFLHDKG-- 116
Query: 814 RIIHRDVKASNVLLDADLVPKISDFGLAK--LYDDKKTHISTRVAGTIGYLAPEYAMRGH 871
II+RD+K NVLLD + K++DFG+ K +++ K T + GT Y+APE
Sbjct: 117 -IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTT---STFCGTPDYIAPEILQEML 172
Query: 872 LTEKTDVFAFGVLALETVSG 891
D +A GVL E + G
Sbjct: 173 YGPSVDWWAMGVLLYEMLCG 192
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 4e-12
Identities = 70/276 (25%), Positives = 114/276 (41%), Gaps = 40/276 (14%)
Query: 701 LGEGGFGPVYKGK---LGDGRA-----IAVKQLSVASRQGKSQFVAEIATISAVQHRNLV 752
LG+G F ++KG +GD + +K L + R F + +S + H++LV
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 753 KLHGCCIEGAERLLVYEYLENKSLDQALFGQRSL-TLDWATRYEICSGVARGLAYLHEES 811
+G C+ G E ++V EY++ SLD L ++L + W + E+ +A L +L ++
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISW--KLEVAKQLAWALHFLEDKG 120
Query: 812 RVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVAGT------IGYLAPE 865
+ H +V A NVLL + K + KL D IS V I ++ PE
Sbjct: 121 ---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPG---ISITVLPKEILLERIPWVPPE 174
Query: 866 YAMRG-HLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEIELAD 924
+L+ D ++FG E SG ++ L L+ L +L
Sbjct: 175 CIENPQNLSLAADKWSFGTTLWEIFSG--------GDKPLSALDSQKKLQFYEDRHQLPA 226
Query: 925 PKLIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVV 960
PK E L + C P RPS ++
Sbjct: 227 PKWTE--------LANLINQCMDYEPDFRPSFRAII 254
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 5e-12
Identities = 59/165 (35%), Positives = 77/165 (46%), Gaps = 16/165 (9%)
Query: 751 LVKLHGCCIEGAERLLVYEYLENKSLDQALFGQRSLTLDWATRY--EICSGVARGLAYLH 808
LV LH C + LV EY+ L + QR L + A Y EIC L +LH
Sbjct: 58 LVGLHSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIA----LNFLH 113
Query: 809 EESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVAGTIGYLAPEYAM 868
E II+RD+K NVLLDAD K++D+G+ K ST GT Y+APE
Sbjct: 114 ERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTST-FCGTPNYIAPEILR 169
Query: 869 RGHLTEKTDVFAFGVLALETVSGRPNSD-----PSLDEEKLYLLE 908
D +A GVL E ++GR D P ++ E YL +
Sbjct: 170 GEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTED-YLFQ 213
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 5e-12
Identities = 66/221 (29%), Positives = 105/221 (47%), Gaps = 20/221 (9%)
Query: 694 NFSPSNKLGEGGFGPVYKGKL-GDGRAIAVKQLS--VASRQGKSQFVAEIATISAVQHRN 750
+F+ LG+G FG V + G A+K L V + + + A+Q +
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKP 60
Query: 751 --LVKLHGCCIEGAERL-LVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYL 807
L +LH C + +RL V EY+ L + A Y + ++ GL +L
Sbjct: 61 PFLTQLHSC-FQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFY--AAEISVGLFFL 117
Query: 808 HEESRVRIIHRDVKASNVLLDADLVPKISDFGLAK--LYDDKKTHISTRV-AGTIGYLAP 864
H II+RD+K NV+LD++ KI+DFG+ K + D ++TR GT Y+AP
Sbjct: 118 HRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG----VTTRTFCGTPDYIAP 170
Query: 865 EYAMRGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLY 905
E + D +A+GVL E ++G+P D DE++L+
Sbjct: 171 EIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGE-DEDELF 210
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 67.9 bits (167), Expect = 5e-12
Identities = 60/212 (28%), Positives = 97/212 (45%), Gaps = 33/212 (15%)
Query: 701 LGEGGFGPVYKGK-LGDGRAIAVKQLSVASRQGKSQFVA-----EIATISAVQHRNLVKL 754
+G G +G V GR +A+K++S A EI + ++H N++ L
Sbjct: 8 IGSGAYGVVCSAVDKRTGRKVAIKKIS---NVFDDLIDAKRILREIKLLRHLRHENIIGL 64
Query: 755 HGCCIEGAERL-------LVYEYLENKSLDQALFGQRSLTLDWATR--YEICSGVARGLA 805
I +V E +E L + + + LT D Y+I RGL
Sbjct: 65 LD--ILRPPSPEDFNDVYIVTELMET-DLHKVIKSPQPLTDDHIQYFLYQIL----RGLK 117
Query: 806 YLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYD---DKKTHISTRVAGTIGYL 862
YLH +IHRD+K SN+L++++ KI DFGLA+ D D+K ++ V T Y
Sbjct: 118 YLH---SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVV-TRWYR 173
Query: 863 APEYAMRG-HLTEKTDVFAFGVLALETVSGRP 893
APE + T+ D+++ G + E ++ +P
Sbjct: 174 APELLLSSSRYTKAIDIWSVGCIFAELLTRKP 205
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 7e-12
Identities = 62/201 (30%), Positives = 93/201 (46%), Gaps = 19/201 (9%)
Query: 701 LGEGGFGPVYKGKL-GDGRAIAVKQLS---VASRQGKSQFVAEIATISAVQHRNLVKLHG 756
LG+GGFG V ++ G+ A K+L + R+G++ + E + V R +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSL-A 66
Query: 757 CCIEGAERL-LVYEYLENKSLDQALF--GQRSLTLDWATRY--EICSGVARGLAYLHEES 811
E + L LV + L ++ G A Y E+C G L +
Sbjct: 67 YAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCG-------LEDLQ 119
Query: 812 RVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVAGTIGYLAPEYAMRGH 871
R RI++RD+K N+LLD +ISD GLA + +T + RV GT+GY+APE
Sbjct: 120 RERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET-VRGRV-GTVGYMAPEVINNEK 177
Query: 872 LTEKTDVFAFGVLALETVSGR 892
T D + G L E + G+
Sbjct: 178 YTFSPDWWGLGCLIYEMIQGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.0 bits (164), Expect = 7e-12
Identities = 64/210 (30%), Positives = 103/210 (49%), Gaps = 35/210 (16%)
Query: 700 KLGEGGFGPVYKGKLG-DGRAIAVKQLSVASRQGKSQFVA--EIATISAVQHRNLVKLHG 756
KLGEG + VYKG+ G+ +A+K++ + +G + F A E + + ++H N+V LH
Sbjct: 12 KLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEG-APFTAIREASLLKDLKHANIVTLHD 70
Query: 757 CCIEGAERLL--VYEYLENKSLDQALFGQRSLTLDWATRYEICSGVA-------RGLAYL 807
I ++ L V+EYL+ L Q +D V RGLAY
Sbjct: 71 --IIHTKKTLTLVFEYLD-TDLKQ--------YMDDCGGGLSMHNVRLFLFQLLRGLAYC 119
Query: 808 HEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYD-DKKTHISTRVAGTIGYLAPEY 866
H+ R++HRD+K N+L+ K++DFGLA+ KT+ + V T+ Y P+
Sbjct: 120 HQR---RVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVV--TLWYRPPDV 174
Query: 867 AMRGHLTEKT---DVFAFGVLALETVSGRP 893
+ TE + D++ G + E +GRP
Sbjct: 175 LLGS--TEYSTSLDMWGVGCIFYEMATGRP 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 8e-12
Identities = 52/152 (34%), Positives = 74/152 (48%), Gaps = 12/152 (7%)
Query: 744 SAVQHRNLVKLHGCCIEGAERLLVYEYLENKSLDQALFGQRSLTLDWATRY--EICSGVA 801
+A H LV LH C + V E++ L + QR L + A Y EI
Sbjct: 51 TASNHPFLVGLHSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEIS---- 106
Query: 802 RGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVAGTIGY 861
L +LHE II+RD+K NVLLDA+ K++D+G+ K + ++ GT Y
Sbjct: 107 LALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCK-EGIRPGDTTSTFCGTPNY 162
Query: 862 LAPEYAMRGHLTE-KTDVFAFGVLALETVSGR 892
+APE +RG D +A GVL E ++GR
Sbjct: 163 IAPE-ILRGEDYGFSVDWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 1e-11
Identities = 41/116 (35%), Positives = 65/116 (56%), Gaps = 6/116 (5%)
Query: 96 GTVCHITQLKVYALNVVGVIPDELWNLTSLFNLNLGQNYLTGPLSPSVGNLTAMQYLNLA 155
G++ + QLK+ + G IPDEL + L +L+L N L+G + S + + L+L+
Sbjct: 496 GSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLS 555
Query: 156 INALSGELPKELGQLTELLILGIGTNNFSGPLPSELGSLSKLQELYIDSAGVSGEI 211
N LSGE+PK LG + L+ + I N+ G LPS G+ L I+++ V+G I
Sbjct: 556 QNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPST-GAF-----LAINASAVAGNI 605
|
Length = 968 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 1e-11
Identities = 64/200 (32%), Positives = 94/200 (47%), Gaps = 15/200 (7%)
Query: 701 LGEGGFGPVY--KGKLGDGRAIAVKQLS---VASRQGKSQFVAEIAT-ISAVQHRNLVKL 754
+G+G FG V K K DG+ AVK L + ++ + +AE + V+H LV L
Sbjct: 3 IGKGSFGKVLLAKHKA-DGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGL 61
Query: 755 HGCCIEGAERL-LVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRV 813
H + A++L V +Y+ L L +RS A Y + +A L YLH +
Sbjct: 62 H-YSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFY--AAEIASALGYLHS---L 115
Query: 814 RIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVAGTIGYLAPEYAMRGHLT 873
II+RD+K N+LLD+ ++DFGL K + ST GT YLAPE +
Sbjct: 116 NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTST-FCGTPEYLAPEVLRKQPYD 174
Query: 874 EKTDVFAFGVLALETVSGRP 893
D + G + E + G P
Sbjct: 175 RTVDWWCLGAVLYEMLYGLP 194
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 1e-11
Identities = 55/209 (26%), Positives = 97/209 (46%), Gaps = 20/209 (9%)
Query: 692 TENFSPSNKLGEGGFGPVYKGK-LGDGRAIAVKQL--SVASRQGKSQFVAEIATISAVQH 748
T + +G G FG V + G+ +A+K++ ++ + E+ + ++H
Sbjct: 9 TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRH 68
Query: 749 RNLVKLHGCCIEGAERLLVYEYLENKSLDQALFGQRSLTLDWATR--YEICSGVARGLAY 806
N++ L I E + L L + L R L + Y+I RGL Y
Sbjct: 69 ENIISLSDIFISPLEDIYFVTELLGTDLHR-LLTSRPLEKQFIQYFLYQI----LRGLKY 123
Query: 807 LHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKT-HISTRVAGTIGYLAPE 865
+H ++HRD+K SN+L++ + KI DFGLA++ D + T ++STR Y APE
Sbjct: 124 VHSAG---VVHRDLKPSNILINENCDLKICDFGLARIQDPQMTGYVSTRY-----YRAPE 175
Query: 866 YAMRGH-LTEKTDVFAFGVLALETVSGRP 893
+ + D+++ G + E + G+P
Sbjct: 176 IMLTWQKYDVEVDIWSAGCIFAEMLEGKP 204
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 1e-11
Identities = 59/199 (29%), Positives = 91/199 (45%), Gaps = 12/199 (6%)
Query: 701 LGEGGFGPVYKGKL-GDGRAIAVKQLS---VASRQGKSQFVAEIATISAVQHRNLVKLHG 756
LG+GGFG V ++ G+ A K+L+ + R+G + E ++ V R +V L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60
Query: 757 CCIEGAERLLVYEYLENKSLDQALFG--QRSLTLDWATRYEICSGVARGLAYLHEESRVR 814
+ LV + L ++ + + + + GL +LH+ R
Sbjct: 61 AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR---R 117
Query: 815 IIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTR-VAGTIGYLAPEYAMRGHLT 873
II+RD+K NVLLD D +ISD GLA D ++ T+ AGT G++APE
Sbjct: 118 IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS--KTKGYAGTPGFMAPELLQGEEYD 175
Query: 874 EKTDVFAFGVLALETVSGR 892
D FA GV E ++ R
Sbjct: 176 FSVDYFALGVTLYEMIAAR 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 66.9 bits (164), Expect = 1e-11
Identities = 35/94 (37%), Positives = 54/94 (57%), Gaps = 10/94 (10%)
Query: 802 RGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKT-HISTRVAGTIG 860
RGL Y+H IIHRD+K SN+ ++ D KI DFGLA+ DD+ T +++TR
Sbjct: 129 RGLKYIHS---AGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDEMTGYVATR-----W 180
Query: 861 YLAPEYAM-RGHLTEKTDVFAFGVLALETVSGRP 893
Y APE + H + D+++ G + E ++G+
Sbjct: 181 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKT 214
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 65.7 bits (160), Expect = 2e-11
Identities = 58/228 (25%), Positives = 101/228 (44%), Gaps = 20/228 (8%)
Query: 695 FSPSNKLGEGGFGPVYKGKL----GDGRAIAVKQLS--VASRQGKSQFVAEIATISAVQH 748
F+ LG+G FG V + +L G + +AVK L + S +F+ E A + H
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60
Query: 749 RNLVKLHGCCIEGAER------LLVYEYLENKSLDQALF----GQRSLTLDWATRYEICS 798
N++KL G + + +++ ++++ L L G+ TL T
Sbjct: 61 PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMI 120
Query: 799 GVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLA-KLYDDKKTHISTRVAG 857
+A G+ YL S IHRD+ A N +L+ ++ ++DFGL+ K+Y
Sbjct: 121 DIASGMEYL---SSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKL 177
Query: 858 TIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLY 905
+ +LA E T +DV+AFGV E ++ ++ ++Y
Sbjct: 178 PVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIY 225
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 2e-11
Identities = 68/216 (31%), Positives = 94/216 (43%), Gaps = 24/216 (11%)
Query: 701 LGEGGFGPVYKGKL-GDGRAIAVKQLS----VASRQGKSQFVAEIATISAVQHRNLVKLH 755
LG+G FG V +L G A+K L + + V A +H L L
Sbjct: 3 LGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLF 62
Query: 756 GCCIEGAERLL-VYEYLENKSLDQALFGQRSLTLDWATRY--EICSGVARGLAYLHEESR 812
C + E L V EYL L + A Y EI G L +LH++
Sbjct: 63 -CTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICG----LQFLHKKG- 116
Query: 813 VRIIHRDVKASNVLLDADLVPKISDFGLAK--LYDDKKTHISTRVAGTIGYLAPEYAMRG 870
II+RD+K NVLLD D KI+DFG+ K + + K + GT Y+APE
Sbjct: 117 --IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKA---STFCGTPDYIAPEILKGQ 171
Query: 871 HLTEKTDVFAFGVLALETVSGR-PNSDPSLDEEKLY 905
E D ++FGVL E + G+ P DE++L+
Sbjct: 172 KYNESVDWWSFGVLLYEMLIGQSPFH--GEDEDELF 205
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 2e-11
Identities = 66/220 (30%), Positives = 99/220 (45%), Gaps = 19/220 (8%)
Query: 688 LKTATENFSPSNKLGEGGFGPVYK-GKLGDGRAIAVKQLSVASRQGKSQFVAEIATISAV 746
L T+ + +G+G +G VYK DG AVK L S + + AE + ++
Sbjct: 17 LGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDE-EIEAEYNILQSL 75
Query: 747 -QHRNLVKLHGCCIE-----GAERLLVYEYLENKSLDQALFG--QRSLTLDWATRYEICS 798
H N+VK +G + G + LV E S+ + + G LD A I
Sbjct: 76 PNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILY 135
Query: 799 GVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVAGT 858
G GL +LH RIIHRDVK +N+LL + K+ DFG++ + +T V GT
Sbjct: 136 GALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV-GT 191
Query: 859 IGYLAPEY-----AMRGHLTEKTDVFAFGVLALETVSGRP 893
++APE + DV++ G+ A+E G P
Sbjct: 192 PFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDP 231
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 2e-11
Identities = 61/199 (30%), Positives = 98/199 (49%), Gaps = 13/199 (6%)
Query: 700 KLGEGGFGPVYKG-KLGDGRAIAVKQLSVASRQGKSQFVA--EIATISAVQHRNLVKLHG 756
KLGEG + VYKG +G+ +A+K +S+ + +G F A E + + ++H N+V LH
Sbjct: 12 KLGEGSYATVYKGISRINGQLVALKVISMKTEEG-VPFTAIREASLLKGLKHANIVLLHD 70
Query: 757 CCIEGAERL-LVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRI 815
I E L V+EY+ L Q + Q L + RGLAY+H I
Sbjct: 71 -IIHTKETLTFVFEYMHT-DLAQYM-IQHPGGLHPYNVRLFMFQLLRGLAYIH---GQHI 124
Query: 816 IHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVAGTIGYLAPEYAMRG-HLTE 874
+HRD+K N+L+ K++DFGLA+ S+ V T+ Y P+ + +
Sbjct: 125 LHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV-TLWYRPPDVLLGATDYSS 183
Query: 875 KTDVFAFGVLALETVSGRP 893
D++ G + +E + G+P
Sbjct: 184 ALDIWGAGCIFIEMLQGQP 202
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 2e-11
Identities = 67/215 (31%), Positives = 102/215 (47%), Gaps = 22/215 (10%)
Query: 701 LGEGGFGPVYKGKL-GDGRAIAVKQLS----VASRQGKSQFVAEIATISAVQHRNLVKLH 755
LG+G FG V +L G G AVK L + + V + A ++ L L+
Sbjct: 3 LGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLY 62
Query: 756 GCCIEGAERLL-VYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVR 814
C + E L V E+L L + + L AT Y + + GL +LH +
Sbjct: 63 -CTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFY--AAEIVCGLQFLHSKG--- 116
Query: 815 IIHRDVKASNVLLDADLVPKISDFGLAK--LYDDKKTHISTRVAGTIGYLAPEYAMRGHL 872
II+RD+K NV+LD D KI+DFG+ K ++ D + ++ GT Y+APE
Sbjct: 117 IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNR---ASTFCGTPDYIAPEILQGLKY 173
Query: 873 TEKTDVFAFGVLALETVSGRP--NSDPSLDEEKLY 905
T D ++FGVL E + G+ + D DE++L+
Sbjct: 174 TFSVDWWSFGVLLYEMLIGQSPFHGD---DEDELF 205
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 2e-11
Identities = 65/201 (32%), Positives = 94/201 (46%), Gaps = 19/201 (9%)
Query: 701 LGEGGFGPVYKGKL-GDGRAIAVKQLS---VASRQGKSQFVAEIATISAVQHRNLVKLHG 756
LG+GGFG V ++ G+ A K+L + R+G++ + E + V R +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSL-A 66
Query: 757 CCIEGAERL-LVYEYLENKSLDQALF--GQRSLTLDWATRY--EICSGVARGLAYLHEES 811
E + L LV + L ++ G + A Y EI G L LH E
Sbjct: 67 YAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCG----LEDLHRE- 121
Query: 812 RVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVAGTIGYLAPEYAMRGH 871
RI++RD+K N+LLD +ISD GLA + +T I RV GT+GY+APE
Sbjct: 122 --RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET-IRGRV-GTVGYMAPEVVKNER 177
Query: 872 LTEKTDVFAFGVLALETVSGR 892
T D + G L E + G+
Sbjct: 178 YTFSPDWWGLGCLIYEMIEGK 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 2e-11
Identities = 62/201 (30%), Positives = 93/201 (46%), Gaps = 19/201 (9%)
Query: 701 LGEGGFGPVYKGKL-GDGRAIAVKQLS---VASRQGKSQFVAEIATISAVQHRNLVKLHG 756
LG+GGFG V ++ G+ A K+L + R+G+S + E + V + +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNL-A 66
Query: 757 CCIEGAERL-LVYEYLENKSLDQALF--GQRSLTLDWATRY--EICSGVARGLAYLHEES 811
E + L LV + L ++ G + A Y EI G L LH E+
Sbjct: 67 YAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCG----LEDLHREN 122
Query: 812 RVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVAGTIGYLAPEYAMRGH 871
++RD+K N+LLD +ISD GLA + ++ I RV GT+GY+APE
Sbjct: 123 ---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES-IRGRV-GTVGYMAPEVLNNQR 177
Query: 872 LTEKTDVFAFGVLALETVSGR 892
T D + G L E + G+
Sbjct: 178 YTLSPDYWGLGCLIYEMIEGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 65.9 bits (160), Expect = 2e-11
Identities = 50/152 (32%), Positives = 72/152 (47%), Gaps = 6/152 (3%)
Query: 745 AVQHRNLVKLHGCCIEGAERLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGL 804
A H LV LH C + V EY+ L + QR L + A Y + ++ L
Sbjct: 52 ASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYS--AEISLAL 109
Query: 805 AYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVAGTIGYLAP 864
YLHE II+RD+K NVLLD++ K++D+G+ K + ++ GT Y+AP
Sbjct: 110 NYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCK-EGLRPGDTTSTFCGTPNYIAP 165
Query: 865 EYAMRGHLTEKTDVFAFGVLALETVSGRPNSD 896
E D +A GVL E ++GR D
Sbjct: 166 EILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 3e-11
Identities = 58/192 (30%), Positives = 94/192 (48%), Gaps = 10/192 (5%)
Query: 701 LGEGGFGPVYKGK-LGDGRAIAVKQLSV--ASRQGKSQFVAEIATISAVQHRNLVKLHGC 757
+G+G +G V + DG+ +K+L++ ASR+ + E +S ++H N+V +
Sbjct: 8 VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIV-AYRE 66
Query: 758 CIEGAERLL--VYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRI 815
EG + LL V + E L L Q+ L E +A L YLHE+ I
Sbjct: 67 SWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEK---HI 123
Query: 816 IHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVAGTIGYLAPEYAMRGHLTEK 875
+HRD+K NV L + K+ D G+A++ +++ ST + GT Y++PE K
Sbjct: 124 LHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLI-GTPYYMSPELFSNKPYNYK 182
Query: 876 TDVFAFGVLALE 887
+DV+A G E
Sbjct: 183 SDVWALGCCVYE 194
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 5e-11
Identities = 99/401 (24%), Positives = 165/401 (41%), Gaps = 91/401 (22%)
Query: 680 PYTFSY--AELKTATENFSPSNKLGEGGFGPV-YKGKLGDGRAIAVKQLSVA--SRQGKS 734
P TF+ A K + + S LG G G V ++ DG AVK + + S K+
Sbjct: 17 PDTFAKDEATAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKN 76
Query: 735 QFVAEIATISAVQHRNLVKLHGCCIEGAERLLVYEYLENKSLDQALFGQRSLTLDWAT-- 792
+ AE+ + ++VK H + N + +L LD+A
Sbjct: 77 RAQAEVCCLLNCDFFSIVKCH--------EDFAKKDPRNPENVLMI----ALVLDYANAG 124
Query: 793 --RYEICSGVARG----------------LAYLHEESRVRIIHRDVKASNVLLDADLVPK 834
R EI S LA H S+ +IHRD+K++N+LL ++ + K
Sbjct: 125 DLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSK-HMIHRDIKSANILLCSNGLVK 183
Query: 835 ISDFGLAKLY-----DDKKTHISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETV 889
+ DFG +K+Y DD + GT Y+APE R ++K D+F+ GVL E +
Sbjct: 184 LGDFGFSKMYAATVSDD----VGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELL 239
Query: 890 SGRPNSDPSLDEEKLYLLEWAWHLHENNQEI---ELA---DPKLIEFNEEEVKRLIGVAL 943
+ + D EN +E+ LA DP + E + I AL
Sbjct: 240 TLKRPFD-----------------GENMEEVMHKTLAGRYDPLPPSISPE--MQEIVTAL 280
Query: 944 LCTQTLPSLRPSMSRVVAM------LCGDMEVSTVTAKPGYLTDWKFDDITSFVRTDEAT 997
L + P RPS S+++ M + G +E+ V +PG+ + D I+ ++ +
Sbjct: 281 LSSD--PKRRPSSSKLLNMPICKLFISGLLEI--VQTQPGFSGPLR-DTISRQIQQTKQL 335
Query: 998 KGTDTSH--------YTSSSSTSIVAEAEHLSRNGKPLLHD 1030
+ ++++ST+I+ A L+ G L++
Sbjct: 336 LQVERRRIVRQMEESLSTAASTTILEGATPLTTLGGLTLYE 376
|
Length = 496 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 64.3 bits (157), Expect = 6e-11
Identities = 38/103 (36%), Positives = 53/103 (51%), Gaps = 20/103 (19%)
Query: 800 VARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVAGTI 859
+ + L YL E+ V IHRDVK SN+LLDA K+ DFG++ D K TR AG
Sbjct: 123 IVKALHYLKEKHGV--IHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAK--TRSAGCA 178
Query: 860 GYLAPE----------YAMRGHLTEKTDVFAFGVLALETVSGR 892
Y+APE Y +R DV++ G+ +E +G+
Sbjct: 179 AYMAPERIDPPDPNPKYDIR------ADVWSLGISLVELATGQ 215
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 7e-11
Identities = 33/78 (42%), Positives = 47/78 (60%)
Query: 287 IRDMKSLSILELRNNNISDSIPSNIGEYRSLQHLDLSFNNLGGSIPDSLFNLSSLTHLFL 346
I ++ L + L N+I +IP ++G SL+ LDLS+N+ GSIP+SL L+SL L L
Sbjct: 438 ISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNL 497
Query: 347 GNNKLNGTLPARKSPLLL 364
N L+G +PA LL
Sbjct: 498 NGNSLSGRVPAALGGRLL 515
|
Length = 623 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 63.9 bits (156), Expect = 7e-11
Identities = 65/239 (27%), Positives = 104/239 (43%), Gaps = 61/239 (25%)
Query: 683 FSYAELKTATENFSPSNKLGEGGFGPVYKGKLGD-GRAIAVKQLSVASRQGKSQ--FVAE 739
F+ +LK E +G G FG V K G +AVK++ K Q + +
Sbjct: 1 FTAEDLKDLGE-------IGRGAFGTVNKMLHKPSGTIMAVKRIRSTV-DEKEQKRLLMD 52
Query: 740 I-ATISAVQHRNLVKLHG-------C--CIE----GAERL--LVYEYLENKSLDQALFGQ 783
+ + + +VK +G C C+E ++ VYE + + + + G+
Sbjct: 53 LDVVMRSSDCPYIVKFYGALFREGDCWICMELMDISLDKFYKYVYE-VLKSVIPEEILGK 111
Query: 784 RSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLA-K 842
I + L YL EE ++IIHRDVK SN+LLD + K+ DFG++ +
Sbjct: 112 ------------IAVATVKALNYLKEE--LKIIHRDVKPSNILLDRNGNIKLCDFGISGQ 157
Query: 843 LYDDKKTHISTRVAGTIGYLAPE---------YAMRGHLTEKTDVFAFGVLALETVSGR 892
L D + TR AG Y+APE Y +R +DV++ G+ E +G+
Sbjct: 158 LVD---SIAKTRDAGCRPYMAPERIDPSARDGYDVR------SDVWSLGITLYEVATGK 207
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 1e-10
Identities = 65/246 (26%), Positives = 103/246 (41%), Gaps = 10/246 (4%)
Query: 160 SGELPKELGQLTELLILGIGTNNFSGPLPSELGSLSKLQELYIDSAGV--SGEIPSSFAN 217
S L L + + + N S L SLS+L L + S S + + N
Sbjct: 32 SINLNFPDSNLESVAVNRLALNLSSNTLLLLPSSLSRLLSLDLLSPSGISSLDGSENLLN 91
Query: 218 LQSLTKWWASDTRLTGRIPDFIGNWSKLTALRFQGNSFNGPIPSSFSNLTSVTELRISDL 277
L L + RL I + + LT+L N+ IP L S L+ DL
Sbjct: 92 LLPLPSLDLNLNRLRSNI-SELLELTNLTSLDLDNNNIT-DIPPLIGLLKS--NLKELDL 147
Query: 278 SNGSSKLAF--IRDMKSLSILELRNNNISDSIPSNIGEYRSLQHLDLSFNNLGGSIPDSL 335
S+ + +R++ +L L+L N++SD +P + +L +LDLS N + +P +
Sbjct: 148 SDNKIESLPSPLRNLPNLKNLDLSFNDLSD-LPKLLSNLSNLNNLDLSGNKIS-DLPPEI 205
Query: 336 FNLSSLTHLFLGNNKLNGTLPARKSPLLLNIDVSYNNLQGNLPSWINGQQNLQINLVANN 395
LS+L L L NN + L + + L+ NN +LP I NL+ ++NN
Sbjct: 206 ELLSALEELDLSNNSIIELLSSLSNLKNLSGLELSNNKLEDLPESIGNLSNLETLDLSNN 265
Query: 396 LTIRSS 401
S
Sbjct: 266 QISSIS 271
|
Length = 394 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 1e-10
Identities = 61/214 (28%), Positives = 91/214 (42%), Gaps = 20/214 (9%)
Query: 694 NFSPSNKLGEGGFGPVYKGKL-GDGRAIAVKQL---SVASRQGKSQFVAEIATISAVQHR 749
+F LG G FG V K G G A+K L + + E + + + H
Sbjct: 19 DFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHP 78
Query: 750 NLVKLHGCCIEGAERL-LVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLH 808
+V + C + R+ + E++ L L D A Y + + YLH
Sbjct: 79 FIVNMM-CSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFY--HAELVLAFEYLH 135
Query: 809 EESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVAGTIGYLAPEYAM 868
+ II+RD+K N+LLD K++DFG AK K + + GT YLAPE
Sbjct: 136 SKD---IIYRDLKPENLLLDNKGHVKVTDFGFAK----KVPDRTFTLCGTPEYLAPEVIQ 188
Query: 869 -RGHLTEKTDVFAFGVLALETVSGRPNSDPSLDE 901
+GH + D + GVL E ++G P P D+
Sbjct: 189 SKGH-GKAVDWWTMGVLLYEFIAGYP---PFFDD 218
|
Length = 329 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 1e-10
Identities = 57/207 (27%), Positives = 102/207 (49%), Gaps = 19/207 (9%)
Query: 693 ENFSPSNKLGEGGFGPVYKGKLG-DGRAIAVKQLSVASRQGKSQFVA--EIATISAVQHR 749
+++ KLGEG + VYKGK +G+ +A+K + + +G + F A E + + ++H
Sbjct: 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEG-TPFTAIREASLLKGLKHA 63
Query: 750 NLVKLHGCCIEGAERLLVYEYLEN---KSLDQALFGQRSLTLDWATRYEICSGVARGLAY 806
N+V LH LV+EY+ + +D+ G L + + + RGL+Y
Sbjct: 64 NIVLLHDIIHTKETLTLVFEYVHTDLCQYMDKHPGG---LHPENVKLFLF--QLLRGLSY 118
Query: 807 LHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVAGTIGYLAPEY 866
+H+ I+HRD+K N+L+ K++DFGLA+ +H + T+ Y P+
Sbjct: 119 IHQRY---ILHRDLKPQNLLISDTGELKLADFGLARA-KSVPSHTYSNEVVTLWYRPPD- 173
Query: 867 AMRGHLTEKT--DVFAFGVLALETVSG 891
+ G T D++ G + +E + G
Sbjct: 174 VLLGSTEYSTCLDMWGVGCIFVEMIQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 1e-10
Identities = 53/219 (24%), Positives = 96/219 (43%), Gaps = 27/219 (12%)
Query: 693 ENFSPSNKLGEGGFGPVYKGK-LGDGRAIAVKQ--LSVASRQGKSQFVAEIATISAVQHR 749
+ + K+GEG +G VYK + G+ +A+K+ L + + EI+ + +
Sbjct: 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSES 60
Query: 750 N-LVKLHGCCIEGAER-------LLVYEYLEN--KSLDQALFGQRSLTLDWATRYEICSG 799
+V+L +E E LV+EYL++ K + L T
Sbjct: 61 IYIVRL--LDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQ 118
Query: 800 VARGLAYLHEESRVRIIHRDVKASNVLLDADL-VPKISDFGLAKLYD---DKKTHISTRV 855
+ +G+A+ H+ ++HRD+K N+L+D + KI+D GL + + TH
Sbjct: 119 LLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIV-- 173
Query: 856 AGTIGYLAPEYAMRG-HLTEKTDVFAFGVLALETVSGRP 893
T+ Y APE + H + D+++ G + E +P
Sbjct: 174 --TLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQP 210
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 63.9 bits (156), Expect = 1e-10
Identities = 51/221 (23%), Positives = 98/221 (44%), Gaps = 35/221 (15%)
Query: 693 ENFSPSNKLGEGGFGPVYKG-KLGDGRAIAVKQLSVASR--QGKSQFVAEIATISAVQHR 749
+ P +G G +G V G+ +A+K++ A + + E+ + +H
Sbjct: 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHD 64
Query: 750 NLVKLHGCCI---------EGAERLLVYEYLENKSLDQALFGQRSLTLDWATR--YEICS 798
N++ I + + +V + +E+ L + + LT + Y++
Sbjct: 65 NII-----AIRDILRPPGADFKDVYVVMDLMES-DLHHIIHSDQPLTEEHIRYFLYQLL- 117
Query: 799 GVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYD----DKKTHISTR 854
RGL Y+H + +IHRD+K SN+L++ D +I DFG+A+ + K ++
Sbjct: 118 ---RGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEY 171
Query: 855 VAGTIGYLAPE--YAMRGHLTEKTDVFAFGVLALETVSGRP 893
VA T Y APE ++ + T D+++ G + E + R
Sbjct: 172 VA-TRWYRAPELLLSLPEY-TTAIDMWSVGCIFAEMLGRRQ 210
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 1e-10
Identities = 42/157 (26%), Positives = 69/157 (43%), Gaps = 31/157 (19%)
Query: 746 VQHRNLVKLHGCCIEGAERLLV--------YEYLENKS----LDQALFGQRSLTLDWATR 793
V H +++++ + GA +V Y YL +S +DQAL ++
Sbjct: 114 VNHPSVIRMKDTLVSGAITCMVLPHYSSDLYTYLTKRSRPLPIDQALIIEKQ-------- 165
Query: 794 YEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHIST 853
+ GL YLH + RIIHRDVK N+ ++ I D G A+ +
Sbjct: 166 ------ILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLG- 215
Query: 854 RVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVS 890
+AGT+ APE R K D+++ G++ E ++
Sbjct: 216 -LAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLA 251
|
Length = 357 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 1e-10
Identities = 64/227 (28%), Positives = 104/227 (45%), Gaps = 29/227 (12%)
Query: 687 ELKTATENFSPSNKLGEGGFGPVYKGKL-----GD-GRAIAVKQLS-VASRQGKSQFVAE 739
E+ +T F +LGE FG VYKG L G+ +A+A+K L A + +F E
Sbjct: 1 EINLSTVRFM--EELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHE 58
Query: 740 IATISAVQHRNLVKLHGCCIEGAERLLVYEYLENKSLDQALFGQRS-------------- 785
S +QH N+V L G + +++ Y + L + L RS
Sbjct: 59 AMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLV-MRSPHSDVGSTDDDKTV 117
Query: 786 -LTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAK-L 843
TL+ A I + +A G+ +L S ++H+D+ NVL+ L KISD GL + +
Sbjct: 118 KSTLEPADFVHIVTQIAAGMEFL---SSHHVVHKDLATRNVLVFDKLNVKISDLGLFREV 174
Query: 844 YDDKKTHISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVS 890
Y + I +++PE M G + +D++++GV+ E S
Sbjct: 175 YAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 2e-10
Identities = 53/191 (27%), Positives = 89/191 (46%), Gaps = 20/191 (10%)
Query: 717 GRAIAVKQLSVASRQGKSQ---FVAEIATISAVQHRNLVKLHGCCIEGAERLL-VYEYLE 772
G +A+K L + + + Q F E A + + H N+V L L V+EY+
Sbjct: 3 GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVP 62
Query: 773 NKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDA-DL 831
++L + L +L + V LA H + I+HRD+K N+++ +
Sbjct: 63 GRTLREVLAADGALPA--GETGRLMLQVLDALACAHNQG---IVHRDLKPQNIMVSQTGV 117
Query: 832 VP--KISDFGLAKL------YDDKKTHISTRVAGTIGYLAPEYAMRGH-LTEKTDVFAFG 882
P K+ DFG+ L D +T V GT Y APE +RG +T +D++A+G
Sbjct: 118 RPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPE-QLRGEPVTPNSDLYAWG 176
Query: 883 VLALETVSGRP 893
++ LE ++G+
Sbjct: 177 LIFLECLTGQR 187
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 2e-10
Identities = 65/210 (30%), Positives = 103/210 (49%), Gaps = 28/210 (13%)
Query: 699 NKLGEGGFGPVYKGK-LGDGRAIAVKQLSVASRQGK-SQFVAEIATISAVQHRNLVKLHG 756
++LG+G +G VYK G +A+K++ + + K +Q + E+ + +V +G
Sbjct: 7 DELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYG 66
Query: 757 C-CIEGAERLLVY---EYLENKSLDQALFGQRSLT--LDWATRYEICSGVARGLAYLHEE 810
IEGA VY EY++ SLD+ L+ T + I V +GL +L EE
Sbjct: 67 AFFIEGA----VYMCMEYMDAGSLDK-LYAGGVATEGIPEDVLRRITYAVVKGLKFLKEE 121
Query: 811 SRVRIIHRDVKASNVLLDADLVPKISDFGLAK--LYDDKKTHISTRVAGTIGYLAPEY-- 866
IIHRDVK +NVL++ + K+ DFG++ + KT+I G Y+APE
Sbjct: 122 HN--IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTNI-----GCQSYMAPERIK 174
Query: 867 ----AMRGHLTEKTDVFAFGVLALETVSGR 892
T ++DV++ G+ LE GR
Sbjct: 175 SGGPNQNPTYTVQSDVWSLGLSILEMALGR 204
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 2e-10
Identities = 64/222 (28%), Positives = 96/222 (43%), Gaps = 26/222 (11%)
Query: 694 NFSPSNKLGEGGFGPVY----KGKLGDGRAIAVKQLS----VASRQGKSQFVAEIATISA 745
NF LG G +G V+ G G+ A+K L V + E + A
Sbjct: 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEA 60
Query: 746 VQHRN-LVKLHGCCIEGAERLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGL 804
V+ LV LH + L+ +Y+ L L+ + T R I V L
Sbjct: 61 VRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTES-EVRVYIAEIVL-AL 118
Query: 805 AYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVAGTIGYLAP 864
+LH+ + II+RD+K N+LLD++ ++DFGL+K + ++ + GTI Y+AP
Sbjct: 119 DHLHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAP 175
Query: 865 EYAMR---GHLTEKTDVFAFGVLALE--------TVSGRPNS 895
E GH + D ++ GVL E TV G NS
Sbjct: 176 EVIRGGSGGH-DKAVDWWSLGVLTFELLTGASPFTVDGEQNS 216
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 61.9 bits (151), Expect = 3e-10
Identities = 56/214 (26%), Positives = 100/214 (46%), Gaps = 40/214 (18%)
Query: 699 NKLGEGGFGPVYKGK-LGDGRAIAVKQLSVASRQGKSQF--VAEIATISAVQ-------H 748
K+GEG F V K + G+ A+K + K F + ++ + +Q H
Sbjct: 5 GKIGEGTFSEVLKAQSRKTGKYYAIKCM-------KKHFKSLEQVNNLREIQALRRLSPH 57
Query: 749 RNLVKLHGCCIE-GAERL-LVYEYLENKSLDQALFGQRSLTLDWATR---YEICSGVARG 803
N+++L + RL LV+E ++ +L + + G++ + + Y++ +
Sbjct: 58 PNILRLIEVLFDRKTGRLALVFELMD-MNLYELIKGRKRPLPEKRVKSYMYQLL----KS 112
Query: 804 LAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTH---ISTRVAGTIG 860
L ++H R I HRD+K N+L+ D++ K++DFG + K + ISTR
Sbjct: 113 LDHMH---RNGIFHRDIKPENILIKDDIL-KLADFGSCRGIYSKPPYTEYISTR-----W 163
Query: 861 YLAPEYAMR-GHLTEKTDVFAFGVLALETVSGRP 893
Y APE + G+ K D++A G + E +S P
Sbjct: 164 YRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFP 197
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.7 bits (153), Expect = 3e-10
Identities = 65/222 (29%), Positives = 101/222 (45%), Gaps = 39/222 (17%)
Query: 693 ENFSPSNKLGEGGFGPVYKGK-LGDGRAIAVKQLSVASRQGKSQ-FVAEIATISAVQHRN 750
+ + +GEG +G V G +A+K++S Q Q + EI + +H N
Sbjct: 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHEN 64
Query: 751 LVKLHGCCIEGA-----ERLLVYEYLENKSLDQALFGQRSLTLDWATR--YEICSGVARG 803
++ + + + +V E +E L + + Q L+ D Y+I RG
Sbjct: 65 IIGILDIIRPPSFESFNDVYIVQELMET-DLYKLIKTQH-LSNDHIQYFLYQIL----RG 118
Query: 804 LAYLHEESRVRIIHRDVKASNVLLDA--DLVPKISDFGLAKLYDDKKTHISTR-----VA 856
L Y+H + ++HRD+K SN+LL+ DL KI DFGLA++ D H T VA
Sbjct: 119 LKYIHSAN---VLHRDLKPSNLLLNTNCDL--KICDFGLARIAD--PEHDHTGFLTEYVA 171
Query: 857 GTIGYLAPEYAMRGHLTEKT-----DVFAFGVLALETVSGRP 893
T Y APE M L K D+++ G + E +S RP
Sbjct: 172 -TRWYRAPE-IM---LNSKGYTKAIDIWSVGCILAEMLSNRP 208
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 4e-10
Identities = 51/165 (30%), Positives = 81/165 (49%), Gaps = 10/165 (6%)
Query: 243 SKLTALRFQGNSFNGP--IPSSFSNLTSVTELRISDLSNGSSKLAFIRDMKSLSILELRN 300
S+L +L S + NL + L ++ S+ ++ + ++ +L+ L+L N
Sbjct: 67 SRLLSLDLLSPSGISSLDGSENLLNLLPLPSLDLNLNRLRSN-ISELLELTNLTSLDLDN 125
Query: 301 NNISDSIPSNIGEYRS-LQHLDLSFNNLGGSIPDSLFNLSSLTHLFLGNNKLNGTLPA-- 357
NNI+D IP IG +S L+ LDLS N + S+P L NL +L +L L N L+ LP
Sbjct: 126 NNITD-IPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS-DLPKLL 182
Query: 358 RKSPLLLNIDVSYNNLQGNLPSWINGQQNLQINLVANNLTIRSSD 402
L N+D+S N + +LP I L+ ++NN I
Sbjct: 183 SNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSIIELLS 226
|
Length = 394 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 4e-10
Identities = 62/199 (31%), Positives = 94/199 (47%), Gaps = 13/199 (6%)
Query: 701 LGEGGFGPVYKGKLG-DGRAIAVKQLS---VASRQGKSQFVAEI-ATISAVQHRNLVKLH 755
+G+G FG V K DG+ AVK L V +R+ + +AE + V+H LV LH
Sbjct: 3 IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 756 GCCIEGAERL-LVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVR 814
+ E+L V +++ L L +RS A Y + +A L YLH +
Sbjct: 63 -YSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFY--AAEIASALGYLHS---IN 116
Query: 815 IIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVAGTIGYLAPEYAMRGHLTE 874
I++RD+K N+LLD+ ++DFGL K ++ +T GT YLAPE +
Sbjct: 117 IVYRDLKPENILLDSQGHVVLTDFGLCK-EGIAQSDTTTTFCGTPEYLAPEVIRKQPYDN 175
Query: 875 KTDVFAFGVLALETVSGRP 893
D + G + E + G P
Sbjct: 176 TVDWWCLGAVLYEMLYGLP 194
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 4e-10
Identities = 62/199 (31%), Positives = 94/199 (47%), Gaps = 13/199 (6%)
Query: 701 LGEGGFGPVYKGKL-GDGRAIAVKQL---SVASRQGKSQFVAEIATI-SAVQHRNLVKLH 755
+G+G FG V K DG AVK L ++ ++ ++ +AE + ++H LV LH
Sbjct: 3 IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLH 62
Query: 756 GCCIEGAERL-LVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVR 814
+ AE+L V +Y+ L L +R A Y + VA + YLH +
Sbjct: 63 -YSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFY--AAEVASAIGYLHS---LN 116
Query: 815 IIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVAGTIGYLAPEYAMRGHLTE 874
II+RD+K N+LLD+ ++DFGL K + + ST GT YLAPE +
Sbjct: 117 IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTST-FCGTPEYLAPEVLRKEPYDR 175
Query: 875 KTDVFAFGVLALETVSGRP 893
D + G + E + G P
Sbjct: 176 TVDWWCLGAVLYEMLYGLP 194
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 4e-10
Identities = 54/171 (31%), Positives = 83/171 (48%), Gaps = 22/171 (12%)
Query: 800 VARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAK-LYDDKKTHISTRVAGT 858
VARG+ +L SR + IHRD+ A N+LL + V KI DFGLA+ +Y D
Sbjct: 182 VARGMEFL--ASR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 238
Query: 859 IGYLAPEYAMRGHLTEKTDVFAFGVLALE--TVSGRPNSDPSLDEEKLYLLEWAWHLHEN 916
+ ++APE T ++DV++FGVL E ++ P +DEE L+
Sbjct: 239 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLK-------- 290
Query: 917 NQEIELADPKLIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVAMLCGDM 967
+ + P E+ E+ ++ L C P RP+ S +V +L GD+
Sbjct: 291 -EGTRMRAP---EYATPEIYSIM---LDCWHNNPEDRPTFSELVEIL-GDL 333
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 4e-10
Identities = 55/210 (26%), Positives = 95/210 (45%), Gaps = 19/210 (9%)
Query: 700 KLGEGGFGPVYKGKLGDGRAIAVKQLSVASRQGKSQFVA-EIATISAVQHRNLVKLHGCC 758
K+G G +G VYK K DG+ L G S EIA + ++H N++ L
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVF 67
Query: 759 IEGAER--LLVYEYLENKSLDQALF------GQRSLTLDWATRYEICSGVARGLAYLHEE 810
+ A+R L+++Y E+ F ++ + L + + G+ YLH
Sbjct: 68 LSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN 127
Query: 811 SRVRIIHRDVKASNVLLDADLVP----KISDFGLAKLYDDKKTHIS--TRVAGTIGYLAP 864
++HRD+K +N+L+ + KI+D G A+L++ ++ V T Y AP
Sbjct: 128 ---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAP 184
Query: 865 EYAMRG-HLTEKTDVFAFGVLALETVSGRP 893
E + H T+ D++A G + E ++ P
Sbjct: 185 ELLLGARHYTKAIDIWAIGCIFAELLTSEP 214
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 6e-10
Identities = 51/159 (32%), Positives = 82/159 (51%), Gaps = 15/159 (9%)
Query: 751 LVKLHGCCIEGAERL-LVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHE 809
L +LH C + +RL V EY+ L + A Y + +A GL +LH
Sbjct: 63 LTQLHSC-FQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFY--AAEIAIGLFFLHS 119
Query: 810 ESRVRIIHRDVKASNVLLDADLVPKISDFGLAK--LYDDKKTHISTRV-AGTIGYLAPEY 866
+ II+RD+K NV+LD++ KI+DFG+ K ++D ++T+ GT Y+APE
Sbjct: 120 KG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG----VTTKTFCGTPDYIAPEI 172
Query: 867 AMRGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLY 905
+ D +AFGVL E ++G+ + DE++L+
Sbjct: 173 IAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGE-DEDELF 210
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 6e-10
Identities = 70/235 (29%), Positives = 112/235 (47%), Gaps = 32/235 (13%)
Query: 687 ELKTATENFSPSNKLGEGGFGPVYKG-KLGDGRAIAVKQLS--VASRQGKSQFVAEIATI 743
E+ +N SP +G G +G V G +AVK+LS S + E+ +
Sbjct: 14 EVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 70
Query: 744 SAVQHRNLVKL-----HGCCIEGAERLLVYEYLENKSLDQALFGQRSLTLDWATR--YEI 796
++H N++ L +E + + +L L+ + Q+ LT D Y+I
Sbjct: 71 KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK-LTDDHVQFLIYQI 129
Query: 797 CSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKT-HISTRV 855
RGL Y+H IIHRD+K SN+ ++ D KI DFGLA+ DD+ T +++TR
Sbjct: 130 L----RGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR- 181
Query: 856 AGTIGYLAPEYAMRG-HLTEKTDVFAFGVLALETVSGR---PNSDPSLDEEKLYL 906
Y APE + H + D+++ G + E ++GR P +D +D+ KL L
Sbjct: 182 ----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD-HIDQLKLIL 231
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 7e-10
Identities = 58/204 (28%), Positives = 102/204 (50%), Gaps = 20/204 (9%)
Query: 701 LGEGGFGPVYKGK-LGDGRAIAVKQL--SVASRQGKSQFVAEIATISAVQHRNLVKLHGC 757
LG G +G V K + + G +AVK++ +V S++ K + ++ +V V +G
Sbjct: 9 LGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGA 68
Query: 758 CIEGAERLLVYEYLENKSLDQALFGQ---RSLTLDWATRYEICSGVARGLAYLHEESRVR 814
+ + E + + SLD+ + + + LT+ +I + + L YLH ++
Sbjct: 69 LFREGDVWICME-VMDTSLDK-FYKKVYDKGLTIPEDILGKIAVSIVKALEYLHS--KLS 124
Query: 815 IIHRDVKASNVLLDADLVPKISDFGLA-KLYDDKKTHISTRVAGTIGYLAPE-----YAM 868
+IHRDVK SNVL++ + K+ DFG++ L D T AG Y+APE
Sbjct: 125 VIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSV---AKTIDAGCKPYMAPERINPELNQ 181
Query: 869 RGHLTEKTDVFAFGVLALETVSGR 892
+G+ K+DV++ G+ +E +GR
Sbjct: 182 KGY-DVKSDVWSLGITMIELATGR 204
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 61.2 bits (149), Expect = 8e-10
Identities = 58/209 (27%), Positives = 103/209 (49%), Gaps = 18/209 (8%)
Query: 695 FSPSNKLGEGGFGPVYKGKLGD-GRAIAVKQLSVA--SRQGKSQFVAEIATISAVQHRNL 751
+ P +G G +G V K + +A+K+++ A +R + + EI + + H N+
Sbjct: 7 YVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENV 66
Query: 752 VKLHGCCIEGAER------LLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLA 805
+ + + R +VYE L + L Q + ++L+ D +Y + + RGL
Sbjct: 67 IAIKDI-MPPPHREAFNDVYIVYE-LMDTDLHQIIRSSQTLSDD-HCQYFLYQ-LLRGLK 122
Query: 806 YLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVAGTIGYLAPE 865
Y+H + ++HRD+K SN+LL+A+ KI DFGLA+ +K ++ V T Y APE
Sbjct: 123 YIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVV-TRWYRAPE 178
Query: 866 YAMR-GHLTEKTDVFAFGVLALETVSGRP 893
+ T DV++ G + E + +P
Sbjct: 179 LLLNCSEYTTAIDVWSVGCIFAELLGRKP 207
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 8e-10
Identities = 53/194 (27%), Positives = 89/194 (45%), Gaps = 14/194 (7%)
Query: 701 LGEGGFGPVYKG-KLGDGRAIAVKQLSV-ASRQGKSQFVAEIATISAVQHRNLVKLHGCC 758
LG G G VYK L R +AVK + + + + + Q ++E+ + ++ +G
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAF 68
Query: 759 IEGAERLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHR 818
+ E+++ SLD R + R I V +GL YL ++I+HR
Sbjct: 69 FVENRISICTEFMDGGSLDV----YRKIPEHVLGR--IAVAVVKGLTYLWS---LKILHR 119
Query: 819 DVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVAGTIGYLAPEYAMRGHLTEKTDV 878
DVK SN+L++ K+ DFG++ + I+ GT Y+APE +DV
Sbjct: 120 DVKPSNMLVNTRGQVKLCDFGVSTQLVNS---IAKTYVGTNAYMAPERISGEQYGIHSDV 176
Query: 879 FAFGVLALETVSGR 892
++ G+ +E GR
Sbjct: 177 WSLGISFMELALGR 190
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 1e-09
Identities = 54/171 (31%), Positives = 78/171 (45%), Gaps = 22/171 (12%)
Query: 800 VARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAK-LYDDKKTHISTRVAGT 858
VARG+ +L SR + IHRD+ A N+LL + V KI DFGLA+ +Y D
Sbjct: 183 VARGMEFL--ASR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLP 239
Query: 859 IGYLAPEYAMRGHLTEKTDVFAFGVLALETVS--GRPNSDPSLDEEKLYLLEWAWHLHEN 916
+ ++APE T ++DV++FGVL E S P ++EE
Sbjct: 240 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQ----------- 288
Query: 917 NQEIELADPKLIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVAMLCGDM 967
L D + E + + L C Q P RP+ S +V +L GD+
Sbjct: 289 ----RLKDGTRMRAPENATPEIYRIMLACWQGDPKERPTFSALVEIL-GDL 334
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 60.5 bits (146), Expect = 1e-09
Identities = 54/210 (25%), Positives = 96/210 (45%), Gaps = 19/210 (9%)
Query: 700 KLGEGGFGPVYKGKLGDGRAIAVKQLSVASRQGKSQFVA-EIATISAVQHRNLVKLHGCC 758
K+G G +G VYK K DG+ L G S EIA + ++H N++ L
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVF 67
Query: 759 IEGAER--LLVYEYLENKSLDQALF------GQRSLTLDWATRYEICSGVARGLAYLHEE 810
+ ++R L+++Y E+ F ++ + L + + + G+ YLH
Sbjct: 68 LSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN 127
Query: 811 SRVRIIHRDVKASNVLLDADLVP----KISDFGLAKLYDDKKTHIS--TRVAGTIGYLAP 864
++HRD+K +N+L+ + KI+D G A+L++ ++ V T Y AP
Sbjct: 128 ---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAP 184
Query: 865 EYAMRG-HLTEKTDVFAFGVLALETVSGRP 893
E + H T+ D++A G + E ++ P
Sbjct: 185 ELLLGARHYTKAIDIWAIGCIFAELLTSEP 214
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 2e-09
Identities = 58/204 (28%), Positives = 94/204 (46%), Gaps = 26/204 (12%)
Query: 701 LGEGGFGPVYKGKLGD-GRAIAVKQLS---VASRQGKSQFVAEIATISAVQHRNLVKLHG 756
+G GGFG VY + D G+ A+K L + +QG++ + E +S LV
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLS------LVSTGD 55
Query: 757 C----CIEGA----ERLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLH 808
C C+ A ++L L N Q + + R+ + + GL ++H
Sbjct: 56 CPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRF-YATEIILGLEHMH 114
Query: 809 EESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVAGTIGYLAPEYAM 868
+++RD+K +N+LLD +ISD GLA + KK H S GT GY+APE
Sbjct: 115 NRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMAPEVLQ 168
Query: 869 RGHLTEKT-DVFAFGVLALETVSG 891
+G + + D F+ G + + + G
Sbjct: 169 KGTAYDSSADWFSLGCMLFKLLRG 192
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 2e-09
Identities = 58/204 (28%), Positives = 94/204 (46%), Gaps = 26/204 (12%)
Query: 701 LGEGGFGPVYKGKLGD-GRAIAVKQLS---VASRQGKSQFVAEIATISAVQHRNLVKLHG 756
+G GGFG VY + D G+ A+K L + +QG++ + E +S LV
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLS------LVSTGD 55
Query: 757 C----CIEGA----ERLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLH 808
C C+ A ++L L N Q + + R+ + + GL ++H
Sbjct: 56 CPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRF-YAAEIILGLEHMH 114
Query: 809 EESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVAGTIGYLAPEYAM 868
+++RD+K +N+LLD +ISD GLA + KK H S GT GY+APE
Sbjct: 115 NRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMAPEVLQ 168
Query: 869 RGHLTEKT-DVFAFGVLALETVSG 891
+G + + D F+ G + + + G
Sbjct: 169 KGVAYDSSADWFSLGCMLFKLLRG 192
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 2e-09
Identities = 61/227 (26%), Positives = 109/227 (48%), Gaps = 33/227 (14%)
Query: 701 LGEGGFGPVYKGKL---GDGRAIA-VKQLSVASRQGKS------QFVAEIATISAVQHRN 750
LG+G F +YKG L D + +++SV + S F + +S + H++
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62
Query: 751 LVKLHGCCIEGAERLLVYEYLENKSLDQALFGQR-SLTLDWATRYEICSGVARGLAYLHE 809
LVKL+G C+ E ++V EY++ LD L ++ +++L W + ++ +A L YL +
Sbjct: 63 LVKLYGVCVR-DENIMVEEYVKFGPLDVFLHREKNNVSLHW--KLDVAKQLASALHYLED 119
Query: 810 ESRVRIIHRDVKASNVLL-----DADLVP--KISDFGLAKLYDDKKTHISTRVAGTIGYL 862
+ +++H +V N+L+ + VP K+SD G+ ++ + I ++
Sbjct: 120 K---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERVE-----RIPWI 171
Query: 863 APEYAMRGH--LTEKTDVFAFGVLALETVSG--RPNSDPSLDEEKLY 905
APE G LT D ++FG LE S P S S E++ +
Sbjct: 172 APECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERF 218
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 2e-09
Identities = 56/207 (27%), Positives = 94/207 (45%), Gaps = 27/207 (13%)
Query: 700 KLGEGGFGPVYKGKLGDGRAIA---VKQLSV-ASRQGKSQFVAEIATISAVQHRNLVKLH 755
++G G FG V ++ +A VK+L AS + +++F+ + +QH N+++
Sbjct: 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCL 61
Query: 756 GCCIEGAERLLVYEYLENKSL------DQALFGQRSLTLDWATRYEICSGVARGLAYLHE 809
G C+E LLV+EY E L +Q L L EI A G+ ++H+
Sbjct: 62 GQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEI----AAGVTHMHK 117
Query: 810 ESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHIST--RVAGTIGYLAPEYA 867
+ +H D+ N L +DL K+ D+G+ K+ +I T + +LAPE
Sbjct: 118 HN---FLHSDLALRNCFLTSDLTVKVGDYGIG-PSRYKEDYIETEDDKCVPLRWLAPELV 173
Query: 868 MRGH-------LTEKTDVFAFGVLALE 887
H T+ ++V+A GV E
Sbjct: 174 GEFHGGLITAEQTKPSNVWALGVTLWE 200
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 4e-09
Identities = 63/231 (27%), Positives = 97/231 (41%), Gaps = 26/231 (11%)
Query: 694 NFSPSNKLGEGGFGPVY---KGKLGD-GRAIAVKQLSVASRQGKSQFVAEIATISAV--- 746
NF LG G +G V+ K D G+ A+K L A+ K++ T V
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60
Query: 747 --QHRNLVKLHGCCIEGAERLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGL 804
Q LV LH + L+ +Y+ L L + Y + L
Sbjct: 61 IRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIY--SGEIVLAL 118
Query: 805 AYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVAGTIGYLAP 864
+LH ++ II+RD+K N+LLD++ ++DFGL+K + + + + GTI Y+AP
Sbjct: 119 EHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAP 175
Query: 865 EYAM---RGHLTEKTDVFAFGVLALE--------TVSGRPNSDPSLDEEKL 904
+ GH + D ++ GVL E TV G NS + L
Sbjct: 176 DIVRGGDGGH-DKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRIL 225
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 4e-09
Identities = 72/220 (32%), Positives = 95/220 (43%), Gaps = 29/220 (13%)
Query: 701 LGEGGFGPVY--KGKLGDGRAIAVKQLSVASRQGKSQFVAEIATISAV----QHRNLVKL 754
LG+G FG V + K G+ A+K L K + VA T S V +H L L
Sbjct: 3 LGKGTFGKVILVREKAT-GKYYAMKILKKEVIIAKDE-VAHTLTESRVLQNTRHPFLTAL 60
Query: 755 HGCCIEGAERL-LVYEYLENKSLDQALFGQRSLTLDWATRY--EICSGVARGLAYLHEES 811
+ +RL V EY L L +R + D A Y EI S L YLH
Sbjct: 61 K-YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSA----LGYLHSCD 115
Query: 812 RVRIIHRDVKASNVLLDADLVPKISDFGLAK--LYDDKKTHISTRVAGTIGYLAPEYAMR 869
+++RD+K N++LD D KI+DFGL K + D GT YLAPE
Sbjct: 116 ---VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATM---KTFCGTPEYLAPEVLED 169
Query: 870 GHLTEKTDVFAFGVLALETVSGRPNSDP--SLDEEKLYLL 907
D + GV+ E + GR P + D EKL+ L
Sbjct: 170 NDYGRAVDWWGLGVVMYEMMCGRL---PFYNQDHEKLFEL 206
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 4e-09
Identities = 55/212 (25%), Positives = 93/212 (43%), Gaps = 14/212 (6%)
Query: 687 ELKTATENFSPSNKLGEGGFGPVY--KGKLGDGRAIAVKQLSVAS--RQGKSQFV-AEIA 741
+ K E+F+ LG G FG V K D +A+K+ + +Q + V +E
Sbjct: 24 KNKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERK 83
Query: 742 TISAVQHRNLVKLHGCCIEGAERLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVA 801
++ + H V L+G + + LV E++ L + D Y + +
Sbjct: 84 ILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFY--AAQIV 141
Query: 802 RGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVAGTIGY 861
YL + I++RD+K N+LLD D K++DFG AK+ D + + + GT Y
Sbjct: 142 LIFEYLQS---LNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR----TYTLCGTPEY 194
Query: 862 LAPEYAMRGHLTEKTDVFAFGVLALETVSGRP 893
+APE + + D + G+ E + G P
Sbjct: 195 IAPEILLNVGHGKAADWWTLGIFIYEILVGCP 226
|
Length = 340 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 59.1 bits (144), Expect = 5e-09
Identities = 33/97 (34%), Positives = 55/97 (56%), Gaps = 8/97 (8%)
Query: 802 RGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAK----LYDDKKTHISTRVAG 857
+ L Y+H S +IHRD+K SN+LL++D K++DFGLA+ L ++ + + T
Sbjct: 118 KALKYIH--SG-NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVA 174
Query: 858 TIGYLAPEYAMRGHL-TEKTDVFAFGVLALETVSGRP 893
T Y APE + T+ D+++ G + E + G+P
Sbjct: 175 TRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKP 211
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 5e-09
Identities = 63/208 (30%), Positives = 96/208 (46%), Gaps = 32/208 (15%)
Query: 701 LGEGGFGPVYKGKLGD-GRAIAVKQLSVASRQGKSQFVAEIATISAVQHRN--------- 750
+G+G FG VY+ + D R A+K LS K + VA+ + RN
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLS------KKEIVAKKEVAHTIGERNILVRTLLDE 54
Query: 751 ---LVKLHGCCIEGAERLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYL 807
+V L ++ LV +Y+ L L + + D A Y + + L +L
Sbjct: 55 SPFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFY--IAELVLALEHL 112
Query: 808 HEESRVRIIHRDVKASNVLLDADLVPKISDFGLAK--LYDDKKTHISTRVAGTIGYLAPE 865
H+ I++RD+K N+LLDA + DFGL+K L D+K T+ GT YLAPE
Sbjct: 113 HKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNT---FCGTTEYLAPE 166
Query: 866 YAM--RGHLTEKTDVFAFGVLALETVSG 891
+ +G+ T+ D ++ GVL E G
Sbjct: 167 VLLDEKGY-TKHVDFWSLGVLVFEMCCG 193
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 6e-09
Identities = 37/100 (37%), Positives = 56/100 (56%), Gaps = 13/100 (13%)
Query: 802 RGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKT-HISTRVAGTIG 860
RGL Y+H IIHRD+K SNV ++ D +I DFGLA+ DD+ T +++TR
Sbjct: 129 RGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLARQADDEMTGYVATR-----W 180
Query: 861 YLAPEYAMRG-HLTEKTDVFAFGVLALETVSGR---PNSD 896
Y APE + H + D+++ G + E + G+ P +D
Sbjct: 181 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGND 220
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 6e-09
Identities = 55/224 (24%), Positives = 98/224 (43%), Gaps = 51/224 (22%)
Query: 700 KLGEGGFGPVYKGKLGD---GRAIAVKQ----LSVASRQGKSQFVAEIATISAVQHRNLV 752
+G+GG G VY D R +A+K+ LS K +F+ E + + H +V
Sbjct: 9 LIGKGGMGEVYLAY--DPVCSRRVALKKIREDLSENPLL-KKRFLREAKIAADLIHPGIV 65
Query: 753 KLHGCCIEGAERLLVYEYLENKSLDQAL---FGQRSLTLDWATR----------YEICSG 799
++ C +G Y+E +L L + + SL+ + A + ++IC+
Sbjct: 66 PVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICAT 125
Query: 800 VARGLAYLHEESRVRIIHRDVKASNVLLD--ADLVPKISDFGLAKLYDDKKTH------- 850
+ Y+H + ++HRD+K N+LL ++V I D+G A ++
Sbjct: 126 IE----YVHSKG---VLHRDLKPDNILLGLFGEVV--ILDWGAAIFKKLEEEDLLDIDVD 176
Query: 851 ----------ISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVL 884
I ++ GT Y+APE + +E TD++A GV+
Sbjct: 177 ERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVI 220
|
Length = 932 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 6e-09
Identities = 70/215 (32%), Positives = 95/215 (44%), Gaps = 18/215 (8%)
Query: 701 LGEGGFGPVYKGK-LGDGRAIAVKQLS---VASRQGKSQFVAEIATISAVQHRNLVKLHG 756
LG+G FG V K GR A+K L + ++ + + E + +H L L
Sbjct: 3 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK- 61
Query: 757 CCIEGAERL-LVYEYLENKSLDQALFGQRSLTLDWATRY--EICSGVARGLAYLHEESRV 813
+ +RL V EY L L +R + D A Y EI S L YLH E V
Sbjct: 62 YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSA----LDYLHSEKNV 117
Query: 814 RIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVAGTIGYLAPEYAMRGHLT 873
++RD+K N++LD D KI+DFGL K + T GT YLAPE
Sbjct: 118 --VYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT-FCGTPEYLAPEVLEDNDYG 174
Query: 874 EKTDVFAFGVLALETVSGR-PNSDPSLDEEKLYLL 907
D + GV+ E + GR P + D EKL+ L
Sbjct: 175 RAVDWWGLGVVMYEMMCGRLPFYNQ--DHEKLFEL 207
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 8e-09
Identities = 52/175 (29%), Positives = 86/175 (49%), Gaps = 21/175 (12%)
Query: 738 AEIATISAVQHRNLVKLHGCCIEGAERLLVYEYLE----NKSLDQAL-----FGQRSLTL 788
+E+ ++A H +VK + LL+ EY NK + Q L F + + L
Sbjct: 114 SELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGL 173
Query: 789 DWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKK 848
+ Y+I LA SR +++HRD+K++N+ L + K+ DFG +K Y D
Sbjct: 174 LF---YQIV------LALDEVHSR-KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSV 223
Query: 849 T-HISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVS-GRPNSDPSLDE 901
+ +++ GT YLAPE R ++K D+++ GV+ E ++ RP PS E
Sbjct: 224 SLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQRE 278
|
Length = 478 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 9e-09
Identities = 62/199 (31%), Positives = 86/199 (43%), Gaps = 16/199 (8%)
Query: 701 LGEGGFGPVYKGK-LGDGRAIAVKQLS---VASRQGKSQFVAEIATISAVQHRNLVKLHG 756
LG+G FG V + GR A+K L + ++ + V E + +H L L
Sbjct: 3 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK- 61
Query: 757 CCIEGAERL-LVYEYLENKSLDQALFGQRSLTLDWATRY--EICSGVARGLAYLHEESRV 813
+ +RL V EY L L +R T + A Y EI S L YLH
Sbjct: 62 YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSA----LEYLHSRD-- 115
Query: 814 RIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVAGTIGYLAPEYAMRGHLT 873
+++RD+K N++LD D KI+DFGL K + T GT YLAPE
Sbjct: 116 -VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT-FCGTPEYLAPEVLEDNDYG 173
Query: 874 EKTDVFAFGVLALETVSGR 892
D + GV+ E + GR
Sbjct: 174 RAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 1e-08
Identities = 53/171 (30%), Positives = 82/171 (47%), Gaps = 22/171 (12%)
Query: 800 VARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAK-LYDDKKTHISTRVAGT 858
VA+G+ +L SR + IHRD+ A N+LL + V KI DFGLA+ +Y D
Sbjct: 188 VAKGMEFL--ASR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 244
Query: 859 IGYLAPEYAMRGHLTEKTDVFAFGVLALETVS--GRPNSDPSLDEEKLYLLEWAWHLHEN 916
+ ++APE T ++DV++FGVL E S P +DE E+ L E
Sbjct: 245 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE------EFCRRLKEG 298
Query: 917 NQEIELADPKLIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVAMLCGDM 967
+ + ++ E+ + + L C PS RP+ S +V L G++
Sbjct: 299 TRM------RAPDYTTPEMYQTM---LDCWHGEPSQRPTFSELVEHL-GNL 339
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 1e-08
Identities = 55/233 (23%), Positives = 103/233 (44%), Gaps = 38/233 (16%)
Query: 692 TENFSPSNK-LGEGGFGPVYKGK-LGDGRAIAVKQLSV--------ASRQGKSQ----FV 737
+E + LGEG +G V K G+ +A+K++ + RQ F
Sbjct: 7 SERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFT 66
Query: 738 A--EIATISAVQHRNLVKLHGCCIEGAERLLVYEYLENKSLDQALFGQRSLTLDWATRYE 795
E+ ++ ++H N++ L +EG LV + + + D R + L +
Sbjct: 67 TLRELKIMNEIKHENIMGLVDVYVEGDFINLVMDIMAS---DLKKVVDRKIRLTESQVKC 123
Query: 796 ICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLY----------D 845
I + GL LH+ +HRD+ +N+ +++ + KI+DFGLA+ Y
Sbjct: 124 ILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSK 180
Query: 846 DK----KTHISTRVAGTIGYLAPEYAMRGH-LTEKTDVFAFGVLALETVSGRP 893
D+ + ++++V T+ Y APE M D+++ G + E ++G+P
Sbjct: 181 DETMQRREEMTSKVV-TLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKP 232
|
Length = 335 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 1e-08
Identities = 34/94 (36%), Positives = 53/94 (56%), Gaps = 10/94 (10%)
Query: 802 RGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKT-HISTRVAGTIG 860
+GL Y+H IIHRD+K N+ ++ D KI DFGLA+ D + T ++ TR
Sbjct: 129 KGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQTDSEMTGYVVTR-----W 180
Query: 861 YLAPEYAMRG-HLTEKTDVFAFGVLALETVSGRP 893
Y APE + H T+ D+++ G + E ++G+P
Sbjct: 181 YRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKP 214
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 1e-08
Identities = 59/210 (28%), Positives = 99/210 (47%), Gaps = 19/210 (9%)
Query: 694 NFSPSNKLGEGGFGPVY----KGKLGDGRAIAVKQLSVASRQGKSQFVAEIATISAV--- 746
NF LG G +G V+ G+ A+K L A+ K++ V T V
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60
Query: 747 --QHRNLVKLHGCCIEGAERLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSG-VARG 803
Q LV LH A+ L+ +Y+ + L+ + + + D Y SG +
Sbjct: 61 VRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFY---SGEIILA 117
Query: 804 LAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVAGTIGYLA 863
L +LH ++ I++RD+K N+LLD++ ++DFGL+K + ++ + GTI Y+A
Sbjct: 118 LEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMA 174
Query: 864 PEY--AMRGHLTEKTDVFAFGVLALETVSG 891
PE GH + D ++ G+L E ++G
Sbjct: 175 PEIIRGKGGH-GKAVDWWSLGILIFELLTG 203
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 2e-08
Identities = 32/90 (35%), Positives = 54/90 (60%), Gaps = 2/90 (2%)
Query: 296 LELRNNNISDSIPSNIGEYRSLQHLDLSFNNLGGSIPDSLFNLSSLTHLFLGNNKLNGTL 355
L L N + IP++I + R LQ ++LS N++ G+IP SL +++SL L L N NG++
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 356 PARKSPL--LLNIDVSYNNLQGNLPSWING 383
P L L ++++ N+L G +P+ + G
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALGG 512
|
Length = 623 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 3e-08
Identities = 59/207 (28%), Positives = 93/207 (44%), Gaps = 15/207 (7%)
Query: 701 LGEGGFGPVYKGKLGDGRAI----AVKQLSVASRQGKSQFVAEIATISAVQHRNLVKLHG 756
+G+G FG V + + D + I +++ + SR + +AE ++ V +V L
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLK- 59
Query: 757 CCIEGAERL-LVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRI 815
+ E+L LV ++ L L QR D + + + L LH+ +
Sbjct: 60 FSFQSPEKLYLVLAFINGGELFHHL--QREGRFDLSRARFYTAELLCALENLHK---FNV 114
Query: 816 IHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVAGTIGYLAPEYAMRGHLTEK 875
I+RD+K N+LLD + DFGL KL + K + GT YLAPE + T+
Sbjct: 115 IYRDLKPENILLDYQGHIALCDFGLCKL-NMKDDDKTNTFCGTPEYLAPELLLGHGYTKA 173
Query: 876 TDVFAFGVLALETVSGRPNSDPSLDEE 902
D + GVL E ++G P P DE
Sbjct: 174 VDWWTLGVLLYEMLTGLP---PFYDEN 197
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 3e-08
Identities = 47/196 (23%), Positives = 92/196 (46%), Gaps = 8/196 (4%)
Query: 701 LGEGGFGPVYKGKLGDGRAI-AVKQL--SVASRQGKSQFVAEIATISAVQHRNLVKLHGC 757
+GEG +G V K + + + I A+K+ S + + K + E+ + ++ N+V+L
Sbjct: 9 VGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEA 68
Query: 758 CIEGAERLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIH 817
+ LV+EY+E L+ L + + ++ S + + + +H + I+H
Sbjct: 69 FRRRGKLYLVFEYVEKNMLE--LLEEMP---NGVPPEKVRSYIYQLIKAIHWCHKNDIVH 123
Query: 818 RDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVAGTIGYLAPEYAMRGHLTEKTD 877
RD+K N+L+ + V K+ DFG A+ + T T Y +PE + + D
Sbjct: 124 RDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAPYGKAVD 183
Query: 878 VFAFGVLALETVSGRP 893
+++ G + E G+P
Sbjct: 184 MWSVGCILGELSDGQP 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 4e-08
Identities = 51/196 (26%), Positives = 87/196 (44%), Gaps = 20/196 (10%)
Query: 701 LGEGGFGP--VYKGKLGDGRAIAVKQLSV-ASRQGKSQFVAEIATISAVQHRNLVKLHGC 757
+GEG FG + + D + A+K++ + S E ++ ++H N+V
Sbjct: 8 VGEGSFGRALLVQHVNSD-QKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKES 66
Query: 758 CIEGAERLLVYEYLENKSLDQALFGQR------SLTLDWATRYEICSGVARGLAYLHEES 811
+V EY + L Q + QR L W ++C GV ++HE+
Sbjct: 67 FEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFV--QMCLGVQ----HIHEK- 119
Query: 812 RVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVAGTIGYLAPEYAMRGH 871
R++HRD+K+ N+ L + K+ DFG A+L + T V GT Y+ PE
Sbjct: 120 --RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYV-GTPYYVPPEIWENMP 176
Query: 872 LTEKTDVFAFGVLALE 887
K+D+++ G + E
Sbjct: 177 YNNKSDIWSLGCILYE 192
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 55.9 bits (134), Expect = 4e-08
Identities = 63/213 (29%), Positives = 94/213 (44%), Gaps = 15/213 (7%)
Query: 701 LGEGGFGPVYKGK-LGDGRAIAVKQLS---VASRQGKSQFVAEIATISAVQHRNLVKLHG 756
LG+G FG V + G+ A+K L + ++ + + E + +H L L
Sbjct: 3 LGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLK- 61
Query: 757 CCIEGAERL-LVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRI 815
+ +RL V EY+ L L +R + D Y + + L YLH +I
Sbjct: 62 YSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYG--AEIVSALDYLHSG---KI 116
Query: 816 IHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVAGTIGYLAPEYAMRGHLTEK 875
++RD+K N++LD D KI+DFGL K + T GT YLAPE
Sbjct: 117 VYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKT-FCGTPEYLAPEVLEDNDYGRA 175
Query: 876 TDVFAFGVLALETVSGR-PNSDPSLDEEKLYLL 907
D + GV+ E + GR P + D EKL+ L
Sbjct: 176 VDWWGLGVVMYEMMCGRLPFYNQ--DHEKLFEL 206
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 4e-08
Identities = 55/198 (27%), Positives = 88/198 (44%), Gaps = 11/198 (5%)
Query: 701 LGEGGFGPVYKGK-LGDGRAIAVKQL---SVASRQGKSQFVAEI-ATISAVQHRNLVKLH 755
+G+G FG V + + + AVK L ++ ++ + ++E + V+H LV LH
Sbjct: 3 IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 62
Query: 756 GCCIEGAERLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRI 815
+ V +Y+ L L +R A Y + +A L YLH + I
Sbjct: 63 FSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFY--AAEIASALGYLHS---LNI 117
Query: 816 IHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVAGTIGYLAPEYAMRGHLTEK 875
++RD+K N+LLD+ ++DFGL K + ST GT YLAPE +
Sbjct: 118 VYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTST-FCGTPEYLAPEVLHKQPYDRT 176
Query: 876 TDVFAFGVLALETVSGRP 893
D + G + E + G P
Sbjct: 177 VDWWCLGAVLYEMLYGLP 194
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 1e-07
Identities = 27/91 (29%), Positives = 45/91 (49%), Gaps = 2/91 (2%)
Query: 174 LILGIGTNN--FSGPLPSELGSLSKLQELYIDSAGVSGEIPSSFANLQSLTKWWASDTRL 231
I G+G +N G +P+++ L LQ + + + G IP S ++ SL S
Sbjct: 419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSF 478
Query: 232 TGRIPDFIGNWSKLTALRFQGNSFNGPIPSS 262
G IP+ +G + L L GNS +G +P++
Sbjct: 479 NGSIPESLGQLTSLRILNLNGNSLSGRVPAA 509
|
Length = 623 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 55.5 bits (133), Expect = 1e-07
Identities = 63/256 (24%), Positives = 104/256 (40%), Gaps = 43/256 (16%)
Query: 667 HDDDEELLGMDARPYTFSYAELKTATE---NFSPSNKLGEGGFGPVY------------- 710
H D +E A P + A+LK E +F + L G FG ++
Sbjct: 119 HLDFDEAPPDAAGPVPLAQAKLKHDDEFLAHFRVIDDLPAGAFGKIFICALRASTEEAEA 178
Query: 711 --------KGKLGDGRAIAVKQLSVASRQGKSQFVAEIATISAVQHRNLVKLHGCCIEGA 762
+GK R IA K++ SR Q EI + + H N++K IE
Sbjct: 179 RRGVNSTNQGKPKCERLIA-KRVKAGSRAA-IQLENEILALGRLNHENILK-----IEEI 231
Query: 763 ERLLVYEYLENKSLDQAL--------FGQRSLTLDWATRYEICSGVARGLAYLHEESRVR 814
R Y+ + D L F + L TR I + + Y+H++ +
Sbjct: 232 LRSEANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTR-AIMKQLLCAVEYIHDK---K 287
Query: 815 IIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVAGTIGYLAPEYAMRGHLTE 874
+IHRD+K N+ L+ D + DFG A ++ ++ GT+ +PE E
Sbjct: 288 LIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCE 347
Query: 875 KTDVFAFGVLALETVS 890
TD+++ G++ L+ +S
Sbjct: 348 ITDIWSCGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 1e-07
Identities = 37/107 (34%), Positives = 55/107 (51%), Gaps = 4/107 (3%)
Query: 785 SLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAK-L 843
S LD S VA+G+ +L ++ IHRDV A NVLL V KI DFGLA+ +
Sbjct: 206 SWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDI 262
Query: 844 YDDKKTHISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVS 890
+D + + ++APE T ++DV+++G+L E S
Sbjct: 263 MNDSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 309
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 51.6 bits (124), Expect = 1e-07
Identities = 31/148 (20%), Positives = 58/148 (39%), Gaps = 14/148 (9%)
Query: 700 KLGEGGFGPVYKGKLGDGRAIAVKQLSVASRQGKSQFVAEIATISAVQHRNLV--KLHGC 757
L G VY D + +K SR+ + E+A + + + L K+
Sbjct: 5 LLKGGLTNRVYLLGTKDEDYV-LKINP--SREKGADREREVAILQLLARKGLPVPKVLAS 61
Query: 758 CIEGAERLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIH 817
L+ E++E ++LD+ + + +I +A LA LH+ + + H
Sbjct: 62 GESDGWSYLLMEWIEGETLDE---------VSEEEKEDIAEQLAELLAKLHQLPLLVLCH 112
Query: 818 RDVKASNVLLDADLVPKISDFGLAKLYD 845
D+ N+L+D + I D+ A
Sbjct: 113 GDLHPGNILVDDGKILGIIDWEYAGYGP 140
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 1e-07
Identities = 56/207 (27%), Positives = 96/207 (46%), Gaps = 25/207 (12%)
Query: 704 GGFGPVYKGKLGDGRA-IAVKQL---SVASRQGKSQFVAEIATISAVQHRNLVKLHGCCI 759
G +G VY + + R A+K++ ++ R Q E ++ ++ +V + C
Sbjct: 12 GAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMF-CSF 70
Query: 760 EGAERL-LVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHR 818
E L +V EY+E L +L +D A Y + +A L YLH I+HR
Sbjct: 71 ETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLA--LEYLHNYG---IVHR 125
Query: 819 DVKASNVLLDADLVPKISDFGLAKL------------YDDKKTH--ISTRVAGTIGYLAP 864
D+K N+L+ + K++DFGL+K+ + +K T + +V GT Y+AP
Sbjct: 126 DLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAP 185
Query: 865 EYAMRGHLTEKTDVFAFGVLALETVSG 891
E +R + D +A G++ E + G
Sbjct: 186 EVILRQGYGKPVDWWAMGIILYEFLVG 212
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 2e-07
Identities = 34/96 (35%), Positives = 52/96 (54%), Gaps = 7/96 (7%)
Query: 802 RGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKL-YDDKKTHIS-TRVAGTI 859
R L Y+H + + HRD+K N+L +AD KI DFGLA++ ++D T I T T
Sbjct: 114 RALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATR 170
Query: 860 GYLAPEY--AMRGHLTEKTDVFAFGVLALETVSGRP 893
Y APE + T D+++ G + E ++G+P
Sbjct: 171 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKP 206
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 53.9 bits (130), Expect = 2e-07
Identities = 48/216 (22%), Positives = 83/216 (38%), Gaps = 44/216 (20%)
Query: 701 LGEGGFGPVYKGKLGDGRAIAVKQ--LSVASRQGKSQFVAEIATISAVQHRNLVKLHGCC 758
+ + K K +AVK+ L S++ EI T +QH N++
Sbjct: 10 FEDLMIVHLAKHK-PTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSF 68
Query: 759 IEGAERLLVYEYLENKSLDQALFGQRSLTLD---------WATRYEICSGVARGLAYLHE 809
I +E +V + +G L A + I V L Y+H
Sbjct: 69 IVDSELYVVSPLMA--------YGSCEDLLKTHFPEGLPELAIAF-ILKDVLNALDYIHS 119
Query: 810 ESRVRIIHRDVKASNVLLDADLVPKIS-----------DFGLAKLYDDKKTHISTRVAGT 858
+ IHR VKAS++LL D +S ++D K+ +
Sbjct: 120 KG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVK-----N 171
Query: 859 IGYLAPEY---AMRGHLTEKTDVFAFGVLALETVSG 891
+ +L+PE ++G+ EK+D+++ G+ A E +G
Sbjct: 172 LPWLSPEVLQQNLQGY-NEKSDIYSVGITACELANG 206
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 53.9 bits (130), Expect = 2e-07
Identities = 56/215 (26%), Positives = 97/215 (45%), Gaps = 34/215 (15%)
Query: 700 KLGEGGFGPVYKGK---LGDGRAIAVKQLSVASRQGKSQFVAEIATISAVQ--------- 747
+LG+G +G V + + +A+K+++ F +I A++
Sbjct: 7 ELGQGAYGIVCSARNAETSEEETVAIKKITNV-------FSKKILAKRALRELKLLRHFR 59
Query: 748 -HRNLVKLHGCCI---EGAERLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARG 803
H+N+ L+ I L +YE L L Q + + LT D + I + G
Sbjct: 60 GHKNITCLYDMDIVFPGNFNELYLYEELMEADLHQIIRSGQPLT-DAHFQSFIYQ-ILCG 117
Query: 804 LAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKT----HISTRVAGTI 859
L Y+H + ++HRD+K N+L++AD KI DFGLA+ + + ++ VA T
Sbjct: 118 LKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVA-TR 173
Query: 860 GYLAPEYAMRGH-LTEKTDVFAFGVLALETVSGRP 893
Y APE + T+ DV++ G + E + +P
Sbjct: 174 WYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKP 208
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 2e-07
Identities = 35/116 (30%), Positives = 58/116 (50%), Gaps = 10/116 (8%)
Query: 779 ALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDF 838
+ + L LD VA+G+++L ++ IHRD+ A N+LL + KI DF
Sbjct: 202 EILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDF 258
Query: 839 GLAKLYDDKKTHISTRVAGT----IGYLAPEYAMRGHLTEKTDVFAFGVLALETVS 890
GLA+ D + + V G + ++APE T ++DV+++G+L E S
Sbjct: 259 GLAR---DIRNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFS 311
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 48.3 bits (116), Expect = 2e-07
Identities = 21/60 (35%), Positives = 29/60 (48%)
Query: 292 SLSILELRNNNISDSIPSNIGEYRSLQHLDLSFNNLGGSIPDSLFNLSSLTHLFLGNNKL 351
+L L+L NN ++ +L+ LDLS NNL P++ L SL L L N L
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 3e-07
Identities = 34/113 (30%), Positives = 49/113 (43%), Gaps = 24/113 (21%)
Query: 200 LYIDSAGVSGEIPSSFANLQSLTKWWASDTRLTGRIPDFIGNWSKLTALRFQGNSFNGPI 259
L +D+ G+ G IP+ + L+ L S + G IP +G+ + L L NSFNG I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 260 PSSFSNLTSVTELRISDLSNGSSKLAFIRDMKSLSILELRNNNISDSIPSNIG 312
P S LT SL IL L N++S +P+ +G
Sbjct: 483 PESLGQLT------------------------SLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 3e-07
Identities = 57/207 (27%), Positives = 91/207 (43%), Gaps = 19/207 (9%)
Query: 701 LGEGGFGPVYK-GKLGDGRAIAVKQLSVASRQGKSQFVAEIATISAVQ-HRNLVKLHGC- 757
+G+G +G V+K +G AVK L + AE + A+ H N+VK +G
Sbjct: 26 IGKGTYGKVFKVLNKKNGSKAAVKILD-PIHDIDEEIEAEYNILKALSDHPNVVKFYGMY 84
Query: 758 ----CIEGAERLLVYEYLENKSLDQALFG--QRSLTLDWATRYEICSGVARGLAYLHEES 811
G + LV E S+ + G +R ++ I GL +LH
Sbjct: 85 YKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN- 143
Query: 812 RVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVAGTIGYLAPEY----- 866
+ IHRDVK +N+LL + K+ DFG++ + +T V GT ++APE
Sbjct: 144 --KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV-GTPFWMAPEVIACEQ 200
Query: 867 AMRGHLTEKTDVFAFGVLALETVSGRP 893
+ + DV++ G+ A+E G P
Sbjct: 201 QLDSTYDARCDVWSLGITAIELGDGDP 227
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 3e-07
Identities = 57/216 (26%), Positives = 93/216 (43%), Gaps = 16/216 (7%)
Query: 700 KLGEGGFGPVYKGKLGD-GRAIAVKQLS---VASRQGKSQFVAEIATISAVQHRNLVKLH 755
++G+GG+G V+ K D G +A+K++ + + E ++ + LVKL
Sbjct: 8 QVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLL 67
Query: 756 GCCIEGAERLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRI 815
+ L EY+ L L+ D A Y +A + +
Sbjct: 68 YAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFY-----MAEMFEAVDALHELGY 122
Query: 816 IHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVAGTIGYLAPEYAMRGHLTEK 875
IHRD+K N L+DA K++DFGL+K + V G+ Y+APE +RG +
Sbjct: 123 IHRDLKPENFLIDASGHIKLTDFGLSK----GIVTYANSVVGSPDYMAPE-VLRGKGYDF 177
Query: 876 T-DVFAFGVLALETVSG-RPNSDPSLDEEKLYLLEW 909
T D ++ G + E + G P S + +E L W
Sbjct: 178 TVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYW 213
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 5e-07
Identities = 62/220 (28%), Positives = 94/220 (42%), Gaps = 22/220 (10%)
Query: 686 AELKTATENFSPSNKLGEGGFGPVYKGKLGDGRAI-AVKQLSVAS--RQGKSQFVAEIAT 742
+L+ E+F +G G FG V + + + A+K LS ++ S F E
Sbjct: 36 TKLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERD 95
Query: 743 ISAVQHRN---LVKLHGCCIEGAERL-LVYEYLENKSLDQALFGQRSLTLDWATRYEICS 798
I A H N +V+LH + + L +V EY+ L L + WA Y +
Sbjct: 96 IMA--HANSEWIVQLH-YAFQDDKYLYMVMEYMPGGDL-VNLMSNYDIPEKWARFY--TA 149
Query: 799 GVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLA-KLYDDKKTHISTRVAG 857
V L +H + IHRDVK N+LLD K++DFG K+ + T V G
Sbjct: 150 EVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAV-G 205
Query: 858 TIGYLAPEYAMR----GHLTEKTDVFAFGVLALETVSGRP 893
T Y++PE G+ + D ++ GV E + G
Sbjct: 206 TPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDT 245
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 7e-07
Identities = 32/93 (34%), Positives = 50/93 (53%), Gaps = 10/93 (10%)
Query: 802 RGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKT-HISTRVAGTIG 860
GL Y+H IIHRD+K N+ ++ D KI DFGLA+ D + T ++ TR
Sbjct: 128 CGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTR-----W 179
Query: 861 YLAPEYAMRG-HLTEKTDVFAFGVLALETVSGR 892
Y APE + H + D+++ G + E ++G+
Sbjct: 180 YRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 9e-07
Identities = 52/201 (25%), Positives = 88/201 (43%), Gaps = 12/201 (5%)
Query: 693 ENFSPSNKLGEGGFGPVYKGKLGDGRAIAVKQLS--VASRQGKSQFVAEIATISAVQHRN 750
+N P +G Y L R +A+K+LS ++ + E+ + V H+N
Sbjct: 20 QNLKPIGSGAQGIVCAAYDAVLD--RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKN 77
Query: 751 LVKLHGCCIEGAERLLVYE--YLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLH 808
++ L + L ++ YL + +D L + LD + + G+ +LH
Sbjct: 78 IISLLNV-FTPQKSLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH 136
Query: 809 EESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVAGTIGYLAPEYAM 868
IIHRD+K SN+++ +D KI DFGLA+ + + T T Y APE +
Sbjct: 137 SAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG--TSFMMTPYVVTRYYRAPEVIL 191
Query: 869 RGHLTEKTDVFAFGVLALETV 889
E D+++ G + E V
Sbjct: 192 GMGYKENVDIWSVGCIMGEMV 212
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 1e-06
Identities = 51/185 (27%), Positives = 84/185 (45%), Gaps = 22/185 (11%)
Query: 717 GRAIAVKQLSVASRQGKSQFVA-----EIATISAVQHRNLVKLHGC-----CIEGAERLL 766
G +AVK+LS R ++Q A E+ + V H+N++ L +E + +
Sbjct: 46 GINVAVKKLS---RPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVY 102
Query: 767 VYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVL 826
+ L + +L Q + + LD + + G+ +LH IIHRD+K SN++
Sbjct: 103 LVMELMDANLCQVI----HMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIV 155
Query: 827 LDADLVPKISDFGLAKLYDDKKTHISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLAL 886
+ +D KI DFGLA+ + T T Y APE + E D+++ G +
Sbjct: 156 VKSDCTLKILDFGLAR--TACTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMG 213
Query: 887 ETVSG 891
E V G
Sbjct: 214 ELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 1e-06
Identities = 49/183 (26%), Positives = 89/183 (48%), Gaps = 21/183 (11%)
Query: 716 DGRAIAV--KQLSVASRQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLVYEYLEN 773
+GR + V K L + R F + +S V H +L +HG C+ G+E ++V E++E+
Sbjct: 41 NGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEH 100
Query: 774 KSLDQALFGQRS-LTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVL-----L 827
LD L ++ + + W + + +A L+YL +++ ++H +V A N+L L
Sbjct: 101 GPLDVCLRKEKGRVPVAW--KITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGL 155
Query: 828 DADLVP--KISDFGLAKLYDDKKTHISTRVAGTIGYLAPEYAMRG-HLTEKTDVFAFGVL 884
P K+SD G++ ++ + I ++APE G L+ D ++FG
Sbjct: 156 AEGTSPFIKLSDPGVSFTALSREERVE-----RIPWIAPECVPGGNSLSTAADKWSFGTT 210
Query: 885 ALE 887
LE
Sbjct: 211 LLE 213
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 1e-06
Identities = 61/232 (26%), Positives = 102/232 (43%), Gaps = 39/232 (16%)
Query: 701 LGEGGFGPVYKGKL-----------GDGRAIAV--KQLSVASRQGKSQFVAEIATISAVQ 747
LG G +Y G L + I V K L + R F + + V
Sbjct: 3 LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVS 62
Query: 748 HRNLVKLHGCCIEGAERLLVYEYLENKSLDQALFGQRS---LTLDWATRYEICSGVARGL 804
H+++V L+G C+ E ++V E++E LD LF R LT W ++++ +A L
Sbjct: 63 HKHIVLLYGVCVRDVENIMVEEFVEFGPLD--LFMHRKSDVLTTPW--KFKVAKQLASAL 118
Query: 805 AYLHEESRVRIIHRDVKASNVLL-----DADLVP--KISDFGLAKLYDDKKTHISTRVAG 857
+YL ++ ++H +V N+LL D + P K+SD G+ ++ +
Sbjct: 119 SYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSRQECVE----- 170
Query: 858 TIGYLAPEYAM-RGHLTEKTDVFAFGVLALETV-SGR-PNSDPSLDE-EKLY 905
I ++APE +L+ D ++FG E +G P D +L E E+ Y
Sbjct: 171 RIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKERFY 222
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 1e-06
Identities = 57/235 (24%), Positives = 99/235 (42%), Gaps = 28/235 (11%)
Query: 679 RPYTFSYAELKTAT-------ENFSPSNKLGEGGFGPVYKGKLGDGRAIAVKQLS--VAS 729
R F E+ +T +N P +G Y L R +A+K+LS +
Sbjct: 6 RDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQN 63
Query: 730 RQGKSQFVAEIATISAVQHRNLVKLHGC-----CIEGAERLLVYEYLENKSLDQALFGQR 784
+ + E+ + V H+N++ L +E + + + L + +L Q +
Sbjct: 64 QTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVI---- 119
Query: 785 SLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLY 844
+ LD + + G+ +LH IIHRD+K SN+++ +D KI DFGLA+
Sbjct: 120 QMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA 176
Query: 845 DDKKTHISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGR---PNSD 896
+ + T T Y APE + E D+++ G + E + G P +D
Sbjct: 177 G--TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTD 229
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 2e-06
Identities = 46/176 (26%), Positives = 71/176 (40%), Gaps = 25/176 (14%)
Query: 725 LSVASRQGKSQFVAEIATISAVQHRNLVKLHG--------CCIEGAERLLVYEYLENKSL 776
+ R G E + A+ H ++++L G C I + +Y YL K
Sbjct: 122 IKAGQRGGT---ATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYKTDLYCYLAAK-- 176
Query: 777 DQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKIS 836
R++ + I V R + YLHE RIIHRD+KA N+ ++ +
Sbjct: 177 -------RNIAI--CDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLG 224
Query: 837 DFGLAKLYDDKKTHISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGR 892
DFG A D + AGTI APE R D+++ G++ E +
Sbjct: 225 DFGAACFPVDINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCH 280
|
Length = 391 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 2e-06
Identities = 50/158 (31%), Positives = 71/158 (44%), Gaps = 15/158 (9%)
Query: 693 ENFSPSNKLGEGGFGPVYKG-KLGDGRAIAVKQLSVASRQGK---SQFVAEIATISAVQH 748
E F + G FG VY G K + + AVK + A K Q AE ++ +
Sbjct: 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKS 63
Query: 749 RNLVKLHGCCIEGAERLLVYEYL---ENKSLDQALFGQRSLTLDWATRYEICSGVARGLA 805
+V L+ LV EYL + KSL ++G D + S VA L
Sbjct: 64 PFIVHLYYSLQSANNVYLVMEYLIGGDVKSL-LHIYGY----FDEEMAVKYISEVALALD 118
Query: 806 YLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKL 843
YLH IIHRD+K N+L+ + K++DFGL+K+
Sbjct: 119 YLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSKV 153
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 3e-06
Identities = 32/100 (32%), Positives = 49/100 (49%), Gaps = 14/100 (14%)
Query: 803 GLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKT---HISTRVAGTI 859
G+ +LH IIHRD+K SN+++ +D KI DFGLA+ ++ TR
Sbjct: 130 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY---- 182
Query: 860 GYLAPEYAMRGHLTEKTDVFAFGVLALETVSGR---PNSD 896
Y APE + E D+++ G + E + G P +D
Sbjct: 183 -YRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTD 221
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 4e-06
Identities = 39/146 (26%), Positives = 61/146 (41%), Gaps = 47/146 (32%)
Query: 816 IHRDVKASNVLLDADLVPKISDFGL--------------------------AKLYDD--- 846
IHRD+K N+L+D D K++DFGL + L+DD
Sbjct: 123 IHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSN 182
Query: 847 --------------KKTH---ISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETV 889
K H ++ + GT Y+APE +R T+ D ++ GV+ E +
Sbjct: 183 CRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEML 242
Query: 890 SGRPNS-DPSLDEEKLYLLEWAWHLH 914
G+P P+ E +L ++ W LH
Sbjct: 243 VGQPPFLAPTPTETQLKVINWENTLH 268
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 49.7 bits (118), Expect = 5e-06
Identities = 58/239 (24%), Positives = 94/239 (39%), Gaps = 43/239 (17%)
Query: 693 ENFSPSNKLGEGGFGPVYKGKLGD-GRAIAVKQLSVASRQGKSQ---FVAEIATISAVQH 748
E+F +G G FG V + D G A+K L A K Q AE +
Sbjct: 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADS 60
Query: 749 RNLVKLHGCCIEGAERLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLH 808
+VK+ + L+ E+L + L + +LT + T++ I V + +H
Sbjct: 61 LWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLT-EEETQFYIAETVL-AIDSIH 118
Query: 809 EESRVRIIHRDVKASNVLLDADLVPKISDFGL---------------------------- 840
+ + IHRD+K N+LLD+ K+SDFGL
Sbjct: 119 Q---LGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQN 175
Query: 841 ------AKLYDDKKTHISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRP 893
A+ + + ++ GT Y+APE M+ + D ++ GV+ E + G P
Sbjct: 176 MNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 6e-06
Identities = 35/109 (32%), Positives = 58/109 (53%), Gaps = 12/109 (11%)
Query: 800 VARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVAGT- 858
VA G+ +L ++ +HRD+ A NVL+ + KI DFGLA+ +IS G+
Sbjct: 248 VANGMEFLASKN---CVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISK---GST 301
Query: 859 ---IGYLAPEYAMRGHLTEKTDVFAFGVLALE--TVSGRPNSDPSLDEE 902
+ ++APE T +DV++FG+L E T+ G P + ++E+
Sbjct: 302 FLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQ 350
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.3 bits (118), Expect = 6e-06
Identities = 63/243 (25%), Positives = 98/243 (40%), Gaps = 48/243 (19%)
Query: 693 ENFSPSNKLGEGGFGPVYKGKLGD-GRAIAVKQLSVASRQGKSQFV---AEIATISAVQH 748
++F +G G FG V + D G A+K+L + K Q AE ++ +
Sbjct: 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADN 60
Query: 749 RNLVKLHGCCIEGAERL-LVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYL 807
+VKL+ + L L+ EYL + L + + T + TR+ I + LA +
Sbjct: 61 PWVVKLY-YSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEE-ETRFYIAETI---LA-I 114
Query: 808 HEESRVRIIHRDVKASNVLLDADLVPKISDFGL----------------------AKLYD 845
++ IHRD+K N+LLDA K+SDFGL L
Sbjct: 115 DSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDF 174
Query: 846 DKKTHISTRVA---------------GTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVS 890
K S R A GT Y+APE ++ ++ D ++ GV+ E +
Sbjct: 175 ISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLV 234
Query: 891 GRP 893
G P
Sbjct: 235 GYP 237
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 7e-06
Identities = 31/92 (33%), Positives = 49/92 (53%), Gaps = 4/92 (4%)
Query: 800 VARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHIST-RVAGT 858
VARG+ +L ++ +HRD+ A NVLL + KI DFGLA+ ++S
Sbjct: 246 VARGMEFLASKN---CVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLP 302
Query: 859 IGYLAPEYAMRGHLTEKTDVFAFGVLALETVS 890
+ ++APE T +DV+++G+L E S
Sbjct: 303 VKWMAPESIFDNLYTTLSDVWSYGILLWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 1e-05
Identities = 62/261 (23%), Positives = 99/261 (37%), Gaps = 52/261 (19%)
Query: 701 LGEGGFGPVYKGKLGDGRAI-AVKQL---SVASRQGKSQFVAEIATISAVQHRNLVKLHG 756
+G G FG V + D A+ A+K L V R + AE ++ + +VKL+
Sbjct: 9 IGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYY 68
Query: 757 CCIEGAERLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRII 816
+ V +Y+ + L D A R+ I + + +H ++ I
Sbjct: 69 SFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLA-RFYIAE-LTCAIESVH---KMGFI 123
Query: 817 HRDVKASNVLLDADLVPKISDFGLA--------KLYDDKKTHI----------------- 851
HRD+K N+L+D D K++DFGL Y K H
Sbjct: 124 HRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRC 183
Query: 852 ------------STRV-----AGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRPN 894
R GT Y+APE +R T+ D ++ GV+ E + G+P
Sbjct: 184 RLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPP 243
Query: 895 -SDPSLDEEKLYLLEWAWHLH 914
+ E +L ++ W LH
Sbjct: 244 FLADTPAETQLKVINWETTLH 264
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 42.9 bits (102), Expect = 2e-05
Identities = 20/61 (32%), Positives = 29/61 (47%), Gaps = 4/61 (6%)
Query: 316 SLQHLDLSFNNLGGSIPDSLFNLSSLTHLFLGNNKLNGTLPAR---KSPLLLNIDVSYNN 372
+L+ LDLS N L + L +L L L N L ++ P L ++D+S NN
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLT-SISPEAFSGLPSLRSLDLSGNN 59
Query: 373 L 373
L
Sbjct: 60 L 60
|
Length = 60 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 2e-05
Identities = 27/85 (31%), Positives = 42/85 (49%), Gaps = 5/85 (5%)
Query: 812 RVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVAGTIGYLAPEY--AM- 868
++ +HRD+K NVLLD + +++DFG T S GT Y++PE AM
Sbjct: 120 QLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAME 179
Query: 869 --RGHLTEKTDVFAFGVLALETVSG 891
+G + D ++ GV E + G
Sbjct: 180 DGKGRYGPECDWWSLGVCMYEMLYG 204
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 2e-05
Identities = 58/213 (27%), Positives = 90/213 (42%), Gaps = 16/213 (7%)
Query: 688 LKTATENFSPSNKLGEGGFGPVYKGKLGDGRAI-AVKQLSVAS--RQGKSQFVAEIATIS 744
L+ E++ +G G FG V + + + A+K LS ++ S F E I
Sbjct: 38 LQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIM 97
Query: 745 AVQHRNLVKLHGCCIEGAERL-LVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARG 803
A + V C + + L +V EY+ L L + WA Y + V
Sbjct: 98 AFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVN-LMSNYDVPEKWAKFYT--AEVVLA 154
Query: 804 LAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLA-KLYDDKKTHISTRVAGTIGYL 862
L +H + +IHRDVK N+LLD K++DFG K+ + T V GT Y+
Sbjct: 155 LDAIHS---MGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAV-GTPDYI 210
Query: 863 APEYAMR----GHLTEKTDVFAFGVLALETVSG 891
+PE G+ + D ++ GV E + G
Sbjct: 211 SPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 3e-05
Identities = 58/239 (24%), Positives = 95/239 (39%), Gaps = 43/239 (17%)
Query: 693 ENFSPSNKLGEGGFGPVYKGKLGD-GRAIAVKQLSVASRQGKSQFV---AEIATISAVQH 748
++F +G G FG V + D G A+K L A K Q AE +
Sbjct: 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADG 60
Query: 749 RNLVKLHGCCIEGAERLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLH 808
+VK+ + L+ E+L + L + +L+ + AT++ I V + +H
Sbjct: 61 AWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLS-EEATQFYIAETVL-AIDAIH 118
Query: 809 EESRVRIIHRDVKASNVLLDADLVPKISDFGL---------------------------- 840
+ + IHRD+K N+LLDA K+SDFGL
Sbjct: 119 Q---LGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQN 175
Query: 841 ------AKLYDDKKTHISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRP 893
A+ + + ++ GT Y+APE M+ + D ++ GV+ E + G P
Sbjct: 176 MNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 3e-05
Identities = 45/164 (27%), Positives = 72/164 (43%), Gaps = 11/164 (6%)
Query: 693 ENFSPSNKLGEGGFGPV-YKGKLGDGRAIAVKQLSVASRQGKSQFV---AEIATISAVQH 748
E+F +G+G FG V K G+ A+K L + K Q AE ++
Sbjct: 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDS 60
Query: 749 RNLVKLHGCCIEGAERLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLH 808
+V L+ + L+ E+L L L + + D TR+ + V + +H
Sbjct: 61 PWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSED-VTRFYMAECVL-AIEAVH 118
Query: 809 EESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHIS 852
++ IHRD+K N+L+D K+SDFGL+ + K H S
Sbjct: 119 ---KLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGF--HKQHDS 157
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 3e-05
Identities = 30/83 (36%), Positives = 40/83 (48%), Gaps = 6/83 (7%)
Query: 816 IHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVAGTIGYLAPEY--AMRGHLT 873
+HRD+K NVL+D K++DFG A K S GT Y+APE M G
Sbjct: 124 VHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGK 183
Query: 874 EKTDV----FAFGVLALETVSGR 892
V ++ GV+A E + GR
Sbjct: 184 GTYGVECDWWSLGVIAYEMIYGR 206
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 4e-05
Identities = 64/274 (23%), Positives = 103/274 (37%), Gaps = 62/274 (22%)
Query: 695 FSPSNKLGEGGFGPVYKGKLGDGRAI-AVKQL---SVASRQGKSQFVAEIATISAVQHRN 750
F LG G FG V + D +A+ A+K L V R + AE ++ +
Sbjct: 3 FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEW 62
Query: 751 LVKLHGCCIEGAERLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEE 810
+V+L+ + V +Y+ + L D A Y +A +
Sbjct: 63 VVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFY-----IAELTCAVESV 117
Query: 811 SRVRIIHRDVKASNVLLDADLVPKISDFGL---------AKLYD---------------- 845
++ IHRD+K N+L+D D K++DFGL +K Y
Sbjct: 118 HKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEW 177
Query: 846 ---------DKKTHISTRVA------------GTIGYLAPEYAMRGHLTEKTDVFAFGVL 884
D+ + R A GT Y+APE +R T+ D ++ GV+
Sbjct: 178 GDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVI 237
Query: 885 ALETVSGRPNSDPSLD----EEKLYLLEWAWHLH 914
E + G+P P L E ++ ++ W LH
Sbjct: 238 LYEMLVGQP---PFLAQTPLETQMKVINWQTSLH 268
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 8e-05
Identities = 44/161 (27%), Positives = 67/161 (41%), Gaps = 29/161 (18%)
Query: 739 EIATISAVQHRNLVKL-HG-------CCIEGAERLLVYEYLENKS---LDQALFGQRSLT 787
EI + + HR ++ L H C + + ++ Y++ L+QA+ QR
Sbjct: 136 EIDILKTISHRAIINLIHAYRWKSTVCMVMPKYKCDLFTYVDRSGPLPLEQAITIQR--- 192
Query: 788 LDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLA-KLYDD 846
+ LAYLH IIHRDVK N+ LD + DFG A KL
Sbjct: 193 -----------RLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDAH 238
Query: 847 KKTHISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALE 887
T +GT+ +PE KTD+++ G++ E
Sbjct: 239 PDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFE 279
|
Length = 392 |
| >gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Score = 45.4 bits (108), Expect = 9e-05
Identities = 53/219 (24%), Positives = 82/219 (37%), Gaps = 29/219 (13%)
Query: 163 LPKELGQLTELLILGIGTNNFSGPLPSELGSLSK---LQELYIDSAGVSGEI-PSSFANL 218
L + L + L L + N L SL + LQEL +++ G+ L
Sbjct: 73 LLQGLTKGCGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGL 132
Query: 219 QS----LTKWWASDTRLTGRIPDFIGN----WSKLTALRFQGNSFNGP-IPSSFSNLTSV 269
+ L K RL G + + L L N I + L +
Sbjct: 133 KDLPPALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKAN 192
Query: 270 TELRISDLSN------GSSKLA-FIRDMKSLSILELRNNNISDSI-----PSNIGEYRSL 317
L + DL+N G+S LA + +KSL +L L +NN++D+ + + SL
Sbjct: 193 CNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTDAGAAALASALLSPNISL 252
Query: 318 QHLDLSFNNLG----GSIPDSLFNLSSLTHLFLGNNKLN 352
L LS N++ + + L SL L L NK
Sbjct: 253 LTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFG 291
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 46.3 bits (109), Expect = 9e-05
Identities = 56/230 (24%), Positives = 100/230 (43%), Gaps = 46/230 (20%)
Query: 700 KLGEGGFGPVYKGKLGDGRAI----AVKQLSVASRQGKSQFVAEIATISAVQHRNLVKLH 755
K+G G FG V+ K + A+ + R+ KSQ V E+ + ++H+N+V+
Sbjct: 20 KIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKERE-KSQLVIEVNVMRELKHKNIVRYI 78
Query: 756 GCCIEGAERLL--VYEYLENKSLDQ------ALFGQRSLTLDWATRYEICSGVARGLAYL 807
+ A + L + E+ + L + +FG+ ++ +I + LAY
Sbjct: 79 DRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGK----IEEHAIVDITRQLLHALAYC 134
Query: 808 HE----ESRVRIIHRDVKASNVLLDADL-----------------VPKISDFGLAKLYDD 846
H + R++HRD+K N+ L + + KI DFGL+K +
Sbjct: 135 HNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSK--NI 192
Query: 847 KKTHISTRVAGTIGYLAPEYAMRGHLT----EKTDVFAFGVLALETVSGR 892
++ GT Y +PE + H T +K+D++A G + E SG+
Sbjct: 193 GIESMAHSCVGTPYYWSPELLL--HETKSYDDKSDMWALGCIIYELCSGK 240
|
Length = 1021 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 44.5 bits (106), Expect = 1e-04
Identities = 45/164 (27%), Positives = 76/164 (46%), Gaps = 19/164 (11%)
Query: 748 HRNLVKLHGCCIEGAERLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYL 807
+ N +KL+ +L+ +Y+++ L L + L+ + I + L L
Sbjct: 68 NPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGKLSEA-EVKK-IIRQLVEALNDL 125
Query: 808 HEESRVRIIHRDVKASNVLLDA--DLVPKISDFGLAKLYDDKKTHISTRVAGTIGYLAPE 865
H + IIH D+K NVL D D + + D+GL K+ + GT+ Y +PE
Sbjct: 126 H---KHNIIHNDIKLENVLYDRAKDRI-YLCDYGLCKIIGTPSCY-----DGTLDYFSPE 176
Query: 866 YAMRGHLTEKT-DVFAFGVLALETVSGR----PNSDPSLDEEKL 904
++GH + + D +A GVL E ++G+ + D LD E L
Sbjct: 177 -KIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESL 219
|
Length = 267 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 2e-04
Identities = 29/97 (29%), Positives = 48/97 (49%), Gaps = 5/97 (5%)
Query: 800 VARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVAGTI 859
+A + +H ++ +HRD+K NVLLD + +++DFG + T S+ GT
Sbjct: 108 IAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTP 167
Query: 860 GYLAPEY--AMR---GHLTEKTDVFAFGVLALETVSG 891
Y++PE AM G + D ++ GV E + G
Sbjct: 168 DYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYG 204
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.6 bits (106), Expect = 2e-04
Identities = 60/234 (25%), Positives = 92/234 (39%), Gaps = 43/234 (18%)
Query: 695 FSPSNKLGEGGFGPVYKGKL-GDGRAIAVKQLS---VASRQGKSQFVAEIATISAVQHRN 750
F LG+G G V+ +L G G+ A+K L + R + + E ++ + H
Sbjct: 3 FKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPF 62
Query: 751 LVKLHGCCIEGAERL-LVYEYLENKSLDQALFGQ--RSLTLDWATRYEICSGVARGLAYL 807
L L+ + L LV +Y L + L Q + L+ + A Y + V L YL
Sbjct: 63 LPTLY-ASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFY--AAEVLLALEYL 119
Query: 808 HEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHIS--------------- 852
H I++RD+K N+LL +SDF L+K D + +S
Sbjct: 120 HLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSI 176
Query: 853 ---TRVA----------GTIGYLAPEY-AMRGHLTEKTDVFAFGVLALETVSGR 892
T GT Y+APE + GH D + G+L E + G
Sbjct: 177 PSETFSEEPSFRSNSFVGTEEYIAPEVISGDGH-GSAVDWWTLGILLYEMLYGT 229
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 44.3 bits (104), Expect = 2e-04
Identities = 58/228 (25%), Positives = 109/228 (47%), Gaps = 43/228 (18%)
Query: 689 KTATENFSPSNKLGEGGFGPVYKGKLGD-GRAIAVKQLSVASRQGKSQFVAEIATISAVQ 747
++ +++ N +G G FG VY+ D +A+K++ + Q K++ E+ + +
Sbjct: 62 RSPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKV-LQDPQYKNR---ELLIMKNLN 117
Query: 748 HRNLVKL----HGCCIEGAERLL------------VYEYLENKSLD-QALFGQRSLTLDW 790
H N++ L + C + E+ + V++Y+++ + + AL L L
Sbjct: 118 HINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHAL----PLFLVK 173
Query: 791 ATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADL-VPKISDFGLAK-LYDDKK 848
Y++C R LAY+H + I HRD+K N+L+D + K+ DFG AK L ++
Sbjct: 174 LYSYQLC----RALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQR 226
Query: 849 --THISTRVAGTIGYLAPEYAMRG-HLTEKTDVFAFGVLALETVSGRP 893
++I +R Y APE + + T D+++ G + E + G P
Sbjct: 227 SVSYICSRF-----YRAPELMLGATNYTTHIDLWSLGCIIAEMILGYP 269
|
Length = 440 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 4e-04
Identities = 31/98 (31%), Positives = 47/98 (47%), Gaps = 10/98 (10%)
Query: 476 GSNNPQYKSSSLSQFTNTLD---SELFQTARLSA---SSLRYYGLGLENGNYTVLLQFAE 529
GS+ + + + +N + L+Q+A +S L Y N NY+V L FAE
Sbjct: 229 GSDQAISTENVIKKASNAPNFYPESLYQSALVSTDTQPDLSYTMDVDPNRNYSVWLHFAE 288
Query: 530 MAILDTNRWESLGRRVFDVYIQGNRVLKDFDIKREAGG 567
+ N + G+RVFDV I G+ KD DI + +G
Sbjct: 289 I----DNSITAEGKRVFDVLINGDTAFKDVDIVKMSGE 322
|
Length = 623 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 4e-04
Identities = 34/108 (31%), Positives = 55/108 (50%), Gaps = 17/108 (15%)
Query: 796 ICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRV 855
I G RGL YLH+ IHR++KAS++L+ D + +S GL+ LY + +V
Sbjct: 106 ILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLS--GLSHLYSLVRNGQKAKV 160
Query: 856 A--------GTIGYLAPEYAMRGHL---TEKTDVFAFGVLALETVSGR 892
+ +L+PE +R L K+D+++ G+ A E +GR
Sbjct: 161 VYDFPQFSTSVLPWLSPEL-LRQDLYGYNVKSDIYSVGITACELATGR 207
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 4e-04
Identities = 57/211 (27%), Positives = 92/211 (43%), Gaps = 19/211 (9%)
Query: 693 ENFSPSNKLGEGGFGPVYKGKLGDG-RAIAVKQLS---VASRQGKSQFVAEIATISAVQH 748
E+F +G G FG V KL + + A+K L+ + R + F E + +
Sbjct: 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDN 60
Query: 749 RNLVKLHGCCIEGAERLLVYEYLENKSLDQAL--FGQRSLTLDWATRYEICSGVARGLAY 806
+ + LH + LV +Y L L F R L D A Y +A +
Sbjct: 61 QWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDR-LPEDMARFY-----LAEMVIA 114
Query: 807 LHEESRVRIIHRDVKASNVLLDADLVPKISDFG-LAKLYDDKKTHISTRVAGTIGYLAPE 865
+ ++ +HRD+K N+L+D + +++DFG KL +D S V GT Y++PE
Sbjct: 115 IDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAV-GTPDYISPE 173
Query: 866 Y--AM---RGHLTEKTDVFAFGVLALETVSG 891
AM +G + D ++ GV E + G
Sbjct: 174 ILQAMEDGKGKYGPECDWWSLGVCMYEMLYG 204
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 4e-04
Identities = 58/214 (27%), Positives = 90/214 (42%), Gaps = 16/214 (7%)
Query: 687 ELKTATENFSPSNKLGEGGFGPVYKGKLGDGRAI-AVKQLSVAS--RQGKSQFVAEIATI 743
+L+ E++ +G G FG V + R + A+K LS ++ S F E I
Sbjct: 37 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDI 96
Query: 744 SAVQHRN-LVKLHGCCIEGAERLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVAR 802
A + +V+L + +V EY+ L L + WA Y + V
Sbjct: 97 MAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVN-LMSNYDVPEKWARFYT--AEVVL 153
Query: 803 GLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLA-KLYDDKKTHISTRVAGTIGY 861
L +H + IHRDVK N+LLD K++DFG K+ + T V GT Y
Sbjct: 154 ALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GTPDY 209
Query: 862 LAPEYAMR----GHLTEKTDVFAFGVLALETVSG 891
++PE G+ + D ++ GV E + G
Sbjct: 210 ISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Score = 43.1 bits (102), Expect = 6e-04
Identities = 40/199 (20%), Positives = 66/199 (33%), Gaps = 51/199 (25%)
Query: 226 ASDTRLTGRIPDFIGNWSKLTALRFQGNSFNGPIPSSFSNLTSVTELRISDLSN---GSS 282
R + + L L N+ +L + L+ L+N G
Sbjct: 64 GRIPRGLQSLLQGLTKGCGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDR 123
Query: 283 KLAFI-----------------------RDMKSLS----------ILELRNNNISDS-IP 308
L + ++L+ L L NN I D+ I
Sbjct: 124 GLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIR 183
Query: 309 S---NIGEYRSLQHLDL---SFNNLGGS-IPDSLFNLSSLTHLFLGNNKLNGT-----LP 356
+ + +L+ LDL + G S + ++L +L SL L LG+N L
Sbjct: 184 ALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTDAGAAALAS 243
Query: 357 ARKSPL--LLNIDVSYNNL 373
A SP LL + +S N++
Sbjct: 244 ALLSPNISLLTLSLSCNDI 262
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319 |
| >gnl|CDD|226168 COG3642, COG3642, Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Score = 40.0 bits (94), Expect = 0.003
Identities = 25/88 (28%), Positives = 41/88 (46%), Gaps = 13/88 (14%)
Query: 759 IEGAERLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHR 818
++ L+V EY+E + L AL R ++ V R + LH+ I+H
Sbjct: 69 VDPDNGLIVMEYIEGELLKDAL---------EEARPDLLREVGRLVGKLHKAG---IVHG 116
Query: 819 DVKASNVLLDADLVPKISDFGLAKLYDD 846
D+ SN++L + I DFGL + D+
Sbjct: 117 DLTTSNIILSGGRIYFI-DFGLGEFSDE 143
|
Length = 204 |
| >gnl|CDD|236586 PRK09605, PRK09605, bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Score = 40.6 bits (96), Expect = 0.004
Identities = 25/81 (30%), Positives = 35/81 (43%), Gaps = 14/81 (17%)
Query: 766 LVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNV 825
+V EY+ K L L G E+ V +A LH+ I+H D+ SN
Sbjct: 413 IVMEYIGGKDLKDVLEG----------NPELVRKVGEIVAKLHKA---GIVHGDLTTSNF 459
Query: 826 LLDADLVPKISDFGLAKLYDD 846
++ D + I DFGL K D
Sbjct: 460 IVRDDRLYLI-DFGLGKYSDL 479
|
Length = 535 |
| >gnl|CDD|205079 pfam12799, LRR_4, Leucine Rich repeats (2 copies) | Back alignment and domain information |
|---|
Score = 35.5 bits (83), Expect = 0.004
Identities = 15/36 (41%), Positives = 21/36 (58%), Gaps = 2/36 (5%)
Query: 316 SLQHLDLSFNNLGGSIPDSLFNLSSLTHLFLGNNKL 351
+L+ LDLS N + +P L NL +L L L NK+
Sbjct: 2 NLETLDLSNNQIT-DLP-PLSNLPNLETLDLSGNKI 35
|
Leucine rich repeats are short sequence motifs present in a number of proteins with diverse functions and cellular locations. These repeats are usually involved in protein-protein interactions. Each Leucine Rich Repeat is composed of a beta-alpha unit. These units form elongated non-globular structures. Leucine Rich Repeats are often flanked by cysteine rich domains. Length = 43 |
| >gnl|CDD|165523 PHA03265, PHA03265, envelope glycoprotein D; Provisional | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.004
Identities = 18/46 (39%), Positives = 25/46 (54%), Gaps = 2/46 (4%)
Query: 621 PTVRPPKEKDNNRTGLIVGIVVGVGVATFLSVLAIFCIVRRRKRPQ 666
PT +PP +N T VGI VG+G+A + V I + RRK+
Sbjct: 335 PTTKPPPTSKSNST--FVGISVGLGIAGLVLVGVILYVCLRRKKEL 378
|
Length = 402 |
Conserved Domains Detected by HHsearch 
Original result of HHsearch against CDD database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 1036 | |||
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.98 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 99.98 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.98 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.98 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 99.98 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.98 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.98 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.98 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.98 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 99.98 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.98 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.98 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.98 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.98 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.98 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.98 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.98 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.98 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.98 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.98 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.97 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 99.97 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.97 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.97 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.97 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.97 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.97 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.97 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.97 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.97 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.97 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.97 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 99.97 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.97 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.97 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.97 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.97 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.97 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.97 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.97 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.97 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.96 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.96 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.96 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.96 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.96 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.96 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.96 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.96 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 99.96 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.96 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 99.96 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.95 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.95 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.95 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.94 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.94 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 99.94 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.94 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.94 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 99.94 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.93 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.93 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.93 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.92 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.92 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.92 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.9 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.9 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.89 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.89 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.89 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.88 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.87 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 99.87 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 99.87 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.86 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.85 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.85 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.84 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.83 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 99.82 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.82 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.82 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.81 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.81 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.8 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.8 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.79 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.79 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.77 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 99.77 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.76 | |
| PF11721 | 174 | Malectin: Di-glucose binding within endoplasmic re | 99.75 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.75 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.75 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.74 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.72 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.72 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.72 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.71 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.7 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.7 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.68 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.67 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.67 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.66 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.66 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.66 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.65 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.6 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.56 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.56 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.55 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.54 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.5 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.41 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.39 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.37 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.33 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.31 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.3 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.24 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.23 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.18 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 99.18 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 99.16 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.16 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.1 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 99.08 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 99.08 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 99.08 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.07 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.07 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 99.06 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.04 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.02 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.0 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.0 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 98.99 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 98.94 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 98.93 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.91 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.84 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 98.81 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.77 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.74 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.73 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 98.7 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.57 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.55 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.54 | |
| KOG2982 | 418 | consensus Uncharacterized conserved protein [Funct | 98.46 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.46 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.43 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.41 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.4 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.39 | |
| COG5238 | 388 | RNA1 Ran GTPase-activating protein (RanGAP) involv | 98.38 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.37 |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-75 Score=756.06 Aligned_cols=853 Identities=24% Similarity=0.394 Sum_probs=538.1
Q ss_pred CHHHHHHHHHHHHhcccCc-CCCCCCCCCCCCCCCCCCCccccCCCCCCCceeeccCCCCCceeeEeEEEEeeccccccC
Q 001658 37 DPNEVRALNSIFQQWRISA-RQGQWNRSGDPCTGAALDDSIVFDNTDYNPFIKCDCSSQNGTVCHITQLKVYALNVVGVI 115 (1036)
Q Consensus 37 ~~~~~~aL~~~~~~~~~~~-~~~~W~~~~d~C~~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~~~l~~L~l~~~~~~~~i 115 (1036)
+|.|..||+++|+++.++. .+.+|+...|+|. |.|+.|+.. .+++.|++.++++.+.+
T Consensus 27 ~~~~~~~l~~~~~~~~~~~~~~~~w~~~~~~c~-----------------w~gv~c~~~----~~v~~L~L~~~~i~~~~ 85 (968)
T PLN00113 27 HAEELELLLSFKSSINDPLKYLSNWNSSADVCL-----------------WQGITCNNS----SRVVSIDLSGKNISGKI 85 (968)
T ss_pred CHHHHHHHHHHHHhCCCCcccCCCCCCCCCCCc-----------------CcceecCCC----CcEEEEEecCCCccccC
Confidence 6789999999999997553 5678988788887 899999752 37899999999999999
Q ss_pred CccccCCCCCCEEEccCCCCCCCCccccc-CCCcCCeeecccccccCCccccccCCCCCcEEEcccCCCCCCCccccCCC
Q 001658 116 PDELWNLTSLFNLNLGQNYLTGPLSPSVG-NLTAMQYLNLAINALSGELPKELGQLTELLILGIGTNNFSGPLPSELGSL 194 (1036)
Q Consensus 116 p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~-~l~~L~~L~Ls~N~l~~~~p~~l~~L~~L~~L~Ls~N~l~~~~p~~l~~l 194 (1036)
|..|..+++|+.|+|++|++++.+|..+. ++++|++|+|++|++++.+|. +.+++|++|+|++|.+++.+|..++++
T Consensus 86 ~~~~~~l~~L~~L~Ls~n~~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~--~~l~~L~~L~Ls~n~~~~~~p~~~~~l 163 (968)
T PLN00113 86 SSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPR--GSIPNLETLDLSNNMLSGEIPNDIGSF 163 (968)
T ss_pred ChHHhCCCCCCEEECCCCccCCcCChHHhccCCCCCEEECcCCccccccCc--cccCCCCEEECcCCcccccCChHHhcC
Confidence 99999999999999999999988887755 899999999999999888775 467889999999999988888889999
Q ss_pred ccCCEEeCccccCCCCCCccccCCCCCcEEeccCCcCCCCChhhhcCCCCCCEEEeeCCcCCCCCCccccCCCCCCEEEc
Q 001658 195 SKLQELYIDSAGVSGEIPSSFANLQSLTKWWASDTRLTGRIPDFIGNWSKLTALRFQGNSFNGPIPSSFSNLTSVTELRI 274 (1036)
Q Consensus 195 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 274 (1036)
++|++|+|++|.+.+.+|..++++++|++|+|++|++.+.+|..++++++|++|+|++|.+.+.+|..++++++|++|+|
T Consensus 164 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L 243 (968)
T PLN00113 164 SSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDL 243 (968)
T ss_pred CCCCEEECccCcccccCChhhhhCcCCCeeeccCCCCcCcCChHHcCcCCccEEECcCCccCCcCChhHhcCCCCCEEEC
Confidence 99999999999988888888888999999999999988888888888999999999999988888888888999999999
Q ss_pred cCCCCCCCchhhhcCCCCCCEEEccCCccCccccccccCCCCccEEeCCCCCCCCCCchhccCCCCccEEEccCcccccc
Q 001658 275 SDLSNGSSKLAFIRDMKSLSILELRNNNISDSIPSNIGEYRSLQHLDLSFNNLGGSIPDSLFNLSSLTHLFLGNNKLNGT 354 (1036)
Q Consensus 275 ~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~ 354 (1036)
++|.+....+..+..+++|+.|+|++|.+.+.+|..+..+++|++|+|++|++.+.+|..+.++++|+.|+|++|.+++.
T Consensus 244 ~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~ 323 (968)
T PLN00113 244 VYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGK 323 (968)
T ss_pred cCceeccccChhHhCCCCCCEEECcCCeeeccCchhHhhccCcCEEECcCCeeccCCChhHcCCCCCcEEECCCCccCCc
Confidence 98888877777888888899999999888888888888888889999998888888888888888888888888888888
Q ss_pred CCCCc--CCCccEEEeeCccCCCCCchhhhccCCcceeeecCCccccCCCCCccCcccccccccCccC-CCCcccccce-
Q 001658 355 LPARK--SPLLLNIDVSYNNLQGNLPSWINGQQNLQINLVANNLTIRSSDNSVLPRGLICLQRNFPCN-RGYAIYADFA- 430 (1036)
Q Consensus 355 ~p~~~--~~~L~~Ldls~N~l~g~~p~~l~~l~~L~~~~~~nn~~~~~~~~~~~p~~l~~~~~~~~c~-~~~~~~~~~~- 430 (1036)
+|..+ .+.|+.|++++|.+++.+|..+..+++|+.+.+++|-... .+|..+.-...+..-. ..+......+
T Consensus 324 ~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~~~~L~~L~Ls~n~l~~-----~~p~~~~~~~~L~~L~l~~n~l~~~~p~ 398 (968)
T PLN00113 324 IPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTG-----EIPEGLCSSGNLFKLILFSNSLEGEIPK 398 (968)
T ss_pred CChhHhcCCCCCEEECcCCCCcCcCChHHhCCCCCcEEECCCCeeEe-----eCChhHhCcCCCCEEECcCCEecccCCH
Confidence 87654 3568888888888888888888888888888777663211 1121110000000000 0000000000
Q ss_pred --eccCCCceeecCCeEEe------------------cCCCCcccceeeecCCCceeeeccccccCCCCc------cc--
Q 001658 431 --IKSGGPQIRSSNGVVYE------------------RDNATLGPATYYVTDSNKWGVSNVGLFTGSNNP------QY-- 482 (1036)
Q Consensus 431 --~~~~~~~~~~~~~~~~~------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~-- 482 (1036)
..|...+.-...++... .++...|.. +...|...+--...-+.|. ..
T Consensus 399 ~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~-----~~~~~~l~~L~~L~L~~n~~~~~~p~~~~ 473 (968)
T PLN00113 399 SLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRI-----NSRKWDMPSLQMLSLARNKFFGGLPDSFG 473 (968)
T ss_pred HHhCCCCCCEEECcCCEeeeECChhHhcCCCCCEEECcCCcccCcc-----ChhhccCCCCcEEECcCceeeeecCcccc
Confidence 00000000000000000 000000000 0000100000000000000 00
Q ss_pred ------ccccccccccccchhhhhhhccCcccceeecccccCcceEeeehhhHHhhccccccccccceeeEEeecccee-
Q 001658 483 ------KSSSLSQFTNTLDSELFQTARLSASSLRYYGLGLENGNYTVLLQFAEMAILDTNRWESLGRRVFDVYIQGNRV- 555 (1036)
Q Consensus 483 ------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 555 (1036)
-.-+...+.......+.+-..+.-+.|.+ |-..|.+ . ..++.+. .+-.+.+.+...
T Consensus 474 ~~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~---N~l~~~~------p-------~~~~~l~-~L~~L~Ls~N~l~ 536 (968)
T PLN00113 474 SKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSE---NKLSGEI------P-------DELSSCK-KLVSLDLSHNQLS 536 (968)
T ss_pred cccceEEECcCCccCCccChhhhhhhccCEEECcC---CcceeeC------C-------hHHcCcc-CCCEEECCCCccc
Confidence 00000000000000111101111111100 0000000 0 0000000 000111111100
Q ss_pred ------------eecccee--eccCCCCcee--eeeeeeeEeecCeeEEEEEEccCCcccCCCCCCCCCcc-cccc----
Q 001658 556 ------------LKDFDIK--REAGGVSKRA--IQREIKTRVSENYLEIHLFWAGKGTCCVPAQGTYGPSI-SAIR---- 614 (1036)
Q Consensus 556 ------------~~~~~~~--~~~~~~~~~~--~~~~~~~~v~~~~~~i~~~w~g~g~~~~p~~~~~gp~~-s~i~---- 614 (1036)
.+..++. +-.+...... ...-....+.+|.+ .+++|..+.+.... ..+.
T Consensus 537 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l----------~~~~p~~~~~~~~~~~~~~~n~~ 606 (968)
T PLN00113 537 GQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHL----------HGSLPSTGAFLAINASAVAGNID 606 (968)
T ss_pred ccCChhHhCcccCCEEECCCCcccccCChhHhcCcccCEEeccCCcc----------eeeCCCcchhcccChhhhcCCcc
Confidence 0000000 0000000000 00000112222222 12233222111100 0000
Q ss_pred -cCCCCCCCCCCCCCC-CCCccceeehhhHHHHHHHHHHHHHHHhhhhhccCCCCC--CchhhccCC----CCCCccCHH
Q 001658 615 -VTPDFTPTVRPPKEK-DNNRTGLIVGIVVGVGVATFLSVLAIFCIVRRRKRPQHD--DDEELLGMD----ARPYTFSYA 686 (1036)
Q Consensus 615 -~~p~~~~~~~~~~~~-~~~~~~~i~~i~~~~~~~~~~~~~~~~~~~~rr~~~~~~--~~~~~~~~~----~~~~~~~~~ 686 (1036)
+.+......++.... ......+++++++++++++++++++++++++|++..... ......... .....++++
T Consensus 607 lc~~~~~~~~~~c~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 686 (968)
T PLN00113 607 LCGGDTTSGLPPCKRVRKTPSWWFYITCTLGAFLVLALVAFGFVFIRGRNNLELKRVENEDGTWELQFFDSKVSKSITIN 686 (968)
T ss_pred ccCCccccCCCCCccccccceeeeehhHHHHHHHHHHHHHHHHHHHHhhhcccccccccccccccccccccccchhhhHH
Confidence 000000000000001 111222333333333332222222222222222111111 000000000 001123333
Q ss_pred HHHHHhcCCCCCCccccCCCEEEEEeEe-CCCcEEEEEEccccchhcHHHHHHHHHHHHhhccCCcceeEeEEEcCceeE
Q 001658 687 ELKTATENFSPSNKLGEGGFGPVYKGKL-GDGRAIAVKQLSVASRQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERL 765 (1036)
Q Consensus 687 ~l~~~~~~~~~~~~iG~G~fG~Vy~~~~-~~g~~vAvK~~~~~~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~ 765 (1036)
+ ....|+..+.||+|+||.||+|+. .+++.||||++...... ...|++++++++|||||+++|+|.+.+..+
T Consensus 687 ~---~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~ 759 (968)
T PLN00113 687 D---ILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEKGAY 759 (968)
T ss_pred H---HHhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCCCCE
Confidence 3 345677888999999999999986 57899999998643322 235688999999999999999999999999
Q ss_pred EEEEecCCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeec
Q 001658 766 LVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYD 845 (1036)
Q Consensus 766 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~ 845 (1036)
+||||+++|+|.++++ .++|.++.+|+.|+|+||+|||..+.++|+||||||+||+++.++.+++. ||......
T Consensus 760 lv~Ey~~~g~L~~~l~-----~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~ 833 (968)
T PLN00113 760 LIHEYIEGKNLSEVLR-----NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLC 833 (968)
T ss_pred EEEeCCCCCcHHHHHh-----cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccc
Confidence 9999999999999994 37999999999999999999997766679999999999999999988875 66654432
Q ss_pred CCCCccccccccccCccCccccccCCCCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhcCccccccCc
Q 001658 846 DKKTHISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEIELADP 925 (1036)
Q Consensus 846 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 925 (1036)
.. ....||+.|||||++.+..++.|+|||||||++|||+||+.||+.... ......+|+.............||
T Consensus 834 ~~-----~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 907 (968)
T PLN00113 834 TD-----TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFG-VHGSIVEWARYCYSDCHLDMWIDP 907 (968)
T ss_pred cC-----CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccC-CCCcHHHHHHHhcCccchhheeCc
Confidence 21 123588999999999999999999999999999999999999965432 233456676655544444445565
Q ss_pred ccc---cCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcccC
Q 001658 926 KLI---EFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVAMLCGDME 968 (1036)
Q Consensus 926 ~~~---~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 968 (1036)
.+. ....++..++.+++.+||+.+|++||||.||+++|++...
T Consensus 908 ~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~ 953 (968)
T PLN00113 908 SIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR 953 (968)
T ss_pred cccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhc
Confidence 542 3346777889999999999999999999999999987654
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-54 Score=485.35 Aligned_cols=289 Identities=53% Similarity=0.845 Sum_probs=255.9
Q ss_pred CCCccCHHHHHHHhcCCCCCCccccCCCEEEEEeEeCCCcEEEEEEccccchhcHHHHHHHHHHHHhhccCCcceeEeEE
Q 001658 679 RPYTFSYAELKTATENFSPSNKLGEGGFGPVYKGKLGDGRAIAVKQLSVASRQGKSQFVAEIATISAVQHRNLVKLHGCC 758 (1036)
Q Consensus 679 ~~~~~~~~~l~~~~~~~~~~~~iG~G~fG~Vy~~~~~~g~~vAvK~~~~~~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~ 758 (1036)
....|+++++..||++|...+.||+|+||.||+|.+.+|+.||||++.....+...+|..|+.++.+++|||+|+++|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 45679999999999999999999999999999999999999999988755433145699999999999999999999999
Q ss_pred EcCc-eeEEEEEecCCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEE
Q 001658 759 IEGA-ERLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISD 837 (1036)
Q Consensus 759 ~~~~-~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~D 837 (1036)
.+.+ +.+||||||++|+|+++|+......++|.+|++||.++|+||+|||+.++++||||||||+|||||+++++||+|
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsD 220 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSD 220 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccC
Confidence 9998 599999999999999999886544889999999999999999999999998999999999999999999999999
Q ss_pred cCcceeecCCCCccccccccccCccCccccccCCCCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhcC
Q 001658 838 FGLAKLYDDKKTHISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENN 917 (1036)
Q Consensus 838 FGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~ 917 (1036)
||+|+..........+...||.+|+|||++..+..+.|+|||||||+|+|++||+.+.+.........+++|++..+..+
T Consensus 221 FGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~ 300 (361)
T KOG1187|consen 221 FGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEG 300 (361)
T ss_pred ccCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCc
Confidence 99997654312222221179999999999999999999999999999999999999998765555556899999999999
Q ss_pred ccccccCcccc--cCCH-HHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhccc
Q 001658 918 QEIELADPKLI--EFNE-EEVKRLIGVALLCTQTLPSLRPSMSRVVAMLCGDM 967 (1036)
Q Consensus 918 ~~~~~~d~~~~--~~~~-~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~ 967 (1036)
...+++||++. .+.. +++.++..++++|++.+|.+||+|.||+++|+...
T Consensus 301 ~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~ 353 (361)
T KOG1187|consen 301 KLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGIL 353 (361)
T ss_pred chhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhc
Confidence 99999999984 4443 78999999999999999999999999999996443
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-45 Score=410.59 Aligned_cols=257 Identities=33% Similarity=0.455 Sum_probs=212.5
Q ss_pred CCCccccCCCEEEEEeEeCCCcEEEEEEccccchhc--HHHHHHHHHHHHhhccCCcceeEeEEEcCc-eeEEEEEecCC
Q 001658 697 PSNKLGEGGFGPVYKGKLGDGRAIAVKQLSVASRQG--KSQFVAEIATISAVQHRNLVKLHGCCIEGA-ERLLVYEYLEN 773 (1036)
Q Consensus 697 ~~~~iG~G~fG~Vy~~~~~~g~~vAvK~~~~~~~~~--~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~-~~~lV~E~~~~ 773 (1036)
..+.||+|+||+||+|.+.....||||++....... .++|.+|+.+|.+++|||||+++|+|.+.. ..++|||||++
T Consensus 45 ~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~ 124 (362)
T KOG0192|consen 45 IEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPG 124 (362)
T ss_pred hhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCC
Confidence 345699999999999999655559999997643222 568999999999999999999999999887 79999999999
Q ss_pred CChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCC-ceEEEEcCcceeecCCCCccc
Q 001658 774 KSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADL-VPKISDFGLAKLYDDKKTHIS 852 (1036)
Q Consensus 774 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~-~~kl~DFGla~~~~~~~~~~~ 852 (1036)
|+|.++++......+++..+++||.|||+||.|||++++ ||||||||+|||++.++ ++||+|||+++...... ...
T Consensus 125 GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~-~~~ 201 (362)
T KOG0192|consen 125 GSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK-TSM 201 (362)
T ss_pred CcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCCccceeecccc-ccc
Confidence 999999988667889999999999999999999999874 99999999999999997 99999999998765432 223
Q ss_pred cccccccCccCccccc--cCCCCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhcCccccccCcccccC
Q 001658 853 TRVAGTIGYLAPEYAM--RGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEIELADPKLIEF 930 (1036)
Q Consensus 853 ~~~~gt~~y~APE~~~--~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~ 930 (1036)
+...||+.|||||++. ...|+.|+|||||||++|||+||+.||...........+ .. ....|.+
T Consensus 202 ~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v------~~-----~~~Rp~~--- 267 (362)
T KOG0192|consen 202 TSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAV------VV-----GGLRPPI--- 267 (362)
T ss_pred cCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHH------Hh-----cCCCCCC---
Confidence 3467999999999999 669999999999999999999999999876552222111 11 1112222
Q ss_pred CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcccCCC
Q 001658 931 NEEEVKRLIGVALLCTQTLPSLRPSMSRVVAMLCGDMEVS 970 (1036)
Q Consensus 931 ~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~ 970 (1036)
+......+..++..||+.||..||++.|++..|+..+...
T Consensus 268 p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~ 307 (362)
T KOG0192|consen 268 PKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHI 307 (362)
T ss_pred CccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhh
Confidence 2225567778888899999999999999999999776533
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-44 Score=381.00 Aligned_cols=247 Identities=29% Similarity=0.411 Sum_probs=205.6
Q ss_pred CCCccccCCCEEEEEeEeC-CCcEEEEEEcccc-chhcHHHHHHHHHHHHhhccCCcceeEeEEEcCc-eeEEEEEecCC
Q 001658 697 PSNKLGEGGFGPVYKGKLG-DGRAIAVKQLSVA-SRQGKSQFVAEIATISAVQHRNLVKLHGCCIEGA-ERLLVYEYLEN 773 (1036)
Q Consensus 697 ~~~~iG~G~fG~Vy~~~~~-~g~~vAvK~~~~~-~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~-~~~lV~E~~~~ 773 (1036)
..+.||+|..|+|||++++ +++.+|+|.+... +....+++.+|++++++.+||+||++||+|.... +..++||||++
T Consensus 83 ~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYMDg 162 (364)
T KOG0581|consen 83 RLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYMDG 162 (364)
T ss_pred hhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhcCC
Confidence 4588999999999999975 6889999999543 4445788999999999999999999999999988 59999999999
Q ss_pred CChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeecCCCCcccc
Q 001658 774 KSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHIST 853 (1036)
Q Consensus 774 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 853 (1036)
|||++++... ..+++...-+|+.++++||.|||+.. +||||||||+|||++..|++||||||.++.+.+. ...
T Consensus 163 GSLd~~~k~~--g~i~E~~L~~ia~~VL~GL~YLh~~~--~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS---~a~ 235 (364)
T KOG0581|consen 163 GSLDDILKRV--GRIPEPVLGKIARAVLRGLSYLHEER--KIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS---IAN 235 (364)
T ss_pred CCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhhcc--CeeeccCCHHHeeeccCCCEEeccccccHHhhhh---hcc
Confidence 9999998654 45888999999999999999999732 4999999999999999999999999999987654 345
Q ss_pred ccccccCccCccccccCCCCchhhHHhHHHHHHHHHhCCCCCCCCC--hhhHHHHHHHHHHHhhcCccccccCcccccCC
Q 001658 854 RVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRPNSDPSL--DEEKLYLLEWAWHLHENNQEIELADPKLIEFN 931 (1036)
Q Consensus 854 ~~~gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~--~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~ 931 (1036)
.++||..|||||.+.+..|+.++||||||+.++|+.+|+.|+.+.. ..+...+..++ ..-.-|++...
T Consensus 236 tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~I---------v~~ppP~lP~~- 305 (364)
T KOG0581|consen 236 TFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAI---------VDEPPPRLPEG- 305 (364)
T ss_pred cccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHH---------hcCCCCCCCcc-
Confidence 6789999999999999999999999999999999999999998752 12333333322 11112333221
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 001658 932 EEEVKRLIGVALLCTQTLPSLRPSMSRVVA 961 (1036)
Q Consensus 932 ~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 961 (1036)
....++..++..|+++||.+||++.|+++
T Consensus 306 -~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~ 334 (364)
T KOG0581|consen 306 -EFSPEFRSFVSCCLRKDPSERPSAKQLLQ 334 (364)
T ss_pred -cCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 34556777778999999999999999976
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-44 Score=396.26 Aligned_cols=253 Identities=33% Similarity=0.463 Sum_probs=214.7
Q ss_pred CCCccccCCCEEEEEeEeCCCcEEEEEEccccchhcHHHHHHHHHHHHhhccCCcceeEeEEEcCceeEEEEEecCCCCh
Q 001658 697 PSNKLGEGGFGPVYKGKLGDGRAIAVKQLSVASRQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLVYEYLENKSL 776 (1036)
Q Consensus 697 ~~~~iG~G~fG~Vy~~~~~~g~~vAvK~~~~~~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL 776 (1036)
..+.||+|-||.||.|.++....||+|.++... ...+.|.+|+++|++++|+|||+++|+|..++..+||||||+.|+|
T Consensus 210 l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~-m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~GsL 288 (468)
T KOG0197|consen 210 LIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGS-MSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKGSL 288 (468)
T ss_pred HHHHhcCCccceEEEEEEcCCCcccceEEeccc-cChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccCcH
Confidence 457899999999999999877799999998653 3467899999999999999999999999998899999999999999
Q ss_pred hhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeecCCCCccccccc
Q 001658 777 DQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVA 856 (1036)
Q Consensus 777 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 856 (1036)
.++|.......+...+.+.++.|||+||+||++++ +|||||.++||||+++..+||+|||+|+...++.........
T Consensus 289 l~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~~~~~k 365 (468)
T KOG0197|consen 289 LDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTASEGGK 365 (468)
T ss_pred HHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEcccccccccCCCceeecCCCC
Confidence 99998766778999999999999999999999998 999999999999999999999999999966655554545555
Q ss_pred cccCccCccccccCCCCchhhHHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHHHHHhhcCccccccCcccccCCHHHH
Q 001658 857 GTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVS-GRPNSDPSLDEEKLYLLEWAWHLHENNQEIELADPKLIEFNEEEV 935 (1036)
Q Consensus 857 gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 935 (1036)
-++.|.|||.+..++++.|||||||||+||||+| |+.|+......+....++ .+. .+ ..+..++
T Consensus 366 fPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le-------~Gy--Rl------p~P~~CP 430 (468)
T KOG0197|consen 366 FPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLE-------RGY--RL------PRPEGCP 430 (468)
T ss_pred CCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHh-------ccC--cC------CCCCCCC
Confidence 6779999999999999999999999999999999 666666555544443332 111 11 1233455
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHHHhhcccC
Q 001658 936 KRLIGVALLCTQTLPSLRPSMSRVVAMLCGDME 968 (1036)
Q Consensus 936 ~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 968 (1036)
..+.++|..||+.+|++|||++.+...|+....
T Consensus 431 ~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~ 463 (468)
T KOG0197|consen 431 DEVYELMKSCWHEDPEDRPTFETLREVLEDFFT 463 (468)
T ss_pred HHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhh
Confidence 678889999999999999999999988876543
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=371.94 Aligned_cols=206 Identities=30% Similarity=0.521 Sum_probs=183.8
Q ss_pred hcCCCCCCccccCCCEEEEEeEeC-CCcEEEEEEcccc--chhcHHHHHHHHHHHHhhccCCcceeEeEEEcCceeEEEE
Q 001658 692 TENFSPSNKLGEGGFGPVYKGKLG-DGRAIAVKQLSVA--SRQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLVY 768 (1036)
Q Consensus 692 ~~~~~~~~~iG~G~fG~Vy~~~~~-~g~~vAvK~~~~~--~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~ 768 (1036)
..+|...+.||+|+||+||+|+++ ++..||||.+... .....+....|+++|+.++|||||++++++..++..+|||
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM 88 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM 88 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence 457888888999999999999965 6799999999765 5556677899999999999999999999999999999999
Q ss_pred EecCCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCC------CceEEEEcCcce
Q 001658 769 EYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDAD------LVPKISDFGLAK 842 (1036)
Q Consensus 769 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~------~~~kl~DFGla~ 842 (1036)
|||.+|+|.+|++..+ .+++.+...++.|+|.||++||+++ ||||||||+||||+.. -.+||+|||+|+
T Consensus 89 EyC~gGDLs~yi~~~~--~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR 163 (429)
T KOG0595|consen 89 EYCNGGDLSDYIRRRG--RLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKIADFGFAR 163 (429)
T ss_pred EeCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEecccchhh
Confidence 9999999999997653 6889999999999999999999998 9999999999999765 468999999999
Q ss_pred eecCCCCccccccccccCccCccccccCCCCchhhHHhHHHHHHHHHhCCCCCCCCChhhHH
Q 001658 843 LYDDKKTHISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKL 904 (1036)
Q Consensus 843 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~ 904 (1036)
.+.+. ......+|++-|||||+++..+|+.|+|+||+|+|+|||++|++||+.....+-.
T Consensus 164 ~L~~~--~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~ 223 (429)
T KOG0595|consen 164 FLQPG--SMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELL 223 (429)
T ss_pred hCCch--hHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHH
Confidence 88643 3345678999999999999999999999999999999999999999976665433
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=404.30 Aligned_cols=261 Identities=28% Similarity=0.448 Sum_probs=220.1
Q ss_pred hcCCCCCCccccCCCEEEEEeEeC------CCcEEEEEEccccchh-cHHHHHHHHHHHHhhccCCcceeEeEEEcCcee
Q 001658 692 TENFSPSNKLGEGGFGPVYKGKLG------DGRAIAVKQLSVASRQ-GKSQFVAEIATISAVQHRNLVKLHGCCIEGAER 764 (1036)
Q Consensus 692 ~~~~~~~~~iG~G~fG~Vy~~~~~------~g~~vAvK~~~~~~~~-~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~ 764 (1036)
..+....+.||+|+||+||+|+.. +...||||.++..... .+.+|++|++++..++|||||+|+|+|.+++..
T Consensus 485 r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~ 564 (774)
T KOG1026|consen 485 RSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPL 564 (774)
T ss_pred hhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCee
Confidence 445566789999999999999843 3468999999876544 788999999999999999999999999999999
Q ss_pred EEEEEecCCCChhhhhhcCC------------CCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCc
Q 001658 765 LLVYEYLENKSLDQALFGQR------------SLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLV 832 (1036)
Q Consensus 765 ~lV~E~~~~gsL~~~l~~~~------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~ 832 (1036)
++|+|||..|+|.++|.... ..+++..+.+.||.|||.||.||-++. +|||||..+|+||.++..
T Consensus 565 ~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLVge~l~ 641 (774)
T KOG1026|consen 565 CMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLVGENLV 641 (774)
T ss_pred EEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhceeccceE
Confidence 99999999999999996432 233888999999999999999999887 999999999999999999
Q ss_pred eEEEEcCcceeecCCCCcccc-ccccccCccCccccccCCCCchhhHHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHH
Q 001658 833 PKISDFGLAKLYDDKKTHIST-RVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVS-GRPNSDPSLDEEKLYLLEWA 910 (1036)
Q Consensus 833 ~kl~DFGla~~~~~~~~~~~~-~~~gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~ 910 (1036)
|||+|||+++..-..+.+... .-.=+++|||||.+..++|+.+||||||||+|||+++ |+.|++...+++....+.
T Consensus 642 VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~-- 719 (774)
T KOG1026|consen 642 VKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIR-- 719 (774)
T ss_pred EEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHHHHH--
Confidence 999999999866544443322 3334679999999999999999999999999999999 788888777666554432
Q ss_pred HHHhhcCccccccCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcccCCC
Q 001658 911 WHLHENNQEIELADPKLIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVAMLCGDMEVS 970 (1036)
Q Consensus 911 ~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~ 970 (1036)
.+ .+...++..+.++..||+.||+..|.+||+++||-..|+......
T Consensus 720 -----~g--------~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s 766 (774)
T KOG1026|consen 720 -----AG--------QLLSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQAS 766 (774)
T ss_pred -----cC--------CcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcC
Confidence 22 223345567788999999999999999999999999999876644
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=387.66 Aligned_cols=247 Identities=25% Similarity=0.389 Sum_probs=211.4
Q ss_pred cCCCCCCccccCCCEEEEEeEe-CCCcEEEEEEcccc---chhcHHHHHHHHHHHHhhccCCcceeEeEEEcCceeEEEE
Q 001658 693 ENFSPSNKLGEGGFGPVYKGKL-GDGRAIAVKQLSVA---SRQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLVY 768 (1036)
Q Consensus 693 ~~~~~~~~iG~G~fG~Vy~~~~-~~g~~vAvK~~~~~---~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~ 768 (1036)
.+|...+.||+|||+.||+++. ..|+.||+|++.+. .....+...+||++.++++|||||+++++|.+.+..|+|.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 5688899999999999999996 88999999999753 3445677889999999999999999999999999999999
Q ss_pred EecCCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeecCCC
Q 001658 769 EYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKK 848 (1036)
Q Consensus 769 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~ 848 (1036)
|+|++++|.+++. ++.++++..++.++.||+.||.|||+.+ |+|||||..|++|++++++||+|||||..+..+.
T Consensus 98 ELC~~~sL~el~K--rrk~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~ 172 (592)
T KOG0575|consen 98 ELCHRGSLMELLK--RRKPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDG 172 (592)
T ss_pred EecCCccHHHHHH--hcCCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccceeeeecCcc
Confidence 9999999999986 5678999999999999999999999998 9999999999999999999999999999887442
Q ss_pred CccccccccccCccCccccccCCCCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhcCccccccCcccc
Q 001658 849 THISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEIELADPKLI 928 (1036)
Q Consensus 849 ~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~ 928 (1036)
. .....+|||.|+|||++.+...+..+||||+|||+|-|++|+|||+...-.+.+..+ ...+..++
T Consensus 173 E-rk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~I-------------k~~~Y~~P 238 (592)
T KOG0575|consen 173 E-RKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKI-------------KLNEYSMP 238 (592)
T ss_pred c-ccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHH-------------HhcCcccc
Confidence 2 334578999999999999999999999999999999999999999976554444322 22233333
Q ss_pred cCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 001658 929 EFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVA 961 (1036)
Q Consensus 929 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 961 (1036)
.....+ ..+++..+++.+|.+|||+++|+.
T Consensus 239 ~~ls~~---A~dLI~~lL~~~P~~Rpsl~~vL~ 268 (592)
T KOG0575|consen 239 SHLSAE---AKDLIRKLLRPNPSERPSLDEVLD 268 (592)
T ss_pred cccCHH---HHHHHHHHhcCCcccCCCHHHHhc
Confidence 333333 445556788999999999999986
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=353.01 Aligned_cols=257 Identities=25% Similarity=0.368 Sum_probs=209.0
Q ss_pred CCCCCCccccCCCEEEEEeE-eCCCcEEEEEEcccc--chhcHHHHHHHHHHHHhhccCCcceeEe-EEEcCce-eEEEE
Q 001658 694 NFSPSNKLGEGGFGPVYKGK-LGDGRAIAVKQLSVA--SRQGKSQFVAEIATISAVQHRNLVKLHG-CCIEGAE-RLLVY 768 (1036)
Q Consensus 694 ~~~~~~~iG~G~fG~Vy~~~-~~~g~~vAvK~~~~~--~~~~~~~f~~Ei~~L~~l~H~nIv~l~g-~~~~~~~-~~lV~ 768 (1036)
+|++.++||+|.||+|||+. ..+|..||.|.++.. +....++...|+.+|++++|||||++++ .+.++.+ .+|||
T Consensus 20 ~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivm 99 (375)
T KOG0591|consen 20 DYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVM 99 (375)
T ss_pred HHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHH
Confidence 46677899999999999997 568999999998743 4555678899999999999999999999 4555555 78999
Q ss_pred EecCCCChhhhhhc--CCCCCcChHHHHHHHHHHHHHHHHHHhcCC-ccccccccCCCcEEecCCCceEEEEcCcceeec
Q 001658 769 EYLENKSLDQALFG--QRSLTLDWATRYEICSGVARGLAYLHEESR-VRIIHRDVKASNVLLDADLVPKISDFGLAKLYD 845 (1036)
Q Consensus 769 E~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~-~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~ 845 (1036)
|++..|+|...+.. .....+++.+++++..|+++||.++|..-+ .-|+||||||.||+|+.+|.+||+|||+++++.
T Consensus 100 E~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l~ 179 (375)
T KOG0591|consen 100 ELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFLS 179 (375)
T ss_pred HhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHhc
Confidence 99999999999864 346679999999999999999999998431 128899999999999999999999999999987
Q ss_pred CCCCccccccccccCccCccccccCCCCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhcCccccccCc
Q 001658 846 DKKTHISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEIELADP 925 (1036)
Q Consensus 846 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 925 (1036)
.... .....+|||.||+||.+...+|+.||||||+||++|||+.-++||++..-. .+-+. .+.+
T Consensus 180 s~~t-fA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~---~L~~K----I~qg-------- 243 (375)
T KOG0591|consen 180 SKTT-FAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLL---SLCKK----IEQG-------- 243 (375)
T ss_pred chhH-HHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHH---HHHHH----HHcC--------
Confidence 6543 345578999999999999999999999999999999999999999976321 11111 1111
Q ss_pred ccccCC-HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcc
Q 001658 926 KLIEFN-EEEVKRLIGVALLCTQTLPSLRPSMSRVVAMLCGD 966 (1036)
Q Consensus 926 ~~~~~~-~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 966 (1036)
.....+ .-...++..++..|+..||+.||+...+++.+...
T Consensus 244 d~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~~ 285 (375)
T KOG0591|consen 244 DYPPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQSE 285 (375)
T ss_pred CCCCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHHH
Confidence 111122 45567788888999999999999976666666553
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-42 Score=387.05 Aligned_cols=271 Identities=26% Similarity=0.448 Sum_probs=225.5
Q ss_pred ccCHHHHHHHhcCC---------CCCCccccCCCEEEEEeEeC----CCcEEEEEEcccc-chhcHHHHHHHHHHHHhhc
Q 001658 682 TFSYAELKTATENF---------SPSNKLGEGGFGPVYKGKLG----DGRAIAVKQLSVA-SRQGKSQFVAEIATISAVQ 747 (1036)
Q Consensus 682 ~~~~~~l~~~~~~~---------~~~~~iG~G~fG~Vy~~~~~----~g~~vAvK~~~~~-~~~~~~~f~~Ei~~L~~l~ 747 (1036)
.++|+|...|...| ++.++||.|.||.||+|+++ ....||||.++.. .+..+.+|..|+.+|.+++
T Consensus 609 P~TYEDPnqAvreFakEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFd 688 (996)
T KOG0196|consen 609 PHTYEDPNQAVREFAKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFD 688 (996)
T ss_pred CccccCccHHHHHhhhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCC
Confidence 46777766665444 45789999999999999875 2357999999875 3455778999999999999
Q ss_pred cCCcceeEeEEEcCceeEEEEEecCCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEe
Q 001658 748 HRNLVKLHGCCIEGAERLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLL 827 (1036)
Q Consensus 748 H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl 827 (1036)
||||++|.|+.......+||+|||+||+|+.+|+.+. .++.+.+...++++||.||+||-+.+ +|||||.++|||+
T Consensus 689 HPNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~~D-GqftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILV 764 (996)
T KOG0196|consen 689 HPNIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQND-GQFTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILV 764 (996)
T ss_pred CCcEEEEEEEEecCceeEEEhhhhhCCcHHHHHhhcC-CceEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheee
Confidence 9999999999999999999999999999999997665 56999999999999999999999998 9999999999999
Q ss_pred cCCCceEEEEcCcceeecCCCCcccccccc--ccCccCccccccCCCCchhhHHhHHHHHHHHHh-CCCCCCCCChhhHH
Q 001658 828 DADLVPKISDFGLAKLYDDKKTHISTRVAG--TIGYLAPEYAMRGHLTEKTDVFAFGVLALETVS-GRPNSDPSLDEEKL 904 (1036)
Q Consensus 828 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~g--t~~y~APE~~~~~~~~~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~ 904 (1036)
+.+..+||+|||+++.+.++.....+...| +++|.|||.+..++++.+||||||||||||.++ |..|+-...+.+..
T Consensus 765 NsnLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVI 844 (996)
T KOG0196|consen 765 NSNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVI 844 (996)
T ss_pred ccceEEEeccccceeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHH
Confidence 999999999999999886655333333322 569999999999999999999999999999877 77777665554444
Q ss_pred HHHHHHHHHhhcCccccccCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcccCCCc
Q 001658 905 YLLEWAWHLHENNQEIELADPKLIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVAMLCGDMEVST 971 (1036)
Q Consensus 905 ~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~~ 971 (1036)
..++ + +.++ ..+.+++..|.+||+.||++|-.+||+++||+.+|.+....+.
T Consensus 845 kaIe-------~-------gyRL-PpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP~ 896 (996)
T KOG0196|consen 845 KAIE-------Q-------GYRL-PPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNPN 896 (996)
T ss_pred HHHH-------h-------ccCC-CCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCch
Confidence 3222 1 1111 2345677789999999999999999999999999998876553
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=361.34 Aligned_cols=253 Identities=24% Similarity=0.354 Sum_probs=198.9
Q ss_pred HhcCCCCCCccccCCCEEEEEeE-eCCCcEEEEEEccccch-------hcHHHHHHHHHHHHhhccCCcceeEeEEEcCc
Q 001658 691 ATENFSPSNKLGEGGFGPVYKGK-LGDGRAIAVKQLSVASR-------QGKSQFVAEIATISAVQHRNLVKLHGCCIEGA 762 (1036)
Q Consensus 691 ~~~~~~~~~~iG~G~fG~Vy~~~-~~~g~~vAvK~~~~~~~-------~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~ 762 (1036)
..+.|.+.+.||+|+||.|-+|. .++|+.||||+++...- .......+|+++|++++|||||++++++...+
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 34567788999999999999997 55899999999965311 11233579999999999999999999999999
Q ss_pred eeEEEEEecCCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCC---CceEEEEcC
Q 001658 763 ERLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDAD---LVPKISDFG 839 (1036)
Q Consensus 763 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~---~~~kl~DFG 839 (1036)
..|+|+|||+||.|.+.+-.++. +.+.....++.|++.|+.|||++| |+||||||+|||+..+ ..+||+|||
T Consensus 250 s~YmVlE~v~GGeLfd~vv~nk~--l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llKItDFG 324 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVVANKY--LREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLKITDFG 324 (475)
T ss_pred ceEEEEEEecCccHHHHHHhccc--cccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEEecccc
Confidence 99999999999999999876544 455555678999999999999999 9999999999999765 789999999
Q ss_pred cceeecCCCCccccccccccCccCccccccCC---CCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhc
Q 001658 840 LAKLYDDKKTHISTRVAGTIGYLAPEYAMRGH---LTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHEN 916 (1036)
Q Consensus 840 la~~~~~~~~~~~~~~~gt~~y~APE~~~~~~---~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~ 916 (1036)
+|+... ........+||+.|.|||++.+.. +..|+|+||+||+||-+++|.+||....... .+.+ ....
T Consensus 325 lAK~~g--~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~--sl~e----QI~~ 396 (475)
T KOG0615|consen 325 LAKVSG--EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDP--SLKE----QILK 396 (475)
T ss_pred hhhccc--cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCc--cHHH----HHhc
Confidence 999875 233445678999999999998654 3348899999999999999999998643321 1111 1111
Q ss_pred CccccccCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 001658 917 NQEIELADPKLIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVA 961 (1036)
Q Consensus 917 ~~~~~~~d~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 961 (1036)
++. .+.| ....+...+..+++.+++..||++||+++|+++
T Consensus 397 G~y--~f~p---~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~ 436 (475)
T KOG0615|consen 397 GRY--AFGP---LQWDRISEEALDLINWMLVVDPENRPSADEALN 436 (475)
T ss_pred Ccc--cccC---hhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence 111 1111 122344456677778999999999999999986
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-41 Score=371.79 Aligned_cols=266 Identities=26% Similarity=0.440 Sum_probs=213.9
Q ss_pred HHHHHHHhcCCCCCCccccCCCEEEEEeEeCCCcEEEEEEcccc--chhcHHHHHHHHHHHHhhccCCcceeEeEEEcCc
Q 001658 685 YAELKTATENFSPSNKLGEGGFGPVYKGKLGDGRAIAVKQLSVA--SRQGKSQFVAEIATISAVQHRNLVKLHGCCIEGA 762 (1036)
Q Consensus 685 ~~~l~~~~~~~~~~~~iG~G~fG~Vy~~~~~~g~~vAvK~~~~~--~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~ 762 (1036)
.++.+...+.+.+.+.||+|.||+||+|+|.. .||||+++.. ..+..+.|+.|+.++++-||.||+-+.|||..+.
T Consensus 384 ~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~ 461 (678)
T KOG0193|consen 384 LEEWEIPPEEVLLGERIGSGSFGTVYRGRWHG--DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPP 461 (678)
T ss_pred ccccccCHHHhhccceeccccccceeeccccc--ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCc
Confidence 35555556667778999999999999999853 4999999764 3445678999999999999999999999999887
Q ss_pred eeEEEEEecCCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcce
Q 001658 763 ERLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAK 842 (1036)
Q Consensus 763 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~ 842 (1036)
. .||+.+|+|-+|+.++|..+ ..++..+.+.||+|||+||.|||.++ |||||||+.||++++++.|||+|||++.
T Consensus 462 ~-AIiTqwCeGsSLY~hlHv~e-tkfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kVkIgDFGLat 536 (678)
T KOG0193|consen 462 L-AIITQWCEGSSLYTHLHVQE-TKFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKVKIGDFGLAT 536 (678)
T ss_pred e-eeeehhccCchhhhhccchh-hhhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcEEEeccccee
Confidence 7 99999999999999998764 67999999999999999999999998 9999999999999999999999999997
Q ss_pred eecCCC-CccccccccccCccCcccccc---CCCCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhcCc
Q 001658 843 LYDDKK-THISTRVAGTIGYLAPEYAMR---GHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQ 918 (1036)
Q Consensus 843 ~~~~~~-~~~~~~~~gt~~y~APE~~~~---~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 918 (1036)
.-..-. ........|...|||||++.. .+|++.+||||||+|+|||+||..|+.....+..... .++
T Consensus 537 vk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifm---------VGr 607 (678)
T KOG0193|consen 537 VKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFM---------VGR 607 (678)
T ss_pred eeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEE---------ecc
Confidence 543211 111223457889999999964 4689999999999999999999999984333222211 111
Q ss_pred cccccCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcccC
Q 001658 919 EIELADPKLIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVAMLCGDME 968 (1036)
Q Consensus 919 ~~~~~d~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 968 (1036)
. ...|.+........+++.+|+..||..++++||.+.+|+..|+....
T Consensus 608 G--~l~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~ 655 (678)
T KOG0193|consen 608 G--YLMPDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLP 655 (678)
T ss_pred c--ccCccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence 1 11233333344556677778889999999999999999998887655
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-40 Score=350.03 Aligned_cols=243 Identities=24% Similarity=0.311 Sum_probs=198.7
Q ss_pred HhcCCCCCCccccCCCEEEEEeEe-CCCcEEEEEEcccc---chhcHHHHHHHHHHHHhhccCCcceeEeEEEcCceeEE
Q 001658 691 ATENFSPSNKLGEGGFGPVYKGKL-GDGRAIAVKQLSVA---SRQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLL 766 (1036)
Q Consensus 691 ~~~~~~~~~~iG~G~fG~Vy~~~~-~~g~~vAvK~~~~~---~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~l 766 (1036)
..++|++.++||+|+||+||.++. +.++.+|+|++++. .....+...+|..+|.+++||.||+++..|++.+..|+
T Consensus 23 ~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLyl 102 (357)
T KOG0598|consen 23 GPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYL 102 (357)
T ss_pred ChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEE
Confidence 356789999999999999999985 46889999999764 23346678899999999999999999999999999999
Q ss_pred EEEecCCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeecC
Q 001658 767 VYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDD 846 (1036)
Q Consensus 767 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~ 846 (1036)
|+||+.||.|...|.+ ...+++..+.-++..|+.||.|||+.+ ||||||||+|||||++|+++|+|||+++....
T Consensus 103 Vld~~~GGeLf~hL~~--eg~F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL~k~~~~ 177 (357)
T KOG0598|consen 103 VLDYLNGGELFYHLQR--EGRFSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGLCKEDLK 177 (357)
T ss_pred EEeccCCccHHHHHHh--cCCcchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccccchhccc
Confidence 9999999999999964 455778878888999999999999998 99999999999999999999999999986543
Q ss_pred CCCccccccccccCccCccccccCCCCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhcCccccccCcc
Q 001658 847 KKTHISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEIELADPK 926 (1036)
Q Consensus 847 ~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 926 (1036)
.. .....++||+.|||||++.+..|+..+|.||+|+++|||++|.+||...........+ ... + -+.
T Consensus 178 ~~-~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I------~~~-k-----~~~ 244 (357)
T KOG0598|consen 178 DG-DATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKI------LKG-K-----LPL 244 (357)
T ss_pred CC-CccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHH------hcC-c-----CCC
Confidence 32 2334578999999999999999999999999999999999999999976543322211 111 0 111
Q ss_pred cccCCHHHHHHHHHHHHHhcccCCCCCC
Q 001658 927 LIEFNEEEVKRLIGVALLCTQTLPSLRP 954 (1036)
Q Consensus 927 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RP 954 (1036)
...+...+. .+++...+..||++|-
T Consensus 245 ~p~~ls~~a---rdll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 245 PPGYLSEEA---RDLLKKLLKRDPRQRL 269 (357)
T ss_pred CCccCCHHH---HHHHHHHhccCHHHhc
Confidence 122233434 4455567799999995
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=354.71 Aligned_cols=265 Identities=28% Similarity=0.423 Sum_probs=216.1
Q ss_pred HhcCCCCCCccccCCCEEEEEeEeCCCcEEEEEEcccc-chhcHHHHHHHHHHHHhhccCCcceeEeEEEcCceeEEEEE
Q 001658 691 ATENFSPSNKLGEGGFGPVYKGKLGDGRAIAVKQLSVA-SRQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLVYE 769 (1036)
Q Consensus 691 ~~~~~~~~~~iG~G~fG~Vy~~~~~~g~~vAvK~~~~~-~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E 769 (1036)
......+.++||+|-||.|..+....+..||||+++.. ......+|.+|+++|.+++|||||+++|+|..++..++|+|
T Consensus 536 PRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~E 615 (807)
T KOG1094|consen 536 PRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITE 615 (807)
T ss_pred chhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHH
Confidence 34566778999999999999999988899999999875 44556899999999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeecCCCC
Q 001658 770 YLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKT 849 (1036)
Q Consensus 770 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~ 849 (1036)
||++|+|.+++..+....++-....+|+.|||.||+||.+.. +|||||.++|+|+|.++++||+|||+++-+-..+.
T Consensus 616 YmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~y 692 (807)
T KOG1094|consen 616 YMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDY 692 (807)
T ss_pred HHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCcccccccccCCc
Confidence 999999999998775555666777889999999999999887 99999999999999999999999999995544443
Q ss_pred c-cccccccccCccCccccccCCCCchhhHHhHHHHHHHHHh--CCCCCCCCChhhHHHHHHHHHHHhhcCccccccCcc
Q 001658 850 H-ISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVS--GRPNSDPSLDEEKLYLLEWAWHLHENNQEIELADPK 926 (1036)
Q Consensus 850 ~-~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~ellt--G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 926 (1036)
+ ...+.+-+++|||||.+.-++++.++|||+||+++||+++ ...|+....++... +.............
T Consensus 693 y~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vv---en~~~~~~~~~~~~----- 764 (807)
T KOG1094|consen 693 YRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVV---ENAGEFFRDQGRQV----- 764 (807)
T ss_pred eeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHH---HhhhhhcCCCCcce-----
Confidence 3 3345566789999999999999999999999999999866 55677655443332 22222222211111
Q ss_pred cccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcc
Q 001658 927 LIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVAMLCGD 966 (1036)
Q Consensus 927 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 966 (1036)
....+.-++..+.++++.||+.+-++||+++++...|++.
T Consensus 765 ~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 765 VLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred eccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 0122344556788999999999999999999999988754
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=351.41 Aligned_cols=267 Identities=31% Similarity=0.402 Sum_probs=202.7
Q ss_pred cCCCCCCccccCCCEEEEEeEeCCCcEEEEEEccccchhcHHHHHHHHHHHH--hhccCCcceeEeEEEcCc----eeEE
Q 001658 693 ENFSPSNKLGEGGFGPVYKGKLGDGRAIAVKQLSVASRQGKSQFVAEIATIS--AVQHRNLVKLHGCCIEGA----ERLL 766 (1036)
Q Consensus 693 ~~~~~~~~iG~G~fG~Vy~~~~~~g~~vAvK~~~~~~~~~~~~f~~Ei~~L~--~l~H~nIv~l~g~~~~~~----~~~l 766 (1036)
...+..++||+|+||.||||++. ++.||||++.. +.++.|..|-++.+ .++|+||++++++-.... +++|
T Consensus 210 ~pl~l~eli~~Grfg~V~KaqL~-~~~VAVKifp~---~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywL 285 (534)
T KOG3653|consen 210 DPLQLLELIGRGRFGCVWKAQLD-NRLVAVKIFPE---QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWL 285 (534)
T ss_pred CchhhHHHhhcCccceeehhhcc-CceeEEEecCH---HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeE
Confidence 44556788999999999999995 59999999974 34567787777665 468999999999977655 8899
Q ss_pred EEEecCCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcC------CccccccccCCCcEEecCCCceEEEEcCc
Q 001658 767 VYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEES------RVRIIHRDVKASNVLLDADLVPKISDFGL 840 (1036)
Q Consensus 767 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~------~~~ivHrDikp~NILl~~~~~~kl~DFGl 840 (1036)
|+||.++|||.+||. ...++|....+|+..+++||+|||+.- +++|+|||||++||||..|+++.|+|||+
T Consensus 286 Vt~fh~kGsL~dyL~---~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGL 362 (534)
T KOG3653|consen 286 VTEFHPKGSLCDYLK---ANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGL 362 (534)
T ss_pred EeeeccCCcHHHHHH---hccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccce
Confidence 999999999999994 457899999999999999999999863 67899999999999999999999999999
Q ss_pred ceeecCCCCc-cccccccccCccCccccccCC-CC-----chhhHHhHHHHHHHHHhCCCCCCCC-ChhhHHH-------
Q 001658 841 AKLYDDKKTH-ISTRVAGTIGYLAPEYAMRGH-LT-----EKTDVFAFGVLALETVSGRPNSDPS-LDEEKLY------- 905 (1036)
Q Consensus 841 a~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~-~~-----~ksDVwS~Gvvl~elltG~~p~~~~-~~~~~~~------- 905 (1036)
|..+...... .....+||.+|||||++.+.. +. .+.||||+|.|||||++...-+++. .++...-
T Consensus 363 Al~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~ 442 (534)
T KOG3653|consen 363 ALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGN 442 (534)
T ss_pred eEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcC
Confidence 9988643222 223467999999999997643 22 3799999999999999976544321 1110000
Q ss_pred --HHHHHHHHhhcCccccccCcccccC--CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcccCCC
Q 001658 906 --LLEWAWHLHENNQEIELADPKLIEF--NEEEVKRLIGVALLCTQTLPSLRPSMSRVVAMLCGDMEVS 970 (1036)
Q Consensus 906 --l~~~~~~~~~~~~~~~~~d~~~~~~--~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~ 970 (1036)
-.+.++... ..+...|.+.+. .-..+..+.+.+..||+.||+.|-|+.=|.+.+.+++...
T Consensus 443 hPt~e~mq~~V----V~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~ 507 (534)
T KOG3653|consen 443 HPTLEEMQELV----VRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLW 507 (534)
T ss_pred CCCHHHHHHHH----HhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccC
Confidence 011111111 112233444221 1255667888889999999999999999999888765433
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-40 Score=336.56 Aligned_cols=263 Identities=24% Similarity=0.344 Sum_probs=210.2
Q ss_pred cCCCCCCccccCCCEEEEEeEeC-CCcEEEEEEcccc--chhcHHHHHHHHHHHHhhccCCcceeEeEEEcCceeEEEEE
Q 001658 693 ENFSPSNKLGEGGFGPVYKGKLG-DGRAIAVKQLSVA--SRQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLVYE 769 (1036)
Q Consensus 693 ~~~~~~~~iG~G~fG~Vy~~~~~-~g~~vAvK~~~~~--~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E 769 (1036)
+.|+...++|+|+||+|||++.+ .|+.||||++... ++.-++-..+|+++|++++|+|+|.++++|......+||+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 45777889999999999999965 6999999998643 23445667899999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeecCCCC
Q 001658 770 YLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKT 849 (1036)
Q Consensus 770 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~ 849 (1036)
|++..-|++ |... ...++.....+++.|+++|+.|+|+++ ||||||||+|||++.++.+||||||.|+.+.. ..
T Consensus 82 ~~dhTvL~e-Le~~-p~G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR~L~~-pg 155 (396)
T KOG0593|consen 82 YCDHTVLHE-LERY-PNGVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFARTLSA-PG 155 (396)
T ss_pred ecchHHHHH-HHhc-cCCCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhHhhcC-Cc
Confidence 998755544 3222 345788888999999999999999998 99999999999999999999999999998874 34
Q ss_pred ccccccccccCccCcccccc-CCCCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHH--------HHhhcCcc-
Q 001658 850 HISTRVAGTIGYLAPEYAMR-GHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAW--------HLHENNQE- 919 (1036)
Q Consensus 850 ~~~~~~~gt~~y~APE~~~~-~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~--------~~~~~~~~- 919 (1036)
..++..+.|..|.|||.+.+ ..|...+||||+||++.||++|.+.|.+..+-+..+++...- ..+..+..
T Consensus 156 d~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F 235 (396)
T KOG0593|consen 156 DNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFF 235 (396)
T ss_pred chhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCce
Confidence 44566778999999999987 689999999999999999999999998888877777664332 12221111
Q ss_pred c--cccCc---cc-ccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 001658 920 I--ELADP---KL-IEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVA 961 (1036)
Q Consensus 920 ~--~~~d~---~~-~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 961 (1036)
. .+.+| +- ....+....-+++++..|++.||++|++-+|++.
T Consensus 236 ~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 236 HGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred eeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 1 11111 11 1112233346889999999999999999999875
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=354.61 Aligned_cols=254 Identities=27% Similarity=0.417 Sum_probs=202.5
Q ss_pred cCCCCCCccccCCCEEEEEeEeC-CCcEEEEEEccccchhcHHHHHHHHHHHHhhccCCcceeEeEEEcCc--eeEEEEE
Q 001658 693 ENFSPSNKLGEGGFGPVYKGKLG-DGRAIAVKQLSVASRQGKSQFVAEIATISAVQHRNLVKLHGCCIEGA--ERLLVYE 769 (1036)
Q Consensus 693 ~~~~~~~~iG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~--~~~lV~E 769 (1036)
.+|...+.||+|+||+||++... +|+..|||.....+....+.+.+|+.+|++++|||||+.+|...... ...++||
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE 96 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME 96 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence 45667899999999999999865 48999999987654333667899999999999999999999855444 6899999
Q ss_pred ecCCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecC-CCceEEEEcCcceeecC--
Q 001658 770 YLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDA-DLVPKISDFGLAKLYDD-- 846 (1036)
Q Consensus 770 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~-~~~~kl~DFGla~~~~~-- 846 (1036)
|+++|+|.+++.+.+. .+++..+...+.||++||+|||+++ ||||||||+|||++. ++.+||+|||+++....
T Consensus 97 y~~~GsL~~~~~~~g~-~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~ 172 (313)
T KOG0198|consen 97 YAPGGSLSDLIKRYGG-KLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLAKKLESKG 172 (313)
T ss_pred ccCCCcHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCcccccccccc
Confidence 9999999999987766 7999999999999999999999998 999999999999999 79999999999987763
Q ss_pred CCCccccccccccCccCccccccCC-CCchhhHHhHHHHHHHHHhCCCCCCCC-ChhhHHHHHHHHHHHhhcCccccccC
Q 001658 847 KKTHISTRVAGTIGYLAPEYAMRGH-LTEKTDVFAFGVLALETVSGRPNSDPS-LDEEKLYLLEWAWHLHENNQEIELAD 924 (1036)
Q Consensus 847 ~~~~~~~~~~gt~~y~APE~~~~~~-~~~ksDVwS~Gvvl~elltG~~p~~~~-~~~~~~~l~~~~~~~~~~~~~~~~~d 924 (1036)
..........||+.|||||++..+. ...++||||+||+++||+||++||... ...+.. ...... ...
T Consensus 173 ~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~------~~ig~~-----~~~ 241 (313)
T KOG0198|consen 173 TKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEAL------LLIGRE-----DSL 241 (313)
T ss_pred ccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHH------HHHhcc-----CCC
Confidence 2222234578999999999999643 345999999999999999999999863 111111 111111 122
Q ss_pred cccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 001658 925 PKLIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVAMLC 964 (1036)
Q Consensus 925 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~ 964 (1036)
|.+.....+ +..+++..|++.+|++|||++++++..-
T Consensus 242 P~ip~~ls~---~a~~Fl~~C~~~~p~~Rpta~eLL~hpf 278 (313)
T KOG0198|consen 242 PEIPDSLSD---EAKDFLRKCFKRDPEKRPTAEELLEHPF 278 (313)
T ss_pred CCCCcccCH---HHHHHHHHHhhcCcccCcCHHHHhhChh
Confidence 333333333 4455567899999999999999987543
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=362.51 Aligned_cols=249 Identities=27% Similarity=0.477 Sum_probs=212.1
Q ss_pred cCCCCCCccccCCCEEEEEeE-eCCCcEEEEEEccccchhcHHHHHHHHHHHHhhccCCcceeEeEEEcCceeEEEEEec
Q 001658 693 ENFSPSNKLGEGGFGPVYKGK-LGDGRAIAVKQLSVASRQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLVYEYL 771 (1036)
Q Consensus 693 ~~~~~~~~iG~G~fG~Vy~~~-~~~g~~vAvK~~~~~~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~~ 771 (1036)
..|..-.+||+|+.|.||.|. ...++.||||++.......++-..+|+.+|+..+|+|||.+++.|...++.|+|||||
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym 352 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYM 352 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeec
Confidence 456666889999999999997 5678899999998776666777899999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeecCCCCcc
Q 001658 772 ENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHI 851 (1036)
Q Consensus 772 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 851 (1036)
++|+|.|.+. ...+++.++..|+.++++||+|||.++ |+|||||.+|||++.++.+||+|||++..+......
T Consensus 353 ~ggsLTDvVt---~~~~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~K- 425 (550)
T KOG0578|consen 353 EGGSLTDVVT---KTRMTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQSK- 425 (550)
T ss_pred CCCchhhhhh---cccccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeeccccccCc-
Confidence 9999999984 445899999999999999999999998 999999999999999999999999999988765543
Q ss_pred ccccccccCccCccccccCCCCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhcCccccccCcccccCC
Q 001658 852 STRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEIELADPKLIEFN 931 (1036)
Q Consensus 852 ~~~~~gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~ 931 (1036)
....+||+.|||||+.....|.+|+||||||++++||+.|.+||-...+-...+++. .+. .|++ ...
T Consensus 426 R~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa-------~ng-----~P~l-k~~ 492 (550)
T KOG0578|consen 426 RSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA-------TNG-----TPKL-KNP 492 (550)
T ss_pred cccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHh-------hcC-----CCCc-CCc
Confidence 345679999999999999999999999999999999999999998765544444332 111 1222 122
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 001658 932 EEEVKRLIGVALLCTQTLPSLRPSMSRVVA 961 (1036)
Q Consensus 932 ~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 961 (1036)
......+.++..+|++.|+++||++.|+++
T Consensus 493 ~klS~~~kdFL~~cL~~dv~~RasA~eLL~ 522 (550)
T KOG0578|consen 493 EKLSPELKDFLDRCLVVDVEQRASAKELLE 522 (550)
T ss_pred cccCHHHHHHHHHHhhcchhcCCCHHHHhc
Confidence 233446677778999999999999999986
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=353.30 Aligned_cols=264 Identities=24% Similarity=0.364 Sum_probs=209.5
Q ss_pred cCCCCCCccccCCCEEEEEeE-eCCCcEEEEEEccccc--hhcHHHHHHHHHHHHhhccCCcceeEeEEEcC--ceeEEE
Q 001658 693 ENFSPSNKLGEGGFGPVYKGK-LGDGRAIAVKQLSVAS--RQGKSQFVAEIATISAVQHRNLVKLHGCCIEG--AERLLV 767 (1036)
Q Consensus 693 ~~~~~~~~iG~G~fG~Vy~~~-~~~g~~vAvK~~~~~~--~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~--~~~~lV 767 (1036)
+.|+..++||+|.||.||||+ ..+|+.||+|+++... +....-..+||.+|++++||||+++.+...+. ...|||
T Consensus 117 ~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlV 196 (560)
T KOG0600|consen 117 DSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLV 196 (560)
T ss_pred HHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEE
Confidence 345556889999999999998 5689999999997654 34455667899999999999999999998876 689999
Q ss_pred EEecCCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeecCC
Q 001658 768 YEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDK 847 (1036)
Q Consensus 768 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~ 847 (1036)
+|||+. +|.-++.. ....++..++..++.|++.||+|+|.++ |+|||||.+|||||.+|.+||+|||||+++...
T Consensus 197 FeYMdh-DL~GLl~~-p~vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~ 271 (560)
T KOG0600|consen 197 FEYMDH-DLSGLLSS-PGVKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFGLARFYTPS 271 (560)
T ss_pred Eecccc-hhhhhhcC-CCcccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEeccccceeeccCC
Confidence 999976 77776643 3567999999999999999999999998 999999999999999999999999999999877
Q ss_pred CCccccccccccCccCccccccC-CCCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhh-cCcc-c----
Q 001658 848 KTHISTRVAGTIGYLAPEYAMRG-HLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHE-NNQE-I---- 920 (1036)
Q Consensus 848 ~~~~~~~~~gt~~y~APE~~~~~-~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~-~~~~-~---- 920 (1036)
.....+..+-|..|.|||.+.+. .|+.++|+||.||||.||++|++.+.+..+.++...+-..-.... ..+. .
T Consensus 272 ~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~ 351 (560)
T KOG0600|consen 272 GSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPH 351 (560)
T ss_pred CCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCCc
Confidence 66666777789999999999875 699999999999999999999999998877766655422211111 1111 0
Q ss_pred -cccCcc------cccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 001658 921 -ELADPK------LIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVA 961 (1036)
Q Consensus 921 -~~~d~~------~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 961 (1036)
..+.|. +.+.........++++..++..||.+|.|+.++++
T Consensus 352 ~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 352 ATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred ccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 011111 01111112234667777888999999999999875
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-40 Score=354.41 Aligned_cols=266 Identities=23% Similarity=0.346 Sum_probs=213.2
Q ss_pred HhcCCCCCCccccCCCEEEEEeE-eCCCcEEEEEEccccchh-cHHHHHHHHHHHHhhc-cCCcceeEeEEEcCc-eeEE
Q 001658 691 ATENFSPSNKLGEGGFGPVYKGK-LGDGRAIAVKQLSVASRQ-GKSQFVAEIATISAVQ-HRNLVKLHGCCIEGA-ERLL 766 (1036)
Q Consensus 691 ~~~~~~~~~~iG~G~fG~Vy~~~-~~~g~~vAvK~~~~~~~~-~~~~f~~Ei~~L~~l~-H~nIv~l~g~~~~~~-~~~l 766 (1036)
.-++|...++||.|.||.||+|+ ...|+.||||+++..-.. ++..-.+|++.|+++. |||||++.+++.+.+ ..++
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~f 87 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYF 87 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEee
Confidence 34577888999999999999998 457899999998754322 2223458999999998 999999999999888 8999
Q ss_pred EEEecCCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeecC
Q 001658 767 VYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDD 846 (1036)
Q Consensus 767 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~ 846 (1036)
|||||+ .+|++++.++ +..+++.+++.|+.||++||+|+|++| +.|||+||+|||+..+..+||+|||+|+....
T Consensus 88 VfE~Md-~NLYqLmK~R-~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFGLARev~S 162 (538)
T KOG0661|consen 88 VFEFMD-CNLYQLMKDR-NRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFGLAREVRS 162 (538)
T ss_pred eHHhhh-hhHHHHHhhc-CCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEeccccccccccc
Confidence 999995 6999999776 788999999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCccccccccccCccCccccc-cCCCCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhcCc------c
Q 001658 847 KKTHISTRVAGTIGYLAPEYAM-RGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQ------E 919 (1036)
Q Consensus 847 ~~~~~~~~~~gt~~y~APE~~~-~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~------~ 919 (1036)
... .+..+.|..|+|||++. .+.|+.+.|||++|||++|+.+-++.|.+..+-++.+.+--+-....+.. .
T Consensus 163 kpP--YTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~L 240 (538)
T KOG0661|consen 163 KPP--YTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNL 240 (538)
T ss_pred CCC--cchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHH
Confidence 433 35567899999999985 56799999999999999999999999988776666654432221111100 0
Q ss_pred ccccC---cc-----cccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 001658 920 IELAD---PK-----LIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVAML 963 (1036)
Q Consensus 920 ~~~~d---~~-----~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L 963 (1036)
...+. |. +....+....+.++++..|+++||.+|||+.|.+++-
T Consensus 241 a~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~p 292 (538)
T KOG0661|consen 241 ASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHP 292 (538)
T ss_pred HHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCc
Confidence 00111 11 1222234667888999999999999999999998853
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=342.52 Aligned_cols=259 Identities=25% Similarity=0.352 Sum_probs=209.7
Q ss_pred hcCCCCCCccccCCCEEEEEeE-eCCCcEEEEEEccccch-hcHHHHHHHHHHHHhhccCCcceeEeEEEcCceeEEEEE
Q 001658 692 TENFSPSNKLGEGGFGPVYKGK-LGDGRAIAVKQLSVASR-QGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLVYE 769 (1036)
Q Consensus 692 ~~~~~~~~~iG~G~fG~Vy~~~-~~~g~~vAvK~~~~~~~-~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E 769 (1036)
.+.|++.++||.|.-++||+|+ ...++.||||++....- ...+.+.+|+..|+.++||||++.+..|..+...|+||.
T Consensus 25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmp 104 (516)
T KOG0582|consen 25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMP 104 (516)
T ss_pred ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeeh
Confidence 4578888999999999999998 45679999999976532 335788999999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeecCCCC
Q 001658 770 YLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKT 849 (1036)
Q Consensus 770 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~ 849 (1036)
||.+||+.+.+...-...+++..+..|++++++||.|||.+| .||||||+.||||+.+|.|||+|||.+..+.+...
T Consensus 105 fMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~ 181 (516)
T KOG0582|consen 105 FMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGD 181 (516)
T ss_pred hhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceeeeeecccCc
Confidence 999999999998776777999999999999999999999998 99999999999999999999999998876654322
Q ss_pred cc---ccccccccCccCcccccc--CCCCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhcCccccccC
Q 001658 850 HI---STRVAGTIGYLAPEYAMR--GHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEIELAD 924 (1036)
Q Consensus 850 ~~---~~~~~gt~~y~APE~~~~--~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 924 (1036)
.. ...++||+.|||||+++. ..|+.|+||||||++..||.+|..||....+.....+. . .+.. ...+
T Consensus 182 R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~t--L-----qn~p-p~~~ 253 (516)
T KOG0582|consen 182 RQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLT--L-----QNDP-PTLL 253 (516)
T ss_pred eeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHH--h-----cCCC-CCcc
Confidence 11 145689999999999654 46999999999999999999999999876554333211 0 0000 0000
Q ss_pred ccc--ccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 001658 925 PKL--IEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVA 961 (1036)
Q Consensus 925 ~~~--~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 961 (1036)
... .+......+.+.+++..|+++||.+|||+++++.
T Consensus 254 t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk 292 (516)
T KOG0582|consen 254 TSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK 292 (516)
T ss_pred cccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 000 1112233346778888999999999999999976
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=362.70 Aligned_cols=261 Identities=26% Similarity=0.395 Sum_probs=204.5
Q ss_pred HhcCCCCCCccccCCCEEEEEeEe------CCCcEEEEEEccccc-hhcHHHHHHHHHHHHhh-ccCCcceeEeEEEcC-
Q 001658 691 ATENFSPSNKLGEGGFGPVYKGKL------GDGRAIAVKQLSVAS-RQGKSQFVAEIATISAV-QHRNLVKLHGCCIEG- 761 (1036)
Q Consensus 691 ~~~~~~~~~~iG~G~fG~Vy~~~~------~~g~~vAvK~~~~~~-~~~~~~f~~Ei~~L~~l-~H~nIv~l~g~~~~~- 761 (1036)
..++|++.+.||+|+||.||+|.. .+++.||||++.... ......+.+|+.++.++ +||||++++++|...
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (338)
T cd05102 5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPN 84 (338)
T ss_pred chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCC
Confidence 346788899999999999999973 235689999987532 23356789999999999 899999999998764
Q ss_pred ceeEEEEEecCCCChhhhhhcCC---------------------------------------------------------
Q 001658 762 AERLLVYEYLENKSLDQALFGQR--------------------------------------------------------- 784 (1036)
Q Consensus 762 ~~~~lV~E~~~~gsL~~~l~~~~--------------------------------------------------------- 784 (1036)
...++||||+++|+|.+++....
T Consensus 85 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (338)
T cd05102 85 GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETD 164 (338)
T ss_pred CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcc
Confidence 45789999999999999986532
Q ss_pred ---CCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeecCCCCcc-ccccccccC
Q 001658 785 ---SLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHI-STRVAGTIG 860 (1036)
Q Consensus 785 ---~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~-~~~~~gt~~ 860 (1036)
...+++..+..++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+++......... .....++..
T Consensus 165 ~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~ 241 (338)
T cd05102 165 DLWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLK 241 (338)
T ss_pred ccccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCcc
Confidence 134788889999999999999999987 9999999999999999999999999998654332221 123446788
Q ss_pred ccCccccccCCCCchhhHHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHHHHHhhcCccccccCcccccCCHHHHHHHH
Q 001658 861 YLAPEYAMRGHLTEKTDVFAFGVLALETVS-GRPNSDPSLDEEKLYLLEWAWHLHENNQEIELADPKLIEFNEEEVKRLI 939 (1036)
Q Consensus 861 y~APE~~~~~~~~~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~ 939 (1036)
|+|||++.+..++.++|||||||++|||++ |+.||.......... . ....+. .+. .+......+.
T Consensus 242 y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~--~----~~~~~~-----~~~---~~~~~~~~l~ 307 (338)
T cd05102 242 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFC--Q----RLKDGT-----RMR---APENATPEIY 307 (338)
T ss_pred ccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHH--H----HHhcCC-----CCC---CCCCCCHHHH
Confidence 999999999899999999999999999997 999987643322111 0 111111 011 1112234678
Q ss_pred HHHHHhcccCCCCCCCHHHHHHHhhcccC
Q 001658 940 GVALLCTQTLPSLRPSMSRVVAMLCGDME 968 (1036)
Q Consensus 940 ~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 968 (1036)
+++.+||+.||.+|||+.|++++|+....
T Consensus 308 ~li~~cl~~dp~~RPs~~el~~~l~~~~~ 336 (338)
T cd05102 308 RIMLACWQGDPKERPTFSALVEILGDLLQ 336 (338)
T ss_pred HHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 88999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=348.17 Aligned_cols=251 Identities=24% Similarity=0.309 Sum_probs=204.9
Q ss_pred HhcCCCCCCccccCCCEEEEEeE-eCCCcEEEEEEcccc---chhcHHHHHHHHHHHHhh-ccCCcceeEeEEEcCceeE
Q 001658 691 ATENFSPSNKLGEGGFGPVYKGK-LGDGRAIAVKQLSVA---SRQGKSQFVAEIATISAV-QHRNLVKLHGCCIEGAERL 765 (1036)
Q Consensus 691 ~~~~~~~~~~iG~G~fG~Vy~~~-~~~g~~vAvK~~~~~---~~~~~~~f~~Ei~~L~~l-~H~nIv~l~g~~~~~~~~~ 765 (1036)
...+|...+.||+|+|++||+|+ ...++.+|||++.+. .+...+-...|-.+|.+| .||.|++|+.-|.+....|
T Consensus 71 ~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLY 150 (604)
T KOG0592|consen 71 TPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLY 150 (604)
T ss_pred ChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceE
Confidence 44678888999999999999998 457899999998643 222234456788899999 8999999999999999999
Q ss_pred EEEEecCCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeec
Q 001658 766 LVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYD 845 (1036)
Q Consensus 766 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~ 845 (1036)
+|+||+++|+|.++|++. ..+++...+-++.+|+.||+|||++| ||||||||+|||||+||++||+|||.|+.+.
T Consensus 151 FvLe~A~nGdll~~i~K~--Gsfde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITDFGsAK~l~ 225 (604)
T KOG0592|consen 151 FVLEYAPNGDLLDLIKKY--GSFDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITDFGSAKILS 225 (604)
T ss_pred EEEEecCCCcHHHHHHHh--CcchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEeeccccccCC
Confidence 999999999999999765 46788888889999999999999999 9999999999999999999999999999886
Q ss_pred CCCCc----------cc--cccccccCccCccccccCCCCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHH
Q 001658 846 DKKTH----------IS--TRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHL 913 (1036)
Q Consensus 846 ~~~~~----------~~--~~~~gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~ 913 (1036)
+.... .+ ..++||..|.+||++..+..++.+|+|+||||+|+|+.|++||...++.-....
T Consensus 226 ~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqk------- 298 (604)
T KOG0592|consen 226 PSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQK------- 298 (604)
T ss_pred hhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHH-------
Confidence 43211 11 448999999999999999999999999999999999999999987654322211
Q ss_pred hhcCccccccCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 001658 914 HENNQEIELADPKLIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVAM 962 (1036)
Q Consensus 914 ~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 962 (1036)
+...+..+....+ ....+|+.+.+..||.+|+|..||-+.
T Consensus 299 ------I~~l~y~fp~~fp---~~a~dLv~KLLv~dp~~Rlt~~qIk~H 338 (604)
T KOG0592|consen 299 ------IQALDYEFPEGFP---EDARDLIKKLLVRDPSDRLTSQQIKAH 338 (604)
T ss_pred ------HHHhcccCCCCCC---HHHHHHHHHHHccCccccccHHHHhhC
Confidence 1123333332223 344555567779999999999888763
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=320.51 Aligned_cols=261 Identities=24% Similarity=0.355 Sum_probs=209.4
Q ss_pred cCCCCCCccccCCCEEEEEeE-eCCCcEEEEEEccccchh--cHHHHHHHHHHHHhhccCCcceeEeEEEcCceeEEEEE
Q 001658 693 ENFSPSNKLGEGGFGPVYKGK-LGDGRAIAVKQLSVASRQ--GKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLVYE 769 (1036)
Q Consensus 693 ~~~~~~~~iG~G~fG~Vy~~~-~~~g~~vAvK~~~~~~~~--~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E 769 (1036)
++|...+++|+|.||.||+|+ ...|+.||||+++..... -.....+|++.|+.++|+||+.++++|.+.+...||+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 457777899999999999998 457999999999765322 24567899999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeecCCCC
Q 001658 770 YLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKT 849 (1036)
Q Consensus 770 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~ 849 (1036)
||+. +|+..+.. +...+....+..++.++++|++|||++. |+||||||.|+|++++|.+||+|||+|+.+.....
T Consensus 82 fm~t-dLe~vIkd-~~i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~ 156 (318)
T KOG0659|consen 82 FMPT-DLEVVIKD-KNIILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNR 156 (318)
T ss_pred eccc-cHHHHhcc-cccccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhccCCCCc
Confidence 9964 99888854 4567888999999999999999999998 99999999999999999999999999999876544
Q ss_pred ccccccccccCccCccccccC-CCCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhcCcc------ccc
Q 001658 850 HISTRVAGTIGYLAPEYAMRG-HLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQE------IEL 922 (1036)
Q Consensus 850 ~~~~~~~gt~~y~APE~~~~~-~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~------~~~ 922 (1036)
... ..+-|..|.|||.+.+. .|+..+||||.|||+.||+-|.+-|.+..+-++...+- ...+.... ..+
T Consensus 157 ~~~-~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If---~~LGTP~~~~WP~~~~l 232 (318)
T KOG0659|consen 157 IQT-HQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIF---RALGTPTPDQWPEMTSL 232 (318)
T ss_pred ccc-cceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHH---HHcCCCCcccCcccccc
Confidence 333 33678899999999875 59999999999999999999998887766655544332 22111111 111
Q ss_pred cC---------cccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 001658 923 AD---------PKLIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVAM 962 (1036)
Q Consensus 923 ~d---------~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 962 (1036)
.| +...........+.++++..++..+|.+|.+++|++++
T Consensus 233 pdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 233 PDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred ccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 11 11122233445567899999999999999999998864
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=380.82 Aligned_cols=260 Identities=32% Similarity=0.440 Sum_probs=210.4
Q ss_pred cCCCCCCccccCCCEEEEEeEeC--CCc----EEEEEEcccc-chhcHHHHHHHHHHHHhhccCCcceeEeEEEcCceeE
Q 001658 693 ENFSPSNKLGEGGFGPVYKGKLG--DGR----AIAVKQLSVA-SRQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERL 765 (1036)
Q Consensus 693 ~~~~~~~~iG~G~fG~Vy~~~~~--~g~----~vAvK~~~~~-~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~ 765 (1036)
...+..+.||+|+||.||+|... +|. .||||.++.. +.+...+|.+|..+|++++|||||+++|.|.+....+
T Consensus 692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~ 771 (1025)
T KOG1095|consen 692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPL 771 (1025)
T ss_pred hheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcE
Confidence 34456678999999999999864 233 4999999764 5667889999999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhhcCC-----CCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCc
Q 001658 766 LVYEYLENKSLDQALFGQR-----SLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGL 840 (1036)
Q Consensus 766 lV~E~~~~gsL~~~l~~~~-----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGl 840 (1036)
+++|||++|+|..+|+..+ ...+.....+.|+.|||+|+.||++++ +|||||..+|+||++...|||+|||+
T Consensus 772 i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIaDFGl 848 (1025)
T KOG1095|consen 772 ILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIADFGL 848 (1025)
T ss_pred EEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEcccch
Confidence 9999999999999997653 456888899999999999999999987 99999999999999999999999999
Q ss_pred ceeecCCCCccc-cccccccCccCccccccCCCCchhhHHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHHHHHhhcCc
Q 001658 841 AKLYDDKKTHIS-TRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVS-GRPNSDPSLDEEKLYLLEWAWHLHENNQ 918 (1036)
Q Consensus 841 a~~~~~~~~~~~-~~~~gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~ 918 (1036)
|+.+........ ....-+.+|||||.++.+.++.|+|||||||++||++| |..|+......+....+ ...+
T Consensus 849 ArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~------~~gg- 921 (1025)
T KOG1095|consen 849 ARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDV------LEGG- 921 (1025)
T ss_pred hHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHH------HhCC-
Confidence 995543333222 22234569999999999999999999999999999999 55666544333322211 1111
Q ss_pred cccccCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcccCCC
Q 001658 919 EIELADPKLIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVAMLCGDMEVS 970 (1036)
Q Consensus 919 ~~~~~d~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~ 970 (1036)
.+ +.+..++..+.++|..||+.+|++||++..+++.+.......
T Consensus 922 ---RL-----~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~ 965 (1025)
T KOG1095|consen 922 ---RL-----DPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAA 965 (1025)
T ss_pred ---cc-----CCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhh
Confidence 11 233445567789999999999999999999999887765543
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-39 Score=350.64 Aligned_cols=248 Identities=27% Similarity=0.451 Sum_probs=201.8
Q ss_pred CccCHHHHHHHhcCCCCCCccccCCCEEEEEeEeCCCcEEEEEEccccchhcHHHHHHHHHHHHhhccCCcceeEeEEEc
Q 001658 681 YTFSYAELKTATENFSPSNKLGEGGFGPVYKGKLGDGRAIAVKQLSVASRQGKSQFVAEIATISAVQHRNLVKLHGCCIE 760 (1036)
Q Consensus 681 ~~~~~~~l~~~~~~~~~~~~iG~G~fG~Vy~~~~~~g~~vAvK~~~~~~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~ 760 (1036)
..+.|++|. .++.||.|+.|.||.|+++ ++.||||+++. .-+.+|+-|++++|+||+.|.|+|..
T Consensus 119 WeiPFe~Is-------ELeWlGSGaQGAVF~Grl~-netVAVKKV~e-------lkETdIKHLRkLkH~NII~FkGVCtq 183 (904)
T KOG4721|consen 119 WEIPFEEIS-------ELEWLGSGAQGAVFLGRLH-NETVAVKKVRE-------LKETDIKHLRKLKHPNIITFKGVCTQ 183 (904)
T ss_pred ccCCHHHhh-------hhhhhccCcccceeeeecc-CceehhHHHhh-------hhhhhHHHHHhccCcceeeEeeeecC
Confidence 345555553 3578999999999999995 58899998852 22457889999999999999999999
Q ss_pred CceeEEEEEecCCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCc
Q 001658 761 GAERLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGL 840 (1036)
Q Consensus 761 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGl 840 (1036)
...++||||||..|-|..+|... .++.-.....+..+||.||.|||.+. |||||||+-||||..+..+||+|||-
T Consensus 184 sPcyCIiMEfCa~GqL~~VLka~--~~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDFGT 258 (904)
T KOG4721|consen 184 SPCYCIIMEFCAQGQLYEVLKAG--RPITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDFGT 258 (904)
T ss_pred CceeEEeeeccccccHHHHHhcc--CccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEeccccc
Confidence 99999999999999999999654 45666677788999999999999987 99999999999999999999999999
Q ss_pred ceeecCCCCccccccccccCccCccccccCCCCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhcC-cc
Q 001658 841 AKLYDDKKTHISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENN-QE 919 (1036)
Q Consensus 841 a~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~-~~ 919 (1036)
++...+..+. ..++||+.|||||++.+.+.++|+||||||||||||+||..|+..-...... | .-+ ..
T Consensus 259 S~e~~~~STk--MSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAII----w-----GVGsNs 327 (904)
T KOG4721|consen 259 SKELSDKSTK--MSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAII----W-----GVGSNS 327 (904)
T ss_pred hHhhhhhhhh--hhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeE----E-----eccCCc
Confidence 9977654332 3578999999999999999999999999999999999999998753221111 1 111 11
Q ss_pred ccccCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhc
Q 001658 920 IELADPKLIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVAMLCG 965 (1036)
Q Consensus 920 ~~~~d~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~ 965 (1036)
.. ...+..+++-+.-++..||+..|..||++.+++..|+-
T Consensus 328 L~------LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldI 367 (904)
T KOG4721|consen 328 LH------LPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDI 367 (904)
T ss_pred cc------ccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhh
Confidence 11 12234455566667788999999999999999998863
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=358.94 Aligned_cols=259 Identities=31% Similarity=0.417 Sum_probs=207.1
Q ss_pred cCCCCCCccccCCCEEEEEeEeCC--C--cE-EEEEEccc---cchhcHHHHHHHHHHHHhhccCCcceeEeEEEcCcee
Q 001658 693 ENFSPSNKLGEGGFGPVYKGKLGD--G--RA-IAVKQLSV---ASRQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAER 764 (1036)
Q Consensus 693 ~~~~~~~~iG~G~fG~Vy~~~~~~--g--~~-vAvK~~~~---~~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~ 764 (1036)
++....++||+|+||.||+|++.. + .. ||||..+. ..+....+|.+|+++|+.++|||||++||++......
T Consensus 157 ~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl 236 (474)
T KOG0194|consen 157 SDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPL 236 (474)
T ss_pred cCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCcc
Confidence 344455899999999999998642 3 23 89999874 3466778999999999999999999999999999999
Q ss_pred EEEEEecCCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceee
Q 001658 765 LLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLY 844 (1036)
Q Consensus 765 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~ 844 (1036)
++|||+|.||+|.++|..... .++..++++++.++|+||+|||+++ +|||||.++|+|++.++.+||+|||+++.-
T Consensus 237 ~ivmEl~~gGsL~~~L~k~~~-~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~vKISDFGLs~~~ 312 (474)
T KOG0194|consen 237 MLVMELCNGGSLDDYLKKNKK-SLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGVVKISDFGLSRAG 312 (474)
T ss_pred EEEEEecCCCcHHHHHHhCCC-CCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCeEEeCccccccCC
Confidence 999999999999999976544 6899999999999999999999998 999999999999999999999999998754
Q ss_pred cCCCCccccccccccCccCccccccCCCCchhhHHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHHHHHhhcCcccccc
Q 001658 845 DDKKTHISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVS-GRPNSDPSLDEEKLYLLEWAWHLHENNQEIELA 923 (1036)
Q Consensus 845 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 923 (1036)
....... ....-+.+|+|||.+..+.+++++|||||||++||+++ |..|+.+....+.. .++ ...+.
T Consensus 313 ~~~~~~~-~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~---~kI---~~~~~----- 380 (474)
T KOG0194|consen 313 SQYVMKK-FLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVK---AKI---VKNGY----- 380 (474)
T ss_pred cceeecc-ccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHH---HHH---HhcCc-----
Confidence 3111111 11234579999999999999999999999999999999 78888765543222 111 11111
Q ss_pred CcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcccCCC
Q 001658 924 DPKLIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVAMLCGDMEVS 970 (1036)
Q Consensus 924 d~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~ 970 (1036)
+. ..+...+..+..++..||..+|++||+|.++.+.++......
T Consensus 381 --r~-~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~ 424 (474)
T KOG0194|consen 381 --RM-PIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKK 424 (474)
T ss_pred --cC-CCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcc
Confidence 11 112234456666777999999999999999999998776544
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=348.84 Aligned_cols=246 Identities=25% Similarity=0.362 Sum_probs=208.3
Q ss_pred cCCCCCCccccCCCEEEEEeEeC-CCcEEEEEEccccch--hcHHHHHHHHHHHHhhccCCcceeEeEEEcCceeEEEEE
Q 001658 693 ENFSPSNKLGEGGFGPVYKGKLG-DGRAIAVKQLSVASR--QGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLVYE 769 (1036)
Q Consensus 693 ~~~~~~~~iG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~--~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E 769 (1036)
++|.+.+.||+|.||.||||+.+ +.+.||+|.+.+..+ .+.+...+|++++++++|||||.++++|....+.++|+|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 46778889999999999999854 678999999976433 345668899999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeecCCCC
Q 001658 770 YLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKT 849 (1036)
Q Consensus 770 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~ 849 (1036)
|+.+ +|..+|.. ...+++..+..|+.++..||.|||+.. |+|||+||.|||++.++.+|+||||+|+.+.. .+
T Consensus 82 ~a~g-~L~~il~~--d~~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~-~t 154 (808)
T KOG0597|consen 82 YAVG-DLFTILEQ--DGKLPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLARAMST-NT 154 (808)
T ss_pred hhhh-hHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhhhccc-Cc
Confidence 9976 99999954 456889999999999999999999998 99999999999999999999999999997764 44
Q ss_pred ccccccccccCccCccccccCCCCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhcCccccccCccccc
Q 001658 850 HISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEIELADPKLIE 929 (1036)
Q Consensus 850 ~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~ 929 (1036)
..-+.+.||+-|||||...++.|+..+|+||+|||+||+++|++||... ....+++.+ . .||. .
T Consensus 155 ~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~---si~~Lv~~I---~--------~d~v--~ 218 (808)
T KOG0597|consen 155 SVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYAR---SITQLVKSI---L--------KDPV--K 218 (808)
T ss_pred eeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHH---HHHHHHHHH---h--------cCCC--C
Confidence 4556788999999999999999999999999999999999999999753 223333211 1 1221 2
Q ss_pred CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 001658 930 FNEEEVKRLIGVALLCTQTLPSLRPSMSRVVA 961 (1036)
Q Consensus 930 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 961 (1036)
++.+....+..+....+.+||..|-|..+++.
T Consensus 219 ~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~ 250 (808)
T KOG0597|consen 219 PPSTASSSFVNFLQGLLIKDPAQRLTWTDLLG 250 (808)
T ss_pred CcccccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence 23355667778888899999999999999875
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=333.09 Aligned_cols=268 Identities=22% Similarity=0.319 Sum_probs=206.1
Q ss_pred HHHhcCCCCCCccccCCCEEEEEeEeCCCcEEEEEEccccchhcHHHHHHHHHHHH--hhccCCcceeEeEEEcC----c
Q 001658 689 KTATENFSPSNKLGEGGFGPVYKGKLGDGRAIAVKQLSVASRQGKSQFVAEIATIS--AVQHRNLVKLHGCCIEG----A 762 (1036)
Q Consensus 689 ~~~~~~~~~~~~iG~G~fG~Vy~~~~~~g~~vAvK~~~~~~~~~~~~f~~Ei~~L~--~l~H~nIv~l~g~~~~~----~ 762 (1036)
+.........+.||+|.||.||+|++ .|+.||||++...+ ++.+.+|.++.+ .++|+||+.+++.-..+ .
T Consensus 207 RTiarqI~L~e~IGkGRyGEVwrG~w-rGe~VAVKiF~srd---E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~T 282 (513)
T KOG2052|consen 207 RTIARQIVLQEIIGKGRFGEVWRGRW-RGEDVAVKIFSSRD---ERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWT 282 (513)
T ss_pred HhhhheeEEEEEecCccccceeeccc-cCCceEEEEecccc---hhhhhhHHHHHHHHHhccchhhhhhhccccCCCceE
Confidence 44567788889999999999999999 57899999997443 334555655555 46999999999986544 3
Q ss_pred eeEEEEEecCCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHh-----cCCccccccccCCCcEEecCCCceEEEE
Q 001658 763 ERLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHE-----ESRVRIIHRDVKASNVLLDADLVPKISD 837 (1036)
Q Consensus 763 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-----~~~~~ivHrDikp~NILl~~~~~~kl~D 837 (1036)
+.|||++|.+.|||+|||.. ..++-...++++..+|.||+|||- +|+|.|.|||||++|||+..++.+.|+|
T Consensus 283 QLwLvTdYHe~GSL~DyL~r---~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IAD 359 (513)
T KOG2052|consen 283 QLWLVTDYHEHGSLYDYLNR---NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIAD 359 (513)
T ss_pred EEEEeeecccCCcHHHHHhh---ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEee
Confidence 57999999999999999953 678999999999999999999995 4789999999999999999999999999
Q ss_pred cCcceeecCCCCcc---ccccccccCccCccccccCC----C-C-chhhHHhHHHHHHHHHh----------CCCCCCCC
Q 001658 838 FGLAKLYDDKKTHI---STRVAGTIGYLAPEYAMRGH----L-T-EKTDVFAFGVLALETVS----------GRPNSDPS 898 (1036)
Q Consensus 838 FGla~~~~~~~~~~---~~~~~gt~~y~APE~~~~~~----~-~-~ksDVwS~Gvvl~ellt----------G~~p~~~~ 898 (1036)
+|+|.......... ....+||.+|||||++...- + + ..+||||||.|+||+.. -++||+..
T Consensus 360 LGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~ 439 (513)
T KOG2052|consen 360 LGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDV 439 (513)
T ss_pred ceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccC
Confidence 99998776553322 34567999999999996432 1 1 26999999999999976 24666654
Q ss_pred ChhhHHHHHHHHHHHhhcCccccccCccc--ccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcccCC
Q 001658 899 LDEEKLYLLEWAWHLHENNQEIELADPKL--IEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVAMLCGDMEV 969 (1036)
Q Consensus 899 ~~~~~~~l~~~~~~~~~~~~~~~~~d~~~--~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~ 969 (1036)
.+.+.... -+.+. --.+...|.+ .....+.+..+.++|..||..+|..|-|+-.+-+.|.+..+.
T Consensus 440 Vp~DPs~e--eMrkV----VCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~~ 506 (513)
T KOG2052|consen 440 VPSDPSFE--EMRKV----VCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSNS 506 (513)
T ss_pred CCCCCCHH--HHhcc----eeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhcC
Confidence 33222210 00000 1122233433 234568889999999999999999999999999888876543
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=341.39 Aligned_cols=245 Identities=18% Similarity=0.253 Sum_probs=198.8
Q ss_pred CccccCCCEEEEEeEeCCCcEEEEEEccccchhc---HHHHHHHHHHHHhhccCCcceeEeEEEc----CceeEEEEEec
Q 001658 699 NKLGEGGFGPVYKGKLGDGRAIAVKQLSVASRQG---KSQFVAEIATISAVQHRNLVKLHGCCIE----GAERLLVYEYL 771 (1036)
Q Consensus 699 ~~iG~G~fG~Vy~~~~~~g~~vAvK~~~~~~~~~---~~~f~~Ei~~L~~l~H~nIv~l~g~~~~----~~~~~lV~E~~ 771 (1036)
..||+|++|.||+|++ +|+.||||.++...... .+.|.+|+.+|.+++||||++++|++.+ ....++||||+
T Consensus 26 ~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~ 104 (283)
T PHA02988 26 VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC 104 (283)
T ss_pred eEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence 6799999999999998 68999999997543332 4678899999999999999999999876 34678999999
Q ss_pred CCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhc-CCccccccccCCCcEEecCCCceEEEEcCcceeecCCCCc
Q 001658 772 ENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEE-SRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTH 850 (1036)
Q Consensus 772 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~ 850 (1036)
++|+|.+++... ..++|....+++.+++.||+|||+. + ++||||||+||++++++.+||+|||+++.+....
T Consensus 105 ~~g~L~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~---~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~-- 177 (283)
T PHA02988 105 TRGYLREVLDKE--KDLSFKTKLDMAIDCCKGLYNLYKYTN---KPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP-- 177 (283)
T ss_pred CCCcHHHHHhhC--CCCChhHHHHHHHHHHHHHHHHHhcCC---CCCCcCChhhEEECCCCcEEEcccchHhhhcccc--
Confidence 999999999653 4688999999999999999999985 5 7899999999999999999999999998654322
Q ss_pred cccccccccCccCcccccc--CCCCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhcCccccccCcccc
Q 001658 851 ISTRVAGTIGYLAPEYAMR--GHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEIELADPKLI 928 (1036)
Q Consensus 851 ~~~~~~gt~~y~APE~~~~--~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~ 928 (1036)
....|+..|+|||++.+ ..++.++|||||||++|||++|+.||......+....+ ...+. .+.+
T Consensus 178 --~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i------~~~~~-----~~~~- 243 (283)
T PHA02988 178 --FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLI------INKNN-----SLKL- 243 (283)
T ss_pred --ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHH------HhcCC-----CCCC-
Confidence 23458899999999976 68999999999999999999999999865433222111 11111 1111
Q ss_pred cCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhccc
Q 001658 929 EFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVAMLCGDM 967 (1036)
Q Consensus 929 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~ 967 (1036)
+......+.+++.+||+.||++|||++|+++.|+...
T Consensus 244 --~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~ 280 (283)
T PHA02988 244 --PLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK 280 (283)
T ss_pred --CCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence 1123346778888999999999999999999998643
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-37 Score=343.72 Aligned_cols=260 Identities=27% Similarity=0.407 Sum_probs=202.7
Q ss_pred cCCCCCCccccCCCEEEEEeEeCC-----------------CcEEEEEEcccc-chhcHHHHHHHHHHHHhhccCCccee
Q 001658 693 ENFSPSNKLGEGGFGPVYKGKLGD-----------------GRAIAVKQLSVA-SRQGKSQFVAEIATISAVQHRNLVKL 754 (1036)
Q Consensus 693 ~~~~~~~~iG~G~fG~Vy~~~~~~-----------------g~~vAvK~~~~~-~~~~~~~f~~Ei~~L~~l~H~nIv~l 754 (1036)
++|.+.++||+|+||.||+|...+ +..||+|.+... ......+|.+|++++.+++||||+++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 84 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL 84 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence 567888999999999999997532 346999998754 23345679999999999999999999
Q ss_pred EeEEEcCceeEEEEEecCCCChhhhhhcCC-----------------CCCcChHHHHHHHHHHHHHHHHHHhcCCccccc
Q 001658 755 HGCCIEGAERLLVYEYLENKSLDQALFGQR-----------------SLTLDWATRYEICSGVARGLAYLHEESRVRIIH 817 (1036)
Q Consensus 755 ~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~-----------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH 817 (1036)
++++.+.+..++||||+++|+|.+++.... ...++|..+++++.||++||+|||+.+ |+|
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---ivH 161 (304)
T cd05096 85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FVH 161 (304)
T ss_pred EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---ccc
Confidence 999999999999999999999999885432 134788899999999999999999988 999
Q ss_pred cccCCCcEEecCCCceEEEEcCcceeecCCCCc-cccccccccCccCccccccCCCCchhhHHhHHHHHHHHHh--CCCC
Q 001658 818 RDVKASNVLLDADLVPKISDFGLAKLYDDKKTH-ISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVS--GRPN 894 (1036)
Q Consensus 818 rDikp~NILl~~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~ellt--G~~p 894 (1036)
|||||+|||+++++.+||+|||+++.+...... ......++..|+|||++..+.++.++||||||+++|||++ +..|
T Consensus 162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p 241 (304)
T cd05096 162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP 241 (304)
T ss_pred cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCC
Confidence 999999999999999999999999866433221 1223446789999999998899999999999999999987 4566
Q ss_pred CCCCChhhHHHHHHHHHHHhhcC-ccccccCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 001658 895 SDPSLDEEKLYLLEWAWHLHENN-QEIELADPKLIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVAMLC 964 (1036)
Q Consensus 895 ~~~~~~~~~~~l~~~~~~~~~~~-~~~~~~d~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~ 964 (1036)
|......+. ...+....... ...... ........+.+++.+||+.+|.+|||+.||++.|+
T Consensus 242 ~~~~~~~~~---~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~ 303 (304)
T cd05096 242 YGELTDEQV---IENAGEFFRDQGRQVYLF------RPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT 303 (304)
T ss_pred CCcCCHHHH---HHHHHHHhhhcccccccc------CCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence 665433222 12221111111 111111 11123356788899999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=338.01 Aligned_cols=255 Identities=25% Similarity=0.359 Sum_probs=204.4
Q ss_pred cCCCCCCccccCCCEEEEEeEeC----CCcEEEEEEccccc-hhcHHHHHHHHHHHHhhccCCcceeEeEEEcCceeEEE
Q 001658 693 ENFSPSNKLGEGGFGPVYKGKLG----DGRAIAVKQLSVAS-RQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLV 767 (1036)
Q Consensus 693 ~~~~~~~~iG~G~fG~Vy~~~~~----~g~~vAvK~~~~~~-~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV 767 (1036)
++|++.+.||+|+||.||+|.+. .+..||+|.++... ......|.+|+.++.+++||||++++|++..++..++|
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 84 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIV 84 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEE
Confidence 46788899999999999999753 35689999987542 33356789999999999999999999999999999999
Q ss_pred EEecCCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeecCC
Q 001658 768 YEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDK 847 (1036)
Q Consensus 768 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~ 847 (1036)
|||+++|+|.+++... ...+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.++++|||.+......
T Consensus 85 ~e~~~~~~L~~~l~~~-~~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~ 160 (266)
T cd05064 85 TEYMSNGALDSFLRKH-EGQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSE 160 (266)
T ss_pred EEeCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCccccccccc
Confidence 9999999999998654 346899999999999999999999987 999999999999999999999999987654322
Q ss_pred CCccccccccccCccCccccccCCCCchhhHHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHHHHHhhcCccccccCcc
Q 001658 848 KTHISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVS-GRPNSDPSLDEEKLYLLEWAWHLHENNQEIELADPK 926 (1036)
Q Consensus 848 ~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 926 (1036)
.........++..|+|||.+.+..++.++|||||||++||+++ |+.||......+... .. ..+. .+
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~---~~----~~~~-----~~- 227 (266)
T cd05064 161 AIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIK---AV----EDGF-----RL- 227 (266)
T ss_pred chhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHH---HH----HCCC-----CC-
Confidence 2111122345678999999999999999999999999999775 999997654332211 11 1111 00
Q ss_pred cccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcc
Q 001658 927 LIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVAMLCGD 966 (1036)
Q Consensus 927 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 966 (1036)
.........+.+++..||+.+|.+||++.|+.+.|++.
T Consensus 228 --~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 228 --PAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred --CCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 11122345677888999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-37 Score=337.33 Aligned_cols=252 Identities=23% Similarity=0.292 Sum_probs=201.2
Q ss_pred HHhcCCCCCCccccCCCEEEEEeEe-CCCcEEEEEEccccc---hhcHHHHHHHHHHHHhhccCCcceeEeEEEcCceeE
Q 001658 690 TATENFSPSNKLGEGGFGPVYKGKL-GDGRAIAVKQLSVAS---RQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERL 765 (1036)
Q Consensus 690 ~~~~~~~~~~~iG~G~fG~Vy~~~~-~~g~~vAvK~~~~~~---~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~ 765 (1036)
...++|+.+..||+|+||.||.|+- ..|..+|+|++++.. ....+....|-.+|...++|.||+++..|.+.+..|
T Consensus 138 ~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LY 217 (550)
T KOG0605|consen 138 LSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLY 217 (550)
T ss_pred CCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeE
Confidence 3567899999999999999999984 579999999998754 334566788999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeec
Q 001658 766 LVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYD 845 (1036)
Q Consensus 766 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~ 845 (1036)
|||||++||++..+|... ..+++......+.+++-|+.-||+.| +|||||||+|+|||..|++||+||||+.-+.
T Consensus 218 LiMEylPGGD~mTLL~~~--~~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~ 292 (550)
T KOG0605|consen 218 LIMEYLPGGDMMTLLMRK--DTLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFGLSTGLD 292 (550)
T ss_pred EEEEecCCccHHHHHHhc--CcCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeeccccccchhh
Confidence 999999999999999654 45666666677899999999999999 9999999999999999999999999985332
Q ss_pred CC-----------------------CC----cc-------------------ccccccccCccCccccccCCCCchhhHH
Q 001658 846 DK-----------------------KT----HI-------------------STRVAGTIGYLAPEYAMRGHLTEKTDVF 879 (1036)
Q Consensus 846 ~~-----------------------~~----~~-------------------~~~~~gt~~y~APE~~~~~~~~~ksDVw 879 (1036)
.. .. .. ....+|||.|||||++.+..|+..+|.|
T Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwW 372 (550)
T KOG0605|consen 293 KKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWW 372 (550)
T ss_pred hhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHH
Confidence 10 00 00 0125799999999999999999999999
Q ss_pred hHHHHHHHHHhCCCCCCCCChhhHHH-HHHHHHHHhhcCccccccCcccccCCHHHHHHHHHHHHHhcccCCCCCCC---
Q 001658 880 AFGVLALETVSGRPNSDPSLDEEKLY-LLEWAWHLHENNQEIELADPKLIEFNEEEVKRLIGVALLCTQTLPSLRPS--- 955 (1036)
Q Consensus 880 S~Gvvl~elltG~~p~~~~~~~~~~~-l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt--- 955 (1036)
|+|||+|||+.|.+||....+.+... ++.|..... -|.-.. .. .+..+++.+|+. ||++|--
T Consensus 373 SLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~---------fP~~~~-~s---~eA~DLI~rll~-d~~~RLG~~G 438 (550)
T KOG0605|consen 373 SLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLK---------FPEEVD-LS---DEAKDLITRLLC-DPENRLGSKG 438 (550)
T ss_pred HHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhcc---------CCCcCc-cc---HHHHHHHHHHhc-CHHHhcCccc
Confidence 99999999999999999888766543 444432211 111111 11 345566667777 9999975
Q ss_pred HHHHH
Q 001658 956 MSRVV 960 (1036)
Q Consensus 956 ~~evl 960 (1036)
+.||-
T Consensus 439 ~~EIK 443 (550)
T KOG0605|consen 439 AEEIK 443 (550)
T ss_pred HHHHh
Confidence 55543
|
|
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-37 Score=334.32 Aligned_cols=252 Identities=26% Similarity=0.406 Sum_probs=204.5
Q ss_pred cCCCCCCccccCCCEEEEEeEeCCCcEEEEEEccccchhcHHHHHHHHHHHHhhccCCcceeEeEEEcCceeEEEEEecC
Q 001658 693 ENFSPSNKLGEGGFGPVYKGKLGDGRAIAVKQLSVASRQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLVYEYLE 772 (1036)
Q Consensus 693 ~~~~~~~~iG~G~fG~Vy~~~~~~g~~vAvK~~~~~~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~~~ 772 (1036)
++|++.+.||+|+||.||+|+++++..+|+|.+.... ...++|.+|++++++++||||+++++++...+..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 82 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME 82 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence 3577788999999999999998888899999886432 335678999999999999999999999999999999999999
Q ss_pred CCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeecCCCCccc
Q 001658 773 NKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHIS 852 (1036)
Q Consensus 773 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 852 (1036)
+|+|.++++... ..+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||.++..........
T Consensus 83 ~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~~ 158 (256)
T cd05114 83 NGCLLNYLRQRQ-GKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSS 158 (256)
T ss_pred CCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccCCCceecc
Confidence 999999986543 35889999999999999999999988 99999999999999999999999999986543322222
Q ss_pred cccccccCccCccccccCCCCchhhHHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHHHHHhhcCccccccCcccccCC
Q 001658 853 TRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVS-GRPNSDPSLDEEKLYLLEWAWHLHENNQEIELADPKLIEFN 931 (1036)
Q Consensus 853 ~~~~gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~ 931 (1036)
....++..|+|||++.+..++.++||||||+++|||++ |+.||......+... .... +. ....+.
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~---~i~~----~~--~~~~~~----- 224 (256)
T cd05114 159 SGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVE---MISR----GF--RLYRPK----- 224 (256)
T ss_pred CCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHH---HHHC----CC--CCCCCC-----
Confidence 23345678999999988889999999999999999999 899987654322221 1111 11 011111
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 001658 932 EEEVKRLIGVALLCTQTLPSLRPSMSRVVAMLC 964 (1036)
Q Consensus 932 ~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~ 964 (1036)
.....+.+++.+||+.+|++||+++|+++.|.
T Consensus 225 -~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~ 256 (256)
T cd05114 225 -LASMTVYEVMYSCWHEKPEGRPTFAELLRAIT 256 (256)
T ss_pred -CCCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 12346788999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=341.95 Aligned_cols=250 Identities=24% Similarity=0.317 Sum_probs=201.3
Q ss_pred CCCCCccccCCCEEEEEeEe-CCCcEEEEEEccccc---hhcHHHHHHHHHHHHhhccCCcceeEeEEEcCceeEEEEEe
Q 001658 695 FSPSNKLGEGGFGPVYKGKL-GDGRAIAVKQLSVAS---RQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLVYEY 770 (1036)
Q Consensus 695 ~~~~~~iG~G~fG~Vy~~~~-~~g~~vAvK~~~~~~---~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~ 770 (1036)
|+..+.||+|+||.||+|.. .+|+.||+|.+.... ......+.+|+.++.+++|+||+++++++.+.+..++|+||
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence 66778999999999999985 578999999986432 22345678899999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeecCCCCc
Q 001658 771 LENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTH 850 (1036)
Q Consensus 771 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~ 850 (1036)
+++|+|.+++.......+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||++........
T Consensus 82 ~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~- 157 (285)
T cd05631 82 MNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET- 157 (285)
T ss_pred cCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCe-
Confidence 99999998886655567899999999999999999999988 99999999999999999999999999987643222
Q ss_pred cccccccccCccCccccccCCCCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhcCccccccCcccccC
Q 001658 851 ISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEIELADPKLIEF 930 (1036)
Q Consensus 851 ~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~ 930 (1036)
.....||..|+|||++.+..++.++|||||||++|||++|+.||............. ..... . ...+
T Consensus 158 -~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~---~~~~~--------~-~~~~ 224 (285)
T cd05631 158 -VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVD---RRVKE--------D-QEEY 224 (285)
T ss_pred -ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHH---HHhhc--------c-cccC
Confidence 234568999999999999999999999999999999999999998644322111110 00000 0 0111
Q ss_pred CHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 001658 931 NEEEVKRLIGVALLCTQTLPSLRPS-----MSRVVA 961 (1036)
Q Consensus 931 ~~~~~~~l~~l~~~Cl~~dP~~RPt-----~~evl~ 961 (1036)
..+....+.+++.+||+.||.+||+ ++++++
T Consensus 225 ~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 260 (285)
T cd05631 225 SEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ 260 (285)
T ss_pred CccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence 2223346777888999999999997 777765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=343.30 Aligned_cols=263 Identities=24% Similarity=0.343 Sum_probs=219.2
Q ss_pred HHHHhcCCCCCCccccCCCEEEEEeEeCC-CcEEEEEEccccchhcHHHHHHHHHHHHhhccCCcceeEeEEEcCceeEE
Q 001658 688 LKTATENFSPSNKLGEGGFGPVYKGKLGD-GRAIAVKQLSVASRQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLL 766 (1036)
Q Consensus 688 l~~~~~~~~~~~~iG~G~fG~Vy~~~~~~-g~~vAvK~~~~~~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~l 766 (1036)
.+....+....++||-|-||.||.|.|+. .-.||||.++.. ....++|..|..+|+.++|||+|+++|+|..+..+||
T Consensus 262 WEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED-tMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYI 340 (1157)
T KOG4278|consen 262 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYI 340 (1157)
T ss_pred hhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhc-chhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEE
Confidence 33334455677899999999999999864 567999999754 3457899999999999999999999999999999999
Q ss_pred EEEecCCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeecC
Q 001658 767 VYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDD 846 (1036)
Q Consensus 767 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~ 846 (1036)
|+|||..|+|.+||....+..++-...+.+|.||+.||.||..+. +|||||..+|+|+.++..+||+|||+++++..
T Consensus 341 iTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvADFGLsRlMtg 417 (1157)
T KOG4278|consen 341 ITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVADFGLSRLMTG 417 (1157)
T ss_pred EEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeeccchhhhhcC
Confidence 999999999999999888888888889999999999999999887 99999999999999999999999999999887
Q ss_pred CCCccccccccccCccCccccccCCCCchhhHHhHHHHHHHHHhC-CCCCCCCChhhHHHHHHHHHHHhhcCccccccCc
Q 001658 847 KKTHISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSG-RPNSDPSLDEEKLYLLEWAWHLHENNQEIELADP 925 (1036)
Q Consensus 847 ~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~elltG-~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 925 (1036)
+.........-++.|.|||-+....++.|+|||+|||+|||+.|. -.|+.+-.-...+.+. +.+.
T Consensus 418 DTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LL-------Ekgy------- 483 (1157)
T KOG4278|consen 418 DTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLL-------EKGY------- 483 (1157)
T ss_pred CceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHH-------hccc-------
Confidence 665554445557799999999999999999999999999999994 4555443323333333 2221
Q ss_pred ccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcccCC
Q 001658 926 KLIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVAMLCGDMEV 969 (1036)
Q Consensus 926 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~ 969 (1036)
+ .+.++.++..+.++|+.||++.|.+||+++|+.+.++.+...
T Consensus 484 R-M~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~~ 526 (1157)
T KOG4278|consen 484 R-MDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFSS 526 (1157)
T ss_pred c-ccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhcc
Confidence 1 123445666888999999999999999999999998865443
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-37 Score=345.98 Aligned_cols=251 Identities=22% Similarity=0.299 Sum_probs=205.0
Q ss_pred HHhcCCCCCCccccCCCEEEEEeEe-CCCcEEEEEEcccc----ch-hcHHHHHHHHHHHHhhc-cCCcceeEeEEEcCc
Q 001658 690 TATENFSPSNKLGEGGFGPVYKGKL-GDGRAIAVKQLSVA----SR-QGKSQFVAEIATISAVQ-HRNLVKLHGCCIEGA 762 (1036)
Q Consensus 690 ~~~~~~~~~~~iG~G~fG~Vy~~~~-~~g~~vAvK~~~~~----~~-~~~~~f~~Ei~~L~~l~-H~nIv~l~g~~~~~~ 762 (1036)
....+|.+.+.||+|+||+|+.|.. .+++.||+|++... .. ...+.+.+|+.++++++ ||||++++.++....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 3456888999999999999999974 47899999977543 11 23455668999999999 999999999999999
Q ss_pred eeEEEEEecCCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCC-CceEEEEcCcc
Q 001658 763 ERLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDAD-LVPKISDFGLA 841 (1036)
Q Consensus 763 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~-~~~kl~DFGla 841 (1036)
..++||||+.+|+|.+++.. ...+.+....+++.|++.|++|+|+.+ |+||||||+|||+|.+ +++||+|||++
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~--~g~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl~DFG~s 168 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVN--KGRLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKLSDFGLS 168 (370)
T ss_pred eEEEEEEecCCccHHHHHHH--cCCCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEEeccccc
Confidence 99999999999999999976 456777889999999999999999998 9999999999999999 99999999999
Q ss_pred eeecCCCCccccccccccCccCccccccCC-CC-chhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhcCcc
Q 001658 842 KLYDDKKTHISTRVAGTIGYLAPEYAMRGH-LT-EKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQE 919 (1036)
Q Consensus 842 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~-~~-~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 919 (1036)
.... .........+||+.|+|||++.+.. |+ .++||||+||+||-|++|+.||+..........+
T Consensus 169 ~~~~-~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki------------ 235 (370)
T KOG0583|consen 169 AISP-GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKI------------ 235 (370)
T ss_pred cccC-CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHH------------
Confidence 9874 2223345578999999999999877 75 7899999999999999999999974433222111
Q ss_pred ccccCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 001658 920 IELADPKLIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVA 961 (1036)
Q Consensus 920 ~~~~d~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 961 (1036)
......+..... ..++..++.+|++.+|.+|+++.+++.
T Consensus 236 -~~~~~~~p~~~~--S~~~~~Li~~mL~~~P~~R~t~~~i~~ 274 (370)
T KOG0583|consen 236 -RKGEFKIPSYLL--SPEARSLIEKMLVPDPSTRITLLEILE 274 (370)
T ss_pred -hcCCccCCCCcC--CHHHHHHHHHHcCCCcccCCCHHHHhh
Confidence 011111122221 456777888999999999999999983
|
|
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-37 Score=334.25 Aligned_cols=255 Identities=27% Similarity=0.417 Sum_probs=209.3
Q ss_pred hcCCCCCCccccCCCEEEEEeEeCCCcEEEEEEccccchhcHHHHHHHHHHHHhhccCCcceeEeEEEcCceeEEEEEec
Q 001658 692 TENFSPSNKLGEGGFGPVYKGKLGDGRAIAVKQLSVASRQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLVYEYL 771 (1036)
Q Consensus 692 ~~~~~~~~~iG~G~fG~Vy~~~~~~g~~vAvK~~~~~~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~~ 771 (1036)
.++|++.++||+|+||.||+|...+++.||+|.+..... ..+.+.+|+.++++++|+||+++++++...+..++||||+
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTM-SVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYM 83 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCch-hHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecC
Confidence 356888899999999999999988888999999865332 3568899999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeecCCCCcc
Q 001658 772 ENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHI 851 (1036)
Q Consensus 772 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 851 (1036)
++++|.+++.......+++.+++.++.|+++||+|||+.+ ++||||||+||++++++.++|+|||+++.........
T Consensus 84 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~ 160 (261)
T cd05072 84 AKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTA 160 (261)
T ss_pred CCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceecCCCceec
Confidence 9999999997766667899999999999999999999987 9999999999999999999999999998765433222
Q ss_pred ccccccccCccCccccccCCCCchhhHHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHHHHHhhcCccccccCcccccC
Q 001658 852 STRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVS-GRPNSDPSLDEEKLYLLEWAWHLHENNQEIELADPKLIEF 930 (1036)
Q Consensus 852 ~~~~~gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~ 930 (1036)
.....++..|+|||+.....++.++|||||||++|||+| |+.||......... .+.. .... .+..
T Consensus 161 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~---~~~~----~~~~----~~~~--- 226 (261)
T cd05072 161 REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVM---SALQ----RGYR----MPRM--- 226 (261)
T ss_pred cCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHH---HHHH----cCCC----CCCC---
Confidence 223346778999999998889999999999999999998 99998754433222 1111 1110 1111
Q ss_pred CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhc
Q 001658 931 NEEEVKRLIGVALLCTQTLPSLRPSMSRVVAMLCG 965 (1036)
Q Consensus 931 ~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~ 965 (1036)
......+.+++.+|++.+|++||+++++.++|+.
T Consensus 227 -~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 227 -ENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred -CCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 1123457788899999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=337.13 Aligned_cols=248 Identities=33% Similarity=0.532 Sum_probs=194.8
Q ss_pred CCccccCCCEEEEEeEeC-----CCcEEEEEEcccc-chhcHHHHHHHHHHHHhhccCCcceeEeEEEcCceeEEEEEec
Q 001658 698 SNKLGEGGFGPVYKGKLG-----DGRAIAVKQLSVA-SRQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLVYEYL 771 (1036)
Q Consensus 698 ~~~iG~G~fG~Vy~~~~~-----~g~~vAvK~~~~~-~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~~ 771 (1036)
.+.||.|.||.||+|.+. .+..|+||.++.. .....+.|.+|++.+++++||||++++|++...+..++|+||+
T Consensus 4 ~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~~ 83 (259)
T PF07714_consen 4 IKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEYC 83 (259)
T ss_dssp EEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE--
T ss_pred eeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccccc
Confidence 467999999999999875 3578999999653 3334788999999999999999999999999888899999999
Q ss_pred CCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeecCCCC-c
Q 001658 772 ENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKT-H 850 (1036)
Q Consensus 772 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~-~ 850 (1036)
++|+|.+++.......+++..+.+|+.||++||+|||+.+ |+|+||+++||++++++.+||+|||+++....... .
T Consensus 84 ~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~~ 160 (259)
T PF07714_consen 84 PGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKYK 160 (259)
T ss_dssp TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSEE
T ss_pred cccccccccccccccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccccc
Confidence 9999999998876678999999999999999999999987 99999999999999999999999999987632222 1
Q ss_pred cccccccccCccCccccccCCCCchhhHHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHHHHHhhcCccccccCccccc
Q 001658 851 ISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVS-GRPNSDPSLDEEKLYLLEWAWHLHENNQEIELADPKLIE 929 (1036)
Q Consensus 851 ~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~ 929 (1036)
......+...|+|||.+....++.++||||||+++|||++ |+.|+......+.. .. . ..+.. ..
T Consensus 161 ~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~---~~---~-~~~~~--------~~ 225 (259)
T PF07714_consen 161 NDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEII---EK---L-KQGQR--------LP 225 (259)
T ss_dssp ESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHH---HH---H-HTTEE--------TT
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccc---cc---c-ccccc--------ce
Confidence 2233456779999999999999999999999999999999 67887655332211 11 1 11111 11
Q ss_pred CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 001658 930 FNEEEVKRLIGVALLCTQTLPSLRPSMSRVVAML 963 (1036)
Q Consensus 930 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L 963 (1036)
........+.+++..||+.+|++||++.++++.|
T Consensus 226 ~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 226 IPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp SBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred eccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 1122345677888999999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=340.18 Aligned_cols=248 Identities=26% Similarity=0.403 Sum_probs=206.1
Q ss_pred cCCCCCCccccCCCEEEEEeEe-CCCcEEEEEEcccc-chhcHHHHHHHHHHHHhhccCCcceeEeEEEcCceeEEEEEe
Q 001658 693 ENFSPSNKLGEGGFGPVYKGKL-GDGRAIAVKQLSVA-SRQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLVYEY 770 (1036)
Q Consensus 693 ~~~~~~~~iG~G~fG~Vy~~~~-~~g~~vAvK~~~~~-~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~ 770 (1036)
..|+..+.||+|.||.||||.. ..++.||+|++... .+...++..+|+.+|.+++++||.++||.+..+...+++|||
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey 92 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY 92 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence 3466678999999999999984 46889999999764 344567889999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeecCCCCc
Q 001658 771 LENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTH 850 (1036)
Q Consensus 771 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~ 850 (1036)
|.+|++.+.+... ..+++....-|+.++..|+.|||.++ .+|||||+.|||+..+|.+||+|||++..+......
T Consensus 93 ~~gGsv~~lL~~~--~~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~r 167 (467)
T KOG0201|consen 93 CGGGSVLDLLKSG--NILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKR 167 (467)
T ss_pred hcCcchhhhhccC--CCCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeeeechhhc
Confidence 9999999999533 33477777778999999999999998 999999999999999999999999999887655443
Q ss_pred cccccccccCccCccccccCCCCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhcCccccccCcccccC
Q 001658 851 ISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEIELADPKLIEF 930 (1036)
Q Consensus 851 ~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~ 930 (1036)
. ..++||+.|||||++....|+.|+||||||++.+||.+|.+|+....+....+++ .+-.-|.+..
T Consensus 168 r-~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflI------------pk~~PP~L~~- 233 (467)
T KOG0201|consen 168 R-KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLI------------PKSAPPRLDG- 233 (467)
T ss_pred c-ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEec------------cCCCCCcccc-
Confidence 3 5678999999999999889999999999999999999999999865553322211 1112223322
Q ss_pred CHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 001658 931 NEEEVKRLIGVALLCTQTLPSLRPSMSRVVA 961 (1036)
Q Consensus 931 ~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 961 (1036)
.....+.+++..|++++|+.||++.++++
T Consensus 234 --~~S~~~kEFV~~CL~k~P~~RpsA~~LLK 262 (467)
T KOG0201|consen 234 --DFSPPFKEFVEACLDKNPEFRPSAKELLK 262 (467)
T ss_pred --ccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence 44455777778999999999999999976
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-37 Score=352.15 Aligned_cols=257 Identities=26% Similarity=0.426 Sum_probs=203.0
Q ss_pred cCCCCCCccccCCCEEEEEeEe------CCCcEEEEEEccccc-hhcHHHHHHHHHHHHhh-ccCCcceeEeEEEcCcee
Q 001658 693 ENFSPSNKLGEGGFGPVYKGKL------GDGRAIAVKQLSVAS-RQGKSQFVAEIATISAV-QHRNLVKLHGCCIEGAER 764 (1036)
Q Consensus 693 ~~~~~~~~iG~G~fG~Vy~~~~------~~g~~vAvK~~~~~~-~~~~~~f~~Ei~~L~~l-~H~nIv~l~g~~~~~~~~ 764 (1036)
++|++.+.||+|+||.||+|+. ..+..||||+++... ....+.+.+|+.++..+ +||||++++++|.+.+..
T Consensus 35 ~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~ 114 (375)
T cd05104 35 NRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGPT 114 (375)
T ss_pred HHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCcc
Confidence 4677889999999999999963 245689999986432 33456788999999999 899999999999999999
Q ss_pred EEEEEecCCCChhhhhhcCC------------------------------------------------------------
Q 001658 765 LLVYEYLENKSLDQALFGQR------------------------------------------------------------ 784 (1036)
Q Consensus 765 ~lV~E~~~~gsL~~~l~~~~------------------------------------------------------------ 784 (1036)
++||||+++|+|.+++....
T Consensus 115 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (375)
T cd05104 115 LVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSY 194 (375)
T ss_pred eeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccccccee
Confidence 99999999999999986432
Q ss_pred -------------CCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeecCCCCcc
Q 001658 785 -------------SLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHI 851 (1036)
Q Consensus 785 -------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 851 (1036)
...++|..+.+++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++.........
T Consensus 195 ~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 271 (375)
T cd05104 195 IDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYV 271 (375)
T ss_pred cccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccCccccc
Confidence 125788999999999999999999987 9999999999999999999999999998764332211
Q ss_pred -ccccccccCccCccccccCCCCchhhHHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHHHHHhhcCccccccCccccc
Q 001658 852 -STRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVS-GRPNSDPSLDEEKLYLLEWAWHLHENNQEIELADPKLIE 929 (1036)
Q Consensus 852 -~~~~~gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~ 929 (1036)
.....++..|+|||++.+..++.++|||||||++|||++ |..||......... ..+. ..+.. ...+ .
T Consensus 272 ~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~--~~~~----~~~~~--~~~~---~ 340 (375)
T cd05104 272 VKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKF--YKMI----KEGYR--MLSP---E 340 (375)
T ss_pred ccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHH--HHHH----HhCcc--CCCC---C
Confidence 122335678999999999999999999999999999998 88888654332211 1111 11110 0011 1
Q ss_pred CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcc
Q 001658 930 FNEEEVKRLIGVALLCTQTLPSLRPSMSRVVAMLCGD 966 (1036)
Q Consensus 930 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 966 (1036)
. ...++.+++.+||+.||++||++.||+++|++.
T Consensus 341 ~---~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 341 C---APSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred C---CCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 1 134677888999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=333.78 Aligned_cols=256 Identities=29% Similarity=0.423 Sum_probs=212.8
Q ss_pred HhcCCCCCCccccCCCEEEEEeEeCCCcEEEEEEccccchhcHHHHHHHHHHHHhhccCCcceeEeEEEcCceeEEEEEe
Q 001658 691 ATENFSPSNKLGEGGFGPVYKGKLGDGRAIAVKQLSVASRQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLVYEY 770 (1036)
Q Consensus 691 ~~~~~~~~~~iG~G~fG~Vy~~~~~~g~~vAvK~~~~~~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~ 770 (1036)
...+|+..+.||+|+||.||+|...+++.+|+|.+..........+..|+.+++.++|+||+++++++.+.+..++||||
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 83 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITEL 83 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEee
Confidence 44568888999999999999999888999999999866655567899999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeecCCCCc
Q 001658 771 LENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTH 850 (1036)
Q Consensus 771 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~ 850 (1036)
+++++|.+++.......+++..++.++.|+++||+|||+.+ |+||||||+||++++++.+||+|||.+.........
T Consensus 84 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~ 160 (261)
T cd05148 84 MEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYL 160 (261)
T ss_pred cccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhcCCcccc
Confidence 99999999998766677899999999999999999999988 999999999999999999999999999876433222
Q ss_pred cccccccccCccCccccccCCCCchhhHHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHHHHHhhcCccccccCccccc
Q 001658 851 ISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVS-GRPNSDPSLDEEKLYLLEWAWHLHENNQEIELADPKLIE 929 (1036)
Q Consensus 851 ~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~ 929 (1036)
.....++..|+|||++.+..++.++||||||+++|||++ |+.||......+.... .. ... .+.
T Consensus 161 -~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~---~~----~~~-----~~~--- 224 (261)
T cd05148 161 -SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQ---IT----AGY-----RMP--- 224 (261)
T ss_pred -ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHH---HH----hCC-----cCC---
Confidence 123346778999999998899999999999999999998 8899876543322221 11 000 011
Q ss_pred CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhc
Q 001658 930 FNEEEVKRLIGVALLCTQTLPSLRPSMSRVVAMLCG 965 (1036)
Q Consensus 930 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~ 965 (1036)
........+.+++.+||+.+|.+|||+.++++.|+.
T Consensus 225 ~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 225 CPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN 260 (261)
T ss_pred CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence 112223467788899999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=331.26 Aligned_cols=255 Identities=28% Similarity=0.412 Sum_probs=208.7
Q ss_pred hcCCCCCCccccCCCEEEEEeEeCCCcEEEEEEccccchhcHHHHHHHHHHHHhhccCCcceeEeEEEcCceeEEEEEec
Q 001658 692 TENFSPSNKLGEGGFGPVYKGKLGDGRAIAVKQLSVASRQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLVYEYL 771 (1036)
Q Consensus 692 ~~~~~~~~~iG~G~fG~Vy~~~~~~g~~vAvK~~~~~~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~~ 771 (1036)
.++|++.+.||+|+||.||+|...+++.||+|.++... ...+++.+|+.++++++|+||+++++++...+..++||||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELM 83 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecc
Confidence 45688889999999999999998778899999987543 33567899999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeecCCCCcc
Q 001658 772 ENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHI 851 (1036)
Q Consensus 772 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 851 (1036)
++++|.+++.......+++..+.+++.|++.|+.|||+.+ |+||||||+||++++++.+||+|||+++.........
T Consensus 84 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~ 160 (261)
T cd05068 84 KYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEA 160 (261)
T ss_pred cCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEEccCCcccc
Confidence 9999999997655567899999999999999999999987 9999999999999999999999999998775332221
Q ss_pred ccccccccCccCccccccCCCCchhhHHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHHHHHhhcCccccccCcccccC
Q 001658 852 STRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVS-GRPNSDPSLDEEKLYLLEWAWHLHENNQEIELADPKLIEF 930 (1036)
Q Consensus 852 ~~~~~gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~ 930 (1036)
......+..|+|||++.+..++.++||||||+++|||++ |+.||............ .... .. ..
T Consensus 161 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~-------~~~~-----~~---~~ 225 (261)
T cd05068 161 REGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQV-------DQGY-----RM---PC 225 (261)
T ss_pred cCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH-------HcCC-----CC---CC
Confidence 122223458999999998899999999999999999999 99998765432222111 1110 00 01
Q ss_pred CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhc
Q 001658 931 NEEEVKRLIGVALLCTQTLPSLRPSMSRVVAMLCG 965 (1036)
Q Consensus 931 ~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~ 965 (1036)
.......+.+++.+|++.+|.+||++.++++.|+.
T Consensus 226 ~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 226 PPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred CCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 12233567888899999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=334.71 Aligned_cols=255 Identities=28% Similarity=0.484 Sum_probs=206.7
Q ss_pred cCCCCCCccccCCCEEEEEeEeCC------CcEEEEEEccccc-hhcHHHHHHHHHHHHhhccCCcceeEeEEEcCceeE
Q 001658 693 ENFSPSNKLGEGGFGPVYKGKLGD------GRAIAVKQLSVAS-RQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERL 765 (1036)
Q Consensus 693 ~~~~~~~~iG~G~fG~Vy~~~~~~------g~~vAvK~~~~~~-~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~ 765 (1036)
++|++.+.||+|+||.||+|.... ...||+|.+.... ......|.+|+.++.+++||||+++++++...+..+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 467788999999999999997532 2579999986432 334567899999999999999999999999989999
Q ss_pred EEEEecCCCChhhhhhcCCC--------------CCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCC
Q 001658 766 LVYEYLENKSLDQALFGQRS--------------LTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADL 831 (1036)
Q Consensus 766 lV~E~~~~gsL~~~l~~~~~--------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~ 831 (1036)
++|||+++++|.+++..... ..+++..++.++.|++.||+|||+.+ |+||||||+||++++++
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGL 161 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcCCC
Confidence 99999999999999865421 45788999999999999999999988 99999999999999999
Q ss_pred ceEEEEcCcceeecCCCC-ccccccccccCccCccccccCCCCchhhHHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHH
Q 001658 832 VPKISDFGLAKLYDDKKT-HISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVS-GRPNSDPSLDEEKLYLLEW 909 (1036)
Q Consensus 832 ~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~ 909 (1036)
.+||+|||+++....... .......+++.|+|||++.+..++.++|||||||++|||++ |..||......+....+
T Consensus 162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~i-- 239 (283)
T cd05048 162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMI-- 239 (283)
T ss_pred cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH--
Confidence 999999999986543322 12233456889999999998899999999999999999998 99999865443322111
Q ss_pred HHHHhhcCccccccCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhc
Q 001658 910 AWHLHENNQEIELADPKLIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVAMLCG 965 (1036)
Q Consensus 910 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~ 965 (1036)
.... ...........+.+++.+||+.+|.+||++.||++.|++
T Consensus 240 -----~~~~--------~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 240 -----RSRQ--------LLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred -----HcCC--------cCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 0110 111223344678888999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=331.08 Aligned_cols=252 Identities=26% Similarity=0.410 Sum_probs=204.4
Q ss_pred cCCCCCCccccCCCEEEEEeEeCCCcEEEEEEccccchhcHHHHHHHHHHHHhhccCCcceeEeEEEcCceeEEEEEecC
Q 001658 693 ENFSPSNKLGEGGFGPVYKGKLGDGRAIAVKQLSVASRQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLVYEYLE 772 (1036)
Q Consensus 693 ~~~~~~~~iG~G~fG~Vy~~~~~~g~~vAvK~~~~~~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~~~ 772 (1036)
++|++.+.||+|+||.||+|+..++..||+|.+.... ...+.|.+|+.++++++||||+++++++...+..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS 82 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence 3567788999999999999998777789999987433 335679999999999999999999999998888999999999
Q ss_pred CCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeecCCCCccc
Q 001658 773 NKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHIS 852 (1036)
Q Consensus 773 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 852 (1036)
+|+|.+++..... .+++..+++++.||+.||+|||+.+ ++|+||||+||++++++.+||+|||+++..........
T Consensus 83 ~~~l~~~i~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~ 158 (256)
T cd05113 83 NGCLLNYLREHGK-RFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSS 158 (256)
T ss_pred CCcHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecCCCceeec
Confidence 9999999865433 6899999999999999999999987 99999999999999999999999999986644332222
Q ss_pred cccccccCccCccccccCCCCchhhHHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHHHHHhhcCccccccCcccccCC
Q 001658 853 TRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVS-GRPNSDPSLDEEKLYLLEWAWHLHENNQEIELADPKLIEFN 931 (1036)
Q Consensus 853 ~~~~gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~ 931 (1036)
....++..|+|||+..+..++.++|||||||++|||++ |+.||......+..... . .+.. +. ..
T Consensus 159 ~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~------~-~~~~-----~~---~~ 223 (256)
T cd05113 159 VGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKV------S-QGLR-----LY---RP 223 (256)
T ss_pred CCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHH------h-cCCC-----CC---CC
Confidence 22345678999999998889999999999999999999 99998765433221111 1 1100 00 01
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 001658 932 EEEVKRLIGVALLCTQTLPSLRPSMSRVVAMLC 964 (1036)
Q Consensus 932 ~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~ 964 (1036)
......+.+++.+||+.+|.+||++.++++.|+
T Consensus 224 ~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 224 HLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred CCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 112357788899999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=344.25 Aligned_cols=253 Identities=22% Similarity=0.257 Sum_probs=204.4
Q ss_pred cCCCCCCccccCCCEEEEEeEeC-CCcEEEEEEccccc---hhcHHHHHHHHHHHHhhccCCcceeEeEEEcCceeEEEE
Q 001658 693 ENFSPSNKLGEGGFGPVYKGKLG-DGRAIAVKQLSVAS---RQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLVY 768 (1036)
Q Consensus 693 ~~~~~~~~iG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~ 768 (1036)
++|++.+.||+|+||.||+|+.. +++.||+|++.... ......+..|++++..++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 36888899999999999999865 58899999987532 233456889999999999999999999999999999999
Q ss_pred EecCCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeecCCC
Q 001658 769 EYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKK 848 (1036)
Q Consensus 769 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~ 848 (1036)
||+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 81 e~~~g~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~-- 153 (333)
T cd05600 81 EYVPGGDFRTLLNNL--GVLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIVT-- 153 (333)
T ss_pred eCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCCccccc--
Confidence 999999999999643 45788899999999999999999988 99999999999999999999999999986543
Q ss_pred CccccccccccCccCccccccCCCCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhcCccccccCcccc
Q 001658 849 THISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEIELADPKLI 928 (1036)
Q Consensus 849 ~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~ 928 (1036)
......||+.|+|||++.+..++.++|||||||++|||++|+.||......+....+.. + ......|...
T Consensus 154 --~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~----~----~~~~~~~~~~ 223 (333)
T cd05600 154 --YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKY----W----KETLQRPVYD 223 (333)
T ss_pred --ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHh----c----cccccCCCCC
Confidence 22345699999999999999999999999999999999999999986554333221110 0 0001111111
Q ss_pred cCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 001658 929 EFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVAM 962 (1036)
Q Consensus 929 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 962 (1036)
.........+.+++.+|++.+|.+||++.|+++.
T Consensus 224 ~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 224 DPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred ccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 1112234567778889999999999999999875
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=350.69 Aligned_cols=259 Identities=28% Similarity=0.455 Sum_probs=203.5
Q ss_pred hcCCCCCCccccCCCEEEEEeEe------CCCcEEEEEEccccc-hhcHHHHHHHHHHHHhh-ccCCcceeEeEEEcCce
Q 001658 692 TENFSPSNKLGEGGFGPVYKGKL------GDGRAIAVKQLSVAS-RQGKSQFVAEIATISAV-QHRNLVKLHGCCIEGAE 763 (1036)
Q Consensus 692 ~~~~~~~~~iG~G~fG~Vy~~~~------~~g~~vAvK~~~~~~-~~~~~~f~~Ei~~L~~l-~H~nIv~l~g~~~~~~~ 763 (1036)
.++|++.+.||+|+||.||+|+. .+++.||+|+++... ......+.+|+++++.+ +|+|||+++++|...+.
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~ 116 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGP 116 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCC
Confidence 34688889999999999999873 234579999997532 33356788999999999 89999999999999999
Q ss_pred eEEEEEecCCCChhhhhhcCC-----------------------------------------------------------
Q 001658 764 RLLVYEYLENKSLDQALFGQR----------------------------------------------------------- 784 (1036)
Q Consensus 764 ~~lV~E~~~~gsL~~~l~~~~----------------------------------------------------------- 784 (1036)
.++||||+++|+|.+++....
T Consensus 117 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (374)
T cd05106 117 VLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSD 196 (374)
T ss_pred eEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccccc
Confidence 999999999999999885421
Q ss_pred ---------CCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeecCCCCc-cccc
Q 001658 785 ---------SLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTH-ISTR 854 (1036)
Q Consensus 785 ---------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~-~~~~ 854 (1036)
...+++..+++|+.||++||+|||+.+ |+||||||+|||+++++.+||+|||+++........ ....
T Consensus 197 ~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~ 273 (374)
T cd05106 197 SKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGN 273 (374)
T ss_pred ccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccC
Confidence 124788899999999999999999987 999999999999999999999999999865433221 1122
Q ss_pred cccccCccCccccccCCCCchhhHHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHHHHHhhcCccccccCcccccCCHH
Q 001658 855 VAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVS-GRPNSDPSLDEEKLYLLEWAWHLHENNQEIELADPKLIEFNEE 933 (1036)
Q Consensus 855 ~~gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~ 933 (1036)
..++..|||||++.+..++.++|||||||++|||++ |+.||.......... . ....+ ..+.....
T Consensus 274 ~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~--~----~~~~~-----~~~~~~~~--- 339 (374)
T cd05106 274 ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFY--K----MVKRG-----YQMSRPDF--- 339 (374)
T ss_pred CCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHH--H----HHHcc-----cCccCCCC---
Confidence 335678999999998899999999999999999997 999987643322111 0 11111 01111111
Q ss_pred HHHHHHHHHHHhcccCCCCCCCHHHHHHHhhccc
Q 001658 934 EVKRLIGVALLCTQTLPSLRPSMSRVVAMLCGDM 967 (1036)
Q Consensus 934 ~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~ 967 (1036)
....+.+++.+||+.+|.+||++.+|+++|++++
T Consensus 340 ~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 340 APPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 1346778888999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=341.75 Aligned_cols=241 Identities=22% Similarity=0.248 Sum_probs=195.6
Q ss_pred CccccCCCEEEEEeEe-CCCcEEEEEEccccc---hhcHHHHHHHHHHHHhhccCCcceeEeEEEcCceeEEEEEecCCC
Q 001658 699 NKLGEGGFGPVYKGKL-GDGRAIAVKQLSVAS---RQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLVYEYLENK 774 (1036)
Q Consensus 699 ~~iG~G~fG~Vy~~~~-~~g~~vAvK~~~~~~---~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~g 774 (1036)
+.||+|+||.||+++. .+|+.||+|+++... ......+.+|++++++++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999985 478999999987532 233456788999999999999999999999999999999999999
Q ss_pred ChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeecCCCCccccc
Q 001658 775 SLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTR 854 (1036)
Q Consensus 775 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 854 (1036)
+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++....... ....
T Consensus 81 ~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~-~~~~ 154 (323)
T cd05571 81 ELFFHLSRE--RVFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGA-TMKT 154 (323)
T ss_pred cHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCC-cccc
Confidence 999998643 46789999999999999999999998 99999999999999999999999999875432221 1234
Q ss_pred cccccCccCccccccCCCCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhcCccccccCcccccCCHHH
Q 001658 855 VAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEIELADPKLIEFNEEE 934 (1036)
Q Consensus 855 ~~gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 934 (1036)
..||+.|+|||++.+..++.++|||||||++|||++|+.||............ .. .+..+ +...
T Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~------~~-------~~~~~---p~~~ 218 (323)
T cd05571 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI------LM-------EEIRF---PRTL 218 (323)
T ss_pred eecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHH------Hc-------CCCCC---CCCC
Confidence 56999999999999999999999999999999999999999765432221111 00 01111 1222
Q ss_pred HHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 001658 935 VKRLIGVALLCTQTLPSLRP-----SMSRVVA 961 (1036)
Q Consensus 935 ~~~l~~l~~~Cl~~dP~~RP-----t~~evl~ 961 (1036)
...+.+++.+|++.||++|| ++.++++
T Consensus 219 ~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 219 SPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME 250 (323)
T ss_pred CHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence 34567788899999999999 7888865
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=330.10 Aligned_cols=255 Identities=25% Similarity=0.358 Sum_probs=207.0
Q ss_pred cCCCCCCccccCCCEEEEEeEeC-CCcEEEEEEccccchhcHHHHHHHHHHHHhhccCCcceeEeEEEcCceeEEEEEec
Q 001658 693 ENFSPSNKLGEGGFGPVYKGKLG-DGRAIAVKQLSVASRQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLVYEYL 771 (1036)
Q Consensus 693 ~~~~~~~~iG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~~ 771 (1036)
.+|...+.||+|+||.||+|... .++.||+|.+.... ....++.+|++++++++|+||+++++++...+..++||||+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 84 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc-hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence 34677789999999999999864 58899999987433 33567899999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeecCCCCcc
Q 001658 772 ENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHI 851 (1036)
Q Consensus 772 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 851 (1036)
++++|.+++.......+++..++.++.|+++||+|||+.+ ++||||||+||++++++.+||+|||++..........
T Consensus 85 ~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~~ 161 (263)
T cd05052 85 TYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTA 161 (263)
T ss_pred CCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCccccccccceeec
Confidence 9999999997666667899999999999999999999987 9999999999999999999999999998765433222
Q ss_pred ccccccccCccCccccccCCCCchhhHHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHHHHHhhcCccccccCcccccC
Q 001658 852 STRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVS-GRPNSDPSLDEEKLYLLEWAWHLHENNQEIELADPKLIEF 930 (1036)
Q Consensus 852 ~~~~~gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~ 930 (1036)
.....++..|+|||++.+..++.++|||||||++|||++ |..|+......+.... ..... .+. .
T Consensus 162 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~-------~~~~~-----~~~---~ 226 (263)
T cd05052 162 HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYEL-------LEKGY-----RME---R 226 (263)
T ss_pred cCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH-------HHCCC-----CCC---C
Confidence 222334668999999998899999999999999999998 8888875433222111 11110 111 1
Q ss_pred CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcc
Q 001658 931 NEEEVKRLIGVALLCTQTLPSLRPSMSRVVAMLCGD 966 (1036)
Q Consensus 931 ~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 966 (1036)
.......+.+++.+||+.+|++||++.|++++|+..
T Consensus 227 ~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 227 PEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred CCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 112235677788999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-36 Score=328.95 Aligned_cols=255 Identities=27% Similarity=0.430 Sum_probs=206.1
Q ss_pred cCCCCCCccccCCCEEEEEeEeCC----CcEEEEEEcccc-chhcHHHHHHHHHHHHhhccCCcceeEeEEEcCceeEEE
Q 001658 693 ENFSPSNKLGEGGFGPVYKGKLGD----GRAIAVKQLSVA-SRQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLV 767 (1036)
Q Consensus 693 ~~~~~~~~iG~G~fG~Vy~~~~~~----g~~vAvK~~~~~-~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV 767 (1036)
++|++.+.||+|+||.||+|++.. ...||||.++.. .......|.+|+.++++++||||+++++++...+..++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 83 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII 83 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence 568889999999999999998642 457999998754 333456789999999999999999999999999999999
Q ss_pred EEecCCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeecCC
Q 001658 768 YEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDK 847 (1036)
Q Consensus 768 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~ 847 (1036)
|||+++++|.+++.... ..+++..+++++.|++.|++|||+.+ |+||||||+||++++++.++|+|||+++.+...
T Consensus 84 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~ 159 (266)
T cd05033 84 TEYMENGSLDKFLREND-GKFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDS 159 (266)
T ss_pred EEcCCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchhhccccc
Confidence 99999999999996543 36899999999999999999999987 999999999999999999999999999877522
Q ss_pred CCc-cccccccccCccCccccccCCCCchhhHHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHHHHHhhcCccccccCc
Q 001658 848 KTH-ISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVS-GRPNSDPSLDEEKLYLLEWAWHLHENNQEIELADP 925 (1036)
Q Consensus 848 ~~~-~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 925 (1036)
... ......++..|+|||.+.+..++.++||||||+++|||++ |..||......... ... .... ..+
T Consensus 160 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~---~~~----~~~~----~~~ 228 (266)
T cd05033 160 EATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVI---KAV----EDGY----RLP 228 (266)
T ss_pred ccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHH---HHH----HcCC----CCC
Confidence 221 1122345678999999998899999999999999999998 99998654432221 111 1110 001
Q ss_pred ccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcc
Q 001658 926 KLIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVAMLCGD 966 (1036)
Q Consensus 926 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 966 (1036)
. .......+.+++.+||+.+|++||++.||+++|++.
T Consensus 229 ~----~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 229 P----PMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred C----CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 1 112335678899999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=305.86 Aligned_cols=249 Identities=25% Similarity=0.340 Sum_probs=210.8
Q ss_pred hcCCCCCCccccCCCEEEEEeEeC-CCcEEEEEEccccc---hhcHHHHHHHHHHHHhhccCCcceeEeEEEcCceeEEE
Q 001658 692 TENFSPSNKLGEGGFGPVYKGKLG-DGRAIAVKQLSVAS---RQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLV 767 (1036)
Q Consensus 692 ~~~~~~~~~iG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV 767 (1036)
.++|++.+.||+|-||.||.|+.+ ++-.||+|++.+.. .+...++.+|+++-+.++||||.++|++|.+....||+
T Consensus 21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi 100 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI 100 (281)
T ss_pred hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence 467889999999999999999854 67889999986542 33457889999999999999999999999999999999
Q ss_pred EEecCCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeecCC
Q 001658 768 YEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDK 847 (1036)
Q Consensus 768 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~ 847 (1036)
+||.++|+|...|..++...+++.....++.|+|.||.|+|..+ |+||||||+|+|++.++..||+|||-+..-.
T Consensus 101 lEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p-- 175 (281)
T KOG0580|consen 101 LEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAP-- 175 (281)
T ss_pred EEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCCCceeecC--
Confidence 99999999999998888888999999999999999999999887 9999999999999999999999999987543
Q ss_pred CCccccccccccCccCccccccCCCCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhcCccccccCccc
Q 001658 848 KTHISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEIELADPKL 927 (1036)
Q Consensus 848 ~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~ 927 (1036)
.......+||..|.+||...+...+.++|+|++|++.||++.|.+||......+.+..+. ..+..+|
T Consensus 176 -~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~----------k~~~~~p-- 242 (281)
T KOG0580|consen 176 -SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIR----------KVDLKFP-- 242 (281)
T ss_pred -CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHH----------HccccCC--
Confidence 233345789999999999999999999999999999999999999998765433332221 1222233
Q ss_pred ccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 001658 928 IEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVAM 962 (1036)
Q Consensus 928 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 962 (1036)
........+++.+|+..+|.+|.+..||++.
T Consensus 243 ----~~is~~a~dlI~~ll~~~p~~r~~l~~v~~h 273 (281)
T KOG0580|consen 243 ----STISGGAADLISRLLVKNPIERLALTEVMDH 273 (281)
T ss_pred ----cccChhHHHHHHHHhccCccccccHHHHhhh
Confidence 2223455667789999999999999999864
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-36 Score=339.88 Aligned_cols=260 Identities=24% Similarity=0.338 Sum_probs=203.9
Q ss_pred hcCCCCCCccccCCCEEEEEeEeC-CCcEEEEEEcccc-chhcHHHHHHHHHHHHhhccCCcceeEeEEEcCceeEEEEE
Q 001658 692 TENFSPSNKLGEGGFGPVYKGKLG-DGRAIAVKQLSVA-SRQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLVYE 769 (1036)
Q Consensus 692 ~~~~~~~~~iG~G~fG~Vy~~~~~-~g~~vAvK~~~~~-~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E 769 (1036)
.++|+..+.||+|+||.||+++.. +|..||+|.+... .......+.+|++++++++||||+++++++..++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 367888999999999999999865 6889999998754 23345679999999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeecCCCC
Q 001658 770 YLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKT 849 (1036)
Q Consensus 770 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~ 849 (1036)
|+++|+|.+++... ..+++..+..++.|++.||.|||+.+ .|+||||||+|||++.++.+||+|||+++......
T Consensus 84 ~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~- 158 (331)
T cd06649 84 HMDGGSLDQVLKEA--KRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM- 158 (331)
T ss_pred cCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCcccccccccc-
Confidence 99999999999653 35788899999999999999999853 39999999999999999999999999997654322
Q ss_pred ccccccccccCccCccccccCCCCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhcCc--cc-------
Q 001658 850 HISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQ--EI------- 920 (1036)
Q Consensus 850 ~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~--~~------- 920 (1036)
.....||..|+|||++.+..++.++|||||||++|||++|+.||......+....... ....... ..
T Consensus 159 --~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~ 234 (331)
T cd06649 159 --ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGR--PVVDGEEGEPHSISPRPR 234 (331)
T ss_pred --cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcc--cccccccCCccccCcccc
Confidence 2335689999999999998999999999999999999999999975443221111100 0000000 00
Q ss_pred ---------------------------cccCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 001658 921 ---------------------------ELADPKLIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVAM 962 (1036)
Q Consensus 921 ---------------------------~~~d~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 962 (1036)
....+.. .......++.+++.+||+.||++|||+.|+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h 301 (331)
T cd06649 235 PPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKL--PNGVFTPDFQEFVNKCLIKNPAERADLKMLMNH 301 (331)
T ss_pred cccccccccccccccchhHHHHHHHHHhCCCcCC--CCccccHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 0000000 001233568889999999999999999999864
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-36 Score=326.56 Aligned_cols=253 Identities=30% Similarity=0.444 Sum_probs=205.6
Q ss_pred cCCCCCCccccCCCEEEEEeEeCCCcEEEEEEccccchhcHHHHHHHHHHHHhhccCCcceeEeEEEcCceeEEEEEecC
Q 001658 693 ENFSPSNKLGEGGFGPVYKGKLGDGRAIAVKQLSVASRQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLVYEYLE 772 (1036)
Q Consensus 693 ~~~~~~~~iG~G~fG~Vy~~~~~~g~~vAvK~~~~~~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~~~ 772 (1036)
++|++.+.||+|+||.||+|...++..||+|.+..... ..+.|.+|+.++++++|+|++++++++. ....++||||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~ 83 (260)
T cd05070 6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMS 83 (260)
T ss_pred HHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecC
Confidence 46788899999999999999988888899999875433 3567999999999999999999999875 456789999999
Q ss_pred CCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeecCCCCccc
Q 001658 773 NKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHIS 852 (1036)
Q Consensus 773 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 852 (1036)
+++|.+++.......+++.++..++.|++.||+|||+.+ |+||||||+||++++++.++|+|||++..+........
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~~ 160 (260)
T cd05070 84 KGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTAR 160 (260)
T ss_pred CCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeeccCcccccc
Confidence 999999997765667899999999999999999999988 99999999999999999999999999987654332222
Q ss_pred cccccccCccCccccccCCCCchhhHHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHHHHHhhcCccccccCcccccCC
Q 001658 853 TRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVS-GRPNSDPSLDEEKLYLLEWAWHLHENNQEIELADPKLIEFN 931 (1036)
Q Consensus 853 ~~~~gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~ 931 (1036)
....++..|+|||+..+..++.++||||||+++|||++ |+.||......+.. ++. .... .+ ...
T Consensus 161 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~---~~~----~~~~-----~~---~~~ 225 (260)
T cd05070 161 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVL---EQV----ERGY-----RM---PCP 225 (260)
T ss_pred cCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHH---HHH----HcCC-----CC---CCC
Confidence 22345678999999988889999999999999999999 88888754332211 111 0100 01 111
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhc
Q 001658 932 EEEVKRLIGVALLCTQTLPSLRPSMSRVVAMLCG 965 (1036)
Q Consensus 932 ~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~ 965 (1036)
......+.+++.+|++.+|++|||++++.+.|+.
T Consensus 226 ~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 226 QDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred CcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 2233568888999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=326.48 Aligned_cols=255 Identities=29% Similarity=0.436 Sum_probs=206.6
Q ss_pred hcCCCCCCccccCCCEEEEEeEeCCCcEEEEEEccccchhcHHHHHHHHHHHHhhccCCcceeEeEEEcCceeEEEEEec
Q 001658 692 TENFSPSNKLGEGGFGPVYKGKLGDGRAIAVKQLSVASRQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLVYEYL 771 (1036)
Q Consensus 692 ~~~~~~~~~iG~G~fG~Vy~~~~~~g~~vAvK~~~~~~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~~ 771 (1036)
.++|++.++||+|+||.||+|+..++..||+|++..... ..+.|.+|++++++++|+||+++++++. .+..++||||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~ 82 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYM 82 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcC
Confidence 356888999999999999999987777899999875332 3467899999999999999999999875 45678999999
Q ss_pred CCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeecCCCCcc
Q 001658 772 ENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHI 851 (1036)
Q Consensus 772 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 851 (1036)
++|+|.+++.......+++..+..++.|+++||+|||+.+ |+||||||+||++++++.++|+|||.++.+.......
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~~ 159 (262)
T cd05071 83 SKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA 159 (262)
T ss_pred CCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeecccccccc
Confidence 9999999997655556899999999999999999999987 9999999999999999999999999998765433222
Q ss_pred ccccccccCccCccccccCCCCchhhHHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHHHHHhhcCccccccCcccccC
Q 001658 852 STRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVS-GRPNSDPSLDEEKLYLLEWAWHLHENNQEIELADPKLIEF 930 (1036)
Q Consensus 852 ~~~~~gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~ 930 (1036)
.....++..|+|||+..+..++.++||||||+++|||+| |+.||............ .... .. ..
T Consensus 160 ~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~-------~~~~-----~~---~~ 224 (262)
T cd05071 160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV-------ERGY-----RM---PC 224 (262)
T ss_pred ccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHH-------hcCC-----CC---CC
Confidence 223446778999999998899999999999999999999 78888654432221111 0100 00 11
Q ss_pred CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcc
Q 001658 931 NEEEVKRLIGVALLCTQTLPSLRPSMSRVVAMLCGD 966 (1036)
Q Consensus 931 ~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 966 (1036)
..+....+.+++.+|++.+|++||++.+++++|+..
T Consensus 225 ~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 225 PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred ccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 223445678999999999999999999999999854
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-36 Score=346.32 Aligned_cols=259 Identities=24% Similarity=0.371 Sum_probs=205.6
Q ss_pred hcCCCCCCccccCCCEEEEEeEeC------CCcEEEEEEccccc-hhcHHHHHHHHHHHHhhc-cCCcceeEeEEEcCce
Q 001658 692 TENFSPSNKLGEGGFGPVYKGKLG------DGRAIAVKQLSVAS-RQGKSQFVAEIATISAVQ-HRNLVKLHGCCIEGAE 763 (1036)
Q Consensus 692 ~~~~~~~~~iG~G~fG~Vy~~~~~------~g~~vAvK~~~~~~-~~~~~~f~~Ei~~L~~l~-H~nIv~l~g~~~~~~~ 763 (1036)
.++|.+.+.||+|+||.||+|+.. .+..||||++.... ....+.|.+|+++++++. ||||++++++|.+.+.
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~ 115 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGP 115 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCc
Confidence 457888899999999999999742 23479999996533 334567999999999996 9999999999999999
Q ss_pred eEEEEEecCCCChhhhhhcCC-----------------------------------------------------------
Q 001658 764 RLLVYEYLENKSLDQALFGQR----------------------------------------------------------- 784 (1036)
Q Consensus 764 ~~lV~E~~~~gsL~~~l~~~~----------------------------------------------------------- 784 (1036)
.++||||+++|+|.++++.+.
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (400)
T cd05105 116 IYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIK 195 (400)
T ss_pred eEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhh
Confidence 999999999999999886532
Q ss_pred -----------------------------------CCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecC
Q 001658 785 -----------------------------------SLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDA 829 (1036)
Q Consensus 785 -----------------------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~ 829 (1036)
...+++..+.+++.|+++||+|||+.+ |+||||||+|||+++
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~Nill~~ 272 (400)
T cd05105 196 EASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNVLLAQ 272 (400)
T ss_pred hhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHhEEEeC
Confidence 124788888999999999999999987 999999999999999
Q ss_pred CCceEEEEcCcceeecCCCCcc-ccccccccCccCccccccCCCCchhhHHhHHHHHHHHHh-CCCCCCCCChhhHHHHH
Q 001658 830 DLVPKISDFGLAKLYDDKKTHI-STRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVS-GRPNSDPSLDEEKLYLL 907 (1036)
Q Consensus 830 ~~~~kl~DFGla~~~~~~~~~~-~~~~~gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~ 907 (1036)
++.+||+|||+++......... .....++..|+|||.+.+..++.++|||||||++|||++ |+.||..........
T Consensus 273 ~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~-- 350 (400)
T cd05105 273 GKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFY-- 350 (400)
T ss_pred CCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHHH--
Confidence 9999999999998764332221 223446788999999998899999999999999999997 888887543222111
Q ss_pred HHHHHHhhcCccccccCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhccc
Q 001658 908 EWAWHLHENNQEIELADPKLIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVAMLCGDM 967 (1036)
Q Consensus 908 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~ 967 (1036)
. ....+. .+ .........+.+++.+||+.+|++||++.+|.++|++..
T Consensus 351 ~----~~~~~~-----~~---~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~ 398 (400)
T cd05105 351 N----KIKSGY-----RM---AKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL 398 (400)
T ss_pred H----HHhcCC-----CC---CCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHc
Confidence 1 111110 01 111233456788999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-36 Score=331.38 Aligned_cols=254 Identities=27% Similarity=0.442 Sum_probs=205.9
Q ss_pred cCCCCCCccccCCCEEEEEeEeCC------CcEEEEEEccccchh-cHHHHHHHHHHHHhhccCCcceeEeEEEcCceeE
Q 001658 693 ENFSPSNKLGEGGFGPVYKGKLGD------GRAIAVKQLSVASRQ-GKSQFVAEIATISAVQHRNLVKLHGCCIEGAERL 765 (1036)
Q Consensus 693 ~~~~~~~~iG~G~fG~Vy~~~~~~------g~~vAvK~~~~~~~~-~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~ 765 (1036)
++|.+.+.||+|+||.||+|...+ ++.||||.++..... ..+.|.+|++++++++|+||+++++++......+
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 84 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI 84 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence 457778999999999999998633 478999998765433 4578999999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhhcCC------------CCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCce
Q 001658 766 LVYEYLENKSLDQALFGQR------------SLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVP 833 (1036)
Q Consensus 766 lV~E~~~~gsL~~~l~~~~------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~ 833 (1036)
+||||+++++|.+++.... ...+++..+..++.|++.|++|||+.+ ++||||||+||+++.++.+
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~ 161 (280)
T cd05049 85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDLVV 161 (280)
T ss_pred EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCCeE
Confidence 9999999999999996542 245789999999999999999999988 9999999999999999999
Q ss_pred EEEEcCcceeecCCCC-ccccccccccCccCccccccCCCCchhhHHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHHH
Q 001658 834 KISDFGLAKLYDDKKT-HISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVS-GRPNSDPSLDEEKLYLLEWAW 911 (1036)
Q Consensus 834 kl~DFGla~~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~ 911 (1036)
||+|||+++....... .......+++.|+|||++.+..++.++|||||||++|||++ |+.||......+... ...
T Consensus 162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~---~~~ 238 (280)
T cd05049 162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIE---CIT 238 (280)
T ss_pred EECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHH---HHH
Confidence 9999999986533221 11223346788999999999999999999999999999999 999987544333221 111
Q ss_pred HHhhcCccccccCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 001658 912 HLHENNQEIELADPKLIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVAMLC 964 (1036)
Q Consensus 912 ~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~ 964 (1036)
.+. ...........+.+++..||+.+|++||++.||++.|+
T Consensus 239 ----~~~--------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 239 ----QGR--------LLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred ----cCC--------cCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 111 01111223456788899999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=333.68 Aligned_cols=264 Identities=19% Similarity=0.273 Sum_probs=203.4
Q ss_pred cCCCCCCccccCCCEEEEEeEeC-CCcEEEEEEccccc--hhcHHHHHHHHHHHHhhccCCcceeEeEEEcCceeEEEEE
Q 001658 693 ENFSPSNKLGEGGFGPVYKGKLG-DGRAIAVKQLSVAS--RQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLVYE 769 (1036)
Q Consensus 693 ~~~~~~~~iG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~--~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E 769 (1036)
++|++.+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|+++++.++||||+++++++..++..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 36888999999999999999875 67899999986432 2335678899999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeecCCCC
Q 001658 770 YLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKT 849 (1036)
Q Consensus 770 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~ 849 (1036)
|++++.+..+... ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++.......
T Consensus 81 ~~~~~~l~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 155 (287)
T cd07848 81 YVEKNMLELLEEM--PNGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSN 155 (287)
T ss_pred cCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCccccccccc
Confidence 9998877655432 346888999999999999999999987 99999999999999999999999999987654333
Q ss_pred ccccccccccCccCccccccCCCCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHH---------HhhcCccc
Q 001658 850 HISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWH---------LHENNQEI 920 (1036)
Q Consensus 850 ~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~---------~~~~~~~~ 920 (1036)
.......||+.|+|||++.+..++.++|||||||++|||++|++||......+....+..... ........
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (287)
T cd07848 156 ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFH 235 (287)
T ss_pred ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhc
Confidence 333345689999999999988899999999999999999999999986544333222211100 00000000
Q ss_pred cccCcccc-------cCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 001658 921 ELADPKLI-------EFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVA 961 (1036)
Q Consensus 921 ~~~d~~~~-------~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 961 (1036)
....+... .........+.+++.+|++.||++|||++|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 236 GLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred ccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 00001000 001112346889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=331.73 Aligned_cols=260 Identities=26% Similarity=0.404 Sum_probs=216.0
Q ss_pred HHHhcCCCCCCccccCCCEEEEEeEeC---CC--cEEEEEEccc-cchhcHHHHHHHHHHHHhhccCCcceeEeEEEcCc
Q 001658 689 KTATENFSPSNKLGEGGFGPVYKGKLG---DG--RAIAVKQLSV-ASRQGKSQFVAEIATISAVQHRNLVKLHGCCIEGA 762 (1036)
Q Consensus 689 ~~~~~~~~~~~~iG~G~fG~Vy~~~~~---~g--~~vAvK~~~~-~~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~ 762 (1036)
+...+.....++||+|-||.||+|.+. .| -.||||..+. ......+.|.+|..+|+.++|||||+++|.|.+.
T Consensus 385 el~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~- 463 (974)
T KOG4257|consen 385 ELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ- 463 (974)
T ss_pred eeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-
Confidence 344455666789999999999999853 23 3589998876 3455678899999999999999999999999754
Q ss_pred eeEEEEEecCCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcce
Q 001658 763 ERLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAK 842 (1036)
Q Consensus 763 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~ 842 (1036)
..|+|||.++-|.|..||..+ ...++..+...++.||+.||+|||+.. +|||||..+|||+.....+||+|||+++
T Consensus 464 P~WivmEL~~~GELr~yLq~n-k~sL~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CVKLaDFGLSR 539 (974)
T KOG4257|consen 464 PMWIVMELAPLGELREYLQQN-KDSLPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCVKLADFGLSR 539 (974)
T ss_pred ceeEEEecccchhHHHHHHhc-cccchHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcceeeecccchhh
Confidence 689999999999999999764 456888999999999999999999987 9999999999999999999999999999
Q ss_pred eecCCCCccccccccccCccCccccccCCCCchhhHHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHHHHHhhcCcccc
Q 001658 843 LYDDKKTHISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVS-GRPNSDPSLDEEKLYLLEWAWHLHENNQEIE 921 (1036)
Q Consensus 843 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 921 (1036)
.+.++.....+...-++.|||||.+.-++++.+||||.|||++||++. |..||..-...+... .
T Consensus 540 ~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~---------------~ 604 (974)
T KOG4257|consen 540 YLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIG---------------H 604 (974)
T ss_pred hccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEE---------------E
Confidence 998777666666666789999999999999999999999999999876 889998754433221 1
Q ss_pred ccCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcccC
Q 001658 922 LADPKLIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVAMLCGDME 968 (1036)
Q Consensus 922 ~~d~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 968 (1036)
+...+....++.++..+..++.+||..+|.+||++.|+...|+....
T Consensus 605 iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q 651 (974)
T KOG4257|consen 605 IENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ 651 (974)
T ss_pred ecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence 11222223445566778899999999999999999999988876544
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-36 Score=332.42 Aligned_cols=263 Identities=24% Similarity=0.361 Sum_probs=198.1
Q ss_pred cCCCCCCccccCCCEEEEEeEe-C-CCcEEEEEEccccc--hhcHHHHHHHHHHHHhh---ccCCcceeEeEEEc-----
Q 001658 693 ENFSPSNKLGEGGFGPVYKGKL-G-DGRAIAVKQLSVAS--RQGKSQFVAEIATISAV---QHRNLVKLHGCCIE----- 760 (1036)
Q Consensus 693 ~~~~~~~~iG~G~fG~Vy~~~~-~-~g~~vAvK~~~~~~--~~~~~~f~~Ei~~L~~l---~H~nIv~l~g~~~~----- 760 (1036)
++|++.+.||+|+||.||+|+. . +++.||+|.++... ......+.+|+.+++.+ +||||++++++|..
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 3688899999999999999985 2 46889999886432 22234566787777766 69999999999862
Q ss_pred CceeEEEEEecCCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCc
Q 001658 761 GAERLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGL 840 (1036)
Q Consensus 761 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGl 840 (1036)
....++|+||++ ++|.+++.......+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~kl~Dfg~ 156 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGL 156 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCEEEccccc
Confidence 345789999996 69999997665667899999999999999999999988 99999999999999999999999999
Q ss_pred ceeecCCCCccccccccccCccCccccccCCCCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHH-HHHHHHhhcCcc
Q 001658 841 AKLYDDKKTHISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLL-EWAWHLHENNQE 919 (1036)
Q Consensus 841 a~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~-~~~~~~~~~~~~ 919 (1036)
++..... .......||+.|+|||++.+..++.++|||||||++|||++|++||......+....+ +...........
T Consensus 157 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~ 234 (290)
T cd07862 157 ARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP 234 (290)
T ss_pred eEeccCC--cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhch
Confidence 9876533 2223456899999999999889999999999999999999999999876543332211 110000000000
Q ss_pred c------cccCcc----cccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 001658 920 I------ELADPK----LIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVA 961 (1036)
Q Consensus 920 ~------~~~d~~----~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 961 (1036)
. ....+. +..........+.+++.+|++.||++|||+.|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 235 RDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred hhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 0 000000 00111122345678899999999999999999884
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-36 Score=325.86 Aligned_cols=250 Identities=27% Similarity=0.401 Sum_probs=202.5
Q ss_pred CCCCCCccccCCCEEEEEeEeCCCcEEEEEEccccchhcHHHHHHHHHHHHhhccCCcceeEeEEEcCceeEEEEEecCC
Q 001658 694 NFSPSNKLGEGGFGPVYKGKLGDGRAIAVKQLSVASRQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLVYEYLEN 773 (1036)
Q Consensus 694 ~~~~~~~iG~G~fG~Vy~~~~~~g~~vAvK~~~~~~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~ 773 (1036)
+|++.+.||+|+||.||+|+.+++..+|+|.+..... ....|.+|++++++++|+||+++++++...+..++|+||+++
T Consensus 5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd05059 5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAM-SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMAN 83 (256)
T ss_pred HcchhhhhccCCCceEEEeEecCCccEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCC
Confidence 4778899999999999999987778899999864322 345788999999999999999999999999999999999999
Q ss_pred CChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeecCCCCcccc
Q 001658 774 KSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHIST 853 (1036)
Q Consensus 774 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 853 (1036)
++|.+++.... ..+++..++.|+.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++...+.......
T Consensus 84 ~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~~ 159 (256)
T cd05059 84 GCLLNYLRERK-GKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQ 159 (256)
T ss_pred CCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceecccccccccC
Confidence 99999986543 36899999999999999999999988 999999999999999999999999999866433222222
Q ss_pred ccccccCccCccccccCCCCchhhHHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHHHHHhhcCccccccCcccccCCH
Q 001658 854 RVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVS-GRPNSDPSLDEEKLYLLEWAWHLHENNQEIELADPKLIEFNE 932 (1036)
Q Consensus 854 ~~~gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~ 932 (1036)
...++..|+|||.+.+..++.++||||||+++|||++ |+.||......+... .. ... ..+.. ..
T Consensus 160 ~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~---~~----~~~-----~~~~~---~~ 224 (256)
T cd05059 160 GTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVE---SV----SAG-----YRLYR---PK 224 (256)
T ss_pred CCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHH---HH----HcC-----CcCCC---CC
Confidence 2234568999999998899999999999999999999 789987654332211 11 011 01111 11
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 001658 933 EEVKRLIGVALLCTQTLPSLRPSMSRVVAML 963 (1036)
Q Consensus 933 ~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L 963 (1036)
.....+.+++.+||+.+|++|||+.|+++.|
T Consensus 225 ~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 225 LAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred CCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 2344688899999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-36 Score=330.50 Aligned_cols=256 Identities=23% Similarity=0.408 Sum_probs=203.6
Q ss_pred HhcCCCCCCccccCCCEEEEEeEeC------CCcEEEEEEccccc-hhcHHHHHHHHHHHHhhccCCcceeEeEEEcCce
Q 001658 691 ATENFSPSNKLGEGGFGPVYKGKLG------DGRAIAVKQLSVAS-RQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAE 763 (1036)
Q Consensus 691 ~~~~~~~~~~iG~G~fG~Vy~~~~~------~g~~vAvK~~~~~~-~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~ 763 (1036)
++++|+..+.||+|+||.||+|... .++.||+|.+.... .....+|.+|+.+++.++|+||+++++++.+...
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 5678999999999999999998743 35679999986432 2345678999999999999999999999999999
Q ss_pred eEEEEEecCCCChhhhhhcCC--------CCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEE
Q 001658 764 RLLVYEYLENKSLDQALFGQR--------SLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKI 835 (1036)
Q Consensus 764 ~~lV~E~~~~gsL~~~l~~~~--------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl 835 (1036)
.++||||+++|+|.+++.... ...+++..+..++.|+++||+|||+.+ ++||||||+||++++++.++|
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCCEEE
Confidence 999999999999999986532 234678899999999999999999987 999999999999999999999
Q ss_pred EEcCcceeecCCCCcc-ccccccccCccCccccccCCCCchhhHHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHHHHH
Q 001658 836 SDFGLAKLYDDKKTHI-STRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVS-GRPNSDPSLDEEKLYLLEWAWHL 913 (1036)
Q Consensus 836 ~DFGla~~~~~~~~~~-~~~~~gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~ 913 (1036)
+|||+++......... .....+++.|+|||++.++.++.++|||||||++|||++ |..||............
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~------ 234 (277)
T cd05062 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFV------ 234 (277)
T ss_pred CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH------
Confidence 9999987654322211 122345778999999998899999999999999999999 68888754433222111
Q ss_pred hhcCccccccCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 001658 914 HENNQEIELADPKLIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVAMLC 964 (1036)
Q Consensus 914 ~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~ 964 (1036)
..... ..........+.+++.+|++.+|++||++.|+++.|+
T Consensus 235 -~~~~~--------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 276 (277)
T cd05062 235 -MEGGL--------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276 (277)
T ss_pred -HcCCc--------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence 11110 0111123346788899999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=335.30 Aligned_cols=244 Identities=21% Similarity=0.230 Sum_probs=199.1
Q ss_pred cCCCCCCccccCCCEEEEEeEeC-CCcEEEEEEccccc---hhcHHHHHHHHHHHHhhccCCcceeEeEEEcCceeEEEE
Q 001658 693 ENFSPSNKLGEGGFGPVYKGKLG-DGRAIAVKQLSVAS---RQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLVY 768 (1036)
Q Consensus 693 ~~~~~~~~iG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~ 768 (1036)
++|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.++++++||||+++++++.+....++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 36888899999999999999865 68999999986432 223456889999999999999999999999999999999
Q ss_pred EecCCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeecCCC
Q 001658 769 EYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKK 848 (1036)
Q Consensus 769 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~ 848 (1036)
||+++|+|.+++... ..+++.....++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++......
T Consensus 81 e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~ 155 (291)
T cd05612 81 EYVPGGELFSYLRNS--GRFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRT 155 (291)
T ss_pred eCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcchhccCCc
Confidence 999999999999653 45788899999999999999999988 9999999999999999999999999998664321
Q ss_pred CccccccccccCccCccccccCCCCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhcCccccccCcccc
Q 001658 849 THISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEIELADPKLI 928 (1036)
Q Consensus 849 ~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~ 928 (1036)
....||+.|+|||++.+..++.++|||||||++|||++|+.||...........+ .. + ...+
T Consensus 156 ----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i------~~-~------~~~~- 217 (291)
T cd05612 156 ----WTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKI------LA-G------KLEF- 217 (291)
T ss_pred ----ccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH------Hh-C------CcCC-
Confidence 2346899999999999888999999999999999999999999865433222111 10 0 0111
Q ss_pred cCCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 001658 929 EFNEEEVKRLIGVALLCTQTLPSLRPS-----MSRVVA 961 (1036)
Q Consensus 929 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt-----~~evl~ 961 (1036)
+......+.+++.+|++.||.+||+ +.|+++
T Consensus 218 --~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 253 (291)
T cd05612 218 --PRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKN 253 (291)
T ss_pred --CccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhc
Confidence 1111335677888999999999995 777664
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=331.72 Aligned_cols=258 Identities=26% Similarity=0.427 Sum_probs=208.6
Q ss_pred cCCCCCCccccCCCEEEEEeEeC------CCcEEEEEEccccchhcHHHHHHHHHHHHhhccCCcceeEeEEEcCceeEE
Q 001658 693 ENFSPSNKLGEGGFGPVYKGKLG------DGRAIAVKQLSVASRQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLL 766 (1036)
Q Consensus 693 ~~~~~~~~iG~G~fG~Vy~~~~~------~g~~vAvK~~~~~~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~l 766 (1036)
.+|...+.||+|+||.||+|+.. ++..+++|.+........+.+.+|++++++++|+||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 35677789999999999999742 356799999876665556789999999999999999999999999999999
Q ss_pred EEEecCCCChhhhhhcCC--------------CCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCc
Q 001658 767 VYEYLENKSLDQALFGQR--------------SLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLV 832 (1036)
Q Consensus 767 V~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~ 832 (1036)
||||+++++|.+++.... ...++|..+++++.||+.||+|||+.+ |+||||||+||+++.++.
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~~~ 161 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANLL 161 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCc
Confidence 999999999999996532 234899999999999999999999998 999999999999999999
Q ss_pred eEEEEcCcceeecCCCC-ccccccccccCccCccccccCCCCchhhHHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHH
Q 001658 833 PKISDFGLAKLYDDKKT-HISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVS-GRPNSDPSLDEEKLYLLEWA 910 (1036)
Q Consensus 833 ~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~ 910 (1036)
++|+|||+++....... .......++..|+|||++.+..++.++|||||||++|||+| |+.||......+.. +.
T Consensus 162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~---~~- 237 (291)
T cd05094 162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVI---EC- 237 (291)
T ss_pred EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHH---HH-
Confidence 99999999976543221 11223456788999999998899999999999999999999 99998765443221 11
Q ss_pred HHHhhcCccccccCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcccC
Q 001658 911 WHLHENNQEIELADPKLIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVAMLCGDME 968 (1036)
Q Consensus 911 ~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 968 (1036)
...+... .........+.+++.+||+.+|++||++.+|+++|++...
T Consensus 238 ---~~~~~~~--------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~ 284 (291)
T cd05094 238 ---ITQGRVL--------ERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGK 284 (291)
T ss_pred ---HhCCCCC--------CCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHh
Confidence 1111110 1111234567889999999999999999999999987744
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-36 Score=348.93 Aligned_cols=258 Identities=25% Similarity=0.260 Sum_probs=211.5
Q ss_pred cCCCCCCccccCCCEEEEEeEeCCC-cEEEEEEccccchhcHHHHHHHHHHHHhhc-cCCcceeEeE-EEc------Cce
Q 001658 693 ENFSPSNKLGEGGFGPVYKGKLGDG-RAIAVKQLSVASRQGKSQFVAEIATISAVQ-HRNLVKLHGC-CIE------GAE 763 (1036)
Q Consensus 693 ~~~~~~~~iG~G~fG~Vy~~~~~~g-~~vAvK~~~~~~~~~~~~f~~Ei~~L~~l~-H~nIv~l~g~-~~~------~~~ 763 (1036)
.++++.++|.+|||+.||.|+...+ ..||+|++-..++...+...+|+++|++|+ |+|||.+++. ... .-+
T Consensus 37 ~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~E 116 (738)
T KOG1989|consen 37 HRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWE 116 (738)
T ss_pred EEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeE
Confidence 3456778999999999999997665 999999987778888889999999999997 9999999993 221 246
Q ss_pred eEEEEEecCCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCccee
Q 001658 764 RLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKL 843 (1036)
Q Consensus 764 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~ 843 (1036)
++|.||||.+|+|-|++..+....|++.++++|+.|+++|+++||.. ++||||||||.+||||+.++..||||||.|.-
T Consensus 117 vllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFGSatt 195 (738)
T KOG1989|consen 117 VLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFGSATT 195 (738)
T ss_pred EEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCccccccc
Confidence 78999999999999999876666799999999999999999999987 47799999999999999999999999999874
Q ss_pred ecCCCCcc--------ccccccccCccCccccc---cCCCCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHH
Q 001658 844 YDDKKTHI--------STRVAGTIGYLAPEYAM---RGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWH 912 (1036)
Q Consensus 844 ~~~~~~~~--------~~~~~gt~~y~APE~~~---~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~ 912 (1036)
........ ......|+.|+|||++. +..+++|+|||+|||+||-|+....||+....-
T Consensus 196 ~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~l----------- 264 (738)
T KOG1989|consen 196 KILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKL----------- 264 (738)
T ss_pred ccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcce-----------
Confidence 43222111 11234789999999974 667999999999999999999999999864221
Q ss_pred HhhcCccccccCcccc-cCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcccCCC
Q 001658 913 LHENNQEIELADPKLI-EFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVAMLCGDMEVS 970 (1036)
Q Consensus 913 ~~~~~~~~~~~d~~~~-~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~ 970 (1036)
.+.+..+. ...+.+...|.+|+..||+.+|.+||++.||+..+.++....
T Consensus 265 --------aIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~ 315 (738)
T KOG1989|consen 265 --------AILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKP 315 (738)
T ss_pred --------eEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCC
Confidence 11222221 112567788899999999999999999999999998776644
|
|
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=330.11 Aligned_cols=258 Identities=26% Similarity=0.436 Sum_probs=207.9
Q ss_pred cCCCCCCccccCCCEEEEEeEe------CCCcEEEEEEccccchhcHHHHHHHHHHHHhhccCCcceeEeEEEcCceeEE
Q 001658 693 ENFSPSNKLGEGGFGPVYKGKL------GDGRAIAVKQLSVASRQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLL 766 (1036)
Q Consensus 693 ~~~~~~~~iG~G~fG~Vy~~~~------~~g~~vAvK~~~~~~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~l 766 (1036)
.+|.+.+.||+|+||.||++.. .++..+|+|.+..........+.+|++++++++|+||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 84 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 5678889999999999999974 2345699999876655566789999999999999999999999999999999
Q ss_pred EEEecCCCChhhhhhcCC-----------CCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEE
Q 001658 767 VYEYLENKSLDQALFGQR-----------SLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKI 835 (1036)
Q Consensus 767 V~E~~~~gsL~~~l~~~~-----------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl 835 (1036)
||||+++++|.+++.... ...+++.+++.++.|++.||+|||+.+ ++||||||+||++++++.+||
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~~kl 161 (288)
T cd05093 85 VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKI 161 (288)
T ss_pred EEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcEEe
Confidence 999999999999986432 235899999999999999999999988 999999999999999999999
Q ss_pred EEcCcceeecCCCCc-cccccccccCccCccccccCCCCchhhHHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHHHHH
Q 001658 836 SDFGLAKLYDDKKTH-ISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVS-GRPNSDPSLDEEKLYLLEWAWHL 913 (1036)
Q Consensus 836 ~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~ 913 (1036)
+|||+++........ ......++..|+|||++.+..++.++|||||||++|||++ |++||......+....+
T Consensus 162 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i------ 235 (288)
T cd05093 162 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECI------ 235 (288)
T ss_pred ccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH------
Confidence 999999865432211 1223346778999999998889999999999999999999 89988765433221111
Q ss_pred hhcCccccccCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcccC
Q 001658 914 HENNQEIELADPKLIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVAMLCGDME 968 (1036)
Q Consensus 914 ~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 968 (1036)
..+.. +.. .......+.+++.+||+.+|.+|||+.||++.|+....
T Consensus 236 -~~~~~-----~~~---~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~ 281 (288)
T cd05093 236 -TQGRV-----LQR---PRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAK 281 (288)
T ss_pred -HcCCc-----CCC---CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHH
Confidence 11110 011 11123457889999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=343.46 Aligned_cols=258 Identities=19% Similarity=0.176 Sum_probs=196.8
Q ss_pred hcCCCCCCccccCCCEEEEEeEe-CCCcEEEEEEccccchhcHHHHHHHHHHHHhhccCCcceeEeEEEcCceeEEEEEe
Q 001658 692 TENFSPSNKLGEGGFGPVYKGKL-GDGRAIAVKQLSVASRQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLVYEY 770 (1036)
Q Consensus 692 ~~~~~~~~~iG~G~fG~Vy~~~~-~~g~~vAvK~~~~~~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~ 770 (1036)
..+|++.+.||+|+||.||++.. ..++.||+|... ...+.+|++++++++||||+++++++......++|+|+
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~ 164 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR 164 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEec
Confidence 35789999999999999999985 468899999753 24578899999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeecCCCCc
Q 001658 771 LENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTH 850 (1036)
Q Consensus 771 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~ 850 (1036)
+. ++|.+++... ..+++..++.|+.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++........
T Consensus 165 ~~-~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~ 238 (391)
T PHA03212 165 YK-TDLYCYLAAK--RNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPVDINAN 238 (391)
T ss_pred CC-CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCccccccccccc
Confidence 95 7888888543 45789999999999999999999987 999999999999999999999999999764433322
Q ss_pred cccccccccCccCccccccCCCCchhhHHhHHHHHHHHHhCCCCCCCCChhh----HHHHHHHHHHHhhc---Cc-----
Q 001658 851 ISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEE----KLYLLEWAWHLHEN---NQ----- 918 (1036)
Q Consensus 851 ~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~----~~~l~~~~~~~~~~---~~----- 918 (1036)
......||+.|+|||++.+..++.++|||||||++|||++|+.|+......+ .............. ..
T Consensus 239 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~ 318 (391)
T PHA03212 239 KYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQ 318 (391)
T ss_pred ccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchh
Confidence 3344679999999999999899999999999999999999998765322100 00000000000000 00
Q ss_pred -----------cccccCcccc---cCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 001658 919 -----------EIELADPKLI---EFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVA 961 (1036)
Q Consensus 919 -----------~~~~~d~~~~---~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 961 (1036)
......+... ....+....+.+++.+|++.||.+|||+.|+++
T Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~ 375 (391)
T PHA03212 319 ANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD 375 (391)
T ss_pred HHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence 0000000000 001123456888999999999999999999985
|
|
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-36 Score=340.09 Aligned_cols=260 Identities=26% Similarity=0.389 Sum_probs=203.9
Q ss_pred hcCCCCCCccccCCCEEEEEeEeC------CCcEEEEEEccccc-hhcHHHHHHHHHHHHhh-ccCCcceeEeEEEcC-c
Q 001658 692 TENFSPSNKLGEGGFGPVYKGKLG------DGRAIAVKQLSVAS-RQGKSQFVAEIATISAV-QHRNLVKLHGCCIEG-A 762 (1036)
Q Consensus 692 ~~~~~~~~~iG~G~fG~Vy~~~~~------~g~~vAvK~~~~~~-~~~~~~f~~Ei~~L~~l-~H~nIv~l~g~~~~~-~ 762 (1036)
.++|++.+.||+|+||.||+|... .++.||+|+++... ....+.+..|+.++.++ +|+||++++++|... .
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~ 85 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG 85 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence 357888999999999999999632 34789999987432 23345678899999999 899999999988654 5
Q ss_pred eeEEEEEecCCCChhhhhhcCCC---------------------------------------------------------
Q 001658 763 ERLLVYEYLENKSLDQALFGQRS--------------------------------------------------------- 785 (1036)
Q Consensus 763 ~~~lV~E~~~~gsL~~~l~~~~~--------------------------------------------------------- 785 (1036)
..++++||+++++|.+++.....
T Consensus 86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (337)
T cd05054 86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL 165 (337)
T ss_pred CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence 67899999999999999864321
Q ss_pred --CCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeecCCCCcc-ccccccccCcc
Q 001658 786 --LTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHI-STRVAGTIGYL 862 (1036)
Q Consensus 786 --~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~-~~~~~gt~~y~ 862 (1036)
..++|..+.+++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+++.+....... .....++..|+
T Consensus 166 ~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~ 242 (337)
T cd05054 166 YKEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM 242 (337)
T ss_pred hhcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcccc
Confidence 26899999999999999999999987 9999999999999999999999999998764332222 22344677899
Q ss_pred CccccccCCCCchhhHHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHHHHHhhcCccccccCcccccCCHHHHHHHHHH
Q 001658 863 APEYAMRGHLTEKTDVFAFGVLALETVS-GRPNSDPSLDEEKLYLLEWAWHLHENNQEIELADPKLIEFNEEEVKRLIGV 941 (1036)
Q Consensus 863 APE~~~~~~~~~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l 941 (1036)
|||++.+..++.++|||||||++|||++ |+.||......+.. .. ....... + ..+......+.++
T Consensus 243 aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~--~~----~~~~~~~-----~---~~~~~~~~~~~~l 308 (337)
T cd05054 243 APESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEF--CR----RLKEGTR-----M---RAPEYATPEIYSI 308 (337)
T ss_pred CcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHH--HH----HHhccCC-----C---CCCccCCHHHHHH
Confidence 9999999999999999999999999998 99998753322211 11 1111110 0 0111223567889
Q ss_pred HHHhcccCCCCCCCHHHHHHHhhcccC
Q 001658 942 ALLCTQTLPSLRPSMSRVVAMLCGDME 968 (1036)
Q Consensus 942 ~~~Cl~~dP~~RPt~~evl~~L~~~~~ 968 (1036)
+.+||+.+|++||++.||+++|+....
T Consensus 309 ~~~cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 309 MLDCWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred HHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=337.27 Aligned_cols=251 Identities=23% Similarity=0.372 Sum_probs=213.2
Q ss_pred cCCCCCCccccCCCEEEEEeEeC-CCcEEEEEEccccc--hhcHHHHHHHHHHHHhhccCCcceeEeEEEcCce-eEEEE
Q 001658 693 ENFSPSNKLGEGGFGPVYKGKLG-DGRAIAVKQLSVAS--RQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAE-RLLVY 768 (1036)
Q Consensus 693 ~~~~~~~~iG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~--~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~-~~lV~ 768 (1036)
++|...+.+|+|+||.++..+.+ +++.+++|.+.... ....+...+|+.++++++|||||.+.+.+.+++. .+|||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 56778899999999999999854 67899999986543 3345577899999999999999999999999888 89999
Q ss_pred EecCCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeecCCC
Q 001658 769 EYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKK 848 (1036)
Q Consensus 769 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~ 848 (1036)
+|++||+|.+.+..++...+++..+.+++.|++.|+.|||++. |+|||||+.||+++.+..+||+|||+|+.+....
T Consensus 84 ~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~ 160 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFGLAKILNPED 160 (426)
T ss_pred eecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchhhhhhcCCch
Confidence 9999999999998888888999999999999999999999876 9999999999999999999999999999987665
Q ss_pred CccccccccccCccCccccccCCCCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhcCccccccCcccc
Q 001658 849 THISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEIELADPKLI 928 (1036)
Q Consensus 849 ~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~ 928 (1036)
. ....++||+.||.||.+.+.+|..|+||||+||++|||++-+++|.......-...+ . + ... .
T Consensus 161 ~-~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki------~---~--~~~----~ 224 (426)
T KOG0589|consen 161 S-LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKI------N---R--GLY----S 224 (426)
T ss_pred h-hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHH------h---h--ccC----C
Confidence 3 334577999999999999999999999999999999999999999876543322111 0 0 011 2
Q ss_pred cCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 001658 929 EFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVAM 962 (1036)
Q Consensus 929 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 962 (1036)
..+..+..++..++..|++.+|..||++.+++.+
T Consensus 225 Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 225 PLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred CCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 2334455667778889999999999999999875
|
|
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=329.17 Aligned_cols=255 Identities=26% Similarity=0.419 Sum_probs=202.9
Q ss_pred cCCCCCCccccCCCEEEEEeEe-----CCCcEEEEEEcccc-chhcHHHHHHHHHHHHhhccCCcceeEeEEEcCceeEE
Q 001658 693 ENFSPSNKLGEGGFGPVYKGKL-----GDGRAIAVKQLSVA-SRQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLL 766 (1036)
Q Consensus 693 ~~~~~~~~iG~G~fG~Vy~~~~-----~~g~~vAvK~~~~~-~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~l 766 (1036)
.+|++.+.||+|+||.||+|.. ..++.||+|.+... .......|.+|++++++++||||+++++++..+...++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 4567789999999999999974 24678999998743 33344678999999999999999999999999999999
Q ss_pred EEEecCCCChhhhhhcCC---------------CCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCC
Q 001658 767 VYEYLENKSLDQALFGQR---------------SLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADL 831 (1036)
Q Consensus 767 V~E~~~~gsL~~~l~~~~---------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~ 831 (1036)
||||+++++|.+++.... ...+++.+.+.++.|++.||+|||+.+ |+||||||+|||+++++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcCCC
Confidence 999999999999985322 235789999999999999999999988 99999999999999999
Q ss_pred ceEEEEcCcceeecCCCC-ccccccccccCccCccccccCCCCchhhHHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHH
Q 001658 832 VPKISDFGLAKLYDDKKT-HISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVS-GRPNSDPSLDEEKLYLLEW 909 (1036)
Q Consensus 832 ~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~ 909 (1036)
.+||+|||+++....... .......++..|+|||++.+..++.++|||||||++|||++ |..||...........+.
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~~~- 240 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVR- 240 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-
Confidence 999999999986543221 11223346778999999988889999999999999999998 888887644322221111
Q ss_pred HHHHhhcCccccccCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhc
Q 001658 910 AWHLHENNQEIELADPKLIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVAMLCG 965 (1036)
Q Consensus 910 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~ 965 (1036)
.... + .........+.+++.+||+.+|.+||++.+|.++|.+
T Consensus 241 ------~~~~-----~---~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 241 ------KRQL-----L---PCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred ------cCCc-----C---CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 0000 0 1111223457778889999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=324.56 Aligned_cols=254 Identities=30% Similarity=0.444 Sum_probs=207.4
Q ss_pred hcCCCCCCccccCCCEEEEEeEeCCCcEEEEEEccccchhcHHHHHHHHHHHHhhccCCcceeEeEEEcCceeEEEEEec
Q 001658 692 TENFSPSNKLGEGGFGPVYKGKLGDGRAIAVKQLSVASRQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLVYEYL 771 (1036)
Q Consensus 692 ~~~~~~~~~iG~G~fG~Vy~~~~~~g~~vAvK~~~~~~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~~ 771 (1036)
.++|++.++||+|+||.||+|..++++.||+|.+..... ...+|.+|+.++++++|+||+++++++. .+..++|+||+
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~ 82 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYM 82 (260)
T ss_pred hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcC
Confidence 457888899999999999999988899999999875433 3567899999999999999999999874 45689999999
Q ss_pred CCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeecCCCCcc
Q 001658 772 ENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHI 851 (1036)
Q Consensus 772 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 851 (1036)
++++|.+++.......+++.++..++.|++.||+|||+.+ ++||||||+||++++++.++|+|||++..........
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~ 159 (260)
T cd05067 83 ENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTA 159 (260)
T ss_pred CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeecCCCCccc
Confidence 9999999997766677899999999999999999999987 9999999999999999999999999998765333222
Q ss_pred ccccccccCccCccccccCCCCchhhHHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHHHHHhhcCccccccCcccccC
Q 001658 852 STRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVS-GRPNSDPSLDEEKLYLLEWAWHLHENNQEIELADPKLIEF 930 (1036)
Q Consensus 852 ~~~~~gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~ 930 (1036)
.....++..|+|||++....++.++||||||+++||+++ |+.||......+..... .... .+..
T Consensus 160 ~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~-------~~~~-----~~~~--- 224 (260)
T cd05067 160 REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNL-------ERGY-----RMPR--- 224 (260)
T ss_pred ccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHH-------HcCC-----CCCC---
Confidence 223446778999999998889999999999999999999 99999755432222111 1110 0111
Q ss_pred CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhc
Q 001658 931 NEEEVKRLIGVALLCTQTLPSLRPSMSRVVAMLCG 965 (1036)
Q Consensus 931 ~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~ 965 (1036)
.......+.+++.+|++.+|++||+++++..+|+.
T Consensus 225 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 225 PDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 11123468888899999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=311.80 Aligned_cols=283 Identities=22% Similarity=0.301 Sum_probs=209.8
Q ss_pred cCCCCCCccccCCCEEEEEeEeC-CCcEEEEEEccccchh--cHHHHHHHHHHHHhhccCCcceeEeEEEc--CceeEEE
Q 001658 693 ENFSPSNKLGEGGFGPVYKGKLG-DGRAIAVKQLSVASRQ--GKSQFVAEIATISAVQHRNLVKLHGCCIE--GAERLLV 767 (1036)
Q Consensus 693 ~~~~~~~~iG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~~--~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~--~~~~~lV 767 (1036)
++|+.++.|++|+||.||+|+.+ +++.||+|+++...+. -.-.-.+||.+|.+++|||||.+-.+... -+..|+|
T Consensus 76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V 155 (419)
T KOG0663|consen 76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV 155 (419)
T ss_pred HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence 45777899999999999999854 6889999999754321 12345789999999999999999888764 3678999
Q ss_pred EEecCCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeecCC
Q 001658 768 YEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDK 847 (1036)
Q Consensus 768 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~ 847 (1036)
||||+. +|..+++..+ .++...+..-++.|+++|++|||.+. |+|||||++|+|+...|.+||+|||+|+.+...
T Consensus 156 Me~~Eh-DLksl~d~m~-q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp 230 (419)
T KOG0663|consen 156 MEYVEH-DLKSLMETMK-QPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGLAREYGSP 230 (419)
T ss_pred HHHHHh-hHHHHHHhcc-CCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccchhhhhcCC
Confidence 999976 8888886654 57888888889999999999999998 999999999999999999999999999998765
Q ss_pred CCccccccccccCccCccccccC-CCCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHH-----hhcCcccc
Q 001658 848 KTHISTRVAGTIGYLAPEYAMRG-HLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHL-----HENNQEIE 921 (1036)
Q Consensus 848 ~~~~~~~~~gt~~y~APE~~~~~-~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~-----~~~~~~~~ 921 (1036)
. ...+..+-|..|.|||.+.+. .|++..|+||+|||+.||+++++.|.+..+-++.+.+-..-.. |..-....
T Consensus 231 ~-k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp 309 (419)
T KOG0663|consen 231 L-KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELP 309 (419)
T ss_pred c-ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccc
Confidence 3 334667789999999999875 5999999999999999999999999887665555433111100 10000000
Q ss_pred ccC-ccccc---------CCHH-HHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcccCCCcCCCCCCCCcCcc
Q 001658 922 LAD-PKLIE---------FNEE-EVKRLIGVALLCTQTLPSLRPSMSRVVAMLCGDMEVSTVTAKPGYLTDWK 983 (1036)
Q Consensus 922 ~~d-~~~~~---------~~~~-~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~~~~~~p~~~~~~~ 983 (1036)
... -.+.. +... -...-++++...+..||.+|-|+.|.++. +.....+.+..|++++.|.
T Consensus 310 ~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h--~~F~e~P~p~~P~~~Pt~P 380 (419)
T KOG0663|consen 310 AVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH--EYFRETPLPIDPSMFPTWP 380 (419)
T ss_pred hhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc--cccccCCCCCChhhcCCCc
Confidence 000 00100 1000 11344566677889999999999997753 1111223455666666554
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-36 Score=306.52 Aligned_cols=201 Identities=30% Similarity=0.368 Sum_probs=179.9
Q ss_pred cCCCCCCccccCCCEEEEEeEeC-CCcEEEEEEccccch---hcHHHHHHHHHHHHhhccCCcceeEeEEEcCceeEEEE
Q 001658 693 ENFSPSNKLGEGGFGPVYKGKLG-DGRAIAVKQLSVASR---QGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLVY 768 (1036)
Q Consensus 693 ~~~~~~~~iG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~---~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~ 768 (1036)
++|+..+.||.|+||.|..++.+ +|..+|+|++.+..- ...+...+|..+|+.+.||.++++++.+.+....++||
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm 123 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM 123 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence 46778899999999999999864 688999999976432 23455678999999999999999999999999999999
Q ss_pred EecCCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeecCCC
Q 001658 769 EYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKK 848 (1036)
Q Consensus 769 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~ 848 (1036)
||++||-|..++++ ...+++...+-+|.||+.||+|||+.+ |++||+||+|||+|++|.+||+|||.|+.....
T Consensus 124 eyv~GGElFS~Lrk--~~rF~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r- 197 (355)
T KOG0616|consen 124 EYVPGGELFSYLRK--SGRFSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR- 197 (355)
T ss_pred eccCCccHHHHHHh--cCCCCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccceEEecCc-
Confidence 99999999999965 456888889999999999999999998 999999999999999999999999999987644
Q ss_pred CccccccccccCccCccccccCCCCchhhHHhHHHHHHHHHhCCCCCCCCChhh
Q 001658 849 THISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEE 902 (1036)
Q Consensus 849 ~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~ 902 (1036)
.-..+||+.|+|||++....+..++|.|||||++|||+.|.+||....+..
T Consensus 198 ---T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~ 248 (355)
T KOG0616|consen 198 ---TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQ 248 (355)
T ss_pred ---EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHH
Confidence 234789999999999999999999999999999999999999999876643
|
|
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=322.71 Aligned_cols=253 Identities=29% Similarity=0.433 Sum_probs=204.6
Q ss_pred cCCCCCCccccCCCEEEEEeEeCCCcEEEEEEccccchhcHHHHHHHHHHHHhhccCCcceeEeEEEcCceeEEEEEecC
Q 001658 693 ENFSPSNKLGEGGFGPVYKGKLGDGRAIAVKQLSVASRQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLVYEYLE 772 (1036)
Q Consensus 693 ~~~~~~~~iG~G~fG~Vy~~~~~~g~~vAvK~~~~~~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~~~ 772 (1036)
++|.+.+.||+|+||.||+|....+..||+|.+.... ...+.+.+|++++++++|+|++++++++. .+..++||||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~ 83 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMG 83 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCC
Confidence 4577888999999999999998777789999886433 23567899999999999999999999875 456789999999
Q ss_pred CCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeecCCCCccc
Q 001658 773 NKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHIS 852 (1036)
Q Consensus 773 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 852 (1036)
+++|.+++.......+++..+..++.|++.||+|||+.+ |+||||||+||++++++.++|+|||+++..........
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~~~ 160 (260)
T cd05069 84 KGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTAR 160 (260)
T ss_pred CCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEccCCccccc
Confidence 999999997665566899999999999999999999987 99999999999999999999999999987643322222
Q ss_pred cccccccCccCccccccCCCCchhhHHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHHHHHhhcCccccccCcccccCC
Q 001658 853 TRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVS-GRPNSDPSLDEEKLYLLEWAWHLHENNQEIELADPKLIEFN 931 (1036)
Q Consensus 853 ~~~~gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~ 931 (1036)
....++..|+|||+..+..++.++||||||+++|||++ |+.||......+.. .+. .... .+. ..
T Consensus 161 ~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~---~~~----~~~~-----~~~---~~ 225 (260)
T cd05069 161 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVL---EQV----ERGY-----RMP---CP 225 (260)
T ss_pred CCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHH---HHH----HcCC-----CCC---CC
Confidence 23346778999999998899999999999999999999 88888765433221 111 1110 011 11
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhc
Q 001658 932 EEEVKRLIGVALLCTQTLPSLRPSMSRVVAMLCG 965 (1036)
Q Consensus 932 ~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~ 965 (1036)
......+.+++.+||+.+|++||++++|+++|+.
T Consensus 226 ~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 226 QGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred cccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 2234567888889999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=353.48 Aligned_cols=250 Identities=20% Similarity=0.305 Sum_probs=202.8
Q ss_pred CCCCCCccccCCCEEEEEeEeC-C-CcEEEEEEccccchhcHHHHHHHHHHHHhhccCCcceeEeEEEcCceeEEEEEec
Q 001658 694 NFSPSNKLGEGGFGPVYKGKLG-D-GRAIAVKQLSVASRQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLVYEYL 771 (1036)
Q Consensus 694 ~~~~~~~iG~G~fG~Vy~~~~~-~-g~~vAvK~~~~~~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~~ 771 (1036)
.|.+.+.||+|+||.||+|... + ++.||+|.+..........+..|+.+++.++|||||++++++...+..++||||+
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~ 147 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG 147 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence 3778899999999999999743 3 6788999876555555567888999999999999999999999999999999999
Q ss_pred CCCChhhhhhcC--CCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeecCCCC
Q 001658 772 ENKSLDQALFGQ--RSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKT 849 (1036)
Q Consensus 772 ~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~ 849 (1036)
++|+|.+++... ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+.....
T Consensus 148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~ 224 (478)
T PTZ00267 148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS 224 (478)
T ss_pred CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence 999999988642 3456889999999999999999999987 99999999999999999999999999987654322
Q ss_pred -ccccccccccCccCccccccCCCCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhcCccccccCcccc
Q 001658 850 -HISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEIELADPKLI 928 (1036)
Q Consensus 850 -~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~ 928 (1036)
.......||++|+|||++.+..++.++|||||||++|||++|+.||......+.... .... . .++
T Consensus 225 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~------~~~~-~----~~~--- 290 (478)
T PTZ00267 225 LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQ------VLYG-K----YDP--- 290 (478)
T ss_pred cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH------HHhC-C----CCC---
Confidence 123345699999999999999999999999999999999999999976443221111 1100 0 011
Q ss_pred cCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 001658 929 EFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVA 961 (1036)
Q Consensus 929 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 961 (1036)
........+.+++..||+.+|++||++.+++.
T Consensus 291 -~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 291 -FPCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred -CCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 11122346778888999999999999999864
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-36 Score=322.68 Aligned_cols=256 Identities=25% Similarity=0.313 Sum_probs=201.6
Q ss_pred HHHhcCCCCCCccccCCCEEEEEeEe-CCCcEEEEEEccccch--------------hcHHHHHHHHHHHHhhccCCcce
Q 001658 689 KTATENFSPSNKLGEGGFGPVYKGKL-GDGRAIAVKQLSVASR--------------QGKSQFVAEIATISAVQHRNLVK 753 (1036)
Q Consensus 689 ~~~~~~~~~~~~iG~G~fG~Vy~~~~-~~g~~vAvK~~~~~~~--------------~~~~~f~~Ei~~L~~l~H~nIv~ 753 (1036)
.+..++|++.+.||+|.||.|-+|+. .+++.||||++.+... ...+...+||.+|++++|||||+
T Consensus 93 ~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~ 172 (576)
T KOG0585|consen 93 RKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVK 172 (576)
T ss_pred ceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeE
Confidence 34567899999999999999999984 4789999999964321 11357889999999999999999
Q ss_pred eEeEEEcC--ceeEEEEEecCCCChhhhhhcCCCCC-cChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCC
Q 001658 754 LHGCCIEG--AERLLVYEYLENKSLDQALFGQRSLT-LDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDAD 830 (1036)
Q Consensus 754 l~g~~~~~--~~~~lV~E~~~~gsL~~~l~~~~~~~-l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~ 830 (1036)
++++..+. +..|||+|||..|.+...- .... +++.+.++++.++..||+|||.++ ||||||||+|+||+++
T Consensus 173 LiEvLDDP~s~~~YlVley~s~G~v~w~p---~d~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsNLLl~~~ 246 (576)
T KOG0585|consen 173 LIEVLDDPESDKLYLVLEYCSKGEVKWCP---PDKPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSNLLLSSD 246 (576)
T ss_pred EEEeecCcccCceEEEEEeccCCccccCC---CCcccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEEcCC
Confidence 99998764 6789999999998876533 2333 899999999999999999999998 9999999999999999
Q ss_pred CceEEEEcCcceeecCCCC----ccccccccccCccCccccccCC----CCchhhHHhHHHHHHHHHhCCCCCCCCChhh
Q 001658 831 LVPKISDFGLAKLYDDKKT----HISTRVAGTIGYLAPEYAMRGH----LTEKTDVFAFGVLALETVSGRPNSDPSLDEE 902 (1036)
Q Consensus 831 ~~~kl~DFGla~~~~~~~~----~~~~~~~gt~~y~APE~~~~~~----~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~ 902 (1036)
|++||+|||.+........ ..-...+||+.|||||...++. .+.+.||||+||+||.|+.|+.||-.....+
T Consensus 247 g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~ 326 (576)
T KOG0585|consen 247 GTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELE 326 (576)
T ss_pred CcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHH
Confidence 9999999999987732211 1123467999999999987633 4668999999999999999999998654433
Q ss_pred HHHHHHHHHHHhhcCccccccCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 001658 903 KLYLLEWAWHLHENNQEIELADPKLIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVAMLC 964 (1036)
Q Consensus 903 ~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~ 964 (1036)
....+. .+|-.....++...++.+++.+++++||++|.+..+|.....
T Consensus 327 l~~KIv--------------n~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpw 374 (576)
T KOG0585|consen 327 LFDKIV--------------NDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPW 374 (576)
T ss_pred HHHHHh--------------cCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecce
Confidence 222110 111111122345567778888999999999999999976553
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=330.22 Aligned_cols=263 Identities=23% Similarity=0.303 Sum_probs=200.1
Q ss_pred cCCCCCCccccCCCEEEEEeEeC-CCcEEEEEEccccc-hhcHHHHHHHHHHHHhhccCCcceeEeEEEcCceeEEEEEe
Q 001658 693 ENFSPSNKLGEGGFGPVYKGKLG-DGRAIAVKQLSVAS-RQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLVYEY 770 (1036)
Q Consensus 693 ~~~~~~~~iG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~-~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~ 770 (1036)
++|...+.||+|+||.||+|+.. +++.||+|.++... ......+.+|+.++++++||||+++++++...+..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 46888899999999999999864 68899999986432 23345678999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeecCCCCc
Q 001658 771 LENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTH 850 (1036)
Q Consensus 771 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~ 850 (1036)
++ |+|.+++... ...+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++.......
T Consensus 85 ~~-~~l~~~l~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~- 158 (288)
T cd07871 85 LD-SDLKQYLDNC-GNLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK- 158 (288)
T ss_pred CC-cCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceeeccCCCc-
Confidence 97 5999888543 335788899999999999999999988 99999999999999999999999999986543222
Q ss_pred cccccccccCccCcccccc-CCCCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHH-----hhc----Cccc
Q 001658 851 ISTRVAGTIGYLAPEYAMR-GHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHL-----HEN----NQEI 920 (1036)
Q Consensus 851 ~~~~~~gt~~y~APE~~~~-~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~-----~~~----~~~~ 920 (1036)
......|++.|+|||++.+ ..++.++||||+||++|||+||++||......+........... +.. ....
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (288)
T cd07871 159 TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFR 238 (288)
T ss_pred cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhh
Confidence 1233468999999999875 56899999999999999999999999876544433222111000 000 0000
Q ss_pred cccCcccc-----cCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 001658 921 ELADPKLI-----EFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVA 961 (1036)
Q Consensus 921 ~~~d~~~~-----~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 961 (1036)
....+... ........++.+++.+|++.||.+|||+.|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 239 SYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred ccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 00011100 000112245678889999999999999999874
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=334.22 Aligned_cols=256 Identities=24% Similarity=0.388 Sum_probs=202.7
Q ss_pred cCCCCCCccccCCCEEEEEeEeC-CCc----EEEEEEccccc-hhcHHHHHHHHHHHHhhccCCcceeEeEEEcCceeEE
Q 001658 693 ENFSPSNKLGEGGFGPVYKGKLG-DGR----AIAVKQLSVAS-RQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLL 766 (1036)
Q Consensus 693 ~~~~~~~~iG~G~fG~Vy~~~~~-~g~----~vAvK~~~~~~-~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~l 766 (1036)
.+|+..+.||+|+||.||+|++. +++ .||+|.++... ....++|.+|+.+++.++||||++++|+|... ..++
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~ 85 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 85 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence 46888899999999999999853 333 48999986542 34456789999999999999999999999865 5679
Q ss_pred EEEecCCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeecC
Q 001658 767 VYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDD 846 (1036)
Q Consensus 767 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~ 846 (1036)
|+||+++|+|.+++... ...+++..+++++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+++.+..
T Consensus 86 v~e~~~~g~l~~~l~~~-~~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~ 161 (316)
T cd05108 86 ITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 161 (316)
T ss_pred eeecCCCCCHHHHHHhc-cccCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEccccccccccC
Confidence 99999999999998754 345788999999999999999999988 99999999999999999999999999987654
Q ss_pred CCCccc-cccccccCccCccccccCCCCchhhHHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHHHHHhhcCccccccC
Q 001658 847 KKTHIS-TRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVS-GRPNSDPSLDEEKLYLLEWAWHLHENNQEIELAD 924 (1036)
Q Consensus 847 ~~~~~~-~~~~gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 924 (1036)
...... ....++..|+|||++.+..++.++|||||||++|||++ |+.||......+... ...... ....
T Consensus 162 ~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~-------~~~~~~--~~~~ 232 (316)
T cd05108 162 DEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISS-------ILEKGE--RLPQ 232 (316)
T ss_pred CCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHH-------HHhCCC--CCCC
Confidence 332211 22234678999999999999999999999999999998 999987643322111 111111 0011
Q ss_pred cccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcccC
Q 001658 925 PKLIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVAMLCGDME 968 (1036)
Q Consensus 925 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 968 (1036)
+ ......+.+++..||+.+|.+||++.+++..+.....
T Consensus 233 ~------~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~ 270 (316)
T cd05108 233 P------PICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 270 (316)
T ss_pred C------CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHc
Confidence 1 1123457788899999999999999999999886644
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-36 Score=336.03 Aligned_cols=241 Identities=23% Similarity=0.278 Sum_probs=193.1
Q ss_pred cccCCCEEEEEeEeC-CCcEEEEEEcccc---chhcHHHHHHHHHHHHhhccCCcceeEeEEEcCceeEEEEEecCCCCh
Q 001658 701 LGEGGFGPVYKGKLG-DGRAIAVKQLSVA---SRQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLVYEYLENKSL 776 (1036)
Q Consensus 701 iG~G~fG~Vy~~~~~-~g~~vAvK~~~~~---~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL 776 (1036)
||+|+||.||+|+.. +++.||+|++... .......+..|+.++.+++||||+++++++...+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 799999999999864 5789999998643 233456688899999999999999999999999999999999999999
Q ss_pred hhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeecCCCCccccccc
Q 001658 777 DQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVA 856 (1036)
Q Consensus 777 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 856 (1036)
.+++... ..+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++...... .......
T Consensus 81 ~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~ 154 (312)
T cd05585 81 FHHLQRE--GRFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD-DKTNTFC 154 (312)
T ss_pred HHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCccCC-Ccccccc
Confidence 9999653 45888999999999999999999988 9999999999999999999999999998643222 2223456
Q ss_pred cccCccCccccccCCCCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhcCccccccCcccccCCHHHHH
Q 001658 857 GTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEIELADPKLIEFNEEEVK 936 (1036)
Q Consensus 857 gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~ 936 (1036)
||+.|+|||++.+..++.++|||||||++|||++|+.||.......... ..... ...+ +.....
T Consensus 155 gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~------~~~~~-------~~~~---~~~~~~ 218 (312)
T cd05585 155 GTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYR------KILQE-------PLRF---PDGFDR 218 (312)
T ss_pred CCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHH------HHHcC-------CCCC---CCcCCH
Confidence 9999999999999999999999999999999999999997654322111 11110 1111 112234
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHHHh
Q 001658 937 RLIGVALLCTQTLPSLRPSMSRVVAML 963 (1036)
Q Consensus 937 ~l~~l~~~Cl~~dP~~RPt~~evl~~L 963 (1036)
.+.+++.+||+.||.+||++.++.+.|
T Consensus 219 ~~~~li~~~L~~dp~~R~~~~~~~e~l 245 (312)
T cd05585 219 DAKDLLIGLLSRDPTRRLGYNGAQEIK 245 (312)
T ss_pred HHHHHHHHHcCCCHHHcCCCCCHHHHH
Confidence 567788899999999998654444433
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-36 Score=339.39 Aligned_cols=244 Identities=23% Similarity=0.256 Sum_probs=198.8
Q ss_pred cCCCCCCccccCCCEEEEEeEeC-CCcEEEEEEccccc---hhcHHHHHHHHHHHHhhccCCcceeEeEEEcCceeEEEE
Q 001658 693 ENFSPSNKLGEGGFGPVYKGKLG-DGRAIAVKQLSVAS---RQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLVY 768 (1036)
Q Consensus 693 ~~~~~~~~iG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~ 768 (1036)
++|++.+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|+.++++++||||+++++++.+++..++||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 56788899999999999999865 68899999986432 233456889999999999999999999999999999999
Q ss_pred EecCCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeecCCC
Q 001658 769 EYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKK 848 (1036)
Q Consensus 769 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~ 848 (1036)
||+++|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 98 e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~ 172 (329)
T PTZ00263 98 EFVVGGELFTHLRKA--GRFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRT 172 (329)
T ss_pred cCCCCChHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccCceEcCCCc
Confidence 999999999998654 45778888889999999999999988 9999999999999999999999999998764322
Q ss_pred CccccccccccCccCccccccCCCCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhcCccccccCcccc
Q 001658 849 THISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEIELADPKLI 928 (1036)
Q Consensus 849 ~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~ 928 (1036)
....||+.|+|||++.+..++.++|||||||++|||++|+.||........... .. .+. ..+.
T Consensus 173 ----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~------i~-~~~------~~~p 235 (329)
T PTZ00263 173 ----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEK------IL-AGR------LKFP 235 (329)
T ss_pred ----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHH------Hh-cCC------cCCC
Confidence 234699999999999998999999999999999999999999976543221111 11 110 1111
Q ss_pred cCCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 001658 929 EFNEEEVKRLIGVALLCTQTLPSLRPS-----MSRVVA 961 (1036)
Q Consensus 929 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt-----~~evl~ 961 (1036)
.. ....+.+++.+||+.||.+||+ +.+++.
T Consensus 236 ~~---~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 270 (329)
T PTZ00263 236 NW---FDGRARDLVKGLLQTDHTKRLGTLKGGVADVKN 270 (329)
T ss_pred CC---CCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 11 2235677888999999999997 566654
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=336.34 Aligned_cols=241 Identities=24% Similarity=0.259 Sum_probs=194.9
Q ss_pred CccccCCCEEEEEeEe-CCCcEEEEEEccccc---hhcHHHHHHHHHHHHhhccCCcceeEeEEEcCceeEEEEEecCCC
Q 001658 699 NKLGEGGFGPVYKGKL-GDGRAIAVKQLSVAS---RQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLVYEYLENK 774 (1036)
Q Consensus 699 ~~iG~G~fG~Vy~~~~-~~g~~vAvK~~~~~~---~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~g 774 (1036)
+.||+|+||.||+++. .+|+.||+|++.... ......+.+|++++++++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 4699999999999985 468999999987532 233456778999999999999999999999999999999999999
Q ss_pred ChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeecCCCCccccc
Q 001658 775 SLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTR 854 (1036)
Q Consensus 775 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 854 (1036)
+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++....... ....
T Consensus 81 ~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~-~~~~ 154 (323)
T cd05595 81 ELFFHLSRE--RVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA-TMKT 154 (323)
T ss_pred cHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccccCCCC-cccc
Confidence 999888543 46889999999999999999999988 99999999999999999999999999875432221 1233
Q ss_pred cccccCccCccccccCCCCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhcCccccccCcccccCCHHH
Q 001658 855 VAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEIELADPKLIEFNEEE 934 (1036)
Q Consensus 855 ~~gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 934 (1036)
..||+.|+|||++.+..++.++|||||||++|||++|+.||............ ... +..+ +...
T Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~------~~~-------~~~~---p~~~ 218 (323)
T cd05595 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI------LME-------EIRF---PRTL 218 (323)
T ss_pred ccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHH------hcC-------CCCC---CCCC
Confidence 56999999999999999999999999999999999999999765433222111 000 1111 1122
Q ss_pred HHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 001658 935 VKRLIGVALLCTQTLPSLRP-----SMSRVVA 961 (1036)
Q Consensus 935 ~~~l~~l~~~Cl~~dP~~RP-----t~~evl~ 961 (1036)
...+.+++.+|++.||++|| ++.++++
T Consensus 219 ~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~ 250 (323)
T cd05595 219 SPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 250 (323)
T ss_pred CHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence 34567788899999999998 7888765
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=320.13 Aligned_cols=250 Identities=28% Similarity=0.403 Sum_probs=206.3
Q ss_pred CCCCCCccccCCCEEEEEeEeC-CCcEEEEEEcccc--chhcHHHHHHHHHHHHhhccCCcceeEeEEEcCceeEEEEEe
Q 001658 694 NFSPSNKLGEGGFGPVYKGKLG-DGRAIAVKQLSVA--SRQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLVYEY 770 (1036)
Q Consensus 694 ~~~~~~~iG~G~fG~Vy~~~~~-~g~~vAvK~~~~~--~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~ 770 (1036)
+|+..+.||+|++|.||+|... +++.|++|.+... .....+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 4677789999999999999864 6899999998643 344567789999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeecCCCCc
Q 001658 771 LENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTH 850 (1036)
Q Consensus 771 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~ 850 (1036)
+++++|.+++.......+++..++.++.|++.||.|||+.+ |+||||||+||++++++.++|+|||+++.+......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~ 157 (256)
T cd08529 81 AENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNF 157 (256)
T ss_pred CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccceeccCccch
Confidence 99999999998765667899999999999999999999987 999999999999999999999999999876543322
Q ss_pred cccccccccCccCccccccCCCCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhcCccccccCcccccC
Q 001658 851 ISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEIELADPKLIEF 930 (1036)
Q Consensus 851 ~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~ 930 (1036)
.....|++.|+|||+..+..++.++||||||+++|||++|+.||......... .. ... + ..+ ..
T Consensus 158 -~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~---~~---~~~-~-----~~~---~~ 221 (256)
T cd08529 158 -ANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALI---LK---IIR-G-----VFP---PV 221 (256)
T ss_pred -hhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHH---HH---HHc-C-----CCC---CC
Confidence 23346888999999999989999999999999999999999999765432211 11 110 0 011 11
Q ss_pred CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 001658 931 NEEEVKRLIGVALLCTQTLPSLRPSMSRVVAM 962 (1036)
Q Consensus 931 ~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 962 (1036)
.......+.+++.+||+.+|++||++.++++.
T Consensus 222 ~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 222 SQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred ccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 12334568888999999999999999999863
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=333.78 Aligned_cols=201 Identities=26% Similarity=0.405 Sum_probs=175.2
Q ss_pred hcCCCCCCccccCCCEEEEEeEeC-CCcEEEEEEcccc-chhcHHHHHHHHHHHHhhccCCcceeEeEEEcCceeEEEEE
Q 001658 692 TENFSPSNKLGEGGFGPVYKGKLG-DGRAIAVKQLSVA-SRQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLVYE 769 (1036)
Q Consensus 692 ~~~~~~~~~iG~G~fG~Vy~~~~~-~g~~vAvK~~~~~-~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E 769 (1036)
.++|++.++||+|+||.||++... +++.+|+|.+... .......+.+|++++++++|+||++++++|.+.+..++|||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 468899999999999999999865 6788999988654 23345678999999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeecCCCC
Q 001658 770 YLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKT 849 (1036)
Q Consensus 770 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~ 849 (1036)
|+++|+|.+++... ..+++.....++.|+++||.|||+.+ +|+||||||+|||+++++.+||+|||++..+....
T Consensus 84 ~~~~~~L~~~l~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~- 158 (333)
T cd06650 84 HMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM- 158 (333)
T ss_pred cCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhhhhc-
Confidence 99999999999653 35788889999999999999999752 39999999999999999999999999997654321
Q ss_pred ccccccccccCccCccccccCCCCchhhHHhHHHHHHHHHhCCCCCCCCC
Q 001658 850 HISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRPNSDPSL 899 (1036)
Q Consensus 850 ~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~ 899 (1036)
.....||..|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 159 --~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~ 206 (333)
T cd06650 159 --ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPD 206 (333)
T ss_pred --cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcc
Confidence 123468999999999998889999999999999999999999997643
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=325.86 Aligned_cols=254 Identities=26% Similarity=0.426 Sum_probs=204.6
Q ss_pred cCCCCCCccccCCCEEEEEeEe------CCCcEEEEEEccccchhcHHHHHHHHHHHHhhccCCcceeEeEEEcCceeEE
Q 001658 693 ENFSPSNKLGEGGFGPVYKGKL------GDGRAIAVKQLSVASRQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLL 766 (1036)
Q Consensus 693 ~~~~~~~~iG~G~fG~Vy~~~~------~~g~~vAvK~~~~~~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~l 766 (1036)
.+|...++||+|+||.||++.. .++..+|+|.+..........|.+|++++++++|+||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM 84 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence 4567789999999999999963 2356899999876666667789999999999999999999999999999999
Q ss_pred EEEecCCCChhhhhhcCCC-------------CCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCce
Q 001658 767 VYEYLENKSLDQALFGQRS-------------LTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVP 833 (1036)
Q Consensus 767 V~E~~~~gsL~~~l~~~~~-------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~ 833 (1036)
|+||+++++|.+++..... ..+++.+++.++.|++.|++|||+.+ |+||||||+||++++++.+
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~~~~ 161 (280)
T cd05092 85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGLVV 161 (280)
T ss_pred EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCCCCE
Confidence 9999999999999865431 35889999999999999999999988 9999999999999999999
Q ss_pred EEEEcCcceeecCCCCc-cccccccccCccCccccccCCCCchhhHHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHHH
Q 001658 834 KISDFGLAKLYDDKKTH-ISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVS-GRPNSDPSLDEEKLYLLEWAW 911 (1036)
Q Consensus 834 kl~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~ 911 (1036)
||+|||+++........ ......+++.|+|||++.+..++.++|||||||++|||++ |++||......+......
T Consensus 162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~--- 238 (280)
T cd05092 162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECIT--- 238 (280)
T ss_pred EECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHHH---
Confidence 99999999765432211 1122345778999999998899999999999999999998 899987544333221110
Q ss_pred HHhhcCccccccCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 001658 912 HLHENNQEIELADPKLIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVAMLC 964 (1036)
Q Consensus 912 ~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~ 964 (1036)
.+.. +.. .......+.+++.+||+.||.+||++.||.+.|+
T Consensus 239 ----~~~~-----~~~---~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 239 ----QGRE-----LER---PRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred ----cCcc-----CCC---CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 1100 011 1122345778889999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=338.99 Aligned_cols=247 Identities=26% Similarity=0.353 Sum_probs=192.5
Q ss_pred CCCCCCccccCCCEEEEEeEeC-CCcEEEEEEccccc-hhcHHHHHHHHHHHHhhccCCcceeEeEEEcCceeEEEEEec
Q 001658 694 NFSPSNKLGEGGFGPVYKGKLG-DGRAIAVKQLSVAS-RQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLVYEYL 771 (1036)
Q Consensus 694 ~~~~~~~iG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~-~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~~ 771 (1036)
+|+..+.||+|+||.||+|+.. +++.||||++.... ......+.+|+++++.++|+||+++++++.+.+..++||||+
T Consensus 75 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 154 (353)
T PLN00034 75 ELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFM 154 (353)
T ss_pred HHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecC
Confidence 3456688999999999999864 68999999986432 334567899999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeecCCCCcc
Q 001658 772 ENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHI 851 (1036)
Q Consensus 772 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 851 (1036)
++|+|.+.. ..++..+..++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+++.+..... .
T Consensus 155 ~~~~L~~~~------~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~-~ 224 (353)
T PLN00034 155 DGGSLEGTH------IADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD-P 224 (353)
T ss_pred CCCcccccc------cCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccceecccccc-c
Confidence 999987542 3456777889999999999999988 99999999999999999999999999987643321 1
Q ss_pred ccccccccCccCcccccc-----CCCCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhcCccccccCcc
Q 001658 852 STRVAGTIGYLAPEYAMR-----GHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEIELADPK 926 (1036)
Q Consensus 852 ~~~~~gt~~y~APE~~~~-----~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 926 (1036)
.....||..|+|||++.. ...+.++|||||||++|||++|+.||......+...+..... . . ..+.
T Consensus 225 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~--~--~-----~~~~ 295 (353)
T PLN00034 225 CNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAIC--M--S-----QPPE 295 (353)
T ss_pred ccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHh--c--c-----CCCC
Confidence 233569999999998743 234568999999999999999999997433222111111100 0 0 0011
Q ss_pred cccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 001658 927 LIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVAM 962 (1036)
Q Consensus 927 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 962 (1036)
........+.+++.+||+.+|++||++.|+++.
T Consensus 296 ---~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 296 ---APATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred ---CCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 112233467788889999999999999999863
|
|
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=329.11 Aligned_cols=251 Identities=25% Similarity=0.319 Sum_probs=201.8
Q ss_pred CCCCCCccccCCCEEEEEeEeC-CCcEEEEEEccccc---hhcHHHHHHHHHHHHhhccCCcceeEeEEEcCceeEEEEE
Q 001658 694 NFSPSNKLGEGGFGPVYKGKLG-DGRAIAVKQLSVAS---RQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLVYE 769 (1036)
Q Consensus 694 ~~~~~~~iG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E 769 (1036)
.|+..+.||+|+||+||++... +++.||+|++.... ......+.+|+.++++++|+||+++++++..++..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 3677889999999999999854 68999999986432 2224567889999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeecCCCC
Q 001658 770 YLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKT 849 (1036)
Q Consensus 770 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~ 849 (1036)
|+++|+|.+++.......+++..+..++.|++.||+|||+.+ |+||||||+||++++++.++|+|||+++.......
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 157 (285)
T cd05605 81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET 157 (285)
T ss_pred ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCceecCCCCc
Confidence 999999999887655567899999999999999999999988 99999999999999999999999999987643222
Q ss_pred ccccccccccCccCccccccCCCCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhcCccccccCccccc
Q 001658 850 HISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEIELADPKLIE 929 (1036)
Q Consensus 850 ~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~ 929 (1036)
.....|+..|+|||++.+..++.++||||+||++|||++|+.||...........+ ...... ....
T Consensus 158 --~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~---~~~~~~---------~~~~ 223 (285)
T cd05605 158 --IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEV---ERRVKE---------DQEE 223 (285)
T ss_pred --cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHH---HHHhhh---------cccc
Confidence 12346899999999999888999999999999999999999999864332211111 111100 0011
Q ss_pred CCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 001658 930 FNEEEVKRLIGVALLCTQTLPSLRP-----SMSRVVA 961 (1036)
Q Consensus 930 ~~~~~~~~l~~l~~~Cl~~dP~~RP-----t~~evl~ 961 (1036)
+.......+.+++..||+.||.+|| ++.++++
T Consensus 224 ~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05605 224 YSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKA 260 (285)
T ss_pred cCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhc
Confidence 2223345677888999999999999 7778754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-36 Score=334.73 Aligned_cols=247 Identities=23% Similarity=0.266 Sum_probs=202.6
Q ss_pred cCCCCCCccccCCCEEEEEeEe-CCCcEEEEEEccccc---hhcHHHHHHHHHHHHhhccCCcceeEeEEEcCceeEEEE
Q 001658 693 ENFSPSNKLGEGGFGPVYKGKL-GDGRAIAVKQLSVAS---RQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLVY 768 (1036)
Q Consensus 693 ~~~~~~~~iG~G~fG~Vy~~~~-~~g~~vAvK~~~~~~---~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~ 768 (1036)
.-|+..+.||+|+-|.|-.|+. ..|+.+|||++.... ......+++|+.+|+-+.||||+++|+++.+..+.|+|.
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl 91 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL 91 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence 3467788999999999999985 579999999997542 223456889999999999999999999999999999999
Q ss_pred EecCCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeecCCC
Q 001658 769 EYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKK 848 (1036)
Q Consensus 769 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~ 848 (1036)
||+++|-|.+++-. ..++.+....+++.||+.|+.|+|..+ |+|||+||+|+|||..+++||+|||+|.+-.++.
T Consensus 92 Eyv~gGELFdylv~--kG~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gk 166 (786)
T KOG0588|consen 92 EYVPGGELFDYLVR--KGPLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMASLEVPGK 166 (786)
T ss_pred EecCCchhHHHHHh--hCCCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccceeecccCCc
Confidence 99999999999965 456788888899999999999999987 9999999999999999999999999998654332
Q ss_pred CccccccccccCccCccccccCCC-CchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhcCccccccCccc
Q 001658 849 THISTRVAGTIGYLAPEYAMRGHL-TEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEIELADPKL 927 (1036)
Q Consensus 849 ~~~~~~~~gt~~y~APE~~~~~~~-~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~ 927 (1036)
.-..-+|++.|.|||++++.+| ..++||||.|||||.|+||+.||++.+-.. +...+++ + ...+
T Consensus 167 --lLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~---LLlKV~~----G------~f~M 231 (786)
T KOG0588|consen 167 --LLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRV---LLLKVQR----G------VFEM 231 (786)
T ss_pred --cccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHH---HHHHHHc----C------cccC
Confidence 2234579999999999999987 569999999999999999999999544322 2222211 0 0112
Q ss_pred ccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 001658 928 IEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVAM 962 (1036)
Q Consensus 928 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 962 (1036)
... ...+..+++.+|+..||++|-|++||++.
T Consensus 232 Ps~---Is~eaQdLLr~ml~VDp~~RiT~~eI~kH 263 (786)
T KOG0588|consen 232 PSN---ISSEAQDLLRRMLDVDPSTRITTEEILKH 263 (786)
T ss_pred CCc---CCHHHHHHHHHHhccCccccccHHHHhhC
Confidence 222 23445666678999999999999999874
|
|
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=317.37 Aligned_cols=247 Identities=28% Similarity=0.381 Sum_probs=199.7
Q ss_pred CccccCCCEEEEEeEeCCCcEEEEEEccccc-hhcHHHHHHHHHHHHhhccCCcceeEeEEEcCceeEEEEEecCCCChh
Q 001658 699 NKLGEGGFGPVYKGKLGDGRAIAVKQLSVAS-RQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLVYEYLENKSLD 777 (1036)
Q Consensus 699 ~~iG~G~fG~Vy~~~~~~g~~vAvK~~~~~~-~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~ 777 (1036)
+.||+|+||.||+|...+++.||+|.++... ......|.+|++++++++||||+++++++...+..++||||+++++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 4699999999999998888999999987543 233457889999999999999999999999999999999999999999
Q ss_pred hhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeecCCCCcccccccc
Q 001658 778 QALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVAG 857 (1036)
Q Consensus 778 ~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~g 857 (1036)
+++... ...+++..+++++.|++.||.|||+.+ ++||||||+||++++++.+||+|||++...............+
T Consensus 81 ~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~ 156 (250)
T cd05085 81 SFLRKK-KDELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQI 156 (250)
T ss_pred HHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceeccccccccCCCCCC
Confidence 998654 345789999999999999999999987 9999999999999999999999999997654322221122334
Q ss_pred ccCccCccccccCCCCchhhHHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHHHHHhhcCccccccCcccccCCHHHHH
Q 001658 858 TIGYLAPEYAMRGHLTEKTDVFAFGVLALETVS-GRPNSDPSLDEEKLYLLEWAWHLHENNQEIELADPKLIEFNEEEVK 936 (1036)
Q Consensus 858 t~~y~APE~~~~~~~~~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~ 936 (1036)
+..|+|||+..++.++.++||||||+++||+++ |..||............ ..... . ........
T Consensus 157 ~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~-------~~~~~-----~---~~~~~~~~ 221 (250)
T cd05085 157 PIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQV-------EKGYR-----M---SCPQKCPD 221 (250)
T ss_pred cccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH-------HcCCC-----C---CCCCCCCH
Confidence 668999999998899999999999999999998 99998765432221111 11110 0 11112345
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 001658 937 RLIGVALLCTQTLPSLRPSMSRVVAMLC 964 (1036)
Q Consensus 937 ~l~~l~~~Cl~~dP~~RPt~~evl~~L~ 964 (1036)
.+.+++.+|++.+|++||++.|+++.|.
T Consensus 222 ~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 222 DVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred HHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 6788899999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=336.07 Aligned_cols=242 Identities=24% Similarity=0.252 Sum_probs=195.7
Q ss_pred CccccCCCEEEEEeEe-CCCcEEEEEEcccc---chhcHHHHHHHHHHHHhhccCCcceeEeEEEcCceeEEEEEecCCC
Q 001658 699 NKLGEGGFGPVYKGKL-GDGRAIAVKQLSVA---SRQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLVYEYLENK 774 (1036)
Q Consensus 699 ~~iG~G~fG~Vy~~~~-~~g~~vAvK~~~~~---~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~g 774 (1036)
+.||+|+||.||+++. .+|+.||+|++... .......+.+|+++++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999985 46899999998653 2234567888999999999999999999999999999999999999
Q ss_pred ChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeecCCCCccccc
Q 001658 775 SLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTR 854 (1036)
Q Consensus 775 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 854 (1036)
+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++....... ....
T Consensus 81 ~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~-~~~~ 154 (328)
T cd05593 81 ELFFHLSRE--RVFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAA-TMKT 154 (328)
T ss_pred CHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccCCCccc-cccc
Confidence 999888543 46889999999999999999999988 99999999999999999999999999875432221 1234
Q ss_pred cccccCccCccccccCCCCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhcCccccccCcccccCCHHH
Q 001658 855 VAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEIELADPKLIEFNEEE 934 (1036)
Q Consensus 855 ~~gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 934 (1036)
..||+.|+|||++.+..++.++|||||||++|||++|+.||............ .. .+..+. ...
T Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~------~~-------~~~~~p---~~~ 218 (328)
T cd05593 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI------LM-------EDIKFP---RTL 218 (328)
T ss_pred ccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHh------cc-------CCccCC---CCC
Confidence 56999999999999889999999999999999999999999764432221111 00 111111 122
Q ss_pred HHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 001658 935 VKRLIGVALLCTQTLPSLRP-----SMSRVVAM 962 (1036)
Q Consensus 935 ~~~l~~l~~~Cl~~dP~~RP-----t~~evl~~ 962 (1036)
..++.+++.+|++.||.+|| ++.|+++.
T Consensus 219 ~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 219 SADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred CHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 34567788899999999997 88888754
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=338.11 Aligned_cols=246 Identities=21% Similarity=0.242 Sum_probs=198.9
Q ss_pred hcCCCCCCccccCCCEEEEEeEeCC--CcEEEEEEccccc---hhcHHHHHHHHHHHHhhccCCcceeEeEEEcCceeEE
Q 001658 692 TENFSPSNKLGEGGFGPVYKGKLGD--GRAIAVKQLSVAS---RQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLL 766 (1036)
Q Consensus 692 ~~~~~~~~~iG~G~fG~Vy~~~~~~--g~~vAvK~~~~~~---~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~l 766 (1036)
.++|++.+.||+|+||.||+|+..+ +..||+|.+.... ....+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 108 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL 108 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence 3568888999999999999998543 3689999986432 2334568899999999999999999999999999999
Q ss_pred EEEecCCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeecC
Q 001658 767 VYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDD 846 (1036)
Q Consensus 767 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~ 846 (1036)
||||+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 109 v~Ey~~~g~L~~~i~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~ 183 (340)
T PTZ00426 109 VLEFVIGGEFFTFLRRN--KRFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT 183 (340)
T ss_pred EEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCCCeecCC
Confidence 99999999999999654 45788899999999999999999988 99999999999999999999999999987643
Q ss_pred CCCccccccccccCccCccccccCCCCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhcCccccccCcc
Q 001658 847 KKTHISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEIELADPK 926 (1036)
Q Consensus 847 ~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 926 (1036)
.. ....||+.|+|||++.+..++.++|||||||++|||++|+.||........... ... +. ..
T Consensus 184 ~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~------i~~-~~------~~ 246 (340)
T PTZ00426 184 RT----YTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQK------ILE-GI------IY 246 (340)
T ss_pred Cc----ceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHH------Hhc-CC------CC
Confidence 21 235699999999999988899999999999999999999999986543221111 111 00 01
Q ss_pred cccCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 001658 927 LIEFNEEEVKRLIGVALLCTQTLPSLRP-----SMSRVVAM 962 (1036)
Q Consensus 927 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----t~~evl~~ 962 (1036)
+... ....+.+++.+|++.+|.+|+ ++.|+++.
T Consensus 247 ~p~~---~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 247 FPKF---LDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred CCCC---CCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 1111 123456778899999999995 78887653
|
|
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=320.62 Aligned_cols=256 Identities=30% Similarity=0.450 Sum_probs=208.9
Q ss_pred HhcCCCCCCccccCCCEEEEEeEeCCCcEEEEEEccccchhcHHHHHHHHHHHHhhccCCcceeEeEEEcCceeEEEEEe
Q 001658 691 ATENFSPSNKLGEGGFGPVYKGKLGDGRAIAVKQLSVASRQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLVYEY 770 (1036)
Q Consensus 691 ~~~~~~~~~~iG~G~fG~Vy~~~~~~g~~vAvK~~~~~~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~ 770 (1036)
..++|.+.+.||+|+||.||+|..++++.||||.+.... ...+++.+|+.++++++|+||+++++++......++||||
T Consensus 4 ~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 82 (261)
T cd05034 4 PRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEY 82 (261)
T ss_pred chhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEec
Confidence 346788899999999999999998888899999987533 3356799999999999999999999999988899999999
Q ss_pred cCCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeecCCCCc
Q 001658 771 LENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTH 850 (1036)
Q Consensus 771 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~ 850 (1036)
+++++|.+++.......+++.++..++.|++.|++|||+.+ |+|+||||+||++++++.+||+|||+++.+......
T Consensus 83 ~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~ 159 (261)
T cd05034 83 MSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLIEDDEYT 159 (261)
T ss_pred cCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceeccchhhh
Confidence 99999999997766667899999999999999999999988 999999999999999999999999999876532222
Q ss_pred cccccccccCccCccccccCCCCchhhHHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHHHHHhhcCccccccCccccc
Q 001658 851 ISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVS-GRPNSDPSLDEEKLYLLEWAWHLHENNQEIELADPKLIE 929 (1036)
Q Consensus 851 ~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~ 929 (1036)
......++..|+|||.+.+..++.++||||||+++||+++ |+.||.......... .... .. ....
T Consensus 160 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~---~~~~----~~--~~~~----- 225 (261)
T cd05034 160 AREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLE---QVER----GY--RMPR----- 225 (261)
T ss_pred hhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHH---HHHc----CC--CCCC-----
Confidence 1222334568999999998889999999999999999999 999986544322211 1100 00 0000
Q ss_pred CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhc
Q 001658 930 FNEEEVKRLIGVALLCTQTLPSLRPSMSRVVAMLCG 965 (1036)
Q Consensus 930 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~ 965 (1036)
.......+.+++.+|++.+|++||++.++++.|+.
T Consensus 226 -~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 226 -PPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred -CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 11123467888999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=325.39 Aligned_cols=256 Identities=29% Similarity=0.411 Sum_probs=203.5
Q ss_pred HhcCCCCCCccccCCCEEEEEeEeCC------CcEEEEEEccccc-hhcHHHHHHHHHHHHhhccCCcceeEeEEEcCce
Q 001658 691 ATENFSPSNKLGEGGFGPVYKGKLGD------GRAIAVKQLSVAS-RQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAE 763 (1036)
Q Consensus 691 ~~~~~~~~~~iG~G~fG~Vy~~~~~~------g~~vAvK~~~~~~-~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~ 763 (1036)
.+++|++.+.||+|+||.||+|...+ +..||+|.+.... ......|..|+.++++++|+||+++++++.+.+.
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP 83 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 35678889999999999999998643 5689999886433 3345679999999999999999999999999999
Q ss_pred eEEEEEecCCCChhhhhhcCCC-----CCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCC---ceEE
Q 001658 764 RLLVYEYLENKSLDQALFGQRS-----LTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADL---VPKI 835 (1036)
Q Consensus 764 ~~lV~E~~~~gsL~~~l~~~~~-----~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~---~~kl 835 (1036)
.++||||+++++|.+++...+. ..++|..+++++.||++||+|||+.+ ++||||||+||+++.++ .+||
T Consensus 84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~kl 160 (277)
T cd05036 84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKI 160 (277)
T ss_pred cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcceEe
Confidence 9999999999999999976432 35899999999999999999999987 99999999999998754 6999
Q ss_pred EEcCcceeecCCCCcc-ccccccccCccCccccccCCCCchhhHHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHHHHH
Q 001658 836 SDFGLAKLYDDKKTHI-STRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVS-GRPNSDPSLDEEKLYLLEWAWHL 913 (1036)
Q Consensus 836 ~DFGla~~~~~~~~~~-~~~~~gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~ 913 (1036)
+|||+++......... .....++..|+|||++.+..++.++|||||||++|||++ |+.||...........+
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~------ 234 (277)
T cd05036 161 ADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFV------ 234 (277)
T ss_pred ccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH------
Confidence 9999998763322111 112234568999999999999999999999999999997 99998765443322111
Q ss_pred hhcCccccccCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 001658 914 HENNQEIELADPKLIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVAMLC 964 (1036)
Q Consensus 914 ~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~ 964 (1036)
.. ... + ..+......+.+++.+|++.+|++||++.+|++.|+
T Consensus 235 ~~-~~~-----~---~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 235 TG-GGR-----L---DPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred Hc-CCc-----C---CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 11 000 0 111222356788889999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=325.83 Aligned_cols=257 Identities=27% Similarity=0.375 Sum_probs=204.4
Q ss_pred CCCCCCccccCCCEEEEEeEeC------CCcEEEEEEccccc-hhcHHHHHHHHHHHHhhccCCcceeEeEEEcCceeEE
Q 001658 694 NFSPSNKLGEGGFGPVYKGKLG------DGRAIAVKQLSVAS-RQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLL 766 (1036)
Q Consensus 694 ~~~~~~~iG~G~fG~Vy~~~~~------~g~~vAvK~~~~~~-~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~l 766 (1036)
+|++.+.||+|+||.||+|... ....+|+|.+.... .....++.+|+.+++.++||||+++++++...+..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 4677899999999999999742 23578999886543 2335678999999999999999999999999999999
Q ss_pred EEEecCCCChhhhhhcCC----------------------CCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCc
Q 001658 767 VYEYLENKSLDQALFGQR----------------------SLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASN 824 (1036)
Q Consensus 767 V~E~~~~gsL~~~l~~~~----------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~N 824 (1036)
|+||+++++|.+++.... ...+++.+++.++.|++.||+|||+.+ |+||||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhhhe
Confidence 999999999999985421 235789999999999999999999987 9999999999
Q ss_pred EEecCCCceEEEEcCcceeecCCCCcc-ccccccccCccCccccccCCCCchhhHHhHHHHHHHHHh-CCCCCCCCChhh
Q 001658 825 VLLDADLVPKISDFGLAKLYDDKKTHI-STRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVS-GRPNSDPSLDEE 902 (1036)
Q Consensus 825 ILl~~~~~~kl~DFGla~~~~~~~~~~-~~~~~gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~ 902 (1036)
|++++++.+||+|||+++......... .....++..|+|||++.+..++.++||||||+++|||++ |+.||.......
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~ 237 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPER 237 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence 999999999999999998654332211 122345678999999988889999999999999999999 999987654332
Q ss_pred HHHHHHHHHHHhhcCccccccCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcccC
Q 001658 903 KLYLLEWAWHLHENNQEIELADPKLIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVAMLCGDME 968 (1036)
Q Consensus 903 ~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 968 (1036)
... +. .... .+. ........+.+++.+|++.+|++||+++|+++.|++++.
T Consensus 238 ~~~---~~----~~~~-----~~~---~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~ 288 (290)
T cd05045 238 LFN---LL----KTGY-----RME---RPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV 288 (290)
T ss_pred HHH---HH----hCCC-----CCC---CCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence 221 11 1110 011 111223467788999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=334.26 Aligned_cols=251 Identities=22% Similarity=0.278 Sum_probs=196.8
Q ss_pred CCCCCCccccCCCEEEEEeEe----CCCcEEEEEEccccc----hhcHHHHHHHHHHHHhh-ccCCcceeEeEEEcCcee
Q 001658 694 NFSPSNKLGEGGFGPVYKGKL----GDGRAIAVKQLSVAS----RQGKSQFVAEIATISAV-QHRNLVKLHGCCIEGAER 764 (1036)
Q Consensus 694 ~~~~~~~iG~G~fG~Vy~~~~----~~g~~vAvK~~~~~~----~~~~~~f~~Ei~~L~~l-~H~nIv~l~g~~~~~~~~ 764 (1036)
+|++.+.||+|+||.||+++. .+++.||+|++.... ....+.+..|+.++..+ +|+||+++++++...+..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 477889999999999999874 357899999986432 22345678899999999 599999999999999999
Q ss_pred EEEEEecCCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceee
Q 001658 765 LLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLY 844 (1036)
Q Consensus 765 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~ 844 (1036)
++||||+++|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+
T Consensus 81 ~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG~~~~~ 155 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQR--DNFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKEF 155 (332)
T ss_pred EEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCcCCccc
Confidence 9999999999999998643 45788999999999999999999988 999999999999999999999999999865
Q ss_pred cCCCCccccccccccCccCccccccC-CCCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhcCcccccc
Q 001658 845 DDKKTHISTRVAGTIGYLAPEYAMRG-HLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEIELA 923 (1036)
Q Consensus 845 ~~~~~~~~~~~~gt~~y~APE~~~~~-~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 923 (1036)
............||+.|+|||++.+. .++.++|||||||++|||+||+.||............ ..... ..
T Consensus 156 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~--~~~~~-------~~ 226 (332)
T cd05614 156 LSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEV--SRRIL-------KC 226 (332)
T ss_pred cccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHH--HHHHh-------cC
Confidence 44333333345799999999999865 4788999999999999999999999753322111111 00111 11
Q ss_pred CcccccCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 001658 924 DPKLIEFNEEEVKRLIGVALLCTQTLPSLRP-----SMSRVVA 961 (1036)
Q Consensus 924 d~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----t~~evl~ 961 (1036)
++.+.. .....+.+++.+|++.||++|| ++.++++
T Consensus 227 ~~~~~~---~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 266 (332)
T cd05614 227 DPPFPS---FIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE 266 (332)
T ss_pred CCCCCC---CCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence 222211 1234566778899999999999 6667664
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=327.41 Aligned_cols=254 Identities=25% Similarity=0.385 Sum_probs=201.2
Q ss_pred CCCCCCccccCCCEEEEEeEeC------CCcEEEEEEccccch-hcHHHHHHHHHHHHhhccCCcceeEeEEEcCceeEE
Q 001658 694 NFSPSNKLGEGGFGPVYKGKLG------DGRAIAVKQLSVASR-QGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLL 766 (1036)
Q Consensus 694 ~~~~~~~iG~G~fG~Vy~~~~~------~g~~vAvK~~~~~~~-~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~l 766 (1036)
+|.+.+.||+|+||.||+|... .++.||+|+++.... ...+.|.+|+.++..++||||+++++++......++
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~ 85 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSM 85 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEE
Confidence 3556788999999999999853 247899999975432 234678899999999999999999999999999999
Q ss_pred EEEecCCCChhhhhhcCC--------------CCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCc
Q 001658 767 VYEYLENKSLDQALFGQR--------------SLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLV 832 (1036)
Q Consensus 767 V~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~ 832 (1036)
++||+++++|.+++.... ...+++..+.+++.|+++||+|||+.+ |+||||||+||++++++.
T Consensus 86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~ 162 (283)
T cd05091 86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKLN 162 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCCCc
Confidence 999999999999985321 235788899999999999999999988 999999999999999999
Q ss_pred eEEEEcCcceeecCCCC-ccccccccccCccCccccccCCCCchhhHHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHH
Q 001658 833 PKISDFGLAKLYDDKKT-HISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVS-GRPNSDPSLDEEKLYLLEWA 910 (1036)
Q Consensus 833 ~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~ 910 (1036)
+||+|||+++....... .......+++.|+|||++.++.++.++|||||||++|||++ |..||......+....+
T Consensus 163 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i--- 239 (283)
T cd05091 163 VKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMI--- 239 (283)
T ss_pred eEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH---
Confidence 99999999886543221 11223346789999999988889999999999999999998 77888765433222111
Q ss_pred HHHhhcCccccccCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhc
Q 001658 911 WHLHENNQEIELADPKLIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVAMLCG 965 (1036)
Q Consensus 911 ~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~ 965 (1036)
.. . ............+.+++..||+.+|.+||+++||++.|+.
T Consensus 240 ---~~-~--------~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 240 ---RN-R--------QVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred ---Hc-C--------CcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 11 0 1111122334557788899999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-36 Score=338.32 Aligned_cols=252 Identities=21% Similarity=0.237 Sum_probs=200.9
Q ss_pred cCCCCCCccccCCCEEEEEeEeC-CCcEEEEEEccccc---hhcHHHHHHHHHHHHhhccCCcceeEeEEEcCceeEEEE
Q 001658 693 ENFSPSNKLGEGGFGPVYKGKLG-DGRAIAVKQLSVAS---RQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLVY 768 (1036)
Q Consensus 693 ~~~~~~~~iG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~ 768 (1036)
++|++.+.||+|+||.||+++.. +|+.||+|+++... ....+.+.+|+.+++.++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 36888899999999999999854 68999999987542 234566889999999999999999999999999999999
Q ss_pred EecCCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeecCCC
Q 001658 769 EYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKK 848 (1036)
Q Consensus 769 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~ 848 (1036)
||+++|+|.+++... ...+++..+..++.|+++||.|||+.+ |+||||||+|||++.++.+||+|||++..+....
T Consensus 81 e~~~~~~L~~~l~~~-~~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~ 156 (330)
T cd05601 81 EYQPGGDLLSLLNRY-EDQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARLTANK 156 (330)
T ss_pred CCCCCCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCCeECCCCC
Confidence 999999999998654 246889999999999999999999988 9999999999999999999999999998775443
Q ss_pred CccccccccccCccCccccc------cCCCCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhcCccccc
Q 001658 849 THISTRVAGTIGYLAPEYAM------RGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEIEL 922 (1036)
Q Consensus 849 ~~~~~~~~gt~~y~APE~~~------~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 922 (1036)
........||+.|+|||++. ...++.++|||||||++|||++|+.||.......... ..........
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~------~i~~~~~~~~- 229 (330)
T cd05601 157 MVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYN------NIMNFQRFLK- 229 (330)
T ss_pred ceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHH------HHHcCCCccC-
Confidence 33333456999999999986 4567889999999999999999999998654432221 1111111111
Q ss_pred cCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 001658 923 ADPKLIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVA 961 (1036)
Q Consensus 923 ~d~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 961 (1036)
.|.. ......+.+++..|++ +|.+||++.+++.
T Consensus 230 -~~~~----~~~~~~~~~li~~ll~-~p~~R~t~~~l~~ 262 (330)
T cd05601 230 -FPED----PKVSSDFLDLIQSLLC-GQKERLGYEGLCC 262 (330)
T ss_pred -CCCC----CCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence 1111 1123446667778887 9999999999875
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=330.81 Aligned_cols=243 Identities=28% Similarity=0.412 Sum_probs=200.2
Q ss_pred ccccCCCEEEEEeEeC-CCcEEEEEEccccchhcHHHHHHHHHHHHhhccCCcceeEeEEEcCceeEEEEEecCCCChhh
Q 001658 700 KLGEGGFGPVYKGKLG-DGRAIAVKQLSVASRQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLVYEYLENKSLDQ 778 (1036)
Q Consensus 700 ~iG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~ 778 (1036)
+||+|.||+||-|+.. +...+|||.+...+....+.+.+|+...++++|.|||+++|.|.+++..-+.||-++||||.+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 6999999999999854 556799999987666667778999999999999999999999999999999999999999999
Q ss_pred hhhcCCCCCc--ChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecC-CCceEEEEcCcceeecCCCCcccccc
Q 001658 779 ALFGQRSLTL--DWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDA-DLVPKISDFGLAKLYDDKKTHISTRV 855 (1036)
Q Consensus 779 ~l~~~~~~~l--~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~-~~~~kl~DFGla~~~~~~~~~~~~~~ 855 (1036)
+|... -.++ .+.+.--...||++||.|||++. |||||||-.|||++- .|.+||+|||-++.+..-. .....+
T Consensus 662 LLrsk-WGPlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgin-P~TETF 736 (1226)
T KOG4279|consen 662 LLRSK-WGPLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGIN-PCTETF 736 (1226)
T ss_pred HHHhc-cCCCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhccCC-cccccc
Confidence 99653 3344 67777778999999999999987 999999999999965 6899999999998775332 234457
Q ss_pred ccccCccCccccccC--CCCchhhHHhHHHHHHHHHhCCCCCCCCChhh-HHHHHHHHHHHhhcCccccccCcccccCCH
Q 001658 856 AGTIGYLAPEYAMRG--HLTEKTDVFAFGVLALETVSGRPNSDPSLDEE-KLYLLEWAWHLHENNQEIELADPKLIEFNE 932 (1036)
Q Consensus 856 ~gt~~y~APE~~~~~--~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~-~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~ 932 (1036)
.||..|||||++..+ .|..++|||||||++.||.||++||....... ..+.+ ......|. .+.
T Consensus 737 TGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkV-----------GmyKvHP~---iPe 802 (1226)
T KOG4279|consen 737 TGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKV-----------GMYKVHPP---IPE 802 (1226)
T ss_pred ccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhh-----------cceecCCC---CcH
Confidence 799999999999876 48889999999999999999999998543321 11111 11223343 345
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 001658 933 EEVKRLIGVALLCTQTLPSLRPSMSRVVA 961 (1036)
Q Consensus 933 ~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 961 (1036)
+...+...++++|+..||.+||++.++++
T Consensus 803 elsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 803 ELSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred HHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 56667777889999999999999999876
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=337.03 Aligned_cols=204 Identities=25% Similarity=0.341 Sum_probs=175.9
Q ss_pred cCCCCCCccccCCCEEEEEeEeC-CCcEEEEEEccccc---hhcHHHHHHHHHHHHhhccCCcceeEeEEEcCceeEEEE
Q 001658 693 ENFSPSNKLGEGGFGPVYKGKLG-DGRAIAVKQLSVAS---RQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLVY 768 (1036)
Q Consensus 693 ~~~~~~~~iG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~ 768 (1036)
++|+..+.||+|+||+||+|+.. +++.||+|++.... ......+..|+.++.+++|+||+++++++.+....++||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 46888999999999999999854 68899999986532 223456788999999999999999999999999999999
Q ss_pred EecCCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeecCCC
Q 001658 769 EYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKK 848 (1036)
Q Consensus 769 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~ 848 (1036)
||+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+....
T Consensus 81 E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~ 155 (363)
T cd05628 81 EFLPGGDMMTLLMKK--DTLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAH 155 (363)
T ss_pred cCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCcccccccc
Confidence 999999999999653 46889999999999999999999988 9999999999999999999999999987543211
Q ss_pred C----------------------------------ccccccccccCccCccccccCCCCchhhHHhHHHHHHHHHhCCCC
Q 001658 849 T----------------------------------HISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRPN 894 (1036)
Q Consensus 849 ~----------------------------------~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~elltG~~p 894 (1036)
. .......||+.|+|||++.+..++.++|||||||++|||++|+.|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~P 235 (363)
T cd05628 156 RTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235 (363)
T ss_pred cccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCC
Confidence 0 001235799999999999999999999999999999999999999
Q ss_pred CCCCChh
Q 001658 895 SDPSLDE 901 (1036)
Q Consensus 895 ~~~~~~~ 901 (1036)
|......
T Consensus 236 f~~~~~~ 242 (363)
T cd05628 236 FCSETPQ 242 (363)
T ss_pred CCCCCHH
Confidence 9865543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=328.81 Aligned_cols=260 Identities=29% Similarity=0.415 Sum_probs=207.2
Q ss_pred HHhcCCCCCCccccCCCEEEEEeEeC------CCcEEEEEEcccc-chhcHHHHHHHHHHHHhh-ccCCcceeEeEEEcC
Q 001658 690 TATENFSPSNKLGEGGFGPVYKGKLG------DGRAIAVKQLSVA-SRQGKSQFVAEIATISAV-QHRNLVKLHGCCIEG 761 (1036)
Q Consensus 690 ~~~~~~~~~~~iG~G~fG~Vy~~~~~------~g~~vAvK~~~~~-~~~~~~~f~~Ei~~L~~l-~H~nIv~l~g~~~~~ 761 (1036)
...++|+..+.||+|+||.||+|... ....+|+|.+... ......++.+|++++.++ +|+||+++++++..+
T Consensus 9 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 88 (293)
T cd05053 9 LPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQE 88 (293)
T ss_pred cCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCC
Confidence 34567888899999999999999853 2368999998753 233346688999999999 799999999999999
Q ss_pred ceeEEEEEecCCCChhhhhhcC--------------CCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEe
Q 001658 762 AERLLVYEYLENKSLDQALFGQ--------------RSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLL 827 (1036)
Q Consensus 762 ~~~~lV~E~~~~gsL~~~l~~~--------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl 827 (1036)
+..++||||+++|+|.+++... ....+++..+++++.|++.||+|||+.+ |+||||||+||++
T Consensus 89 ~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~Nil~ 165 (293)
T cd05053 89 GPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARNVLV 165 (293)
T ss_pred CCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceeeEEE
Confidence 9999999999999999998642 2356899999999999999999999987 9999999999999
Q ss_pred cCCCceEEEEcCcceeecCCCCcc-ccccccccCccCccccccCCCCchhhHHhHHHHHHHHHh-CCCCCCCCChhhHHH
Q 001658 828 DADLVPKISDFGLAKLYDDKKTHI-STRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVS-GRPNSDPSLDEEKLY 905 (1036)
Q Consensus 828 ~~~~~~kl~DFGla~~~~~~~~~~-~~~~~gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~ 905 (1036)
++++.+||+|||+++.+....... .....++..|+|||++.+..++.++|||||||++|||++ |..||......+...
T Consensus 166 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~ 245 (293)
T cd05053 166 TEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFK 245 (293)
T ss_pred cCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHHHH
Confidence 999999999999998765432211 122335678999999998899999999999999999998 888887544322221
Q ss_pred HHHHHHHHhhcCccccccCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhccc
Q 001658 906 LLEWAWHLHENNQEIELADPKLIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVAMLCGDM 967 (1036)
Q Consensus 906 l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~ 967 (1036)
.. .... ...........+.+++.+||+.+|++|||+.|+++.|+..+
T Consensus 246 ~~-------~~~~--------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 246 LL-------KEGY--------RMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred HH-------HcCC--------cCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 11 1110 01112223456788999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-35 Score=320.81 Aligned_cols=254 Identities=24% Similarity=0.400 Sum_probs=197.8
Q ss_pred CCCCCccccCCCEEEEEeEeCC-Cc--EEEEEEcccc--chhcHHHHHHHHHHHHhhccCCcceeEeEEEcC------ce
Q 001658 695 FSPSNKLGEGGFGPVYKGKLGD-GR--AIAVKQLSVA--SRQGKSQFVAEIATISAVQHRNLVKLHGCCIEG------AE 763 (1036)
Q Consensus 695 ~~~~~~iG~G~fG~Vy~~~~~~-g~--~vAvK~~~~~--~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~------~~ 763 (1036)
|.+.+.||+|+||.||+|+..+ +. .||+|.++.. .....+.+..|+++++.++|+||+++++++... ..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 3467889999999999998654 32 6899988653 344456789999999999999999999987532 24
Q ss_pred eEEEEEecCCCChhhhhhcC----CCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcC
Q 001658 764 RLLVYEYLENKSLDQALFGQ----RSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFG 839 (1036)
Q Consensus 764 ~~lV~E~~~~gsL~~~l~~~----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFG 839 (1036)
.++|+||+++|+|.+++... ....+++.....++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg 157 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFG 157 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECCCC
Confidence 68999999999999987432 2345899999999999999999999987 9999999999999999999999999
Q ss_pred cceeecCCCCcc-ccccccccCccCccccccCCCCchhhHHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHHHHHhhcC
Q 001658 840 LAKLYDDKKTHI-STRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVS-GRPNSDPSLDEEKLYLLEWAWHLHENN 917 (1036)
Q Consensus 840 la~~~~~~~~~~-~~~~~gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~ 917 (1036)
+++.+....... .....+++.|+|||+..+..++.++||||||+++|||++ |+.||......... +. ...+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~---~~----~~~~ 230 (272)
T cd05075 158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIY---DY----LRQG 230 (272)
T ss_pred cccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHH---HH----HHcC
Confidence 998765332211 122346778999999999899999999999999999999 78888654332211 11 1111
Q ss_pred ccccccCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcc
Q 001658 918 QEIELADPKLIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVAMLCGD 966 (1036)
Q Consensus 918 ~~~~~~d~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 966 (1036)
... . ........+.+++.+||+.+|++|||+.++++.|+..
T Consensus 231 ~~~-----~---~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 231 NRL-----K---QPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred CCC-----C---CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 110 0 1112234578889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=327.54 Aligned_cols=258 Identities=26% Similarity=0.396 Sum_probs=206.4
Q ss_pred hcCCCCCCccccCCCEEEEEeEe------CCCcEEEEEEccccc-hhcHHHHHHHHHHHHhh-ccCCcceeEeEEEcCce
Q 001658 692 TENFSPSNKLGEGGFGPVYKGKL------GDGRAIAVKQLSVAS-RQGKSQFVAEIATISAV-QHRNLVKLHGCCIEGAE 763 (1036)
Q Consensus 692 ~~~~~~~~~iG~G~fG~Vy~~~~------~~g~~vAvK~~~~~~-~~~~~~f~~Ei~~L~~l-~H~nIv~l~g~~~~~~~ 763 (1036)
.++|...+.||+|+||.||+|.. ..+..||+|.++... ....+.+.+|+++++++ +|+||+++++++...+.
T Consensus 34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 113 (302)
T cd05055 34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGP 113 (302)
T ss_pred HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCc
Confidence 35688889999999999999973 134579999987543 33356789999999999 79999999999999999
Q ss_pred eEEEEEecCCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCccee
Q 001658 764 RLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKL 843 (1036)
Q Consensus 764 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~ 843 (1036)
.++||||+++|+|.+++.......+++.++..++.|++.||+|||+.+ |+|+||||+||+++.++.++++|||+++.
T Consensus 114 ~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~dfg~~~~ 190 (302)
T cd05055 114 ILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLARD 190 (302)
T ss_pred eEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECCCccccc
Confidence 999999999999999997655555899999999999999999999987 99999999999999999999999999986
Q ss_pred ecCCCCc-cccccccccCccCccccccCCCCchhhHHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHHHHHhhcCcccc
Q 001658 844 YDDKKTH-ISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVS-GRPNSDPSLDEEKLYLLEWAWHLHENNQEIE 921 (1036)
Q Consensus 844 ~~~~~~~-~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 921 (1036)
....... ......++..|+|||.+.+..++.++|||||||++|||++ |+.||......+... .. ...+.
T Consensus 191 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~--~~----~~~~~--- 261 (302)
T cd05055 191 IMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFY--KL----IKEGY--- 261 (302)
T ss_pred ccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHH--HH----HHcCC---
Confidence 6433221 1122346778999999998899999999999999999998 999987544322211 11 11110
Q ss_pred ccCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcc
Q 001658 922 LADPKLIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVAMLCGD 966 (1036)
Q Consensus 922 ~~d~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 966 (1036)
.+. ........+.+++.+|++.+|++||++.|+++.|++.
T Consensus 262 --~~~---~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 262 --RMA---QPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred --cCC---CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 000 1111234678889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-35 Score=321.25 Aligned_cols=254 Identities=25% Similarity=0.401 Sum_probs=200.8
Q ss_pred CCCCCccccCCCEEEEEeEeCC----CcEEEEEEcccc--chhcHHHHHHHHHHHHhhccCCcceeEeEEEcCce-----
Q 001658 695 FSPSNKLGEGGFGPVYKGKLGD----GRAIAVKQLSVA--SRQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAE----- 763 (1036)
Q Consensus 695 ~~~~~~iG~G~fG~Vy~~~~~~----g~~vAvK~~~~~--~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~----- 763 (1036)
|++.+.||+|+||.||+|.... +..||+|+++.. .......+.+|++.++.++|+||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 5677899999999999998642 367999998743 23335678999999999999999999999876554
Q ss_pred -eEEEEEecCCCChhhhhhcC----CCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEc
Q 001658 764 -RLLVYEYLENKSLDQALFGQ----RSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDF 838 (1036)
Q Consensus 764 -~~lV~E~~~~gsL~~~l~~~----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DF 838 (1036)
.++|+||+++|+|.+++... ....+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEECCc
Confidence 68999999999999988543 2346899999999999999999999987 999999999999999999999999
Q ss_pred CcceeecCCCCcc-ccccccccCccCccccccCCCCchhhHHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHHHHHhhc
Q 001658 839 GLAKLYDDKKTHI-STRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVS-GRPNSDPSLDEEKLYLLEWAWHLHEN 916 (1036)
Q Consensus 839 Gla~~~~~~~~~~-~~~~~gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~ 916 (1036)
|+++......... .....++..|+|||++.+..++.++|||||||++|||++ |..||......+. .++.. .
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~---~~~~~----~ 230 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEI---YDYLR----H 230 (273)
T ss_pred cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHH---HHHHH----c
Confidence 9998765433221 112235678999999988889999999999999999999 8888865443221 11111 1
Q ss_pred CccccccCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcc
Q 001658 917 NQEIELADPKLIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVAMLCGD 966 (1036)
Q Consensus 917 ~~~~~~~d~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 966 (1036)
+. .+ ..+......+.+++.+||+.||++||++.|+++.|++.
T Consensus 231 ~~-----~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 231 GN-----RL---KQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred CC-----CC---CCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 11 01 11122345678888999999999999999999999754
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=336.41 Aligned_cols=262 Identities=21% Similarity=0.312 Sum_probs=195.1
Q ss_pred CCCCCCccccCCCEEEEEeEe-CCCcEEEEEEcccc--chhcHHHHHHHHHHHHhhccCCcceeEeEEEcC-----ceeE
Q 001658 694 NFSPSNKLGEGGFGPVYKGKL-GDGRAIAVKQLSVA--SRQGKSQFVAEIATISAVQHRNLVKLHGCCIEG-----AERL 765 (1036)
Q Consensus 694 ~~~~~~~iG~G~fG~Vy~~~~-~~g~~vAvK~~~~~--~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~-----~~~~ 765 (1036)
+|++.+.||+|+||.||+|+. .+++.||||++... .......+.+|++++++++||||+++++++... ...+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 477789999999999999985 46899999998643 223345688999999999999999999988643 2479
Q ss_pred EEEEecCCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeec
Q 001658 766 LVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYD 845 (1036)
Q Consensus 766 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~ 845 (1036)
+||||+. ++|.+++... ..+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 81 lv~e~~~-~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~ 154 (338)
T cd07859 81 VVFELME-SDLHQVIKAN--DDLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVAF 154 (338)
T ss_pred EEEecCC-CCHHHHHHhc--ccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccCccccccc
Confidence 9999995 6899988543 45889999999999999999999998 9999999999999999999999999998653
Q ss_pred CCCC--ccccccccccCccCcccccc--CCCCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHH---------HH
Q 001658 846 DKKT--HISTRVAGTIGYLAPEYAMR--GHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWA---------WH 912 (1036)
Q Consensus 846 ~~~~--~~~~~~~gt~~y~APE~~~~--~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~---------~~ 912 (1036)
.... .......||..|+|||++.+ ..++.++|||||||++|||++|++||...........+... ..
T Consensus 155 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (338)
T cd07859 155 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISR 234 (338)
T ss_pred cccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHH
Confidence 2221 11234569999999999875 67899999999999999999999999765432221111000 00
Q ss_pred HhhcC--cccc-c--cCc-ccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 001658 913 LHENN--QEIE-L--ADP-KLIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVA 961 (1036)
Q Consensus 913 ~~~~~--~~~~-~--~d~-~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 961 (1036)
..... .... . ..+ ............+.+++.+|++.+|++|||++|+++
T Consensus 235 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~ 289 (338)
T cd07859 235 VRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALA 289 (338)
T ss_pred hhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 00000 0000 0 000 000000112245678899999999999999999986
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-35 Score=323.06 Aligned_cols=256 Identities=26% Similarity=0.392 Sum_probs=200.8
Q ss_pred cCCCCCCccccCCCEEEEEeEeC-CCc----EEEEEEccccc-hhcHHHHHHHHHHHHhhccCCcceeEeEEEcCceeEE
Q 001658 693 ENFSPSNKLGEGGFGPVYKGKLG-DGR----AIAVKQLSVAS-RQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLL 766 (1036)
Q Consensus 693 ~~~~~~~~iG~G~fG~Vy~~~~~-~g~----~vAvK~~~~~~-~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~l 766 (1036)
++|++.+.||+|+||+||+|++. +++ .|++|.+.... .....++..|+..+++++||||+++++++.. ...++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEE
Confidence 46777899999999999999863 444 47888875432 2334567888889999999999999998764 45778
Q ss_pred EEEecCCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeecC
Q 001658 767 VYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDD 846 (1036)
Q Consensus 767 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~ 846 (1036)
|+||+++|+|.+++... ...++|..+..|+.||+.||+|||+.+ ++||||||+||++++++.+||+|||+++....
T Consensus 86 i~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~ 161 (279)
T cd05111 86 VTQLSPLGSLLDHVRQH-RDSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYP 161 (279)
T ss_pred EEEeCCCCcHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCccceeccC
Confidence 99999999999999653 346899999999999999999999987 99999999999999999999999999987643
Q ss_pred CCCc-cccccccccCccCccccccCCCCchhhHHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHHHHHhhcCccccccC
Q 001658 847 KKTH-ISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVS-GRPNSDPSLDEEKLYLLEWAWHLHENNQEIELAD 924 (1036)
Q Consensus 847 ~~~~-~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 924 (1036)
.... ......++..|+|||++.++.++.++|||||||++||+++ |+.||..........+. ..+... ..
T Consensus 162 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~-------~~~~~~--~~ 232 (279)
T cd05111 162 DDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLL-------EKGERL--AQ 232 (279)
T ss_pred CCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH-------HCCCcC--CC
Confidence 3221 2234557789999999998899999999999999999998 99998765432221111 111111 11
Q ss_pred cccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcccC
Q 001658 925 PKLIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVAMLCGDME 968 (1036)
Q Consensus 925 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 968 (1036)
+. . ....+.+++.+||+.+|.+|||+.|+++.|.....
T Consensus 233 ~~---~---~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~ 270 (279)
T cd05111 233 PQ---I---CTIDVYMVMVKCWMIDENVRPTFKELANEFTRMAR 270 (279)
T ss_pred CC---C---CCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence 11 1 12356777889999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-35 Score=320.75 Aligned_cols=258 Identities=23% Similarity=0.365 Sum_probs=207.1
Q ss_pred cCCCCCCccccCCCEEEEEeEeC-CCcEEEEEEcccc---chhcHHHHHHHHHHHHhhccCCcceeEeEEEcCceeEEEE
Q 001658 693 ENFSPSNKLGEGGFGPVYKGKLG-DGRAIAVKQLSVA---SRQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLVY 768 (1036)
Q Consensus 693 ~~~~~~~~iG~G~fG~Vy~~~~~-~g~~vAvK~~~~~---~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~ 768 (1036)
++|++.+.||+|+||.||+|+.. +++.||||.+... .......+.+|+++++.++||||+++++++...+..++|+
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 57888999999999999999854 7899999987532 2334567889999999999999999999999999999999
Q ss_pred EecCCCChhhhhhcC--CCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeecC
Q 001658 769 EYLENKSLDQALFGQ--RSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDD 846 (1036)
Q Consensus 769 E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~ 846 (1036)
||+++|+|.+++... ....+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 999999999988532 2345788899999999999999999987 99999999999999999999999999987654
Q ss_pred CCCccccccccccCccCccccccCCCCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhcCccccccCcc
Q 001658 847 KKTHISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEIELADPK 926 (1036)
Q Consensus 847 ~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 926 (1036)
.... .....|+..|+|||.+.+..++.++||||||+++|||++|+.||...... ...... .... ...+.
T Consensus 159 ~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~-~~~~~~---~~~~------~~~~~ 227 (267)
T cd08228 159 KTTA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN-LFSLCQ---KIEQ------CDYPP 227 (267)
T ss_pred hhHH-HhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCcccccc-HHHHHH---HHhc------CCCCC
Confidence 3221 12345888999999999888999999999999999999999998653321 111111 1110 01111
Q ss_pred cccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcc
Q 001658 927 LIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVAMLCGD 966 (1036)
Q Consensus 927 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 966 (1036)
. ........+.+++.+||+.+|++||++.+|++.++++
T Consensus 228 ~--~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 228 L--PTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred C--ChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence 1 1123345678888999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=333.90 Aligned_cols=244 Identities=26% Similarity=0.321 Sum_probs=192.9
Q ss_pred CCCCCccccCCCEEEEEeEeC-CCcEEEEEEccccc---hhcHHHHHHHHHHH---HhhccCCcceeEeEEEcCceeEEE
Q 001658 695 FSPSNKLGEGGFGPVYKGKLG-DGRAIAVKQLSVAS---RQGKSQFVAEIATI---SAVQHRNLVKLHGCCIEGAERLLV 767 (1036)
Q Consensus 695 ~~~~~~iG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~f~~Ei~~L---~~l~H~nIv~l~g~~~~~~~~~lV 767 (1036)
|++.+.||+|+||.||+|... +++.||||+++... ....+.+..|++++ +.++||||+++++++...+..++|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 566789999999999999864 68999999987532 22344566676655 466799999999999999999999
Q ss_pred EEecCCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeecCC
Q 001658 768 YEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDK 847 (1036)
Q Consensus 768 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~ 847 (1036)
|||+++|+|..++.. ..+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++.....
T Consensus 81 ~E~~~~~~L~~~~~~---~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~ 154 (324)
T cd05589 81 MEYAAGGDLMMHIHT---DVFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGF 154 (324)
T ss_pred EcCCCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccCCccCCCC
Confidence 999999999988843 46899999999999999999999988 999999999999999999999999998754322
Q ss_pred CCccccccccccCccCccccccCCCCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhcCccccccCccc
Q 001658 848 KTHISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEIELADPKL 927 (1036)
Q Consensus 848 ~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~ 927 (1036)
.. ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+....+ ... .+..
T Consensus 155 ~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i------~~~-------~~~~ 220 (324)
T cd05589 155 GD-RTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSI------VND-------EVRY 220 (324)
T ss_pred CC-cccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHH------HhC-------CCCC
Confidence 21 223456999999999999989999999999999999999999999865443322111 100 1111
Q ss_pred ccCCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 001658 928 IEFNEEEVKRLIGVALLCTQTLPSLRPS-----MSRVVA 961 (1036)
Q Consensus 928 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt-----~~evl~ 961 (1036)
+......+.+++.+|++.||.+||+ +.++++
T Consensus 221 ---p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~ 256 (324)
T cd05589 221 ---PRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK 256 (324)
T ss_pred ---CCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence 1112345677888999999999994 555544
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-35 Score=317.00 Aligned_cols=247 Identities=26% Similarity=0.384 Sum_probs=197.2
Q ss_pred CccccCCCEEEEEeEeC-CCcEEEEEEcccc-chhcHHHHHHHHHHHHhhccCCcceeEeEEEcCceeEEEEEecCCCCh
Q 001658 699 NKLGEGGFGPVYKGKLG-DGRAIAVKQLSVA-SRQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLVYEYLENKSL 776 (1036)
Q Consensus 699 ~~iG~G~fG~Vy~~~~~-~g~~vAvK~~~~~-~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL 776 (1036)
+.||+|+||.||+|+.. +++.||+|.+... .......|.+|++++++++||||+++++++......++|+||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 46999999999999864 7899999987643 234456799999999999999999999999999999999999999999
Q ss_pred hhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeecCCCCccc-ccc
Q 001658 777 DQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHIS-TRV 855 (1036)
Q Consensus 777 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~-~~~ 855 (1036)
.+++... ...+++.+++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++........... ...
T Consensus 81 ~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 156 (252)
T cd05084 81 LTFLRTE-GPRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMK 156 (252)
T ss_pred HHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCcccccccccccCCCC
Confidence 9998643 346889999999999999999999987 99999999999999999999999999876543211110 111
Q ss_pred ccccCccCccccccCCCCchhhHHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHHHHHhhcCccccccCcccccCCHHH
Q 001658 856 AGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVS-GRPNSDPSLDEEKLYLLEWAWHLHENNQEIELADPKLIEFNEEE 934 (1036)
Q Consensus 856 ~gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 934 (1036)
.++..|+|||.+.++.++.++||||||+++|||++ |..||............ .... .+ ......
T Consensus 157 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~-------~~~~-----~~---~~~~~~ 221 (252)
T cd05084 157 QIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAI-------EQGV-----RL---PCPELC 221 (252)
T ss_pred CCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHH-------HcCC-----CC---CCcccC
Confidence 23457999999998899999999999999999998 88888654432221111 1100 00 111222
Q ss_pred HHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 001658 935 VKRLIGVALLCTQTLPSLRPSMSRVVAMLC 964 (1036)
Q Consensus 935 ~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~ 964 (1036)
...+.+++.+|++.+|++||++.||.++|+
T Consensus 222 ~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 222 PDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 456788889999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-35 Score=326.85 Aligned_cols=258 Identities=28% Similarity=0.368 Sum_probs=202.9
Q ss_pred cCCCCCCccccCCCEEEEEeEeC-CC--cEEEEEEcccc-chhcHHHHHHHHHHHHhh-ccCCcceeEeEEEcCceeEEE
Q 001658 693 ENFSPSNKLGEGGFGPVYKGKLG-DG--RAIAVKQLSVA-SRQGKSQFVAEIATISAV-QHRNLVKLHGCCIEGAERLLV 767 (1036)
Q Consensus 693 ~~~~~~~~iG~G~fG~Vy~~~~~-~g--~~vAvK~~~~~-~~~~~~~f~~Ei~~L~~l-~H~nIv~l~g~~~~~~~~~lV 767 (1036)
++|++.+.||+|+||.||+|... ++ ..+++|.++.. .....+.|.+|+.++.++ +||||+++++++...+..++|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 46888899999999999999864 33 34788888642 334456789999999999 799999999999999999999
Q ss_pred EEecCCCChhhhhhcCC--------------CCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCce
Q 001658 768 YEYLENKSLDQALFGQR--------------SLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVP 833 (1036)
Q Consensus 768 ~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~ 833 (1036)
+||+++++|.+++.... ...+++..++.|+.|++.||+|||+.+ |+||||||+|||+++++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCCCeE
Confidence 99999999999996532 134788999999999999999999987 9999999999999999999
Q ss_pred EEEEcCcceeecCCCCccccccccccCccCccccccCCCCchhhHHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHHHH
Q 001658 834 KISDFGLAKLYDDKKTHISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVS-GRPNSDPSLDEEKLYLLEWAWH 912 (1036)
Q Consensus 834 kl~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~ 912 (1036)
||+|||++........ ......+..|+|||++....++.++|||||||++|||++ |+.||......+....
T Consensus 159 kl~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~------ 230 (297)
T cd05089 159 KIADFGLSRGEEVYVK--KTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEK------ 230 (297)
T ss_pred EECCcCCCccccceec--cCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH------
Confidence 9999999864321111 111223557999999998889999999999999999998 9999976543322111
Q ss_pred HhhcCccccccCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcccCCC
Q 001658 913 LHENNQEIELADPKLIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVAMLCGDMEVS 970 (1036)
Q Consensus 913 ~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~ 970 (1036)
...+ ..+.. .......+.+++.+||+.+|.+||+++++++.|+.+....
T Consensus 231 -~~~~-----~~~~~---~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~ 279 (297)
T cd05089 231 -LPQG-----YRMEK---PRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEAR 279 (297)
T ss_pred -HhcC-----CCCCC---CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 0000 01111 1122346778889999999999999999999998776544
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=351.08 Aligned_cols=257 Identities=26% Similarity=0.351 Sum_probs=204.9
Q ss_pred HHHHhcCCCCCCccccCCCEEEEEeEe-CCCcEEEEEEcccc--chhcHHHHHHHHHHHHhhccCCcceeEeEEEcCc--
Q 001658 688 LKTATENFSPSNKLGEGGFGPVYKGKL-GDGRAIAVKQLSVA--SRQGKSQFVAEIATISAVQHRNLVKLHGCCIEGA-- 762 (1036)
Q Consensus 688 l~~~~~~~~~~~~iG~G~fG~Vy~~~~-~~g~~vAvK~~~~~--~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~-- 762 (1036)
.....++|.+.+.||+|+||+||+|+. .+|+.||||++... .......+.+|+..+..++|+||+++++.+...+
T Consensus 27 ~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~ 106 (496)
T PTZ00283 27 AKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPR 106 (496)
T ss_pred ccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceeccccc
Confidence 344567899999999999999999984 57899999998643 3344567889999999999999999988775432
Q ss_pred ------eeEEEEEecCCCChhhhhhcCC--CCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceE
Q 001658 763 ------ERLLVYEYLENKSLDQALFGQR--SLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPK 834 (1036)
Q Consensus 763 ------~~~lV~E~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~k 834 (1036)
..++||||+++|+|.+++.... ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+|
T Consensus 107 ~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~~~vk 183 (496)
T PTZ00283 107 NPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNGLVK 183 (496)
T ss_pred CcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCCCCEE
Confidence 3579999999999999986532 456889999999999999999999987 99999999999999999999
Q ss_pred EEEcCcceeecCCCC-ccccccccccCccCccccccCCCCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHH
Q 001658 835 ISDFGLAKLYDDKKT-HISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHL 913 (1036)
Q Consensus 835 l~DFGla~~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~ 913 (1036)
|+|||+++.+..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||......+... ..
T Consensus 184 L~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~------~~ 257 (496)
T PTZ00283 184 LGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMH------KT 257 (496)
T ss_pred EEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHH------HH
Confidence 999999987653322 22234579999999999999999999999999999999999999997654322211 11
Q ss_pred hhcCccccccCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 001658 914 HENNQEIELADPKLIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVAM 962 (1036)
Q Consensus 914 ~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 962 (1036)
.. +. .++ .+......+.+++..||+.+|.+||++.+++++
T Consensus 258 ~~-~~----~~~----~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 258 LA-GR----YDP----LPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred hc-CC----CCC----CCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 11 00 111 112223467788889999999999999999864
|
|
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=337.92 Aligned_cols=263 Identities=23% Similarity=0.306 Sum_probs=200.4
Q ss_pred CCCCCCccccCCCEEEEEeEe-CCCcEEEEEEcccc--chhcHHHHHHHHHHHHhhccCCcceeEeEEEcCc-----eeE
Q 001658 694 NFSPSNKLGEGGFGPVYKGKL-GDGRAIAVKQLSVA--SRQGKSQFVAEIATISAVQHRNLVKLHGCCIEGA-----ERL 765 (1036)
Q Consensus 694 ~~~~~~~iG~G~fG~Vy~~~~-~~g~~vAvK~~~~~--~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~-----~~~ 765 (1036)
+|++.+.||+|+||.||+|.. .+|+.||+|++... .....+++.+|+++++.++|+||+++++++...+ ..+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 477889999999999999985 47899999998643 2234567889999999999999999999998776 789
Q ss_pred EEEEecCCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeec
Q 001658 766 LVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYD 845 (1036)
Q Consensus 766 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~ 845 (1036)
+|+||+. ++|.+++.. ...+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 81 lv~e~~~-~~l~~~~~~--~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~ 154 (372)
T cd07853 81 VVTELMQ-SDLHKIIVS--PQPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVEE 154 (372)
T ss_pred EEeeccc-cCHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEeccccceeecc
Confidence 9999996 688887744 346889999999999999999999988 9999999999999999999999999998765
Q ss_pred CCCCccccccccccCccCccccccC-CCCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHH--------------
Q 001658 846 DKKTHISTRVAGTIGYLAPEYAMRG-HLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWA-------------- 910 (1036)
Q Consensus 846 ~~~~~~~~~~~gt~~y~APE~~~~~-~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~-------------- 910 (1036)
...........+|..|+|||++.+. .++.++|||||||++|||++|+.||......+....+...
T Consensus 155 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~ 234 (372)
T cd07853 155 PDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACE 234 (372)
T ss_pred cCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhH
Confidence 4333333445688999999998774 4789999999999999999999999876543332221110
Q ss_pred --HHHhhcCccccccCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 001658 911 --WHLHENNQEIELADPKLIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVAM 962 (1036)
Q Consensus 911 --~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 962 (1036)
..............+............+.+++.+|++.||.+|||+.|+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 235 GARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred HHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 0000000000000000001111224567788999999999999999999863
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-35 Score=326.08 Aligned_cols=262 Identities=23% Similarity=0.341 Sum_probs=198.1
Q ss_pred hcCCCCCCccccCCCEEEEEeEeC-CCcEEEEEEccccch-hcHHHHHHHHHHHHhhccCCcceeEeEEEcCceeEEEEE
Q 001658 692 TENFSPSNKLGEGGFGPVYKGKLG-DGRAIAVKQLSVASR-QGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLVYE 769 (1036)
Q Consensus 692 ~~~~~~~~~iG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~-~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E 769 (1036)
.++|++.+.||+|+||.||+|+.. +++.||||++..... .....+.+|+.+++.++||||+++++++.+....++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 467889999999999999999865 688999999865432 234467889999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeecCCCC
Q 001658 770 YLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKT 849 (1036)
Q Consensus 770 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~ 849 (1036)
|++ ++|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++.......
T Consensus 84 ~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 158 (303)
T cd07869 84 YVH-TDLCQYMDKH-PGGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVPSH 158 (303)
T ss_pred CCC-cCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcceeccCCCc
Confidence 995 6888877543 345788889999999999999999988 99999999999999999999999999976533221
Q ss_pred ccccccccccCccCcccccc-CCCCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhcCc--------cc
Q 001658 850 HISTRVAGTIGYLAPEYAMR-GHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQ--------EI 920 (1036)
Q Consensus 850 ~~~~~~~gt~~y~APE~~~~-~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~--------~~ 920 (1036)
......||+.|+|||++.+ ..++.++||||+||++|||++|+.||....+.... .+.......... ..
T Consensus 159 -~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 235 (303)
T cd07869 159 -TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQ--LERIFLVLGTPNEDTWPGVHSL 235 (303)
T ss_pred -cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHH--HHHHHHHhCCCChhhccchhhc
Confidence 2233568999999999865 45889999999999999999999999864332111 111111110000 00
Q ss_pred cccCcc-cccCC----H------HHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 001658 921 ELADPK-LIEFN----E------EEVKRLIGVALLCTQTLPSLRPSMSRVVA 961 (1036)
Q Consensus 921 ~~~d~~-~~~~~----~------~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 961 (1036)
...++. ..... . .....+.+++.+|++.||++|||+.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 236 PHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred cccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 000110 00000 0 01235667888999999999999999875
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-35 Score=320.70 Aligned_cols=256 Identities=25% Similarity=0.434 Sum_probs=204.7
Q ss_pred cCCCCCCccccCCCEEEEEeEeC-CC---cEEEEEEcccc-chhcHHHHHHHHHHHHhhccCCcceeEeEEEcCceeEEE
Q 001658 693 ENFSPSNKLGEGGFGPVYKGKLG-DG---RAIAVKQLSVA-SRQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLV 767 (1036)
Q Consensus 693 ~~~~~~~~iG~G~fG~Vy~~~~~-~g---~~vAvK~~~~~-~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV 767 (1036)
++|+..+.||+|+||.||+|+.. ++ ..+|+|.+... .....+.+..|++++++++|+||+++++++...+..++|
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMII 84 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEE
Confidence 46777899999999999999864 23 37999998654 233456789999999999999999999999999999999
Q ss_pred EEecCCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeecCC
Q 001658 768 YEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDK 847 (1036)
Q Consensus 768 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~ 847 (1036)
|||+++++|.+++... ...+++.++..++.|++.|++|||+.+ ++||||||+||++++++.+||+|||++......
T Consensus 85 ~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~ 160 (268)
T cd05063 85 TEYMENGALDKYLRDH-DGEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSRVLEDD 160 (268)
T ss_pred EEcCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCccceecccc
Confidence 9999999999998653 356899999999999999999999987 999999999999999999999999999876533
Q ss_pred CCccc--cccccccCccCccccccCCCCchhhHHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHHHHHhhcCccccccC
Q 001658 848 KTHIS--TRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVS-GRPNSDPSLDEEKLYLLEWAWHLHENNQEIELAD 924 (1036)
Q Consensus 848 ~~~~~--~~~~gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 924 (1036)
..... .....+..|+|||++....++.++|||||||++|||++ |+.||......+.... . .... ..
T Consensus 161 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~------i-~~~~----~~ 229 (268)
T cd05063 161 PEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKA------I-NDGF----RL 229 (268)
T ss_pred cccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHH------H-hcCC----CC
Confidence 22211 11223457999999998889999999999999999998 9999875443221111 1 1110 11
Q ss_pred cccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhccc
Q 001658 925 PKLIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVAMLCGDM 967 (1036)
Q Consensus 925 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~ 967 (1036)
+. ..+....+.+++.+||+.+|++||++.+|++.|++.+
T Consensus 230 ~~----~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~~ 268 (268)
T cd05063 230 PA----PMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKLL 268 (268)
T ss_pred CC----CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhhC
Confidence 11 1123356788999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-35 Score=324.89 Aligned_cols=259 Identities=24% Similarity=0.428 Sum_probs=204.5
Q ss_pred HhcCCCCCCccccCCCEEEEEeEeC------CCcEEEEEEccccc-hhcHHHHHHHHHHHHhhccCCcceeEeEEEcCce
Q 001658 691 ATENFSPSNKLGEGGFGPVYKGKLG------DGRAIAVKQLSVAS-RQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAE 763 (1036)
Q Consensus 691 ~~~~~~~~~~iG~G~fG~Vy~~~~~------~g~~vAvK~~~~~~-~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~ 763 (1036)
..++|++.+.||+|+||.||+|..+ .+..||+|.+.... ......+.+|+.++++++|+||+++++++.+.+.
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP 83 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 4678899999999999999999643 24589999886433 2334568889999999999999999999999999
Q ss_pred eEEEEEecCCCChhhhhhcCC--------CCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEE
Q 001658 764 RLLVYEYLENKSLDQALFGQR--------SLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKI 835 (1036)
Q Consensus 764 ~~lV~E~~~~gsL~~~l~~~~--------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl 835 (1036)
.++||||+++|+|.+++.... ....++..+.+++.|++.||+|||+.+ |+||||||+||++++++.++|
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~~~L 160 (288)
T cd05061 84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVKI 160 (288)
T ss_pred cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCcEEE
Confidence 999999999999999996532 234567788899999999999999987 999999999999999999999
Q ss_pred EEcCcceeecCCCCc-cccccccccCccCccccccCCCCchhhHHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHHHHH
Q 001658 836 SDFGLAKLYDDKKTH-ISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVS-GRPNSDPSLDEEKLYLLEWAWHL 913 (1036)
Q Consensus 836 ~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~ 913 (1036)
+|||+++........ ......++..|+|||.+.++.++.++|||||||++|||++ |..||......+... . .
T Consensus 161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~---~---~ 234 (288)
T cd05061 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLK---F---V 234 (288)
T ss_pred CcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHH---H---H
Confidence 999999865432221 1122345678999999998899999999999999999999 788887543322111 1 1
Q ss_pred hhcCccccccCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhccc
Q 001658 914 HENNQEIELADPKLIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVAMLCGDM 967 (1036)
Q Consensus 914 ~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~ 967 (1036)
.. + ............+.+++.+|++.+|++|||+.++++.|++.+
T Consensus 235 ~~-~--------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 279 (288)
T cd05061 235 MD-G--------GYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL 279 (288)
T ss_pred Hc-C--------CCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence 11 0 011111222357888899999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=334.64 Aligned_cols=243 Identities=26% Similarity=0.332 Sum_probs=202.9
Q ss_pred HhcCCCCCCccccCCCEEEEEeEeC-CCcEEEEEEcccc---chhcHHHHHHHHHHHHhh-ccCCcceeEeEEEcCceeE
Q 001658 691 ATENFSPSNKLGEGGFGPVYKGKLG-DGRAIAVKQLSVA---SRQGKSQFVAEIATISAV-QHRNLVKLHGCCIEGAERL 765 (1036)
Q Consensus 691 ~~~~~~~~~~iG~G~fG~Vy~~~~~-~g~~vAvK~~~~~---~~~~~~~f~~Ei~~L~~l-~H~nIv~l~g~~~~~~~~~ 765 (1036)
..++|...++||+|.||+|+.+..+ +++.+|||.+++. .+++.+..+.|-+++... +||.++.++.+|...++.+
T Consensus 366 ~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~ 445 (694)
T KOG0694|consen 366 TLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLF 445 (694)
T ss_pred cccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEE
Confidence 4567889999999999999999865 6789999999865 345566778888888777 5999999999999999999
Q ss_pred EEEEecCCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeec
Q 001658 766 LVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYD 845 (1036)
Q Consensus 766 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~ 845 (1036)
+||||+.||++..+. ....+++..+.-++..|+.||+|||+++ ||+||||.+|||||.+|.+||+|||+++.-.
T Consensus 446 fvmey~~Ggdm~~~~---~~~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m 519 (694)
T KOG0694|consen 446 FVMEYVAGGDLMHHI---HTDVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADFGLCKEGM 519 (694)
T ss_pred EEEEecCCCcEEEEE---ecccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEecccccccccC
Confidence 999999999954443 4567899999999999999999999998 9999999999999999999999999998654
Q ss_pred CCCCccccccccccCccCccccccCCCCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhcCccccccCc
Q 001658 846 DKKTHISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEIELADP 925 (1036)
Q Consensus 846 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 925 (1036)
.... ....++||+.|||||++.+..|+..+|.|||||+||||+.|..||.+..+++..+-+ ...|+
T Consensus 520 ~~g~-~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI-------------~~d~~ 585 (694)
T KOG0694|consen 520 GQGD-RTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSI-------------VNDEV 585 (694)
T ss_pred CCCC-ccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH-------------hcCCC
Confidence 2222 345689999999999999999999999999999999999999999987665544322 12233
Q ss_pred ccccCCHHHHHHHHHHHHHhcccCCCCCCCH
Q 001658 926 KLIEFNEEEVKRLIGVALLCTQTLPSLRPSM 956 (1036)
Q Consensus 926 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~ 956 (1036)
.. +.-..++.+.++.+.+..+|++|--+
T Consensus 586 ~y---P~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 586 RY---PRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred CC---CCcccHHHHHHHHHHhccCcccccCC
Confidence 33 33334556677778889999999876
|
|
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-35 Score=318.67 Aligned_cols=254 Identities=29% Similarity=0.459 Sum_probs=206.8
Q ss_pred hcCCCCCCccccCCCEEEEEeEeCCCcEEEEEEccccchhcHHHHHHHHHHHHhhccCCcceeEeEEEcCceeEEEEEec
Q 001658 692 TENFSPSNKLGEGGFGPVYKGKLGDGRAIAVKQLSVASRQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLVYEYL 771 (1036)
Q Consensus 692 ~~~~~~~~~iG~G~fG~Vy~~~~~~g~~vAvK~~~~~~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~~ 771 (1036)
.++|++.+.||+|+||.||+|...++..+|+|.+.... ...+.|.+|++++++++|+||+++++++.+ ...++||||+
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~ 82 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFM 82 (260)
T ss_pred ccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeC
Confidence 46788899999999999999998778889999887533 335678999999999999999999999887 6789999999
Q ss_pred CCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeecCCCCcc
Q 001658 772 ENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHI 851 (1036)
Q Consensus 772 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 851 (1036)
++++|.+++.......+++.+++.++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||.+..........
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~ 159 (260)
T cd05073 83 AKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTA 159 (260)
T ss_pred CCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeeccCCCccc
Confidence 9999999997766667899999999999999999999987 9999999999999999999999999998664332222
Q ss_pred ccccccccCccCccccccCCCCchhhHHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHHHHHhhcCccccccCcccccC
Q 001658 852 STRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVS-GRPNSDPSLDEEKLYLLEWAWHLHENNQEIELADPKLIEF 930 (1036)
Q Consensus 852 ~~~~~gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~ 930 (1036)
.....++..|+|||++....++.++|||||||++||++| |+.||......... .+. ...... + .
T Consensus 160 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~---~~~----~~~~~~----~----~ 224 (260)
T cd05073 160 REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVI---RAL----ERGYRM----P----R 224 (260)
T ss_pred ccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHH---HHH----hCCCCC----C----C
Confidence 223345678999999998889999999999999999999 89888754332221 111 111100 0 1
Q ss_pred CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhc
Q 001658 931 NEEEVKRLIGVALLCTQTLPSLRPSMSRVVAMLCG 965 (1036)
Q Consensus 931 ~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~ 965 (1036)
.......+.+++.+|++.+|++||++.++.++|+.
T Consensus 225 ~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 225 PENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred cccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 12233567888899999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=332.18 Aligned_cols=241 Identities=27% Similarity=0.358 Sum_probs=193.7
Q ss_pred CccccCCCEEEEEeEe----CCCcEEEEEEccccc----hhcHHHHHHHHHHHHhhccCCcceeEeEEEcCceeEEEEEe
Q 001658 699 NKLGEGGFGPVYKGKL----GDGRAIAVKQLSVAS----RQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLVYEY 770 (1036)
Q Consensus 699 ~~iG~G~fG~Vy~~~~----~~g~~vAvK~~~~~~----~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~ 770 (1036)
+.||+|+||.||+++. .+++.||+|+++... ......+..|+.+++.++||||+++++++..++..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 6799999999999974 357899999986432 22345678899999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeecCCCCc
Q 001658 771 LENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTH 850 (1036)
Q Consensus 771 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~ 850 (1036)
+++|+|.+++... ..+.+..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 82 ~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~- 155 (323)
T cd05584 82 LSGGELFMHLERE--GIFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT- 155 (323)
T ss_pred CCCchHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC-
Confidence 9999999998653 35677888889999999999999988 99999999999999999999999999975433222
Q ss_pred cccccccccCccCccccccCCCCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhcCccccccCcccccC
Q 001658 851 ISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEIELADPKLIEF 930 (1036)
Q Consensus 851 ~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~ 930 (1036)
......||+.|+|||++.+..++.++|||||||++|||++|+.||.......... ..... ...+
T Consensus 156 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~------~~~~~-------~~~~--- 219 (323)
T cd05584 156 VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTID------KILKG-------KLNL--- 219 (323)
T ss_pred cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHH------HHHcC-------CCCC---
Confidence 2234569999999999998889999999999999999999999998654322111 11110 0111
Q ss_pred CHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 001658 931 NEEEVKRLIGVALLCTQTLPSLRP-----SMSRVVA 961 (1036)
Q Consensus 931 ~~~~~~~l~~l~~~Cl~~dP~~RP-----t~~evl~ 961 (1036)
+......+.+++.+|++.+|++|| ++.++++
T Consensus 220 ~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 220 PPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS 255 (323)
T ss_pred CCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence 111234567888899999999999 7888765
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-36 Score=341.16 Aligned_cols=252 Identities=24% Similarity=0.272 Sum_probs=203.1
Q ss_pred cCCCCCCccccCCCEEEEEeEeC-CCcEEEEEEccccc---hhcHHHHHHHHHHHHhhccCCcceeEeEEEcCceeEEEE
Q 001658 693 ENFSPSNKLGEGGFGPVYKGKLG-DGRAIAVKQLSVAS---RQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLVY 768 (1036)
Q Consensus 693 ~~~~~~~~iG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~ 768 (1036)
++|.+.+.||+|+||+||+|+.. +++.||+|+++... ......+.+|++++..++|+||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 46888899999999999999865 68999999987532 234567889999999999999999999999999999999
Q ss_pred EecCCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeecCCC
Q 001658 769 EYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKK 848 (1036)
Q Consensus 769 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~ 848 (1036)
||+++++|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 81 e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~ 155 (350)
T cd05573 81 EYMPGGDLMNLLIRK--DVFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMNKAK 155 (350)
T ss_pred cCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCCccCcccC
Confidence 999999999999654 56888999999999999999999987 9999999999999999999999999998665432
Q ss_pred ----------------------------CccccccccccCccCccccccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCh
Q 001658 849 ----------------------------THISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRPNSDPSLD 900 (1036)
Q Consensus 849 ----------------------------~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~ 900 (1036)
........||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~ 235 (350)
T cd05573 156 DREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTL 235 (350)
T ss_pred cccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCH
Confidence 1122345699999999999999999999999999999999999999987553
Q ss_pred hhHHHHHHHHHHHhhcCccccccCcccccCCHHHHHHHHHHHHHhcccCCCCCCC-HHHHHHH
Q 001658 901 EEKLYLLEWAWHLHENNQEIELADPKLIEFNEEEVKRLIGVALLCTQTLPSLRPS-MSRVVAM 962 (1036)
Q Consensus 901 ~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt-~~evl~~ 962 (1036)
......+ .. .......|.... ....+.+++..|++ +|.+||+ +.|+++.
T Consensus 236 ~~~~~~i------~~--~~~~~~~p~~~~----~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 236 QETYNKI------IN--WKESLRFPPDPP----VSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred HHHHHHH------hc--cCCcccCCCCCC----CCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 3222111 10 000011111111 23456677788997 9999999 9999864
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-35 Score=324.92 Aligned_cols=260 Identities=25% Similarity=0.380 Sum_probs=201.8
Q ss_pred cCCCCCCccccCCCEEEEEeEeCC---------------CcEEEEEEcccc-chhcHHHHHHHHHHHHhhccCCcceeEe
Q 001658 693 ENFSPSNKLGEGGFGPVYKGKLGD---------------GRAIAVKQLSVA-SRQGKSQFVAEIATISAVQHRNLVKLHG 756 (1036)
Q Consensus 693 ~~~~~~~~iG~G~fG~Vy~~~~~~---------------g~~vAvK~~~~~-~~~~~~~f~~Ei~~L~~l~H~nIv~l~g 756 (1036)
++|++.+.||+|+||.||+++..+ ...||+|.++.. .......|.+|++++++++|+||+++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~ 84 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG 84 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence 578888999999999999987532 235899998753 3344567999999999999999999999
Q ss_pred EEEcCceeEEEEEecCCCChhhhhhcCC----------CCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEE
Q 001658 757 CCIEGAERLLVYEYLENKSLDQALFGQR----------SLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVL 826 (1036)
Q Consensus 757 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~----------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIL 826 (1036)
++......++||||+++++|.+++.... ...+++..++.++.|+++||+|||+.+ ++||||||+||+
T Consensus 85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil 161 (295)
T cd05097 85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNCL 161 (295)
T ss_pred EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhhEE
Confidence 9999999999999999999999985432 124788999999999999999999988 999999999999
Q ss_pred ecCCCceEEEEcCcceeecCCCCc-cccccccccCccCccccccCCCCchhhHHhHHHHHHHHHh--CCCCCCCCChhhH
Q 001658 827 LDADLVPKISDFGLAKLYDDKKTH-ISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVS--GRPNSDPSLDEEK 903 (1036)
Q Consensus 827 l~~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~ellt--G~~p~~~~~~~~~ 903 (1036)
+++++.+||+|||++......... ......++..|+|||+...+.++.++|||||||++|||++ |..||........
T Consensus 162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~~ 241 (295)
T cd05097 162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQV 241 (295)
T ss_pred EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHHH
Confidence 999999999999999765432211 1122345778999999998899999999999999999998 5567765443322
Q ss_pred HHHHHHHHHHhhc-CccccccCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 001658 904 LYLLEWAWHLHEN-NQEIELADPKLIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVAMLC 964 (1036)
Q Consensus 904 ~~l~~~~~~~~~~-~~~~~~~d~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~ 964 (1036)
.... ...... ........ .......+.+++.+||+.+|++||++++|++.|+
T Consensus 242 ~~~~---~~~~~~~~~~~~~~~------~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 242 IENT---GEFFRNQGRQIYLSQ------TPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred HHHH---HHhhhhccccccCCC------CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 2111 111111 11011111 1112347889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=325.95 Aligned_cols=266 Identities=27% Similarity=0.369 Sum_probs=201.1
Q ss_pred CCCCCccccCCCEEEEEeEe-----CCCcEEEEEEccccc-hhcHHHHHHHHHHHHhhccCCcceeEeEEEcC--ceeEE
Q 001658 695 FSPSNKLGEGGFGPVYKGKL-----GDGRAIAVKQLSVAS-RQGKSQFVAEIATISAVQHRNLVKLHGCCIEG--AERLL 766 (1036)
Q Consensus 695 ~~~~~~iG~G~fG~Vy~~~~-----~~g~~vAvK~~~~~~-~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~--~~~~l 766 (1036)
|+..+.||+|+||+||++.. .+++.||+|.+.... ......|.+|++++++++||||+++++++... ...++
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL 85 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence 37789999999999988652 357889999987543 23456788999999999999999999998754 35789
Q ss_pred EEEecCCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeecC
Q 001658 767 VYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDD 846 (1036)
Q Consensus 767 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~ 846 (1036)
||||+++++|.+++.. ..+++..++.++.|+++||+|||+.+ |+||||||+||++++++.+||+|||+++....
T Consensus 86 v~e~~~~~~l~~~~~~---~~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~ 159 (283)
T cd05080 86 IMEYVPLGSLRDYLPK---HKLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE 159 (283)
T ss_pred EecCCCCCCHHHHHHH---cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeecccccccCC
Confidence 9999999999999854 35899999999999999999999987 99999999999999999999999999987653
Q ss_pred CCCcc--ccccccccCccCccccccCCCCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhcCccccccC
Q 001658 847 KKTHI--STRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEIELAD 924 (1036)
Q Consensus 847 ~~~~~--~~~~~gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 924 (1036)
..... .....++..|+|||.+....++.++||||||+++|||+||+.|+....... .....+..............+
T Consensus 160 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 238 (283)
T cd05080 160 GHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKF-EEMIGPKQGQMTVVRLIELLE 238 (283)
T ss_pred cchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchh-hhhhcccccccchhhhhhhhh
Confidence 32211 122345667999999998889999999999999999999999986533211 011110000000000000111
Q ss_pred ccc-ccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhccc
Q 001658 925 PKL-IEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVAMLCGDM 967 (1036)
Q Consensus 925 ~~~-~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~ 967 (1036)
... ..........+.+++..||+.+|++|||+++|+++|++..
T Consensus 239 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 239 RGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred cCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 100 1112233457888899999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=316.75 Aligned_cols=250 Identities=29% Similarity=0.434 Sum_probs=206.5
Q ss_pred hcCCCCCCccccCCCEEEEEeEeCCCcEEEEEEccccchhcHHHHHHHHHHHHhhccCCcceeEeEEEcCceeEEEEEec
Q 001658 692 TENFSPSNKLGEGGFGPVYKGKLGDGRAIAVKQLSVASRQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLVYEYL 771 (1036)
Q Consensus 692 ~~~~~~~~~iG~G~fG~Vy~~~~~~g~~vAvK~~~~~~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~~ 771 (1036)
.++|++.+.||+|+||.||+|... |+.||+|.+..... ..+++.+|+.++++++|+||+++++++......++||||+
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 82 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYM 82 (256)
T ss_pred hhhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEec
Confidence 356788899999999999999874 78999999976544 4678999999999999999999999999889999999999
Q ss_pred CCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeecCCCCcc
Q 001658 772 ENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHI 851 (1036)
Q Consensus 772 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 851 (1036)
++++|.+++.......+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||.++.......
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~-- 157 (256)
T cd05039 83 AKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD-- 157 (256)
T ss_pred CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEcccccccccccccc--
Confidence 9999999997665557899999999999999999999988 99999999999999999999999999987643222
Q ss_pred ccccccccCccCccccccCCCCchhhHHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHHHHHhhcCccccccCcccccC
Q 001658 852 STRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVS-GRPNSDPSLDEEKLYLLEWAWHLHENNQEIELADPKLIEF 930 (1036)
Q Consensus 852 ~~~~~gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~ 930 (1036)
...++..|+|||++..+.++.++||||||+++||+++ |+.||......+..... .... .+..
T Consensus 158 --~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~-------~~~~-----~~~~--- 220 (256)
T cd05039 158 --SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHV-------EKGY-----RMEA--- 220 (256)
T ss_pred --cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH-------hcCC-----CCCC---
Confidence 2234668999999998889999999999999999997 99998765433221111 1110 0111
Q ss_pred CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhc
Q 001658 931 NEEEVKRLIGVALLCTQTLPSLRPSMSRVVAMLCG 965 (1036)
Q Consensus 931 ~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~ 965 (1036)
.......+.+++.+|++.+|++||++.|++.+|+.
T Consensus 221 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 221 PEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred ccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 11223567788899999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=326.44 Aligned_cols=262 Identities=26% Similarity=0.370 Sum_probs=201.6
Q ss_pred cCCCCCCccccCCCEEEEEeEe-----CCCcEEEEEEccccchhcHHHHHHHHHHHHhhccCCcceeEeEEEcC--ceeE
Q 001658 693 ENFSPSNKLGEGGFGPVYKGKL-----GDGRAIAVKQLSVASRQGKSQFVAEIATISAVQHRNLVKLHGCCIEG--AERL 765 (1036)
Q Consensus 693 ~~~~~~~~iG~G~fG~Vy~~~~-----~~g~~vAvK~~~~~~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~--~~~~ 765 (1036)
.+|++.+.||+|+||.||+|.. .+++.||+|.+........+.|.+|++++++++||||+++++++... ...+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 4677889999999999999974 25789999998766666667899999999999999999999987543 4678
Q ss_pred EEEEecCCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeec
Q 001658 766 LVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYD 845 (1036)
Q Consensus 766 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~ 845 (1036)
+|+||+++++|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++...
T Consensus 84 lv~e~~~~~~L~~~l~~~-~~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~ 159 (284)
T cd05081 84 LVMEYLPYGSLRDYLQKH-RERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLTKVLP 159 (284)
T ss_pred EEEEecCCCCHHHHHHhc-CcCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCccccccc
Confidence 999999999999998653 245899999999999999999999988 9999999999999999999999999998765
Q ss_pred CCCCcc--ccccccccCccCccccccCCCCchhhHHhHHHHHHHHHhCCCCCCCCChhhHH---------HHHHHHHHHh
Q 001658 846 DKKTHI--STRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKL---------YLLEWAWHLH 914 (1036)
Q Consensus 846 ~~~~~~--~~~~~gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~---------~l~~~~~~~~ 914 (1036)
...... .....++..|+|||++.+..++.++|||||||++|||++|..++......... ..........
T Consensus 160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (284)
T cd05081 160 QDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELL 239 (284)
T ss_pred CCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHHH
Confidence 432211 11222445699999999888999999999999999999998765432111000 0000000000
Q ss_pred hcCccccccCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcc
Q 001658 915 ENNQEIELADPKLIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVAMLCGD 966 (1036)
Q Consensus 915 ~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 966 (1036)
.. .............+.+++.+||+.+|++|||+.||++.|+.+
T Consensus 240 ~~--------~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 240 KN--------NGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred hc--------CCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 00 000011122335688889999999999999999999999854
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-35 Score=323.00 Aligned_cols=248 Identities=25% Similarity=0.299 Sum_probs=196.4
Q ss_pred cccCCCEEEEEeEeC-CCcEEEEEEccccc---hhcHHHHHHHHHHHHhhccCCcceeEeEEEcCceeEEEEEecCCCCh
Q 001658 701 LGEGGFGPVYKGKLG-DGRAIAVKQLSVAS---RQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLVYEYLENKSL 776 (1036)
Q Consensus 701 iG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL 776 (1036)
||+|+||.||+++.. +|+.||+|.+.... ......+..|++++++++||||+++++++..+...++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 799999999999864 68999999986422 12234566799999999999999999999999999999999999999
Q ss_pred hhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeecCCCCccccccc
Q 001658 777 DQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVA 856 (1036)
Q Consensus 777 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 856 (1036)
.+++.......+++..+..++.|++.||+|||+.+ |+||||||+||++++++.++|+|||++........ .....
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~--~~~~~ 155 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT--ITQRA 155 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCCCce--eeccC
Confidence 99887666667899999999999999999999988 99999999999999999999999999987653321 23346
Q ss_pred cccCccCccccccCCCCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhcCccccccCcccccCCHHHHH
Q 001658 857 GTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEIELADPKLIEFNEEEVK 936 (1036)
Q Consensus 857 gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~ 936 (1036)
|+..|+|||++.+..++.++||||+||++|||++|+.||......... .+......... ... .......
T Consensus 156 ~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~--~~~~~~~~~~~-------~~~--~~~~~~~ 224 (277)
T cd05607 156 GTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAK--EELKRRTLEDE-------VKF--EHQNFTE 224 (277)
T ss_pred CCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhH--HHHHHHhhccc-------ccc--ccccCCH
Confidence 899999999999888999999999999999999999999754321111 11111111100 000 0012234
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 001658 937 RLIGVALLCTQTLPSLRPSMSRVVAMLC 964 (1036)
Q Consensus 937 ~l~~l~~~Cl~~dP~~RPt~~evl~~L~ 964 (1036)
++.+++..|++.+|++||++.|+++.+.
T Consensus 225 ~~~~li~~~L~~~P~~R~~~~~~~~~~~ 252 (277)
T cd05607 225 ESKDICRLFLAKKPEDRLGSREKNDDPR 252 (277)
T ss_pred HHHHHHHHHhccCHhhCCCCccchhhhh
Confidence 5678888999999999999988765443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=340.76 Aligned_cols=253 Identities=23% Similarity=0.323 Sum_probs=194.5
Q ss_pred CCCCCCccccCCCEEEEEeEe-CCCcEEEEEEccccc---hhcHHHHHHHHHHHHhhccCCcceeEeEEEcCceeEEEEE
Q 001658 694 NFSPSNKLGEGGFGPVYKGKL-GDGRAIAVKQLSVAS---RQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLVYE 769 (1036)
Q Consensus 694 ~~~~~~~iG~G~fG~Vy~~~~-~~g~~vAvK~~~~~~---~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E 769 (1036)
.|+..+.||+|+||+||+|+. .+++.||+|++.... ......+.+|++++++++|+||+++++++.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 577889999999999999985 467899999986532 2334678899999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeecCCCC
Q 001658 770 YLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKT 849 (1036)
Q Consensus 770 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~ 849 (1036)
|+++|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+.....
T Consensus 82 ~~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~ 156 (381)
T cd05626 82 YIPGGDMMSLLIRM--EVFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHN 156 (381)
T ss_pred cCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCcccccccc
Confidence 99999999998653 35788888899999999999999988 99999999999999999999999999764321000
Q ss_pred ----------------------------------------------ccccccccccCccCccccccCCCCchhhHHhHHH
Q 001658 850 ----------------------------------------------HISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFGV 883 (1036)
Q Consensus 850 ----------------------------------------------~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~Gv 883 (1036)
.......||+.|+|||++.+..++.++|||||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~ 236 (381)
T cd05626 157 SKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGV 236 (381)
T ss_pred cccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhh
Confidence 0012356999999999999888999999999999
Q ss_pred HHHHHHhCCCCCCCCChhhHHH-HHHHHHHHhhcCccccccCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 001658 884 LALETVSGRPNSDPSLDEEKLY-LLEWAWHLHENNQEIELADPKLIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVAM 962 (1036)
Q Consensus 884 vl~elltG~~p~~~~~~~~~~~-l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 962 (1036)
++|||++|+.||......+... ...| .. ...-|...... .+..+++.-+ .|+..+|..||++.|++..
T Consensus 237 il~elltG~~Pf~~~~~~~~~~~i~~~-------~~--~~~~~~~~~~s-~~~~dli~~l-l~~~~~~~~R~~~~~~l~h 305 (381)
T cd05626 237 ILFEMLVGQPPFLAPTPTETQLKVINW-------EN--TLHIPPQVKLS-PEAVDLITKL-CCSAEERLGRNGADDIKAH 305 (381)
T ss_pred HHHHHHhCCCCCcCCCHHHHHHHHHcc-------cc--ccCCCCCCCCC-HHHHHHHHHH-ccCcccccCCCCHHHHhcC
Confidence 9999999999998655433221 1110 00 01111111122 2233333222 2667777779999999864
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=341.06 Aligned_cols=254 Identities=21% Similarity=0.239 Sum_probs=199.9
Q ss_pred HhcCCCCCCccccCCCEEEEEeEeC-CCcEEEEEEcccc---chhcHHHHHHHHHHHHhhccCCcceeEeEEEcCceeEE
Q 001658 691 ATENFSPSNKLGEGGFGPVYKGKLG-DGRAIAVKQLSVA---SRQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLL 766 (1036)
Q Consensus 691 ~~~~~~~~~~iG~G~fG~Vy~~~~~-~g~~vAvK~~~~~---~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~l 766 (1036)
..++|++.+.||+|+||.||+|+.. +++.||+|++... .......+.+|+.+++.++||||+++++++.++...++
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l 120 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM 120 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence 4567888999999999999999864 6889999998643 22334557889999999999999999999999999999
Q ss_pred EEEecCCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeecC
Q 001658 767 VYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDD 846 (1036)
Q Consensus 767 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~ 846 (1036)
||||+++|+|.+++... .+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++....
T Consensus 121 v~Ey~~gg~L~~~l~~~---~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~ 194 (370)
T cd05596 121 VMEYMPGGDLVNLMSNY---DIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMDA 194 (370)
T ss_pred EEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEeccceeeccC
Confidence 99999999999998542 4677778889999999999999988 99999999999999999999999999987654
Q ss_pred CCCccccccccccCccCccccccC----CCCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhcCccccc
Q 001658 847 KKTHISTRVAGTIGYLAPEYAMRG----HLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEIEL 922 (1036)
Q Consensus 847 ~~~~~~~~~~gt~~y~APE~~~~~----~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 922 (1036)
..........||+.|+|||++.+. .++.++|||||||++|||++|+.||........... ...... ..
T Consensus 195 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~------i~~~~~--~~ 266 (370)
T cd05596 195 NGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSK------IMDHKN--SL 266 (370)
T ss_pred CCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHH------HHcCCC--cC
Confidence 332223345799999999998653 478899999999999999999999986543222111 111100 01
Q ss_pred cCcccccCCHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 001658 923 ADPKLIEFNEEEVKRLIGVALLCTQTLPSL--RPSMSRVVAM 962 (1036)
Q Consensus 923 ~d~~~~~~~~~~~~~l~~l~~~Cl~~dP~~--RPt~~evl~~ 962 (1036)
..|. .......+.+++..|++.+|.+ ||++.|+++.
T Consensus 267 ~~~~----~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 267 TFPD----DIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred CCCC----cCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 1111 1112345667778899989988 9999999764
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-35 Score=323.28 Aligned_cols=244 Identities=25% Similarity=0.313 Sum_probs=194.2
Q ss_pred cccCCCEEEEEeEeC-CCcEEEEEEccccch---hcHHHHHHHHHHHHhhccCCcceeEeEEEcCceeEEEEEecCCCCh
Q 001658 701 LGEGGFGPVYKGKLG-DGRAIAVKQLSVASR---QGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLVYEYLENKSL 776 (1036)
Q Consensus 701 iG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~---~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL 776 (1036)
||+|+||+||++... +++.||+|.+..... ...+.+..|++++++++|+||+++.+++......++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 799999999999854 688999999864322 2335678899999999999999999999999999999999999999
Q ss_pred hhhhhcC--CCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeecCCCCccccc
Q 001658 777 DQALFGQ--RSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTR 854 (1036)
Q Consensus 777 ~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 854 (1036)
.+++... ....+++..+..++.||+.||+|||+.+ |+||||||+||++++++.+||+|||++..+..... ....
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~-~~~~ 156 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS-KTKG 156 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCCCCc-cccc
Confidence 9887542 3456899999999999999999999988 99999999999999999999999999987654322 2233
Q ss_pred cccccCccCccccccCCCCchhhHHhHHHHHHHHHhCCCCCCCCChhhHH-HHHHHHHHHhhcCccccccCcccccCCHH
Q 001658 855 VAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKL-YLLEWAWHLHENNQEIELADPKLIEFNEE 933 (1036)
Q Consensus 855 ~~gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~-~l~~~~~~~~~~~~~~~~~d~~~~~~~~~ 933 (1036)
..||+.|+|||++.+..++.++|||||||++|||++|+.||......... .... .... .+ ......
T Consensus 157 ~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~---~~~~--------~~--~~~~~~ 223 (280)
T cd05608 157 YAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQ---RILN--------DS--VTYPDK 223 (280)
T ss_pred cCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHH---hhcc--------cC--CCCccc
Confidence 56899999999999999999999999999999999999999764322111 1110 0000 00 112223
Q ss_pred HHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 001658 934 EVKRLIGVALLCTQTLPSLRP-----SMSRVVA 961 (1036)
Q Consensus 934 ~~~~l~~l~~~Cl~~dP~~RP-----t~~evl~ 961 (1036)
....+.+++..|++.+|++|| +++++++
T Consensus 224 ~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~ 256 (280)
T cd05608 224 FSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT 256 (280)
T ss_pred CCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence 345677888899999999999 6666664
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=340.01 Aligned_cols=251 Identities=22% Similarity=0.274 Sum_probs=193.7
Q ss_pred CCCCCCccccCCCEEEEEeEeC-CCcEEEEEEccccc---hhcHHHHHHHHHHHHhhccCCcceeEeEEEcCceeEEEEE
Q 001658 694 NFSPSNKLGEGGFGPVYKGKLG-DGRAIAVKQLSVAS---RQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLVYE 769 (1036)
Q Consensus 694 ~~~~~~~iG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E 769 (1036)
+|++.+.||+|+||.||+|+.. +++.||||++.... ......+.+|++++++++|+||+++++.+.+++..++|||
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E 81 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEe
Confidence 6888999999999999999854 68999999986432 2234568899999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeecCCC-
Q 001658 770 YLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKK- 848 (1036)
Q Consensus 770 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~- 848 (1036)
|+++|+|.+++... ..+++.....++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++..+....
T Consensus 82 ~~~~g~L~~~i~~~--~~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~ 156 (376)
T cd05598 82 YIPGGDMMSLLIRL--GIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD 156 (376)
T ss_pred CCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCCcccccccc
Confidence 99999999999653 35778888889999999999999988 9999999999999999999999999975331000
Q ss_pred -----------------------------------------CccccccccccCccCccccccCCCCchhhHHhHHHHHHH
Q 001658 849 -----------------------------------------THISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALE 887 (1036)
Q Consensus 849 -----------------------------------------~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~e 887 (1036)
........||+.|||||++.+..++.++|||||||++||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilye 236 (376)
T cd05598 157 SKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYE 236 (376)
T ss_pred ccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeee
Confidence 000113469999999999999999999999999999999
Q ss_pred HHhCCCCCCCCChhhHHHHHHHHHHHhhcCccccccCcccccCCHHHHHHHHHHHHHhcccCCCCCC---CHHHHHHH
Q 001658 888 TVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEIELADPKLIEFNEEEVKRLIGVALLCTQTLPSLRP---SMSRVVAM 962 (1036)
Q Consensus 888 lltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP---t~~evl~~ 962 (1036)
|++|+.||......+....+ .. .......+...... ..+.+++.+|+ .+|.+|+ ++.|+++.
T Consensus 237 ll~G~~Pf~~~~~~~~~~~i------~~--~~~~~~~~~~~~~s----~~~~~li~~l~-~~p~~R~~~~t~~ell~h 301 (376)
T cd05598 237 MLVGQPPFLADTPAETQLKV------IN--WETTLHIPSQAKLS----REASDLILRLC-CGAEDRLGKNGADEIKAH 301 (376)
T ss_pred hhhCCCCCCCCCHHHHHHHH------hc--cCccccCCCCCCCC----HHHHHHHHHHh-cCHhhcCCCCCHHHHhCC
Confidence 99999999876543322111 00 00011111111112 23344444554 4999999 88888754
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=339.81 Aligned_cols=251 Identities=22% Similarity=0.273 Sum_probs=196.8
Q ss_pred cCCCCCCccccCCCEEEEEeEeC-CCcEEEEEEccccc---hhcHHHHHHHHHHHHhhccCCcceeEeEEEcCceeEEEE
Q 001658 693 ENFSPSNKLGEGGFGPVYKGKLG-DGRAIAVKQLSVAS---RQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLVY 768 (1036)
Q Consensus 693 ~~~~~~~~iG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~ 768 (1036)
++|++.+.||+|+||.||+|+.. +++.||||++.... ......+.+|+.++..++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 46888999999999999999864 68999999996532 233456788999999999999999999999999999999
Q ss_pred EecCCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeecCCC
Q 001658 769 EYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKK 848 (1036)
Q Consensus 769 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~ 848 (1036)
||+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+....
T Consensus 81 E~~~~g~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 155 (364)
T cd05599 81 EYLPGGDMMTLLMKK--DTFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSH 155 (364)
T ss_pred CCCCCcHHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccceeccccc
Confidence 999999999998653 35889999999999999999999998 9999999999999999999999999997653211
Q ss_pred Cc-------------------------------------cccccccccCccCccccccCCCCchhhHHhHHHHHHHHHhC
Q 001658 849 TH-------------------------------------ISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSG 891 (1036)
Q Consensus 849 ~~-------------------------------------~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~elltG 891 (1036)
.. ......||+.|+|||++.+..++.++|||||||++|||++|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G 235 (364)
T cd05599 156 RTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVG 235 (364)
T ss_pred cccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcC
Confidence 00 01124699999999999999999999999999999999999
Q ss_pred CCCCCCCChhhHHHHHHHHHHHhhcCccccccCcccccCCHHHHHHHHHHHHHhcccCCCCCCC---HHHHHH
Q 001658 892 RPNSDPSLDEEKLYLLEWAWHLHENNQEIELADPKLIEFNEEEVKRLIGVALLCTQTLPSLRPS---MSRVVA 961 (1036)
Q Consensus 892 ~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt---~~evl~ 961 (1036)
+.||...........+ ..... ....|.... ....+.+++.+|+. +|.+|++ +.|+++
T Consensus 236 ~~Pf~~~~~~~~~~~i------~~~~~--~~~~~~~~~----~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~ 295 (364)
T cd05599 236 YPPFCSDNPQETYRKI------INWKE--TLQFPDEVP----LSPEAKDLIKRLCC-EAERRLGNNGVNEIKS 295 (364)
T ss_pred CCCCCCCCHHHHHHHH------HcCCC--ccCCCCCCC----CCHHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence 9999865443222111 00000 001111111 12244555666775 8999998 888765
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=316.36 Aligned_cols=248 Identities=27% Similarity=0.391 Sum_probs=201.2
Q ss_pred CccccCCCEEEEEeEeCC--C--cEEEEEEccccch-hcHHHHHHHHHHHHhhccCCcceeEeEEEcCceeEEEEEecCC
Q 001658 699 NKLGEGGFGPVYKGKLGD--G--RAIAVKQLSVASR-QGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLVYEYLEN 773 (1036)
Q Consensus 699 ~~iG~G~fG~Vy~~~~~~--g--~~vAvK~~~~~~~-~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~ 773 (1036)
+.||+|++|.||+|.+.+ + ..||+|.+..... ...+.|.+|+.++++++|+||+++++++.. ...++|+||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 468999999999998643 3 3699999976555 556789999999999999999999999988 888999999999
Q ss_pred CChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeecCCCCc--c
Q 001658 774 KSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTH--I 851 (1036)
Q Consensus 774 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~--~ 851 (1036)
++|.+++.......++|...+.++.|+++||+|||+.+ ++||||||+||+++.++.+||+|||+++.+...... .
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 156 (257)
T cd05040 80 GSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVM 156 (257)
T ss_pred CcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEeccccccccccccccceec
Confidence 99999997654457899999999999999999999987 999999999999999999999999999876543221 1
Q ss_pred ccccccccCccCccccccCCCCchhhHHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHHHHHhhcCccccccCcccccC
Q 001658 852 STRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVS-GRPNSDPSLDEEKLYLLEWAWHLHENNQEIELADPKLIEF 930 (1036)
Q Consensus 852 ~~~~~gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~ 930 (1036)
.....++..|+|||++.+..++.++|||||||++|||++ |+.||......+..... .. .... ...
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~---~~---~~~~--------~~~ 222 (257)
T cd05040 157 EEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKI---DK---EGER--------LER 222 (257)
T ss_pred ccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH---Hh---cCCc--------CCC
Confidence 123457789999999998899999999999999999999 99999755443322111 11 0000 011
Q ss_pred CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 001658 931 NEEEVKRLIGVALLCTQTLPSLRPSMSRVVAMLC 964 (1036)
Q Consensus 931 ~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~ 964 (1036)
.......+.+++.+|++.+|++||++.|+++.|.
T Consensus 223 ~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 223 PEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred CccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 1223456888899999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=315.12 Aligned_cols=251 Identities=29% Similarity=0.485 Sum_probs=203.6
Q ss_pred cCCCCCCccccCCCEEEEEeEeCCCcEEEEEEccccchhcHHHHHHHHHHHHhhccCCcceeEeEEEcCceeEEEEEecC
Q 001658 693 ENFSPSNKLGEGGFGPVYKGKLGDGRAIAVKQLSVASRQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLVYEYLE 772 (1036)
Q Consensus 693 ~~~~~~~~iG~G~fG~Vy~~~~~~g~~vAvK~~~~~~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~~~ 772 (1036)
.+|+..+.||+|+||.||+|...+++.+|+|.+..... ....|.+|++++++++||||+++++++......++|+||++
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAM-SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME 82 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCC-CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence 35677899999999999999887788999999864332 34678999999999999999999999999999999999999
Q ss_pred CCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeecCCCCccc
Q 001658 773 NKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHIS 852 (1036)
Q Consensus 773 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 852 (1036)
+++|.+++.... ..+++..+..++.|++.|++|||+.+ ++||||||+||+++.++.+||+|||+++..........
T Consensus 83 ~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~ 158 (256)
T cd05112 83 HGCLSDYLRAQR-GKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSS 158 (256)
T ss_pred CCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeecccCccccc
Confidence 999999986543 35789999999999999999999987 99999999999999999999999999986644322222
Q ss_pred cccccccCccCccccccCCCCchhhHHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHHHHHhhcCccccccCcccccCC
Q 001658 853 TRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVS-GRPNSDPSLDEEKLYLLEWAWHLHENNQEIELADPKLIEFN 931 (1036)
Q Consensus 853 ~~~~gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~ 931 (1036)
....++.+|+|||++.++.++.++||||||+++|||++ |+.||............ ..+ .....+..
T Consensus 159 ~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~-------~~~--~~~~~~~~---- 225 (256)
T cd05112 159 TGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETI-------NAG--FRLYKPRL---- 225 (256)
T ss_pred CCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHH-------hCC--CCCCCCCC----
Confidence 22335678999999998899999999999999999998 89998764432211111 111 11112221
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 001658 932 EEEVKRLIGVALLCTQTLPSLRPSMSRVVAML 963 (1036)
Q Consensus 932 ~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L 963 (1036)
....+.+++.+||+.+|++||++.|++++|
T Consensus 226 --~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 226 --ASQSVYELMQHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred --CCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence 235688889999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-35 Score=321.34 Aligned_cols=253 Identities=27% Similarity=0.424 Sum_probs=201.2
Q ss_pred HHhcCCCCCCccccCCCEEEEEeEeC-CCcEEEEEEccccchhcHHHHHHHHHHHHhh-ccCCcceeEeEEEcC------
Q 001658 690 TATENFSPSNKLGEGGFGPVYKGKLG-DGRAIAVKQLSVASRQGKSQFVAEIATISAV-QHRNLVKLHGCCIEG------ 761 (1036)
Q Consensus 690 ~~~~~~~~~~~iG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~f~~Ei~~L~~l-~H~nIv~l~g~~~~~------ 761 (1036)
.+++.|+..+.||+|+||.||+|... +++.||+|.+.... .....+..|+.++.++ +|+||+++++++...
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (272)
T cd06637 3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 81 (272)
T ss_pred ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence 45677888899999999999999864 67899999986443 3356788999999998 799999999998753
Q ss_pred ceeEEEEEecCCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcc
Q 001658 762 AERLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLA 841 (1036)
Q Consensus 762 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla 841 (1036)
...++||||+++++|.+++.......+++..+..++.|++.||+|||+.+ |+||||||+||++++++.++|+|||++
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~Dfg~~ 158 (272)
T cd06637 82 DQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVS 158 (272)
T ss_pred cEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEccCCCc
Confidence 45789999999999999997655667899999999999999999999987 999999999999999999999999999
Q ss_pred eeecCCCCccccccccccCccCccccc-----cCCCCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhc
Q 001658 842 KLYDDKKTHISTRVAGTIGYLAPEYAM-----RGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHEN 916 (1036)
Q Consensus 842 ~~~~~~~~~~~~~~~gt~~y~APE~~~-----~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~ 916 (1036)
........ ......|+..|+|||++. +..++.++|||||||++|||++|+.||............ ..
T Consensus 159 ~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~------~~- 230 (272)
T cd06637 159 AQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLI------PR- 230 (272)
T ss_pred eecccccc-cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHH------hc-
Confidence 86543222 223456899999999986 345788999999999999999999999754332222111 00
Q ss_pred CccccccCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 001658 917 NQEIELADPKLIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVA 961 (1036)
Q Consensus 917 ~~~~~~~d~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 961 (1036)
. ..+.. ........+.+++.+||+.+|.+|||+.|+++
T Consensus 231 ~-----~~~~~--~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 231 N-----PAPRL--KSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred C-----CCCCC--CCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 0 01111 01122346778889999999999999999875
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=329.49 Aligned_cols=238 Identities=26% Similarity=0.310 Sum_probs=189.2
Q ss_pred CccccCCCEEEEEeEeC-CCcEEEEEEccccc---hhcHHHHHHHHHHHHhh-ccCCcceeEeEEEcCceeEEEEEecCC
Q 001658 699 NKLGEGGFGPVYKGKLG-DGRAIAVKQLSVAS---RQGKSQFVAEIATISAV-QHRNLVKLHGCCIEGAERLLVYEYLEN 773 (1036)
Q Consensus 699 ~~iG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~f~~Ei~~L~~l-~H~nIv~l~g~~~~~~~~~lV~E~~~~ 773 (1036)
+.||+|+||.||+|+.. +++.||+|.++... ....+.+..|..++... +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999864 57889999987532 22344556677777654 899999999999999999999999999
Q ss_pred CChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeecCCCCcccc
Q 001658 774 KSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHIST 853 (1036)
Q Consensus 774 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 853 (1036)
|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ....
T Consensus 81 g~L~~~~~~~--~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-~~~~ 154 (316)
T cd05592 81 GDLMFHIQSS--GRFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-GKAS 154 (316)
T ss_pred CcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-Cccc
Confidence 9999988653 35788889999999999999999987 9999999999999999999999999998654322 2223
Q ss_pred ccccccCccCccccccCCCCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhcCccccccCcccccCCHH
Q 001658 854 RVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEIELADPKLIEFNEE 933 (1036)
Q Consensus 854 ~~~gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~ 933 (1036)
...||+.|+|||++.+..++.++|||||||++|||++|+.||...........+ .. ..+.+. ..
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i------~~-------~~~~~~---~~ 218 (316)
T cd05592 155 TFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSI------LN-------DRPHFP---RW 218 (316)
T ss_pred cccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHH------Hc-------CCCCCC---CC
Confidence 456999999999999989999999999999999999999999865442222111 10 011111 11
Q ss_pred HHHHHHHHHHHhcccCCCCCCCHHH
Q 001658 934 EVKRLIGVALLCTQTLPSLRPSMSR 958 (1036)
Q Consensus 934 ~~~~l~~l~~~Cl~~dP~~RPt~~e 958 (1036)
....+.+++.+||+.+|.+||++.+
T Consensus 219 ~~~~~~~ll~~~l~~~P~~R~~~~~ 243 (316)
T cd05592 219 ISKEAKDCLSKLFERDPTKRLGVDG 243 (316)
T ss_pred CCHHHHHHHHHHccCCHHHcCCChH
Confidence 2345667788999999999999864
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-35 Score=327.08 Aligned_cols=258 Identities=27% Similarity=0.376 Sum_probs=202.4
Q ss_pred cCCCCCCccccCCCEEEEEeEeC-CCc--EEEEEEcccc-chhcHHHHHHHHHHHHhh-ccCCcceeEeEEEcCceeEEE
Q 001658 693 ENFSPSNKLGEGGFGPVYKGKLG-DGR--AIAVKQLSVA-SRQGKSQFVAEIATISAV-QHRNLVKLHGCCIEGAERLLV 767 (1036)
Q Consensus 693 ~~~~~~~~iG~G~fG~Vy~~~~~-~g~--~vAvK~~~~~-~~~~~~~f~~Ei~~L~~l-~H~nIv~l~g~~~~~~~~~lV 767 (1036)
++|++.+.||+|+||.||+|... ++. .+|+|.+... .......|.+|++++.++ +|+||+++++++..++..++|
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv 86 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 86 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence 46788899999999999999864 444 4678877543 334456788999999999 899999999999999999999
Q ss_pred EEecCCCChhhhhhcCC--------------CCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCce
Q 001658 768 YEYLENKSLDQALFGQR--------------SLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVP 833 (1036)
Q Consensus 768 ~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~ 833 (1036)
+||+++++|.++++... ...+++.+++.++.|+++||+|||+.+ |+||||||+|||+++++.+
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~~~~ 163 (303)
T cd05088 87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 163 (303)
T ss_pred EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCCCcE
Confidence 99999999999997543 235789999999999999999999987 9999999999999999999
Q ss_pred EEEEcCcceeecCCCCccccccccccCccCccccccCCCCchhhHHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHHHH
Q 001658 834 KISDFGLAKLYDDKKTHISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVS-GRPNSDPSLDEEKLYLLEWAWH 912 (1036)
Q Consensus 834 kl~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~ 912 (1036)
||+|||+++...... ......++..|+|||++.+..++.++|||||||++|||+| |..||......+.. +..
T Consensus 164 kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~---~~~-- 236 (303)
T cd05088 164 KIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELY---EKL-- 236 (303)
T ss_pred EeCccccCcccchhh--hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHH---HHH--
Confidence 999999986432111 1111234668999999988889999999999999999998 99998754332211 111
Q ss_pred HhhcCccccccCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcccCCC
Q 001658 913 LHENNQEIELADPKLIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVAMLCGDMEVS 970 (1036)
Q Consensus 913 ~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~ 970 (1036)
... ..+. ........+.+++.+||+.+|++||++.++++.|+...+..
T Consensus 237 --~~~-----~~~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~ 284 (303)
T cd05088 237 --PQG-----YRLE---KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 284 (303)
T ss_pred --hcC-----CcCC---CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 000 0000 11112345778889999999999999999999998765544
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-36 Score=315.30 Aligned_cols=248 Identities=22% Similarity=0.327 Sum_probs=206.0
Q ss_pred cCCCCCCccccCCCEEEEEeE-eCCCcEEEEEEcccc---chhcHHHHHHHHHHHHhhccCCcceeEeEEEcCceeEEEE
Q 001658 693 ENFSPSNKLGEGGFGPVYKGK-LGDGRAIAVKQLSVA---SRQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLVY 768 (1036)
Q Consensus 693 ~~~~~~~~iG~G~fG~Vy~~~-~~~g~~vAvK~~~~~---~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~ 768 (1036)
.+|++.+.||+|.||.|-+|. ...|+.||||.+++. ++++.-.+.+|+++|+.++||||+++|.+|...+...|||
T Consensus 53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivM 132 (668)
T KOG0611|consen 53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVM 132 (668)
T ss_pred hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEE
Confidence 356677889999999999997 478999999999764 3344456788999999999999999999999999999999
Q ss_pred EecCCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeecCCC
Q 001658 769 EYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKK 848 (1036)
Q Consensus 769 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~ 848 (1036)
||..+|.|++|+.. ...+++.....++.||..|+.|+|.++ ++|||||.+|||+|+++++||+|||++.++.+..
T Consensus 133 EYaS~GeLYDYiSe--r~~LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGLSNly~~~k 207 (668)
T KOG0611|consen 133 EYASGGELYDYISE--RGSLSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGLSNLYADKK 207 (668)
T ss_pred EecCCccHHHHHHH--hccccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccchhhhhcccc
Confidence 99999999999965 456889999999999999999999987 9999999999999999999999999998876433
Q ss_pred CccccccccccCccCccccccCCC-CchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhcCccccccCccc
Q 001658 849 THISTRVAGTIGYLAPEYAMRGHL-TEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEIELADPKL 927 (1036)
Q Consensus 849 ~~~~~~~~gt~~y~APE~~~~~~~-~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~ 927 (1036)
.-+.++|++-|.+||+..+.+| .+.+|-||+||+||-|+.|..||++......+ . ....+..
T Consensus 208 --fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lv---r----QIs~GaY-------- 270 (668)
T KOG0611|consen 208 --FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLV---R----QISRGAY-------- 270 (668)
T ss_pred --HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHH---H----Hhhcccc--------
Confidence 3456889999999999999887 57899999999999999999999975433222 1 1111111
Q ss_pred ccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 001658 928 IEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVAMLC 964 (1036)
Q Consensus 928 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~ 964 (1036)
..++.+.....++.||+..+|++|.|+.+|.....
T Consensus 271 --rEP~~PSdA~gLIRwmLmVNP~RRATieDiAsHWW 305 (668)
T KOG0611|consen 271 --REPETPSDASGLIRWMLMVNPERRATIEDIASHWW 305 (668)
T ss_pred --cCCCCCchHHHHHHHHHhcCcccchhHHHHhhhhe
Confidence 11222334456778999999999999999987653
|
|
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-35 Score=320.34 Aligned_cols=255 Identities=25% Similarity=0.384 Sum_probs=202.1
Q ss_pred hcCCCCCCccccCCCEEEEEeEe-CCCcEEEEEEccccchhcHHHHHHHHHHHHhhccCCcceeEeEEEcCceeEEEEEe
Q 001658 692 TENFSPSNKLGEGGFGPVYKGKL-GDGRAIAVKQLSVASRQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLVYEY 770 (1036)
Q Consensus 692 ~~~~~~~~~iG~G~fG~Vy~~~~-~~g~~vAvK~~~~~~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~ 770 (1036)
.++|++.+.||+|+||.||+|+. .+++.||+|++..........+.+|+.++++++||||+++++++...+..++|+||
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~ 87 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY 87 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence 35788899999999999999985 57889999998755444456788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeecCCCCc
Q 001658 771 LENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTH 850 (1036)
Q Consensus 771 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~ 850 (1036)
+++++|.++++.. ..+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++.......
T Consensus 88 ~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~- 161 (267)
T cd06646 88 CGGGSLQDIYHVT--GPLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKITATIA- 161 (267)
T ss_pred CCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccceeeccccc-
Confidence 9999999998643 46789999999999999999999987 99999999999999999999999999987643221
Q ss_pred cccccccccCccCccccc---cCCCCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhcCccccccCccc
Q 001658 851 ISTRVAGTIGYLAPEYAM---RGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEIELADPKL 927 (1036)
Q Consensus 851 ~~~~~~gt~~y~APE~~~---~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~ 927 (1036)
......|+..|+|||.+. ...++.++|||||||++|||++|+.|+............ . ......+..
T Consensus 162 ~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~-------~---~~~~~~~~~ 231 (267)
T cd06646 162 KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLM-------S---KSNFQPPKL 231 (267)
T ss_pred ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheee-------e---cCCCCCCCC
Confidence 122346888999999884 345788999999999999999999998643322111100 0 000011111
Q ss_pred ccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 001658 928 IEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVAML 963 (1036)
Q Consensus 928 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L 963 (1036)
.........+.+++.+||+.+|++||+++++++.+
T Consensus 232 -~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 232 -KDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred -ccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 11112335677888999999999999999998753
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-35 Score=322.74 Aligned_cols=255 Identities=25% Similarity=0.421 Sum_probs=204.4
Q ss_pred hcCCCCCCccccCCCEEEEEeEeC------CCcEEEEEEccccc-hhcHHHHHHHHHHHHhhccCCcceeEeEEEcCcee
Q 001658 692 TENFSPSNKLGEGGFGPVYKGKLG------DGRAIAVKQLSVAS-RQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAER 764 (1036)
Q Consensus 692 ~~~~~~~~~iG~G~fG~Vy~~~~~------~g~~vAvK~~~~~~-~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~ 764 (1036)
.++|.+.+.||+|+||.||+|... .+..||+|.+.... ......+.+|+.+++.++|+||+++++++......
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT 84 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence 357788899999999999999753 23689999986442 33456788999999999999999999999999999
Q ss_pred EEEEEecCCCChhhhhhcCC--------CCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEE
Q 001658 765 LLVYEYLENKSLDQALFGQR--------SLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKIS 836 (1036)
Q Consensus 765 ~lV~E~~~~gsL~~~l~~~~--------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~ 836 (1036)
++||||+++|+|.+++.... ...++|..++.++.|++.||.|||+.+ |+||||||+||++++++.+||+
T Consensus 85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~kl~ 161 (277)
T cd05032 85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKIG 161 (277)
T ss_pred EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCEEEC
Confidence 99999999999999986532 234788999999999999999999987 9999999999999999999999
Q ss_pred EcCcceeecCCCC-ccccccccccCccCccccccCCCCchhhHHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHHHHHh
Q 001658 837 DFGLAKLYDDKKT-HISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVS-GRPNSDPSLDEEKLYLLEWAWHLH 914 (1036)
Q Consensus 837 DFGla~~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~ 914 (1036)
|||+++....... .......++..|+|||.+.++.++.++|||||||++||+++ |+.||.......... +.
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~---~~---- 234 (277)
T cd05032 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLK---FV---- 234 (277)
T ss_pred CcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHH---HH----
Confidence 9999976543322 11223456789999999998889999999999999999998 888887544332221 11
Q ss_pred hcCccccccCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 001658 915 ENNQEIELADPKLIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVAMLC 964 (1036)
Q Consensus 915 ~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~ 964 (1036)
..+. .+.. +......+.+++.+||+.+|++|||+.|+++.|+
T Consensus 235 ~~~~-----~~~~---~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 235 IDGG-----HLDL---PENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred hcCC-----CCCC---CCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 1111 1111 1122457788899999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=333.87 Aligned_cols=242 Identities=23% Similarity=0.247 Sum_probs=194.8
Q ss_pred CccccCCCEEEEEeEe-CCCcEEEEEEccccc---hhcHHHHHHHHHHHHhhccCCcceeEeEEEcCceeEEEEEecCCC
Q 001658 699 NKLGEGGFGPVYKGKL-GDGRAIAVKQLSVAS---RQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLVYEYLENK 774 (1036)
Q Consensus 699 ~~iG~G~fG~Vy~~~~-~~g~~vAvK~~~~~~---~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~g 774 (1036)
+.||+|+||.||+++. .+|+.||+|++.... ......+..|++++..++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999985 478999999987532 233456788999999999999999999999999999999999999
Q ss_pred ChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHh-cCCccccccccCCCcEEecCCCceEEEEcCcceeecCCCCcccc
Q 001658 775 SLDQALFGQRSLTLDWATRYEICSGVARGLAYLHE-ESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHIST 853 (1036)
Q Consensus 775 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 853 (1036)
+|.+++... ..+++..+..++.||+.||+|||+ .+ |+||||||+|||++.++.+||+|||+++........ ..
T Consensus 81 ~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~-~~ 154 (325)
T cd05594 81 ELFFHLSRE--RVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT-MK 154 (325)
T ss_pred cHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCeecCCCCcc-cc
Confidence 999988543 468899999999999999999997 56 999999999999999999999999998754322221 22
Q ss_pred ccccccCccCccccccCCCCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhcCccccccCcccccCCHH
Q 001658 854 RVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEIELADPKLIEFNEE 933 (1036)
Q Consensus 854 ~~~gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~ 933 (1036)
...||+.|+|||++.+..++.++|||||||++|||++|+.||............. . ....+. ..
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~------~-------~~~~~p---~~ 218 (325)
T cd05594 155 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELIL------M-------EEIRFP---RT 218 (325)
T ss_pred cccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHh------c-------CCCCCC---CC
Confidence 3569999999999999999999999999999999999999997654432221110 0 011111 11
Q ss_pred HHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 001658 934 EVKRLIGVALLCTQTLPSLRP-----SMSRVVAM 962 (1036)
Q Consensus 934 ~~~~l~~l~~~Cl~~dP~~RP-----t~~evl~~ 962 (1036)
....+.+++.+|++.||++|+ ++.++++.
T Consensus 219 ~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 219 LSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred CCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 234567788899999999996 89998754
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=335.97 Aligned_cols=260 Identities=24% Similarity=0.373 Sum_probs=203.9
Q ss_pred HhcCCCCCCccccCCCEEEEEeEeC------CCcEEEEEEccccc-hhcHHHHHHHHHHHHhhc-cCCcceeEeEEEcCc
Q 001658 691 ATENFSPSNKLGEGGFGPVYKGKLG------DGRAIAVKQLSVAS-RQGKSQFVAEIATISAVQ-HRNLVKLHGCCIEGA 762 (1036)
Q Consensus 691 ~~~~~~~~~~iG~G~fG~Vy~~~~~------~g~~vAvK~~~~~~-~~~~~~f~~Ei~~L~~l~-H~nIv~l~g~~~~~~ 762 (1036)
..++|.+.+.||+|+||.||+|++. .++.||+|+++... ....+.+..|++++.++. ||||++++++|...+
T Consensus 35 ~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~ 114 (401)
T cd05107 35 PRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGG 114 (401)
T ss_pred cHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCC
Confidence 3446777899999999999999853 34689999997542 233457889999999997 999999999999999
Q ss_pred eeEEEEEecCCCChhhhhhcCCC---------------------------------------------------------
Q 001658 763 ERLLVYEYLENKSLDQALFGQRS--------------------------------------------------------- 785 (1036)
Q Consensus 763 ~~~lV~E~~~~gsL~~~l~~~~~--------------------------------------------------------- 785 (1036)
..++|+||+++|+|.++++..+.
T Consensus 115 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (401)
T cd05107 115 PIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQD 194 (401)
T ss_pred CcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhc
Confidence 99999999999999999975321
Q ss_pred ---------------------------------------CCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEE
Q 001658 786 ---------------------------------------LTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVL 826 (1036)
Q Consensus 786 ---------------------------------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIL 826 (1036)
..++|....+|+.|+++||+|||+.+ |+||||||+|||
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlkp~NiL 271 (401)
T cd05107 195 MKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAARNVL 271 (401)
T ss_pred chhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCCcceEE
Confidence 23677888999999999999999887 999999999999
Q ss_pred ecCCCceEEEEcCcceeecCCCCc-cccccccccCccCccccccCCCCchhhHHhHHHHHHHHHh-CCCCCCCCChhhHH
Q 001658 827 LDADLVPKISDFGLAKLYDDKKTH-ISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVS-GRPNSDPSLDEEKL 904 (1036)
Q Consensus 827 l~~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~ 904 (1036)
+++++.+||+|||+++.+...... ......++..|+|||.+.+..++.++|||||||++|||++ |+.||......+..
T Consensus 272 l~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~ 351 (401)
T cd05107 272 ICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQF 351 (401)
T ss_pred EeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHHH
Confidence 999999999999999865432221 1122357789999999998889999999999999999998 88888654322211
Q ss_pred HHHHHHHHHhhcCccccccCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhccc
Q 001658 905 YLLEWAWHLHENNQEIELADPKLIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVAMLCGDM 967 (1036)
Q Consensus 905 ~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~ 967 (1036)
. .....+. .+.. +......+.+++..||+.+|.+||+++||++.|+..+
T Consensus 352 ~------~~~~~~~-----~~~~---p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 352 Y------NAIKRGY-----RMAK---PAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred H------HHHHcCC-----CCCC---CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 1 0111110 0111 1112346778888999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=333.04 Aligned_cols=238 Identities=25% Similarity=0.316 Sum_probs=192.7
Q ss_pred CccccCCCEEEEEeEe----CCCcEEEEEEccccc--hhcHHHHHHHHHHHHhhccCCcceeEeEEEcCceeEEEEEecC
Q 001658 699 NKLGEGGFGPVYKGKL----GDGRAIAVKQLSVAS--RQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLVYEYLE 772 (1036)
Q Consensus 699 ~~iG~G~fG~Vy~~~~----~~g~~vAvK~~~~~~--~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~~~ 772 (1036)
+.||+|+||.||+++. .+|+.||+|++.... ......+..|++++++++||||+++++++...+..++||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5799999999999874 367899999987532 2234567789999999999999999999999999999999999
Q ss_pred CCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeecCCCCccc
Q 001658 773 NKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHIS 852 (1036)
Q Consensus 773 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 852 (1036)
+|+|.+++.. ...+++..+..++.||++||+|||+.+ |+||||||+||++++++.+||+|||+++....... ..
T Consensus 82 ~~~L~~~l~~--~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~-~~ 155 (318)
T cd05582 82 GGDLFTRLSK--EVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK-KA 155 (318)
T ss_pred CCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC-ce
Confidence 9999999854 346899999999999999999999988 99999999999999999999999999986543322 22
Q ss_pred cccccccCccCccccccCCCCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhcCccccccCcccccCCH
Q 001658 853 TRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEIELADPKLIEFNE 932 (1036)
Q Consensus 853 ~~~~gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~ 932 (1036)
....||+.|+|||++.+..++.++|||||||++|||++|+.||...........+ ... ...+ +.
T Consensus 156 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i------~~~-------~~~~---p~ 219 (318)
T cd05582 156 YSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMI------LKA-------KLGM---PQ 219 (318)
T ss_pred ecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHH------HcC-------CCCC---CC
Confidence 3456999999999999888999999999999999999999999865432222111 110 0011 11
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCHHH
Q 001658 933 EEVKRLIGVALLCTQTLPSLRPSMSR 958 (1036)
Q Consensus 933 ~~~~~l~~l~~~Cl~~dP~~RPt~~e 958 (1036)
.....+.+++.+|++.||++||++.+
T Consensus 220 ~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 220 FLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred CCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 12345677888999999999999666
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-35 Score=319.34 Aligned_cols=258 Identities=23% Similarity=0.371 Sum_probs=206.9
Q ss_pred cCCCCCCccccCCCEEEEEeEe-CCCcEEEEEEcccc---chhcHHHHHHHHHHHHhhccCCcceeEeEEEcCceeEEEE
Q 001658 693 ENFSPSNKLGEGGFGPVYKGKL-GDGRAIAVKQLSVA---SRQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLVY 768 (1036)
Q Consensus 693 ~~~~~~~~iG~G~fG~Vy~~~~-~~g~~vAvK~~~~~---~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~ 768 (1036)
++|++.+.||+|+||.||+|+. .+++.||||.+... ......++.+|+.+++.++|+||+++++++.+++..++||
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 4677889999999999999985 57899999987542 2333467889999999999999999999999999999999
Q ss_pred EecCCCChhhhhhcC--CCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeecC
Q 001658 769 EYLENKSLDQALFGQ--RSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDD 846 (1036)
Q Consensus 769 E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~ 846 (1036)
||+++++|.+++... ....+++..++.++.|+++||+|||+.+ ++|+||||+||+++.++.++|+|||++..+..
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 999999999988642 2456899999999999999999999988 99999999999999999999999999887643
Q ss_pred CCCccccccccccCccCccccccCCCCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhcCccccccCcc
Q 001658 847 KKTHISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEIELADPK 926 (1036)
Q Consensus 847 ~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 926 (1036)
.... .....|+..|+|||++.+..++.++||||||+++|||++|..||...... ...... ... ....+.
T Consensus 159 ~~~~-~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-~~~~~~---~~~------~~~~~~ 227 (267)
T cd08229 159 KTTA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN-LYSLCK---KIE------QCDYPP 227 (267)
T ss_pred CCcc-cccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccch-HHHHhh---hhh------cCCCCC
Confidence 3221 22346888999999999888999999999999999999999998653321 111111 000 111111
Q ss_pred cccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcc
Q 001658 927 LIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVAMLCGD 966 (1036)
Q Consensus 927 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 966 (1036)
.. .......+.+++.+||+.+|++||||.+|++++++.
T Consensus 228 ~~--~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~ 265 (267)
T cd08229 228 LP--SDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM 265 (267)
T ss_pred CC--cccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence 11 112344677888899999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=339.23 Aligned_cols=252 Identities=20% Similarity=0.255 Sum_probs=194.7
Q ss_pred cCCCCCCccccCCCEEEEEeEe-CCCcEEEEEEccccc---hhcHHHHHHHHHHHHhhccCCcceeEeEEEcCceeEEEE
Q 001658 693 ENFSPSNKLGEGGFGPVYKGKL-GDGRAIAVKQLSVAS---RQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLVY 768 (1036)
Q Consensus 693 ~~~~~~~~iG~G~fG~Vy~~~~-~~g~~vAvK~~~~~~---~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~ 768 (1036)
++|++.+.||+|+||.||+++. .+++.||||++.... ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 4688889999999999999985 478999999986432 233456888999999999999999999999999999999
Q ss_pred EecCCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeecCCC
Q 001658 769 EYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKK 848 (1036)
Q Consensus 769 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~ 848 (1036)
||+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+....
T Consensus 81 E~~~gg~L~~~l~~~--~~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~ 155 (377)
T cd05629 81 EFLPGGDLMTMLIKY--DTFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQH 155 (377)
T ss_pred eCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeeccccccccccc
Confidence 999999999998643 45788888899999999999999998 9999999999999999999999999996432110
Q ss_pred Cc----------------------------------------------cccccccccCccCccccccCCCCchhhHHhHH
Q 001658 849 TH----------------------------------------------ISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFG 882 (1036)
Q Consensus 849 ~~----------------------------------------------~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~G 882 (1036)
.. ......||+.|+|||++.+..++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG 235 (377)
T cd05629 156 DSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLG 235 (377)
T ss_pred ccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecc
Confidence 00 00124699999999999998999999999999
Q ss_pred HHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhcCccccccCcccccCCHHHHHHHHHHHHHhcccCCCCC---CCHHHH
Q 001658 883 VLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEIELADPKLIEFNEEEVKRLIGVALLCTQTLPSLR---PSMSRV 959 (1036)
Q Consensus 883 vvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~Cl~~dP~~R---Pt~~ev 959 (1036)
|++|||++|++||......+....+ ........ -|.... ....+.+++.+|++ +|.+| +++.|+
T Consensus 236 vil~elltG~~Pf~~~~~~~~~~~i------~~~~~~~~--~p~~~~----~s~~~~dli~~lL~-~~~~r~~r~~~~~~ 302 (377)
T cd05629 236 AIMFECLIGWPPFCSENSHETYRKI------INWRETLY--FPDDIH----LSVEAEDLIRRLIT-NAENRLGRGGAHEI 302 (377)
T ss_pred hhhhhhhcCCCCCCCCCHHHHHHHH------HccCCccC--CCCCCC----CCHHHHHHHHHHhc-CHhhcCCCCCHHHH
Confidence 9999999999999765443222111 00000011 111111 12345566677886 66664 699998
Q ss_pred HHH
Q 001658 960 VAM 962 (1036)
Q Consensus 960 l~~ 962 (1036)
++.
T Consensus 303 l~h 305 (377)
T cd05629 303 KSH 305 (377)
T ss_pred hcC
Confidence 764
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=316.52 Aligned_cols=245 Identities=27% Similarity=0.379 Sum_probs=195.5
Q ss_pred ccccCCCEEEEEeEe---CCCcEEEEEEccccc--hhcHHHHHHHHHHHHhhccCCcceeEeEEEcCceeEEEEEecCCC
Q 001658 700 KLGEGGFGPVYKGKL---GDGRAIAVKQLSVAS--RQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLVYEYLENK 774 (1036)
Q Consensus 700 ~iG~G~fG~Vy~~~~---~~g~~vAvK~~~~~~--~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~g 774 (1036)
+||+|+||.||+|.+ .+++.||+|+++... ....+++..|+.++++++|+||+++++++. .+..++||||+++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 589999999999964 357889999986432 234567899999999999999999999885 45678999999999
Q ss_pred ChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeecCCCCcc--c
Q 001658 775 SLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHI--S 852 (1036)
Q Consensus 775 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~--~ 852 (1036)
+|.+++... ..+++..+.+++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++......... .
T Consensus 81 ~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 155 (257)
T cd05116 81 PLNKFLQKN--KHVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAK 155 (257)
T ss_pred cHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeec
Confidence 999998643 45889999999999999999999988 9999999999999999999999999998765433211 1
Q ss_pred cccccccCccCccccccCCCCchhhHHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHHHHHhhcCccccccCcccccCC
Q 001658 853 TRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVS-GRPNSDPSLDEEKLYLLEWAWHLHENNQEIELADPKLIEFN 931 (1036)
Q Consensus 853 ~~~~gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~ 931 (1036)
....++..|+|||.+....++.++|||||||++|||++ |+.||......+..... ..+.. +.. +
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i-------~~~~~-----~~~---~ 220 (257)
T cd05116 156 THGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMI-------ESGER-----MEC---P 220 (257)
T ss_pred CCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH-------HCCCC-----CCC---C
Confidence 22234678999999988889999999999999999998 99999765433222111 11111 111 1
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhc
Q 001658 932 EEEVKRLIGVALLCTQTLPSLRPSMSRVVAMLCG 965 (1036)
Q Consensus 932 ~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~ 965 (1036)
......+.+++.+||+.+|++||++++|++.|+.
T Consensus 221 ~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~ 254 (257)
T cd05116 221 QRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN 254 (257)
T ss_pred CCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence 1233457788899999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=338.49 Aligned_cols=255 Identities=20% Similarity=0.231 Sum_probs=197.2
Q ss_pred HHhcCCCCCCccccCCCEEEEEeEeC-CCcEEEEEEcccc---chhcHHHHHHHHHHHHhhccCCcceeEeEEEcCceeE
Q 001658 690 TATENFSPSNKLGEGGFGPVYKGKLG-DGRAIAVKQLSVA---SRQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERL 765 (1036)
Q Consensus 690 ~~~~~~~~~~~iG~G~fG~Vy~~~~~-~g~~vAvK~~~~~---~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~ 765 (1036)
...++|++.+.||+|+||.||+++.. +++.||+|.+... .......+.+|+.+++.++||||+++++++.+++..+
T Consensus 40 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~ 119 (370)
T cd05621 40 MKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLY 119 (370)
T ss_pred CCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEE
Confidence 34578899999999999999999865 5789999998642 2223456788999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeec
Q 001658 766 LVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYD 845 (1036)
Q Consensus 766 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~ 845 (1036)
+||||+++|+|.+++... .+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++...
T Consensus 120 lv~Ey~~gg~L~~~l~~~---~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~ 193 (370)
T cd05621 120 MVMEYMPGGDLVNLMSNY---DVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCMKMD 193 (370)
T ss_pred EEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEecccceecc
Confidence 999999999999998543 4788888899999999999999988 9999999999999999999999999998765
Q ss_pred CCCCccccccccccCccCccccccC----CCCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhcCcccc
Q 001658 846 DKKTHISTRVAGTIGYLAPEYAMRG----HLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEIE 921 (1036)
Q Consensus 846 ~~~~~~~~~~~gt~~y~APE~~~~~----~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 921 (1036)
...........||+.|+|||++.+. .++.++||||+||++|||++|+.||........... .........
T Consensus 194 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~------i~~~~~~~~ 267 (370)
T cd05621 194 ETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSK------IMDHKNSLN 267 (370)
T ss_pred cCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHH------HHhCCcccC
Confidence 4333223346799999999998754 378899999999999999999999986543322211 111100000
Q ss_pred ccCcccccCCHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 001658 922 LADPKLIEFNEEEVKRLIGVALLCTQTLPSL--RPSMSRVVAM 962 (1036)
Q Consensus 922 ~~d~~~~~~~~~~~~~l~~l~~~Cl~~dP~~--RPt~~evl~~ 962 (1036)
-|. .......+.+++..|++.++.+ ||++.|+++.
T Consensus 268 --~p~----~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 268 --FPE----DVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred --CCC----cccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 011 0112234455566777655543 8899998764
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-35 Score=353.61 Aligned_cols=260 Identities=22% Similarity=0.289 Sum_probs=203.9
Q ss_pred cCCCCCCccccCCCEEEEEeEeC-CCcEEEEEEccccc---hhcHHHHHHHHHHHHhhccCCcceeEeEEEcCceeEEEE
Q 001658 693 ENFSPSNKLGEGGFGPVYKGKLG-DGRAIAVKQLSVAS---RQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLVY 768 (1036)
Q Consensus 693 ~~~~~~~~iG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~ 768 (1036)
++|++.++||+|+||.||+|... +|+.||+|++.... ....++|.+|++++++++||||+++++++.+++..++||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 47888999999999999999864 68999999986432 233567899999999999999999999999999999999
Q ss_pred EecCCCChhhhhhcCC---------CCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcC
Q 001658 769 EYLENKSLDQALFGQR---------SLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFG 839 (1036)
Q Consensus 769 E~~~~gsL~~~l~~~~---------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFG 839 (1036)
||+++|+|.+++.... ....++..+++++.||++||+|||+.+ |+||||||+||+++.++.+||+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEecC
Confidence 9999999999886421 234567788999999999999999987 9999999999999999999999999
Q ss_pred cceeecCCCC-----------------ccccccccccCccCccccccCCCCchhhHHhHHHHHHHHHhCCCCCCCCChhh
Q 001658 840 LAKLYDDKKT-----------------HISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEE 902 (1036)
Q Consensus 840 la~~~~~~~~-----------------~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~ 902 (1036)
+++....... .......||+.|||||++.+..++.++|||||||++|||+||+.||.......
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k 238 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK 238 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence 9987621110 01123569999999999999999999999999999999999999997633221
Q ss_pred HHHHHHHHHHHhhcCccccccCcccccCCHHHHHHHHHHHHHhcccCCCCCC-CHHHHHHHhhcccC
Q 001658 903 KLYLLEWAWHLHENNQEIELADPKLIEFNEEEVKRLIGVALLCTQTLPSLRP-SMSRVVAMLCGDME 968 (1036)
Q Consensus 903 ~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-t~~evl~~L~~~~~ 968 (1036)
.... ....+|.......+....+.+++.+|++.||++|| +++++.+.|+..+.
T Consensus 239 i~~~-------------~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq 292 (932)
T PRK13184 239 ISYR-------------DVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQ 292 (932)
T ss_pred hhhh-------------hhccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 1100 00011111001112334577888999999999995 67777777776544
|
|
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=322.33 Aligned_cols=256 Identities=29% Similarity=0.463 Sum_probs=204.1
Q ss_pred hcCCCCCCccccCCCEEEEEeEeC------CCcEEEEEEccccc-hhcHHHHHHHHHHHHhhccCCcceeEeEEEcCcee
Q 001658 692 TENFSPSNKLGEGGFGPVYKGKLG------DGRAIAVKQLSVAS-RQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAER 764 (1036)
Q Consensus 692 ~~~~~~~~~iG~G~fG~Vy~~~~~------~g~~vAvK~~~~~~-~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~ 764 (1036)
.++|+..+.||+|+||.||+|... +++.||+|.+.... .....+|.+|+.++++++||||+++++++.+++..
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 457888999999999999999853 46789999987542 34456799999999999999999999999999999
Q ss_pred EEEEEecCCCChhhhhhcCC--------------------CCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCc
Q 001658 765 LLVYEYLENKSLDQALFGQR--------------------SLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASN 824 (1036)
Q Consensus 765 ~lV~E~~~~gsL~~~l~~~~--------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~N 824 (1036)
++|+||+++|+|.+++.... ...+++..++.++.|++.||+|||+.+ ++||||||+|
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~n 160 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATRN 160 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccHhh
Confidence 99999999999999996432 235788899999999999999999987 9999999999
Q ss_pred EEecCCCceEEEEcCcceeecCCCC-ccccccccccCccCccccccCCCCchhhHHhHHHHHHHHHh-CCCCCCCCChhh
Q 001658 825 VLLDADLVPKISDFGLAKLYDDKKT-HISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVS-GRPNSDPSLDEE 902 (1036)
Q Consensus 825 ILl~~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~ 902 (1036)
|++++++.++|+|||+++.+..... .......++..|+|||.+.+..++.++|||||||++|||++ |..||......+
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~ 240 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEE 240 (288)
T ss_pred eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 9999999999999999876543221 11122335678999999998899999999999999999998 878886544332
Q ss_pred HHHHHHHHHHHhhcCccccccCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhc
Q 001658 903 KLYLLEWAWHLHENNQEIELADPKLIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVAMLCG 965 (1036)
Q Consensus 903 ~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~ 965 (1036)
..... ..+.. ..........+.+++.+|++.+|++|||+.|+++.|++
T Consensus 241 ~~~~~-------~~~~~--------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 241 VIYYV-------RDGNV--------LSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred HHHHH-------hcCCC--------CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 22111 11111 01111233567889999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=315.91 Aligned_cols=247 Identities=23% Similarity=0.360 Sum_probs=195.9
Q ss_pred ccccCCCEEEEEeEeC---CCcEEEEEEccccc-hhcHHHHHHHHHHHHhhccCCcceeEeEEEcCceeEEEEEecCCCC
Q 001658 700 KLGEGGFGPVYKGKLG---DGRAIAVKQLSVAS-RQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLVYEYLENKS 775 (1036)
Q Consensus 700 ~iG~G~fG~Vy~~~~~---~g~~vAvK~~~~~~-~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gs 775 (1036)
.||+|+||.||+|++. .+..||+|++.... ....+.|.+|+.++++++|+||+++++++. .+..++||||+++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 3899999999999753 35679999986543 333567999999999999999999999885 456899999999999
Q ss_pred hhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeecCCCCccc--c
Q 001658 776 LDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHIS--T 853 (1036)
Q Consensus 776 L~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~--~ 853 (1036)
|.+++... ...+++..+.+++.|+++||+|||+.+ ++||||||+||+++.++.+||+|||+++.+........ .
T Consensus 81 L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 156 (257)
T cd05115 81 LNKFLSGK-KDEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARS 156 (257)
T ss_pred HHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCCccceeccC
Confidence 99998643 346899999999999999999999987 99999999999999999999999999986643322211 1
Q ss_pred ccccccCccCccccccCCCCchhhHHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHHHHHhhcCccccccCcccccCCH
Q 001658 854 RVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVS-GRPNSDPSLDEEKLYLLEWAWHLHENNQEIELADPKLIEFNE 932 (1036)
Q Consensus 854 ~~~gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~ 932 (1036)
...++..|+|||.+....++.++|||||||++||+++ |+.||......+....+ ..+.. + ..+.
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~-------~~~~~-----~---~~~~ 221 (257)
T cd05115 157 AGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFI-------EQGKR-----L---DCPA 221 (257)
T ss_pred CCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHH-------HCCCC-----C---CCCC
Confidence 2234578999999988889999999999999999996 99999765443222111 11111 1 1112
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcc
Q 001658 933 EEVKRLIGVALLCTQTLPSLRPSMSRVVAMLCGD 966 (1036)
Q Consensus 933 ~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 966 (1036)
.....+.+++..||+.+|++||++.+|.+.|+..
T Consensus 222 ~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 222 ECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 2345677888999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-35 Score=326.20 Aligned_cols=261 Identities=27% Similarity=0.421 Sum_probs=206.7
Q ss_pred HhcCCCCCCccccCCCEEEEEeEe--------CCCcEEEEEEcccc-chhcHHHHHHHHHHHHhh-ccCCcceeEeEEEc
Q 001658 691 ATENFSPSNKLGEGGFGPVYKGKL--------GDGRAIAVKQLSVA-SRQGKSQFVAEIATISAV-QHRNLVKLHGCCIE 760 (1036)
Q Consensus 691 ~~~~~~~~~~iG~G~fG~Vy~~~~--------~~g~~vAvK~~~~~-~~~~~~~f~~Ei~~L~~l-~H~nIv~l~g~~~~ 760 (1036)
..++|.+.+.||+|+||.||+|+. .++..||+|.+... .....+++.+|+.+++.+ +||||+++++++..
T Consensus 13 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 92 (304)
T cd05101 13 SRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 92 (304)
T ss_pred cHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEec
Confidence 345678889999999999999973 12457999998643 234456789999999999 89999999999999
Q ss_pred CceeEEEEEecCCCChhhhhhcCC--------------CCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEE
Q 001658 761 GAERLLVYEYLENKSLDQALFGQR--------------SLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVL 826 (1036)
Q Consensus 761 ~~~~~lV~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIL 826 (1036)
....++||||+++|+|.+++.... ...++|.++..++.||++||+|||+.+ |+||||||+||+
T Consensus 93 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nil 169 (304)
T cd05101 93 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARNVL 169 (304)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccceEE
Confidence 999999999999999999997542 235788899999999999999999988 999999999999
Q ss_pred ecCCCceEEEEcCcceeecCCCCcc-ccccccccCccCccccccCCCCchhhHHhHHHHHHHHHh-CCCCCCCCChhhHH
Q 001658 827 LDADLVPKISDFGLAKLYDDKKTHI-STRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVS-GRPNSDPSLDEEKL 904 (1036)
Q Consensus 827 l~~~~~~kl~DFGla~~~~~~~~~~-~~~~~gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~ 904 (1036)
+++++.+||+|||+++......... .....++..|+|||++.+..++.++||||||+++|||++ |..||......+..
T Consensus 170 i~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~ 249 (304)
T cd05101 170 VTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF 249 (304)
T ss_pred EcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHH
Confidence 9999999999999998765432221 122346678999999998889999999999999999998 77887654332222
Q ss_pred HHHHHHHHHhhcCccccccCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcccCC
Q 001658 905 YLLEWAWHLHENNQEIELADPKLIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVAMLCGDMEV 969 (1036)
Q Consensus 905 ~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~ 969 (1036)
... ..... . .........+.+++.+||+.+|.+||++.||++.|++....
T Consensus 250 ~~~-------~~~~~-----~---~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~ 299 (304)
T cd05101 250 KLL-------KEGHR-----M---DKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTL 299 (304)
T ss_pred HHH-------HcCCc-----C---CCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHh
Confidence 111 11110 0 11122335677788899999999999999999999876554
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-35 Score=322.75 Aligned_cols=259 Identities=24% Similarity=0.354 Sum_probs=206.9
Q ss_pred HhcCCCCCCccccCCCEEEEEeEeCC-----CcEEEEEEcccc-chhcHHHHHHHHHHHHhhccCCcceeEeEEEc-Cce
Q 001658 691 ATENFSPSNKLGEGGFGPVYKGKLGD-----GRAIAVKQLSVA-SRQGKSQFVAEIATISAVQHRNLVKLHGCCIE-GAE 763 (1036)
Q Consensus 691 ~~~~~~~~~~iG~G~fG~Vy~~~~~~-----g~~vAvK~~~~~-~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~-~~~ 763 (1036)
..++|++.+.||+|+||.||+|...+ +..||+|++... .......+.+|+.++++++|+||+++++++.. ...
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 83 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP 83 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 35678888999999999999998755 688999988643 33445678899999999999999999999876 467
Q ss_pred eEEEEEecCCCChhhhhhcCCC------CCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEE
Q 001658 764 RLLVYEYLENKSLDQALFGQRS------LTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISD 837 (1036)
Q Consensus 764 ~~lV~E~~~~gsL~~~l~~~~~------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~D 837 (1036)
.++++||+++++|.+++..... ..+++.++..++.|++.||+|||+.+ ++||||||+||++++++.+||+|
T Consensus 84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kl~d 160 (280)
T cd05043 84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKITD 160 (280)
T ss_pred CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEEECC
Confidence 8999999999999999865432 46899999999999999999999987 99999999999999999999999
Q ss_pred cCcceeecCCCCc-cccccccccCccCccccccCCCCchhhHHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHHHHHhh
Q 001658 838 FGLAKLYDDKKTH-ISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVS-GRPNSDPSLDEEKLYLLEWAWHLHE 915 (1036)
Q Consensus 838 FGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~ 915 (1036)
||+++.+...... ......++..|+|||++.+..++.++||||||+++||+++ |+.||......+ +..+..
T Consensus 161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~~~~~~---- 233 (280)
T cd05043 161 NALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFE---MAAYLK---- 233 (280)
T ss_pred CCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHH---HHHHHH----
Confidence 9999866433222 1122346778999999998889999999999999999999 999997643322 121111
Q ss_pred cCccccccCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhccc
Q 001658 916 NNQEIELADPKLIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVAMLCGDM 967 (1036)
Q Consensus 916 ~~~~~~~~d~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~ 967 (1036)
.+. .+.. .......+.+++.+||+.+|++|||+.|+++.|+...
T Consensus 234 ~~~-----~~~~---~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~ 277 (280)
T cd05043 234 DGY-----RLAQ---PINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFH 277 (280)
T ss_pred cCC-----CCCC---CCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 110 0000 1112346788899999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=316.58 Aligned_cols=258 Identities=24% Similarity=0.374 Sum_probs=208.1
Q ss_pred cCCCCCCccccCCCEEEEEeEeC-CCcEEEEEEcccc---chhcHHHHHHHHHHHHhhccCCcceeEeEEEcCceeEEEE
Q 001658 693 ENFSPSNKLGEGGFGPVYKGKLG-DGRAIAVKQLSVA---SRQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLVY 768 (1036)
Q Consensus 693 ~~~~~~~~iG~G~fG~Vy~~~~~-~g~~vAvK~~~~~---~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~ 768 (1036)
++|++.+.||+|+||.||+|... +|+.||+|.++.. .....+.+.+|++++++++|+||+++++++...+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57888999999999999999876 7899999988632 2333567899999999999999999999999999999999
Q ss_pred EecCCCChhhhhhcC--CCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeecC
Q 001658 769 EYLENKSLDQALFGQ--RSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDD 846 (1036)
Q Consensus 769 E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~ 846 (1036)
||+++++|.+++... ....+++.++..++.++++||+|||+.+ |+||||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 999999999988642 2456899999999999999999999988 99999999999999999999999999986643
Q ss_pred CCCccccccccccCccCccccccCCCCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhcCccccccCcc
Q 001658 847 KKTHISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEIELADPK 926 (1036)
Q Consensus 847 ~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 926 (1036)
.... .....|+..|+|||.+.+..++.++|||||||++|||++|+.||...... .....+ ... .+ ..+.
T Consensus 159 ~~~~-~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-~~~~~~---~~~-~~-----~~~~ 227 (267)
T cd08224 159 KTTA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN-LYSLCK---KIE-KC-----DYPP 227 (267)
T ss_pred CCcc-cceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCcc-HHHHHh---hhh-cC-----CCCC
Confidence 3222 22345888999999999888999999999999999999999998653311 111111 100 00 0011
Q ss_pred cccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcc
Q 001658 927 LIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVAMLCGD 966 (1036)
Q Consensus 927 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 966 (1036)
.. .......+.+++.+||+.+|++||++.+|+++|+++
T Consensus 228 ~~--~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~ 265 (267)
T cd08224 228 LP--ADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEM 265 (267)
T ss_pred CC--hhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHh
Confidence 10 113345677888999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=318.73 Aligned_cols=255 Identities=25% Similarity=0.401 Sum_probs=203.9
Q ss_pred cCCCCCCccccCCCEEEEEeEeC----CCcEEEEEEccccc-hhcHHHHHHHHHHHHhhccCCcceeEeEEEcCceeEEE
Q 001658 693 ENFSPSNKLGEGGFGPVYKGKLG----DGRAIAVKQLSVAS-RQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLV 767 (1036)
Q Consensus 693 ~~~~~~~~iG~G~fG~Vy~~~~~----~g~~vAvK~~~~~~-~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV 767 (1036)
.+|++.+.||+|+||.||+|... .+..+|+|.++... ....+.|..|+.++++++||||+++++++..++..++|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 46778899999999999999853 23479999986532 33356789999999999999999999999999999999
Q ss_pred EEecCCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeecCC
Q 001658 768 YEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDK 847 (1036)
Q Consensus 768 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~ 847 (1036)
|||+++++|.+++.... ..+++.+++.|+.|++.||+|||+.+ ++||||||+||+++.++.++|+|||+++.+...
T Consensus 84 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd05066 84 TEYMENGSLDAFLRKHD-GQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 159 (267)
T ss_pred EEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCcccccccc
Confidence 99999999999996543 46899999999999999999999988 999999999999999999999999999876543
Q ss_pred CCccc--cccccccCccCccccccCCCCchhhHHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHHHHHhhcCccccccC
Q 001658 848 KTHIS--TRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVS-GRPNSDPSLDEEKLYLLEWAWHLHENNQEIELAD 924 (1036)
Q Consensus 848 ~~~~~--~~~~gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 924 (1036)
..... ....++..|+|||++.+..++.++||||||+++||+++ |+.||......+.. .... ... . .
T Consensus 160 ~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~---~~~~----~~~--~--~ 228 (267)
T cd05066 160 PEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVI---KAIE----EGY--R--L 228 (267)
T ss_pred cceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHH---HHHh----CCC--c--C
Confidence 32221 12223568999999998899999999999999999886 99998754432221 1111 110 0 0
Q ss_pred cccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcc
Q 001658 925 PKLIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVAMLCGD 966 (1036)
Q Consensus 925 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 966 (1036)
+. .......+.+++.+|++.+|.+||+|.++++.|++.
T Consensus 229 ~~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 229 PA----PMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred CC----CCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 11 112234677888999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=327.86 Aligned_cols=204 Identities=24% Similarity=0.280 Sum_probs=175.0
Q ss_pred cCCCCCCccccCCCEEEEEeEeC-CCcEEEEEEcccc---chhcHHHHHHHHHHHHhhccCCcceeEeEEEcCceeEEEE
Q 001658 693 ENFSPSNKLGEGGFGPVYKGKLG-DGRAIAVKQLSVA---SRQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLVY 768 (1036)
Q Consensus 693 ~~~~~~~~iG~G~fG~Vy~~~~~-~g~~vAvK~~~~~---~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~ 768 (1036)
++|++.+.||+|+||.||+++.. +++.||+|++... .....+.+.+|+.++..++|+||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 46888999999999999999864 6899999998642 2233456889999999999999999999999999999999
Q ss_pred EecCCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeecCCC
Q 001658 769 EYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKK 848 (1036)
Q Consensus 769 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~ 848 (1036)
||+++|+|.+++... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++..+....
T Consensus 81 e~~~g~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 156 (331)
T cd05597 81 DYYVGGDLLTLLSKF-EDRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADG 156 (331)
T ss_pred ecCCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCceeecCCCC
Confidence 999999999998642 345788899999999999999999988 9999999999999999999999999998765433
Q ss_pred CccccccccccCccCcccccc-----CCCCchhhHHhHHHHHHHHHhCCCCCCCCCh
Q 001658 849 THISTRVAGTIGYLAPEYAMR-----GHLTEKTDVFAFGVLALETVSGRPNSDPSLD 900 (1036)
Q Consensus 849 ~~~~~~~~gt~~y~APE~~~~-----~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~ 900 (1036)
........||+.|+|||++.. ..++.++|||||||++|||++|+.||.....
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~ 213 (331)
T cd05597 157 TVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESL 213 (331)
T ss_pred CccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCH
Confidence 333333569999999999863 4578899999999999999999999976543
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=330.57 Aligned_cols=237 Identities=23% Similarity=0.280 Sum_probs=186.8
Q ss_pred CccccCCCEEEEEeEeC-CCcEEEEEEccccc---hhcHHHHHHHHH-HHHhhccCCcceeEeEEEcCceeEEEEEecCC
Q 001658 699 NKLGEGGFGPVYKGKLG-DGRAIAVKQLSVAS---RQGKSQFVAEIA-TISAVQHRNLVKLHGCCIEGAERLLVYEYLEN 773 (1036)
Q Consensus 699 ~~iG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~f~~Ei~-~L~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~ 773 (1036)
+.||+|+||.||+|+.. +++.||+|++.... ......+..|.. +++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999864 68899999986432 222344555554 57888999999999999999999999999999
Q ss_pred CChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeecCCCCcccc
Q 001658 774 KSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHIST 853 (1036)
Q Consensus 774 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 853 (1036)
|+|.+++.. ...+++..+..++.||++||+|||+.+ |+||||||+||+++.++.+||+|||+++...... ....
T Consensus 81 ~~L~~~l~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~~~ 154 (321)
T cd05603 81 GELFFHLQR--ERCFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE-ETTS 154 (321)
T ss_pred CCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccCCCCC-Cccc
Confidence 999988854 345778888889999999999999987 9999999999999999999999999987532222 1223
Q ss_pred ccccccCccCccccccCCCCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhcCccccccCcccccCCHH
Q 001658 854 RVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEIELADPKLIEFNEE 933 (1036)
Q Consensus 854 ~~~gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~ 933 (1036)
...||+.|+|||++.+..++.++|||||||++|||++|+.||......... +. .... .. ..+..
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~---~~---i~~~-------~~---~~~~~ 218 (321)
T cd05603 155 TFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMY---DN---ILHK-------PL---QLPGG 218 (321)
T ss_pred cccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHH---HH---HhcC-------CC---CCCCC
Confidence 456999999999999889999999999999999999999999865432211 11 1110 00 11112
Q ss_pred HHHHHHHHHHHhcccCCCCCCCHH
Q 001658 934 EVKRLIGVALLCTQTLPSLRPSMS 957 (1036)
Q Consensus 934 ~~~~l~~l~~~Cl~~dP~~RPt~~ 957 (1036)
....+.+++.+|++.+|.+||+..
T Consensus 219 ~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 219 KTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred CCHHHHHHHHHHccCCHhhcCCCC
Confidence 234577888899999999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=316.13 Aligned_cols=251 Identities=23% Similarity=0.353 Sum_probs=201.6
Q ss_pred cCCCCCCccccCCCEEEEEeEe-CCCcEEEEEEccccc-----hhcHHHHHHHHHHHHhhccCCcceeEeEEEcCceeEE
Q 001658 693 ENFSPSNKLGEGGFGPVYKGKL-GDGRAIAVKQLSVAS-----RQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLL 766 (1036)
Q Consensus 693 ~~~~~~~~iG~G~fG~Vy~~~~-~~g~~vAvK~~~~~~-----~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~l 766 (1036)
++|+..+.||+|++|.||+|.. .+++.||+|.+.... ....+.+.+|++++++++||||+++++++.+.+..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 5688899999999999999985 468999999886432 1223568899999999999999999999999999999
Q ss_pred EEEecCCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeecC
Q 001658 767 VYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDD 846 (1036)
Q Consensus 767 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~ 846 (1036)
|+||+++++|.+++... ..+++..+.+++.|++.||+|||+.+ |+||||||+||++++++.++|+|||+++....
T Consensus 82 v~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~ 156 (263)
T cd06625 82 FMEYMPGGSVKDQLKAY--GALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQT 156 (263)
T ss_pred EEEECCCCcHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceeccc
Confidence 99999999999998653 35788888999999999999999988 99999999999999999999999999986643
Q ss_pred CCCccc--cccccccCccCccccccCCCCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhcCccccccC
Q 001658 847 KKTHIS--TRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEIELAD 924 (1036)
Q Consensus 847 ~~~~~~--~~~~gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 924 (1036)
...... ....|+..|+|||++.+..++.++||||||+++|||++|+.||.......... + ..... ..
T Consensus 157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~---~---~~~~~-----~~ 225 (263)
T cd06625 157 ICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIF---K---IATQP-----TN 225 (263)
T ss_pred cccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHH---H---HhccC-----CC
Confidence 222111 23457889999999999889999999999999999999999987543322211 0 00000 01
Q ss_pred cccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 001658 925 PKLIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVAM 962 (1036)
Q Consensus 925 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 962 (1036)
+ .........+.+++..||+.+|.+|||+.|+++.
T Consensus 226 ~---~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 226 P---QLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred C---CCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 1 1122233467778889999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-35 Score=326.41 Aligned_cols=260 Identities=28% Similarity=0.414 Sum_probs=205.1
Q ss_pred hcCCCCCCccccCCCEEEEEeEeC--------CCcEEEEEEccccc-hhcHHHHHHHHHHHHhh-ccCCcceeEeEEEcC
Q 001658 692 TENFSPSNKLGEGGFGPVYKGKLG--------DGRAIAVKQLSVAS-RQGKSQFVAEIATISAV-QHRNLVKLHGCCIEG 761 (1036)
Q Consensus 692 ~~~~~~~~~iG~G~fG~Vy~~~~~--------~g~~vAvK~~~~~~-~~~~~~f~~Ei~~L~~l-~H~nIv~l~g~~~~~ 761 (1036)
.++|.+.+.||+|+||.||+|+.. ++..+|+|.+.... .....++..|++++.++ +|+||+++++++...
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 96 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 96 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 457889999999999999999742 23579999987532 33456788899999999 799999999999999
Q ss_pred ceeEEEEEecCCCChhhhhhcCCC--------------CCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEe
Q 001658 762 AERLLVYEYLENKSLDQALFGQRS--------------LTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLL 827 (1036)
Q Consensus 762 ~~~~lV~E~~~~gsL~~~l~~~~~--------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl 827 (1036)
+..++||||+++|+|.+++..... ..++|.++++++.|++.||+|||+.+ ++||||||+||++
T Consensus 97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill 173 (307)
T cd05098 97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV 173 (307)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHheEE
Confidence 999999999999999999975432 35889999999999999999999987 9999999999999
Q ss_pred cCCCceEEEEcCcceeecCCCCcc-ccccccccCccCccccccCCCCchhhHHhHHHHHHHHHh-CCCCCCCCChhhHHH
Q 001658 828 DADLVPKISDFGLAKLYDDKKTHI-STRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVS-GRPNSDPSLDEEKLY 905 (1036)
Q Consensus 828 ~~~~~~kl~DFGla~~~~~~~~~~-~~~~~gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~ 905 (1036)
++++.+||+|||+++......... .....++..|+|||++.+..++.++|||||||++|||++ |+.||......+...
T Consensus 174 ~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~~~ 253 (307)
T cd05098 174 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK 253 (307)
T ss_pred cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHH
Confidence 999999999999997654322111 112234568999999998889999999999999999998 888886543322111
Q ss_pred HHHHHHHHhhcCccccccCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcccCC
Q 001658 906 LLEWAWHLHENNQEIELADPKLIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVAMLCGDMEV 969 (1036)
Q Consensus 906 l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~ 969 (1036)
.. ..... ...+......+.+++..|++.+|.+||++.+|++.|++....
T Consensus 254 ~~-------~~~~~--------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~ 302 (307)
T cd05098 254 LL-------KEGHR--------MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILAL 302 (307)
T ss_pred HH-------HcCCC--------CCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHH
Confidence 11 11110 011122335677788999999999999999999999876543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=322.32 Aligned_cols=262 Identities=26% Similarity=0.395 Sum_probs=204.8
Q ss_pred hcCCCCCCccccCCCEEEEEeEeCC-----------------CcEEEEEEccccc-hhcHHHHHHHHHHHHhhccCCcce
Q 001658 692 TENFSPSNKLGEGGFGPVYKGKLGD-----------------GRAIAVKQLSVAS-RQGKSQFVAEIATISAVQHRNLVK 753 (1036)
Q Consensus 692 ~~~~~~~~~iG~G~fG~Vy~~~~~~-----------------g~~vAvK~~~~~~-~~~~~~f~~Ei~~L~~l~H~nIv~ 753 (1036)
..+|++.+.||+|+||.||+|...+ +..||+|.+.... ....+.+.+|++++++++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 3578889999999999999987532 2468999987542 344678899999999999999999
Q ss_pred eEeEEEcCceeEEEEEecCCCChhhhhhcCC---------CCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCc
Q 001658 754 LHGCCIEGAERLLVYEYLENKSLDQALFGQR---------SLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASN 824 (1036)
Q Consensus 754 l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~---------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~N 824 (1036)
+++++..++..++|+||+++++|.+++.... ...+++..++.++.|++.||+|||+.+ |+||||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhc
Confidence 9999999999999999999999999986543 236899999999999999999999987 9999999999
Q ss_pred EEecCCCceEEEEcCcceeecCCCC-ccccccccccCccCccccccCCCCchhhHHhHHHHHHHHHh--CCCCCCCCChh
Q 001658 825 VLLDADLVPKISDFGLAKLYDDKKT-HISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVS--GRPNSDPSLDE 901 (1036)
Q Consensus 825 ILl~~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~ellt--G~~p~~~~~~~ 901 (1036)
|+++.++.++|+|||+++....... .......++..|+|||++.+..++.++|||||||++|||++ |..|+......
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQ 240 (296)
T ss_pred eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChH
Confidence 9999999999999999986543321 11223456789999999998889999999999999999998 66777643322
Q ss_pred hHHHHHHHHHHHhhcCccccccCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 001658 902 EKLYLLEWAWHLHENNQEIELADPKLIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVAMLC 964 (1036)
Q Consensus 902 ~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~ 964 (1036)
.. ................ .........++.+++.+|++.+|.+|||+.||++.|+
T Consensus 241 ~~---~~~~~~~~~~~~~~~~-----~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 241 QV---IENAGHFFRDDGRQIY-----LPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred HH---HHHHHhcccccccccc-----CCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 21 2222111111100000 0111223357888999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=321.62 Aligned_cols=261 Identities=26% Similarity=0.392 Sum_probs=202.3
Q ss_pred cCCCCCCccccCCCEEEEEeEeC-----------------CCcEEEEEEcccc-chhcHHHHHHHHHHHHhhccCCccee
Q 001658 693 ENFSPSNKLGEGGFGPVYKGKLG-----------------DGRAIAVKQLSVA-SRQGKSQFVAEIATISAVQHRNLVKL 754 (1036)
Q Consensus 693 ~~~~~~~~iG~G~fG~Vy~~~~~-----------------~g~~vAvK~~~~~-~~~~~~~f~~Ei~~L~~l~H~nIv~l 754 (1036)
++|++.+.||+|+||.||++... ++..||+|.+... ......+|.+|+.++++++|+||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~ 84 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL 84 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence 46888999999999999998532 2346999998754 33445689999999999999999999
Q ss_pred EeEEEcCceeEEEEEecCCCChhhhhhcCCC---------CCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcE
Q 001658 755 HGCCIEGAERLLVYEYLENKSLDQALFGQRS---------LTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNV 825 (1036)
Q Consensus 755 ~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~---------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NI 825 (1036)
++++...+..++||||+++++|.+++..... ..+++.+...++.|++.||+|||+.+ |+||||||+||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~Ni 161 (296)
T cd05095 85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRNC 161 (296)
T ss_pred EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChheE
Confidence 9999999999999999999999999865431 34778899999999999999999988 99999999999
Q ss_pred EecCCCceEEEEcCcceeecCCCCcc-ccccccccCccCccccccCCCCchhhHHhHHHHHHHHHh--CCCCCCCCChhh
Q 001658 826 LLDADLVPKISDFGLAKLYDDKKTHI-STRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVS--GRPNSDPSLDEE 902 (1036)
Q Consensus 826 Ll~~~~~~kl~DFGla~~~~~~~~~~-~~~~~gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~ellt--G~~p~~~~~~~~ 902 (1036)
++++++.++|+|||+++.+....... .....++..|+|||....+.++.++|||||||++|||++ |..||......+
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~ 241 (296)
T cd05095 162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQ 241 (296)
T ss_pred EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHH
Confidence 99999999999999998654332211 122335678999999988899999999999999999998 667776543322
Q ss_pred HHHHHHHHHHHhhcCccccccCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 001658 903 KLYLLEWAWHLHENNQEIELADPKLIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVAMLC 964 (1036)
Q Consensus 903 ~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~ 964 (1036)
... ........... ....+. .......+.+++.+||+.+|.+||++.||++.|+
T Consensus 242 ~~~---~~~~~~~~~~~-~~~~~~----~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 295 (296)
T cd05095 242 VIE---NTGEFFRDQGR-QVYLPK----PALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL 295 (296)
T ss_pred HHH---HHHHHHhhccc-cccCCC----CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 221 11111111100 001111 1122356788899999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-35 Score=328.82 Aligned_cols=237 Identities=25% Similarity=0.295 Sum_probs=187.7
Q ss_pred CccccCCCEEEEEeEeC-CCcEEEEEEccccc---hhcHHHHHHHHH-HHHhhccCCcceeEeEEEcCceeEEEEEecCC
Q 001658 699 NKLGEGGFGPVYKGKLG-DGRAIAVKQLSVAS---RQGKSQFVAEIA-TISAVQHRNLVKLHGCCIEGAERLLVYEYLEN 773 (1036)
Q Consensus 699 ~~iG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~f~~Ei~-~L~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~ 773 (1036)
+.||+|+||+||+|+.. +|+.||+|++.... ......+..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 46999999999999864 68999999986432 222344555554 46778999999999999999999999999999
Q ss_pred CChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeecCCCCcccc
Q 001658 774 KSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHIST 853 (1036)
Q Consensus 774 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 853 (1036)
|+|.+++.. ...+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ....
T Consensus 81 g~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~~~ 154 (323)
T cd05575 81 GELFFHLQR--ERSFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS-KTTS 154 (323)
T ss_pred CCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCcccccCC-Cccc
Confidence 999998864 346788889999999999999999988 9999999999999999999999999987543222 1223
Q ss_pred ccccccCccCccccccCCCCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhcCccccccCcccccCCHH
Q 001658 854 RVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEIELADPKLIEFNEE 933 (1036)
Q Consensus 854 ~~~gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~ 933 (1036)
...||+.|+|||++.+..++.++|||||||++|||++|+.||......+... ..... ...+ ...
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~------~i~~~-------~~~~---~~~ 218 (323)
T cd05575 155 TFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYD------NILNK-------PLRL---KPN 218 (323)
T ss_pred cccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHH------HHHcC-------CCCC---CCC
Confidence 4569999999999999999999999999999999999999998654322111 11110 0111 111
Q ss_pred HHHHHHHHHHHhcccCCCCCCCHH
Q 001658 934 EVKRLIGVALLCTQTLPSLRPSMS 957 (1036)
Q Consensus 934 ~~~~l~~l~~~Cl~~dP~~RPt~~ 957 (1036)
....+.+++.+|++.+|.+||++.
T Consensus 219 ~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 219 ISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred CCHHHHHHHHHHhhcCHHhCCCCC
Confidence 234567788899999999999985
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=316.82 Aligned_cols=240 Identities=24% Similarity=0.369 Sum_probs=189.8
Q ss_pred CccccCCCEEEEEeEeCC-------------CcEEEEEEccccchhcHHHHHHHHHHHHhhccCCcceeEeEEEcCceeE
Q 001658 699 NKLGEGGFGPVYKGKLGD-------------GRAIAVKQLSVASRQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERL 765 (1036)
Q Consensus 699 ~~iG~G~fG~Vy~~~~~~-------------g~~vAvK~~~~~~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~ 765 (1036)
+.||+|+||.||+|++.. ...||+|.+..........|.+|+.+++.++||||+++++++......+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 468999999999998532 2358999887655555667889999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCc-------eEEEEc
Q 001658 766 LVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLV-------PKISDF 838 (1036)
Q Consensus 766 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~-------~kl~DF 838 (1036)
+||||+++|+|..++... ...+++..+++++.||++||+|||+.+ |+||||||+|||++.++. ++++||
T Consensus 81 lv~e~~~~~~l~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~ 156 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRK-SDVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFIKLSDP 156 (262)
T ss_pred EEEecccCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCceeEeCCC
Confidence 999999999999888643 345899999999999999999999987 999999999999987664 899999
Q ss_pred CcceeecCCCCccccccccccCccCccccc-cCCCCchhhHHhHHHHHHHHH-hCCCCCCCCChhhHHHHHHHHHHHhhc
Q 001658 839 GLAKLYDDKKTHISTRVAGTIGYLAPEYAM-RGHLTEKTDVFAFGVLALETV-SGRPNSDPSLDEEKLYLLEWAWHLHEN 916 (1036)
Q Consensus 839 Gla~~~~~~~~~~~~~~~gt~~y~APE~~~-~~~~~~ksDVwS~Gvvl~ell-tG~~p~~~~~~~~~~~l~~~~~~~~~~ 916 (1036)
|++...... ....++..|+|||.+. +..++.++|||||||++|||+ +|+.|+......+... ....
T Consensus 157 g~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~-------~~~~ 224 (262)
T cd05077 157 GIPITVLSR-----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKER-------FYEG 224 (262)
T ss_pred CCCccccCc-----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHH-------HHhc
Confidence 998755322 1235788999999886 466899999999999999997 5888776533221110 0000
Q ss_pred CccccccCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 001658 917 NQEIELADPKLIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVAMLC 964 (1036)
Q Consensus 917 ~~~~~~~d~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~ 964 (1036)
. .. . .......+.+++.+||+.||.+||++.++++.|+
T Consensus 225 -~-~~-----~---~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~ 262 (262)
T cd05077 225 -Q-CM-----L---VTPSCKELADLMTHCMNYDPNQRPFFRAIMRDIN 262 (262)
T ss_pred -C-cc-----C---CCCChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence 0 00 0 0111345778889999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-35 Score=329.17 Aligned_cols=241 Identities=24% Similarity=0.310 Sum_probs=193.3
Q ss_pred CccccCCCEEEEEeEeC-CCcEEEEEEccccc---hhcHHHHHHHHHHHHhh-ccCCcceeEeEEEcCceeEEEEEecCC
Q 001658 699 NKLGEGGFGPVYKGKLG-DGRAIAVKQLSVAS---RQGKSQFVAEIATISAV-QHRNLVKLHGCCIEGAERLLVYEYLEN 773 (1036)
Q Consensus 699 ~~iG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~f~~Ei~~L~~l-~H~nIv~l~g~~~~~~~~~lV~E~~~~ 773 (1036)
+.||+|+||.||+|+.. +++.||+|++.... ....+.+..|.+++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 46999999999999865 57899999987532 23345677899988866 799999999999999999999999999
Q ss_pred CChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeecCCCCcccc
Q 001658 774 KSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHIST 853 (1036)
Q Consensus 774 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 853 (1036)
|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++....... ...
T Consensus 81 ~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~-~~~ 154 (321)
T cd05591 81 GDLMFQIQRS--RKFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV-TTT 154 (321)
T ss_pred CcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceecccCCc-ccc
Confidence 9999988643 45788899999999999999999998 99999999999999999999999999976432222 223
Q ss_pred ccccccCccCccccccCCCCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhcCccccccCcccccCCHH
Q 001658 854 RVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEIELADPKLIEFNEE 933 (1036)
Q Consensus 854 ~~~gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~ 933 (1036)
...||+.|+|||++.+..++.++|||||||++|||++|+.||........... .... +..... .
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~------i~~~-------~~~~p~---~ 218 (321)
T cd05591 155 TFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFES------ILHD-------DVLYPV---W 218 (321)
T ss_pred ccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHH------HHcC-------CCCCCC---C
Confidence 45699999999999998999999999999999999999999986554332211 1110 011111 1
Q ss_pred HHHHHHHHHHHhcccCCCCCC-------CHHHHHH
Q 001658 934 EVKRLIGVALLCTQTLPSLRP-------SMSRVVA 961 (1036)
Q Consensus 934 ~~~~l~~l~~~Cl~~dP~~RP-------t~~evl~ 961 (1036)
....+.+++..|++.+|++|| ++.++++
T Consensus 219 ~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~ 253 (321)
T cd05591 219 LSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQ 253 (321)
T ss_pred CCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhc
Confidence 224567788899999999999 6777664
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=327.64 Aligned_cols=260 Identities=28% Similarity=0.420 Sum_probs=205.9
Q ss_pred cCCCCCCccccCCCEEEEEeEeC--------CCcEEEEEEccccc-hhcHHHHHHHHHHHHhh-ccCCcceeEeEEEcCc
Q 001658 693 ENFSPSNKLGEGGFGPVYKGKLG--------DGRAIAVKQLSVAS-RQGKSQFVAEIATISAV-QHRNLVKLHGCCIEGA 762 (1036)
Q Consensus 693 ~~~~~~~~iG~G~fG~Vy~~~~~--------~g~~vAvK~~~~~~-~~~~~~f~~Ei~~L~~l-~H~nIv~l~g~~~~~~ 762 (1036)
.+|++.+.||+|+||.||+|... .+..||+|.++... ....+++.+|+++++++ +|+||++++++|...+
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 91 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence 46788999999999999999742 12368999887432 33456889999999999 7999999999999999
Q ss_pred eeEEEEEecCCCChhhhhhcCC--------------CCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEec
Q 001658 763 ERLLVYEYLENKSLDQALFGQR--------------SLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLD 828 (1036)
Q Consensus 763 ~~~lV~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~ 828 (1036)
..++|+||+++|+|.+++.... ...++|.+++.++.|+++||+|||+.+ |+||||||+||+++
T Consensus 92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nill~ 168 (334)
T cd05100 92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAARNVLVT 168 (334)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEc
Confidence 9999999999999999986532 235789999999999999999999988 99999999999999
Q ss_pred CCCceEEEEcCcceeecCCCCcc-ccccccccCccCccccccCCCCchhhHHhHHHHHHHHHh-CCCCCCCCChhhHHHH
Q 001658 829 ADLVPKISDFGLAKLYDDKKTHI-STRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVS-GRPNSDPSLDEEKLYL 906 (1036)
Q Consensus 829 ~~~~~kl~DFGla~~~~~~~~~~-~~~~~gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l 906 (1036)
+++.+||+|||+++......... .....++..|+|||++.+..++.++||||||+++|||++ |..||......+....
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~ 248 (334)
T cd05100 169 EDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKL 248 (334)
T ss_pred CCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Confidence 99999999999998664332211 122234568999999999999999999999999999998 8888865443322211
Q ss_pred HHHHHHHhhcCccccccCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcccCCC
Q 001658 907 LEWAWHLHENNQEIELADPKLIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVAMLCGDMEVS 970 (1036)
Q Consensus 907 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~ 970 (1036)
. . .... ..........+.+++.+||+.+|.+||++.|+++.|++.....
T Consensus 249 ~------~-~~~~--------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~ 297 (334)
T cd05100 249 L------K-EGHR--------MDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVT 297 (334)
T ss_pred H------H-cCCC--------CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhc
Confidence 1 0 1100 0111223346778899999999999999999999999887544
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=325.11 Aligned_cols=243 Identities=28% Similarity=0.455 Sum_probs=198.8
Q ss_pred CCCCCccccCCCEEEEEeEe-CCCcEEEEEEccccch---hcHHHHHHHHHHHHhhccCCcceeEeEEEcCceeEEEEEe
Q 001658 695 FSPSNKLGEGGFGPVYKGKL-GDGRAIAVKQLSVASR---QGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLVYEY 770 (1036)
Q Consensus 695 ~~~~~~iG~G~fG~Vy~~~~-~~g~~vAvK~~~~~~~---~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~ 770 (1036)
|.-++.||.|+||.||-|+. .+.+.||||++....+ ..+.++..|+..|.+++|||++.+-|||..+...||||||
T Consensus 28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEY 107 (948)
T KOG0577|consen 28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEY 107 (948)
T ss_pred HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHH
Confidence 33456799999999999984 5778999999875433 3467889999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeecCCCCc
Q 001658 771 LENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTH 850 (1036)
Q Consensus 771 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~ 850 (1036)
| -||-.|++.-. ..++.+..+..|+.+.+.||+|||+.+ .||||||..|||+.+.|.|||+|||.|....+.
T Consensus 108 C-lGSAsDlleVh-kKplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA--- 179 (948)
T KOG0577|consen 108 C-LGSASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSASIMAPA--- 179 (948)
T ss_pred H-hccHHHHHHHH-hccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchhhcCch---
Confidence 9 56888877443 457888888999999999999999998 999999999999999999999999999876543
Q ss_pred cccccccccCccCccccc---cCCCCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhcCccccccCccc
Q 001658 851 ISTRVAGTIGYLAPEYAM---RGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEIELADPKL 927 (1036)
Q Consensus 851 ~~~~~~gt~~y~APE~~~---~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~ 927 (1036)
..++|||.|||||++. .+.|+-|+||||+|++..||...++|.-..+.....+-+ .. ...|.+
T Consensus 180 --nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHI-------AQ-----NesPtL 245 (948)
T KOG0577|consen 180 --NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI-------AQ-----NESPTL 245 (948)
T ss_pred --hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHH-------Hh-----cCCCCC
Confidence 3478999999999984 578999999999999999999999987654433333211 11 112333
Q ss_pred ccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 001658 928 IEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVA 961 (1036)
Q Consensus 928 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 961 (1036)
. ..+....+..++..|+++-|.+|||.+++++
T Consensus 246 q--s~eWS~~F~~Fvd~CLqKipqeRptse~ll~ 277 (948)
T KOG0577|consen 246 Q--SNEWSDYFRNFVDSCLQKIPQERPTSEELLK 277 (948)
T ss_pred C--CchhHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence 2 2445566777778999999999999998876
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=297.47 Aligned_cols=263 Identities=23% Similarity=0.290 Sum_probs=208.4
Q ss_pred HHhcCCCCCCccccCCCEEEEEeE-eCCCcEEEEEEccccchhcHHHHHHHHHHHHhhccCCcceeEeEEEcC-----ce
Q 001658 690 TATENFSPSNKLGEGGFGPVYKGK-LGDGRAIAVKQLSVASRQGKSQFVAEIATISAVQHRNLVKLHGCCIEG-----AE 763 (1036)
Q Consensus 690 ~~~~~~~~~~~iG~G~fG~Vy~~~-~~~g~~vAvK~~~~~~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~-----~~ 763 (1036)
...++|.+.+.+|+|||+.||.++ ..+++.+|+|++...+.++.+..++|++..++++|||+++++++...+ .+
T Consensus 18 In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~ 97 (302)
T KOG2345|consen 18 INNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHE 97 (302)
T ss_pred EcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCcee
Confidence 345678899999999999999998 668899999999776767788899999999999999999999987644 34
Q ss_pred eEEEEEecCCCChhhhhhcCC--CCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcc
Q 001658 764 RLLVYEYLENKSLDQALFGQR--SLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLA 841 (1036)
Q Consensus 764 ~~lV~E~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla 841 (1036)
.|+++.|...|+|.+.+.... ...+++.+.+.|+.+|++||++||+.. +++.||||||.|||+.+.+.+++.|||.+
T Consensus 98 ~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~GS~ 176 (302)
T KOG2345|consen 98 AYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDLGSA 176 (302)
T ss_pred EEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEeccCc
Confidence 899999999999999986543 456899999999999999999999986 57999999999999999999999999998
Q ss_pred eeecCCCCcc--------ccccccccCccCccccc---cCCCCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHH
Q 001658 842 KLYDDKKTHI--------STRVAGTIGYLAPEYAM---RGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWA 910 (1036)
Q Consensus 842 ~~~~~~~~~~--------~~~~~gt~~y~APE~~~---~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~ 910 (1036)
+...-.-... -....-|..|.|||.+. +...++++|||||||++|+|+.|..||+........
T Consensus 177 ~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgS------ 250 (302)
T KOG2345|consen 177 TQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGS------ 250 (302)
T ss_pred cccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCe------
Confidence 7543111000 01123588999999985 456789999999999999999999999753221100
Q ss_pred HHHhhcCccccccCccc-ccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcc
Q 001658 911 WHLHENNQEIELADPKL-IEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVAMLCGD 966 (1036)
Q Consensus 911 ~~~~~~~~~~~~~d~~~-~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 966 (1036)
-...+..+.+ ..........+.+++.+|++.||.+||+..+++..+...
T Consensus 251 -------laLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~L 300 (302)
T KOG2345|consen 251 -------LALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDL 300 (302)
T ss_pred -------EEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence 0011112111 111122567788899999999999999999999887643
|
|
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=323.65 Aligned_cols=249 Identities=25% Similarity=0.433 Sum_probs=203.5
Q ss_pred cCCCCCCccccCCCEEEEEeEe-CCCcEEEEEEccccchhcHHHHHHHHHHHHhhccCCcceeEeEEEcCceeEEEEEec
Q 001658 693 ENFSPSNKLGEGGFGPVYKGKL-GDGRAIAVKQLSVASRQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLVYEYL 771 (1036)
Q Consensus 693 ~~~~~~~~iG~G~fG~Vy~~~~-~~g~~vAvK~~~~~~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~~ 771 (1036)
.+|+..+.||+|+||.||+|.. .+++.||+|.+..........+.+|+.+++.++|+||+++++++..+...++||||+
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~ 99 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeeccc
Confidence 4788889999999999999985 468899999987655555677899999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeecCCCCcc
Q 001658 772 ENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHI 851 (1036)
Q Consensus 772 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 851 (1036)
++++|.+++.. ..+++.++..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++.........
T Consensus 100 ~~~~L~~~~~~---~~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~- 172 (296)
T cd06654 100 AGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK- 172 (296)
T ss_pred CCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchhccccccc-
Confidence 99999999853 35788999999999999999999988 999999999999999999999999998765433221
Q ss_pred ccccccccCccCccccccCCCCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhcCccccccCcccccCC
Q 001658 852 STRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEIELADPKLIEFN 931 (1036)
Q Consensus 852 ~~~~~gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~ 931 (1036)
.....|++.|+|||.+.+..++.++|||||||++|||++|+.||........... + ... . .+.. ...
T Consensus 173 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~--~----~~~-~-----~~~~-~~~ 239 (296)
T cd06654 173 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYL--I----ATN-G-----TPEL-QNP 239 (296)
T ss_pred cCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHH--H----hcC-C-----CCCC-CCc
Confidence 2234688999999999988899999999999999999999999976543222111 0 000 0 0111 111
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 001658 932 EEEVKRLIGVALLCTQTLPSLRPSMSRVVA 961 (1036)
Q Consensus 932 ~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 961 (1036)
......+.+++.+||+.+|++||++.|+++
T Consensus 240 ~~~~~~l~~li~~~l~~~p~~Rpt~~eil~ 269 (296)
T cd06654 240 EKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (296)
T ss_pred cccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence 223356778889999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-35 Score=328.56 Aligned_cols=237 Identities=24% Similarity=0.307 Sum_probs=190.6
Q ss_pred CccccCCCEEEEEeEeC-CCcEEEEEEcccc---chhcHHHHHHHHHHHHhh-ccCCcceeEeEEEcCceeEEEEEecCC
Q 001658 699 NKLGEGGFGPVYKGKLG-DGRAIAVKQLSVA---SRQGKSQFVAEIATISAV-QHRNLVKLHGCCIEGAERLLVYEYLEN 773 (1036)
Q Consensus 699 ~~iG~G~fG~Vy~~~~~-~g~~vAvK~~~~~---~~~~~~~f~~Ei~~L~~l-~H~nIv~l~g~~~~~~~~~lV~E~~~~ 773 (1036)
+.||+|+||.||+|+.+ +++.||+|++... .....+.+..|.+++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999865 6889999998643 223345677888888876 699999999999999999999999999
Q ss_pred CChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeecCCCCcccc
Q 001658 774 KSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHIST 853 (1036)
Q Consensus 774 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 853 (1036)
|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++....... ...
T Consensus 81 g~L~~~i~~~--~~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~-~~~ 154 (320)
T cd05590 81 GDLMFHIQKS--RRFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGK-TTS 154 (320)
T ss_pred chHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCC-ccc
Confidence 9999988653 45888999999999999999999988 99999999999999999999999999875432221 223
Q ss_pred ccccccCccCccccccCCCCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhcCccccccCcccccCCHH
Q 001658 854 RVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEIELADPKLIEFNEE 933 (1036)
Q Consensus 854 ~~~gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~ 933 (1036)
...||+.|+|||++.+..++.++|||||||++|||++|+.||...........+ .. .. +.... .
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i------~~-~~------~~~~~---~ 218 (320)
T cd05590 155 TFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAI------LN-DE------VVYPT---W 218 (320)
T ss_pred ccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHH------hc-CC------CCCCC---C
Confidence 456999999999999889999999999999999999999999865443222111 11 00 11111 1
Q ss_pred HHHHHHHHHHHhcccCCCCCCCHH
Q 001658 934 EVKRLIGVALLCTQTLPSLRPSMS 957 (1036)
Q Consensus 934 ~~~~l~~l~~~Cl~~dP~~RPt~~ 957 (1036)
....+.+++.+|++.||.+||++.
T Consensus 219 ~~~~~~~li~~~L~~dP~~R~~~~ 242 (320)
T cd05590 219 LSQDAVDILKAFMTKNPTMRLGSL 242 (320)
T ss_pred CCHHHHHHHHHHcccCHHHCCCCC
Confidence 234567788899999999999983
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=317.55 Aligned_cols=252 Identities=29% Similarity=0.411 Sum_probs=192.5
Q ss_pred CccccCCCEEEEEeEeCC---CcEEEEEEccccc-hhcHHHHHHHHHHHHhhccCCcceeEeEEEcCceeEEEEEecCCC
Q 001658 699 NKLGEGGFGPVYKGKLGD---GRAIAVKQLSVAS-RQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLVYEYLENK 774 (1036)
Q Consensus 699 ~~iG~G~fG~Vy~~~~~~---g~~vAvK~~~~~~-~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~g 774 (1036)
+.||+|+||.||+|+..+ +..+|+|.++... ......|.+|+.++++++||||+++++++.+....++||||+++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 369999999999998643 4579999886543 334457889999999999999999999999988999999999999
Q ss_pred ChhhhhhcCC---CCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeecCCCCcc
Q 001658 775 SLDQALFGQR---SLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHI 851 (1036)
Q Consensus 775 sL~~~l~~~~---~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 851 (1036)
+|.+++.... ....++..+..++.|+++|++|||+.+ ++||||||+||++++++.+||+|||+++.........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 9999997543 235678888899999999999999987 9999999999999999999999999997543322211
Q ss_pred -ccccccccCccCccccccC-------CCCchhhHHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHHHHHhhcCccccc
Q 001658 852 -STRVAGTIGYLAPEYAMRG-------HLTEKTDVFAFGVLALETVS-GRPNSDPSLDEEKLYLLEWAWHLHENNQEIEL 922 (1036)
Q Consensus 852 -~~~~~gt~~y~APE~~~~~-------~~~~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 922 (1036)
.....|+..|+|||++... .++.++||||||+++|||++ |+.||......+.... .. .+.....
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~---~~----~~~~~~~ 230 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTY---TV----REQQLKL 230 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHH---Hh----hcccCCC
Confidence 2234578899999998642 35789999999999999996 9999976543332211 00 0111122
Q ss_pred cCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 001658 923 ADPKLIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVAMLC 964 (1036)
Q Consensus 923 ~d~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~ 964 (1036)
.++.+..... ..+.+++..|| .+|++|||++||++.|+
T Consensus 231 ~~~~~~~~~~---~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 231 PKPRLKLPLS---DRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCCccCCCCC---hHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 2233221222 34566777898 58999999999998875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=314.52 Aligned_cols=250 Identities=20% Similarity=0.289 Sum_probs=203.6
Q ss_pred CCCCCCccccCCCEEEEEeEeC-CCcEEEEEEcccc-chhcHHHHHHHHHHHHhhccCCcceeEeEEEcCceeEEEEEec
Q 001658 694 NFSPSNKLGEGGFGPVYKGKLG-DGRAIAVKQLSVA-SRQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLVYEYL 771 (1036)
Q Consensus 694 ~~~~~~~iG~G~fG~Vy~~~~~-~g~~vAvK~~~~~-~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~~ 771 (1036)
+|++.+.||+|+||.||+++.. +++.+|+|.++.. .....+.+..|+.+++.++|+||+++++++.+.+..++|+||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 4677899999999999999854 6889999988543 3334567889999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeecCCCCcc
Q 001658 772 ENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHI 851 (1036)
Q Consensus 772 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 851 (1036)
++++|.+++.......+++.....++.|+++||.|||+.+ |+|+||||+||++++++.++++|||++........ .
T Consensus 81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~-~ 156 (255)
T cd08219 81 DGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA-Y 156 (255)
T ss_pred CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceeeccccc-c
Confidence 9999999987655667889999999999999999999988 99999999999999999999999999987653322 2
Q ss_pred ccccccccCccCccccccCCCCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhcCccccccCcccccCC
Q 001658 852 STRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEIELADPKLIEFN 931 (1036)
Q Consensus 852 ~~~~~gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~ 931 (1036)
.....|+..|+|||++.+..++.++||||||+++|+|++|+.||.......... ... .+.. .+ ..
T Consensus 157 ~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~------~~~-~~~~----~~----~~ 221 (255)
T cd08219 157 ACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLIL------KVC-QGSY----KP----LP 221 (255)
T ss_pred cccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHH------HHh-cCCC----CC----CC
Confidence 233568899999999998889999999999999999999999998644322111 111 1110 00 11
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 001658 932 EEEVKRLIGVALLCTQTLPSLRPSMSRVVAM 962 (1036)
Q Consensus 932 ~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 962 (1036)
......+.+++.+||+.+|++||++.|++..
T Consensus 222 ~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 222 SHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred cccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 1223456788889999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-35 Score=329.02 Aligned_cols=241 Identities=25% Similarity=0.308 Sum_probs=192.7
Q ss_pred CCCCCCccccCCCEEEEEeEeC-CCcEEEEEEcccc---chhcHHHHHHHHHHHHhhccC-CcceeEeEEEcCceeEEEE
Q 001658 694 NFSPSNKLGEGGFGPVYKGKLG-DGRAIAVKQLSVA---SRQGKSQFVAEIATISAVQHR-NLVKLHGCCIEGAERLLVY 768 (1036)
Q Consensus 694 ~~~~~~~iG~G~fG~Vy~~~~~-~g~~vAvK~~~~~---~~~~~~~f~~Ei~~L~~l~H~-nIv~l~g~~~~~~~~~lV~ 768 (1036)
+|++.+.||+|+||.||+|+.. +++.||+|++... .....+.+..|.+++..++|+ +|+++++++...+..++||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 4778899999999999999865 5789999998753 223456678899999999765 5888999999999999999
Q ss_pred EecCCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeecCCC
Q 001658 769 EYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKK 848 (1036)
Q Consensus 769 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~ 848 (1036)
||+++|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++......
T Consensus 81 E~~~~g~L~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~ 155 (324)
T cd05587 81 EYVNGGDLMYHIQQV--GKFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG 155 (324)
T ss_pred cCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcceecCCCC
Confidence 999999999998643 45788899999999999999999988 9999999999999999999999999987543222
Q ss_pred CccccccccccCccCccccccCCCCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhcCccccccCcccc
Q 001658 849 THISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEIELADPKLI 928 (1036)
Q Consensus 849 ~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~ 928 (1036)
. ......||+.|+|||++.+..++.++|||||||++|||+||+.||......+....+ .. ..+.+
T Consensus 156 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i------~~-------~~~~~- 220 (324)
T cd05587 156 K-TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSI------ME-------HNVSY- 220 (324)
T ss_pred C-ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHH------Hc-------CCCCC-
Confidence 1 123456999999999999999999999999999999999999999865433222111 10 01111
Q ss_pred cCCHHHHHHHHHHHHHhcccCCCCCCCH
Q 001658 929 EFNEEEVKRLIGVALLCTQTLPSLRPSM 956 (1036)
Q Consensus 929 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~ 956 (1036)
+......+.+++.+|++.+|.+|++.
T Consensus 221 --~~~~~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 221 --PKSLSKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred --CCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 11223456778889999999999986
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=311.65 Aligned_cols=265 Identities=25% Similarity=0.355 Sum_probs=204.0
Q ss_pred cCCCCCCccccCCCEEEEEeEe-CCCcEEEEEEccccch--hcHHHHHHHHHHHHhhccCC-cceeEeEEEcCc------
Q 001658 693 ENFSPSNKLGEGGFGPVYKGKL-GDGRAIAVKQLSVASR--QGKSQFVAEIATISAVQHRN-LVKLHGCCIEGA------ 762 (1036)
Q Consensus 693 ~~~~~~~~iG~G~fG~Vy~~~~-~~g~~vAvK~~~~~~~--~~~~~f~~Ei~~L~~l~H~n-Iv~l~g~~~~~~------ 762 (1036)
..|...++||+|+||+||+|+. .+|+.||+|+++...+ .......+|+.++++++|+| ||++++++....
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~ 90 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG 90 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence 3455567899999999999984 5789999999976533 23455689999999999999 999999999877
Q ss_pred eeEEEEEecCCCChhhhhhcCCC--CCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCc
Q 001658 763 ERLLVYEYLENKSLDQALFGQRS--LTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGL 840 (1036)
Q Consensus 763 ~~~lV~E~~~~gsL~~~l~~~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGl 840 (1036)
..++|+||++ -+|.+++..... ..++-..+..++.||++||+|||+++ |+||||||.||||+++|.+||+|||+
T Consensus 91 ~l~lvfe~~d-~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaDFGl 166 (323)
T KOG0594|consen 91 KLYLVFEFLD-RDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLADFGL 166 (323)
T ss_pred eEEEEEEeec-ccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeeccch
Confidence 7889999995 599999976543 35666888999999999999999998 99999999999999999999999999
Q ss_pred ceeecCCCCccccccccccCccCccccccC-CCCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHh-hcCc
Q 001658 841 AKLYDDKKTHISTRVAGTIGYLAPEYAMRG-HLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLH-ENNQ 918 (1036)
Q Consensus 841 a~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~-~~~~ 918 (1036)
|+.+.-+. ...+..++|..|.|||++.+. .|+...||||+|||+.||+++++.|.+..+.+....+-..-... ++.+
T Consensus 167 Ara~~ip~-~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~W 245 (323)
T KOG0594|consen 167 ARAFSIPM-RTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDW 245 (323)
T ss_pred HHHhcCCc-ccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCC
Confidence 99665222 224566789999999999886 69999999999999999999999998876654443321111111 1111
Q ss_pred cc--cccCcc--cccC------CHHHH---HHHHHHHHHhcccCCCCCCCHHHHHHH
Q 001658 919 EI--ELADPK--LIEF------NEEEV---KRLIGVALLCTQTLPSLRPSMSRVVAM 962 (1036)
Q Consensus 919 ~~--~~~d~~--~~~~------~~~~~---~~l~~l~~~Cl~~dP~~RPt~~evl~~ 962 (1036)
.. ...+.+ +... ..... .+..+++.+|++.+|.+|.++..++++
T Consensus 246 p~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 246 PGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred CCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 11 111111 1111 11111 367888899999999999999998875
|
|
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=313.59 Aligned_cols=247 Identities=29% Similarity=0.425 Sum_probs=197.1
Q ss_pred CccccCCCEEEEEeEeC--C--CcEEEEEEccccch-hcHHHHHHHHHHHHhhccCCcceeEeEEEcCceeEEEEEecCC
Q 001658 699 NKLGEGGFGPVYKGKLG--D--GRAIAVKQLSVASR-QGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLVYEYLEN 773 (1036)
Q Consensus 699 ~~iG~G~fG~Vy~~~~~--~--g~~vAvK~~~~~~~-~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~ 773 (1036)
++||+|+||.||+|+.. + +..||+|.+..... ...+++.+|+.+++.++|+||+++++++. .+..++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 46999999999999743 2 26899999875433 34567899999999999999999999876 4567999999999
Q ss_pred CChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeecCCCCccc-
Q 001658 774 KSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHIS- 852 (1036)
Q Consensus 774 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~- 852 (1036)
|+|.+++.... .+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||+++..........
T Consensus 80 ~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~ 154 (257)
T cd05060 80 GPLLKYLKKRR--EIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRA 154 (257)
T ss_pred CcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeecCCccccc
Confidence 99999996543 6899999999999999999999987 99999999999999999999999999987654332221
Q ss_pred -cccccccCccCccccccCCCCchhhHHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHHHHHhhcCccccccCcccccC
Q 001658 853 -TRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVS-GRPNSDPSLDEEKLYLLEWAWHLHENNQEIELADPKLIEF 930 (1036)
Q Consensus 853 -~~~~gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~ 930 (1036)
....++..|+|||...+..++.++||||||+++|||++ |++||......+. ..+.. ..... ..
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~---~~~~~----~~~~~--------~~ 219 (257)
T cd05060 155 TTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEV---IAMLE----SGERL--------PR 219 (257)
T ss_pred ccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHH---HHHHH----cCCcC--------CC
Confidence 11224568999999998899999999999999999998 9999876543222 11111 11100 11
Q ss_pred CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcc
Q 001658 931 NEEEVKRLIGVALLCTQTLPSLRPSMSRVVAMLCGD 966 (1036)
Q Consensus 931 ~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 966 (1036)
.......+.+++.+||+.+|++||++.++++.|++.
T Consensus 220 ~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 255 (257)
T cd05060 220 PEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD 255 (257)
T ss_pred CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence 112235677889999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=334.39 Aligned_cols=256 Identities=27% Similarity=0.370 Sum_probs=210.0
Q ss_pred CCCCCccccCCCEEEEEeEe-CCCc----EEEEEEcccc-chhcHHHHHHHHHHHHhhccCCcceeEeEEEcCceeEEEE
Q 001658 695 FSPSNKLGEGGFGPVYKGKL-GDGR----AIAVKQLSVA-SRQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLVY 768 (1036)
Q Consensus 695 ~~~~~~iG~G~fG~Vy~~~~-~~g~----~vAvK~~~~~-~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~ 768 (1036)
....++||+|+||+||||.+ .+|+ +||+|++... ..+..+++.+|+.+|.+++|||+++++|+|.... ..||+
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvt 776 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVT 776 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHH
Confidence 34568899999999999974 4454 6899988643 4555778999999999999999999999998776 78999
Q ss_pred EecCCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeecCCC
Q 001658 769 EYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKK 848 (1036)
Q Consensus 769 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~ 848 (1036)
+||+.|+|.++++.+ +..+--...+.|+.|||+||.|||++. +|||||..+||||.+-..+||.|||+++.+..+.
T Consensus 777 q~mP~G~LlDyvr~h-r~~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~ 852 (1177)
T KOG1025|consen 777 QLMPLGCLLDYVREH-RDNIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDE 852 (1177)
T ss_pred HhcccchHHHHHHHh-hccccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchhhccCccc
Confidence 999999999999764 446777788899999999999999887 9999999999999999999999999999887665
Q ss_pred Ccccc-ccccccCccCccccccCCCCchhhHHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHHHHHhhcCccccccCcc
Q 001658 849 THIST-RVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVS-GRPNSDPSLDEEKLYLLEWAWHLHENNQEIELADPK 926 (1036)
Q Consensus 849 ~~~~~-~~~gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 926 (1036)
..... ...-.+.|||-|.+....++.++|||||||++||++| |..|++....++.-.+.+ . ++
T Consensus 853 ~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle-------~--------ge 917 (1177)
T KOG1025|consen 853 KEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLE-------K--------GE 917 (1177)
T ss_pred ccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHh-------c--------cc
Confidence 44332 2334568999999999999999999999999999998 778887655444433332 1 11
Q ss_pred cccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcccCCC
Q 001658 927 LIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVAMLCGDMEVS 970 (1036)
Q Consensus 927 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~ 970 (1036)
....++....++..++.+||..|++.||+++++...+.+....+
T Consensus 918 RLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ardp 961 (1177)
T KOG1025|consen 918 RLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARDP 961 (1177)
T ss_pred cCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcCc
Confidence 22344556678888999999999999999999999887765544
|
|
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=314.37 Aligned_cols=248 Identities=26% Similarity=0.364 Sum_probs=200.5
Q ss_pred cCCCCCCccccCCCEEEEEeEeCCCcEEEEEEccccchhcHHHHHHHHHHHHhhccCCcceeEeEEE-cCceeEEEEEec
Q 001658 693 ENFSPSNKLGEGGFGPVYKGKLGDGRAIAVKQLSVASRQGKSQFVAEIATISAVQHRNLVKLHGCCI-EGAERLLVYEYL 771 (1036)
Q Consensus 693 ~~~~~~~~iG~G~fG~Vy~~~~~~g~~vAvK~~~~~~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~-~~~~~~lV~E~~ 771 (1036)
++|++.+.||+|+||.||+|... |+.||+|.+.... ..+.|.+|+.++++++|+|++++++++. .+...++|+||+
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~ 82 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 82 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence 46778899999999999999874 7889999886432 3467899999999999999999999865 445689999999
Q ss_pred CCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeecCCCCcc
Q 001658 772 ENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHI 851 (1036)
Q Consensus 772 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 851 (1036)
++++|.+++.......+++..+++++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++......
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~--- 156 (256)
T cd05082 83 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--- 156 (256)
T ss_pred CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceeccccC---
Confidence 9999999997766666899999999999999999999987 9999999999999999999999999988654322
Q ss_pred ccccccccCccCccccccCCCCchhhHHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHHHHHhhcCccccccCcccccC
Q 001658 852 STRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVS-GRPNSDPSLDEEKLYLLEWAWHLHENNQEIELADPKLIEF 930 (1036)
Q Consensus 852 ~~~~~gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~ 930 (1036)
....++..|+|||++.+..++.++|||||||++|||++ |+.||......+. ..+.. .+. .+..
T Consensus 157 -~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~---~~~~~----~~~-----~~~~--- 220 (256)
T cd05082 157 -DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV---VPRVE----KGY-----KMDA--- 220 (256)
T ss_pred -CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHH---HHHHh----cCC-----CCCC---
Confidence 12335668999999998889999999999999999998 8988865432221 11111 110 0111
Q ss_pred CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhc
Q 001658 931 NEEEVKRLIGVALLCTQTLPSLRPSMSRVVAMLCG 965 (1036)
Q Consensus 931 ~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~ 965 (1036)
.......+.+++.+|++.+|++|||+.++++.|+.
T Consensus 221 ~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 255 (256)
T cd05082 221 PDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEH 255 (256)
T ss_pred CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence 11233567788899999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=314.00 Aligned_cols=258 Identities=26% Similarity=0.326 Sum_probs=196.4
Q ss_pred CCCCCCccccCCCEEEEEeEeC-CCcEEEEEEccccchhcHHHHHHHHHHHHhhccCCcceeEeEEEcCc-----eeEEE
Q 001658 694 NFSPSNKLGEGGFGPVYKGKLG-DGRAIAVKQLSVASRQGKSQFVAEIATISAVQHRNLVKLHGCCIEGA-----ERLLV 767 (1036)
Q Consensus 694 ~~~~~~~iG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~-----~~~lV 767 (1036)
.|...+++|.|+||.||+|... +++.||||+.-...+ --.+|+++|+.++|||||++.-+|.... ...+|
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV 100 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV 100 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence 4556689999999999999864 578999998754332 2246999999999999999999887432 23589
Q ss_pred EEecCCCChhhhhhcC--CCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCC-CceEEEEcCcceee
Q 001658 768 YEYLENKSLDQALFGQ--RSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDAD-LVPKISDFGLAKLY 844 (1036)
Q Consensus 768 ~E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~-~~~kl~DFGla~~~ 844 (1036)
||||+. +|.++++.. .+..++...+.-++.||++||+|||+.+ |+||||||+|+|+|.+ |.+||||||.|+.+
T Consensus 101 leymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L 176 (364)
T KOG0658|consen 101 LEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDFGSAKVL 176 (364)
T ss_pred HHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccCCcceee
Confidence 999976 999988642 2456677777778999999999999987 9999999999999987 99999999999988
Q ss_pred cCCCCccccccccccCccCccccccC-CCCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhcC------
Q 001658 845 DDKKTHISTRVAGTIGYLAPEYAMRG-HLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENN------ 917 (1036)
Q Consensus 845 ~~~~~~~~~~~~gt~~y~APE~~~~~-~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~------ 917 (1036)
....... ...-|..|+|||.+.+. .|+.+.||||.|||+.||+-|++-|.+....+....+-.+-......
T Consensus 177 ~~~epni--SYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn 254 (364)
T KOG0658|consen 177 VKGEPNI--SYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMN 254 (364)
T ss_pred ccCCCce--eEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcC
Confidence 7654442 34467899999999875 69999999999999999999999998866555544332222111110
Q ss_pred -ccccccCcccc-----c-CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 001658 918 -QEIELADPKLI-----E-FNEEEVKRLIGVALLCTQTLPSLRPSMSRVVA 961 (1036)
Q Consensus 918 -~~~~~~d~~~~-----~-~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 961 (1036)
...+...|.+. . +......+.++++.++++.+|.+|.++.|++.
T Consensus 255 ~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~ 305 (364)
T KOG0658|consen 255 PNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA 305 (364)
T ss_pred cccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence 00111222221 1 22334457888899999999999999999875
|
|
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=328.51 Aligned_cols=244 Identities=24% Similarity=0.256 Sum_probs=191.1
Q ss_pred CccccCCCEEEEEeEe-CCCcEEEEEEcccc---chhcHHHHHHHHH-HHHhhccCCcceeEeEEEcCceeEEEEEecCC
Q 001658 699 NKLGEGGFGPVYKGKL-GDGRAIAVKQLSVA---SRQGKSQFVAEIA-TISAVQHRNLVKLHGCCIEGAERLLVYEYLEN 773 (1036)
Q Consensus 699 ~~iG~G~fG~Vy~~~~-~~g~~vAvK~~~~~---~~~~~~~f~~Ei~-~L~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~ 773 (1036)
+.||+|+||+||+|+. .+|+.||+|++... .......+..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 4699999999999985 46899999998643 2223345566655 46778999999999999999999999999999
Q ss_pred CChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeecCCCCcccc
Q 001658 774 KSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHIST 853 (1036)
Q Consensus 774 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 853 (1036)
|+|.+++.. ...+++..+..++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+++....... ...
T Consensus 81 ~~L~~~l~~--~~~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~-~~~ 154 (325)
T cd05604 81 GELFFHLQR--ERSFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSD-TTT 154 (325)
T ss_pred CCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccCCCCCC-Ccc
Confidence 999988854 346889999999999999999999988 99999999999999999999999999875432211 223
Q ss_pred ccccccCccCccccccCCCCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhcCccccccCcccccCCHH
Q 001658 854 RVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEIELADPKLIEFNEE 933 (1036)
Q Consensus 854 ~~~gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~ 933 (1036)
...||+.|+|||++.+..++.++|||||||++|||++|+.||......+.... .... ...+ ...
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~------~~~~-------~~~~---~~~ 218 (325)
T cd05604 155 TFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDN------ILHK-------PLVL---RPG 218 (325)
T ss_pred cccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHH------HHcC-------CccC---CCC
Confidence 45699999999999999999999999999999999999999986543222111 1110 0001 111
Q ss_pred HHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 001658 934 EVKRLIGVALLCTQTLPSLRPSMSRVVAMLC 964 (1036)
Q Consensus 934 ~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~ 964 (1036)
....+.+++..|++.+|.+||++.+.++.+.
T Consensus 219 ~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i~ 249 (325)
T cd05604 219 ASLTAWSILEELLEKDRQRRLGAKEDFLEIQ 249 (325)
T ss_pred CCHHHHHHHHHHhccCHHhcCCCCCCHHHHh
Confidence 2345667888999999999999875444443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=325.66 Aligned_cols=240 Identities=24% Similarity=0.331 Sum_probs=191.1
Q ss_pred CccccCCCEEEEEeEeC-CCcEEEEEEccccc---hhcHHHHHHHHHHHHhh-ccCCcceeEeEEEcCceeEEEEEecCC
Q 001658 699 NKLGEGGFGPVYKGKLG-DGRAIAVKQLSVAS---RQGKSQFVAEIATISAV-QHRNLVKLHGCCIEGAERLLVYEYLEN 773 (1036)
Q Consensus 699 ~~iG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~f~~Ei~~L~~l-~H~nIv~l~g~~~~~~~~~lV~E~~~~ 773 (1036)
+.||+|+||.||+|+.. +++.||||+++... ......+..|..++... +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999865 57899999987532 22345567788888764 899999999999999999999999999
Q ss_pred CChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeecCCCCcccc
Q 001658 774 KSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHIST 853 (1036)
Q Consensus 774 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 853 (1036)
|+|.+++... ..+++.++..++.|+++||+|||+.+ |+||||||+|||+++++.+||+|||+++....... ...
T Consensus 81 g~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~ 154 (316)
T cd05619 81 GDLMFHIQSC--HKFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA-KTC 154 (316)
T ss_pred CcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC-cee
Confidence 9999998643 45788899999999999999999988 99999999999999999999999999875432221 123
Q ss_pred ccccccCccCccccccCCCCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhcCccccccCcccccCCHH
Q 001658 854 RVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEIELADPKLIEFNEE 933 (1036)
Q Consensus 854 ~~~gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~ 933 (1036)
...||+.|+|||++.+..++.++|||||||++|||++|+.||......+....+. ...+.....
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~-------------~~~~~~~~~--- 218 (316)
T cd05619 155 TFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIR-------------MDNPCYPRW--- 218 (316)
T ss_pred eecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHH-------------hCCCCCCcc---
Confidence 4569999999999999899999999999999999999999998654332221110 011111111
Q ss_pred HHHHHHHHHHHhcccCCCCCCCHH-HHH
Q 001658 934 EVKRLIGVALLCTQTLPSLRPSMS-RVV 960 (1036)
Q Consensus 934 ~~~~l~~l~~~Cl~~dP~~RPt~~-evl 960 (1036)
....+.+++.+|++.+|++||++. ++.
T Consensus 219 ~~~~~~~li~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05619 219 LTREAKDILVKLFVREPERRLGVKGDIR 246 (316)
T ss_pred CCHHHHHHHHHHhccCHhhcCCChHHHH
Confidence 223566778899999999999997 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=313.07 Aligned_cols=249 Identities=27% Similarity=0.424 Sum_probs=204.1
Q ss_pred cCCCCCCccccCCCEEEEEeEeCC-CcEEEEEEccccchhcHHHHHHHHHHHHhhccCCcceeEeEEEcCceeEEEEEec
Q 001658 693 ENFSPSNKLGEGGFGPVYKGKLGD-GRAIAVKQLSVASRQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLVYEYL 771 (1036)
Q Consensus 693 ~~~~~~~~iG~G~fG~Vy~~~~~~-g~~vAvK~~~~~~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~~ 771 (1036)
++|+..+.||+|+||.||+|...+ ++.||+|.+..... .+++.+|++++++++|+||+++++++......++++||+
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~ 80 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYC 80 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecC
Confidence 578888999999999999999764 78999999875433 678999999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeecCCCCcc
Q 001658 772 ENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHI 851 (1036)
Q Consensus 772 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 851 (1036)
++++|.+++... ...+++..+..++.|+++||.|||+.+ |+||||+|+||++++++.++|+|||++........ .
T Consensus 81 ~~~~L~~~l~~~-~~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~-~ 155 (256)
T cd06612 81 GAGSVSDIMKIT-NKTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA-K 155 (256)
T ss_pred CCCcHHHHHHhC-ccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhcccCcc-c
Confidence 999999998543 356899999999999999999999987 99999999999999999999999999987654322 2
Q ss_pred ccccccccCccCccccccCCCCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhcCccccccCcccccCC
Q 001658 852 STRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEIELADPKLIEFN 931 (1036)
Q Consensus 852 ~~~~~gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~ 931 (1036)
.....|+..|+|||++.+..++.++||||||+++|||++|+.||............ .. ..+......
T Consensus 156 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~-------~~------~~~~~~~~~ 222 (256)
T cd06612 156 RNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMI-------PN------KPPPTLSDP 222 (256)
T ss_pred cccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhh-------cc------CCCCCCCch
Confidence 23345888999999999889999999999999999999999999764332211100 00 000001112
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 001658 932 EEEVKRLIGVALLCTQTLPSLRPSMSRVVA 961 (1036)
Q Consensus 932 ~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 961 (1036)
......+.+++.+||+.+|++|||+.||++
T Consensus 223 ~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 223 EKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred hhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 223356788889999999999999999985
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=330.77 Aligned_cols=260 Identities=25% Similarity=0.393 Sum_probs=201.1
Q ss_pred hcCCCCCCccccCCCEEEEEeEe------CCCcEEEEEEccccc-hhcHHHHHHHHHHHHhh-ccCCcceeEeEEEcC-c
Q 001658 692 TENFSPSNKLGEGGFGPVYKGKL------GDGRAIAVKQLSVAS-RQGKSQFVAEIATISAV-QHRNLVKLHGCCIEG-A 762 (1036)
Q Consensus 692 ~~~~~~~~~iG~G~fG~Vy~~~~------~~g~~vAvK~~~~~~-~~~~~~f~~Ei~~L~~l-~H~nIv~l~g~~~~~-~ 762 (1036)
.++|++.+.||+|+||.||+|+. .+++.||||+++... ......+.+|+.++.++ +|+||+++++++... .
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 85 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence 35788999999999999999963 356889999997532 23345688999999999 689999999988654 4
Q ss_pred eeEEEEEecCCCChhhhhhcCC----------------------------------------------------------
Q 001658 763 ERLLVYEYLENKSLDQALFGQR---------------------------------------------------------- 784 (1036)
Q Consensus 763 ~~~lV~E~~~~gsL~~~l~~~~---------------------------------------------------------- 784 (1036)
..++||||+++|+|.+++....
T Consensus 86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (343)
T cd05103 86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE 165 (343)
T ss_pred ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence 5789999999999999986432
Q ss_pred -------CCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeecCCCCcc-ccccc
Q 001658 785 -------SLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHI-STRVA 856 (1036)
Q Consensus 785 -------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~-~~~~~ 856 (1036)
...+++..+.+++.||++||+|||+.+ |+||||||+||++++++.+||+|||+++......... .....
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 242 (343)
T cd05103 166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR 242 (343)
T ss_pred hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCC
Confidence 123688888999999999999999987 9999999999999999999999999998654322211 12234
Q ss_pred cccCccCccccccCCCCchhhHHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHHHHHhhcCccccccCcccccCCHHHH
Q 001658 857 GTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVS-GRPNSDPSLDEEKLYLLEWAWHLHENNQEIELADPKLIEFNEEEV 935 (1036)
Q Consensus 857 gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 935 (1036)
++..|+|||++.+..++.++||||||+++|||++ |..||......... .. ....+.. +..... ..
T Consensus 243 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~--~~----~~~~~~~-----~~~~~~---~~ 308 (343)
T cd05103 243 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF--CR----RLKEGTR-----MRAPDY---TT 308 (343)
T ss_pred CCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHH--HH----HHhccCC-----CCCCCC---CC
Confidence 5678999999988899999999999999999997 88888653322111 11 1111111 111111 12
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHHHhhcccC
Q 001658 936 KRLIGVALLCTQTLPSLRPSMSRVVAMLCGDME 968 (1036)
Q Consensus 936 ~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 968 (1036)
..+.+++..||+.+|++||++.||++.|+..+.
T Consensus 309 ~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~ 341 (343)
T cd05103 309 PEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 341 (343)
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 357888899999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=316.69 Aligned_cols=256 Identities=26% Similarity=0.364 Sum_probs=203.9
Q ss_pred cCCCCCCccccCCCEEEEEeEeCC----CcEEEEEEccccc-hhcHHHHHHHHHHHHhhccCCcceeEeEEEcCceeEEE
Q 001658 693 ENFSPSNKLGEGGFGPVYKGKLGD----GRAIAVKQLSVAS-RQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLV 767 (1036)
Q Consensus 693 ~~~~~~~~iG~G~fG~Vy~~~~~~----g~~vAvK~~~~~~-~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV 767 (1036)
++|.+.+.||+|+||.||+|...+ ...||||...... ....+.+.+|+.++++++||||+++++++.+ ...++|
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv 84 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV 84 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence 457788999999999999998543 2468999886544 4456689999999999999999999998875 457899
Q ss_pred EEecCCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeecCC
Q 001658 768 YEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDK 847 (1036)
Q Consensus 768 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~ 847 (1036)
|||+++|+|.+++.... ..+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||+++.....
T Consensus 85 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 160 (270)
T cd05056 85 MELAPLGELRSYLQVNK-YSLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDE 160 (270)
T ss_pred EEcCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCceeeecccc
Confidence 99999999999996543 35899999999999999999999987 999999999999999999999999999876544
Q ss_pred CCccccccccccCccCccccccCCCCchhhHHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHHHHHhhcCccccccCcc
Q 001658 848 KTHISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVS-GRPNSDPSLDEEKLYLLEWAWHLHENNQEIELADPK 926 (1036)
Q Consensus 848 ~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 926 (1036)
.........++..|+|||.+....++.++||||||+++||+++ |+.||......+..... ..+. .+.
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~-------~~~~-----~~~ 228 (270)
T cd05056 161 SYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRI-------ENGE-----RLP 228 (270)
T ss_pred cceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH-------HcCC-----cCC
Confidence 3222223345568999999988889999999999999999986 99999765443222111 1111 001
Q ss_pred cccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcccC
Q 001658 927 LIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVAMLCGDME 968 (1036)
Q Consensus 927 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 968 (1036)
. .......+.+++.+|+..+|++|||+.++++.|++...
T Consensus 229 ~---~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~ 267 (270)
T cd05056 229 M---PPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQ 267 (270)
T ss_pred C---CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 1 11223467778889999999999999999999987543
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=318.21 Aligned_cols=239 Identities=27% Similarity=0.401 Sum_probs=188.2
Q ss_pred ccccCCCEEEEEeEeCC-------------------------CcEEEEEEccccchhcHHHHHHHHHHHHhhccCCccee
Q 001658 700 KLGEGGFGPVYKGKLGD-------------------------GRAIAVKQLSVASRQGKSQFVAEIATISAVQHRNLVKL 754 (1036)
Q Consensus 700 ~iG~G~fG~Vy~~~~~~-------------------------g~~vAvK~~~~~~~~~~~~f~~Ei~~L~~l~H~nIv~l 754 (1036)
.||+|+||.||+|.+.. ...||+|.+..........|.+|+.+++.++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 69999999999997421 13589999876555555678899999999999999999
Q ss_pred EeEEEcCceeEEEEEecCCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCC---
Q 001658 755 HGCCIEGAERLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADL--- 831 (1036)
Q Consensus 755 ~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~--- 831 (1036)
+++|.+....++||||+++|+|..++... ...+++..+.+++.||++||+|||+.+ |+||||||+|||+++++
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill~~~~~~~ 157 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKE-KGRVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGLAE 157 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEEeccCccc
Confidence 99999999999999999999999988643 346788899999999999999999987 99999999999997643
Q ss_pred ----ceEEEEcCcceeecCCCCccccccccccCccCcccccc-CCCCchhhHHhHHHHHHHH-HhCCCCCCCCChhhHHH
Q 001658 832 ----VPKISDFGLAKLYDDKKTHISTRVAGTIGYLAPEYAMR-GHLTEKTDVFAFGVLALET-VSGRPNSDPSLDEEKLY 905 (1036)
Q Consensus 832 ----~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~ksDVwS~Gvvl~el-ltG~~p~~~~~~~~~~~ 905 (1036)
.+|++|||++....... ...++..|+|||.+.+ ..++.++|||||||++||| ++|+.||..........
T Consensus 158 ~~~~~~kl~d~g~~~~~~~~~-----~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~ 232 (274)
T cd05076 158 GTSPFIKLSDPGVSFTALSRE-----ERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKER 232 (274)
T ss_pred CccceeeecCCcccccccccc-----ccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHH
Confidence 48999999886443221 2347788999998865 5689999999999999998 47899887544322211
Q ss_pred HHHHHHHHhhcCccccccCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 001658 906 LLEWAWHLHENNQEIELADPKLIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVAMLC 964 (1036)
Q Consensus 906 l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~ 964 (1036)
.. ... ..... .....+.+++.+||+.+|++||++.+|++.|.
T Consensus 233 ~~-------~~~-------~~~~~---~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 233 FY-------EKK-------HRLPE---PSCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred HH-------Hhc-------cCCCC---CCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 11 000 00100 11235778889999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=317.51 Aligned_cols=254 Identities=25% Similarity=0.430 Sum_probs=202.1
Q ss_pred CCCCCCccccCCCEEEEEeEeC-CC---cEEEEEEcccc-chhcHHHHHHHHHHHHhhccCCcceeEeEEEcCceeEEEE
Q 001658 694 NFSPSNKLGEGGFGPVYKGKLG-DG---RAIAVKQLSVA-SRQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLVY 768 (1036)
Q Consensus 694 ~~~~~~~iG~G~fG~Vy~~~~~-~g---~~vAvK~~~~~-~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~ 768 (1036)
+|++.+.||+|+||.||+|... ++ ..||||.+... ......+|..|+.++++++||||+++++++.++...++||
T Consensus 5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 84 (269)
T cd05065 5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIIT 84 (269)
T ss_pred HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEE
Confidence 4677899999999999999864 23 36999998754 3444678999999999999999999999999999999999
Q ss_pred EecCCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeecCCC
Q 001658 769 EYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKK 848 (1036)
Q Consensus 769 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~ 848 (1036)
||+++++|.+++... ...+++.+++.++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++.......
T Consensus 85 e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~ 160 (269)
T cd05065 85 EFMENGALDSFLRQN-DGQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 160 (269)
T ss_pred ecCCCCcHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCccccccccCc
Confidence 999999999998654 346899999999999999999999987 9999999999999999999999999988664322
Q ss_pred Ccc--ccccc--cccCccCccccccCCCCchhhHHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHHHHHhhcCcccccc
Q 001658 849 THI--STRVA--GTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVS-GRPNSDPSLDEEKLYLLEWAWHLHENNQEIELA 923 (1036)
Q Consensus 849 ~~~--~~~~~--gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 923 (1036)
... ..... .+..|+|||++.+..++.++|||||||++||+++ |..||......+. ..+.. ....
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~---~~~i~----~~~~---- 229 (269)
T cd05065 161 SDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDV---INAIE----QDYR---- 229 (269)
T ss_pred cccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHH---HHHHH----cCCc----
Confidence 211 11111 2457999999999999999999999999999886 9999876443221 22211 1000
Q ss_pred CcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcc
Q 001658 924 DPKLIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVAMLCGD 966 (1036)
Q Consensus 924 d~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 966 (1036)
.+. ..+.+..+.+++..||+.+|.+||++.+|+.+|++.
T Consensus 230 ~~~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 230 LPP----PMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred CCC----cccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 011 112234577888999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=320.63 Aligned_cols=250 Identities=23% Similarity=0.318 Sum_probs=199.2
Q ss_pred CCCCCccccCCCEEEEEeEe-CCCcEEEEEEccccc---hhcHHHHHHHHHHHHhhccCCcceeEeEEEcCceeEEEEEe
Q 001658 695 FSPSNKLGEGGFGPVYKGKL-GDGRAIAVKQLSVAS---RQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLVYEY 770 (1036)
Q Consensus 695 ~~~~~~iG~G~fG~Vy~~~~-~~g~~vAvK~~~~~~---~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~ 770 (1036)
|+..+.||+|+||+||+|.. .+++.||+|.+.... ......+.+|++++++++|+||+++++++..++..++||||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 55668899999999999986 468899999986432 22234578899999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeecCCCCc
Q 001658 771 LENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTH 850 (1036)
Q Consensus 771 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~ 850 (1036)
+++++|.+++.......+++..+..++.|++.||.|||+.+ |+||||||+||++++++.+||+|||++........
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~- 157 (285)
T cd05632 82 MNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES- 157 (285)
T ss_pred ccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcceecCCCCc-
Confidence 99999999887655567999999999999999999999988 99999999999999999999999999976543221
Q ss_pred cccccccccCccCccccccCCCCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhcCccccccCcccccC
Q 001658 851 ISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEIELADPKLIEF 930 (1036)
Q Consensus 851 ~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~ 930 (1036)
.....|+..|+|||++.+..++.++|+|||||++|||++|+.||............. ..... . .+. +
T Consensus 158 -~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~--~~~~~-~------~~~---~ 224 (285)
T cd05632 158 -IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVD--RRVLE-T------EEV---Y 224 (285)
T ss_pred -ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH--Hhhhc-c------ccc---c
Confidence 123468999999999998899999999999999999999999998654322221111 11110 0 001 1
Q ss_pred CHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 001658 931 NEEEVKRLIGVALLCTQTLPSLRPS-----MSRVVA 961 (1036)
Q Consensus 931 ~~~~~~~l~~l~~~Cl~~dP~~RPt-----~~evl~ 961 (1036)
.......+.+++..|++.+|++||+ +.+++.
T Consensus 225 ~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05632 225 SAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR 260 (285)
T ss_pred CccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence 1222345677888999999999999 555554
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=316.25 Aligned_cols=257 Identities=25% Similarity=0.345 Sum_probs=201.8
Q ss_pred HHHHhcCCCCCCccccCCCEEEEEeEeC-CCcEEEEEEccccchhcHHHHHHHHHHHHhhccCCcceeEeEEEcCceeEE
Q 001658 688 LKTATENFSPSNKLGEGGFGPVYKGKLG-DGRAIAVKQLSVASRQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLL 766 (1036)
Q Consensus 688 l~~~~~~~~~~~~iG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~l 766 (1036)
++.+++++.....||+|+||.||+|+.. +++.||+|.+........+.+.+|+.++++++|+||+++++++..++..++
T Consensus 3 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 82 (268)
T cd06624 3 YEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKI 82 (268)
T ss_pred cccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEE
Confidence 3445667777789999999999999854 678899999876655566789999999999999999999999999999999
Q ss_pred EEEecCCCChhhhhhcCC-CCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecC-CCceEEEEcCcceee
Q 001658 767 VYEYLENKSLDQALFGQR-SLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDA-DLVPKISDFGLAKLY 844 (1036)
Q Consensus 767 V~E~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~-~~~~kl~DFGla~~~ 844 (1036)
|+||+++++|.+++.... ....++..+..++.||++||+|||+.+ |+||||||+||+++. ++.++|+|||++...
T Consensus 83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~ 159 (268)
T cd06624 83 FMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTSKRL 159 (268)
T ss_pred EEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecchhheec
Confidence 999999999999997542 222378888899999999999999987 999999999999986 679999999999866
Q ss_pred cCCCCccccccccccCccCccccccCC--CCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhcCccccc
Q 001658 845 DDKKTHISTRVAGTIGYLAPEYAMRGH--LTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEIEL 922 (1036)
Q Consensus 845 ~~~~~~~~~~~~gt~~y~APE~~~~~~--~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 922 (1036)
..... ......|+..|+|||++.+.. ++.++||||||+++|||++|+.||.......... +..... .
T Consensus 160 ~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~---~~~~~~-------~ 228 (268)
T cd06624 160 AGINP-CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAM---FKVGMF-------K 228 (268)
T ss_pred ccCCC-ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhH---hhhhhh-------c
Confidence 43222 122345889999999986643 7889999999999999999999987533211110 100000 0
Q ss_pred cCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 001658 923 ADPKLIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVA 961 (1036)
Q Consensus 923 ~d~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 961 (1036)
..+. .+.....++.+++.+||+.+|.+|||+.|+++
T Consensus 229 ~~~~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 264 (268)
T cd06624 229 IHPE---IPESLSAEAKNFILRCFEPDPDKRASAHDLLQ 264 (268)
T ss_pred cCCC---CCcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence 1111 12223345778889999999999999999875
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-35 Score=323.25 Aligned_cols=260 Identities=23% Similarity=0.367 Sum_probs=201.5
Q ss_pred CCCCCCccccCCCEEEEEeEe-----CCCcEEEEEEccccc-hhcHHHHHHHHHHHHhhccCCcceeEeEEEcC--ceeE
Q 001658 694 NFSPSNKLGEGGFGPVYKGKL-----GDGRAIAVKQLSVAS-RQGKSQFVAEIATISAVQHRNLVKLHGCCIEG--AERL 765 (1036)
Q Consensus 694 ~~~~~~~iG~G~fG~Vy~~~~-----~~g~~vAvK~~~~~~-~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~--~~~~ 765 (1036)
.|++.+.||+|+||.||+++. .+++.||+|.++... ......+.+|+.++++++||||+++++++... ...+
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK 84 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceE
Confidence 467789999999999999974 357889999987543 33456789999999999999999999998875 5678
Q ss_pred EEEEecCCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeec
Q 001658 766 LVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYD 845 (1036)
Q Consensus 766 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~ 845 (1036)
+||||+++++|.+++... ...++|..+..++.|++.||+|||+.+ |+||||||+||+++.++.++|+|||+++.+.
T Consensus 85 lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~ 160 (284)
T cd05079 85 LIMEFLPSGSLKEYLPRN-KNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKAIE 160 (284)
T ss_pred EEEEccCCCCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCccccccc
Confidence 999999999999998653 235899999999999999999999988 9999999999999999999999999998765
Q ss_pred CCCCc--cccccccccCccCccccccCCCCchhhHHhHHHHHHHHHhCCCCCCCCChhh---------HHHHHHHHHHHh
Q 001658 846 DKKTH--ISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEE---------KLYLLEWAWHLH 914 (1036)
Q Consensus 846 ~~~~~--~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~---------~~~l~~~~~~~~ 914 (1036)
..... ......++..|+|||++.+..++.++|||||||++|||++++.|........ ......+. ...
T Consensus 161 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~ 239 (284)
T cd05079 161 TDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLV-RVL 239 (284)
T ss_pred cCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHH-HHH
Confidence 33221 1123456778999999988889999999999999999999887653321100 00000011 111
Q ss_pred hcCccccccCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcc
Q 001658 915 ENNQEIELADPKLIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVAMLCGD 966 (1036)
Q Consensus 915 ~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 966 (1036)
..+. ...........+.+++.+|++.+|++||++.++++.|+..
T Consensus 240 ~~~~--------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 240 EEGK--------RLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HcCc--------cCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 1110 0011122345788899999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=329.02 Aligned_cols=243 Identities=23% Similarity=0.290 Sum_probs=189.3
Q ss_pred CccccCCCEEEEEeEeC-CCcEEEEEEcccc---chhcHHHHHHHHHHHHhh-ccCCcceeEeEEEcCceeEEEEEecCC
Q 001658 699 NKLGEGGFGPVYKGKLG-DGRAIAVKQLSVA---SRQGKSQFVAEIATISAV-QHRNLVKLHGCCIEGAERLLVYEYLEN 773 (1036)
Q Consensus 699 ~~iG~G~fG~Vy~~~~~-~g~~vAvK~~~~~---~~~~~~~f~~Ei~~L~~l-~H~nIv~l~g~~~~~~~~~lV~E~~~~ 773 (1036)
+.||+|+||.||+|+.. +++.||+|+++.. .....+.+..|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 46999999999999864 6789999998753 223345677898888877 799999999999999999999999999
Q ss_pred CChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeecCCCCcccc
Q 001658 774 KSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHIST 853 (1036)
Q Consensus 774 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 853 (1036)
|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++....... ...
T Consensus 81 ~~L~~~~~~~--~~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~-~~~ 154 (329)
T cd05618 81 GDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD-TTS 154 (329)
T ss_pred CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccccCCCC-ccc
Confidence 9999888543 46889999999999999999999988 99999999999999999999999999975432221 223
Q ss_pred ccccccCccCccccccCCCCchhhHHhHHHHHHHHHhCCCCCCCCChhh--HHHHHHHHHHHhhcCccccccCcccccCC
Q 001658 854 RVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEE--KLYLLEWAWHLHENNQEIELADPKLIEFN 931 (1036)
Q Consensus 854 ~~~gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~--~~~l~~~~~~~~~~~~~~~~~d~~~~~~~ 931 (1036)
...||+.|+|||++.+..++.++|||||||++|||++|+.||....... ......+........ ... .+
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~------~~~---~p 225 (329)
T cd05618 155 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK------QIR---IP 225 (329)
T ss_pred cccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcC------CCC---CC
Confidence 4569999999999999999999999999999999999999996321110 111111221111111 111 11
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCH
Q 001658 932 EEEVKRLIGVALLCTQTLPSLRPSM 956 (1036)
Q Consensus 932 ~~~~~~l~~l~~~Cl~~dP~~RPt~ 956 (1036)
......+.+++.+|++.||++||+.
T Consensus 226 ~~~~~~~~~ll~~~L~~dP~~R~~~ 250 (329)
T cd05618 226 RSLSVKAASVLKSFLNKDPKERLGC 250 (329)
T ss_pred CCCCHHHHHHHHHHhcCCHHHcCCC
Confidence 2223456788889999999999983
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=317.27 Aligned_cols=257 Identities=25% Similarity=0.371 Sum_probs=202.2
Q ss_pred hcCCCCCCccccCCCEEEEEeEe-CCCc----EEEEEEcccc-chhcHHHHHHHHHHHHhhccCCcceeEeEEEcCceeE
Q 001658 692 TENFSPSNKLGEGGFGPVYKGKL-GDGR----AIAVKQLSVA-SRQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERL 765 (1036)
Q Consensus 692 ~~~~~~~~~iG~G~fG~Vy~~~~-~~g~----~vAvK~~~~~-~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~ 765 (1036)
.++|+..+.||+|+||+||+|++ .+++ .||+|.+... .......+.+|+.++..++|+||+++++++... ..+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~ 84 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TVQ 84 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-CcE
Confidence 35677889999999999999985 3444 4899998643 333456788999999999999999999998754 577
Q ss_pred EEEEecCCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeec
Q 001658 766 LVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYD 845 (1036)
Q Consensus 766 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~ 845 (1036)
+++||+++|+|.+++... ...+++..++.++.|+++||+|||+.+ |+||||||+|||+++++.+||+|||+++.+.
T Consensus 85 l~~~~~~~g~l~~~l~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~ 160 (279)
T cd05109 85 LVTQLMPYGCLLDYVREN-KDRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARLLD 160 (279)
T ss_pred EEEEcCCCCCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCceeecc
Confidence 999999999999998653 346889999999999999999999987 9999999999999999999999999998775
Q ss_pred CCCCcc-ccccccccCccCccccccCCCCchhhHHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHHHHHhhcCcccccc
Q 001658 846 DKKTHI-STRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVS-GRPNSDPSLDEEKLYLLEWAWHLHENNQEIELA 923 (1036)
Q Consensus 846 ~~~~~~-~~~~~gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 923 (1036)
...... .....++..|+|||...+..++.++|||||||++|||++ |..||......... .+.. .....
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~---~~~~----~~~~~--- 230 (279)
T cd05109 161 IDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIP---DLLE----KGERL--- 230 (279)
T ss_pred cccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHH---HHHH----CCCcC---
Confidence 332221 112235678999999998899999999999999999998 88988754332211 1111 11100
Q ss_pred CcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcccC
Q 001658 924 DPKLIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVAMLCGDME 968 (1036)
Q Consensus 924 d~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 968 (1036)
+ ........+.+++.+||+.||++||++.++++.|+....
T Consensus 231 -~----~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05109 231 -P----QPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMAR 270 (279)
T ss_pred -C----CCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 0 111233467788899999999999999999999876543
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=316.50 Aligned_cols=250 Identities=22% Similarity=0.326 Sum_probs=197.7
Q ss_pred cCCCCCCccccCCCEEEEEeEe-CCCcEEEEEEcccc-chhcHHHHHHHHHHHHhhccCCcceeEeEEEcCceeEEEEEe
Q 001658 693 ENFSPSNKLGEGGFGPVYKGKL-GDGRAIAVKQLSVA-SRQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLVYEY 770 (1036)
Q Consensus 693 ~~~~~~~~iG~G~fG~Vy~~~~-~~g~~vAvK~~~~~-~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~ 770 (1036)
++|+..+.||+|+||.||+|+. .+++.||+|.+... .......+.+|++++++++||||+++++++...+..++||||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 80 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF 80 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence 3577889999999999999985 57889999998643 233456789999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeecCCCCc
Q 001658 771 LENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTH 850 (1036)
Q Consensus 771 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~ 850 (1036)
+++++|..+. .+++..+..++.|++.||+|||+.+ |+|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~-- 149 (279)
T cd06619 81 MDGGSLDVYR------KIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI-- 149 (279)
T ss_pred CCCCChHHhh------cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceeccccc--
Confidence 9999997653 4678888899999999999999988 9999999999999999999999999998664322
Q ss_pred cccccccccCccCccccccCCCCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHH-HHHHHHHHhhcCccccccCccccc
Q 001658 851 ISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLY-LLEWAWHLHENNQEIELADPKLIE 929 (1036)
Q Consensus 851 ~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~-l~~~~~~~~~~~~~~~~~d~~~~~ 929 (1036)
.....||..|+|||++.+..++.++||||||+++|||++|+.||.......... ...+...... . ..+...
T Consensus 150 -~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~-~-----~~~~~~- 221 (279)
T cd06619 150 -AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVD-E-----DPPVLP- 221 (279)
T ss_pred -ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhc-c-----CCCCCC-
Confidence 223568999999999998899999999999999999999999997533221110 0111111000 0 011111
Q ss_pred CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 001658 930 FNEEEVKRLIGVALLCTQTLPSLRPSMSRVVAM 962 (1036)
Q Consensus 930 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 962 (1036)
......++.+++.+|++.+|++||++.|+++.
T Consensus 222 -~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 222 -VGQFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred -CCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 11123457788889999999999999999864
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-35 Score=337.48 Aligned_cols=202 Identities=23% Similarity=0.325 Sum_probs=172.7
Q ss_pred CCCCCCccccCCCEEEEEeEe-CCCcEEEEEEccccc---hhcHHHHHHHHHHHHhhccCCcceeEeEEEcCceeEEEEE
Q 001658 694 NFSPSNKLGEGGFGPVYKGKL-GDGRAIAVKQLSVAS---RQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLVYE 769 (1036)
Q Consensus 694 ~~~~~~~iG~G~fG~Vy~~~~-~~g~~vAvK~~~~~~---~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E 769 (1036)
.|+..+.||+|+||.||+|+. .+++.||+|++.... ......+.+|++++++++|+||+++++++.+++..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 577889999999999999985 468899999986532 2334578899999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeecCCC-
Q 001658 770 YLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKK- 848 (1036)
Q Consensus 770 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~- 848 (1036)
|+++|+|.+++... ..+++.....++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+....
T Consensus 82 ~~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~ 156 (382)
T cd05625 82 YIPGGDMMSLLIRM--GIFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD 156 (382)
T ss_pred CCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCcccccccc
Confidence 99999999998654 35778888889999999999999988 9999999999999999999999999975321000
Q ss_pred ---------------------------------------------CccccccccccCccCccccccCCCCchhhHHhHHH
Q 001658 849 ---------------------------------------------THISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFGV 883 (1036)
Q Consensus 849 ---------------------------------------------~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~Gv 883 (1036)
........||+.|+|||++.+..++.++|||||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGv 236 (382)
T cd05625 157 SKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGV 236 (382)
T ss_pred ccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechH
Confidence 00012346999999999999999999999999999
Q ss_pred HHHHHHhCCCCCCCCCh
Q 001658 884 LALETVSGRPNSDPSLD 900 (1036)
Q Consensus 884 vl~elltG~~p~~~~~~ 900 (1036)
++|||++|++||.....
T Consensus 237 il~elltG~~Pf~~~~~ 253 (382)
T cd05625 237 ILYEMLVGQPPFLAQTP 253 (382)
T ss_pred HHHHHHhCCCCCCCCCH
Confidence 99999999999986544
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=312.19 Aligned_cols=250 Identities=21% Similarity=0.345 Sum_probs=205.8
Q ss_pred CCCCCCccccCCCEEEEEeEe-CCCcEEEEEEcccc--chhcHHHHHHHHHHHHhhccCCcceeEeEEEcCceeEEEEEe
Q 001658 694 NFSPSNKLGEGGFGPVYKGKL-GDGRAIAVKQLSVA--SRQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLVYEY 770 (1036)
Q Consensus 694 ~~~~~~~iG~G~fG~Vy~~~~-~~g~~vAvK~~~~~--~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~ 770 (1036)
+|+..+.||+|+||.||.++. .+++.+++|.+... +.....++.+|++++++++|+||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 477889999999999999984 46889999987643 344466789999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeecCCCCc
Q 001658 771 LENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTH 850 (1036)
Q Consensus 771 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~ 850 (1036)
+++++|.+++.......+++..+..++.|+++||+|||+.+ ++||||||+||++++++.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~- 156 (256)
T cd08221 81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS- 156 (256)
T ss_pred cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEEcccccc-
Confidence 99999999997665567899999999999999999999987 99999999999999999999999999987654432
Q ss_pred cccccccccCccCccccccCCCCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhcCccccccCcccccC
Q 001658 851 ISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEIELADPKLIEF 930 (1036)
Q Consensus 851 ~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~ 930 (1036)
......|++.|+|||+..+..++.++||||||+++|||++|+.||......+.... ... +. ....
T Consensus 157 ~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~------~~~-~~--------~~~~ 221 (256)
T cd08221 157 MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVK------IVQ-GN--------YTPV 221 (256)
T ss_pred cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHH------HHc-CC--------CCCC
Confidence 22345689999999999888899999999999999999999999976443222211 111 10 1111
Q ss_pred CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 001658 931 NEEEVKRLIGVALLCTQTLPSLRPSMSRVVAM 962 (1036)
Q Consensus 931 ~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 962 (1036)
.......+.+++.+||+.+|++||++.|+++.
T Consensus 222 ~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~ 253 (256)
T cd08221 222 VSVYSSELISLVHSLLQQDPEKRPTADEVLDQ 253 (256)
T ss_pred ccccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence 12234567788889999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=327.72 Aligned_cols=241 Identities=24% Similarity=0.307 Sum_probs=193.2
Q ss_pred CCCCCCccccCCCEEEEEeEeC-CCcEEEEEEccccc---hhcHHHHHHHHHHHHhh-ccCCcceeEeEEEcCceeEEEE
Q 001658 694 NFSPSNKLGEGGFGPVYKGKLG-DGRAIAVKQLSVAS---RQGKSQFVAEIATISAV-QHRNLVKLHGCCIEGAERLLVY 768 (1036)
Q Consensus 694 ~~~~~~~iG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~f~~Ei~~L~~l-~H~nIv~l~g~~~~~~~~~lV~ 768 (1036)
+|.+.+.||+|+||.||+|+.. +++.||+|.+.... ......+..|..++..+ +|++|+++++++...+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 4778899999999999999865 57899999987532 22334567788888777 5899999999999999999999
Q ss_pred EecCCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeecCCC
Q 001658 769 EYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKK 848 (1036)
Q Consensus 769 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~ 848 (1036)
||+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++......
T Consensus 81 E~~~~g~L~~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~ 155 (323)
T cd05616 81 EYVNGGDLMYQIQQV--GRFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG 155 (323)
T ss_pred cCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCceecCCCC
Confidence 999999999988543 45788999999999999999999988 9999999999999999999999999997543222
Q ss_pred CccccccccccCccCccccccCCCCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhcCccccccCcccc
Q 001658 849 THISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEIELADPKLI 928 (1036)
Q Consensus 849 ~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~ 928 (1036)
. ......||+.|+|||++.+..++.++|||||||++|||+||+.||...........+ ... ...
T Consensus 156 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i------~~~-------~~~-- 219 (323)
T cd05616 156 V-TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSI------MEH-------NVA-- 219 (323)
T ss_pred C-ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHH------HhC-------CCC--
Confidence 1 223456999999999999999999999999999999999999999865443222111 110 011
Q ss_pred cCCHHHHHHHHHHHHHhcccCCCCCCCH
Q 001658 929 EFNEEEVKRLIGVALLCTQTLPSLRPSM 956 (1036)
Q Consensus 929 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~ 956 (1036)
++.....++.+++.+|++.+|.+|++.
T Consensus 220 -~p~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 220 -YPKSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred -CCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence 111233466788889999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=311.90 Aligned_cols=248 Identities=35% Similarity=0.503 Sum_probs=202.5
Q ss_pred CccccCCCEEEEEeEeCC----CcEEEEEEccccchh-cHHHHHHHHHHHHhhccCCcceeEeEEEcCceeEEEEEecCC
Q 001658 699 NKLGEGGFGPVYKGKLGD----GRAIAVKQLSVASRQ-GKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLVYEYLEN 773 (1036)
Q Consensus 699 ~~iG~G~fG~Vy~~~~~~----g~~vAvK~~~~~~~~-~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~ 773 (1036)
+.||+|+||.||+|.... +..||+|.++..... ..+.+.+|++.+..++|+||+++++++......++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 469999999999998653 788999999765433 367889999999999999999999999999999999999999
Q ss_pred CChhhhhhcCC-------CCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeecC
Q 001658 774 KSLDQALFGQR-------SLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDD 846 (1036)
Q Consensus 774 gsL~~~l~~~~-------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~ 846 (1036)
++|.+++.... ...+++..+++++.|+++||+|||+.+ |+||||||+||++++++.+||+|||.+.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEccccccccccc
Confidence 99999997642 367899999999999999999999987 99999999999999999999999999987654
Q ss_pred CCC-ccccccccccCccCccccccCCCCchhhHHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHHHHHhhcCccccccC
Q 001658 847 KKT-HISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVS-GRPNSDPSLDEEKLYLLEWAWHLHENNQEIELAD 924 (1036)
Q Consensus 847 ~~~-~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 924 (1036)
... .......++..|+|||.+....++.++||||+|+++|||++ |..||......... +... .+. .
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~---~~~~----~~~-----~ 225 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVL---EYLR----KGY-----R 225 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHH---HHHH----cCC-----C
Confidence 321 12234557889999999998889999999999999999999 58888765332211 1111 110 0
Q ss_pred cccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 001658 925 PKLIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVAMLC 964 (1036)
Q Consensus 925 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~ 964 (1036)
..........+.+++.+|++.+|++||++.|+++.|+
T Consensus 226 ---~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 226 ---LPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred ---CCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 1111222457888889999999999999999998874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-35 Score=334.68 Aligned_cols=261 Identities=20% Similarity=0.236 Sum_probs=200.7
Q ss_pred HHHHHHHhcCCCCCCccccCCCEEEEEeEeC-CCcEEEEEEcccc---chhcHHHHHHHHHHHHhhccCCcceeEeEEEc
Q 001658 685 YAELKTATENFSPSNKLGEGGFGPVYKGKLG-DGRAIAVKQLSVA---SRQGKSQFVAEIATISAVQHRNLVKLHGCCIE 760 (1036)
Q Consensus 685 ~~~l~~~~~~~~~~~~iG~G~fG~Vy~~~~~-~g~~vAvK~~~~~---~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~ 760 (1036)
..++....++|++.+.||+|+||.||+++.. +++.||+|++... .......+.+|+.+++.++||||+++++++.+
T Consensus 35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~ 114 (371)
T cd05622 35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 114 (371)
T ss_pred HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence 3445556789999999999999999999865 6789999998642 22334567889999999999999999999999
Q ss_pred CceeEEEEEecCCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCc
Q 001658 761 GAERLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGL 840 (1036)
Q Consensus 761 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGl 840 (1036)
+...++||||+++|+|.+++.. ..++...+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 115 ~~~~~lv~Ey~~gg~L~~~~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL~DfG~ 188 (371)
T cd05622 115 DRYLYMVMEYMPGGDLVNLMSN---YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGT 188 (371)
T ss_pred CCEEEEEEcCCCCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEEEeCCc
Confidence 9999999999999999999854 34778888889999999999999998 99999999999999999999999999
Q ss_pred ceeecCCCCccccccccccCccCccccccC----CCCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhc
Q 001658 841 AKLYDDKKTHISTRVAGTIGYLAPEYAMRG----HLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHEN 916 (1036)
Q Consensus 841 a~~~~~~~~~~~~~~~gt~~y~APE~~~~~----~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~ 916 (1036)
++..............||+.|+|||++... .++.++|||||||++|||++|+.||........... ....
T Consensus 189 a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~------i~~~ 262 (371)
T cd05622 189 CMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSK------IMNH 262 (371)
T ss_pred eeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHH------HHcC
Confidence 987654333233456799999999998753 378899999999999999999999986543222211 1111
Q ss_pred CccccccCcccccCCHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHHh
Q 001658 917 NQEIELADPKLIEFNEEEVKRLIGVALLCTQTLPSL--RPSMSRVVAML 963 (1036)
Q Consensus 917 ~~~~~~~d~~~~~~~~~~~~~l~~l~~~Cl~~dP~~--RPt~~evl~~L 963 (1036)
...... |. .......+.+++..|++..+.+ ||++.|+++..
T Consensus 263 ~~~~~~--~~----~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~ 305 (371)
T cd05622 263 KNSLTF--PD----DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL 305 (371)
T ss_pred CCcccC--CC----cCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence 111111 11 1122334556667788744433 77888887643
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=315.17 Aligned_cols=249 Identities=27% Similarity=0.383 Sum_probs=195.3
Q ss_pred CccccCCCEEEEEeEeCC-Cc--EEEEEEcccc-chhcHHHHHHHHHHHHhh-ccCCcceeEeEEEcCceeEEEEEecCC
Q 001658 699 NKLGEGGFGPVYKGKLGD-GR--AIAVKQLSVA-SRQGKSQFVAEIATISAV-QHRNLVKLHGCCIEGAERLLVYEYLEN 773 (1036)
Q Consensus 699 ~~iG~G~fG~Vy~~~~~~-g~--~vAvK~~~~~-~~~~~~~f~~Ei~~L~~l-~H~nIv~l~g~~~~~~~~~lV~E~~~~ 773 (1036)
+.||+|+||.||+|+..+ +. .+|+|.++.. .......+.+|++++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 468999999999998753 43 5788888643 334456789999999999 799999999999999999999999999
Q ss_pred CChhhhhhcCC--------------CCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcC
Q 001658 774 KSLDQALFGQR--------------SLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFG 839 (1036)
Q Consensus 774 gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFG 839 (1036)
|+|.+++.... ...+++.++..++.|++.||+|||+.+ ++||||||+||++++++.+||+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECCCC
Confidence 99999986543 134789999999999999999999987 9999999999999999999999999
Q ss_pred cceeecCCCCccccccccccCccCccccccCCCCchhhHHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHHHHHhhcCc
Q 001658 840 LAKLYDDKKTHISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVS-GRPNSDPSLDEEKLYLLEWAWHLHENNQ 918 (1036)
Q Consensus 840 la~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~ 918 (1036)
++....... .......+..|+|||++....++.++|||||||++|||++ |+.||......+.... . ....
T Consensus 158 l~~~~~~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~------~-~~~~ 228 (270)
T cd05047 158 LSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEK------L-PQGY 228 (270)
T ss_pred Cccccchhh--hccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHH------H-hCCC
Confidence 986322111 1111224567999999988889999999999999999997 9999865433221111 1 1110
Q ss_pred cccccCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhccc
Q 001658 919 EIELADPKLIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVAMLCGDM 967 (1036)
Q Consensus 919 ~~~~~d~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~ 967 (1036)
. .. ........+.+++.+||+.+|.+||++.|+++.|+++.
T Consensus 229 ~-----~~---~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 229 R-----LE---KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred C-----CC---CCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 0 00 11122346778899999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=325.51 Aligned_cols=241 Identities=25% Similarity=0.314 Sum_probs=193.8
Q ss_pred CccccCCCEEEEEeEeC-CCcEEEEEEccccc---hhcHHHHHHHHHHHHhh-ccCCcceeEeEEEcCceeEEEEEecCC
Q 001658 699 NKLGEGGFGPVYKGKLG-DGRAIAVKQLSVAS---RQGKSQFVAEIATISAV-QHRNLVKLHGCCIEGAERLLVYEYLEN 773 (1036)
Q Consensus 699 ~~iG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~f~~Ei~~L~~l-~H~nIv~l~g~~~~~~~~~lV~E~~~~ 773 (1036)
+.||+|+||.||+|+.. +++.||+|+++... ......+..|.+++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999865 57899999987532 23345677888998887 699999999999999999999999999
Q ss_pred CChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeecCCCCcccc
Q 001658 774 KSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHIST 853 (1036)
Q Consensus 774 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 853 (1036)
|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++....... ...
T Consensus 81 ~~L~~~~~~~--~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~~ 154 (318)
T cd05570 81 GDLMFHIQRS--GRFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV-TTS 154 (318)
T ss_pred CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeecCcCCC-ccc
Confidence 9999988643 36899999999999999999999988 99999999999999999999999999875322221 123
Q ss_pred ccccccCccCccccccCCCCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhcCccccccCcccccCCHH
Q 001658 854 RVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEIELADPKLIEFNEE 933 (1036)
Q Consensus 854 ~~~gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~ 933 (1036)
...||+.|+|||++.+..++.++|||||||++|||++|+.||........... .... .+.. +..
T Consensus 155 ~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~------i~~~-------~~~~---~~~ 218 (318)
T cd05570 155 TFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQS------ILED-------EVRY---PRW 218 (318)
T ss_pred ceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHH------HHcC-------CCCC---CCc
Confidence 35689999999999999999999999999999999999999976543222111 1100 1111 112
Q ss_pred HHHHHHHHHHHhcccCCCCCCCH-----HHHHH
Q 001658 934 EVKRLIGVALLCTQTLPSLRPSM-----SRVVA 961 (1036)
Q Consensus 934 ~~~~l~~l~~~Cl~~dP~~RPt~-----~evl~ 961 (1036)
....+.+++.+||+.||.+||++ .++++
T Consensus 219 ~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~ 251 (318)
T cd05570 219 LSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG 251 (318)
T ss_pred CCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence 23457788889999999999999 77764
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=328.43 Aligned_cols=247 Identities=23% Similarity=0.272 Sum_probs=192.4
Q ss_pred CccccCCCEEEEEeEeC-CCcEEEEEEccccc---hhcHHHHHHHHHHHHhh-ccCCcceeEeEEEcCceeEEEEEecCC
Q 001658 699 NKLGEGGFGPVYKGKLG-DGRAIAVKQLSVAS---RQGKSQFVAEIATISAV-QHRNLVKLHGCCIEGAERLLVYEYLEN 773 (1036)
Q Consensus 699 ~~iG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~f~~Ei~~L~~l-~H~nIv~l~g~~~~~~~~~lV~E~~~~ 773 (1036)
+.||+|+||.||+|+.. +++.||+|+++... ....+.+..|..++.++ +||||+++++++.+....++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 46999999999999864 68899999997532 23345678899999988 799999999999999999999999999
Q ss_pred CChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeecCCCCcccc
Q 001658 774 KSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHIST 853 (1036)
Q Consensus 774 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 853 (1036)
|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ....
T Consensus 81 g~L~~~~~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~-~~~~ 154 (329)
T cd05588 81 GDLMFHMQRQ--RKLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG-DTTS 154 (329)
T ss_pred CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCccccccccCC-Cccc
Confidence 9999888543 46899999999999999999999988 9999999999999999999999999987532211 1223
Q ss_pred ccccccCccCccccccCCCCchhhHHhHHHHHHHHHhCCCCCCCCChhh--HHHHHHHHHHHhhcCccccccCcccccCC
Q 001658 854 RVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEE--KLYLLEWAWHLHENNQEIELADPKLIEFN 931 (1036)
Q Consensus 854 ~~~gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~--~~~l~~~~~~~~~~~~~~~~~d~~~~~~~ 931 (1036)
...||+.|+|||++.+..++.++|||||||++|||++|+.||+.....+ .....++........ ...+.
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~------~~~~p--- 225 (329)
T cd05588 155 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEK------QIRIP--- 225 (329)
T ss_pred cccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcC------CCCCC---
Confidence 4569999999999999999999999999999999999999997422111 111111221111111 11111
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCC------HHHHH
Q 001658 932 EEEVKRLIGVALLCTQTLPSLRPS------MSRVV 960 (1036)
Q Consensus 932 ~~~~~~l~~l~~~Cl~~dP~~RPt------~~evl 960 (1036)
......+.+++.+|++.||.+||+ +.+++
T Consensus 226 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~ 260 (329)
T cd05588 226 RSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIK 260 (329)
T ss_pred CCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHh
Confidence 112345677888999999999998 55665
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=315.00 Aligned_cols=251 Identities=27% Similarity=0.423 Sum_probs=200.6
Q ss_pred CCCCCccccCCCEEEEEeEeC-CCcEEEEEEccccchhcH--HHHHHHHHHHHhhccCCcceeEeEEEcCceeEEEEEec
Q 001658 695 FSPSNKLGEGGFGPVYKGKLG-DGRAIAVKQLSVASRQGK--SQFVAEIATISAVQHRNLVKLHGCCIEGAERLLVYEYL 771 (1036)
Q Consensus 695 ~~~~~~iG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~~~~--~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~~ 771 (1036)
|+..+.||+|+||+||+++.. +++.||+|.+........ .....|+.++++++||||+++++++.+....++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 445688999999999999965 567899999976543322 23456999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeecCCCCcc
Q 001658 772 ENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHI 851 (1036)
Q Consensus 772 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 851 (1036)
++++|.+++. ....+++..+..++.|+++||+|||+.+ |+||||||+||++++++.++|+|||.+..... ....
T Consensus 81 ~~~~L~~~l~--~~~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~-~~~~ 154 (260)
T PF00069_consen 81 PGGSLQDYLQ--KNKPLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKLSE-NNEN 154 (260)
T ss_dssp TTEBHHHHHH--HHSSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEESTS-TTSE
T ss_pred cccccccccc--cccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccc-cccc
Confidence 9999999996 3456899999999999999999999998 99999999999999999999999999986522 2223
Q ss_pred ccccccccCccCccccc-cCCCCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHH-HhhcCccccccCccccc
Q 001658 852 STRVAGTIGYLAPEYAM-RGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWH-LHENNQEIELADPKLIE 929 (1036)
Q Consensus 852 ~~~~~gt~~y~APE~~~-~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~-~~~~~~~~~~~d~~~~~ 929 (1036)
.....++..|+|||++. +..++.++||||+|+++|+|++|+.|+......+.......... .... . ..
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~---------~-~~ 224 (260)
T PF00069_consen 155 FNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPS---------S-SQ 224 (260)
T ss_dssp BSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHH---------H-TT
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccc---------c-cc
Confidence 34566899999999998 88899999999999999999999999987633333322221111 0000 0 00
Q ss_pred CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 001658 930 FNEEEVKRLIGVALLCTQTLPSLRPSMSRVVA 961 (1036)
Q Consensus 930 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 961 (1036)
........+.+++..|++.+|++||++.++++
T Consensus 225 ~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 225 QSREKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp SHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred ccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00011267888889999999999999999875
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=318.74 Aligned_cols=250 Identities=24% Similarity=0.358 Sum_probs=199.3
Q ss_pred CCCCCccccCCCEEEEEeEeC-CCcEEEEEEccccchhcHHHHHHHHHHHHhhccCCcceeEeEEEcCceeEEEEEecCC
Q 001658 695 FSPSNKLGEGGFGPVYKGKLG-DGRAIAVKQLSVASRQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLVYEYLEN 773 (1036)
Q Consensus 695 ~~~~~~iG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~ 773 (1036)
|++.+.||+|+||.||+|... ++..+|+|.+..........+.+|+++++.++||||+++++++......++|+||+++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 566788999999999999865 5788999998765555567889999999999999999999999999999999999999
Q ss_pred CChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeecCCCCcccc
Q 001658 774 KSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHIST 853 (1036)
Q Consensus 774 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 853 (1036)
++|.+++... ...+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||++........ ...
T Consensus 87 ~~l~~~~~~~-~~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~-~~~ 161 (282)
T cd06643 87 GAVDAVMLEL-ERPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ-RRD 161 (282)
T ss_pred CcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEcccccccccccccc-ccc
Confidence 9999887643 346899999999999999999999987 99999999999999999999999999876543221 223
Q ss_pred ccccccCccCccccc-----cCCCCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhcCccccccCcccc
Q 001658 854 RVAGTIGYLAPEYAM-----RGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEIELADPKLI 928 (1036)
Q Consensus 854 ~~~gt~~y~APE~~~-----~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~ 928 (1036)
...|+..|+|||++. +..++.++|||||||++|||++|++||......+..... . .. . .+..
T Consensus 162 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~--~----~~-~-----~~~~- 228 (282)
T cd06643 162 SFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKI--A----KS-E-----PPTL- 228 (282)
T ss_pred cccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHH--h----hc-C-----CCCC-
Confidence 356899999999984 345788999999999999999999998765432221111 0 00 0 0010
Q ss_pred cCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 001658 929 EFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVAM 962 (1036)
Q Consensus 929 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 962 (1036)
..+......+.+++.+||+.+|.+||++.++++.
T Consensus 229 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 262 (282)
T cd06643 229 AQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQH 262 (282)
T ss_pred CCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0111223467788899999999999999998753
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=310.47 Aligned_cols=265 Identities=23% Similarity=0.311 Sum_probs=202.2
Q ss_pred HhcCCCCCCccccCCCEEEEEeEe-CCCcEEEEEEcc--ccchhcHHHHHHHHHHHHhhccCCcceeEeEEEc-----Cc
Q 001658 691 ATENFSPSNKLGEGGFGPVYKGKL-GDGRAIAVKQLS--VASRQGKSQFVAEIATISAVQHRNLVKLHGCCIE-----GA 762 (1036)
Q Consensus 691 ~~~~~~~~~~iG~G~fG~Vy~~~~-~~g~~vAvK~~~--~~~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~-----~~ 762 (1036)
....|...+.||+|+||.|..+.. .+|+.||||++. .......++-.+|++.|+.++|+||+.+++.+.. -.
T Consensus 20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~ 99 (359)
T KOG0660|consen 20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN 99 (359)
T ss_pred ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence 445566678999999999999985 478999999987 3455556778899999999999999999998865 35
Q ss_pred eeEEEEEecCCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcce
Q 001658 763 ERLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAK 842 (1036)
Q Consensus 763 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~ 842 (1036)
..|+|+|+| .-+|...++.+ ..++.....-++.|+++||.|+|+.+ |+|||+||+|++++.+..+||+|||+|+
T Consensus 100 DvYiV~elM-etDL~~iik~~--~~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~DFGLAR 173 (359)
T KOG0660|consen 100 DVYLVFELM-ETDLHQIIKSQ--QDLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKICDFGLAR 173 (359)
T ss_pred eeEEehhHH-hhHHHHHHHcC--ccccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEecccccee
Confidence 689999999 56999998543 34778888889999999999999988 9999999999999999999999999999
Q ss_pred eecCCC-CccccccccccCccCccccc-cCCCCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhcCccc
Q 001658 843 LYDDKK-THISTRVAGTIGYLAPEYAM-RGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEI 920 (1036)
Q Consensus 843 ~~~~~~-~~~~~~~~gt~~y~APE~~~-~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 920 (1036)
...... ....+..+-|..|.|||++. ...|+...||||.|||+.||++|++-|.+....+...++...-....+....
T Consensus 174 ~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~ 253 (359)
T KOG0660|consen 174 YLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQ 253 (359)
T ss_pred eccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHH
Confidence 875431 11224566899999999975 4679999999999999999999999998765544444332111111000000
Q ss_pred ccc----------Cccc-----ccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 001658 921 ELA----------DPKL-----IEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVA 961 (1036)
Q Consensus 921 ~~~----------d~~~-----~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 961 (1036)
.+. -|.. ....+......+++..+|+..||.+|+|++|.++
T Consensus 254 ~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~ 309 (359)
T KOG0660|consen 254 KIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALA 309 (359)
T ss_pred HhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhc
Confidence 000 0000 1111122345677788999999999999999986
|
|
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=315.92 Aligned_cols=255 Identities=28% Similarity=0.398 Sum_probs=203.1
Q ss_pred cCCCCCCccccCCCEEEEEeEeC------CCcEEEEEEccccchh-cHHHHHHHHHHHHhhccCCcceeEeEEEcCceeE
Q 001658 693 ENFSPSNKLGEGGFGPVYKGKLG------DGRAIAVKQLSVASRQ-GKSQFVAEIATISAVQHRNLVKLHGCCIEGAERL 765 (1036)
Q Consensus 693 ~~~~~~~~iG~G~fG~Vy~~~~~------~g~~vAvK~~~~~~~~-~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~ 765 (1036)
++|+..+.||+|+||.||+|+.+ +.+.||+|.+...... ..+.+.+|++++++++|+||+++++++.+....+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 56788899999999999999853 3467999988654332 4567999999999999999999999999989999
Q ss_pred EEEEecCCCChhhhhhcCCC-------CCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEc
Q 001658 766 LVYEYLENKSLDQALFGQRS-------LTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDF 838 (1036)
Q Consensus 766 lV~E~~~~gsL~~~l~~~~~-------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DF 838 (1036)
+||||+++|+|.+++..... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.++++||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEEccc
Confidence 99999999999999975441 26899999999999999999999988 999999999999999999999999
Q ss_pred CcceeecCCCCccccccccccCccCccccccCCCCchhhHHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHHHHHhhcC
Q 001658 839 GLAKLYDDKKTHISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVS-GRPNSDPSLDEEKLYLLEWAWHLHENN 917 (1036)
Q Consensus 839 Gla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~ 917 (1036)
|+++..............++..|+|||.+.+..++.++||||||+++|||++ |..||.......... .. ...
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~---~~----~~~ 234 (275)
T cd05046 162 SLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLN---RL----QAG 234 (275)
T ss_pred ccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHH---HH----HcC
Confidence 9987543332222233456788999999988889999999999999999999 777886433322111 11 000
Q ss_pred ccccccCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 001658 918 QEIELADPKLIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVAMLC 964 (1036)
Q Consensus 918 ~~~~~~d~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~ 964 (1036)
.. ... ........+.+++.+|++.+|.+||++.|++++|.
T Consensus 235 ~~-~~~------~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 235 KL-ELP------VPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred Cc-CCC------CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 00 000 01122346788899999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=325.01 Aligned_cols=240 Identities=25% Similarity=0.292 Sum_probs=190.6
Q ss_pred CccccCCCEEEEEeEeC-CCcEEEEEEccccc---hhcHHHHHHHHHHHHhh-ccCCcceeEeEEEcCceeEEEEEecCC
Q 001658 699 NKLGEGGFGPVYKGKLG-DGRAIAVKQLSVAS---RQGKSQFVAEIATISAV-QHRNLVKLHGCCIEGAERLLVYEYLEN 773 (1036)
Q Consensus 699 ~~iG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~f~~Ei~~L~~l-~H~nIv~l~g~~~~~~~~~lV~E~~~~ 773 (1036)
+.||+|+||.||+|+.. +|+.||+|.++... ......+..|..++... +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 46999999999999865 68899999987532 22345567788888754 899999999999999999999999999
Q ss_pred CChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeecCCCCcccc
Q 001658 774 KSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHIST 853 (1036)
Q Consensus 774 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 853 (1036)
|+|.+++... ..+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++....... ...
T Consensus 81 g~L~~~i~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~ 154 (316)
T cd05620 81 GDLMFHIQDK--GRFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDN-RAS 154 (316)
T ss_pred CcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeecccCCC-cee
Confidence 9999988643 45788889999999999999999988 99999999999999999999999999875322211 223
Q ss_pred ccccccCccCccccccCCCCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhcCccccccCcccccCCHH
Q 001658 854 RVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEIELADPKLIEFNEE 933 (1036)
Q Consensus 854 ~~~gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~ 933 (1036)
...||+.|+|||++.+..++.++|||||||++|||++|+.||.......... ... ...+.+...
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~---~~~----------~~~~~~~~~--- 218 (316)
T cd05620 155 TFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFE---SIR----------VDTPHYPRW--- 218 (316)
T ss_pred ccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHH---HHH----------hCCCCCCCC---
Confidence 4569999999999999999999999999999999999999997654322111 110 011222111
Q ss_pred HHHHHHHHHHHhcccCCCCCCCHH-HHH
Q 001658 934 EVKRLIGVALLCTQTLPSLRPSMS-RVV 960 (1036)
Q Consensus 934 ~~~~l~~l~~~Cl~~dP~~RPt~~-evl 960 (1036)
...++.+++.+|++.||++||++. ++.
T Consensus 219 ~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 219 ITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred CCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 223566778899999999999985 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-34 Score=314.07 Aligned_cols=252 Identities=28% Similarity=0.396 Sum_probs=189.6
Q ss_pred CccccCCCEEEEEeEeCC---CcEEEEEEccccc-hhcHHHHHHHHHHHHhhccCCcceeEeEEEcCceeEEEEEecCCC
Q 001658 699 NKLGEGGFGPVYKGKLGD---GRAIAVKQLSVAS-RQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLVYEYLENK 774 (1036)
Q Consensus 699 ~~iG~G~fG~Vy~~~~~~---g~~vAvK~~~~~~-~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~g 774 (1036)
+.||+|+||.||+|...+ ...+|+|.+.... ......|.+|+..++.++|+||+++++++.+....++||||+++|
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 369999999999997543 3578888875432 334567889999999999999999999999999999999999999
Q ss_pred ChhhhhhcCCC---CCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeecCCCCc-
Q 001658 775 SLDQALFGQRS---LTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTH- 850 (1036)
Q Consensus 775 sL~~~l~~~~~---~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~- 850 (1036)
+|.+++..... ...++.....++.||+.||+|||+.+ |+||||||+||++++++.+||+|||+++........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~ 157 (269)
T cd05042 81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI 157 (269)
T ss_pred cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEeccccccccccchhee
Confidence 99999976432 33567888899999999999999987 999999999999999999999999998754322211
Q ss_pred cccccccccCccCcccccc-------CCCCchhhHHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHHHHHhhcCccccc
Q 001658 851 ISTRVAGTIGYLAPEYAMR-------GHLTEKTDVFAFGVLALETVS-GRPNSDPSLDEEKLYLLEWAWHLHENNQEIEL 922 (1036)
Q Consensus 851 ~~~~~~gt~~y~APE~~~~-------~~~~~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 922 (1036)
......++..|+|||+... ..++.++|||||||++|||++ |..||....+.+.... ... ......
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~------~~~-~~~~~~ 230 (269)
T cd05042 158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQ------VVR-EQDIKL 230 (269)
T ss_pred ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHH------Hhh-ccCccC
Confidence 1123346778999998743 356889999999999999999 7778765443222111 011 111122
Q ss_pred cCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 001658 923 ADPKLIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVAMLC 964 (1036)
Q Consensus 923 ~d~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~ 964 (1036)
.++.. .......+.+++..|| .||++|||++||++.|.
T Consensus 231 ~~~~~---~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 231 PKPQL---DLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred CCCcc---cccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 22222 1223344556677788 59999999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=323.28 Aligned_cols=259 Identities=27% Similarity=0.415 Sum_probs=204.0
Q ss_pred hcCCCCCCccccCCCEEEEEeEeC--------CCcEEEEEEcccc-chhcHHHHHHHHHHHHhh-ccCCcceeEeEEEcC
Q 001658 692 TENFSPSNKLGEGGFGPVYKGKLG--------DGRAIAVKQLSVA-SRQGKSQFVAEIATISAV-QHRNLVKLHGCCIEG 761 (1036)
Q Consensus 692 ~~~~~~~~~iG~G~fG~Vy~~~~~--------~g~~vAvK~~~~~-~~~~~~~f~~Ei~~L~~l-~H~nIv~l~g~~~~~ 761 (1036)
.++|.+.+.||+|+||.||+|+.. ....||+|.++.. .......+..|+++++++ +||||+++++++...
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQE 90 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence 356778899999999999999742 2457999998743 233456788999999999 699999999999998
Q ss_pred ceeEEEEEecCCCChhhhhhcCC--------------CCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEe
Q 001658 762 AERLLVYEYLENKSLDQALFGQR--------------SLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLL 827 (1036)
Q Consensus 762 ~~~~lV~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl 827 (1036)
+..++|+||+++|+|.+++.... ...++|.++.+++.|++.||+|||+.+ |+||||||+||++
T Consensus 91 ~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill 167 (314)
T cd05099 91 GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNVLV 167 (314)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccceeEEE
Confidence 99999999999999999996532 245889999999999999999999987 9999999999999
Q ss_pred cCCCceEEEEcCcceeecCCCCcc-ccccccccCccCccccccCCCCchhhHHhHHHHHHHHHh-CCCCCCCCChhhHHH
Q 001658 828 DADLVPKISDFGLAKLYDDKKTHI-STRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVS-GRPNSDPSLDEEKLY 905 (1036)
Q Consensus 828 ~~~~~~kl~DFGla~~~~~~~~~~-~~~~~gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~ 905 (1036)
++++.+||+|||+++......... .....++..|+|||++.+..++.++|||||||++|||++ |+.||......+...
T Consensus 168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~ 247 (314)
T cd05099 168 TEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFK 247 (314)
T ss_pred cCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 999999999999998664322211 112234567999999998889999999999999999999 888886543322221
Q ss_pred HHHHHHHHhhcCccccccCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcccC
Q 001658 906 LLEWAWHLHENNQEIELADPKLIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVAMLCGDME 968 (1036)
Q Consensus 906 l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 968 (1036)
.. ..... + .........+.+++.+|++.+|++||++.|+++.|++...
T Consensus 248 ~~-------~~~~~-----~---~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~ 295 (314)
T cd05099 248 LL-------REGHR-----M---DKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLA 295 (314)
T ss_pred HH-------HcCCC-----C---CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHH
Confidence 11 11110 0 1112223467788899999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=317.03 Aligned_cols=240 Identities=26% Similarity=0.388 Sum_probs=189.9
Q ss_pred CccccCCCEEEEEeEeCC--------CcEEEEEEccccchhcHHHHHHHHHHHHhhccCCcceeEeEEEcCceeEEEEEe
Q 001658 699 NKLGEGGFGPVYKGKLGD--------GRAIAVKQLSVASRQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLVYEY 770 (1036)
Q Consensus 699 ~~iG~G~fG~Vy~~~~~~--------g~~vAvK~~~~~~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~ 770 (1036)
+.||+|+||.||+|.... ...||+|.+........+.+.+|+.+++.++||||+++++++..++..++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 469999999999997532 235888888655555567889999999999999999999999998999999999
Q ss_pred cCCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCc--------eEEEEcCcce
Q 001658 771 LENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLV--------PKISDFGLAK 842 (1036)
Q Consensus 771 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~--------~kl~DFGla~ 842 (1036)
+++|+|.+++...+ ..+++..+.+++.||+.||+|||+.+ |+||||||+||+++.++. ++++|||++.
T Consensus 81 ~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~ 156 (258)
T cd05078 81 VKFGSLDTYLKKNK-NLINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISI 156 (258)
T ss_pred CCCCcHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEeccccccc
Confidence 99999999997543 36889999999999999999999987 999999999999987765 6999999886
Q ss_pred eecCCCCccccccccccCccCccccccC-CCCchhhHHhHHHHHHHHHhCC-CCCCCCChhhHHHHHHHHHHHhhcCccc
Q 001658 843 LYDDKKTHISTRVAGTIGYLAPEYAMRG-HLTEKTDVFAFGVLALETVSGR-PNSDPSLDEEKLYLLEWAWHLHENNQEI 920 (1036)
Q Consensus 843 ~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~~~ksDVwS~Gvvl~elltG~-~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 920 (1036)
..... ....++..|+|||++.+. .++.++|||||||++|||++|. +|+............ ..
T Consensus 157 ~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~~-------~~---- 220 (258)
T cd05078 157 TVLPK-----EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFY-------ED---- 220 (258)
T ss_pred ccCCc-----hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHHH-------Hc----
Confidence 54322 224578899999999864 5789999999999999999995 555443222211110 00
Q ss_pred cccCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 001658 921 ELADPKLIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVAMLC 964 (1036)
Q Consensus 921 ~~~d~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~ 964 (1036)
.+.+ +.....++.+++.+||+.+|++|||++++++.|+
T Consensus 221 ---~~~~---~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 221 ---RHQL---PAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred ---cccC---CCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 0011 1112245778889999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=318.75 Aligned_cols=262 Identities=25% Similarity=0.362 Sum_probs=196.5
Q ss_pred CCCCCCccccCCCEEEEEeEeC-CCcEEEEEEccccc--hhcHHHHHHHHHHHHhh---ccCCcceeEeEEEc-----Cc
Q 001658 694 NFSPSNKLGEGGFGPVYKGKLG-DGRAIAVKQLSVAS--RQGKSQFVAEIATISAV---QHRNLVKLHGCCIE-----GA 762 (1036)
Q Consensus 694 ~~~~~~~iG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~--~~~~~~f~~Ei~~L~~l---~H~nIv~l~g~~~~-----~~ 762 (1036)
+|++.+.||+|+||.||+|+.. +++.||+|.++... ......+.+|+.+++.+ +||||+++++++.. ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 4778899999999999999864 68899999986432 22234566777777665 69999999998864 24
Q ss_pred eeEEEEEecCCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcce
Q 001658 763 ERLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAK 842 (1036)
Q Consensus 763 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~ 842 (1036)
..++|+||++ ++|.+++.......+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++
T Consensus 81 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~dfg~~~ 156 (288)
T cd07863 81 KVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLAR 156 (288)
T ss_pred eEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccCccc
Confidence 5789999997 58999887655566899999999999999999999998 9999999999999999999999999998
Q ss_pred eecCCCCccccccccccCccCccccccCCCCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHH-HHHHHHHhhcCcc--
Q 001658 843 LYDDKKTHISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYL-LEWAWHLHENNQE-- 919 (1036)
Q Consensus 843 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l-~~~~~~~~~~~~~-- 919 (1036)
....... .....||..|+|||++.+..++.++||||+||++|||++|++||......+.... .............
T Consensus 157 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (288)
T cd07863 157 IYSCQMA--LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRD 234 (288)
T ss_pred cccCccc--CCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCccc
Confidence 7643221 2345689999999999988999999999999999999999999976544332211 1110000000000
Q ss_pred cc----ccCcc----cccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 001658 920 IE----LADPK----LIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVA 961 (1036)
Q Consensus 920 ~~----~~d~~----~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 961 (1036)
.. ...+. ......+....+.+++.+|++.||++|||+.|++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 235 VTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred ccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 00 00000 01111223356778889999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=325.64 Aligned_cols=246 Identities=22% Similarity=0.249 Sum_probs=190.8
Q ss_pred CccccCCCEEEEEeEeC-CCcEEEEEEccccc---hhcHHHHHHHHH-HHHhhccCCcceeEeEEEcCceeEEEEEecCC
Q 001658 699 NKLGEGGFGPVYKGKLG-DGRAIAVKQLSVAS---RQGKSQFVAEIA-TISAVQHRNLVKLHGCCIEGAERLLVYEYLEN 773 (1036)
Q Consensus 699 ~~iG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~f~~Ei~-~L~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~ 773 (1036)
+.||+|+||.||+|+.. +++.||+|++.... ......+..|.. +++.++|+||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 46999999999999865 57889999986432 122334444544 56778999999999999999999999999999
Q ss_pred CChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeecCCCCcccc
Q 001658 774 KSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHIST 853 (1036)
Q Consensus 774 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 853 (1036)
|+|.+++... ..+.+.....++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++....... ...
T Consensus 81 ~~L~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~-~~~ 154 (325)
T cd05602 81 GELFYHLQRE--RCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG-TTS 154 (325)
T ss_pred CcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCcccccCCC-Ccc
Confidence 9999998653 45677788889999999999999998 99999999999999999999999999975432222 223
Q ss_pred ccccccCccCccccccCCCCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhcCccccccCcccccCCHH
Q 001658 854 RVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEIELADPKLIEFNEE 933 (1036)
Q Consensus 854 ~~~gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~ 933 (1036)
...||+.|+|||++.+..++.++|||||||++|||++|++||......+... .. ... ... ....
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~---~i---~~~-------~~~---~~~~ 218 (325)
T cd05602 155 TFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYD---NI---LNK-------PLQ---LKPN 218 (325)
T ss_pred cccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHH---HH---HhC-------CcC---CCCC
Confidence 4569999999999999999999999999999999999999998654332211 11 110 000 1112
Q ss_pred HHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcc
Q 001658 934 EVKRLIGVALLCTQTLPSLRPSMSRVVAMLCGD 966 (1036)
Q Consensus 934 ~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 966 (1036)
....+.+++.+|++.+|.+||++.+.+..+.+.
T Consensus 219 ~~~~~~~li~~~l~~~p~~R~~~~~~~~~i~~~ 251 (325)
T cd05602 219 ITNSARHLLEGLLQKDRTKRLGAKDDFMEIKNH 251 (325)
T ss_pred CCHHHHHHHHHHcccCHHHCCCCCCCHHHHhcC
Confidence 234567778899999999999988655554443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=320.12 Aligned_cols=250 Identities=26% Similarity=0.431 Sum_probs=203.8
Q ss_pred hcCCCCCCccccCCCEEEEEeEe-CCCcEEEEEEccccchhcHHHHHHHHHHHHhhccCCcceeEeEEEcCceeEEEEEe
Q 001658 692 TENFSPSNKLGEGGFGPVYKGKL-GDGRAIAVKQLSVASRQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLVYEY 770 (1036)
Q Consensus 692 ~~~~~~~~~iG~G~fG~Vy~~~~-~~g~~vAvK~~~~~~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~ 770 (1036)
..+|+..+.||+|+||.||+|.. .+++.||+|.+........+.+.+|+.+++.++|+||+++++++..++..++||||
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 97 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 97 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecc
Confidence 36788899999999999999985 57899999998765555567788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeecCCCCc
Q 001658 771 LENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTH 850 (1036)
Q Consensus 771 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~ 850 (1036)
+++++|.+++.. ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++.........
T Consensus 98 ~~~~~L~~~~~~---~~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~ 171 (297)
T cd06656 98 LAGGSLTDVVTE---TCMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK 171 (297)
T ss_pred cCCCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceEccCCccC
Confidence 999999999853 35788899999999999999999987 999999999999999999999999999865433222
Q ss_pred cccccccccCccCccccccCCCCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhcCccccccCcccccC
Q 001658 851 ISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEIELADPKLIEF 930 (1036)
Q Consensus 851 ~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~ 930 (1036)
.....+++.|+|||.+.+..++.++|||||||++|++++|+.||............ .....+.. ..
T Consensus 172 -~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~------------~~~~~~~~-~~ 237 (297)
T cd06656 172 -RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI------------ATNGTPEL-QN 237 (297)
T ss_pred -cCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeee------------ccCCCCCC-CC
Confidence 22346888999999999888999999999999999999999999764332211100 00001111 11
Q ss_pred CHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 001658 931 NEEEVKRLIGVALLCTQTLPSLRPSMSRVVA 961 (1036)
Q Consensus 931 ~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 961 (1036)
.......+.+++.+||+.+|++||++.++++
T Consensus 238 ~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 238 PERLSAVFRDFLNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred ccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1223345677888999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-34 Score=312.04 Aligned_cols=250 Identities=27% Similarity=0.373 Sum_probs=192.4
Q ss_pred CccccCCCEEEEEeEeC----CCcEEEEEEcccc-chhcHHHHHHHHHHHHhhccCCcceeEeEEEc-CceeEEEEEecC
Q 001658 699 NKLGEGGFGPVYKGKLG----DGRAIAVKQLSVA-SRQGKSQFVAEIATISAVQHRNLVKLHGCCIE-GAERLLVYEYLE 772 (1036)
Q Consensus 699 ~~iG~G~fG~Vy~~~~~----~g~~vAvK~~~~~-~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~-~~~~~lV~E~~~ 772 (1036)
+.||+|+||.||+|... ++..||+|.+... .....+.+.+|+.+++.++||||+++++++.. +...++|+||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 46899999999999853 2457999998543 33445678899999999999999999998764 556789999999
Q ss_pred CCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeecCCCCc--
Q 001658 773 NKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTH-- 850 (1036)
Q Consensus 773 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~-- 850 (1036)
+|+|.+++.... ...++..+..++.|+++||+|||+.+ |+||||||+|||+++++.+||+|||+++........
T Consensus 81 ~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~ 156 (262)
T cd05058 81 HGDLRNFIRSET-HNPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSV 156 (262)
T ss_pred CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCccccccccCCcceee
Confidence 999999986542 34677888899999999999999987 999999999999999999999999999765432211
Q ss_pred -cccccccccCccCccccccCCCCchhhHHhHHHHHHHHHhCC-CCCCCCChhhHHHHHHHHHHHhhcCccccccCcccc
Q 001658 851 -ISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGR-PNSDPSLDEEKLYLLEWAWHLHENNQEIELADPKLI 928 (1036)
Q Consensus 851 -~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~elltG~-~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~ 928 (1036)
......++..|+|||++.+..++.++|||||||++|||++|+ +|+...... .+.... ... . .+..
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~---~~~~~~---~~~-~-----~~~~- 223 (262)
T cd05058 157 HNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSF---DITVYL---LQG-R-----RLLQ- 223 (262)
T ss_pred cccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHH---HHHHHH---hcC-C-----CCCC-
Confidence 112334677899999998889999999999999999999965 555433221 122111 110 0 0111
Q ss_pred cCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhccc
Q 001658 929 EFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVAMLCGDM 967 (1036)
Q Consensus 929 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~ 967 (1036)
....+..+.+++..||+.+|++||++.||++.|++..
T Consensus 224 --~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~ 260 (262)
T cd05058 224 --PEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF 260 (262)
T ss_pred --CCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence 1112346778899999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=320.09 Aligned_cols=250 Identities=26% Similarity=0.331 Sum_probs=198.9
Q ss_pred CCCCCccccCCCEEEEEeEeC-CCcEEEEEEccccc---hhcHHHHHHHHHHHHhhccCCcceeEeEEEcCceeEEEEEe
Q 001658 695 FSPSNKLGEGGFGPVYKGKLG-DGRAIAVKQLSVAS---RQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLVYEY 770 (1036)
Q Consensus 695 ~~~~~~iG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~ 770 (1036)
|+..+.||+|+||.||++... +++.||+|.+.... ......+.+|+.++++++|++|+++++.+.+.+..++||||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 566788999999999999854 68899999986432 22234577899999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeecCCCCc
Q 001658 771 LENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTH 850 (1036)
Q Consensus 771 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~ 850 (1036)
+++++|.+++.......+++..+..++.|++.||.|||+.+ |+||||||+||++++++.++|+|||++........
T Consensus 82 ~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~- 157 (285)
T cd05630 82 MNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT- 157 (285)
T ss_pred cCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccceeecCCCcc-
Confidence 99999999987655567899999999999999999999987 99999999999999999999999999976543222
Q ss_pred cccccccccCccCccccccCCCCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhcCccccccCcccccC
Q 001658 851 ISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEIELADPKLIEF 930 (1036)
Q Consensus 851 ~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~ 930 (1036)
.....|+..|+|||++.+..++.++|||||||++|||++|+.||.............. .... .... .
T Consensus 158 -~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~---~~~~------~~~~---~ 224 (285)
T cd05630 158 -IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVER---LVKE------VQEE---Y 224 (285)
T ss_pred -ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHh---hhhh------hhhh---c
Confidence 1234689999999999999999999999999999999999999986432211111110 0000 0000 1
Q ss_pred CHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 001658 931 NEEEVKRLIGVALLCTQTLPSLRPS-----MSRVVA 961 (1036)
Q Consensus 931 ~~~~~~~l~~l~~~Cl~~dP~~RPt-----~~evl~ 961 (1036)
.......+.+++..||+.||++||| +.|+++
T Consensus 225 ~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 225 SEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred CccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 1112235677888999999999999 778775
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=325.78 Aligned_cols=204 Identities=24% Similarity=0.271 Sum_probs=175.4
Q ss_pred cCCCCCCccccCCCEEEEEeEeC-CCcEEEEEEcccc---chhcHHHHHHHHHHHHhhccCCcceeEeEEEcCceeEEEE
Q 001658 693 ENFSPSNKLGEGGFGPVYKGKLG-DGRAIAVKQLSVA---SRQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLVY 768 (1036)
Q Consensus 693 ~~~~~~~~iG~G~fG~Vy~~~~~-~g~~vAvK~~~~~---~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~ 768 (1036)
++|++.+.||+|+||.||+++.. +++.||+|.+... .......+.+|+.++..++|+||+++++++.+.+..++||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 46888999999999999999864 6788999998642 2223455788999999999999999999999999999999
Q ss_pred EecCCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeecCCC
Q 001658 769 EYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKK 848 (1036)
Q Consensus 769 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~ 848 (1036)
||+++|+|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 81 Ey~~gg~L~~~l~~~-~~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 156 (331)
T cd05624 81 DYYVGGDLLTLLSKF-EDRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDG 156 (331)
T ss_pred eCCCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccceeeccCCC
Confidence 999999999999653 246788889999999999999999988 9999999999999999999999999998765443
Q ss_pred CccccccccccCccCcccccc-----CCCCchhhHHhHHHHHHHHHhCCCCCCCCCh
Q 001658 849 THISTRVAGTIGYLAPEYAMR-----GHLTEKTDVFAFGVLALETVSGRPNSDPSLD 900 (1036)
Q Consensus 849 ~~~~~~~~gt~~y~APE~~~~-----~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~ 900 (1036)
........||+.|+|||++.+ +.++.++|||||||++|||++|+.||.....
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~ 213 (331)
T cd05624 157 TVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESL 213 (331)
T ss_pred ceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCH
Confidence 333334569999999999875 5678899999999999999999999976543
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=321.09 Aligned_cols=261 Identities=25% Similarity=0.336 Sum_probs=200.7
Q ss_pred cCCCCCCccccCCCEEEEEeEeC-CCcEEEEEEcccc-chhcHHHHHHHHHHHHhhccCCcceeEeEEEcCceeEEEEEe
Q 001658 693 ENFSPSNKLGEGGFGPVYKGKLG-DGRAIAVKQLSVA-SRQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLVYEY 770 (1036)
Q Consensus 693 ~~~~~~~~iG~G~fG~Vy~~~~~-~g~~vAvK~~~~~-~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~ 770 (1036)
++|++.+.||+|+||.||+++.. ++..+|+|.+... ......++.+|++++++++||||+++++++..++..++|+||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 36888999999999999999854 6788999988654 233356788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeecCCCCc
Q 001658 771 LENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTH 850 (1036)
Q Consensus 771 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~ 850 (1036)
+++++|.+++... ..+++..+..++.|+++||+|||+.. +++||||||+||++++++.+||+|||++.......
T Consensus 81 ~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-- 154 (308)
T cd06615 81 MDGGSLDQVLKKA--GRIPENILGKISIAVLRGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-- 154 (308)
T ss_pred cCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhhC--CEEECCCChHHEEEecCCcEEEccCCCcccccccc--
Confidence 9999999999654 45788889999999999999999742 39999999999999999999999999987653321
Q ss_pred cccccccccCccCccccccCCCCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhcCcc-----------
Q 001658 851 ISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQE----------- 919 (1036)
Q Consensus 851 ~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~----------- 919 (1036)
.....|+..|+|||.+.+..++.++||||||+++|||++|+.||........................
T Consensus 155 -~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (308)
T cd06615 155 -ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDS 233 (308)
T ss_pred -cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCCc
Confidence 22356889999999998888999999999999999999999998754322211111000000000000
Q ss_pred -------------ccccCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 001658 920 -------------IELADPKLIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVAM 962 (1036)
Q Consensus 920 -------------~~~~d~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 962 (1036)
.....|.... ......+.+++.+|++.+|++||++.||++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 287 (308)
T cd06615 234 PRPMAIFELLDYIVNEPPPKLPS--GAFSDEFQDFVDKCLKKNPKERADLKELTKH 287 (308)
T ss_pred cchhhHHHHHHHHhcCCCccCcC--cccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000000000 0123457889999999999999999999865
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-34 Score=310.62 Aligned_cols=250 Identities=24% Similarity=0.351 Sum_probs=202.5
Q ss_pred CCCCCCccccCCCEEEEEeEeC-CCcEEEEEEcccc--chhcHHHHHHHHHHHHhhccCCcceeEeEEEc-CceeEEEEE
Q 001658 694 NFSPSNKLGEGGFGPVYKGKLG-DGRAIAVKQLSVA--SRQGKSQFVAEIATISAVQHRNLVKLHGCCIE-GAERLLVYE 769 (1036)
Q Consensus 694 ~~~~~~~iG~G~fG~Vy~~~~~-~g~~vAvK~~~~~--~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~-~~~~~lV~E 769 (1036)
+|++.+.||+|++|.||+++.. +++.||+|.+... .....+.+.+|++++++++|+|++++++.+.. ....++|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 4778899999999999999854 5788999998643 23345678899999999999999999998764 445789999
Q ss_pred ecCCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeecCCCC
Q 001658 770 YLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKT 849 (1036)
Q Consensus 770 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~ 849 (1036)
|+++++|.+++.......+++.++..++.+++.|++|||+.+ |+||||||+||+++.++.++|+|||++........
T Consensus 81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~ 157 (257)
T cd08223 81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCD 157 (257)
T ss_pred ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceEEecccCC
Confidence 999999999997655667899999999999999999999988 99999999999999999999999999987653322
Q ss_pred ccccccccccCccCccccccCCCCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhcCccccccCccccc
Q 001658 850 HISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEIELADPKLIE 929 (1036)
Q Consensus 850 ~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~ 929 (1036)
......|++.|+|||++.+..++.++||||||++++||++|+.||.......... .... +. +..
T Consensus 158 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~------~~~~-~~--------~~~ 221 (257)
T cd08223 158 -MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVY------RIIE-GK--------LPP 221 (257)
T ss_pred -ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHH------HHHh-cC--------CCC
Confidence 2234568899999999999999999999999999999999999987544322111 1111 11 011
Q ss_pred CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 001658 930 FNEEEVKRLIGVALLCTQTLPSLRPSMSRVVAM 962 (1036)
Q Consensus 930 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 962 (1036)
........+.+++.+|++.+|++||++.++++.
T Consensus 222 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 222 MPKDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred CccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 122334567888999999999999999999853
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=327.88 Aligned_cols=247 Identities=23% Similarity=0.349 Sum_probs=204.3
Q ss_pred CCCCccccCCCEEEEEeEeC--CCc--EEEEEEccccchh-cHHHHHHHHHHHHhhccCCcceeEeEEEcCceeEEEEEe
Q 001658 696 SPSNKLGEGGFGPVYKGKLG--DGR--AIAVKQLSVASRQ-GKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLVYEY 770 (1036)
Q Consensus 696 ~~~~~iG~G~fG~Vy~~~~~--~g~--~vAvK~~~~~~~~-~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~ 770 (1036)
...++||+|.||.|++|.|+ +|+ .||||.++..... ...+|.+|+.+|.+|+|+|++++||...+ ....+|+|.
T Consensus 113 ~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~EL 191 (1039)
T KOG0199|consen 113 KLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFEL 191 (1039)
T ss_pred HHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhh
Confidence 34578999999999999875 344 5899999866544 56889999999999999999999999887 678899999
Q ss_pred cCCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeecCCCCc
Q 001658 771 LENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTH 850 (1036)
Q Consensus 771 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~ 850 (1036)
++.|||.+.|++.....+-......++.|||.||.||..++ +|||||..+|+||-....+||+|||+.+-+......
T Consensus 192 aplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~ 268 (1039)
T KOG0199|consen 192 APLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMRALGENEDM 268 (1039)
T ss_pred cccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecccceeccCCCCcc
Confidence 99999999998866777888889999999999999999987 999999999999999999999999999988644332
Q ss_pred c--ccccccccCccCccccccCCCCchhhHHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHHHHHhhcCccccccCccc
Q 001658 851 I--STRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVS-GRPNSDPSLDEEKLYLLEWAWHLHENNQEIELADPKL 927 (1036)
Q Consensus 851 ~--~~~~~gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~ 927 (1036)
. .....-.+.|+|||.+...+++.++|||+|||++|||+| |..||-+-.....+..++ +.+.
T Consensus 269 Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD---------------~~er 333 (1039)
T KOG0199|consen 269 YVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNID---------------AGER 333 (1039)
T ss_pred eEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhcc---------------cccc
Confidence 2 222334668999999999999999999999999999999 557777654433332221 1122
Q ss_pred ccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 001658 928 IEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVA 961 (1036)
Q Consensus 928 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 961 (1036)
...+..+.+++.+++..||..+|.+|||+..+.+
T Consensus 334 LpRPk~csedIY~imk~cWah~paDRptFsair~ 367 (1039)
T KOG0199|consen 334 LPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIRE 367 (1039)
T ss_pred CCCCCCChHHHHHHHHHhccCCccccccHHHHHH
Confidence 2334456678999999999999999999999974
|
|
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-34 Score=310.42 Aligned_cols=251 Identities=33% Similarity=0.494 Sum_probs=202.6
Q ss_pred CCCCCccccCCCEEEEEeEeCC-----CcEEEEEEccccchh-cHHHHHHHHHHHHhhccCCcceeEeEEEcCceeEEEE
Q 001658 695 FSPSNKLGEGGFGPVYKGKLGD-----GRAIAVKQLSVASRQ-GKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLVY 768 (1036)
Q Consensus 695 ~~~~~~iG~G~fG~Vy~~~~~~-----g~~vAvK~~~~~~~~-~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~ 768 (1036)
|++.+.||+|+||.||+++..+ +..||+|.+...... ..+.+..|++++..++|+||+++++++.+.+..++||
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 3567889999999999998653 488999999755432 5678999999999999999999999999999999999
Q ss_pred EecCCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeecCCC
Q 001658 769 EYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKK 848 (1036)
Q Consensus 769 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~ 848 (1036)
||+++++|.+++.......+++..+..++.|++.||+|||+.+ ++||||||+||++++++.++|+|||+++......
T Consensus 81 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 157 (258)
T smart00219 81 EYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD 157 (258)
T ss_pred eccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCceeccccc
Confidence 9999999999997654433899999999999999999999987 9999999999999999999999999998765443
Q ss_pred CccccccccccCccCccccccCCCCchhhHHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHHHHHhhcCccccccCccc
Q 001658 849 THISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVS-GRPNSDPSLDEEKLYLLEWAWHLHENNQEIELADPKL 927 (1036)
Q Consensus 849 ~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~ 927 (1036)
........++..|+|||.+.+..++.++||||+|++++||++ |++||.......... .. ..... +
T Consensus 158 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~---~~----~~~~~-----~-- 223 (258)
T smart00219 158 YYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLE---YL----KKGYR-----L-- 223 (258)
T ss_pred ccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH---HH----hcCCC-----C--
Confidence 322222337789999999988889999999999999999998 788877543322211 11 01110 0
Q ss_pred ccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 001658 928 IEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVAML 963 (1036)
Q Consensus 928 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L 963 (1036)
.........+.+++.+|++.+|++|||+.|++++|
T Consensus 224 -~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 224 -PKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred -CCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 11112345678888999999999999999998764
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=321.46 Aligned_cols=263 Identities=25% Similarity=0.345 Sum_probs=199.6
Q ss_pred cCCCCCCccccCCCEEEEEeEeC-CCcEEEEEEccccc-hhcHHHHHHHHHHHHhhccCCcceeEeEEEcCceeEEEEEe
Q 001658 693 ENFSPSNKLGEGGFGPVYKGKLG-DGRAIAVKQLSVAS-RQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLVYEY 770 (1036)
Q Consensus 693 ~~~~~~~~iG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~-~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~ 770 (1036)
++|...+.||+|+||.||+|+.. +++.||+|.++... ......+.+|+.++++++||||+++++++..++..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 56888899999999999999864 67889999986543 23345678899999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeecCCCCc
Q 001658 771 LENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTH 850 (1036)
Q Consensus 771 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~ 850 (1036)
+++ +|.+++... ...+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++........
T Consensus 86 ~~~-~l~~~~~~~-~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 160 (309)
T cd07872 86 LDK-DLKQYMDDC-GNIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSVPTKT 160 (309)
T ss_pred CCC-CHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccceecCCCccc
Confidence 975 888887543 345788899999999999999999988 999999999999999999999999999765432221
Q ss_pred cccccccccCccCcccccc-CCCCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHH--------HHhhcCcc-c
Q 001658 851 ISTRVAGTIGYLAPEYAMR-GHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAW--------HLHENNQE-I 920 (1036)
Q Consensus 851 ~~~~~~gt~~y~APE~~~~-~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~--------~~~~~~~~-~ 920 (1036)
.....+|+.|+|||++.+ ..++.++|||||||++|||+||++||......+......... ........ .
T Consensus 161 -~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (309)
T cd07872 161 -YSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFK 239 (309)
T ss_pred -cccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhh
Confidence 223457899999999865 468899999999999999999999998765444333221110 00000000 0
Q ss_pred cccCccc-----ccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 001658 921 ELADPKL-----IEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVA 961 (1036)
Q Consensus 921 ~~~d~~~-----~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 961 (1036)
....+.. ..........+.+++.+|++.||.+|||+.|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 240 NYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred hhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 0000000 0001112345678889999999999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-34 Score=308.54 Aligned_cols=247 Identities=29% Similarity=0.403 Sum_probs=198.9
Q ss_pred CccccCCCEEEEEeEeCCCcEEEEEEccccch-hcHHHHHHHHHHHHhhccCCcceeEeEEEcCceeEEEEEecCCCChh
Q 001658 699 NKLGEGGFGPVYKGKLGDGRAIAVKQLSVASR-QGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLVYEYLENKSLD 777 (1036)
Q Consensus 699 ~~iG~G~fG~Vy~~~~~~g~~vAvK~~~~~~~-~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~ 777 (1036)
++||+|+||.||++...+++.||+|.+..... .....+.+|++++++++|+||+++++++.+....++|+||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 46999999999999987799999999875433 24568999999999999999999999999999999999999999999
Q ss_pred hhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeecCCCCccc-cccc
Q 001658 778 QALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHIS-TRVA 856 (1036)
Q Consensus 778 ~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~-~~~~ 856 (1036)
+++... ...+++..+..++.+++.|++|||+++ ++||||||+||+++.++.+||+|||+++.......... ....
T Consensus 81 ~~l~~~-~~~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~ 156 (251)
T cd05041 81 TFLRKK-KNRLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQ 156 (251)
T ss_pred HHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCc
Confidence 998654 336789999999999999999999988 99999999999999999999999999986542221111 1123
Q ss_pred cccCccCccccccCCCCchhhHHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHHHHHhhcCccccccCcccccCCHHHH
Q 001658 857 GTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVS-GRPNSDPSLDEEKLYLLEWAWHLHENNQEIELADPKLIEFNEEEV 935 (1036)
Q Consensus 857 gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 935 (1036)
++..|+|||.+.++.++.++|||||||++|||+| |..||............ .... .. .......
T Consensus 157 ~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~-------~~~~--~~------~~~~~~~ 221 (251)
T cd05041 157 IPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERI-------ESGY--RM------PAPQLCP 221 (251)
T ss_pred ceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHH-------hcCC--CC------CCCccCC
Confidence 4567999999998899999999999999999999 78888654432222111 0000 00 0112233
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 001658 936 KRLIGVALLCTQTLPSLRPSMSRVVAMLC 964 (1036)
Q Consensus 936 ~~l~~l~~~Cl~~dP~~RPt~~evl~~L~ 964 (1036)
..+.+++.+|++.+|++||++.||++.|+
T Consensus 222 ~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 222 EEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred HHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 56888899999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=320.35 Aligned_cols=249 Identities=27% Similarity=0.443 Sum_probs=203.4
Q ss_pred cCCCCCCccccCCCEEEEEeEe-CCCcEEEEEEccccchhcHHHHHHHHHHHHhhccCCcceeEeEEEcCceeEEEEEec
Q 001658 693 ENFSPSNKLGEGGFGPVYKGKL-GDGRAIAVKQLSVASRQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLVYEYL 771 (1036)
Q Consensus 693 ~~~~~~~~iG~G~fG~Vy~~~~-~~g~~vAvK~~~~~~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~~ 771 (1036)
.+|+..+.||.|+||.||+|.. .+++.||+|.+........+.+.+|+.+++.++|+||+++++++...+..++|+||+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 98 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL 98 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence 4578889999999999999984 578999999987655455677899999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeecCCCCcc
Q 001658 772 ENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHI 851 (1036)
Q Consensus 772 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 851 (1036)
++++|.+++.. ..+++.++..++.|++.|++|||+.+ ++||||||+||+++.++.+||+|||++.........
T Consensus 99 ~~~~L~~~~~~---~~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~- 171 (296)
T cd06655 99 AGGSLTDVVTE---TCMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSK- 171 (296)
T ss_pred CCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhccccccc-
Confidence 99999998853 35899999999999999999999988 999999999999999999999999998865433221
Q ss_pred ccccccccCccCccccccCCCCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhcCccccccCcccccCC
Q 001658 852 STRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEIELADPKLIEFN 931 (1036)
Q Consensus 852 ~~~~~gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~ 931 (1036)
.....|+..|+|||.+.+..++.++|||||||++|||++|+.||............. . ...... ...
T Consensus 172 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~------~-~~~~~~------~~~ 238 (296)
T cd06655 172 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA------T-NGTPEL------QNP 238 (296)
T ss_pred CCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH------h-cCCccc------CCc
Confidence 223468889999999998889999999999999999999999998755433222110 0 000000 011
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 001658 932 EEEVKRLIGVALLCTQTLPSLRPSMSRVVA 961 (1036)
Q Consensus 932 ~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 961 (1036)
......+.+++.+||+.+|.+||++.+++.
T Consensus 239 ~~~~~~~~~li~~~l~~dp~~Rpt~~~il~ 268 (296)
T cd06655 239 EKLSPIFRDFLNRCLEMDVEKRGSAKELLQ 268 (296)
T ss_pred ccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 122345677888999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=315.63 Aligned_cols=252 Identities=23% Similarity=0.380 Sum_probs=199.6
Q ss_pred cCCCCCCccccCCCEEEEEeEe-CCCcEEEEEEccccchhcHHHHHHHHHHHHhhccCCcceeEeEEEcCceeEEEEEec
Q 001658 693 ENFSPSNKLGEGGFGPVYKGKL-GDGRAIAVKQLSVASRQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLVYEYL 771 (1036)
Q Consensus 693 ~~~~~~~~iG~G~fG~Vy~~~~-~~g~~vAvK~~~~~~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~~ 771 (1036)
++|++.+.||+|+||.||+|+. .+++.||+|.++.........+.+|+.+++.++||||+++++++...+..++|+||+
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 88 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC 88 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence 4677778899999999999985 468899999987654444567889999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeecCCCCcc
Q 001658 772 ENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHI 851 (1036)
Q Consensus 772 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 851 (1036)
++++|.+++... ..+++.+...++.|++.||+|||+.+ |+|+||||+||+++.++.++|+|||++........ .
T Consensus 89 ~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~-~ 162 (267)
T cd06645 89 GGGSLQDIYHVT--GPLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQITATIA-K 162 (267)
T ss_pred CCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeEccCccc-c
Confidence 999999998643 36889999999999999999999988 99999999999999999999999999976643222 2
Q ss_pred ccccccccCccCccccc---cCCCCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhcCccccccCcccc
Q 001658 852 STRVAGTIGYLAPEYAM---RGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEIELADPKLI 928 (1036)
Q Consensus 852 ~~~~~gt~~y~APE~~~---~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~ 928 (1036)
.....|+..|+|||++. ...++.++|||||||++|||++|+.||............. .. . ...+...
T Consensus 163 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~------~~-~---~~~~~~~ 232 (267)
T cd06645 163 RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMT------KS-N---FQPPKLK 232 (267)
T ss_pred cccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhh------cc-C---CCCCccc
Confidence 23456899999999974 4568889999999999999999999986543322211110 00 0 0011110
Q ss_pred cCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 001658 929 EFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVA 961 (1036)
Q Consensus 929 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 961 (1036)
. .......+.+++.+|++.+|++||++++|++
T Consensus 233 ~-~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 233 D-KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred c-cCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence 0 0112235677888999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-34 Score=317.19 Aligned_cols=251 Identities=26% Similarity=0.371 Sum_probs=201.2
Q ss_pred cCCCCCCccccCCCEEEEEeEeC-CCcEEEEEEccccchhcHHHHHHHHHHHHhhccCCcceeEeEEEcCceeEEEEEec
Q 001658 693 ENFSPSNKLGEGGFGPVYKGKLG-DGRAIAVKQLSVASRQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLVYEYL 771 (1036)
Q Consensus 693 ~~~~~~~~iG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~~ 771 (1036)
+.|++.+.||+|+||.||+|+.. +++.||+|.+........+.+.+|+.+++.++|+||+++++++..+...++||||+
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 91 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC 91 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence 56888899999999999999865 58899999997666666778899999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeecCCCCcc
Q 001658 772 ENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHI 851 (1036)
Q Consensus 772 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 851 (1036)
++++|..++... ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++....... ..
T Consensus 92 ~~~~l~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~-~~ 166 (292)
T cd06644 92 PGGAVDAIMLEL-DRGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL-QR 166 (292)
T ss_pred CCCcHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccceeccccc-cc
Confidence 999998887543 346899999999999999999999987 9999999999999999999999999987643321 11
Q ss_pred ccccccccCccCccccc-----cCCCCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhcCccccccCcc
Q 001658 852 STRVAGTIGYLAPEYAM-----RGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEIELADPK 926 (1036)
Q Consensus 852 ~~~~~gt~~y~APE~~~-----~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 926 (1036)
.....++..|+|||++. ...++.++|||||||++|||++|++||......... ... .. . ..+.
T Consensus 167 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~--~~~----~~-~-----~~~~ 234 (292)
T cd06644 167 RDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVL--LKI----AK-S-----EPPT 234 (292)
T ss_pred cceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHH--HHH----hc-C-----CCcc
Confidence 22345888999999984 345788999999999999999999998764432211 110 00 0 0111
Q ss_pred cccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 001658 927 LIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVA 961 (1036)
Q Consensus 927 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 961 (1036)
. ........++.+++.+||+.+|++||++.|+++
T Consensus 235 ~-~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 235 L-SQPSKWSMEFRDFLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred C-CCCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 1 111223345778889999999999999999875
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-34 Score=311.05 Aligned_cols=249 Identities=22% Similarity=0.375 Sum_probs=204.2
Q ss_pred CCCCCCccccCCCEEEEEeEe-CCCcEEEEEEcccc--chhcHHHHHHHHHHHHhhccCCcceeEeEEEcCceeEEEEEe
Q 001658 694 NFSPSNKLGEGGFGPVYKGKL-GDGRAIAVKQLSVA--SRQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLVYEY 770 (1036)
Q Consensus 694 ~~~~~~~iG~G~fG~Vy~~~~-~~g~~vAvK~~~~~--~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~ 770 (1036)
+|+..+.||+|+||.||+++. .+|+.||+|.+... .....+++.+|+.++++++|+||+++++++...+..++|+||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 477889999999999999985 46889999998643 233456789999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeecCCCCc
Q 001658 771 LENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTH 850 (1036)
Q Consensus 771 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~ 850 (1036)
+++++|.+++.......+++.++++++.|++.|++|||+.+ ++|+||+|+||+++.++.++|+|||++.........
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~ 157 (256)
T cd08218 81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVEL 157 (256)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceeecCcchhh
Confidence 99999999997655567889999999999999999999987 999999999999999999999999999876443221
Q ss_pred cccccccccCccCccccccCCCCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhcCccccccCcccccC
Q 001658 851 ISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEIELADPKLIEF 930 (1036)
Q Consensus 851 ~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~ 930 (1036)
.....|+..|+|||+..+..++.++|||||||+++||++|+.||......+... ..... . .+ ..
T Consensus 158 -~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~------~~~~~-~-----~~---~~ 221 (256)
T cd08218 158 -ARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVL------KIIRG-S-----YP---PV 221 (256)
T ss_pred -hhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHH------HHhcC-C-----CC---CC
Confidence 223458889999999998889999999999999999999999987644322211 11110 0 01 11
Q ss_pred CHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 001658 931 NEEEVKRLIGVALLCTQTLPSLRPSMSRVVA 961 (1036)
Q Consensus 931 ~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 961 (1036)
.......+.+++.+||+.+|++||++.||++
T Consensus 222 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~ 252 (256)
T cd08218 222 SSHYSYDLRNLVSQLFKRNPRDRPSVNSILE 252 (256)
T ss_pred cccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 2223456788888999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=312.06 Aligned_cols=238 Identities=27% Similarity=0.439 Sum_probs=189.6
Q ss_pred CccccCCCEEEEEeEeCCCc-----------EEEEEEccccchhcHHHHHHHHHHHHhhccCCcceeEeEEEcCceeEEE
Q 001658 699 NKLGEGGFGPVYKGKLGDGR-----------AIAVKQLSVASRQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLV 767 (1036)
Q Consensus 699 ~~iG~G~fG~Vy~~~~~~g~-----------~vAvK~~~~~~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV 767 (1036)
+.||+|+||.||+|...+.. .|++|.+...... ...|.+|+.++++++|+||+++++++.. ...++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 46999999999999875432 5788877654433 6789999999999999999999999988 778999
Q ss_pred EEecCCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCC-------ceEEEEcCc
Q 001658 768 YEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADL-------VPKISDFGL 840 (1036)
Q Consensus 768 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~-------~~kl~DFGl 840 (1036)
+||+++|+|.+++..... .+++..++.++.||+.||+|||+.+ |+||||||+||+++.++ .+||+|||+
T Consensus 79 ~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~ 154 (259)
T cd05037 79 EEYVKFGPLDVFLHREKN-NVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDPGI 154 (259)
T ss_pred EEcCCCCcHHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEeCCCCc
Confidence 999999999999975432 6889999999999999999999987 99999999999999887 799999999
Q ss_pred ceeecCCCCccccccccccCccCccccccC--CCCchhhHHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHHHHHhhcC
Q 001658 841 AKLYDDKKTHISTRVAGTIGYLAPEYAMRG--HLTEKTDVFAFGVLALETVS-GRPNSDPSLDEEKLYLLEWAWHLHENN 917 (1036)
Q Consensus 841 a~~~~~~~~~~~~~~~gt~~y~APE~~~~~--~~~~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~ 917 (1036)
+...... ....++..|+|||++... .++.++||||||+++|||++ |..|+............ ...
T Consensus 155 a~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~-------~~~ 222 (259)
T cd05037 155 PITVLSR-----EERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFY-------QDQ 222 (259)
T ss_pred ccccccc-----cccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHH-------hcC
Confidence 9865431 223467789999999876 78999999999999999999 46666554322111100 000
Q ss_pred ccccccCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 001658 918 QEIELADPKLIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVAMLC 964 (1036)
Q Consensus 918 ~~~~~~d~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~ 964 (1036)
. ....+ ....+.+++.+||..+|.+|||+.||++.|+
T Consensus 223 ~--~~~~~--------~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 223 H--RLPMP--------DCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred C--CCCCC--------CchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 0 00011 0157788899999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-34 Score=313.26 Aligned_cols=248 Identities=28% Similarity=0.407 Sum_probs=203.0
Q ss_pred cCCCCCCccccCCCEEEEEeEeC-CCcEEEEEEccccc-hhcHHHHHHHHHHHHhhccCCcceeEeEEEcCceeEEEEEe
Q 001658 693 ENFSPSNKLGEGGFGPVYKGKLG-DGRAIAVKQLSVAS-RQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLVYEY 770 (1036)
Q Consensus 693 ~~~~~~~~iG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~-~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~ 770 (1036)
++|+..+.||.|+||.||+|+.. +++.||+|.+.... ......+.+|+++++.++|+||+++++++.++...++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 36778899999999999999864 68899999986543 33456788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeecCCCCc
Q 001658 771 LENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTH 850 (1036)
Q Consensus 771 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~ 850 (1036)
+++++|.+++... .+++..+..++.|++.|+.|||+.+ ++||||+|+||++++++.++|+|||+++.......
T Consensus 81 ~~~~~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~- 153 (274)
T cd06609 81 CGGGSCLDLLKPG---KLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS- 153 (274)
T ss_pred eCCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccceeeccccc-
Confidence 9999999998643 7899999999999999999999987 99999999999999999999999999987764322
Q ss_pred cccccccccCccCccccccCCCCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhcCccccccCcccccC
Q 001658 851 ISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEIELADPKLIEF 930 (1036)
Q Consensus 851 ~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~ 930 (1036)
......|+..|+|||++.+..++.++||||||+++|||+||+.||............ . .. ..+.+...
T Consensus 154 ~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~------~-~~-----~~~~~~~~ 221 (274)
T cd06609 154 KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLI------P-KN-----NPPSLEGN 221 (274)
T ss_pred ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHh------h-hc-----CCCCCccc
Confidence 223356888999999999888999999999999999999999999754432211100 0 00 11111111
Q ss_pred CHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 001658 931 NEEEVKRLIGVALLCTQTLPSLRPSMSRVVA 961 (1036)
Q Consensus 931 ~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 961 (1036)
.....+.+++.+||..+|++|||++++++
T Consensus 222 --~~~~~~~~~l~~~l~~~p~~Rpt~~~il~ 250 (274)
T cd06609 222 --KFSKPFKDFVSLCLNKDPKERPSAKELLK 250 (274)
T ss_pred --ccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 03345778888999999999999999976
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=325.33 Aligned_cols=243 Identities=24% Similarity=0.279 Sum_probs=189.9
Q ss_pred CccccCCCEEEEEeEeC-CCcEEEEEEccccc---hhcHHHHHHHHHHHHhh-ccCCcceeEeEEEcCceeEEEEEecCC
Q 001658 699 NKLGEGGFGPVYKGKLG-DGRAIAVKQLSVAS---RQGKSQFVAEIATISAV-QHRNLVKLHGCCIEGAERLLVYEYLEN 773 (1036)
Q Consensus 699 ~~iG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~f~~Ei~~L~~l-~H~nIv~l~g~~~~~~~~~lV~E~~~~ 773 (1036)
+.||+|+||.||+|+.. +++.||+|+++... ....+.+..|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999864 67899999997532 23345678899999888 699999999999999999999999999
Q ss_pred CChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeecCCCCcccc
Q 001658 774 KSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHIST 853 (1036)
Q Consensus 774 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 853 (1036)
|+|.+++... ..+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++....... ...
T Consensus 81 ~~L~~~~~~~--~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~-~~~ 154 (327)
T cd05617 81 GDLMFHMQRQ--RKLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGD-TTS 154 (327)
T ss_pred CcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceeccCCCC-cee
Confidence 9999888543 45899999999999999999999988 99999999999999999999999999975332211 223
Q ss_pred ccccccCccCccccccCCCCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhcCccccccCcccccCCHH
Q 001658 854 RVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEIELADPKLIEFNEE 933 (1036)
Q Consensus 854 ~~~gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~ 933 (1036)
...||+.|+|||++.+..++.++|||||||++|||++|+.||............++........ ...+. ..
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~------~~~~p---~~ 225 (327)
T cd05617 155 TFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEK------PIRIP---RF 225 (327)
T ss_pred cccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhC------CCCCC---CC
Confidence 4569999999999999999999999999999999999999996432211111111111111111 01111 11
Q ss_pred HHHHHHHHHHHhcccCCCCCCCH
Q 001658 934 EVKRLIGVALLCTQTLPSLRPSM 956 (1036)
Q Consensus 934 ~~~~l~~l~~~Cl~~dP~~RPt~ 956 (1036)
....+.+++.+|++.||++|+++
T Consensus 226 ~~~~~~~li~~~L~~dP~~R~~~ 248 (327)
T cd05617 226 LSVKASHVLKGFLNKDPKERLGC 248 (327)
T ss_pred CCHHHHHHHHHHhccCHHHcCCC
Confidence 22446677889999999999985
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-34 Score=310.40 Aligned_cols=253 Identities=25% Similarity=0.385 Sum_probs=206.0
Q ss_pred cCCCCCCccccCCCEEEEEeEeC-CCcEEEEEEccccchhcHHHHHHHHHHHHhhccCCcceeEeEEEcCceeEEEEEec
Q 001658 693 ENFSPSNKLGEGGFGPVYKGKLG-DGRAIAVKQLSVASRQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLVYEYL 771 (1036)
Q Consensus 693 ~~~~~~~~iG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~~ 771 (1036)
++|+..+.||+|+||.||+|... +++.+|+|.+........+.+.+|++++++++||||+++++++.+.+..+++|||+
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~ 82 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYC 82 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCC
Confidence 57888899999999999999864 57889999987655556678999999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeecCCCCcc
Q 001658 772 ENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHI 851 (1036)
Q Consensus 772 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 851 (1036)
++++|.+++... ...+++..+..++.|++.||+|||+.+ |+|+||||+||++++++.+||+|||++........ .
T Consensus 83 ~~~~l~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~-~ 157 (262)
T cd06613 83 GGGSLQDIYQVT-RGPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA-K 157 (262)
T ss_pred CCCcHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhhhhhhh-c
Confidence 999999988653 246889999999999999999999987 99999999999999999999999999876543221 1
Q ss_pred ccccccccCccCccccccC---CCCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhcCccccccCcccc
Q 001658 852 STRVAGTIGYLAPEYAMRG---HLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEIELADPKLI 928 (1036)
Q Consensus 852 ~~~~~gt~~y~APE~~~~~---~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~ 928 (1036)
.....++..|+|||.+... .++.++||||||+++|||+||++||............. . .. ..+...
T Consensus 158 ~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~-------~---~~-~~~~~~ 226 (262)
T cd06613 158 RKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLIS-------K---SN-FPPPKL 226 (262)
T ss_pred cccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH-------h---cc-CCCccc
Confidence 2234688899999999776 88999999999999999999999997654333221110 0 00 011111
Q ss_pred cCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 001658 929 EFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVA 961 (1036)
Q Consensus 929 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 961 (1036)
.........+.+++.+||+.+|.+|||+.+|+.
T Consensus 227 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 227 KDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred cchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 122344567889999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=337.36 Aligned_cols=261 Identities=20% Similarity=0.271 Sum_probs=192.9
Q ss_pred HhcCCCCCCccccCCCEEEEEeEe-CCCcEEEEEEccccchhcHHHHHHHHHHHHhhccCCcceeEeEEEcC--------
Q 001658 691 ATENFSPSNKLGEGGFGPVYKGKL-GDGRAIAVKQLSVASRQGKSQFVAEIATISAVQHRNLVKLHGCCIEG-------- 761 (1036)
Q Consensus 691 ~~~~~~~~~~iG~G~fG~Vy~~~~-~~g~~vAvK~~~~~~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~-------- 761 (1036)
..++|++.+.||+|+||.||+|.. .+++.||||++.... ....+|+.+++.++||||+++++++...
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~ 139 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKN 139 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCc
Confidence 346788999999999999999986 468899999885322 2345799999999999999999987532
Q ss_pred ceeEEEEEecCCCChhhhhhc--CCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCC-ceEEEEc
Q 001658 762 AERLLVYEYLENKSLDQALFG--QRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADL-VPKISDF 838 (1036)
Q Consensus 762 ~~~~lV~E~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~-~~kl~DF 838 (1036)
...++||||++ ++|.+++.. .....+++..+..++.||++||+|||+.+ |+||||||+|||++.++ .+||+||
T Consensus 140 ~~l~lvmE~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL~DF 215 (440)
T PTZ00036 140 IFLNVVMEFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDF 215 (440)
T ss_pred eEEEEEEecCC-ccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceeeecc
Confidence 23568999997 477777643 23456889999999999999999999988 99999999999999764 7999999
Q ss_pred CcceeecCCCCccccccccccCccCccccccC-CCCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhc-
Q 001658 839 GLAKLYDDKKTHISTRVAGTIGYLAPEYAMRG-HLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHEN- 916 (1036)
Q Consensus 839 Gla~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~- 916 (1036)
|+++.+..... .....||+.|+|||++.+. .++.++|||||||++|||++|++||......+..............
T Consensus 216 Gla~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~ 293 (440)
T PTZ00036 216 GSAKNLLAGQR--SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTED 293 (440)
T ss_pred ccchhccCCCC--cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Confidence 99987643322 2235689999999998754 6899999999999999999999999875543332221111000000
Q ss_pred ------CccccccCccc------ccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 001658 917 ------NQEIELADPKL------IEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVA 961 (1036)
Q Consensus 917 ------~~~~~~~d~~~------~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 961 (1036)
.......-+.. ..++.....++.+++.+||+.||.+|||+.|+++
T Consensus 294 ~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~ 350 (440)
T PTZ00036 294 QLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALA 350 (440)
T ss_pred HHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhC
Confidence 00000000000 0011122356788899999999999999999985
|
|
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-34 Score=312.65 Aligned_cols=250 Identities=23% Similarity=0.398 Sum_probs=200.0
Q ss_pred CCCCCCccccCCCEEEEEeEeCCCcEEEEEEccccc------hhcHHHHHHHHHHHHhhccCCcceeEeEEEcCceeEEE
Q 001658 694 NFSPSNKLGEGGFGPVYKGKLGDGRAIAVKQLSVAS------RQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLV 767 (1036)
Q Consensus 694 ~~~~~~~iG~G~fG~Vy~~~~~~g~~vAvK~~~~~~------~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV 767 (1036)
+|+..+.||+|+||.||+|...+++.+|+|.+.... ......+.+|++++++++|+||+++++++.+.+..++|
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 477889999999999999998889999999886421 12235688999999999999999999999999999999
Q ss_pred EEecCCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeecCC
Q 001658 768 YEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDK 847 (1036)
Q Consensus 768 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~ 847 (1036)
+||+++++|.+++... ..+++..+..++.|++.||+|||+.+ |+|+||||+||++++++.++|+|||++......
T Consensus 81 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 155 (265)
T cd06631 81 MEFVPGGSISSILNRF--GPLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWV 155 (265)
T ss_pred EecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchhhHhhhhc
Confidence 9999999999999643 35788999999999999999999987 999999999999999999999999998765321
Q ss_pred C-----CccccccccccCccCccccccCCCCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhcCccccc
Q 001658 848 K-----THISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEIEL 922 (1036)
Q Consensus 848 ~-----~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 922 (1036)
. ........|+..|+|||++.+..++.++|||||||++|||++|+.||............ .. ...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~------~~----~~~ 225 (265)
T cd06631 156 GLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYI------GA----HRG 225 (265)
T ss_pred cccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHh------hh----ccC
Confidence 1 11122356889999999999888999999999999999999999999754332211100 00 000
Q ss_pred cCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 001658 923 ADPKLIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVA 961 (1036)
Q Consensus 923 ~d~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 961 (1036)
..+.+ .......+.+++.+||+.+|.+||++.|+++
T Consensus 226 ~~~~~---~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 226 LMPRL---PDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred CCCCC---CCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 11112 1223345677888999999999999999874
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=305.68 Aligned_cols=248 Identities=27% Similarity=0.421 Sum_probs=209.4
Q ss_pred CCCCCCccccCCCEEEEEeEeC-CCcEEEEEEccccchhcHHHHHHHHHHHHhhccCCcceeEeEEEcCceeEEEEEecC
Q 001658 694 NFSPSNKLGEGGFGPVYKGKLG-DGRAIAVKQLSVASRQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLVYEYLE 772 (1036)
Q Consensus 694 ~~~~~~~iG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~~~ 772 (1036)
-|.++++||+|+||.||||.++ .|..||||.+...+ +.+++..|+.++++.+.|++|++||.|......|+|||||-
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~s--DLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCG 111 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDT--DLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCG 111 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccc--hHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcC
Confidence 3567789999999999999864 79999999987543 35788999999999999999999999999999999999999
Q ss_pred CCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeecCCCCccc
Q 001658 773 NKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHIS 852 (1036)
Q Consensus 773 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 852 (1036)
.||..+.++. ++.++.+..+..|+...++||+|||... -||||||..|||++.+|.+||+|||.|-.+.+.-.. .
T Consensus 112 AGSiSDI~R~-R~K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAK-R 186 (502)
T KOG0574|consen 112 AGSISDIMRA-RRKPLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAK-R 186 (502)
T ss_pred CCcHHHHHHH-hcCCccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccchhhhhHHh-h
Confidence 9999998854 4678999999999999999999999876 799999999999999999999999999876543222 3
Q ss_pred cccccccCccCccccccCCCCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhcCccccccCcccccCCH
Q 001658 853 TRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEIELADPKLIEFNE 932 (1036)
Q Consensus 853 ~~~~gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~ 932 (1036)
..+.||+.|||||++..-.|+.++||||+|+...||..|++|+..-.+....+ .+....|.-...++
T Consensus 187 NTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIF-------------MIPT~PPPTF~KPE 253 (502)
T KOG0574|consen 187 NTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIF-------------MIPTKPPPTFKKPE 253 (502)
T ss_pred CccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeE-------------eccCCCCCCCCChH
Confidence 45789999999999999999999999999999999999999997654432221 11111222234456
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 001658 933 EEVKRLIGVALLCTQTLPSLRPSMSRVVA 961 (1036)
Q Consensus 933 ~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 961 (1036)
+...++-+++..|+-+.|++|-|+.++++
T Consensus 254 ~WS~~F~DFi~~CLiK~PE~R~TA~~L~~ 282 (502)
T KOG0574|consen 254 EWSSEFNDFIRSCLIKKPEERKTALRLCE 282 (502)
T ss_pred hhhhHHHHHHHHHhcCCHHHHHHHHHHhh
Confidence 67778999999999999999999999876
|
|
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-33 Score=325.63 Aligned_cols=259 Identities=19% Similarity=0.198 Sum_probs=194.5
Q ss_pred cCCCCCCccccCCCEEEEEeEeC-CCcEEEEEEccccchhcHHHHHHHHHHHHhhccCCcceeEeEEEcCceeEEEEEec
Q 001658 693 ENFSPSNKLGEGGFGPVYKGKLG-DGRAIAVKQLSVASRQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLVYEYL 771 (1036)
Q Consensus 693 ~~~~~~~~iG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~~ 771 (1036)
.+|.+.+.||+|+||.||+|... .++.||||... ...+.+|++++++++|+|||++++++..++..++|||++
T Consensus 169 ~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~ 242 (461)
T PHA03211 169 LGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKY 242 (461)
T ss_pred CCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEcc
Confidence 36888899999999999999865 57889999643 234678999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeecCCCCc-
Q 001658 772 ENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTH- 850 (1036)
Q Consensus 772 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~- 850 (1036)
. ++|.+++... ...++|..+..|+.|+++||.|||+.+ ||||||||+|||++.++.+||+|||+++........
T Consensus 243 ~-~~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~ 317 (461)
T PHA03211 243 R-SDLYTYLGAR-LRPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTP 317 (461)
T ss_pred C-CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceecccccccc
Confidence 4 7898888543 346899999999999999999999988 999999999999999999999999999876433221
Q ss_pred cccccccccCccCccccccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCh--------hhHHHHHHHHHHHhhcCcc---
Q 001658 851 ISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRPNSDPSLD--------EEKLYLLEWAWHLHENNQE--- 919 (1036)
Q Consensus 851 ~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~--------~~~~~l~~~~~~~~~~~~~--- 919 (1036)
......||..|+|||++.+..++.++|||||||++|||++|..|+..... ......+.+.......-..
T Consensus 318 ~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~ 397 (461)
T PHA03211 318 FHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAG 397 (461)
T ss_pred cccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcc
Confidence 22345699999999999999999999999999999999998866532211 1111112111100000000
Q ss_pred -----------ccccCccccc--C--CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 001658 920 -----------IELADPKLIE--F--NEEEVKRLIGVALLCTQTLPSLRPSMSRVVAM 962 (1036)
Q Consensus 920 -----------~~~~d~~~~~--~--~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 962 (1036)
.....+.... + .......+.+++.+|++.||.+|||+.|+++.
T Consensus 398 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 398 SRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred hHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 0000000000 0 00112357778889999999999999999864
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=295.64 Aligned_cols=251 Identities=23% Similarity=0.298 Sum_probs=199.4
Q ss_pred hcCCCCCCccccCCCEEEEEeEe-CCCcEEEEEEcccc--chhcHHHHHHHHHHHHhhccCCcceeEeEEEcCceeEEEE
Q 001658 692 TENFSPSNKLGEGGFGPVYKGKL-GDGRAIAVKQLSVA--SRQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLVY 768 (1036)
Q Consensus 692 ~~~~~~~~~iG~G~fG~Vy~~~~-~~g~~vAvK~~~~~--~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~ 768 (1036)
.+.|++.+.||+|.|+.||++.. ..|+.+|+|++... ...+.+++.+|+++-+.++|||||++.+.+.+....++|+
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF 89 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 89 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence 45677788999999999999974 57899999988542 3446778899999999999999999999999999999999
Q ss_pred EecCCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecC---CCceEEEEcCcceeec
Q 001658 769 EYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDA---DLVPKISDFGLAKLYD 845 (1036)
Q Consensus 769 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~---~~~~kl~DFGla~~~~ 845 (1036)
|+|+|++|..-+-. +..+++...-..++||+++|+|+|.++ |||||+||.|+++-. ..-+||+|||+|..+.
T Consensus 90 e~m~G~dl~~eIV~--R~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~ 164 (355)
T KOG0033|consen 90 DLVTGGELFEDIVA--REFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN 164 (355)
T ss_pred ecccchHHHHHHHH--HHHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecccceEEEeC
Confidence 99999999764432 245677777788999999999999998 999999999999944 3469999999999887
Q ss_pred CCCCccccccccccCccCccccccCCCCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhcCccccccCc
Q 001658 846 DKKTHISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEIELADP 925 (1036)
Q Consensus 846 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 925 (1036)
........+|||+|||||++.+.+|+..+|||+.|||||-|+.|++||......+.+..+. . ..--+++
T Consensus 165 --~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~-------~--g~yd~~~ 233 (355)
T KOG0033|consen 165 --DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIK-------A--GAYDYPS 233 (355)
T ss_pred --CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHh-------c--cccCCCC
Confidence 3333455789999999999999999999999999999999999999998744333221111 0 1111222
Q ss_pred ccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 001658 926 KLIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVA 961 (1036)
Q Consensus 926 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 961 (1036)
...+...++++. ++.+|+..||.+|.|+.|.+.
T Consensus 234 ~~w~~is~~Ak~---LvrrML~~dP~kRIta~EAL~ 266 (355)
T KOG0033|consen 234 PEWDTVTPEAKS---LIRRMLTVNPKKRITADEALK 266 (355)
T ss_pred cccCcCCHHHHH---HHHHHhccChhhhccHHHHhC
Confidence 222333445554 456788999999999999875
|
|
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=319.27 Aligned_cols=262 Identities=27% Similarity=0.418 Sum_probs=203.9
Q ss_pred cCCCCCCccccCCCEEEEEeEeC-----CCcEEEEEEccccchh-cHHHHHHHHHHHHhhccCCcceeEeEEEc--Ccee
Q 001658 693 ENFSPSNKLGEGGFGPVYKGKLG-----DGRAIAVKQLSVASRQ-GKSQFVAEIATISAVQHRNLVKLHGCCIE--GAER 764 (1036)
Q Consensus 693 ~~~~~~~~iG~G~fG~Vy~~~~~-----~g~~vAvK~~~~~~~~-~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~--~~~~ 764 (1036)
+.|+..+.||+|+||.||+|++. +++.||||.+...... ..+.|.+|+++++.++|+||+++++++.. ....
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 35667789999999999999853 3688999998755442 46789999999999999999999999887 5578
Q ss_pred EEEEEecCCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceee
Q 001658 765 LLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLY 844 (1036)
Q Consensus 765 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~ 844 (1036)
++||||+++++|.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.++|+|||++...
T Consensus 84 ~lv~e~~~~~~l~~~l~~~~-~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 159 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRHR-DQINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAKVL 159 (284)
T ss_pred EEEEecCCCCCHHHHHHhCc-cccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEccccccccc
Confidence 99999999999999996543 35899999999999999999999987 999999999999999999999999999876
Q ss_pred cCCCCcc--ccccccccCccCccccccCCCCchhhHHhHHHHHHHHHhCCCCCCCCChhhHH--------HHHHHHHHHh
Q 001658 845 DDKKTHI--STRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKL--------YLLEWAWHLH 914 (1036)
Q Consensus 845 ~~~~~~~--~~~~~gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~--------~l~~~~~~~~ 914 (1036)
....... .....++..|+|||......++.++||||||+++|||++|+.|+......... ..........
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (284)
T cd05038 160 PEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELL 239 (284)
T ss_pred ccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHH
Confidence 5332211 11234556799999998889999999999999999999999988653221100 0000000001
Q ss_pred hcCccccccCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcc
Q 001658 915 ENNQEIELADPKLIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVAMLCGD 966 (1036)
Q Consensus 915 ~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 966 (1036)
.... . ..........+.+++.+||+.+|++|||+.||+++|+..
T Consensus 240 ~~~~-------~-~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 240 KEGE-------R-LPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HcCC-------c-CCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 0000 0 011122235688899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-34 Score=326.31 Aligned_cols=262 Identities=24% Similarity=0.267 Sum_probs=196.5
Q ss_pred HhcCCCCCCccccCCCEEEEEeEe-CCCcEEEEEEcccc--chhcHHHHHHHHHHHHhhccCCcceeEeEEEcCc-----
Q 001658 691 ATENFSPSNKLGEGGFGPVYKGKL-GDGRAIAVKQLSVA--SRQGKSQFVAEIATISAVQHRNLVKLHGCCIEGA----- 762 (1036)
Q Consensus 691 ~~~~~~~~~~iG~G~fG~Vy~~~~-~~g~~vAvK~~~~~--~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~----- 762 (1036)
..++|+..+.||+|+||.||++.. .+|+.||+|++... .......+.+|+.+++.++||||+++++++....
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 457899999999999999999985 46899999998643 2334567889999999999999999999986543
Q ss_pred -eeEEEEEecCCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcc
Q 001658 763 -ERLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLA 841 (1036)
Q Consensus 763 -~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla 841 (1036)
..++||||+++ +|.+.++ ..+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 99 ~~~~lv~e~~~~-~l~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~kl~Dfg~a 170 (359)
T cd07876 99 QDVYLVMELMDA-NLCQVIH----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 170 (359)
T ss_pred ceeEEEEeCCCc-CHHHHHh----ccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEecCCCc
Confidence 46899999965 6666663 24788888999999999999999998 999999999999999999999999999
Q ss_pred eeecCCCCccccccccccCccCccccccCCCCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHH--------------
Q 001658 842 KLYDDKKTHISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLL-------------- 907 (1036)
Q Consensus 842 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~-------------- 907 (1036)
+...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+.....
T Consensus 171 ~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (359)
T cd07876 171 RTACTNF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNR 248 (359)
T ss_pred cccccCc--cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHH
Confidence 7543221 223456899999999999999999999999999999999999999865432211100
Q ss_pred --HHHHHHhhcCccc------ccc----CcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 001658 908 --EWAWHLHENNQEI------ELA----DPKLIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVAM 962 (1036)
Q Consensus 908 --~~~~~~~~~~~~~------~~~----d~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 962 (1036)
............. +.. .+............+.+++.+|++.||++|||+.|+++.
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 315 (359)
T cd07876 249 LQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH 315 (359)
T ss_pred HHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence 0000000000000 000 000000111123457788899999999999999999863
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=324.87 Aligned_cols=204 Identities=23% Similarity=0.281 Sum_probs=174.5
Q ss_pred cCCCCCCccccCCCEEEEEeEeC-CCcEEEEEEcccc---chhcHHHHHHHHHHHHhhccCCcceeEeEEEcCceeEEEE
Q 001658 693 ENFSPSNKLGEGGFGPVYKGKLG-DGRAIAVKQLSVA---SRQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLVY 768 (1036)
Q Consensus 693 ~~~~~~~~iG~G~fG~Vy~~~~~-~g~~vAvK~~~~~---~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~ 768 (1036)
++|++.+.||+|+||.||+++.+ +++.||+|++... .......|.+|+.++..++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 46888899999999999999865 5788999998642 2223445888999999999999999999999999999999
Q ss_pred EecCCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeecCCC
Q 001658 769 EYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKK 848 (1036)
Q Consensus 769 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~ 848 (1036)
||+++|+|.+++... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 81 ey~~~g~L~~~l~~~-~~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~ 156 (332)
T cd05623 81 DYYVGGDLLTLLSKF-EDRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG 156 (332)
T ss_pred eccCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchheecccCC
Confidence 999999999999653 345788899999999999999999988 9999999999999999999999999997664433
Q ss_pred CccccccccccCccCccccc-----cCCCCchhhHHhHHHHHHHHHhCCCCCCCCCh
Q 001658 849 THISTRVAGTIGYLAPEYAM-----RGHLTEKTDVFAFGVLALETVSGRPNSDPSLD 900 (1036)
Q Consensus 849 ~~~~~~~~gt~~y~APE~~~-----~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~ 900 (1036)
........||+.|+|||++. ...++.++|||||||++|||++|+.||.....
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~ 213 (332)
T cd05623 157 TVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESL 213 (332)
T ss_pred cceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCH
Confidence 33333457999999999986 34688899999999999999999999986543
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=328.85 Aligned_cols=263 Identities=21% Similarity=0.245 Sum_probs=207.0
Q ss_pred HhcCCCCCCccccCCCEEEEEeEe-CCCcEEEEEEccccchhcHHHHHHHHHHHHhhc-cC-----CcceeEeEEEcCce
Q 001658 691 ATENFSPSNKLGEGGFGPVYKGKL-GDGRAIAVKQLSVASRQGKSQFVAEIATISAVQ-HR-----NLVKLHGCCIEGAE 763 (1036)
Q Consensus 691 ~~~~~~~~~~iG~G~fG~Vy~~~~-~~g~~vAvK~~~~~~~~~~~~f~~Ei~~L~~l~-H~-----nIv~l~g~~~~~~~ 763 (1036)
...+|.+.+.||+|+||.|-||.. ++++.||||+++.... -..+-..|+.+|..++ |. |+|+++++|...++
T Consensus 184 i~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~-f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~H 262 (586)
T KOG0667|consen 184 IAYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKR-FLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNH 262 (586)
T ss_pred eEEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccChH-HHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccc
Confidence 344888999999999999999974 5699999999975432 2455677999999997 43 79999999999999
Q ss_pred eEEEEEecCCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCC--CceEEEEcCcc
Q 001658 764 RLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDAD--LVPKISDFGLA 841 (1036)
Q Consensus 764 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~--~~~kl~DFGla 841 (1036)
.+||+|.+ .-+|++++..++...++...++.|+.||+.||.+||+.+ |||+||||+||||.+- ..+||+|||.+
T Consensus 263 lciVfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKVIDFGSS 338 (586)
T KOG0667|consen 263 LCIVFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKVIDFGSS 338 (586)
T ss_pred eeeeehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeEEecccc
Confidence 99999998 569999999988888999999999999999999999988 9999999999999653 47999999999
Q ss_pred eeecCCCCccccccccccCccCccccccCCCCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHH---------
Q 001658 842 KLYDDKKTHISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWH--------- 912 (1036)
Q Consensus 842 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~--------- 912 (1036)
+.....-. ....+..|+|||++.+.+|+.+.||||||||+.||++|.+.|.+..+.+....+..+..
T Consensus 339 c~~~q~vy----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~ 414 (586)
T KOG0667|consen 339 CFESQRVY----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDT 414 (586)
T ss_pred cccCCcce----eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 97653322 34467789999999999999999999999999999999988887766655543321110
Q ss_pred ------Hhhc-Ccc--------------------------ccccCc-cc---ccCCH-HHHHHHHHHHHHhcccCCCCCC
Q 001658 913 ------LHEN-NQE--------------------------IELADP-KL---IEFNE-EEVKRLIGVALLCTQTLPSLRP 954 (1036)
Q Consensus 913 ------~~~~-~~~--------------------------~~~~d~-~~---~~~~~-~~~~~l~~l~~~Cl~~dP~~RP 954 (1036)
.+.. ... .+..-| .. ..... ..-+.+++++.+|++.||.+|+
T Consensus 415 ~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~ 494 (586)
T KOG0667|consen 415 AKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERI 494 (586)
T ss_pred ccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcC
Confidence 0111 000 000001 00 00111 3445689999999999999999
Q ss_pred CHHHHHHH
Q 001658 955 SMSRVVAM 962 (1036)
Q Consensus 955 t~~evl~~ 962 (1036)
|..|+++.
T Consensus 495 tp~qal~H 502 (586)
T KOG0667|consen 495 TPAQALNH 502 (586)
T ss_pred CHHHHhcC
Confidence 99999874
|
|
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=339.85 Aligned_cols=264 Identities=20% Similarity=0.206 Sum_probs=195.5
Q ss_pred HHHHHhcCCCCCCccccCCCEEEEEeEeC-CCcEEEEEEccccchhcHHHHHHHHHHHHhhccC------CcceeEeEEE
Q 001658 687 ELKTATENFSPSNKLGEGGFGPVYKGKLG-DGRAIAVKQLSVASRQGKSQFVAEIATISAVQHR------NLVKLHGCCI 759 (1036)
Q Consensus 687 ~l~~~~~~~~~~~~iG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~f~~Ei~~L~~l~H~------nIv~l~g~~~ 759 (1036)
++...+++|++.++||+|+||+||+|... .++.||||+++.... ....+..|+.++..++|. +++++++++.
T Consensus 123 ~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~-~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~ 201 (467)
T PTZ00284 123 DIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPK-YTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQ 201 (467)
T ss_pred ccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchh-hHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEE
Confidence 34456788999999999999999999854 578899999864322 234566788888777654 5888999887
Q ss_pred cC-ceeEEEEEecCCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhc-CCccccccccCCCcEEecCCC------
Q 001658 760 EG-AERLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEE-SRVRIIHRDVKASNVLLDADL------ 831 (1036)
Q Consensus 760 ~~-~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~ivHrDikp~NILl~~~~------ 831 (1036)
.. ...++|||++ +++|.+++... ..+++..+..|+.||+.||+|||++ + ||||||||+|||++.++
T Consensus 202 ~~~~~~~iv~~~~-g~~l~~~l~~~--~~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NILl~~~~~~~~~~ 275 (467)
T PTZ00284 202 NETGHMCIVMPKY-GPCLLDWIMKH--GPFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENILMETSDTVVDPV 275 (467)
T ss_pred cCCceEEEEEecc-CCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEecCCcccccc
Confidence 64 5678999988 78899888643 4688999999999999999999974 6 99999999999998765
Q ss_pred ----------ceEEEEcCcceeecCCCCccccccccccCccCccccccCCCCchhhHHhHHHHHHHHHhCCCCCCCCChh
Q 001658 832 ----------VPKISDFGLAKLYDDKKTHISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRPNSDPSLDE 901 (1036)
Q Consensus 832 ----------~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~ 901 (1036)
.+||+|||.+..... ......||+.|+|||++.+..++.++|||||||++|||++|++||......
T Consensus 276 ~~~~~~~~~~~vkl~DfG~~~~~~~----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~ 351 (467)
T PTZ00284 276 TNRALPPDPCRVRICDLGGCCDERH----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNL 351 (467)
T ss_pred cccccCCCCceEEECCCCccccCcc----ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH
Confidence 499999998764322 223467999999999999999999999999999999999999999876554
Q ss_pred hHHHHHHHHHH-----------------Hhhc-CccccccCccc-----c-c--CCHHHHHHHHHHHHHhcccCCCCCCC
Q 001658 902 EKLYLLEWAWH-----------------LHEN-NQEIELADPKL-----I-E--FNEEEVKRLIGVALLCTQTLPSLRPS 955 (1036)
Q Consensus 902 ~~~~l~~~~~~-----------------~~~~-~~~~~~~d~~~-----~-~--~~~~~~~~l~~l~~~Cl~~dP~~RPt 955 (1036)
+....+..... .+.. .......++.. . . ........+.+++.+|++.||.+|||
T Consensus 352 ~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t 431 (467)
T PTZ00284 352 EHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLN 431 (467)
T ss_pred HHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCC
Confidence 43333221100 0000 00000001100 0 0 00011245778999999999999999
Q ss_pred HHHHHH
Q 001658 956 MSRVVA 961 (1036)
Q Consensus 956 ~~evl~ 961 (1036)
+.|+++
T Consensus 432 a~e~L~ 437 (467)
T PTZ00284 432 ARQMTT 437 (467)
T ss_pred HHHHhc
Confidence 999986
|
|
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=316.50 Aligned_cols=252 Identities=24% Similarity=0.374 Sum_probs=202.6
Q ss_pred hcCCCCCCccccCCCEEEEEeEeC-CCcEEEEEEccccchhcHHHHHHHHHHHHhhccCCcceeEeEEEcCceeEEEEEe
Q 001658 692 TENFSPSNKLGEGGFGPVYKGKLG-DGRAIAVKQLSVASRQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLVYEY 770 (1036)
Q Consensus 692 ~~~~~~~~~iG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~ 770 (1036)
.++|++.+.||+|+||.||+|... +++.||+|.+........+.|..|++++++++|+||+++++++..+...++||||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF 83 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence 456888899999999999999864 6889999998766655667899999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeecCCCCc
Q 001658 771 LENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTH 850 (1036)
Q Consensus 771 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~ 850 (1036)
+++++|.+++... ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++........
T Consensus 84 ~~~~~L~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~- 158 (280)
T cd06611 84 CDGGALDSIMLEL-ERGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ- 158 (280)
T ss_pred cCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchhhccccc-
Confidence 9999999988643 346899999999999999999999998 99999999999999999999999999876543222
Q ss_pred cccccccccCccCccccc-----cCCCCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhcCccccccCc
Q 001658 851 ISTRVAGTIGYLAPEYAM-----RGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEIELADP 925 (1036)
Q Consensus 851 ~~~~~~gt~~y~APE~~~-----~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 925 (1036)
......|+..|+|||.+. ...++.++||||||+++|||++|+.||......... ..+ . ... .+
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~--~~~----~-~~~-----~~ 226 (280)
T cd06611 159 KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVL--LKI----L-KSE-----PP 226 (280)
T ss_pred ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHH--HHH----h-cCC-----CC
Confidence 123356899999999975 345778999999999999999999999764332211 111 1 000 01
Q ss_pred ccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 001658 926 KLIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVA 961 (1036)
Q Consensus 926 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 961 (1036)
.+ .........+.+++..||+.+|.+||++.++++
T Consensus 227 ~~-~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (280)
T cd06611 227 TL-DQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLK 261 (280)
T ss_pred Cc-CCcccCCHHHHHHHHHHhccChhhCcCHHHHhc
Confidence 11 111222345677888999999999999999976
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-34 Score=316.71 Aligned_cols=262 Identities=24% Similarity=0.333 Sum_probs=204.0
Q ss_pred cCHHHHHHHhcCCCCCCccccCCCEEEEEeEeC-CCcEEEEEEccccchhcHHHHHHHHHHHHhh-ccCCcceeEeEEE-
Q 001658 683 FSYAELKTATENFSPSNKLGEGGFGPVYKGKLG-DGRAIAVKQLSVASRQGKSQFVAEIATISAV-QHRNLVKLHGCCI- 759 (1036)
Q Consensus 683 ~~~~~l~~~~~~~~~~~~iG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~f~~Ei~~L~~l-~H~nIv~l~g~~~- 759 (1036)
+.++.+..+.++|++.+.||+|+||.||+|+.. +++.+|+|.+.... .....+.+|+.+++++ +|+||+++++++.
T Consensus 8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 86 (286)
T cd06638 8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYK 86 (286)
T ss_pred EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeee
Confidence 344566678899999999999999999999864 67899999876432 2245688899999999 6999999999884
Q ss_pred ----cCceeEEEEEecCCCChhhhhhcC--CCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCce
Q 001658 760 ----EGAERLLVYEYLENKSLDQALFGQ--RSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVP 833 (1036)
Q Consensus 760 ----~~~~~~lV~E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~ 833 (1036)
.++..++||||+++++|.+++... ....+++..+..++.|+++||.|||+.+ |+||||||+||++++++.+
T Consensus 87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~ 163 (286)
T cd06638 87 KDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGGV 163 (286)
T ss_pred cccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCCCCE
Confidence 345689999999999999987642 2456889999999999999999999987 9999999999999999999
Q ss_pred EEEEcCcceeecCCCCccccccccccCccCcccccc-----CCCCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHH
Q 001658 834 KISDFGLAKLYDDKKTHISTRVAGTIGYLAPEYAMR-----GHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLE 908 (1036)
Q Consensus 834 kl~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~-----~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~ 908 (1036)
||+|||+++....... ......|+..|+|||++.. ..++.++|||||||++|||++|+.|+.......... .
T Consensus 164 kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~--~ 240 (286)
T cd06638 164 KLVDFGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALF--K 240 (286)
T ss_pred EEccCCceeecccCCC-ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHh--h
Confidence 9999999987643322 1223468999999999753 457889999999999999999999987643322111 0
Q ss_pred HHHHHhhcCccccccCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 001658 909 WAWHLHENNQEIELADPKLIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVAM 962 (1036)
Q Consensus 909 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 962 (1036)
..........++. .....+.+++.+||+.+|++||++.|+++.
T Consensus 241 -----~~~~~~~~~~~~~------~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 283 (286)
T cd06638 241 -----IPRNPPPTLHQPE------LWSNEFNDFIRKCLTKDYEKRPTVSDLLQH 283 (286)
T ss_pred -----ccccCCCcccCCC------CcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence 0000001111111 122457788899999999999999999864
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-34 Score=322.72 Aligned_cols=242 Identities=24% Similarity=0.310 Sum_probs=192.7
Q ss_pred CCCCCCccccCCCEEEEEeEeC-CCcEEEEEEccccc---hhcHHHHHHHHHHHHhhc-cCCcceeEeEEEcCceeEEEE
Q 001658 694 NFSPSNKLGEGGFGPVYKGKLG-DGRAIAVKQLSVAS---RQGKSQFVAEIATISAVQ-HRNLVKLHGCCIEGAERLLVY 768 (1036)
Q Consensus 694 ~~~~~~~iG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~f~~Ei~~L~~l~-H~nIv~l~g~~~~~~~~~lV~ 768 (1036)
+|+..+.||+|+||.||+|+.. +|+.||+|++.... ....+.+..|.+++..+. |++|+++++++.+.+..++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 3667789999999999999854 68899999987532 233456778888888885 577888999999999999999
Q ss_pred EecCCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeecCCC
Q 001658 769 EYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKK 848 (1036)
Q Consensus 769 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~ 848 (1036)
||+++|+|.+++... ..+++.++..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++......
T Consensus 81 Ey~~~g~L~~~i~~~--~~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~ 155 (323)
T cd05615 81 EYVNGGDLMYHIQQV--GKFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG 155 (323)
T ss_pred cCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeccccccccCCCC
Confidence 999999999998543 45889999999999999999999988 9999999999999999999999999987543222
Q ss_pred CccccccccccCccCccccccCCCCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhcCccccccCcccc
Q 001658 849 THISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEIELADPKLI 928 (1036)
Q Consensus 849 ~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~ 928 (1036)
. ......||+.|+|||++.+..++.++|||||||++|||++|+.||.......... .. ... ...
T Consensus 156 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~---~i---~~~-------~~~-- 219 (323)
T cd05615 156 V-TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQ---SI---MEH-------NVS-- 219 (323)
T ss_pred c-cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHH---HH---HhC-------CCC--
Confidence 1 2233569999999999998899999999999999999999999998654332211 11 110 001
Q ss_pred cCCHHHHHHHHHHHHHhcccCCCCCCCHH
Q 001658 929 EFNEEEVKRLIGVALLCTQTLPSLRPSMS 957 (1036)
Q Consensus 929 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ 957 (1036)
.+......+.+++.+|++.+|.+|++..
T Consensus 220 -~p~~~~~~~~~li~~~l~~~p~~R~~~~ 247 (323)
T cd05615 220 -YPKSLSKEAVSICKGLMTKHPSKRLGCG 247 (323)
T ss_pred -CCccCCHHHHHHHHHHcccCHhhCCCCC
Confidence 1112234567788899999999999853
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-34 Score=312.66 Aligned_cols=248 Identities=31% Similarity=0.465 Sum_probs=196.5
Q ss_pred CccccCCCEEEEEeEeCC-------CcEEEEEEccccc-hhcHHHHHHHHHHHHhhccCCcceeEeEEEcCceeEEEEEe
Q 001658 699 NKLGEGGFGPVYKGKLGD-------GRAIAVKQLSVAS-RQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLVYEY 770 (1036)
Q Consensus 699 ~~iG~G~fG~Vy~~~~~~-------g~~vAvK~~~~~~-~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~ 770 (1036)
+.||+|+||.||+|+..+ ++.||+|.+.... ......|.+|+.+++.++||||+++++++...+..++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 369999999999998642 2579999886432 23466789999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCC-----CCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCC-----ceEEEEcCc
Q 001658 771 LENKSLDQALFGQR-----SLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADL-----VPKISDFGL 840 (1036)
Q Consensus 771 ~~~gsL~~~l~~~~-----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~-----~~kl~DFGl 840 (1036)
+++++|.+++.... ...+++.+++.++.|++.||+|||+.+ ++|+||||+||+++.++ .++++|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECCccc
Confidence 99999999996532 244789999999999999999999887 99999999999999877 899999999
Q ss_pred ceeecCCCCc-cccccccccCccCccccccCCCCchhhHHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHHHHHhhcCc
Q 001658 841 AKLYDDKKTH-ISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVS-GRPNSDPSLDEEKLYLLEWAWHLHENNQ 918 (1036)
Q Consensus 841 a~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~ 918 (1036)
++........ ......++..|+|||++.++.++.++|||||||++|||++ |+.||......+... .. ..+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~---~~----~~~~ 230 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQ---HV----TAGG 230 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHH---HH----hcCC
Confidence 9765432211 1122345778999999999999999999999999999998 999987544322111 11 0000
Q ss_pred cccccCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 001658 919 EIELADPKLIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVAMLC 964 (1036)
Q Consensus 919 ~~~~~d~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~ 964 (1036)
...........+.+++.+||+.+|.+||++.+|++.|+
T Consensus 231 --------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 268 (269)
T cd05044 231 --------RLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268 (269)
T ss_pred --------ccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 00111223456778889999999999999999999886
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=310.41 Aligned_cols=248 Identities=25% Similarity=0.425 Sum_probs=198.9
Q ss_pred CCCCCCccccCCCEEEEEeEe-CCCcEEEEEEccccchh---------cHHHHHHHHHHHHhhccCCcceeEeEEEcCce
Q 001658 694 NFSPSNKLGEGGFGPVYKGKL-GDGRAIAVKQLSVASRQ---------GKSQFVAEIATISAVQHRNLVKLHGCCIEGAE 763 (1036)
Q Consensus 694 ~~~~~~~iG~G~fG~Vy~~~~-~~g~~vAvK~~~~~~~~---------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~ 763 (1036)
+|.+...||+|+||.||+|.. .+++.||+|.+...... ..+.+.+|+.++++++||||+++++++.+.+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 467788999999999999985 46789999988643221 22568889999999999999999999999999
Q ss_pred eEEEEEecCCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCccee
Q 001658 764 RLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKL 843 (1036)
Q Consensus 764 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~ 843 (1036)
.++|+||+++++|.+++... ..+++..+..++.|++.||+|||+.+ ++||||||+||++++++.++|+|||+++.
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~dfg~~~~ 155 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNY--GAFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISKK 155 (267)
T ss_pred cEEEEEecCCCCHHHHHHhc--cCccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEecccCCCcc
Confidence 99999999999999999643 45788899999999999999999987 99999999999999999999999999987
Q ss_pred ecCCCCc-----cccccccccCccCccccccCCCCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhcCc
Q 001658 844 YDDKKTH-----ISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQ 918 (1036)
Q Consensus 844 ~~~~~~~-----~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 918 (1036)
....... ......|+..|+|||.+.+..++.++|||||||++|||++|+.||.......... ...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~------~~~---- 225 (267)
T cd06628 156 LEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIF------KIG---- 225 (267)
T ss_pred cccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHH------HHh----
Confidence 6532111 1122458889999999998889999999999999999999999997643322111 000
Q ss_pred cccccCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 001658 919 EIELADPKLIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVA 961 (1036)
Q Consensus 919 ~~~~~d~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 961 (1036)
....+.+ +......+.+++.+||+.+|.+||++.|+++
T Consensus 226 --~~~~~~~---~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 226 --ENASPEI---PSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred --ccCCCcC---CcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 0111121 1223456777888999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=314.40 Aligned_cols=263 Identities=22% Similarity=0.344 Sum_probs=198.1
Q ss_pred CCCCCCccccCCCEEEEEeEeC-CCcEEEEEEccccc--hhcHHHHHHHHHHHHhhccCCcceeEeEEEcCceeEEEEEe
Q 001658 694 NFSPSNKLGEGGFGPVYKGKLG-DGRAIAVKQLSVAS--RQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLVYEY 770 (1036)
Q Consensus 694 ~~~~~~~iG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~--~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~ 770 (1036)
+|++.+.||+|++|.||+|+.. +++.||+|.+.... ......+.+|+.++++++||||+++++++.+++..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 4777899999999999999864 68999999986432 22346788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCC-CCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeecCCCC
Q 001658 771 LENKSLDQALFGQR-SLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKT 849 (1036)
Q Consensus 771 ~~~gsL~~~l~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~ 849 (1036)
++ ++|.+++.... ...+++..+..++.|+++||+|||+.+ |+||||||+||++++++.+||+|||++........
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 156 (285)
T cd07861 81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR 156 (285)
T ss_pred CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceeecCCCcc
Confidence 97 68988886533 357899999999999999999999987 99999999999999999999999999986543221
Q ss_pred ccccccccccCccCccccccC-CCCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHH-HHHHHH----HhhcCcccc--
Q 001658 850 HISTRVAGTIGYLAPEYAMRG-HLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYL-LEWAWH----LHENNQEIE-- 921 (1036)
Q Consensus 850 ~~~~~~~gt~~y~APE~~~~~-~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l-~~~~~~----~~~~~~~~~-- 921 (1036)
......+++.|+|||++.+. .++.++|||||||++|||+||++||......+.... ...... .+.......
T Consensus 157 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (285)
T cd07861 157 -VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDY 235 (285)
T ss_pred -cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHH
Confidence 22234578899999988654 578899999999999999999999986543322211 000000 000000000
Q ss_pred ------ccCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 001658 922 ------LADPKLIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVA 961 (1036)
Q Consensus 922 ------~~d~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 961 (1036)
...............++.+++.+|++.||++|||+.+|+.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 236 KNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred HhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 0000000001112345678889999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=307.94 Aligned_cols=247 Identities=28% Similarity=0.425 Sum_probs=200.1
Q ss_pred CCCCCCccccCCCEEEEEeEeC-CCcEEEEEEccccc-----hhcHHHHHHHHHHHHhhccCCcceeEeEEEcCceeEEE
Q 001658 694 NFSPSNKLGEGGFGPVYKGKLG-DGRAIAVKQLSVAS-----RQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLV 767 (1036)
Q Consensus 694 ~~~~~~~iG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~-----~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV 767 (1036)
+|+..+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|+.++++++|+||+++++++..+...++|
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 4667789999999999999875 78999999886533 23456789999999999999999999999999999999
Q ss_pred EEecCCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeecCC
Q 001658 768 YEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDK 847 (1036)
Q Consensus 768 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~ 847 (1036)
+||+++++|.+++... ..+++..+..++.|+++||+|||+.+ |+|+||+|+||+++.++.+||+|||++......
T Consensus 81 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~ 155 (258)
T cd06632 81 LELVPGGSLAKLLKKY--GSFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQVVEF 155 (258)
T ss_pred EEecCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccceecccc
Confidence 9999999999998643 35789999999999999999999988 999999999999999999999999999876433
Q ss_pred CCccccccccccCccCccccccCC-CCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhcCccccccCcc
Q 001658 848 KTHISTRVAGTIGYLAPEYAMRGH-LTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEIELADPK 926 (1036)
Q Consensus 848 ~~~~~~~~~gt~~y~APE~~~~~~-~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 926 (1036)
. ......|+..|+|||.+.... ++.++|+||||+++|||++|+.||.......... ...... .
T Consensus 156 ~--~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~------~~~~~~--------~ 219 (258)
T cd06632 156 S--FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVF------KIGRSK--------E 219 (258)
T ss_pred c--cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHH------HHHhcc--------c
Confidence 2 123456888999999987766 8999999999999999999999997654222111 111000 0
Q ss_pred cccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 001658 927 LIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVA 961 (1036)
Q Consensus 927 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 961 (1036)
...........+.+++.+||+.+|.+||++.+++.
T Consensus 220 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 220 LPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred CCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 01111222355677888999999999999999875
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=316.05 Aligned_cols=246 Identities=26% Similarity=0.427 Sum_probs=199.6
Q ss_pred CCCCCccccCCCEEEEEeEeC-CCcEEEEEEccccc-hhcHHHHHHHHHHHHhhccCCcceeEeEEEcCceeEEEEEecC
Q 001658 695 FSPSNKLGEGGFGPVYKGKLG-DGRAIAVKQLSVAS-RQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLVYEYLE 772 (1036)
Q Consensus 695 ~~~~~~iG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~-~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~~~ 772 (1036)
|+..+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|++++++++||||+++++++......++|+||++
T Consensus 6 y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (277)
T cd06642 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLG 85 (277)
T ss_pred HHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEccC
Confidence 445678999999999999854 57899999986432 3345678999999999999999999999999999999999999
Q ss_pred CCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeecCCCCccc
Q 001658 773 NKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHIS 852 (1036)
Q Consensus 773 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 852 (1036)
+++|.+++.. ..+++..+..++.|+++|+.|||+.+ ++|+||+|+||++++++.++|+|||++..+..... ..
T Consensus 86 ~~~L~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~-~~ 158 (277)
T cd06642 86 GGSALDLLKP---GPLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI-KR 158 (277)
T ss_pred CCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccccccCcch-hh
Confidence 9999998843 46789999999999999999999987 99999999999999999999999999986653322 12
Q ss_pred cccccccCccCccccccCCCCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhcCccccccCcccccCCH
Q 001658 853 TRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEIELADPKLIEFNE 932 (1036)
Q Consensus 853 ~~~~gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~ 932 (1036)
....|+..|+|||++.+..++.++|||||||++|||++|+.|+.......... + .... ..+. ...
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~---~----~~~~-----~~~~---~~~ 223 (277)
T cd06642 159 NTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLF---L----IPKN-----SPPT---LEG 223 (277)
T ss_pred hcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHh---h----hhcC-----CCCC---CCc
Confidence 23458889999999998889999999999999999999999987543222111 0 0000 1111 122
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 001658 933 EEVKRLIGVALLCTQTLPSLRPSMSRVVAM 962 (1036)
Q Consensus 933 ~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 962 (1036)
.....+.+++.+||+.+|++||++.++++.
T Consensus 224 ~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 224 QYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred ccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 334567888899999999999999999974
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-34 Score=314.52 Aligned_cols=260 Identities=27% Similarity=0.415 Sum_probs=205.6
Q ss_pred cCHHHHHHHhcCCCCCCccccCCCEEEEEeEe-CCCcEEEEEEccccchhcHHHHHHHHHHHHhh-ccCCcceeEeEEEc
Q 001658 683 FSYAELKTATENFSPSNKLGEGGFGPVYKGKL-GDGRAIAVKQLSVASRQGKSQFVAEIATISAV-QHRNLVKLHGCCIE 760 (1036)
Q Consensus 683 ~~~~~l~~~~~~~~~~~~iG~G~fG~Vy~~~~-~~g~~vAvK~~~~~~~~~~~~f~~Ei~~L~~l-~H~nIv~l~g~~~~ 760 (1036)
.++.++....+.|++.+.||+|+||.||+|+. .+++.||+|.+.... ....++..|+.++.++ +|+||+++++++..
T Consensus 6 ~~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 84 (282)
T cd06636 6 IDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIK 84 (282)
T ss_pred hhhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhc
Confidence 35566667788999999999999999999986 467899999886443 2345688899999998 69999999999863
Q ss_pred ------CceeEEEEEecCCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceE
Q 001658 761 ------GAERLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPK 834 (1036)
Q Consensus 761 ------~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~k 834 (1036)
....++||||+++|+|.+++.......+++..+..++.|+++||+|||+.+ |+||||||+||++++++.++
T Consensus 85 ~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~~~~~~ 161 (282)
T cd06636 85 KSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAEVK 161 (282)
T ss_pred ccccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEE
Confidence 456799999999999999997666667888889999999999999999988 99999999999999999999
Q ss_pred EEEcCcceeecCCCCccccccccccCccCccccc-----cCCCCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHH
Q 001658 835 ISDFGLAKLYDDKKTHISTRVAGTIGYLAPEYAM-----RGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEW 909 (1036)
Q Consensus 835 l~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~-----~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~ 909 (1036)
|+|||++........ ......|+..|+|||.+. ...++.++|||||||++|||++|+.||.............
T Consensus 162 l~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~- 239 (282)
T cd06636 162 LVDFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIP- 239 (282)
T ss_pred EeeCcchhhhhcccc-CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHh-
Confidence 999999876542221 123356899999999975 3467889999999999999999999997544322221110
Q ss_pred HHHHhhcCccccccCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 001658 910 AWHLHENNQEIELADPKLIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVA 961 (1036)
Q Consensus 910 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 961 (1036)
....+.. ........+.+++.+||+.+|.+||++.|+++
T Consensus 240 -----------~~~~~~~--~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 240 -----------RNPPPKL--KSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred -----------hCCCCCC--cccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 0001111 11123356888889999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=310.31 Aligned_cols=248 Identities=27% Similarity=0.423 Sum_probs=203.6
Q ss_pred cCCCCCCccccCCCEEEEEeEeC-CCcEEEEEEccccc-hhcHHHHHHHHHHHHhhccCCcceeEeEEEcCceeEEEEEe
Q 001658 693 ENFSPSNKLGEGGFGPVYKGKLG-DGRAIAVKQLSVAS-RQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLVYEY 770 (1036)
Q Consensus 693 ~~~~~~~~iG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~-~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~ 770 (1036)
..|+..+.||+|+||.||+|... +++.||+|.+.... ......+.+|++++++++|+||+++++++.++...++||||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence 34667788999999999999864 58899999986432 34456789999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeecCCCCc
Q 001658 771 LENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTH 850 (1036)
Q Consensus 771 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~ 850 (1036)
+++++|.+++.. ..+++.....++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 84 ~~~~~L~~~i~~---~~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~- 156 (277)
T cd06640 84 LGGGSALDLLRA---GPFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI- 156 (277)
T ss_pred CCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccceeccCCcc-
Confidence 999999999853 35788899999999999999999987 99999999999999999999999999987654322
Q ss_pred cccccccccCccCccccccCCCCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhcCccccccCcccccC
Q 001658 851 ISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEIELADPKLIEF 930 (1036)
Q Consensus 851 ~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~ 930 (1036)
......++..|+|||++.+..++.++|||||||++|||++|+.||............ .. .. ....
T Consensus 157 ~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~-------~~------~~--~~~~ 221 (277)
T cd06640 157 KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLI-------PK------NN--PPTL 221 (277)
T ss_pred ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhh-------hc------CC--CCCC
Confidence 122345888999999999888999999999999999999999999765432221110 00 00 1122
Q ss_pred CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 001658 931 NEEEVKRLIGVALLCTQTLPSLRPSMSRVVAM 962 (1036)
Q Consensus 931 ~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 962 (1036)
.......+.+++.+||+.+|++||++.++++.
T Consensus 222 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 222 TGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred chhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 34455678889999999999999999999764
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=310.07 Aligned_cols=252 Identities=26% Similarity=0.392 Sum_probs=200.3
Q ss_pred CCCCCCccccCCCEEEEEeEeCC--CcEEEEEEcccc----------chhcHHHHHHHHHHHHh-hccCCcceeEeEEEc
Q 001658 694 NFSPSNKLGEGGFGPVYKGKLGD--GRAIAVKQLSVA----------SRQGKSQFVAEIATISA-VQHRNLVKLHGCCIE 760 (1036)
Q Consensus 694 ~~~~~~~iG~G~fG~Vy~~~~~~--g~~vAvK~~~~~----------~~~~~~~f~~Ei~~L~~-l~H~nIv~l~g~~~~ 760 (1036)
+|++.+.||+|+||.||+|.... ++.+|+|.+... ......++.+|+.++.+ ++||||+++++++.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47778999999999999999754 688999987532 12233557788888875 799999999999999
Q ss_pred CceeEEEEEecCCCChhhhhhc--CCCCCcChHHHHHHHHHHHHHHHHHHh-cCCccccccccCCCcEEecCCCceEEEE
Q 001658 761 GAERLLVYEYLENKSLDQALFG--QRSLTLDWATRYEICSGVARGLAYLHE-ESRVRIIHRDVKASNVLLDADLVPKISD 837 (1036)
Q Consensus 761 ~~~~~lV~E~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivHrDikp~NILl~~~~~~kl~D 837 (1036)
++..++||||+++++|.+++.. .....+++..+++++.|++.||.|||+ .+ ++|+||||+||++++++.+||+|
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~---i~H~dl~~~nil~~~~~~~~l~d 157 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR---IVHRDLTPNNIMLGEDDKVTITD 157 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCc---eeecCCCHHHEEECCCCcEEEec
Confidence 9999999999999999998754 234568899999999999999999996 44 99999999999999999999999
Q ss_pred cCcceeecCCCCccccccccccCccCccccccCCCCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhcC
Q 001658 838 FGLAKLYDDKKTHISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENN 917 (1036)
Q Consensus 838 FGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~ 917 (1036)
||++....... ......|+..|+|||...+..++.++||||||+++|||++|++||.......... .... .
T Consensus 158 fg~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~------~~~~-~ 228 (269)
T cd08528 158 FGLAKQKQPES--KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLAT------KIVE-A 228 (269)
T ss_pred ccceeeccccc--ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHH------HHhh-c
Confidence 99998765433 2234568899999999998889999999999999999999999987543322111 1111 0
Q ss_pred ccccccCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 001658 918 QEIELADPKLIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVAMLC 964 (1036)
Q Consensus 918 ~~~~~~d~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~ 964 (1036)
. ..+... ......+.+++.+||+.+|++||++.||..+++
T Consensus 229 ~----~~~~~~---~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 229 V----YEPLPE---GMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred c----CCcCCc---ccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 0 001000 112346778888999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-34 Score=320.75 Aligned_cols=252 Identities=22% Similarity=0.314 Sum_probs=207.4
Q ss_pred HhcCCCCCCccccCCCEEEEEeEeC-CCcEEEEEEccccchh---cHHHHHHHHHHHHhhc-cCCcceeEeEEEcCceeE
Q 001658 691 ATENFSPSNKLGEGGFGPVYKGKLG-DGRAIAVKQLSVASRQ---GKSQFVAEIATISAVQ-HRNLVKLHGCCIEGAERL 765 (1036)
Q Consensus 691 ~~~~~~~~~~iG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~~---~~~~f~~Ei~~L~~l~-H~nIv~l~g~~~~~~~~~ 765 (1036)
..+.|++.+.||+|.||.||+++.+ +|+.+|+|.+.+.... ....+.+|+.+|+++. |||||.+++++.+....+
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~ 112 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY 112 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence 4567888899999999999999865 4999999999764332 3468899999999998 999999999999999999
Q ss_pred EEEEecCCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCC----CceEEEEcCcc
Q 001658 766 LVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDAD----LVPKISDFGLA 841 (1036)
Q Consensus 766 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~----~~~kl~DFGla 841 (1036)
+|||++.||.|.+.+... .+++.....++.|++.+++|||+.+ |+||||||+|+|+... +.+|++|||++
T Consensus 113 lvmEL~~GGeLfd~i~~~---~~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik~~DFGla 186 (382)
T KOG0032|consen 113 LVMELCEGGELFDRIVKK---HYSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIKLIDFGLA 186 (382)
T ss_pred EEEEecCCchHHHHHHHc---cCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEEEeeCCCc
Confidence 999999999999999665 3899999999999999999999988 9999999999999543 57999999999
Q ss_pred eeecCCCCccccccccccCccCccccccCCCCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhcCcccc
Q 001658 842 KLYDDKKTHISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEIE 921 (1036)
Q Consensus 842 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 921 (1036)
..... .......+||+.|+|||++....|+..+||||+||++|.|++|.+||...........+. .+. ..
T Consensus 187 ~~~~~--~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~-------~~~-~~ 256 (382)
T KOG0032|consen 187 KFIKP--GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAIL-------RGD-FD 256 (382)
T ss_pred eEccC--CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHH-------cCC-CC
Confidence 98865 334456789999999999999999999999999999999999999999876544333111 111 01
Q ss_pred ccCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 001658 922 LADPKLIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVAM 962 (1036)
Q Consensus 922 ~~d~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 962 (1036)
..++. -.......-+++..|+..||.+|+|+.++++.
T Consensus 257 f~~~~----w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 257 FTSEP----WDDISESAKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred CCCCC----ccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence 11111 12223345556668899999999999999983
|
|
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-34 Score=315.21 Aligned_cols=252 Identities=25% Similarity=0.390 Sum_probs=200.2
Q ss_pred cCCCCCCccccCCCEEEEEeEeC-CCcEEEEEEcccc-chhcHHHHHHHHHHHHhhccCCcceeEeEEEcCceeEEEEEe
Q 001658 693 ENFSPSNKLGEGGFGPVYKGKLG-DGRAIAVKQLSVA-SRQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLVYEY 770 (1036)
Q Consensus 693 ~~~~~~~~iG~G~fG~Vy~~~~~-~g~~vAvK~~~~~-~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~ 770 (1036)
++|++.+.||+|+||.||+++.. +++.||+|.+... .......+.+|++++++++|+||+++++++...+..++|+||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 36788899999999999999875 7899999988653 333356789999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCC-CCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeecCCCC
Q 001658 771 LENKSLDQALFGQR-SLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKT 849 (1036)
Q Consensus 771 ~~~gsL~~~l~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~ 849 (1036)
+++++|.+++.... ...+++..+..++.|++.||.|||+.. +|+||||||+||+++.++.+||+|||++..+....
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~- 157 (286)
T cd06622 81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEH--NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL- 157 (286)
T ss_pred cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcC--CEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc-
Confidence 99999999886532 346899999999999999999999742 39999999999999999999999999997654322
Q ss_pred ccccccccccCccCccccccCC------CCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhcCcccccc
Q 001658 850 HISTRVAGTIGYLAPEYAMRGH------LTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEIELA 923 (1036)
Q Consensus 850 ~~~~~~~gt~~y~APE~~~~~~------~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 923 (1036)
.....|+..|+|||.+.+.. ++.++|||||||++|||++|+.||............. .. .
T Consensus 158 --~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~---~~---------~ 223 (286)
T cd06622 158 --AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLS---AI---------V 223 (286)
T ss_pred --cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHH---HH---------h
Confidence 12345888999999985543 5789999999999999999999997643322211111 00 0
Q ss_pred CcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 001658 924 DPKLIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVA 961 (1036)
Q Consensus 924 d~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 961 (1036)
+.............+.+++.+||+.+|++||++.+++.
T Consensus 224 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 261 (286)
T cd06622 224 DGDPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE 261 (286)
T ss_pred hcCCCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence 11111122334556778889999999999999999886
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=308.55 Aligned_cols=247 Identities=28% Similarity=0.428 Sum_probs=199.9
Q ss_pred cCCCCCCccccCCCEEEEEeEeCCCcEEEEEEccccchhcHHHHHHHHHHHHhhccCCcceeEeEEEcCceeEEEEEecC
Q 001658 693 ENFSPSNKLGEGGFGPVYKGKLGDGRAIAVKQLSVASRQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLVYEYLE 772 (1036)
Q Consensus 693 ~~~~~~~~iG~G~fG~Vy~~~~~~g~~vAvK~~~~~~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~~~ 772 (1036)
++|++.+.||+|+||.||+|.. .++.||+|.++... ....+.+|+.++++++||||+++++++... ..++||||++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~ 81 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS 81 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence 4578889999999999999975 67889999986432 346789999999999999999999998765 4789999999
Q ss_pred CCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeecCCCCccc
Q 001658 773 NKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHIS 852 (1036)
Q Consensus 773 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 852 (1036)
+++|.+++.......+++..+.+++.|+++|++|||+.+ ++||||||+||+++.++.+||+|||+++......
T Consensus 82 ~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~---- 154 (254)
T cd05083 82 KGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV---- 154 (254)
T ss_pred CCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceeccccC----
Confidence 999999997766667899999999999999999999987 9999999999999999999999999997643221
Q ss_pred cccccccCccCccccccCCCCchhhHHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHHHHHhhcCccccccCcccccCC
Q 001658 853 TRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVS-GRPNSDPSLDEEKLYLLEWAWHLHENNQEIELADPKLIEFN 931 (1036)
Q Consensus 853 ~~~~gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~ 931 (1036)
.....+..|+|||++.++.++.++||||||+++|||++ |+.||......+..... ..+.. .++ .
T Consensus 155 ~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~-------~~~~~---~~~-----~ 219 (254)
T cd05083 155 DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECV-------EKGYR---MEP-----P 219 (254)
T ss_pred CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHH-------hCCCC---CCC-----C
Confidence 12234568999999998899999999999999999998 99998765432221111 11110 111 1
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhc
Q 001658 932 EEEVKRLIGVALLCTQTLPSLRPSMSRVVAMLCG 965 (1036)
Q Consensus 932 ~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~ 965 (1036)
......+.+++.+||+.+|++||+++++++.|++
T Consensus 220 ~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 220 EGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred CcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 1223566788899999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=317.20 Aligned_cols=195 Identities=27% Similarity=0.421 Sum_probs=160.5
Q ss_pred CCccccCCCEEEEEeEeC---CCcEEEEEEccccchhcHHHHHHHHHHHHhhccCCcceeEeEEEc--CceeEEEEEecC
Q 001658 698 SNKLGEGGFGPVYKGKLG---DGRAIAVKQLSVASRQGKSQFVAEIATISAVQHRNLVKLHGCCIE--GAERLLVYEYLE 772 (1036)
Q Consensus 698 ~~~iG~G~fG~Vy~~~~~---~g~~vAvK~~~~~~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~--~~~~~lV~E~~~ 772 (1036)
.++||+|+||.||+|+.. +++.||+|.+.... ....+.+|+.++++++||||+++++++.. ....++|+||+.
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 468999999999999854 46789999986432 23457889999999999999999999864 456789999985
Q ss_pred CCChhhhhhcC-------CCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEe----cCCCceEEEEcCcc
Q 001658 773 NKSLDQALFGQ-------RSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLL----DADLVPKISDFGLA 841 (1036)
Q Consensus 773 ~gsL~~~l~~~-------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl----~~~~~~kl~DFGla 841 (1036)
++|.+++... ....+++..+..++.||+.||+|||+.+ |+||||||+|||+ +.++.+||+|||++
T Consensus 84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 84 -HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred -CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 5888877432 1235888999999999999999999998 9999999999999 45679999999999
Q ss_pred eeecCCCCc--cccccccccCccCcccccc-CCCCchhhHHhHHHHHHHHHhCCCCCCCC
Q 001658 842 KLYDDKKTH--ISTRVAGTIGYLAPEYAMR-GHLTEKTDVFAFGVLALETVSGRPNSDPS 898 (1036)
Q Consensus 842 ~~~~~~~~~--~~~~~~gt~~y~APE~~~~-~~~~~ksDVwS~Gvvl~elltG~~p~~~~ 898 (1036)
+.+...... ......||+.|+|||++.+ ..++.++||||+||++|||++|++||...
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~ 219 (317)
T cd07868 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence 876533221 1234578999999999876 45899999999999999999999999753
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=323.53 Aligned_cols=262 Identities=22% Similarity=0.254 Sum_probs=197.4
Q ss_pred HhcCCCCCCccccCCCEEEEEeEeC-CCcEEEEEEcccc--chhcHHHHHHHHHHHHhhccCCcceeEeEEEcC------
Q 001658 691 ATENFSPSNKLGEGGFGPVYKGKLG-DGRAIAVKQLSVA--SRQGKSQFVAEIATISAVQHRNLVKLHGCCIEG------ 761 (1036)
Q Consensus 691 ~~~~~~~~~~iG~G~fG~Vy~~~~~-~g~~vAvK~~~~~--~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~------ 761 (1036)
..++|+..+.||+|+||.||+|... .++.||||++... .......+.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 4578999999999999999999854 6889999998643 233346788899999999999999999987543
Q ss_pred ceeEEEEEecCCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcc
Q 001658 762 AERLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLA 841 (1036)
Q Consensus 762 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla 841 (1036)
...++||||++ ++|.+++. ..+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 102 ~~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a 173 (364)
T cd07875 102 QDVYIVMELMD-ANLCQVIQ----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 173 (364)
T ss_pred CeEEEEEeCCC-CCHHHHHH----hcCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEEEEeCCCc
Confidence 35699999996 47777763 34788899999999999999999988 999999999999999999999999999
Q ss_pred eeecCCCCccccccccccCccCccccccCCCCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHH------------
Q 001658 842 KLYDDKKTHISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEW------------ 909 (1036)
Q Consensus 842 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~------------ 909 (1036)
+...... ......||..|+|||++.+..++.++|||||||++|||++|+.||......+....+-.
T Consensus 174 ~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (364)
T cd07875 174 RTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKK 251 (364)
T ss_pred cccCCCC--cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHh
Confidence 8654322 22345689999999999999999999999999999999999999976544322211100
Q ss_pred ----HHHHhhcCcccc-----ccCccc-----ccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 001658 910 ----AWHLHENNQEIE-----LADPKL-----IEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVAM 962 (1036)
Q Consensus 910 ----~~~~~~~~~~~~-----~~d~~~-----~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 962 (1036)
............ ...+.. ..........+.+++.+|++.||.+|||+.|+++.
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 252 LQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred hhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 000000000000 000000 00111123467888999999999999999999863
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-34 Score=316.29 Aligned_cols=262 Identities=27% Similarity=0.365 Sum_probs=205.0
Q ss_pred cCHHHHHHHhcCCCCCCccccCCCEEEEEeEe-CCCcEEEEEEccccchhcHHHHHHHHHHHHhh-ccCCcceeEeEEEc
Q 001658 683 FSYAELKTATENFSPSNKLGEGGFGPVYKGKL-GDGRAIAVKQLSVASRQGKSQFVAEIATISAV-QHRNLVKLHGCCIE 760 (1036)
Q Consensus 683 ~~~~~l~~~~~~~~~~~~iG~G~fG~Vy~~~~-~~g~~vAvK~~~~~~~~~~~~f~~Ei~~L~~l-~H~nIv~l~g~~~~ 760 (1036)
++.+++..+.++|++.+.||+|+||.||+|.. .+++.+|+|.+.... .....+.+|+.++.++ +|||++++++++..
T Consensus 12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~ 90 (291)
T cd06639 12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYK 90 (291)
T ss_pred hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence 44566677889999999999999999999986 468899999986432 2245678899999999 79999999999875
Q ss_pred C-----ceeEEEEEecCCCChhhhhhcC--CCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCce
Q 001658 761 G-----AERLLVYEYLENKSLDQALFGQ--RSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVP 833 (1036)
Q Consensus 761 ~-----~~~~lV~E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~ 833 (1036)
. +..++|+||+++++|.++++.. ....+++..++.++.|++.||+|||+.+ |+||||||+||++++++.+
T Consensus 91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~~~~ 167 (291)
T cd06639 91 ADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGGV 167 (291)
T ss_pred ccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCE
Confidence 4 3579999999999999988642 3456899999999999999999999987 9999999999999999999
Q ss_pred EEEEcCcceeecCCCCccccccccccCccCccccccC-----CCCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHH
Q 001658 834 KISDFGLAKLYDDKKTHISTRVAGTIGYLAPEYAMRG-----HLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLE 908 (1036)
Q Consensus 834 kl~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~-----~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~ 908 (1036)
||+|||+++........ .....|+..|+|||.+... .++.++|||||||++|||++|+.||.......... .
T Consensus 168 kl~dfg~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~--~ 244 (291)
T cd06639 168 KLVDFGVSAQLTSTRLR-RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLF--K 244 (291)
T ss_pred EEeecccchhccccccc-ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHH--H
Confidence 99999998865432221 1234588899999997643 36889999999999999999999997643322221 1
Q ss_pred HHHHHhhcCccccccCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 001658 909 WAWHLHENNQEIELADPKLIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVAM 962 (1036)
Q Consensus 909 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 962 (1036)
+. .... +.+ ....+....+.+++.+||+.+|++||++.|+++.
T Consensus 245 ~~-----~~~~-----~~~-~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 245 IP-----RNPP-----PTL-LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred Hh-----cCCC-----CCC-CcccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 10 0000 111 1112233468888999999999999999999863
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=320.47 Aligned_cols=260 Identities=19% Similarity=0.237 Sum_probs=194.6
Q ss_pred CCCccccC--CCEEEEEeEe-CCCcEEEEEEccccc--hhcHHHHHHHHHHHHhhccCCcceeEeEEEcCceeEEEEEec
Q 001658 697 PSNKLGEG--GFGPVYKGKL-GDGRAIAVKQLSVAS--RQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLVYEYL 771 (1036)
Q Consensus 697 ~~~~iG~G--~fG~Vy~~~~-~~g~~vAvK~~~~~~--~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~~ 771 (1036)
+.++||+| +||+||+++. .+|+.||+|++.... ....+.+.+|+++++.++||||+++++++..++..++|+||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 45789999 7899999985 478999999986532 233456778999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeecCCCCc-
Q 001658 772 ENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTH- 850 (1036)
Q Consensus 772 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~- 850 (1036)
++|+|.+++.......+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.++++||+...........
T Consensus 82 ~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~ 158 (327)
T cd08227 82 AYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRL 158 (327)
T ss_pred CCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhccccccccc
Confidence 9999999996654556899999999999999999999988 999999999999999999999999865433211110
Q ss_pred -----cccccccccCccCcccccc--CCCCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhc-------
Q 001658 851 -----ISTRVAGTIGYLAPEYAMR--GHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHEN------- 916 (1036)
Q Consensus 851 -----~~~~~~gt~~y~APE~~~~--~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~------- 916 (1036)
......++..|+|||++.+ ..++.++|||||||++|||++|+.||......... ..........
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~--~~~~~~~~~~~~~~~~~ 236 (327)
T cd08227 159 RVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQML--LEKLNGTVPCLLDTTTI 236 (327)
T ss_pred cccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHH--HHHhcCCccccccccch
Confidence 1122346778999999976 45889999999999999999999999754322111 1100000000
Q ss_pred --C-----ccccccCccc------------------ccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 001658 917 --N-----QEIELADPKL------------------IEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVA 961 (1036)
Q Consensus 917 --~-----~~~~~~d~~~------------------~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 961 (1036)
. ......+... ..........+.+++.+||+.||++|||++|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~ 306 (327)
T cd08227 237 PAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLN 306 (327)
T ss_pred hhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhc
Confidence 0 0000000000 0111223346788999999999999999999986
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=312.32 Aligned_cols=256 Identities=25% Similarity=0.383 Sum_probs=203.1
Q ss_pred cCCCCCCccccCCCEEEEEeEeC-CCc----EEEEEEccccc-hhcHHHHHHHHHHHHhhccCCcceeEeEEEcCceeEE
Q 001658 693 ENFSPSNKLGEGGFGPVYKGKLG-DGR----AIAVKQLSVAS-RQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLL 766 (1036)
Q Consensus 693 ~~~~~~~~iG~G~fG~Vy~~~~~-~g~----~vAvK~~~~~~-~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~l 766 (1036)
.+|++.+.||+|+||.||+|... +|+ .||+|.+.... ......+.+|+.++++++|+||+++++++.. ...++
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 85 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL 85 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence 46778899999999999999854 333 68999886543 3345678899999999999999999999987 78899
Q ss_pred EEEecCCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeecC
Q 001658 767 VYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDD 846 (1036)
Q Consensus 767 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~ 846 (1036)
|+||+++|+|.+++.... ..+++..+..++.|+++||+|||+.+ |+||||||+||++++++.+||+|||+++....
T Consensus 86 v~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~ 161 (279)
T cd05057 86 ITQLMPLGCLLDYVRNHK-DNIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLDV 161 (279)
T ss_pred EEecCCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCcccccccC
Confidence 999999999999996543 35899999999999999999999987 99999999999999999999999999987653
Q ss_pred CCCccc-cccccccCccCccccccCCCCchhhHHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHHHHHhhcCccccccC
Q 001658 847 KKTHIS-TRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVS-GRPNSDPSLDEEKLYLLEWAWHLHENNQEIELAD 924 (1036)
Q Consensus 847 ~~~~~~-~~~~gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 924 (1036)
...... ....++..|+|||.+....++.++||||||+++||+++ |+.||......+... ... .+. ....
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~---~~~----~~~--~~~~ 232 (279)
T cd05057 162 DEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPD---LLE----KGE--RLPQ 232 (279)
T ss_pred cccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHH---HHh----CCC--CCCC
Confidence 322211 12224568999999988889999999999999999999 999997654332211 111 110 0011
Q ss_pred cccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcccC
Q 001658 925 PKLIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVAMLCGDME 968 (1036)
Q Consensus 925 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 968 (1036)
+ ......+.+++.+||..+|.+||++.++++.|.....
T Consensus 233 ~------~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05057 233 P------PICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMAR 270 (279)
T ss_pred C------CCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 1 1122457788889999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-34 Score=325.05 Aligned_cols=263 Identities=24% Similarity=0.279 Sum_probs=198.0
Q ss_pred HHhcCCCCCCccccCCCEEEEEeEeC-CCcEEEEEEcccc--chhcHHHHHHHHHHHHhhccCCcceeEeEEEcC-----
Q 001658 690 TATENFSPSNKLGEGGFGPVYKGKLG-DGRAIAVKQLSVA--SRQGKSQFVAEIATISAVQHRNLVKLHGCCIEG----- 761 (1036)
Q Consensus 690 ~~~~~~~~~~~iG~G~fG~Vy~~~~~-~g~~vAvK~~~~~--~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~----- 761 (1036)
...++|+..+.||+|+||.||++... .++.||||++... .......+.+|+.+++.++||||+++++++...
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 93 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE 93 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence 34578999999999999999999853 6889999998643 233346778899999999999999999988643
Q ss_pred -ceeEEEEEecCCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCc
Q 001658 762 -AERLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGL 840 (1036)
Q Consensus 762 -~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGl 840 (1036)
...++||||+++ +|.+.+. ..+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 94 ~~~~~lv~e~~~~-~l~~~~~----~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~kl~Dfg~ 165 (355)
T cd07874 94 FQDVYLVMELMDA-NLCQVIQ----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 165 (355)
T ss_pred cceeEEEhhhhcc-cHHHHHh----hcCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEEEeeCcc
Confidence 346899999964 6777663 34788899999999999999999988 99999999999999999999999999
Q ss_pred ceeecCCCCccccccccccCccCccccccCCCCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHH-H-----------
Q 001658 841 AKLYDDKKTHISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLL-E----------- 908 (1036)
Q Consensus 841 a~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~-~----------- 908 (1036)
++...... ......||..|+|||++.+..++.++|||||||++|||++|+.||......+..... +
T Consensus 166 ~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (355)
T cd07874 166 ARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMK 243 (355)
T ss_pred cccCCCcc--ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 98654321 223456899999999999989999999999999999999999999765432221110 0
Q ss_pred ----HHHHHhhcC-ccccccCccc---------ccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 001658 909 ----WAWHLHENN-QEIELADPKL---------IEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVAM 962 (1036)
Q Consensus 909 ----~~~~~~~~~-~~~~~~d~~~---------~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 962 (1036)
......... .......+.. ..........+.+++.+|++.||++|||+.|+++.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 244 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred hhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 000000000 0000000000 00111223467888999999999999999999874
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=310.26 Aligned_cols=252 Identities=23% Similarity=0.367 Sum_probs=188.6
Q ss_pred CccccCCCEEEEEeEeCCC---cEEEEEEccccc-hhcHHHHHHHHHHHHhhccCCcceeEeEEEcCceeEEEEEecCCC
Q 001658 699 NKLGEGGFGPVYKGKLGDG---RAIAVKQLSVAS-RQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLVYEYLENK 774 (1036)
Q Consensus 699 ~~iG~G~fG~Vy~~~~~~g---~~vAvK~~~~~~-~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~g 774 (1036)
+.||+|+||.||+|+..++ ..+++|.+.... ....+.|.+|+.+++.++||||++++++|.+....++||||+++|
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 80 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG 80 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence 3699999999999975433 346677665432 334678999999999999999999999999999999999999999
Q ss_pred ChhhhhhcCC--CCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeecCCC-Ccc
Q 001658 775 SLDQALFGQR--SLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKK-THI 851 (1036)
Q Consensus 775 sL~~~l~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~-~~~ 851 (1036)
+|.+++.... ....++.....++.||++||+|||+.+ |+||||||+|||++.++.+||+|||++....... ...
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 157 (268)
T cd05086 81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET 157 (268)
T ss_pred cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccccCcchhhhc
Confidence 9999997543 234677778899999999999999987 9999999999999999999999999986432111 111
Q ss_pred ccccccccCccCcccccc-------CCCCchhhHHhHHHHHHHHHhC-CCCCCCCChhhHHHHHHHHHHHhhcCcccccc
Q 001658 852 STRVAGTIGYLAPEYAMR-------GHLTEKTDVFAFGVLALETVSG-RPNSDPSLDEEKLYLLEWAWHLHENNQEIELA 923 (1036)
Q Consensus 852 ~~~~~gt~~y~APE~~~~-------~~~~~ksDVwS~Gvvl~elltG-~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 923 (1036)
.....++..|+|||++.. ..++.++|||||||++|||+++ ..||......+.... ... +......
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~------~~~-~~~~~~~ 230 (268)
T cd05086 158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNH------VIK-DQQVKLF 230 (268)
T ss_pred ccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHH------HHh-hcccccC
Confidence 233457889999998753 2457899999999999999974 667765433222211 111 1122233
Q ss_pred CcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 001658 924 DPKLIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVAMLC 964 (1036)
Q Consensus 924 d~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~ 964 (1036)
+|.+... ....+.+++..|| .+|++||++.||++.|.
T Consensus 231 ~~~~~~~---~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 231 KPQLELP---YSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred CCccCCC---CcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 4443222 2234566777899 67999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=312.49 Aligned_cols=263 Identities=25% Similarity=0.325 Sum_probs=201.5
Q ss_pred cCCCCCCccccCCCEEEEEeEeC-CCcEEEEEEccccc--hhcHHHHHHHHHHHHhhccCCcceeEeEEEcCceeEEEEE
Q 001658 693 ENFSPSNKLGEGGFGPVYKGKLG-DGRAIAVKQLSVAS--RQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLVYE 769 (1036)
Q Consensus 693 ~~~~~~~~iG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~--~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E 769 (1036)
++|+..+.||+|+||.||+|+.. +|+.||+|++.... ....+.+.+|+.++++++|+||+++++++......++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 46888899999999999999865 68999999886432 2234568899999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeecCCCC
Q 001658 770 YLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKT 849 (1036)
Q Consensus 770 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~ 849 (1036)
|++++.|..++.. ...+++..+..++.|+++||+|||+.+ |+||||||+||++++++.++|+|||++........
T Consensus 81 ~~~~~~l~~~~~~--~~~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 155 (286)
T cd07847 81 YCDHTVLNELEKN--PRGVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTGPGD 155 (286)
T ss_pred ccCccHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccceecCCCcc
Confidence 9999988887643 335899999999999999999999987 99999999999999999999999999987654332
Q ss_pred ccccccccccCccCcccccc-CCCCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHH-H-------HhhcCc-c
Q 001658 850 HISTRVAGTIGYLAPEYAMR-GHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAW-H-------LHENNQ-E 919 (1036)
Q Consensus 850 ~~~~~~~gt~~y~APE~~~~-~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~-~-------~~~~~~-~ 919 (1036)
......++..|+|||++.+ ..++.++||||||+++|||++|++||......+......... . .+.... .
T Consensus 156 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (286)
T cd07847 156 -DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFF 234 (286)
T ss_pred -cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccccccc
Confidence 1223457889999999876 457899999999999999999999998655433322211100 0 000000 0
Q ss_pred ccccCcccc------cCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 001658 920 IELADPKLI------EFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVA 961 (1036)
Q Consensus 920 ~~~~d~~~~------~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 961 (1036)
.....+... .........+.+++.+||+.+|++||++.|++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 235 KGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred ccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 000011100 001122456788999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=324.24 Aligned_cols=240 Identities=22% Similarity=0.235 Sum_probs=185.1
Q ss_pred cccCCCEEEEEeEeC-CCcEEEEEEccccch---hcHHHHHHHHHHHHhh---ccCCcceeEeEEEcCceeEEEEEecCC
Q 001658 701 LGEGGFGPVYKGKLG-DGRAIAVKQLSVASR---QGKSQFVAEIATISAV---QHRNLVKLHGCCIEGAERLLVYEYLEN 773 (1036)
Q Consensus 701 iG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~---~~~~~f~~Ei~~L~~l---~H~nIv~l~g~~~~~~~~~lV~E~~~~ 773 (1036)
||+|+||+||+|+.. +++.||||++..... .....+..|..++.+. +||||+++++++.+....++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 799999999999864 689999999864321 2233455677777665 699999999999999999999999999
Q ss_pred CChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeecCCCCcccc
Q 001658 774 KSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHIST 853 (1036)
Q Consensus 774 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 853 (1036)
|+|.+++.. ...+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++....... ...
T Consensus 81 g~L~~~l~~--~~~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~-~~~ 154 (330)
T cd05586 81 GELFWHLQK--EGRFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTDNK-TTN 154 (330)
T ss_pred ChHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCC-Ccc
Confidence 999998864 345789999999999999999999988 99999999999999999999999999875432221 223
Q ss_pred ccccccCccCccccccC-CCCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhcCccccccCcccccCCH
Q 001658 854 RVAGTIGYLAPEYAMRG-HLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEIELADPKLIEFNE 932 (1036)
Q Consensus 854 ~~~gt~~y~APE~~~~~-~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~ 932 (1036)
...||..|+|||++.+. .++.++|||||||++|||++|+.||...........+ ..+ +..+.. .
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i-------~~~------~~~~~~--~ 219 (330)
T cd05586 155 TFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNI-------AFG------KVRFPK--N 219 (330)
T ss_pred CccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHH-------HcC------CCCCCC--c
Confidence 45699999999998764 4789999999999999999999999765432211111 000 111111 0
Q ss_pred HHHHHHHHHHHHhcccCCCCCCC----HHHHHH
Q 001658 933 EEVKRLIGVALLCTQTLPSLRPS----MSRVVA 961 (1036)
Q Consensus 933 ~~~~~l~~l~~~Cl~~dP~~RPt----~~evl~ 961 (1036)
.....+.+++.+|++.+|.+||+ +.|+++
T Consensus 220 ~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 220 VLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred cCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 12235567788999999999984 555544
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=329.81 Aligned_cols=204 Identities=25% Similarity=0.345 Sum_probs=175.3
Q ss_pred cCCCCCCccccCCCEEEEEeEeC-CCcEEEEEEccccc---hhcHHHHHHHHHHHHhhccCCcceeEeEEEcCceeEEEE
Q 001658 693 ENFSPSNKLGEGGFGPVYKGKLG-DGRAIAVKQLSVAS---RQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLVY 768 (1036)
Q Consensus 693 ~~~~~~~~iG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~ 768 (1036)
++|+..+.||+|+||.||+++.. +++.||+|+++... ......+..|+.++..++|+||+++++++.+.+..++||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 36788899999999999999864 68899999986432 233456788999999999999999999999999999999
Q ss_pred EecCCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeecCCC
Q 001658 769 EYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKK 848 (1036)
Q Consensus 769 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~ 848 (1036)
||+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+....
T Consensus 81 E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~ 155 (360)
T cd05627 81 EFLPGGDMMTLLMKK--DTLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAH 155 (360)
T ss_pred eCCCCccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCCccccccc
Confidence 999999999998643 45788899999999999999999988 9999999999999999999999999987543211
Q ss_pred C----------------------------------ccccccccccCccCccccccCCCCchhhHHhHHHHHHHHHhCCCC
Q 001658 849 T----------------------------------HISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRPN 894 (1036)
Q Consensus 849 ~----------------------------------~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~elltG~~p 894 (1036)
. .......||+.|+|||++.+..++.++|||||||++|||++|+.|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~P 235 (360)
T cd05627 156 RTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235 (360)
T ss_pred ccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCC
Confidence 0 001234699999999999999999999999999999999999999
Q ss_pred CCCCChh
Q 001658 895 SDPSLDE 901 (1036)
Q Consensus 895 ~~~~~~~ 901 (1036)
|......
T Consensus 236 f~~~~~~ 242 (360)
T cd05627 236 FCSETPQ 242 (360)
T ss_pred CCCCCHH
Confidence 9865543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=313.62 Aligned_cols=256 Identities=24% Similarity=0.354 Sum_probs=203.1
Q ss_pred cCCCCCCccccCCCEEEEEeEeC-CCcEEEEEEccccc-hhcHHHHHHHHHHHHhhccCCcceeEeEEEcCceeEEEEEe
Q 001658 693 ENFSPSNKLGEGGFGPVYKGKLG-DGRAIAVKQLSVAS-RQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLVYEY 770 (1036)
Q Consensus 693 ~~~~~~~~iG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~-~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~ 770 (1036)
++|++.+.||+|+||+||++... +|+.||+|++.... ....+.+.+|+++++.++||||+++++++......++||||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF 84 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence 46777899999999999999854 68899999876532 33457889999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeecCCCCc
Q 001658 771 LENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTH 850 (1036)
Q Consensus 771 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~ 850 (1036)
+++++|.+++... ..+++..+..++.+++.||.|||+.. +++||||||+||++++++.++|+|||++........
T Consensus 85 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~~- 159 (284)
T cd06620 85 MDCGSLDRIYKKG--GPIPVEILGKIAVAVVEGLTYLYNVH--RIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIA- 159 (284)
T ss_pred CCCCCHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHHhc--CeeccCCCHHHEEECCCCcEEEccCCcccchhhhcc-
Confidence 9999999988653 45889999999999999999999742 399999999999999999999999999875432211
Q ss_pred cccccccccCccCccccccCCCCchhhHHhHHHHHHHHHhCCCCCCCCChhh-----HHHHHHHHHHHhhcCccccccCc
Q 001658 851 ISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEE-----KLYLLEWAWHLHENNQEIELADP 925 (1036)
Q Consensus 851 ~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~-----~~~l~~~~~~~~~~~~~~~~~d~ 925 (1036)
....|+..|+|||++.+..++.++|||||||++||+++|+.||....... .....++........ .+
T Consensus 160 --~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~ 231 (284)
T cd06620 160 --DTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEP------PP 231 (284)
T ss_pred --CccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhcc------CC
Confidence 23568999999999988899999999999999999999999998644321 111112222211110 11
Q ss_pred ccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 001658 926 KLIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVAML 963 (1036)
Q Consensus 926 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L 963 (1036)
.+. ..+....+.+++.+|++.||++|||+.|++++.
T Consensus 232 ~~~--~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~ 267 (284)
T cd06620 232 RLP--SSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP 267 (284)
T ss_pred CCC--chhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence 111 112345677888999999999999999999763
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-34 Score=315.73 Aligned_cols=263 Identities=26% Similarity=0.361 Sum_probs=201.0
Q ss_pred cCCCCCCccccCCCEEEEEeEeC-CCcEEEEEEccccc--hhcHHHHHHHHHHHHhhccCCcceeEeEEEcCceeEEEEE
Q 001658 693 ENFSPSNKLGEGGFGPVYKGKLG-DGRAIAVKQLSVAS--RQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLVYE 769 (1036)
Q Consensus 693 ~~~~~~~~iG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~--~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E 769 (1036)
++|+..+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|+++++.++||||+++++++..++..++|+|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 46788899999999999999975 58999999886432 2234578899999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeecCCCC
Q 001658 770 YLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKT 849 (1036)
Q Consensus 770 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~ 849 (1036)
|+++++|.++.... ..++|..+..++.|+++||+|||+.+ |+||||+|+||++++++.++|+|||++........
T Consensus 81 ~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~ 155 (286)
T cd07846 81 FVDHTVLDDLEKYP--NGLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE 155 (286)
T ss_pred cCCccHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeeeeccCCcc
Confidence 99999998876432 34899999999999999999999987 99999999999999999999999999987644332
Q ss_pred ccccccccccCccCcccccc-CCCCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHH-h-------hcCcc-
Q 001658 850 HISTRVAGTIGYLAPEYAMR-GHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHL-H-------ENNQE- 919 (1036)
Q Consensus 850 ~~~~~~~gt~~y~APE~~~~-~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~-~-------~~~~~- 919 (1036)
......++..|+|||++.+ ..++.++||||||+++|||++|++||......+........... . .....
T Consensus 156 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (286)
T cd07846 156 -VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLF 234 (286)
T ss_pred -ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHh
Confidence 2233457889999999875 45788999999999999999999998754432222111111000 0 00000
Q ss_pred ccccCcccc------cCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 001658 920 IELADPKLI------EFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVA 961 (1036)
Q Consensus 920 ~~~~d~~~~------~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 961 (1036)
.....+... .........+.+++.+||+.+|++||++.++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 235 AGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred hccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 000011110 001123456888999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=307.40 Aligned_cols=249 Identities=24% Similarity=0.370 Sum_probs=193.4
Q ss_pred cCCCCCCccccCCCEEEEEeEe-CCCcEEEEEEccccc-----hhcHHHHHHHHHHHHhhccCCcceeEeEEEcC--cee
Q 001658 693 ENFSPSNKLGEGGFGPVYKGKL-GDGRAIAVKQLSVAS-----RQGKSQFVAEIATISAVQHRNLVKLHGCCIEG--AER 764 (1036)
Q Consensus 693 ~~~~~~~~iG~G~fG~Vy~~~~-~~g~~vAvK~~~~~~-----~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~--~~~ 764 (1036)
.+|+..+.||+|+||.||+|.. ..++.||+|.+.... ......+.+|+.++++++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 3688889999999999999985 468899999885431 22345688999999999999999999998753 567
Q ss_pred EEEEEecCCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceee
Q 001658 765 LLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLY 844 (1036)
Q Consensus 765 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~ 844 (1036)
++++||+++++|.+++... ..+++.....++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++..
T Consensus 82 ~l~~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~dfg~~~~~ 156 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAY--GALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRL 156 (266)
T ss_pred EEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCCCcccc
Confidence 8999999999999999653 34788899999999999999999887 999999999999999999999999999865
Q ss_pred cCCCC--ccccccccccCccCccccccCCCCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhcCccccc
Q 001658 845 DDKKT--HISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEIEL 922 (1036)
Q Consensus 845 ~~~~~--~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 922 (1036)
..... .......++..|+|||++.+..++.++|||||||++|||++|+.||.......... ... ...
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~------~~~-----~~~ 225 (266)
T cd06651 157 QTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIF------KIA-----TQP 225 (266)
T ss_pred ccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHH------HHh-----cCC
Confidence 43211 11123458889999999998889999999999999999999999997543222111 000 011
Q ss_pred cCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 001658 923 ADPKLIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVA 961 (1036)
Q Consensus 923 ~d~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 961 (1036)
..+.+. ......+.+++ .||..+|++||++.||++
T Consensus 226 ~~~~~~---~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 226 TNPQLP---SHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred CCCCCc---hhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 122221 11222333333 689999999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=308.79 Aligned_cols=254 Identities=27% Similarity=0.384 Sum_probs=205.0
Q ss_pred cCCCCCCccccCCCEEEEEeEeC-CCcEEEEEEccccc-hhcHHHHHHHHHHHHhhccCCcceeEeEEEcCceeEEEEEe
Q 001658 693 ENFSPSNKLGEGGFGPVYKGKLG-DGRAIAVKQLSVAS-RQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLVYEY 770 (1036)
Q Consensus 693 ~~~~~~~~iG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~-~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~ 770 (1036)
++|++.+.||.|+||+||+|... ++..+|+|++.... ....+.+.+|+++++.++|+||+++++.+..++..++|+|+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 46888999999999999999854 67899999986432 23467789999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCC-CCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeecCCCC
Q 001658 771 LENKSLDQALFGQRS-LTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKT 849 (1036)
Q Consensus 771 ~~~gsL~~~l~~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~ 849 (1036)
+++++|.+++..... ..+++.....++.|++.||+|||+.+ |+||||||+||++++++.++|+|||++..+.....
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~ 157 (267)
T cd06610 81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD 157 (267)
T ss_pred cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence 999999999976433 56899999999999999999999988 99999999999999999999999999976654332
Q ss_pred c---cccccccccCccCccccccC-CCCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhcCccccccCc
Q 001658 850 H---ISTRVAGTIGYLAPEYAMRG-HLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEIELADP 925 (1036)
Q Consensus 850 ~---~~~~~~gt~~y~APE~~~~~-~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 925 (1036)
. ......|+..|+|||++... .++.++|||||||++|||++|+.||......... .+. ... ..+
T Consensus 158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~--~~~----~~~------~~~ 225 (267)
T cd06610 158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVL--MLT----LQN------DPP 225 (267)
T ss_pred ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhH--HHH----hcC------CCC
Confidence 2 12334688999999998877 7899999999999999999999999764432211 111 110 111
Q ss_pred ccccC--CHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 001658 926 KLIEF--NEEEVKRLIGVALLCTQTLPSLRPSMSRVVA 961 (1036)
Q Consensus 926 ~~~~~--~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 961 (1036)
..... .......+.+++.+|++.+|++||++.|+++
T Consensus 226 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 226 SLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred CcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 11111 1233456788889999999999999999885
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=316.02 Aligned_cols=257 Identities=25% Similarity=0.408 Sum_probs=200.8
Q ss_pred hcCCCCCCccccCCCEEEEEeEeC-CCc----EEEEEEccccc-hhcHHHHHHHHHHHHhhccCCcceeEeEEEcCceeE
Q 001658 692 TENFSPSNKLGEGGFGPVYKGKLG-DGR----AIAVKQLSVAS-RQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERL 765 (1036)
Q Consensus 692 ~~~~~~~~~iG~G~fG~Vy~~~~~-~g~----~vAvK~~~~~~-~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~ 765 (1036)
.++|+..+.||+|+||.||+|... +|+ .||+|.+.... .....++.+|+.++++++||||++++|+|... ..+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~ 84 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQ 84 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cce
Confidence 346777899999999999999853 443 57899886543 23345788999999999999999999998754 467
Q ss_pred EEEEecCCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeec
Q 001658 766 LVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYD 845 (1036)
Q Consensus 766 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~ 845 (1036)
+|+||+++|+|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++.+.
T Consensus 85 ~v~e~~~~g~l~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~ 160 (303)
T cd05110 85 LVTQLMPHGCLLDYVHEH-KDNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLLE 160 (303)
T ss_pred eeehhcCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEcccccccccc
Confidence 899999999999998653 335789999999999999999999987 9999999999999999999999999998765
Q ss_pred CCCCcc-ccccccccCccCccccccCCCCchhhHHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHHHHHhhcCcccccc
Q 001658 846 DKKTHI-STRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVS-GRPNSDPSLDEEKLYLLEWAWHLHENNQEIELA 923 (1036)
Q Consensus 846 ~~~~~~-~~~~~gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 923 (1036)
...... .....++..|+|||++.+..++.++|||||||++|||++ |+.||......... ++. ..+.. ..
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~---~~~----~~~~~--~~ 231 (303)
T cd05110 161 GDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIP---DLL----EKGER--LP 231 (303)
T ss_pred CcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHH---HHH----HCCCC--CC
Confidence 332211 122345778999999998899999999999999999997 88888754332221 111 11110 00
Q ss_pred CcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcccC
Q 001658 924 DPKLIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVAMLCGDME 968 (1036)
Q Consensus 924 d~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 968 (1036)
.+ ......+.+++..||..+|++||++.++++.|+...+
T Consensus 232 ~~------~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~ 270 (303)
T cd05110 232 QP------PICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMAR 270 (303)
T ss_pred CC------CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 11 1123467788899999999999999999999987644
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=313.66 Aligned_cols=260 Identities=23% Similarity=0.340 Sum_probs=200.3
Q ss_pred CCCCCCccccCCCEEEEEeEeC-CCcEEEEEEccccchh-----cHHHHHHHHHHHHhhccCCcceeEeEEEcCceeEEE
Q 001658 694 NFSPSNKLGEGGFGPVYKGKLG-DGRAIAVKQLSVASRQ-----GKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLV 767 (1036)
Q Consensus 694 ~~~~~~~iG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~~-----~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV 767 (1036)
+|+..+.||+|+||.||+|... +++.||+|.+...... ....+..|++++++++|+||+++++++.+.+..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 4677889999999999999864 6899999998654322 345577899999999999999999999999999999
Q ss_pred EEecCCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeecCC
Q 001658 768 YEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDK 847 (1036)
Q Consensus 768 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~ 847 (1036)
|||+ +++|.+++.... ..+++..+.+++.||++||+|||+.+ |+||||||+||+++.++.++|+|||+++.....
T Consensus 81 ~e~~-~~~L~~~i~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~ 155 (298)
T cd07841 81 FEFM-ETDLEKVIKDKS-IVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGSP 155 (298)
T ss_pred Eccc-CCCHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccceeeeeccCC
Confidence 9999 999999996543 46899999999999999999999998 999999999999999999999999999876543
Q ss_pred CCccccccccccCccCcccccc-CCCCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhcC---------
Q 001658 848 KTHISTRVAGTIGYLAPEYAMR-GHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENN--------- 917 (1036)
Q Consensus 848 ~~~~~~~~~gt~~y~APE~~~~-~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~--------- 917 (1036)
... .....+++.|+|||.+.+ ..++.++|||||||++|||++|.+||....+.+..... .......
T Consensus 156 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~ 231 (298)
T cd07841 156 NRK-MTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKI---FEALGTPTEENWPGVT 231 (298)
T ss_pred Ccc-ccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHH---HHHcCCCchhhhhhcc
Confidence 221 223356788999999865 45789999999999999999998888754432222111 0000000
Q ss_pred ccccc------cCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 001658 918 QEIEL------ADPKLIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVAM 962 (1036)
Q Consensus 918 ~~~~~------~d~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 962 (1036)
..... ...............+.+++.+||+.+|++|||+.|++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 232 SLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred cccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 00000 0000011112234678889999999999999999999873
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=306.59 Aligned_cols=248 Identities=24% Similarity=0.360 Sum_probs=201.8
Q ss_pred CCCCCCccccCCCEEEEEeEe-CCCcEEEEEEcccc--chhcHHHHHHHHHHHHhhccCCcceeEeEEEcCceeEEEEEe
Q 001658 694 NFSPSNKLGEGGFGPVYKGKL-GDGRAIAVKQLSVA--SRQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLVYEY 770 (1036)
Q Consensus 694 ~~~~~~~iG~G~fG~Vy~~~~-~~g~~vAvK~~~~~--~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~ 770 (1036)
+|+..+.||+|+||.||++.. .+++.+|+|.+... .......+.+|++++++++||||+++++.+..++..++|+||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 477889999999999999985 46789999998643 233456789999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCC-CceEEEEcCcceeecCCCC
Q 001658 771 LENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDAD-LVPKISDFGLAKLYDDKKT 849 (1036)
Q Consensus 771 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~-~~~kl~DFGla~~~~~~~~ 849 (1036)
+++++|.+++.......+++..+.+++.++++||+|||+.+ |+||||||+||+++++ +.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~ 157 (256)
T cd08220 81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK 157 (256)
T ss_pred CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcc
Confidence 99999999997765667899999999999999999999987 9999999999999865 5689999999987654322
Q ss_pred ccccccccccCccCccccccCCCCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhcCccccccCccccc
Q 001658 850 HISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEIELADPKLIE 929 (1036)
Q Consensus 850 ~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~ 929 (1036)
.....|+..|+|||.+.+..++.++||||||+++|+|++|+.||......... ... ... . ...
T Consensus 158 --~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~---~~~---~~~-~--------~~~ 220 (256)
T cd08220 158 --AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALV---LKI---MSG-T--------FAP 220 (256)
T ss_pred --ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHH---HHH---Hhc-C--------CCC
Confidence 22346888999999999888999999999999999999999999765432211 111 000 0 001
Q ss_pred CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 001658 930 FNEEEVKRLIGVALLCTQTLPSLRPSMSRVVA 961 (1036)
Q Consensus 930 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 961 (1036)
........+.+++..||+.+|++|||+.|+++
T Consensus 221 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~ 252 (256)
T cd08220 221 ISDRYSPDLRQLILSMLNLDPSKRPQLSQIMA 252 (256)
T ss_pred CCCCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 11123446778889999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-34 Score=317.16 Aligned_cols=248 Identities=24% Similarity=0.396 Sum_probs=198.7
Q ss_pred CCCCCccccCCCEEEEEeEeC-CCcEEEEEEccccchhcHHHHHHHHHHHHhhccCCcceeEeEEEcCceeEEEEEecCC
Q 001658 695 FSPSNKLGEGGFGPVYKGKLG-DGRAIAVKQLSVASRQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLVYEYLEN 773 (1036)
Q Consensus 695 ~~~~~~iG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~ 773 (1036)
|.....||+|+||.||++... +++.||||.+........+.+.+|+.+++.++|+||+++++.+..++..++||||+++
T Consensus 24 ~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~ 103 (292)
T cd06658 24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEG 103 (292)
T ss_pred HhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCC
Confidence 333467999999999999854 6889999998765555567789999999999999999999999999999999999999
Q ss_pred CChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeecCCCCcccc
Q 001658 774 KSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHIST 853 (1036)
Q Consensus 774 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 853 (1036)
++|.+++.. ..+++..+..++.||+.||+|||+.+ |+||||||+||++++++.++|+|||++......... ..
T Consensus 104 ~~L~~~~~~---~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~-~~ 176 (292)
T cd06658 104 GALTDIVTH---TRMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPK-RK 176 (292)
T ss_pred CcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhccccccc-Cc
Confidence 999998843 35789999999999999999999987 999999999999999999999999998765433221 22
Q ss_pred ccccccCccCccccccCCCCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhcCccccccCcccccCCHH
Q 001658 854 RVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEIELADPKLIEFNEE 933 (1036)
Q Consensus 854 ~~~gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~ 933 (1036)
...|+..|+|||+..+..++.++||||||+++|||++|+.||............. . ...+... ....
T Consensus 177 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~---~---------~~~~~~~-~~~~ 243 (292)
T cd06658 177 SLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIR---D---------NLPPRVK-DSHK 243 (292)
T ss_pred eeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH---h---------cCCCccc-cccc
Confidence 3458899999999988889999999999999999999999997644322221110 0 0111111 1111
Q ss_pred HHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 001658 934 EVKRLIGVALLCTQTLPSLRPSMSRVVAM 962 (1036)
Q Consensus 934 ~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 962 (1036)
....+.+++..|++.+|.+|||+.|+++.
T Consensus 244 ~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 244 VSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred cCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 22356677788999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=315.48 Aligned_cols=263 Identities=24% Similarity=0.337 Sum_probs=198.6
Q ss_pred cCCCCCCccccCCCEEEEEeEeC-CCcEEEEEEccccc-hhcHHHHHHHHHHHHhhccCCcceeEeEEEcCceeEEEEEe
Q 001658 693 ENFSPSNKLGEGGFGPVYKGKLG-DGRAIAVKQLSVAS-RQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLVYEY 770 (1036)
Q Consensus 693 ~~~~~~~~iG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~-~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~ 770 (1036)
++|...+.||+|+||.||+|+.. +++.||+|.+.... ......+.+|+.++++++|+||+++++++...+..++|+||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 46888899999999999999864 67899999986432 23345678899999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeecCCCCc
Q 001658 771 LENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTH 850 (1036)
Q Consensus 771 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~ 850 (1036)
++ ++|.+++... ...+++..+..++.|+++||+|||+.+ |+||||||+||++++++.+||+|||++.........
T Consensus 86 ~~-~~l~~~l~~~-~~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~ 160 (301)
T cd07873 86 LD-KDLKQYLDDC-GNSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKT 160 (301)
T ss_pred cc-cCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhccCCCCCc
Confidence 97 6898888654 345788999999999999999999987 999999999999999999999999999765432221
Q ss_pred cccccccccCccCccccccC-CCCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHH--------HHHh-hcCccc
Q 001658 851 ISTRVAGTIGYLAPEYAMRG-HLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWA--------WHLH-ENNQEI 920 (1036)
Q Consensus 851 ~~~~~~gt~~y~APE~~~~~-~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~--------~~~~-~~~~~~ 920 (1036)
.....+++.|+|||++.+. .++.++|||||||++|||++|++||......+........ |... ......
T Consensus 161 -~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (301)
T cd07873 161 -YSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFK 239 (301)
T ss_pred -ccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhcccccc
Confidence 1234578899999998654 5788999999999999999999999865443322111100 0000 000000
Q ss_pred cccCcccc-----cCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 001658 921 ELADPKLI-----EFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVA 961 (1036)
Q Consensus 921 ~~~d~~~~-----~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 961 (1036)
....+... .........+.+++.+|++.||.+|||++|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 240 SYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred ccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 00001100 001112335678889999999999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=309.49 Aligned_cols=254 Identities=24% Similarity=0.365 Sum_probs=198.3
Q ss_pred CCCCCccccCCCEEEEEeEeC----CCcEEEEEEcccc--chhcHHHHHHHHHHHHhhccCCcceeEeEEEcCc------
Q 001658 695 FSPSNKLGEGGFGPVYKGKLG----DGRAIAVKQLSVA--SRQGKSQFVAEIATISAVQHRNLVKLHGCCIEGA------ 762 (1036)
Q Consensus 695 ~~~~~~iG~G~fG~Vy~~~~~----~g~~vAvK~~~~~--~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~------ 762 (1036)
|.+.+.||+|+||.||+|.+. .++.||||++... .....+++.+|++++++++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 556789999999999999753 3688999998643 2334567889999999999999999999886542
Q ss_pred eeEEEEEecCCCChhhhhhcC----CCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEc
Q 001658 763 ERLLVYEYLENKSLDQALFGQ----RSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDF 838 (1036)
Q Consensus 763 ~~~lV~E~~~~gsL~~~l~~~----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DF 838 (1036)
..++++||+++|+|.+++... ....+++....+++.|++.||+|||+.+ |+||||||+||+++.++.+||+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEECcc
Confidence 237889999999999887532 2335788999999999999999999987 999999999999999999999999
Q ss_pred CcceeecCCCCc-cccccccccCccCccccccCCCCchhhHHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHHHHHhhc
Q 001658 839 GLAKLYDDKKTH-ISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVS-GRPNSDPSLDEEKLYLLEWAWHLHEN 916 (1036)
Q Consensus 839 Gla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~ 916 (1036)
|+++........ ......++..|++||.+....++.++||||||+++|||++ |++||......+. ..+...
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~---~~~~~~---- 230 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEI---YNYLIK---- 230 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHH---HHHHHc----
Confidence 999866432211 1122345678999999998889999999999999999999 8888875433221 111111
Q ss_pred CccccccCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcc
Q 001658 917 NQEIELADPKLIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVAMLCGD 966 (1036)
Q Consensus 917 ~~~~~~~d~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 966 (1036)
.. ... ........+.+++.+|++.+|++||++.|+++.|++.
T Consensus 231 ~~-----~~~---~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 231 GN-----RLK---QPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred CC-----cCC---CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 00 000 1112335788899999999999999999999999754
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-34 Score=312.92 Aligned_cols=251 Identities=24% Similarity=0.384 Sum_probs=201.8
Q ss_pred HhcCCCCCCccccCCCEEEEEeEeCCCcEEEEEEccc--cchhcHHHHHHHHHHHHhhc-cCCcceeEeEEEcCceeEEE
Q 001658 691 ATENFSPSNKLGEGGFGPVYKGKLGDGRAIAVKQLSV--ASRQGKSQFVAEIATISAVQ-HRNLVKLHGCCIEGAERLLV 767 (1036)
Q Consensus 691 ~~~~~~~~~~iG~G~fG~Vy~~~~~~g~~vAvK~~~~--~~~~~~~~f~~Ei~~L~~l~-H~nIv~l~g~~~~~~~~~lV 767 (1036)
....|++.++||+||.+.||++...+.+.+|+|++.. .+.+....|.+|+..|.+++ |.+||++++|-..++..|+|
T Consensus 359 kg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmv 438 (677)
T KOG0596|consen 359 KGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMV 438 (677)
T ss_pred CcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEE
Confidence 3456788899999999999999988888999998753 45666788999999999995 99999999999999999999
Q ss_pred EEecCCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeecCC
Q 001658 768 YEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDK 847 (1036)
Q Consensus 768 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~ 847 (1036)
|||- ..+|..+|........+| .+..+..|++.|+.++|+++ |||.||||.|+|+- .|.+||+|||+|.-+..+
T Consensus 439 mE~G-d~DL~kiL~k~~~~~~~~-~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~D 512 (677)
T KOG0596|consen 439 MECG-DIDLNKILKKKKSIDPDW-FLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLV-KGRLKLIDFGIANAIQPD 512 (677)
T ss_pred eecc-cccHHHHHHhccCCCchH-HHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEE-eeeEEeeeechhcccCcc
Confidence 9986 569999998777666777 66678999999999999998 99999999999984 578999999999988766
Q ss_pred CCcc-ccccccccCccCccccccC-----------CCCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhh
Q 001658 848 KTHI-STRVAGTIGYLAPEYAMRG-----------HLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHE 915 (1036)
Q Consensus 848 ~~~~-~~~~~gt~~y~APE~~~~~-----------~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~ 915 (1036)
.+.. ....+||+.||+||.+... +.++++||||+|||||+|+-|++||+.... ...
T Consensus 513 TTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n-----~~a------- 580 (677)
T KOG0596|consen 513 TTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIIN-----QIA------- 580 (677)
T ss_pred ccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHH-----HHH-------
Confidence 5543 2456799999999998532 366799999999999999999999975321 111
Q ss_pred cCccccccCccc-ccCC-HHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 001658 916 NNQEIELADPKL-IEFN-EEEVKRLIGVALLCTQTLPSLRPSMSRVVA 961 (1036)
Q Consensus 916 ~~~~~~~~d~~~-~~~~-~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 961 (1036)
+...+.||.- .+++ .....+++++|..|++.||++||+..|+++
T Consensus 581 --Kl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLq 626 (677)
T KOG0596|consen 581 --KLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQ 626 (677)
T ss_pred --HHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhc
Confidence 1112233311 0111 111123899999999999999999999986
|
|
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=328.06 Aligned_cols=260 Identities=20% Similarity=0.181 Sum_probs=197.4
Q ss_pred hcCCCCCCccccCCCEEEEEeEeC---CCcEEEEEEccccchhcHHHHHHHHHHHHhhccCCcceeEeEEEcCceeEEEE
Q 001658 692 TENFSPSNKLGEGGFGPVYKGKLG---DGRAIAVKQLSVASRQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLVY 768 (1036)
Q Consensus 692 ~~~~~~~~~iG~G~fG~Vy~~~~~---~g~~vAvK~~~~~~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~ 768 (1036)
..+|.+.+.||+|+||.||++... .++.||+|.+... ..+.+|++++++++||||+++++++......++||
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 165 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVM 165 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence 356888999999999999999743 3578999987632 23568999999999999999999999999999999
Q ss_pred EecCCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeecCCC
Q 001658 769 EYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKK 848 (1036)
Q Consensus 769 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~ 848 (1036)
|++. ++|.+++. ....+++..++.|+.||+.||+|||+.+ |+||||||+|||++.++.++|+|||+++.+....
T Consensus 166 e~~~-~~l~~~l~--~~~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~ 239 (392)
T PHA03207 166 PKYK-CDLFTYVD--RSGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDAHP 239 (392)
T ss_pred hhcC-CCHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCccccccCccc
Confidence 9985 68888883 3456899999999999999999999988 9999999999999999999999999998665432
Q ss_pred Cc-cccccccccCccCccccccCCCCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhcCcc--------
Q 001658 849 TH-ISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQE-------- 919 (1036)
Q Consensus 849 ~~-~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~-------- 919 (1036)
.. ......||+.|+|||++....++.++|||||||++|||++|+.||..............+.........
T Consensus 240 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~ 319 (392)
T PHA03207 240 DTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGST 319 (392)
T ss_pred ccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccch
Confidence 22 223457999999999999999999999999999999999999999764332111111111111000000
Q ss_pred ---------ccccCccc--ccC--CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 001658 920 ---------IELADPKL--IEF--NEEEVKRLIGVALLCTQTLPSLRPSMSRVVAM 962 (1036)
Q Consensus 920 ---------~~~~d~~~--~~~--~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 962 (1036)
.....+.. ... ......++.+++.+|++.||++||++.|++..
T Consensus 320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 320 NLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred hHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 00000000 000 00122456778889999999999999999864
|
|
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=311.45 Aligned_cols=261 Identities=28% Similarity=0.384 Sum_probs=203.1
Q ss_pred CCCCCCccccCCCEEEEEeEeC-CCcEEEEEEccccc--hhcHHHHHHHHHHHHhhccCCcceeEeEEEcCceeEEEEEe
Q 001658 694 NFSPSNKLGEGGFGPVYKGKLG-DGRAIAVKQLSVAS--RQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLVYEY 770 (1036)
Q Consensus 694 ~~~~~~~iG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~--~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~ 770 (1036)
+|++.+.||+|+||.||+|+.. +|+.||+|++.... ......+.+|+.++++++|+||+++++++..+...++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 4778899999999999999864 68999999987543 33356789999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeecCCCCc
Q 001658 771 LENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTH 850 (1036)
Q Consensus 771 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~ 850 (1036)
+ +++|.+++.... ..+++.+++.++.||++||+|||+.+ ++|+||||+||++++++.++|+|||++.........
T Consensus 81 ~-~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~ 155 (286)
T cd07832 81 M-PSDLSEVLRDEE-RPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEEEPR 155 (286)
T ss_pred c-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCC
Confidence 9 999999986543 56899999999999999999999987 999999999999999999999999999876544322
Q ss_pred cccccccccCccCccccccC-CCCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhcCcc----------
Q 001658 851 ISTRVAGTIGYLAPEYAMRG-HLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQE---------- 919 (1036)
Q Consensus 851 ~~~~~~gt~~y~APE~~~~~-~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~---------- 919 (1036)
......|+..|+|||++.+. .++.++||||+|++++||++|++||....+..... +..........
T Consensus 156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~ 232 (286)
T cd07832 156 LYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLA---IVFRTLGTPNEETWPGLTSLP 232 (286)
T ss_pred ccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHH---HHHHHcCCCChHHHhhccCcc
Confidence 23345689999999998654 46899999999999999999988886554322221 11111100000
Q ss_pred --ccccCcc-----cccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 001658 920 --IELADPK-----LIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVAM 962 (1036)
Q Consensus 920 --~~~~d~~-----~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 962 (1036)
.....+. +.....+....+.+++.+|++.+|.+||++++++..
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 233 DYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred hhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0000000 001111234678889999999999999999999863
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=323.50 Aligned_cols=192 Identities=23% Similarity=0.310 Sum_probs=164.7
Q ss_pred HhcCCCCCCccccCCCEEEEEeEeC-CCcEEEEEEccccchhcHHHHHHHHHHHHhhccCCcceeEeEEEcCceeEEEEE
Q 001658 691 ATENFSPSNKLGEGGFGPVYKGKLG-DGRAIAVKQLSVASRQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLVYE 769 (1036)
Q Consensus 691 ~~~~~~~~~~iG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E 769 (1036)
...+|++.+.||+|+||.||+|+.. +++.||+|..... ....|+.++++++|+||+++++++......++|+|
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 137 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLP 137 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEE
Confidence 3457999999999999999999864 5678999975422 23568999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeecCCCC
Q 001658 770 YLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKT 849 (1036)
Q Consensus 770 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~ 849 (1036)
++ .++|.+++... ...+++..+..|+.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 138 ~~-~~~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~- 211 (357)
T PHA03209 138 HY-SSDLYTYLTKR-SRPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP- 211 (357)
T ss_pred cc-CCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCccccccccCc-
Confidence 99 46888888543 456899999999999999999999988 9999999999999999999999999997543221
Q ss_pred ccccccccccCccCccccccCCCCchhhHHhHHHHHHHHHhCCCCC
Q 001658 850 HISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRPNS 895 (1036)
Q Consensus 850 ~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~ 895 (1036)
......||+.|+|||++.+..++.++|||||||++|||+++..++
T Consensus 212 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 212 -AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred -ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 123356999999999999999999999999999999999866554
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=301.50 Aligned_cols=251 Identities=24% Similarity=0.223 Sum_probs=206.3
Q ss_pred CCCCCCccccCCCEEEEEeEeCC-CcEEEEEEccccc---hhcHHHHHHHHHHHHhhccCCcceeEeEEEcCceeEEEEE
Q 001658 694 NFSPSNKLGEGGFGPVYKGKLGD-GRAIAVKQLSVAS---RQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLVYE 769 (1036)
Q Consensus 694 ~~~~~~~iG~G~fG~Vy~~~~~~-g~~vAvK~~~~~~---~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E 769 (1036)
.|+..+.||+|.-|+||.++.++ +..+|+|++.+.. +....+...|-+||+.++||.++.+|+.+..++..++|||
T Consensus 78 ~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~me 157 (459)
T KOG0610|consen 78 HFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVME 157 (459)
T ss_pred HHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEe
Confidence 34456889999999999999764 5889999997643 3344567789999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeecC---
Q 001658 770 YLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDD--- 846 (1036)
Q Consensus 770 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~--- 846 (1036)
||+||+|+.+++++....+++..+.-++..++-||+|||-.| ||.|||||+||||.++|++.|+||.++.....
T Consensus 158 yCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS~~~~~~Pt 234 (459)
T KOG0610|consen 158 YCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLSLRCPVSPT 234 (459)
T ss_pred cCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeeccccccCCCCCe
Confidence 999999999999999999999999999999999999999998 99999999999999999999999998743310
Q ss_pred ------------------------------CCC----------------------ccccccccccCccCccccccCCCCc
Q 001658 847 ------------------------------KKT----------------------HISTRVAGTIGYLAPEYAMRGHLTE 874 (1036)
Q Consensus 847 ------------------------------~~~----------------------~~~~~~~gt~~y~APE~~~~~~~~~ 874 (1036)
... ..+..++||-.|+|||++.+...+.
T Consensus 235 ~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHgs 314 (459)
T KOG0610|consen 235 LVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHGS 314 (459)
T ss_pred eeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCCc
Confidence 000 0122367999999999999999999
Q ss_pred hhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhcCccccccCcccccCCHHHHHHHHHHHHHhcccCCCCCC
Q 001658 875 KTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEIELADPKLIEFNEEEVKRLIGVALLCTQTLPSLRP 954 (1036)
Q Consensus 875 ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP 954 (1036)
++|.|+|||++|||+.|+-||.+....+...-+ -..++++.+.. +....+.+++.+.+.+||.+|-
T Consensus 315 AVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NI-------------v~~~l~Fp~~~-~vs~~akDLIr~LLvKdP~kRl 380 (459)
T KOG0610|consen 315 AVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNI-------------VGQPLKFPEEP-EVSSAAKDLIRKLLVKDPSKRL 380 (459)
T ss_pred hhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHH-------------hcCCCcCCCCC-cchhHHHHHHHHHhccChhhhh
Confidence 999999999999999999999987765544311 11122332222 4445677778889999999999
Q ss_pred C----HHHHHH
Q 001658 955 S----MSRVVA 961 (1036)
Q Consensus 955 t----~~evl~ 961 (1036)
. ++||-+
T Consensus 381 g~~rGA~eIK~ 391 (459)
T KOG0610|consen 381 GSKRGAAEIKR 391 (459)
T ss_pred ccccchHHhhc
Confidence 7 777654
|
|
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=316.41 Aligned_cols=245 Identities=25% Similarity=0.401 Sum_probs=197.8
Q ss_pred CCccccCCCEEEEEeEeC-CCcEEEEEEccccchhcHHHHHHHHHHHHhhccCCcceeEeEEEcCceeEEEEEecCCCCh
Q 001658 698 SNKLGEGGFGPVYKGKLG-DGRAIAVKQLSVASRQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLVYEYLENKSL 776 (1036)
Q Consensus 698 ~~~iG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL 776 (1036)
...||+|+||.||+|... +++.||+|.+........+.+.+|+.++..++||||+++++++..++..++|+||+++++|
T Consensus 26 ~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L 105 (297)
T cd06659 26 YIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGAL 105 (297)
T ss_pred hhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCH
Confidence 357999999999999854 6899999998755545566788999999999999999999999999999999999999999
Q ss_pred hhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeecCCCCccccccc
Q 001658 777 DQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVA 856 (1036)
Q Consensus 777 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 856 (1036)
.+++.. ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++......... .....
T Consensus 106 ~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~-~~~~~ 178 (297)
T cd06659 106 TDIVSQ---TRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK-RKSLV 178 (297)
T ss_pred HHHHhh---cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhccccccc-cccee
Confidence 998743 45789999999999999999999988 999999999999999999999999998755433221 22356
Q ss_pred cccCccCccccccCCCCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhcCccccccCcccccCCHHHHH
Q 001658 857 GTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEIELADPKLIEFNEEEVK 936 (1036)
Q Consensus 857 gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~ 936 (1036)
|+..|+|||++.+..++.++|||||||++|||++|+.||............ . ... .+.. ........
T Consensus 179 ~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~---~----~~~-----~~~~-~~~~~~~~ 245 (297)
T cd06659 179 GTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRL---R----DSP-----PPKL-KNAHKISP 245 (297)
T ss_pred cCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---h----ccC-----CCCc-cccCCCCH
Confidence 889999999999888999999999999999999999999764432222111 0 000 0000 01111234
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHHH
Q 001658 937 RLIGVALLCTQTLPSLRPSMSRVVAM 962 (1036)
Q Consensus 937 ~l~~l~~~Cl~~dP~~RPt~~evl~~ 962 (1036)
.+.+++..|++.+|.+||++.++++.
T Consensus 246 ~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 246 VLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred HHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 56778889999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=290.11 Aligned_cols=253 Identities=25% Similarity=0.354 Sum_probs=200.8
Q ss_pred HHhcCCCCCCccccCCCEEEEEeEeC-CCcEEEEEEccccc-----hh---cHHHHHHHHHHHHhh-ccCCcceeEeEEE
Q 001658 690 TATENFSPSNKLGEGGFGPVYKGKLG-DGRAIAVKQLSVAS-----RQ---GKSQFVAEIATISAV-QHRNLVKLHGCCI 759 (1036)
Q Consensus 690 ~~~~~~~~~~~iG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~-----~~---~~~~f~~Ei~~L~~l-~H~nIv~l~g~~~ 759 (1036)
..-+.|...+.+|+|..++|.++..+ .|...|+|++.... +. -.+.-.+|+.+|+++ .||+|+++.+++.
T Consensus 14 ~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~ye 93 (411)
T KOG0599|consen 14 GFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYE 93 (411)
T ss_pred hHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeecc
Confidence 34467788899999999999998754 67889999885421 11 123456799999998 5999999999999
Q ss_pred cCceeEEEEEecCCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcC
Q 001658 760 EGAERLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFG 839 (1036)
Q Consensus 760 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFG 839 (1036)
.+...++|+|.|+.|.|.|+|. ....++++...+|+.|+.+|++|||... ||||||||+|||+|++.++||+|||
T Consensus 94 s~sF~FlVFdl~prGELFDyLt--s~VtlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~i~isDFG 168 (411)
T KOG0599|consen 94 SDAFVFLVFDLMPRGELFDYLT--SKVTLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMNIKISDFG 168 (411)
T ss_pred CcchhhhhhhhcccchHHHHhh--hheeecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccceEEeccc
Confidence 9999999999999999999995 4577899999999999999999999988 9999999999999999999999999
Q ss_pred cceeecCCCCccccccccccCccCccccc------cCCCCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHH
Q 001658 840 LAKLYDDKKTHISTRVAGTIGYLAPEYAM------RGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHL 913 (1036)
Q Consensus 840 la~~~~~~~~~~~~~~~gt~~y~APE~~~------~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~ 913 (1036)
.++.+.+... -...+||++|+|||.+. ...|+..+|+|++|||+|-|+.|.+||.... ..... ++
T Consensus 169 Fa~~l~~Gek--LrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRk---QmlML----R~ 239 (411)
T KOG0599|consen 169 FACQLEPGEK--LRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRK---QMLML----RM 239 (411)
T ss_pred eeeccCCchh--HHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHH---HHHHH----HH
Confidence 9998865433 34578999999999985 3458889999999999999999999997421 11111 11
Q ss_pred hhcCccccccCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 001658 914 HENNQEIELADPKLIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVA 961 (1036)
Q Consensus 914 ~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 961 (1036)
..+++. +.-.|+ -.+......+++.+|++.||.+|-|+.|+++
T Consensus 240 ImeGky-qF~spe----Wadis~~~KdLIsrlLqVdp~~Ritake~La 282 (411)
T KOG0599|consen 240 IMEGKY-QFRSPE----WADISATVKDLISRLLQVDPTKRITAKEALA 282 (411)
T ss_pred HHhccc-ccCCcc----hhhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence 111111 111222 1233345667778999999999999999976
|
|
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-34 Score=345.78 Aligned_cols=256 Identities=23% Similarity=0.349 Sum_probs=198.8
Q ss_pred HHHhcCCCCCCccccCCCEEEEEeEeC-CCcEEEEEEcccc--chhcHHHHHHHHHHHHhhccCCcceeEeEEEcC--ce
Q 001658 689 KTATENFSPSNKLGEGGFGPVYKGKLG-DGRAIAVKQLSVA--SRQGKSQFVAEIATISAVQHRNLVKLHGCCIEG--AE 763 (1036)
Q Consensus 689 ~~~~~~~~~~~~iG~G~fG~Vy~~~~~-~g~~vAvK~~~~~--~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~--~~ 763 (1036)
....++|.+.+.||+|+||+||+|+.. .++.||+|.+... .......|..|+.++++++|||||++++++... ..
T Consensus 9 e~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ 88 (1021)
T PTZ00266 9 ESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQK 88 (1021)
T ss_pred ccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCE
Confidence 345578999999999999999999864 5778999988643 333456789999999999999999999988643 56
Q ss_pred eEEEEEecCCCChhhhhhcCC--CCCcChHHHHHHHHHHHHHHHHHHhcCC----ccccccccCCCcEEecCC-------
Q 001658 764 RLLVYEYLENKSLDQALFGQR--SLTLDWATRYEICSGVARGLAYLHEESR----VRIIHRDVKASNVLLDAD------- 830 (1036)
Q Consensus 764 ~~lV~E~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~----~~ivHrDikp~NILl~~~------- 830 (1036)
.++||||+++|+|.++|.... ...+++..++.|+.||+.||+|||+.+. .+||||||||+||||+.+
T Consensus 89 lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i 168 (1021)
T PTZ00266 89 LYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKI 168 (1021)
T ss_pred EEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccc
Confidence 899999999999999986532 3568999999999999999999998542 349999999999999642
Q ss_pred ----------CceEEEEcCcceeecCCCCccccccccccCccCcccccc--CCCCchhhHHhHHHHHHHHHhCCCCCCCC
Q 001658 831 ----------LVPKISDFGLAKLYDDKKTHISTRVAGTIGYLAPEYAMR--GHLTEKTDVFAFGVLALETVSGRPNSDPS 898 (1036)
Q Consensus 831 ----------~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~--~~~~~ksDVwS~Gvvl~elltG~~p~~~~ 898 (1036)
..+||+|||++..+.... ......||+.|+|||++.+ ..++.++|||||||++|||+||+.||...
T Consensus 169 ~~~~~n~ng~~iVKLsDFGlAr~l~~~s--~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~ 246 (1021)
T PTZ00266 169 TAQANNLNGRPIAKIGDFGLSKNIGIES--MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKA 246 (1021)
T ss_pred cccccccCCCCceEEccCCccccccccc--cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcC
Confidence 358999999998664322 2234569999999999854 45889999999999999999999999754
Q ss_pred ChhhHHHHHHHHHHHhhcCccccccCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 001658 899 LDEEKLYLLEWAWHLHENNQEIELADPKLIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVA 961 (1036)
Q Consensus 899 ~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 961 (1036)
...... .. ..... +.+. .......+.+++..||+.+|.+||++.|++.
T Consensus 247 ~~~~ql--i~----~lk~~-------p~lp--i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 247 NNFSQL--IS----ELKRG-------PDLP--IKGKSKELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred CcHHHH--HH----HHhcC-------CCCC--cCCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 332211 11 01100 1110 0112346778889999999999999999984
|
|
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=315.12 Aligned_cols=252 Identities=23% Similarity=0.243 Sum_probs=202.0
Q ss_pred cCCCCCCccccCCCEEEEEeEeC-CCcEEEEEEccccch---hcHHHHHHHHHHHHhhccCCcceeEeEEEcCceeEEEE
Q 001658 693 ENFSPSNKLGEGGFGPVYKGKLG-DGRAIAVKQLSVASR---QGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLVY 768 (1036)
Q Consensus 693 ~~~~~~~~iG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~---~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~ 768 (1036)
++|+..+.||+|+||.||+|... +++.||+|.+..... ...+.+..|+++++.++|+||+++++.+.+....++||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 36788899999999999999865 589999999865432 24567889999999999999999999999999999999
Q ss_pred EecCCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeecCCC
Q 001658 769 EYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKK 848 (1036)
Q Consensus 769 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~ 848 (1036)
||+++++|.+++.......+++..+..++.|+++||+|||+.+ ++||||||+||+++.++.++|+|||++.......
T Consensus 81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~ 157 (316)
T cd05574 81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEP 157 (316)
T ss_pred EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchhhcccccc
Confidence 9999999999997655667899999999999999999999987 9999999999999999999999999987553221
Q ss_pred Cc----------------------------cccccccccCccCccccccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCh
Q 001658 849 TH----------------------------ISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRPNSDPSLD 900 (1036)
Q Consensus 849 ~~----------------------------~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~ 900 (1036)
.. ......||..|+|||++.+..++.++||||||+++|||++|+.||.....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~ 237 (316)
T cd05574 158 PPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNR 237 (316)
T ss_pred cccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCch
Confidence 10 11124688999999999988899999999999999999999999976543
Q ss_pred hhHHHHHHHHHHHhhcCccccccCcccccCCHHHHHHHHHHHHHhcccCCCCCCC----HHHHHH
Q 001658 901 EEKLYLLEWAWHLHENNQEIELADPKLIEFNEEEVKRLIGVALLCTQTLPSLRPS----MSRVVA 961 (1036)
Q Consensus 901 ~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt----~~evl~ 961 (1036)
...... .... ++.... .......+.+++.+|++.+|++||+ +.|++.
T Consensus 238 ~~~~~~------~~~~-------~~~~~~-~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 238 DETFSN------ILKK-------EVTFPG-SPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred HHHHHH------HhcC-------CccCCC-ccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 322111 0100 011111 1114467888889999999999999 555544
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=309.52 Aligned_cols=254 Identities=27% Similarity=0.405 Sum_probs=201.9
Q ss_pred HHhcCCCCCCccccCCCEEEEEeEeC-CCcEEEEEEccccchhcHHHHHHHHHHHHhh-ccCCcceeEeEEEcCc-----
Q 001658 690 TATENFSPSNKLGEGGFGPVYKGKLG-DGRAIAVKQLSVASRQGKSQFVAEIATISAV-QHRNLVKLHGCCIEGA----- 762 (1036)
Q Consensus 690 ~~~~~~~~~~~iG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~f~~Ei~~L~~l-~H~nIv~l~g~~~~~~----- 762 (1036)
.++++|++.+.||+|+||.||+|... +++.+++|++..... ..+.+.+|+.+++++ +|+||+++++++....
T Consensus 3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (275)
T cd06608 3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND 81 (275)
T ss_pred CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence 35688999999999999999999864 678999999875443 356789999999999 6999999999997644
Q ss_pred -eeEEEEEecCCCChhhhhhcCC--CCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcC
Q 001658 763 -ERLLVYEYLENKSLDQALFGQR--SLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFG 839 (1036)
Q Consensus 763 -~~~lV~E~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFG 839 (1036)
..++||||+++++|.+++.... ...+++..+..++.|+++||+|||+.+ ++|+||+|+||++++++.+||+|||
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~d~~ 158 (275)
T cd06608 82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFG 158 (275)
T ss_pred eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEECCCc
Confidence 4799999999999999986543 567899999999999999999999987 9999999999999999999999999
Q ss_pred cceeecCCCCccccccccccCccCcccccc-----CCCCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHh
Q 001658 840 LAKLYDDKKTHISTRVAGTIGYLAPEYAMR-----GHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLH 914 (1036)
Q Consensus 840 la~~~~~~~~~~~~~~~gt~~y~APE~~~~-----~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~ 914 (1036)
++........ ......|+..|+|||++.. ..++.++|||||||++|||++|+.||.......... . ..
T Consensus 159 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~--~----~~ 231 (275)
T cd06608 159 VSAQLDSTLG-RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALF--K----IP 231 (275)
T ss_pred cceecccchh-hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHH--H----hh
Confidence 9986543222 2233458899999998753 346789999999999999999999997543322111 1 00
Q ss_pred hcCccccccCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 001658 915 ENNQEIELADPKLIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVA 961 (1036)
Q Consensus 915 ~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 961 (1036)
.. ..+.. .........+.+++.+|+..||++|||+.|+++
T Consensus 232 -~~-----~~~~~-~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 232 -RN-----PPPTL-KSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred -cc-----CCCCC-CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 00 01111 112234457788899999999999999999985
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=321.48 Aligned_cols=258 Identities=23% Similarity=0.271 Sum_probs=195.6
Q ss_pred HHhcCCCCCCccccCCCEEEEEeEe-CCCcEEEEEEccccc--hhcHHHHHHHHHHHHhhccCCcceeEeEEEcC-----
Q 001658 690 TATENFSPSNKLGEGGFGPVYKGKL-GDGRAIAVKQLSVAS--RQGKSQFVAEIATISAVQHRNLVKLHGCCIEG----- 761 (1036)
Q Consensus 690 ~~~~~~~~~~~iG~G~fG~Vy~~~~-~~g~~vAvK~~~~~~--~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~----- 761 (1036)
...++|+..+.||+|+||.||+|.. .+++.||||++.... ......+.+|++++++++||||+++++++...
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07878 12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN 91 (343)
T ss_pred hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence 4567899999999999999999985 467899999986432 22345677899999999999999999987543
Q ss_pred -ceeEEEEEecCCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCc
Q 001658 762 -AERLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGL 840 (1036)
Q Consensus 762 -~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGl 840 (1036)
...++++|++ +++|.+++. ...+++..+..++.||++||+|||+.+ |+||||||+||++++++.+||+|||+
T Consensus 92 ~~~~~~~~~~~-~~~l~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~ 164 (343)
T cd07878 92 FNEVYLVTNLM-GADLNNIVK---CQKLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGL 164 (343)
T ss_pred cCcEEEEeecC-CCCHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEEEcCCcc
Confidence 3468999988 789988874 345889999999999999999999998 99999999999999999999999999
Q ss_pred ceeecCCCCccccccccccCccCcccccc-CCCCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhcCcc
Q 001658 841 AKLYDDKKTHISTRVAGTIGYLAPEYAMR-GHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQE 919 (1036)
Q Consensus 841 a~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 919 (1036)
++...... ....||..|+|||++.+ ..++.++|||||||++|||++|+.||......+...... ........
T Consensus 165 ~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~---~~~~~~~~ 237 (343)
T cd07878 165 ARQADDEM----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIM---EVVGTPSP 237 (343)
T ss_pred ceecCCCc----CCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHH---HHhCCCCH
Confidence 98654322 23468999999999876 568999999999999999999999997644322221110 00000000
Q ss_pred --cccc--------CcccccCC--------HHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 001658 920 --IELA--------DPKLIEFN--------EEEVKRLIGVALLCTQTLPSLRPSMSRVVA 961 (1036)
Q Consensus 920 --~~~~--------d~~~~~~~--------~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 961 (1036)
.... ...+.... ......+.+++.+|++.||.+|||+.|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~ 297 (343)
T cd07878 238 EVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALA 297 (343)
T ss_pred HHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0000 00000000 011224678889999999999999999985
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=316.21 Aligned_cols=194 Identities=27% Similarity=0.420 Sum_probs=159.7
Q ss_pred CccccCCCEEEEEeEeC---CCcEEEEEEccccchhcHHHHHHHHHHHHhhccCCcceeEeEEEc--CceeEEEEEecCC
Q 001658 699 NKLGEGGFGPVYKGKLG---DGRAIAVKQLSVASRQGKSQFVAEIATISAVQHRNLVKLHGCCIE--GAERLLVYEYLEN 773 (1036)
Q Consensus 699 ~~iG~G~fG~Vy~~~~~---~g~~vAvK~~~~~~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~--~~~~~lV~E~~~~ 773 (1036)
.+||+|+||.||+|+.. +++.||+|.+.... ....+.+|++++++++||||+++++++.. ....++|+||++
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~- 83 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE- 83 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC-
Confidence 57999999999999864 35789999886432 23467889999999999999999999854 456789999986
Q ss_pred CChhhhhhcC-------CCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEe----cCCCceEEEEcCcce
Q 001658 774 KSLDQALFGQ-------RSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLL----DADLVPKISDFGLAK 842 (1036)
Q Consensus 774 gsL~~~l~~~-------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl----~~~~~~kl~DFGla~ 842 (1036)
++|.+++... ....+++..+..++.||+.||+|||+.+ |+||||||+|||+ ++++.+||+|||+++
T Consensus 84 ~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07867 84 HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence 5787776422 2345888999999999999999999988 9999999999999 566799999999998
Q ss_pred eecCCCCc--cccccccccCccCcccccc-CCCCchhhHHhHHHHHHHHHhCCCCCCCC
Q 001658 843 LYDDKKTH--ISTRVAGTIGYLAPEYAMR-GHLTEKTDVFAFGVLALETVSGRPNSDPS 898 (1036)
Q Consensus 843 ~~~~~~~~--~~~~~~gt~~y~APE~~~~-~~~~~ksDVwS~Gvvl~elltG~~p~~~~ 898 (1036)
........ ......||+.|+|||++.+ ..++.++|||||||++|||+||++||...
T Consensus 161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~ 219 (317)
T cd07867 161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred ccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence 76543221 1234568999999999876 45899999999999999999999999753
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=310.41 Aligned_cols=263 Identities=22% Similarity=0.304 Sum_probs=199.3
Q ss_pred CCCCCCccccCCCEEEEEeEeC-CCcEEEEEEccccc--hhcHHHHHHHHHHHHhhccCCcceeEeEEEcCceeEEEEEe
Q 001658 694 NFSPSNKLGEGGFGPVYKGKLG-DGRAIAVKQLSVAS--RQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLVYEY 770 (1036)
Q Consensus 694 ~~~~~~~iG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~--~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~ 770 (1036)
+|+..+.||+|++|.||+|+.. +++.||||.+.... ......+.+|++++++++||||+++++++.+++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 4778899999999999999864 68899999886432 22345788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeecCCCCc
Q 001658 771 LENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTH 850 (1036)
Q Consensus 771 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~ 850 (1036)
+. ++|.+++.......+++..+..++.|+++||+|||+.+ ++||||+|+||++++++.+||+|||+++.......
T Consensus 81 ~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~- 155 (284)
T cd07860 81 LH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR- 155 (284)
T ss_pred cc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhhcccCcc-
Confidence 95 68999987666677899999999999999999999987 99999999999999999999999999876543222
Q ss_pred cccccccccCccCccccccCC-CCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHH-HHHHH-------HHhhc-----
Q 001658 851 ISTRVAGTIGYLAPEYAMRGH-LTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYL-LEWAW-------HLHEN----- 916 (1036)
Q Consensus 851 ~~~~~~gt~~y~APE~~~~~~-~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l-~~~~~-------~~~~~----- 916 (1036)
......++..|+|||++.+.. ++.++||||||+++|||+||+.||......+.... .++.. .....
T Consensus 156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd07860 156 TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYK 235 (284)
T ss_pred ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHH
Confidence 122335788999999887644 68899999999999999999999976543322211 11000 00000
Q ss_pred CccccccCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 001658 917 NQEIELADPKLIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVA 961 (1036)
Q Consensus 917 ~~~~~~~d~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 961 (1036)
..........+..........+.+++.+|++.||++|||+.|++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 236 PSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred hhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 000000000000001112245678889999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=312.21 Aligned_cols=264 Identities=23% Similarity=0.359 Sum_probs=204.0
Q ss_pred cCCCCCCccccCCCEEEEEeEeC-CCcEEEEEEcccc--chhcHHHHHHHHHHHHhhccCCcceeEeEEEcCceeEEEEE
Q 001658 693 ENFSPSNKLGEGGFGPVYKGKLG-DGRAIAVKQLSVA--SRQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLVYE 769 (1036)
Q Consensus 693 ~~~~~~~~iG~G~fG~Vy~~~~~-~g~~vAvK~~~~~--~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E 769 (1036)
++|++.+.||+|+||.||+|... +++.||+|.++.. .....+.+.+|++++++++|+||+++++++..++..++|+|
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 36788899999999999999865 5789999988643 23345678999999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeecCCCC
Q 001658 770 YLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKT 849 (1036)
Q Consensus 770 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~ 849 (1036)
|++++.+..+... ...+++..+..++.|+++||+|||+.+ ++||||+|+||++++++.+||+|||++........
T Consensus 81 ~~~~~~l~~~~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~ 155 (288)
T cd07833 81 YVERTLLELLEAS--PGGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRARPA 155 (288)
T ss_pred cCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecccccCCCcc
Confidence 9998777665533 345889999999999999999999987 99999999999999999999999999987665443
Q ss_pred ccccccccccCccCccccccC-CCCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhh--------cCc--
Q 001658 850 HISTRVAGTIGYLAPEYAMRG-HLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHE--------NNQ-- 918 (1036)
Q Consensus 850 ~~~~~~~gt~~y~APE~~~~~-~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~--------~~~-- 918 (1036)
.......++..|+|||++.+. .++.++||||||+++|||++|++||......+............. ...
T Consensus 156 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (288)
T cd07833 156 SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRF 235 (288)
T ss_pred ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccc
Confidence 233345688899999999887 889999999999999999999999976544333222111110000 000
Q ss_pred -cccccCccc-----ccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 001658 919 -EIELADPKL-----IEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVA 961 (1036)
Q Consensus 919 -~~~~~d~~~-----~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 961 (1036)
..+..++.. ..+.......+.+++.+||+.+|++||+++++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 236 AGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred cccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 000000000 0111122567889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-33 Score=304.89 Aligned_cols=253 Identities=25% Similarity=0.365 Sum_probs=201.8
Q ss_pred CCCCCCccccCCCEEEEEeEe-CCCcEEEEEEcccc--chhcHHHHHHHHHHHHhhccCCcceeEeEEEc--CceeEEEE
Q 001658 694 NFSPSNKLGEGGFGPVYKGKL-GDGRAIAVKQLSVA--SRQGKSQFVAEIATISAVQHRNLVKLHGCCIE--GAERLLVY 768 (1036)
Q Consensus 694 ~~~~~~~iG~G~fG~Vy~~~~-~~g~~vAvK~~~~~--~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~--~~~~~lV~ 768 (1036)
+|++.+.||+|+||.||++.. .+++.||+|.+... .....+++..|++++++++|+||+++++++.. ....+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 477789999999999999985 46789999988643 33445678899999999999999999998764 35578999
Q ss_pred EecCCCChhhhhhcC--CCCCcChHHHHHHHHHHHHHHHHHHhcC--CccccccccCCCcEEecCCCceEEEEcCcceee
Q 001658 769 EYLENKSLDQALFGQ--RSLTLDWATRYEICSGVARGLAYLHEES--RVRIIHRDVKASNVLLDADLVPKISDFGLAKLY 844 (1036)
Q Consensus 769 E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~--~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~ 844 (1036)
||+++++|.+++... ....+++..++.++.|+++||+|||..+ ..+|+|+||||+||++++++.+||+|||++...
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~ 160 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL 160 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence 999999999998653 2457899999999999999999999332 234999999999999999999999999999876
Q ss_pred cCCCCccccccccccCccCccccccCCCCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhcCccccccC
Q 001658 845 DDKKTHISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEIELAD 924 (1036)
Q Consensus 845 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 924 (1036)
...... .....|+..|+|||++.+..++.++||||||+++|+|++|+.||....... ..+.. ..
T Consensus 161 ~~~~~~-~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~---~~~~~----~~-------- 224 (265)
T cd08217 161 GHDSSF-AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQ---LASKI----KE-------- 224 (265)
T ss_pred cCCccc-ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHH---HHHHH----hc--------
Confidence 543321 223468999999999998889999999999999999999999998654221 11111 11
Q ss_pred cccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 001658 925 PKLIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVAM 962 (1036)
Q Consensus 925 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 962 (1036)
.............+.+++.+|++.+|++||++.+|+++
T Consensus 225 ~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 225 GKFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred CCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 11112223445678888999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-33 Score=307.06 Aligned_cols=254 Identities=26% Similarity=0.387 Sum_probs=197.9
Q ss_pred CCCCCCccccCCCEEEEEeEe-CCCcEEEEEEccccch----------hcHHHHHHHHHHHHhhccCCcceeEeEEEcCc
Q 001658 694 NFSPSNKLGEGGFGPVYKGKL-GDGRAIAVKQLSVASR----------QGKSQFVAEIATISAVQHRNLVKLHGCCIEGA 762 (1036)
Q Consensus 694 ~~~~~~~iG~G~fG~Vy~~~~-~~g~~vAvK~~~~~~~----------~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~ 762 (1036)
+|...+.||+|+||.||+|.. .+|+.||+|.++.... ...+.+..|+.++++++|+||+++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 466778999999999999975 4689999998753211 11246788999999999999999999999999
Q ss_pred eeEEEEEecCCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcce
Q 001658 763 ERLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAK 842 (1036)
Q Consensus 763 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~ 842 (1036)
..++|+||+++++|.+++... ..+++..+..++.|++.||.|||+.+ ++||||||+||++++++.++|+|||+++
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d~~~~~ 156 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTY--GRFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGISK 156 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEEeeccccc
Confidence 999999999999999999654 46888999999999999999999987 9999999999999999999999999997
Q ss_pred eecCCCCc-cccccccccCccCccccccCC--CCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhcCcc
Q 001658 843 LYDDKKTH-ISTRVAGTIGYLAPEYAMRGH--LTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQE 919 (1036)
Q Consensus 843 ~~~~~~~~-~~~~~~gt~~y~APE~~~~~~--~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 919 (1036)
........ ......|+..|+|||.+.... ++.++||||||+++||+++|+.||.......... ..... ..
T Consensus 157 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~------~~~~~-~~ 229 (272)
T cd06629 157 KSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMF------KLGNK-RS 229 (272)
T ss_pred cccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHH------Hhhcc-cc
Confidence 65432211 123345888999999987654 7899999999999999999999986433221111 00000 00
Q ss_pred ccccCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 001658 920 IELADPKLIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVAM 962 (1036)
Q Consensus 920 ~~~~d~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 962 (1036)
.....+ .........+.+++..|++.+|++||++.||++.
T Consensus 230 ~~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 230 APPIPP---DVSMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred CCcCCc---cccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 001111 1112234577788889999999999999999863
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=319.87 Aligned_cols=251 Identities=22% Similarity=0.357 Sum_probs=206.7
Q ss_pred cCCCCCCccccCCCEEEEEeEeCCCc-EEEEEEccccchhcHHHHHHHHHHHHhhccCCcceeEeEEEcCceeEEEEEec
Q 001658 693 ENFSPSNKLGEGGFGPVYKGKLGDGR-AIAVKQLSVASRQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLVYEYL 771 (1036)
Q Consensus 693 ~~~~~~~~iG~G~fG~Vy~~~~~~g~-~vAvK~~~~~~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~~ 771 (1036)
+.|.+...||.|+||.||+|+.++.. ..|.|++...+....++|.-||++|...+||+||++++.|+..+..|++.|||
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC 111 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFC 111 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeec
Confidence 44667788999999999999876543 45678888777788889999999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeecCCCCcc
Q 001658 772 ENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHI 851 (1036)
Q Consensus 772 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 851 (1036)
.||-.+..+..- ...+.+.++.-++.|++.||.|||++. |||||||..|||++-+|.++|+|||++...... ...
T Consensus 112 ~GGAVDaimlEL-~r~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t-~qk 186 (1187)
T KOG0579|consen 112 GGGAVDAIMLEL-GRVLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSAKNKST-RQK 186 (1187)
T ss_pred CCchHhHHHHHh-ccccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeecccccccchhH-Hhh
Confidence 999998876543 457888999999999999999999987 999999999999999999999999998654322 222
Q ss_pred ccccccccCccCccccc-----cCCCCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhcCccccccCcc
Q 001658 852 STRVAGTIGYLAPEYAM-----RGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEIELADPK 926 (1036)
Q Consensus 852 ~~~~~gt~~y~APE~~~-----~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 926 (1036)
...+.||+.|||||+.+ ..+|+.++||||||++|.||..+.+|-....+......+ ..-+|.
T Consensus 187 RDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKi-------------aKSePP 253 (1187)
T KOG0579|consen 187 RDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKI-------------AKSEPP 253 (1187)
T ss_pred hccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHH-------------hhcCCC
Confidence 34578999999999874 467999999999999999999999998765554433211 112233
Q ss_pred cccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 001658 927 LIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVA 961 (1036)
Q Consensus 927 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 961 (1036)
-.-.+......+.++...|+..+|..||+++++++
T Consensus 254 TLlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~ 288 (1187)
T KOG0579|consen 254 TLLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLK 288 (1187)
T ss_pred cccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence 22334556677888888999999999999999976
|
|
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-33 Score=304.82 Aligned_cols=251 Identities=27% Similarity=0.413 Sum_probs=200.9
Q ss_pred CCCCCCccccCCCEEEEEeEeC-CCcEEEEEEccccch--hcHHHHHHHHHHHHhhccCCcceeEeEEEcCceeEEEEEe
Q 001658 694 NFSPSNKLGEGGFGPVYKGKLG-DGRAIAVKQLSVASR--QGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLVYEY 770 (1036)
Q Consensus 694 ~~~~~~~iG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~--~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~ 770 (1036)
+|+..+.||+|+||.||+|... +++.||+|.++.... ...+.+..|+.++++++|+||+++++++...+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 4778899999999999999854 688999999875433 3567899999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeecCCCCc
Q 001658 771 LENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTH 850 (1036)
Q Consensus 771 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~ 850 (1036)
+++++|.+++... ..+++..+..|+.|+++||+|||+.+ |+|+||+|+||++++++.+||+|||++.........
T Consensus 81 ~~~~~L~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~ 155 (264)
T cd06626 81 CSGGTLEELLEHG--RILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTT 155 (264)
T ss_pred CCCCcHHHHHhhc--CCCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccccCCCCCc
Confidence 9999999998653 34788899999999999999999988 999999999999999999999999999876544332
Q ss_pred ccc---ccccccCccCccccccCC---CCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhcCccccccC
Q 001658 851 IST---RVAGTIGYLAPEYAMRGH---LTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEIELAD 924 (1036)
Q Consensus 851 ~~~---~~~gt~~y~APE~~~~~~---~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 924 (1036)
... ...++..|+|||++.... ++.++||||||+++||+++|+.||.......... . .... ...
T Consensus 156 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~--~---~~~~------~~~ 224 (264)
T cd06626 156 MGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIM--F---HVGA------GHK 224 (264)
T ss_pred ccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHH--H---HHhc------CCC
Confidence 211 345788999999998766 8899999999999999999999997543221111 0 0000 011
Q ss_pred cccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 001658 925 PKLIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVA 961 (1036)
Q Consensus 925 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 961 (1036)
+.+... ......+.+++.+||+.+|.+||++.|++.
T Consensus 225 ~~~~~~-~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 225 PPIPDS-LQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred CCCCcc-cccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 111111 112345667888999999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=312.14 Aligned_cols=250 Identities=26% Similarity=0.445 Sum_probs=203.2
Q ss_pred cCCCCCCccccCCCEEEEEeEe-CCCcEEEEEEccccchhcHHHHHHHHHHHHhhccCCcceeEeEEEcCceeEEEEEec
Q 001658 693 ENFSPSNKLGEGGFGPVYKGKL-GDGRAIAVKQLSVASRQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLVYEYL 771 (1036)
Q Consensus 693 ~~~~~~~~iG~G~fG~Vy~~~~-~~g~~vAvK~~~~~~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~~ 771 (1036)
.+|...+.||+|+||.||+|.. .+++.||+|.+........+.+.+|+.++++++||||+++++++...+..++|+||+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~ 98 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL 98 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence 5788889999999999999985 467899999987555555677899999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeecCCCCcc
Q 001658 772 ENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHI 851 (1036)
Q Consensus 772 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 851 (1036)
++++|.+++.. ..+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||++.........
T Consensus 99 ~~~~L~~~~~~---~~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~~- 171 (293)
T cd06647 99 AGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK- 171 (293)
T ss_pred CCCcHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceecccccccc-
Confidence 99999999853 35788999999999999999999988 999999999999999999999999998765543322
Q ss_pred ccccccccCccCccccccCCCCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhcCccccccCcccccCC
Q 001658 852 STRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEIELADPKLIEFN 931 (1036)
Q Consensus 852 ~~~~~gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~ 931 (1036)
.....|++.|+|||.+....++.++||||||+++||+++|+.||............ ...+ .+.. ...
T Consensus 172 ~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~------~~~~------~~~~-~~~ 238 (293)
T cd06647 172 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI------ATNG------TPEL-QNP 238 (293)
T ss_pred cccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeeh------hcCC------CCCC-CCc
Confidence 22346888999999998888999999999999999999999999764432211100 0000 0111 111
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 001658 932 EEEVKRLIGVALLCTQTLPSLRPSMSRVVAM 962 (1036)
Q Consensus 932 ~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 962 (1036)
......+.+++..||+.+|++||++.+++.+
T Consensus 239 ~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 239 EKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred cccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 2233467788899999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=305.39 Aligned_cols=249 Identities=22% Similarity=0.380 Sum_probs=201.6
Q ss_pred CCCCCCccccCCCEEEEEeEeC-CCcEEEEEEccccc--hhcHHHHHHHHHHHHhhccCCcceeEeEEEcCceeEEEEEe
Q 001658 694 NFSPSNKLGEGGFGPVYKGKLG-DGRAIAVKQLSVAS--RQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLVYEY 770 (1036)
Q Consensus 694 ~~~~~~~iG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~--~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~ 770 (1036)
+|+..+.||+|+||.||+|... +|..||+|.+.... ....+.+.+|+++++.++|+||+++++.+......++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 4677889999999999999865 57899999986532 23456788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCC-ceEEEEcCcceeecCCCC
Q 001658 771 LENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADL-VPKISDFGLAKLYDDKKT 849 (1036)
Q Consensus 771 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~-~~kl~DFGla~~~~~~~~ 849 (1036)
+++++|.+++.......+++..+..++.|+++||+|||+.+ ++|+||||+||++++++ .+||+|||.+........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~ 157 (257)
T cd08225 81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME 157 (257)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccchhccCCcc
Confidence 99999999997666667899999999999999999999987 99999999999999885 579999999986653322
Q ss_pred ccccccccccCccCccccccCCCCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhcCccccccCccccc
Q 001658 850 HISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEIELADPKLIE 929 (1036)
Q Consensus 850 ~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~ 929 (1036)
......|++.|+|||+..+..++.++||||||+++|||++|+.||......... ...... . .. .
T Consensus 158 -~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~------~~~~~~-~----~~----~ 221 (257)
T cd08225 158 -LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLV------LKICQG-Y----FA----P 221 (257)
T ss_pred -cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHH------HHHhcc-c----CC----C
Confidence 222345889999999998888999999999999999999999998754332211 111110 0 11 1
Q ss_pred CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 001658 930 FNEEEVKRLIGVALLCTQTLPSLRPSMSRVVA 961 (1036)
Q Consensus 930 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 961 (1036)
........+.+++.+|++.+|++|||+.|+++
T Consensus 222 ~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 253 (257)
T cd08225 222 ISPNFSRDLRSLISQLFKVSPRDRPSITSILK 253 (257)
T ss_pred CCCCCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 11122346778888999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-33 Score=303.83 Aligned_cols=249 Identities=22% Similarity=0.321 Sum_probs=194.8
Q ss_pred cCCCCCCccccCCCEEEEEeEeC-CCcEEEEEEccccc-----hhcHHHHHHHHHHHHhhccCCcceeEeEEEcC--cee
Q 001658 693 ENFSPSNKLGEGGFGPVYKGKLG-DGRAIAVKQLSVAS-----RQGKSQFVAEIATISAVQHRNLVKLHGCCIEG--AER 764 (1036)
Q Consensus 693 ~~~~~~~~iG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~-----~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~--~~~ 764 (1036)
.+|++.+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|+.++++++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 46888899999999999999864 58999999875321 12345788899999999999999999998764 457
Q ss_pred EEEEEecCCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceee
Q 001658 765 LLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLY 844 (1036)
Q Consensus 765 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~ 844 (1036)
++||||+++++|.+++... ..+++....+++.|++.||+|||+.+ |+|+||||+||+++.++.++|+|||+++..
T Consensus 82 ~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~ 156 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSY--GALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKRL 156 (265)
T ss_pred EEEEEecCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECcCcccccc
Confidence 7999999999999998643 34788888999999999999999988 999999999999999999999999999865
Q ss_pred cCCCC--ccccccccccCccCccccccCCCCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhcCccccc
Q 001658 845 DDKKT--HISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEIEL 922 (1036)
Q Consensus 845 ~~~~~--~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 922 (1036)
..... .......|+..|+|||.+.+..++.++|||||||++|||++|+.||.......... ...
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~------~~~-------- 222 (265)
T cd06652 157 QTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIF------KIA-------- 222 (265)
T ss_pred ccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHH------HHh--------
Confidence 42211 11223458889999999988889999999999999999999999997543222111 000
Q ss_pred cCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 001658 923 ADPKLIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVA 961 (1036)
Q Consensus 923 ~d~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 961 (1036)
..+.....+......+.+++.+|+. +|++||+++||++
T Consensus 223 ~~~~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~ 260 (265)
T cd06652 223 TQPTNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR 260 (265)
T ss_pred cCCCCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence 0011111223344566677778884 8999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=313.42 Aligned_cols=255 Identities=21% Similarity=0.247 Sum_probs=201.0
Q ss_pred cCCCCCCccccCCCEEEEEeEeC-CCcEEEEEEccccc---hhcHHHHHHHHHHHHhhccCCcceeEeEEEcCceeEEEE
Q 001658 693 ENFSPSNKLGEGGFGPVYKGKLG-DGRAIAVKQLSVAS---RQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLVY 768 (1036)
Q Consensus 693 ~~~~~~~~iG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~ 768 (1036)
++|+..+.||+|+||.||++... .++.||+|.+.... ......+.+|+++++.++||||+++++.+..++..++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 36788899999999999999864 57899999986543 233457889999999999999999999999999999999
Q ss_pred EecCCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeecCCC
Q 001658 769 EYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKK 848 (1036)
Q Consensus 769 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~ 848 (1036)
||+++++|.+++... ..+++..+..++.|+++||+|||+.+ ++||||||+||+++.++.+||+|||+++......
T Consensus 81 e~~~g~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~ 155 (305)
T cd05609 81 EYVEGGDCATLLKNI--GALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSL 155 (305)
T ss_pred ecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCccccCcCc
Confidence 999999999999654 45889999999999999999999987 9999999999999999999999999987421100
Q ss_pred --------------CccccccccccCccCccccccCCCCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHh
Q 001658 849 --------------THISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLH 914 (1036)
Q Consensus 849 --------------~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~ 914 (1036)
........|+..|+|||++.+..++.++|+|||||++|||++|+.||......+... ...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~------~~~ 229 (305)
T cd05609 156 TTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFG------QVI 229 (305)
T ss_pred cccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH------HHH
Confidence 001112457889999999988889999999999999999999999997544322111 111
Q ss_pred hcCccccccCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhc
Q 001658 915 ENNQEIELADPKLIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVAMLCG 965 (1036)
Q Consensus 915 ~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~ 965 (1036)
.. ....+... ......+.+++.+||+.+|++||++.++.+.|+.
T Consensus 230 ~~----~~~~~~~~---~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 230 SD----DIEWPEGD---EALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred hc----ccCCCCcc---ccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 00 01111111 1233456788899999999999998777777764
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-33 Score=309.13 Aligned_cols=262 Identities=23% Similarity=0.347 Sum_probs=199.1
Q ss_pred CCCCCccccCCCEEEEEeEeC-CCcEEEEEEccccc--hhcHHHHHHHHHHHHhhccCCcceeEeEEEcCceeEEEEEec
Q 001658 695 FSPSNKLGEGGFGPVYKGKLG-DGRAIAVKQLSVAS--RQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLVYEYL 771 (1036)
Q Consensus 695 ~~~~~~iG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~--~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~~ 771 (1036)
|+..+.||+|++|.||+|... +|+.||+|++.... ......+.+|++++++++|+|++++++++.+++..++||||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 567789999999999999854 78999999986443 223457889999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeecCCCCcc
Q 001658 772 ENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHI 851 (1036)
Q Consensus 772 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 851 (1036)
+ ++|.+++.......+++..+.+++.|+++||+|||+.+ ++||||+|+||++++++.++|+|||+++........
T Consensus 81 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~- 155 (283)
T cd07835 81 D-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRT- 155 (283)
T ss_pred C-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeecccccccCCCccc-
Confidence 5 69999987655557899999999999999999999987 999999999999999999999999999765432221
Q ss_pred ccccccccCccCccccccC-CCCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHH-HHHH-------HHHhhcC-c-c-
Q 001658 852 STRVAGTIGYLAPEYAMRG-HLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYL-LEWA-------WHLHENN-Q-E- 919 (1036)
Q Consensus 852 ~~~~~gt~~y~APE~~~~~-~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l-~~~~-------~~~~~~~-~-~- 919 (1036)
.....++..|+|||++.+. .++.++||||||+++|||++|++||........... .++. +...... . .
T Consensus 156 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (283)
T cd07835 156 YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKP 235 (283)
T ss_pred cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhh
Confidence 1223568899999988664 578899999999999999999999976544322211 1100 0000000 0 0
Q ss_pred --ccccCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 001658 920 --IELADPKLIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVA 961 (1036)
Q Consensus 920 --~~~~d~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 961 (1036)
.....+............+.+++.+|++.+|.+|||+.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 236 TFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred hcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 000000011111222356778999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-33 Score=305.59 Aligned_cols=247 Identities=28% Similarity=0.435 Sum_probs=200.4
Q ss_pred CCCCCCccccCCCEEEEEeEe-CCCcEEEEEEccccc-hhcHHHHHHHHHHHHhhccCCcceeEeEEEcCceeEEEEEec
Q 001658 694 NFSPSNKLGEGGFGPVYKGKL-GDGRAIAVKQLSVAS-RQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLVYEYL 771 (1036)
Q Consensus 694 ~~~~~~~iG~G~fG~Vy~~~~-~~g~~vAvK~~~~~~-~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~~ 771 (1036)
-|+..+.||+|+||.||+|.. .+++.||+|.+.... ......+.+|++++.+++||||+++++++..++..++||||+
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL 84 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence 366778999999999999985 468899999876432 333567889999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeecCCCCcc
Q 001658 772 ENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHI 851 (1036)
Q Consensus 772 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 851 (1036)
++++|.+++.. ..+++.....++.|++.|+.|||+.+ ++|+||||+||+++.++.++|+|||++.........
T Consensus 85 ~~~~l~~~i~~---~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~~- 157 (277)
T cd06641 85 GGGSALDLLEP---GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK- 157 (277)
T ss_pred CCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceecccchhh-
Confidence 99999999853 45889999999999999999999987 999999999999999999999999999866433221
Q ss_pred ccccccccCccCccccccCCCCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhcCccccccCcccccCC
Q 001658 852 STRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEIELADPKLIEFN 931 (1036)
Q Consensus 852 ~~~~~gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~ 931 (1036)
.....|+..|+|||++.+..++.++|||||||++|||++|..|+.......... .... .. .+ ...
T Consensus 158 ~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~------~~~~-~~-----~~---~~~ 222 (277)
T cd06641 158 RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLF------LIPK-NN-----PP---TLE 222 (277)
T ss_pred hccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHH------HHhc-CC-----CC---CCC
Confidence 223458889999999988889999999999999999999999987543321111 1110 00 01 111
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 001658 932 EEEVKRLIGVALLCTQTLPSLRPSMSRVVAM 962 (1036)
Q Consensus 932 ~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 962 (1036)
......+.+++.+||+.+|.+||++.++++.
T Consensus 223 ~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 223 GNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred cccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 2234567788899999999999999999984
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-33 Score=302.63 Aligned_cols=252 Identities=26% Similarity=0.403 Sum_probs=206.6
Q ss_pred cCCCCCCccccCCCEEEEEeEeC-CCcEEEEEEccccch-hcHHHHHHHHHHHHhhccCCcceeEeEEEcCceeEEEEEe
Q 001658 693 ENFSPSNKLGEGGFGPVYKGKLG-DGRAIAVKQLSVASR-QGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLVYEY 770 (1036)
Q Consensus 693 ~~~~~~~~iG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~-~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~ 770 (1036)
++|++.+.||+|++|.||+|+.. +++.||+|++..... .....+..|+.++.+++|+||+++++++......++|+||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 36788899999999999999875 589999999876543 4467899999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHh-cCCccccccccCCCcEEecCCCceEEEEcCcceeecCCCC
Q 001658 771 LENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHE-ESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKT 849 (1036)
Q Consensus 771 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~ 849 (1036)
+++++|.+++... ..+++..+..++.|+++|++|||+ .+ ++||||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~ 155 (264)
T cd06623 81 MDGGSLADLLKKV--GKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLD 155 (264)
T ss_pred cCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccceecccCCC
Confidence 9999999999654 568999999999999999999999 87 99999999999999999999999999987654332
Q ss_pred ccccccccccCccCccccccCCCCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhcCccccccCccccc
Q 001658 850 HISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEIELADPKLIE 929 (1036)
Q Consensus 850 ~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~ 929 (1036)
. .....++..|+|||.+.+..++.++||||||+++|||++|+.||.............+.. .. ..+ .
T Consensus 156 ~-~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~----~~-----~~~---~ 222 (264)
T cd06623 156 Q-CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAIC----DG-----PPP---S 222 (264)
T ss_pred c-ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHh----cC-----CCC---C
Confidence 2 123458889999999998899999999999999999999999997654212222222211 00 011 1
Q ss_pred CCHH-HHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 001658 930 FNEE-EVKRLIGVALLCTQTLPSLRPSMSRVVAM 962 (1036)
Q Consensus 930 ~~~~-~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 962 (1036)
.... ....+.+++..|++.+|++||++.|+++.
T Consensus 223 ~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 223 LPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred CCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 1122 44578888889999999999999999873
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=306.86 Aligned_cols=252 Identities=26% Similarity=0.381 Sum_probs=201.5
Q ss_pred CCCCCCccccCCCEEEEEeEeC-CCcEEEEEEccccc-hhcHHHHHHHHHHHHhhccCCcceeEeEEEcCceeEEEEEec
Q 001658 694 NFSPSNKLGEGGFGPVYKGKLG-DGRAIAVKQLSVAS-RQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLVYEYL 771 (1036)
Q Consensus 694 ~~~~~~~iG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~-~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~~ 771 (1036)
+|+..+.||+|+||.||++... +++.||+|.+.... ....+++.+|++++++++||||+++++++......++|+||+
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYM 81 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEec
Confidence 5777889999999999999875 68899999986543 344567899999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHh-cCCccccccccCCCcEEecCCCceEEEEcCcceeecCCCCc
Q 001658 772 ENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHE-ESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTH 850 (1036)
Q Consensus 772 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~ 850 (1036)
++++|.+++.... ..+++....+++.|+++||+|||+ .+ ++||||||+||++++++.++|+|||.+.........
T Consensus 82 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~ 157 (265)
T cd06605 82 DGGSLDKILKEVQ-GRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAK 157 (265)
T ss_pred CCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccchhhHHHHhh
Confidence 9999999986543 568888999999999999999998 76 999999999999999999999999998765432221
Q ss_pred cccccccccCccCccccccCCCCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhcCccccccCcccccC
Q 001658 851 ISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEIELADPKLIEF 930 (1036)
Q Consensus 851 ~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~ 930 (1036)
...++..|+|||++.+..++.++||||||+++|+|++|+.||........ ...+........ ..+.+..
T Consensus 158 ---~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~-~~~~~~~~~~~~------~~~~~~~- 226 (265)
T cd06605 158 ---TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPD-GIFELLQYIVNE------PPPRLPS- 226 (265)
T ss_pred ---cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccc-cHHHHHHHHhcC------CCCCCCh-
Confidence 15688899999999988999999999999999999999999975421111 111111111111 0111111
Q ss_pred CHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 001658 931 NEEEVKRLIGVALLCTQTLPSLRPSMSRVVA 961 (1036)
Q Consensus 931 ~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 961 (1036)
......+.+++..||..+|++|||+.|++.
T Consensus 227 -~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 256 (265)
T cd06605 227 -GKFSPDFQDFVNLCLIKDPRERPSYKELLE 256 (265)
T ss_pred -hhcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence 113455778888999999999999999875
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-33 Score=305.20 Aligned_cols=247 Identities=26% Similarity=0.411 Sum_probs=199.5
Q ss_pred CCCCCCccccCCCEEEEEeEe-CCCcEEEEEEcccc-chhcHHHHHHHHHHHHhhc---cCCcceeEeEEEcCceeEEEE
Q 001658 694 NFSPSNKLGEGGFGPVYKGKL-GDGRAIAVKQLSVA-SRQGKSQFVAEIATISAVQ---HRNLVKLHGCCIEGAERLLVY 768 (1036)
Q Consensus 694 ~~~~~~~iG~G~fG~Vy~~~~-~~g~~vAvK~~~~~-~~~~~~~f~~Ei~~L~~l~---H~nIv~l~g~~~~~~~~~lV~ 768 (1036)
.|+..+.||+|+||.||+|.. .+++.||+|.+... ......++.+|+.++++++ |||++++++++..+...++||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 467778999999999999985 57899999998654 2334567889999999997 999999999999999999999
Q ss_pred EecCCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeecCCC
Q 001658 769 EYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKK 848 (1036)
Q Consensus 769 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~ 848 (1036)
||+++++|.+++.. ..+++.....++.|+++||.|||+.+ |+||||+|+||++++++.++|+|||++..+....
T Consensus 82 e~~~~~~L~~~~~~---~~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06917 82 EYAEGGSVRTLMKA---GPIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS 155 (277)
T ss_pred ecCCCCcHHHHHHc---cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCceeecCCCc
Confidence 99999999999854 26889999999999999999999988 9999999999999999999999999998775443
Q ss_pred CccccccccccCccCccccccC-CCCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhcCccccccCccc
Q 001658 849 THISTRVAGTIGYLAPEYAMRG-HLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEIELADPKL 927 (1036)
Q Consensus 849 ~~~~~~~~gt~~y~APE~~~~~-~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~ 927 (1036)
.. .....|+..|+|||++.++ .++.++|||||||++|||++|+.||........... . .....+.+
T Consensus 156 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~-------~-----~~~~~~~~ 222 (277)
T cd06917 156 SK-RSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMML-------I-----PKSKPPRL 222 (277)
T ss_pred cc-cccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhc-------c-----ccCCCCCC
Confidence 22 2334689999999998754 468899999999999999999999976433221110 0 00011111
Q ss_pred ccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 001658 928 IEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVA 961 (1036)
Q Consensus 928 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 961 (1036)
.. ......+.+++.+||+.+|++||++.|++.
T Consensus 223 ~~--~~~~~~~~~~i~~~l~~~p~~R~~~~~il~ 254 (277)
T cd06917 223 ED--NGYSKLLREFVAACLDEEPKERLSAEELLK 254 (277)
T ss_pred Cc--ccCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence 11 113456778889999999999999999976
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-33 Score=303.99 Aligned_cols=252 Identities=26% Similarity=0.411 Sum_probs=200.9
Q ss_pred CCCCCCccccCCCEEEEEeEe-CCCcEEEEEEccccc------hhcHHHHHHHHHHHHhhccCCcceeEeEEEcCceeEE
Q 001658 694 NFSPSNKLGEGGFGPVYKGKL-GDGRAIAVKQLSVAS------RQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLL 766 (1036)
Q Consensus 694 ~~~~~~~iG~G~fG~Vy~~~~-~~g~~vAvK~~~~~~------~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~l 766 (1036)
+|+..+.||+|+||.||+|.. .+++.||+|.+.... ....+.+.+|++++++++|+||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 477889999999999999985 578999999986432 1234678899999999999999999999999999999
Q ss_pred EEEecCCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCC-ceEEEEcCcceeec
Q 001658 767 VYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADL-VPKISDFGLAKLYD 845 (1036)
Q Consensus 767 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~-~~kl~DFGla~~~~ 845 (1036)
|+||+++++|.+++... ..+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++ .+||+|||.+..+.
T Consensus 81 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~ 155 (268)
T cd06630 81 FVEWMAGGSVSHLLSKY--GAFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAARLA 155 (268)
T ss_pred EEeccCCCcHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEcccccccccc
Confidence 99999999999998643 46788999999999999999999988 99999999999998776 69999999998765
Q ss_pred CCCCc---cccccccccCccCccccccCCCCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhcCccccc
Q 001658 846 DKKTH---ISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEIEL 922 (1036)
Q Consensus 846 ~~~~~---~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 922 (1036)
..... ......|+..|+|||.+.+..++.++||||+|++++||++|+.||............. .... ..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~---~~~~-----~~ 227 (268)
T cd06630 156 AKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIF---KIAS-----AT 227 (268)
T ss_pred cccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHH---HHhc-----cC
Confidence 43211 1123468889999999988889999999999999999999999997543222111110 1000 00
Q ss_pred cCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 001658 923 ADPKLIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVA 961 (1036)
Q Consensus 923 ~d~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 961 (1036)
.. ...+......+.+++.+|++.+|++||++.|++.
T Consensus 228 ~~---~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 228 TA---PSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred CC---CCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 01 1223334467788899999999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-33 Score=308.02 Aligned_cols=247 Identities=25% Similarity=0.401 Sum_probs=199.8
Q ss_pred CCCCCccccCCCEEEEEeEe-CCCcEEEEEEccccchhcHHHHHHHHHHHHhhccCCcceeEeEEEcCceeEEEEEecCC
Q 001658 695 FSPSNKLGEGGFGPVYKGKL-GDGRAIAVKQLSVASRQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLVYEYLEN 773 (1036)
Q Consensus 695 ~~~~~~iG~G~fG~Vy~~~~-~~g~~vAvK~~~~~~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~ 773 (1036)
|...+.||+|++|.||+|.. .+++.||+|.+........+.+.+|+.+++.++|+||+++++++...+..++|+||+++
T Consensus 21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~ 100 (285)
T cd06648 21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEG 100 (285)
T ss_pred hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCC
Confidence 44457899999999999985 46889999998655555566788999999999999999999999999999999999999
Q ss_pred CChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeecCCCCcccc
Q 001658 774 KSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHIST 853 (1036)
Q Consensus 774 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 853 (1036)
++|.+++.. ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.++|+|||.+........ ...
T Consensus 101 ~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~-~~~ 173 (285)
T cd06648 101 GALTDIVTH---TRMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP-RRK 173 (285)
T ss_pred CCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhccCCc-ccc
Confidence 999999864 45889999999999999999999988 99999999999999999999999998875543222 122
Q ss_pred ccccccCccCccccccCCCCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhcCccccccCcccccCCHH
Q 001658 854 RVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEIELADPKLIEFNEE 933 (1036)
Q Consensus 854 ~~~gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~ 933 (1036)
...|+..|+|||...+..++.++|||||||++|||++|+.||............ ... ..+.. .....
T Consensus 174 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~------~~~------~~~~~-~~~~~ 240 (285)
T cd06648 174 SLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRI------RDN------LPPKL-KNLHK 240 (285)
T ss_pred cccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHH------Hhc------CCCCC-ccccc
Confidence 345889999999998888999999999999999999999998764432222111 100 01111 11112
Q ss_pred HHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 001658 934 EVKRLIGVALLCTQTLPSLRPSMSRVVA 961 (1036)
Q Consensus 934 ~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 961 (1036)
....+.+++.+||+.+|++||++.++++
T Consensus 241 ~~~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 241 VSPRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred CCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence 3356788899999999999999999885
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-33 Score=307.37 Aligned_cols=252 Identities=28% Similarity=0.472 Sum_probs=205.2
Q ss_pred HhcCCCCCCccccCCCEEEEEeEeC-CCcEEEEEEccccchhcHHHHHHHHHHHHhhccCCcceeEeEEEcCceeEEEEE
Q 001658 691 ATENFSPSNKLGEGGFGPVYKGKLG-DGRAIAVKQLSVASRQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLVYE 769 (1036)
Q Consensus 691 ~~~~~~~~~~iG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E 769 (1036)
.++.|+..+.||+|+||.||+|... +++.||+|.+..... ....+.+|++++++++|+||+++++++......++|+|
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 95 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVME 95 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEe
Confidence 4567788889999999999999876 688999999876544 46678999999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeecCCCC
Q 001658 770 YLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKT 849 (1036)
Q Consensus 770 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~ 849 (1036)
|+++++|.+++.... ..+++..+..++.|++.||+|||+.+ |+|+||+|+||+++.++.++|+|||++........
T Consensus 96 ~~~~~~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 171 (286)
T cd06614 96 YMDGGSLTDIITQNF-VRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS 171 (286)
T ss_pred ccCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhhhhccchh
Confidence 999999999997643 47899999999999999999999987 99999999999999999999999999876543222
Q ss_pred ccccccccccCccCccccccCCCCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhcCccccccCccccc
Q 001658 850 HISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEIELADPKLIE 929 (1036)
Q Consensus 850 ~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~ 929 (1036)
......++..|+|||++.+..++.++|||||||++|||++|+.|+............ . .... +.. .
T Consensus 172 -~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~--~-----~~~~-----~~~-~ 237 (286)
T cd06614 172 -KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLI--T-----TKGI-----PPL-K 237 (286)
T ss_pred -hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHH--H-----hcCC-----CCC-c
Confidence 122345788999999998888999999999999999999999998765433222111 0 0000 011 0
Q ss_pred CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 001658 930 FNEEEVKRLIGVALLCTQTLPSLRPSMSRVVA 961 (1036)
Q Consensus 930 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 961 (1036)
........+.+++.+|++.+|.+||++.+++.
T Consensus 238 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 269 (286)
T cd06614 238 NPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ 269 (286)
T ss_pred chhhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 11113356778889999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=298.25 Aligned_cols=249 Identities=31% Similarity=0.506 Sum_probs=204.3
Q ss_pred CCCCCCccccCCCEEEEEeEeC-CCcEEEEEEccccchhcHHHHHHHHHHHHhhccCCcceeEeEEEcCceeEEEEEecC
Q 001658 694 NFSPSNKLGEGGFGPVYKGKLG-DGRAIAVKQLSVASRQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLVYEYLE 772 (1036)
Q Consensus 694 ~~~~~~~iG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~~~ 772 (1036)
+|+..+.||+|++|.||++... +++.+++|++..........+.+|++++++++|+||+++++++......++++||++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 4677889999999999999875 688999999976655456789999999999999999999999999999999999999
Q ss_pred CCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeecCCCCccc
Q 001658 773 NKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHIS 852 (1036)
Q Consensus 773 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 852 (1036)
+++|.+++.... ..+++..+..++.|+++||+|||+.+ ++||||+|+||++++++.++|+|||.+........ .
T Consensus 81 ~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--~ 154 (253)
T cd05122 81 GGSLKDLLKSTN-QTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA--R 154 (253)
T ss_pred CCcHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeecccccccccccc--c
Confidence 999999986542 56899999999999999999999987 99999999999999999999999999987654432 2
Q ss_pred cccccccCccCccccccCCCCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhcCccccccCcccccCCH
Q 001658 853 TRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEIELADPKLIEFNE 932 (1036)
Q Consensus 853 ~~~~gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~ 932 (1036)
....|+..|+|||++....++.++||||||++++||++|+.||............. . .. .+.. ....
T Consensus 155 ~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~------~-~~-----~~~~-~~~~ 221 (253)
T cd05122 155 NTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIA------T-NG-----PPGL-RNPE 221 (253)
T ss_pred cceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHH------h-cC-----CCCc-Cccc
Confidence 34568889999999998889999999999999999999999987653322221110 0 00 0111 0111
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 001658 933 EEVKRLIGVALLCTQTLPSLRPSMSRVVA 961 (1036)
Q Consensus 933 ~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 961 (1036)
.....+.+++.+|++.+|++|||+.|+++
T Consensus 222 ~~~~~~~~~i~~~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 222 KWSDEFKDFLKKCLQKNPEKRPTAEQLLK 250 (253)
T ss_pred ccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 12356788888999999999999999875
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=305.85 Aligned_cols=262 Identities=24% Similarity=0.357 Sum_probs=200.4
Q ss_pred CCCCCccccCCCEEEEEeEeC-CCcEEEEEEccccc--hhcHHHHHHHHHHHHhhccCCcceeEeEEEcC--ceeEEEEE
Q 001658 695 FSPSNKLGEGGFGPVYKGKLG-DGRAIAVKQLSVAS--RQGKSQFVAEIATISAVQHRNLVKLHGCCIEG--AERLLVYE 769 (1036)
Q Consensus 695 ~~~~~~iG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~--~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~--~~~~lV~E 769 (1036)
|++.+.||+|+||.||+|+.. +++.||+|.+.... ......+.+|++++++++|+|++++++++... +..++|+|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 566789999999999999865 58899999997653 33346788999999999999999999999988 78999999
Q ss_pred ecCCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeecCCCC
Q 001658 770 YLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKT 849 (1036)
Q Consensus 770 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~ 849 (1036)
|++ ++|.+++... ...+++..++.++.|+++||+|||+.+ ++|+||||+||++++++.+||+|||++........
T Consensus 81 ~~~-~~l~~~~~~~-~~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~ 155 (287)
T cd07840 81 YMD-HDLTGLLDSP-EVKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS 155 (287)
T ss_pred ccc-ccHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccceeeccCCCc
Confidence 997 4898888543 257899999999999999999999987 99999999999999999999999999987765432
Q ss_pred ccccccccccCccCcccccc-CCCCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhcCccc--------
Q 001658 850 HISTRVAGTIGYLAPEYAMR-GHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEI-------- 920 (1036)
Q Consensus 850 ~~~~~~~gt~~y~APE~~~~-~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~-------- 920 (1036)
.......++..|+|||.+.+ ..++.++||||||+++|||++|+.||.........................
T Consensus 156 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (287)
T cd07840 156 ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWF 235 (287)
T ss_pred ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhh
Confidence 22334457889999998765 457899999999999999999999998755433222211110000000000
Q ss_pred cccCc------ccccCCHH-HHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 001658 921 ELADP------KLIEFNEE-EVKRLIGVALLCTQTLPSLRPSMSRVVA 961 (1036)
Q Consensus 921 ~~~d~------~~~~~~~~-~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 961 (1036)
....+ .+.+.... ....+.+++.+|++.+|.+||++.++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 236 ENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred hhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 00000 00000111 2567889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-33 Score=307.83 Aligned_cols=260 Identities=25% Similarity=0.369 Sum_probs=196.5
Q ss_pred cCCCCCCccccCCCEEEEEeEeC-CCcEEEEEEccccch-hcHHHHHHHHHHHHhhccCCcceeEeEEEcCceeEEEEEe
Q 001658 693 ENFSPSNKLGEGGFGPVYKGKLG-DGRAIAVKQLSVASR-QGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLVYEY 770 (1036)
Q Consensus 693 ~~~~~~~~iG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~-~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~ 770 (1036)
++|+..+.||+|++|.||+|... +++.||+|.+..... .....+.+|++++++++|+||+++++++.+.+..++||||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY 84 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence 57888899999999999999865 689999999864332 2234577899999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeecCCCCc
Q 001658 771 LENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTH 850 (1036)
Q Consensus 771 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~ 850 (1036)
++ ++|.+++.... ..+++.....++.|+++||.|||+.+ |+||||||+||++++++.+||+|||+++.......
T Consensus 85 ~~-~~L~~~~~~~~-~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~- 158 (291)
T cd07844 85 LD-TDLKQYMDDCG-GGLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAKSVPSK- 158 (291)
T ss_pred CC-CCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECccccccccCCCCc-
Confidence 97 59999886543 36889999999999999999999987 99999999999999999999999999875432211
Q ss_pred cccccccccCccCcccccc-CCCCchhhHHhHHHHHHHHHhCCCCCCCCChh-hHHHHHHHHHHHhhcCccc--------
Q 001658 851 ISTRVAGTIGYLAPEYAMR-GHLTEKTDVFAFGVLALETVSGRPNSDPSLDE-EKLYLLEWAWHLHENNQEI-------- 920 (1036)
Q Consensus 851 ~~~~~~gt~~y~APE~~~~-~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~-~~~~l~~~~~~~~~~~~~~-------- 920 (1036)
......++..|+|||++.+ ..++.++||||+|+++|||++|+.||...... +..... +.........
T Consensus 159 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~ 235 (291)
T cd07844 159 TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKI---FRVLGTPTEETWPGVSSN 235 (291)
T ss_pred cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHH---HHhcCCCChhhhhhhhhc
Confidence 1122346889999999875 45889999999999999999999999754421 111111 1111000000
Q ss_pred ----c----cc-CcccccC--CHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 001658 921 ----E----LA-DPKLIEF--NEEEVKRLIGVALLCTQTLPSLRPSMSRVVA 961 (1036)
Q Consensus 921 ----~----~~-d~~~~~~--~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 961 (1036)
. .. ...+... .......+.+++.+|++.+|++||++.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 236 PEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred cccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 0 00 0000000 0011256778889999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-33 Score=308.57 Aligned_cols=260 Identities=21% Similarity=0.300 Sum_probs=195.6
Q ss_pred CCCCCCccccCCCEEEEEeEeC-CCcEEEEEEccccc--hhcHHHHHHHHHHHHhhccCCcceeEeEEEcCceeEEEEEe
Q 001658 694 NFSPSNKLGEGGFGPVYKGKLG-DGRAIAVKQLSVAS--RQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLVYEY 770 (1036)
Q Consensus 694 ~~~~~~~iG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~--~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~ 770 (1036)
+|+..+.||+|+||.||+|+.. +|+.||+|.+.... ......+.+|++++++++|+||+++++++.+....++|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 4777889999999999999864 68999999986432 22235678899999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeecCCCCc
Q 001658 771 LENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTH 850 (1036)
Q Consensus 771 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~ 850 (1036)
++ ++|.+++... ...+++..+..++.||++||.|||+.+ |+||||||+||+++.++.+||+|||+++.+......
T Consensus 81 ~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~ 155 (284)
T cd07839 81 CD-QDLKKYFDSC-NGDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRC 155 (284)
T ss_pred CC-CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhccCCCCCC
Confidence 96 5888877543 345899999999999999999999988 999999999999999999999999999865432221
Q ss_pred cccccccccCccCccccccC-CCCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhcCc------ccccc
Q 001658 851 ISTRVAGTIGYLAPEYAMRG-HLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQ------EIELA 923 (1036)
Q Consensus 851 ~~~~~~gt~~y~APE~~~~~-~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~------~~~~~ 923 (1036)
.....++..|+|||++.+. .++.++|||||||++|||+||+.|+....+.... .+.......... .....
T Consensus 156 -~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 232 (284)
T cd07839 156 -YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQ--LKRIFRLLGTPTEESWPGVSKLP 232 (284)
T ss_pred -cCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHH--HHHHHHHhCCCChHHhHHhhhcc
Confidence 2234578899999998764 4789999999999999999999886543332111 111111000000 00000
Q ss_pred C----cccc------cCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 001658 924 D----PKLI------EFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVA 961 (1036)
Q Consensus 924 d----~~~~------~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 961 (1036)
+ +... .........+.+++.+|++.||.+|||++|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 233 DYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred cccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 0 0000 011122356678889999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=306.60 Aligned_cols=263 Identities=24% Similarity=0.324 Sum_probs=197.0
Q ss_pred HhcCCCCCCccccCCCEEEEEeEe-CCCcEEEEEEccccc-hhcHHHHHHHHHHHHhhccCCcceeEeEEEcCceeEEEE
Q 001658 691 ATENFSPSNKLGEGGFGPVYKGKL-GDGRAIAVKQLSVAS-RQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLVY 768 (1036)
Q Consensus 691 ~~~~~~~~~~iG~G~fG~Vy~~~~-~~g~~vAvK~~~~~~-~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~ 768 (1036)
++++|...+.||+|+||.||+|.. .+++.||+|.+.... ......+.+|+.+++.++|+||+++++++..++..++|+
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 457888999999999999999985 468899999986543 233346788999999999999999999999999999999
Q ss_pred EecCCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeecCCC
Q 001658 769 EYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKK 848 (1036)
Q Consensus 769 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~ 848 (1036)
||+. ++|.+++... ...+.+..+..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++......
T Consensus 83 e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 157 (291)
T cd07870 83 EYMH-TDLAQYMIQH-PGGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAKSIPS 157 (291)
T ss_pred eccc-CCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEeccccccccCCCC
Confidence 9995 6787776543 245778888899999999999999987 9999999999999999999999999997643322
Q ss_pred CccccccccccCccCccccccC-CCCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhcCc---------
Q 001658 849 THISTRVAGTIGYLAPEYAMRG-HLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQ--------- 918 (1036)
Q Consensus 849 ~~~~~~~~gt~~y~APE~~~~~-~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~--------- 918 (1036)
.. .....++..|+|||++.+. .++.++|||||||++|||++|+.||+...+.... ....+.......
T Consensus 158 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 234 (291)
T cd07870 158 QT-YSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQ--LEKIWTVLGVPTEDTWPGVSK 234 (291)
T ss_pred CC-CCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHH--HHHHHHHcCCCChhhhhhhhh
Confidence 11 1234578899999998754 5788999999999999999999999865432211 111111110000
Q ss_pred ----cccc--cC-c-cccc--CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 001658 919 ----EIEL--AD-P-KLIE--FNEEEVKRLIGVALLCTQTLPSLRPSMSRVVA 961 (1036)
Q Consensus 919 ----~~~~--~d-~-~~~~--~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 961 (1036)
.... .. + .+.. ........+.+++.+|++.||.+|||+.|++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 235 LPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred cccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 0000 00 0 0000 00011346678889999999999999999874
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=307.00 Aligned_cols=246 Identities=28% Similarity=0.458 Sum_probs=196.9
Q ss_pred cCCCCCCccccCCCEEEEEeEeC-CCcEEEEEEccccc---hhcHHHHHHHHHHHHhhccCCcceeEeEEEcCceeEEEE
Q 001658 693 ENFSPSNKLGEGGFGPVYKGKLG-DGRAIAVKQLSVAS---RQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLVY 768 (1036)
Q Consensus 693 ~~~~~~~~iG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~ 768 (1036)
+.|+..+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|+++++.++||||+++++++.+.+..++|+
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 45788899999999999999864 68999999886432 223456889999999999999999999999999999999
Q ss_pred EecCCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeecCCC
Q 001658 769 EYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKK 848 (1036)
Q Consensus 769 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~ 848 (1036)
||++ |++.+++... ...+++..+..++.|++.||.|||+.+ |+||||+|+||++++++.++|+|||++.......
T Consensus 95 e~~~-g~l~~~~~~~-~~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~~ 169 (307)
T cd06607 95 EYCL-GSASDILEVH-KKPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVSPAN 169 (307)
T ss_pred HhhC-CCHHHHHHHc-ccCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcceecCCCC
Confidence 9996 6777776533 345899999999999999999999987 9999999999999999999999999987654322
Q ss_pred CccccccccccCccCccccc---cCCCCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhcCccccccCc
Q 001658 849 THISTRVAGTIGYLAPEYAM---RGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEIELADP 925 (1036)
Q Consensus 849 ~~~~~~~~gt~~y~APE~~~---~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 925 (1036)
...|+..|+|||++. .+.++.++||||||+++|||+||++||............. .. ..+
T Consensus 170 -----~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~-------~~-----~~~ 232 (307)
T cd06607 170 -----SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA-------QN-----DSP 232 (307)
T ss_pred -----CccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHh-------cC-----CCC
Confidence 245788999999874 4568889999999999999999999987654322221110 00 011
Q ss_pred ccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 001658 926 KLIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVAM 962 (1036)
Q Consensus 926 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 962 (1036)
.. ........+.+++.+||+.+|++||++.+|+..
T Consensus 233 ~~--~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 233 TL--SSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred CC--CchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 11 112234568888899999999999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-33 Score=301.37 Aligned_cols=249 Identities=22% Similarity=0.331 Sum_probs=209.0
Q ss_pred HhcCCCCCCccccCCCEEEEEeEe-CCCcEEEEEEcccc--chhcHHHHHHHHHHHHhhccCCcceeEeEEEcCceeEEE
Q 001658 691 ATENFSPSNKLGEGGFGPVYKGKL-GDGRAIAVKQLSVA--SRQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLV 767 (1036)
Q Consensus 691 ~~~~~~~~~~iG~G~fG~Vy~~~~-~~g~~vAvK~~~~~--~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV 767 (1036)
+..-|...+.||+|.|+.|-.|++ -.|+.||||++.+. +.-....+.+|++.|+.++|||||++|++.......|||
T Consensus 16 IAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLi 95 (864)
T KOG4717|consen 16 IAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLI 95 (864)
T ss_pred eeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEE
Confidence 345577788999999999999974 47999999999764 334466788999999999999999999999989999999
Q ss_pred EEecCCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecC-CCceEEEEcCcceeecC
Q 001658 768 YEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDA-DLVPKISDFGLAKLYDD 846 (1036)
Q Consensus 768 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~-~~~~kl~DFGla~~~~~ 846 (1036)
+|.-++|+|++|+.++. ..+.+....+++.||+.|+.|+|+.. +|||||||+||.+-+ -|-|||.|||++..+.+
T Consensus 96 LELGD~GDl~DyImKHe-~Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~P 171 (864)
T KOG4717|consen 96 LELGDGGDLFDYIMKHE-EGLNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQP 171 (864)
T ss_pred EEecCCchHHHHHHhhh-ccccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccccCCC
Confidence 99999999999997653 45778888899999999999999887 999999999998855 58999999999977654
Q ss_pred CCCccccccccccCccCccccccCCCC-chhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhcCccccccCc
Q 001658 847 KKTHISTRVAGTIGYLAPEYAMRGHLT-EKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEIELADP 925 (1036)
Q Consensus 847 ~~~~~~~~~~gt~~y~APE~~~~~~~~-~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 925 (1036)
... -+..+|+..|-|||++.+..|+ +++||||+|||||.|++|++||+..++.+....+ +|-
T Consensus 172 G~k--L~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmI---------------mDC 234 (864)
T KOG4717|consen 172 GKK--LTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMI---------------MDC 234 (864)
T ss_pred cch--hhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhh---------------hcc
Confidence 332 3456799999999999998886 5899999999999999999999987776554322 332
Q ss_pred ccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 001658 926 KLIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVA 961 (1036)
Q Consensus 926 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 961 (1036)
+. ..+.....++.+++..|+..||.+|.+.+||+.
T Consensus 235 KY-tvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s 269 (864)
T KOG4717|consen 235 KY-TVPSHVSKECRDLIQSMLVRDPKKRASLEEIVS 269 (864)
T ss_pred cc-cCchhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence 22 344556678888899999999999999999975
|
|
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-32 Score=303.46 Aligned_cols=257 Identities=26% Similarity=0.350 Sum_probs=200.7
Q ss_pred cCCCCCCccccCCCEEEEEeEeC-CCcEEEEEEccccc-hhcHHHHHHHHHHHHhhccCCcceeEeEEEcC--ceeEEEE
Q 001658 693 ENFSPSNKLGEGGFGPVYKGKLG-DGRAIAVKQLSVAS-RQGKSQFVAEIATISAVQHRNLVKLHGCCIEG--AERLLVY 768 (1036)
Q Consensus 693 ~~~~~~~~iG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~-~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~--~~~~lV~ 768 (1036)
++|...+.||.|++|.||+|... +++.+|+|.+.... .....++.+|++++++++||||+++++++... ...++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 35777889999999999999964 67899999987432 23456789999999999999999999998654 4679999
Q ss_pred EecCCCChhhhhhc--CCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeecC
Q 001658 769 EYLENKSLDQALFG--QRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDD 846 (1036)
Q Consensus 769 E~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~ 846 (1036)
||+++++|.+++.. .....+++.....|+.|++.||+|||+.+ ++|+||+|+||++++++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 157 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELVN 157 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence 99999999998753 23456788999999999999999999988 99999999999999999999999999875543
Q ss_pred CCCccccccccccCccCccccccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCh--hhHHHHHHHHHHHhhcCccccccC
Q 001658 847 KKTHISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRPNSDPSLD--EEKLYLLEWAWHLHENNQEIELAD 924 (1036)
Q Consensus 847 ~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~--~~~~~l~~~~~~~~~~~~~~~~~d 924 (1036)
... ....++..|+|||.+.+..++.++||||||+++|||++|+.||..... ........+.... ......+
T Consensus 158 ~~~---~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~~~ 230 (287)
T cd06621 158 SLA---GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNM----PNPELKD 230 (287)
T ss_pred ccc---ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcC----Cchhhcc
Confidence 221 234578899999999988999999999999999999999999986522 1112222221110 0001100
Q ss_pred cccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 001658 925 PKLIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVA 961 (1036)
Q Consensus 925 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 961 (1036)
. ..........+.+++.+||+.+|.+|||+.|+++
T Consensus 231 ~--~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~ 265 (287)
T cd06621 231 E--PGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265 (287)
T ss_pred C--CCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 0 0111123456788999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=305.61 Aligned_cols=263 Identities=22% Similarity=0.325 Sum_probs=199.0
Q ss_pred cCCCCCCccccCCCEEEEEeEeC-CCcEEEEEEccccch--hcHHHHHHHHHHHHhhccCCcceeEeEEEcC--ceeEEE
Q 001658 693 ENFSPSNKLGEGGFGPVYKGKLG-DGRAIAVKQLSVASR--QGKSQFVAEIATISAVQHRNLVKLHGCCIEG--AERLLV 767 (1036)
Q Consensus 693 ~~~~~~~~iG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~--~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~--~~~~lV 767 (1036)
++|+..+.||+|+||.||+|... +++.||+|.++.... .....+.+|+.++.+++||||+++++++... ...++|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 46888899999999999999875 588999999864332 2234577899999999999999999998877 889999
Q ss_pred EEecCCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeecCC
Q 001658 768 YEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDK 847 (1036)
Q Consensus 768 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~ 847 (1036)
+||++ ++|.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++......
T Consensus 85 ~e~~~-~~L~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 159 (293)
T cd07843 85 MEYVE-HDLKSLMETMK-QPFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGSP 159 (293)
T ss_pred ehhcC-cCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCceeeccCC
Confidence 99997 59999886543 36899999999999999999999988 999999999999999999999999999876543
Q ss_pred CCccccccccccCccCccccccC-CCCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHH-HHH-------HHHhhc--
Q 001658 848 KTHISTRVAGTIGYLAPEYAMRG-HLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLL-EWA-------WHLHEN-- 916 (1036)
Q Consensus 848 ~~~~~~~~~gt~~y~APE~~~~~-~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~-~~~-------~~~~~~-- 916 (1036)
... .....++..|+|||.+.+. .++.++|+||||+++|||++|++||......+..... ... |.....
T Consensus 160 ~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (293)
T cd07843 160 LKP-YTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELP 238 (293)
T ss_pred ccc-cccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccc
Confidence 221 2234578899999998754 4688999999999999999999999865543322211 000 000000
Q ss_pred ----CccccccCcccc-cCCHH-HHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 001658 917 ----NQEIELADPKLI-EFNEE-EVKRLIGVALLCTQTLPSLRPSMSRVVA 961 (1036)
Q Consensus 917 ----~~~~~~~d~~~~-~~~~~-~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 961 (1036)
..........+. .+... ....+.+++..|++.+|++|||+.|++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 239 GAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred hhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 000000000010 11111 2456778888999999999999999975
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=306.39 Aligned_cols=264 Identities=23% Similarity=0.349 Sum_probs=198.3
Q ss_pred cCCCCCCccccCCCEEEEEeEeC-CCcEEEEEEccccc--hhcHHHHHHHHHHHHhhccCCcceeEeEEEcCceeEEEEE
Q 001658 693 ENFSPSNKLGEGGFGPVYKGKLG-DGRAIAVKQLSVAS--RQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLVYE 769 (1036)
Q Consensus 693 ~~~~~~~~iG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~--~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E 769 (1036)
++|+..+.||+|++|.||+|+.. +++.||+|.+.... ....+.+.+|++++++++|+||+++++++......++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 46888899999999999999864 68899999986432 2234678899999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecC-CCceEEEEcCcceeecCCC
Q 001658 770 YLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDA-DLVPKISDFGLAKLYDDKK 848 (1036)
Q Consensus 770 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~-~~~~kl~DFGla~~~~~~~ 848 (1036)
|++ ++|.+++.......+++.....++.||+.||+|||+.+ |+||||||+||++++ ++.+||+|||++.......
T Consensus 82 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~ 157 (294)
T PLN00009 82 YLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV 157 (294)
T ss_pred ccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccccccccCCCc
Confidence 995 58888876555556788888899999999999999987 999999999999985 5679999999997654322
Q ss_pred CccccccccccCccCccccccC-CCCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHH-HHHHHHhhcCcc--ccc--
Q 001658 849 THISTRVAGTIGYLAPEYAMRG-HLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLL-EWAWHLHENNQE--IEL-- 922 (1036)
Q Consensus 849 ~~~~~~~~gt~~y~APE~~~~~-~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~-~~~~~~~~~~~~--~~~-- 922 (1036)
. ......+++.|+|||++.+. .++.++|||||||++|||+||++||......+..... ..........+. ..+
T Consensus 158 ~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (294)
T PLN00009 158 R-TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPD 236 (294)
T ss_pred c-ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchh
Confidence 1 12234578899999998664 5789999999999999999999999765443322211 100000000000 000
Q ss_pred --------cCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 001658 923 --------ADPKLIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVA 961 (1036)
Q Consensus 923 --------~d~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 961 (1036)
...............+.+++.+|++.+|++||++.++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 237 YKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred hhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 000000111222345778889999999999999999986
|
|
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=305.33 Aligned_cols=244 Identities=25% Similarity=0.296 Sum_probs=198.7
Q ss_pred cCCCCCCccccCCCEEEEEeEeC-CCcEEEEEEccccc---hhcHHHHHHHHHHHHhhccCCcceeEeEEEcCceeEEEE
Q 001658 693 ENFSPSNKLGEGGFGPVYKGKLG-DGRAIAVKQLSVAS---RQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLVY 768 (1036)
Q Consensus 693 ~~~~~~~~iG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~ 768 (1036)
++|++.+.||+|+||.||++... +++.||+|.+.... ....+.+.+|++++++++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 36788899999999999999864 68999999986432 233567889999999999999999999999999999999
Q ss_pred EecCCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeecCCC
Q 001658 769 EYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKK 848 (1036)
Q Consensus 769 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~ 848 (1036)
||+++++|.+++... ..+++..+..++.|++.||+|||+.+ |+||||+|+||++++++.+||+|||+++.....
T Consensus 81 e~~~~~~L~~~~~~~--~~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~- 154 (290)
T cd05580 81 EYVPGGELFSHLRKS--GRFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR- 154 (290)
T ss_pred ecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCccccCCC-
Confidence 999999999998654 46888999999999999999999987 999999999999999999999999999876543
Q ss_pred CccccccccccCccCccccccCCCCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhcCccccccCcccc
Q 001658 849 THISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEIELADPKLI 928 (1036)
Q Consensus 849 ~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~ 928 (1036)
.....|++.|+|||.+.+...+.++||||||+++|||++|+.||............ . .+ .+.+.
T Consensus 155 ---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~------~-~~------~~~~~ 218 (290)
T cd05580 155 ---TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKI------L-EG------KVRFP 218 (290)
T ss_pred ---CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH------h-cC------CccCC
Confidence 22346889999999998888899999999999999999999999765422111100 0 10 11111
Q ss_pred cCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 001658 929 EFNEEEVKRLIGVALLCTQTLPSLRP-----SMSRVVA 961 (1036)
Q Consensus 929 ~~~~~~~~~l~~l~~~Cl~~dP~~RP-----t~~evl~ 961 (1036)
......+.+++.+||+.+|.+|| +++|+++
T Consensus 219 ---~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~ 253 (290)
T cd05580 219 ---SFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN 253 (290)
T ss_pred ---ccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence 11235667788899999999999 6666653
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=305.34 Aligned_cols=250 Identities=26% Similarity=0.366 Sum_probs=192.9
Q ss_pred cCCCCCCccccCCCEEEEEeEeC-CCcEEEEEEccccc-hhcHHHHHHHHHH-HHhhccCCcceeEeEEEcCceeEEEEE
Q 001658 693 ENFSPSNKLGEGGFGPVYKGKLG-DGRAIAVKQLSVAS-RQGKSQFVAEIAT-ISAVQHRNLVKLHGCCIEGAERLLVYE 769 (1036)
Q Consensus 693 ~~~~~~~~iG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~-~~~~~~f~~Ei~~-L~~l~H~nIv~l~g~~~~~~~~~lV~E 769 (1036)
++|++.+.||+|+||.||+|+.. +|+.||+|+++... .....++..|+.. ++..+||||+++++++..++..++|||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 36788899999999999999864 68999999986532 2234456667665 566689999999999999999999999
Q ss_pred ecCCCChhhhhhcC--CCCCcChHHHHHHHHHHHHHHHHHHhc-CCccccccccCCCcEEecCCCceEEEEcCcceeecC
Q 001658 770 YLENKSLDQALFGQ--RSLTLDWATRYEICSGVARGLAYLHEE-SRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDD 846 (1036)
Q Consensus 770 ~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~ 846 (1036)
|++ |+|.+++... ....+++..++.++.|++.||+|||++ + ++||||||+||++++++.+||+|||++.....
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~---i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~ 156 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS---VIHRDVKPSNVLINRNGQVKLCDFGISGYLVD 156 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence 996 6888887542 245689999999999999999999986 5 99999999999999999999999999986543
Q ss_pred CCCccccccccccCccCcccccc----CCCCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhcCccccc
Q 001658 847 KKTHISTRVAGTIGYLAPEYAMR----GHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEIEL 922 (1036)
Q Consensus 847 ~~~~~~~~~~gt~~y~APE~~~~----~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 922 (1036)
.. ......|+..|+|||.+.+ ..++.++|+|||||++|||++|+.||........ .+... .. .
T Consensus 157 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~-~~~~~----~~------~ 223 (283)
T cd06617 157 SV--AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQ-QLKQV----VE------E 223 (283)
T ss_pred cc--ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHH-HHHHH----Hh------c
Confidence 22 1233468889999998864 4468899999999999999999999864322111 11110 00 0
Q ss_pred cCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 001658 923 ADPKLIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVA 961 (1036)
Q Consensus 923 ~d~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 961 (1036)
..+.+. .......+.+++.+||+.+|++||++.++++
T Consensus 224 ~~~~~~--~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 224 PSPQLP--AEKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred CCCCCC--ccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 111111 0112346778889999999999999999976
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-32 Score=302.99 Aligned_cols=263 Identities=25% Similarity=0.406 Sum_probs=199.9
Q ss_pred CCCCCCccccCCCEEEEEeEeC-CCcEEEEEEccccch-hcHHHHHHHHHHHHhhccCCcceeEeEEEcCceeEEEEEec
Q 001658 694 NFSPSNKLGEGGFGPVYKGKLG-DGRAIAVKQLSVASR-QGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLVYEYL 771 (1036)
Q Consensus 694 ~~~~~~~iG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~-~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~~ 771 (1036)
+|+..+.||+|++|.||+|+.. +|+.||||.+..... .....+.+|++++++++|+||+++++++.+.+..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 4778899999999999999964 688999999875432 23466788999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCC-CCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeecCCCCc
Q 001658 772 ENKSLDQALFGQR-SLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTH 850 (1036)
Q Consensus 772 ~~gsL~~~l~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~ 850 (1036)
++ +|.+++.... ...+++..+..++.|+++||+|||+.+ ++||||||+||++++++.++|+|||++........
T Consensus 81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~- 155 (284)
T cd07836 81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN- 155 (284)
T ss_pred Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc-
Confidence 75 8888876543 356899999999999999999999987 99999999999999999999999999976543221
Q ss_pred cccccccccCccCccccccC-CCCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHH-HHH-------HHHhhcCcccc
Q 001658 851 ISTRVAGTIGYLAPEYAMRG-HLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLL-EWA-------WHLHENNQEIE 921 (1036)
Q Consensus 851 ~~~~~~gt~~y~APE~~~~~-~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~-~~~-------~~~~~~~~~~~ 921 (1036)
......++..|+|||++.+. .++.++|||||||++|||++|+.||......+..... +.. +..........
T Consensus 156 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd07836 156 TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYK 235 (284)
T ss_pred ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhc
Confidence 11234578899999998654 5788999999999999999999999865443322111 100 00000000000
Q ss_pred ccCccc-----ccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 001658 922 LADPKL-----IEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVA 961 (1036)
Q Consensus 922 ~~d~~~-----~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 961 (1036)
...+.. ....+.....+.+++.+|++.+|.+||++.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 236 PTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred ccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 000000 1111223456778899999999999999999875
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=306.30 Aligned_cols=252 Identities=24% Similarity=0.346 Sum_probs=194.0
Q ss_pred CCCCCCccccCCCEEEEEeEeC-CCcEEEEEEccccc-hhcHHHHHHHHHHHHhhc-cCCcceeEeEEEcCceeEEEEEe
Q 001658 694 NFSPSNKLGEGGFGPVYKGKLG-DGRAIAVKQLSVAS-RQGKSQFVAEIATISAVQ-HRNLVKLHGCCIEGAERLLVYEY 770 (1036)
Q Consensus 694 ~~~~~~~iG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~-~~~~~~f~~Ei~~L~~l~-H~nIv~l~g~~~~~~~~~lV~E~ 770 (1036)
+|...+.||+|+||.||+++.. +++.||+|.+.... ......+.+|+.++.++. |+||+++++++..+...+++|||
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~ 84 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL 84 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence 3445678999999999999854 68999999986432 334567889999999996 99999999999999899999999
Q ss_pred cCCCChhhh---hhcCCCCCcChHHHHHHHHHHHHHHHHHHhc-CCccccccccCCCcEEecCCCceEEEEcCcceeecC
Q 001658 771 LENKSLDQA---LFGQRSLTLDWATRYEICSGVARGLAYLHEE-SRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDD 846 (1036)
Q Consensus 771 ~~~gsL~~~---l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~ 846 (1036)
+. +++.++ +.......+++....+++.++++||+|||+. + |+||||||+||++++++.+||+|||+++.+..
T Consensus 85 ~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 160 (288)
T cd06616 85 MD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK---IIHRDVKPSNILLDRNGNIKLCDFGISGQLVD 160 (288)
T ss_pred cc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC---eeccCCCHHHEEEccCCcEEEeecchhHHhcc
Confidence 86 465543 3333446789999999999999999999975 5 99999999999999999999999999976543
Q ss_pred CCCccccccccccCccCccccccC---CCCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhcCcccccc
Q 001658 847 KKTHISTRVAGTIGYLAPEYAMRG---HLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEIELA 923 (1036)
Q Consensus 847 ~~~~~~~~~~gt~~y~APE~~~~~---~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 923 (1036)
.... ....|+..|+|||++.+. .++.++|||||||++|||++|+.||..... . .+....... ..
T Consensus 161 ~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~--~---~~~~~~~~~------~~ 227 (288)
T cd06616 161 SIAK--TRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS--V---FDQLTQVVK------GD 227 (288)
T ss_pred CCcc--ccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch--H---HHHHhhhcC------CC
Confidence 2221 234588899999998776 689999999999999999999999875431 1 111111110 01
Q ss_pred Ccccc-cCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 001658 924 DPKLI-EFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVAM 962 (1036)
Q Consensus 924 d~~~~-~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 962 (1036)
.+.+. .........+.+++.+||+.+|++|||+.||+..
T Consensus 228 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 228 PPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred CCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11111 1112344567888899999999999999998863
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=309.01 Aligned_cols=263 Identities=23% Similarity=0.294 Sum_probs=195.9
Q ss_pred CCCCCCccccCCCEEEEEeEeC---CCcEEEEEEccccc---hhcHHHHHHHHHHHHhhccCCcceeEeEEEcC--ceeE
Q 001658 694 NFSPSNKLGEGGFGPVYKGKLG---DGRAIAVKQLSVAS---RQGKSQFVAEIATISAVQHRNLVKLHGCCIEG--AERL 765 (1036)
Q Consensus 694 ~~~~~~~iG~G~fG~Vy~~~~~---~g~~vAvK~~~~~~---~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~--~~~~ 765 (1036)
+|++.+.||+|+||.||+|... +++.||+|.+.... ......+.+|+.++++++||||+++++++.+. ...+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 4677889999999999999864 47899999987632 33345678899999999999999999999988 7899
Q ss_pred EEEEecCCCChhhhhhcCC---CCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecC----CCceEEEEc
Q 001658 766 LVYEYLENKSLDQALFGQR---SLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDA----DLVPKISDF 838 (1036)
Q Consensus 766 lV~E~~~~gsL~~~l~~~~---~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~----~~~~kl~DF 838 (1036)
+||||+++ +|.+++.... ...+++..+..|+.|++.||+|||+.+ |+||||||+||+++. ++.+||+||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 99999975 6777664322 236889999999999999999999988 999999999999999 899999999
Q ss_pred CcceeecCCCC--ccccccccccCccCccccccC-CCCchhhHHhHHHHHHHHHhCCCCCCCCChhh-------HHHHHH
Q 001658 839 GLAKLYDDKKT--HISTRVAGTIGYLAPEYAMRG-HLTEKTDVFAFGVLALETVSGRPNSDPSLDEE-------KLYLLE 908 (1036)
Q Consensus 839 Gla~~~~~~~~--~~~~~~~gt~~y~APE~~~~~-~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~-------~~~l~~ 908 (1036)
|+++....... .......++..|+|||++.+. .++.++|||||||+++||++|++||....... ...+..
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER 236 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence 99987643322 112335678899999988764 57899999999999999999999997544322 000111
Q ss_pred HHHHHhhcC------------cccc----ccCcccc-cCCH-------HHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 001658 909 WAWHLHENN------------QEIE----LADPKLI-EFNE-------EEVKRLIGVALLCTQTLPSLRPSMSRVVA 961 (1036)
Q Consensus 909 ~~~~~~~~~------------~~~~----~~d~~~~-~~~~-------~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 961 (1036)
.. ...... .... ....... .... ....++.+++.+|++.+|++|||+.|+++
T Consensus 237 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~ 312 (316)
T cd07842 237 IF-EVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE 312 (316)
T ss_pred HH-HHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 00 000000 0000 0000000 0000 23346888999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=306.08 Aligned_cols=267 Identities=23% Similarity=0.326 Sum_probs=200.6
Q ss_pred HHhcCCCCCCccccCCCEEEEEeEeC-CCcEEEEEEccccc--hhcHHHHHHHHHHHHhhccCCcceeEeEEEcCc----
Q 001658 690 TATENFSPSNKLGEGGFGPVYKGKLG-DGRAIAVKQLSVAS--RQGKSQFVAEIATISAVQHRNLVKLHGCCIEGA---- 762 (1036)
Q Consensus 690 ~~~~~~~~~~~iG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~--~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~---- 762 (1036)
...++|++.+.||+|+||.||+|... +|+.||+|.++... ......+.+|++++++++||||+++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 45678999999999999999999975 58899999986542 223456788999999999999999999987654
Q ss_pred ------eeEEEEEecCCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEE
Q 001658 763 ------ERLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKIS 836 (1036)
Q Consensus 763 ------~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~ 836 (1036)
..++|+||+++ ++.+.+... ...+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~kl~ 158 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLESG-LVHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKLA 158 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCcEEeC
Confidence 78999999975 777777543 446899999999999999999999987 9999999999999999999999
Q ss_pred EcCcceeecCCCCccccccccccCccCcccccc-CCCCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhh
Q 001658 837 DFGLAKLYDDKKTHISTRVAGTIGYLAPEYAMR-GHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHE 915 (1036)
Q Consensus 837 DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~ 915 (1036)
|||++...............++..|+|||.+.+ ..++.++|||||||++|||++|++||......+....+........
T Consensus 159 dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~ 238 (302)
T cd07864 159 DFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPC 238 (302)
T ss_pred cccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Confidence 999998765443222233456788999998865 4578899999999999999999999986544332222211100000
Q ss_pred cCcccc--------ccCc------ccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 001658 916 NNQEIE--------LADP------KLIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVA 961 (1036)
Q Consensus 916 ~~~~~~--------~~d~------~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 961 (1036)
...... ..++ ............+.+++..||+.+|.+||++.+++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 239 PAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred hhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 000000 0000 000001112356788899999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=304.99 Aligned_cols=243 Identities=25% Similarity=0.393 Sum_probs=197.0
Q ss_pred CccccCCCEEEEEeEe-CCCcEEEEEEccccchhcHHHHHHHHHHHHhhccCCcceeEeEEEcCceeEEEEEecCCCChh
Q 001658 699 NKLGEGGFGPVYKGKL-GDGRAIAVKQLSVASRQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLVYEYLENKSLD 777 (1036)
Q Consensus 699 ~~iG~G~fG~Vy~~~~-~~g~~vAvK~~~~~~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~ 777 (1036)
.+||+|+||.||++.. .+++.||+|.+..........+.+|+.+++.++|+||+++++++...+..++||||+++++|.
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 105 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT 105 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHH
Confidence 5799999999999986 478999999986555555677999999999999999999999999999999999999999999
Q ss_pred hhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeecCCCCcccccccc
Q 001658 778 QALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVAG 857 (1036)
Q Consensus 778 ~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~g 857 (1036)
+++.. ..+++.....++.|++.|++|||+.+ ++||||||+||++++++.++|+|||++........ ......|
T Consensus 106 ~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~ 178 (292)
T cd06657 106 DIVTH---TRMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-RRKSLVG 178 (292)
T ss_pred HHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceecccccc-ccccccc
Confidence 98743 35789999999999999999999987 99999999999999999999999999876543322 1233468
Q ss_pred ccCccCccccccCCCCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhcCccccccCcccccCCHHHHHH
Q 001658 858 TIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEIELADPKLIEFNEEEVKR 937 (1036)
Q Consensus 858 t~~y~APE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~ 937 (1036)
+..|+|||++.+..++.++||||||+++|||++|+.||............. .. ..+.+. ........
T Consensus 179 ~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~---~~---------~~~~~~-~~~~~~~~ 245 (292)
T cd06657 179 TPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIR---DN---------LPPKLK-NLHKVSPS 245 (292)
T ss_pred CccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH---hh---------CCcccC-CcccCCHH
Confidence 899999999988889999999999999999999999987644332221111 00 011110 11112335
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHH
Q 001658 938 LIGVALLCTQTLPSLRPSMSRVVA 961 (1036)
Q Consensus 938 l~~l~~~Cl~~dP~~RPt~~evl~ 961 (1036)
+.+++.+||+.+|.+||++.++++
T Consensus 246 l~~li~~~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 246 LKGFLDRLLVRDPAQRATAAELLK 269 (292)
T ss_pred HHHHHHHHHhCCcccCcCHHHHhc
Confidence 677788999999999999999886
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-32 Score=285.87 Aligned_cols=262 Identities=25% Similarity=0.301 Sum_probs=210.5
Q ss_pred HHHHHHhcCCCCCCccccCCCEEEEEeEeC------CCcEEEEEEccc-cchhcHHHHHHHHHHHHhhccCCcceeEeEE
Q 001658 686 AELKTATENFSPSNKLGEGGFGPVYKGKLG------DGRAIAVKQLSV-ASRQGKSQFVAEIATISAVQHRNLVKLHGCC 758 (1036)
Q Consensus 686 ~~l~~~~~~~~~~~~iG~G~fG~Vy~~~~~------~g~~vAvK~~~~-~~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~ 758 (1036)
+++.....+++...++-+|.||.||+|.+. +.+.|-||.++. .++.....|..|--.+..+.|||+.++.+.+
T Consensus 277 ~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ 356 (563)
T KOG1024|consen 277 QELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVS 356 (563)
T ss_pred HhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEE
Confidence 455556677888889999999999999654 345677787753 4555567788999999999999999999998
Q ss_pred EcC-ceeEEEEEecCCCChhhhhhcC------CCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCC
Q 001658 759 IEG-AERLLVYEYLENKSLDQALFGQ------RSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADL 831 (1036)
Q Consensus 759 ~~~-~~~~lV~E~~~~gsL~~~l~~~------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~ 831 (1036)
.++ +..+++|.++.-|+|..+|... ....+.-.+...++.|++.|++|||.++ |||.||..+|.+||+..
T Consensus 357 ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvIdd~L 433 (563)
T KOG1024|consen 357 IEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVIDDQL 433 (563)
T ss_pred eeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcceehhhe
Confidence 765 5668889999999999999722 2456777888899999999999999998 99999999999999999
Q ss_pred ceEEEEcCcceeecCCCCccc-cccccccCccCccccccCCCCchhhHHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHH
Q 001658 832 VPKISDFGLAKLYDDKKTHIS-TRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVS-GRPNSDPSLDEEKLYLLEW 909 (1036)
Q Consensus 832 ~~kl~DFGla~~~~~~~~~~~-~~~~gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~ 909 (1036)
++||+|=.+++.+.+.+.+.- .....+..||+||.+.+..|+.++|||||||+||||+| |+.|+..-.+.+.....
T Consensus 434 qVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~yl-- 511 (563)
T KOG1024|consen 434 QVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYL-- 511 (563)
T ss_pred eEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHH--
Confidence 999999999998766554432 22335679999999999999999999999999999998 77777654443332211
Q ss_pred HHHHhhcCccccccCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhc
Q 001658 910 AWHLHENNQEIELADPKLIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVAMLCG 965 (1036)
Q Consensus 910 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~ 965 (1036)
.|......+.+++.+++.+|.-||..+|++||+++|++..|.+
T Consensus 512 -------------kdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLse 554 (563)
T KOG1024|consen 512 -------------KDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSE 554 (563)
T ss_pred -------------hccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHH
Confidence 1222223345667789999999999999999999999999874
|
|
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=328.72 Aligned_cols=265 Identities=20% Similarity=0.256 Sum_probs=188.1
Q ss_pred HhcCCCCCCccccCCCEEEEEeEeCC--CcEEEEE------------------EccccchhcHHHHHHHHHHHHhhccCC
Q 001658 691 ATENFSPSNKLGEGGFGPVYKGKLGD--GRAIAVK------------------QLSVASRQGKSQFVAEIATISAVQHRN 750 (1036)
Q Consensus 691 ~~~~~~~~~~iG~G~fG~Vy~~~~~~--g~~vAvK------------------~~~~~~~~~~~~f~~Ei~~L~~l~H~n 750 (1036)
..++|++.+.||+|+||+||++..+. +..+++| .+. ........+.+|+.++++++|+|
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~-~~~~~~~~~~~Ei~il~~l~Hpn 224 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVK-AGSRAAIQLENEILALGRLNHEN 224 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhh-cchHHHHHHHHHHHHHHhCCCCC
Confidence 45789999999999999999987532 2222222 111 11223456889999999999999
Q ss_pred cceeEeEEEcCceeEEEEEecCCCChhhhhhcCC---CCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEe
Q 001658 751 LVKLHGCCIEGAERLLVYEYLENKSLDQALFGQR---SLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLL 827 (1036)
Q Consensus 751 Iv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~---~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl 827 (1036)
|+++++++...+..++|+|++. ++|.+++.... ...........|+.||+.||+|||+.+ ||||||||+|||+
T Consensus 225 Iv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NILl 300 (501)
T PHA03210 225 ILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENIFL 300 (501)
T ss_pred cCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEE
Confidence 9999999999999999999984 57777765432 122334566789999999999999988 9999999999999
Q ss_pred cCCCceEEEEcCcceeecCCCCccccccccccCccCccccccCCCCchhhHHhHHHHHHHHHhCCCCCC-CCChhhHHHH
Q 001658 828 DADLVPKISDFGLAKLYDDKKTHISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRPNSD-PSLDEEKLYL 906 (1036)
Q Consensus 828 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~-~~~~~~~~~l 906 (1036)
+.++.+||+|||+++.+............||..|+|||++.+..++.++|||||||++|||++|+.++. .........+
T Consensus 301 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~ 380 (501)
T PHA03210 301 NCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQL 380 (501)
T ss_pred CCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHH
Confidence 999999999999998776544333344679999999999999999999999999999999999985443 2221111111
Q ss_pred HHHHHHHhhcCccccccCc-----------cc---ccCCH------HHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 001658 907 LEWAWHLHENNQEIELADP-----------KL---IEFNE------EEVKRLIGVALLCTQTLPSLRPSMSRVVAM 962 (1036)
Q Consensus 907 ~~~~~~~~~~~~~~~~~d~-----------~~---~~~~~------~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 962 (1036)
.+..... ... ..+..++ .+ ..... ....++.+++.+|++.||.+|||+.|++++
T Consensus 381 ~~~~~~~-~~~-~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h 454 (501)
T PHA03210 381 LKIIDSL-SVC-DEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL 454 (501)
T ss_pred HHHHHhc-ccC-hhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 1111100 000 0000000 00 00000 011345667789999999999999999863
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-32 Score=301.58 Aligned_cols=256 Identities=18% Similarity=0.220 Sum_probs=184.2
Q ss_pred HhcCCCCCCccccCCCEEEEEeEeCC----CcEEEEEEccccchhc-----------HHHHHHHHHHHHhhccCCcceeE
Q 001658 691 ATENFSPSNKLGEGGFGPVYKGKLGD----GRAIAVKQLSVASRQG-----------KSQFVAEIATISAVQHRNLVKLH 755 (1036)
Q Consensus 691 ~~~~~~~~~~iG~G~fG~Vy~~~~~~----g~~vAvK~~~~~~~~~-----------~~~f~~Ei~~L~~l~H~nIv~l~ 755 (1036)
..++|++.+.||+|+||.||+|...+ +..+|+|......... ......+...+..++|+|+++++
T Consensus 10 ~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~ 89 (294)
T PHA02882 10 TGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYY 89 (294)
T ss_pred CCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEE
Confidence 34678899999999999999998654 3566777543222111 01122334455667899999999
Q ss_pred eEEEcCc----eeEEEEEecCCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCC
Q 001658 756 GCCIEGA----ERLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADL 831 (1036)
Q Consensus 756 g~~~~~~----~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~ 831 (1036)
+++.... ..++++|++. .++.+.+... ...++..+..|+.|+++||+|||+.+ |+||||||+|||++.++
T Consensus 90 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nill~~~~ 163 (294)
T PHA02882 90 GCGSFKRCRMYYRFILLEKLV-ENTKEIFKRI--KCKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMVDGNN 163 (294)
T ss_pred EeeeEecCCceEEEEEEehhc-cCHHHHHHhh--ccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCC
Confidence 9876543 3467777763 4666665432 23567888899999999999999987 99999999999999999
Q ss_pred ceEEEEcCcceeecCCCCc------cccccccccCccCccccccCCCCchhhHHhHHHHHHHHHhCCCCCCCCChhhH-H
Q 001658 832 VPKISDFGLAKLYDDKKTH------ISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEK-L 904 (1036)
Q Consensus 832 ~~kl~DFGla~~~~~~~~~------~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~-~ 904 (1036)
.++|+|||+++.+...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||........ .
T Consensus 164 ~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~ 243 (294)
T PHA02882 164 RGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLI 243 (294)
T ss_pred cEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHH
Confidence 9999999999876432211 11234699999999999999999999999999999999999999986532221 1
Q ss_pred HHH--HHHHHHhhcCccccccCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 001658 905 YLL--EWAWHLHENNQEIELADPKLIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVAML 963 (1036)
Q Consensus 905 ~l~--~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L 963 (1036)
... ++..... . +.. ........+.+++..|++.+|++||+++++.+.|
T Consensus 244 ~~~~~~~~~~~~-~--------~~~--~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 244 HAAKCDFIKRLH-E--------GKI--KIKNANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred HHhHHHHHHHhh-h--------hhh--ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 111 1111111 1 110 0011235677888899999999999999999876
|
|
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-32 Score=301.75 Aligned_cols=241 Identities=26% Similarity=0.298 Sum_probs=191.0
Q ss_pred cccCCCEEEEEeEe-CCCcEEEEEEccccc---hhcHHHHHHHHHHHHhhccCCcceeEeEEEcCceeEEEEEecCCCCh
Q 001658 701 LGEGGFGPVYKGKL-GDGRAIAVKQLSVAS---RQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLVYEYLENKSL 776 (1036)
Q Consensus 701 iG~G~fG~Vy~~~~-~~g~~vAvK~~~~~~---~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL 776 (1036)
||+|+||+||++.. .+|+.||+|.+.... ......+..|++++++++||||+++++++...+..++|+||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 69999999999975 468999999986432 22345677899999999999999999999999999999999999999
Q ss_pred hhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeecCCCCccccccc
Q 001658 777 DQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVA 856 (1036)
Q Consensus 777 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 856 (1036)
.+++.......+++..+..++.|++.||.|||+.+ ++||||+|+||++++++.++|+|||++....... ......
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~--~~~~~~ 155 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK--KIKGRA 155 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhccCC--cccccc
Confidence 99997766567899999999999999999999988 9999999999999999999999999987654321 122345
Q ss_pred cccCccCccccccCCCCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhcCccccccCcccccCCHHHHH
Q 001658 857 GTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEIELADPKLIEFNEEEVK 936 (1036)
Q Consensus 857 gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~ 936 (1036)
++..|+|||++.+..++.++|||||||++|||++|+.||............. .. ...... ........
T Consensus 156 ~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~---~~------~~~~~~---~~~~~~~~ 223 (277)
T cd05577 156 GTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELK---RR------TLEMAV---EYPDKFSP 223 (277)
T ss_pred CCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHH---hc------cccccc---cCCccCCH
Confidence 7889999999988889999999999999999999999997643311111110 00 000011 11122244
Q ss_pred HHHHHHHHhcccCCCCCCCHHH
Q 001658 937 RLIGVALLCTQTLPSLRPSMSR 958 (1036)
Q Consensus 937 ~l~~l~~~Cl~~dP~~RPt~~e 958 (1036)
.+.+++.+||+.+|.+||+..|
T Consensus 224 ~~~~li~~~l~~~p~~R~~~~~ 245 (277)
T cd05577 224 EAKDLCEALLQKDPEKRLGCRG 245 (277)
T ss_pred HHHHHHHHHccCChhHccCCCc
Confidence 6778888999999999994444
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=313.14 Aligned_cols=267 Identities=22% Similarity=0.300 Sum_probs=199.2
Q ss_pred hcCCCCCCccccCCCEEEEEeEe-CCCcEEEEEEccccc-hhcHHHHHHHHHHHHhhccCCcceeEeEEEcC-----cee
Q 001658 692 TENFSPSNKLGEGGFGPVYKGKL-GDGRAIAVKQLSVAS-RQGKSQFVAEIATISAVQHRNLVKLHGCCIEG-----AER 764 (1036)
Q Consensus 692 ~~~~~~~~~iG~G~fG~Vy~~~~-~~g~~vAvK~~~~~~-~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~-----~~~ 764 (1036)
+++|++.+.||+|+||.||+|+. .+|+.||+|.+.... ......+.+|+.++++++|+||+++++++... ...
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 56899999999999999999985 468999999986432 23345688899999999999999999987654 347
Q ss_pred EEEEEecCCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceee
Q 001658 765 LLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLY 844 (1036)
Q Consensus 765 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~ 844 (1036)
++|+||++ ++|.+++. ...+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++..
T Consensus 84 ~lv~e~~~-~~l~~~~~---~~~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~ 156 (336)
T cd07849 84 YIVQELME-TDLYKLIK---TQHLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARIA 156 (336)
T ss_pred EEEehhcc-cCHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECcccceeec
Confidence 89999996 58887774 346899999999999999999999988 999999999999999999999999999876
Q ss_pred cCCCCc--cccccccccCccCcccccc-CCCCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhcCcc--
Q 001658 845 DDKKTH--ISTRVAGTIGYLAPEYAMR-GHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQE-- 919 (1036)
Q Consensus 845 ~~~~~~--~~~~~~gt~~y~APE~~~~-~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~-- 919 (1036)
...... ......||..|+|||.+.+ ..++.++|||||||++|||++|++||.......... ...........
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~---~~~~~~~~~~~~~ 233 (336)
T cd07849 157 DPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLN---LILGVLGTPSQED 233 (336)
T ss_pred cccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH---HHHHHcCCCCHHH
Confidence 432221 1123468899999998754 568999999999999999999999997543221111 11111100000
Q ss_pred -cccc-------------Cccc--ccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--hhcccC
Q 001658 920 -IELA-------------DPKL--IEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVAM--LCGDME 968 (1036)
Q Consensus 920 -~~~~-------------d~~~--~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~--L~~~~~ 968 (1036)
.... .+.. ....+.....+.+++.+||+.+|++|||+.|+++. ++....
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~ 300 (336)
T cd07849 234 LNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHD 300 (336)
T ss_pred HHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCC
Confidence 0000 0000 00011224568899999999999999999999875 554443
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-32 Score=294.36 Aligned_cols=250 Identities=26% Similarity=0.394 Sum_probs=204.4
Q ss_pred CCCCCCccccCCCEEEEEeEeC-CCcEEEEEEccccc--hhcHHHHHHHHHHHHhhccCCcceeEeEEEcC--ceeEEEE
Q 001658 694 NFSPSNKLGEGGFGPVYKGKLG-DGRAIAVKQLSVAS--RQGKSQFVAEIATISAVQHRNLVKLHGCCIEG--AERLLVY 768 (1036)
Q Consensus 694 ~~~~~~~iG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~--~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~--~~~~lV~ 768 (1036)
+|+..+.||+|++|.||+|... +++.|++|++.... ....+.+.+|++++++++|+||+++++.+... ...++|+
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4677789999999999999875 68999999987544 24567889999999999999999999999988 8899999
Q ss_pred EecCCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeecCCC
Q 001658 769 EYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKK 848 (1036)
Q Consensus 769 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~ 848 (1036)
||+++++|.+++.... .+++..+..++.|+++||+|||+.+ ++|+||+|+||+++.++.++|+|||.+.......
T Consensus 81 e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 155 (260)
T cd06606 81 EYVSGGSLSSLLKKFG--KLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIE 155 (260)
T ss_pred EecCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccEEeccccc
Confidence 9999999999986543 7899999999999999999999987 9999999999999999999999999998776443
Q ss_pred Cc-cccccccccCccCccccccCCCCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhcCccccccCccc
Q 001658 849 TH-ISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEIELADPKL 927 (1036)
Q Consensus 849 ~~-~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~ 927 (1036)
.. ......++..|+|||.......+.++||||||+++++|++|+.||......... .+.... . ...
T Consensus 156 ~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~-----~~~~~~-----~---~~~ 222 (260)
T cd06606 156 TGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAA-----LYKIGS-----S---GEP 222 (260)
T ss_pred ccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHH-----HHhccc-----c---CCC
Confidence 21 123356888999999999888999999999999999999999999865421111 111100 0 011
Q ss_pred ccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 001658 928 IEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVA 961 (1036)
Q Consensus 928 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 961 (1036)
...+......+.+++.+|++.+|++||++.|+++
T Consensus 223 ~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 223 PEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred cCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 1122233567888889999999999999999985
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-32 Score=303.95 Aligned_cols=248 Identities=27% Similarity=0.445 Sum_probs=196.3
Q ss_pred CCCCCccccCCCEEEEEeEe-CCCcEEEEEEccccc---hhcHHHHHHHHHHHHhhccCCcceeEeEEEcCceeEEEEEe
Q 001658 695 FSPSNKLGEGGFGPVYKGKL-GDGRAIAVKQLSVAS---RQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLVYEY 770 (1036)
Q Consensus 695 ~~~~~~iG~G~fG~Vy~~~~-~~g~~vAvK~~~~~~---~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~ 770 (1036)
|+..+.||+|+||.||+|+. .+++.||+|.+.... ......+..|++++++++|+|++++++++.++...++||||
T Consensus 27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 106 (317)
T cd06635 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY 106 (317)
T ss_pred hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence 55678899999999999985 468899999986432 22345788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeecCCCCc
Q 001658 771 LENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTH 850 (1036)
Q Consensus 771 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~ 850 (1036)
++ |+|.+.+... ...++|.++..++.|++.||.|||+.+ |+||||+|+||+++.++.++|+|||++......
T Consensus 107 ~~-g~l~~~~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~--- 178 (317)
T cd06635 107 CL-GSASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASPA--- 178 (317)
T ss_pred CC-CCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCccccCCc---
Confidence 96 5887776543 446899999999999999999999988 999999999999999999999999998754432
Q ss_pred cccccccccCccCccccc---cCCCCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhcCccccccCccc
Q 001658 851 ISTRVAGTIGYLAPEYAM---RGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEIELADPKL 927 (1036)
Q Consensus 851 ~~~~~~gt~~y~APE~~~---~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~ 927 (1036)
....|+..|+|||++. .+.++.++|||||||++|||++|+.||............ . ... .+..
T Consensus 179 --~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~--~----~~~------~~~~ 244 (317)
T cd06635 179 --NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI--A----QNE------SPTL 244 (317)
T ss_pred --ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHH--H----hcc------CCCC
Confidence 2245888999999974 456889999999999999999999998764332222111 0 000 0111
Q ss_pred ccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcc
Q 001658 928 IEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVAMLCGD 966 (1036)
Q Consensus 928 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 966 (1036)
........+.+++.+||+.+|.+||++.++++.+...
T Consensus 245 --~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~ 281 (317)
T cd06635 245 --QSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVL 281 (317)
T ss_pred --CCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhh
Confidence 1122334577888899999999999999999865543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-32 Score=303.62 Aligned_cols=261 Identities=22% Similarity=0.305 Sum_probs=195.9
Q ss_pred cCCCCCCccccCCCEEEEEeEeC-CCcEEEEEEccccc--hhcHHHHHHHHHHHHhhc-cCCcceeEeEEEcCce-----
Q 001658 693 ENFSPSNKLGEGGFGPVYKGKLG-DGRAIAVKQLSVAS--RQGKSQFVAEIATISAVQ-HRNLVKLHGCCIEGAE----- 763 (1036)
Q Consensus 693 ~~~~~~~~iG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~--~~~~~~f~~Ei~~L~~l~-H~nIv~l~g~~~~~~~----- 763 (1036)
++|+..+.||+|+||.||+|... +++.||+|.++... ......+.+|+.++++++ |+||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 46888899999999999999864 68999999876532 223457888999999995 6999999999887665
Q ss_pred eEEEEEecCCCChhhhhhcCC---CCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecC-CCceEEEEcC
Q 001658 764 RLLVYEYLENKSLDQALFGQR---SLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDA-DLVPKISDFG 839 (1036)
Q Consensus 764 ~~lV~E~~~~gsL~~~l~~~~---~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~-~~~~kl~DFG 839 (1036)
.++||||+++ +|.+++.... ...+++..+..++.||++||+|||+.+ |+||||||+||+++. ++.+||+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEEeecc
Confidence 7999999985 8988886543 346899999999999999999999987 999999999999998 8999999999
Q ss_pred cceeecCCCCccccccccccCccCcccccc-CCCCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhcCc
Q 001658 840 LAKLYDDKKTHISTRVAGTIGYLAPEYAMR-GHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQ 918 (1036)
Q Consensus 840 la~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 918 (1036)
+++.+..... ......+++.|+|||++.+ ..++.++||||||+++|||++|..||............ . .......
T Consensus 157 ~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~--~-~~~~~~~ 232 (295)
T cd07837 157 LGRAFSIPVK-SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHI--F-KLLGTPT 232 (295)
T ss_pred cceecCCCcc-ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH--H-HHhCCCC
Confidence 9986543221 1223356889999998865 45789999999999999999999999765433222111 0 0000000
Q ss_pred cc------ccc----Ccc-----cccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 001658 919 EI------ELA----DPK-----LIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVA 961 (1036)
Q Consensus 919 ~~------~~~----d~~-----~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 961 (1036)
.. ... .+. +....+.....+.+++.+|++.+|.+||++.|++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 233 EQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred hhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 00 000 000 00011123456788899999999999999999875
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-32 Score=300.02 Aligned_cols=256 Identities=20% Similarity=0.272 Sum_probs=194.4
Q ss_pred CCCCCccccCCCEEEEEeEe-CCCcEEEEEEccccc-hhcHHHHHHHHHHHHhhc-cCCcceeEeEEEcC--ceeEEEEE
Q 001658 695 FSPSNKLGEGGFGPVYKGKL-GDGRAIAVKQLSVAS-RQGKSQFVAEIATISAVQ-HRNLVKLHGCCIEG--AERLLVYE 769 (1036)
Q Consensus 695 ~~~~~~iG~G~fG~Vy~~~~-~~g~~vAvK~~~~~~-~~~~~~f~~Ei~~L~~l~-H~nIv~l~g~~~~~--~~~~lV~E 769 (1036)
|++.+.||+|+||.||+|.. .+++.||+|+++... .........|+.++.++. |+||+++++++.+. +..++|+|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 56678899999999999985 468899999986532 222334557888999885 99999999999987 88999999
Q ss_pred ecCCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeecCCCC
Q 001658 770 YLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKT 849 (1036)
Q Consensus 770 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~ 849 (1036)
|++ ++|.+++.... ..++|..+..++.|++.||+|||+.+ |+||||||+||+++. +.+||+|||+++.......
T Consensus 81 ~~~-~~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~ 154 (282)
T cd07831 81 LMD-MNLYELIKGRK-RPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRGIYSKPP 154 (282)
T ss_pred cCC-ccHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEecccccccccCCC
Confidence 996 58888875432 46899999999999999999999988 999999999999999 9999999999987643322
Q ss_pred ccccccccccCccCcccccc-CCCCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhh-----------cC
Q 001658 850 HISTRVAGTIGYLAPEYAMR-GHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHE-----------NN 917 (1036)
Q Consensus 850 ~~~~~~~gt~~y~APE~~~~-~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~-----------~~ 917 (1036)
. ....++..|+|||++.. +.++.++|||||||++|||++|++||......+... +...... ..
T Consensus 155 ~--~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~ 229 (282)
T cd07831 155 Y--TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIA---KIHDVLGTPDAEVLKKFRKS 229 (282)
T ss_pred c--CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHH---HHHHHcCCCCHHHHHhhccc
Confidence 1 23457889999997654 557889999999999999999999997654433221 1111110 00
Q ss_pred ccccccCccc-----ccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 001658 918 QEIELADPKL-----IEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVA 961 (1036)
Q Consensus 918 ~~~~~~d~~~-----~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 961 (1036)
.......+.. ..........+.+++.+|++.+|++||++.++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 230 RHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR 278 (282)
T ss_pred ccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence 0011111110 0111234577889999999999999999999885
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-32 Score=310.67 Aligned_cols=265 Identities=23% Similarity=0.328 Sum_probs=199.0
Q ss_pred HhcCCCCCCccccCCCEEEEEeEeC-CCcEEEEEEcccc--chhcHHHHHHHHHHHHhh-ccCCcceeEeEEEcC--cee
Q 001658 691 ATENFSPSNKLGEGGFGPVYKGKLG-DGRAIAVKQLSVA--SRQGKSQFVAEIATISAV-QHRNLVKLHGCCIEG--AER 764 (1036)
Q Consensus 691 ~~~~~~~~~~iG~G~fG~Vy~~~~~-~g~~vAvK~~~~~--~~~~~~~f~~Ei~~L~~l-~H~nIv~l~g~~~~~--~~~ 764 (1036)
..++|++.+.||+|+||.||+|... +++.||+|++... .......+.+|+.+++++ +|+||+++++++... ...
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 4567888899999999999999865 6889999988532 223345677899999999 999999999998653 367
Q ss_pred EEEEEecCCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceee
Q 001658 765 LLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLY 844 (1036)
Q Consensus 765 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~ 844 (1036)
++||||++ ++|.+++... .++|..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||+++..
T Consensus 85 ~lv~e~~~-~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d~g~~~~~ 157 (337)
T cd07852 85 YLVFEYME-TDLHAVIRAN---ILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARSL 157 (337)
T ss_pred EEEecccc-cCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccchhcc
Confidence 99999997 5999888543 7889999999999999999999987 999999999999999999999999999866
Q ss_pred cCCCCc----cccccccccCccCcccccc-CCCCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHH------
Q 001658 845 DDKKTH----ISTRVAGTIGYLAPEYAMR-GHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHL------ 913 (1036)
Q Consensus 845 ~~~~~~----~~~~~~gt~~y~APE~~~~-~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~------ 913 (1036)
...... ......|+..|+|||++.+ ..++.++||||||+++|||++|+.||......+...........
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 237 (337)
T cd07852 158 SELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDI 237 (337)
T ss_pred ccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence 533221 2233568999999998765 45788999999999999999999999765433322111110000
Q ss_pred --hhc---Ccccc-ccC---cccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 001658 914 --HEN---NQEIE-LAD---PKLIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVAM 962 (1036)
Q Consensus 914 --~~~---~~~~~-~~d---~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 962 (1036)
... ..... ... +............+.+++.+||+.+|++|||+.++++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 238 ESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 000 00000 000 00111111234578889999999999999999999864
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=301.71 Aligned_cols=247 Identities=23% Similarity=0.284 Sum_probs=200.5
Q ss_pred CCCCCCccccCCCEEEEEeEeC-CCcEEEEEEccccc---hhcHHHHHHHHHHHHhhccCCcceeEeEEEcCceeEEEEE
Q 001658 694 NFSPSNKLGEGGFGPVYKGKLG-DGRAIAVKQLSVAS---RQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLVYE 769 (1036)
Q Consensus 694 ~~~~~~~iG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E 769 (1036)
+|++.+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|++++++++||||+++++++.++...++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 4777899999999999999865 58999999986432 2345788999999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeecCCCC
Q 001658 770 YLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKT 849 (1036)
Q Consensus 770 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~ 849 (1036)
|+++++|.+++... ..+++..+..++.|+++||+|||+.+ ++|+||||+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~- 154 (258)
T cd05578 81 LLLGGDLRYHLSQK--VKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT- 154 (258)
T ss_pred CCCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccccccCCCc-
Confidence 99999999998654 57889999999999999999999987 9999999999999999999999999988664332
Q ss_pred ccccccccccCccCccccccCCCCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhcCccccccCccccc
Q 001658 850 HISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEIELADPKLIE 929 (1036)
Q Consensus 850 ~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~ 929 (1036)
......|+..|+|||.+.+..++.++||||||+++|+|++|+.||............ ..... ..+ .
T Consensus 155 -~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~----~~~~~------~~~---~ 220 (258)
T cd05578 155 -LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIR----AKQET------ADV---L 220 (258)
T ss_pred -cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHH----HHhcc------ccc---c
Confidence 123355888999999999888999999999999999999999999865432111111 11100 001 1
Q ss_pred CCHHHHHHHHHHHHHhcccCCCCCCCH--HHHH
Q 001658 930 FNEEEVKRLIGVALLCTQTLPSLRPSM--SRVV 960 (1036)
Q Consensus 930 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~--~evl 960 (1036)
.+......+.+++.+||+.+|.+||++ .|++
T Consensus 221 ~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 221 YPATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred CcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 112233677788899999999999999 5544
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-32 Score=295.43 Aligned_cols=247 Identities=28% Similarity=0.427 Sum_probs=203.2
Q ss_pred CCCCCCccccCCCEEEEEeEe-CCCcEEEEEEccccc--hhcHHHHHHHHHHHHhhccCCcceeEeEEEcCceeEEEEEe
Q 001658 694 NFSPSNKLGEGGFGPVYKGKL-GDGRAIAVKQLSVAS--RQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLVYEY 770 (1036)
Q Consensus 694 ~~~~~~~iG~G~fG~Vy~~~~-~~g~~vAvK~~~~~~--~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~ 770 (1036)
+|++.+.||+|+||.||+++. .+++.+|+|.+.... ......+.+|++++++++|+||+++++++.+....++|+||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 477789999999999999975 467899999986532 33456788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCC--CCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeecCCC
Q 001658 771 LENKSLDQALFGQR--SLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKK 848 (1036)
Q Consensus 771 ~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~ 848 (1036)
+++++|.+++.... ...+++..++.++.|+++||+|||+.+ ++|+||+|+||++++++.+||+|||+++......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~ 157 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVLKKNM 157 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhhhccCC
Confidence 99999999986522 356899999999999999999999988 9999999999999999999999999998765441
Q ss_pred CccccccccccCccCccccccCCCCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhcCccccccCcccc
Q 001658 849 THISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEIELADPKLI 928 (1036)
Q Consensus 849 ~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~ 928 (1036)
.....|+..|+|||...+..++.++|+||||+++|||++|+.||.......... .. .. ....
T Consensus 158 ---~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~---~~----~~--------~~~~ 219 (256)
T cd08530 158 ---AKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRY---KV----QR--------GKYP 219 (256)
T ss_pred ---cccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH---HH----hc--------CCCC
Confidence 122457889999999999889999999999999999999999997654322111 00 00 1111
Q ss_pred cCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 001658 929 EFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVA 961 (1036)
Q Consensus 929 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 961 (1036)
........++.+++.+|++.+|++||++.|+++
T Consensus 220 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 252 (256)
T cd08530 220 PIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA 252 (256)
T ss_pred CCchhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 222344567888999999999999999999985
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-32 Score=298.88 Aligned_cols=261 Identities=25% Similarity=0.345 Sum_probs=197.7
Q ss_pred CCCCCccccCCCEEEEEeEeC-CCcEEEEEEccccch--hcHHHHHHHHHHHHhh---ccCCcceeEeEEEcCce-----
Q 001658 695 FSPSNKLGEGGFGPVYKGKLG-DGRAIAVKQLSVASR--QGKSQFVAEIATISAV---QHRNLVKLHGCCIEGAE----- 763 (1036)
Q Consensus 695 ~~~~~~iG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~--~~~~~f~~Ei~~L~~l---~H~nIv~l~g~~~~~~~----- 763 (1036)
|++.+.||+|+||.||+|+.. +++.||+|.++.... .....+.+|+.++.++ +|+||+++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 566789999999999999976 489999999864322 2234566788877666 59999999999988776
Q ss_pred eEEEEEecCCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCccee
Q 001658 764 RLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKL 843 (1036)
Q Consensus 764 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~ 843 (1036)
.+++|||+. ++|.+++.......+++..+..++.|+++||+|||+.+ ++|+||+|+||++++++.+||+|||++..
T Consensus 81 ~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~dfg~~~~ 156 (287)
T cd07838 81 LTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARI 156 (287)
T ss_pred eEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEeccCccee
Confidence 899999996 58999887655557899999999999999999999987 99999999999999999999999999987
Q ss_pred ecCCCCccccccccccCccCccccccCCCCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHH-HHHHHHhhcCccccc
Q 001658 844 YDDKKTHISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLL-EWAWHLHENNQEIEL 922 (1036)
Q Consensus 844 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~-~~~~~~~~~~~~~~~ 922 (1036)
+..... .....++..|+|||++.+..++.++|||||||++|||++|++||......+..... +..............
T Consensus 157 ~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (287)
T cd07838 157 YSFEMA--LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNV 234 (287)
T ss_pred ccCCcc--cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCc
Confidence 653322 12335788999999999989999999999999999999999999865543322111 100000000000000
Q ss_pred ------cC----cccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 001658 923 ------AD----PKLIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVA 961 (1036)
Q Consensus 923 ------~d----~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 961 (1036)
.. ........+....+.+++.+||+.||++||++.|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 235 SLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred ccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 00 0001112233466778899999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=355.76 Aligned_cols=295 Identities=31% Similarity=0.487 Sum_probs=189.3
Q ss_pred eeEeEEEEeeccccccCCccccCCCCCCEEEccCCCCCCCCcccccCCCcCCeeecccccccCCccccccCCCCCcEEEc
Q 001658 99 CHITQLKVYALNVVGVIPDELWNLTSLFNLNLGQNYLTGPLSPSVGNLTAMQYLNLAINALSGELPKELGQLTELLILGI 178 (1036)
Q Consensus 99 ~~l~~L~l~~~~~~~~ip~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~L~~L~~L~L 178 (1036)
.+++.|++++|++.+.+|. ..+++|++|+|++|.+++.+|..|+++++|++|+|++|.+.+.+|..++++++|++|+|
T Consensus 118 ~~L~~L~Ls~n~l~~~~p~--~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L 195 (968)
T PLN00113 118 SSLRYLNLSNNNFTGSIPR--GSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTL 195 (968)
T ss_pred CCCCEEECcCCccccccCc--cccCCCCEEECcCCcccccCChHHhcCCCCCEEECccCcccccCChhhhhCcCCCeeec
Confidence 3566677777766666664 34566666666666666666666666666666666666666666666666666666666
Q ss_pred ccCCCCCCCccccCCCccCCEEeCccccCCCCCCccccCCCCCcEEeccCCcCCCCChhhhcCCCCCCEEEeeCCcCCCC
Q 001658 179 GTNNFSGPLPSELGSLSKLQELYIDSAGVSGEIPSSFANLQSLTKWWASDTRLTGRIPDFIGNWSKLTALRFQGNSFNGP 258 (1036)
Q Consensus 179 s~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~ 258 (1036)
++|.+.+.+|..+.++++|++|+|++|++++.+|..++.+++|++|+|++|++.+.+|..++++++|++|+|++|.+.+.
T Consensus 196 ~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~ 275 (968)
T PLN00113 196 ASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGP 275 (968)
T ss_pred cCCCCcCcCChHHcCcCCccEEECcCCccCCcCChhHhcCCCCCEEECcCceeccccChhHhCCCCCCEEECcCCeeecc
Confidence 66666666666666666666666666666666666666666666666666666666666666666666666666666666
Q ss_pred CCccccCCCCCCEEEccCCCCCCCchhhhcCCCCCCEEEccCCccCccccccccCCCCccEEeCCCCCCCCCCchhccCC
Q 001658 259 IPSSFSNLTSVTELRISDLSNGSSKLAFIRDMKSLSILELRNNNISDSIPSNIGEYRSLQHLDLSFNNLGGSIPDSLFNL 338 (1036)
Q Consensus 259 ~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l 338 (1036)
+|..+.++++|+.|+|++|.+....+..+..+++|+.|+|++|.+.+.+|..+..+++|+.|+|++|++.+.+|..++.+
T Consensus 276 ~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~~ 355 (968)
T PLN00113 276 IPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKH 355 (968)
T ss_pred CchhHhhccCcCEEECcCCeeccCCChhHcCCCCCcEEECCCCccCCcCChhHhcCCCCCEEECcCCCCcCcCChHHhCC
Confidence 66666666666666666666665555556666666666666666666666666666666666666666666666666666
Q ss_pred CCccEEEccCccccccCCCCcC--CCccEEEeeCccCCCCCchhhhccCCcceeeecCC
Q 001658 339 SSLTHLFLGNNKLNGTLPARKS--PLLLNIDVSYNNLQGNLPSWINGQQNLQINLVANN 395 (1036)
Q Consensus 339 ~~L~~L~Ls~N~l~g~~p~~~~--~~L~~Ldls~N~l~g~~p~~l~~l~~L~~~~~~nn 395 (1036)
++|+.|+|++|++++.+|..+. +.|+.|++++|++.+.+|..+..+++|+.+.+.+|
T Consensus 356 ~~L~~L~Ls~n~l~~~~p~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~L~~L~L~~n 414 (968)
T PLN00113 356 NNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDN 414 (968)
T ss_pred CCCcEEECCCCeeEeeCChhHhCcCCCCEEECcCCEecccCCHHHhCCCCCCEEECcCC
Confidence 6666666666666665555433 33555555555555555555555555555555444
|
|
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-32 Score=294.61 Aligned_cols=249 Identities=22% Similarity=0.385 Sum_probs=204.4
Q ss_pred CCCCCCccccCCCEEEEEeEeC-CCcEEEEEEccccch--hcHHHHHHHHHHHHhhccCCcceeEeEEEcCceeEEEEEe
Q 001658 694 NFSPSNKLGEGGFGPVYKGKLG-DGRAIAVKQLSVASR--QGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLVYEY 770 (1036)
Q Consensus 694 ~~~~~~~iG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~--~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~ 770 (1036)
+|+..+.||+|+||.||++... +++.||+|++..... .....+.+|+++++.++|+|++++++.+...+..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 4777889999999999999864 688999999875432 4566789999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCC--CCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeecCCC
Q 001658 771 LENKSLDQALFGQR--SLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKK 848 (1036)
Q Consensus 771 ~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~ 848 (1036)
+++++|.+++.... ...+++..+..++.+++.||+|||+.+ ++|+||+|+||++++++.++|+|||.+.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 99999999997643 467899999999999999999999987 9999999999999999999999999998765443
Q ss_pred CccccccccccCccCccccccCCCCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhcCccccccCcccc
Q 001658 849 THISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEIELADPKLI 928 (1036)
Q Consensus 849 ~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~ 928 (1036)
.......|++.|+|||...+..++.++||||+|+++++|++|+.||.......... .... .. .+
T Consensus 158 -~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~------~~~~-~~-----~~--- 221 (258)
T cd08215 158 -DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELAL------KILK-GQ-----YP--- 221 (258)
T ss_pred -ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHH------HHhc-CC-----CC---
Confidence 12233468889999999988889999999999999999999999987643221111 1111 00 11
Q ss_pred cCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 001658 929 EFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVA 961 (1036)
Q Consensus 929 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 961 (1036)
.........+.+++.+||..+|++||++.|+++
T Consensus 222 ~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 254 (258)
T cd08215 222 PIPSQYSSELRNLVSSLLQKDPEERPSIAQILQ 254 (258)
T ss_pred CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 111123356778889999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-33 Score=313.03 Aligned_cols=245 Identities=24% Similarity=0.388 Sum_probs=191.0
Q ss_pred CCCCccccCCCEEEEEeEeC-CCcEEEEEEccc----cchhcHHHHHHHHHHHHhhccCCcceeEeEEEcCce--eEEEE
Q 001658 696 SPSNKLGEGGFGPVYKGKLG-DGRAIAVKQLSV----ASRQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAE--RLLVY 768 (1036)
Q Consensus 696 ~~~~~iG~G~fG~Vy~~~~~-~g~~vAvK~~~~----~~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~--~~lV~ 768 (1036)
+...+||+|+|-+||||... +|..||=-.++. .+....++|..|+.+|+.|+|+||+++|.++.+... ..+|+
T Consensus 43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT 122 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT 122 (632)
T ss_pred ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence 34578999999999999854 566676333321 133345789999999999999999999999987655 67899
Q ss_pred EecCCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCC-CceEEEEcCcceeecCC
Q 001658 769 EYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDAD-LVPKISDFGLAKLYDDK 847 (1036)
Q Consensus 769 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~-~~~kl~DFGla~~~~~~ 847 (1036)
|.|..|+|..|+.+.+ .++......|++||++||.|||++. |||||||||-+||+|+.+ |.|||+|.|||......
T Consensus 123 EL~TSGtLr~Y~kk~~--~vn~kaik~W~RQILkGL~yLHs~~-PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s 199 (632)
T KOG0584|consen 123 ELFTSGTLREYRKKHR--RVNIKAIKSWCRQILKGLVYLHSQD-PPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKS 199 (632)
T ss_pred ecccCCcHHHHHHHhc--cCCHHHHHHHHHHHHHHhhhhhcCC-CCccccccccceEEEcCCcCceeecchhHHHHhhcc
Confidence 9999999999997654 4566788899999999999999985 779999999999999876 89999999999987543
Q ss_pred CCccccccccccCccCccccccCCCCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhcCccccccCccc
Q 001658 848 KTHISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEIELADPKL 927 (1036)
Q Consensus 848 ~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~ 927 (1036)
.. ..++|||.|||||++. ..|++.+||||||++++||+|+..|+..-......+ +.+..-........+.||
T Consensus 200 ~a---ksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIY--KKV~SGiKP~sl~kV~dP-- 271 (632)
T KOG0584|consen 200 HA---KSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIY--KKVTSGIKPAALSKVKDP-- 271 (632)
T ss_pred cc---ceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHH--HHHHcCCCHHHhhccCCH--
Confidence 22 3478999999999988 789999999999999999999999987543333222 111111111111222222
Q ss_pred ccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 001658 928 IEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVA 961 (1036)
Q Consensus 928 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 961 (1036)
++.+++.+|+.. .++|||+.|++.
T Consensus 272 ---------evr~fIekCl~~-~~~R~sa~eLL~ 295 (632)
T KOG0584|consen 272 ---------EVREFIEKCLAT-KSERLSAKELLK 295 (632)
T ss_pred ---------HHHHHHHHHhcC-chhccCHHHHhh
Confidence 355667799999 999999999986
|
|
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-32 Score=292.95 Aligned_cols=247 Identities=30% Similarity=0.463 Sum_probs=202.3
Q ss_pred CCCCCCccccCCCEEEEEeEeC-CCcEEEEEEccccch--hcHHHHHHHHHHHHhhccCCcceeEeEEEcCceeEEEEEe
Q 001658 694 NFSPSNKLGEGGFGPVYKGKLG-DGRAIAVKQLSVASR--QGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLVYEY 770 (1036)
Q Consensus 694 ~~~~~~~iG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~--~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~ 770 (1036)
+|+..+.||+|++|.||+|+.. +++.||+|.+..... ...+.+.+|++++++++|+|++++++++.+....++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 4677899999999999999864 678999999876543 4456899999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeecCCCCc
Q 001658 771 LENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTH 850 (1036)
Q Consensus 771 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~ 850 (1036)
+++++|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++.........
T Consensus 81 ~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 155 (254)
T cd06627 81 AENGSLRQIIKKF--GPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD 155 (254)
T ss_pred CCCCcHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccceecCCCccc
Confidence 9999999998644 56899999999999999999999987 999999999999999999999999999877644332
Q ss_pred cccccccccCccCccccccCCCCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhcCccccccCcccccC
Q 001658 851 ISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEIELADPKLIEF 930 (1036)
Q Consensus 851 ~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~ 930 (1036)
.....++..|+|||...+..++.++||||+|+++|||++|+.||.......... .... . ..+..
T Consensus 156 -~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~------~~~~-~-----~~~~~--- 219 (254)
T cd06627 156 -DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALF------RIVQ-D-----DHPPL--- 219 (254)
T ss_pred -ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHH------HHhc-c-----CCCCC---
Confidence 233468889999999988888999999999999999999999987543221111 1100 0 11111
Q ss_pred CHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 001658 931 NEEEVKRLIGVALLCTQTLPSLRPSMSRVVA 961 (1036)
Q Consensus 931 ~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 961 (1036)
.......+.+++.+|+..+|++||++.|++.
T Consensus 220 ~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 220 PEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred CCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 1122356778888999999999999999874
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-32 Score=300.12 Aligned_cols=258 Identities=22% Similarity=0.340 Sum_probs=201.0
Q ss_pred CCCCCccccCCCEEEEEeEeC-CCcEEEEEEccccch--hcHHHHHHHHHHHHhhccCCcceeEeEEEcCceeEEEEEec
Q 001658 695 FSPSNKLGEGGFGPVYKGKLG-DGRAIAVKQLSVASR--QGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLVYEYL 771 (1036)
Q Consensus 695 ~~~~~~iG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~--~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~~ 771 (1036)
|+..+.||+|++|.||+|... +++.+|+|.+..... .....+.+|+.++++++|+||+++++++..+...++|+||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 556788999999999999864 788999999865432 24567889999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeecCCCCcc
Q 001658 772 ENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHI 851 (1036)
Q Consensus 772 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 851 (1036)
++ +|.+++.... ..+++..+..++.|+++||+|||+.+ |+|+||||+||++++++.++|+|||.+....... ..
T Consensus 81 ~~-~l~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~-~~ 154 (283)
T cd05118 81 DT-DLYKLIKDRQ-RGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPV-RP 154 (283)
T ss_pred CC-CHHHHHHhhc-ccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc-cc
Confidence 75 8888876533 57899999999999999999999988 9999999999999999999999999998775443 12
Q ss_pred ccccccccCccCccccccC-CCCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhcC-------------
Q 001658 852 STRVAGTIGYLAPEYAMRG-HLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENN------------- 917 (1036)
Q Consensus 852 ~~~~~gt~~y~APE~~~~~-~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~------------- 917 (1036)
.....++..|+|||.+.+. .++.++||||||+++|+|+||+.||......+...... ......
T Consensus 155 ~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~ 231 (283)
T cd05118 155 YTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIF---RTLGTPDPEVWPKFTSLAR 231 (283)
T ss_pred ccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH---HHcCCCchHhcccchhhhh
Confidence 2334578899999998876 78999999999999999999999997654433222111 000000
Q ss_pred -cccccc---CcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 001658 918 -QEIELA---DPKLIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVA 961 (1036)
Q Consensus 918 -~~~~~~---d~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 961 (1036)
...... +............++.+++..||+.+|.+||++.+++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 232 NYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred hhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 000000 00001111234567889999999999999999999985
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=289.44 Aligned_cols=261 Identities=26% Similarity=0.357 Sum_probs=203.2
Q ss_pred CCCCccCHHHHHHHhcCCCCCCccccCCCEEEEEeEeC-CCcEEEEEEccccc-hhcHHHHHHHHHHHHhh-ccCCccee
Q 001658 678 ARPYTFSYAELKTATENFSPSNKLGEGGFGPVYKGKLG-DGRAIAVKQLSVAS-RQGKSQFVAEIATISAV-QHRNLVKL 754 (1036)
Q Consensus 678 ~~~~~~~~~~l~~~~~~~~~~~~iG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~-~~~~~~f~~Ei~~L~~l-~H~nIv~l 754 (1036)
...+.|+-++++. +..||.|+||+|+|-..+ .|+..|||+++... ..+++++..|.+...+- ++||||++
T Consensus 56 ~~~~~F~~~~Lqd-------lg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkf 128 (361)
T KOG1006|consen 56 AHLHTFTSDNLQD-------LGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKF 128 (361)
T ss_pred ccccccccchHHH-------HHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHH
Confidence 4456677666654 367999999999999864 79999999997653 35677888888876554 79999999
Q ss_pred EeEEEcCceeEEEEEecCCCChhhh---hhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCC
Q 001658 755 HGCCIEGAERLLVYEYLENKSLDQA---LFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADL 831 (1036)
Q Consensus 755 ~g~~~~~~~~~lV~E~~~~gsL~~~---l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~ 831 (1036)
||++..++..|+.||.|+ .||+.+ .+......+++...-.|+.-+.+||.||.+.. +|||||+||+|||+|..|
T Consensus 129 yGa~F~EGdcWiCMELMd-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G 205 (361)
T KOG1006|consen 129 YGALFSEGDCWICMELMD-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHG 205 (361)
T ss_pred hhhhhcCCceeeeHHHHh-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCC
Confidence 999999999999999994 576543 44445667888888889999999999998865 699999999999999999
Q ss_pred ceEEEEcCcceeecCCCCccccccccccCccCcccccc--CCCCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHH
Q 001658 832 VPKISDFGLAKLYDDKKTHISTRVAGTIGYLAPEYAMR--GHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEW 909 (1036)
Q Consensus 832 ~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~--~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~ 909 (1036)
.+||||||++-.+.+. ...+.-+|...|||||.+.. ..|+.+|||||+|++|+|+.||+.|+..... .. +.
T Consensus 206 ~vKLCDFGIcGqLv~S--iAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s--vf---eq 278 (361)
T KOG1006|consen 206 DVKLCDFGICGQLVDS--IAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS--VF---EQ 278 (361)
T ss_pred CEeeecccchHhHHHH--HHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH--HH---HH
Confidence 9999999998766432 22345578889999999964 3589999999999999999999999986543 11 11
Q ss_pred HHHHhhcCccccccCcccccCC---HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 001658 910 AWHLHENNQEIELADPKLIEFN---EEEVKRLIGVALLCTQTLPSLRPSMSRVVAM 962 (1036)
Q Consensus 910 ~~~~~~~~~~~~~~d~~~~~~~---~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 962 (1036)
... ....||.....+ .+....+..++-.|+.+|-.+||.+.++..+
T Consensus 279 l~~-------Vv~gdpp~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 279 LCQ-------VVIGDPPILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred HHH-------HHcCCCCeecCcccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 111 122344432222 3355677888888999999999999998753
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-33 Score=314.80 Aligned_cols=265 Identities=27% Similarity=0.372 Sum_probs=200.1
Q ss_pred CCCCCccccCCCEEEEEeEe-CCCcEEEEEEcccc-chhcHHHHHHHHHHHHhhccCCcceeEeEEEcC------ceeEE
Q 001658 695 FSPSNKLGEGGFGPVYKGKL-GDGRAIAVKQLSVA-SRQGKSQFVAEIATISAVQHRNLVKLHGCCIEG------AERLL 766 (1036)
Q Consensus 695 ~~~~~~iG~G~fG~Vy~~~~-~~g~~vAvK~~~~~-~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~------~~~~l 766 (1036)
|...+.||+|+||.||+|+. ..|+.||||.++.. .....+...+|+++|++++|+|||++++.-.+. ....+
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl 94 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL 94 (732)
T ss_pred eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence 44567899999999999994 57999999999764 344566778999999999999999999975543 35689
Q ss_pred EEEecCCCChhhhhhcCC-CCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEec--CCC--ceEEEEcCcc
Q 001658 767 VYEYLENKSLDQALFGQR-SLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLD--ADL--VPKISDFGLA 841 (1036)
Q Consensus 767 V~E~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~--~~~--~~kl~DFGla 841 (1036)
|||||.+|||+..|.... ...+++.+.+.++.+++.||.|||+++ ||||||||.||++- ++| .-||+|||.|
T Consensus 95 vmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A 171 (732)
T KOG4250|consen 95 VMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA 171 (732)
T ss_pred EEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence 999999999999997643 567999999999999999999999998 99999999999993 333 5799999999
Q ss_pred eeecCCCCccccccccccCccCcccccc-CCCCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhcCccc
Q 001658 842 KLYDDKKTHISTRVAGTIGYLAPEYAMR-GHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEI 920 (1036)
Q Consensus 842 ~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 920 (1036)
+.++++. ..+.++||..|.+||.+.. +.|+..+|.|||||++||++||..||.+........-+.|..........+
T Consensus 172 rel~d~s--~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v~ 249 (732)
T KOG4250|consen 172 RELDDNS--LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGVA 249 (732)
T ss_pred ccCCCCC--eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCcee
Confidence 9886554 4566889999999999995 889999999999999999999999998765543222222222111111111
Q ss_pred cccCccc-------------ccCCHHHHHHHHHHHHHhcccCCCCCC--CHHHHHHHhh
Q 001658 921 ELADPKL-------------IEFNEEEVKRLIGVALLCTQTLPSLRP--SMSRVVAMLC 964 (1036)
Q Consensus 921 ~~~d~~~-------------~~~~~~~~~~l~~l~~~Cl~~dP~~RP--t~~evl~~L~ 964 (1036)
...+++. .........++-.....++..+|.+|- ...+....+.
T Consensus 250 i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~ 308 (732)
T KOG4250|consen 250 IGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVD 308 (732)
T ss_pred EeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHH
Confidence 1111111 112244455566666667788888887 5444444333
|
|
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-32 Score=304.13 Aligned_cols=264 Identities=25% Similarity=0.321 Sum_probs=197.6
Q ss_pred hcCCCCCCccccCCCEEEEEeEeC-CCcEEEEEEccccch--hcHHHHHHHHHHHHhhccCCcceeEeEEEcC--ceeEE
Q 001658 692 TENFSPSNKLGEGGFGPVYKGKLG-DGRAIAVKQLSVASR--QGKSQFVAEIATISAVQHRNLVKLHGCCIEG--AERLL 766 (1036)
Q Consensus 692 ~~~~~~~~~iG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~--~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~--~~~~l 766 (1036)
.++|++.+.||+|+||.||+|... +|+.||+|.++.... .....+.+|+.++++++|+||+++++++... +..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 457888999999999999999864 689999999864322 2233567899999999999999999998755 46799
Q ss_pred EEEecCCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeecC
Q 001658 767 VYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDD 846 (1036)
Q Consensus 767 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~ 846 (1036)
||||++ ++|.+++... ...+++..+..++.|+++||+|||+.+ ++||||||+||++++++.+||+|||++.....
T Consensus 86 v~e~~~-~~l~~~l~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~ 160 (309)
T cd07845 86 VMEYCE-QDLASLLDNM-PTPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGL 160 (309)
T ss_pred EEecCC-CCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccceeeecCC
Confidence 999996 5888887643 356899999999999999999999998 99999999999999999999999999987654
Q ss_pred CCCccccccccccCccCcccccc-CCCCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHH--------hhcC
Q 001658 847 KKTHISTRVAGTIGYLAPEYAMR-GHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHL--------HENN 917 (1036)
Q Consensus 847 ~~~~~~~~~~gt~~y~APE~~~~-~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~--------~~~~ 917 (1036)
.... .....++..|+|||.+.+ ..++.++||||+||++|||++|++||......+....+...... ....
T Consensus 161 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (309)
T cd07845 161 PAKP-MTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDL 239 (309)
T ss_pred ccCC-CCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhcc
Confidence 3221 223346788999999865 45789999999999999999999999865544333222110000 0000
Q ss_pred c---cccccCcccc---cCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 001658 918 Q---EIELADPKLI---EFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVA 961 (1036)
Q Consensus 918 ~---~~~~~d~~~~---~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 961 (1036)
. .......... .........+.+++.+|++.||++|||+.|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~ 289 (309)
T cd07845 240 PLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE 289 (309)
T ss_pred cccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 0 0000000000 000112345678889999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.7e-32 Score=296.26 Aligned_cols=245 Identities=25% Similarity=0.320 Sum_probs=196.5
Q ss_pred cccCCCEEEEEeEeC-CCcEEEEEEccccch---hcHHHHHHHHHHHHhhccCCcceeEeEEEcCceeEEEEEecCCCCh
Q 001658 701 LGEGGFGPVYKGKLG-DGRAIAVKQLSVASR---QGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLVYEYLENKSL 776 (1036)
Q Consensus 701 iG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~---~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL 776 (1036)
||+|+||.||+++.. +|+.||+|.+..... ...+.+.+|++++++++|+||+++++.+..+...++|+||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 689999999999976 489999999865432 3456788999999999999999999999999999999999999999
Q ss_pred hhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeecCCCC-------
Q 001658 777 DQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKT------- 849 (1036)
Q Consensus 777 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~------- 849 (1036)
.+++.... .+++..+..++.|+++||+|||+.+ ++||||+|+||++++++.++|+|||++........
T Consensus 81 ~~~l~~~~--~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~ 155 (265)
T cd05579 81 ASLLENVG--SLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDE 155 (265)
T ss_pred HHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccccc
Confidence 99996543 6899999999999999999999988 99999999999999999999999999876543211
Q ss_pred ccccccccccCccCccccccCCCCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhcCccccccCccccc
Q 001658 850 HISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEIELADPKLIE 929 (1036)
Q Consensus 850 ~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~ 929 (1036)
.......++..|+|||.......+.++||||||+++||+++|+.||............ .. +. .. ...
T Consensus 156 ~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~------~~-~~----~~--~~~ 222 (265)
T cd05579 156 KEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNI------LN-GK----IE--WPE 222 (265)
T ss_pred ccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH------hc-CC----cC--CCc
Confidence 1223355788999999998888999999999999999999999999765433222111 10 00 00 000
Q ss_pred CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 001658 930 FNEEEVKRLIGVALLCTQTLPSLRPSMSRVVAMLC 964 (1036)
Q Consensus 930 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~ 964 (1036)
. ......+.+++.+|++.+|++|||+.++.+.|+
T Consensus 223 ~-~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~ 256 (265)
T cd05579 223 D-VEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN 256 (265)
T ss_pred c-ccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence 0 012456778888999999999999966666654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.7e-32 Score=299.06 Aligned_cols=242 Identities=22% Similarity=0.267 Sum_probs=186.1
Q ss_pred ccccCCCEEEEEeEe-CCCcEEEEEEccccc---hhcHHHHHHHHHHHHh---hccCCcceeEeEEEcCceeEEEEEecC
Q 001658 700 KLGEGGFGPVYKGKL-GDGRAIAVKQLSVAS---RQGKSQFVAEIATISA---VQHRNLVKLHGCCIEGAERLLVYEYLE 772 (1036)
Q Consensus 700 ~iG~G~fG~Vy~~~~-~~g~~vAvK~~~~~~---~~~~~~f~~Ei~~L~~---l~H~nIv~l~g~~~~~~~~~lV~E~~~ 772 (1036)
.||+|+||.||++.. .+++.||+|.+.... ......+.+|..+++. .+|+||+++++++...+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 489999999999986 468999999886432 1222334455544443 379999999999999999999999999
Q ss_pred CCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeecCCCCccc
Q 001658 773 NKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHIS 852 (1036)
Q Consensus 773 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 852 (1036)
+|+|.+++... ..+++..+..|+.|++.||+|||+.+ |+||||||+||++++++.++|+|||++........
T Consensus 81 ~~~L~~~i~~~--~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~~--- 152 (279)
T cd05633 81 GGDLHYHLSQH--GVFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP--- 152 (279)
T ss_pred CCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceeccccCc---
Confidence 99999988643 45899999999999999999999988 99999999999999999999999999976543221
Q ss_pred cccccccCccCcccccc-CCCCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhcCccccccCcccccCC
Q 001658 853 TRVAGTIGYLAPEYAMR-GHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEIELADPKLIEFN 931 (1036)
Q Consensus 853 ~~~~gt~~y~APE~~~~-~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~ 931 (1036)
....|+..|+|||...+ ..++.++|||||||++|||++|+.||.............. . ...... .+
T Consensus 153 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~----~------~~~~~~---~~ 219 (279)
T cd05633 153 HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM----T------LTVNVE---LP 219 (279)
T ss_pred cCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHH----h------hcCCcC---Cc
Confidence 23468999999999864 5589999999999999999999999975433222111110 0 001111 12
Q ss_pred HHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 001658 932 EEEVKRLIGVALLCTQTLPSLRP-----SMSRVVAM 962 (1036)
Q Consensus 932 ~~~~~~l~~l~~~Cl~~dP~~RP-----t~~evl~~ 962 (1036)
.....++.+++..|++.+|.+|| +++|++++
T Consensus 220 ~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 220 DSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred cccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 22334677788899999999999 58888764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.6e-33 Score=281.09 Aligned_cols=249 Identities=23% Similarity=0.344 Sum_probs=193.7
Q ss_pred CCCCCccccCCCEEEEEeEeC-CCcEEEEEEcccc-chhcHHHHHHHHHHHHhh-ccCCcceeEeEEEcCceeEEEEEec
Q 001658 695 FSPSNKLGEGGFGPVYKGKLG-DGRAIAVKQLSVA-SRQGKSQFVAEIATISAV-QHRNLVKLHGCCIEGAERLLVYEYL 771 (1036)
Q Consensus 695 ~~~~~~iG~G~fG~Vy~~~~~-~g~~vAvK~~~~~-~~~~~~~f~~Ei~~L~~l-~H~nIv~l~g~~~~~~~~~lV~E~~ 771 (1036)
.+....||.|.-|.|++++.+ .|..+|||.+... +.++.+++...++++..- ++|.||+.+|||..+...++.||.|
T Consensus 94 l~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelM 173 (391)
T KOG0983|consen 94 LENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELM 173 (391)
T ss_pred hhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHH
Confidence 344577999999999999865 5899999998653 455566777778776665 4999999999999999999999998
Q ss_pred CCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeecCCCCcc
Q 001658 772 ENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHI 851 (1036)
Q Consensus 772 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 851 (1036)
. -.++.++.. -..++++...-++...+.+||.||.++. .|+|||+||+|||+|+.|++|+||||++-++.+...
T Consensus 174 s-~C~ekLlkr-ik~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkA-- 247 (391)
T KOG0983|consen 174 S-TCAEKLLKR-IKGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKA-- 247 (391)
T ss_pred H-HHHHHHHHH-hcCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeecccc--
Confidence 4 355555533 3456888888899999999999998875 599999999999999999999999999987765443
Q ss_pred ccccccccCccCcccccc---CCCCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhcCccccccCcccc
Q 001658 852 STRVAGTIGYLAPEYAMR---GHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEIELADPKLI 928 (1036)
Q Consensus 852 ~~~~~gt~~y~APE~~~~---~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~ 928 (1036)
.+..+|-+.|||||.+.- ..|+.++||||||+.++||.||+.||..-..+-+. ... ... . ..|.+
T Consensus 248 htrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~--ltk---vln--~----ePP~L- 315 (391)
T KOG0983|consen 248 HTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEV--LTK---VLN--E----EPPLL- 315 (391)
T ss_pred cccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHH--HHH---HHh--c----CCCCC-
Confidence 355679999999999864 46888999999999999999999999864332211 111 111 1 11222
Q ss_pred cCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 001658 929 EFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVA 961 (1036)
Q Consensus 929 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 961 (1036)
.........+.+++..|+++|+.+||.+.++++
T Consensus 316 ~~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~ 348 (391)
T KOG0983|consen 316 PGHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLE 348 (391)
T ss_pred CcccCcCHHHHHHHHHHhhcCcccCcchHHHhc
Confidence 111224456778888999999999999999876
|
|
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-31 Score=302.54 Aligned_cols=258 Identities=22% Similarity=0.250 Sum_probs=194.2
Q ss_pred CCccccCCCEEEEEeEeCCCcEEEEEEcccc--chhcHHHHHHHHHHHHhhccCCcceeEeEEEcCceeEEEEEecCCCC
Q 001658 698 SNKLGEGGFGPVYKGKLGDGRAIAVKQLSVA--SRQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLVYEYLENKS 775 (1036)
Q Consensus 698 ~~~iG~G~fG~Vy~~~~~~g~~vAvK~~~~~--~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gs 775 (1036)
.+.+|.|+++.||+++. +++.||||++... .....+.+.+|++++++++|+||+++++++.+.+..+++|||+++|+
T Consensus 7 ~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~ 85 (314)
T cd08216 7 GKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGS 85 (314)
T ss_pred hHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCC
Confidence 34455666666666655 6899999998654 34456789999999999999999999999999999999999999999
Q ss_pred hhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeecCCCC------
Q 001658 776 LDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKT------ 849 (1036)
Q Consensus 776 L~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~------ 849 (1036)
|.+++.......+++.....++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||.+..+.....
T Consensus 86 l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~ 162 (314)
T cd08216 86 CEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVH 162 (314)
T ss_pred HHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeeccccccccccc
Confidence 999997665567889999999999999999999988 99999999999999999999999999876542211
Q ss_pred ccccccccccCccCcccccc--CCCCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHh----hc------C
Q 001658 850 HISTRVAGTIGYLAPEYAMR--GHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLH----EN------N 917 (1036)
Q Consensus 850 ~~~~~~~gt~~y~APE~~~~--~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~----~~------~ 917 (1036)
.......++..|+|||++.. ..++.++|||||||++|||++|+.||........ ..+...... .. .
T Consensus 163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 240 (314)
T cd08216 163 DFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQM--LLEKVRGTVPCLLDKSTYPLYE 240 (314)
T ss_pred cccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHhccCccccccCchhhhc
Confidence 11123457788999999876 3588899999999999999999999986433221 111110000 00 0
Q ss_pred cccc-----ccCccc-----ccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 001658 918 QEIE-----LADPKL-----IEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVA 961 (1036)
Q Consensus 918 ~~~~-----~~d~~~-----~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 961 (1036)
.... ..++.. .........++.+++..||+.+|++|||+.|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~ 294 (314)
T cd08216 241 DSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLN 294 (314)
T ss_pred CCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhc
Confidence 0000 001110 1112233456888999999999999999999986
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-31 Score=293.68 Aligned_cols=242 Identities=25% Similarity=0.319 Sum_probs=194.0
Q ss_pred cccCCCEEEEEeEeC-CCcEEEEEEccccc---hhcHHHHHHHHHHHHhhccCCcceeEeEEEcCceeEEEEEecCCCCh
Q 001658 701 LGEGGFGPVYKGKLG-DGRAIAVKQLSVAS---RQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLVYEYLENKSL 776 (1036)
Q Consensus 701 iG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL 776 (1036)
||+|+||.||+|+.. +++.||+|.+.... ....+.+.+|+.++++++||||+++++++.++...++|+||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 699999999999965 48899999986432 23456789999999999999999999999999999999999999999
Q ss_pred hhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeecCCCCccccccc
Q 001658 777 DQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVA 856 (1036)
Q Consensus 777 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 856 (1036)
.+++... ..+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||+++...... ......
T Consensus 81 ~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--~~~~~~ 153 (262)
T cd05572 81 WTILRDR--GLFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--KTWTFC 153 (262)
T ss_pred HHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--cccccc
Confidence 9999653 34788999999999999999999987 9999999999999999999999999998765432 122346
Q ss_pred cccCccCccccccCCCCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhcCccccccCcccccCCHHHHH
Q 001658 857 GTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEIELADPKLIEFNEEEVK 936 (1036)
Q Consensus 857 gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~ 936 (1036)
|+..|+|||.+....++.++|+||||+++|||++|+.||.....+. ..... ...... .. ..++.....
T Consensus 154 ~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~~~~---~~~~~~-----~~---~~~~~~~~~ 221 (262)
T cd05572 154 GTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDP-MEIYN---DILKGN-----GK---LEFPNYIDK 221 (262)
T ss_pred CCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCH-HHHHH---HHhccC-----CC---CCCCcccCH
Confidence 8889999999988889999999999999999999999998654211 11111 111000 01 111112245
Q ss_pred HHHHHHHHhcccCCCCCCC-----HHHHHH
Q 001658 937 RLIGVALLCTQTLPSLRPS-----MSRVVA 961 (1036)
Q Consensus 937 ~l~~l~~~Cl~~dP~~RPt-----~~evl~ 961 (1036)
.+.+++.+||+.+|++||+ +.|+++
T Consensus 222 ~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 222 AAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred HHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 7888899999999999999 555554
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.8e-32 Score=303.42 Aligned_cols=265 Identities=22% Similarity=0.328 Sum_probs=196.6
Q ss_pred hcCCCCCCccccCCCEEEEEeEeC-CCcEEEEEEccccc--hhcHHHHHHHHHHHHhhccCCcceeEeEEEcCc------
Q 001658 692 TENFSPSNKLGEGGFGPVYKGKLG-DGRAIAVKQLSVAS--RQGKSQFVAEIATISAVQHRNLVKLHGCCIEGA------ 762 (1036)
Q Consensus 692 ~~~~~~~~~iG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~--~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~------ 762 (1036)
.++|+..+.||+|+||.||+|+.. +++.||||.+.... ......+.+|++++++++||||+++++++...+
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 90 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY 90 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence 457888999999999999999864 68999999885432 222345678999999999999999999987654
Q ss_pred --eeEEEEEecCCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCc
Q 001658 763 --ERLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGL 840 (1036)
Q Consensus 763 --~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGl 840 (1036)
..++||||+. ++|.+++... ...+++.++..++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||+
T Consensus 91 ~~~~~lv~e~~~-~~l~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~ 165 (310)
T cd07865 91 KGSFYLVFEFCE-HDLAGLLSNK-NVKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADFGL 165 (310)
T ss_pred CceEEEEEcCCC-cCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcEEECcCCC
Confidence 3499999996 5888877543 346899999999999999999999987 99999999999999999999999999
Q ss_pred ceeecCCCCc---cccccccccCccCccccccC-CCCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhc
Q 001658 841 AKLYDDKKTH---ISTRVAGTIGYLAPEYAMRG-HLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHEN 916 (1036)
Q Consensus 841 a~~~~~~~~~---~~~~~~gt~~y~APE~~~~~-~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~ 916 (1036)
+..+...... ......++..|+|||.+.+. .++.++||||||+++|||++|++||.....................
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (310)
T cd07865 166 ARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITP 245 (310)
T ss_pred cccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCh
Confidence 9866433221 11234578899999988764 4788999999999999999999999876544333333222111000
Q ss_pred C-----ccccccCc-ccccC----------CHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 001658 917 N-----QEIELADP-KLIEF----------NEEEVKRLIGVALLCTQTLPSLRPSMSRVVA 961 (1036)
Q Consensus 917 ~-----~~~~~~d~-~~~~~----------~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 961 (1036)
. ......+. ..... .......+.+++.+|++.+|.+|||++|+++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~ 306 (310)
T cd07865 246 EVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN 306 (310)
T ss_pred hhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence 0 00000000 00000 0011235678999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-31 Score=296.63 Aligned_cols=260 Identities=25% Similarity=0.387 Sum_probs=199.0
Q ss_pred CCCCCccccCCCEEEEEeEeC-CCcEEEEEEccccch-hcHHHHHHHHHHHHhhc-cCCcceeEeEEEcCceeEEEEEec
Q 001658 695 FSPSNKLGEGGFGPVYKGKLG-DGRAIAVKQLSVASR-QGKSQFVAEIATISAVQ-HRNLVKLHGCCIEGAERLLVYEYL 771 (1036)
Q Consensus 695 ~~~~~~iG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~-~~~~~f~~Ei~~L~~l~-H~nIv~l~g~~~~~~~~~lV~E~~ 771 (1036)
|++.+.||+|+||+||+|+.. +++.||+|++..... .......+|+..+.+++ |+||+++++++.+++..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 567789999999999999975 578899999864322 22334567999999999 999999999999999999999999
Q ss_pred CCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeecCCCCcc
Q 001658 772 ENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHI 851 (1036)
Q Consensus 772 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 851 (1036)
+|+|.+++.......+++..+..++.|++++|.|||+.+ ++|+||+|+||++++++.++|+|||++........
T Consensus 81 -~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~-- 154 (283)
T cd07830 81 -EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP-- 154 (283)
T ss_pred -CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceeccCCCC--
Confidence 889999987665567899999999999999999999988 99999999999999999999999999987653322
Q ss_pred ccccccccCccCcccccc-CCCCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHH----------HHHHHhhcCccc
Q 001658 852 STRVAGTIGYLAPEYAMR-GHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLE----------WAWHLHENNQEI 920 (1036)
Q Consensus 852 ~~~~~gt~~y~APE~~~~-~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~----------~~~~~~~~~~~~ 920 (1036)
.....++..|+|||++.+ ..++.++||||||++++||++|++||......+...... |......... .
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~ 233 (283)
T cd07830 155 YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASK-L 233 (283)
T ss_pred cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcc-c
Confidence 223457889999998754 457899999999999999999999997654433222111 1000000000 0
Q ss_pred cccCc-----ccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 001658 921 ELADP-----KLIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVA 961 (1036)
Q Consensus 921 ~~~d~-----~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 961 (1036)
....+ .+..........+.+++.+||+.+|++|||+.|++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 279 (283)
T cd07830 234 GFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ 279 (283)
T ss_pred cccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence 00000 001111122457889999999999999999999875
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1e-33 Score=337.75 Aligned_cols=253 Identities=26% Similarity=0.387 Sum_probs=199.9
Q ss_pred HhcCCCCCCccccCCCEEEEEeE-eCCCcEEEEEEccccc--hhcHHHHHHHHHHHHhhccCCcceeEeEEEcCceeEEE
Q 001658 691 ATENFSPSNKLGEGGFGPVYKGK-LGDGRAIAVKQLSVAS--RQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLV 767 (1036)
Q Consensus 691 ~~~~~~~~~~iG~G~fG~Vy~~~-~~~g~~vAvK~~~~~~--~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV 767 (1036)
.+-+|+....||.|.||.||-|. ..+|+..|+|-++... ........+|+.++..++|||+|+++|+-.+.+..+|.
T Consensus 1233 V~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IF 1312 (1509)
T KOG4645|consen 1233 VTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIF 1312 (1509)
T ss_pred ceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHH
Confidence 35577888999999999999998 5679999999886432 33345677899999999999999999999999999999
Q ss_pred EEecCCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeecCC
Q 001658 768 YEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDK 847 (1036)
Q Consensus 768 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~ 847 (1036)
||||++|+|.+.+.. ....++.....+..|++.|++|||++| ||||||||.||+|+.+|.+|++|||.|..+...
T Consensus 1313 MEyC~~GsLa~ll~~--gri~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~ 1387 (1509)
T KOG4645|consen 1313 MEYCEGGSLASLLEH--GRIEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSAVKIKNN 1387 (1509)
T ss_pred HHHhccCcHHHHHHh--cchhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeecccceeEecCc
Confidence 999999999999854 334667777778999999999999999 999999999999999999999999999987654
Q ss_pred CCcc---ccccccccCccCccccccCC---CCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhcCcccc
Q 001658 848 KTHI---STRVAGTIGYLAPEYAMRGH---LTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEIE 921 (1036)
Q Consensus 848 ~~~~---~~~~~gt~~y~APE~~~~~~---~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 921 (1036)
.... -...+||+.|||||++.+.. -..+.||||+|||++||+||+.||.....+-... .+ .+.+
T Consensus 1388 ~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIM-----y~-V~~g---- 1457 (1509)
T KOG4645|consen 1388 AQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIM-----YH-VAAG---- 1457 (1509)
T ss_pred hhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHH-----hH-Hhcc----
Confidence 3222 23467999999999997643 5668999999999999999999998643321110 00 1111
Q ss_pred ccCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 001658 922 LADPKLIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVAM 962 (1036)
Q Consensus 922 ~~d~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 962 (1036)
-.| ..+......-.+++..|++.||++|.++.|+++.
T Consensus 1458 -h~P---q~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1458 -HKP---QIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred -CCC---CCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence 112 2233334445566679999999999999887754
|
|
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.9e-31 Score=292.78 Aligned_cols=249 Identities=22% Similarity=0.325 Sum_probs=195.4
Q ss_pred cCCCCCCccccCCCEEEEEeEe-CCCcEEEEEEcccc-----chhcHHHHHHHHHHHHhhccCCcceeEeEEEcC--cee
Q 001658 693 ENFSPSNKLGEGGFGPVYKGKL-GDGRAIAVKQLSVA-----SRQGKSQFVAEIATISAVQHRNLVKLHGCCIEG--AER 764 (1036)
Q Consensus 693 ~~~~~~~~iG~G~fG~Vy~~~~-~~g~~vAvK~~~~~-----~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~--~~~ 764 (1036)
.+|.+.+.||+|+||.||+|.. .+++.||+|.+... .......+.+|++++++++|+||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 4688899999999999999985 46899999987432 123345788999999999999999999998764 457
Q ss_pred EEEEEecCCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceee
Q 001658 765 LLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLY 844 (1036)
Q Consensus 765 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~ 844 (1036)
++|+||+++++|.+++... ..+++....+++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||+++..
T Consensus 82 ~~v~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~ 156 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAY--GALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRI 156 (264)
T ss_pred EEEEEeCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcccccccc
Confidence 8999999999999998643 34788889999999999999999988 999999999999999999999999999865
Q ss_pred cCCCC--ccccccccccCccCccccccCCCCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhcCccccc
Q 001658 845 DDKKT--HISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEIEL 922 (1036)
Q Consensus 845 ~~~~~--~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 922 (1036)
..... .......|+..|+|||++.+..++.++|||||||++|||++|+.||.......... + .... .
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~--~----~~~~-----~ 225 (264)
T cd06653 157 QTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIF--K----IATQ-----P 225 (264)
T ss_pred ccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHH--H----HHcC-----C
Confidence 42111 11123468899999999998889999999999999999999999997543222111 0 0000 0
Q ss_pred cCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 001658 923 ADPKLIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVA 961 (1036)
Q Consensus 923 ~d~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 961 (1036)
..+ ..+......+.+++.+|++ +|..||+..+++.
T Consensus 226 ~~~---~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 226 TKP---MLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred CCC---CCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 111 1223334557777788998 5799999998765
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-31 Score=307.29 Aligned_cols=261 Identities=23% Similarity=0.273 Sum_probs=197.2
Q ss_pred HhcCCCCCCccccCCCEEEEEeEe-CCCcEEEEEEcccc--chhcHHHHHHHHHHHHhhccCCcceeEeEEEcC------
Q 001658 691 ATENFSPSNKLGEGGFGPVYKGKL-GDGRAIAVKQLSVA--SRQGKSQFVAEIATISAVQHRNLVKLHGCCIEG------ 761 (1036)
Q Consensus 691 ~~~~~~~~~~iG~G~fG~Vy~~~~-~~g~~vAvK~~~~~--~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~------ 761 (1036)
..++|+..+.||+|+||.||+|.. .+++.||+|.+... .......+.+|+.++++++|+||+++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 457899999999999999999985 47899999998642 233345677899999999999999999988643
Q ss_pred ceeEEEEEecCCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcc
Q 001658 762 AERLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLA 841 (1036)
Q Consensus 762 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla 841 (1036)
...++||||+. ++|.+.+.. .+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||++
T Consensus 94 ~~~~lv~e~~~-~~l~~~~~~----~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~kL~Dfg~~ 165 (353)
T cd07850 94 QDVYLVMELMD-ANLCQVIQM----DLDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 165 (353)
T ss_pred CcEEEEEeccC-CCHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCccc
Confidence 34689999995 588888743 2788899999999999999999988 999999999999999999999999999
Q ss_pred eeecCCCCccccccccccCccCccccccCCCCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHH-H--------H---
Q 001658 842 KLYDDKKTHISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLL-E--------W--- 909 (1036)
Q Consensus 842 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~-~--------~--- 909 (1036)
+....... .....++..|+|||.+.+..++.++|||||||++|+|++|+.||...........+ . +
T Consensus 166 ~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (353)
T cd07850 166 RTAGTSFM--MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSR 243 (353)
T ss_pred eeCCCCCC--CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHH
Confidence 87643221 23345888999999999999999999999999999999999999754332211100 0 0
Q ss_pred ----HHHHhhcCccc------cccCccc-----ccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 001658 910 ----AWHLHENNQEI------ELADPKL-----IEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVA 961 (1036)
Q Consensus 910 ----~~~~~~~~~~~------~~~d~~~-----~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 961 (1036)
........... +...... ..........+.+++.+|++.||++|||+.|+++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~ 310 (353)
T cd07850 244 LQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQ 310 (353)
T ss_pred hhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 00000000000 0000000 0001123456788999999999999999999986
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.6e-31 Score=303.22 Aligned_cols=258 Identities=20% Similarity=0.277 Sum_probs=192.8
Q ss_pred CccccC--CCEEEEEeEe-CCCcEEEEEEccccc--hhcHHHHHHHHHHHHhhccCCcceeEeEEEcCceeEEEEEecCC
Q 001658 699 NKLGEG--GFGPVYKGKL-GDGRAIAVKQLSVAS--RQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLVYEYLEN 773 (1036)
Q Consensus 699 ~~iG~G--~fG~Vy~~~~-~~g~~vAvK~~~~~~--~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~ 773 (1036)
..||+| +||+||+++. .+|+.||+|++.... ....+.+.+|+.+++.++||||+++++++..++..++|+||+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 456776 9999999986 478999999986432 23346788999999999999999999999999999999999999
Q ss_pred CChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeecCCCCcc--
Q 001658 774 KSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHI-- 851 (1036)
Q Consensus 774 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~-- 851 (1036)
++|.+++.......+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.++++||+.+..........
T Consensus 84 ~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (328)
T cd08226 84 GSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKV 160 (328)
T ss_pred CCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccc
Confidence 99999987655566899999999999999999999987 9999999999999999999999998654332111100
Q ss_pred ----ccccccccCccCccccccC--CCCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHh-----------
Q 001658 852 ----STRVAGTIGYLAPEYAMRG--HLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLH----------- 914 (1036)
Q Consensus 852 ----~~~~~gt~~y~APE~~~~~--~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~----------- 914 (1036)
.....++..|+|||++.+. .++.++|||||||++|||++|+.||......... ........
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~ 238 (328)
T cd08226 161 VYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQML--LQKLKGPPYSPLDITTFPC 238 (328)
T ss_pred cccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHH--HHHhcCCCCCCccccccch
Confidence 1112345679999999764 4789999999999999999999999765432211 11000000
Q ss_pred ---------------------hcCccccccCccc-ccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 001658 915 ---------------------ENNQEIELADPKL-IEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVA 961 (1036)
Q Consensus 915 ---------------------~~~~~~~~~d~~~-~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 961 (1036)
.........+..+ ..........+.+++.+||+.||++|||+.|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~ 307 (328)
T cd08226 239 EESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLS 307 (328)
T ss_pred hhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 0000000000011 1112234567889999999999999999999975
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.5e-31 Score=292.48 Aligned_cols=249 Identities=23% Similarity=0.259 Sum_probs=192.4
Q ss_pred HHHHHHhcCCCCCCcc--ccCCCEEEEEeEe-CCCcEEEEEEccccchhcHHHHHHHHHHHHhh-ccCCcceeEeEEEcC
Q 001658 686 AELKTATENFSPSNKL--GEGGFGPVYKGKL-GDGRAIAVKQLSVASRQGKSQFVAEIATISAV-QHRNLVKLHGCCIEG 761 (1036)
Q Consensus 686 ~~l~~~~~~~~~~~~i--G~G~fG~Vy~~~~-~~g~~vAvK~~~~~~~~~~~~f~~Ei~~L~~l-~H~nIv~l~g~~~~~ 761 (1036)
.+.....++|++.+.+ |+|+||.||++.. .+++.+|+|.+....... .|+.....+ +|+||+++++++...
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-----~e~~~~~~~~~h~~iv~~~~~~~~~ 81 (267)
T PHA03390 7 SELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-----IEPMVHQLMKDNPNFIKLYYSVTTL 81 (267)
T ss_pred HHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-----hhHHHHHHhhcCCCEEEEEEEEecC
Confidence 4445556677777777 9999999999985 467889999986432111 122222222 799999999999999
Q ss_pred ceeEEEEEecCCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCC-ceEEEEcCc
Q 001658 762 AERLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADL-VPKISDFGL 840 (1036)
Q Consensus 762 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~-~~kl~DFGl 840 (1036)
+..++||||+++++|.+++.... .+++..+..++.|+++||.|||+.+ ++||||||+||+++.++ .++|+|||+
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~dfg~ 156 (267)
T PHA03390 82 KGHVLIMDYIKDGDLFDLLKKEG--KLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDYGL 156 (267)
T ss_pred CeeEEEEEcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEecCcc
Confidence 99999999999999999996543 7899999999999999999999988 99999999999999998 999999999
Q ss_pred ceeecCCCCccccccccccCccCccccccCCCCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhcCccc
Q 001658 841 AKLYDDKKTHISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEI 920 (1036)
Q Consensus 841 a~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 920 (1036)
++...... ...|+..|+|||++.+..++.++||||||+++|||++|+.||...... ......+..... .
T Consensus 157 ~~~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~-~~~~~~~~~~~~---~-- 225 (267)
T PHA03390 157 CKIIGTPS-----CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDE-ELDLESLLKRQQ---K-- 225 (267)
T ss_pred ceecCCCc-----cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcc-hhhHHHHHHhhc---c--
Confidence 88664322 235888999999999889999999999999999999999999844322 222222221110 0
Q ss_pred cccCcccccCCHHHHHHHHHHHHHhcccCCCCCCC-HHHHHH
Q 001658 921 ELADPKLIEFNEEEVKRLIGVALLCTQTLPSLRPS-MSRVVA 961 (1036)
Q Consensus 921 ~~~d~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt-~~evl~ 961 (1036)
.. .........+.+++..|++.+|.+||+ ++|+++
T Consensus 226 ---~~---~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 226 ---KL---PFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred ---cC---CcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 00 111133446777888999999999996 688774
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.2e-32 Score=307.91 Aligned_cols=263 Identities=21% Similarity=0.278 Sum_probs=195.2
Q ss_pred hcCCCCCCccccCCCEEEEEeEe-CCCcEEEEEEcccc--chhcHHHHHHHHHHHHhhccCCcceeEeEEEcC------c
Q 001658 692 TENFSPSNKLGEGGFGPVYKGKL-GDGRAIAVKQLSVA--SRQGKSQFVAEIATISAVQHRNLVKLHGCCIEG------A 762 (1036)
Q Consensus 692 ~~~~~~~~~iG~G~fG~Vy~~~~-~~g~~vAvK~~~~~--~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~------~ 762 (1036)
..+|...+.||+|+||.||+|+. .+|+.||+|++... .......+.+|+.++++++|+||+++++++... .
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 37888999999999999999985 46899999998643 222345688999999999999999999998754 2
Q ss_pred eeEEEEEecCCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcce
Q 001658 763 ERLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAK 842 (1036)
Q Consensus 763 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~ 842 (1036)
..++|+||+. .+|.+++ ...+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++
T Consensus 94 ~~~lv~e~~~-~~l~~~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL~dfg~~~ 165 (342)
T cd07879 94 DFYLVMPYMQ-TDLQKIM----GHPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLAR 165 (342)
T ss_pred eEEEEecccc-cCHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCCCCc
Confidence 4689999996 4777665 235789999999999999999999988 9999999999999999999999999987
Q ss_pred eecCCCCccccccccccCccCcccccc-CCCCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHH--------H
Q 001658 843 LYDDKKTHISTRVAGTIGYLAPEYAMR-GHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWH--------L 913 (1036)
Q Consensus 843 ~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~--------~ 913 (1036)
..... .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||................. .
T Consensus 166 ~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (342)
T cd07879 166 HADAE----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQK 241 (342)
T ss_pred CCCCC----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHH
Confidence 64322 123457889999999876 4688999999999999999999999986543222211111000 0
Q ss_pred hhcCccc-------cccCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--hhcc
Q 001658 914 HENNQEI-------ELADPKLIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVAM--LCGD 966 (1036)
Q Consensus 914 ~~~~~~~-------~~~d~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~--L~~~ 966 (1036)
....... ......+....+.....+.+++.+|++.||.+||+++|++.. ++..
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~ 303 (342)
T cd07879 242 LEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSF 303 (342)
T ss_pred hcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhc
Confidence 0000000 000000000001223457789999999999999999999853 5444
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.4e-32 Score=306.83 Aligned_cols=263 Identities=22% Similarity=0.287 Sum_probs=202.2
Q ss_pred CCCCCCccccCCCEEEEEeEeC-CCcEEEEEEccccc--hhcHHHHHHHHHHHHhhccCCcceeEeEEEcCc-----eeE
Q 001658 694 NFSPSNKLGEGGFGPVYKGKLG-DGRAIAVKQLSVAS--RQGKSQFVAEIATISAVQHRNLVKLHGCCIEGA-----ERL 765 (1036)
Q Consensus 694 ~~~~~~~iG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~--~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~-----~~~ 765 (1036)
+|++.+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|+.+++.++|+||+++++++...+ ..+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 4778899999999999999865 58999999987543 344567899999999999999999999988775 789
Q ss_pred EEEEecCCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeec
Q 001658 766 LVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYD 845 (1036)
Q Consensus 766 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~ 845 (1036)
+||||++ ++|.+++... ..+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.++|+|||++....
T Consensus 81 lv~e~~~-~~l~~~l~~~--~~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~~~~~~ 154 (330)
T cd07834 81 IVTELME-TDLHKVIKSP--QPLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGVD 154 (330)
T ss_pred EEecchh-hhHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCceEeec
Confidence 9999997 5898888543 37899999999999999999999988 9999999999999999999999999998775
Q ss_pred CCCC--ccccccccccCccCccccccC-CCCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhcC-----
Q 001658 846 DKKT--HISTRVAGTIGYLAPEYAMRG-HLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENN----- 917 (1036)
Q Consensus 846 ~~~~--~~~~~~~gt~~y~APE~~~~~-~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~----- 917 (1036)
.... .......++..|+|||++.+. .++.++||||||+++|+|++|++||......+....+..........
T Consensus 155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 234 (330)
T cd07834 155 PDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFI 234 (330)
T ss_pred ccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhc
Confidence 4431 112334578899999999887 78999999999999999999999998665433222111000000000
Q ss_pred ---ccccc---cCc----ccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 001658 918 ---QEIEL---ADP----KLIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVAM 962 (1036)
Q Consensus 918 ---~~~~~---~d~----~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 962 (1036)
..... ... ............+.+++.+||+.+|.+||++.++++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 289 (330)
T cd07834 235 TSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAH 289 (330)
T ss_pred cccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 00000 000 0001112234567889999999999999999999874
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.7e-32 Score=308.15 Aligned_cols=268 Identities=24% Similarity=0.309 Sum_probs=200.3
Q ss_pred hcCCCCCCccccCCCEEEEEeEe-CCCcEEEEEEcccc--chhcHHHHHHHHHHHHhhccCCcceeEeEEEcC-----ce
Q 001658 692 TENFSPSNKLGEGGFGPVYKGKL-GDGRAIAVKQLSVA--SRQGKSQFVAEIATISAVQHRNLVKLHGCCIEG-----AE 763 (1036)
Q Consensus 692 ~~~~~~~~~iG~G~fG~Vy~~~~-~~g~~vAvK~~~~~--~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~-----~~ 763 (1036)
.++|.+.+.||+|+||+||+|+. .+++.||||.+... .......+.+|+.+++.++|+||+++++++... ..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 45788899999999999999985 46899999998643 233345677899999999999999999988654 34
Q ss_pred eEEEEEecCCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCccee
Q 001658 764 RLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKL 843 (1036)
Q Consensus 764 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~ 843 (1036)
.++|+||+. ++|.+++... ..+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++.
T Consensus 84 ~~lv~e~~~-~~L~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~ 157 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRSS--QTLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLART 157 (337)
T ss_pred EEEEEeCCC-CCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcCccccc
Confidence 799999995 7898888543 46889999999999999999999987 99999999999999999999999999986
Q ss_pred ecCCCCccccccccccCccCcccccc-CCCCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHH--------h
Q 001658 844 YDDKKTHISTRVAGTIGYLAPEYAMR-GHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHL--------H 914 (1036)
Q Consensus 844 ~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~--------~ 914 (1036)
..... .......++..|+|||.+.. ..++.++|||||||++|||++|++||.................. .
T Consensus 158 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (337)
T cd07858 158 TSEKG-DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFI 236 (337)
T ss_pred cCCCc-ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhc
Confidence 64332 22233457889999998865 46889999999999999999999999765332222111100000 0
Q ss_pred hcCc-------cccccCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--hhcc
Q 001658 915 ENNQ-------EIELADPKLIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVAM--LCGD 966 (1036)
Q Consensus 915 ~~~~-------~~~~~d~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~--L~~~ 966 (1036)
.... .....++............+.+++.+|++.+|++|||+.|+++. ++..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~ 297 (337)
T cd07858 237 RNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL 297 (337)
T ss_pred CchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhh
Confidence 0000 00000111111112334567899999999999999999999875 5443
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.5e-32 Score=301.09 Aligned_cols=255 Identities=23% Similarity=0.300 Sum_probs=198.8
Q ss_pred CCCCCCccccCCCEEEEEeEe----CCCcEEEEEEccccc----hhcHHHHHHHHHHHHhh-ccCCcceeEeEEEcCcee
Q 001658 694 NFSPSNKLGEGGFGPVYKGKL----GDGRAIAVKQLSVAS----RQGKSQFVAEIATISAV-QHRNLVKLHGCCIEGAER 764 (1036)
Q Consensus 694 ~~~~~~~iG~G~fG~Vy~~~~----~~g~~vAvK~~~~~~----~~~~~~f~~Ei~~L~~l-~H~nIv~l~g~~~~~~~~ 764 (1036)
+|++.+.||+|+||.||+++. .+++.||||.++... ....+.+.+|++++.++ +|+||+++++.+..+...
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 366778999999999999974 357889999986432 22345688999999999 599999999999999999
Q ss_pred EEEEEecCCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceee
Q 001658 765 LLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLY 844 (1036)
Q Consensus 765 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~ 844 (1036)
++||||+++|+|.+++... ..+++.....++.|+++||+|||+.+ ++||||||+||+++.++.++|+|||+++..
T Consensus 81 ~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 155 (288)
T cd05583 81 HLILDYVNGGELFTHLYQR--EHFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKEF 155 (288)
T ss_pred EEEEecCCCCcHHHHHhhc--CCcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEECcccccc
Confidence 9999999999999998643 45788899999999999999999987 999999999999999999999999999876
Q ss_pred cCCCCccccccccccCccCccccccCC--CCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhcCccccc
Q 001658 845 DDKKTHISTRVAGTIGYLAPEYAMRGH--LTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEIEL 922 (1036)
Q Consensus 845 ~~~~~~~~~~~~gt~~y~APE~~~~~~--~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 922 (1036)
............|+..|+|||...+.. .+.++||||||+++|||++|+.||......... .+.......
T Consensus 156 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~--~~~~~~~~~------- 226 (288)
T cd05583 156 LAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQ--SEISRRILK------- 226 (288)
T ss_pred ccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchH--HHHHHHHHc-------
Confidence 543332223356889999999987655 788999999999999999999998643221111 111111111
Q ss_pred cCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhc
Q 001658 923 ADPKLIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVAMLCG 965 (1036)
Q Consensus 923 ~d~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~ 965 (1036)
..+.. .......+.+++.+||+.+|++|||+.++.+.|+.
T Consensus 227 ~~~~~---~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~ 266 (288)
T cd05583 227 SKPPF---PKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH 266 (288)
T ss_pred cCCCC---CcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence 01111 11122456778889999999999999988887753
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.1e-32 Score=300.08 Aligned_cols=250 Identities=23% Similarity=0.317 Sum_probs=194.1
Q ss_pred CCCCCCccccCCCEEEEEeEe----CCCcEEEEEEccccch----hcHHHHHHHHHHHHhh-ccCCcceeEeEEEcCcee
Q 001658 694 NFSPSNKLGEGGFGPVYKGKL----GDGRAIAVKQLSVASR----QGKSQFVAEIATISAV-QHRNLVKLHGCCIEGAER 764 (1036)
Q Consensus 694 ~~~~~~~iG~G~fG~Vy~~~~----~~g~~vAvK~~~~~~~----~~~~~f~~Ei~~L~~l-~H~nIv~l~g~~~~~~~~ 764 (1036)
+|++.+.||+|+||.||+++. .+|+.||+|++..... ...+.+..|++++.++ +|+||+++++++..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 467789999999999999975 3688999999865322 2346678899999999 599999999999999899
Q ss_pred EEEEEecCCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceee
Q 001658 765 LLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLY 844 (1036)
Q Consensus 765 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~ 844 (1036)
++|+||+++++|.+++... ..+++.....++.|+++||.|||+.+ ++||||||+|||+++++.+||+|||+++..
T Consensus 81 ~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~ 155 (290)
T cd05613 81 HLILDYINGGELFTHLSQR--ERFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEF 155 (290)
T ss_pred EEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCccceec
Confidence 9999999999999998653 45788888899999999999999987 999999999999999999999999999876
Q ss_pred cCCCCccccccccccCccCccccccC--CCCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhcCccccc
Q 001658 845 DDKKTHISTRVAGTIGYLAPEYAMRG--HLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEIEL 922 (1036)
Q Consensus 845 ~~~~~~~~~~~~gt~~y~APE~~~~~--~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 922 (1036)
............|+..|+|||.+... .++.++||||||+++|||++|+.||......... .........
T Consensus 156 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~--~~~~~~~~~------- 226 (290)
T cd05613 156 HEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQ--AEISRRILK------- 226 (290)
T ss_pred ccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccH--HHHHHHhhc-------
Confidence 54332222345688999999998753 4678999999999999999999998743221111 111111111
Q ss_pred cCcccccCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHH
Q 001658 923 ADPKLIEFNEEEVKRLIGVALLCTQTLPSLRP-----SMSRVV 960 (1036)
Q Consensus 923 ~d~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----t~~evl 960 (1036)
..+. +.......+.+++.+|++.+|++|| +..+++
T Consensus 227 ~~~~---~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~ 266 (290)
T cd05613 227 SEPP---YPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIK 266 (290)
T ss_pred cCCC---CCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHH
Confidence 0111 1122334667888899999999997 555554
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.6e-32 Score=300.88 Aligned_cols=252 Identities=25% Similarity=0.390 Sum_probs=193.6
Q ss_pred hcCCCCCCccccCCCEEEEEeEeCC-CcEEEEEEccccc-hhcHHHHHHHHHHHHhhc-cCCcceeEeEEEcCceeEEEE
Q 001658 692 TENFSPSNKLGEGGFGPVYKGKLGD-GRAIAVKQLSVAS-RQGKSQFVAEIATISAVQ-HRNLVKLHGCCIEGAERLLVY 768 (1036)
Q Consensus 692 ~~~~~~~~~iG~G~fG~Vy~~~~~~-g~~vAvK~~~~~~-~~~~~~f~~Ei~~L~~l~-H~nIv~l~g~~~~~~~~~lV~ 768 (1036)
.++|++.+.||+|+||.||+|+..+ ++.||||.++... ......+..|+.++.+.. |+||+++++++.+....++||
T Consensus 14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~ 93 (296)
T cd06618 14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICM 93 (296)
T ss_pred cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEe
Confidence 3567888999999999999999764 8999999986532 233456677887777765 999999999999999999999
Q ss_pred EecCCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhc-CCccccccccCCCcEEecCCCceEEEEcCcceeecCC
Q 001658 769 EYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEE-SRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDK 847 (1036)
Q Consensus 769 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~ 847 (1036)
||++ ++|.+++... ...+++..+.+|+.|+++||+|||+. + |+||||+|+||++++++.+||+|||++..+...
T Consensus 94 e~~~-~~l~~l~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~~---i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~ 168 (296)
T cd06618 94 ELMS-TCLDKLLKRI-QGPIPEDILGKMTVAIVKALHYLKEKHG---VIHRDVKPSNILLDASGNVKLCDFGISGRLVDS 168 (296)
T ss_pred eccC-cCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhhCC---EecCCCcHHHEEEcCCCCEEECccccchhccCC
Confidence 9985 5777766443 34789999999999999999999974 5 999999999999999999999999999866433
Q ss_pred CCccccccccccCccCccccccCC----CCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhcCcccccc
Q 001658 848 KTHISTRVAGTIGYLAPEYAMRGH----LTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEIELA 923 (1036)
Q Consensus 848 ~~~~~~~~~gt~~y~APE~~~~~~----~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 923 (1036)
... ....++..|+|||.+.+.. ++.++||||||+++|||++|+.||........ ... ......
T Consensus 169 ~~~--~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~--~~~---~~~~~~------ 235 (296)
T cd06618 169 KAK--TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFE--VLT---KILQEE------ 235 (296)
T ss_pred Ccc--cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHH--HHH---HHhcCC------
Confidence 221 2335788999999987553 78899999999999999999999975322111 111 111111
Q ss_pred CcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 001658 924 DPKLIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVAM 962 (1036)
Q Consensus 924 d~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 962 (1036)
.+... .......++.+++.+||+.+|.+||++.+++++
T Consensus 236 ~~~~~-~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 236 PPSLP-PNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred CCCCC-CCCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 01110 011223467888899999999999999999864
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.1e-32 Score=308.14 Aligned_cols=265 Identities=20% Similarity=0.288 Sum_probs=198.6
Q ss_pred hcCCCCCCccccCCCEEEEEeEeC-CCcEEEEEEccccc--hhcHHHHHHHHHHHHhhccCCcceeEeEEEc----Ccee
Q 001658 692 TENFSPSNKLGEGGFGPVYKGKLG-DGRAIAVKQLSVAS--RQGKSQFVAEIATISAVQHRNLVKLHGCCIE----GAER 764 (1036)
Q Consensus 692 ~~~~~~~~~iG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~--~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~----~~~~ 764 (1036)
.++|++.+.||+|+||.||+|... +|+.||+|++.... ......+.+|+.++++++||||+++++++.. ....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 468888999999999999999854 68999999986532 2335667889999999999999999998763 3467
Q ss_pred EEEEEecCCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceee
Q 001658 765 LLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLY 844 (1036)
Q Consensus 765 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~ 844 (1036)
++|+||+. ++|.+++... ..+++..+..++.||++||+|||+.+ |+||||||+||++++++.+||+|||+++..
T Consensus 84 ~lv~e~~~-~~l~~~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~ 157 (334)
T cd07855 84 YVVMDLME-SDLHHIIHSD--QPLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGL 157 (334)
T ss_pred EEEEehhh-hhHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEecccccceee
Confidence 99999995 6899988543 34899999999999999999999987 999999999999999999999999999866
Q ss_pred cCCCCc---cccccccccCccCcccccc-CCCCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHH-------
Q 001658 845 DDKKTH---ISTRVAGTIGYLAPEYAMR-GHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHL------- 913 (1036)
Q Consensus 845 ~~~~~~---~~~~~~gt~~y~APE~~~~-~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~------- 913 (1036)
...... ......|+..|+|||.+.+ ..++.++|||||||++|||++|+.||..................
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~ 237 (334)
T cd07855 158 SSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLN 237 (334)
T ss_pred cccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhh
Confidence 433221 1123468899999999865 45889999999999999999999999765432221111000000
Q ss_pred -hhcCccccccC--ccc-----ccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 001658 914 -HENNQEIELAD--PKL-----IEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVAM 962 (1036)
Q Consensus 914 -~~~~~~~~~~d--~~~-----~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 962 (1036)
..........+ +.. ..........+.+++.+|++.+|++||++++++..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 294 (334)
T cd07855 238 RIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH 294 (334)
T ss_pred hhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 00000000000 000 01112235678889999999999999999998873
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.1e-32 Score=325.91 Aligned_cols=261 Identities=29% Similarity=0.420 Sum_probs=205.3
Q ss_pred HHhcCCCCCCccccCCCEEEEEeEeC----C----CcEEEEEEcccc-chhcHHHHHHHHHHHHhh-ccCCcceeEeEEE
Q 001658 690 TATENFSPSNKLGEGGFGPVYKGKLG----D----GRAIAVKQLSVA-SRQGKSQFVAEIATISAV-QHRNLVKLHGCCI 759 (1036)
Q Consensus 690 ~~~~~~~~~~~iG~G~fG~Vy~~~~~----~----g~~vAvK~~~~~-~~~~~~~f~~Ei~~L~~l-~H~nIv~l~g~~~ 759 (1036)
...++..+.+.+|+|.||.|++|... . ...||||.++.. .....+.+..|+++|+.+ +|+||+.++|+|.
T Consensus 293 ~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t 372 (609)
T KOG0200|consen 293 IPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACT 372 (609)
T ss_pred echhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeec
Confidence 33445556679999999999999742 1 457999999753 345678899999999998 6999999999999
Q ss_pred cCceeEEEEEecCCCChhhhhhcCC------------C--CCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcE
Q 001658 760 EGAERLLVYEYLENKSLDQALFGQR------------S--LTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNV 825 (1036)
Q Consensus 760 ~~~~~~lV~E~~~~gsL~~~l~~~~------------~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NI 825 (1036)
.++..++|.||++.|+|.++++..+ . ..+.....+.++.|||.||+||++.. +|||||..+||
T Consensus 373 ~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRDLAaRNV 449 (609)
T KOG0200|consen 373 QDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHRDLAARNV 449 (609)
T ss_pred cCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccchhhhhhhE
Confidence 9999999999999999999997655 0 23788899999999999999999886 99999999999
Q ss_pred EecCCCceEEEEcCcceeecCCCCcccccccc--ccCccCccccccCCCCchhhHHhHHHHHHHHHhCC-CCCCCCChhh
Q 001658 826 LLDADLVPKISDFGLAKLYDDKKTHISTRVAG--TIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGR-PNSDPSLDEE 902 (1036)
Q Consensus 826 Ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~g--t~~y~APE~~~~~~~~~ksDVwS~Gvvl~elltG~-~p~~~~~~~~ 902 (1036)
|+.++..+||+|||+|+...+........-.| +..|||||.+....|+.|+|||||||+|||++|.. .|+.......
T Consensus 450 Li~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~ 529 (609)
T KOG0200|consen 450 LITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTE 529 (609)
T ss_pred EecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcHH
Confidence 99999999999999999765544443222222 44699999999999999999999999999999954 5554321112
Q ss_pred HHHHHHHHHHHhhcCccccccCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhccc
Q 001658 903 KLYLLEWAWHLHENNQEIELADPKLIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVAMLCGDM 967 (1036)
Q Consensus 903 ~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~ 967 (1036)
.. .++ ...+.. .+.+.....++.++|..||+.+|++||++.|+++.++..+
T Consensus 530 ~l--~~~----l~~G~r--------~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l 580 (609)
T KOG0200|consen 530 EL--LEF----LKEGNR--------MEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHL 580 (609)
T ss_pred HH--HHH----HhcCCC--------CCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHH
Confidence 11 211 112211 1122233456778999999999999999999999998753
|
|
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-31 Score=292.03 Aligned_cols=244 Identities=23% Similarity=0.247 Sum_probs=188.9
Q ss_pred CccccCCCEEEEEeEe-CCCcEEEEEEccccch---hcHHHHHHHHHHH-HhhccCCcceeEeEEEcCceeEEEEEecCC
Q 001658 699 NKLGEGGFGPVYKGKL-GDGRAIAVKQLSVASR---QGKSQFVAEIATI-SAVQHRNLVKLHGCCIEGAERLLVYEYLEN 773 (1036)
Q Consensus 699 ~~iG~G~fG~Vy~~~~-~~g~~vAvK~~~~~~~---~~~~~f~~Ei~~L-~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~ 773 (1036)
+.||+|+||.||+|.. .+++.||+|.+..... .....+..|..++ ...+|+|++++++++..++..++|+||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 5699999999999986 4688999999865322 2223345555544 445899999999999999999999999999
Q ss_pred CChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeecCCCCcccc
Q 001658 774 KSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHIST 853 (1036)
Q Consensus 774 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 853 (1036)
++|.+++... ..+++..+..++.|++.||.|||+.+ ++||||+|+||++++++.++|+|||+++..... .
T Consensus 82 ~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-----~ 151 (260)
T cd05611 82 GDCASLIKTL--GGLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLEN-----K 151 (260)
T ss_pred CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceecccc-----c
Confidence 9999998643 35788888899999999999999987 999999999999999999999999998764331 2
Q ss_pred ccccccCccCccccccCCCCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhcCccccccCcccccCCHH
Q 001658 854 RVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEIELADPKLIEFNEE 933 (1036)
Q Consensus 854 ~~~gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~ 933 (1036)
...|+..|+|||...+..++.++||||||+++|||++|..||............ .... .. ..+. ....
T Consensus 152 ~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~-------~~~~-~~-~~~~---~~~~ 219 (260)
T cd05611 152 KFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNI-------LSRR-IN-WPEE---VKEF 219 (260)
T ss_pred cCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHH-------Hhcc-cC-CCCc---cccc
Confidence 345888999999998888899999999999999999999999765433221111 0000 00 0001 1112
Q ss_pred HHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 001658 934 EVKRLIGVALLCTQTLPSLRPSMSRVVAMLC 964 (1036)
Q Consensus 934 ~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~ 964 (1036)
....+.+++.+||+.+|++||++.++.+.|.
T Consensus 220 ~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~ 250 (260)
T cd05611 220 CSPEAVDLINRLLCMDPAKRLGANGYQEIKS 250 (260)
T ss_pred CCHHHHHHHHHHccCCHHHccCCCcHHHHHc
Confidence 3456788889999999999998876655543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-32 Score=294.50 Aligned_cols=245 Identities=25% Similarity=0.336 Sum_probs=199.1
Q ss_pred cCCCCCCccccCCCEEEEEeEe-CCCcEEEEEEcccc---chhcHHHHHHHHHHHHhhccCCcceeEeEEEcCceeEEEE
Q 001658 693 ENFSPSNKLGEGGFGPVYKGKL-GDGRAIAVKQLSVA---SRQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLVY 768 (1036)
Q Consensus 693 ~~~~~~~~iG~G~fG~Vy~~~~-~~g~~vAvK~~~~~---~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~ 768 (1036)
+.|..-++||+||||.||-++. ..|+.+|.|.+.+. .+.+......|-.+|.+++.+.||.+-.+|...+..++|+
T Consensus 185 n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVL 264 (591)
T KOG0986|consen 185 NTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVL 264 (591)
T ss_pred cceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEE
Confidence 4566778999999999999975 47999999998542 3455666788999999999999999999999999999999
Q ss_pred EecCCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeecCCC
Q 001658 769 EYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKK 848 (1036)
Q Consensus 769 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~ 848 (1036)
..|.||+|.-+|...++..+++...+-.+.+|+.||++||... ||.||+||+|||+|+.|+++|+|.|+|..+....
T Consensus 265 tlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~ 341 (591)
T KOG0986|consen 265 TLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLGLAVEIPEGK 341 (591)
T ss_pred EeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccceEEecCCCC
Confidence 9999999999998877888999999999999999999999988 9999999999999999999999999999887654
Q ss_pred CccccccccccCccCccccccCCCCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhcCccccccCcccc
Q 001658 849 THISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEIELADPKLI 928 (1036)
Q Consensus 849 ~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~ 928 (1036)
... ..+||.+|||||++.++.|+...|.||+||++|||+.|+.||..........-++ + .-+.|+.
T Consensus 342 ~~~--~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvd---r-------r~~~~~~-- 407 (591)
T KOG0986|consen 342 PIR--GRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVD---R-------RTLEDPE-- 407 (591)
T ss_pred ccc--cccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHH---H-------HHhcchh--
Confidence 432 3479999999999999999999999999999999999999997543221111111 0 0011111
Q ss_pred cCCHHHHHHHHHHHHHhcccCCCCCC
Q 001658 929 EFNEEEVKRLIGVALLCTQTLPSLRP 954 (1036)
Q Consensus 929 ~~~~~~~~~l~~l~~~Cl~~dP~~RP 954 (1036)
.+......+..++....++.||.+|-
T Consensus 408 ey~~kFS~eakslc~~LL~Kdp~~RL 433 (591)
T KOG0986|consen 408 EYSDKFSEEAKSLCEGLLTKDPEKRL 433 (591)
T ss_pred hcccccCHHHHHHHHHHHccCHHHhc
Confidence 22233334445555566799999986
|
|
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.8e-32 Score=302.30 Aligned_cols=265 Identities=26% Similarity=0.331 Sum_probs=196.3
Q ss_pred hcCCCCCCccccCCCEEEEEeEeC-CCcEEEEEEccccch--hcHHHHHHHHHHHHhhccCCcceeEeEEEcCc------
Q 001658 692 TENFSPSNKLGEGGFGPVYKGKLG-DGRAIAVKQLSVASR--QGKSQFVAEIATISAVQHRNLVKLHGCCIEGA------ 762 (1036)
Q Consensus 692 ~~~~~~~~~iG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~--~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~------ 762 (1036)
.++|++.+.||+|+||.||+|+.. +++.||+|++..... .....+.+|++++++++|+||+++++++.+..
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 468899999999999999999864 688999998864322 22346788999999999999999999875433
Q ss_pred --eeEEEEEecCCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCc
Q 001658 763 --ERLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGL 840 (1036)
Q Consensus 763 --~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGl 840 (1036)
..++|+||+.+ +|...+... ...+++..+..++.|+++||+|||+.+ |+||||||+||++++++.++|+|||+
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~~-~~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~ 161 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLENP-SVKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFGL 161 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcCcc
Confidence 46899999964 777776543 346899999999999999999999988 99999999999999999999999999
Q ss_pred ceeecCCCCc----------cccccccccCccCccccccC-CCCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHH
Q 001658 841 AKLYDDKKTH----------ISTRVAGTIGYLAPEYAMRG-HLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEW 909 (1036)
Q Consensus 841 a~~~~~~~~~----------~~~~~~gt~~y~APE~~~~~-~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~ 909 (1036)
++........ ..+...|++.|+|||.+.+. .++.++|||||||++|||++|++||..............
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~ 241 (311)
T cd07866 162 ARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFK 241 (311)
T ss_pred chhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 9865432211 11234578889999988654 578999999999999999999999986554433222211
Q ss_pred HHHHhhcC--------c-----cc-cccCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 001658 910 AWHLHENN--------Q-----EI-ELADPKLIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVA 961 (1036)
Q Consensus 910 ~~~~~~~~--------~-----~~-~~~d~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 961 (1036)
........ . .. ....+............+.+++.+|++.+|++|||+.|++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 242 LCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred HhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 11100000 0 00 00000110111122256788999999999999999999874
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-31 Score=298.36 Aligned_cols=246 Identities=28% Similarity=0.443 Sum_probs=194.4
Q ss_pred CCCCCCccccCCCEEEEEeEeC-CCcEEEEEEcccc---chhcHHHHHHHHHHHHhhccCCcceeEeEEEcCceeEEEEE
Q 001658 694 NFSPSNKLGEGGFGPVYKGKLG-DGRAIAVKQLSVA---SRQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLVYE 769 (1036)
Q Consensus 694 ~~~~~~~iG~G~fG~Vy~~~~~-~g~~vAvK~~~~~---~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E 769 (1036)
.|+..+.||+|+||.||+|+.. +++.||+|.+... ......++.+|+++++.++|+|++++++++......++|+|
T Consensus 16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 95 (308)
T cd06634 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (308)
T ss_pred HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEE
Confidence 3556688999999999999854 6788999988642 22334568889999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeecCCCC
Q 001658 770 YLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKT 849 (1036)
Q Consensus 770 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~ 849 (1036)
|+. |+|.+++... ...+++.++..++.|++.|+.|||+.+ ++||||||+||+++.++.++|+|||++.......
T Consensus 96 ~~~-~~l~~~~~~~-~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~- 169 (308)
T cd06634 96 YCL-GSASDLLEVH-KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPAN- 169 (308)
T ss_pred ccC-CCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccceeecCcc-
Confidence 996 6888777543 345789999999999999999999987 9999999999999999999999999998764322
Q ss_pred ccccccccccCccCccccc---cCCCCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhcCccccccCcc
Q 001658 850 HISTRVAGTIGYLAPEYAM---RGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEIELADPK 926 (1036)
Q Consensus 850 ~~~~~~~gt~~y~APE~~~---~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 926 (1036)
...|+..|+|||.+. .+.++.++|||||||++|||++|+.|+............ . ... .+.
T Consensus 170 ----~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~------~-~~~-----~~~ 233 (308)
T cd06634 170 ----XFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI------A-QNE-----SPA 233 (308)
T ss_pred ----cccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHH------h-hcC-----CCC
Confidence 245788999999974 356788999999999999999999998654322221111 0 000 011
Q ss_pred cccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 001658 927 LIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVAML 963 (1036)
Q Consensus 927 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L 963 (1036)
. ........+.+++.+||+.+|++||++.+++..-
T Consensus 234 ~--~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~ 268 (308)
T cd06634 234 L--QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHR 268 (308)
T ss_pred c--CcccccHHHHHHHHHHhhCCcccCCCHHHHhhCc
Confidence 1 1122335577888899999999999999998653
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-31 Score=291.52 Aligned_cols=248 Identities=26% Similarity=0.353 Sum_probs=194.5
Q ss_pred CCCCCCccccCCCEEEEEeEeC-CCcEEEEEEcccc-----chhcHHHHHHHHHHHHhhccCCcceeEeEEEcCceeEEE
Q 001658 694 NFSPSNKLGEGGFGPVYKGKLG-DGRAIAVKQLSVA-----SRQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLV 767 (1036)
Q Consensus 694 ~~~~~~~iG~G~fG~Vy~~~~~-~g~~vAvK~~~~~-----~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV 767 (1036)
+|.+.+.||+|+||.||+++.. .+..+++|.++.. ......++..|+.++++++||||+++++++.+....++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 4778899999999999999854 3444555555421 122344577899999999999999999999998899999
Q ss_pred EEecCCCChhhhhhc--CCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeec
Q 001658 768 YEYLENKSLDQALFG--QRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYD 845 (1036)
Q Consensus 768 ~E~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~ 845 (1036)
+||+++++|.+++.. .....+++..+..++.|+++||.|||+.+ ++|+||||+||++++ +.++|+|||+++...
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCceeecC
Confidence 999999999998864 23457899999999999999999999987 999999999999975 569999999998764
Q ss_pred CCCCccccccccccCccCccccccCCCCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhcCccccccCc
Q 001658 846 DKKTHISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEIELADP 925 (1036)
Q Consensus 846 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 925 (1036)
.... ......|+..|+|||...+..++.++||||||+++|+|++|+.||......... . ... ....+
T Consensus 157 ~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~---~---~~~------~~~~~ 223 (260)
T cd08222 157 GSCD-LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVV---L---RIV------EGPTP 223 (260)
T ss_pred CCcc-cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHH---H---HHH------cCCCC
Confidence 3322 223345888999999998888899999999999999999999998654321111 1 111 00111
Q ss_pred ccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 001658 926 KLIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVA 961 (1036)
Q Consensus 926 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 961 (1036)
.........+.+++.+||+.+|++||++.|+++
T Consensus 224 ---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 224 ---SLPETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred ---CCcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 122344457788889999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-31 Score=303.12 Aligned_cols=269 Identities=20% Similarity=0.278 Sum_probs=199.9
Q ss_pred HHHhcCCCCCCccccCCCEEEEEeEe-CCCcEEEEEEcccc--chhcHHHHHHHHHHHHhhccCCcceeEeEEEcCc---
Q 001658 689 KTATENFSPSNKLGEGGFGPVYKGKL-GDGRAIAVKQLSVA--SRQGKSQFVAEIATISAVQHRNLVKLHGCCIEGA--- 762 (1036)
Q Consensus 689 ~~~~~~~~~~~~iG~G~fG~Vy~~~~-~~g~~vAvK~~~~~--~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~--- 762 (1036)
....++|+..+.||+|+||.||+|.. .+++.||||++... .......+.+|++++++++|+||+++++++....
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07880 11 WEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLD 90 (343)
T ss_pred hccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccc
Confidence 34567899999999999999999984 47899999998542 2233456889999999999999999999987543
Q ss_pred ---eeEEEEEecCCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcC
Q 001658 763 ---ERLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFG 839 (1036)
Q Consensus 763 ---~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFG 839 (1036)
..++||||+ +++|.+++.. ..+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.++|+|||
T Consensus 91 ~~~~~~lv~e~~-~~~l~~~~~~---~~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~kl~dfg 163 (343)
T cd07880 91 RFHDFYLVMPFM-GTDLGKLMKH---EKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFG 163 (343)
T ss_pred ccceEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecc
Confidence 358999999 7799888743 46889999999999999999999988 9999999999999999999999999
Q ss_pred cceeecCCCCccccccccccCccCcccccc-CCCCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHH-H--------H
Q 001658 840 LAKLYDDKKTHISTRVAGTIGYLAPEYAMR-GHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLL-E--------W 909 (1036)
Q Consensus 840 la~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~-~--------~ 909 (1036)
++....... ....++..|+|||.+.+ ..++.++||||||+++|++++|+.||............ . +
T Consensus 164 ~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 239 (343)
T cd07880 164 LARQTDSEM----TGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEF 239 (343)
T ss_pred cccccccCc----cccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence 998654321 23457889999999876 45889999999999999999999999865432221110 0 0
Q ss_pred HHHHhhcCc------cccccCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH--HhhcccC
Q 001658 910 AWHLHENNQ------EIELADPKLIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVA--MLCGDME 968 (1036)
Q Consensus 910 ~~~~~~~~~------~~~~~d~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~--~L~~~~~ 968 (1036)
......... ........+..........+.+++.+|++.+|.+|||+.+++. .++...+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~~ 306 (343)
T cd07880 240 VQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHD 306 (343)
T ss_pred HHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhcC
Confidence 000000000 0000000011111122345778899999999999999999983 4444433
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-31 Score=295.28 Aligned_cols=248 Identities=24% Similarity=0.316 Sum_probs=201.3
Q ss_pred cCCCCCCccccCCCEEEEEeEeC-CCcEEEEEEcccc---chhcHHHHHHHHHHHHhhc-cCCcceeEeEEEcCceeEEE
Q 001658 693 ENFSPSNKLGEGGFGPVYKGKLG-DGRAIAVKQLSVA---SRQGKSQFVAEIATISAVQ-HRNLVKLHGCCIEGAERLLV 767 (1036)
Q Consensus 693 ~~~~~~~~iG~G~fG~Vy~~~~~-~g~~vAvK~~~~~---~~~~~~~f~~Ei~~L~~l~-H~nIv~l~g~~~~~~~~~lV 767 (1036)
++|.+.+.||+|+||.||+|... +++.||+|++... .....+.+..|++++++++ |+||+++++++...+..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 46888899999999999999864 7899999998642 2333567889999999998 99999999999999999999
Q ss_pred EEecCCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeecCC
Q 001658 768 YEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDK 847 (1036)
Q Consensus 768 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~ 847 (1036)
|||+++++|.+++... ..+++..+..|+.|++.||+|||+.+ ++|+||||+||+++.++.++++|||++......
T Consensus 81 ~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~ 155 (280)
T cd05581 81 LEYAPNGELLQYIRKY--GSLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDPN 155 (280)
T ss_pred EcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCccccccCCc
Confidence 9999999999999654 36899999999999999999999988 999999999999999999999999999866543
Q ss_pred CC-------------------ccccccccccCccCccccccCCCCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHH
Q 001658 848 KT-------------------HISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLE 908 (1036)
Q Consensus 848 ~~-------------------~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~ 908 (1036)
.. .......|+..|+|||......++.++||||||++++|+++|+.||......... .
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~---~ 232 (280)
T cd05581 156 SSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTF---Q 232 (280)
T ss_pred cccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHH---H
Confidence 21 1122346788999999998888999999999999999999999999865422111 1
Q ss_pred HHHHHhhcCccccccCcccccCCHHHHHHHHHHHHHhcccCCCCCCCH----HHHHH
Q 001658 909 WAWHLHENNQEIELADPKLIEFNEEEVKRLIGVALLCTQTLPSLRPSM----SRVVA 961 (1036)
Q Consensus 909 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~----~evl~ 961 (1036)
.. .. .. ..........+.+++..|++.+|.+||++ .|+++
T Consensus 233 ~~---~~-------~~---~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 233 KI---LK-------LE---YSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred HH---Hh-------cC---CCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 11 00 00 01112224567888899999999999999 77654
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-32 Score=323.48 Aligned_cols=251 Identities=27% Similarity=0.421 Sum_probs=187.8
Q ss_pred HHhcCCCCCCccccCCCEEEEEeEeC-CCcEEEEEEcccc-chhcHHHHHHHHHHHHhhccCCcceeEeEEEcC------
Q 001658 690 TATENFSPSNKLGEGGFGPVYKGKLG-DGRAIAVKQLSVA-SRQGKSQFVAEIATISAVQHRNLVKLHGCCIEG------ 761 (1036)
Q Consensus 690 ~~~~~~~~~~~iG~G~fG~Vy~~~~~-~g~~vAvK~~~~~-~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~------ 761 (1036)
....+|+..+.||+||||.|||++.+ ||+.+|||++... +........+|+..|++++|||||+++..+.+.
T Consensus 476 RY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~ 555 (1351)
T KOG1035|consen 476 RYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTV 555 (1351)
T ss_pred hHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccc
Confidence 34556777889999999999999966 8999999999754 344456788999999999999999988754310
Q ss_pred --------------------------------------------------------------------------------
Q 001658 762 -------------------------------------------------------------------------------- 761 (1036)
Q Consensus 762 -------------------------------------------------------------------------------- 761 (1036)
T Consensus 556 ~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~ 635 (1351)
T KOG1035|consen 556 LEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSD 635 (1351)
T ss_pred ccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccc
Confidence
Q ss_pred ---------------------------------ceeEEEEEecCCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHH
Q 001658 762 ---------------------------------AERLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLH 808 (1036)
Q Consensus 762 ---------------------------------~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH 808 (1036)
...||-||||+...|.++++.+.... .-...++++.+|++||+|+|
T Consensus 636 ~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~-~~d~~wrLFreIlEGLaYIH 714 (1351)
T KOG1035|consen 636 SEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS-QRDEAWRLFREILEGLAYIH 714 (1351)
T ss_pred cCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch-hhHHHHHHHHHHHHHHHHHH
Confidence 01246677777766766665443221 34566789999999999999
Q ss_pred hcCCccccccccCCCcEEecCCCceEEEEcCcceeec------C-----------CCCccccccccccCccCccccccC-
Q 001658 809 EESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYD------D-----------KKTHISTRVAGTIGYLAPEYAMRG- 870 (1036)
Q Consensus 809 ~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~------~-----------~~~~~~~~~~gt~~y~APE~~~~~- 870 (1036)
++| ||||||||.||++|++..|||+|||+|+... . ......+..+||.-|+|||++.+.
T Consensus 715 ~~g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~ 791 (1351)
T KOG1035|consen 715 DQG---IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTS 791 (1351)
T ss_pred hCc---eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccc
Confidence 998 9999999999999999999999999998721 0 011123567899999999999754
Q ss_pred --CCCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhcCccccccCccc---ccCCHHHHHHHHHHHHHh
Q 001658 871 --HLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEIELADPKL---IEFNEEEVKRLIGVALLC 945 (1036)
Q Consensus 871 --~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~---~~~~~~~~~~l~~l~~~C 945 (1036)
.|+.|+|+||+|||++||+. ||...++ ....... +.++.+ .++..+....=.+++.++
T Consensus 792 ~~~Yn~KiDmYSLGIVlFEM~y---PF~TsME--Ra~iL~~------------LR~g~iP~~~~f~~~~~~~e~slI~~L 854 (1351)
T KOG1035|consen 792 SNKYNSKIDMYSLGIVLFEMLY---PFGTSME--RASILTN------------LRKGSIPEPADFFDPEHPEEASLIRWL 854 (1351)
T ss_pred cccccchhhhHHHHHHHHHHhc---cCCchHH--HHHHHHh------------cccCCCCCCcccccccchHHHHHHHHH
Confidence 49999999999999999995 5665433 2222211 111111 233444445556778899
Q ss_pred cccCCCCCCCHHHHHH
Q 001658 946 TQTLPSLRPSMSRVVA 961 (1036)
Q Consensus 946 l~~dP~~RPt~~evl~ 961 (1036)
++.||.+|||+.|++.
T Consensus 855 l~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 855 LSHDPSKRPTATELLN 870 (1351)
T ss_pred hcCCCccCCCHHHHhh
Confidence 9999999999999875
|
|
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-31 Score=293.71 Aligned_cols=241 Identities=23% Similarity=0.277 Sum_probs=186.0
Q ss_pred ccccCCCEEEEEeEe-CCCcEEEEEEccccc---hhcHHHHHHHHHHH---HhhccCCcceeEeEEEcCceeEEEEEecC
Q 001658 700 KLGEGGFGPVYKGKL-GDGRAIAVKQLSVAS---RQGKSQFVAEIATI---SAVQHRNLVKLHGCCIEGAERLLVYEYLE 772 (1036)
Q Consensus 700 ~iG~G~fG~Vy~~~~-~~g~~vAvK~~~~~~---~~~~~~f~~Ei~~L---~~l~H~nIv~l~g~~~~~~~~~lV~E~~~ 772 (1036)
.||+|+||.||+|.. .+++.||+|.+.... ......+..|..++ +...||+|+++++++...+..++|+||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 489999999999985 468899999886432 12222344454443 34579999999999999999999999999
Q ss_pred CCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeecCCCCccc
Q 001658 773 NKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHIS 852 (1036)
Q Consensus 773 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 852 (1036)
+|+|.+++.. ...+++..+..++.|+++||+|||+.+ |+||||||+||++++++.+||+|||++..+.....
T Consensus 81 g~~L~~~l~~--~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~~--- 152 (278)
T cd05606 81 GGDLHYHLSQ--HGVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP--- 152 (278)
T ss_pred CCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccCccCC---
Confidence 9999998854 346899999999999999999999987 99999999999999999999999999876543222
Q ss_pred cccccccCccCccccccC-CCCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhcCccccccCcccccCC
Q 001658 853 TRVAGTIGYLAPEYAMRG-HLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEIELADPKLIEFN 931 (1036)
Q Consensus 853 ~~~~gt~~y~APE~~~~~-~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~ 931 (1036)
....|+..|+|||++.++ .++.++||||+||++|||++|+.||............. . ....++.+..
T Consensus 153 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~-~---------~~~~~~~~~~-- 220 (278)
T cd05606 153 HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDR-M---------TLTMAVELPD-- 220 (278)
T ss_pred cCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHH-H---------hhccCCCCCC--
Confidence 234689999999998754 68999999999999999999999997653322111110 0 0011112211
Q ss_pred HHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 001658 932 EEEVKRLIGVALLCTQTLPSLRP-----SMSRVVA 961 (1036)
Q Consensus 932 ~~~~~~l~~l~~~Cl~~dP~~RP-----t~~evl~ 961 (1036)
.....+.+++.+|++.+|.+|| ++.++++
T Consensus 221 -~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 254 (278)
T cd05606 221 -SFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 254 (278)
T ss_pred -cCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence 1235677778899999999999 9999874
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=294.43 Aligned_cols=244 Identities=28% Similarity=0.465 Sum_probs=192.4
Q ss_pred CCCCCccccCCCEEEEEeEe-CCCcEEEEEEccccch---hcHHHHHHHHHHHHhhccCCcceeEeEEEcCceeEEEEEe
Q 001658 695 FSPSNKLGEGGFGPVYKGKL-GDGRAIAVKQLSVASR---QGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLVYEY 770 (1036)
Q Consensus 695 ~~~~~~iG~G~fG~Vy~~~~-~~g~~vAvK~~~~~~~---~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~ 770 (1036)
|...+.||+|+||.||+|+. .+++.||+|.+..... .....+.+|+++++.++|+|++++++++.+....++||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 55567899999999999985 4688999999864322 2345688899999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeecCCCCc
Q 001658 771 LENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTH 850 (1036)
Q Consensus 771 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~ 850 (1036)
+. |++.+++... ...+++.++..++.|++.|++|||+.+ |+||||||+||+++.++.+||+|||++......
T Consensus 103 ~~-~~l~~~l~~~-~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~~~~~~--- 174 (313)
T cd06633 103 CL-GSASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSSPA--- 174 (313)
T ss_pred CC-CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCcccCCC---
Confidence 95 6787777543 346899999999999999999999988 999999999999999999999999998643221
Q ss_pred cccccccccCccCccccc---cCCCCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhcCccccccCccc
Q 001658 851 ISTRVAGTIGYLAPEYAM---RGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEIELADPKL 927 (1036)
Q Consensus 851 ~~~~~~gt~~y~APE~~~---~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~ 927 (1036)
....|+..|+|||++. ...++.++|||||||++|||++|++|+............ ... . .+..
T Consensus 175 --~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~------~~~-~-----~~~~ 240 (313)
T cd06633 175 --NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI------AQN-D-----SPTL 240 (313)
T ss_pred --CCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH------Hhc-C-----CCCC
Confidence 2346888999999984 456888999999999999999999998765432222111 000 0 0111
Q ss_pred ccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 001658 928 IEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVAM 962 (1036)
Q Consensus 928 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 962 (1036)
. .......+.+++.+|++.+|.+||++.+++..
T Consensus 241 ~--~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 241 Q--SNEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred C--ccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0 11122357778889999999999999999853
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-31 Score=300.76 Aligned_cols=260 Identities=22% Similarity=0.301 Sum_probs=195.2
Q ss_pred cCCC-CCCccccCCCEEEEEeEeC-CCcEEEEEEccccchhc--------------HHHHHHHHHHHHhhccCCcceeEe
Q 001658 693 ENFS-PSNKLGEGGFGPVYKGKLG-DGRAIAVKQLSVASRQG--------------KSQFVAEIATISAVQHRNLVKLHG 756 (1036)
Q Consensus 693 ~~~~-~~~~iG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~~~--------------~~~f~~Ei~~L~~l~H~nIv~l~g 756 (1036)
++|. +.+.||+|+||.||+|+.. +++.||||.+....... ...+.+|++++++++|+||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 4454 3567999999999999854 68999999986432211 124778999999999999999999
Q ss_pred EEEcCceeEEEEEecCCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEE
Q 001658 757 CCIEGAERLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKIS 836 (1036)
Q Consensus 757 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~ 836 (1036)
++...+..++||||++ |+|.+++.. ...+++.....++.|+++||+|||+.+ |+||||||+||+++.++.++|+
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~l~~--~~~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~~~~kl~ 161 (335)
T PTZ00024 88 VYVEGDFINLVMDIMA-SDLKKVVDR--KIRLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIA 161 (335)
T ss_pred EEecCCcEEEEEeccc-cCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCCCCEEEC
Confidence 9999999999999996 699998854 345788899999999999999999988 9999999999999999999999
Q ss_pred EcCcceeecCCC-------------CccccccccccCccCccccccC-CCCchhhHHhHHHHHHHHHhCCCCCCCCChhh
Q 001658 837 DFGLAKLYDDKK-------------THISTRVAGTIGYLAPEYAMRG-HLTEKTDVFAFGVLALETVSGRPNSDPSLDEE 902 (1036)
Q Consensus 837 DFGla~~~~~~~-------------~~~~~~~~gt~~y~APE~~~~~-~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~ 902 (1036)
|||+++...... ........++..|+|||++.+. .++.++|||||||++|||++|++||....+.+
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~ 241 (335)
T PTZ00024 162 DFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEID 241 (335)
T ss_pred CccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 999998665111 1111223468899999998764 46889999999999999999999998665433
Q ss_pred HHHHHHHHHHHhhcCccc----c-----------ccCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 001658 903 KLYLLEWAWHLHENNQEI----E-----------LADPKLIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVA 961 (1036)
Q Consensus 903 ~~~l~~~~~~~~~~~~~~----~-----------~~d~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 961 (1036)
... ............ . ...+............+.+++..|++.+|++||+++|++.
T Consensus 242 ~~~---~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 312 (335)
T PTZ00024 242 QLG---RIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALK 312 (335)
T ss_pred HHH---HHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence 221 111111100000 0 0000111111122456778899999999999999999985
|
|
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-31 Score=303.59 Aligned_cols=268 Identities=22% Similarity=0.260 Sum_probs=199.8
Q ss_pred CHHHHHHHhcCCCCCCccccCCCEEEEEeEe-CCCcEEEEEEccccc--hhcHHHHHHHHHHHHhhccCCcceeEeEEEc
Q 001658 684 SYAELKTATENFSPSNKLGEGGFGPVYKGKL-GDGRAIAVKQLSVAS--RQGKSQFVAEIATISAVQHRNLVKLHGCCIE 760 (1036)
Q Consensus 684 ~~~~l~~~~~~~~~~~~iG~G~fG~Vy~~~~-~~g~~vAvK~~~~~~--~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~ 760 (1036)
..+++....++|.+.+.||+|+||.||+|.. .+++.||+|++.... ....+.+.+|+.++++++|+||+++++++..
T Consensus 8 ~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~ 87 (345)
T cd07877 8 LNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTP 87 (345)
T ss_pred HHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeee
Confidence 3456777889999999999999999999984 578999999986432 2234568889999999999999999998864
Q ss_pred C------ceeEEEEEecCCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceE
Q 001658 761 G------AERLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPK 834 (1036)
Q Consensus 761 ~------~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~k 834 (1036)
. ...+++++++ +++|.+++.. ..+++..+..++.|+++||+|||+.+ |+||||||+||++++++.+|
T Consensus 88 ~~~~~~~~~~~lv~~~~-~~~L~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~k 160 (345)
T cd07877 88 ARSLEEFNDVYLVTHLM-GADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELK 160 (345)
T ss_pred cccccccccEEEEehhc-ccCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcCCCCEE
Confidence 3 3367788876 7899888743 35889999999999999999999988 99999999999999999999
Q ss_pred EEEcCcceeecCCCCccccccccccCccCcccccc-CCCCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHH-
Q 001658 835 ISDFGLAKLYDDKKTHISTRVAGTIGYLAPEYAMR-GHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWH- 912 (1036)
Q Consensus 835 l~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~- 912 (1036)
|+|||+++..... .....|+..|+|||.+.+ ..++.++|||||||++|||++|+.||.................
T Consensus 161 l~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~ 236 (345)
T cd07877 161 ILDFGLARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT 236 (345)
T ss_pred Eeccccccccccc----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence 9999998764322 123467889999999866 5688899999999999999999999965443222211100000
Q ss_pred -------HhhcCcc-------ccccCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 001658 913 -------LHENNQE-------IELADPKLIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVAM 962 (1036)
Q Consensus 913 -------~~~~~~~-------~~~~d~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 962 (1036)
....... .........+........+.+++.+|++.+|.+||++.+++..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 237 PGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred CCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 0000000 0000000000001123457788999999999999999998763
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.6e-31 Score=292.28 Aligned_cols=261 Identities=27% Similarity=0.382 Sum_probs=199.7
Q ss_pred CCCCCccccCCCEEEEEeEeC-CCcEEEEEEccccc--hhcHHHHHHHHHHHHhhccCCcceeEeEEEcCceeEEEEEec
Q 001658 695 FSPSNKLGEGGFGPVYKGKLG-DGRAIAVKQLSVAS--RQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLVYEYL 771 (1036)
Q Consensus 695 ~~~~~~iG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~--~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~~ 771 (1036)
|+..+.||+|+||.||+|+.. +++.||+|.+.... ....+.+..|+.++++++|+||+++++++.+.+..++|+||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 456688999999999999865 58999999987643 333567888999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeecCCCCcc
Q 001658 772 ENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHI 851 (1036)
Q Consensus 772 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 851 (1036)
+ ++|.+++.... ..+++..+.+++.|+++||+|||+.+ |+||||+|+||++++++.++|+|||+++....... .
T Consensus 81 ~-~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~-~ 154 (282)
T cd07829 81 D-MDLKKYLDKRP-GPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR-T 154 (282)
T ss_pred C-cCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccccCCCcc-c
Confidence 7 59999996542 46899999999999999999999988 99999999999999999999999999987654322 1
Q ss_pred ccccccccCccCccccccC-CCCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHH-HH-------HHHHhhcCccccc
Q 001658 852 STRVAGTIGYLAPEYAMRG-HLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLL-EW-------AWHLHENNQEIEL 922 (1036)
Q Consensus 852 ~~~~~gt~~y~APE~~~~~-~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~-~~-------~~~~~~~~~~~~~ 922 (1036)
.....++..|+|||.+.+. .++.++|||||||++|||++|++||......+..... +. .|...........
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (282)
T cd07829 155 YTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKP 234 (282)
T ss_pred cCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccc
Confidence 2233467789999998776 7899999999999999999999999765433222111 00 0000000000000
Q ss_pred cCccc-----ccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 001658 923 ADPKL-----IEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVA 961 (1036)
Q Consensus 923 ~d~~~-----~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 961 (1036)
.-+.. ..........+.+++..|++.+|++||++.+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 235 TFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred cccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 00000 0111122457889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-31 Score=299.44 Aligned_cols=263 Identities=22% Similarity=0.300 Sum_probs=197.9
Q ss_pred HHHHhcCCCCCCccccCCCEEEEEeEeC-CCcEEEEEEcccc--chhcHHHHHHHHHHHHhhccCCcceeEeEEEc-Cce
Q 001658 688 LKTATENFSPSNKLGEGGFGPVYKGKLG-DGRAIAVKQLSVA--SRQGKSQFVAEIATISAVQHRNLVKLHGCCIE-GAE 763 (1036)
Q Consensus 688 l~~~~~~~~~~~~iG~G~fG~Vy~~~~~-~g~~vAvK~~~~~--~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~-~~~ 763 (1036)
+..++++|+..+.||+|+||.||+|... +++.||+|++... .....+.+..|++++.+++||||+++++++.. ...
T Consensus 5 ~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 84 (328)
T cd07856 5 VFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLED 84 (328)
T ss_pred eeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCc
Confidence 3456788999999999999999999854 7899999987542 22334678899999999999999999999875 457
Q ss_pred eEEEEEecCCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCccee
Q 001658 764 RLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKL 843 (1036)
Q Consensus 764 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~ 843 (1036)
.++|+||+ +++|.+++.. ..+++.....++.|+++||+|||+.+ |+||||||+||++++++.++|+|||++..
T Consensus 85 ~~lv~e~~-~~~L~~~~~~---~~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~dfg~~~~ 157 (328)
T cd07856 85 IYFVTELL-GTDLHRLLTS---RPLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARI 157 (328)
T ss_pred EEEEeehh-ccCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCccccccc
Confidence 88999998 5689888843 35778888899999999999999988 99999999999999999999999999875
Q ss_pred ecCCCCccccccccccCccCcccccc-CCCCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHH-HH--------HHHH
Q 001658 844 YDDKKTHISTRVAGTIGYLAPEYAMR-GHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLL-EW--------AWHL 913 (1036)
Q Consensus 844 ~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~-~~--------~~~~ 913 (1036)
..... ....++..|+|||.+.+ ..++.++||||||+++|||++|++||............ ++ ....
T Consensus 158 ~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (328)
T cd07856 158 QDPQM----TGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTI 233 (328)
T ss_pred cCCCc----CCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhc
Confidence 43221 23457889999998766 56899999999999999999999999765432221111 10 0000
Q ss_pred hhcCcccccc-Cccc-cc-----CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 001658 914 HENNQEIELA-DPKL-IE-----FNEEEVKRLIGVALLCTQTLPSLRPSMSRVVAM 962 (1036)
Q Consensus 914 ~~~~~~~~~~-d~~~-~~-----~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 962 (1036)
.... ..+.. .... .. ........+.+++.+|++.+|++||++.+++..
T Consensus 234 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 234 CSEN-TLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred cchh-hHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0000 00000 0000 00 011223577888899999999999999999764
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-31 Score=303.24 Aligned_cols=263 Identities=24% Similarity=0.306 Sum_probs=194.8
Q ss_pred hcCCCCCCccccCCCEEEEEeEe-CCCcEEEEEEccccchhcHHHHHHHHHHHHhhccCCcceeEeEEEcC---------
Q 001658 692 TENFSPSNKLGEGGFGPVYKGKL-GDGRAIAVKQLSVASRQGKSQFVAEIATISAVQHRNLVKLHGCCIEG--------- 761 (1036)
Q Consensus 692 ~~~~~~~~~iG~G~fG~Vy~~~~-~~g~~vAvK~~~~~~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~--------- 761 (1036)
..+|...+.||+|+||.||+|.. .+|+.||+|.+........+.+.+|++++++++||||+++++++...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG 83 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence 35788899999999999999985 46889999998765555567788999999999999999999876543
Q ss_pred -----ceeEEEEEecCCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecC-CCceEE
Q 001658 762 -----AERLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDA-DLVPKI 835 (1036)
Q Consensus 762 -----~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~-~~~~kl 835 (1036)
...++|+||++ ++|.+++.. ..+++.....++.||++||.|||+.+ |+||||||+||+++. ++.+||
T Consensus 84 ~~~~~~~~~lv~e~~~-~~L~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~~~~~~kl 156 (342)
T cd07854 84 SLTELNSVYIVQEYME-TDLANVLEQ---GPLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLKI 156 (342)
T ss_pred cccccceEEEEeeccc-ccHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCceEEE
Confidence 35689999997 589888743 35788999999999999999999988 999999999999974 567899
Q ss_pred EEcCcceeecCCCCcc--ccccccccCccCcccccc-CCCCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHH
Q 001658 836 SDFGLAKLYDDKKTHI--STRVAGTIGYLAPEYAMR-GHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWH 912 (1036)
Q Consensus 836 ~DFGla~~~~~~~~~~--~~~~~gt~~y~APE~~~~-~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~ 912 (1036)
+|||+++......... .....|+..|+|||.+.. ..++.++|||||||++|||++|+.||....+.+..........
T Consensus 157 ~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~ 236 (342)
T cd07854 157 GDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVP 236 (342)
T ss_pred CCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcC
Confidence 9999998664322111 123357889999998754 5688899999999999999999999976544322211110000
Q ss_pred H---------hhcC--ccc-cccCcc--cccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 001658 913 L---------HENN--QEI-ELADPK--LIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVA 961 (1036)
Q Consensus 913 ~---------~~~~--~~~-~~~d~~--~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 961 (1036)
. .... ... ....+. ..........++.+++.+|++.||.+|||+.|++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~ 299 (342)
T cd07854 237 VVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM 299 (342)
T ss_pred CCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence 0 0000 000 000000 00011123356778899999999999999999985
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.4e-32 Score=317.70 Aligned_cols=289 Identities=24% Similarity=0.242 Sum_probs=217.7
Q ss_pred CHHHHHHHhcCCCCCCccccCCCEEEEEeEeC-CCcEEEEEEcccc---chhcHHHHHHHHHHHHhhccCCcceeEeEEE
Q 001658 684 SYAELKTATENFSPSNKLGEGGFGPVYKGKLG-DGRAIAVKQLSVA---SRQGKSQFVAEIATISAVQHRNLVKLHGCCI 759 (1036)
Q Consensus 684 ~~~~l~~~~~~~~~~~~iG~G~fG~Vy~~~~~-~g~~vAvK~~~~~---~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~ 759 (1036)
...+++...++|.+.++||+|+||.|..++.+ .++.+|+|++++. .+....-|..|-.+|..-+.+-|++++-+|.
T Consensus 66 ~v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQ 145 (1317)
T KOG0612|consen 66 KVKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQ 145 (1317)
T ss_pred HHHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhc
Confidence 34566667789999999999999999999975 5789999999762 3445567889999999999999999999999
Q ss_pred cCceeEEEEEecCCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcC
Q 001658 760 EGAERLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFG 839 (1036)
Q Consensus 760 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFG 839 (1036)
+....|+|||||+||+|-.++.... .+++..+.-++..|.-||.-||+.| +|||||||+|||||..|++||+|||
T Consensus 146 D~~~LYlVMdY~pGGDlltLlSk~~--~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHikLADFG 220 (1317)
T KOG0612|consen 146 DERYLYLVMDYMPGGDLLTLLSKFD--RLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIKLADFG 220 (1317)
T ss_pred CccceEEEEecccCchHHHHHhhcC--CChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEeeccch
Confidence 9999999999999999999997665 4555555567889999999999998 9999999999999999999999999
Q ss_pred cceeecCCCCccccccccccCccCccccc----c-CCCCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHh
Q 001658 840 LAKLYDDKKTHISTRVAGTIGYLAPEYAM----R-GHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLH 914 (1036)
Q Consensus 840 la~~~~~~~~~~~~~~~gt~~y~APE~~~----~-~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~ 914 (1036)
.+-.+..+....+...+|||.|++||++. + +.|++.+|.||+||++|||+.|.-||+...-.+.+.. ..
T Consensus 221 sClkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~K------Im 294 (1317)
T KOG0612|consen 221 SCLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGK------IM 294 (1317)
T ss_pred hHHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHH------Hh
Confidence 99888777666677788999999999985 2 6799999999999999999999999987543333322 22
Q ss_pred hcCccccccCcccccCCHHHHHHHHHHHHHhcccCCCCCCC---HHHHHHH--hhcccCCCcCCCCCCCCcCccccCCCc
Q 001658 915 ENNQEIELADPKLIEFNEEEVKRLIGVALLCTQTLPSLRPS---MSRVVAM--LCGDMEVSTVTAKPGYLTDWKFDDITS 989 (1036)
Q Consensus 915 ~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt---~~evl~~--L~~~~~~~~~~~~p~~~~~~~~~~~~~ 989 (1036)
.......+. .-.+ ..++.+.++.-.+ -+|+.|-. +.++-.. +++.-........|+|.++...++.++
T Consensus 295 ~hk~~l~FP--~~~~-VSeeakdLI~~ll----~~~e~RLgrngiedik~HpFF~g~~W~~iR~~~pP~vPevssd~DTs 367 (1317)
T KOG0612|consen 295 NHKESLSFP--DETD-VSEEAKDLIEALL----CDREVRLGRNGIEDIKNHPFFEGIDWDNIRESVPPVVPEVSSDDDTS 367 (1317)
T ss_pred chhhhcCCC--cccc-cCHHHHHHHHHHh----cChhhhcccccHHHHHhCccccCCChhhhhhcCCCCCCcCCCCCccc
Confidence 211111111 1111 3456666664222 35677766 7776542 333333222334455555554444444
Q ss_pred c
Q 001658 990 F 990 (1036)
Q Consensus 990 ~ 990 (1036)
.
T Consensus 368 n 368 (1317)
T KOG0612|consen 368 N 368 (1317)
T ss_pred c
Confidence 3
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.4e-31 Score=298.36 Aligned_cols=262 Identities=21% Similarity=0.273 Sum_probs=191.5
Q ss_pred CCCCCCccccCCCEEEEEeEeC-C--CcEEEEEEcccc--chhcHHHHHHHHHHHHhh-ccCCcceeEeEEEcC----ce
Q 001658 694 NFSPSNKLGEGGFGPVYKGKLG-D--GRAIAVKQLSVA--SRQGKSQFVAEIATISAV-QHRNLVKLHGCCIEG----AE 763 (1036)
Q Consensus 694 ~~~~~~~iG~G~fG~Vy~~~~~-~--g~~vAvK~~~~~--~~~~~~~f~~Ei~~L~~l-~H~nIv~l~g~~~~~----~~ 763 (1036)
+|++.+.||+|+||.||+++.. . ++.||+|.+... .....+.+.+|+.+++++ +||||+++++++... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 4677789999999999999864 3 778999998643 222345688899999999 599999999975432 34
Q ss_pred eEEEEEecCCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCccee
Q 001658 764 RLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKL 843 (1036)
Q Consensus 764 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~ 843 (1036)
.++++||+. ++|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+||++++++.+||+|||+++.
T Consensus 81 ~~~~~e~~~-~~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~Dfg~a~~ 154 (332)
T cd07857 81 LYLYEELME-ADLHQIIRS--GQPLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLARG 154 (332)
T ss_pred EEEEEeccc-CCHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCcCCCcee
Confidence 678888885 689998854 346889999999999999999999988 99999999999999999999999999987
Q ss_pred ecCCCCc---cccccccccCccCcccccc-CCCCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHH---------
Q 001658 844 YDDKKTH---ISTRVAGTIGYLAPEYAMR-GHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWA--------- 910 (1036)
Q Consensus 844 ~~~~~~~---~~~~~~gt~~y~APE~~~~-~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~--------- 910 (1036)
+...... ......||..|+|||+..+ ..++.++||||+||++|+|++|++||...............
T Consensus 155 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 234 (332)
T cd07857 155 FSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETL 234 (332)
T ss_pred cccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 6532221 1123568999999998765 46899999999999999999999999764432211110000
Q ss_pred HHHhhcC------ccccccCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 001658 911 WHLHENN------QEIELADPKLIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVA 961 (1036)
Q Consensus 911 ~~~~~~~------~~~~~~d~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 961 (1036)
....... .........+..........+.+++.+|++.+|.+|||+.|++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~ 291 (332)
T cd07857 235 SRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE 291 (332)
T ss_pred HhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 0000000 00000000011111112356788899999999999999999864
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-31 Score=297.30 Aligned_cols=249 Identities=22% Similarity=0.286 Sum_probs=200.1
Q ss_pred HhcCCCCCCccccCCCEEEEEeEe-CCCcEEEEEEccccc--hhcHHHHHHHHHHHHhhccCCcceeEeEEEcCceeEEE
Q 001658 691 ATENFSPSNKLGEGGFGPVYKGKL-GDGRAIAVKQLSVAS--RQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLV 767 (1036)
Q Consensus 691 ~~~~~~~~~~iG~G~fG~Vy~~~~-~~g~~vAvK~~~~~~--~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV 767 (1036)
-...|.+...||+|.|+.|..|+. ..+..||+|.+++.. ......+.+|+++|..++|||||+++.+.......++|
T Consensus 54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV 133 (596)
T KOG0586|consen 54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLV 133 (596)
T ss_pred cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEE
Confidence 345788899999999999999985 468999999997643 23335588999999999999999999999999999999
Q ss_pred EEecCCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeecCC
Q 001658 768 YEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDK 847 (1036)
Q Consensus 768 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~ 847 (1036)
|||+.+|.+++++...+. ........+..|+.+|++|||.++ |||||||++||||+.++++||+|||++.++..
T Consensus 134 ~eya~~ge~~~yl~~~gr--~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~- 207 (596)
T KOG0586|consen 134 MEYASGGELFDYLVKHGR--MKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGFSTFFDY- 207 (596)
T ss_pred EEeccCchhHHHHHhccc--chhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeeccccceeecc-
Confidence 999999999999976543 333677778999999999999998 99999999999999999999999999998863
Q ss_pred CCccccccccccCccCccccccCCC-CchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhcCccccccCcc
Q 001658 848 KTHISTRVAGTIGYLAPEYAMRGHL-TEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEIELADPK 926 (1036)
Q Consensus 848 ~~~~~~~~~gt~~y~APE~~~~~~~-~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 926 (1036)
.......+|++.|.|||++.+..| .+++|+||+|+++|-|+.|..||+...-.+-. ..++..+
T Consensus 208 -~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr---------------~rvl~gk 271 (596)
T KOG0586|consen 208 -GLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELR---------------PRVLRGK 271 (596)
T ss_pred -cccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccccccc---------------chheeee
Confidence 333456789999999999998775 57999999999999999999999864321100 0001111
Q ss_pred cccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 001658 927 LIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVAM 962 (1036)
Q Consensus 927 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 962 (1036)
+ ..+.-...++-+++.+++-.+|.+|++++++.+.
T Consensus 272 ~-rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~ 306 (596)
T KOG0586|consen 272 Y-RIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKD 306 (596)
T ss_pred e-cccceeechhHHHHHHhhccCccccCCHHHhhhh
Confidence 1 1111222345556667788999999999999763
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-31 Score=274.00 Aligned_cols=203 Identities=27% Similarity=0.395 Sum_probs=169.6
Q ss_pred hcCCCCCCccccCCCEEEEEeEeCC-----CcEEEEEEccccchh--cHHHHHHHHHHHHhhccCCcceeEeEEEc-Cce
Q 001658 692 TENFSPSNKLGEGGFGPVYKGKLGD-----GRAIAVKQLSVASRQ--GKSQFVAEIATISAVQHRNLVKLHGCCIE-GAE 763 (1036)
Q Consensus 692 ~~~~~~~~~iG~G~fG~Vy~~~~~~-----g~~vAvK~~~~~~~~--~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~-~~~ 763 (1036)
...|+....||+|.||.||||.-.+ .+.+|+|+++..... -.....+|+..++.++||||+.+..++.. +..
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~ 102 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKK 102 (438)
T ss_pred HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCce
Confidence 3568888999999999999996332 237999999754221 12456789999999999999999999887 778
Q ss_pred eEEEEEecCCCChhhhhhcCC---CCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCC----CceEEE
Q 001658 764 RLLVYEYLENKSLDQALFGQR---SLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDAD----LVPKIS 836 (1036)
Q Consensus 764 ~~lV~E~~~~gsL~~~l~~~~---~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~----~~~kl~ 836 (1036)
.++++||.+. +|.+.++..+ ...++-.....|+.||+.|+.|||++- |+||||||.|||+..+ |.|||+
T Consensus 103 v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VKIa 178 (438)
T KOG0666|consen 103 VWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVKIA 178 (438)
T ss_pred EEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeEee
Confidence 8999999976 8888886443 456888888999999999999999998 9999999999999877 899999
Q ss_pred EcCcceeecCCCCc--cccccccccCccCccccccC-CCCchhhHHhHHHHHHHHHhCCCCCCCC
Q 001658 837 DFGLAKLYDDKKTH--ISTRVAGTIGYLAPEYAMRG-HLTEKTDVFAFGVLALETVSGRPNSDPS 898 (1036)
Q Consensus 837 DFGla~~~~~~~~~--~~~~~~gt~~y~APE~~~~~-~~~~ksDVwS~Gvvl~elltG~~p~~~~ 898 (1036)
|||+++.+.+.-.. ....++-|+.|.|||.+.+. .|+.+.|||+.|||+.||+|-.+-|...
T Consensus 179 DlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~ 243 (438)
T KOG0666|consen 179 DLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGR 243 (438)
T ss_pred cccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccch
Confidence 99999988654332 23457789999999999875 5899999999999999999999888653
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-31 Score=302.72 Aligned_cols=261 Identities=23% Similarity=0.309 Sum_probs=197.5
Q ss_pred HHhcCCCCCCccccCCCEEEEEeEeC-CCcEEEEEEcccc--chhcHHHHHHHHHHHHhhccCCcceeEeEEEcCce---
Q 001658 690 TATENFSPSNKLGEGGFGPVYKGKLG-DGRAIAVKQLSVA--SRQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAE--- 763 (1036)
Q Consensus 690 ~~~~~~~~~~~iG~G~fG~Vy~~~~~-~g~~vAvK~~~~~--~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~--- 763 (1036)
...++|+..+.||+|+||.||+|+.. +++.||+|++... .......+.+|+.++++++|+||+++++++...+.
T Consensus 12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07851 12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLED 91 (343)
T ss_pred cccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccc
Confidence 34678889999999999999999865 5789999998643 22334567789999999999999999998776554
Q ss_pred ---eEEEEEecCCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCc
Q 001658 764 ---RLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGL 840 (1036)
Q Consensus 764 ---~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGl 840 (1036)
.++|+||+ +++|.+++.. ..+++..+..++.|+++||+|||+.+ |+||||||+||++++++.++|+|||+
T Consensus 92 ~~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~kL~dfg~ 164 (343)
T cd07851 92 FQDVYLVTHLM-GADLNNIVKC---QKLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGL 164 (343)
T ss_pred cccEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEccccc
Confidence 89999998 6799998853 46899999999999999999999987 99999999999999999999999999
Q ss_pred ceeecCCCCccccccccccCccCcccccc-CCCCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHH-HH--------H
Q 001658 841 AKLYDDKKTHISTRVAGTIGYLAPEYAMR-GHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLL-EW--------A 910 (1036)
Q Consensus 841 a~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~-~~--------~ 910 (1036)
+...... .....++..|+|||...+ ..++.++|||||||++|||++|+.||............ +. .
T Consensus 165 ~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 240 (343)
T cd07851 165 ARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELL 240 (343)
T ss_pred ccccccc----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHH
Confidence 9865432 223457889999999865 36789999999999999999999999765433222111 00 0
Q ss_pred HHHhhcCc------cccccCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 001658 911 WHLHENNQ------EIELADPKLIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVA 961 (1036)
Q Consensus 911 ~~~~~~~~------~~~~~d~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 961 (1036)
........ ......+.+..........+.+++.+|++.+|++|||+.||++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~ 297 (343)
T cd07851 241 QKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA 297 (343)
T ss_pred hhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence 00000000 0000000000111122457889999999999999999999875
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-31 Score=275.16 Aligned_cols=263 Identities=22% Similarity=0.307 Sum_probs=197.9
Q ss_pred CHHHHHHHhcCCCCCCccccCCCEEEEEeE-eCCCcEEEEEEccccchhcHHHHHHHHHHHHhhc-cCCcceeEeEEEcC
Q 001658 684 SYAELKTATENFSPSNKLGEGGFGPVYKGK-LGDGRAIAVKQLSVASRQGKSQFVAEIATISAVQ-HRNLVKLHGCCIEG 761 (1036)
Q Consensus 684 ~~~~l~~~~~~~~~~~~iG~G~fG~Vy~~~-~~~g~~vAvK~~~~~~~~~~~~f~~Ei~~L~~l~-H~nIv~l~g~~~~~ 761 (1036)
+++++.+.|+ +.||+|+|+.|--++ +.+|..+|||++.+.......+..+|++++...+ |+||++++++|.++
T Consensus 74 ~F~d~YkLt~-----e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd 148 (463)
T KOG0607|consen 74 KFEDMYKLTS-----ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDD 148 (463)
T ss_pred hHHHHHHhHH-----HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhccc
Confidence 4567766665 569999999999987 6789999999998777777888999999999885 99999999999999
Q ss_pred ceeEEEEEecCCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCC---ceEEEEc
Q 001658 762 AERLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADL---VPKISDF 838 (1036)
Q Consensus 762 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~---~~kl~DF 838 (1036)
...|||||.|.||+|...++.+ ..+++....++..+|+.||.|||.+| |.|||+||+|||-.... -+|||||
T Consensus 149 ~~FYLVfEKm~GGplLshI~~~--~~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKiCDf 223 (463)
T KOG0607|consen 149 TRFYLVFEKMRGGPLLSHIQKR--KHFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKICDF 223 (463)
T ss_pred ceEEEEEecccCchHHHHHHHh--hhccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceeeecc
Confidence 9999999999999999999654 45788888999999999999999998 99999999999996543 5899999
Q ss_pred Ccceeec--CCCCccc----cccccccCccCccccc-----cCCCCchhhHHhHHHHHHHHHhCCCCCCCCChhhHH---
Q 001658 839 GLAKLYD--DKKTHIS----TRVAGTIGYLAPEYAM-----RGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKL--- 904 (1036)
Q Consensus 839 Gla~~~~--~~~~~~~----~~~~gt~~y~APE~~~-----~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~--- 904 (1036)
.+..-.. .+-+..+ ...+|+..|||||+.. ...|+.++|.||+|||+|-|++|.+||.+.-..+-.
T Consensus 224 DLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdr 303 (463)
T KOG0607|consen 224 DLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDR 303 (463)
T ss_pred ccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccC
Confidence 8875432 1111111 2356889999999863 346889999999999999999999999763222100
Q ss_pred -----HHHHHHHHHhhcCccccccCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 001658 905 -----YLLEWAWHLHENNQEIELADPKLIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVA 961 (1036)
Q Consensus 905 -----~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 961 (1036)
.-.+.......++. -++.|.+. .-...+.++++. ..+..|+.+|-++.+++.
T Consensus 304 Ge~Cr~CQ~~LFesIQEGk-YeFPdkdW-ahIS~eakdlis---nLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 304 GEVCRVCQNKLFESIQEGK-YEFPDKDW-AHISSEAKDLIS---NLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred CCccHHHHHHHHHHHhccC-CcCChhhh-HHhhHHHHHHHH---HHHhccHHhhhhhhhccC
Confidence 00011111122211 11122111 112344455554 445699999999999887
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-30 Score=319.23 Aligned_cols=145 Identities=31% Similarity=0.397 Sum_probs=129.8
Q ss_pred cCCCCCCccccCCCEEEEEeEeC-CCcEEEEEEccccc---hhcHHHHHHHHHHHHhhccCCcceeEeEEEcCceeEEEE
Q 001658 693 ENFSPSNKLGEGGFGPVYKGKLG-DGRAIAVKQLSVAS---RQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLVY 768 (1036)
Q Consensus 693 ~~~~~~~~iG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~ 768 (1036)
++|.+.++||+|+||.||+|... +++.||||+++... ......+..|+.++..++|+||+++++++......++||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 57888899999999999999865 68999999986532 233467889999999999999999999999999999999
Q ss_pred EecCCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcce
Q 001658 769 EYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAK 842 (1036)
Q Consensus 769 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~ 842 (1036)
||+++++|.+++... ..+++..++.|+.||+.||+|||..+ ||||||||+|||++.++.+||+|||+++
T Consensus 84 Ey~~g~~L~~li~~~--~~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 84 EYLIGGDVKSLLHIY--GYFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred eCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 999999999998643 35788889999999999999999987 9999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=301.89 Aligned_cols=259 Identities=25% Similarity=0.385 Sum_probs=213.4
Q ss_pred HHHHHHHhcCCCCCCccccCCCEEEEEeE-eCCCcEEEEEEccccchhcHHHHHHHHHHHHhh-ccCCcceeEeEEEc--
Q 001658 685 YAELKTATENFSPSNKLGEGGFGPVYKGK-LGDGRAIAVKQLSVASRQGKSQFVAEIATISAV-QHRNLVKLHGCCIE-- 760 (1036)
Q Consensus 685 ~~~l~~~~~~~~~~~~iG~G~fG~Vy~~~-~~~g~~vAvK~~~~~~~~~~~~f~~Ei~~L~~l-~H~nIv~l~g~~~~-- 760 (1036)
++.+-..++.|.+.+.||+|.+|.||+++ .++++.+|+|+...... ..++.+.|.++++.. +|||++.++|++..
T Consensus 11 ~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d-~deEiE~eynil~~~~~hpnv~~fyg~~~k~~ 89 (953)
T KOG0587|consen 11 LSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTED-EEEEIELEYNMLKKYSHHPNVATFYGAFIKKD 89 (953)
T ss_pred hhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcc-ccHHHHHHHHHHHhccCCCCcceEEEEEEEec
Confidence 34444456778889999999999999998 45789999999875443 356788899999888 69999999999873
Q ss_pred ---CceeEEEEEecCCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEE
Q 001658 761 ---GAERLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISD 837 (1036)
Q Consensus 761 ---~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~D 837 (1036)
+++.|||||||.+||..|++.+-....++|..+.-|+..+++|+.+||.+. ++|||||=.|||++.++.||++|
T Consensus 90 ~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~VKLvD 166 (953)
T KOG0587|consen 90 PGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAEVKLVD 166 (953)
T ss_pred CCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCcEEEee
Confidence 578999999999999999998777888999999999999999999999886 99999999999999999999999
Q ss_pred cCcceeecCCCCccccccccccCccCcccccc-----CCCCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHH
Q 001658 838 FGLAKLYDDKKTHISTRVAGTIGYLAPEYAMR-----GHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWH 912 (1036)
Q Consensus 838 FGla~~~~~~~~~~~~~~~gt~~y~APE~~~~-----~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~ 912 (1036)
||++..+...... .....||+.|||||++.- ..|+..+|+||+|++..||--|.+|+-...+.....++
T Consensus 167 FGvSaQldsT~gr-RnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~I----- 240 (953)
T KOG0587|consen 167 FGVSAQLDSTVGR-RNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLI----- 240 (953)
T ss_pred eeeeeeeeccccc-ccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccC-----
Confidence 9999887644332 334679999999999853 34777999999999999999999999876654433211
Q ss_pred HhhcCccccccCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 001658 913 LHENNQEIELADPKLIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVA 961 (1036)
Q Consensus 913 ~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 961 (1036)
..-..|+ ...+....+++.+++..|+.+|..+||++.++++
T Consensus 241 -------pRNPPPk-Lkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~ 281 (953)
T KOG0587|consen 241 -------PRNPPPK-LKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK 281 (953)
T ss_pred -------CCCCCcc-ccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence 1111122 2335677788999999999999999999998875
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-31 Score=274.12 Aligned_cols=241 Identities=26% Similarity=0.281 Sum_probs=193.5
Q ss_pred hcCCCCCCccccCCCEEEEEeEe-CCCcEEEEEEccccc---hhcHHHHHHHHHHHHhhccCCcceeEeEEEcCceeEEE
Q 001658 692 TENFSPSNKLGEGGFGPVYKGKL-GDGRAIAVKQLSVAS---RQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLV 767 (1036)
Q Consensus 692 ~~~~~~~~~iG~G~fG~Vy~~~~-~~g~~vAvK~~~~~~---~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV 767 (1036)
-++|..+++||+|.||.|-.++- ..|+.+|+|++++.. +.....-..|-++|+..+||.+..+-..|...+..++|
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV 246 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV 246 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence 36788889999999999999984 478999999998653 33344456789999999999999998889999999999
Q ss_pred EEecCCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeecCC
Q 001658 768 YEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDK 847 (1036)
Q Consensus 768 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~ 847 (1036)
|||..||.|.-+|.+ ...+++...+-.-..|..||.|||+++ ||.||+|.+|.|+|.||++||+|||+++.--..
T Consensus 247 MeyanGGeLf~HLsr--er~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~ 321 (516)
T KOG0690|consen 247 MEYANGGELFFHLSR--ERVFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFGLCKEEIKY 321 (516)
T ss_pred EEEccCceEeeehhh--hhcccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeecccchhcccc
Confidence 999999999887744 456777777778889999999999987 999999999999999999999999999854322
Q ss_pred CCccccccccccCccCccccccCCCCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhcCccccccCccc
Q 001658 848 KTHISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEIELADPKL 927 (1036)
Q Consensus 848 ~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~ 927 (1036)
......++||+.|+|||++....|...+|.|.+|||+|||++|+.||+....+.-..++ -..|-++
T Consensus 322 -g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLI-------------l~ed~kF 387 (516)
T KOG0690|consen 322 -GDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELI-------------LMEDLKF 387 (516)
T ss_pred -cceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHH-------------HhhhccC
Confidence 22335688999999999999999999999999999999999999999875543333222 1122233
Q ss_pred ccCCHHHHHHHHHHHHHhcccCCCCCC
Q 001658 928 IEFNEEEVKRLIGVALLCTQTLPSLRP 954 (1036)
Q Consensus 928 ~~~~~~~~~~l~~l~~~Cl~~dP~~RP 954 (1036)
+.....+++.+ ....+.+||.+|-
T Consensus 388 Pr~ls~eAktL---LsGLL~kdP~kRL 411 (516)
T KOG0690|consen 388 PRTLSPEAKTL---LSGLLKKDPKKRL 411 (516)
T ss_pred CccCCHHHHHH---HHHHhhcChHhhc
Confidence 33333344433 3456789999995
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.3e-30 Score=277.90 Aligned_cols=236 Identities=28% Similarity=0.310 Sum_probs=191.9
Q ss_pred cccCCCEEEEEeEeC-CCcEEEEEEccccch---hcHHHHHHHHHHHHhhccCCcceeEeEEEcCceeEEEEEecCCCCh
Q 001658 701 LGEGGFGPVYKGKLG-DGRAIAVKQLSVASR---QGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLVYEYLENKSL 776 (1036)
Q Consensus 701 iG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~---~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL 776 (1036)
||+|+||.||++... +++.||+|.+..... .....+..|++++++++|+||+++++.+..+...++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 699999999999865 588999999865432 2456788999999999999999999999999999999999999999
Q ss_pred hhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeecCCCCccccccc
Q 001658 777 DQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVA 856 (1036)
Q Consensus 777 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 856 (1036)
.+++... ..+++.....++.|+++|+.|||+.+ ++|+||||+||+++.++.++|+|||++........ ......
T Consensus 81 ~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~ 154 (250)
T cd05123 81 FSHLSKE--GRFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS-RTNTFC 154 (250)
T ss_pred HHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceecccCCC-cccCCc
Confidence 9999654 35899999999999999999999987 99999999999999999999999999987654321 223456
Q ss_pred cccCccCccccccCCCCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhcCccccccCcccccCCHHHHH
Q 001658 857 GTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEIELADPKLIEFNEEEVK 936 (1036)
Q Consensus 857 gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~ 936 (1036)
++..|+|||...+...+.++|+||||+++||+++|+.||........ .... .. ....+ +.....
T Consensus 155 ~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~---~~~~---~~-------~~~~~---~~~~~~ 218 (250)
T cd05123 155 GTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEI---YEKI---LK-------DPLRF---PEFLSP 218 (250)
T ss_pred CCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHH---HHHH---hc-------CCCCC---CCCCCH
Confidence 88899999999888899999999999999999999999975433111 1111 10 01111 111245
Q ss_pred HHHHHHHHhcccCCCCCCCHHH
Q 001658 937 RLIGVALLCTQTLPSLRPSMSR 958 (1036)
Q Consensus 937 ~l~~l~~~Cl~~dP~~RPt~~e 958 (1036)
.+.+++.+|+..||++||++.+
T Consensus 219 ~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 219 EARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred HHHHHHHHHhcCCHhhCCCccc
Confidence 6778889999999999999954
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.2e-31 Score=280.02 Aligned_cols=263 Identities=19% Similarity=0.245 Sum_probs=207.6
Q ss_pred HHhcCCCCCCccccCCCEEEEEeEeC-CCcEEEEEEccccchhcHHHHHHHHHHHHhhc-c-CC----cceeEeEEEcCc
Q 001658 690 TATENFSPSNKLGEGGFGPVYKGKLG-DGRAIAVKQLSVASRQGKSQFVAEIATISAVQ-H-RN----LVKLHGCCIEGA 762 (1036)
Q Consensus 690 ~~~~~~~~~~~iG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~f~~Ei~~L~~l~-H-~n----Iv~l~g~~~~~~ 762 (1036)
..+++|.+...+|+|.||.|-++... .+..||||+++...+. .+...-|+++|+++. + |+ +|++.+||...+
T Consensus 86 ~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kY-reAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrg 164 (415)
T KOG0671|consen 86 ILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKY-REAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRG 164 (415)
T ss_pred ccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHH-hhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccC
Confidence 34789999999999999999999743 4789999999754433 455677999999994 2 22 788899999999
Q ss_pred eeEEEEEecCCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecC-------------
Q 001658 763 ERLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDA------------- 829 (1036)
Q Consensus 763 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~------------- 829 (1036)
+.++|+|.+ |.|+.++|..+.-.+++...+..|+.|++++++|||+.+ ++|-||||+|||+-+
T Consensus 165 hiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~~~~~~~~k~~~ 240 (415)
T KOG0671|consen 165 HICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSEYFKTYNPKKKV 240 (415)
T ss_pred ceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccceEEEeccCCcc
Confidence 999999988 679999998888888999999999999999999999988 999999999999921
Q ss_pred -------CCceEEEEcCcceeecCCCCccccccccccCccCccccccCCCCchhhHHhHHHHHHHHHhCCCCCCCCChhh
Q 001658 830 -------DLVPKISDFGLAKLYDDKKTHISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEE 902 (1036)
Q Consensus 830 -------~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~ 902 (1036)
+..+||+|||.|++-.... ..++.|..|.|||++.+-.++.++||||+||||+|+.||...|+...+.+
T Consensus 241 ~~~r~~ks~~I~vIDFGsAtf~~e~h----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~E 316 (415)
T KOG0671|consen 241 CFIRPLKSTAIKVIDFGSATFDHEHH----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLE 316 (415)
T ss_pred ceeccCCCcceEEEecCCcceeccCc----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHH
Confidence 3468999999998754333 44678999999999999999999999999999999999999998766555
Q ss_pred HHHHHHHHHH--------------HhhcCcc-----------ccccC-ccc----ccCCHHHHHHHHHHHHHhcccCCCC
Q 001658 903 KLYLLEWAWH--------------LHENNQE-----------IELAD-PKL----IEFNEEEVKRLIGVALLCTQTLPSL 952 (1036)
Q Consensus 903 ~~~l~~~~~~--------------~~~~~~~-----------~~~~d-~~~----~~~~~~~~~~l~~l~~~Cl~~dP~~ 952 (1036)
...+.+.+-. .+..++. ....+ ++. ......+..+|++++..++..||.+
T Consensus 317 HLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~ 396 (415)
T KOG0671|consen 317 HLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPAR 396 (415)
T ss_pred HHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccc
Confidence 4433322211 1111100 00011 110 1223567778999999999999999
Q ss_pred CCCHHHHHH
Q 001658 953 RPSMSRVVA 961 (1036)
Q Consensus 953 RPt~~evl~ 961 (1036)
|+|+.|+++
T Consensus 397 RiTl~EAL~ 405 (415)
T KOG0671|consen 397 RITLREALS 405 (415)
T ss_pred cccHHHHhc
Confidence 999999875
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.6e-31 Score=268.75 Aligned_cols=252 Identities=21% Similarity=0.193 Sum_probs=193.0
Q ss_pred HhcCCCC-CCccccCCCEEEEEeEeC-CCcEEEEEEccccchhcHHHHHHHHHHHHhh-ccCCcceeEeEEEc----Cce
Q 001658 691 ATENFSP-SNKLGEGGFGPVYKGKLG-DGRAIAVKQLSVASRQGKSQFVAEIATISAV-QHRNLVKLHGCCIE----GAE 763 (1036)
Q Consensus 691 ~~~~~~~-~~~iG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~f~~Ei~~L~~l-~H~nIv~l~g~~~~----~~~ 763 (1036)
.+++|++ .++||-|-.|.|-.+..+ .|+.+|+|++... ....+|++..-.. .|||||+++++|.. ...
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc 133 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKC 133 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence 5666665 367999999999999754 7899999998632 2346788776555 69999999999864 355
Q ss_pred eEEEEEecCCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecC---CCceEEEEcCc
Q 001658 764 RLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDA---DLVPKISDFGL 840 (1036)
Q Consensus 764 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~---~~~~kl~DFGl 840 (1036)
.++|||.|+||.|.+.+..++...+++.++-+|+.||+.|+.|||+.. |.||||||+|+|... |..+||+|||+
T Consensus 134 LLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na~lKLtDfGF 210 (400)
T KOG0604|consen 134 LLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNAPLKLTDFGF 210 (400)
T ss_pred eEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCcceEeccccc
Confidence 689999999999999999999999999999999999999999999998 999999999999964 56799999999
Q ss_pred ceeecCCCCccccccccccCccCccccccCCCCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhcCccc
Q 001658 841 AKLYDDKKTHISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEI 920 (1036)
Q Consensus 841 a~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 920 (1036)
|+..... ..-...+-|+.|.|||++-..+|+..+|+||+||++|-|++|.+||+........- . .. ..+
T Consensus 211 AK~t~~~--~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aisp--g-Mk------~rI 279 (400)
T KOG0604|consen 211 AKETQEP--GDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP--G-MK------RRI 279 (400)
T ss_pred ccccCCC--ccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCCh--h-HH------hHh
Confidence 9865432 12233457999999999999999999999999999999999999998654311100 0 00 001
Q ss_pred cccCcccccC-CHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 001658 921 ELADPKLIEF-NEEEVKRLIGVALLCTQTLPSLRPSMSRVVA 961 (1036)
Q Consensus 921 ~~~d~~~~~~-~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 961 (1036)
......+.+. -....+...+++...+..+|.+|-|+.|++.
T Consensus 280 ~~gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~ 321 (400)
T KOG0604|consen 280 RTGQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMD 321 (400)
T ss_pred hccCccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhc
Confidence 1111111111 1222234445566777999999999999976
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.6e-31 Score=284.98 Aligned_cols=244 Identities=26% Similarity=0.340 Sum_probs=194.4
Q ss_pred CCccccCCCEEEEEeEe-CCCcEEEEEEcccc--chhcHHHHHHHHHHHHhhccCCcceeEeEEEcCceeEEEEEecCCC
Q 001658 698 SNKLGEGGFGPVYKGKL-GDGRAIAVKQLSVA--SRQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLVYEYLENK 774 (1036)
Q Consensus 698 ~~~iG~G~fG~Vy~~~~-~~g~~vAvK~~~~~--~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~g 774 (1036)
.+.||+|-||+||-|+. ++|+.||||++.+. ......++.+|+.+|++++||.||.+-..|...+..++|||.+ +|
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl-~G 647 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKL-HG 647 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhh-cc
Confidence 57899999999999985 57999999998653 2334578899999999999999999999999999999999999 55
Q ss_pred ChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCC---CceEEEEcCcceeecCCCCcc
Q 001658 775 SLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDAD---LVPKISDFGLAKLYDDKKTHI 851 (1036)
Q Consensus 775 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~---~~~kl~DFGla~~~~~~~~~~ 851 (1036)
+..+.+.......+++....-++.||+.||.|||.++ |||+||||+|||+.+. -++||||||.|+++.+.. .
T Consensus 648 DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEks--F 722 (888)
T KOG4236|consen 648 DMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKS--F 722 (888)
T ss_pred hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccccceeecchhh--h
Confidence 6666666666778888888888999999999999998 9999999999999653 489999999999986543 3
Q ss_pred ccccccccCccCccccccCCCCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhcCccccccCcccccCC
Q 001658 852 STRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEIELADPKLIEFN 931 (1036)
Q Consensus 852 ~~~~~gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~ 931 (1036)
...++||+.|+|||++....|...-|+||.|||+|--++|..||....+- .+.++.+ ..+..|.- -
T Consensus 723 RrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdI--ndQIQNA---------aFMyPp~P---W 788 (888)
T KOG4236|consen 723 RRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDI--NDQIQNA---------AFMYPPNP---W 788 (888)
T ss_pred hhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccch--hHHhhcc---------ccccCCCc---h
Confidence 34578999999999999999999999999999999999999999765432 2222211 11111211 1
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 001658 932 EEEVKRLIGVALLCTQTLPSLRPSMSRVVA 961 (1036)
Q Consensus 932 ~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 961 (1036)
.+.....++++...++..-.+|-+.++-+.
T Consensus 789 ~eis~~AidlIn~LLqVkm~kRysvdk~ls 818 (888)
T KOG4236|consen 789 SEISPEAIDLINNLLQVKMRKRYSVDKSLS 818 (888)
T ss_pred hhcCHHHHHHHHHHHHHHHHHhcchHhhcc
Confidence 233334556666777887788888776543
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-30 Score=277.54 Aligned_cols=254 Identities=26% Similarity=0.348 Sum_probs=193.2
Q ss_pred hcCCCCCCccccCCCEEEEEeE-eCCCcEEEEEEccccc--hh-----cHHHHHHHHHHHHhhccCCcceeEeEEE-cCc
Q 001658 692 TENFSPSNKLGEGGFGPVYKGK-LGDGRAIAVKQLSVAS--RQ-----GKSQFVAEIATISAVQHRNLVKLHGCCI-EGA 762 (1036)
Q Consensus 692 ~~~~~~~~~iG~G~fG~Vy~~~-~~~g~~vAvK~~~~~~--~~-----~~~~f~~Ei~~L~~l~H~nIv~l~g~~~-~~~ 762 (1036)
.++|-.+.+||+|||+.||||. +...+.||||+-.... ++ -.+...+|.++.+.++||.||++|+|+. +.+
T Consensus 462 n~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtd 541 (775)
T KOG1151|consen 462 NDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTD 541 (775)
T ss_pred HHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccc
Confidence 4567778899999999999997 5677899999753321 11 1234678999999999999999999986 456
Q ss_pred eeEEEEEecCCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecC---CCceEEEEcC
Q 001658 763 ERLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDA---DLVPKISDFG 839 (1036)
Q Consensus 763 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~---~~~~kl~DFG 839 (1036)
.++-|+|||+|.+|+-||.. ...+++..++.|+.||+.||.||.+.. +||||-||||.|||+-. -|.+||.|||
T Consensus 542 sFCTVLEYceGNDLDFYLKQ--hklmSEKEARSIiMQiVnAL~YLNEik-pPIIHYDLKPgNILLv~GtacGeIKITDFG 618 (775)
T KOG1151|consen 542 SFCTVLEYCEGNDLDFYLKQ--HKLMSEKEARSIIMQIVNALKYLNEIK-PPIIHYDLKPGNILLVNGTACGEIKITDFG 618 (775)
T ss_pred cceeeeeecCCCchhHHHHh--hhhhhHHHHHHHHHHHHHHHHHHhccC-CCeeeeccCCccEEEecCcccceeEeeecc
Confidence 78899999999999999954 345788999999999999999999875 77999999999999954 4789999999
Q ss_pred cceeecCCCCc------cccccccccCccCcccccc----CCCCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHH
Q 001658 840 LAKLYDDKKTH------ISTRVAGTIGYLAPEYAMR----GHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEW 909 (1036)
Q Consensus 840 la~~~~~~~~~------~~~~~~gt~~y~APE~~~~----~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~ 909 (1036)
+++.+.++... .....+||..|++||.+.- .+++.|+||||.|||+|+++-|+.||....... .+.+
T Consensus 619 LSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQ--dILq- 695 (775)
T KOG1151|consen 619 LSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQ--DILQ- 695 (775)
T ss_pred hhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHH--HHHh-
Confidence 99988754322 3456789999999999853 357889999999999999999999998654322 2211
Q ss_pred HHHHhhcCccccccCcccc--cCCHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 001658 910 AWHLHENNQEIELADPKLI--EFNEEEVKRLIGVALLCTQTLPSLRPSMSRVV 960 (1036)
Q Consensus 910 ~~~~~~~~~~~~~~d~~~~--~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl 960 (1036)
++.++..-.-.++ .....+ ...++.+|++.--++|....|+.
T Consensus 696 ------eNTIlkAtEVqFP~KPvVsse---AkaFIRRCLaYRKeDR~DV~qLA 739 (775)
T KOG1151|consen 696 ------ENTILKATEVQFPPKPVVSSE---AKAFIRRCLAYRKEDRIDVQQLA 739 (775)
T ss_pred ------hhchhcceeccCCCCCccCHH---HHHHHHHHHHhhhhhhhhHHHHc
Confidence 1111111111111 111223 34456789999999998877654
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-29 Score=273.27 Aligned_cols=221 Identities=20% Similarity=0.158 Sum_probs=175.6
Q ss_pred CCCEEEEEeEe-CCCcEEEEEEccccchhcHHHHHHHHHHHHhhccCCcceeEeEEEcCceeEEEEEecCCCChhhhhhc
Q 001658 704 GGFGPVYKGKL-GDGRAIAVKQLSVASRQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLVYEYLENKSLDQALFG 782 (1036)
Q Consensus 704 G~fG~Vy~~~~-~~g~~vAvK~~~~~~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~ 782 (1036)
|.||.||+++. .+++.||+|.+.... .+..|...+....||||+++++++.+.+..++||||+++|+|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 89999999985 478899999987543 234455556666799999999999999999999999999999999865
Q ss_pred CCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeecCCCCccccccccccCcc
Q 001658 783 QRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVAGTIGYL 862 (1036)
Q Consensus 783 ~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~ 862 (1036)
. ..+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.++++|||.+....... ....++..|+
T Consensus 79 ~--~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~----~~~~~~~~y~ 149 (237)
T cd05576 79 F--LNIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC----DGEAVENMYC 149 (237)
T ss_pred h--cCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhcccccc----ccCCcCcccc
Confidence 3 35889999999999999999999987 9999999999999999999999999886654321 1234567899
Q ss_pred CccccccCCCCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhcCccccccCcccccCCHHHHHHHHHHH
Q 001658 863 APEYAMRGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEIELADPKLIEFNEEEVKRLIGVA 942 (1036)
Q Consensus 863 APE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~ 942 (1036)
|||.+.+..++.++||||+|+++|||++|+.|+....... . .. ....+ +......+.+++
T Consensus 150 aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~------------~--~~---~~~~~---~~~~~~~~~~li 209 (237)
T cd05576 150 APEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI------------N--TH---TTLNI---PEWVSEEARSLL 209 (237)
T ss_pred CCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc------------c--cc---cccCC---cccCCHHHHHHH
Confidence 9999988889999999999999999999998765321100 0 00 00011 112234567788
Q ss_pred HHhcccCCCCCCCHHH
Q 001658 943 LLCTQTLPSLRPSMSR 958 (1036)
Q Consensus 943 ~~Cl~~dP~~RPt~~e 958 (1036)
.+|++.||++||++.+
T Consensus 210 ~~~l~~dp~~R~~~~~ 225 (237)
T cd05576 210 QQLLQFNPTERLGAGV 225 (237)
T ss_pred HHHccCCHHHhcCCCc
Confidence 8999999999999743
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=3e-29 Score=293.29 Aligned_cols=259 Identities=20% Similarity=0.241 Sum_probs=178.9
Q ss_pred HhcCCCCCCccccCCCEEEEEeEe-----------------CCCcEEEEEEccccchhcHHH--------------HHHH
Q 001658 691 ATENFSPSNKLGEGGFGPVYKGKL-----------------GDGRAIAVKQLSVASRQGKSQ--------------FVAE 739 (1036)
Q Consensus 691 ~~~~~~~~~~iG~G~fG~Vy~~~~-----------------~~g~~vAvK~~~~~~~~~~~~--------------f~~E 739 (1036)
..++|++.++||+|+||.||+|.. .+++.||||++........++ +..|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 467899999999999999999963 245689999986543322222 3457
Q ss_pred HHHHHhhccCCc-----ceeEeEEEc--------CceeEEEEEecCCCChhhhhhcCC----------------------
Q 001658 740 IATISAVQHRNL-----VKLHGCCIE--------GAERLLVYEYLENKSLDQALFGQR---------------------- 784 (1036)
Q Consensus 740 i~~L~~l~H~nI-----v~l~g~~~~--------~~~~~lV~E~~~~gsL~~~l~~~~---------------------- 784 (1036)
+.++.+++|.++ ++++++|.. .+..++||||+++++|.++++...
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 778888876654 678888753 356799999999999999987531
Q ss_pred CCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeecCCCCccccccccccCccCc
Q 001658 785 SLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVAGTIGYLAP 864 (1036)
Q Consensus 785 ~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~AP 864 (1036)
...++|..+..|+.|+++||.|||+.+ |+||||||+|||++.++.+||+|||+++..............+|+.|+||
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aP 379 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPP 379 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeCh
Confidence 123567888999999999999999987 99999999999999999999999999976543322222223457899999
Q ss_pred cccccCCC----------------------CchhhHHhHHHHHHHHHhCCC-CCCCCChhh------HHHHHHHHHHHhh
Q 001658 865 EYAMRGHL----------------------TEKTDVFAFGVLALETVSGRP-NSDPSLDEE------KLYLLEWAWHLHE 915 (1036)
Q Consensus 865 E~~~~~~~----------------------~~ksDVwS~Gvvl~elltG~~-p~~~~~~~~------~~~l~~~~~~~~~ 915 (1036)
|.+..... ..+.||||+||+++||++|.. |+....... ...+..|. ...
T Consensus 380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r--~~~ 457 (507)
T PLN03224 380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWR--MYK 457 (507)
T ss_pred hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHH--hhc
Confidence 98754321 124799999999999999875 554311100 01111111 111
Q ss_pred cCccccccCcccccCCHHHHHHHHHHHHHhcccCC---CCCCCHHHHHH
Q 001658 916 NNQEIELADPKLIEFNEEEVKRLIGVALLCTQTLP---SLRPSMSRVVA 961 (1036)
Q Consensus 916 ~~~~~~~~d~~~~~~~~~~~~~l~~l~~~Cl~~dP---~~RPt~~evl~ 961 (1036)
.. ..+....+... ....+++.+++..+| .+|+|++|+++
T Consensus 458 ~~----~~~~~~~d~~s---~~~~dLi~~LL~~~~~~~~~RlSa~eaL~ 499 (507)
T PLN03224 458 GQ----KYDFSLLDRNK---EAGWDLACKLITKRDQANRGRLSVGQALS 499 (507)
T ss_pred cc----CCCcccccccC---hHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence 11 01111112222 344555666777655 78999999885
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.6e-29 Score=269.48 Aligned_cols=238 Identities=25% Similarity=0.350 Sum_probs=193.3
Q ss_pred CCEEEEEeEeC-CCcEEEEEEccccchhc-HHHHHHHHHHHHhhccCCcceeEeEEEcCceeEEEEEecCCCChhhhhhc
Q 001658 705 GFGPVYKGKLG-DGRAIAVKQLSVASRQG-KSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLVYEYLENKSLDQALFG 782 (1036)
Q Consensus 705 ~fG~Vy~~~~~-~g~~vAvK~~~~~~~~~-~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~ 782 (1036)
+||.||+|+.. +++.+|+|++....... .+.+.+|++.+++++|+||+++++++......++++||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 58999999976 48999999997655444 67899999999999999999999999999999999999999999999865
Q ss_pred CCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeecCCCCccccccccccCcc
Q 001658 783 QRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVAGTIGYL 862 (1036)
Q Consensus 783 ~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~ 862 (1036)
... +++..++.++.++++++.|||+.+ ++|+||+|+||++++++.++|+|||.+....... ......++..|+
T Consensus 81 ~~~--~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~ 153 (244)
T smart00220 81 RGR--LSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFVGTPEYM 153 (244)
T ss_pred ccC--CCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeecccc--ccccccCCcCCC
Confidence 433 889999999999999999999987 9999999999999999999999999998775432 223456888999
Q ss_pred CccccccCCCCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhcCccccccCcccccCCHHHHHHHHHHH
Q 001658 863 APEYAMRGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEIELADPKLIEFNEEEVKRLIGVA 942 (1036)
Q Consensus 863 APE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~ 942 (1036)
+||......++.++||||||++++|+++|..||........ ..++.. .. ..............+.+++
T Consensus 154 ~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~--~~~~~~----~~------~~~~~~~~~~~~~~~~~~i 221 (244)
T smart00220 154 APEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLE--LFKKIG----KP------KPPFPPPEWKISPEAKDLI 221 (244)
T ss_pred CHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHH--HHHHHh----cc------CCCCccccccCCHHHHHHH
Confidence 99999988899999999999999999999999876322111 111111 00 0000000001345788899
Q ss_pred HHhcccCCCCCCCHHHHHH
Q 001658 943 LLCTQTLPSLRPSMSRVVA 961 (1036)
Q Consensus 943 ~~Cl~~dP~~RPt~~evl~ 961 (1036)
.+|+..+|++||++.++++
T Consensus 222 ~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 222 RKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HHHccCCchhccCHHHHhh
Confidence 9999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-29 Score=241.37 Aligned_cols=262 Identities=21% Similarity=0.301 Sum_probs=192.1
Q ss_pred CCCCCCccccCCCEEEEEeEe-CCCcEEEEEEcccc--chhcHHHHHHHHHHHHhhccCCcceeEeEEEcCceeEEEEEe
Q 001658 694 NFSPSNKLGEGGFGPVYKGKL-GDGRAIAVKQLSVA--SRQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLVYEY 770 (1036)
Q Consensus 694 ~~~~~~~iG~G~fG~Vy~~~~-~~g~~vAvK~~~~~--~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~ 770 (1036)
+|...++||+|.||+||||+. ..++.||+|.++.. ++.-.....+|+-+|+.++|+|||++++....+...-+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 455668899999999999985 46889999998654 333456788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeecCCCCc
Q 001658 771 LENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTH 850 (1036)
Q Consensus 771 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~ 850 (1036)
|. .+|..+...- +..++......++.|+++||.|+|++. +.|||+||.|.|++.+|+.|++|||+++-++-.-..
T Consensus 83 cd-qdlkkyfdsl-ng~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglarafgipvrc 157 (292)
T KOG0662|consen 83 CD-QDLKKYFDSL-NGDLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRC 157 (292)
T ss_pred hh-HHHHHHHHhc-CCcCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhhcCCceEe
Confidence 95 4788776443 567888999999999999999999998 999999999999999999999999999977644322
Q ss_pred cccccccccCccCccccccCC-CCchhhHHhHHHHHHHHHhCCCCCCCCCh-hhHHHHHHHHHHHhhcC-c--cccccCc
Q 001658 851 ISTRVAGTIGYLAPEYAMRGH-LTEKTDVFAFGVLALETVSGRPNSDPSLD-EEKLYLLEWAWHLHENN-Q--EIELADP 925 (1036)
Q Consensus 851 ~~~~~~gt~~y~APE~~~~~~-~~~ksDVwS~Gvvl~elltG~~p~~~~~~-~~~~~l~~~~~~~~~~~-~--~~~~~d~ 925 (1036)
....+-|..|.+|.++.+.+ |+...|+||.|||+.|+.....|.-+..+ .++...+-|.-....+. + ...+.|.
T Consensus 158 -ysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdy 236 (292)
T KOG0662|consen 158 -YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDY 236 (292)
T ss_pred -eeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCC
Confidence 23345688999999998865 88999999999999999875555444333 34433333332222211 1 1223332
Q ss_pred cc-ccCC---------HHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 001658 926 KL-IEFN---------EEEVKRLIGVALLCTQTLPSLRPSMSRVVA 961 (1036)
Q Consensus 926 ~~-~~~~---------~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 961 (1036)
.. ..++ +.....=.++....+.-+|.+|.++++.++
T Consensus 237 k~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq 282 (292)
T KOG0662|consen 237 KPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ 282 (292)
T ss_pred cccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence 22 1111 111111223333444557999999888765
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.8e-29 Score=301.35 Aligned_cols=259 Identities=22% Similarity=0.241 Sum_probs=170.2
Q ss_pred HhcCCCCCCccccCCCEEEEEeEeC-C----CcEEEEEEccccchhcHHHHHHHHHHHHhhccCCcceeEeE------EE
Q 001658 691 ATENFSPSNKLGEGGFGPVYKGKLG-D----GRAIAVKQLSVASRQGKSQFVAEIATISAVQHRNLVKLHGC------CI 759 (1036)
Q Consensus 691 ~~~~~~~~~~iG~G~fG~Vy~~~~~-~----g~~vAvK~~~~~~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~------~~ 759 (1036)
..++|++.+.||+|+||.||+|+.. + +..||+|++..... .+.+..| .+....+.+++.++.. +.
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~--~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA--VEIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch--hHHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 5678999999999999999999865 4 68999998763221 1111111 1122222222222221 24
Q ss_pred cCceeEEEEEecCCCChhhhhhcCCCC------------------CcChHHHHHHHHHHHHHHHHHHhcCCccccccccC
Q 001658 760 EGAERLLVYEYLENKSLDQALFGQRSL------------------TLDWATRYEICSGVARGLAYLHEESRVRIIHRDVK 821 (1036)
Q Consensus 760 ~~~~~~lV~E~~~~gsL~~~l~~~~~~------------------~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik 821 (1036)
.+...++|+||+++++|.+++...... ...+..+..|+.|+++||+|||+.+ |+|||||
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDLK 282 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVK 282 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcCC
Confidence 566789999999999999998653210 1122345579999999999999987 9999999
Q ss_pred CCcEEecC-CCceEEEEcCcceeecCCCCccccccccccCccCccccccC----------------------CCCchhhH
Q 001658 822 ASNVLLDA-DLVPKISDFGLAKLYDDKKTHISTRVAGTIGYLAPEYAMRG----------------------HLTEKTDV 878 (1036)
Q Consensus 822 p~NILl~~-~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~----------------------~~~~ksDV 878 (1036)
|+|||+++ ++.+||+|||+++.+............||+.|||||.+... .+..++||
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DV 362 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDI 362 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCccc
Confidence 99999986 58999999999987654444444556789999999966322 23456799
Q ss_pred HhHHHHHHHHHhCCCCCCCCChhhH-------HHHHHHHHHHhhcCccccccCccc---ccCCHHHHHHHHHHHHHhccc
Q 001658 879 FAFGVLALETVSGRPNSDPSLDEEK-------LYLLEWAWHLHENNQEIELADPKL---IEFNEEEVKRLIGVALLCTQT 948 (1036)
Q Consensus 879 wS~Gvvl~elltG~~p~~~~~~~~~-------~~l~~~~~~~~~~~~~~~~~d~~~---~~~~~~~~~~l~~l~~~Cl~~ 948 (1036)
|||||++|||+++..+++....... .....|....... ..+.. .+..........+++.+|++.
T Consensus 363 wSlGviL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~d~~~~~~~dLi~~mL~~ 436 (566)
T PLN03225 363 YSAGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLVEPR------ASPDLRRGFEVLDLDGGAGWELLKSMMRF 436 (566)
T ss_pred HHHHHHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhhccc------cchhhhhhhhhccccchHHHHHHHHHccC
Confidence 9999999999997765442111000 0011121111000 00000 000011122345788899999
Q ss_pred CCCCCCCHHHHHHH
Q 001658 949 LPSLRPSMSRVVAM 962 (1036)
Q Consensus 949 dP~~RPt~~evl~~ 962 (1036)
||.+|||+.|+++.
T Consensus 437 dP~kR~ta~e~L~H 450 (566)
T PLN03225 437 KGRQRISAKAALAH 450 (566)
T ss_pred CcccCCCHHHHhCC
Confidence 99999999999863
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-30 Score=261.35 Aligned_cols=264 Identities=24% Similarity=0.385 Sum_probs=195.8
Q ss_pred CCCCCCccccCCCEEEEEeEeC-CCcEEEEEEccccc--hhcHHHHHHHHHHHHhhccCCcceeEeEEEc--------Cc
Q 001658 694 NFSPSNKLGEGGFGPVYKGKLG-DGRAIAVKQLSVAS--RQGKSQFVAEIATISAVQHRNLVKLHGCCIE--------GA 762 (1036)
Q Consensus 694 ~~~~~~~iG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~--~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~--------~~ 762 (1036)
.|....+||+|.||.||+|+.+ .|+.||+|++-... ..-.....+|+++|..++|+|++.+++.|.. ..
T Consensus 18 ~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~ 97 (376)
T KOG0669|consen 18 KYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRA 97 (376)
T ss_pred HHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccc
Confidence 3445578999999999999865 57889998764322 2223456789999999999999999998863 23
Q ss_pred eeEEEEEecCCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcce
Q 001658 763 ERLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAK 842 (1036)
Q Consensus 763 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~ 842 (1036)
..++|+++|+. +|.-+|. +....++..++.+++.++..||.|+|... |+|||+|+.|+||+.++.+||+|||+++
T Consensus 98 t~ylVf~~ceh-DLaGlLs-n~~vr~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgilklADFGlar 172 (376)
T KOG0669|consen 98 TFYLVFDFCEH-DLAGLLS-NRKVRFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGILKLADFGLAR 172 (376)
T ss_pred eeeeeHHHhhh-hHHHHhc-CccccccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceEEeecccccc
Confidence 57999999975 7777663 34567888899999999999999999887 9999999999999999999999999998
Q ss_pred eecCCCC---ccccccccccCccCcccccc-CCCCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHh----
Q 001658 843 LYDDKKT---HISTRVAGTIGYLAPEYAMR-GHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLH---- 914 (1036)
Q Consensus 843 ~~~~~~~---~~~~~~~gt~~y~APE~~~~-~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~---- 914 (1036)
.+..... ...+..+-|..|.+||.+.+ ..|+++.|||..|||+.||+|+.+-++...+.....++...-...
T Consensus 173 ~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkev 252 (376)
T KOG0669|consen 173 AFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEV 252 (376)
T ss_pred ceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCccc
Confidence 6653322 22344567999999999886 469999999999999999999999998877766666554322111
Q ss_pred -hcCccccc---cC-cccc----cCCHHHHH------HHHHHHHHhcccCCCCCCCHHHHHHH
Q 001658 915 -ENNQEIEL---AD-PKLI----EFNEEEVK------RLIGVALLCTQTLPSLRPSMSRVVAM 962 (1036)
Q Consensus 915 -~~~~~~~~---~d-~~~~----~~~~~~~~------~l~~l~~~Cl~~dP~~RPt~~evl~~ 962 (1036)
.+-...++ +. +.+. ....+..+ ...+++..++..||.+|+++++++..
T Consensus 253 WP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh 315 (376)
T KOG0669|consen 253 WPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNH 315 (376)
T ss_pred CCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhch
Confidence 11110000 00 0010 01111222 45566677889999999999998764
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-29 Score=286.88 Aligned_cols=240 Identities=27% Similarity=0.337 Sum_probs=189.4
Q ss_pred HhcCCCCCCccccCCCEEEEEeEe-CCCcEEEEEEccccchhcHHHHHHHHHHHHhh-ccCCcceeEeEEEcCceeEEEE
Q 001658 691 ATENFSPSNKLGEGGFGPVYKGKL-GDGRAIAVKQLSVASRQGKSQFVAEIATISAV-QHRNLVKLHGCCIEGAERLLVY 768 (1036)
Q Consensus 691 ~~~~~~~~~~iG~G~fG~Vy~~~~-~~g~~vAvK~~~~~~~~~~~~f~~Ei~~L~~l-~H~nIv~l~g~~~~~~~~~lV~ 768 (1036)
.++.|.....+|.|+|+.|-++.. .+++..+||++.... .+-.+|+.++... +||||+++.+.+.+..+.++||
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~ 395 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVM 395 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheeccccc----cccccccchhhhhcCCCcceeecceecCCceeeeee
Confidence 356777788899999999999975 467889999997542 2334567666665 6999999999999999999999
Q ss_pred EecCCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEe-cCCCceEEEEcCcceeecCC
Q 001658 769 EYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLL-DADLVPKISDFGLAKLYDDK 847 (1036)
Q Consensus 769 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl-~~~~~~kl~DFGla~~~~~~ 847 (1036)
|.+.++-+.+.+...+. ....+..|+.+|+.|+.|||++| |||||+||+|||+ ++.++++|+|||.++.....
T Consensus 396 e~l~g~ell~ri~~~~~---~~~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~ 469 (612)
T KOG0603|consen 396 ELLDGGELLRRIRSKPE---FCSEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS 469 (612)
T ss_pred hhccccHHHHHHHhcch---hHHHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechhhhCchh
Confidence 99999988887754432 22677789999999999999998 9999999999999 58899999999999877654
Q ss_pred CCccccccccccCccCccccccCCCCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhcCccccccCccc
Q 001658 848 KTHISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEIELADPKL 927 (1036)
Q Consensus 848 ~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~ 927 (1036)
....+-|..|.|||+.....|++++|+||||++||+|++|+.||.....+... .. .+..+.+
T Consensus 470 ----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei--~~------------~i~~~~~ 531 (612)
T KOG0603|consen 470 ----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEI--HT------------RIQMPKF 531 (612)
T ss_pred ----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHH--HH------------hhcCCcc
Confidence 12234577999999999999999999999999999999999999875544111 11 0111222
Q ss_pred ccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 001658 928 IEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVA 961 (1036)
Q Consensus 928 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 961 (1036)
.....+. ..+++.+|++.||.+||+|.|+..
T Consensus 532 s~~vS~~---AKdLl~~LL~~dP~~Rl~~~~i~~ 562 (612)
T KOG0603|consen 532 SECVSDE---AKDLLQQLLQVDPALRLGADEIGA 562 (612)
T ss_pred ccccCHH---HHHHHHHhccCChhhCcChhhhcc
Confidence 2223344 445556899999999999999865
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-29 Score=248.08 Aligned_cols=201 Identities=27% Similarity=0.375 Sum_probs=165.9
Q ss_pred CCCCCCccccCCCEEEEEeEe-CCCcEEEEEEcccc-chhcHHHHHHHHHHHHh-hccCCcceeEeEEEcCceeEEEEEe
Q 001658 694 NFSPSNKLGEGGFGPVYKGKL-GDGRAIAVKQLSVA-SRQGKSQFVAEIATISA-VQHRNLVKLHGCCIEGAERLLVYEY 770 (1036)
Q Consensus 694 ~~~~~~~iG~G~fG~Vy~~~~-~~g~~vAvK~~~~~-~~~~~~~f~~Ei~~L~~-l~H~nIv~l~g~~~~~~~~~lV~E~ 770 (1036)
.......||+|++|.|-+-++ .+|+..|+|.+... ..+..++...|+.+..+ ..+|.+|.+||...+....++.||.
T Consensus 47 ~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~ 126 (282)
T KOG0984|consen 47 DLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMEL 126 (282)
T ss_pred hhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHH
Confidence 334457799999999998884 58999999998653 34456677888887654 4799999999999999999999999
Q ss_pred cCCCChhhhhhc--CCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeecCCC
Q 001658 771 LENKSLDQALFG--QRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKK 848 (1036)
Q Consensus 771 ~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~ 848 (1036)
|. -||+.+-.. .+...+++...-+||..+.+||.|||++- .++|||+||+|||++.+|++|+||||++-.+.+.-
T Consensus 127 M~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSi 203 (282)
T KOG0984|consen 127 MD-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFGISGYLVDSI 203 (282)
T ss_pred hh-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcccccceeehhhh
Confidence 94 588765432 23567888888899999999999999975 69999999999999999999999999998775432
Q ss_pred CccccccccccCccCcccccc----CCCCchhhHHhHHHHHHHHHhCCCCCCCCC
Q 001658 849 THISTRVAGTIGYLAPEYAMR----GHLTEKTDVFAFGVLALETVSGRPNSDPSL 899 (1036)
Q Consensus 849 ~~~~~~~~gt~~y~APE~~~~----~~~~~ksDVwS~Gvvl~elltG~~p~~~~~ 899 (1036)
. .+-..|...|||||.+.. ..|+.|+||||+|+.+.||.+++.|++...
T Consensus 204 A--kt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~ 256 (282)
T KOG0984|consen 204 A--KTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWG 256 (282)
T ss_pred H--HHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccC
Confidence 2 122457889999999853 368999999999999999999999998644
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-30 Score=287.92 Aligned_cols=300 Identities=21% Similarity=0.215 Sum_probs=267.4
Q ss_pred eeeEeEEEEeeccccccCCccccCCCCCCEEEccCCCCCCCCcccccCCCcCCeeecccccccCCccccccCCCCCcEEE
Q 001658 98 VCHITQLKVYALNVVGVIPDELWNLTSLFNLNLGQNYLTGPLSPSVGNLTAMQYLNLAINALSGELPKELGQLTELLILG 177 (1036)
Q Consensus 98 ~~~l~~L~l~~~~~~~~ip~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~L~~L~~L~ 177 (1036)
..+++.|+|.+|-++..-.+++..++.|+.||||.|.|+.+.-.+|..-.++++|+|++|+|+..-...|..|.+|..|.
T Consensus 124 sghl~~L~L~~N~I~sv~se~L~~l~alrslDLSrN~is~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tlk 203 (873)
T KOG4194|consen 124 SGHLEKLDLRHNLISSVTSEELSALPALRSLDLSRNLISEIPKPSFPAKVNIKKLNLASNRITTLETGHFDSLNSLLTLK 203 (873)
T ss_pred ccceeEEeeeccccccccHHHHHhHhhhhhhhhhhchhhcccCCCCCCCCCceEEeeccccccccccccccccchheeee
Confidence 35789999999988888888999999999999999999966567788888999999999999988888999999999999
Q ss_pred cccCCCCCCCccccCCCccCCEEeCccccCCCCCCccccCCCCCcEEeccCCcCCCCChhhhcCCCCCCEEEeeCCcCCC
Q 001658 178 IGTNNFSGPLPSELGSLSKLQELYIDSAGVSGEIPSSFANLQSLTKWWASDTRLTGRIPDFIGNWSKLTALRFQGNSFNG 257 (1036)
Q Consensus 178 Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~ 257 (1036)
|++|+++...+..|.+|++|+.|+|..|+|.-..--.|.+|++|+.|.|..|.+.......|-.|.++++|+|..|++..
T Consensus 204 LsrNrittLp~r~Fk~L~~L~~LdLnrN~irive~ltFqgL~Sl~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N~l~~ 283 (873)
T KOG4194|consen 204 LSRNRITTLPQRSFKRLPKLESLDLNRNRIRIVEGLTFQGLPSLQNLKLQRNDISKLDDGAFYGLEKMEHLNLETNRLQA 283 (873)
T ss_pred cccCcccccCHHHhhhcchhhhhhccccceeeehhhhhcCchhhhhhhhhhcCcccccCcceeeecccceeecccchhhh
Confidence 99999997777888889999999999999986657788999999999999999998888899999999999999999998
Q ss_pred CCCccccCCCCCCEEEccCCCCCCCchhhhcCCCCCCEEEccCCccCccccccccCCCCccEEeCCCCCCCCCCchhccC
Q 001658 258 PIPSSFSNLTSVTELRISDLSNGSSKLAFIRDMKSLSILELRNNNISDSIPSNIGEYRSLQHLDLSFNNLGGSIPDSLFN 337 (1036)
Q Consensus 258 ~~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~ 337 (1036)
.-..++.+|+.|+.|+|++|.+..+..+.+.-.++|+.|+|++|+|+..-+..|..+..|+.|+|++|.|...-...|..
T Consensus 284 vn~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~ 363 (873)
T KOG4194|consen 284 VNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLAEGAFVG 363 (873)
T ss_pred hhcccccccchhhhhccchhhhheeecchhhhcccceeEeccccccccCChhHHHHHHHhhhhcccccchHHHHhhHHHH
Confidence 88889999999999999999999999999988999999999999999777788999999999999999999655667889
Q ss_pred CCCccEEEccCccccccCCCCc-----CCCccEEEeeCccCCCCCchhhhccCCcceeeecCCcc
Q 001658 338 LSSLTHLFLGNNKLNGTLPARK-----SPLLLNIDVSYNNLQGNLPSWINGQQNLQINLVANNLT 397 (1036)
Q Consensus 338 l~~L~~L~Ls~N~l~g~~p~~~-----~~~L~~Ldls~N~l~g~~p~~l~~l~~L~~~~~~nn~~ 397 (1036)
+.+|+.|||++|.|++.+.+.. .+.|+.|+|.+|+|.......|.++++|+.+++++|..
T Consensus 364 lssL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~l~gNqlk~I~krAfsgl~~LE~LdL~~Nai 428 (873)
T KOG4194|consen 364 LSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRKLRLTGNQLKSIPKRAFSGLEALEHLDLGDNAI 428 (873)
T ss_pred hhhhhhhcCcCCeEEEEEecchhhhccchhhhheeecCceeeecchhhhccCcccceecCCCCcc
Confidence 9999999999999998876642 35699999999999965557899999999999999954
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.2e-29 Score=265.86 Aligned_cols=244 Identities=25% Similarity=0.317 Sum_probs=189.8
Q ss_pred HHHhcCCCCCCccccCCCEEEEEeEeC-CCcEEEEEEccccch---hcHHHHHHHHHHHHhh-ccCCcceeEeEEEcCce
Q 001658 689 KTATENFSPSNKLGEGGFGPVYKGKLG-DGRAIAVKQLSVASR---QGKSQFVAEIATISAV-QHRNLVKLHGCCIEGAE 763 (1036)
Q Consensus 689 ~~~~~~~~~~~~iG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~---~~~~~f~~Ei~~L~~l-~H~nIv~l~g~~~~~~~ 763 (1036)
+....+|..+.+||+|+||.|-.|..+ ..+.+|||++++... .+.+--+.|-++|..- +-|.++++..++..-+.
T Consensus 345 ~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDR 424 (683)
T KOG0696|consen 345 RIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDR 424 (683)
T ss_pred ceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhh
Confidence 334567888999999999999999754 467899999976422 1222234566666655 57889999999999999
Q ss_pred eEEEEEecCCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCccee
Q 001658 764 RLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKL 843 (1036)
Q Consensus 764 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~ 843 (1036)
.|+||||+.||+|--.+... ..+.+..+.-.|..||-||-+||+++ ||.||||..|||+|.+|.+||+|||+++.
T Consensus 425 LyFVMEyvnGGDLMyhiQQ~--GkFKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGmcKE 499 (683)
T KOG0696|consen 425 LYFVMEYVNGGDLMYHIQQV--GKFKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKE 499 (683)
T ss_pred eeeEEEEecCchhhhHHHHh--cccCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeecccccc
Confidence 99999999999998777544 34566677778999999999999998 99999999999999999999999999985
Q ss_pred ecCCCCccccccccccCccCccccccCCCCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhcCcccccc
Q 001658 844 YDDKKTHISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEIELA 923 (1036)
Q Consensus 844 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 923 (1036)
---+. .....++||+.|+|||++...+|+..+|.|||||+||||+.|++||++..+++....+.
T Consensus 500 ni~~~-~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~--------------- 563 (683)
T KOG0696|consen 500 NIFDG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIM--------------- 563 (683)
T ss_pred cccCC-cceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH---------------
Confidence 43222 22345789999999999999999999999999999999999999999865544332111
Q ss_pred CcccccCCHHHHHHHHHHHHHhcccCCCCCC
Q 001658 924 DPKLIEFNEEEVKRLIGVALLCTQTLPSLRP 954 (1036)
Q Consensus 924 d~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP 954 (1036)
+.. ..++....++.+.+...-+-+.|.+|-
T Consensus 564 ehn-vsyPKslSkEAv~ickg~ltK~P~kRL 593 (683)
T KOG0696|consen 564 EHN-VSYPKSLSKEAVAICKGLLTKHPGKRL 593 (683)
T ss_pred Hcc-CcCcccccHHHHHHHHHHhhcCCcccc
Confidence 001 123333344555666667788899885
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-29 Score=275.93 Aligned_cols=243 Identities=24% Similarity=0.286 Sum_probs=199.5
Q ss_pred hcCCCCCCccccCCCEEEEEeEeCCCc-EEEEEEcccc---chhcHHHHHHHHHHHHhhccCCcceeEeEEEcCceeEEE
Q 001658 692 TENFSPSNKLGEGGFGPVYKGKLGDGR-AIAVKQLSVA---SRQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLV 767 (1036)
Q Consensus 692 ~~~~~~~~~iG~G~fG~Vy~~~~~~g~-~vAvK~~~~~---~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV 767 (1036)
..+++....||-||||.|-.++....+ .+|+|++++. +....+....|-.+|...+.|.||++|--|.+....|+.
T Consensus 419 l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmL 498 (732)
T KOG0614|consen 419 LSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYML 498 (732)
T ss_pred hhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhh
Confidence 345566678999999999999875443 4888888653 344456678899999999999999999999999999999
Q ss_pred EEecCCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeecCC
Q 001658 768 YEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDK 847 (1036)
Q Consensus 768 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~ 847 (1036)
||-|-||.|...|.. +..++..+..-++..+.+|++|||.++ ||.|||||+|.++|.+|.+||.|||.|+.+...
T Consensus 499 mEaClGGElWTiLrd--Rg~Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g 573 (732)
T KOG0614|consen 499 MEACLGGELWTILRD--RGSFDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSG 573 (732)
T ss_pred HHhhcCchhhhhhhh--cCCcccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhHHHhccC
Confidence 999999999999965 456788888888999999999999998 999999999999999999999999999988755
Q ss_pred CCccccccccccCccCccccccCCCCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhcCccccccCccc
Q 001658 848 KTHISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEIELADPKL 927 (1036)
Q Consensus 848 ~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~ 927 (1036)
... -.++||+.|.|||++.....+..+|.||+|+++|||++|++||....+...+.++-.. ++ .
T Consensus 574 ~KT--wTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkG---------id-----~ 637 (732)
T KOG0614|consen 574 RKT--WTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKG---------ID-----K 637 (732)
T ss_pred Cce--eeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhh---------hh-----h
Confidence 443 3578999999999999999999999999999999999999999987665544433111 11 1
Q ss_pred ccCCHHHHHHHHHHHHHhcccCCCCCCC
Q 001658 928 IEFNEEEVKRLIGVALLCTQTLPSLRPS 955 (1036)
Q Consensus 928 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt 955 (1036)
..++....+...+++.+.++.+|.+|-.
T Consensus 638 i~~Pr~I~k~a~~Lik~LCr~~P~ERLG 665 (732)
T KOG0614|consen 638 IEFPRRITKTATDLIKKLCRDNPTERLG 665 (732)
T ss_pred hhcccccchhHHHHHHHHHhcCcHhhhc
Confidence 2233444455666777777999999975
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.1e-30 Score=281.76 Aligned_cols=295 Identities=20% Similarity=0.184 Sum_probs=244.0
Q ss_pred eEeEEEEeeccccccCCccccCCCCCCEEEccCCCCCCCCcccccCCCcCCeeecccccccCCccccccCCCCCcEEEcc
Q 001658 100 HITQLKVYALNVVGVIPDELWNLTSLFNLNLGQNYLTGPLSPSVGNLTAMQYLNLAINALSGELPKELGQLTELLILGIG 179 (1036)
Q Consensus 100 ~l~~L~l~~~~~~~~ip~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~L~~L~~L~Ls 179 (1036)
....|++++|.+...-+..|.++++|+.++|.+|.|+ .+|...+...+|+.|+|.+|.|+..-..++.-++.|+.||||
T Consensus 79 ~t~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt-~IP~f~~~sghl~~L~L~~N~I~sv~se~L~~l~alrslDLS 157 (873)
T KOG4194|consen 79 QTQTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELT-RIPRFGHESGHLEKLDLRHNLISSVTSEELSALPALRSLDLS 157 (873)
T ss_pred ceeeeeccccccccCcHHHHhcCCcceeeeeccchhh-hcccccccccceeEEeeeccccccccHHHHHhHhhhhhhhhh
Confidence 4567999999988888899999999999999999999 888877778889999999999998777889999999999999
Q ss_pred cCCCCCCCccccCCCccCCEEeCccccCCCCCCccccCCCCCcEEeccCCcCCCCChhhhcCCCCCCEEEeeCCcCCCCC
Q 001658 180 TNNFSGPLPSELGSLSKLQELYIDSAGVSGEIPSSFANLQSLTKWWASDTRLTGRIPDFIGNWSKLTALRFQGNSFNGPI 259 (1036)
Q Consensus 180 ~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~ 259 (1036)
.|.|+...-..|..-.++++|+|++|.|+......|.++.+|..|.|+.|+++...+..|.+|++|+.|+|..|+|.-..
T Consensus 158 rN~is~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tlkLsrNrittLp~r~Fk~L~~L~~LdLnrN~irive 237 (873)
T KOG4194|consen 158 RNLISEIPKPSFPAKVNIKKLNLASNRITTLETGHFDSLNSLLTLKLSRNRITTLPQRSFKRLPKLESLDLNRNRIRIVE 237 (873)
T ss_pred hchhhcccCCCCCCCCCceEEeeccccccccccccccccchheeeecccCcccccCHHHhhhcchhhhhhccccceeeeh
Confidence 99999666677777789999999999999888899999999999999999999888888999999999999999998544
Q ss_pred CccccCCCCCCEEEccCCCCCCCchhhhcCCCCCCEEEccCCccCccccccccCCCCccEEeCCCCCCCCCCchhccCCC
Q 001658 260 PSSFSNLTSVTELRISDLSNGSSKLAFIRDMKSLSILELRNNNISDSIPSNIGEYRSLQHLDLSFNNLGGSIPDSLFNLS 339 (1036)
Q Consensus 260 p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~ 339 (1036)
-..|.+|++|+.|.|..|.+..+....|..+.++++|+|+.|+++..-..++.++.+|+.|+||+|.|...-+++....+
T Consensus 238 ~ltFqgL~Sl~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~Wsftq 317 (873)
T KOG4194|consen 238 GLTFQGLPSLQNLKLQRNDISKLDDGAFYGLEKMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQ 317 (873)
T ss_pred hhhhcCchhhhhhhhhhcCcccccCcceeeecccceeecccchhhhhhcccccccchhhhhccchhhhheeecchhhhcc
Confidence 56788888888888888888888888888888888888888888766667777888888888888888866677777778
Q ss_pred CccEEEccCccccccCCCCcC--CCccEEEeeCccCCCCCchhhhccCCcceeeecCC
Q 001658 340 SLTHLFLGNNKLNGTLPARKS--PLLLNIDVSYNNLQGNLPSWINGQQNLQINLVANN 395 (1036)
Q Consensus 340 ~L~~L~Ls~N~l~g~~p~~~~--~~L~~Ldls~N~l~g~~p~~l~~l~~L~~~~~~nn 395 (1036)
+|++|+|++|+|+...+..+. ..|+.|+|++|.++-.--..|.++.+|+.+++.+|
T Consensus 318 kL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr~N 375 (873)
T KOG4194|consen 318 KLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLAEGAFVGLSSLHKLDLRSN 375 (873)
T ss_pred cceeEeccccccccCChhHHHHHHHhhhhcccccchHHHHhhHHHHhhhhhhhcCcCC
Confidence 888888888888754444433 34777777777776554455667777776666555
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.6e-28 Score=270.83 Aligned_cols=206 Identities=24% Similarity=0.347 Sum_probs=172.9
Q ss_pred CCCCCCccccCCCEEEEEeE-eCCCcEEEEEEccccc---hhcHHHHHHHHHHHHhhccCCcceeEeEEEcCceeEEEEE
Q 001658 694 NFSPSNKLGEGGFGPVYKGK-LGDGRAIAVKQLSVAS---RQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLVYE 769 (1036)
Q Consensus 694 ~~~~~~~iG~G~fG~Vy~~~-~~~g~~vAvK~~~~~~---~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E 769 (1036)
-|...+.||-|+||.|..++ .+....+|.|.+++.+ +........|-+||...+.+-||+||-.|.+.+..|+|||
T Consensus 630 mFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMd 709 (1034)
T KOG0608|consen 630 MFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 709 (1034)
T ss_pred ceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEe
Confidence 46667889999999999996 4456779999997654 3344567789999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeec--C-
Q 001658 770 YLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYD--D- 846 (1036)
Q Consensus 770 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~--~- 846 (1036)
|++||++-.+|.+. ..+++..++-++..+..|+++.|..| +|||||||+|||||.+|.+||.||||+.-+. .
T Consensus 710 YIPGGDmMSLLIrm--gIFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHd 784 (1034)
T KOG0608|consen 710 YIPGGDMMSLLIRM--GIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD 784 (1034)
T ss_pred ccCCccHHHHHHHh--ccCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeeeeccccccceeccc
Confidence 99999999988654 34666666667889999999999998 9999999999999999999999999986432 0
Q ss_pred -----CCCc---------------------------------cccccccccCccCccccccCCCCchhhHHhHHHHHHHH
Q 001658 847 -----KKTH---------------------------------ISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALET 888 (1036)
Q Consensus 847 -----~~~~---------------------------------~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~el 888 (1036)
...+ .....+||+.|+|||++....++.-+|.||.|||||||
T Consensus 785 skYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em 864 (1034)
T KOG0608|consen 785 SKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEM 864 (1034)
T ss_pred cccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHH
Confidence 0000 00125699999999999999999999999999999999
Q ss_pred HhCCCCCCCCChhhHH
Q 001658 889 VSGRPNSDPSLDEEKL 904 (1036)
Q Consensus 889 ltG~~p~~~~~~~~~~ 904 (1036)
+.|++||....+.+..
T Consensus 865 ~~g~~pf~~~tp~~tq 880 (1034)
T KOG0608|consen 865 LVGQPPFLADTPGETQ 880 (1034)
T ss_pred hhCCCCccCCCCCcce
Confidence 9999999987765544
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.9e-29 Score=285.08 Aligned_cols=244 Identities=29% Similarity=0.398 Sum_probs=185.1
Q ss_pred CCCCCccccCCCE-EEEEeEeCCCcEEEEEEccccchhcHHHHHHHHHHHHhh-ccCCcceeEeEEEcCceeEEEEEecC
Q 001658 695 FSPSNKLGEGGFG-PVYKGKLGDGRAIAVKQLSVASRQGKSQFVAEIATISAV-QHRNLVKLHGCCIEGAERLLVYEYLE 772 (1036)
Q Consensus 695 ~~~~~~iG~G~fG-~Vy~~~~~~g~~vAvK~~~~~~~~~~~~f~~Ei~~L~~l-~H~nIv~l~g~~~~~~~~~lV~E~~~ 772 (1036)
|...+.+|.|+.| .||+|.. +|+.||||++-... .+...+|+..|+.- +|||||++++.-.+....|+..|.|
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~e~---~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC- 585 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVY-EGREVAVKRLLEEF---FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC- 585 (903)
T ss_pred eccHHHcccCCCCcEEEEEee-CCceehHHHHhhHh---HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh-
Confidence 3445678999987 5799999 67999999985332 33557899999887 5999999999999999999999999
Q ss_pred CCChhhhhhcC-CCCC-cChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecC---C--CceEEEEcCcceeec
Q 001658 773 NKSLDQALFGQ-RSLT-LDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDA---D--LVPKISDFGLAKLYD 845 (1036)
Q Consensus 773 ~gsL~~~l~~~-~~~~-l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~---~--~~~kl~DFGla~~~~ 845 (1036)
..+|.+++... .... ..-...+.+..|+++||++||+.+ ||||||||.||||+. + .+++|+|||+++.+.
T Consensus 586 ~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~ 662 (903)
T KOG1027|consen 586 ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA 662 (903)
T ss_pred hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence 56999999763 1111 111345678899999999999987 999999999999976 3 579999999999887
Q ss_pred CCCCccc--cccccccCccCccccccCCCCchhhHHhHHHHHHHHHhC-CCCCCCCChhhHHHHHHHHHHHhhcCccccc
Q 001658 846 DKKTHIS--TRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSG-RPNSDPSLDEEKLYLLEWAWHLHENNQEIEL 922 (1036)
Q Consensus 846 ~~~~~~~--~~~~gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~elltG-~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 922 (1036)
.+..... ....||-||+|||++....-+.++||||+|||+|+.++| ..||+.....+ ..+.. .+.....
T Consensus 663 ~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~-~NIl~-------~~~~L~~ 734 (903)
T KOG1027|consen 663 GGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQ-ANILT-------GNYTLVH 734 (903)
T ss_pred CCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhh-hhhhc-------Cccceee
Confidence 6544332 356799999999999998888899999999999999997 78887643321 11110 1111111
Q ss_pred cCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 001658 923 ADPKLIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVA 961 (1036)
Q Consensus 923 ~d~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 961 (1036)
+.+ .... ...+++.+|+..+|..||++.+|+.
T Consensus 735 L~~----~~d~---eA~dLI~~ml~~dP~~RPsa~~VL~ 766 (903)
T KOG1027|consen 735 LEP----LPDC---EAKDLISRMLNPDPQLRPSATDVLN 766 (903)
T ss_pred ecc----CchH---HHHHHHHHhcCCCcccCCCHHHHhC
Confidence 111 1111 5566677899999999999999974
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.3e-29 Score=252.31 Aligned_cols=262 Identities=22% Similarity=0.325 Sum_probs=193.9
Q ss_pred CCCCCccccCCCEEEEEeEe-CCCcEEEEEEcccc--chhcHHHHHHHHHHHHhhccCCcceeEeEEEcC-----ceeEE
Q 001658 695 FSPSNKLGEGGFGPVYKGKL-GDGRAIAVKQLSVA--SRQGKSQFVAEIATISAVQHRNLVKLHGCCIEG-----AERLL 766 (1036)
Q Consensus 695 ~~~~~~iG~G~fG~Vy~~~~-~~g~~vAvK~~~~~--~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~-----~~~~l 766 (1036)
.+..+.||-|+||.||.+.. ++|+.||.|++... +-...+.+.+|+++|..++|.|++..++...-. .+.|+
T Consensus 55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV 134 (449)
T KOG0664|consen 55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYV 134 (449)
T ss_pred CCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHH
Confidence 34568899999999999975 58999999988543 233457889999999999999999988876533 35678
Q ss_pred EEEecCCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeecC
Q 001658 767 VYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDD 846 (1036)
Q Consensus 767 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~ 846 (1036)
|+|.|. .+|++.+-. ...++-..+.-+..||++||+|||+.+ |.||||||.|.|++.+...||||||+++....
T Consensus 135 ~TELmQ-SDLHKIIVS--PQ~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGLARvee~ 208 (449)
T KOG0664|consen 135 LTELMQ-SDLHKIIVS--PQALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGLARTWDQ 208 (449)
T ss_pred HHHHHH-hhhhheecc--CCCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEecccccccccch
Confidence 899884 588887744 334555556667999999999999988 99999999999999999999999999997765
Q ss_pred CCCccccccccccCccCccccccC-CCCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHH---------HHHHHhhc
Q 001658 847 KKTHISTRVAGTIGYLAPEYAMRG-HLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLE---------WAWHLHEN 916 (1036)
Q Consensus 847 ~~~~~~~~~~gt~~y~APE~~~~~-~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~---------~~~~~~~~ 916 (1036)
+.....+..+-|..|.|||++++. .|+.+.||||.|||+.|++..+..|+...+-+...++. .+...-+
T Consensus 209 d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACE- 287 (449)
T KOG0664|consen 209 RDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACE- 287 (449)
T ss_pred hhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhh-
Confidence 554444555678899999999975 58999999999999999999999998766655554431 1111111
Q ss_pred Cccccc-----cCccc---ccC--CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 001658 917 NQEIEL-----ADPKL---IEF--NEEEVKRLIGVALLCTQTLPSLRPSMSRVVAML 963 (1036)
Q Consensus 917 ~~~~~~-----~d~~~---~~~--~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L 963 (1036)
+....+ ..|.+ ... ....-.+.+.+...++..||++|.+.++.+..+
T Consensus 288 GAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~ 344 (449)
T KOG0664|consen 288 GAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHR 344 (449)
T ss_pred hhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccc
Confidence 111111 11211 111 112222344455567899999999999987755
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.5e-26 Score=239.09 Aligned_cols=210 Identities=34% Similarity=0.526 Sum_probs=182.7
Q ss_pred cccCCCEEEEEeEeCC-CcEEEEEEccccchh-cHHHHHHHHHHHHhhccCCcceeEeEEEcCceeEEEEEecCCCChhh
Q 001658 701 LGEGGFGPVYKGKLGD-GRAIAVKQLSVASRQ-GKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLVYEYLENKSLDQ 778 (1036)
Q Consensus 701 iG~G~fG~Vy~~~~~~-g~~vAvK~~~~~~~~-~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~ 778 (1036)
||+|.+|.||++...+ ++.+++|++...... ..+.+.+|++.++.++|++|+++++++......++++||+++++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6899999999999754 899999999755432 35679999999999999999999999999899999999999999999
Q ss_pred hhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecC-CCceEEEEcCcceeecCCCCcccccccc
Q 001658 779 ALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDA-DLVPKISDFGLAKLYDDKKTHISTRVAG 857 (1036)
Q Consensus 779 ~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~-~~~~kl~DFGla~~~~~~~~~~~~~~~g 857 (1036)
++.... ..+++..+..++.+++++++|||+.+ ++|+||+|.||+++. ++.++|+|||.+........ ......+
T Consensus 81 ~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~ 155 (215)
T cd00180 81 LLKENE-GKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLKTIVG 155 (215)
T ss_pred HHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-hhhcccC
Confidence 986432 46889999999999999999999987 999999999999999 89999999999987654321 1223457
Q ss_pred ccCccCccccccC-CCCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhcCccccccCcccccCCHHHHH
Q 001658 858 TIGYLAPEYAMRG-HLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEIELADPKLIEFNEEEVK 936 (1036)
Q Consensus 858 t~~y~APE~~~~~-~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~ 936 (1036)
...|++||..... ..+.++|+|++|++++++ .
T Consensus 156 ~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-----------------------------------------------~ 188 (215)
T cd00180 156 TPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL-----------------------------------------------P 188 (215)
T ss_pred CCCccChhHhcccCCCCchhhhHHHHHHHHHH-----------------------------------------------H
Confidence 7899999999887 788999999999999999 4
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHHH
Q 001658 937 RLIGVALLCTQTLPSLRPSMSRVVAM 962 (1036)
Q Consensus 937 ~l~~l~~~Cl~~dP~~RPt~~evl~~ 962 (1036)
.+.+++..|++.+|++||++.++++.
T Consensus 189 ~~~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 189 ELKDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred HHHHHHHHHhhCCcccCcCHHHHhhC
Confidence 66778889999999999999999864
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.3e-27 Score=242.44 Aligned_cols=201 Identities=26% Similarity=0.357 Sum_probs=172.4
Q ss_pred HhcCCCCCCccccCCCEEEEEeEeC-CCcEEEEEEcccc---chhcHHHHHHHHHHHHhh-ccCCcceeEeEEEcCceeE
Q 001658 691 ATENFSPSNKLGEGGFGPVYKGKLG-DGRAIAVKQLSVA---SRQGKSQFVAEIATISAV-QHRNLVKLHGCCIEGAERL 765 (1036)
Q Consensus 691 ~~~~~~~~~~iG~G~fG~Vy~~~~~-~g~~vAvK~~~~~---~~~~~~~f~~Ei~~L~~l-~H~nIv~l~g~~~~~~~~~ 765 (1036)
...+|..+.+||+|+|+.|..++++ ..+.+|+|++++. +.+..+..+.|-.+..+. +||.+|-+..+|..+...+
T Consensus 248 ~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlf 327 (593)
T KOG0695|consen 248 GLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLF 327 (593)
T ss_pred ccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEE
Confidence 3468899999999999999999865 5678999998753 333445566777777666 7999999999999999999
Q ss_pred EEEEecCCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeec
Q 001658 766 LVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYD 845 (1036)
Q Consensus 766 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~ 845 (1036)
+|.||+++|+|--.+. +...++++.++-....|.-||.|||+.| ||.||+|..|||+|..|.+|+.|+|+++.--
T Consensus 328 fvieyv~ggdlmfhmq--rqrklpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygmcke~l 402 (593)
T KOG0695|consen 328 FVIEYVNGGDLMFHMQ--RQRKLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGL 402 (593)
T ss_pred EEEEEecCcceeeehh--hhhcCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccchhhcCC
Confidence 9999999999976564 4456778888888899999999999999 9999999999999999999999999998543
Q ss_pred CCCCccccccccccCccCccccccCCCCchhhHHhHHHHHHHHHhCCCCCCC
Q 001658 846 DKKTHISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRPNSDP 897 (1036)
Q Consensus 846 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~ 897 (1036)
.+ ......++||+.|+|||++.+..|...+|.|++||+++||+.|+.||+.
T Consensus 403 ~~-gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdi 453 (593)
T KOG0695|consen 403 GP-GDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDI 453 (593)
T ss_pred CC-CcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcce
Confidence 22 2334568899999999999999999999999999999999999999984
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.4e-29 Score=274.34 Aligned_cols=294 Identities=22% Similarity=0.326 Sum_probs=205.8
Q ss_pred CceeeEeEEEEeecccc-ccCCccccCCCCCCEEEccCCCCCCCCcccccCCCcCCeeecccccccCCccccccCCCCCc
Q 001658 96 GTVCHITQLKVYALNVV-GVIPDELWNLTSLFNLNLGQNYLTGPLSPSVGNLTAMQYLNLAINALSGELPKELGQLTELL 174 (1036)
Q Consensus 96 ~~~~~l~~L~l~~~~~~-~~ip~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~L~~L~ 174 (1036)
+++.-++.+++++|.+. +..|..+..+++++.|.|...++. .+|+.++.|.+|++|.+++|++. .+-..++.|+.|+
T Consensus 4 gVLpFVrGvDfsgNDFsg~~FP~~v~qMt~~~WLkLnrt~L~-~vPeEL~~lqkLEHLs~~HN~L~-~vhGELs~Lp~LR 81 (1255)
T KOG0444|consen 4 GVLPFVRGVDFSGNDFSGDRFPHDVEQMTQMTWLKLNRTKLE-QVPEELSRLQKLEHLSMAHNQLI-SVHGELSDLPRLR 81 (1255)
T ss_pred cccceeecccccCCcCCCCcCchhHHHhhheeEEEechhhhh-hChHHHHHHhhhhhhhhhhhhhH-hhhhhhccchhhH
Confidence 34445667777777777 457777777777777777777777 67777777777777777777777 5566677777777
Q ss_pred EEEcccCCCC-CCCccccCCCccCCEEeCccccCCCCCCccccCCCCCcEEeccCCcCCCCChhhhcCCCCCCEEEeeCC
Q 001658 175 ILGIGTNNFS-GPLPSELGSLSKLQELYIDSAGVSGEIPSSFANLQSLTKWWASDTRLTGRIPDFIGNWSKLTALRFQGN 253 (1036)
Q Consensus 175 ~L~Ls~N~l~-~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N 253 (1036)
.+++.+|++. .-+|..+..|..|..|+|++|++. +.|..+..-+++-.|+|++|+|..+....|.+++.|-.|||++|
T Consensus 82 sv~~R~N~LKnsGiP~diF~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~IetIPn~lfinLtDLLfLDLS~N 160 (1255)
T KOG0444|consen 82 SVIVRDNNLKNSGIPTDIFRLKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIETIPNSLFINLTDLLFLDLSNN 160 (1255)
T ss_pred HHhhhccccccCCCCchhcccccceeeecchhhhh-hcchhhhhhcCcEEEEcccCccccCCchHHHhhHhHhhhccccc
Confidence 7777777774 346667777777777777777777 67777777777777777777777555566667777777777777
Q ss_pred cCCCCCCccccCCCCCCEEEccCCCCCCCchhhhcCCCCCCEEEccCCccC-ccccccccCCCCccEEeCCCCCCCCCCc
Q 001658 254 SFNGPIPSSFSNLTSVTELRISDLSNGSSKLAFIRDMKSLSILELRNNNIS-DSIPSNIGEYRSLQHLDLSFNNLGGSIP 332 (1036)
Q Consensus 254 ~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~p 332 (1036)
++. .+|..+..|.+|+.|.|++|.+.......+..+++|+.|.+++.+-+ ..+|..+..+.+|..+|||.|.|. .+|
T Consensus 161 rLe-~LPPQ~RRL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhms~TqRTl~N~Ptsld~l~NL~dvDlS~N~Lp-~vP 238 (1255)
T KOG0444|consen 161 RLE-MLPPQIRRLSMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHMSNTQRTLDNIPTSLDDLHNLRDVDLSENNLP-IVP 238 (1255)
T ss_pred hhh-hcCHHHHHHhhhhhhhcCCChhhHHHHhcCccchhhhhhhcccccchhhcCCCchhhhhhhhhccccccCCC-cch
Confidence 777 56667777777777777777777666666666777777777765432 346677777777777777777777 677
Q ss_pred hhccCCCCccEEEccCccccccCCC-CcCCCccEEEeeCccCCCCCchhhhccCCcceeeecCC
Q 001658 333 DSLFNLSSLTHLFLGNNKLNGTLPA-RKSPLLLNIDVSYNNLQGNLPSWINGQQNLQINLVANN 395 (1036)
Q Consensus 333 ~~l~~l~~L~~L~Ls~N~l~g~~p~-~~~~~L~~Ldls~N~l~g~~p~~l~~l~~L~~~~~~nn 395 (1036)
+.+.++.+|+.|+||+|+|+..--. ..-..|+.|++|.|+|+ .+|..+..+++|+-++..+|
T Consensus 239 ecly~l~~LrrLNLS~N~iteL~~~~~~W~~lEtLNlSrNQLt-~LP~avcKL~kL~kLy~n~N 301 (1255)
T KOG0444|consen 239 ECLYKLRNLRRLNLSGNKITELNMTEGEWENLETLNLSRNQLT-VLPDAVCKLTKLTKLYANNN 301 (1255)
T ss_pred HHHhhhhhhheeccCcCceeeeeccHHHHhhhhhhccccchhc-cchHHHhhhHHHHHHHhccC
Confidence 7777777777777777777632111 11133667777777776 56666666666665555444
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.8e-26 Score=246.85 Aligned_cols=131 Identities=31% Similarity=0.405 Sum_probs=113.7
Q ss_pred cCCCCCCccccCCCEEEEEeEe-CCCcEEEEEEccccchhcHHHHHHHHHHHHhhc-----c---CCcceeEeEEEc---
Q 001658 693 ENFSPSNKLGEGGFGPVYKGKL-GDGRAIAVKQLSVASRQGKSQFVAEIATISAVQ-----H---RNLVKLHGCCIE--- 760 (1036)
Q Consensus 693 ~~~~~~~~iG~G~fG~Vy~~~~-~~g~~vAvK~~~~~~~~~~~~f~~Ei~~L~~l~-----H---~nIv~l~g~~~~--- 760 (1036)
.+|.+.++||-|.|++||.+.. .+.+.||+|+.+.+. .-.+....||++|++++ | .+||+|++.|..
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq-hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGp 156 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ-HYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGP 156 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhh-HHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCC
Confidence 5788899999999999999974 567899999987543 23456788999999984 3 369999999974
Q ss_pred -CceeEEEEEecCCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEe
Q 001658 761 -GAERLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLL 827 (1036)
Q Consensus 761 -~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl 827 (1036)
+.++++|+|++ |.+|..+|....-..++...+.+|++||+.||.|||.++ .|||-||||+|||+
T Consensus 157 NG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl 221 (590)
T KOG1290|consen 157 NGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLL 221 (590)
T ss_pred CCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeee
Confidence 46789999999 789999998887788999999999999999999999987 79999999999999
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.5e-25 Score=238.71 Aligned_cols=199 Identities=32% Similarity=0.460 Sum_probs=173.0
Q ss_pred CCCCCccccCCCEEEEEeEeCC-CcEEEEEEccccchh-cHHHHHHHHHHHHhhccCCcceeEeEEEcCceeEEEEEecC
Q 001658 695 FSPSNKLGEGGFGPVYKGKLGD-GRAIAVKQLSVASRQ-GKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLVYEYLE 772 (1036)
Q Consensus 695 ~~~~~~iG~G~fG~Vy~~~~~~-g~~vAvK~~~~~~~~-~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~~~ 772 (1036)
|...+.||+|++|.||++...+ ++.+|+|.+...... ..+.+.+|++.+++++|+|++++++++......++++||++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 4567889999999999999764 889999999765444 56788999999999999999999999999899999999999
Q ss_pred CCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeecCCCCccc
Q 001658 773 NKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHIS 852 (1036)
Q Consensus 773 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 852 (1036)
+++|.+++..... .+++.....++.++++++.|||+.+ ++|+||+|+||+++.++.++|+|||.+...........
T Consensus 81 ~~~L~~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~ 156 (225)
T smart00221 81 GGDLFDYLRKKGG-KLSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALL 156 (225)
T ss_pred CCCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccccc
Confidence 9999999865432 1789999999999999999999987 99999999999999999999999999988765431122
Q ss_pred cccccccCccCcccc-ccCCCCchhhHHhHHHHHHHHHhCCCCCCC
Q 001658 853 TRVAGTIGYLAPEYA-MRGHLTEKTDVFAFGVLALETVSGRPNSDP 897 (1036)
Q Consensus 853 ~~~~gt~~y~APE~~-~~~~~~~ksDVwS~Gvvl~elltG~~p~~~ 897 (1036)
....++..|++||.. ....++.++|||+||++++||++|+.||..
T Consensus 157 ~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 157 KTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred cceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 334578899999998 667788899999999999999999999965
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.2e-29 Score=274.44 Aligned_cols=291 Identities=23% Similarity=0.328 Sum_probs=249.0
Q ss_pred eEeEEEEeecccc-ccCCccccCCCCCCEEEccCCCCCCCCcccccCCCcCCeeecccccccCCccc-cccCCCCCcEEE
Q 001658 100 HITQLKVYALNVV-GVIPDELWNLTSLFNLNLGQNYLTGPLSPSVGNLTAMQYLNLAINALSGELPK-ELGQLTELLILG 177 (1036)
Q Consensus 100 ~l~~L~l~~~~~~-~~ip~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~-~l~~L~~L~~L~ 177 (1036)
+++++.+.+|++. .-||+.|.+|..|+.||||+|+++ +.|..+..-+++-.|+||+|+|. .||. .|-+|+.|-+||
T Consensus 79 ~LRsv~~R~N~LKnsGiP~diF~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~Ie-tIPn~lfinLtDLLfLD 156 (1255)
T KOG0444|consen 79 RLRSVIVRDNNLKNSGIPTDIFRLKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIE-TIPNSLFINLTDLLFLD 156 (1255)
T ss_pred hhHHHhhhccccccCCCCchhcccccceeeecchhhhh-hcchhhhhhcCcEEEEcccCccc-cCCchHHHhhHhHhhhc
Confidence 4566677777764 458999999999999999999999 88999999999999999999999 5665 466899999999
Q ss_pred cccCCCCCCCccccCCCccCCEEeCccccCCCCCCccccCCCCCcEEeccCCcC-CCCChhhhcCCCCCCEEEeeCCcCC
Q 001658 178 IGTNNFSGPLPSELGSLSKLQELYIDSAGVSGEIPSSFANLQSLTKWWASDTRL-TGRIPDFIGNWSKLTALRFQGNSFN 256 (1036)
Q Consensus 178 Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l-~~~~p~~l~~l~~L~~L~L~~N~l~ 256 (1036)
||+|++. .+|+.+..|..|++|.|++|.+...--..+..|++|+.|.+++.+- ...+|..+..+.+|..+||+.|.+.
T Consensus 157 LS~NrLe-~LPPQ~RRL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhms~TqRTl~N~Ptsld~l~NL~dvDlS~N~Lp 235 (1255)
T KOG0444|consen 157 LSNNRLE-MLPPQIRRLSMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHMSNTQRTLDNIPTSLDDLHNLRDVDLSENNLP 235 (1255)
T ss_pred cccchhh-hcCHHHHHHhhhhhhhcCCChhhHHHHhcCccchhhhhhhcccccchhhcCCCchhhhhhhhhccccccCCC
Confidence 9999998 7888899999999999999998765555666778888888888543 3467888889999999999999998
Q ss_pred CCCCccccCCCCCCEEEccCCCCCCCchhhhcCCCCCCEEEccCCccCccccccccCCCCccEEeCCCCCCCC-CCchhc
Q 001658 257 GPIPSSFSNLTSVTELRISDLSNGSSKLAFIRDMKSLSILELRNNNISDSIPSNIGEYRSLQHLDLSFNNLGG-SIPDSL 335 (1036)
Q Consensus 257 ~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~-~~p~~l 335 (1036)
..|+.+.++.+|+.|+|++|.++.+... .....+|++|+||.|+++ .+|+.+.++++|+.|.+.+|+|+= -||..+
T Consensus 236 -~vPecly~l~~LrrLNLS~N~iteL~~~-~~~W~~lEtLNlSrNQLt-~LP~avcKL~kL~kLy~n~NkL~FeGiPSGI 312 (1255)
T KOG0444|consen 236 -IVPECLYKLRNLRRLNLSGNKITELNMT-EGEWENLETLNLSRNQLT-VLPDAVCKLTKLTKLYANNNKLTFEGIPSGI 312 (1255)
T ss_pred -cchHHHhhhhhhheeccCcCceeeeecc-HHHHhhhhhhccccchhc-cchHHHhhhHHHHHHHhccCcccccCCccch
Confidence 8899999999999999999999887654 234568999999999998 899999999999999999999873 489999
Q ss_pred cCCCCccEEEccCccccccCCCCcC--CCccEEEeeCccCCCCCchhhhccCCcceeeecCCccc
Q 001658 336 FNLSSLTHLFLGNNKLNGTLPARKS--PLLLNIDVSYNNLQGNLPSWINGQQNLQINLVANNLTI 398 (1036)
Q Consensus 336 ~~l~~L~~L~Ls~N~l~g~~p~~~~--~~L~~Ldls~N~l~g~~p~~l~~l~~L~~~~~~nn~~~ 398 (1036)
+.|.+|+.+..++|+|. .+|.+++ +.|+.|.|+.|+|. .+|+.+.-++.|+++.+.+|..+
T Consensus 313 GKL~~Levf~aanN~LE-lVPEglcRC~kL~kL~L~~NrLi-TLPeaIHlL~~l~vLDlreNpnL 375 (1255)
T KOG0444|consen 313 GKLIQLEVFHAANNKLE-LVPEGLCRCVKLQKLKLDHNRLI-TLPEAIHLLPDLKVLDLRENPNL 375 (1255)
T ss_pred hhhhhhHHHHhhccccc-cCchhhhhhHHHHHhccccccee-echhhhhhcCCcceeeccCCcCc
Confidence 99999999999999998 7888766 45999999999988 68998999999999988888543
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.1e-27 Score=265.41 Aligned_cols=253 Identities=23% Similarity=0.352 Sum_probs=203.7
Q ss_pred hcCCCCCCccccCCCEEEEEeEe-CCCcEEEEEEccccchhcHHHHHHHHHHHHhhccCCcceeEeEEEcCceeEEEEEe
Q 001658 692 TENFSPSNKLGEGGFGPVYKGKL-GDGRAIAVKQLSVASRQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLVYEY 770 (1036)
Q Consensus 692 ~~~~~~~~~iG~G~fG~Vy~~~~-~~g~~vAvK~~~~~~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~ 770 (1036)
.++|.....+|.|.||.|||++. ..++..|+|+++........-..+|+-+++..+|+|||.++|.+...+..|++|||
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEy 93 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEY 93 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEe
Confidence 45677889999999999999984 57899999999877666677788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeecCCCCc
Q 001658 771 LENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTH 850 (1036)
Q Consensus 771 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~ 850 (1036)
+.+|+|.+.-+. ..++++.+..-+++..++|++|||+.+ -+|||||-.|||+++.+.+|++|||.+..+... ..
T Consensus 94 cgggslQdiy~~--TgplselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaqitat-i~ 167 (829)
T KOG0576|consen 94 CGGGSLQDIYHV--TGPLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQITAT-IA 167 (829)
T ss_pred cCCCcccceeee--cccchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhhhhhh-hh
Confidence 999999997643 567888888889999999999999998 789999999999999999999999998766432 12
Q ss_pred cccccccccCccCcccc---ccCCCCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhcCccccccCccc
Q 001658 851 ISTRVAGTIGYLAPEYA---MRGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEIELADPKL 927 (1036)
Q Consensus 851 ~~~~~~gt~~y~APE~~---~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~ 927 (1036)
....+.||+.|||||+. ..+.|..++|||+.|+...|+-.-++|.-...+....++... ...+|.-
T Consensus 168 KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTk-----------S~~qpp~ 236 (829)
T KOG0576|consen 168 KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTK-----------SGFQPPT 236 (829)
T ss_pred hhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhc-----------cCCCCCc
Confidence 23457899999999987 467799999999999999999988888766555555444321 1122221
Q ss_pred ccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 001658 928 IEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVA 961 (1036)
Q Consensus 928 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 961 (1036)
..........+-+++..|+-.+|++||++..+++
T Consensus 237 lkDk~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 237 LKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred ccCCccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 1111222334555666788999999999887654
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.93 E-value=7.6e-26 Score=223.99 Aligned_cols=255 Identities=20% Similarity=0.295 Sum_probs=189.7
Q ss_pred hcCCCCCCccccCCCEEEEEeE-eCCCcEEEEEEccccchhcHHHHHHHHHHHHhhc-cCCcceeEeEEEcC--ceeEEE
Q 001658 692 TENFSPSNKLGEGGFGPVYKGK-LGDGRAIAVKQLSVASRQGKSQFVAEIATISAVQ-HRNLVKLHGCCIEG--AERLLV 767 (1036)
Q Consensus 692 ~~~~~~~~~iG~G~fG~Vy~~~-~~~g~~vAvK~~~~~~~~~~~~f~~Ei~~L~~l~-H~nIv~l~g~~~~~--~~~~lV 767 (1036)
.++|++.+++|+|-|+.||.|. ..+.+.++||++++.. ++.+.+|+.+|..++ ||||+++++...+. ....||
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk---kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLi 113 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK---KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLI 113 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH---HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhH
Confidence 5678888999999999999997 5678899999997543 467889999999997 99999999998765 456799
Q ss_pred EEecCCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCC-CceEEEEcCcceeecC
Q 001658 768 YEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDAD-LVPKISDFGLAKLYDD 846 (1036)
Q Consensus 768 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~-~~~kl~DFGla~~~~~ 846 (1036)
+||+.+.+...+- ..++...+.-.+.++++||.|+|+.| |.|||+||.|+++|.. ..++|+|+|+|.++.+
T Consensus 114 FE~v~n~Dfk~ly-----~tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp 185 (338)
T KOG0668|consen 114 FEYVNNTDFKQLY-----PTLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP 185 (338)
T ss_pred hhhhccccHHHHh-----hhhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeecchHhhcCC
Confidence 9999987776544 34566677778999999999999999 9999999999999875 5799999999998865
Q ss_pred CCCccccccccccCccCcccccc-CCCCchhhHHhHHHHHHHHHhCCCCCCCCCh-hhHHHHHHHHH------HHhhcCc
Q 001658 847 KKTHISTRVAGTIGYLAPEYAMR-GHLTEKTDVFAFGVLALETVSGRPNSDPSLD-EEKLYLLEWAW------HLHENNQ 918 (1036)
Q Consensus 847 ~~~~~~~~~~gt~~y~APE~~~~-~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~-~~~~~l~~~~~------~~~~~~~ 918 (1036)
.... ...+.+..|.-||.+.. ..|+..-|+|||||++..|+..+.||-...+ .++...+..+- ..... .
T Consensus 186 ~~eY--nVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~K-Y 262 (338)
T KOG0668|consen 186 GKEY--NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNK-Y 262 (338)
T ss_pred Ccee--eeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHH-H
Confidence 4332 22335667899999865 5688899999999999999999999865433 23222221110 00000 0
Q ss_pred cccccCccccc------------CC----H-HHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 001658 919 EIELADPKLIE------------FN----E-EEVKRLIGVALLCTQTLPSLRPSMSRVVA 961 (1036)
Q Consensus 919 ~~~~~d~~~~~------------~~----~-~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 961 (1036)
.+. .||++.+ +. . -...+.++++...+..|-.+|||+.|.+.
T Consensus 263 ~i~-Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~ 321 (338)
T KOG0668|consen 263 QID-LDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA 321 (338)
T ss_pred ccC-CChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence 011 2332211 00 0 01134567777888999999999999764
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.6e-26 Score=230.99 Aligned_cols=254 Identities=19% Similarity=0.283 Sum_probs=184.5
Q ss_pred hcCCCCCCccccCCCEEEEEeEeC-CCcEEEEEEccccchhcHHHHHHHHHHHHhh-ccCCcceeEeE-EEcCceeEEEE
Q 001658 692 TENFSPSNKLGEGGFGPVYKGKLG-DGRAIAVKQLSVASRQGKSQFVAEIATISAV-QHRNLVKLHGC-CIEGAERLLVY 768 (1036)
Q Consensus 692 ~~~~~~~~~iG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~f~~Ei~~L~~l-~H~nIv~l~g~-~~~~~~~~lV~ 768 (1036)
.+.|.+.+.+|+|.||.+-.++++ ..+.+++|.+.... ...++|.+|...--.+ .|.||+.-|+. |...+.+++++
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~-tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~q 101 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ-TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQ 101 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch-hhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEee
Confidence 456888899999999999999975 56789999886443 3367899998765555 69999987765 56677888999
Q ss_pred EecCCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEe-cCC-CceEEEEcCcceeecC
Q 001658 769 EYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLL-DAD-LVPKISDFGLAKLYDD 846 (1036)
Q Consensus 769 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl-~~~-~~~kl~DFGla~~~~~ 846 (1036)
||++.|+|.+-+. ...+-+....+++.|++.|+.|||++. +||||||.+|||| +.| .++||||||+.+..+.
T Consensus 102 E~aP~gdL~snv~---~~GigE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~ 175 (378)
T KOG1345|consen 102 EFAPRGDLRSNVE---AAGIGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKLCDFGLTRKVGT 175 (378)
T ss_pred ccCccchhhhhcC---cccccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEeeecccccccCc
Confidence 9999999998874 345677788899999999999999998 9999999999999 333 5899999999875432
Q ss_pred CCCccccccccccCccCccccccC-----CCCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhcCcccc
Q 001658 847 KKTHISTRVAGTIGYLAPEYAMRG-----HLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEIE 921 (1036)
Q Consensus 847 ~~~~~~~~~~gt~~y~APE~~~~~-----~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 921 (1036)
.- ....-+..|.|||..... ...+.+|||.||++++.++||++||+.....+.. -|.|..+..+...
T Consensus 176 tV----~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~---Y~~~~~w~~rk~~- 247 (378)
T KOG1345|consen 176 TV----KYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKP---YWEWEQWLKRKNP- 247 (378)
T ss_pred ee----hhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCch---HHHHHHHhcccCc-
Confidence 11 122345579999987532 3567899999999999999999999954332222 2334444433222
Q ss_pred ccCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 001658 922 LADPKLIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVAMLC 964 (1036)
Q Consensus 922 ~~d~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~ 964 (1036)
+.+..-.....+++++..+-+..+|++|-...++.++..
T Consensus 248 ----~~P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk 286 (378)
T KOG1345|consen 248 ----ALPKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRK 286 (378)
T ss_pred ----cCchhhcccCHHHHHHHHHhcCCcccccchhHHHHHHHH
Confidence 221111122233444455677899999966666655543
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=6.2e-26 Score=250.89 Aligned_cols=196 Identities=24% Similarity=0.312 Sum_probs=166.0
Q ss_pred cCCCCCCccccCCCEEEEEeEeC-CCcEEEEEEccccchhc--------HHHHHHHHHHHHhhc---cCCcceeEeEEEc
Q 001658 693 ENFSPSNKLGEGGFGPVYKGKLG-DGRAIAVKQLSVASRQG--------KSQFVAEIATISAVQ---HRNLVKLHGCCIE 760 (1036)
Q Consensus 693 ~~~~~~~~iG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~~~--------~~~f~~Ei~~L~~l~---H~nIv~l~g~~~~ 760 (1036)
.+|...+.+|+|+||.|+.|.++ +...|+||.+.+...-. .-..-.|+.+|..++ |+||++++++|.+
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence 46888999999999999999875 45789999986532111 112456999999997 9999999999999
Q ss_pred CceeEEEEEec-CCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcC
Q 001658 761 GAERLLVYEYL-ENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFG 839 (1036)
Q Consensus 761 ~~~~~lV~E~~-~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFG 839 (1036)
++.++|+||-. ++.+|.+++.. ...+++....-|..||+.|+++||+.+ |||||||-+||.++.+|-+||+|||
T Consensus 641 dd~yyl~te~hg~gIDLFd~IE~--kp~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~~klidfg 715 (772)
T KOG1152|consen 641 DDYYYLETEVHGEGIDLFDFIEF--KPRMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGFVKLIDFG 715 (772)
T ss_pred CCeeEEEecCCCCCcchhhhhhc--cCccchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCeEEEeecc
Confidence 99999999975 45688999854 456788888899999999999999998 9999999999999999999999999
Q ss_pred cceeecCCCCccccccccccCccCccccccCCC-CchhhHHhHHHHHHHHHhCCCCCC
Q 001658 840 LAKLYDDKKTHISTRVAGTIGYLAPEYAMRGHL-TEKTDVFAFGVLALETVSGRPNSD 896 (1036)
Q Consensus 840 la~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~-~~ksDVwS~Gvvl~elltG~~p~~ 896 (1036)
.+.+.....- ..++||.+|.|||++.+.+| ...-|||++|++||-++....|++
T Consensus 716 saa~~ksgpf---d~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 716 SAAYTKSGPF---DVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred chhhhcCCCc---ceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 9987654432 35789999999999998876 557899999999999988777765
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=8.3e-26 Score=235.12 Aligned_cols=259 Identities=24% Similarity=0.279 Sum_probs=191.7
Q ss_pred cCCCCCCccccCCCEEEEEeE-eCCCcEEEEEEcccc--chhcHHHHHHHHHHHHhhccCCcceeEeEEEcC------ce
Q 001658 693 ENFSPSNKLGEGGFGPVYKGK-LGDGRAIAVKQLSVA--SRQGKSQFVAEIATISAVQHRNLVKLHGCCIEG------AE 763 (1036)
Q Consensus 693 ~~~~~~~~iG~G~fG~Vy~~~-~~~g~~vAvK~~~~~--~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~------~~ 763 (1036)
.+|.-++.+|.|.- .|-.+. .-.++.||+|+.... .....++..+|...+..+.|+||++++.++.-. .+
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e 95 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE 95 (369)
T ss_pred eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence 45666778899988 555554 235789999987432 334456778899999999999999999998633 45
Q ss_pred eEEEEEecCCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCccee
Q 001658 764 RLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKL 843 (1036)
Q Consensus 764 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~ 843 (1036)
.++|||+| .++|...++ ..++-.+...|..|++.|++|||+.+ |+||||||+||++..++.+||.|||+|+.
T Consensus 96 ~y~v~e~m-~~nl~~vi~----~elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~dfg~ar~ 167 (369)
T KOG0665|consen 96 VYLVMELM-DANLCQVIL----MELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILDFGLART 167 (369)
T ss_pred HHHHHHhh-hhHHHHHHH----HhcchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeeccchhhcc
Confidence 79999999 568988885 56788899999999999999999998 99999999999999999999999999985
Q ss_pred ecCCCCccccccccccCccCccccccCCCCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHH----------------
Q 001658 844 YDDKKTHISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLL---------------- 907 (1036)
Q Consensus 844 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~---------------- 907 (1036)
-... ...+..+.|..|.|||++.+..+.+.+||||.||++.||++|+..|.+...-+....+
T Consensus 168 e~~~--~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~ 245 (369)
T KOG0665|consen 168 EDTD--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQ 245 (369)
T ss_pred cCcc--cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhh
Confidence 4332 3456677899999999999888999999999999999999999888643222111111
Q ss_pred HHHHHHhhcCc-------cccccCccc---ccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 001658 908 EWAWHLHENNQ-------EIELADPKL---IEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVAM 962 (1036)
Q Consensus 908 ~~~~~~~~~~~-------~~~~~d~~~---~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 962 (1036)
..+.-...... ...+.|..+ .+...-......+++.+|+-.+|++|-+++++++.
T Consensus 246 ~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H 310 (369)
T KOG0665|consen 246 PTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH 310 (369)
T ss_pred HHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence 00000000000 000111111 11111233456677889999999999999999874
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1e-25 Score=246.02 Aligned_cols=265 Identities=17% Similarity=0.202 Sum_probs=203.4
Q ss_pred HHHhcCCCCCCccccCCCEEEEEeEeC-CCcEEEEEEccccchhcHHHHHHHHHHHHhhc------cCCcceeEeEEEcC
Q 001658 689 KTATENFSPSNKLGEGGFGPVYKGKLG-DGRAIAVKQLSVASRQGKSQFVAEIATISAVQ------HRNLVKLHGCCIEG 761 (1036)
Q Consensus 689 ~~~~~~~~~~~~iG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~f~~Ei~~L~~l~------H~nIv~l~g~~~~~ 761 (1036)
+..-.+|.+....|+|-|++|.+|... .|..||||++..... ..+.=..|+++|++|. --|+++++-.|...
T Consensus 428 E~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~-M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hk 506 (752)
T KOG0670|consen 428 ELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEV-MHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHK 506 (752)
T ss_pred hhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchH-HhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhc
Confidence 345568888899999999999999853 578999999975432 2344567999999995 34789999999999
Q ss_pred ceeEEEEEecCCCChhhhhhcCC-CCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCC-CceEEEEcC
Q 001658 762 AERLLVYEYLENKSLDQALFGQR-SLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDAD-LVPKISDFG 839 (1036)
Q Consensus 762 ~~~~lV~E~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~-~~~kl~DFG 839 (1036)
.+.|||+|-+ ..+|.++|...+ +..+....+..++.|+.-||..|...+ |+|.||||.|||+++. ..+||||||
T Consensus 507 nHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVNE~k~iLKLCDfG 582 (752)
T KOG0670|consen 507 NHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVNESKNILKLCDFG 582 (752)
T ss_pred ceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEeccCcceeeeccCc
Confidence 9999999987 569999997654 677888999999999999999999887 9999999999999886 578999999
Q ss_pred cceeecCCCCccccccccccCccCccccccCCCCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHH--------
Q 001658 840 LAKLYDDKKTHISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAW-------- 911 (1036)
Q Consensus 840 la~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~-------- 911 (1036)
.|........ ++..-+..|.|||++.+-.|+...|+||.||+||||.||+..|.+......+.+..-+.
T Consensus 583 SA~~~~enei---tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~Kml 659 (752)
T KOG0670|consen 583 SASFASENEI---TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKML 659 (752)
T ss_pred cccccccccc---cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHh
Confidence 9987764433 22334557999999999999999999999999999999999998766554433321110
Q ss_pred -------HHhhcC-----------------ccccccCc------------ccccCCHHHHHHHHHHHHHhcccCCCCCCC
Q 001658 912 -------HLHENN-----------------QEIELADP------------KLIEFNEEEVKRLIGVALLCTQTLPSLRPS 955 (1036)
Q Consensus 912 -------~~~~~~-----------------~~~~~~d~------------~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt 955 (1036)
.++... ..+..+.| .+.+........+.+|...|+..||++|-|
T Consensus 660 RKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit 739 (752)
T KOG0670|consen 660 RKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRIT 739 (752)
T ss_pred hhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCC
Confidence 111100 00011112 112223445567888999999999999999
Q ss_pred HHHHHH
Q 001658 956 MSRVVA 961 (1036)
Q Consensus 956 ~~evl~ 961 (1036)
..|.+.
T Consensus 740 ~nqAL~ 745 (752)
T KOG0670|consen 740 VNQALK 745 (752)
T ss_pred HHHHhc
Confidence 999875
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.8e-24 Score=229.87 Aligned_cols=201 Identities=29% Similarity=0.432 Sum_probs=165.9
Q ss_pred HHHhcCCCCCCccccCCCEEEEEeEeC----CCcEEEEEEccccchhcHHHHHHHHHHHHhhc-cCCcceeEeEEEcCce
Q 001658 689 KTATENFSPSNKLGEGGFGPVYKGKLG----DGRAIAVKQLSVASRQGKSQFVAEIATISAVQ-HRNLVKLHGCCIEGAE 763 (1036)
Q Consensus 689 ~~~~~~~~~~~~iG~G~fG~Vy~~~~~----~g~~vAvK~~~~~~~~~~~~f~~Ei~~L~~l~-H~nIv~l~g~~~~~~~ 763 (1036)
....+.|...++||+|.|++||++... ..+.||+|.+...+. ..+...|+++|..+. +.||+++.+++...+.
T Consensus 32 p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~--p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~ 109 (418)
T KOG1167|consen 32 PFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS--PSRILNELEMLYRLGGSDNIIKLNGCFRNNDQ 109 (418)
T ss_pred hhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC--chHHHHHHHHHHHhccchhhhcchhhhccCCe
Confidence 344567889999999999999999743 467899999875543 356889999999995 9999999999999999
Q ss_pred eEEEEEecCCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCC-CceEEEEcCcce
Q 001658 764 RLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDAD-LVPKISDFGLAK 842 (1036)
Q Consensus 764 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~-~~~kl~DFGla~ 842 (1036)
..+|+||++.....++.. .++.......+..+++||+++|..| ||||||||+|+|.+.. +.-.|.|||+|.
T Consensus 110 v~ivlp~~~H~~f~~l~~-----~l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~LvDFgLA~ 181 (418)
T KOG1167|consen 110 VAIVLPYFEHDRFRDLYR-----SLSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLVDFGLAQ 181 (418)
T ss_pred eEEEecccCccCHHHHHh-----cCCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEEechhHH
Confidence 999999999998888873 3557777888999999999999998 9999999999999764 678899999997
Q ss_pred eecCCC------C-------------------------------------ccccccccccCccCcccccc-CCCCchhhH
Q 001658 843 LYDDKK------T-------------------------------------HISTRVAGTIGYLAPEYAMR-GHLTEKTDV 878 (1036)
Q Consensus 843 ~~~~~~------~-------------------------------------~~~~~~~gt~~y~APE~~~~-~~~~~ksDV 878 (1036)
...... . ......+||+||.|||++.+ ...++++||
T Consensus 182 ~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDi 261 (418)
T KOG1167|consen 182 RYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDI 261 (418)
T ss_pred HHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccce
Confidence 321000 0 00112569999999999875 557889999
Q ss_pred HhHHHHHHHHHhCCCCCCCCC
Q 001658 879 FAFGVLALETVSGRPNSDPSL 899 (1036)
Q Consensus 879 wS~Gvvl~elltG~~p~~~~~ 899 (1036)
||.|||++-+++++.||-...
T Consensus 262 ws~GVI~Lslls~~~PFf~a~ 282 (418)
T KOG1167|consen 262 WSAGVILLSLLSRRYPFFKAK 282 (418)
T ss_pred eeccceeehhhccccccccCc
Confidence 999999999999999987543
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.5e-24 Score=273.72 Aligned_cols=195 Identities=17% Similarity=0.213 Sum_probs=138.8
Q ss_pred hhcc-CCcceeEeEE-------EcCceeEEEEEecCCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCcccc
Q 001658 745 AVQH-RNLVKLHGCC-------IEGAERLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRII 816 (1036)
Q Consensus 745 ~l~H-~nIv~l~g~~-------~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iv 816 (1036)
.++| .||++++++| .+.+..+.++||+ +++|.+++... ...+++..+..|+.||++||+|||+++ |+
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~g---Iv 102 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP-DRSVDAFECFHVFRQIVEIVNAAHSQG---IV 102 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc-cccccHHHHHHHHHHHHHHHHHHHhCC---ee
Confidence 3455 5788888877 2334567788987 66999999643 356899999999999999999999988 99
Q ss_pred ccccCCCcEEecC-------------------CCceEEEEcCcceeecCCCC---------------ccccccccccCcc
Q 001658 817 HRDVKASNVLLDA-------------------DLVPKISDFGLAKLYDDKKT---------------HISTRVAGTIGYL 862 (1036)
Q Consensus 817 HrDikp~NILl~~-------------------~~~~kl~DFGla~~~~~~~~---------------~~~~~~~gt~~y~ 862 (1036)
||||||+||||+. ++.+|++|||+++....... .......||+.||
T Consensus 103 HrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~ 182 (793)
T PLN00181 103 VHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYT 182 (793)
T ss_pred eccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceE
Confidence 9999999999954 44566667776653211000 0011245888999
Q ss_pred CccccccCCCCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhcCccccccCcccccCCHHHHHHHHHHH
Q 001658 863 APEYAMRGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEIELADPKLIEFNEEEVKRLIGVA 942 (1036)
Q Consensus 863 APE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~ 942 (1036)
|||++.+..++.++|||||||+||||++|.+|+..... . ....... ...+.. .........++
T Consensus 183 APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~--~--~~~~~~~---------~~~~~~----~~~~~~~~~~~ 245 (793)
T PLN00181 183 SPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR--T--MSSLRHR---------VLPPQI----LLNWPKEASFC 245 (793)
T ss_pred ChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH--H--HHHHHHh---------hcChhh----hhcCHHHHHHH
Confidence 99999999999999999999999999999887642111 1 1111000 011111 11123345777
Q ss_pred HHhcccCCCCCCCHHHHHH
Q 001658 943 LLCTQTLPSLRPSMSRVVA 961 (1036)
Q Consensus 943 ~~Cl~~dP~~RPt~~evl~ 961 (1036)
.+||+.+|.+||+|.|+++
T Consensus 246 ~~~L~~~P~~Rps~~eil~ 264 (793)
T PLN00181 246 LWLLHPEPSCRPSMSELLQ 264 (793)
T ss_pred HHhCCCChhhCcChHHHhh
Confidence 8999999999999999976
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.89 E-value=8.7e-23 Score=209.56 Aligned_cols=167 Identities=20% Similarity=0.228 Sum_probs=126.3
Q ss_pred CChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeecCCCCcccc
Q 001658 774 KSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHIST 853 (1036)
Q Consensus 774 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 853 (1036)
|+|.+++... ...++|.+++.|+.||++||+|||+.+ ||+|||++.++.+|+ ||+++......
T Consensus 1 GsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~~----- 63 (176)
T smart00750 1 VSLADILEVR-GRPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPEQ----- 63 (176)
T ss_pred CcHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeecccc-----
Confidence 7899999643 346999999999999999999999875 999999999999999 99998765432
Q ss_pred ccccccCccCccccccCCCCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhcCccccccCcccccCCHH
Q 001658 854 RVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEIELADPKLIEFNEE 933 (1036)
Q Consensus 854 ~~~gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~ 933 (1036)
..||+.|||||++.+..++.++|||||||++|||+||+.||........ .+..+...... .++........
T Consensus 64 -~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~-~~~~~~~~~~~-------~~~~~~~~~~~ 134 (176)
T smart00750 64 -SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSA-ILEILLNGMPA-------DDPRDRSNLES 134 (176)
T ss_pred -CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcH-HHHHHHHHhcc-------CCccccccHHH
Confidence 2588999999999999999999999999999999999999865432111 11111111100 11111111112
Q ss_pred HH--HHHHHHHHHhcccCCCCCCCHHHHHHHhhcc
Q 001658 934 EV--KRLIGVALLCTQTLPSLRPSMSRVVAMLCGD 966 (1036)
Q Consensus 934 ~~--~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 966 (1036)
.. ..+.+++.+||+.+|.+||++.|+++.+...
T Consensus 135 ~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~ 169 (176)
T smart00750 135 VSAARSFADFMRVCASRLPQRREAANHYLAHCRAL 169 (176)
T ss_pred HHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHH
Confidence 22 2588999999999999999999999987644
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=7.3e-24 Score=214.53 Aligned_cols=249 Identities=21% Similarity=0.306 Sum_probs=192.8
Q ss_pred CCCccccCCCEEEEEeEeCCCcEEEEEEcccc--chhcHHHHHHHHHHHHhhccCCcceeEeEEEcCceeEEEEEecCCC
Q 001658 697 PSNKLGEGGFGPVYKGKLGDGRAIAVKQLSVA--SRQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLVYEYLENK 774 (1036)
Q Consensus 697 ~~~~iG~G~fG~Vy~~~~~~g~~vAvK~~~~~--~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~g 774 (1036)
...+|.+...|..|+|+++ |..+++|++... .....++|..|.-.|+-+.||||..++|.|.......++..||+.|
T Consensus 194 l~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~g 272 (448)
T KOG0195|consen 194 LITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFG 272 (448)
T ss_pred hhhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccch
Confidence 3456888999999999995 456777777542 3333567999999999999999999999999999999999999999
Q ss_pred ChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeecCCCCccccc
Q 001658 775 SLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTR 854 (1036)
Q Consensus 775 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 854 (1036)
||+..+|++.....+..+..+++.+||+|++|||+..+ -|-.--+.+..|++|++.+++|+ .+-+++-.... .
T Consensus 273 slynvlhe~t~vvvd~sqav~faldiargmaflhslep-~ipr~~lns~hvmidedltaris-mad~kfsfqe~-----g 345 (448)
T KOG0195|consen 273 SLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEP-MIPRFYLNSKHVMIDEDLTARIS-MADTKFSFQEV-----G 345 (448)
T ss_pred HHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcch-hhhhhhcccceEEecchhhhhee-cccceeeeecc-----c
Confidence 99999999999999999999999999999999999862 24455689999999999988875 12122211111 1
Q ss_pred cccccCccCccccccCCC---CchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhcCccccccCcccccCC
Q 001658 855 VAGTIGYLAPEYAMRGHL---TEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEIELADPKLIEFN 931 (1036)
Q Consensus 855 ~~gt~~y~APE~~~~~~~---~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~ 931 (1036)
..-.+.||+||.+...+- -+++|+|||++++||+.|...||....+.+....+. .+-..+ ..+
T Consensus 346 r~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkia-----------leglrv---~ip 411 (448)
T KOG0195|consen 346 RAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIA-----------LEGLRV---HIP 411 (448)
T ss_pred cccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhh-----------hccccc---cCC
Confidence 223568999999987653 347999999999999999999998765544332110 111222 234
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhccc
Q 001658 932 EEEVKRLIGVALLCTQTLPSLRPSMSRVVAMLCGDM 967 (1036)
Q Consensus 932 ~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~ 967 (1036)
+.....+.+++.-|+..||.+||.++.|+-.|+++.
T Consensus 412 pgis~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 412 PGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred CCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 445556777777899999999999999999998753
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=4.7e-22 Score=224.36 Aligned_cols=262 Identities=19% Similarity=0.214 Sum_probs=197.3
Q ss_pred CCCCCCccccCCCEEEEEeEeCCC--cEEEEEEccccchhcHHHHHHHHHHHHhhcc----CCcceeEeEE-EcCceeEE
Q 001658 694 NFSPSNKLGEGGFGPVYKGKLGDG--RAIAVKQLSVASRQGKSQFVAEIATISAVQH----RNLVKLHGCC-IEGAERLL 766 (1036)
Q Consensus 694 ~~~~~~~iG~G~fG~Vy~~~~~~g--~~vAvK~~~~~~~~~~~~f~~Ei~~L~~l~H----~nIv~l~g~~-~~~~~~~l 766 (1036)
+|.+.++||+|+||.||.+...+. +.+|+|............+..|+.++..+.. +++.++++.. ......++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 789999999999999999986543 5788988765433322367889999998873 6899999998 47778899
Q ss_pred EEEecCCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCC-----CceEEEEcCcc
Q 001658 767 VYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDAD-----LVPKISDFGLA 841 (1036)
Q Consensus 767 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~-----~~~kl~DFGla 841 (1036)
||+.+ |.+|.++........++..+.++|+.|++.+|++||+.| ++||||||.|+++... ..+.|.|||++
T Consensus 99 VM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla 174 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA 174 (322)
T ss_pred EEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence 99987 889999886555678999999999999999999999998 9999999999999764 46999999999
Q ss_pred e--eecCCCCc----c---ccccccccCccCccccccCCCCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHH
Q 001658 842 K--LYDDKKTH----I---STRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWH 912 (1036)
Q Consensus 842 ~--~~~~~~~~----~---~~~~~gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~ 912 (1036)
+ .+...... . .....||..|++++...+...+++.|+||++.++.|++.|..||...............
T Consensus 175 r~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~-- 252 (322)
T KOG1164|consen 175 RRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKD-- 252 (322)
T ss_pred ccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHH--
Confidence 8 43222211 1 12456999999999999999999999999999999999999999754432221111100
Q ss_pred HhhcCccccccCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcccCCC
Q 001658 913 LHENNQEIELADPKLIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVAMLCGDMEVS 970 (1036)
Q Consensus 913 ~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~ 970 (1036)
.. ...... .....+.+...+. ..+-..+..++|....+...++..+...
T Consensus 253 -~~----~~~~~~-~~~~~~~~~~~~~---~~~~~~~~~~~Pdy~~~~~~l~~~~~~~ 301 (322)
T KOG1164|consen 253 -PR----KLLTDR-FGDLKPEEFAKIL---EYIDSLDYEDKPDYEKLAELLKDVFDSE 301 (322)
T ss_pred -hh----hhcccc-ccCCChHHHHHHH---HHhhccCCcCCCCHHHHHHHHHHHHHhc
Confidence 00 000000 1222334444444 3444688999999999999988776654
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.2e-22 Score=223.86 Aligned_cols=166 Identities=21% Similarity=0.233 Sum_probs=130.7
Q ss_pred HHHhcCCCCCCccccCCCEEEEEeEeC--CCcEEEEEEcccc-----chhcHHHHHHHHHHHHhhccCCcce-eEeEEEc
Q 001658 689 KTATENFSPSNKLGEGGFGPVYKGKLG--DGRAIAVKQLSVA-----SRQGKSQFVAEIATISAVQHRNLVK-LHGCCIE 760 (1036)
Q Consensus 689 ~~~~~~~~~~~~iG~G~fG~Vy~~~~~--~g~~vAvK~~~~~-----~~~~~~~f~~Ei~~L~~l~H~nIv~-l~g~~~~ 760 (1036)
....++|...+.||+|+||+||+|... +++.||||++... .....+.|.+|+++|++++|+|+++ ++++
T Consensus 14 ~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~--- 90 (365)
T PRK09188 14 PALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT--- 90 (365)
T ss_pred ccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc---
Confidence 345678999999999999999999864 5778899986532 1223566899999999999999985 4432
Q ss_pred CceeEEEEEecCCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCcccccccc-CCCcEEecCCCceEEEEcC
Q 001658 761 GAERLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDV-KASNVLLDADLVPKISDFG 839 (1036)
Q Consensus 761 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDi-kp~NILl~~~~~~kl~DFG 839 (1036)
+..++||||+++++|.. +.. . . ...++.++++||+|||+.+ |+|||| ||+|||++.++.+||+|||
T Consensus 91 -~~~~LVmE~~~G~~L~~-~~~--~---~---~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ikLiDFG 157 (365)
T PRK09188 91 -GKDGLVRGWTEGVPLHL-ARP--H---G---DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAAVIDFQ 157 (365)
T ss_pred -CCcEEEEEccCCCCHHH-hCc--c---c---hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEEEEECc
Confidence 45799999999999973 211 0 1 1457889999999999988 999999 9999999999999999999
Q ss_pred cceeecCCCCcc-------ccccccccCccCccccccC
Q 001658 840 LAKLYDDKKTHI-------STRVAGTIGYLAPEYAMRG 870 (1036)
Q Consensus 840 la~~~~~~~~~~-------~~~~~gt~~y~APE~~~~~ 870 (1036)
+++.+....... -+...+++.|+|||++...
T Consensus 158 lA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 158 LASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred cceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 999776432211 1346788999999998643
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.6e-21 Score=237.52 Aligned_cols=327 Identities=20% Similarity=0.279 Sum_probs=235.6
Q ss_pred ccCCCHHHHHHHHHHHHhcccCcCCCC----CCCCCCCCCCCCC-CCc-cccCCCCCCCceeeccCCCCCceeeEeEEEE
Q 001658 33 QATTDPNEVRALNSIFQQWRISARQGQ----WNRSGDPCTGAAL-DDS-IVFDNTDYNPFIKCDCSSQNGTVCHITQLKV 106 (1036)
Q Consensus 33 ~~~~~~~~~~aL~~~~~~~~~~~~~~~----W~~~~d~C~~~~~-~~~-~~~~~~~~~~~~~~~c~~~~~~~~~l~~L~l 106 (1036)
.+.+.++|.+.+.++++.+..|....+ |+..+|.|....- +.. ....+ .+-..+.|.... ++.+.+
T Consensus 57 ~~~~~~~~~~~~~~~~~~l~~p~~~~~~~~~~~~~~~fc~~~~~~~~~l~~~~~---~~~~tv~~~~~~-----vt~l~~ 128 (754)
T PRK15370 57 PETASPEEIKSKFECLRMLAFPAYADNIQYSRGGADQYCILSENSQEILSIVFN---TEGYTVEGGGKS-----VTYTRV 128 (754)
T ss_pred CCCCCHHHHHHHHHHHHHhcCCchhhccccccCCCCcccccCCcchhhheeeec---CCceEEecCCCc-----cccccc
Confidence 467889999999999999988876666 9999999963220 000 00000 134567776532 233332
Q ss_pred eeccc--------------------cc-cCCc-------cc-----cCCCCCCEEEccCCCCCCCCcccccCCCcCCeee
Q 001658 107 YALNV--------------------VG-VIPD-------EL-----WNLTSLFNLNLGQNYLTGPLSPSVGNLTAMQYLN 153 (1036)
Q Consensus 107 ~~~~~--------------------~~-~ip~-------~l-----~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~ 153 (1036)
.+... .. ..+. .+ .-..+...|+|+++.++ .+|..+. ++|+.|+
T Consensus 129 ~g~~~~~~~~~~~~~~~~~~~w~~w~~~~~~~~~~~r~~a~~r~~~Cl~~~~~~L~L~~~~Lt-sLP~~Ip--~~L~~L~ 205 (754)
T PRK15370 129 TESEQASSASGSKDAVNYELIWSEWVKEAPAKEAANREEAVQRMRDCLKNNKTELRLKILGLT-TIPACIP--EQITTLI 205 (754)
T ss_pred ccccccccCCCCCChhhHHHHHHHHHhcCCCCccccHHHHHHHHHhhcccCceEEEeCCCCcC-cCCcccc--cCCcEEE
Confidence 22100 00 0000 01 11245788999999999 5776654 5799999
Q ss_pred cccccccCCccccccCCCCCcEEEcccCCCCCCCccccCCCccCCEEeCccccCCCCCCccccCCCCCcEEeccCCcCCC
Q 001658 154 LAINALSGELPKELGQLTELLILGIGTNNFSGPLPSELGSLSKLQELYIDSAGVSGEIPSSFANLQSLTKWWASDTRLTG 233 (1036)
Q Consensus 154 Ls~N~l~~~~p~~l~~L~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 233 (1036)
|++|+|+ .+|..+. ++|+.|+|++|+|+ .+|..+. .+|+.|+|++|++. .+|..+. .+|+.|+|++|+|+
T Consensus 206 Ls~N~Lt-sLP~~l~--~nL~~L~Ls~N~Lt-sLP~~l~--~~L~~L~Ls~N~L~-~LP~~l~--s~L~~L~Ls~N~L~- 275 (754)
T PRK15370 206 LDNNELK-SLPENLQ--GNIKTLYANSNQLT-SIPATLP--DTIQEMELSINRIT-ELPERLP--SALQSLDLFHNKIS- 275 (754)
T ss_pred ecCCCCC-cCChhhc--cCCCEEECCCCccc-cCChhhh--ccccEEECcCCccC-cCChhHh--CCCCEEECcCCccC-
Confidence 9999999 6676554 58999999999998 5676554 47999999999998 6676664 58999999999998
Q ss_pred CChhhhcCCCCCCEEEeeCCcCCCCCCccccCCCCCCEEEccCCCCCCCchhhhcCCCCCCEEEccCCccCccccccccC
Q 001658 234 RIPDFIGNWSKLTALRFQGNSFNGPIPSSFSNLTSVTELRISDLSNGSSKLAFIRDMKSLSILELRNNNISDSIPSNIGE 313 (1036)
Q Consensus 234 ~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~ 313 (1036)
.+|..+. ++|+.|+|++|+|++ +|..+. ++|+.|++++|.+..++... .++|+.|++++|.++ .+|..+.
T Consensus 276 ~LP~~l~--~sL~~L~Ls~N~Lt~-LP~~lp--~sL~~L~Ls~N~Lt~LP~~l---~~sL~~L~Ls~N~Lt-~LP~~l~- 345 (754)
T PRK15370 276 CLPENLP--EELRYLSVYDNSIRT-LPAHLP--SGITHLNVQSNSLTALPETL---PPGLKTLEAGENALT-SLPASLP- 345 (754)
T ss_pred ccccccC--CCCcEEECCCCcccc-Ccccch--hhHHHHHhcCCccccCCccc---cccceeccccCCccc-cCChhhc-
Confidence 4676554 589999999999984 555443 47889999999998776543 268999999999998 4776654
Q ss_pred CCCccEEeCCCCCCCCCCchhccCCCCccEEEccCccccccCCCCcCCCccEEEeeCccCCCCCchhh----hccCCcce
Q 001658 314 YRSLQHLDLSFNNLGGSIPDSLFNLSSLTHLFLGNNKLNGTLPARKSPLLLNIDVSYNNLQGNLPSWI----NGQQNLQI 389 (1036)
Q Consensus 314 l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~L~~Ldls~N~l~g~~p~~l----~~l~~L~~ 389 (1036)
++|+.|+|++|+|+ .+|..+. ++|+.|+|++|+|+ .+|..+...|+.|++++|+|+ .+|..+ ..++++..
T Consensus 346 -~sL~~L~Ls~N~L~-~LP~~lp--~~L~~LdLs~N~Lt-~LP~~l~~sL~~LdLs~N~L~-~LP~sl~~~~~~~~~l~~ 419 (754)
T PRK15370 346 -PELQVLDVSKNQIT-VLPETLP--PTITTLDVSRNALT-NLPENLPAALQIMQASRNNLV-RLPESLPHFRGEGPQPTR 419 (754)
T ss_pred -CcccEEECCCCCCC-cCChhhc--CCcCEEECCCCcCC-CCCHhHHHHHHHHhhccCCcc-cCchhHHHHhhcCCCccE
Confidence 78999999999998 6777664 68999999999998 566666667999999999998 455543 44567777
Q ss_pred eeecCCc
Q 001658 390 NLVANNL 396 (1036)
Q Consensus 390 ~~~~nn~ 396 (1036)
+.+.+|.
T Consensus 420 L~L~~Np 426 (754)
T PRK15370 420 IIVEYNP 426 (754)
T ss_pred EEeeCCC
Confidence 7777663
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.87 E-value=7.2e-25 Score=233.13 Aligned_cols=263 Identities=27% Similarity=0.369 Sum_probs=218.5
Q ss_pred EeEEEEeeccccccCCccccCCCCCCEEEccCCCCCCCCcccccCCCcCCeeecccccccCCccccccCCCCCcEEEccc
Q 001658 101 ITQLKVYALNVVGVIPDELWNLTSLFNLNLGQNYLTGPLSPSVGNLTAMQYLNLAINALSGELPKELGQLTELLILGIGT 180 (1036)
Q Consensus 101 l~~L~l~~~~~~~~ip~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~L~~L~~L~Ls~ 180 (1036)
+..+.+.+|++.. +.+.+.+|..|.+|++.+|+++ ..|++++.+..++.|+.++|+++ .+|..++.+.+|..|+.++
T Consensus 47 l~~lils~N~l~~-l~~dl~nL~~l~vl~~~~n~l~-~lp~aig~l~~l~~l~vs~n~ls-~lp~~i~s~~~l~~l~~s~ 123 (565)
T KOG0472|consen 47 LQKLILSHNDLEV-LREDLKNLACLTVLNVHDNKLS-QLPAAIGELEALKSLNVSHNKLS-ELPEQIGSLISLVKLDCSS 123 (565)
T ss_pred hhhhhhccCchhh-ccHhhhcccceeEEEeccchhh-hCCHHHHHHHHHHHhhcccchHh-hccHHHhhhhhhhhhhccc
Confidence 4566677766543 5566788888999999999988 78888999999999999999998 8888899999999999999
Q ss_pred CCCCCCCccccCCCccCCEEeCccccCCCCCCccccCCCCCcEEeccCCcCCCCChhhhcCCCCCCEEEeeCCcCCCCCC
Q 001658 181 NNFSGPLPSELGSLSKLQELYIDSAGVSGEIPSSFANLQSLTKWWASDTRLTGRIPDFIGNWSKLTALRFQGNSFNGPIP 260 (1036)
Q Consensus 181 N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p 260 (1036)
|.+. .+|+.++.+..|+.|+..+|+++ ..|..+.++.+|..|++.+|+++...|+.+. ++.|++||+..|.++ .+|
T Consensus 124 n~~~-el~~~i~~~~~l~dl~~~~N~i~-slp~~~~~~~~l~~l~~~~n~l~~l~~~~i~-m~~L~~ld~~~N~L~-tlP 199 (565)
T KOG0472|consen 124 NELK-ELPDSIGRLLDLEDLDATNNQIS-SLPEDMVNLSKLSKLDLEGNKLKALPENHIA-MKRLKHLDCNSNLLE-TLP 199 (565)
T ss_pred ccee-ecCchHHHHhhhhhhhccccccc-cCchHHHHHHHHHHhhccccchhhCCHHHHH-HHHHHhcccchhhhh-cCC
Confidence 9988 77888888889999999999988 7788888888888999999999866555555 889999999998887 788
Q ss_pred ccccCCCCCCEEEccCCCCCCCchhhhcCCCCCCEEEccCCccCccccccc-cCCCCccEEeCCCCCCCCCCchhccCCC
Q 001658 261 SSFSNLTSVTELRISDLSNGSSKLAFIRDMKSLSILELRNNNISDSIPSNI-GEYRSLQHLDLSFNNLGGSIPDSLFNLS 339 (1036)
Q Consensus 261 ~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~-~~l~~L~~L~Ls~N~l~~~~p~~l~~l~ 339 (1036)
..++.+.+|..|+|..|++..++ .|.++..|++|+++.|.|+ .+|+.. .++++|..|||..|+++ +.|+.+.-+.
T Consensus 200 ~~lg~l~~L~~LyL~~Nki~~lP--ef~gcs~L~Elh~g~N~i~-~lpae~~~~L~~l~vLDLRdNklk-e~Pde~clLr 275 (565)
T KOG0472|consen 200 PELGGLESLELLYLRRNKIRFLP--EFPGCSLLKELHVGENQIE-MLPAEHLKHLNSLLVLDLRDNKLK-EVPDEICLLR 275 (565)
T ss_pred hhhcchhhhHHHHhhhcccccCC--CCCccHHHHHHHhcccHHH-hhHHHHhcccccceeeeccccccc-cCchHHHHhh
Confidence 88899999999999999988887 6788888999999999987 666664 48888999999999999 8899999888
Q ss_pred CccEEEccCccccccCCCCcCCCccEEEeeCccCC
Q 001658 340 SLTHLFLGNNKLNGTLPARKSPLLLNIDVSYNNLQ 374 (1036)
Q Consensus 340 ~L~~L~Ls~N~l~g~~p~~~~~~L~~Ldls~N~l~ 374 (1036)
+|..||||+|.+++..+.-..-.|+.|-+.+|++.
T Consensus 276 sL~rLDlSNN~is~Lp~sLgnlhL~~L~leGNPlr 310 (565)
T KOG0472|consen 276 SLERLDLSNNDISSLPYSLGNLHLKFLALEGNPLR 310 (565)
T ss_pred hhhhhcccCCccccCCcccccceeeehhhcCCchH
Confidence 99999999999985444322225888888888876
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.87 E-value=6.1e-25 Score=233.69 Aligned_cols=241 Identities=29% Similarity=0.446 Sum_probs=152.1
Q ss_pred EeEEEEeeccccccCCccccCCCCCCEEEccCCCCCCCCcccccCCCcCCeeecccccccCCccccccCCCCCcEEEccc
Q 001658 101 ITQLKVYALNVVGVIPDELWNLTSLFNLNLGQNYLTGPLSPSVGNLTAMQYLNLAINALSGELPKELGQLTELLILGIGT 180 (1036)
Q Consensus 101 l~~L~l~~~~~~~~ip~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~L~~L~~L~Ls~ 180 (1036)
++.|.+.+++++ ..|++++.+..++.|+.++|++. .+|..++.+..|+.|+.++|.+. .+|+.++.+-.|+.|+..+
T Consensus 70 l~vl~~~~n~l~-~lp~aig~l~~l~~l~vs~n~ls-~lp~~i~s~~~l~~l~~s~n~~~-el~~~i~~~~~l~dl~~~~ 146 (565)
T KOG0472|consen 70 LTVLNVHDNKLS-QLPAAIGELEALKSLNVSHNKLS-ELPEQIGSLISLVKLDCSSNELK-ELPDSIGRLLDLEDLDATN 146 (565)
T ss_pred eeEEEeccchhh-hCCHHHHHHHHHHHhhcccchHh-hccHHHhhhhhhhhhhcccccee-ecCchHHHHhhhhhhhccc
Confidence 455555555443 35556666666666666666666 66666666666666666666666 5566666666666666666
Q ss_pred CCCCCCCccccCCCccCCEEeCccccCCCCCCccccCCCCCcEEeccCCcCCCCChhhhcCCCCCCEEEeeCCcCCCCCC
Q 001658 181 NNFSGPLPSELGSLSKLQELYIDSAGVSGEIPSSFANLQSLTKWWASDTRLTGRIPDFIGNWSKLTALRFQGNSFNGPIP 260 (1036)
Q Consensus 181 N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p 260 (1036)
|+++ ..|+.+.++.+|..|++.+|++....|..+. ++.|++||...|-++ .+|..++.+.+|..|+|.+|+|. .+|
T Consensus 147 N~i~-slp~~~~~~~~l~~l~~~~n~l~~l~~~~i~-m~~L~~ld~~~N~L~-tlP~~lg~l~~L~~LyL~~Nki~-~lP 222 (565)
T KOG0472|consen 147 NQIS-SLPEDMVNLSKLSKLDLEGNKLKALPENHIA-MKRLKHLDCNSNLLE-TLPPELGGLESLELLYLRRNKIR-FLP 222 (565)
T ss_pred cccc-cCchHHHHHHHHHHhhccccchhhCCHHHHH-HHHHHhcccchhhhh-cCChhhcchhhhHHHHhhhcccc-cCC
Confidence 6666 5566666666666666666666643333333 666666666666665 55556666666666666666666 445
Q ss_pred ccccCCCCCCEEEccCCCCCCCchhhhcCCCCCCEEEccCCccCccccccccCCCCccEEeCCCCCCCCCCchhccCCCC
Q 001658 261 SSFSNLTSVTELRISDLSNGSSKLAFIRDMKSLSILELRNNNISDSIPSNIGEYRSLQHLDLSFNNLGGSIPDSLFNLSS 340 (1036)
Q Consensus 261 ~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~ 340 (1036)
.|.+++.|++|+++.|.+..++.+....+++|..|||.+|+++ ..|+.+..+.+|..||+|+|.|+ .+|.+++++ .
T Consensus 223 -ef~gcs~L~Elh~g~N~i~~lpae~~~~L~~l~vLDLRdNklk-e~Pde~clLrsL~rLDlSNN~is-~Lp~sLgnl-h 298 (565)
T KOG0472|consen 223 -EFPGCSLLKELHVGENQIEMLPAEHLKHLNSLLVLDLRDNKLK-EVPDEICLLRSLERLDLSNNDIS-SLPYSLGNL-H 298 (565)
T ss_pred -CCCccHHHHHHHhcccHHHhhHHHHhcccccceeeeccccccc-cCchHHHHhhhhhhhcccCCccc-cCCcccccc-e
Confidence 5666666666666666666666666666666666666666666 56666666666666666666666 456666666 6
Q ss_pred ccEEEccCcccc
Q 001658 341 LTHLFLGNNKLN 352 (1036)
Q Consensus 341 L~~L~Ls~N~l~ 352 (1036)
|+.|-|.||++.
T Consensus 299 L~~L~leGNPlr 310 (565)
T KOG0472|consen 299 LKFLALEGNPLR 310 (565)
T ss_pred eeehhhcCCchH
Confidence 666666666665
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=8.9e-21 Score=198.03 Aligned_cols=264 Identities=22% Similarity=0.246 Sum_probs=199.1
Q ss_pred cCCCCCCccccCCCEEEEEeE-eCCCcEEEEEEccccchhcHHHHHHHHHHHHhh-ccCCcceeEeEEEcCceeEEEEEe
Q 001658 693 ENFSPSNKLGEGGFGPVYKGK-LGDGRAIAVKQLSVASRQGKSQFVAEIATISAV-QHRNLVKLHGCCIEGAERLLVYEY 770 (1036)
Q Consensus 693 ~~~~~~~~iG~G~fG~Vy~~~-~~~g~~vAvK~~~~~~~~~~~~f~~Ei~~L~~l-~H~nIv~l~g~~~~~~~~~lV~E~ 770 (1036)
-.|.+.++||+|.||..+.|+ +-+++.||||.-...++ .-++..|.+..+.+ ..++|...|-|..++..-.||+|.
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~--APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidL 105 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSE--APQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDL 105 (449)
T ss_pred ccceeccccccCcceeeecccccccCceEEEEeccccCC--cchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhh
Confidence 367889999999999999998 56889999998654333 34577888888877 589999999998889899999998
Q ss_pred cCCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCC-----CceEEEEcCcceeec
Q 001658 771 LENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDAD-----LVPKISDFGLAKLYD 845 (1036)
Q Consensus 771 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~-----~~~kl~DFGla~~~~ 845 (1036)
+ |.||+|++.-. ...++.+++..||.|++.-++|+|++. +|.|||||+|+||..- ..+.|+|||+|+.+.
T Consensus 106 L-GPSLEDLFD~C-gR~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Yr 180 (449)
T KOG1165|consen 106 L-GPSLEDLFDLC-GRRFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYR 180 (449)
T ss_pred h-CcCHHHHHHHh-cCcccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEeccchhhhc
Confidence 8 88999977543 457899999999999999999999998 9999999999999643 468999999999987
Q ss_pred CCCCcc------ccccccccCccCccccccCCCCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhcCcc
Q 001658 846 DKKTHI------STRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQE 919 (1036)
Q Consensus 846 ~~~~~~------~~~~~gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 919 (1036)
+..+.. .....||.+||+-....+.+.+.+.|+-|+|=|+...+.|..||++-.....-...+ + ..+.+.
T Consensus 181 Dp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYe---K-IGe~Kr 256 (449)
T KOG1165|consen 181 DPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYE---K-IGETKR 256 (449)
T ss_pred CccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHH---H-hccccc
Confidence 665443 234569999999999999999999999999999999999999999743221111111 0 111000
Q ss_pred ccccCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcccCCCc
Q 001658 920 IELADPKLIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVAMLCGDMEVST 971 (1036)
Q Consensus 920 ~~~~d~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~~ 971 (1036)
. ..-..+....++++..-++.+. ..+-.+-|..+-+...+....+...
T Consensus 257 ~-T~i~~Lc~g~P~efa~Yl~yvR---~L~F~E~PDYdylr~Lf~dvldr~g 304 (449)
T KOG1165|consen 257 S-TPIEVLCEGFPEEFATYLRYVR---RLDFFETPDYDYLRKLFDDVLDRLG 304 (449)
T ss_pred c-CCHHHHHhcCHHHHHHHHHHHH---hcCcccCCCHHHHHHHHHHHHHhcC
Confidence 0 0001112223444444444444 7778888988887777766555443
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=6.7e-21 Score=230.32 Aligned_cols=254 Identities=28% Similarity=0.300 Sum_probs=205.2
Q ss_pred EeEEEEeeccccccCCccccCCCCCCEEEccCCCCCCCCcccccCCCcCCeeecccccccCCccccccCCCCCcEEEccc
Q 001658 101 ITQLKVYALNVVGVIPDELWNLTSLFNLNLGQNYLTGPLSPSVGNLTAMQYLNLAINALSGELPKELGQLTELLILGIGT 180 (1036)
Q Consensus 101 l~~L~l~~~~~~~~ip~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~L~~L~~L~Ls~ 180 (1036)
-..|++..++++ .+|+.+. ++|+.|+|++|+|+ .+|. .+++|++|+|++|+|+ .+|.. .++|+.|+|++
T Consensus 203 ~~~LdLs~~~Lt-sLP~~l~--~~L~~L~L~~N~Lt-~LP~---lp~~Lk~LdLs~N~Lt-sLP~l---p~sL~~L~Ls~ 271 (788)
T PRK15387 203 NAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPA---LPPELRTLEVSGNQLT-SLPVL---PPGLLELSIFS 271 (788)
T ss_pred CcEEEcCCCCCC-cCCcchh--cCCCEEEccCCcCC-CCCC---CCCCCcEEEecCCccC-cccCc---ccccceeeccC
Confidence 356888999887 5888876 48999999999999 5664 3589999999999999 56643 46899999999
Q ss_pred CCCCCCCccccCCCccCCEEeCccccCCCCCCccccCCCCCcEEeccCCcCCCCChhhhcCCCCCCEEEeeCCcCCCCCC
Q 001658 181 NNFSGPLPSELGSLSKLQELYIDSAGVSGEIPSSFANLQSLTKWWASDTRLTGRIPDFIGNWSKLTALRFQGNSFNGPIP 260 (1036)
Q Consensus 181 N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p 260 (1036)
|.|+ .+|..+ ++|+.|+|++|+++ .+|.. +++|+.|+|++|++++ +|.. ..+|+.|++++|.|++ +|
T Consensus 272 N~L~-~Lp~lp---~~L~~L~Ls~N~Lt-~LP~~---p~~L~~LdLS~N~L~~-Lp~l---p~~L~~L~Ls~N~L~~-LP 338 (788)
T PRK15387 272 NPLT-HLPALP---SGLCKLWIFGNQLT-SLPVL---PPGLQELSVSDNQLAS-LPAL---PSELCKLWAYNNQLTS-LP 338 (788)
T ss_pred Cchh-hhhhch---hhcCEEECcCCccc-ccccc---ccccceeECCCCcccc-CCCC---cccccccccccCcccc-cc
Confidence 9998 555533 57899999999998 45542 4789999999999995 4543 2468899999999984 55
Q ss_pred ccccCCCCCCEEEccCCCCCCCchhhhcCCCCCCEEEccCCccCccccccccCCCCccEEeCCCCCCCCCCchhccCCCC
Q 001658 261 SSFSNLTSVTELRISDLSNGSSKLAFIRDMKSLSILELRNNNISDSIPSNIGEYRSLQHLDLSFNNLGGSIPDSLFNLSS 340 (1036)
Q Consensus 261 ~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~ 340 (1036)
.. ..+|+.|+|++|.+..++.. ..+|+.|++++|+|+ .+|.. +.+|+.|+|++|+|+ .+|.. .++
T Consensus 339 ~l---p~~Lq~LdLS~N~Ls~LP~l----p~~L~~L~Ls~N~L~-~LP~l---~~~L~~LdLs~N~Lt-~LP~l---~s~ 403 (788)
T PRK15387 339 TL---PSGLQELSVSDNQLASLPTL----PSELYKLWAYNNRLT-SLPAL---PSGLKELIVSGNRLT-SLPVL---PSE 403 (788)
T ss_pred cc---ccccceEecCCCccCCCCCC----Ccccceehhhccccc-cCccc---ccccceEEecCCccc-CCCCc---ccC
Confidence 32 25899999999999987652 358899999999998 56653 357999999999999 56654 368
Q ss_pred ccEEEccCccccccCCCCcCCCccEEEeeCccCCCCCchhhhccCCcceeeecCCc
Q 001658 341 LTHLFLGNNKLNGTLPARKSPLLLNIDVSYNNLQGNLPSWINGQQNLQINLVANNL 396 (1036)
Q Consensus 341 L~~L~Ls~N~l~g~~p~~~~~~L~~Ldls~N~l~g~~p~~l~~l~~L~~~~~~nn~ 396 (1036)
|+.|+|++|+|++ +|.. ...|+.|++++|+|+ .+|..+.++++|+.+.+++|.
T Consensus 404 L~~LdLS~N~Lss-IP~l-~~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~N~ 456 (788)
T PRK15387 404 LKELMVSGNRLTS-LPML-PSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNP 456 (788)
T ss_pred CCEEEccCCcCCC-CCcc-hhhhhhhhhccCccc-ccChHHhhccCCCeEECCCCC
Confidence 9999999999995 6653 346889999999998 789999999999988888774
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=3.5e-21 Score=192.67 Aligned_cols=280 Identities=20% Similarity=0.247 Sum_probs=208.2
Q ss_pred HhcCCCCCCccccCCCEEEEEeE-eCCCcEEEEEEccccchhcHHHHHHHHHHHHhhc-cCCcceeEeEEEcCceeEEEE
Q 001658 691 ATENFSPSNKLGEGGFGPVYKGK-LGDGRAIAVKQLSVASRQGKSQFVAEIATISAVQ-HRNLVKLHGCCIEGAERLLVY 768 (1036)
Q Consensus 691 ~~~~~~~~~~iG~G~fG~Vy~~~-~~~g~~vAvK~~~~~~~~~~~~f~~Ei~~L~~l~-H~nIv~l~g~~~~~~~~~lV~ 768 (1036)
...+|...++||+|+||.+|.|. ..+|+.||||.-....+. .++..|.++...++ ...|..+..|..+.....+||
T Consensus 13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~h--pqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVM 90 (341)
T KOG1163|consen 13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKH--PQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVM 90 (341)
T ss_pred eccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCC--cchhHHHHHHHHhccCCCCchhhhhccccccceeee
Confidence 35678899999999999999997 678999999987644333 35667888888886 467888888888899999999
Q ss_pred EecCCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCC---CceEEEEcCcceeec
Q 001658 769 EYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDAD---LVPKISDFGLAKLYD 845 (1036)
Q Consensus 769 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~---~~~kl~DFGla~~~~ 845 (1036)
|.+ |.||++++.-. ...++..+.+.++.|++.-++|+|..+ +|||||||+|+|..-+ ..+.++|||+|+.+.
T Consensus 91 dLL-GPsLEdLfnfC-~R~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~ 165 (341)
T KOG1163|consen 91 DLL-GPSLEDLFNFC-SRRFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYR 165 (341)
T ss_pred ecc-CccHHHHHHHH-hhhhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEeccchhhhc
Confidence 988 88999987543 446788899999999999999999998 9999999999999644 468999999999876
Q ss_pred CCCCcc------ccccccccCccCccccccCCCCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhcCcc
Q 001658 846 DKKTHI------STRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQE 919 (1036)
Q Consensus 846 ~~~~~~------~~~~~gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 919 (1036)
+..+.. .....||.+|.+-....+...+.+.|+-|+|.+|..+-.|..||++-.........+.+ .+..
T Consensus 166 d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI---~EkK-- 240 (341)
T KOG1163|consen 166 DIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKI---SEKK-- 240 (341)
T ss_pred cccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHH---HHhh--
Confidence 443322 23467999999999888888999999999999999999999999976544333222211 1110
Q ss_pred ccccCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcccCCCcCCCCCCCCcCccccCC
Q 001658 920 IELADPKLIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVAMLCGDMEVSTVTAKPGYLTDWKFDDI 987 (1036)
Q Consensus 920 ~~~~d~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~~~~~~p~~~~~~~~~~~ 987 (1036)
....+...+...+.++.-.+..|-..--++-|...-+-+.+.-... ..-..++|.-+|.....
T Consensus 241 ---~s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr--~ln~~~d~iyDW~~lkq 303 (341)
T KOG1163|consen 241 ---MSTPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFR--TLNHQYDYIYDWTMLKQ 303 (341)
T ss_pred ---cCCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHh--hccccCCeEeeHHHHHH
Confidence 0111111222333444555567888888889988777666653322 22345677777876553
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.4e-19 Score=201.39 Aligned_cols=258 Identities=29% Similarity=0.390 Sum_probs=196.3
Q ss_pred CCCCCccccCCCEEEEEeEeCCCcEEEEEEccccchh---cHHHHHHHHHHHHhhccC-CcceeEeEEEcCceeEEEEEe
Q 001658 695 FSPSNKLGEGGFGPVYKGKLGDGRAIAVKQLSVASRQ---GKSQFVAEIATISAVQHR-NLVKLHGCCIEGAERLLVYEY 770 (1036)
Q Consensus 695 ~~~~~~iG~G~fG~Vy~~~~~~g~~vAvK~~~~~~~~---~~~~f~~Ei~~L~~l~H~-nIv~l~g~~~~~~~~~lV~E~ 770 (1036)
|...+.||.|+||.||++... ..+|+|.+...... ....|.+|+.++..+.|+ +|+++++.+......++++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 556788999999999999876 78999998754332 367899999999999988 799999999777778999999
Q ss_pred cCCCChhhhhhcCCC-CCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCC-ceEEEEcCcceeecCCC
Q 001658 771 LENKSLDQALFGQRS-LTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADL-VPKISDFGLAKLYDDKK 848 (1036)
Q Consensus 771 ~~~gsL~~~l~~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~-~~kl~DFGla~~~~~~~ 848 (1036)
+.++++.+++..... ..+.......++.|++.++.|+|+.+ ++|||+||+||+++... .++++|||.++.+....
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~ 156 (384)
T COG0515 80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG 156 (384)
T ss_pred CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence 999999976643322 26788888999999999999999998 99999999999999988 79999999998665443
Q ss_pred Cc-----cccccccccCccCcccccc---CCCCchhhHHhHHHHHHHHHhCCCCCCCCChh-hHHHHHHHHHHHhhcCcc
Q 001658 849 TH-----ISTRVAGTIGYLAPEYAMR---GHLTEKTDVFAFGVLALETVSGRPNSDPSLDE-EKLYLLEWAWHLHENNQE 919 (1036)
Q Consensus 849 ~~-----~~~~~~gt~~y~APE~~~~---~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~-~~~~l~~~~~~~~~~~~~ 919 (1036)
.. ......||..|+|||.+.. ..+....|+||+|++++++++|..|+...... ......+........
T Consensus 157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~--- 233 (384)
T COG0515 157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTP--- 233 (384)
T ss_pred ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCc---
Confidence 22 2345679999999999987 57889999999999999999999997655431 011111111111100
Q ss_pred ccccCccc-ccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 001658 920 IELADPKL-IEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVAM 962 (1036)
Q Consensus 920 ~~~~d~~~-~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 962 (1036)
...... ..........+.+++..|+..+|..|.++.+....
T Consensus 234 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 234 --SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred --ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 000000 00002223466777788999999999999887764
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.8e-19 Score=234.46 Aligned_cols=273 Identities=22% Similarity=0.245 Sum_probs=160.5
Q ss_pred cCCccccCCC-CCCEEEccCCCCCCCCcccccCCCcCCeeecccccccCCccccccCCCCCcEEEcccCCCCCCCccccC
Q 001658 114 VIPDELWNLT-SLFNLNLGQNYLTGPLSPSVGNLTAMQYLNLAINALSGELPKELGQLTELLILGIGTNNFSGPLPSELG 192 (1036)
Q Consensus 114 ~ip~~l~~l~-~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~L~~L~~L~Ls~N~l~~~~p~~l~ 192 (1036)
.+|..+..++ +|+.|++.++.++ .+|..| .+.+|+.|+|.+|++. .++..+..+++|+.|+|++|.....+|. +.
T Consensus 579 ~lp~~~~~lp~~Lr~L~~~~~~l~-~lP~~f-~~~~L~~L~L~~s~l~-~L~~~~~~l~~Lk~L~Ls~~~~l~~ip~-ls 654 (1153)
T PLN03210 579 HLPEGFDYLPPKLRLLRWDKYPLR-CMPSNF-RPENLVKLQMQGSKLE-KLWDGVHSLTGLRNIDLRGSKNLKEIPD-LS 654 (1153)
T ss_pred ecCcchhhcCcccEEEEecCCCCC-CCCCcC-CccCCcEEECcCcccc-ccccccccCCCCCEEECCCCCCcCcCCc-cc
Confidence 3444444442 3555555555544 444444 3445555555555554 3444444555555555554433323332 44
Q ss_pred CCccCCEEeCccccCCCCCCccccCCCCCcEEeccCCcCCCCChhhhcCCCCCCEEEeeCCcCCCC--------------
Q 001658 193 SLSKLQELYIDSAGVSGEIPSSFANLQSLTKWWASDTRLTGRIPDFIGNWSKLTALRFQGNSFNGP-------------- 258 (1036)
Q Consensus 193 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~-------------- 258 (1036)
.+++|+.|+|++|.....+|..+..+++|+.|++++|.....+|..+ ++++|+.|+|++|...+.
T Consensus 655 ~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~i-~l~sL~~L~Lsgc~~L~~~p~~~~nL~~L~L~ 733 (1153)
T PLN03210 655 MATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMSRCENLEILPTGI-NLKSLYRLNLSGCSRLKSFPDISTNISWLDLD 733 (1153)
T ss_pred cCCcccEEEecCCCCccccchhhhccCCCCEEeCCCCCCcCccCCcC-CCCCCCEEeCCCCCCccccccccCCcCeeecC
Confidence 45555555555544444455555555555555555543333344333 344455555554433323
Q ss_pred ------CCccccCCCCCCEEEccCCCCCC-------CchhhhcCCCCCCEEEccCCccCccccccccCCCCccEEeCCCC
Q 001658 259 ------IPSSFSNLTSVTELRISDLSNGS-------SKLAFIRDMKSLSILELRNNNISDSIPSNIGEYRSLQHLDLSFN 325 (1036)
Q Consensus 259 ------~p~~~~~l~~L~~L~L~~n~l~~-------~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 325 (1036)
+|..+ .+++|+.|.+.++.... +....+...++|+.|+|++|...+.+|..++++++|+.|+|++|
T Consensus 734 ~n~i~~lP~~~-~l~~L~~L~l~~~~~~~l~~~~~~l~~~~~~~~~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C 812 (1153)
T PLN03210 734 ETAIEEFPSNL-RLENLDELILCEMKSEKLWERVQPLTPLMTMLSPSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENC 812 (1153)
T ss_pred CCccccccccc-cccccccccccccchhhccccccccchhhhhccccchheeCCCCCCccccChhhhCCCCCCEEECCCC
Confidence 33322 34444444444322111 11111223468899999999877789999999999999999988
Q ss_pred CCCCCCchhccCCCCccEEEccCccccccCCCCcCCCccEEEeeCccCCCCCchhhhccCCcceeeecCC
Q 001658 326 NLGGSIPDSLFNLSSLTHLFLGNNKLNGTLPARKSPLLLNIDVSYNNLQGNLPSWINGQQNLQINLVANN 395 (1036)
Q Consensus 326 ~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~L~~Ldls~N~l~g~~p~~l~~l~~L~~~~~~nn 395 (1036)
...+.+|..+ ++++|+.|+|++|.....+|.. ...|+.|+|++|.++ .+|.++..+++|+.+.+.++
T Consensus 813 ~~L~~LP~~~-~L~sL~~L~Ls~c~~L~~~p~~-~~nL~~L~Ls~n~i~-~iP~si~~l~~L~~L~L~~C 879 (1153)
T PLN03210 813 INLETLPTGI-NLESLESLDLSGCSRLRTFPDI-STNISDLNLSRTGIE-EVPWWIEKFSNLSFLDMNGC 879 (1153)
T ss_pred CCcCeeCCCC-CccccCEEECCCCCcccccccc-ccccCEeECCCCCCc-cChHHHhcCCCCCEEECCCC
Confidence 6555788766 7899999999998766566543 457999999999998 68989999999998887653
|
syringae 6; Provisional |
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=3.3e-22 Score=233.08 Aligned_cols=285 Identities=23% Similarity=0.239 Sum_probs=225.0
Q ss_pred eEeEEEEeeccccccCCccccCCCCCCEEEccCCCCCCCCcccccCCCcCCeeecccccccCCccccccCCCCCcEEEcc
Q 001658 100 HITQLKVYALNVVGVIPDELWNLTSLFNLNLGQNYLTGPLSPSVGNLTAMQYLNLAINALSGELPKELGQLTELLILGIG 179 (1036)
Q Consensus 100 ~l~~L~l~~~~~~~~ip~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~L~~L~~L~Ls 179 (1036)
+++.|+..+|.++...+.. .-.+|+++++++|+++ .+|..+..+.+|+.|++.+|+|. .+|..+..+++|+.|++.
T Consensus 220 ~l~~L~a~~n~l~~~~~~p--~p~nl~~~dis~n~l~-~lp~wi~~~~nle~l~~n~N~l~-~lp~ri~~~~~L~~l~~~ 295 (1081)
T KOG0618|consen 220 SLTALYADHNPLTTLDVHP--VPLNLQYLDISHNNLS-NLPEWIGACANLEALNANHNRLV-ALPLRISRITSLVSLSAA 295 (1081)
T ss_pred chheeeeccCcceeecccc--ccccceeeecchhhhh-cchHHHHhcccceEecccchhHH-hhHHHHhhhhhHHHHHhh
Confidence 4566666666666333322 2257888899998888 56688888889999999899886 888888888889999999
Q ss_pred cCCCCCCCccccCCCccCCEEeCccccCCCCCCccccCCC-CCcEEeccCCcCCCCChhhhcCCCCCCEEEeeCCcCCCC
Q 001658 180 TNNFSGPLPSELGSLSKLQELYIDSAGVSGEIPSSFANLQ-SLTKWWASDTRLTGRIPDFIGNWSKLTALRFQGNSFNGP 258 (1036)
Q Consensus 180 ~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~-~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~ 258 (1036)
+|.+. .+|..+..++.|++|+|..|+|....+..+..+. .|+.|+.+.|++....--.=..++.|+.|++.+|.++..
T Consensus 296 ~nel~-yip~~le~~~sL~tLdL~~N~L~~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~LylanN~Ltd~ 374 (1081)
T KOG0618|consen 296 YNELE-YIPPFLEGLKSLRTLDLQSNNLPSLPDNFLAVLNASLNTLNVSSNKLSTLPSYEENNHAALQELYLANNHLTDS 374 (1081)
T ss_pred hhhhh-hCCCcccccceeeeeeehhccccccchHHHhhhhHHHHHHhhhhccccccccccchhhHHHHHHHHhcCccccc
Confidence 99888 7787888888899999999988844443334443 377788888888743322222457799999999999987
Q ss_pred CCccccCCCCCCEEEccCCCCCCCchhhhcCCCCCCEEEccCCccCccccccccCCCCccEEeCCCCCCCCCCchhccCC
Q 001658 259 IPSSFSNLTSVTELRISDLSNGSSKLAFIRDMKSLSILELRNNNISDSIPSNIGEYRSLQHLDLSFNNLGGSIPDSLFNL 338 (1036)
Q Consensus 259 ~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l 338 (1036)
.-..+.+.++|+.|+|++|.+..++...+.++..|++|+||+|+|+ .+|..+..+..|+.|...+|+|. ..| .+..+
T Consensus 375 c~p~l~~~~hLKVLhLsyNrL~~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~-~fP-e~~~l 451 (1081)
T KOG0618|consen 375 CFPVLVNFKHLKVLHLSYNRLNSFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLL-SFP-ELAQL 451 (1081)
T ss_pred chhhhccccceeeeeecccccccCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCcee-ech-hhhhc
Confidence 7778899999999999999999999999999999999999999998 88999999999999999999999 788 89999
Q ss_pred CCccEEEccCccccc-cCCCCcC-CCccEEEeeCccCCCCCchhhhccCCcceeee
Q 001658 339 SSLTHLFLGNNKLNG-TLPARKS-PLLLNIDVSYNNLQGNLPSWINGQQNLQINLV 392 (1036)
Q Consensus 339 ~~L~~L~Ls~N~l~g-~~p~~~~-~~L~~Ldls~N~l~g~~p~~l~~l~~L~~~~~ 392 (1036)
+.|+.+||+.|.|+. .+|.... +.|++|||++|.-.-.--..|..++++....+
T Consensus 452 ~qL~~lDlS~N~L~~~~l~~~~p~p~LkyLdlSGN~~l~~d~~~l~~l~~l~~~~i 507 (1081)
T KOG0618|consen 452 PQLKVLDLSCNNLSEVTLPEALPSPNLKYLDLSGNTRLVFDHKTLKVLKSLSQMDI 507 (1081)
T ss_pred CcceEEecccchhhhhhhhhhCCCcccceeeccCCcccccchhhhHHhhhhhheec
Confidence 999999999999984 4565555 78999999999743233334554555544333
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=6.9e-20 Score=221.64 Aligned_cols=247 Identities=26% Similarity=0.278 Sum_probs=196.4
Q ss_pred eeEeEEEEeeccccccCCccccCCCCCCEEEccCCCCCCCCcccccCCCcCCeeecccccccCCccccccCCCCCcEEEc
Q 001658 99 CHITQLKVYALNVVGVIPDELWNLTSLFNLNLGQNYLTGPLSPSVGNLTAMQYLNLAINALSGELPKELGQLTELLILGI 178 (1036)
Q Consensus 99 ~~l~~L~l~~~~~~~~ip~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~L~~L~~L~L 178 (1036)
.+++.|.+.+|+++. +|.. +++|++|+|++|+|+ .+|.. .++|+.|+|++|.|+ .+|..+ ++|+.|+|
T Consensus 222 ~~L~~L~L~~N~Lt~-LP~l---p~~Lk~LdLs~N~Lt-sLP~l---p~sL~~L~Ls~N~L~-~Lp~lp---~~L~~L~L 289 (788)
T PRK15387 222 AHITTLVIPDNNLTS-LPAL---PPELRTLEVSGNQLT-SLPVL---PPGLLELSIFSNPLT-HLPALP---SGLCKLWI 289 (788)
T ss_pred cCCCEEEccCCcCCC-CCCC---CCCCcEEEecCCccC-cccCc---ccccceeeccCCchh-hhhhch---hhcCEEEC
Confidence 367889999988775 5643 578999999999999 55643 468999999999998 566533 67889999
Q ss_pred ccCCCCCCCccccCCCccCCEEeCccccCCCCCCccccCCCCCcEEeccCCcCCCCChhhhcCCCCCCEEEeeCCcCCCC
Q 001658 179 GTNNFSGPLPSELGSLSKLQELYIDSAGVSGEIPSSFANLQSLTKWWASDTRLTGRIPDFIGNWSKLTALRFQGNSFNGP 258 (1036)
Q Consensus 179 s~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~ 258 (1036)
++|+|+ .+|.. +++|+.|+|++|++++ +|... .+|+.|++++|+|++ +|.. ..+|+.|+|++|+|++
T Consensus 290 s~N~Lt-~LP~~---p~~L~~LdLS~N~L~~-Lp~lp---~~L~~L~Ls~N~L~~-LP~l---p~~Lq~LdLS~N~Ls~- 356 (788)
T PRK15387 290 FGNQLT-SLPVL---PPGLQELSVSDNQLAS-LPALP---SELCKLWAYNNQLTS-LPTL---PSGLQELSVSDNQLAS- 356 (788)
T ss_pred cCCccc-ccccc---ccccceeECCCCcccc-CCCCc---ccccccccccCcccc-cccc---ccccceEecCCCccCC-
Confidence 999998 55643 4789999999999995 45432 468889999999984 5542 2589999999999994
Q ss_pred CCccccCCCCCCEEEccCCCCCCCchhhhcCCCCCCEEEccCCccCccccccccCCCCccEEeCCCCCCCCCCchhccCC
Q 001658 259 IPSSFSNLTSVTELRISDLSNGSSKLAFIRDMKSLSILELRNNNISDSIPSNIGEYRSLQHLDLSFNNLGGSIPDSLFNL 338 (1036)
Q Consensus 259 ~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l 338 (1036)
+|.. ..+|+.|++++|.+..++.. ..+|+.|+|++|+|+ .+|.. .++|+.|+|++|+|+ .+|..+
T Consensus 357 LP~l---p~~L~~L~Ls~N~L~~LP~l----~~~L~~LdLs~N~Lt-~LP~l---~s~L~~LdLS~N~Ls-sIP~l~--- 421 (788)
T PRK15387 357 LPTL---PSELYKLWAYNNRLTSLPAL----PSGLKELIVSGNRLT-SLPVL---PSELKELMVSGNRLT-SLPMLP--- 421 (788)
T ss_pred CCCC---CcccceehhhccccccCccc----ccccceEEecCCccc-CCCCc---ccCCCEEEccCCcCC-CCCcch---
Confidence 5543 35788899999999987642 358999999999998 46653 367999999999999 577643
Q ss_pred CCccEEEccCccccccCCCCcC--CCccEEEeeCccCCCCCchhhhccCC
Q 001658 339 SSLTHLFLGNNKLNGTLPARKS--PLLLNIDVSYNNLQGNLPSWINGQQN 386 (1036)
Q Consensus 339 ~~L~~L~Ls~N~l~g~~p~~~~--~~L~~Ldls~N~l~g~~p~~l~~l~~ 386 (1036)
.+|+.|+|++|+|+ .+|..+. +.|..|+|++|+|++.+|..+..+.+
T Consensus 422 ~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~N~Ls~~~~~~L~~l~s 470 (788)
T PRK15387 422 SGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALREITS 470 (788)
T ss_pred hhhhhhhhccCccc-ccChHHhhccCCCeEECCCCCCCchHHHHHHHHhc
Confidence 47889999999998 6787654 56999999999999999887765443
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=3.7e-22 Score=212.70 Aligned_cols=294 Identities=18% Similarity=0.162 Sum_probs=196.9
Q ss_pred CCccccCCCCCCEEEccCCCCCCCCcccccCCCcCCeeecccccccCCccccccCCCCCcEEEccc-CCCCCCCccccCC
Q 001658 115 IPDELWNLTSLFNLNLGQNYLTGPLSPSVGNLTAMQYLNLAINALSGELPKELGQLTELLILGIGT-NNFSGPLPSELGS 193 (1036)
Q Consensus 115 ip~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~L~~L~~L~Ls~-N~l~~~~p~~l~~ 193 (1036)
+|..+. +.-..|.|..|+|+.+.|.+|..+++|+.|||++|+|+.+-|.+|..|++|..|-+.+ |+|+...-..|.+
T Consensus 61 VP~~LP--~~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~~l~k~~F~g 138 (498)
T KOG4237|consen 61 VPANLP--PETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKITDLPKGAFGG 138 (498)
T ss_pred CcccCC--CcceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchhhhhhhHhhh
Confidence 444443 2456788888888877777888888888888888888888888888888877766655 8888666677888
Q ss_pred CccCCEEeCccccCCCCCCccccCCCCCcEEeccCCcCCCCChhhhcCCCCCCEEEeeCCcCC------------CCCCc
Q 001658 194 LSKLQELYIDSAGVSGEIPSSFANLQSLTKWWASDTRLTGRIPDFIGNWSKLTALRFQGNSFN------------GPIPS 261 (1036)
Q Consensus 194 l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~------------~~~p~ 261 (1036)
|..|+.|.+.-|++.-...+.|..|++|..|.+.+|.+...-...|..+..++.+.+..|.+- ...|.
T Consensus 139 L~slqrLllNan~i~Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~icdCnL~wla~~~a~~~i 218 (498)
T KOG4237|consen 139 LSSLQRLLLNANHINCIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFICDCNLPWLADDLAMNPI 218 (498)
T ss_pred HHHHHHHhcChhhhcchhHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhcCccccccccchhhhHHhhchh
Confidence 888888888888888777888888888888888888888444457888888888888888732 23445
Q ss_pred cccCCCCCCEEEccCCCCCCCchhhhcC-CCCCCEEEccCCccCccccc-cccCCCCccEEeCCCCCCCCCCchhccCCC
Q 001658 262 SFSNLTSVTELRISDLSNGSSKLAFIRD-MKSLSILELRNNNISDSIPS-NIGEYRSLQHLDLSFNNLGGSIPDSLFNLS 339 (1036)
Q Consensus 262 ~~~~l~~L~~L~L~~n~l~~~~~~~l~~-l~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~ 339 (1036)
.++...-..-..+.++++..++...|.. +..+..=..+.+...+.-|. .|..+++|+.|+|++|+|++.-+.+|.++.
T Consensus 219 etsgarc~~p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsnN~i~~i~~~aFe~~a 298 (498)
T KOG4237|consen 219 ETSGARCVSPYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPNLRKLNLSNNKITRIEDGAFEGAA 298 (498)
T ss_pred hcccceecchHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcccceEeccCCCccchhhhhhhcchh
Confidence 5555555555556666666555543332 12222112223333334443 377777777777777777766667777777
Q ss_pred CccEEEccCccccccCCCCcC--CCccEEEeeCccCCCCCchhhhccCCcceeeecCCccccCCCCCccCccc
Q 001658 340 SLTHLFLGNNKLNGTLPARKS--PLLLNIDVSYNNLQGNLPSWINGQQNLQINLVANNLTIRSSDNSVLPRGL 410 (1036)
Q Consensus 340 ~L~~L~Ls~N~l~g~~p~~~~--~~L~~Ldls~N~l~g~~p~~l~~l~~L~~~~~~nn~~~~~~~~~~~p~~l 410 (1036)
.|++|.|..|+|...-...+. ..|+.|+|.+|+|+..-|..|..+..|..+.+..|..-+...+.++-.++
T Consensus 299 ~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~Np~~CnC~l~wl~~Wl 371 (498)
T KOG4237|consen 299 ELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSNPFNCNCRLAWLGEWL 371 (498)
T ss_pred hhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeeeehccCcccCccchHHHHHHH
Confidence 777777777777632222222 23777777777777777777777777776666666655555554444443
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.81 E-value=4.4e-20 Score=224.92 Aligned_cols=244 Identities=24% Similarity=0.371 Sum_probs=199.0
Q ss_pred eEeEEEEeeccccccCCccccCCCCCCEEEccCCCCCCCCcccccCCCcCCeeecccccccCCccccccCCCCCcEEEcc
Q 001658 100 HITQLKVYALNVVGVIPDELWNLTSLFNLNLGQNYLTGPLSPSVGNLTAMQYLNLAINALSGELPKELGQLTELLILGIG 179 (1036)
Q Consensus 100 ~l~~L~l~~~~~~~~ip~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~L~~L~~L~Ls 179 (1036)
+.+.|++.+++++. +|..+. ++|+.|+|++|+|+ .+|..+. ++|++|+|++|+|+ .+|..+. .+|+.|+|+
T Consensus 179 ~~~~L~L~~~~Lts-LP~~Ip--~~L~~L~Ls~N~Lt-sLP~~l~--~nL~~L~Ls~N~Lt-sLP~~l~--~~L~~L~Ls 249 (754)
T PRK15370 179 NKTELRLKILGLTT-IPACIP--EQITTLILDNNELK-SLPENLQ--GNIKTLYANSNQLT-SIPATLP--DTIQEMELS 249 (754)
T ss_pred CceEEEeCCCCcCc-CCcccc--cCCcEEEecCCCCC-cCChhhc--cCCCEEECCCCccc-cCChhhh--ccccEEECc
Confidence 45788888887774 676664 58999999999999 6676654 58999999999999 6776654 579999999
Q ss_pred cCCCCCCCccccCCCccCCEEeCccccCCCCCCccccCCCCCcEEeccCCcCCCCChhhhcCCCCCCEEEeeCCcCCCCC
Q 001658 180 TNNFSGPLPSELGSLSKLQELYIDSAGVSGEIPSSFANLQSLTKWWASDTRLTGRIPDFIGNWSKLTALRFQGNSFNGPI 259 (1036)
Q Consensus 180 ~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~ 259 (1036)
+|++. .+|..+. .+|+.|+|++|+|+ .+|..+. ++|+.|+|++|+|+. +|..+. ++|+.|+|++|.++. +
T Consensus 250 ~N~L~-~LP~~l~--s~L~~L~Ls~N~L~-~LP~~l~--~sL~~L~Ls~N~Lt~-LP~~lp--~sL~~L~Ls~N~Lt~-L 319 (754)
T PRK15370 250 INRIT-ELPERLP--SALQSLDLFHNKIS-CLPENLP--EELRYLSVYDNSIRT-LPAHLP--SGITHLNVQSNSLTA-L 319 (754)
T ss_pred CCccC-cCChhHh--CCCCEEECcCCccC-ccccccC--CCCcEEECCCCcccc-Ccccch--hhHHHHHhcCCcccc-C
Confidence 99998 6777664 58999999999999 5677654 589999999999995 555443 579999999999994 5
Q ss_pred CccccCCCCCCEEEccCCCCCCCchhhhcCCCCCCEEEccCCccCccccccccCCCCccEEeCCCCCCCCCCchhccCCC
Q 001658 260 PSSFSNLTSVTELRISDLSNGSSKLAFIRDMKSLSILELRNNNISDSIPSNIGEYRSLQHLDLSFNNLGGSIPDSLFNLS 339 (1036)
Q Consensus 260 p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~ 339 (1036)
|..+. ++|+.|++++|.++.++... .++|+.|+|++|+|+ .+|..+. ++|+.|+|++|+|+ .+|..+. .
T Consensus 320 P~~l~--~sL~~L~Ls~N~Lt~LP~~l---~~sL~~L~Ls~N~L~-~LP~~lp--~~L~~LdLs~N~Lt-~LP~~l~--~ 388 (754)
T PRK15370 320 PETLP--PGLKTLEAGENALTSLPASL---PPELQVLDVSKNQIT-VLPETLP--PTITTLDVSRNALT-NLPENLP--A 388 (754)
T ss_pred Ccccc--ccceeccccCCccccCChhh---cCcccEEECCCCCCC-cCChhhc--CCcCEEECCCCcCC-CCCHhHH--H
Confidence 55443 68999999999999876543 268999999999998 6777663 78999999999999 6777665 3
Q ss_pred CccEEEccCccccccCCCCc------CCCccEEEeeCccCC
Q 001658 340 SLTHLFLGNNKLNGTLPARK------SPLLLNIDVSYNNLQ 374 (1036)
Q Consensus 340 ~L~~L~Ls~N~l~g~~p~~~------~~~L~~Ldls~N~l~ 374 (1036)
.|+.|++++|+|+ .+|..+ .+.+..|+|.+|+|+
T Consensus 389 sL~~LdLs~N~L~-~LP~sl~~~~~~~~~l~~L~L~~Npls 428 (754)
T PRK15370 389 ALQIMQASRNNLV-RLPESLPHFRGEGPQPTRIIVEYNPFS 428 (754)
T ss_pred HHHHHhhccCCcc-cCchhHHHHhhcCCCccEEEeeCCCcc
Confidence 7999999999998 555532 256889999999998
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.7e-20 Score=224.67 Aligned_cols=252 Identities=21% Similarity=0.250 Sum_probs=186.0
Q ss_pred CCCccccCCCEEEEEeEe-CCCcEEEEEEcc----cc-ch-hcHHHHHHHHHHHHhhccCCcceeEeEEEcCceeEEEEE
Q 001658 697 PSNKLGEGGFGPVYKGKL-GDGRAIAVKQLS----VA-SR-QGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLVYE 769 (1036)
Q Consensus 697 ~~~~iG~G~fG~Vy~~~~-~~g~~vAvK~~~----~~-~~-~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E 769 (1036)
..+++|.|++|.|+.... ...+..+.|.+. .. .. .....+..|+.+-..++|+|++..+..+.+.....-+||
T Consensus 322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE 401 (601)
T KOG0590|consen 322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSME 401 (601)
T ss_pred ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhh
Confidence 457899999998887763 234444555433 11 11 111225567777888999999888887777766666699
Q ss_pred ecCCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeecCCCC
Q 001658 770 YLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKT 849 (1036)
Q Consensus 770 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~ 849 (1036)
|+++ +|...+... ..+....+..+..|+.+|++|||+.| |.|||+|++|+++..++.+||+|||.+..+.-...
T Consensus 402 ~~~~-Dlf~~~~~~--~~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e 475 (601)
T KOG0590|consen 402 YCPY-DLFSLVMSN--GKLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGAASVFRYPWE 475 (601)
T ss_pred cccH-HHHHHHhcc--cccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCcceeeccCcc
Confidence 9999 999988543 35666777788999999999999999 99999999999999999999999999986653322
Q ss_pred ---ccccccccccCccCccccccCCCCc-hhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhcCccccccCc
Q 001658 850 ---HISTRVAGTIGYLAPEYAMRGHLTE-KTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEIELADP 925 (1036)
Q Consensus 850 ---~~~~~~~gt~~y~APE~~~~~~~~~-ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 925 (1036)
.....++|+..|+|||++.+..|.+ ..||||.|+++..|.+|+.||......+..+ . .... ........
T Consensus 476 ~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~-~----~~~~--~~~~~~~~ 548 (601)
T KOG0590|consen 476 KNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF-K----TNNY--SDQRNIFE 548 (601)
T ss_pred hhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccch-h----hhcc--cccccccc
Confidence 4456688999999999999999876 6899999999999999999998654433321 0 0000 00000111
Q ss_pred ccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 001658 926 KLIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVA 961 (1036)
Q Consensus 926 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 961 (1036)
.........+.+...++.++++.+|.+|-|+.+|++
T Consensus 549 ~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 549 GPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred ChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 111223455566777888999999999999999986
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.1e-19 Score=189.99 Aligned_cols=172 Identities=13% Similarity=0.160 Sum_probs=134.4
Q ss_pred HHhcCCCCCCccccCCCEEEEEeEeCCCcEEEEEEccccchhcHHH---------HHHHHHHHHhhccCCcceeEeEEEc
Q 001658 690 TATENFSPSNKLGEGGFGPVYKGKLGDGRAIAVKQLSVASRQGKSQ---------FVAEIATISAVQHRNLVKLHGCCIE 760 (1036)
Q Consensus 690 ~~~~~~~~~~~iG~G~fG~Vy~~~~~~g~~vAvK~~~~~~~~~~~~---------f~~Ei~~L~~l~H~nIv~l~g~~~~ 760 (1036)
...++|...+.+|.|+||.||.+.. ++..+|+|.++......... |++|++.+.+++|++|..+.+++..
T Consensus 28 ~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~ 106 (232)
T PRK10359 28 FLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLL 106 (232)
T ss_pred HhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeee
Confidence 3568999999999999999999766 56789999997543332222 6899999999999999999988664
Q ss_pred C--------ceeEEEEEecCCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCc
Q 001658 761 G--------AERLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLV 832 (1036)
Q Consensus 761 ~--------~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~ 832 (1036)
. ...++||||++|.+|.++.. ++. ....+++.++..+|+.+ ++|||+||+||+++.++
T Consensus 107 ~~~~~~~~~~~~~lvmEyi~G~tL~~~~~------~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili~~~g- 172 (232)
T PRK10359 107 AERKTLRYAHTYIMLIEYIEGVELNDMPE------ISE----DVKAKIKASIESLHQHG---MVSGDPHKGNFIVSKNG- 172 (232)
T ss_pred cccccccccCCeEEEEEEECCccHHHhhh------ccH----HHHHHHHHHHHHHHHcC---CccCCCChHHEEEeCCC-
Confidence 3 35789999999999988741 222 24569999999999998 99999999999999988
Q ss_pred eEEEEcCcceeecCCCCccccccccccCccCccccccCCCCchhhHHhHHHHHHHHH
Q 001658 833 PKISDFGLAKLYDDKKTHISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETV 889 (1036)
Q Consensus 833 ~kl~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~ell 889 (1036)
++|+|||..+........ ..+.....+..++|+|+||+.+....
T Consensus 173 i~liDfg~~~~~~e~~a~-------------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 173 LRIIDLSGKRCTAQRKAK-------------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred EEEEECCCcccccchhhH-------------HHHHHHhHhcccccccceeEeehHHH
Confidence 999999988755322111 11344455667999999999876544
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.80 E-value=3.3e-19 Score=184.58 Aligned_cols=140 Identities=16% Similarity=0.171 Sum_probs=109.6
Q ss_pred CCccccCCCEEEEEeEeCCCcEEEEEEccccchh--c-------HH-----------------HHHHHHHHHHhhccCCc
Q 001658 698 SNKLGEGGFGPVYKGKLGDGRAIAVKQLSVASRQ--G-------KS-----------------QFVAEIATISAVQHRNL 751 (1036)
Q Consensus 698 ~~~iG~G~fG~Vy~~~~~~g~~vAvK~~~~~~~~--~-------~~-----------------~f~~Ei~~L~~l~H~nI 751 (1036)
.+.||+|+||.||+|...+|+.||||+++..... . .. ....|++.+.++.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 4679999999999999878999999998653211 1 11 22349999999998887
Q ss_pred ceeEeEEEcCceeEEEEEecCCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHH-HhcCCccccccccCCCcEEecCC
Q 001658 752 VKLHGCCIEGAERLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYL-HEESRVRIIHRDVKASNVLLDAD 830 (1036)
Q Consensus 752 v~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yL-H~~~~~~ivHrDikp~NILl~~~ 830 (1036)
.....+.. ...++||||++++++...... ...+++....+++.|++.+|.|+ |+.+ |+||||||+|||++ +
T Consensus 82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~--~~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~NIli~-~ 153 (190)
T cd05147 82 PCPEPILL--KSHVLVMEFIGDDGWAAPRLK--DAPLSESKARELYLQVIQIMRILYQDCR---LVHADLSEYNLLYH-D 153 (190)
T ss_pred CCCcEEEe--cCCEEEEEEeCCCCCcchhhh--cCCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEE-C
Confidence 54443322 234899999998877654322 34678899999999999999999 6777 99999999999998 4
Q ss_pred CceEEEEcCcceeec
Q 001658 831 LVPKISDFGLAKLYD 845 (1036)
Q Consensus 831 ~~~kl~DFGla~~~~ 845 (1036)
+.++|+|||+|....
T Consensus 154 ~~v~LiDFG~a~~~~ 168 (190)
T cd05147 154 GKLYIIDVSQSVEHD 168 (190)
T ss_pred CcEEEEEccccccCC
Confidence 789999999997643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=1e-21 Score=209.37 Aligned_cols=279 Identities=18% Similarity=0.179 Sum_probs=233.2
Q ss_pred ceeeEeEEEEeeccccccCCccccCCCCCCEEEccCCCCCCCCcccccCCCcCCeeeccc-ccccCCccccccCCCCCcE
Q 001658 97 TVCHITQLKVYALNVVGVIPDELWNLTSLFNLNLGQNYLTGPLSPSVGNLTAMQYLNLAI-NALSGELPKELGQLTELLI 175 (1036)
Q Consensus 97 ~~~~l~~L~l~~~~~~~~ip~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~-N~l~~~~p~~l~~L~~L~~ 175 (1036)
..+..+.++|..|.++...|..|+.+++|+.|||++|+|+.+-|++|..|..|..|-+-+ |+|+...-..|++|..|+.
T Consensus 65 LP~~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~~l~k~~F~gL~slqr 144 (498)
T KOG4237|consen 65 LPPETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKITDLPKGAFGGLSSLQR 144 (498)
T ss_pred CCCcceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchhhhhhhHhhhHHHHHH
Confidence 346788999999999998889999999999999999999999999999999998887666 9999655578999999999
Q ss_pred EEcccCCCCCCCccccCCCccCCEEeCccccCCCCCCccccCCCCCcEEeccCCcC------------CCCChhhhcCCC
Q 001658 176 LGIGTNNFSGPLPSELGSLSKLQELYIDSAGVSGEIPSSFANLQSLTKWWASDTRL------------TGRIPDFIGNWS 243 (1036)
Q Consensus 176 L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l------------~~~~p~~l~~l~ 243 (1036)
|.+.-|++.-...+.|..|++|..|.|.+|.+...--..|..+..++.+.+..|.+ ....|..++...
T Consensus 145 LllNan~i~Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~icdCnL~wla~~~a~~~ietsgar 224 (498)
T KOG4237|consen 145 LLLNANHINCIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFICDCNLPWLADDLAMNPIETSGAR 224 (498)
T ss_pred HhcChhhhcchhHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhcCccccccccchhhhHHhhchhhcccce
Confidence 99999999988899999999999999999999955555899999999999999882 233444555555
Q ss_pred CCCEEEeeCCcCCCCCCccccCC-CCC-CEEEccCCCCCCCchhhhcCCCCCCEEEccCCccCccccccccCCCCccEEe
Q 001658 244 KLTALRFQGNSFNGPIPSSFSNL-TSV-TELRISDLSNGSSKLAFIRDMKSLSILELRNNNISDSIPSNIGEYRSLQHLD 321 (1036)
Q Consensus 244 ~L~~L~L~~N~l~~~~p~~~~~l-~~L-~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 321 (1036)
-..-..|.++++....+..|... ..+ ..+...++.....+...|..+++|+.|+|++|+|+++-+.+|..+..|++|.
T Consensus 225 c~~p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsnN~i~~i~~~aFe~~a~l~eL~ 304 (498)
T KOG4237|consen 225 CVSPYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPNLRKLNLSNNKITRIEDGAFEGAAELQELY 304 (498)
T ss_pred ecchHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcccceEeccCCCccchhhhhhhcchhhhhhhh
Confidence 55666677777765555555432 222 1233344556667778899999999999999999988899999999999999
Q ss_pred CCCCCCCCCCchhccCCCCccEEEccCccccccCCCCcCCC--ccEEEeeCccCCC
Q 001658 322 LSFNNLGGSIPDSLFNLSSLTHLFLGNNKLNGTLPARKSPL--LLNIDVSYNNLQG 375 (1036)
Q Consensus 322 Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~--L~~Ldls~N~l~g 375 (1036)
|..|+|...--..|.++..|+.|+|.+|+|+...|..+.+. |..|+|-.|++..
T Consensus 305 L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~Np~~C 360 (498)
T KOG4237|consen 305 LTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSNPFNC 360 (498)
T ss_pred cCcchHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeeeehccCcccC
Confidence 99999995556678899999999999999998888888765 9999999999864
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.79 E-value=3.3e-18 Score=222.84 Aligned_cols=270 Identities=21% Similarity=0.205 Sum_probs=159.9
Q ss_pred CCccccCCCCCCEEEccCCCCCCCCcccccCCCcCCeeecccccccCCccccccCCCCCcEEEcccCCCCCCCccccCCC
Q 001658 115 IPDELWNLTSLFNLNLGQNYLTGPLSPSVGNLTAMQYLNLAINALSGELPKELGQLTELLILGIGTNNFSGPLPSELGSL 194 (1036)
Q Consensus 115 ip~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~L~~L~~L~Ls~N~l~~~~p~~l~~l 194 (1036)
++..+..+++|+.|+|++|.....+| .++.+++|++|+|++|.....+|..+.++++|+.|++++|...+.+|..+ ++
T Consensus 626 L~~~~~~l~~Lk~L~Ls~~~~l~~ip-~ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~i-~l 703 (1153)
T PLN03210 626 LWDGVHSLTGLRNIDLRGSKNLKEIP-DLSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMSRCENLEILPTGI-NL 703 (1153)
T ss_pred cccccccCCCCCEEECCCCCCcCcCC-ccccCCcccEEEecCCCCccccchhhhccCCCCEEeCCCCCCcCccCCcC-CC
Confidence 33344444444444444433222333 24444444444444443333444444444444444444433222334333 34
Q ss_pred ccCCEEeCccccCCCCCCccccCCCCCcEEeccCCcCCCCChhhhcCCCCCCEEEeeCCcCC-------CCCCccccCCC
Q 001658 195 SKLQELYIDSAGVSGEIPSSFANLQSLTKWWASDTRLTGRIPDFIGNWSKLTALRFQGNSFN-------GPIPSSFSNLT 267 (1036)
Q Consensus 195 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~-------~~~p~~~~~l~ 267 (1036)
++|+.|+|++|.....+|.. ..+|++|+|++|.+. .+|..+ .+++|+.|++.++... ...+..+...+
T Consensus 704 ~sL~~L~Lsgc~~L~~~p~~---~~nL~~L~L~~n~i~-~lP~~~-~l~~L~~L~l~~~~~~~l~~~~~~l~~~~~~~~~ 778 (1153)
T PLN03210 704 KSLYRLNLSGCSRLKSFPDI---STNISWLDLDETAIE-EFPSNL-RLENLDELILCEMKSEKLWERVQPLTPLMTMLSP 778 (1153)
T ss_pred CCCCEEeCCCCCCccccccc---cCCcCeeecCCCccc-cccccc-cccccccccccccchhhccccccccchhhhhccc
Confidence 44444444444433333321 234555555555554 334333 3556666666553221 11122233457
Q ss_pred CCCEEEccCCCCCCCchhhhcCCCCCCEEEccCCccCccccccccCCCCccEEeCCCCCCCCCCchhccCCCCccEEEcc
Q 001658 268 SVTELRISDLSNGSSKLAFIRDMKSLSILELRNNNISDSIPSNIGEYRSLQHLDLSFNNLGGSIPDSLFNLSSLTHLFLG 347 (1036)
Q Consensus 268 ~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls 347 (1036)
+|+.|+|++|......+..+.++++|+.|+|++|...+.+|..+ .+++|+.|+|++|.....+|.. ..+|+.|+|+
T Consensus 779 sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~-~L~sL~~L~Ls~c~~L~~~p~~---~~nL~~L~Ls 854 (1153)
T PLN03210 779 SLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGI-NLESLESLDLSGCSRLRTFPDI---STNISDLNLS 854 (1153)
T ss_pred cchheeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCCC-CccccCEEECCCCCcccccccc---ccccCEeECC
Confidence 89999999987665556678899999999999986555778766 6899999999998765566653 3689999999
Q ss_pred CccccccCCCCc--CCCccEEEeeCc-cCCCCCchhhhccCCcceeeecCCcc
Q 001658 348 NNKLNGTLPARK--SPLLLNIDVSYN-NLQGNLPSWINGQQNLQINLVANNLT 397 (1036)
Q Consensus 348 ~N~l~g~~p~~~--~~~L~~Ldls~N-~l~g~~p~~l~~l~~L~~~~~~nn~~ 397 (1036)
+|.++ .+|..+ .+.|+.|+|+++ +|. .+|..+..+++|+.+.+.+...
T Consensus 855 ~n~i~-~iP~si~~l~~L~~L~L~~C~~L~-~l~~~~~~L~~L~~L~l~~C~~ 905 (1153)
T PLN03210 855 RTGIE-EVPWWIEKFSNLSFLDMNGCNNLQ-RVSLNISKLKHLETVDFSDCGA 905 (1153)
T ss_pred CCCCc-cChHHHhcCCCCCEEECCCCCCcC-ccCcccccccCCCeeecCCCcc
Confidence 99998 566654 466999999985 555 5777788888888877776533
|
syringae 6; Provisional |
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.77 E-value=2.9e-18 Score=178.19 Aligned_cols=141 Identities=19% Similarity=0.270 Sum_probs=111.8
Q ss_pred CCccccCCCEEEEEeEeCCCcEEEEEEccccchh--------------------------cHHHHHHHHHHHHhhccCCc
Q 001658 698 SNKLGEGGFGPVYKGKLGDGRAIAVKQLSVASRQ--------------------------GKSQFVAEIATISAVQHRNL 751 (1036)
Q Consensus 698 ~~~iG~G~fG~Vy~~~~~~g~~vAvK~~~~~~~~--------------------------~~~~f~~Ei~~L~~l~H~nI 751 (1036)
.+.||+|+||.||+|...+|+.||||+++..... ....+..|.+.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 4689999999999999778999999998754211 01234678999999999988
Q ss_pred ceeEeEEEcCceeEEEEEecCCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHh-cCCccccccccCCCcEEecCC
Q 001658 752 VKLHGCCIEGAERLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHE-ESRVRIIHRDVKASNVLLDAD 830 (1036)
Q Consensus 752 v~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivHrDikp~NILl~~~ 830 (1036)
.....+... ..++||||++++++..... ....++.....+++.|++.++.++|+ .+ |+||||||+||+++ +
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l--~~~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~NIll~-~ 153 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRL--KDVPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEYNILYH-D 153 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhh--hhccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChhhEEEE-C
Confidence 655444333 2489999999886544321 12456778889999999999999999 77 99999999999999 8
Q ss_pred CceEEEEcCcceeecC
Q 001658 831 LVPKISDFGLAKLYDD 846 (1036)
Q Consensus 831 ~~~kl~DFGla~~~~~ 846 (1036)
+.++|+|||+++....
T Consensus 154 ~~~~liDFG~a~~~~~ 169 (190)
T cd05145 154 GKPYIIDVSQAVELDH 169 (190)
T ss_pred CCEEEEEcccceecCC
Confidence 8999999999987654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=2e-20 Score=218.36 Aligned_cols=244 Identities=26% Similarity=0.376 Sum_probs=180.7
Q ss_pred CcCCeeecccccccCCccccccCCCCCcEEEcccCCCCCCCccccCCCccCCEEeCccccCCCCCCccccCCCCCcEEec
Q 001658 147 TAMQYLNLAINALSGELPKELGQLTELLILGIGTNNFSGPLPSELGSLSKLQELYIDSAGVSGEIPSSFANLQSLTKWWA 226 (1036)
Q Consensus 147 ~~L~~L~Ls~N~l~~~~p~~l~~L~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 226 (1036)
.+|+++++++|+++ .+|..++.+.+|+.|+..+|+|+ .+|..+..+.+|+.|.+..|.++ -+|.....++.|++|+|
T Consensus 241 ~nl~~~dis~n~l~-~lp~wi~~~~nle~l~~n~N~l~-~lp~ri~~~~~L~~l~~~~nel~-yip~~le~~~sL~tLdL 317 (1081)
T KOG0618|consen 241 LNLQYLDISHNNLS-NLPEWIGACANLEALNANHNRLV-ALPLRISRITSLVSLSAAYNELE-YIPPFLEGLKSLRTLDL 317 (1081)
T ss_pred ccceeeecchhhhh-cchHHHHhcccceEecccchhHH-hhHHHHhhhhhHHHHHhhhhhhh-hCCCcccccceeeeeee
Confidence 45666777777666 55566666677777777777764 66666666666777777777666 55556666677777777
Q ss_pred cCCcCCCCChhhhcCCCC-CCEEEeeCCcCCCCCCccccCCCCCCEEEccCCCCCCCchhhhcCCCCCCEEEccCCccCc
Q 001658 227 SDTRLTGRIPDFIGNWSK-LTALRFQGNSFNGPIPSSFSNLTSVTELRISDLSNGSSKLAFIRDMKSLSILELRNNNISD 305 (1036)
Q Consensus 227 ~~N~l~~~~p~~l~~l~~-L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~ 305 (1036)
..|+|....+..|..+.. |..|+.+.|++.......=..++.|+.|++.+|.+++--...+.++++|+.|+|++|+|.
T Consensus 318 ~~N~L~~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~- 396 (1081)
T KOG0618|consen 318 QSNNLPSLPDNFLAVLNASLNTLNVSSNKLSTLPSYEENNHAALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLN- 396 (1081)
T ss_pred hhccccccchHHHhhhhHHHHHHhhhhccccccccccchhhHHHHHHHHhcCcccccchhhhccccceeeeeecccccc-
Confidence 777776444433433333 566666666666222112233567888999999999999999999999999999999998
Q ss_pred ccccc-ccCCCCccEEeCCCCCCCCCCchhccCCCCccEEEccCccccccCCC-CcCCCccEEEeeCccCCCC-Cchhhh
Q 001658 306 SIPSN-IGEYRSLQHLDLSFNNLGGSIPDSLFNLSSLTHLFLGNNKLNGTLPA-RKSPLLLNIDVSYNNLQGN-LPSWIN 382 (1036)
Q Consensus 306 ~~p~~-~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~~p~-~~~~~L~~Ldls~N~l~g~-~p~~l~ 382 (1036)
.+|+. +.+++.|++|+||+|+|+ .+|..+.++..|+.|...+|+|. ..|. ...+.|+.+|||.|+|+.. +|..+.
T Consensus 397 ~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~-~fPe~~~l~qL~~lDlS~N~L~~~~l~~~~p 474 (1081)
T KOG0618|consen 397 SFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLL-SFPELAQLPQLKVLDLSCNNLSEVTLPEALP 474 (1081)
T ss_pred cCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCcee-echhhhhcCcceEEecccchhhhhhhhhhCC
Confidence 56654 889999999999999999 89999999999999999999999 4554 4567899999999999753 343333
Q ss_pred ccCCcceeeecCCcc
Q 001658 383 GQQNLQINLVANNLT 397 (1036)
Q Consensus 383 ~l~~L~~~~~~nn~~ 397 (1036)
-++|+.+++.+|..
T Consensus 475 -~p~LkyLdlSGN~~ 488 (1081)
T KOG0618|consen 475 -SPNLKYLDLSGNTR 488 (1081)
T ss_pred -CcccceeeccCCcc
Confidence 27999999999964
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.76 E-value=8e-18 Score=172.07 Aligned_cols=185 Identities=19% Similarity=0.120 Sum_probs=140.7
Q ss_pred CCCccccCCCEEEEEeEeCCCcEEEEEEccccchh----cHHHHHHHHHHHHhhc-cCCcceeEeEEEcCceeEEEEEec
Q 001658 697 PSNKLGEGGFGPVYKGKLGDGRAIAVKQLSVASRQ----GKSQFVAEIATISAVQ-HRNLVKLHGCCIEGAERLLVYEYL 771 (1036)
Q Consensus 697 ~~~~iG~G~fG~Vy~~~~~~g~~vAvK~~~~~~~~----~~~~f~~Ei~~L~~l~-H~nIv~l~g~~~~~~~~~lV~E~~ 771 (1036)
....|++|+||+||.+.. .+.+++.+.+...... ....|.+|+++|+++. |+++++++++ ...+++|||+
T Consensus 6 ~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI 80 (218)
T PRK12274 6 VNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYL 80 (218)
T ss_pred cceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeee
Confidence 457899999999997766 6788888877644321 1225889999999995 5889999986 3468999999
Q ss_pred CCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCcccccccc-CCCcEEecCCCceEEEEcCcceeecCCCCc
Q 001658 772 ENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDV-KASNVLLDADLVPKISDFGLAKLYDDKKTH 850 (1036)
Q Consensus 772 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDi-kp~NILl~~~~~~kl~DFGla~~~~~~~~~ 850 (1036)
+|.+|.+.+.. ....++.|++++|.++|+.+ |+|||| ||.|||+++++.++|+|||++.........
T Consensus 81 ~G~~L~~~~~~---------~~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~ 148 (218)
T PRK12274 81 AGAAMYQRPPR---------GDLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARW 148 (218)
T ss_pred cCccHHhhhhh---------hhHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCceecCCcchH
Confidence 99998765411 11346789999999999998 999999 799999999999999999999865433210
Q ss_pred ----c--------ccccccccCccCccccccC-CCC-chhhHHhHHHHHHHHHhCCCCCCCC
Q 001658 851 ----I--------STRVAGTIGYLAPEYAMRG-HLT-EKTDVFAFGVLALETVSGRPNSDPS 898 (1036)
Q Consensus 851 ----~--------~~~~~gt~~y~APE~~~~~-~~~-~ksDVwS~Gvvl~elltG~~p~~~~ 898 (1036)
. ......++.|++|+...-- ..+ ...+.++-|.-+|.++|++.+.-..
T Consensus 149 ~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~ 210 (218)
T PRK12274 149 MRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWED 210 (218)
T ss_pred HHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcccc
Confidence 0 0112367788888865422 233 5678999999999999999876543
|
|
| >PF11721 Malectin: Di-glucose binding within endoplasmic reticulum; InterPro: IPR021720 Malectin is a membrane-anchored protein of the endoplasmic reticulum that recognises and binds Glc2-N-glycan | Back alignment and domain information |
|---|
Probab=99.75 E-value=5.3e-19 Score=179.29 Aligned_cols=169 Identities=44% Similarity=0.713 Sum_probs=112.3
Q ss_pred ceeccCCCceeecCCeEEecCCCCcccce-eeecCCCceeeeccccccCCCCcccccccccccccccchhhhhhhccCcc
Q 001658 429 FAIKSGGPQIRSSNGVVYERDNATLGPAT-YYVTDSNKWGVSNVGLFTGSNNPQYKSSSLSQFTNTLDSELFQTARLSAS 507 (1036)
Q Consensus 429 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 507 (1036)
.+|+||++......+..|+.|..-.|... |+.+ ..+..+.........++.|.+||+++|..|.
T Consensus 3 ~~IN~Gg~~~~~~~g~~w~~D~~~~~g~~~y~~~---------------~~~~~~~~~~~~~i~~t~d~~Lyqt~R~g~~ 67 (174)
T PF11721_consen 3 LRINAGGPAYTDSSGIVWEADQYYTGGSWGYYVS---------------SDNNGSTSSTNSSIPGTTDDPLYQTERYGPS 67 (174)
T ss_dssp EEEEETSSSEEETTTEEE-SSSSSTTSS--------------------------SSTTS--TTS-HHHHHTTT-----SS
T ss_pred EEEECCCCcccCCCCCEEcCCCCCCCCCcccccc---------------cccccccccccccccCCCchhhhHhhcCCCC
Confidence 57999999988888899999987654332 2211 2222223334456678889999999999999
Q ss_pred cceeecccccCcceEeeehhhHHhhccccccccccceeeEEeeccceeeeccceeeccCCCCceeeeeeeeeEeecCeeE
Q 001658 508 SLRYYGLGLENGNYTVLLQFAEMAILDTNRWESLGRRVFDVYIQGNRVLKDFDIKREAGGVSKRAIQREIKTRVSENYLE 587 (1036)
Q Consensus 508 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~~~~~ 587 (1036)
+++|...|+.+|.|+|+|||||+.+..+..++..|+|+|||+++|++++++|+|.+++|+..+++..+-+...|.+..+.
T Consensus 68 ~f~Y~ip~~~~G~Y~V~L~FaE~~~~~~~~~~~~G~RvFdV~v~g~~vl~~~Di~~~~G~~~~~~~~~~~~v~v~dg~L~ 147 (174)
T PF11721_consen 68 SFSYDIPVVPNGTYTVRLHFAELYFGASGGASGPGQRVFDVYVNGETVLKNFDIYAEAGGFNKAAVRRFFNVTVTDGTLN 147 (174)
T ss_dssp SEEEEEE--S-EEEEEEEEEE-SSS--------SSSS-EEEEETTEEEEEEE-HHHHHSSSS---EEEEEEEEEETTEEE
T ss_pred ceEEEEecCCCcEEEEEEEeccccccccccccCCCceEEEEEecceEEEeccCHHHHcCCCceEEEEEEEEEEEeCCcEE
Confidence 99999999999999999999999999999999999999999999999999999999999998666633337889999999
Q ss_pred EEEEEccCCcccCCCCCCCC-Ccccc
Q 001658 588 IHLFWAGKGTCCVPAQGTYG-PSISA 612 (1036)
Q Consensus 588 i~~~w~g~g~~~~p~~~~~g-p~~s~ 612 (1036)
|+|.|+++|.||++..+.++ |.+++
T Consensus 148 i~f~~~~~~~~~i~~~~~~~~p~Isa 173 (174)
T PF11721_consen 148 IQFVWAGKGTLCIPFIGSYGNPLISA 173 (174)
T ss_dssp TTEEEE--SEEEEEEESSSSSSSEEE
T ss_pred EEEEecCCCcEEeeccccCCCcEEee
Confidence 99999999999998766666 65554
|
It carries a signal peptide from residues 1-26, a C-terminal transmembrane helix from residues 255-274, and a highly conserved central part of approximately 190 residues followed by an acidic, glutamate-rich region. Carbohydrate-binding is mediated by the four aromatic residues, Y67, Y89, Y116, and F117 and the aspartate at D186. NMR-based ligand-screening studies has shown binding of the protein to maltose and related oligosaccharides, on the basis of which the protein has been designated "malectin", and its endogenous ligand is found to be Glc2-high-mannose N-glycan [. This entry represents a malectin domain, and can also be found in probable receptor-like serine/threonine-protein kinases from plants [] and in proteins described as glycoside hydrolases. ; PDB: 2KR2_A 2JWP_A 2K46_A. |
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.75 E-value=6.4e-19 Score=208.66 Aligned_cols=249 Identities=22% Similarity=0.244 Sum_probs=177.5
Q ss_pred CCCCCCccccCCCEEEEEeEeCCCcEEEEEEccccc-hhcHHHHHHHHHHH--HhhccCCcceeEeEEEcCceeEEEEEe
Q 001658 694 NFSPSNKLGEGGFGPVYKGKLGDGRAIAVKQLSVAS-RQGKSQFVAEIATI--SAVQHRNLVKLHGCCIEGAERLLVYEY 770 (1036)
Q Consensus 694 ~~~~~~~iG~G~fG~Vy~~~~~~g~~vAvK~~~~~~-~~~~~~f~~Ei~~L--~~l~H~nIv~l~g~~~~~~~~~lV~E~ 770 (1036)
++...+.||++.|=+|.+|+.++|. |+||++-+.. .-..+.|.++++-+ ..++|||.+++.-+-......|||-+|
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqy 102 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQY 102 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence 5667789999999999999998888 8899875433 34455666555444 445899999988776666667888888
Q ss_pred cCCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcce--eecCCC
Q 001658 771 LENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAK--LYDDKK 848 (1036)
Q Consensus 771 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~--~~~~~~ 848 (1036)
.. -+|+|.+.. +.-+...+..-|+.|++.|+..+|..+ |+|||||.+||||+.-.-+.|+||..-+ ++..++
T Consensus 103 vk-hnLyDRlST--RPFL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDN 176 (1431)
T KOG1240|consen 103 VK-HNLYDRLST--RPFLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDN 176 (1431)
T ss_pred Hh-hhhhhhhcc--chHHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccCCccCCCCC
Confidence 84 589998843 334556666779999999999999998 9999999999999999999999997664 223332
Q ss_pred Cccccccccc----cCccCccccccC-----------CCCchhhHHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHHHH
Q 001658 849 THISTRVAGT----IGYLAPEYAMRG-----------HLTEKTDVFAFGVLALETVS-GRPNSDPSLDEEKLYLLEWAWH 912 (1036)
Q Consensus 849 ~~~~~~~~gt----~~y~APE~~~~~-----------~~~~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~ 912 (1036)
....+.+..| .+|+|||.+... ..+++-||||+||++.||++ |+++|.-. . +..+..
T Consensus 177 Padf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS----Q--L~aYr~- 249 (1431)
T KOG1240|consen 177 PADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS----Q--LLAYRS- 249 (1431)
T ss_pred cccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH----H--HHhHhc-
Confidence 2222222222 379999987541 16778999999999999987 57777531 1 111100
Q ss_pred HhhcCccccccCccc--ccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcc
Q 001658 913 LHENNQEIELADPKL--IEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVAMLCGD 966 (1036)
Q Consensus 913 ~~~~~~~~~~~d~~~--~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 966 (1036)
....+++. ..... ..+..+++.|++.||++|-++++.++.-++.
T Consensus 250 -------~~~~~~e~~Le~Ied---~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG~ 295 (1431)
T KOG1240|consen 250 -------GNADDPEQLLEKIED---VSLRNLILSMIQRDPSKRLSAEDYLQKYRGL 295 (1431)
T ss_pred -------cCccCHHHHHHhCcC---ccHHHHHHHHHccCchhccCHHHHHHhhhcc
Confidence 00112211 11111 1567778899999999999999999875544
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.75 E-value=3.2e-18 Score=195.47 Aligned_cols=216 Identities=26% Similarity=0.403 Sum_probs=164.9
Q ss_pred HHhhccCCcceeEeEEEcCceeEEEEEecCCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccc-cccccC
Q 001658 743 ISAVQHRNLVKLHGCCIEGAERLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRI-IHRDVK 821 (1036)
Q Consensus 743 L~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~i-vHrDik 821 (1036)
|+.+.|.|+.+++|.+.++...+.|.+|+..|+|.|.+.. ....++|.....+..+|++||+|||... | .|+.++
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~-~~~~~d~~F~~s~~rdi~~Gl~ylh~s~---i~~hg~l~ 76 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN-EDIKLDYFFILSFIRDISKGLAYLHNSP---IGYHGALK 76 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc-cccCccHHHHHHHHHHHHHHHHHHhcCc---ceeeeeec
Confidence 4568999999999999999999999999999999999865 5778999999999999999999999864 4 899999
Q ss_pred CCcEEecCCCceEEEEcCcceeecCC-CCccccccccccCccCccccccCC-------CCchhhHHhHHHHHHHHHhCCC
Q 001658 822 ASNVLLDADLVPKISDFGLAKLYDDK-KTHISTRVAGTIGYLAPEYAMRGH-------LTEKTDVFAFGVLALETVSGRP 893 (1036)
Q Consensus 822 p~NILl~~~~~~kl~DFGla~~~~~~-~~~~~~~~~gt~~y~APE~~~~~~-------~~~ksDVwS~Gvvl~elltG~~ 893 (1036)
++|.++|....+||+|||+....... .........-..-|.|||.+.... .+.+.||||||++++|+++.+.
T Consensus 77 s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~ 156 (484)
T KOG1023|consen 77 SSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSG 156 (484)
T ss_pred cccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccC
Confidence 99999999999999999998876421 111111122344699999987531 4668999999999999999999
Q ss_pred CCCCCChhh-HHHHHHHHHHHhhcCccccccCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcccC
Q 001658 894 NSDPSLDEE-KLYLLEWAWHLHENNQEIELADPKLIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVAMLCGDME 968 (1036)
Q Consensus 894 p~~~~~~~~-~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 968 (1036)
||+...... ...++.++.. .......|.+.... +....+..++..||..+|.+||++++|-..++....
T Consensus 157 ~~~~~~~~~~~~eii~~~~~-----~~~~~~rP~i~~~~-e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~ 226 (484)
T KOG1023|consen 157 PFDLRNLVEDPDEIILRVKK-----GGSNPFRPSIELLN-ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINK 226 (484)
T ss_pred ccccccccCChHHHHHHHHh-----cCCCCcCcchhhhh-hcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcc
Confidence 998643322 1222322222 12223344443222 333478889999999999999999999887765543
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.74 E-value=2.1e-19 Score=203.05 Aligned_cols=249 Identities=22% Similarity=0.269 Sum_probs=122.2
Q ss_pred EEEeecccc-ccCCccccCCCCCCEEEccCCCCCCC----CcccccCCCcCCeeecccccccC------CccccccCCCC
Q 001658 104 LKVYALNVV-GVIPDELWNLTSLFNLNLGQNYLTGP----LSPSVGNLTAMQYLNLAINALSG------ELPKELGQLTE 172 (1036)
Q Consensus 104 L~l~~~~~~-~~ip~~l~~l~~L~~L~Ls~n~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~------~~p~~l~~L~~ 172 (1036)
|+|..+++. ...+..+..+.+|+.|+++++.++.. ++..+...+.|++|+++++.+.+ .++..+.++++
T Consensus 3 l~L~~~~l~~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~~ 82 (319)
T cd00116 3 LSLKGELLKTERATELLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGCG 82 (319)
T ss_pred cccccCcccccchHHHHHHHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCcchHHHHHHHHHHhcCc
Confidence 344444444 23344455555566666666666432 33444555566666666665551 22334555566
Q ss_pred CcEEEcccCCCCCCCccccCCCcc---CCEEeCccccCCC----CCCccccCC-CCCcEEeccCCcCCCC----Chhhhc
Q 001658 173 LLILGIGTNNFSGPLPSELGSLSK---LQELYIDSAGVSG----EIPSSFANL-QSLTKWWASDTRLTGR----IPDFIG 240 (1036)
Q Consensus 173 L~~L~Ls~N~l~~~~p~~l~~l~~---L~~L~L~~N~l~~----~~p~~~~~l-~~L~~L~L~~N~l~~~----~p~~l~ 240 (1036)
|+.|+|++|.+.+..+..+..+.+ |++|++++|+++. .+...+..+ ++|+.|+|++|.+++. ++..+.
T Consensus 83 L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~ 162 (319)
T cd00116 83 LQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKALR 162 (319)
T ss_pred eeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHHHHHH
Confidence 666666666665444444444443 6666666666552 222233444 5566666666665532 223344
Q ss_pred CCCCCCEEEeeCCcCCCC----CCccccCCCCCCEEEccCCCCCCCchh----hhcCCCCCCEEEccCCccCcccccccc
Q 001658 241 NWSKLTALRFQGNSFNGP----IPSSFSNLTSVTELRISDLSNGSSKLA----FIRDMKSLSILELRNNNISDSIPSNIG 312 (1036)
Q Consensus 241 ~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~L~~n~l~~~~~~----~l~~l~~L~~L~Ls~N~l~~~~p~~~~ 312 (1036)
.+++|++|+|++|.+++. ++..+..+++|+.|+|++|.+...... .+..+++|++|++++|.+++.....+.
T Consensus 163 ~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~~L~~L~ls~n~l~~~~~~~l~ 242 (319)
T cd00116 163 ANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTDAGAAALA 242 (319)
T ss_pred hCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHHHHHHHhcccCCCCEEecCCCcCchHHHHHHH
Confidence 455566666666655531 122333444555555555555433321 233345555555555555432111111
Q ss_pred -----CCCCccEEeCCCCCCCC----CCchhccCCCCccEEEccCcccc
Q 001658 313 -----EYRSLQHLDLSFNNLGG----SIPDSLFNLSSLTHLFLGNNKLN 352 (1036)
Q Consensus 313 -----~l~~L~~L~Ls~N~l~~----~~p~~l~~l~~L~~L~Ls~N~l~ 352 (1036)
..++|++|++++|.++. .+...+..+++|++|++++|.++
T Consensus 243 ~~~~~~~~~L~~L~l~~n~i~~~~~~~l~~~~~~~~~L~~l~l~~N~l~ 291 (319)
T cd00116 243 SALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFG 291 (319)
T ss_pred HHHhccCCCceEEEccCCCCCcHHHHHHHHHHhcCCCccEEECCCCCCc
Confidence 12455555555555541 12233344455555555555554
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.72 E-value=2.5e-17 Score=177.45 Aligned_cols=230 Identities=21% Similarity=0.219 Sum_probs=148.5
Q ss_pred CCCCccccCCCEEEEEeEeC-CCcEEEEEEcccc---chhcHHHHHHHHHHHHhhc----------cCCcceeEeEEE--
Q 001658 696 SPSNKLGEGGFGPVYKGKLG-DGRAIAVKQLSVA---SRQGKSQFVAEIATISAVQ----------HRNLVKLHGCCI-- 759 (1036)
Q Consensus 696 ~~~~~iG~G~fG~Vy~~~~~-~g~~vAvK~~~~~---~~~~~~~f~~Ei~~L~~l~----------H~nIv~l~g~~~-- 759 (1036)
...+.||.|+++.||.++.. .++.+|||++... .....+++.+|.-....+. |-.++..++...
T Consensus 15 ~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~ 94 (288)
T PF14531_consen 15 VRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIP 94 (288)
T ss_dssp EEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEET
T ss_pred EEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEc
Confidence 34578999999999999865 5899999998543 2334566777765554422 323332223221
Q ss_pred -------cC---c-----eeEEEEEecCCCChhhhhh---cC--CCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccc
Q 001658 760 -------EG---A-----ERLLVYEYLENKSLDQALF---GQ--RSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRD 819 (1036)
Q Consensus 760 -------~~---~-----~~~lV~E~~~~gsL~~~l~---~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrD 819 (1036)
.. . ..+++|+-+ .++|.+++. .. ....+....++.+..|+++.+++||..| +||+|
T Consensus 95 ~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lVHgd 170 (288)
T PF14531_consen 95 GKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG---LVHGD 170 (288)
T ss_dssp TS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EEEST
T ss_pred CCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc---eEecc
Confidence 11 1 225677776 568887753 21 1234667778888999999999999999 99999
Q ss_pred cCCCcEEecCCCceEEEEcCcceeecCCCCccccccccccCccCccccccC--------CCCchhhHHhHHHHHHHHHhC
Q 001658 820 VKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVAGTIGYLAPEYAMRG--------HLTEKTDVFAFGVLALETVSG 891 (1036)
Q Consensus 820 ikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~--------~~~~ksDVwS~Gvvl~elltG 891 (1036)
|||+|++++++|.++|+||+.....+.... . ...+..|.+||..... .++.+.|.|++|+++|.|++|
T Consensus 171 i~~~nfll~~~G~v~Lg~F~~~~r~g~~~~---~-~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~ 246 (288)
T PF14531_consen 171 IKPENFLLDQDGGVFLGDFSSLVRAGTRYR---C-SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCG 246 (288)
T ss_dssp -SGGGEEE-TTS-EEE--GGGEEETTEEEE---G-GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHS
T ss_pred cceeeEEEcCCCCEEEcChHHHeecCceee---c-cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHc
Confidence 999999999999999999988775443211 1 2345789999987542 478899999999999999999
Q ss_pred CCCCCCCChhhHHHHHHHHHHHhhcCccccccCcccccCCHHHHHHHHHHHHHhcccCCCCC
Q 001658 892 RPNSDPSLDEEKLYLLEWAWHLHENNQEIELADPKLIEFNEEEVKRLIGVALLCTQTLPSLR 953 (1036)
Q Consensus 892 ~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~Cl~~dP~~R 953 (1036)
+.||+........ +..+.... +.++.+..++..+++.+|.+|
T Consensus 247 ~lPf~~~~~~~~~-------------------~~~f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 247 RLPFGLSSPEADP-------------------EWDFSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp S-STCCCGGGSTS-------------------GGGGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred cCCCCCCCccccc-------------------cccchhcC-CcCHHHHHHHHHHccCCcccC
Confidence 9999865332111 01222333 666677777888999999887
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.72 E-value=5.2e-17 Score=169.67 Aligned_cols=137 Identities=14% Similarity=0.197 Sum_probs=105.6
Q ss_pred CCCCCccccCCCEEEEEeEeCCCcEEEEEEccccchhcHHHHHHHHHHHHhh-----ccCCcceeEeEEEcCc---e-eE
Q 001658 695 FSPSNKLGEGGFGPVYKGKLGDGRAIAVKQLSVASRQGKSQFVAEIATISAV-----QHRNLVKLHGCCIEGA---E-RL 765 (1036)
Q Consensus 695 ~~~~~~iG~G~fG~Vy~~~~~~g~~vAvK~~~~~~~~~~~~f~~Ei~~L~~l-----~H~nIv~l~g~~~~~~---~-~~ 765 (1036)
+...+.||+|+||.||. ..+....+||++........+.+.+|+.+++.+ .||||++++|++.++. . ..
T Consensus 4 L~~~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~ 81 (210)
T PRK10345 4 LSEQSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYD 81 (210)
T ss_pred cCCcceecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEE
Confidence 34457899999999996 433233469988765444567899999999999 5799999999998763 3 33
Q ss_pred EEEEe--cCCCChhhhhhcCCCCCcChHHHHHHHHHHHHHH-HHHHhcCCccccccccCCCcEEecC----CCceEEEEc
Q 001658 766 LVYEY--LENKSLDQALFGQRSLTLDWATRYEICSGVARGL-AYLHEESRVRIIHRDVKASNVLLDA----DLVPKISDF 838 (1036)
Q Consensus 766 lV~E~--~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL-~yLH~~~~~~ivHrDikp~NILl~~----~~~~kl~DF 838 (1036)
+|+|| +++|+|.+++... .+++. ..++.+++.++ +|||+++ |+||||||+|||++. +..++|+||
T Consensus 82 ~I~e~~G~~~~tL~~~l~~~---~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~~LiDg 153 (210)
T PRK10345 82 VIADFDGKPSITLTEFAEQC---RYEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVIPVVCDN 153 (210)
T ss_pred EEecCCCCcchhHHHHHHcc---cccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcEEEEEC
Confidence 78999 5579999999542 34444 24577888777 9999998 999999999999974 348999995
Q ss_pred Ccc
Q 001658 839 GLA 841 (1036)
Q Consensus 839 Gla 841 (1036)
+-+
T Consensus 154 ~G~ 156 (210)
T PRK10345 154 IGE 156 (210)
T ss_pred CCC
Confidence 433
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.72 E-value=2.8e-17 Score=199.96 Aligned_cols=250 Identities=18% Similarity=0.178 Sum_probs=182.0
Q ss_pred HHHHHhcCCCCCCccccCCCEEEEEeEeCCCcEEEEEEccccchhcHHHHHHHHHHHHhhc---cCCcceeEeEEEcCce
Q 001658 687 ELKTATENFSPSNKLGEGGFGPVYKGKLGDGRAIAVKQLSVASRQGKSQFVAEIATISAVQ---HRNLVKLHGCCIEGAE 763 (1036)
Q Consensus 687 ~l~~~~~~~~~~~~iG~G~fG~Vy~~~~~~g~~vAvK~~~~~~~~~~~~f~~Ei~~L~~l~---H~nIv~l~g~~~~~~~ 763 (1036)
+.+...+.|.+.+.||+|+||+||+|...+|+.||+|+-+.....+ |.-=.+++.+|+ -+-|..+..++.-.+.
T Consensus 692 ~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WE---fYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~ 768 (974)
T KOG1166|consen 692 EFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWE---FYICLQVMERLKPQMLPSIMHISSAHVFQNA 768 (974)
T ss_pred eeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCcee---eeehHHHHHhhchhhhcchHHHHHHHccCCc
Confidence 4455677899999999999999999998889999999987665442 111223333443 2345555555555677
Q ss_pred eEEEEEecCCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEec-------CCCceEEE
Q 001658 764 RLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLD-------ADLVPKIS 836 (1036)
Q Consensus 764 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~-------~~~~~kl~ 836 (1036)
-+||+||.+.|+|.+++. ....++|...+.++.|+++.+++||..+ |||+||||+|.||. ...-++|+
T Consensus 769 S~lv~ey~~~Gtlld~~N--~~~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~~l~lI 843 (974)
T KOG1166|consen 769 SVLVSEYSPYGTLLDLIN--TNKVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSKGLYLI 843 (974)
T ss_pred ceeeeeccccccHHHhhc--cCCCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCcccceEEE
Confidence 789999999999999995 5667899999999999999999999998 99999999999993 23568999
Q ss_pred EcCcceeecCC-CCccccccccccCccCccccccCCCCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhh
Q 001658 837 DFGLAKLYDDK-KTHISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHE 915 (1036)
Q Consensus 837 DFGla~~~~~~-~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~ 915 (1036)
|||.+..+.-- +......+.+|-.+-.+|+..+..+++..|.|.++-+++-|+.|+.-- .
T Consensus 844 DfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~q------------------~- 904 (974)
T KOG1166|consen 844 DFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYME------------------V- 904 (974)
T ss_pred ecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHHH------------------h-
Confidence 99999755422 222345567899999999999999999999999999999999987310 0
Q ss_pred cCccccccCcccccCC-HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcc
Q 001658 916 NNQEIELADPKLIEFN-EEEVKRLIGVALLCTQTLPSLRPSMSRVVAMLCGD 966 (1036)
Q Consensus 916 ~~~~~~~~d~~~~~~~-~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 966 (1036)
.+.....+++.+..+. .+.-.+++++++. .|-..=|...++...|+++
T Consensus 905 ~~g~~~~~~~~~~Ry~~~~~W~~~F~~lLN---~~~~~~p~l~~lr~~~~~~ 953 (974)
T KOG1166|consen 905 KNGSSWMVKTNFPRYWKRDMWNKFFDLLLN---PDCDTLPNLQELRTELEEV 953 (974)
T ss_pred cCCcceeccccchhhhhHHHHHHHHHHHhC---cCcccchhHHHHHHHHHHH
Confidence 1111222333343333 3333466666553 4444446666666666654
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.71 E-value=1.2e-18 Score=196.99 Aligned_cols=252 Identities=21% Similarity=0.270 Sum_probs=198.7
Q ss_pred eEeEEEEeeccccc----cCCccccCCCCCCEEEccCCCCCC------CCcccccCCCcCCeeecccccccCCccccccC
Q 001658 100 HITQLKVYALNVVG----VIPDELWNLTSLFNLNLGQNYLTG------PLSPSVGNLTAMQYLNLAINALSGELPKELGQ 169 (1036)
Q Consensus 100 ~l~~L~l~~~~~~~----~ip~~l~~l~~L~~L~Ls~n~l~~------~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~ 169 (1036)
+++.|.+.++.+.. .++..+...++|++|+++++.+.+ .++..+.++++|++|+|++|.+.+..+..+..
T Consensus 24 ~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~~~~~~~~~~~~ 103 (319)
T cd00116 24 CLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGCGLQELDLSDNALGPDGCGVLES 103 (319)
T ss_pred hccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCcchHHHHHHHHHHhcCceeEEEccCCCCChhHHHHHHH
Confidence 47889999988754 367778888999999999998873 23456788999999999999998777777766
Q ss_pred CCC---CcEEEcccCCCCC----CCccccCCC-ccCCEEeCccccCCCC----CCccccCCCCCcEEeccCCcCCCC---
Q 001658 170 LTE---LLILGIGTNNFSG----PLPSELGSL-SKLQELYIDSAGVSGE----IPSSFANLQSLTKWWASDTRLTGR--- 234 (1036)
Q Consensus 170 L~~---L~~L~Ls~N~l~~----~~p~~l~~l-~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~--- 234 (1036)
+.+ |++|++++|++++ .+...+..+ ++|+.|+|++|.+++. ++..+..+++|++|+|++|.+++.
T Consensus 104 l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~ 183 (319)
T cd00116 104 LLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIR 183 (319)
T ss_pred HhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHHHHHHhCCCcCEEECcCCCCchHHHH
Confidence 666 9999999999973 333456667 8999999999999843 344566778999999999999853
Q ss_pred -ChhhhcCCCCCCEEEeeCCcCCCC----CCccccCCCCCCEEEccCCCCCCCchhhhc-----CCCCCCEEEccCCccC
Q 001658 235 -IPDFIGNWSKLTALRFQGNSFNGP----IPSSFSNLTSVTELRISDLSNGSSKLAFIR-----DMKSLSILELRNNNIS 304 (1036)
Q Consensus 235 -~p~~l~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~-----~l~~L~~L~Ls~N~l~ 304 (1036)
++..+..+++|++|+|++|.+++. +...+..+++|++|++++|.++......+. ..++|++|++++|.++
T Consensus 184 ~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~~L~~L~ls~n~l~~~~~~~l~~~~~~~~~~L~~L~l~~n~i~ 263 (319)
T cd00116 184 ALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSCNDIT 263 (319)
T ss_pred HHHHHHHhCCCCCEEeccCCccChHHHHHHHHHhcccCCCCEEecCCCcCchHHHHHHHHHHhccCCCceEEEccCCCCC
Confidence 344566678999999999999753 344567889999999999998875443332 2479999999999997
Q ss_pred c----cccccccCCCCccEEeCCCCCCCCC----CchhccCC-CCccEEEccCccc
Q 001658 305 D----SIPSNIGEYRSLQHLDLSFNNLGGS----IPDSLFNL-SSLTHLFLGNNKL 351 (1036)
Q Consensus 305 ~----~~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~l~~l-~~L~~L~Ls~N~l 351 (1036)
+ .+...+..+++|++|++++|.++.. +...+... +.|+.|++.+|++
T Consensus 264 ~~~~~~l~~~~~~~~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (319)
T cd00116 264 DDGAKDLAEVLAEKESLLELDLRGNKFGEEGAQLLAESLLEPGNELESLWVKDDSF 319 (319)
T ss_pred cHHHHHHHHHHhcCCCccEEECCCCCCcHHHHHHHHHHHhhcCCchhhcccCCCCC
Confidence 2 2445567779999999999999965 44455555 7899999998875
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.70 E-value=4.6e-18 Score=193.38 Aligned_cols=186 Identities=30% Similarity=0.344 Sum_probs=155.1
Q ss_pred ccccCCCEEEEEeE----eCCCcEEEEEEccccchh--cHHHHHHHHHHHHhhc-cCCcceeEeEEEcCceeEEEEEecC
Q 001658 700 KLGEGGFGPVYKGK----LGDGRAIAVKQLSVASRQ--GKSQFVAEIATISAVQ-HRNLVKLHGCCIEGAERLLVYEYLE 772 (1036)
Q Consensus 700 ~iG~G~fG~Vy~~~----~~~g~~vAvK~~~~~~~~--~~~~f~~Ei~~L~~l~-H~nIv~l~g~~~~~~~~~lV~E~~~ 772 (1036)
.+|+|.||.|+.++ .+.|..+|+|.++..... .......|..++...+ ||.+|++...+..+...+++.+|..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 37999999999774 345778899988654321 1124566888888887 9999999999999999999999999
Q ss_pred CCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeecCCCCccc
Q 001658 773 NKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHIS 852 (1036)
Q Consensus 773 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 852 (1036)
+|.|...+.. ...+++.........++-+++++|+.+ |+|||+|++||+++.+|.+++.|||+++..-.....
T Consensus 81 gg~lft~l~~--~~~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~-- 153 (612)
T KOG0603|consen 81 GGDLFTRLSK--EVMFDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA-- 153 (612)
T ss_pred cchhhhcccc--CCchHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhHhhhhc--
Confidence 9999887743 344566666667778999999999998 999999999999999999999999999876544332
Q ss_pred cccccccCccCccccccCCCCchhhHHhHHHHHHHHHhCCCCCCC
Q 001658 853 TRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRPNSDP 897 (1036)
Q Consensus 853 ~~~~gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~ 897 (1036)
+||..|||||++. .....+|.||||++++||+||..||..
T Consensus 154 ---cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~ 193 (612)
T KOG0603|consen 154 ---CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG 193 (612)
T ss_pred ---ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch
Confidence 7999999999998 567789999999999999999999986
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.70 E-value=3.6e-19 Score=169.41 Aligned_cols=160 Identities=27% Similarity=0.498 Sum_probs=121.2
Q ss_pred ccCCCCCCEEEccCCCCCCCCcccccCCCcCCeeecccccccCCccccccCCCCCcEEEcccCCCCCCCccccCCCccCC
Q 001658 119 LWNLTSLFNLNLGQNYLTGPLSPSVGNLTAMQYLNLAINALSGELPKELGQLTELLILGIGTNNFSGPLPSELGSLSKLQ 198 (1036)
Q Consensus 119 l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~L~~L~~L~Ls~N~l~~~~p~~l~~l~~L~ 198 (1036)
+.++.+.+.|.||+|+++ .+|+.++.|.+|+.|++++|+|. .+|..++.|++|+.|+++-|++. .+|..|+.++.|+
T Consensus 29 Lf~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~le 105 (264)
T KOG0617|consen 29 LFNMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALE 105 (264)
T ss_pred ccchhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhh
Confidence 445667778888888888 77778888888888888888888 78888888888888888888887 7888888888888
Q ss_pred EEeCccccCC-CCCCccccCCCCCcEEeccCCcCCCCChhhhcCCCCCCEEEeeCCcCCCCCCccccCCCCCCEEEccCC
Q 001658 199 ELYIDSAGVS-GEIPSSFANLQSLTKWWASDTRLTGRIPDFIGNWSKLTALRFQGNSFNGPIPSSFSNLTSVTELRISDL 277 (1036)
Q Consensus 199 ~L~L~~N~l~-~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n 277 (1036)
.|+|..|++. ..+|..|..|+.|+-|+|++|.+. .+|..++++++|+.|.+..|.+- .+|..++.++.|++|++.+|
T Consensus 106 vldltynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrelhiqgn 183 (264)
T KOG0617|consen 106 VLDLTYNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELHIQGN 183 (264)
T ss_pred hhhccccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHHhcccc
Confidence 8888888876 356777777777877888888777 66777777777777777777776 56766666655555544444
Q ss_pred CCCCCc
Q 001658 278 SNGSSK 283 (1036)
Q Consensus 278 ~l~~~~ 283 (1036)
+++.++
T Consensus 184 rl~vlp 189 (264)
T KOG0617|consen 184 RLTVLP 189 (264)
T ss_pred eeeecC
Confidence 444333
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.68 E-value=5.5e-17 Score=173.21 Aligned_cols=197 Identities=24% Similarity=0.272 Sum_probs=133.1
Q ss_pred ccCCcceeEeEEEcC---------------------------ceeEEEEEecCCCChhhhhhcCCCCCcChHHHHHHHHH
Q 001658 747 QHRNLVKLHGCCIEG---------------------------AERLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSG 799 (1036)
Q Consensus 747 ~H~nIv~l~g~~~~~---------------------------~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ 799 (1036)
+|||||++.++|.+. ...|+||...+ .+|.+++..+. .+...+.-|+.|
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~~~---~s~r~~~~~laQ 349 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWTRH---RSYRTGRVILAQ 349 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhcCC---CchHHHHHHHHH
Confidence 599999999987642 24578887764 58888885432 344455668889
Q ss_pred HHHHHHHHHhcCCccccccccCCCcEEe--cCCC--ceEEEEcCcceeecCC-----CCccccccccccCccCccccccC
Q 001658 800 VARGLAYLHEESRVRIIHRDVKASNVLL--DADL--VPKISDFGLAKLYDDK-----KTHISTRVAGTIGYLAPEYAMRG 870 (1036)
Q Consensus 800 ia~gL~yLH~~~~~~ivHrDikp~NILl--~~~~--~~kl~DFGla~~~~~~-----~~~~~~~~~gt~~y~APE~~~~~ 870 (1036)
+++|+.|||+++ |.|||+|++|||+ |+|. ...|+|||++---... .........|.-.-||||+....
T Consensus 350 lLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~ 426 (598)
T KOG4158|consen 350 LLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAV 426 (598)
T ss_pred HHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcC
Confidence 999999999998 9999999999999 4444 5789999987432210 01111224477789999998643
Q ss_pred C-----C-CchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhcCccccccCcccccCCHHHHHHHHHHHHH
Q 001658 871 H-----L-TEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEIELADPKLIEFNEEEVKRLIGVALL 944 (1036)
Q Consensus 871 ~-----~-~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~ 944 (1036)
+ . -.|+|.|+.|.+.||+++...||+...+ ...+...+ .+-.-|.+.+ .....+.+++..
T Consensus 427 PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGe-m~L~~r~Y----------qe~qLPalp~---~vpp~~rqlV~~ 492 (598)
T KOG4158|consen 427 PGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGE-MLLDTRTY----------QESQLPALPS---RVPPVARQLVFD 492 (598)
T ss_pred CCCceeeccchhhhhhhhhhHHHHhccCCcccccch-heechhhh----------hhhhCCCCcc---cCChHHHHHHHH
Confidence 2 1 2389999999999999999999986221 11111110 1111123322 223345566677
Q ss_pred hcccCCCCCCCHHHHHHHhh
Q 001658 945 CTQTLPSLRPSMSRVVAMLC 964 (1036)
Q Consensus 945 Cl~~dP~~RPt~~evl~~L~ 964 (1036)
.++.||.+|++..-....|.
T Consensus 493 lL~r~pskRvsp~iAANvl~ 512 (598)
T KOG4158|consen 493 LLKRDPSKRVSPNIAANVLN 512 (598)
T ss_pred HhcCCccccCCccHHHhHHH
Confidence 88999999998766555543
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.67 E-value=5.1e-16 Score=164.39 Aligned_cols=134 Identities=21% Similarity=0.296 Sum_probs=113.7
Q ss_pred CccccCCCEEEEEeEeCCCcEEEEEEccccch--------hcHHHHHHHHHHHHhhccCCcceeEeEEEcCceeEEEEEe
Q 001658 699 NKLGEGGFGPVYKGKLGDGRAIAVKQLSVASR--------QGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLVYEY 770 (1036)
Q Consensus 699 ~~iG~G~fG~Vy~~~~~~g~~vAvK~~~~~~~--------~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~ 770 (1036)
+.||+|++|.||+|.. .|..|++|+...... .....+.+|+.++..++|++|.....++......++||||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5799999999999987 677899997653221 1234678899999999999998888887777888999999
Q ss_pred cCCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCccee
Q 001658 771 LENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKL 843 (1036)
Q Consensus 771 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~ 843 (1036)
+++++|.+++.... + .+..++.+++.+|.++|+.+ ++|||++|.|||++ ++.++|+|||++..
T Consensus 81 ~~G~~L~~~~~~~~-----~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSNG-----M-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhcc-----H-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 99999999985321 2 77889999999999999988 99999999999999 78999999999875
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.67 E-value=7.8e-16 Score=161.23 Aligned_cols=144 Identities=22% Similarity=0.210 Sum_probs=112.4
Q ss_pred HHHHhcCCCCCCccccCCCEEEEEeEeCCCcEEEEEEccccch----------------------hcHHHHHHHHHHHHh
Q 001658 688 LKTATENFSPSNKLGEGGFGPVYKGKLGDGRAIAVKQLSVASR----------------------QGKSQFVAEIATISA 745 (1036)
Q Consensus 688 l~~~~~~~~~~~~iG~G~fG~Vy~~~~~~g~~vAvK~~~~~~~----------------------~~~~~f~~Ei~~L~~ 745 (1036)
+......|...+.||+|+||.||++...+|+.||||+++.... .....+..|+.++..
T Consensus 10 ~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 89 (198)
T cd05144 10 LVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKA 89 (198)
T ss_pred HHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHH
Confidence 3333344777899999999999999988899999998754220 011236778999999
Q ss_pred hccCC--cceeEeEEEcCceeEEEEEecCCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCC
Q 001658 746 VQHRN--LVKLHGCCIEGAERLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKAS 823 (1036)
Q Consensus 746 l~H~n--Iv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~ 823 (1036)
+.|++ +++.++. ...++||||+++++|.+.... .....++.++++++.++|+.+ |+||||||+
T Consensus 90 l~~~~i~v~~~~~~----~~~~lv~e~~~g~~L~~~~~~--------~~~~~~~~~i~~~l~~lh~~g---i~H~Dl~p~ 154 (198)
T cd05144 90 LYEEGFPVPKPIDW----NRHAVVMEYIDGVELYRVRVL--------EDPEEVLDEILEEIVKAYKHG---IIHGDLSEF 154 (198)
T ss_pred HHHcCCCCCceeec----CCceEEEEEeCCcchhhcccc--------ccHHHHHHHHHHHHHHHHHCC---CCcCCCCcc
Confidence 98874 4455543 345899999999999775421 234578899999999999987 999999999
Q ss_pred cEEecCCCceEEEEcCcceeecC
Q 001658 824 NVLLDADLVPKISDFGLAKLYDD 846 (1036)
Q Consensus 824 NILl~~~~~~kl~DFGla~~~~~ 846 (1036)
||++++++.++|+|||++.....
T Consensus 155 Nill~~~~~~~liDfg~~~~~~~ 177 (198)
T cd05144 155 NILVDDDEKIYIIDWPQMVSTDH 177 (198)
T ss_pred cEEEcCCCcEEEEECCccccCCC
Confidence 99999999999999999975543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.66 E-value=7.4e-16 Score=185.81 Aligned_cols=145 Identities=23% Similarity=0.309 Sum_probs=116.1
Q ss_pred HHHHHHHhcCCCCCCccccCCCEEEEEeEeCCCcEEEEEE-cccc-------chhcHHHHHHHHHHHHhhccCCcceeEe
Q 001658 685 YAELKTATENFSPSNKLGEGGFGPVYKGKLGDGRAIAVKQ-LSVA-------SRQGKSQFVAEIATISAVQHRNLVKLHG 756 (1036)
Q Consensus 685 ~~~l~~~~~~~~~~~~iG~G~fG~Vy~~~~~~g~~vAvK~-~~~~-------~~~~~~~f~~Ei~~L~~l~H~nIv~l~g 756 (1036)
+.........|...+.||+|+||+||+|.+.+.. +++|+ .... .....+.+.+|++++..++|++++....
T Consensus 325 ~~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~~~-~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~ 403 (535)
T PRK09605 325 WIKEEEVKRRKIPDHLIGKGAEADIKKGEYLGRD-AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVI 403 (535)
T ss_pred eccccccccccCccceeccCCcEEEEEEeecCcc-ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEE
Confidence 3333444556677899999999999999875443 44443 2211 1112356889999999999999998888
Q ss_pred EEEcCceeEEEEEecCCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEE
Q 001658 757 CCIEGAERLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKIS 836 (1036)
Q Consensus 757 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~ 836 (1036)
++......++||||+++++|.+++. ....++.+++++|.|||+.+ |+||||||+|||+ +++.++|+
T Consensus 404 ~~~~~~~~~lv~E~~~g~~L~~~l~----------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~li 469 (535)
T PRK09605 404 YDVDPEEKTIVMEYIGGKDLKDVLE----------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYLI 469 (535)
T ss_pred EEEeCCCCEEEEEecCCCcHHHHHH----------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEEE
Confidence 8887778899999999999999884 35678999999999999988 9999999999999 67899999
Q ss_pred EcCcceee
Q 001658 837 DFGLAKLY 844 (1036)
Q Consensus 837 DFGla~~~ 844 (1036)
|||+++..
T Consensus 470 DFGla~~~ 477 (535)
T PRK09605 470 DFGLGKYS 477 (535)
T ss_pred eCcccccC
Confidence 99999753
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.66 E-value=4.9e-16 Score=166.45 Aligned_cols=143 Identities=17% Similarity=0.217 Sum_probs=111.8
Q ss_pred CCCCCCccccCCCEEEEEeE--eCCCcEEEEEEccccchh------------------------cHHHHHHHHHHHHhhc
Q 001658 694 NFSPSNKLGEGGFGPVYKGK--LGDGRAIAVKQLSVASRQ------------------------GKSQFVAEIATISAVQ 747 (1036)
Q Consensus 694 ~~~~~~~iG~G~fG~Vy~~~--~~~g~~vAvK~~~~~~~~------------------------~~~~f~~Ei~~L~~l~ 747 (1036)
.|++.+.||+|+||.||+|. ..+|+.||+|+++..... ....+..|+..+.++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 46778899999999999998 568999999998643210 1123568999999997
Q ss_pred cCC--cceeEeEEEcCceeEEEEEecCCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcE
Q 001658 748 HRN--LVKLHGCCIEGAERLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNV 825 (1036)
Q Consensus 748 H~n--Iv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NI 825 (1036)
+.. +.+++++ ...++||||+++++|...... ....+......++.|++.++++||+.+ .|+||||||+||
T Consensus 109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~g--~iiH~Dikp~NI 180 (237)
T smart00090 109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLK--DVEPEEEEEFELYDDILEEMRKLYKEG--ELVHGDLSEYNI 180 (237)
T ss_pred hcCCCCCeeeEe----cCceEEEEEecCCcccccccc--cCCcchHHHHHHHHHHHHHHHHHHhcC--CEEeCCCChhhE
Confidence 643 4455543 235899999999888765422 234556667789999999999999875 499999999999
Q ss_pred EecCCCceEEEEcCcceeec
Q 001658 826 LLDADLVPKISDFGLAKLYD 845 (1036)
Q Consensus 826 Ll~~~~~~kl~DFGla~~~~ 845 (1036)
+++ ++.++|+|||.+....
T Consensus 181 li~-~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 181 LVH-DGKVVIIDVSQSVELD 199 (237)
T ss_pred EEE-CCCEEEEEChhhhccC
Confidence 999 8899999999987654
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.66 E-value=1.3e-18 Score=165.58 Aligned_cols=156 Identities=26% Similarity=0.468 Sum_probs=106.3
Q ss_pred CCCCCcEEEcccCCCCCCCccccCCCccCCEEeCccccCCCCCCccccCCCCCcEEeccCCcCCCCChhhhcCCCCCCEE
Q 001658 169 QLTELLILGIGTNNFSGPLPSELGSLSKLQELYIDSAGVSGEIPSSFANLQSLTKWWASDTRLTGRIPDFIGNWSKLTAL 248 (1036)
Q Consensus 169 ~L~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L 248 (1036)
++.+.+.|.||+|+++ .+|..+..+.+|+.|++.+|+|+ .+|..++.|++|+.|+++-|++. ..|..|+.++.|+.|
T Consensus 31 ~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~levl 107 (264)
T KOG0617|consen 31 NMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVL 107 (264)
T ss_pred chhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhhhh
Confidence 3444455555555555 44555555555555555555555 55555666666666666666665 566666777777777
Q ss_pred EeeCCcCCC-CCCccccCCCCCCEEEccCCCCCCCchhhhcCCCCCCEEEccCCccCccccccccCCCCccEEeCCCCCC
Q 001658 249 RFQGNSFNG-PIPSSFSNLTSVTELRISDLSNGSSKLAFIRDMKSLSILELRNNNISDSIPSNIGEYRSLQHLDLSFNNL 327 (1036)
Q Consensus 249 ~L~~N~l~~-~~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 327 (1036)
||..|.+.. .+|..|.. +..|+.|+|++|.+. .+|..++++++|+.|.+..|.+
T Consensus 108 dltynnl~e~~lpgnff~------------------------m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdndl 162 (264)
T KOG0617|consen 108 DLTYNNLNENSLPGNFFY------------------------MTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDL 162 (264)
T ss_pred hccccccccccCCcchhH------------------------HHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCch
Confidence 777766653 34554443 345667778888886 7888888888888888888888
Q ss_pred CCCCchhccCCCCccEEEccCccccc
Q 001658 328 GGSIPDSLFNLSSLTHLFLGNNKLNG 353 (1036)
Q Consensus 328 ~~~~p~~l~~l~~L~~L~Ls~N~l~g 353 (1036)
- .+|..++.++.|++|++.+|+++-
T Consensus 163 l-~lpkeig~lt~lrelhiqgnrl~v 187 (264)
T KOG0617|consen 163 L-SLPKEIGDLTRLRELHIQGNRLTV 187 (264)
T ss_pred h-hCcHHHHHHHHHHHHhcccceeee
Confidence 8 788888989999999999999883
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.65 E-value=8.5e-16 Score=161.10 Aligned_cols=131 Identities=23% Similarity=0.338 Sum_probs=107.7
Q ss_pred ccccCCCEEEEEeEeCCCcEEEEEEccccc--------hhcHHHHHHHHHHHHhhccCCcceeEeEEEcCceeEEEEEec
Q 001658 700 KLGEGGFGPVYKGKLGDGRAIAVKQLSVAS--------RQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLVYEYL 771 (1036)
Q Consensus 700 ~iG~G~fG~Vy~~~~~~g~~vAvK~~~~~~--------~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~~ 771 (1036)
.||+|+||.||+|.+ +|..|++|...... .....++.+|++++..++|+++.....++......++||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 489999999999996 57889999864321 112356788999999999988766666666677789999999
Q ss_pred CCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceee
Q 001658 772 ENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLY 844 (1036)
Q Consensus 772 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~ 844 (1036)
++++|.+++..... .++.+++++|.+||+.+ ++|||++|.||+++ ++.+++.|||+++..
T Consensus 80 ~g~~l~~~~~~~~~---------~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~~ 139 (199)
T TIGR03724 80 EGKPLKDVIEEGND---------ELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKYS 139 (199)
T ss_pred CCccHHHHHhhcHH---------HHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence 99999998743211 78999999999999988 99999999999999 889999999998753
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.60 E-value=3e-16 Score=175.51 Aligned_cols=122 Identities=28% Similarity=0.440 Sum_probs=107.4
Q ss_pred eeEEEEEecCCCChhhhhhcCC-CCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcc
Q 001658 763 ERLLVYEYLENKSLDQALFGQR-SLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLA 841 (1036)
Q Consensus 763 ~~~lV~E~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla 841 (1036)
..++.|+++...+|.+||.+.+ ....+|.....++.|++.|++| ++ .+|||+||.||....+..+||.|||+.
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgDFgl~ 403 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGDFGLV 403 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhhhhhe
Confidence 4679999999999999997543 5567888999999999999999 55 899999999999999999999999999
Q ss_pred eeecCCC-----CccccccccccCccCccccccCCCCchhhHHhHHHHHHHHHh
Q 001658 842 KLYDDKK-----THISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVS 890 (1036)
Q Consensus 842 ~~~~~~~-----~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~ellt 890 (1036)
....... ....+...||..||+||.+.+..|+.|+||||+|++|+|+++
T Consensus 404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~ 457 (516)
T KOG1033|consen 404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI 457 (516)
T ss_pred eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence 8766544 223456789999999999999999999999999999999997
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.56 E-value=1.5e-14 Score=176.25 Aligned_cols=158 Identities=31% Similarity=0.561 Sum_probs=103.0
Q ss_pred cCCCHHHHHHHHHHHHhcccCcCCCCCCCCCCCCCCCCCCCccccCCCCCCCceeeccCCCCC-ceeeEeEEEEeecccc
Q 001658 34 ATTDPNEVRALNSIFQQWRISARQGQWNRSGDPCTGAALDDSIVFDNTDYNPFIKCDCSSQNG-TVCHITQLKVYALNVV 112 (1036)
Q Consensus 34 ~~~~~~~~~aL~~~~~~~~~~~~~~~W~~~~d~C~~~~~~~~~~~~~~~~~~~~~~~c~~~~~-~~~~l~~L~l~~~~~~ 112 (1036)
..+++.|+.||+.+|+++..+.. .+|+ +|||.. ...+|.|+.|..... ....++.|+|.++++.
T Consensus 367 ~~t~~~~~~aL~~~k~~~~~~~~-~~W~--g~~C~p------------~~~~w~Gv~C~~~~~~~~~~v~~L~L~~n~L~ 431 (623)
T PLN03150 367 SKTLLEEVSALQTLKSSLGLPLR-FGWN--GDPCVP------------QQHPWSGADCQFDSTKGKWFIDGLGLDNQGLR 431 (623)
T ss_pred cccCchHHHHHHHHHHhcCCccc-CCCC--CCCCCC------------cccccccceeeccCCCCceEEEEEECCCCCcc
Confidence 46788999999999999976542 3675 588852 124599999964221 1234666666666666
Q ss_pred ccCCccccCCCCCCEEEccCCCCCCCCcccccCCCcCCeeecccccccCCccccccCCCCCcEEEcccCCCCCCCccccC
Q 001658 113 GVIPDELWNLTSLFNLNLGQNYLTGPLSPSVGNLTAMQYLNLAINALSGELPKELGQLTELLILGIGTNNFSGPLPSELG 192 (1036)
Q Consensus 113 ~~ip~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~L~~L~~L~Ls~N~l~~~~p~~l~ 192 (1036)
|.+|..|.++++|+.|+|++|.++|.+|..++.+++|+.|+|++|++++.+|..+++|++|++|+|++|+++|.+|..+.
T Consensus 432 g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~l~ 511 (623)
T PLN03150 432 GFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALG 511 (623)
T ss_pred ccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcCCcccccCChHHh
Confidence 66666666666666666666666666666666666666666666666666666666666666666666666666666555
Q ss_pred CC-ccCCEEeCcccc
Q 001658 193 SL-SKLQELYIDSAG 206 (1036)
Q Consensus 193 ~l-~~L~~L~L~~N~ 206 (1036)
.+ .++..+++.+|.
T Consensus 512 ~~~~~~~~l~~~~N~ 526 (623)
T PLN03150 512 GRLLHRASFNFTDNA 526 (623)
T ss_pred hccccCceEEecCCc
Confidence 42 244455555444
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.56 E-value=2.7e-15 Score=178.53 Aligned_cols=212 Identities=23% Similarity=0.291 Sum_probs=138.9
Q ss_pred cCCCCCCccccCCCEEEEEeEeCC-CcEEEEEEccccchhcHHHHHHHHHHHHhhccCCcceeEeEEEcCceeEEEEEec
Q 001658 693 ENFSPSNKLGEGGFGPVYKGKLGD-GRAIAVKQLSVASRQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLVYEYL 771 (1036)
Q Consensus 693 ~~~~~~~~iG~G~fG~Vy~~~~~~-g~~vAvK~~~~~~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~~ 771 (1036)
.+|...+.|-.|+||.||..+++. .+.+|+|+ ++... +.+- ++.....|. .|
T Consensus 83 ~df~~IklisngAygavylvrh~~trqrfa~ki-Nkq~l-----ilRn--ilt~a~npf---------------vv---- 135 (1205)
T KOG0606|consen 83 SDFNTIKLISNGAYGAVYLVRHKETRQRFAMKI-NKQNL-----ILRN--ILTFAGNPF---------------VV---- 135 (1205)
T ss_pred cccceeEeeccCCCCceeeeeccccccchhhcc-cccch-----hhhc--cccccCCcc---------------ee----
Confidence 467778999999999999998753 56678843 21111 0000 121112222 22
Q ss_pred CCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeecCCC---
Q 001658 772 ENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKK--- 848 (1036)
Q Consensus 772 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~--- 848 (1036)
|+-...+..-+..+. +++.+++|||+.+ |+|||+||+|.+|+.-|.+|+.|||+++......
T Consensus 136 --gDc~tllk~~g~lPv----------dmvla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atn 200 (1205)
T KOG0606|consen 136 --GDCATLLKNIGPLPV----------DMVLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATN 200 (1205)
T ss_pred --chhhhhcccCCCCcc----------hhhHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhhhhhccch
Confidence 444444433222222 2378899999988 9999999999999999999999999987432110
Q ss_pred ---------C--ccccccccccCccCccccccCCCCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhcC
Q 001658 849 ---------T--HISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENN 917 (1036)
Q Consensus 849 ---------~--~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~ 917 (1036)
. ....+++||+.|+|||++....|...+|.|++|+|+||.+-|+.||..+.+++-+..+- .
T Consensus 201 l~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~vi------s-- 272 (1205)
T KOG0606|consen 201 LKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVI------S-- 272 (1205)
T ss_pred hhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhh------h--
Confidence 0 11235789999999999999999999999999999999999999999887655432110 0
Q ss_pred ccccccCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHH
Q 001658 918 QEIELADPKLIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRV 959 (1036)
Q Consensus 918 ~~~~~~d~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev 959 (1036)
..++. | +.......+..+++...++.+|.+|--....
T Consensus 273 d~i~w--p---E~dea~p~Ea~dli~~LL~qnp~~Rlgt~ga 309 (1205)
T KOG0606|consen 273 DDIEW--P---EEDEALPPEAQDLIEQLLRQNPLCRLGTGGA 309 (1205)
T ss_pred hhccc--c---ccCcCCCHHHHHHHHHHHHhChHhhcccchh
Confidence 00000 1 1111222334445556679999999543333
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.55 E-value=3.8e-14 Score=146.96 Aligned_cols=137 Identities=21% Similarity=0.258 Sum_probs=99.6
Q ss_pred CCccccCCCEEEEEeEeCCCcEEEEEEccccchh--cHHH----------------------HHHHHHHHHhhccCC--c
Q 001658 698 SNKLGEGGFGPVYKGKLGDGRAIAVKQLSVASRQ--GKSQ----------------------FVAEIATISAVQHRN--L 751 (1036)
Q Consensus 698 ~~~iG~G~fG~Vy~~~~~~g~~vAvK~~~~~~~~--~~~~----------------------f~~Ei~~L~~l~H~n--I 751 (1036)
.+.||+|+||+||+|...+|+.||||++...... .... ...|...+.++.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 4679999999999999878999999988643211 1111 135666677765543 4
Q ss_pred ceeEeEEEcCceeEEEEEecCCCChhhh-hhcCCCCCcChHHHHHHHHHHHHHHHHHHh-cCCccccccccCCCcEEecC
Q 001658 752 VKLHGCCIEGAERLLVYEYLENKSLDQA-LFGQRSLTLDWATRYEICSGVARGLAYLHE-ESRVRIIHRDVKASNVLLDA 829 (1036)
Q Consensus 752 v~l~g~~~~~~~~~lV~E~~~~gsL~~~-l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivHrDikp~NILl~~ 829 (1036)
.+.+++ ...++||||++++.+... +... ... ....+++.+++.++.++|. .+ |+||||||+||+++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~---~~~-~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p~Nili~- 149 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDV---RLL-EDPEELYDQILELMRKLYREAG---LVHGDLSEYNILVD- 149 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhh---hhc-ccHHHHHHHHHHHHHHHhhccC---cCcCCCChhhEEEE-
Confidence 455543 235899999998544321 1110 011 5567889999999999998 76 99999999999999
Q ss_pred CCceEEEEcCcceeecC
Q 001658 830 DLVPKISDFGLAKLYDD 846 (1036)
Q Consensus 830 ~~~~kl~DFGla~~~~~ 846 (1036)
++.++++|||.+.....
T Consensus 150 ~~~~~liDfg~a~~~~~ 166 (187)
T cd05119 150 DGKVYIIDVPQAVEIDH 166 (187)
T ss_pred CCcEEEEECcccccccC
Confidence 99999999999976543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.54 E-value=4.7e-14 Score=140.00 Aligned_cols=135 Identities=21% Similarity=0.233 Sum_probs=115.1
Q ss_pred CCCccccCCCEEEEEeEeCCCcEEEEEEccccchhcHHHHHHHHHHHHhhcc--CCcceeEeEEEcCceeEEEEEecCCC
Q 001658 697 PSNKLGEGGFGPVYKGKLGDGRAIAVKQLSVASRQGKSQFVAEIATISAVQH--RNLVKLHGCCIEGAERLLVYEYLENK 774 (1036)
Q Consensus 697 ~~~~iG~G~fG~Vy~~~~~~g~~vAvK~~~~~~~~~~~~f~~Ei~~L~~l~H--~nIv~l~g~~~~~~~~~lV~E~~~~g 774 (1036)
+.+.||+|.++.||++...+ ..+++|....... ...+..|+..+..++| .++++++++....+..++++||++++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~ 78 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE 78 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence 35779999999999999854 7899999865433 5678999999999987 58999999988878899999999987
Q ss_pred ChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCccee
Q 001658 775 SLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKL 843 (1036)
Q Consensus 775 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~ 843 (1036)
.+..+ +......++.++++++++||......++|+|++|+||++++.+.+++.|||.++.
T Consensus 79 ~~~~~---------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 79 TLDEV---------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred ecccC---------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 77654 5566778899999999999986545699999999999999999999999999874
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.50 E-value=2.2e-13 Score=146.40 Aligned_cols=135 Identities=19% Similarity=0.236 Sum_probs=105.3
Q ss_pred Cccc-cCCCEEEEEeEeCCCcEEEEEEccccc-------------hhcHHHHHHHHHHHHhhccCCc--ceeEeEEEcCc
Q 001658 699 NKLG-EGGFGPVYKGKLGDGRAIAVKQLSVAS-------------RQGKSQFVAEIATISAVQHRNL--VKLHGCCIEGA 762 (1036)
Q Consensus 699 ~~iG-~G~fG~Vy~~~~~~g~~vAvK~~~~~~-------------~~~~~~f~~Ei~~L~~l~H~nI--v~l~g~~~~~~ 762 (1036)
..|| .||.|+||++... +..++||.+.... ......+.+|++++.+++|++| ++.+++.....
T Consensus 37 ~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~ 115 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH 115 (239)
T ss_pred ceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence 5687 8999999999874 6789999875321 1223567889999999998885 67777754332
Q ss_pred ----eeEEEEEecCC-CChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEE
Q 001658 763 ----ERLLVYEYLEN-KSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISD 837 (1036)
Q Consensus 763 ----~~~lV~E~~~~-gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~D 837 (1036)
..++|+|++++ .+|.+++... .++.. .+.++++++.+||+.| |+||||||.|||++.++.++|+|
T Consensus 116 ~~~~~~~lV~e~l~G~~~L~~~l~~~---~l~~~----~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~~~v~LID 185 (239)
T PRK01723 116 GLFYRADILIERIEGARDLVALLQEA---PLSEE----QWQAIGQLIARFHDAG---VYHADLNAHNILLDPDGKFWLID 185 (239)
T ss_pred CcceeeeEEEEecCCCCCHHHHHhcC---CCCHH----HHHHHHHHHHHHHHCC---CCCCCCCchhEEEcCCCCEEEEE
Confidence 22599999997 6999887432 33332 3568999999999998 99999999999999999999999
Q ss_pred cCcceee
Q 001658 838 FGLAKLY 844 (1036)
Q Consensus 838 FGla~~~ 844 (1036)
||.+...
T Consensus 186 fg~~~~~ 192 (239)
T PRK01723 186 FDRGELR 192 (239)
T ss_pred CCCcccC
Confidence 9988753
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.41 E-value=2.3e-14 Score=172.11 Aligned_cols=253 Identities=22% Similarity=0.261 Sum_probs=181.7
Q ss_pred CCCCCCccccCCCEEEEEeEeC--CCcEEEEEEccccc--hhcHHHHHHHHHHHHhhc-cCCcceeEeEEEcCceeEEEE
Q 001658 694 NFSPSNKLGEGGFGPVYKGKLG--DGRAIAVKQLSVAS--RQGKSQFVAEIATISAVQ-HRNLVKLHGCCIEGAERLLVY 768 (1036)
Q Consensus 694 ~~~~~~~iG~G~fG~Vy~~~~~--~g~~vAvK~~~~~~--~~~~~~f~~Ei~~L~~l~-H~nIv~l~g~~~~~~~~~lV~ 768 (1036)
.|...+.||+|+|+.|-..... ....+|+|.+.... .........|..+-..+. |+|++++++...+.+..+++.
T Consensus 21 ~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~ 100 (601)
T KOG0590|consen 21 QYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSL 100 (601)
T ss_pred cccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccccc
Confidence 4556677999999999988753 34567777775543 222334445777777776 999999999999999999999
Q ss_pred EecCCCChhhhh-hcCCCCCcChHHHHHHHHHHHHHHHHHH-hcCCccccccccCCCcEEecCCC-ceEEEEcCcceeec
Q 001658 769 EYLENKSLDQAL-FGQRSLTLDWATRYEICSGVARGLAYLH-EESRVRIIHRDVKASNVLLDADL-VPKISDFGLAKLYD 845 (1036)
Q Consensus 769 E~~~~gsL~~~l-~~~~~~~l~~~~~~~i~~~ia~gL~yLH-~~~~~~ivHrDikp~NILl~~~~-~~kl~DFGla~~~~ 845 (1036)
||.+++++.+-+ +... ...+....-....|+..++.|+| +.+ +.||||||+|.+++..+ ..+++|||+|..+.
T Consensus 101 ~~s~g~~~f~~i~~~~~-~~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~ 176 (601)
T KOG0590|consen 101 SYSDGGSLFSKISHPDS-TGTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADFGLATAYR 176 (601)
T ss_pred CcccccccccccccCCc-cCCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCchhhcccc
Confidence 999999999888 3332 13344444557899999999999 777 99999999999999999 99999999998776
Q ss_pred C-C-CCcccccccc-ccCccCccccccC-CCCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhcCcccc
Q 001658 846 D-K-KTHISTRVAG-TIGYLAPEYAMRG-HLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEIE 921 (1036)
Q Consensus 846 ~-~-~~~~~~~~~g-t~~y~APE~~~~~-~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 921 (1036)
. . .........| ++.|+|||...+. ...+..|+||.|+++.-+++|..|++........ ...|.. .. .
T Consensus 177 ~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~-~~~~~~-----~~--~ 248 (601)
T KOG0590|consen 177 NKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGR-YSSWKS-----NK--G 248 (601)
T ss_pred ccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccccc-ceeecc-----cc--c
Confidence 5 2 2222334567 9999999999884 4567899999999999999999999865443211 111110 00 0
Q ss_pred ccCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 001658 922 LADPKLIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVA 961 (1036)
Q Consensus 922 ~~d~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 961 (1036)
..... ..........++...++..+|..|.+..++..
T Consensus 249 ~~~~~---~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~ 285 (601)
T KOG0590|consen 249 RFTQL---PWNSISDQAHDLLHKILKENPSNRLSIEELKL 285 (601)
T ss_pred ccccC---ccccCChhhhhcccccccCCchhccccccccc
Confidence 00001 11122233445555677789999999888643
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.39 E-value=1.5e-12 Score=151.82 Aligned_cols=142 Identities=21% Similarity=0.279 Sum_probs=102.0
Q ss_pred CCccccCCCEEEEEeEeCCCcEEEEEEccccchhc----------------------------------------HHHHH
Q 001658 698 SNKLGEGGFGPVYKGKLGDGRAIAVKQLSVASRQG----------------------------------------KSQFV 737 (1036)
Q Consensus 698 ~~~iG~G~fG~Vy~~~~~~g~~vAvK~~~~~~~~~----------------------------------------~~~f~ 737 (1036)
.+.||.|++|+||+|++.+|+.||||+.++..... +-+|.
T Consensus 122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 36799999999999999999999999986532110 01255
Q ss_pred HHHHHHHhhc----cCCcceeEeEE-EcCceeEEEEEecCCCChhhhhhcCCCCCcChHHHHHHHHHHHH-HHHHHHhcC
Q 001658 738 AEIATISAVQ----HRNLVKLHGCC-IEGAERLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVAR-GLAYLHEES 811 (1036)
Q Consensus 738 ~Ei~~L~~l~----H~nIv~l~g~~-~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~-gL~yLH~~~ 811 (1036)
.|.+.+.+++ |.+-+.+-..+ ......+|||||++|++|.++...... .. .+.+++..+++ .+..+|..+
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~-~~---~~~~ia~~~~~~~l~ql~~~g 277 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA-GL---DRKALAENLARSFLNQVLRDG 277 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc-CC---CHHHHHHHHHHHHHHHHHhCC
Confidence 5666666653 22222222222 223457999999999999987643211 12 34556777766 478889887
Q ss_pred CccccccccCCCcEEecCCCceEEEEcCcceeecC
Q 001658 812 RVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDD 846 (1036)
Q Consensus 812 ~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~ 846 (1036)
++|+|+||.||++++++.++++|||++..+.+
T Consensus 278 ---~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 278 ---FFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred ---ceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 99999999999999999999999999987753
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.37 E-value=2.3e-14 Score=160.02 Aligned_cols=175 Identities=26% Similarity=0.397 Sum_probs=99.4
Q ss_pred EEEcccCCCCCCCccccCCCccCCEEeCccccCCCCCCccccCCCCCcEEeccCCcCCCCChhhhcCCCCCCEEEeeCCc
Q 001658 175 ILGIGTNNFSGPLPSELGSLSKLQELYIDSAGVSGEIPSSFANLQSLTKWWASDTRLTGRIPDFIGNWSKLTALRFQGNS 254 (1036)
Q Consensus 175 ~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~ 254 (1036)
..||+.|++. .+|..+..+..|+.|.|++|.+. .+|..+.++..|..|+|+.|+++ .+|..+..|+ |+.|-+++|+
T Consensus 79 ~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~lp-Lkvli~sNNk 154 (722)
T KOG0532|consen 79 FADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDLP-LKVLIVSNNK 154 (722)
T ss_pred hhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhcCc-ceeEEEecCc
Confidence 3344444444 34444444444444444444444 44444444444444444444444 3444444443 5555555555
Q ss_pred CCCCCCccccCCCCCCEEEccCCCCCCCchhhhcCCCCCCEEEccCCccCccccccccCCCCccEEeCCCCCCCCCCchh
Q 001658 255 FNGPIPSSFSNLTSVTELRISDLSNGSSKLAFIRDMKSLSILELRNNNISDSIPSNIGEYRSLQHLDLSFNNLGGSIPDS 334 (1036)
Q Consensus 255 l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~ 334 (1036)
++ .+|..++.+..|..|+.+.|.+..++.. +..+.+|+.|.+..|++. .+|..+.. -.|..||+|+|++. .+|-.
T Consensus 155 l~-~lp~~ig~~~tl~~ld~s~nei~slpsq-l~~l~slr~l~vrRn~l~-~lp~El~~-LpLi~lDfScNkis-~iPv~ 229 (722)
T KOG0532|consen 155 LT-SLPEEIGLLPTLAHLDVSKNEIQSLPSQ-LGYLTSLRDLNVRRNHLE-DLPEELCS-LPLIRLDFSCNKIS-YLPVD 229 (722)
T ss_pred cc-cCCcccccchhHHHhhhhhhhhhhchHH-hhhHHHHHHHHHhhhhhh-hCCHHHhC-CceeeeecccCcee-ecchh
Confidence 55 4455555555555555555555555443 344566777777777776 56666664 34777888888887 77878
Q ss_pred ccCCCCccEEEccCccccccCCCCc
Q 001658 335 LFNLSSLTHLFLGNNKLNGTLPARK 359 (1036)
Q Consensus 335 l~~l~~L~~L~Ls~N~l~g~~p~~~ 359 (1036)
|.+|..|++|-|.+|+|+ ..|..+
T Consensus 230 fr~m~~Lq~l~LenNPLq-SPPAqI 253 (722)
T KOG0532|consen 230 FRKMRHLQVLQLENNPLQ-SPPAQI 253 (722)
T ss_pred hhhhhhheeeeeccCCCC-CChHHH
Confidence 888888888888888887 444443
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.33 E-value=5e-14 Score=157.40 Aligned_cols=196 Identities=24% Similarity=0.380 Sum_probs=139.5
Q ss_pred CCCCCCEEEccCCCCCCCCcccccCCCcCCeeecccccccCCccccccCCCCCcEEEcccCCCCCCCccccCCCccCCEE
Q 001658 121 NLTSLFNLNLGQNYLTGPLSPSVGNLTAMQYLNLAINALSGELPKELGQLTELLILGIGTNNFSGPLPSELGSLSKLQEL 200 (1036)
Q Consensus 121 ~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~L~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L 200 (1036)
.+..-...||+.|++. ++|..+..+-.|+.|.|..|.|. .+|..+.+|..|++|||+.|+++ .+|..+..| -|+.|
T Consensus 73 ~ltdt~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~l-pLkvl 148 (722)
T KOG0532|consen 73 DLTDTVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDL-PLKVL 148 (722)
T ss_pred cccchhhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhcC-cceeE
Confidence 4555566777777777 77777777777777777777777 77777777777777777777777 666666665 37777
Q ss_pred eCccccCCCCCCccccCCCCCcEEeccCCcCCCCChhhhcCCCCCCEEEeeCCcCCCCCCccccCCCCCCEEEccCCCCC
Q 001658 201 YIDSAGVSGEIPSSFANLQSLTKWWASDTRLTGRIPDFIGNWSKLTALRFQGNSFNGPIPSSFSNLTSVTELRISDLSNG 280 (1036)
Q Consensus 201 ~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~ 280 (1036)
.+++|+++ .+|..++.+..|..|+.+.|.+. .+|..++.+.+|+.|.+..|++. .+|..+..|
T Consensus 149 i~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~-~lp~El~~L-------------- 211 (722)
T KOG0532|consen 149 IVSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLE-DLPEELCSL-------------- 211 (722)
T ss_pred EEecCccc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhh-hCCHHHhCC--------------
Confidence 77777776 66666666666666666666666 45555666666666666666666 444444433
Q ss_pred CCchhhhcCCCCCCEEEccCCccCccccccccCCCCccEEeCCCCCCCCCCchhccCC---CCccEEEccCcc
Q 001658 281 SSKLAFIRDMKSLSILELRNNNISDSIPSNIGEYRSLQHLDLSFNNLGGSIPDSLFNL---SSLTHLFLGNNK 350 (1036)
Q Consensus 281 ~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l---~~L~~L~Ls~N~ 350 (1036)
.|..||+|.|+++ .+|..|.+|..|++|-|.+|.|. ..|..++.. .=.++|+..-++
T Consensus 212 -----------pLi~lDfScNkis-~iPv~fr~m~~Lq~l~LenNPLq-SPPAqIC~kGkVHIFKyL~~qA~q 271 (722)
T KOG0532|consen 212 -----------PLIRLDFSCNKIS-YLPVDFRKMRHLQVLQLENNPLQ-SPPAQICEKGKVHIFKYLSTQACQ 271 (722)
T ss_pred -----------ceeeeecccCcee-ecchhhhhhhhheeeeeccCCCC-CChHHHHhccceeeeeeecchhcc
Confidence 5788999999998 88999999999999999999999 677766633 234666666664
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.31 E-value=2.5e-12 Score=149.85 Aligned_cols=197 Identities=35% Similarity=0.490 Sum_probs=96.0
Q ss_pred EEccCCCCCCCCcccccCCCcCCeeecccccccCCccccccCCC-CCcEEEcccCCCCCCCccccCCCccCCEEeCcccc
Q 001658 128 LNLGQNYLTGPLSPSVGNLTAMQYLNLAINALSGELPKELGQLT-ELLILGIGTNNFSGPLPSELGSLSKLQELYIDSAG 206 (1036)
Q Consensus 128 L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~L~-~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~ 206 (1036)
|+++.|.+. .....+..++.++.|++.+|+++ .+|.....++ +|+.|++++|++. .+|..+..+++|+.|++++|+
T Consensus 98 l~~~~~~~~-~~~~~~~~~~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N~ 174 (394)
T COG4886 98 LDLNLNRLR-SNISELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFND 174 (394)
T ss_pred eeccccccc-cCchhhhcccceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCCch
Confidence 444444443 12223334455555555555555 4444444443 5555555555555 343445555555555555555
Q ss_pred CCCCCCccccCCCCCcEEeccCCcCCCCChhhhcCCCCCCEEEeeCCcCCCCCCccccCCCCCCEEEccCCCCCCCchhh
Q 001658 207 VSGEIPSSFANLQSLTKWWASDTRLTGRIPDFIGNWSKLTALRFQGNSFNGPIPSSFSNLTSVTELRISDLSNGSSKLAF 286 (1036)
Q Consensus 207 l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~ 286 (1036)
++ .+|...+.+++|+.|++++|++. .+|.....+..|++|.+++|.+. ..+..+.++
T Consensus 175 l~-~l~~~~~~~~~L~~L~ls~N~i~-~l~~~~~~~~~L~~l~~~~N~~~-~~~~~~~~~-------------------- 231 (394)
T COG4886 175 LS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLSNL-------------------- 231 (394)
T ss_pred hh-hhhhhhhhhhhhhheeccCCccc-cCchhhhhhhhhhhhhhcCCcce-ecchhhhhc--------------------
Confidence 55 33333334445555555555555 33333333344555555555322 233334444
Q ss_pred hcCCCCCCEEEccCCccCccccccccCCCCccEEeCCCCCCCCCCchhccCCCCccEEEccCccccccCCC
Q 001658 287 IRDMKSLSILELRNNNISDSIPSNIGEYRSLQHLDLSFNNLGGSIPDSLFNLSSLTHLFLGNNKLNGTLPA 357 (1036)
Q Consensus 287 l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~~p~ 357 (1036)
.++..|.+.+|++. .++..+..+++|+.|++++|.++ .++. ++.+.+|+.|++++|.+....|.
T Consensus 232 ----~~l~~l~l~~n~~~-~~~~~~~~l~~l~~L~~s~n~i~-~i~~-~~~~~~l~~L~~s~n~~~~~~~~ 295 (394)
T COG4886 232 ----KNLSGLELSNNKLE-DLPESIGNLSNLETLDLSNNQIS-SISS-LGSLTNLRELDLSGNSLSNALPL 295 (394)
T ss_pred ----ccccccccCCceee-eccchhccccccceecccccccc-cccc-ccccCccCEEeccCccccccchh
Confidence 44444555555554 22444555555666666666665 3333 55555666666666655544444
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.30 E-value=3e-12 Score=149.19 Aligned_cols=201 Identities=30% Similarity=0.403 Sum_probs=128.7
Q ss_pred eeecccccccCCccccccCCCCCcEEEcccCCCCCCCccccCCCc-cCCEEeCccccCCCCCCccccCCCCCcEEeccCC
Q 001658 151 YLNLAINALSGELPKELGQLTELLILGIGTNNFSGPLPSELGSLS-KLQELYIDSAGVSGEIPSSFANLQSLTKWWASDT 229 (1036)
Q Consensus 151 ~L~Ls~N~l~~~~p~~l~~L~~L~~L~Ls~N~l~~~~p~~l~~l~-~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N 229 (1036)
.|+++.|.+. .....+..++.++.|++.+|.++ .++.....++ +|+.|++++|++. .+|..+..+++|+.|++++|
T Consensus 97 ~l~~~~~~~~-~~~~~~~~~~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N 173 (394)
T COG4886 97 SLDLNLNRLR-SNISELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFN 173 (394)
T ss_pred eeeccccccc-cCchhhhcccceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCCc
Confidence 4566666554 22333444455666666666665 4444444443 5555555555555 33344444455555555555
Q ss_pred cCCCCChhhhcCCCCCCEEEeeCCcCCCCCCccccCCCCCCEEEccCCCCCCCchhhhcCCCCCCEEEccCCccCccccc
Q 001658 230 RLTGRIPDFIGNWSKLTALRFQGNSFNGPIPSSFSNLTSVTELRISDLSNGSSKLAFIRDMKSLSILELRNNNISDSIPS 309 (1036)
Q Consensus 230 ~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~ 309 (1036)
++. .+|.....+++|+.|++++|.+..++... .....|++|.+++|.+. ..+.
T Consensus 174 ~l~-------------------------~l~~~~~~~~~L~~L~ls~N~i~~l~~~~-~~~~~L~~l~~~~N~~~-~~~~ 226 (394)
T COG4886 174 DLS-------------------------DLPKLLSNLSNLNNLDLSGNKISDLPPEI-ELLSALEELDLSNNSII-ELLS 226 (394)
T ss_pred hhh-------------------------hhhhhhhhhhhhhheeccCCccccCchhh-hhhhhhhhhhhcCCcce-ecch
Confidence 544 33333334445555555555555544431 12345888888888655 5667
Q ss_pred cccCCCCccEEeCCCCCCCCCCchhccCCCCccEEEccCccccccCCCCcCCCccEEEeeCccCCCCCchhhh
Q 001658 310 NIGEYRSLQHLDLSFNNLGGSIPDSLFNLSSLTHLFLGNNKLNGTLPARKSPLLLNIDVSYNNLQGNLPSWIN 382 (1036)
Q Consensus 310 ~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~L~~Ldls~N~l~g~~p~~l~ 382 (1036)
.+..+.++..|.+.+|++. .++..+..+++|+.|++++|+++...+......|+.||+++|.+...+|....
T Consensus 227 ~~~~~~~l~~l~l~~n~~~-~~~~~~~~l~~l~~L~~s~n~i~~i~~~~~~~~l~~L~~s~n~~~~~~~~~~~ 298 (394)
T COG4886 227 SLSNLKNLSGLELSNNKLE-DLPESIGNLSNLETLDLSNNQISSISSLGSLTNLRELDLSGNSLSNALPLIAL 298 (394)
T ss_pred hhhhcccccccccCCceee-eccchhccccccceeccccccccccccccccCccCEEeccCccccccchhhhc
Confidence 7899999999999999999 56888999999999999999999655534446699999999999977775443
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.24 E-value=1.6e-11 Score=129.23 Aligned_cols=201 Identities=22% Similarity=0.295 Sum_probs=137.7
Q ss_pred HHHHHhhccCCcceeEeEEEcC-----ceeEEEEEecCCCChhhhhhcCC--CCCcChHHHHHHHHHHHHHHHHHHhcCC
Q 001658 740 IATISAVQHRNLVKLHGCCIEG-----AERLLVYEYLENKSLDQALFGQR--SLTLDWATRYEICSGVARGLAYLHEESR 812 (1036)
Q Consensus 740 i~~L~~l~H~nIv~l~g~~~~~-----~~~~lV~E~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~ 812 (1036)
..-|-.+.|.|||+++.|+.+. .+..++.|||..|++..+|++.+ ...+......+++.||..||.|||+. .
T Consensus 118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~-~ 196 (458)
T KOG1266|consen 118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSC-D 196 (458)
T ss_pred HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhcc-C
Confidence 4445567899999999998754 34688999999999999997533 44567777788999999999999986 4
Q ss_pred ccccccccCCCcEEecCCCceEEEEcCcceeecCC----CCccccccccccCccCccccccCCCCchhhHHhHHHHHHHH
Q 001658 813 VRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDK----KTHISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALET 888 (1036)
Q Consensus 813 ~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~----~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~el 888 (1036)
|+|+|+++.-+-|++..++-+|+.--- -...... .........+-++|.|||+-.....+.++|||+||+..+||
T Consensus 197 PpiihgnlTc~tifiq~ngLIkig~~a-p~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlem 275 (458)
T KOG1266|consen 197 PPIIHGNLTCDTIFIQHNGLIKIGSVA-PDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEM 275 (458)
T ss_pred CccccCCcchhheeecCCceEEecccC-ccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHH
Confidence 779999999999999999988874211 1111000 00111123467799999998888888899999999999999
Q ss_pred HhCCCCCCCCChh-hHHHHHHHHHHHhhcCccccccCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 001658 889 VSGRPNSDPSLDE-EKLYLLEWAWHLHENNQEIELADPKLIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVA 961 (1036)
Q Consensus 889 ltG~~p~~~~~~~-~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 961 (1036)
..+..-....... ....-+. +..+...++.- .+.+..|++..|..||+|.+++.
T Consensus 276 ailEiq~tnseS~~~~ee~ia--------~~i~~len~lq-----------r~~i~kcl~~eP~~rp~ar~llf 330 (458)
T KOG1266|consen 276 AILEIQSTNSESKVEVEENIA--------NVIIGLENGLQ-----------RGSITKCLEGEPNGRPDARLLLF 330 (458)
T ss_pred HHheeccCCCcceeehhhhhh--------hheeeccCccc-----------cCcCcccccCCCCCCcchhhhhc
Confidence 8876432221110 0000000 01111111111 12345799999999999998865
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.23 E-value=4.4e-11 Score=121.80 Aligned_cols=129 Identities=19% Similarity=0.138 Sum_probs=97.9
Q ss_pred CccccCCCEEEEEeEeCCCcEEEEEEccccchhcHHHHHHHHHHHHhhccCCcc-eeEeEEEcCceeEEEEEecCCCChh
Q 001658 699 NKLGEGGFGPVYKGKLGDGRAIAVKQLSVASRQGKSQFVAEIATISAVQHRNLV-KLHGCCIEGAERLLVYEYLENKSLD 777 (1036)
Q Consensus 699 ~~iG~G~fG~Vy~~~~~~g~~vAvK~~~~~~~~~~~~f~~Ei~~L~~l~H~nIv-~l~g~~~~~~~~~lV~E~~~~gsL~ 777 (1036)
+.++.|.++.||+++.. ++.|++|....... ....+..|++++..+.+.+++ +++++. ....++||||+++.++.
T Consensus 4 ~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l~ 79 (170)
T cd05151 4 SPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSELL 79 (170)
T ss_pred eecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCccc
Confidence 56899999999999874 77899998764332 234568899999998766654 555543 33458999999998876
Q ss_pred hhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcC--CccccccccCCCcEEecCCCceEEEEcCcce
Q 001658 778 QALFGQRSLTLDWATRYEICSGVARGLAYLHEES--RVRIIHRDVKASNVLLDADLVPKISDFGLAK 842 (1036)
Q Consensus 778 ~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~--~~~ivHrDikp~NILl~~~~~~kl~DFGla~ 842 (1036)
+.- .....++.+++++|+.||..+ +..++|+|++|.||+++ ++.++++|||.+.
T Consensus 80 ~~~----------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 80 TED----------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred ccc----------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 431 111245678999999999876 23369999999999999 6689999999876
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.18 E-value=3e-11 Score=142.39 Aligned_cols=147 Identities=16% Similarity=0.222 Sum_probs=95.0
Q ss_pred hcCCCCCCccccCCCEEEEEeEeCC-CcEEEEEEccccchhc----------------------------------H---
Q 001658 692 TENFSPSNKLGEGGFGPVYKGKLGD-GRAIAVKQLSVASRQG----------------------------------K--- 733 (1036)
Q Consensus 692 ~~~~~~~~~iG~G~fG~Vy~~~~~~-g~~vAvK~~~~~~~~~----------------------------------~--- 733 (1036)
...|+. +.||+|++|+||+|++++ |+.||||+.++..... .
T Consensus 119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l 197 (537)
T PRK04750 119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL 197 (537)
T ss_pred HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence 345766 789999999999999887 9999999997532110 0
Q ss_pred ---HHHHHHHHHHHhhc----cCCcceeEeEEEc-CceeEEEEEecCCCChhhhhhcCCCCCcChHHHHHHHHHHHH-HH
Q 001658 734 ---SQFVAEIATISAVQ----HRNLVKLHGCCIE-GAERLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVAR-GL 804 (1036)
Q Consensus 734 ---~~f~~Ei~~L~~l~----H~nIv~l~g~~~~-~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~-gL 804 (1036)
-+|.+|+..+.+++ +.+.+.+-..+.+ ....+|||||++|+.+.++-.-. ....+. ..++...++ -+
T Consensus 198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~-~~g~d~---~~la~~~v~~~~ 273 (537)
T PRK04750 198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALR-AAGTDM---KLLAERGVEVFF 273 (537)
T ss_pred HHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHH-hcCCCH---HHHHHHHHHHHH
Confidence 12444555555543 3333333333322 34578999999999998742111 111111 112222222 12
Q ss_pred HHHHhcCCccccccccCCCcEEecCCC----ceEEEEcCcceeecC
Q 001658 805 AYLHEESRVRIIHRDVKASNVLLDADL----VPKISDFGLAKLYDD 846 (1036)
Q Consensus 805 ~yLH~~~~~~ivHrDikp~NILl~~~~----~~kl~DFGla~~~~~ 846 (1036)
..+...| ++|+|+||.||+++.++ ++++.|||++..+..
T Consensus 274 ~Qif~~G---ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 274 TQVFRDG---FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred HHHHhCC---eeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 3344566 99999999999999988 999999999987754
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=99.18 E-value=3.8e-12 Score=138.86 Aligned_cols=209 Identities=21% Similarity=0.198 Sum_probs=141.8
Q ss_pred cCCCcCCeeecccccccCCcc--ccccCCCCCcEEEcccCCCCCCCc--cccCCCccCCEEeCccccCCCCCCccc-cCC
Q 001658 144 GNLTAMQYLNLAINALSGELP--KELGQLTELLILGIGTNNFSGPLP--SELGSLSKLQELYIDSAGVSGEIPSSF-ANL 218 (1036)
Q Consensus 144 ~~l~~L~~L~Ls~N~l~~~~p--~~l~~L~~L~~L~Ls~N~l~~~~p--~~l~~l~~L~~L~L~~N~l~~~~p~~~-~~l 218 (1036)
.++++|+.+.|.+..+. ..+ .....+++++.|||+.|-+....+ .....|++|+.|+|+.|++........ ..+
T Consensus 118 sn~kkL~~IsLdn~~V~-~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l 196 (505)
T KOG3207|consen 118 SNLKKLREISLDNYRVE-DAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLL 196 (505)
T ss_pred hhHHhhhheeecCcccc-ccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhh
Confidence 45788888888888887 333 356678888899999888763322 445678888889998888874333222 245
Q ss_pred CCCcEEeccCCcCCCCC-hhhhcCCCCCCEEEeeCCcCCCCCCccccCCCCCCEEEccCCCCCCCch-hhhcCCCCCCEE
Q 001658 219 QSLTKWWASDTRLTGRI-PDFIGNWSKLTALRFQGNSFNGPIPSSFSNLTSVTELRISDLSNGSSKL-AFIRDMKSLSIL 296 (1036)
Q Consensus 219 ~~L~~L~L~~N~l~~~~-p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~-~~l~~l~~L~~L 296 (1036)
+.|+.|.|+.|.|+-.. ...+..+|+|+.|+|..|............+..|++|+|++|.+.+.+. .....++.|..|
T Consensus 197 ~~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li~~~~~~~~~~l~~L~~L 276 (505)
T KOG3207|consen 197 SHLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLIDFDQGYKVGTLPGLNQL 276 (505)
T ss_pred hhhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccCCcccccccccccccccchhhh
Confidence 78888888888887322 2334567888889998885433444455567778888888887766653 335567788888
Q ss_pred EccCCccCcc-cccc-----ccCCCCccEEeCCCCCCCC-CCchhccCCCCccEEEccCccccc
Q 001658 297 ELRNNNISDS-IPSN-----IGEYRSLQHLDLSFNNLGG-SIPDSLFNLSSLTHLFLGNNKLNG 353 (1036)
Q Consensus 297 ~Ls~N~l~~~-~p~~-----~~~l~~L~~L~Ls~N~l~~-~~p~~l~~l~~L~~L~Ls~N~l~g 353 (1036)
+++.|.+... +|+. ...+++|++|+++.|++.. .--..+..+++|+.|.+..|.|+.
T Consensus 277 nls~tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I~~w~sl~~l~~l~nlk~l~~~~n~ln~ 340 (505)
T KOG3207|consen 277 NLSSTGIASIAEPDVESLDKTHTFPKLEYLNISENNIRDWRSLNHLRTLENLKHLRITLNYLNK 340 (505)
T ss_pred hccccCcchhcCCCccchhhhcccccceeeecccCccccccccchhhccchhhhhhcccccccc
Confidence 8888877643 2322 3456778888888888862 112345566777777777777763
|
|
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.16 E-value=4.6e-12 Score=134.87 Aligned_cols=237 Identities=20% Similarity=0.252 Sum_probs=126.0
Q ss_pred CCccccCCCCCCEEEccCCCCCCC----CcccccCCCcCCeeecccc---cccCCcccc-------ccCCCCCcEEEccc
Q 001658 115 IPDELWNLTSLFNLNLGQNYLTGP----LSPSVGNLTAMQYLNLAIN---ALSGELPKE-------LGQLTELLILGIGT 180 (1036)
Q Consensus 115 ip~~l~~l~~L~~L~Ls~n~l~~~----~p~~~~~l~~L~~L~Ls~N---~l~~~~p~~-------l~~L~~L~~L~Ls~ 180 (1036)
+-+.+..+..++.|+|++|.+... +.+.+.+.++|+..++++- ++...+|.. +...++|++||||+
T Consensus 22 v~~~~~~~~s~~~l~lsgnt~G~EAa~~i~~~L~~~~~L~~v~~sd~ftGR~~~Ei~e~L~~l~~aL~~~~~L~~ldLSD 101 (382)
T KOG1909|consen 22 VEEELEPMDSLTKLDLSGNTFGTEAARAIAKVLASKKELREVNLSDMFTGRLKDEIPEALKMLSKALLGCPKLQKLDLSD 101 (382)
T ss_pred HHHHhcccCceEEEeccCCchhHHHHHHHHHHHhhcccceeeehHhhhcCCcHHHHHHHHHHHHHHHhcCCceeEeeccc
Confidence 334556677788888888887632 3345667778888877652 333345543 34456888888888
Q ss_pred CCCCCCCccc----cCCCccCCEEeCccccCCCCCC-------------ccccCCCCCcEEeccCCcCCCCCh----hhh
Q 001658 181 NNFSGPLPSE----LGSLSKLQELYIDSAGVSGEIP-------------SSFANLQSLTKWWASDTRLTGRIP----DFI 239 (1036)
Q Consensus 181 N~l~~~~p~~----l~~l~~L~~L~L~~N~l~~~~p-------------~~~~~l~~L~~L~L~~N~l~~~~p----~~l 239 (1036)
|-|....+.. +.++..|++|.|.+|.+...-- ...+.-+.|+++...+|++..... ..|
T Consensus 102 NA~G~~g~~~l~~ll~s~~~L~eL~L~N~Glg~~ag~~l~~al~~l~~~kk~~~~~~Lrv~i~~rNrlen~ga~~~A~~~ 181 (382)
T KOG1909|consen 102 NAFGPKGIRGLEELLSSCTDLEELYLNNCGLGPEAGGRLGRALFELAVNKKAASKPKLRVFICGRNRLENGGATALAEAF 181 (382)
T ss_pred cccCccchHHHHHHHHhccCHHHHhhhcCCCChhHHHHHHHHHHHHHHHhccCCCcceEEEEeeccccccccHHHHHHHH
Confidence 8876444433 3456778888888887762111 112233456666666666653222 334
Q ss_pred cCCCCCCEEEeeCCcCCCC----CCccccCCCCCCEEEccCCCCCCCch----hhhcCCCCCCEEEccCCccCccccccc
Q 001658 240 GNWSKLTALRFQGNSFNGP----IPSSFSNLTSVTELRISDLSNGSSKL----AFIRDMKSLSILELRNNNISDSIPSNI 311 (1036)
Q Consensus 240 ~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~L~~n~l~~~~~----~~l~~l~~L~~L~Ls~N~l~~~~p~~~ 311 (1036)
...+.|+.+.++.|.|... +...|..+++|+.|+|.+|-++.... ..+..+++|+.|++++|.++..-...|
T Consensus 182 ~~~~~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~LakaL~s~~~L~El~l~dcll~~~Ga~a~ 261 (382)
T KOG1909|consen 182 QSHPTLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVALAKALSSWPHLRELNLGDCLLENEGAIAF 261 (382)
T ss_pred HhccccceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHHHHHHhcccchheeecccccccccccHHHH
Confidence 4455666666666655421 12234555555555555555544332 223344455555555555543222221
Q ss_pred -----cCCCCccEEeCCCCCCCCC----CchhccCCCCccEEEccCccc
Q 001658 312 -----GEYRSLQHLDLSFNNLGGS----IPDSLFNLSSLTHLFLGNNKL 351 (1036)
Q Consensus 312 -----~~l~~L~~L~Ls~N~l~~~----~p~~l~~l~~L~~L~Ls~N~l 351 (1036)
...++|+.|.|.+|.|+.. +...+...+.|..|+|++|++
T Consensus 262 ~~al~~~~p~L~vl~l~gNeIt~da~~~la~~~~ek~dL~kLnLngN~l 310 (382)
T KOG1909|consen 262 VDALKESAPSLEVLELAGNEITRDAALALAACMAEKPDLEKLNLNGNRL 310 (382)
T ss_pred HHHHhccCCCCceeccCcchhHHHHHHHHHHHHhcchhhHHhcCCcccc
Confidence 1234455555555555421 122233344444445544444
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.16 E-value=3.9e-11 Score=137.64 Aligned_cols=247 Identities=23% Similarity=0.283 Sum_probs=176.9
Q ss_pred CCCCCCcccc--CCCEEEEEeEe---CCCcEEEEEEccccc--hhcHHHHHHHHHHHHhhc-cCCcceeEeEEEcCceeE
Q 001658 694 NFSPSNKLGE--GGFGPVYKGKL---GDGRAIAVKQLSVAS--RQGKSQFVAEIATISAVQ-HRNLVKLHGCCIEGAERL 765 (1036)
Q Consensus 694 ~~~~~~~iG~--G~fG~Vy~~~~---~~g~~vAvK~~~~~~--~~~~~~f~~Ei~~L~~l~-H~nIv~l~g~~~~~~~~~ 765 (1036)
.|.+.+.+|. |.+|.||.+.. .++..+|+|.-+..- ......=.+|+...++++ |+|.++.+..+..++..+
T Consensus 115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lf 194 (524)
T KOG0601|consen 115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILF 194 (524)
T ss_pred hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcce
Confidence 4556688999 99999999986 367889999844322 232333456777777774 999999999999999999
Q ss_pred EEEEecCCCChhhhhhcCCCCCcChHHHHHHHHHHHH----HHHHHHhcCCccccccccCCCcEEecCC-CceEEEEcCc
Q 001658 766 LVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVAR----GLAYLHEESRVRIIHRDVKASNVLLDAD-LVPKISDFGL 840 (1036)
Q Consensus 766 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~----gL~yLH~~~~~~ivHrDikp~NILl~~~-~~~kl~DFGl 840 (1036)
+-+|++ +.+|.++.+... .-++....+.+..+..+ |+.++|... ++|-|+||.||+...+ ...++.|||+
T Consensus 195 iqtE~~-~~sl~~~~~~~~-~~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~~s~~~~df~~ 269 (524)
T KOG0601|consen 195 IQTELC-GESLQSYCHTPC-NFLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDWTSCKLTDFGL 269 (524)
T ss_pred eeeccc-cchhHHhhhccc-ccCCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheecccccceeecCCcce
Confidence 999988 578888776432 22455566666777777 999999987 9999999999999999 8999999999
Q ss_pred ceeecCCCCcc----ccccccccCccCccccccCCCCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhc
Q 001658 841 AKLYDDKKTHI----STRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHEN 916 (1036)
Q Consensus 841 a~~~~~~~~~~----~~~~~gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~ 916 (1036)
...+.+..-.. ..+..|...|++||... +.++.++|+|++|.+..|..++-.+....... .| ...
T Consensus 270 v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~------~W--~~~-- 338 (524)
T KOG0601|consen 270 VSKISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPSVGKNS------SW--SQL-- 338 (524)
T ss_pred eEEccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhcccccCCCCC------Cc--ccc--
Confidence 98886554221 12335778899999875 46788999999999999999987655432110 01 101
Q ss_pred CccccccCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 001658 917 NQEIELADPKLIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVA 961 (1036)
Q Consensus 917 ~~~~~~~d~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 961 (1036)
+... .| .++......++......+++.+|..|++.+.+..
T Consensus 339 -r~~~--ip--~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 339 -RQGY--IP--LEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred -cccc--Cc--hhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 0000 11 1222222334444677789999999999888754
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.10 E-value=1.7e-10 Score=140.97 Aligned_cols=107 Identities=27% Similarity=0.509 Sum_probs=78.7
Q ss_pred CCCEEEccCCCCCCCCcccccCCCcCCeeecccccccCCccccccCCCCCcEEEcccCCCCCCCccccCCCccCCEEeCc
Q 001658 124 SLFNLNLGQNYLTGPLSPSVGNLTAMQYLNLAINALSGELPKELGQLTELLILGIGTNNFSGPLPSELGSLSKLQELYID 203 (1036)
Q Consensus 124 ~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~L~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~ 203 (1036)
.++.|+|++|.++|.+|..|+++++|+.|+|++|+++|.+|..++.+++|+.|+|++|++++.+|..++++++|+.|+|+
T Consensus 419 ~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls 498 (623)
T PLN03150 419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLN 498 (623)
T ss_pred EEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECc
Confidence 35677888888888888888888888888888888887777777778888888888888777777777777777777777
Q ss_pred cccCCCCCCccccCC-CCCcEEeccCCc
Q 001658 204 SAGVSGEIPSSFANL-QSLTKWWASDTR 230 (1036)
Q Consensus 204 ~N~l~~~~p~~~~~l-~~L~~L~L~~N~ 230 (1036)
+|+++|.+|..+..+ .++..+++.+|.
T Consensus 499 ~N~l~g~iP~~l~~~~~~~~~l~~~~N~ 526 (623)
T PLN03150 499 GNSLSGRVPAALGGRLLHRASFNFTDNA 526 (623)
T ss_pred CCcccccCChHHhhccccCceEEecCCc
Confidence 777777777666543 244445554443
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=99.08 E-value=1.5e-11 Score=134.16 Aligned_cols=208 Identities=21% Similarity=0.217 Sum_probs=157.1
Q ss_pred cCCCCCCEEEccCCCCCCCCc--ccccCCCcCCeeecccccccCCcc--ccccCCCCCcEEEcccCCCCCCCccc-cCCC
Q 001658 120 WNLTSLFNLNLGQNYLTGPLS--PSVGNLTAMQYLNLAINALSGELP--KELGQLTELLILGIGTNNFSGPLPSE-LGSL 194 (1036)
Q Consensus 120 ~~l~~L~~L~Ls~n~l~~~~p--~~~~~l~~L~~L~Ls~N~l~~~~p--~~l~~L~~L~~L~Ls~N~l~~~~p~~-l~~l 194 (1036)
.++.+|+.+.|.+..+. ..+ .....|++++.|||+.|-+....| .-...|++|+.|+|+.|++....... -..+
T Consensus 118 sn~kkL~~IsLdn~~V~-~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l 196 (505)
T KOG3207|consen 118 SNLKKLREISLDNYRVE-DAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLL 196 (505)
T ss_pred hhHHhhhheeecCcccc-ccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhh
Confidence 46788999999998877 333 356789999999999999885433 34568999999999999986333222 2257
Q ss_pred ccCCEEeCccccCCCCC-CccccCCCCCcEEeccCCcCCCCChhhhcCCCCCCEEEeeCCcCCCCC-CccccCCCCCCEE
Q 001658 195 SKLQELYIDSAGVSGEI-PSSFANLQSLTKWWASDTRLTGRIPDFIGNWSKLTALRFQGNSFNGPI-PSSFSNLTSVTEL 272 (1036)
Q Consensus 195 ~~L~~L~L~~N~l~~~~-p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~-p~~~~~l~~L~~L 272 (1036)
+.|+.|.|+.|.++... ...+..+++|+.|+|..|............+..|++|||++|.+-... -...+.++.|+.|
T Consensus 197 ~~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li~~~~~~~~~~l~~L~~L 276 (505)
T KOG3207|consen 197 SHLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLIDFDQGYKVGTLPGLNQL 276 (505)
T ss_pred hhhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccCCcccccccccccccccchhhh
Confidence 88999999999998322 223456799999999999643344444556788999999999887322 2467889999999
Q ss_pred EccCCCCCCCchhhh------cCCCCCCEEEccCCccCcccc--ccccCCCCccEEeCCCCCCCC
Q 001658 273 RISDLSNGSSKLAFI------RDMKSLSILELRNNNISDSIP--SNIGEYRSLQHLDLSFNNLGG 329 (1036)
Q Consensus 273 ~L~~n~l~~~~~~~l------~~l~~L~~L~Ls~N~l~~~~p--~~~~~l~~L~~L~Ls~N~l~~ 329 (1036)
+++.+.+.++..... ..+++|++|+++.|++. ..+ ..+..+++|+.|.+..|.|+.
T Consensus 277 nls~tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I~-~w~sl~~l~~l~nlk~l~~~~n~ln~ 340 (505)
T KOG3207|consen 277 NLSSTGIASIAEPDVESLDKTHTFPKLEYLNISENNIR-DWRSLNHLRTLENLKHLRITLNYLNK 340 (505)
T ss_pred hccccCcchhcCCCccchhhhcccccceeeecccCccc-cccccchhhccchhhhhhcccccccc
Confidence 999999887654332 56889999999999996 332 346678889999999999984
|
|
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.08 E-value=1.5e-11 Score=130.98 Aligned_cols=234 Identities=18% Similarity=0.238 Sum_probs=169.4
Q ss_pred ccccCCCcCCeeecccccccCC----ccccccCCCCCcEEEcccC---CCCCCCccc-------cCCCccCCEEeCcccc
Q 001658 141 PSVGNLTAMQYLNLAINALSGE----LPKELGQLTELLILGIGTN---NFSGPLPSE-------LGSLSKLQELYIDSAG 206 (1036)
Q Consensus 141 ~~~~~l~~L~~L~Ls~N~l~~~----~p~~l~~L~~L~~L~Ls~N---~l~~~~p~~-------l~~l~~L~~L~L~~N~ 206 (1036)
+.+..+..+++|+|++|.+... +...+.+.++|+..++++= ++...+|+. +...++|++|+||+|-
T Consensus 24 ~~~~~~~s~~~l~lsgnt~G~EAa~~i~~~L~~~~~L~~v~~sd~ftGR~~~Ei~e~L~~l~~aL~~~~~L~~ldLSDNA 103 (382)
T KOG1909|consen 24 EELEPMDSLTKLDLSGNTFGTEAARAIAKVLASKKELREVNLSDMFTGRLKDEIPEALKMLSKALLGCPKLQKLDLSDNA 103 (382)
T ss_pred HHhcccCceEEEeccCCchhHHHHHHHHHHHhhcccceeeehHhhhcCCcHHHHHHHHHHHHHHHhcCCceeEeeccccc
Confidence 4566788999999999999843 4455777889999999863 233344543 4456799999999999
Q ss_pred CCCCCCccc----cCCCCCcEEeccCCcCCCCChhh-------------hcCCCCCCEEEeeCCcCCCC----CCccccC
Q 001658 207 VSGEIPSSF----ANLQSLTKWWASDTRLTGRIPDF-------------IGNWSKLTALRFQGNSFNGP----IPSSFSN 265 (1036)
Q Consensus 207 l~~~~p~~~----~~l~~L~~L~L~~N~l~~~~p~~-------------l~~l~~L~~L~L~~N~l~~~----~p~~~~~ 265 (1036)
+....+..| .++..|++|.|.+|.+...--.. .+.-++|+++...+|++... +...|..
T Consensus 104 ~G~~g~~~l~~ll~s~~~L~eL~L~N~Glg~~ag~~l~~al~~l~~~kk~~~~~~Lrv~i~~rNrlen~ga~~~A~~~~~ 183 (382)
T KOG1909|consen 104 FGPKGIRGLEELLSSCTDLEELYLNNCGLGPEAGGRLGRALFELAVNKKAASKPKLRVFICGRNRLENGGATALAEAFQS 183 (382)
T ss_pred cCccchHHHHHHHHhccCHHHHhhhcCCCChhHHHHHHHHHHHHHHHhccCCCcceEEEEeeccccccccHHHHHHHHHh
Confidence 986665554 45689999999999987322222 23457899999999998742 2345677
Q ss_pred CCCCCEEEccCCCCCCCch----hhhcCCCCCCEEEccCCccCcc----ccccccCCCCccEEeCCCCCCCCCCchhcc-
Q 001658 266 LTSVTELRISDLSNGSSKL----AFIRDMKSLSILELRNNNISDS----IPSNIGEYRSLQHLDLSFNNLGGSIPDSLF- 336 (1036)
Q Consensus 266 l~~L~~L~L~~n~l~~~~~----~~l~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~- 336 (1036)
.+.|+.+.+..|.+..-.. ..|..+++|+.|||.+|.++.. +...+..+++|+.|++++|.+...-..+|.
T Consensus 184 ~~~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~LakaL~s~~~L~El~l~dcll~~~Ga~a~~~ 263 (382)
T KOG1909|consen 184 HPTLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVALAKALSSWPHLRELNLGDCLLENEGAIAFVD 263 (382)
T ss_pred ccccceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHHHHHHhcccchheeecccccccccccHHHHHH
Confidence 7889999999888876554 4466788999999999988733 344567788899999999998865444333
Q ss_pred ----CCCCccEEEccCcccccc------CCCCcCCCccEEEeeCccCC
Q 001658 337 ----NLSSLTHLFLGNNKLNGT------LPARKSPLLLNIDVSYNNLQ 374 (1036)
Q Consensus 337 ----~l~~L~~L~Ls~N~l~g~------~p~~~~~~L~~Ldls~N~l~ 374 (1036)
..++|+.|.|.+|.++-. .+....+.|..|+|++|.+.
T Consensus 264 al~~~~p~L~vl~l~gNeIt~da~~~la~~~~ek~dL~kLnLngN~l~ 311 (382)
T KOG1909|consen 264 ALKESAPSLEVLELAGNEITRDAALALAACMAEKPDLEKLNLNGNRLG 311 (382)
T ss_pred HHhccCCCCceeccCcchhHHHHHHHHHHHHhcchhhHHhcCCccccc
Confidence 467889999999988621 11122455888888888884
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.08 E-value=1.1e-11 Score=144.93 Aligned_cols=246 Identities=26% Similarity=0.303 Sum_probs=141.8
Q ss_pred CCCCCCEEEccCCCCCCCCcccccCCCcCCeeecccccccCCccccccCCCCCcEEEcccCCCCCCCccccCCCccCCEE
Q 001658 121 NLTSLFNLNLGQNYLTGPLSPSVGNLTAMQYLNLAINALSGELPKELGQLTELLILGIGTNNFSGPLPSELGSLSKLQEL 200 (1036)
Q Consensus 121 ~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~L~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L 200 (1036)
.+..++.+++..|.|. .+-..+..+++|+.|+|.+|+|. .+...+..+++|++|+|++|+|+...+ +..++.|+.|
T Consensus 70 ~l~~l~~l~l~~n~i~-~~~~~l~~~~~l~~l~l~~n~i~-~i~~~l~~~~~L~~L~ls~N~I~~i~~--l~~l~~L~~L 145 (414)
T KOG0531|consen 70 SLTSLKELNLRQNLIA-KILNHLSKLKSLEALDLYDNKIE-KIENLLSSLVNLQVLDLSFNKITKLEG--LSTLTLLKEL 145 (414)
T ss_pred HhHhHHhhccchhhhh-hhhcccccccceeeeeccccchh-hcccchhhhhcchheeccccccccccc--hhhccchhhh
Confidence 4556666667777776 33344666777777777777777 333336667777777777777764333 5556667777
Q ss_pred eCccccCCCCCCccccCCCCCcEEeccCCcCCCCCh-hhhcCCCCCCEEEeeCCcCCCCCCccccCCCCCCEEEccCCCC
Q 001658 201 YIDSAGVSGEIPSSFANLQSLTKWWASDTRLTGRIP-DFIGNWSKLTALRFQGNSFNGPIPSSFSNLTSVTELRISDLSN 279 (1036)
Q Consensus 201 ~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l 279 (1036)
++++|.|+.. ..+..++.|+.+++++|++....+ . +..+.+|+.+++.+|.+.. ...+..+..+..+++.+|.+
T Consensus 146 ~l~~N~i~~~--~~~~~l~~L~~l~l~~n~i~~ie~~~-~~~~~~l~~l~l~~n~i~~--i~~~~~~~~l~~~~l~~n~i 220 (414)
T KOG0531|consen 146 NLSGNLISDI--SGLESLKSLKLLDLSYNRIVDIENDE-LSELISLEELDLGGNSIRE--IEGLDLLKKLVLLSLLDNKI 220 (414)
T ss_pred eeccCcchhc--cCCccchhhhcccCCcchhhhhhhhh-hhhccchHHHhccCCchhc--ccchHHHHHHHHhhcccccc
Confidence 7777777622 234446777777777777774433 2 4556677777777777662 22333444444445666665
Q ss_pred CCCchhhhcCCCCCCEEEccCCccCccccccccCCCCccEEeCCCCCCCCCCchhccCCCCccEEEccCccccccC---C
Q 001658 280 GSSKLAFIRDMKSLSILELRNNNISDSIPSNIGEYRSLQHLDLSFNNLGGSIPDSLFNLSSLTHLFLGNNKLNGTL---P 356 (1036)
Q Consensus 280 ~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~~---p 356 (1036)
..+.......+..|+.+++++|.+. .++..+..+.++..|++++|++... ..+.....+..+.+..|++.... .
T Consensus 221 ~~~~~l~~~~~~~L~~l~l~~n~i~-~~~~~~~~~~~l~~l~~~~n~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (414)
T KOG0531|consen 221 SKLEGLNELVMLHLRELYLSGNRIS-RSPEGLENLKNLPVLDLSSNRISNL--EGLERLPKLSELWLNDNKLALSEAISQ 297 (414)
T ss_pred eeccCcccchhHHHHHHhcccCccc-cccccccccccccccchhhcccccc--ccccccchHHHhccCcchhcchhhhhc
Confidence 5544321111112666677777665 3434555666667777777666631 22344455666666666655221 0
Q ss_pred ---CCcCCCccEEEeeCccCCCCCc
Q 001658 357 ---ARKSPLLLNIDVSYNNLQGNLP 378 (1036)
Q Consensus 357 ---~~~~~~L~~Ldls~N~l~g~~p 378 (1036)
....+.+..+.+.+|.+....+
T Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (414)
T KOG0531|consen 298 EYITSAAPTLVTLTLELNPIRKISS 322 (414)
T ss_pred cccccccccccccccccCccccccc
Confidence 1222345666666666654443
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.07 E-value=3e-11 Score=125.27 Aligned_cols=128 Identities=25% Similarity=0.245 Sum_probs=53.1
Q ss_pred CCCcEEeccCCcCCCCChhhhcCCCCCCEEEeeCCcCCCCCCccccCCCCCCEEEccCCCCCCCchhhhcCCCCCCEEEc
Q 001658 219 QSLTKWWASDTRLTGRIPDFIGNWSKLTALRFQGNSFNGPIPSSFSNLTSVTELRISDLSNGSSKLAFIRDMKSLSILEL 298 (1036)
Q Consensus 219 ~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L 298 (1036)
+.|++|||++|.|+ .+.+...-++.++.|++++|.|... . .+..|++|+.|+|++|.+..+.. +-..+.+++.|.|
T Consensus 284 q~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~~v-~-nLa~L~~L~~LDLS~N~Ls~~~G-wh~KLGNIKtL~L 359 (490)
T KOG1259|consen 284 QELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIRTV-Q-NLAELPQLQLLDLSGNLLAECVG-WHLKLGNIKTLKL 359 (490)
T ss_pred hhhhhccccccchh-hhhhhhhhccceeEEeccccceeee-h-hhhhcccceEeecccchhHhhhh-hHhhhcCEeeeeh
Confidence 44555555555555 3444444455555555555555421 1 13334444444444433333221 1112334444444
Q ss_pred cCCccCccccccccCCCCccEEeCCCCCCCCC-CchhccCCCCccEEEccCcccc
Q 001658 299 RNNNISDSIPSNIGEYRSLQHLDLSFNNLGGS-IPDSLFNLSSLTHLFLGNNKLN 352 (1036)
Q Consensus 299 s~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~-~p~~l~~l~~L~~L~Ls~N~l~ 352 (1036)
+.|.|.. + ..++++-+|..||+++|+|... --..++++|-|+.|.|.+|++.
T Consensus 360 a~N~iE~-L-SGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~ 412 (490)
T KOG1259|consen 360 AQNKIET-L-SGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLA 412 (490)
T ss_pred hhhhHhh-h-hhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCcc
Confidence 4444431 1 1233444444444444444421 1123444444444444444444
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.07 E-value=2.5e-11 Score=125.91 Aligned_cols=138 Identities=22% Similarity=0.270 Sum_probs=104.7
Q ss_pred CCChhhhcCCCCCCEEEeeCCcCCCCCCccccCCCCCCEEEccCCCCCCCchhhhcCCCCCCEEEccCCccCcccccccc
Q 001658 233 GRIPDFIGNWSKLTALRFQGNSFNGPIPSSFSNLTSVTELRISDLSNGSSKLAFIRDMKSLSILELRNNNISDSIPSNIG 312 (1036)
Q Consensus 233 ~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~ 312 (1036)
|..-..+..++.|++|||++|.|+ .+.++..-++.++.|+++.|.+..+.. +..+++|..||||+|.++ .+..+-.
T Consensus 274 G~~~~~~dTWq~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~~v~n--La~L~~L~~LDLS~N~Ls-~~~Gwh~ 349 (490)
T KOG1259|consen 274 GSALVSADTWQELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIRTVQN--LAELPQLQLLDLSGNLLA-ECVGWHL 349 (490)
T ss_pred CceEEecchHhhhhhccccccchh-hhhhhhhhccceeEEeccccceeeehh--hhhcccceEeecccchhH-hhhhhHh
Confidence 333344556678999999999998 667777788889999999998888766 677888999999999887 5556666
Q ss_pred CCCCccEEeCCCCCCCCCCchhccCCCCccEEEccCccccccCC---CCcCCCccEEEeeCccCCCC
Q 001658 313 EYRSLQHLDLSFNNLGGSIPDSLFNLSSLTHLFLGNNKLNGTLP---ARKSPLLLNIDVSYNNLQGN 376 (1036)
Q Consensus 313 ~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~~p---~~~~~~L~~Ldls~N~l~g~ 376 (1036)
++-+++.|.|+.|.|.. -..+..+-+|..||+++|+|...-. ....|.|+.|.|.+|+|.+.
T Consensus 350 KLGNIKtL~La~N~iE~--LSGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~~ 414 (490)
T KOG1259|consen 350 KLGNIKTLKLAQNKIET--LSGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAGS 414 (490)
T ss_pred hhcCEeeeehhhhhHhh--hhhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCcccc
Confidence 77888888999888872 3457778888888888888873221 13346688888888888754
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.06 E-value=1.3e-11 Score=144.30 Aligned_cols=238 Identities=24% Similarity=0.234 Sum_probs=178.0
Q ss_pred CCCEEEccCCCCCCCCcccccCCCcCCeeecccccccCCccccccCCCCCcEEEcccCCCCCCCccccCCCccCCEEeCc
Q 001658 124 SLFNLNLGQNYLTGPLSPSVGNLTAMQYLNLAINALSGELPKELGQLTELLILGIGTNNFSGPLPSELGSLSKLQELYID 203 (1036)
Q Consensus 124 ~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~L~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~ 203 (1036)
.++.++...+.+.+.--. ...+..++.+++..|.|. .+-..+..+++|..|+|.+|+|. .+...+..+++|++|+|+
T Consensus 50 ~~~~~~~~~~~~~~~~~~-~~~l~~l~~l~l~~n~i~-~~~~~l~~~~~l~~l~l~~n~i~-~i~~~l~~~~~L~~L~ls 126 (414)
T KOG0531|consen 50 DLEEIDLIFNLDGSDEDL-VESLTSLKELNLRQNLIA-KILNHLSKLKSLEALDLYDNKIE-KIENLLSSLVNLQVLDLS 126 (414)
T ss_pred hhhhhcchhccccchhhh-HHHhHhHHhhccchhhhh-hhhcccccccceeeeeccccchh-hcccchhhhhcchheecc
Confidence 444555555544422111 156778888889999998 45556888999999999999998 444447889999999999
Q ss_pred cccCCCCCCccccCCCCCcEEeccCCcCCCCChhhhcCCCCCCEEEeeCCcCCCCCC-ccccCCCCCCEEEccCCCCCCC
Q 001658 204 SAGVSGEIPSSFANLQSLTKWWASDTRLTGRIPDFIGNWSKLTALRFQGNSFNGPIP-SSFSNLTSVTELRISDLSNGSS 282 (1036)
Q Consensus 204 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~L~~n~l~~~ 282 (1036)
+|+|+... .+..++.|+.|++++|.|+. ...+..++.|+.+++++|++....+ . ...+.+|+.+.+.+|.+..+
T Consensus 127 ~N~I~~i~--~l~~l~~L~~L~l~~N~i~~--~~~~~~l~~L~~l~l~~n~i~~ie~~~-~~~~~~l~~l~l~~n~i~~i 201 (414)
T KOG0531|consen 127 FNKITKLE--GLSTLTLLKELNLSGNLISD--ISGLESLKSLKLLDLSYNRIVDIENDE-LSELISLEELDLGGNSIREI 201 (414)
T ss_pred cccccccc--chhhccchhhheeccCcchh--ccCCccchhhhcccCCcchhhhhhhhh-hhhccchHHHhccCCchhcc
Confidence 99998543 35667779999999999983 2446668999999999999985544 2 57888999999999998776
Q ss_pred chhhhcCCCCCCEEEccCCccCccccccccCCCC--ccEEeCCCCCCCCCCchhccCCCCccEEEccCccccccCCCCcC
Q 001658 283 KLAFIRDMKSLSILELRNNNISDSIPSNIGEYRS--LQHLDLSFNNLGGSIPDSLFNLSSLTHLFLGNNKLNGTLPARKS 360 (1036)
Q Consensus 283 ~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~--L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~ 360 (1036)
... ..+..+..+++..|.++..- .+..+.. |+.+++++|.+. .++..+..+..+..|++.+|++...-.....
T Consensus 202 ~~~--~~~~~l~~~~l~~n~i~~~~--~l~~~~~~~L~~l~l~~n~i~-~~~~~~~~~~~l~~l~~~~n~~~~~~~~~~~ 276 (414)
T KOG0531|consen 202 EGL--DLLKKLVLLSLLDNKISKLE--GLNELVMLHLRELYLSGNRIS-RSPEGLENLKNLPVLDLSSNRISNLEGLERL 276 (414)
T ss_pred cch--HHHHHHHHhhcccccceecc--CcccchhHHHHHHhcccCccc-cccccccccccccccchhhcccccccccccc
Confidence 542 22345556688899887332 2233333 899999999999 5557788889999999999999876555566
Q ss_pred CCccEEEeeCccCC
Q 001658 361 PLLLNIDVSYNNLQ 374 (1036)
Q Consensus 361 ~~L~~Ldls~N~l~ 374 (1036)
+.+..+.+..|.+.
T Consensus 277 ~~~~~~~~~~~~~~ 290 (414)
T KOG0531|consen 277 PKLSELWLNDNKLA 290 (414)
T ss_pred chHHHhccCcchhc
Confidence 66777888888776
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.04 E-value=3.4e-09 Score=108.98 Aligned_cols=138 Identities=15% Similarity=0.138 Sum_probs=99.8
Q ss_pred CCccccCCCEEEEEeEeCC-------CcEEEEEEccccc-----h-----------------hcHHHH----HHHHHHHH
Q 001658 698 SNKLGEGGFGPVYKGKLGD-------GRAIAVKQLSVAS-----R-----------------QGKSQF----VAEIATIS 744 (1036)
Q Consensus 698 ~~~iG~G~fG~Vy~~~~~~-------g~~vAvK~~~~~~-----~-----------------~~~~~f----~~Ei~~L~ 744 (1036)
...||.|--+.||.|.-.+ +..+|||+.+... . ...+.+ ++|++.|.
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 3579999999999997543 4799999875310 0 001223 37999999
Q ss_pred hhcc--CCcceeEeEEEcCceeEEEEEecCCCChhh-hhhcCCCCCcChHHHHHHHHHHHHHHHHH-HhcCCcccccccc
Q 001658 745 AVQH--RNLVKLHGCCIEGAERLLVYEYLENKSLDQ-ALFGQRSLTLDWATRYEICSGVARGLAYL-HEESRVRIIHRDV 820 (1036)
Q Consensus 745 ~l~H--~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~-~l~~~~~~~l~~~~~~~i~~~ia~gL~yL-H~~~~~~ivHrDi 820 (1036)
++.. -++.+++++ ...++||||+.+..+.. .+. ...++..+..++..+++.+|..| |+.+ ||||||
T Consensus 82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lk---d~~~~~~~~~~i~~~i~~~l~~l~H~~g---lVHGDL 151 (197)
T cd05146 82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLK---DAKLNDEEMKNAYYQVLSMMKQLYKECN---LVHADL 151 (197)
T ss_pred HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhh---ccccCHHHHHHHHHHHHHHHHHHHHhCC---eecCCC
Confidence 9964 456677765 45789999997654422 221 22344455667789999999999 7777 999999
Q ss_pred CCCcEEecCCCceEEEEcCcceeecC
Q 001658 821 KASNVLLDADLVPKISDFGLAKLYDD 846 (1036)
Q Consensus 821 kp~NILl~~~~~~kl~DFGla~~~~~ 846 (1036)
++.|||++ ++.++|+|||.+.....
T Consensus 152 s~~NIL~~-~~~v~iIDF~qav~~~h 176 (197)
T cd05146 152 SEYNMLWH-DGKVWFIDVSQSVEPTH 176 (197)
T ss_pred CHHHEEEE-CCcEEEEECCCceeCCC
Confidence 99999997 46799999998876543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.02 E-value=2e-09 Score=114.60 Aligned_cols=142 Identities=23% Similarity=0.327 Sum_probs=111.3
Q ss_pred CccccCCCEEEEEeEeCCCcEEEEEEccccch-hcHHHHHHHHHHHHhhccC--CcceeEeEEEcCc---eeEEEEEecC
Q 001658 699 NKLGEGGFGPVYKGKLGDGRAIAVKQLSVASR-QGKSQFVAEIATISAVQHR--NLVKLHGCCIEGA---ERLLVYEYLE 772 (1036)
Q Consensus 699 ~~iG~G~fG~Vy~~~~~~g~~vAvK~~~~~~~-~~~~~f~~Ei~~L~~l~H~--nIv~l~g~~~~~~---~~~lV~E~~~ 772 (1036)
+.|+.|..+.||+++..+|+.+++|....... .....+..|+++++.+++. .+.+++.+..... ..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 56899999999999987778999999764322 1355788999999999764 4577888776542 5689999999
Q ss_pred CCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcC-----------------------------------------
Q 001658 773 NKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEES----------------------------------------- 811 (1036)
Q Consensus 773 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~----------------------------------------- 811 (1036)
+.++.+.+.. ..++...+..++.+++++|.+||+..
T Consensus 84 G~~l~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (223)
T cd05154 84 GRVLRDRLLR---PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERL 160 (223)
T ss_pred CEecCCCCCC---CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHH
Confidence 9988876531 34677778888999999999998521
Q ss_pred ------------CccccccccCCCcEEecC--CCceEEEEcCccee
Q 001658 812 ------------RVRIIHRDVKASNVLLDA--DLVPKISDFGLAKL 843 (1036)
Q Consensus 812 ------------~~~ivHrDikp~NILl~~--~~~~kl~DFGla~~ 843 (1036)
+..++|+|+++.||+++. ++.+.|+||+.+..
T Consensus 161 ~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 161 LRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 245789999999999998 66789999998763
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.00 E-value=5.1e-09 Score=103.63 Aligned_cols=131 Identities=22% Similarity=0.315 Sum_probs=102.3
Q ss_pred CccccCCCEEEEEeEeCCCcEEEEEEc-cccc-------hhcHHHHHHHHHHHHhhccCCcceeEeEEEcCceeEEEEEe
Q 001658 699 NKLGEGGFGPVYKGKLGDGRAIAVKQL-SVAS-------RQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLVYEY 770 (1036)
Q Consensus 699 ~~iG~G~fG~Vy~~~~~~g~~vAvK~~-~~~~-------~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~ 770 (1036)
..+++|+-+.+|.+.+. |..+++|.- .+.- +-...+-.+|++++.+++--.|.-.+=+..+.+...|+|||
T Consensus 2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 46899999999999874 444666643 2211 11234567899999999877777666677788888999999
Q ss_pred cCCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCccee
Q 001658 771 LENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKL 843 (1036)
Q Consensus 771 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~ 843 (1036)
++|..|.+++... +..++..+-+-+.-||..+ |||+||.++||++..+. +.++|||++.+
T Consensus 81 I~G~~lkd~l~~~---------~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 81 IEGELLKDALEEA---------RPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred eCChhHHHHHHhc---------chHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCcccc
Confidence 9999999888543 3456778888889999998 99999999999997765 99999999874
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.00 E-value=5.1e-09 Score=102.79 Aligned_cols=143 Identities=19% Similarity=0.291 Sum_probs=109.1
Q ss_pred CCCccccCCCEEEEEeEeCCCcEEEEEEc-ccc-------chhcHHHHHHHHHHHHhhccCCcceeEeEEEcCceeEEEE
Q 001658 697 PSNKLGEGGFGPVYKGKLGDGRAIAVKQL-SVA-------SRQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLVY 768 (1036)
Q Consensus 697 ~~~~iG~G~fG~Vy~~~~~~g~~vAvK~~-~~~-------~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~ 768 (1036)
....+-+|+-+.|+++.+ .|+...||.- .+. ..-...+..+|++.|.+++--.|.-..=++.+...-.|+|
T Consensus 11 ~l~likQGAEArv~~~~~-~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF-SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeecc-CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 457899999999999998 5677667643 221 1223456788999999998777766666677777778999
Q ss_pred EecCC-CChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCC---ceEEEEcCccee
Q 001658 769 EYLEN-KSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADL---VPKISDFGLAKL 843 (1036)
Q Consensus 769 E~~~~-gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~---~~kl~DFGla~~ 843 (1036)
||+++ .++.+++...-....+.......+..|-+.+.-||.++ |+|+||..+||++..++ .+.++|||++..
T Consensus 90 E~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceEEEeecchhc
Confidence 99976 47888876544434343444678889999999999998 99999999999997654 458999999864
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.99 E-value=2.3e-09 Score=124.13 Aligned_cols=166 Identities=15% Similarity=0.158 Sum_probs=124.4
Q ss_pred eCCCcEEEEEEccccchhcHHHHHHHHHHHHhhccCCcceeEeEEEcCceeEEEEEecCCCChhhhhhcCCCCCcChHHH
Q 001658 714 LGDGRAIAVKQLSVASRQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLVYEYLENKSLDQALFGQRSLTLDWATR 793 (1036)
Q Consensus 714 ~~~g~~vAvK~~~~~~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~ 793 (1036)
..++.+|.|+..+...........+-++.|+.+|||||++++..+..++..|||+|.+. -|..++.... ....
T Consensus 34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l~-----~~~v 106 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKELG-----KEEV 106 (690)
T ss_pred eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHhH-----HHHH
Confidence 44788888888876555334556677889999999999999999999999999999884 5666664433 2333
Q ss_pred HHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeecCCCCccccccccccCccCccccccCCCC
Q 001658 794 YEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVAGTIGYLAPEYAMRGHLT 873 (1036)
Q Consensus 794 ~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~ 873 (1036)
.-.+.||+.||.|||+.+ .++|++|.-.-|++++.|..||++|.++........ ......--..|..|+.+....
T Consensus 107 ~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-~~~~~~~~~s~~~P~~~~~s~-- 181 (690)
T KOG1243|consen 107 CLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-PAKSLYLIESFDDPEEIDPSE-- 181 (690)
T ss_pred HHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-ccccchhhhcccChhhcCccc--
Confidence 446789999999999876 699999999999999999999999988765432211 001111112466777654433
Q ss_pred chhhHHhHHHHHHHHHhC
Q 001658 874 EKTDVFAFGVLALETVSG 891 (1036)
Q Consensus 874 ~ksDVwS~Gvvl~elltG 891 (1036)
-..|.|-||++++|++.|
T Consensus 182 ~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 182 WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred cchhhhhHHHHHHHHhCc
Confidence 246999999999999999
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=98.94 E-value=5e-10 Score=112.80 Aligned_cols=122 Identities=25% Similarity=0.372 Sum_probs=32.7
Q ss_pred cCCeeecccccccCCcccccc-CCCCCcEEEcccCCCCCCCccccCCCccCCEEeCccccCCCCCCccc-cCCCCCcEEe
Q 001658 148 AMQYLNLAINALSGELPKELG-QLTELLILGIGTNNFSGPLPSELGSLSKLQELYIDSAGVSGEIPSSF-ANLQSLTKWW 225 (1036)
Q Consensus 148 ~L~~L~Ls~N~l~~~~p~~l~-~L~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~-~~l~~L~~L~ 225 (1036)
++++|+|.+|.|+ .+ +.++ .+.+|+.|+|++|.|+. +. .+..+++|++|++++|+|+. +...+ ..+++|++|+
T Consensus 20 ~~~~L~L~~n~I~-~I-e~L~~~l~~L~~L~Ls~N~I~~-l~-~l~~L~~L~~L~L~~N~I~~-i~~~l~~~lp~L~~L~ 94 (175)
T PF14580_consen 20 KLRELNLRGNQIS-TI-ENLGATLDKLEVLDLSNNQITK-LE-GLPGLPRLKTLDLSNNRISS-ISEGLDKNLPNLQELY 94 (175)
T ss_dssp ------------------S--TT-TT--EEE-TTS--S---T-T----TT--EEE--SS---S--CHHHHHH-TT--EEE
T ss_pred ccccccccccccc-cc-cchhhhhcCCCEEECCCCCCcc-cc-CccChhhhhhcccCCCCCCc-cccchHHhCCcCCEEE
Confidence 4445555555544 22 1233 34445555555555542 21 24444555555555555552 22222 2345555555
Q ss_pred ccCCcCCCCCh-hhhcCCCCCCEEEeeCCcCCCCCC---ccccCCCCCCEEEc
Q 001658 226 ASDTRLTGRIP-DFIGNWSKLTALRFQGNSFNGPIP---SSFSNLTSVTELRI 274 (1036)
Q Consensus 226 L~~N~l~~~~p-~~l~~l~~L~~L~L~~N~l~~~~p---~~~~~l~~L~~L~L 274 (1036)
|++|+|..... ..+..+++|+.|+|.+|.+....- ..+..+++|+.||-
T Consensus 95 L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~~~~~YR~~vi~~lP~Lk~LD~ 147 (175)
T PF14580_consen 95 LSNNKISDLNELEPLSSLPKLRVLSLEGNPVCEKKNYRLFVIYKLPSLKVLDG 147 (175)
T ss_dssp -TTS---SCCCCGGGGG-TT--EEE-TT-GGGGSTTHHHHHHHH-TT-SEETT
T ss_pred CcCCcCCChHHhHHHHcCCCcceeeccCCcccchhhHHHHHHHHcChhheeCC
Confidence 55555543211 344556666666666666653211 13455666666654
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=98.93 E-value=6.7e-10 Score=111.88 Aligned_cols=15 Identities=27% Similarity=0.541 Sum_probs=4.4
Q ss_pred CCCCCEEEccCCccC
Q 001658 290 MKSLSILELRNNNIS 304 (1036)
Q Consensus 290 l~~L~~L~Ls~N~l~ 304 (1036)
+++|+.|+|.+|.+.
T Consensus 112 l~~L~~L~L~~NPv~ 126 (175)
T PF14580_consen 112 LPKLRVLSLEGNPVC 126 (175)
T ss_dssp -TT--EEE-TT-GGG
T ss_pred CCCcceeeccCCccc
Confidence 344444444444443
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.91 E-value=8.1e-10 Score=126.98 Aligned_cols=248 Identities=19% Similarity=0.179 Sum_probs=171.7
Q ss_pred HHHhcCCCCCCccccCCCEEEEEeEe--CCCcEEEEEEccccchhcH--HHHHHHHHHHHhh-ccCCcceeEeEEEcCce
Q 001658 689 KTATENFSPSNKLGEGGFGPVYKGKL--GDGRAIAVKQLSVASRQGK--SQFVAEIATISAV-QHRNLVKLHGCCIEGAE 763 (1036)
Q Consensus 689 ~~~~~~~~~~~~iG~G~fG~Vy~~~~--~~g~~vAvK~~~~~~~~~~--~~f~~Ei~~L~~l-~H~nIv~l~g~~~~~~~ 763 (1036)
...+.+|..+..||.|.|+.|++... .++..+++|.+........ ..-..|+.+...+ -|.+++..+..+.....
T Consensus 261 s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~ 340 (524)
T KOG0601|consen 261 SCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQ 340 (524)
T ss_pred eeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccc
Confidence 34456788899999999999999864 3678899998765432222 2224566666666 48888888777777777
Q ss_pred eEEEEEecCCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCC-CceEEEEcCcce
Q 001658 764 RLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDAD-LVPKISDFGLAK 842 (1036)
Q Consensus 764 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~-~~~kl~DFGla~ 842 (1036)
.++--||++++++...+ .-...++...++++..|++.++.++|+.. ++|+|+||+||++..+ +.-++.|||++.
T Consensus 341 ~~ip~e~~~~~s~~l~~--~~~~~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~~~~~~~~~~~~t 415 (524)
T KOG0601|consen 341 GYIPLEFCEGGSSSLRS--VTSQMLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDGFFSKLGDFGCWT 415 (524)
T ss_pred ccCchhhhcCcchhhhh--HHHHhcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccchhhhhcccccccc
Confidence 78999999999987665 23455777788899999999999999887 9999999999999886 888999999987
Q ss_pred eecCCCCccccccccccCcc--CccccccCCCCchhhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhcCccc
Q 001658 843 LYDDKKTHISTRVAGTIGYL--APEYAMRGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEI 920 (1036)
Q Consensus 843 ~~~~~~~~~~~~~~gt~~y~--APE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 920 (1036)
.+.-... ...+.-+++ +|+......+..+.|+||||.-+.|..+|......... |. .+.
T Consensus 416 ~~~~~~~----~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~--------~~-------~i~ 476 (524)
T KOG0601|consen 416 RLAFSSG----VFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQ--------SL-------TIR 476 (524)
T ss_pred ccceecc----cccccccccccchhhccccccccccccccccccccccccCcccCccccc--------ce-------eee
Confidence 5321111 112333445 45555566788899999999999999998754332111 00 000
Q ss_pred cccCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 001658 921 ELADPKLIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVAMLC 964 (1036)
Q Consensus 921 ~~~d~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~ 964 (1036)
.-.-+.. ......+..+...+...++..||.+.++..+.+
T Consensus 477 ~~~~p~~----~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~ 516 (524)
T KOG0601|consen 477 SGDTPNL----PGLKLQLQVLLKVMINPDRKRRPSAVELSLHSE 516 (524)
T ss_pred cccccCC----CchHHhhhhhhhhhcCCccccchhhhhhcccch
Confidence 0001111 111134444445566889999999888765443
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.84 E-value=9.5e-08 Score=107.33 Aligned_cols=168 Identities=19% Similarity=0.291 Sum_probs=129.3
Q ss_pred CEEEEEeE-eCCCcEEEEEEccccchhcHHHHHHHHHHHHhhccCCcceeEeEEE----cCceeEEEEEecCC-CChhhh
Q 001658 706 FGPVYKGK-LGDGRAIAVKQLSVASRQGKSQFVAEIATISAVQHRNLVKLHGCCI----EGAERLLVYEYLEN-KSLDQA 779 (1036)
Q Consensus 706 fG~Vy~~~-~~~g~~vAvK~~~~~~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~----~~~~~~lV~E~~~~-gsL~~~ 779 (1036)
-.+.||+. ..||..|++|+++....+....-..-+++.+++.|.|||++.+++. .+...++||+|.++ ++|.++
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~ 368 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL 368 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence 36789997 4589999999995433332223345578899999999999999887 34567899999986 678776
Q ss_pred hhcCC-------------CCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeecC
Q 001658 780 LFGQR-------------SLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDD 846 (1036)
Q Consensus 780 l~~~~-------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~ 846 (1036)
-+... +...++...|.++.|+..||.++|+.| +.-+-+.+++|+++.+.+++|+..|....+..
T Consensus 369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~ 445 (655)
T KOG3741|consen 369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVLQE 445 (655)
T ss_pred HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceeeecC
Confidence 54321 334678899999999999999999998 88899999999999999999999988877655
Q ss_pred CCCccccccccccCccCccccccCCCCchhhHHhHHHHHHHHHhCCCC
Q 001658 847 KKTHISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRPN 894 (1036)
Q Consensus 847 ~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~elltG~~p 894 (1036)
+... -+. -..+-|.=.||.+++.|.||...
T Consensus 446 d~~~---------------~le---~~Qq~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 446 DPTE---------------PLE---SQQQNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred CCCc---------------chh---HHhhhhHHHHHHHHHHHhhcccc
Confidence 4311 111 12357888999999999999654
|
|
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.81 E-value=2.1e-09 Score=134.04 Aligned_cols=105 Identities=30% Similarity=0.379 Sum_probs=58.5
Q ss_pred CCCEEEccCCC--CCCCCcccccCCCcCCeeecccccccCCccccccCCCCCcEEEcccCCCCCCCccccCCCccCCEEe
Q 001658 124 SLFNLNLGQNY--LTGPLSPSVGNLTAMQYLNLAINALSGELPKELGQLTELLILGIGTNNFSGPLPSELGSLSKLQELY 201 (1036)
Q Consensus 124 ~L~~L~Ls~n~--l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~L~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~ 201 (1036)
.|+.|-+..|. +.......|..++.|+.|||++|.=-+.+|..+++|-+|++|+|++..++ .+|..+.+|++|.+|+
T Consensus 546 ~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~LryL~L~~t~I~-~LP~~l~~Lk~L~~Ln 624 (889)
T KOG4658|consen 546 KLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHLRYLDLSDTGIS-HLPSGLGNLKKLIYLN 624 (889)
T ss_pred ccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhhhcccccCCCcc-ccchHHHHHHhhheec
Confidence 45555555554 33233334555666666666655444456666666666666666666655 5566666666666666
Q ss_pred CccccCCCCCCccccCCCCCcEEeccCC
Q 001658 202 IDSAGVSGEIPSSFANLQSLTKWWASDT 229 (1036)
Q Consensus 202 L~~N~l~~~~p~~~~~l~~L~~L~L~~N 229 (1036)
+..+.-...+|..+..|++|++|.+...
T Consensus 625 l~~~~~l~~~~~i~~~L~~Lr~L~l~~s 652 (889)
T KOG4658|consen 625 LEVTGRLESIPGILLELQSLRVLRLPRS 652 (889)
T ss_pred cccccccccccchhhhcccccEEEeecc
Confidence 6555544444555555566666655443
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.77 E-value=1.1e-07 Score=103.41 Aligned_cols=141 Identities=17% Similarity=0.072 Sum_probs=102.0
Q ss_pred CccccCCCEEEEEeEeCCCcEEEEEEccccch-----------hcHHHHHHHHHHHHhhccCCcc--eeEeEEEc-----
Q 001658 699 NKLGEGGFGPVYKGKLGDGRAIAVKQLSVASR-----------QGKSQFVAEIATISAVQHRNLV--KLHGCCIE----- 760 (1036)
Q Consensus 699 ~~iG~G~fG~Vy~~~~~~g~~vAvK~~~~~~~-----------~~~~~f~~Ei~~L~~l~H~nIv--~l~g~~~~----- 760 (1036)
+.+-+-....|++..+ +|+.|.||....... .....+.+|...+.++...+|. +++++...
T Consensus 28 e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~ 106 (268)
T PRK15123 28 EVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA 106 (268)
T ss_pred cEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence 3344444445777776 678899997643221 1112478999999998655443 55666543
Q ss_pred CceeEEEEEecCCC-ChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecC-------CCc
Q 001658 761 GAERLLVYEYLENK-SLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDA-------DLV 832 (1036)
Q Consensus 761 ~~~~~lV~E~~~~g-sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~-------~~~ 832 (1036)
...-++|+|++++- +|.+++........+...+..++.++++.+.-||..| |+|+|++++|||++. +..
T Consensus 107 ~~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~~~~~~~ 183 (268)
T PRK15123 107 TRTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPGREEDLK 183 (268)
T ss_pred cceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccCCCCCce
Confidence 23468999999875 8999874322334455677789999999999999998 999999999999975 468
Q ss_pred eEEEEcCccee
Q 001658 833 PKISDFGLAKL 843 (1036)
Q Consensus 833 ~kl~DFGla~~ 843 (1036)
+.++||+.+..
T Consensus 184 ~~LIDl~r~~~ 194 (268)
T PRK15123 184 LSVIDLHRAQI 194 (268)
T ss_pred EEEEECCcccc
Confidence 99999998864
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.74 E-value=4.8e-09 Score=126.20 Aligned_cols=250 Identities=19% Similarity=0.185 Sum_probs=162.0
Q ss_pred HHhcCCCCCCccccCCCEEEEEeEe-CCCcEEEEEEccccch---hcHHHHHHHHHHHHhhccCCcceeEeEEEcCceeE
Q 001658 690 TATENFSPSNKLGEGGFGPVYKGKL-GDGRAIAVKQLSVASR---QGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERL 765 (1036)
Q Consensus 690 ~~~~~~~~~~~iG~G~fG~Vy~~~~-~~g~~vAvK~~~~~~~---~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~ 765 (1036)
...+.+.+.+-+-+|.++.++-++- ..|...+.|....... ...+....+-.++-..+||-++...--+.......
T Consensus 801 sS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~ 880 (1205)
T KOG0606|consen 801 SSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLP 880 (1205)
T ss_pred CCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcc
Confidence 3456777778889999999998763 2343344444322211 11112222222222234566665554455567789
Q ss_pred EEEEecCCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcceeec
Q 001658 766 LVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYD 845 (1036)
Q Consensus 766 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~ 845 (1036)
||++|..+++|...|+... ..+..-.......+..+++|||... ++|||++|.|.+...++..+++|||......
T Consensus 881 L~~~~~~~~~~~Skl~~~~--~~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg 955 (1205)
T KOG0606|consen 881 LVGHYLNGGDLPSKLHNSG--CLSAEPARSPILERVQSLESLHSSL---RKHRDLKPDSLLIAYDGHRPLTDFGTLSKVG 955 (1205)
T ss_pred hhhHHhccCCchhhhhcCC--CcccccccchhHHHHhhhhccccch---hhcccccccchhhcccCCcccCccccccccc
Confidence 9999999999999987644 3343334445566788999999875 8999999999999999999999998432211
Q ss_pred C------C---------------C---------CccccccccccCccCccccccCCCCchhhHHhHHHHHHHHHhCCCCC
Q 001658 846 D------K---------------K---------THISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRPNS 895 (1036)
Q Consensus 846 ~------~---------------~---------~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~ 895 (1036)
- . . ........||+.|.|||...+......+|.|++|++++|.++|.+||
T Consensus 956 ~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~ 1035 (1205)
T KOG0606|consen 956 LIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPF 1035 (1205)
T ss_pred cccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCC
Confidence 0 0 0 00122356999999999999999999999999999999999999999
Q ss_pred CCCChhhHHHHHHHHHHHhhcCccccccCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHH
Q 001658 896 DPSLDEEKLYLLEWAWHLHENNQEIELADPKLIEFNEEEVKRLIGVALLCTQTLPSLRPSMS 957 (1036)
Q Consensus 896 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ 957 (1036)
.......... . +-..+........+......+++..-+..+|.+|-.|.
T Consensus 1036 na~tpq~~f~------------n-i~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1036 NAETPQQIFE------------N-ILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred CCcchhhhhh------------c-cccCCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 8776644331 0 11111111112222222333444455578888887665
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.73 E-value=8.4e-08 Score=98.38 Aligned_cols=126 Identities=22% Similarity=0.260 Sum_probs=84.1
Q ss_pred EEEEeEeCCCcEEEEEEccccc--------------h------------hcHHHHHHHHHHHHhhccC--CcceeEeEEE
Q 001658 708 PVYKGKLGDGRAIAVKQLSVAS--------------R------------QGKSQFVAEIATISAVQHR--NLVKLHGCCI 759 (1036)
Q Consensus 708 ~Vy~~~~~~g~~vAvK~~~~~~--------------~------------~~~~~f~~Ei~~L~~l~H~--nIv~l~g~~~ 759 (1036)
.||.|...+|..||||+.+... + .......+|++.|.++... ++.+++++.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 4899999899999999875310 0 0123467899999999766 466776552
Q ss_pred cCceeEEEEEecC--CCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHH-HhcCCccccccccCCCcEEecCCCceEEE
Q 001658 760 EGAERLLVYEYLE--NKSLDQALFGQRSLTLDWATRYEICSGVARGLAYL-HEESRVRIIHRDVKASNVLLDADLVPKIS 836 (1036)
Q Consensus 760 ~~~~~~lV~E~~~--~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yL-H~~~~~~ivHrDikp~NILl~~~~~~kl~ 836 (1036)
...|||||++ +..+..+.. ..++......++.+++..+..+ |..+ |||+|+.+.||+++++ .+.|+
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~~----~~~~~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~NIlv~~~-~~~iI 148 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLKD----VDLSPEEPKELLEEILEEIIKMLHKAG---IVHGDLSEYNILVDDG-KVYII 148 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHHH----CGGGGSTHHHHHHHHHHHHHHHHHCTT---EEESS-STTSEEEETT-CEEE-
T ss_pred ---CCEEEEEecCCCccchhhHHh----ccccchhHHHHHHHHHHHHHHHHHhcC---ceecCCChhhEEeecc-eEEEE
Confidence 4579999998 555544332 1122344566778888866664 6766 9999999999999988 99999
Q ss_pred EcCcceeec
Q 001658 837 DFGLAKLYD 845 (1036)
Q Consensus 837 DFGla~~~~ 845 (1036)
|||.+....
T Consensus 149 Df~qav~~~ 157 (188)
T PF01163_consen 149 DFGQAVDSS 157 (188)
T ss_dssp -GTTEEETT
T ss_pred ecCcceecC
Confidence 999887544
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.70 E-value=1e-08 Score=128.06 Aligned_cols=262 Identities=20% Similarity=0.216 Sum_probs=174.1
Q ss_pred CCCCCCEEEccCCCCCCCCcccccCCCcCCeeeccccc--ccCCccccccCCCCCcEEEcccCCCCCCCccccCCCccCC
Q 001658 121 NLTSLFNLNLGQNYLTGPLSPSVGNLTAMQYLNLAINA--LSGELPKELGQLTELLILGIGTNNFSGPLPSELGSLSKLQ 198 (1036)
Q Consensus 121 ~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~--l~~~~p~~l~~L~~L~~L~Ls~N~l~~~~p~~l~~l~~L~ 198 (1036)
+....+.+.+-+|.+. .++.... .++|++|-+..|. +....+..|..++.|++|||++|.=.+.+|..++.|-+|+
T Consensus 521 ~~~~~rr~s~~~~~~~-~~~~~~~-~~~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~Lr 598 (889)
T KOG4658|consen 521 SWNSVRRMSLMNNKIE-HIAGSSE-NPKLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHLR 598 (889)
T ss_pred chhheeEEEEeccchh-hccCCCC-CCccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhhh
Confidence 3467788888888877 4444443 3479999999996 5634445578899999999999887779999999999999
Q ss_pred EEeCccccCCCCCCccccCCCCCcEEeccCCcCCCCChhhhcCCCCCCEEEeeCCcCC--CCCCccccCCCCCCEEEccC
Q 001658 199 ELYIDSAGVSGEIPSSFANLQSLTKWWASDTRLTGRIPDFIGNWSKLTALRFQGNSFN--GPIPSSFSNLTSVTELRISD 276 (1036)
Q Consensus 199 ~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~--~~~p~~~~~l~~L~~L~L~~ 276 (1036)
+|+|++..+. .+|..+.+|..|.+|++..+.-...+|..+..+.+|++|.+..-... ...-..+.++.+|+.|....
T Consensus 599 yL~L~~t~I~-~LP~~l~~Lk~L~~Lnl~~~~~l~~~~~i~~~L~~Lr~L~l~~s~~~~~~~~l~el~~Le~L~~ls~~~ 677 (889)
T KOG4658|consen 599 YLDLSDTGIS-HLPSGLGNLKKLIYLNLEVTGRLESIPGILLELQSLRVLRLPRSALSNDKLLLKELENLEHLENLSITI 677 (889)
T ss_pred cccccCCCcc-ccchHHHHHHhhheeccccccccccccchhhhcccccEEEeeccccccchhhHHhhhcccchhhheeec
Confidence 9999999999 89999999999999999998876677888888999999999876532 22333445556666555533
Q ss_pred CCCCCCchhhhcCCCCCC----EEEccCCccCccccccccCCCCccEEeCCCCCCCCCCchhccC------CCCccEEEc
Q 001658 277 LSNGSSKLAFIRDMKSLS----ILELRNNNISDSIPSNIGEYRSLQHLDLSFNNLGGSIPDSLFN------LSSLTHLFL 346 (1036)
Q Consensus 277 n~l~~~~~~~l~~l~~L~----~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~------l~~L~~L~L 346 (1036)
... .....+..+..|. .+.+..+... ..+..+..+.+|+.|.+.++.+.......... +++|..+..
T Consensus 678 ~s~--~~~e~l~~~~~L~~~~~~l~~~~~~~~-~~~~~~~~l~~L~~L~i~~~~~~e~~~~~~~~~~~~~~f~~l~~~~~ 754 (889)
T KOG4658|consen 678 SSV--LLLEDLLGMTRLRSLLQSLSIEGCSKR-TLISSLGSLGNLEELSILDCGISEIVIEWEESLIVLLCFPNLSKVSI 754 (889)
T ss_pred chh--HhHhhhhhhHHHHHHhHhhhhcccccc-eeecccccccCcceEEEEcCCCchhhcccccccchhhhHHHHHHHHh
Confidence 332 1111122233333 3333333333 45566788899999999999887433322221 222222222
Q ss_pred cCc-cccccCCCCcCCCccEEEeeCccCCCCCchhhhccCCcc
Q 001658 347 GNN-KLNGTLPARKSPLLLNIDVSYNNLQGNLPSWINGQQNLQ 388 (1036)
Q Consensus 347 s~N-~l~g~~p~~~~~~L~~Ldls~N~l~g~~p~~l~~l~~L~ 388 (1036)
.+. .+....+.-+.+.|+.|.+.+......+.+....+..+.
T Consensus 755 ~~~~~~r~l~~~~f~~~L~~l~l~~~~~~e~~i~~~k~~~~l~ 797 (889)
T KOG4658|consen 755 LNCHMLRDLTWLLFAPHLTSLSLVSCRLLEDIIPKLKALLELK 797 (889)
T ss_pred hccccccccchhhccCcccEEEEecccccccCCCHHHHhhhcc
Confidence 222 112222334667899999998776655555555555444
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.57 E-value=3e-08 Score=82.19 Aligned_cols=61 Identities=39% Similarity=0.541 Sum_probs=39.2
Q ss_pred CCCCEEEccCCccCccccccccCCCCccEEeCCCCCCCCCCchhccCCCCccEEEccCccc
Q 001658 291 KSLSILELRNNNISDSIPSNIGEYRSLQHLDLSFNNLGGSIPDSLFNLSSLTHLFLGNNKL 351 (1036)
Q Consensus 291 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l 351 (1036)
++|++|+|++|+|+...+..|..+++|++|+|++|+|+...|..|.++++|++|+|++|+|
T Consensus 1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 3566666666666644445566666677777777766655555666677777777766654
|
... |
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.55 E-value=3.7e-08 Score=81.63 Aligned_cols=60 Identities=32% Similarity=0.423 Sum_probs=35.2
Q ss_pred CCCEEEccCCCCCCCCcccccCCCcCCeeecccccccCCccccccCCCCCcEEEcccCCC
Q 001658 124 SLFNLNLGQNYLTGPLSPSVGNLTAMQYLNLAINALSGELPKELGQLTELLILGIGTNNF 183 (1036)
Q Consensus 124 ~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~L~~L~~L~Ls~N~l 183 (1036)
+|++|+|++|+|+...+..|..+++|++|+|++|+|+...|..|..+++|++|++++|+|
T Consensus 2 ~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 2 NLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred cCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 455666666666644445566666666666666666655555556666666666666543
|
... |
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.54 E-value=1.2e-09 Score=125.59 Aligned_cols=127 Identities=28% Similarity=0.311 Sum_probs=77.8
Q ss_pred CCcEEeccCCcCCCCChhhhcCCCCCCEEEeeCCcCCCCCCccccCCCCCCEEEccCCCCCCCchhhhcCCCCCCEEEcc
Q 001658 220 SLTKWWASDTRLTGRIPDFIGNWSKLTALRFQGNSFNGPIPSSFSNLTSVTELRISDLSNGSSKLAFIRDMKSLSILELR 299 (1036)
Q Consensus 220 ~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls 299 (1036)
.|...+.+.|++. ....++.-++.|+.|+|++|+++... .+..+++|++|||+.|.+..++--...++. |..|.|+
T Consensus 165 ~L~~a~fsyN~L~-~mD~SLqll~ale~LnLshNk~~~v~--~Lr~l~~LkhLDlsyN~L~~vp~l~~~gc~-L~~L~lr 240 (1096)
T KOG1859|consen 165 KLATASFSYNRLV-LMDESLQLLPALESLNLSHNKFTKVD--NLRRLPKLKHLDLSYNCLRHVPQLSMVGCK-LQLLNLR 240 (1096)
T ss_pred hHhhhhcchhhHH-hHHHHHHHHHHhhhhccchhhhhhhH--HHHhcccccccccccchhccccccchhhhh-heeeeec
Confidence 3444555555555 44455555555666666666655322 455555666666666655555443333333 7788888
Q ss_pred CCccCccccccccCCCCccEEeCCCCCCCCC-CchhccCCCCccEEEccCcccc
Q 001658 300 NNNISDSIPSNIGEYRSLQHLDLSFNNLGGS-IPDSLFNLSSLTHLFLGNNKLN 352 (1036)
Q Consensus 300 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~-~p~~l~~l~~L~~L~Ls~N~l~ 352 (1036)
+|.++.. ..+.+|.+|+.|||++|-|.+. --..++.|..|+.|+|.||++.
T Consensus 241 nN~l~tL--~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~ 292 (1096)
T KOG1859|consen 241 NNALTTL--RGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLC 292 (1096)
T ss_pred ccHHHhh--hhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccc
Confidence 8877632 3467788888888888888753 2334566778888888888886
|
|
| >KOG2982 consensus Uncharacterized conserved protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.46 E-value=2.6e-08 Score=103.95 Aligned_cols=217 Identities=22% Similarity=0.239 Sum_probs=117.3
Q ss_pred CccccCCCCCCEEEccCCCCCCCCc-cccc-CCCcCCeeecccccccC--CccccccCCCCCcEEEcccCCCCCCCcccc
Q 001658 116 PDELWNLTSLFNLNLGQNYLTGPLS-PSVG-NLTAMQYLNLAINALSG--ELPKELGQLTELLILGIGTNNFSGPLPSEL 191 (1036)
Q Consensus 116 p~~l~~l~~L~~L~Ls~n~l~~~~p-~~~~-~l~~L~~L~Ls~N~l~~--~~p~~l~~L~~L~~L~Ls~N~l~~~~p~~l 191 (1036)
+-.+..+.-++.|.+.++.|..+-. ..|+ ..+.++.|||.+|.|+. .+-.-+.+|+.|++|+|+.|.+...|-..-
T Consensus 38 ~~~v~s~ra~ellvln~~~id~~gd~~~~~~~~~~v~elDL~~N~iSdWseI~~ile~lP~l~~LNls~N~L~s~I~~lp 117 (418)
T KOG2982|consen 38 YLGVSSLRALELLVLNGSIIDNEGDVMLFGSSVTDVKELDLTGNLISDWSEIGAILEQLPALTTLNLSCNSLSSDIKSLP 117 (418)
T ss_pred eeeeccccchhhheecCCCCCcchhHHHHHHHhhhhhhhhcccchhccHHHHHHHHhcCccceEeeccCCcCCCccccCc
Confidence 3334444455566666666553211 2233 35678888888888873 333445678888888888888874443322
Q ss_pred CCCccCCEEeCccccCCCC-CCccccCCCCCcEEeccCCcCCCCChhhhcCCCCCCEEEeeCCcCCCCCCc--cccCCCC
Q 001658 192 GSLSKLQELYIDSAGVSGE-IPSSFANLQSLTKWWASDTRLTGRIPDFIGNWSKLTALRFQGNSFNGPIPS--SFSNLTS 268 (1036)
Q Consensus 192 ~~l~~L~~L~L~~N~l~~~-~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~--~~~~l~~ 268 (1036)
..+++|+.|.|.+..+.-. ....+..++.+++|.++.|++. .+++..|.++...+. .+..++.
T Consensus 118 ~p~~nl~~lVLNgT~L~w~~~~s~l~~lP~vtelHmS~N~~r--------------q~n~Dd~c~e~~s~~v~tlh~~~c 183 (418)
T KOG2982|consen 118 LPLKNLRVLVLNGTGLSWTQSTSSLDDLPKVTELHMSDNSLR--------------QLNLDDNCIEDWSTEVLTLHQLPC 183 (418)
T ss_pred ccccceEEEEEcCCCCChhhhhhhhhcchhhhhhhhccchhh--------------hhccccccccccchhhhhhhcCCc
Confidence 4566778887777776522 2233445566666666665433 122223322211110 0111111
Q ss_pred CCEEEccCCCCCCCchhhhcCCCCCCEEEccCCccCccc-cccccCCCCccEEeCCCCCCCCC-CchhccCCCCccEEEc
Q 001658 269 VTELRISDLSNGSSKLAFIRDMKSLSILELRNNNISDSI-PSNIGEYRSLQHLDLSFNNLGGS-IPDSLFNLSSLTHLFL 346 (1036)
Q Consensus 269 L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~Ls~N~l~~~-~p~~l~~l~~L~~L~L 346 (1036)
+..+.++-|++.. -+|++..+.+..|.|+..- ...+..++.+-.|+|+.|+|..- --+++..+++|..|.+
T Consensus 184 ~~~~w~~~~~l~r-------~Fpnv~sv~v~e~PlK~~s~ek~se~~p~~~~LnL~~~~idswasvD~Ln~f~~l~dlRv 256 (418)
T KOG2982|consen 184 LEQLWLNKNKLSR-------IFPNVNSVFVCEGPLKTESSEKGSEPFPSLSCLNLGANNIDSWASVDALNGFPQLVDLRV 256 (418)
T ss_pred HHHHHHHHHhHHh-------hcccchheeeecCcccchhhcccCCCCCcchhhhhcccccccHHHHHHHcCCchhheeec
Confidence 1111111122211 2456777777777665332 23355666677777777777642 2456777777777777
Q ss_pred cCccccc
Q 001658 347 GNNKLNG 353 (1036)
Q Consensus 347 s~N~l~g 353 (1036)
++|+|..
T Consensus 257 ~~~Pl~d 263 (418)
T KOG2982|consen 257 SENPLSD 263 (418)
T ss_pred cCCcccc
Confidence 7777764
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.46 E-value=1.1e-06 Score=92.28 Aligned_cols=133 Identities=22% Similarity=0.221 Sum_probs=97.1
Q ss_pred CCCccccCCCEEEEEeEeCCCcEEEEEEccccch----------------------hcHHHHHHHHHHHHhhccC--Ccc
Q 001658 697 PSNKLGEGGFGPVYKGKLGDGRAIAVKQLSVASR----------------------QGKSQFVAEIATISAVQHR--NLV 752 (1036)
Q Consensus 697 ~~~~iG~G~fG~Vy~~~~~~g~~vAvK~~~~~~~----------------------~~~~~f~~Ei~~L~~l~H~--nIv 752 (1036)
+...||-|--+.||.|...+|.++|||.=+.... -.....++|.++|.++.-. .+.
T Consensus 95 iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~VP 174 (304)
T COG0478 95 IGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVKVP 174 (304)
T ss_pred hccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCCCC
Confidence 4578999999999999999999999996422100 0123457899999998755 677
Q ss_pred eeEeEEEcCceeEEEEEecCCCChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCc
Q 001658 753 KLHGCCIEGAERLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLV 832 (1036)
Q Consensus 753 ~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~ 832 (1036)
+.+++ +...+||||+++--|...- ++....-.|+..|++-+.-+-..| |||+|+.+-||++++||.
T Consensus 175 ~P~~~----nRHaVvMe~ieG~eL~~~r-------~~~en~~~il~~il~~~~~~~~~G---iVHGDlSefNIlV~~dg~ 240 (304)
T COG0478 175 KPIAW----NRHAVVMEYIEGVELYRLR-------LDVENPDEILDKILEEVRKAYRRG---IVHGDLSEFNILVTEDGD 240 (304)
T ss_pred Ccccc----ccceeeeehcccceeeccc-------CcccCHHHHHHHHHHHHHHHHHcC---ccccCCchheEEEecCCC
Confidence 77765 4568999999986665432 123333345555555555555666 999999999999999999
Q ss_pred eEEEEcCccee
Q 001658 833 PKISDFGLAKL 843 (1036)
Q Consensus 833 ~kl~DFGla~~ 843 (1036)
+.++||--+..
T Consensus 241 ~~vIDwPQ~v~ 251 (304)
T COG0478 241 IVVIDWPQAVP 251 (304)
T ss_pred EEEEeCccccc
Confidence 99999975543
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.43 E-value=3.4e-06 Score=87.01 Aligned_cols=138 Identities=16% Similarity=0.139 Sum_probs=103.6
Q ss_pred cccCCCEEEEEeEeCCCcEEEEEEcccc------chhcHHHHHHHHHHHHhhccCC--cceeEeEEEc----CceeEEEE
Q 001658 701 LGEGGFGPVYKGKLGDGRAIAVKQLSVA------SRQGKSQFVAEIATISAVQHRN--LVKLHGCCIE----GAERLLVY 768 (1036)
Q Consensus 701 iG~G~fG~Vy~~~~~~g~~vAvK~~~~~------~~~~~~~f~~Ei~~L~~l~H~n--Iv~l~g~~~~----~~~~~lV~ 768 (1036)
-|+||.+.|++..+. |+.+-+|+-... .+.+...|.+|+..|.++...+ +.++..+... .-.-+||+
T Consensus 26 ~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 26 YRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT 104 (216)
T ss_pred cCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence 367888889998874 456888876411 1345778999999999996433 4455422211 12357999
Q ss_pred EecCC-CChhhhhhcCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCc--eEEEEcCcce
Q 001658 769 EYLEN-KSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLV--PKISDFGLAK 842 (1036)
Q Consensus 769 E~~~~-gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~--~kl~DFGla~ 842 (1036)
|-+++ -+|.+++....-.+.+...+..+..++++.++-||..+ +.|+|+.+.||+++.++. ++++||.-++
T Consensus 105 e~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~lIDlEk~r 178 (216)
T PRK09902 105 EDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGFLDLEKSR 178 (216)
T ss_pred EeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence 98764 68999886544446677778899999999999999998 999999999999986666 9999998765
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.41 E-value=1.2e-06 Score=103.06 Aligned_cols=147 Identities=20% Similarity=0.299 Sum_probs=97.3
Q ss_pred cCCCCCCccccCCCEEEEEeEeCCCcEEEEEEccccchhcH------------------------------H--------
Q 001658 693 ENFSPSNKLGEGGFGPVYKGKLGDGRAIAVKQLSVASRQGK------------------------------S-------- 734 (1036)
Q Consensus 693 ~~~~~~~~iG~G~fG~Vy~~~~~~g~~vAvK~~~~~~~~~~------------------------------~-------- 734 (1036)
.+|+. +-|+.++-|+||+|++++|+.||||+.++.-+... +
T Consensus 126 ~eF~~-~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ 204 (517)
T COG0661 126 SEFEP-EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLRE 204 (517)
T ss_pred HHcCC-CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHH
Confidence 34443 68999999999999999999999999875422110 0
Q ss_pred --HHHHHHHHHHhhc-----cCCcceeEeEEEcCceeEEEEEecCCCChhhhhhcCCCCCcChHHHHHHHHHHHHH-HHH
Q 001658 735 --QFVAEIATISAVQ-----HRNLVKLHGCCIEGAERLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARG-LAY 806 (1036)
Q Consensus 735 --~f~~Ei~~L~~l~-----H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~g-L~y 806 (1036)
++..|...+.+++ .+++.-.-=|..-.....|+|||++|-.+.+...-.. ...+ +..|+..++++ +..
T Consensus 205 ElDy~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d---~k~ia~~~~~~f~~q 280 (517)
T COG0661 205 ELDYRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS-AGID---RKELAELLVRAFLRQ 280 (517)
T ss_pred HhCHHHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh-cCCC---HHHHHHHHHHHHHHH
Confidence 2345555555542 3333211112223456789999999999988742221 3334 23344444443 333
Q ss_pred HHhcCCccccccccCCCcEEecCCCceEEEEcCcceeecCC
Q 001658 807 LHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDK 847 (1036)
Q Consensus 807 LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~ 847 (1036)
+-..| +.|.|.+|.||+++.++.+.+.|||+...+.+.
T Consensus 281 ~~~dg---ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~~ 318 (517)
T COG0661 281 LLRDG---FFHADPHPGNILVRSDGRIVLLDFGIVGRLDPK 318 (517)
T ss_pred HHhcC---ccccCCCccceEEecCCcEEEEcCcceecCCHH
Confidence 33355 999999999999999999999999999877543
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.40 E-value=7.4e-09 Score=119.28 Aligned_cols=194 Identities=23% Similarity=0.260 Sum_probs=136.6
Q ss_pred CCCcEEEcccCCCCCCC-ccccCCCccCCEEeCccccCCCCCCccccCC-CCCcEEeccCCcCC----------CCChhh
Q 001658 171 TELLILGIGTNNFSGPL-PSELGSLSKLQELYIDSAGVSGEIPSSFANL-QSLTKWWASDTRLT----------GRIPDF 238 (1036)
Q Consensus 171 ~~L~~L~Ls~N~l~~~~-p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l-~~L~~L~L~~N~l~----------~~~p~~ 238 (1036)
++++.|.+-.-.=.+.. |-.+..+.+|+.|.|.++.|.. ...+..+ ..|++|.. +|.+. |.+..+
T Consensus 84 qkt~~lkl~~~pa~~pt~pi~ifpF~sLr~LElrg~~L~~--~~GL~~lr~qLe~LIC-~~Sl~Al~~v~ascggd~~ns 160 (1096)
T KOG1859|consen 84 QKTKVLKLLPSPARDPTEPISIFPFRSLRVLELRGCDLST--AKGLQELRHQLEKLIC-HNSLDALRHVFASCGGDISNS 160 (1096)
T ss_pred hhheeeeecccCCCCCCCCceeccccceeeEEecCcchhh--hhhhHHHHHhhhhhhh-hccHHHHHHHHHHhccccccc
Confidence 44445544433322222 6678888999999999999873 2222222 24555432 33322 111111
Q ss_pred hcCCCCCCEEEeeCCcCCCCCCccccCCCCCCEEEccCCCCCCCchhhhcCCCCCCEEEccCCccCcccccc-ccCCCCc
Q 001658 239 IGNWSKLTALRFQGNSFNGPIPSSFSNLTSVTELRISDLSNGSSKLAFIRDMKSLSILELRNNNISDSIPSN-IGEYRSL 317 (1036)
Q Consensus 239 l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~-~~~l~~L 317 (1036)
+ .+..|...+.+.|.+. .+..++.-++.|+.|+|+.|++.... .+..+++|++|||+.|.+. .+|.. ...+. |
T Consensus 161 ~-~Wn~L~~a~fsyN~L~-~mD~SLqll~ale~LnLshNk~~~v~--~Lr~l~~LkhLDlsyN~L~-~vp~l~~~gc~-L 234 (1096)
T KOG1859|consen 161 P-VWNKLATASFSYNRLV-LMDESLQLLPALESLNLSHNKFTKVD--NLRRLPKLKHLDLSYNCLR-HVPQLSMVGCK-L 234 (1096)
T ss_pred h-hhhhHhhhhcchhhHH-hHHHHHHHHHHhhhhccchhhhhhhH--HHHhcccccccccccchhc-cccccchhhhh-h
Confidence 1 1346888899999998 67778888999999999999998887 6888999999999999998 55543 33334 9
Q ss_pred cEEeCCCCCCCCCCchhccCCCCccEEEccCcccccc---CCCCcCCCccEEEeeCccCCC
Q 001658 318 QHLDLSFNNLGGSIPDSLFNLSSLTHLFLGNNKLNGT---LPARKSPLLLNIDVSYNNLQG 375 (1036)
Q Consensus 318 ~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~---~p~~~~~~L~~Ldls~N~l~g 375 (1036)
+.|.|++|.++. -..+.+|.+|+.|||++|-|.+- .|.+....|+.|.|.+|++..
T Consensus 235 ~~L~lrnN~l~t--L~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~c 293 (1096)
T KOG1859|consen 235 QLLNLRNNALTT--LRGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLCC 293 (1096)
T ss_pred eeeeecccHHHh--hhhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCcccc
Confidence 999999999983 34578899999999999998753 333444558999999999863
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.39 E-value=2.4e-06 Score=89.92 Aligned_cols=108 Identities=23% Similarity=0.246 Sum_probs=85.7
Q ss_pred cHHHHHHHHHHHHhhccCC--cceeEeEEEcC----ceeEEEEEecCC-CChhhhhhcCCCCCcChHHHHHHHHHHHHHH
Q 001658 732 GKSQFVAEIATISAVQHRN--LVKLHGCCIEG----AERLLVYEYLEN-KSLDQALFGQRSLTLDWATRYEICSGVARGL 804 (1036)
Q Consensus 732 ~~~~f~~Ei~~L~~l~H~n--Iv~l~g~~~~~----~~~~lV~E~~~~-gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL 804 (1036)
......+|...+..+.... +.+.+++.... ...++|+|++++ -+|.+++..... .+......++.++++.+
T Consensus 54 ~~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~--~~~~~~~~ll~~l~~~i 131 (206)
T PF06293_consen 54 RRSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ--LDPSQRRELLRALARLI 131 (206)
T ss_pred cchHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc--cchhhHHHHHHHHHHHH
Confidence 3456788999988886444 45677776653 234899999987 489998854222 55566778999999999
Q ss_pred HHHHhcCCccccccccCCCcEEecCCC---ceEEEEcCcceee
Q 001658 805 AYLHEESRVRIIHRDVKASNVLLDADL---VPKISDFGLAKLY 844 (1036)
Q Consensus 805 ~yLH~~~~~~ivHrDikp~NILl~~~~---~~kl~DFGla~~~ 844 (1036)
+-||+.+ |+|+|++++|||++.+. .+.++||+-++..
T Consensus 132 ~~lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 132 AKLHDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HHHHHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 9999998 99999999999999887 8999999987754
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG5238 RNA1 Ran GTPase-activating protein (RanGAP) involved in mRNA processing and transport [Signal transduction mechanisms / RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.38 E-value=7.3e-08 Score=99.46 Aligned_cols=91 Identities=23% Similarity=0.348 Sum_probs=53.8
Q ss_pred cccCCCCCCEEEccCCCCCCC----CcccccCCCcCCeeecccc---cccCCcc-------ccccCCCCCcEEEcccCCC
Q 001658 118 ELWNLTSLFNLNLGQNYLTGP----LSPSVGNLTAMQYLNLAIN---ALSGELP-------KELGQLTELLILGIGTNNF 183 (1036)
Q Consensus 118 ~l~~l~~L~~L~Ls~n~l~~~----~p~~~~~l~~L~~L~Ls~N---~l~~~~p-------~~l~~L~~L~~L~Ls~N~l 183 (1036)
.+..+..+..++||+|.|... +...+++-.+|+..+++.- +....++ ..+.++++|+..+||+|.+
T Consensus 25 el~~~d~~~evdLSGNtigtEA~e~l~~~ia~~~~L~vvnfsd~ftgr~kde~~~~L~~Ll~aLlkcp~l~~v~LSDNAf 104 (388)
T COG5238 25 ELEMMDELVEVDLSGNTIGTEAMEELCNVIANVRNLRVVNFSDAFTGRDKDELYSNLVMLLKALLKCPRLQKVDLSDNAF 104 (388)
T ss_pred HHHhhcceeEEeccCCcccHHHHHHHHHHHhhhcceeEeehhhhhhcccHHHHHHHHHHHHHHHhcCCcceeeecccccc
Confidence 344567777888888877643 2334555667777776642 2222222 2345567777777777777
Q ss_pred CCCCccc----cCCCccCCEEeCccccCC
Q 001658 184 SGPLPSE----LGSLSKLQELYIDSAGVS 208 (1036)
Q Consensus 184 ~~~~p~~----l~~l~~L~~L~L~~N~l~ 208 (1036)
....|+. +++-..|++|.|++|.+.
T Consensus 105 g~~~~e~L~d~is~~t~l~HL~l~NnGlG 133 (388)
T COG5238 105 GSEFPEELGDLISSSTDLVHLKLNNNGLG 133 (388)
T ss_pred CcccchHHHHHHhcCCCceeEEeecCCCC
Confidence 6555543 334456667777666654
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.37 E-value=8.8e-06 Score=89.50 Aligned_cols=191 Identities=18% Similarity=0.202 Sum_probs=125.3
Q ss_pred CCCCccccCCCEEEEEeE-eCCCcEEEEEEccccchhcHHHHHHHHHHHHhh-ccCCcceeEeE----E--EcC-ceeEE
Q 001658 696 SPSNKLGEGGFGPVYKGK-LGDGRAIAVKQLSVASRQGKSQFVAEIATISAV-QHRNLVKLHGC----C--IEG-AERLL 766 (1036)
Q Consensus 696 ~~~~~iG~G~fG~Vy~~~-~~~g~~vAvK~~~~~~~~~~~~f~~Ei~~L~~l-~H~nIv~l~g~----~--~~~-~~~~l 766 (1036)
.....||+|+-+.+|-.- ..+ .+.|+++......+.+. +..|... .||-+-.=+.| . -++ ....+
T Consensus 14 ~~gr~LgqGgea~ly~l~e~~d---~VAKIYh~Pppa~~aqk---~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGf 87 (637)
T COG4248 14 PPGRPLGQGGEADLYTLGEVRD---QVAKIYHAPPPAAQAQK---VAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGF 87 (637)
T ss_pred CCCccccCCccceeeecchhhc---hhheeecCCCchHHHHH---HHHhccCCCCcchhhhhcccHHHhhCCCccceeEE
Confidence 356789999999999642 322 45677765433323222 2333333 45543321111 0 111 22456
Q ss_pred EEEecCCCC-hhhhhh----cCCCCCcChHHHHHHHHHHHHHHHHHHhcCCccccccccCCCcEEecCCCceEEEEcCcc
Q 001658 767 VYEYLENKS-LDQALF----GQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLA 841 (1036)
Q Consensus 767 V~E~~~~gs-L~~~l~----~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla 841 (1036)
.|..+++.- ..++.. ++.-...+|...++.+..+|.+.+-||+.| .+-+|+.++|+|+.+++.+.|.|-..-
T Consensus 88 lmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~LVdsDsf 164 (637)
T COG4248 88 LMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVVLVDSDSF 164 (637)
T ss_pred ecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEEEEcccce
Confidence 666665531 222221 122345799999999999999999999998 888999999999999999999986544
Q ss_pred eeecCCCCccccccccccCccCccccc-----cCCCCchhhHHhHHHHHHHHHhC-CCCCCC
Q 001658 842 KLYDDKKTHISTRVAGTIGYLAPEYAM-----RGHLTEKTDVFAFGVLALETVSG-RPNSDP 897 (1036)
Q Consensus 842 ~~~~~~~~~~~~~~~gt~~y~APE~~~-----~~~~~~ksDVwS~Gvvl~elltG-~~p~~~ 897 (1036)
....+ .......+|...|.+||.-. +..-+...|-|.+||++++++.| +.||.+
T Consensus 165 qi~~n--g~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysG 224 (637)
T COG4248 165 QINAN--GTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSG 224 (637)
T ss_pred eeccC--CceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCc
Confidence 33322 22233456888999999765 33456789999999999999887 888864
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST 
Original result of BLAST against Protein Data Bank
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() | |
| Query | 1036 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 6e-66 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 3e-64 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 2e-52 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 2e-52 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-43 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 5e-43 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 2e-42 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 3e-39 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 4e-24 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 4e-24 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 4e-22 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 5e-22 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 5e-22 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 5e-22 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 5e-22 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 6e-22 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 7e-22 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 7e-22 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 7e-22 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 8e-22 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 8e-22 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 8e-22 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 8e-22 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 8e-22 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 8e-22 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 1e-21 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 1e-21 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 1e-21 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 2e-21 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 2e-21 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 2e-21 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 2e-21 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 2e-21 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 2e-21 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 2e-21 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 2e-21 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 2e-21 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 2e-21 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 2e-21 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 2e-21 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 3e-21 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 3e-21 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 3e-21 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 3e-21 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 4e-21 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 4e-21 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 4e-21 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 1e-20 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 1e-20 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 1e-20 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 5e-20 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 5e-20 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 6e-20 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 1e-19 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 1e-19 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 4e-19 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 4e-19 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-19 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 5e-19 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 5e-19 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 5e-19 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 6e-19 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 6e-19 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 6e-19 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 6e-19 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 7e-19 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 8e-19 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 1e-18 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-18 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 1e-18 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 1e-18 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 1e-18 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 1e-18 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 1e-18 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 1e-18 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 1e-18 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 1e-18 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 2e-18 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 2e-18 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 2e-18 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 2e-18 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 4e-18 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 4e-18 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 8e-18 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 8e-18 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 9e-18 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 9e-18 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 9e-18 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 1e-17 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 1e-17 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 1e-17 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-17 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 1e-17 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 1e-17 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 1e-17 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 1e-17 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 1e-17 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 2e-17 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 2e-17 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 2e-17 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 2e-17 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 2e-17 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 2e-17 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 2e-17 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 2e-17 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 2e-17 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 2e-17 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 2e-17 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-17 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-17 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 3e-17 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 3e-17 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 3e-17 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-17 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 3e-17 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 3e-17 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 4e-17 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 5e-17 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 5e-17 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 7e-17 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 7e-17 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 7e-17 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 7e-17 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 8e-17 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 8e-17 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 8e-17 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 8e-17 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 9e-17 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 9e-17 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 9e-17 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 9e-17 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 9e-17 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 1e-16 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 1e-16 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-16 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 1e-16 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 1e-16 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 1e-16 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 1e-16 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 1e-16 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 1e-16 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 1e-16 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 1e-16 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 1e-16 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 1e-16 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 1e-16 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-16 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 2e-16 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 2e-16 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 2e-16 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 2e-16 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-16 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 2e-16 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 2e-16 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 2e-16 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 2e-16 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 2e-16 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 2e-16 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-16 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 2e-16 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-16 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 3e-16 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 3e-16 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 3e-16 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 3e-16 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 3e-16 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 4e-16 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 4e-16 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 4e-16 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 4e-16 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 4e-16 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 5e-16 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 5e-16 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 6e-16 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 6e-16 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 6e-16 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 7e-16 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 7e-16 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 7e-16 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 8e-16 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 8e-16 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 8e-16 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 9e-16 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 9e-16 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 9e-16 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 9e-16 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 9e-16 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 9e-16 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 9e-16 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 9e-16 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 9e-16 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 9e-16 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 9e-16 | ||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 1e-15 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-15 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-15 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 1e-15 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 1e-15 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 1e-15 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-15 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 1e-15 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 1e-15 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 1e-15 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 1e-15 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 1e-15 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-15 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 1e-15 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 1e-15 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-15 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-15 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 1e-15 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 1e-15 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 1e-15 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-15 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-15 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 1e-15 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 1e-15 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-15 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-15 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 2e-15 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 2e-15 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 2e-15 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-15 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 2e-15 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 2e-15 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 2e-15 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 2e-15 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 2e-15 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 2e-15 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 2e-15 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 2e-15 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 2e-15 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-15 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 2e-15 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-15 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 2e-15 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 2e-15 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-15 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-15 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-15 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 3e-15 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 3e-15 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 3e-15 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 3e-15 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-15 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 3e-15 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 3e-15 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 3e-15 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 4e-15 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 5e-15 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 5e-15 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 5e-15 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 6e-15 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 6e-15 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 6e-15 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 6e-15 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 6e-15 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 6e-15 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 6e-15 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 6e-15 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 7e-15 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-15 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 7e-15 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 7e-15 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 8e-15 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 8e-15 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 9e-15 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 9e-15 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 9e-15 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 9e-15 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 1e-14 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-14 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 1e-14 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 1e-14 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 1e-14 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 1e-14 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 1e-14 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 1e-14 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 1e-14 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 1e-14 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-14 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 2e-14 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-14 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 2e-14 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-14 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 2e-14 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 2e-14 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 2e-14 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-14 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 2e-14 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 2e-14 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 2e-14 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-14 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 2e-14 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 2e-14 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 2e-14 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 2e-14 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 3e-14 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 3e-14 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 3e-14 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-14 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 3e-14 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 4e-14 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 4e-14 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 4e-14 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 4e-14 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 4e-14 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 4e-14 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 5e-14 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 5e-14 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 5e-14 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 5e-14 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 5e-14 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 5e-14 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 5e-14 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 5e-14 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 5e-14 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 5e-14 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 5e-14 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 6e-14 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 6e-14 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 6e-14 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 6e-14 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 6e-14 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 6e-14 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 6e-14 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 7e-14 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 7e-14 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 7e-14 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 7e-14 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 7e-14 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 7e-14 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 8e-14 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 8e-14 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 8e-14 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 8e-14 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 8e-14 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 8e-14 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 8e-14 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 8e-14 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 8e-14 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 8e-14 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 9e-14 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 9e-14 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 9e-14 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 9e-14 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 9e-14 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 1e-13 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 1e-13 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 1e-13 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 1e-13 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-13 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 1e-13 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 1e-13 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-13 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 1e-13 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-13 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 1e-13 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-13 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 1e-13 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 1e-13 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 1e-13 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-13 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-13 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 1e-13 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 1e-13 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 1e-13 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 1e-13 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 2e-13 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-13 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 2e-13 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-13 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 2e-13 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 2e-13 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 2e-13 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 2e-13 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 2e-13 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 2e-13 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 2e-13 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 2e-13 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 3e-13 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 3e-13 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 3e-13 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 3e-13 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 3e-13 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 3e-13 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 3e-13 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 3e-13 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 3e-13 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 3e-13 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 3e-13 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 4e-13 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 4e-13 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 4e-13 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 4e-13 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 4e-13 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 5e-13 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 5e-13 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 5e-13 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 5e-13 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 5e-13 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 5e-13 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 5e-13 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 5e-13 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 5e-13 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 5e-13 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-13 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 5e-13 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 5e-13 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 5e-13 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 5e-13 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 5e-13 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 6e-13 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 6e-13 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 6e-13 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 6e-13 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 6e-13 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-13 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 6e-13 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 6e-13 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 7e-13 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 7e-13 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 7e-13 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 7e-13 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-13 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-13 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-13 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 7e-13 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 8e-13 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 8e-13 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 9e-13 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 9e-13 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 9e-13 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 1e-12 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 1e-12 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-12 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 1e-12 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-12 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-12 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 1e-12 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 1e-12 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-12 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-12 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 1e-12 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 1e-12 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 1e-12 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 1e-12 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 1e-12 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 1e-12 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 2e-12 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 2e-12 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 2e-12 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-12 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-12 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 2e-12 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-12 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 2e-12 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-12 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 2e-12 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 2e-12 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-12 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 2e-12 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-12 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 2e-12 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-12 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-12 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-12 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-12 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-12 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 3e-12 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-12 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 3e-12 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 3e-12 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-12 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 3e-12 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 3e-12 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 3e-12 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 3e-12 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-12 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 3e-12 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 4e-12 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 4e-12 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 4e-12 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 4e-12 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 4e-12 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 4e-12 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 4e-12 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 5e-12 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 5e-12 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 5e-12 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 5e-12 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 5e-12 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 5e-12 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 5e-12 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 5e-12 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 5e-12 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 5e-12 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-12 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 6e-12 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-12 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 7e-12 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 7e-12 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 7e-12 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 7e-12 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 7e-12 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 7e-12 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 7e-12 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 7e-12 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 7e-12 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 8e-12 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 8e-12 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 8e-12 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 9e-12 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 9e-12 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 9e-12 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 9e-12 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 1e-11 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 1e-11 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 1e-11 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-11 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 1e-11 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 1e-11 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 1e-11 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 1e-11 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 1e-11 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 1e-11 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 1e-11 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-11 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-11 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-11 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 2e-11 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 2e-11 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 2e-11 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-11 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 2e-11 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-11 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 2e-11 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 2e-11 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 2e-11 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 2e-11 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 2e-11 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 2e-11 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 2e-11 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 2e-11 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 2e-11 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 2e-11 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 2e-11 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-11 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 2e-11 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 2e-11 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 3e-11 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 3e-11 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 3e-11 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 3e-11 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 3e-11 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 3e-11 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-11 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 3e-11 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 3e-11 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 3e-11 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 3e-11 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 3e-11 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 3e-11 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 3e-11 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 3e-11 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 3e-11 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 3e-11 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 3e-11 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 3e-11 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-11 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-11 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 4e-11 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 4e-11 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 4e-11 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 4e-11 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 4e-11 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 4e-11 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 4e-11 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 4e-11 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 4e-11 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 4e-11 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 4e-11 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 4e-11 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 4e-11 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 4e-11 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 4e-11 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 4e-11 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 4e-11 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 4e-11 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 4e-11 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 4e-11 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 4e-11 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 5e-11 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 5e-11 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 5e-11 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 5e-11 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 5e-11 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 5e-11 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 5e-11 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 5e-11 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 5e-11 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 6e-11 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 6e-11 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 6e-11 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 6e-11 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 6e-11 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 6e-11 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 6e-11 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 7e-11 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 7e-11 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 7e-11 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 7e-11 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 7e-11 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 7e-11 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 7e-11 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 7e-11 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 7e-11 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 7e-11 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 7e-11 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 7e-11 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 7e-11 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 7e-11 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 7e-11 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 8e-11 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 8e-11 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 8e-11 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 8e-11 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 8e-11 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 8e-11 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 8e-11 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 8e-11 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 8e-11 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 8e-11 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 8e-11 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 8e-11 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 8e-11 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 8e-11 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 8e-11 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 8e-11 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 8e-11 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 8e-11 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 9e-11 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 9e-11 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 9e-11 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 9e-11 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 1e-10 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 1e-10 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 1e-10 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 1e-10 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 1e-10 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 1e-10 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 2e-10 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-10 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 2e-10 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 2e-10 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 2e-10 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-10 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 2e-10 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-10 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 2e-10 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 2e-10 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 2e-10 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 2e-10 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 2e-10 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 2e-10 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 2e-10 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 2e-10 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 3e-10 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 3e-10 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 3e-10 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 3e-10 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 3e-10 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 3e-10 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 3e-10 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 3e-10 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 3e-10 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 3e-10 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 3e-10 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 3e-10 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 4e-10 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 4e-10 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 4e-10 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 4e-10 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 4e-10 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-10 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 5e-10 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 5e-10 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 5e-10 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 5e-10 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 5e-10 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 5e-10 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 5e-10 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 5e-10 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 6e-10 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 6e-10 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 6e-10 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 6e-10 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 7e-10 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 7e-10 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 7e-10 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 7e-10 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 7e-10 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 7e-10 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 7e-10 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 7e-10 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 8e-10 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 8e-10 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 8e-10 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 8e-10 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 8e-10 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 8e-10 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 8e-10 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 9e-10 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 9e-10 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 9e-10 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 9e-10 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 1e-09 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-09 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 1e-09 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 1e-09 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 1e-09 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 1e-09 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 1e-09 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 1e-09 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 1e-09 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-09 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 1e-09 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 2e-09 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 2e-09 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 2e-09 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 2e-09 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 2e-09 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-09 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 3e-09 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 3e-09 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 3e-09 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 3e-09 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 3e-09 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 3e-09 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 3e-09 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 3e-09 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 3e-09 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 3e-09 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 3e-09 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 3e-09 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 3e-09 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 3e-09 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 3e-09 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 3e-09 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 3e-09 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 4e-09 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 4e-09 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 4e-09 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 4e-09 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 4e-09 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 4e-09 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 4e-09 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 4e-09 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 4e-09 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 5e-09 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 5e-09 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-09 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 5e-09 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 6e-09 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-09 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 6e-09 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 6e-09 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 6e-09 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 6e-09 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 7e-09 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 7e-09 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 8e-09 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 8e-09 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 8e-09 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 8e-09 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 8e-09 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 8e-09 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 9e-09 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 9e-09 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 9e-09 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-08 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 1e-08 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 1e-08 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 1e-08 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-08 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 1e-08 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 1e-08 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 1e-08 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 2e-08 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 2e-08 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 2e-08 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 2e-08 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 2e-08 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 2e-08 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-08 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 2e-08 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 2e-08 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 2e-08 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 2e-08 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 2e-08 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 2e-08 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-08 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 2e-08 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-08 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 3e-08 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 3e-08 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-08 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 3e-08 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 3e-08 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 3e-08 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 3e-08 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 4e-08 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 4e-08 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 4e-08 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 4e-08 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 5e-08 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 5e-08 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-08 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 5e-08 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 5e-08 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-08 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 5e-08 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-08 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 6e-08 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 6e-08 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 6e-08 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 6e-08 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 6e-08 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 6e-08 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 6e-08 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 6e-08 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 6e-08 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 7e-08 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 7e-08 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 7e-08 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 7e-08 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 7e-08 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 8e-08 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 8e-08 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 8e-08 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 8e-08 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 8e-08 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 8e-08 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 9e-08 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 9e-08 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 9e-08 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 9e-08 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 9e-08 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 9e-08 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 9e-08 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 9e-08 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 9e-08 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 1e-07 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 1e-07 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-07 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 1e-07 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-07 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 1e-07 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 1e-07 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 1e-07 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 1e-07 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 1e-07 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-07 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 1e-07 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 1e-07 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 1e-07 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 1e-07 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 1e-07 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 1e-07 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 1e-07 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 1e-07 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 2e-07 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 2e-07 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 2e-07 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 2e-07 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 2e-07 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 2e-07 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-07 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 2e-07 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 2e-07 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 2e-07 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 2e-07 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 2e-07 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 2e-07 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 2e-07 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 2e-07 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 2e-07 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 2e-07 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 2e-07 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-07 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 2e-07 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 2e-07 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 2e-07 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 2e-07 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 2e-07 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 2e-07 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-07 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 2e-07 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 2e-07 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 3e-07 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 3e-07 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 3e-07 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 3e-07 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 3e-07 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-07 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 3e-07 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 3e-07 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 3e-07 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 3e-07 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 3e-07 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 3e-07 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 3e-07 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 3e-07 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-07 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 3e-07 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 3e-07 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 4e-07 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 4e-07 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 5e-07 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 6e-07 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 7e-07 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 8e-07 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 8e-07 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 9e-07 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 1e-06 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 1e-06 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 1e-06 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 1e-06 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 1e-06 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 1e-06 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 1e-06 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 1e-06 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 1e-06 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 1e-06 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 1e-06 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 1e-06 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 1e-06 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 1e-06 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 2e-06 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 2e-06 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 2e-06 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 2e-06 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 2e-06 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 3e-06 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 3e-06 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 3e-06 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 3e-06 | ||
| 3uys_A | 296 | Crystal Structure Of Apo Human Ck1d Length = 296 | 3e-06 | ||
| 1ckj_A | 317 | Casein Kinase I Delta Truncation Mutant Containing | 4e-06 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 4e-06 | ||
| 4hni_A | 296 | Crystal Structure Of Ck1e In Complex With Pf4800567 | 4e-06 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 5e-06 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 6e-06 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 6e-06 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 6e-06 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 7e-06 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 7e-06 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 7e-06 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 7e-06 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 9e-06 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 1e-05 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 1e-05 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 1e-05 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 1e-05 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 1e-05 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 2e-05 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 5e-05 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 7e-05 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 7e-05 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 9e-05 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 9e-05 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 9e-05 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 9e-05 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 1e-04 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 1e-04 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 1e-04 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 1e-04 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 1e-04 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 1e-04 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 1e-04 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 1e-04 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 1e-04 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 2e-04 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 3e-04 | ||
| 4hgl_A | 330 | Crystal Structure Of Ck1g3 With Compound 1 Length = | 3e-04 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 3e-04 | ||
| 3sv0_A | 483 | Crystal Structure Of Casein Kinase-1 Like Protein I | 4e-04 | ||
| 2k46_A | 190 | Xenopus Laevis Malectin Complexed With Nigerose (Gl | 5e-04 | ||
| 2jwp_A | 174 | Malectin Length = 174 | 5e-04 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 5e-04 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 7e-04 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 7e-04 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 8e-04 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 9e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3UYS|A Chain A, Crystal Structure Of Apo Human Ck1d Length = 296 | Back alignment and structure |
|
| >pdb|1CKJ|A Chain A, Casein Kinase I Delta Truncation Mutant Containing Residues 1-317 Complex With Bound Tungstate Length = 317 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|4HNI|A Chain A, Crystal Structure Of Ck1e In Complex With Pf4800567 Length = 296 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|4HGL|A Chain A, Crystal Structure Of Ck1g3 With Compound 1 Length = 330 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483 | Back alignment and structure |
|
| >pdb|2K46|A Chain A, Xenopus Laevis Malectin Complexed With Nigerose (Glcalpha1- 3glc) Length = 190 | Back alignment and structure |
|
| >pdb|2JWP|A Chain A, Malectin Length = 174 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST 
Original result of RPS-BLAST against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 1036 | |||
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 0.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 1e-162 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 1e-153 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 6e-85 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 2e-70 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 3e-68 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 9e-66 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 1e-65 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 1e-60 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 2e-30 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 2e-70 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 2e-60 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 1e-15 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 2e-07 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 2e-69 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 1e-54 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 7e-54 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 5e-52 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 7e-52 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 8e-52 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 1e-50 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 8e-43 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 4e-41 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 2e-05 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 3e-50 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 2e-49 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 1e-48 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 3e-47 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 6e-47 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 3e-46 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 3e-46 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 2e-45 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 8e-45 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 7e-44 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 4e-43 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 1e-42 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 7e-25 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 1e-43 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 2e-43 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 1e-37 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 5e-33 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 2e-08 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 2e-42 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 3e-38 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 1e-37 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 4e-36 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 5e-42 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 7e-38 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 2e-32 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 7e-32 | |
| 2jwp_A | 174 | Malectin, MGC80075; sugar binding, sugar binding p | 9e-41 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 1e-40 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 2e-40 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 8e-40 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 2e-39 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 2e-39 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 3e-39 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 3e-39 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 9e-36 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 2e-35 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 2e-20 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 5e-39 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 6e-39 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 2e-38 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 1e-37 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 5e-33 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 1e-22 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 1e-38 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 2e-38 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 5e-38 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 6e-38 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 7e-38 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 2e-37 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 2e-37 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 3e-37 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 5e-37 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 6e-37 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 7e-37 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 2e-07 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 9e-37 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 9e-37 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 2e-35 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 7e-34 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 2e-27 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 2e-10 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 1e-36 | |
| 3v5q_A | 297 | NT-3 growth factor receptor; kinase domain, kinase | 2e-36 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 2e-36 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 3e-36 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 4e-36 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 4e-36 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 4e-36 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 4e-36 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 7e-36 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 1e-35 | |
| 4apc_A | 350 | Serine/threonine-protein kinase NEK1; transferase; | 1e-35 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 3e-35 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 3e-35 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 3e-35 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 6e-35 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 7e-35 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 8e-35 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 2e-32 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 5e-26 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 4e-24 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 1e-07 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 6e-07 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 8e-35 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 8e-35 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 8e-35 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 9e-35 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 1e-34 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 1e-34 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 1e-34 | |
| 3zzw_A | 289 | Tyrosine-protein kinase transmembrane receptor RO; | 2e-34 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 2e-34 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 3e-34 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 3e-34 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 4e-34 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 6e-34 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 6e-34 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 7e-34 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 2e-33 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 2e-33 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 2e-33 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 2e-33 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 3e-33 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 3e-33 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 3e-33 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 4e-33 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 5e-33 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 5e-33 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 6e-33 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 6e-33 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 8e-33 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 1e-32 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 8e-33 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 8e-33 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 9e-33 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 1e-32 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 2e-32 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 3e-32 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 4e-32 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 5e-32 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 2e-29 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 2e-28 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 2e-27 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 4e-24 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 4e-08 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 6e-32 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 9e-32 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 2e-31 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 2e-31 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 3e-31 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 3e-31 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 5e-31 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 5e-31 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 6e-31 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 7e-31 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 2e-30 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 3e-30 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 8e-25 | |
| 3jqh_A | 167 | C-type lectin domain family 4 member M; DC-signr, | 5e-30 | |
| 3jqh_A | 167 | C-type lectin domain family 4 member M; DC-signr, | 6e-29 | |
| 3jqh_A | 167 | C-type lectin domain family 4 member M; DC-signr, | 2e-23 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 6e-30 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 1e-29 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 2e-29 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 2e-29 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 2e-29 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 3e-29 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 6e-26 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 5e-04 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 1e-28 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 1e-28 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 1e-28 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 4e-28 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 5e-28 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 7e-28 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 2e-27 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 3e-23 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 2e-27 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 8e-27 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 8e-27 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 1e-26 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 2e-26 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 2e-26 | |
| 3pvu_A | 695 | Beta-adrenergic receptor kinase 1; transferase, se | 6e-26 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 6e-26 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 9e-26 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 1e-25 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 2e-25 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 3e-25 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 4e-25 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 5e-25 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 5e-25 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 7e-25 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 1e-24 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 1e-24 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 2e-24 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 4e-24 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 4e-22 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 1e-24 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 2e-24 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 7e-23 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 3e-24 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 3e-23 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 1e-22 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 1e-22 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 2e-17 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 2e-12 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 3e-24 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 3e-24 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 6e-24 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 5e-22 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 3e-24 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 5e-24 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 4e-13 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 2e-12 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 7e-11 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 5e-24 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 2e-23 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 1e-22 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 3e-21 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 4e-21 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 5e-21 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 8e-24 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 1e-23 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 1e-23 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 1e-23 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 1e-23 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 2e-23 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 3e-23 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 4e-23 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 4e-23 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 8e-23 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 8e-23 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 2e-20 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 8e-23 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 1e-22 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 8e-23 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 1e-22 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 1e-22 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 2e-22 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 3e-22 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 3e-22 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 1e-19 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 7e-22 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 9e-22 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 2e-15 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 2e-14 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 4e-09 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 2e-21 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 1e-19 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 1e-16 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 8e-09 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 1e-08 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 2e-21 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 2e-21 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 1e-17 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 2e-21 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 2e-21 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 2e-21 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 2e-21 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 3e-16 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 2e-21 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 3e-21 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 3e-21 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 3e-21 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 3e-21 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 4e-21 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 3e-16 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 1e-12 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 4e-21 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 4e-21 | |
| 1uu3_A | 310 | HPDK1, 3-phosphoinositide dependent protein kinase | 5e-21 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 6e-21 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 9e-21 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 9e-21 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 1e-20 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 1e-20 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 1e-20 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 1e-08 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 1e-20 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 1e-20 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 1e-20 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 1e-20 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 2e-20 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 2e-20 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 2e-08 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 3e-20 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 4e-20 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 5e-20 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 5e-20 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 5e-20 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 5e-16 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 1e-12 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 4e-08 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 6e-20 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 6e-20 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 6e-20 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 6e-20 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 1e-11 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 7e-20 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 9e-20 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 1e-19 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 3e-19 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 3e-19 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 3e-19 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 3e-19 | |
| 3g51_A | 325 | Ribosomal protein S6 kinase alpha-3; N-terminal ki | 3e-19 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 3e-19 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 4e-19 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 5e-19 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 5e-19 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 5e-19 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 8e-19 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 2e-08 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 5e-06 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 9e-19 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 1e-18 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 4e-17 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 3e-07 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 2e-18 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 2e-18 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 2e-18 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 4e-18 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 4e-18 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 4e-18 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 5e-18 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 1e-17 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 1e-14 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 2e-13 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 1e-12 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 5e-18 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 6e-18 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 1e-17 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 2e-17 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 2e-17 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 2e-17 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 2e-17 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 5e-17 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 1e-16 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 5e-09 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 2e-16 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 2e-16 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 3e-16 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 3e-16 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 3e-16 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 7e-12 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 1e-06 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 1e-04 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 1e-15 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 5e-15 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 2e-13 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 6e-15 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 1e-14 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 1e-14 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 6e-14 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 8e-14 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 1e-13 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 1e-13 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 3e-13 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 6e-08 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 2e-13 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 2e-13 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 2e-13 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 3e-13 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 4e-13 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 2e-12 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 7e-13 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 7e-13 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 1e-12 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 2e-12 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 4e-12 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 8e-12 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 1e-07 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 2e-07 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 8e-12 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 2e-11 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 2e-11 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 2e-11 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 3e-11 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 4e-08 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 4e-07 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 7e-05 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 3e-11 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 4e-11 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 4e-11 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 1e-06 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 9e-06 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 4e-11 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 5e-11 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 2e-08 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 1e-10 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 1e-10 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 2e-10 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 3e-10 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 4e-07 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 3e-10 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 4e-10 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 4e-09 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 1e-06 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 4e-10 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 1e-09 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 1e-09 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 2e-09 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 2e-07 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 8e-04 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 6e-09 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 2e-06 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 4e-04 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 7e-09 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 4e-07 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 9e-09 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 2e-07 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 9e-09 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 1e-08 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 1e-08 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 1e-04 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 3e-04 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 2e-08 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 5e-06 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 5e-08 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 1e-07 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 6e-08 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 7e-07 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 5e-06 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 2e-05 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 8e-04 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 7e-08 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 1e-07 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 1e-05 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 7e-07 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 5e-05 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 9e-05 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 4e-06 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 5e-06 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 7e-06 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 1e-05 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 4e-04 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 7e-04 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 2e-05 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 2e-04 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 5e-05 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 6e-05 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 9e-05 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 1e-04 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 1e-04 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 1e-04 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 2e-04 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 5e-04 |
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 534 bits (1379), Expect = 0.0
Identities = 145/309 (46%), Positives = 190/309 (61%), Gaps = 9/309 (2%)
Query: 665 PQHDDDEELLGMDARPYTFSYAELKTATENFSPSNKLGEGGFGPVYKGKLGDGRAIAVKQ 724
P +D E LG + FS EL+ A++NFS N LG GGFG VYKG+L DG +AVK+
Sbjct: 5 PAEEDPEVHLG---QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKR 61
Query: 725 LSVASRQG-KSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLVYEYLENKSLDQALFGQ 783
L QG + QF E+ IS HRNL++L G C+ ERLLVY Y+ N S+ L +
Sbjct: 62 LKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRER 121
Query: 784 RS--LTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLA 841
LDW R I G ARGLAYLH+ +IIHRDVKA+N+LLD + + DFGLA
Sbjct: 122 PESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA 181
Query: 842 KLYDDKKTHISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRPNSDPS--L 899
KL D K TH++T V GTIG++APEY G +EKTDVF +GV+ LE ++G+ D +
Sbjct: 182 KLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLA 241
Query: 900 DEEKLYLLEWAWHLHENNQEIELADPKL-IEFNEEEVKRLIGVALLCTQTLPSLRPSMSR 958
+++ + LL+W L + + L D L + +EEV++LI VALLCTQ+ P RP MS
Sbjct: 242 NDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSE 301
Query: 959 VVAMLCGDM 967
VV ML GD
Sbjct: 302 VVRMLEGDG 310
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 479 bits (1235), Expect = e-162
Identities = 110/308 (35%), Positives = 171/308 (55%), Gaps = 20/308 (6%)
Query: 669 DDEELLGMDARPYTFSYAELKTATENFSP------SNKLGEGGFGPVYKGKLGDGRAIAV 722
+++ L D R ++FS+ ELK T NF NK+GEGGFG VYKG + + +AV
Sbjct: 1 ENKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAV 59
Query: 723 KQLS----VASRQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLVYEYLENKSLDQ 778
K+L+ + + + K QF EI ++ QH NLV+L G +G + LVY Y+ N SL
Sbjct: 60 KKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLD 119
Query: 779 ALFGQR-SLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISD 837
L + L W R +I G A G+ +LHE IHRD+K++N+LLD KISD
Sbjct: 120 RLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISD 176
Query: 838 FGLAKLYD-DKKTHISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRPNSD 896
FGLA+ + +T +++R+ GT Y+APE +RG +T K+D+++FGV+ LE ++G P D
Sbjct: 177 FGLARASEKFAQTVMTSRIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIITGLPAVD 235
Query: 897 PSLDEEKLYLLEWAWHLHENNQEIE-LADPKLIEFNEEEVKRLIGVALLCTQTLPSLRPS 955
+ + LL+ + + + IE D K+ + + V+ + VA C + RP
Sbjct: 236 EHREPQ--LLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPD 293
Query: 956 MSRVVAML 963
+ +V +L
Sbjct: 294 IKKVQQLL 301
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 457 bits (1177), Expect = e-153
Identities = 122/313 (38%), Positives = 177/313 (56%), Gaps = 7/313 (2%)
Query: 661 RRKRPQHDDDEELLGMDARPYTFSYAELKTATENFSPSNKLGEGGFGPVYKGKLGDGRAI 720
+ +D + Y +L+ AT NF +G G FG VYKG L DG +
Sbjct: 7 KATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKV 66
Query: 721 AVKQLSVASRQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLVYEYLENKSLDQAL 780
A+K+ + S QG +F EI T+S +H +LV L G C E E +L+Y+Y+EN +L + L
Sbjct: 67 ALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHL 126
Query: 781 FG--QRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDF 838
+G ++++ W R EIC G ARGL YLH + IIHRDVK+ N+LLD + VPKI+DF
Sbjct: 127 YGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDF 183
Query: 839 GLAKLY-DDKKTHISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRPNSDP 897
G++K + +TH+ST V GT+GY+ PEY ++G LTEK+DV++FGV+ E + R
Sbjct: 184 GISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQ 243
Query: 898 SLDEEKLYLLEWAWHLHENNQEIELADPKLI-EFNEEEVKRLIGVALLCTQTLPSLRPSM 956
SL E + L EWA H N Q ++ DP L + E +++ A+ C RPSM
Sbjct: 244 SLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSM 303
Query: 957 SRVVAMLCGDMEV 969
V+ L + +
Sbjct: 304 GDVLWKLEYALRL 316
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 276 bits (708), Expect = 6e-85
Identities = 73/305 (23%), Positives = 113/305 (37%), Gaps = 29/305 (9%)
Query: 683 FSYAELKTATENFSPSNKLGEGGFGPVYKGKLGDGRAIAVKQLSVASRQGKSQFVAEIAT 742
L + G FG V+K +L +AVK + +Q Q E+ +
Sbjct: 14 LGTENLYFQSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQDKQSW-QNEYEVYS 71
Query: 743 ISAVQHRNLVKLHGCCIEG----AERLLVYEYLENKSLDQALFGQRSLTLDWATRYEICS 798
+ ++H N+++ G G + L+ + E SL L + W I
Sbjct: 72 LPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN---VVSWNELCHIAE 128
Query: 799 GVARGLAYLHEE-------SRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHI 851
+ARGLAYLHE+ + I HRD+K+ NVLL +L I+DFGLA ++ K+
Sbjct: 129 TMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAG 188
Query: 852 -STRVAGTIGYLAPEYAMRGHL-----TEKTDVFAFGVLALETVSGRPNSDPSLDEEKLY 905
+ GT Y+APE + D++A G++ E S +D +DE L
Sbjct: 189 DTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLP 248
Query: 906 LLEWAWHLHENNQEIELADPKLIE-------FNEEEVKRLIGVALLCTQTLPSLRPSMSR 958
E E+ K + L C R S
Sbjct: 249 FEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGC 308
Query: 959 VVAML 963
V +
Sbjct: 309 VGERI 313
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 249 bits (638), Expect = 2e-70
Identities = 84/297 (28%), Positives = 133/297 (44%), Gaps = 18/297 (6%)
Query: 113 GVIPDELW---NLTSLFNLNLGQNYLTGPLSPSVGNLTAMQYLNLAINALSGELPKELGQ 169
G L +L + N ++G + V +++L+++ N S +P LG
Sbjct: 165 GANVVGWVLSDGCGELKHLAISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGIP-FLGD 221
Query: 170 LTELLILGIGTNNFSGPLPSELGSLSKLQELYIDSAGVSGEIPSSFANLQSLTKWWASDT 229
+ L L I N SG + + ++L+ L I S G IP L+SL ++
Sbjct: 222 CSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPL--PLKSLQYLSLAEN 279
Query: 230 RLTGRIPDFI-GNWSKLTALRFQGNSFNGPIPSSFSNLTSVTELRISD--LSNGSSKLAF 286
+ TG IPDF+ G LT L GN F G +P F + + + L +S S G +
Sbjct: 280 KFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFS-GELPMDT 338
Query: 287 IRDMKSLSILELRNNNISDSIPSNIGEYR-SLQHLDLSFNNLGGSIPDSLFN--LSSLTH 343
+ M+ L +L+L N S +P ++ SL LDLS NN G I +L ++L
Sbjct: 339 LLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQE 398
Query: 344 LFLGNNKLNGTLPAR--KSPLLLNIDVSYNNLQGNLPSWINGQQNLQI-NLVANNLT 397
L+L NN G +P L+++ +S+N L G +PS + L+ L N L
Sbjct: 399 LYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLE 455
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 243 bits (622), Expect = 3e-68
Identities = 85/304 (27%), Positives = 137/304 (45%), Gaps = 31/304 (10%)
Query: 110 NVVGVIPDELWNLTSLFNLNLGQNYLTGPLSPSV-GNLTAMQYLNLAINALSGELPKELG 168
+ G +P + + L +L L N +G L + ++ L+L+ N SGELP+ L
Sbjct: 305 HFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLT 364
Query: 169 QLT-ELLILGIGTNNFSGPLPSELG--SLSKLQELYIDSAGVSGEIPSSFANLQSLTKWW 225
L+ LL L + +NNFSGP+ L + LQELY+ + G +G+IP + +N L
Sbjct: 365 NLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLH 424
Query: 226 ASDTRLTGRIPDFIGNWSKLTALRFQGNSFNGPIPSSFSNLTSVTELRISDLSNGSSKLA 285
S L+G IP +G+ SKL L+ N G IP + +
Sbjct: 425 LSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKT----------------- 467
Query: 286 FIRDMKSLSILELRNNNISDSIPSNIGEYRSLQHLDLSFNNLGGSIPDSLFNLSSLTHLF 345
L L L N+++ IPS + +L + LS N L G IP + L +L L
Sbjct: 468 -------LETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILK 520
Query: 346 LGNNKLNGTLPARKSPL--LLNIDVSYNNLQGNLPSWINGQ-QNLQINLVANNLTIRSSD 402
L NN +G +PA L+ +D++ N G +P+ + Q + N +A + +
Sbjct: 521 LSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKN 580
Query: 403 NSVL 406
+ +
Sbjct: 581 DGMK 584
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 235 bits (603), Expect = 9e-66
Identities = 90/288 (31%), Positives = 137/288 (47%), Gaps = 11/288 (3%)
Query: 113 GVIPDELWNLTSLFNLNLGQNYLTGPLSPSVGNLTAMQYLNLAINALSGELPKELGQLTE 172
G IP EL + +L L L N LTG + + N T + +++L+ N L+GE+PK +G+L
Sbjct: 456 GEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLEN 515
Query: 173 LLILGIGTNNFSGPLPSELGSLSKLQELYIDSAGVSGEIPSSFANLQSLTKWWASDTRLT 232
L IL + N+FSG +P+ELG L L +++ +G IP++ + +
Sbjct: 516 LAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKI----AANFIA 571
Query: 233 GRIPDFIGNWSKLTALRFQGN--SFNGPIPSSFSNLTSVTELRISDLSNGSSKLAFIRDM 290
G+ +I N GN F G + L++ I+ G +
Sbjct: 572 GKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNN 631
Query: 291 KSLSILELRNNNISDSIPSNIGEYRSLQHLDLSFNNLGGSIPDSLFNLSSLTHLFLGNNK 350
S+ L++ N +S IP IG L L+L N++ GSIPD + +L L L L +NK
Sbjct: 632 GSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNK 691
Query: 351 LNGTLPARKSPL--LLNIDVSYNNLQGNLPSWINGQ-QNLQINLVANN 395
L+G +P S L L ID+S NNL G +P GQ + NN
Sbjct: 692 LDGRIPQAMSALTMLTEIDLSNNNLSGPIPE--MGQFETFPPAKFLNN 737
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 235 bits (603), Expect = 1e-65
Identities = 94/365 (25%), Positives = 157/365 (43%), Gaps = 43/365 (11%)
Query: 60 WNRSGDPC--TG--------AALDDSIVFDNTDYNPFIKCDCSSQNGTVCHITQLKVYAL 109
W+ + +PC G ++D S N ++ SS ++ + L +
Sbjct: 33 WSSNKNPCTFDGVTCRDDKVTSIDLSSKPLNVGFSAV-----SSSLLSLTGLESLFLSNS 87
Query: 110 NVVGVIPDELWNLTSLFNLNLGQNYLTGPLSP--SVGNLTAMQYLNLAINALSGELPKEL 167
++ G + SL +L+L +N L+GP++ S+G+ + +++LN++ N L
Sbjct: 88 HINGSVS-GFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSG 146
Query: 168 G-QLTELLILGIGTNNFSGPLPSEL---GSLSKLQELYIDSAGVSGEIPSSFANLQSLTK 223
G +L L +L + N+ SG +L+ L I +SG++ + +L
Sbjct: 147 GLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKHLAISGNKISGDVD--VSRCVNLEF 204
Query: 224 WWASDTRLTGRIPDFIGNWSKLTALRFQGNSFNGPIPSSFSNLTSVTELRISD--LSNGS 281
S + IP F+G+ S L L GN +G + S T + L IS G
Sbjct: 205 LDVSSNNFSTGIP-FLGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFV-GP 262
Query: 282 ---SKLAFIRDMKSLSILELRNNNISDSIPSNI-GEYRSLQHLDLSFNNLGGSIPDSLFN 337
L KSL L L N + IP + G +L LDLS N+ G++P +
Sbjct: 263 IPPLPL------KSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGS 316
Query: 338 LSSLTHLFLGNNKLNGTLPA---RKSPLLLNIDVSYNNLQGNLPSWI-NGQQNLQ-INLV 392
S L L L +N +G LP K L +D+S+N G LP + N +L ++L
Sbjct: 317 CSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLS 376
Query: 393 ANNLT 397
+NN +
Sbjct: 377 SNNFS 381
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 221 bits (565), Expect = 1e-60
Identities = 71/292 (24%), Positives = 122/292 (41%), Gaps = 35/292 (11%)
Query: 113 GVIPDELWN--LTSLFNLNLGQNYLTGPLSPSVGNLTAMQYLNLAINALSGELPKELGQL 170
G I L +L L L N TG + P++ N + + L+L+ N LSG +P LG L
Sbjct: 382 GPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSL 441
Query: 171 TELLILGIGTNNFSGPLPSELGSLSKLQELYIDSAGVSGEIPSSFANLQSLTKWWASDTR 230
++L L + N G +P EL + L+ L +D ++GEIPS +N +L S+ R
Sbjct: 442 SKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNR 501
Query: 231 LTGRIPDFIGNWSKLTALRFQGNSFNGPIPSSFSNLTSVTELRISDLSNGSSKLAFIRDM 290
LTG IP +IG L L+ NSF+G IP+ +
Sbjct: 502 LTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDC------------------------ 537
Query: 291 KSLSILELRNNNISDSIPSNIGEYRSLQHLDLSFNNLGGSIPDSLFNLSSLTHLFLGNN- 349
+SL L+L N + +IP+ + + Q ++ N + G + N N
Sbjct: 538 RSLIWLDLNTNLFNGTIPAAMFK----QSGKIAANFIAGKRYVYIKNDGMKKECHGAGNL 593
Query: 350 -KLNGTLPAR--KSPLLLNIDVSYNNLQGNLPSWINGQQNLQ-INLVANNLT 397
+ G + + +++ G+ + ++ +++ N L+
Sbjct: 594 LEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLS 645
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 2e-30
Identities = 48/160 (30%), Positives = 79/160 (49%), Gaps = 1/160 (0%)
Query: 95 NGTVCHITQLKVYALNVVGVIPDELWNLTSLFNLNLGQNYLTGPLSPSVGNLTAMQYLNL 154
N + L G+ ++L L++ N+ G SP+ N +M +L++
Sbjct: 580 NDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDM 639
Query: 155 AINALSGELPKELGQLTELLILGIGTNNFSGPLPSELGSLSKLQELYIDSAGVSGEIPSS 214
+ N LSG +PKE+G + L IL +G N+ SG +P E+G L L L + S + G IP +
Sbjct: 640 SYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQA 699
Query: 215 FANLQSLTKWWASDTRLTGRIPDFIGNWSKLTALRFQGNS 254
+ L LT+ S+ L+G IP+ +G + +F N
Sbjct: 700 MSALTMLTEIDLSNNNLSGPIPE-MGQFETFPPAKFLNNP 738
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 236 bits (604), Expect = 2e-70
Identities = 82/291 (28%), Positives = 133/291 (45%), Gaps = 35/291 (12%)
Query: 112 VGVIPDELWNLTSLFNLNLGQNYLTG--PLSPSVGNLTAMQYLNLA-INALSGELPKELG 168
+GV+ D + NL+L L P+ S+ NL + +L + IN L G +P +
Sbjct: 39 LGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIA 98
Query: 169 QLTELLILGIGTNNFSGPLPSELGSLSKLQELYIDSAGVSGEIPSSFANLQSLTKWWASD 228
+LT+L L I N SG +P L + L L +SG +P S ++L +L
Sbjct: 99 KLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDG 158
Query: 229 TRLTGRIPDFIGNWSKL-TALRFQGNSFNGPIPSSFSNLTSVTELRISDLSNGSSKLAFI 287
R++G IPD G++SKL T++ N G IP +F+NL
Sbjct: 159 NRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANL--------------------- 197
Query: 288 RDMKSLSILELRNNNISDSIPSNIGEYRSLQHLDLSFNNLGGSIPDSLFNLSSLTHLFLG 347
+L+ ++L N + G ++ Q + L+ N+L + + +L L L
Sbjct: 198 ----NLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLR 252
Query: 348 NNKLNGTLPA--RKSPLLLNIDVSYNNLQGNLPSWINGQ-QNLQINLVANN 395
NN++ GTLP + L +++VS+NNL G +P G Q ++ ANN
Sbjct: 253 NNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ--GGNLQRFDVSAYANN 301
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 208 bits (531), Expect = 2e-60
Identities = 71/251 (28%), Positives = 108/251 (43%), Gaps = 30/251 (11%)
Query: 110 NVVGVIPDELWNLTSLFNLNLGQNYLTGPLSPSVGNLTAMQYLNLAINALSGELPKELGQ 169
N+VG IP + LT L L + ++G + + + + L+ + NALSG LP +
Sbjct: 88 NLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISS 147
Query: 170 LTELLILGIGTNNFSGPLPSELGSLSKL-QELYIDSAGVSGEIPSSFANLQSLTKWWASD 228
L L+ + N SG +P GS SKL + I ++G+IP +FANL +L S
Sbjct: 148 LPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANL-NLAFVDLSR 206
Query: 229 TRLTGRIPDFIGNWSKLTALRFQGNSFNGPIPSSFSNLTSVTELRISDLSNGSSKLAFIR 288
L G G+ + NS + +
Sbjct: 207 NMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK-------------------------VG 241
Query: 289 DMKSLSILELRNNNISDSIPSNIGEYRSLQHLDLSFNNLGGSIPDSLFNLSSLTHL-FLG 347
K+L+ L+LRNN I ++P + + + L L++SFNNL G IP NL +
Sbjct: 242 LSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGG-NLQRFDVSAYAN 300
Query: 348 NNKLNGT-LPA 357
N L G+ LPA
Sbjct: 301 NKCLCGSPLPA 311
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 78.3 bits (194), Expect = 1e-15
Identities = 28/104 (26%), Positives = 48/104 (46%), Gaps = 6/104 (5%)
Query: 300 NNNISDSIPSNIGEYRSLQHLDLSFNNLGGS--IPDSLFNLSSLTHLFLGN-NKLNGTLP 356
N + + + +LDLS NL IP SL NL L L++G N L G +P
Sbjct: 35 NRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIP 94
Query: 357 AR--KSPLLLNIDVSYNNLQGNLPSWINGQQNLQ-INLVANNLT 397
K L + +++ N+ G +P +++ + L ++ N L+
Sbjct: 95 PAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALS 138
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 53.3 bits (129), Expect = 2e-07
Identities = 21/102 (20%), Positives = 35/102 (34%), Gaps = 10/102 (9%)
Query: 306 SIPSNIGEYRSLQ----HLDLSFNNLGGSIPDSLFNLSSLTHLFLGNNKLNGTLPARKS- 360
I ++G +L D G + D+ + +L L L P S
Sbjct: 13 QIKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSL 72
Query: 361 ---PLLLNIDVS-YNNLQGNLPSWINGQQNLQ-INLVANNLT 397
P L + + NNL G +P I L + + N++
Sbjct: 73 ANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVS 114
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 234 bits (598), Expect = 2e-69
Identities = 77/317 (24%), Positives = 121/317 (38%), Gaps = 42/317 (13%)
Query: 683 FSYAELKTATENFSPSNKLGEGGFGPVYKGKLGDGRAIAVKQLSVASRQGKSQFVAEIAT 742
+ +E +N +G G +G VYKG L D R +AVK S A+RQ I
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQNFINEK-NIYR 60
Query: 743 ISAVQHRNLVKLHGCCIEG-----AERLLVYEYLENKSLDQALFGQRSLTLDWATRYEIC 797
+ ++H N+ + E LLV EY N SL + L T DW + +
Sbjct: 61 VPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLH---TSDWVSSCRLA 117
Query: 798 SGVARGLAYLHEE------SRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYD------ 845
V RGLAYLH E + I HRD+ + NVL+ D ISDFGL+
Sbjct: 118 HSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVR 177
Query: 846 -DKKTHISTRVAGTIGYLAPEYAM-------RGHLTEKTDVFAFGVLALETVSGRPNSDP 897
++ + + GTI Y+APE ++ D++A G++ E + P
Sbjct: 178 PGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFP 237
Query: 898 SLDEEKLYLLEWAWHLHENNQEIELAD-----------PKLIEFNEEEVKRLIGVALLCT 946
+ Y + + + + ++ P+ + N V+ L C
Sbjct: 238 GESVPE-YQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCW 296
Query: 947 QTLPSLRPSMSRVVAML 963
R + +
Sbjct: 297 DQDAEARLTAQXAEERM 313
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 191 bits (488), Expect = 1e-54
Identities = 85/267 (31%), Positives = 124/267 (46%), Gaps = 24/267 (8%)
Query: 699 NKLGEGGFGPVYKGKLGDGRAIAVKQLSVASRQGKSQFVAEIATISAVQHRNLVKLHGCC 758
+G G FG V K K + +A+KQ+ S + F+ E+ +S V H N+VKL+G C
Sbjct: 14 EVVGRGAFGVVCKAKW-RAKDVAIKQIE--SESERKAFIVELRQLSRVNHPNIVKLYGAC 70
Query: 759 IEGAERLLVYEYLENKSLDQALFGQRSL-TLDWATRYEICSGVARGLAYLHEESRVRIIH 817
+ LV EY E SL L G L A C ++G+AYLH +IH
Sbjct: 71 LN--PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIH 128
Query: 818 RDVKASNVLLDAD-LVPKISDFGLAKLYDDKKTHISTRVAGTIGYLAPEYAMRGHLTEKT 876
RD+K N+LL A V KI DFG A T G+ ++APE + +EK
Sbjct: 129 RDLKPPNLLLVAGGTVLKICDFGTACD----IQTHMTNNKGSAAWMAPEVFEGSNYSEKC 184
Query: 877 DVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEIELADPKLIEFNEEEVK 936
DVF++G++ E ++ R P DE W +H + P LI+ + ++
Sbjct: 185 DVFSWGIILWEVITRR---KPF-DEIGGPAFRIMWAVHNGTR------PPLIKNLPKPIE 234
Query: 937 RLIGVALLCTQTLPSLRPSMSRVVAML 963
L+ C PS RPSM +V ++
Sbjct: 235 SLM---TRCWSKDPSQRPSMEEIVKIM 258
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 189 bits (482), Expect = 7e-54
Identities = 76/309 (24%), Positives = 131/309 (42%), Gaps = 29/309 (9%)
Query: 659 VRRRKRPQHDDDEELLGMDARPYTFSYAELKTATENFSPSNKLGEGGFGPVYKGKLGDGR 718
+ P ++ MD + +L K+G G FG V++ + G
Sbjct: 10 MSDYDIPTTENLYFQGAMDGDDMDIPWCDLNI-------KEKIGAGSFGTVHRAEW-HGS 61
Query: 719 AIAVKQLSVASRQGKS--QFVAEIATISAVQHRNLVKLHGCCIEGAERLLVYEYLENKSL 776
+AVK L + +F+ E+A + ++H N+V G + +V EYL SL
Sbjct: 62 DVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSL 121
Query: 777 DQALFGQRS-LTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKI 835
+ L + LD R + VA+G+ YLH + I+HR++K+ N+L+D K+
Sbjct: 122 YRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPP-IVHRNLKSPNLLVDKKYTVKV 180
Query: 836 SDFGLAKLYDDKKTHISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGR-PN 894
DFGL++L S AGT ++APE EK+DV++FGV+ E + + P
Sbjct: 181 CDFGLSRLKASTFLS-SKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPW 239
Query: 895 SDPSLDEEKLYLLEWAWHLHENNQEIELADPKLIEFNEEEVKRLIGVALLCTQTLPSLRP 954
+ L + + + ++ +V +I C P RP
Sbjct: 240 GN-------LNPAQVVAAVGFKCKR-----LEIPRNLNPQVAAII---EGCWTNEPWKRP 284
Query: 955 SMSRVVAML 963
S + ++ +L
Sbjct: 285 SFATIMDLL 293
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 182 bits (465), Expect = 5e-52
Identities = 73/280 (26%), Positives = 118/280 (42%), Gaps = 39/280 (13%)
Query: 699 NKLGEGGFGPVYKGKLGDGRAIAVKQLSVASRQGKS----QFVAEIATISAVQHRNLVKL 754
+G GGFG VY+ G +AVK + S E + ++H N++ L
Sbjct: 13 EIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIAL 71
Query: 755 HGCCIEGAERLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVR 814
G C++ LV E+ L++ L G+R + +ARG+ YLH+E+ V
Sbjct: 72 RGVCLKEPNLCLVMEFARGGPLNRVLSGKR---IPPDILVNWAVQIARGMNYLHDEAIVP 128
Query: 815 IIHRDVKASNVLLDADLVP--------KISDFGLAKLYDDKKTHISTRVAGTIGYLAPEY 866
IIHRD+K+SN+L+ + KI+DFGLA+ AG ++APE
Sbjct: 129 IIHRDLKSSNILILQKVENGDLSNKILKITDFGLARE---WHRTTKMSAAGAYAWMAPEV 185
Query: 867 AMRGHLTEKTDVFAFGVLALETVSGR---PNSDPSLDEEKLYLLEWAWHLHENNQEIELA 923
++ +DV+++GVL E ++G D L A+ + N
Sbjct: 186 IRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDG---------LAVAYGVAMNKLA---- 232
Query: 924 DPKLIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVAML 963
+ E +L+ C P RPS + ++ L
Sbjct: 233 -LPIPSTCPEPFAKLM---EDCWNPDPHSRPSFTNILDQL 268
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 182 bits (464), Expect = 7e-52
Identities = 58/274 (21%), Positives = 104/274 (37%), Gaps = 33/274 (12%)
Query: 699 NKLGEGGFGPVYKGKLGDGRAIAVKQLSVASRQGKS--QFVAEIATISAVQHRNLVKLHG 756
KL E G ++KG+ G I VK L V + F E + H N++ + G
Sbjct: 16 TKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLG 74
Query: 757 CCIEGAERLL--VYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVR 814
C + ++ SL L + +D + + +ARG+A+LH +
Sbjct: 75 ACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPL- 133
Query: 815 IIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVAGTIGYLAPEYAMRG---- 870
I + + +V++D D+ +IS + + S ++APE A++
Sbjct: 134 IPRHALNSRSVMIDEDMTARISMADVKFSFQ------SPGRMYAPAWVAPE-ALQKKPED 186
Query: 871 HLTEKTDVFAFGVLALETVSGR-PNSDPSLDEEKLYLLEWAWHLHENNQEIELADPKLIE 929
D+++F VL E V+ P +D L +E + P +
Sbjct: 187 TNRRSADMWSFAVLLWELVTREVPFAD-------LSNMEIGMKVALEGLR-----PTIPP 234
Query: 930 FNEEEVKRLIGVALLCTQTLPSLRPSMSRVVAML 963
V +L+ +C P+ RP +V +L
Sbjct: 235 GISPHVSKLM---KICMNEDPAKRPKFDMIVPIL 265
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 182 bits (465), Expect = 8e-52
Identities = 69/280 (24%), Positives = 129/280 (46%), Gaps = 35/280 (12%)
Query: 699 NKLGEGGFGPVYKGK-LGDGRAIAVKQLSVASRQGKS-------QFVAEIATISAVQHRN 750
++G+GGFG V+KG+ + D +A+K L + +G++ +F E+ +S + H N
Sbjct: 25 KQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPN 84
Query: 751 LVKLHGCCIEGAERLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEE 810
+VKL+G +V E++ L L + + W+ + + +A G+ Y+ +
Sbjct: 85 IVKLYGLMHNPP--RMVMEFVPCGDLYHRLLDKAH-PIKWSVKLRLMLDIALGIEYMQNQ 141
Query: 811 SRVRIIHRDVKASNVLLD-----ADLVPKISDFGLAKLYDDKKTHISTRVAGTIGYLAPE 865
+ I+HRD+++ N+ L A + K++DFGL++ H + + G ++APE
Sbjct: 142 NPP-IVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ----SVHSVSGLLGNFQWMAPE 196
Query: 866 --YAMRGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEIELA 923
A TEK D ++F ++ ++G P DE +++ + E
Sbjct: 197 TIGAEEESYTEKADTYSFAMILYTILTGE---GP-FDEYSYGKIKFINMIREEGLR---- 248
Query: 924 DPKLIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVAML 963
P + E ++ +I LC P RP S +V L
Sbjct: 249 -PTIPEDCPPRLRNVI---ELCWSGDPKKRPHFSYIVKEL 284
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 188 bits (480), Expect = 1e-50
Identities = 50/331 (15%), Positives = 100/331 (30%), Gaps = 50/331 (15%)
Query: 115 IPDELWNLTSLFNLNLGQNYLTGP-------------------LSPSVGNLTAMQYLNLA 155
+ + LT L +G + NL + + +
Sbjct: 198 VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVY 257
Query: 156 INALSGELPKELGQLTELLILGIGTNNF--------SGPLPSELGSLSKLQELYIDS-AG 206
+LP L L E+ ++ + N ++ K+Q +YI
Sbjct: 258 NCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNL 317
Query: 207 VSGEIPSSFANLQSLTKWWASDTRLTGRIPDFIGNWSKLTALRFQGNSFNGPIPSSFSNL 266
+ + +S ++ L +L G++P F G+ KL +L N +
Sbjct: 318 KTFPVETSLQKMKKLGMLECLYNQLEGKLPAF-GSEIKLASLNLAYNQITEIPANFCGFT 376
Query: 267 TSVTELRISD--LSNGSSKLAFIRDMKSLSILELRNNNIS-------DSIPSNIGEYRSL 317
V L + L + + + +S ++ N I D + + ++
Sbjct: 377 EQVENLSFAHNKLKYIPNIF-DAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINV 435
Query: 318 QHLDLSFNNLGGSIPDSLFNLSSLTHLFLGNNKLNGTLPARKSPLLLNI---------DV 368
++LS N + + S L+ + L N L N D+
Sbjct: 436 SSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDL 495
Query: 369 SYNNLQGNLPSWINGQ-QNLQ-INLVANNLT 397
+N L + L I+L N+ +
Sbjct: 496 RFNKLTKLSDDFRATTLPYLVGIDLSYNSFS 526
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 165 bits (420), Expect = 8e-43
Identities = 55/354 (15%), Positives = 105/354 (29%), Gaps = 50/354 (14%)
Query: 60 WNRSGDPCT-GAALDDSIVFDNTDYNPFIKCDCSSQNGTVCHITQLKVYALNVVGVIPDE 118
W++ G GA + + D P + + + +T L + G +PD
Sbjct: 47 WSQQGFGTQPGANWNFNKELDMWGAQPGVSLNSNG------RVTGLSLEGFGASGRVPDA 100
Query: 119 LWNLTSLFNLNLGQNYLTGPLSPSVGNLTAMQYLNLAINALSGELPKELGQLTELLILGI 178
+ LT L L LG + PK +
Sbjct: 101 IGQLTELEVLALGSHGEKVNERLF--------------------GPKGISANMSDEQKQK 140
Query: 179 GTNNFSGPLPSELG--SLSKLQELYIDSAGVSGEIPSSFANLQSLTKWWASDTRLTGRIP 236
++ S L + I+S I S T+ +T +
Sbjct: 141 MRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITF-VS 199
Query: 237 DFIGNWSKLTALRFQGNSFNGPIPSSFSNLTSVTELRISDLSNGSSKLAFIRDMKSLSIL 296
+ +KL + F + + + ++K L+ +
Sbjct: 200 KAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLK-----WDNLKDLTDV 254
Query: 297 ELRNNNISDSIPSNIGEYRSLQHLDLSFNNL--------GGSIPDSLFNLSSLTHLFLGN 348
E+ N +P+ + +Q ++++ N + +++G
Sbjct: 255 EVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGY 314
Query: 349 NKLNGTLPARKS----PLLLNIDVSYNNLQGNLPSWINGQQNLQ-INLVANNLT 397
N L T P S L ++ YN L+G LP+ + L +NL N +T
Sbjct: 315 NNLK-TFPVETSLQKMKKLGMLECLYNQLEGKLPA-FGSEIKLASLNLAYNQIT 366
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 4e-41
Identities = 38/284 (13%), Positives = 86/284 (30%), Gaps = 28/284 (9%)
Query: 115 IPDELWNLTSLFNLNLGQNYLTGPLSPSVGNLTAMQYLNLAINALSGELPK--ELGQLTE 172
+ L +LNL N +T + G ++ L+ A N L +P + ++
Sbjct: 345 KLPAFGSEIKLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLK-YIPNIFDAKSVSV 403
Query: 173 LLILGIGTNNFSG-------PLPSELGSLSKLQELYIDSAGVSGEIPSSFANLQSLTKWW 225
+ + N PL + + + + +S F+ L+
Sbjct: 404 MSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSIN 463
Query: 226 ASDTRLTG-------RIPDFIGNWSKLTALRFQGNSFNG-PIPSSFSNLTSVTELRISD- 276
LT + N LT++ + N + L + + +S
Sbjct: 464 LMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLTKLSDDFRATTLPYLVGIDLSYN 523
Query: 277 ----LSNGSSKLAFIRDMKSLSILELRNNNISDSIPSNIGEYRSLQHLDLSFNNLGGSIP 332
+ ++ + + + N P I SL L + N++ +
Sbjct: 524 SFSKFPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDI-RKVN 582
Query: 333 DSLFNLSSLTHLFLGNNKLNGTLPARKSPL--LLNIDVSYNNLQ 374
+ + +++ L + +N + P + Y+ Q
Sbjct: 583 EKI--TPNISVLDIKDNPNISIDLSYVCPYIEAGMYMLFYDKTQ 624
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 2e-05
Identities = 9/70 (12%), Positives = 23/70 (32%), Gaps = 3/70 (4%)
Query: 113 GVIPDELWNLTSLFNLNLGQNYLTGPLSPSVGNLTAMQYLNLAINALSGELPKELGQLTE 172
P+ + SL L +G N + ++ + + L++ N + E
Sbjct: 556 REWPEGITLCPSLTQLQIGSNDIRK-VNEKI--TPNISVLDIKDNPNISIDLSYVCPYIE 612
Query: 173 LLILGIGTNN 182
+ + +
Sbjct: 613 AGMYMLFYDK 622
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 179 bits (455), Expect = 3e-50
Identities = 66/288 (22%), Positives = 111/288 (38%), Gaps = 49/288 (17%)
Query: 699 NKLGEGGFGPVYKGKL-GDGRAIAVKQLSVASRQGKSQFVAEIATISAVQHRNLVKLHGC 757
LG+G FG K G + +K+L + + F+ E+ + ++H N++K G
Sbjct: 16 EVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGV 75
Query: 758 CIEGAERLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIH 817
+ + EY++ +L + S W+ R +A G+AYLH + IIH
Sbjct: 76 LYKDKRLNFITEYIKGGTLRGIIKSMDS-QYPWSQRVSFAKDIASGMAYLHSMN---IIH 131
Query: 818 RDVKASNVLLDADLVPKISDFGLAKLYDDKKTH-------------ISTRVAGTIGYLAP 864
RD+ + N L+ + ++DFGLA+L D+KT V G ++AP
Sbjct: 132 RDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAP 191
Query: 865 EYAMRGHLTEKTDVFAFGVLALETVSG---RPNSDPS-----LDEEKLYLLEWAWHLHEN 916
E EK DVF+FG++ E + P+ P L+
Sbjct: 192 EMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFL----------- 240
Query: 917 NQEI-ELADPKLIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVAML 963
++ P + + C P RPS ++ L
Sbjct: 241 DRYCPPNCPPSFFP-----------ITVRCCDLDPEKRPSFVKLEHWL 277
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 174 bits (442), Expect = 1e-48
Identities = 76/274 (27%), Positives = 132/274 (48%), Gaps = 29/274 (10%)
Query: 699 NKLGEGGFGPVYKGKL-GDGRAIAVKQLSVASRQGKS--QFVAEIATISAVQHRNLVKLH 755
++G G FG VYKGK GD +AVK L+V + + F E+ + +H N++
Sbjct: 30 QRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 86
Query: 756 GCCIEGAERL-LVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVR 814
G +L +V ++ E SL L + + +I ARG+ YLH +S
Sbjct: 87 GYSTA--PQLAIVTQWCEGSSLYHHLHASET-KFEMKKLIDIARQTARGMDYLHAKS--- 140
Query: 815 IIHRDVKASNVLLDADLVPKISDFGLAKL-YDDKKTHISTRVAGTIGYLAPE---YAMRG 870
IIHRD+K++N+ L D KI DFGLA +H +++G+I ++APE
Sbjct: 141 IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSN 200
Query: 871 HLTEKTDVFAFGVLALETVSGR-PNSDPSLDEEKLYLLEWAWHLHENNQEIELADPKLIE 929
+ ++DV+AFG++ E ++G+ P S+ + ++ + ++ + K+
Sbjct: 201 PYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVG--------RGSLSPDLSKVRS 252
Query: 930 FNEEEVKRLIGVALLCTQTLPSLRPSMSRVVAML 963
+ +KRL+ C + RPS R++A +
Sbjct: 253 NCPKRMKRLM---AECLKKKRDERPSFPRILAEI 283
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 170 bits (433), Expect = 6e-47
Identities = 66/290 (22%), Positives = 109/290 (37%), Gaps = 31/290 (10%)
Query: 699 NKLGEGGFGPVYKGKLGDGRAIAVKQLSVASRQGKSQFV-AEIATISAVQHRNLVKLHGC 757
++G+G +G V+ GK G +AVK + + S F EI ++H N++
Sbjct: 43 KQIGKGRYGEVWMGKW-RGEKVAVKVFF--TTEEASWFRETEIYQTVLMRHENILGFIAA 99
Query: 758 CIEGAER----LLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRV 813
I+G L+ +Y EN SL L +S TLD + ++ GL +LH E
Sbjct: 100 DIKGTGSWTQLYLITDYHENGSLYDYL---KSTTLDAKSMLKLAYSSVSGLCHLHTEIFS 156
Query: 814 R-----IIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHI---STRVAGTIGYLAPE 865
I HRD+K+ N+L+ + I+D GLA + + GT Y+ PE
Sbjct: 157 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPE 216
Query: 866 ------YAMRGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQE 919
D+++FG++ E + + + Y +
Sbjct: 217 VLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMR 276
Query: 920 IELADPKL---IEFNEEEVKRLIGVALL---CTQTLPSLRPSMSRVVAML 963
+ KL + L + L C P+ R + RV L
Sbjct: 277 EIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTL 326
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 167 bits (426), Expect = 3e-46
Identities = 58/285 (20%), Positives = 112/285 (39%), Gaps = 46/285 (16%)
Query: 699 NKLGEGGFGPVYKGKL-GDGRAIAVKQLSVA--SRQGKSQFVAEIATISAVQHRNLVKLH 755
+G+G FG VY G+ G+ +A++ + + + F E+ +H N+V
Sbjct: 39 ELIGKGRFGQVYHGRWHGE---VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFM 95
Query: 756 GCCIEGAERLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRI 815
G C+ ++ + ++L + + LD +I + +G+ YLH + I
Sbjct: 96 GACMSPPHLAIITSLCKGRTLYSVVRDAKI-VLDVNKTRQIAQEIVKGMGYLHAKG---I 151
Query: 816 IHRDVKASNVLLDADLVPKISDFGLAKL----YDDKKTHISTRVAGTIGYLAPE------ 865
+H+D+K+ NV D V I+DFGL + ++ G + +LAPE
Sbjct: 152 LHKDLKSKNVFYDNGKV-VITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLS 210
Query: 866 ---YAMRGHLTEKTDVFAFGVLALETVSGR---PNSDPSLDEEKLYLLEWAWHLHENNQE 919
+ ++ +DVFA G + E + W + +
Sbjct: 211 PDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPA---------EAIIWQMGTGMK- 260
Query: 920 IELADPKLIEFN-EEEVKRLIGVALLCTQTLPSLRPSMSRVVAML 963
P L + +E+ ++ L C RP+ ++++ ML
Sbjct: 261 -----PNLSQIGMGKEISDIL---LFCWAFEQEERPTFTKLMDML 297
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 167 bits (424), Expect = 3e-46
Identities = 67/302 (22%), Positives = 119/302 (39%), Gaps = 35/302 (11%)
Query: 689 KTATENFSPSNKLGEGGFGPVYKGKLGDGRAIAVKQLSVASRQGKSQFVAE--IATISAV 746
+T + + +G+G +G V++G G +AVK S + + + E + +
Sbjct: 4 RTVARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFS---SRDEKSWFRETELYNTVML 59
Query: 747 QHRNLVKLHGCCIEGA----ERLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVAR 802
+H N++ + + L+ Y E SL L + TLD + I +A
Sbjct: 60 RHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYL---QLTTLDTVSCLRIVLSIAS 116
Query: 803 GLAYLHEESRVR-----IIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHI---STR 854
GLA+LH E I HRD+K+ N+L+ + I+D GLA ++ + +
Sbjct: 117 GLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNP 176
Query: 855 VAGTIGYLAPE------YAMRGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLE 908
GT Y+APE ++ D++AFG++ E R S+ +++ K +
Sbjct: 177 RVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVAR-RMVSNGIVEDYKPPFYD 235
Query: 909 WAWHLHENNQEIELADPK----LIEFNEEEVKRLIGVALL---CTQTLPSLRPSMSRVVA 961
+ ++ I L +A L C PS R + R+
Sbjct: 236 VVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK 295
Query: 962 ML 963
L
Sbjct: 296 TL 297
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 166 bits (422), Expect = 2e-45
Identities = 66/292 (22%), Positives = 113/292 (38%), Gaps = 35/292 (11%)
Query: 699 NKLGEGGFGPVYKGKLGDGRAIAVKQLSVASRQGKSQFVAE--IATISAVQHRNLVKLHG 756
+G+G FG V++GK G +AVK S + + + E I ++H N++
Sbjct: 48 ESIGKGRFGEVWRGKW-RGEEVAVKIFS---SREERSWFREAEIYQTVMLRHENILGFIA 103
Query: 757 CCIEGA----ERLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEE-- 810
+ + LV +Y E+ SL L T+ ++ A GLA+LH E
Sbjct: 104 ADNKDNGTWTQLWLVSDYHEHGSLFDYL---NRYTVTVEGMIKLALSTASGLAHLHMEIV 160
Query: 811 ---SRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHI---STRVAGTIGYLAP 864
+ I HRD+K+ N+L+ + I+D GLA +D I GT Y+AP
Sbjct: 161 GTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 220
Query: 865 EYAMRGHL-------TEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENN 917
E + + ++ D++A G++ E D + Y
Sbjct: 221 E-VLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEE 279
Query: 918 QEIELADPKL---IEFNEEEVKRLIGVALL---CTQTLPSLRPSMSRVVAML 963
+ + KL I + + L +A + C + R + R+ L
Sbjct: 280 MRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTL 331
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 172 bits (437), Expect = 8e-45
Identities = 64/304 (21%), Positives = 114/304 (37%), Gaps = 15/304 (4%)
Query: 115 IPDELWNLTSLFNLNLGQNYLTGPLSPSVGNLTAMQYLNLAINALSGELPKELGQLTELL 174
+PD+L T++ LNL N L + + + + L++ N +S P+ +L L
Sbjct: 19 VPDDL--PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLK 76
Query: 175 ILGIGTNNFSGPLPSELGSLSKLQELYIDSAGVSGEIPSSFANLQSLTKWWASDTRLTGR 234
+L + N S + L EL++ S + + F ++L S L+
Sbjct: 77 VLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSST 136
Query: 235 IPDFIGNWSKLTALRFQGNSFNGPIPSSFSNLTSVTELRISDLSN----GSSKLAFIRDM 290
L L N + + L+ +LS+ S F +
Sbjct: 137 KLGTQVQLENLQELLLSNNKIQALKSEELDIFAN-SSLKKLELSSNQIKEFSPGCF-HAI 194
Query: 291 KSLSILELRNNNISDSIPSNIGEY---RSLQHLDLSFNNLGGSIPDSLFNL--SSLTHLF 345
L L L N + S+ + S+++L LS + L + + L ++LT L
Sbjct: 195 GRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLD 254
Query: 346 LGNNKLNGTLPA--RKSPLLLNIDVSYNNLQGNLPSWINGQQNLQINLVANNLTIRSSDN 403
L N LN P L + YNN+Q ++G N++ + + T +S
Sbjct: 255 LSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISL 314
Query: 404 SVLP 407
+ LP
Sbjct: 315 ASLP 318
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 169 bits (430), Expect = 7e-44
Identities = 59/313 (18%), Positives = 112/313 (35%), Gaps = 19/313 (6%)
Query: 113 GVIPDELWNLTSLFNLNLGQNYLTGPLSPSVGNLTAMQYLNLAINALSGELPKELGQLTE 172
+ P+ L L LNL N L+ + T + L+L N++ +
Sbjct: 63 KLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKN 122
Query: 173 LLILGIGTNNFSGPLPSELGSLSKLQELYIDSAGVSGEIPSSFANLQ--SLTKWWASDTR 230
L+ L + N S L LQEL + + + SL K S +
Sbjct: 123 LITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQ 182
Query: 231 LTGRIPDFIGNWSKLTALRFQGNSFNGPIPSSFSNLTSVTELRISDLSN----GSSKLAF 286
+ P +L L + + T +R LSN +S F
Sbjct: 183 IKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTF 242
Query: 287 IR-DMKSLSILELRNNNISDSIPSNIGEYRSLQHLDLSFNNLGGSIPDSLFNLSSLTHLF 345
+ +L++L+L NN++ + L++ L +NN+ SL L ++ +L
Sbjct: 243 LGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLN 302
Query: 346 LGNNKLNGTLPARK---------SPL--LLNIDVSYNNLQGNLPSWINGQQNLQ-INLVA 393
L + ++ L L ++++ N++ G + G NL+ ++L
Sbjct: 303 LKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSN 362
Query: 394 NNLTIRSSDNSVL 406
+ ++R+ N
Sbjct: 363 SFTSLRTLTNETF 375
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 167 bits (424), Expect = 4e-43
Identities = 60/309 (19%), Positives = 103/309 (33%), Gaps = 25/309 (8%)
Query: 113 GVIPDELWNLTSLFNLNLGQNYLTG----PLSPSVGNLTAMQYLNLAINALSGELPKELG 168
G+ + L +L L+L ++ + + + + LNL N +S
Sbjct: 343 GIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFS 402
Query: 169 QLTELLILGIGTNNFSGPLP-SELGSLSKLQELYIDSAGVSGEIPSSFANLQSLTKWWAS 227
L L +L +G N L E L + E+Y+ +SFA + SL +
Sbjct: 403 WLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLR 462
Query: 228 DTRLTG--RIPDFIGNWSKLTALRFQGNSFNGPIPSSFSNLTSVTELRISD--------L 277
L P LT L N+ L + L +
Sbjct: 463 RVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKH 522
Query: 278 SNGSSKLAFIRDMKSLSILELRNNNISDSIPSNIGEYRSLQHLDLSFNNLGGSIPDSLFN 337
+N + F++ + L IL L +N + + L+ +DL NNL N
Sbjct: 523 ANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNN 582
Query: 338 LSSLTHLFLGNNKLNGTLPARKSPLLLN---IDVSYNNLQGN------LPSWINGQQNLQ 388
SL L L N + P N +D+ +N +WIN + +
Sbjct: 583 QVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCESIAWFVNWIN-ETHTN 641
Query: 389 INLVANNLT 397
I ++++
Sbjct: 642 IPELSSHYL 650
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 165 bits (420), Expect = 1e-42
Identities = 52/316 (16%), Positives = 117/316 (37%), Gaps = 33/316 (10%)
Query: 110 NVVGVIPDELWNLTSLFNLNLGQNYLTGPLSPSVGNLTAMQYLNLAINALSGELPKELG- 168
++ + + +L L+L N L+ + L +Q L L+ N + +EL
Sbjct: 108 SIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDI 167
Query: 169 -QLTELLILGIGTNNFSGPLPSELGSLSKLQELYIDSAGVSGEIPSSFA---NLQSLTKW 224
+ L L + +N P ++ +L L++++ + + S+
Sbjct: 168 FANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNL 227
Query: 225 WASDTRLTGRIPDFIGN--WSKLTALRFQGNSFNGPIPSSFSNLTSVTEL-----RISDL 277
S+++L+ W+ LT L N+ N SF+ L + I L
Sbjct: 228 SLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHL 287
Query: 278 SNGSSKLAFIRDMKSLSILELRNN---------NISDSIPSNIGEYRSLQHLDLSFNNLG 328
+ S + + ++ L L+ + ++ + + L+HL++ N++
Sbjct: 288 FSHS-----LHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIP 342
Query: 329 GSIPDSLFNLSSLTHLFLGNNKL------NGTLPARKSPLLLNIDVSYNNLQGNLPSWIN 382
G + L +L +L L N+ N T + L ++++ N + +
Sbjct: 343 GIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFS 402
Query: 383 GQQNLQ-INLVANNLT 397
+L+ ++L N +
Sbjct: 403 WLGHLEVLDLGLNEIG 418
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 7e-25
Identities = 48/268 (17%), Positives = 79/268 (29%), Gaps = 48/268 (17%)
Query: 110 NVVGVIPDELWNLTSLFNLNLGQNYLTG-PLSPSV-GNLTAMQYLNLAINALSGELPKEL 167
+ + + + SL L L + L SPS L + L+L+ N ++ L
Sbjct: 441 KYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDML 500
Query: 168 GQLTELLILGIGTNNFSGPLPSELGSLSKLQELYIDSAGVSGEIPSSFANLQSLTKWWAS 227
L +L IL + NN + + G L L
Sbjct: 501 EGLEKLEILDLQHNNLA----------------RLWKHANPGGPIYFLKGLSHLHILNLE 544
Query: 228 DTRLTGRIPDFIGNWSKLTALRFQGNSFNGPIPSSFSNLTSVTELRISDLSNGSSKLAFI 287
+ + +L + N+ N S F+N
Sbjct: 545 SNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQV-------------------- 584
Query: 288 RDMKSLSILELRNNNISDSIPSNIGE-YRSLQHLDLSFNNLGGSIPDSLF-----NLSSL 341
SL L L+ N I+ G +R+L LD+ FN + + N +
Sbjct: 585 ----SLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCESIAWFVNWINETHT 640
Query: 342 THLFLGNNKLNGTLPARKSPLLLNIDVS 369
L ++ L T P + D S
Sbjct: 641 NIPELSSHYLCNTPPHYHGFPVRLFDTS 668
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 1e-43
Identities = 75/282 (26%), Positives = 118/282 (41%), Gaps = 37/282 (13%)
Query: 693 ENFSPSNKLGEGGFGPVYKGKL-GDGRAIAVKQL-SVASRQGKSQFVAEIATISAVQHRN 750
E+ ++G G FG V+ G+L D +AVK K++F+ E + H N
Sbjct: 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPN 173
Query: 751 LVKLHGCCIEGAERLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEE 810
+V+L G C + +V E ++ L + + L T ++ A G+ YL +
Sbjct: 174 IVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGA-RLRVKTLLQMVGDAAAGMEYLESK 232
Query: 811 SRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVAGT----IGYLAPEY 866
IHRD+ A N L+ V KISDFG+++ D + G + + APE
Sbjct: 233 ---CCIHRDLAARNCLVTEKNVLKISDFGMSREEAD---GVYAASGGLRQVPVKWTAPEA 286
Query: 867 AMRGHLTEKTDVFAFGVLALETVS-GRPNSDPSLDEEKLYLLEWAWHLHENNQEIE---- 921
G + ++DV++FG+L ET S G P Y + + +E
Sbjct: 287 LNYGRYSSESDVWSFGILLWETFSLGA---SP-------Y---PNLSNQQTREFVEKGGR 333
Query: 922 LADPKLIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVAML 963
L P+L + V RL+ C P RPS S + L
Sbjct: 334 LPCPELC---PDAVFRLM---EQCWAYEPGQRPSFSTIYQEL 369
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 2e-43
Identities = 50/256 (19%), Positives = 92/256 (35%), Gaps = 18/256 (7%)
Query: 115 IPDELWNLTS--LFNLNLGQNYLTGPLSPSVGNLTAMQYLNLAINALSGELPKELGQLTE 172
D L + T L L L L+ +Q++ + L ELP + Q
Sbjct: 71 TADLLEDATQPGRVALELRSVPLPQ-FPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAG 128
Query: 173 LLILGIGTNNFSGPLPSELGSLSKLQELYIDSAGVSGEIPSSFAN---------LQSLTK 223
L L + N LP+ + SL++L+EL I + E+P A+ L +L
Sbjct: 129 LETLTLARNPLRA-LPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQS 187
Query: 224 WWASDTRLTGRIPDFIGNWSKLTALRFQGNSFNGPIPSSFSNLTSVTELRISDLSNGSSK 283
T + +P I N L +L+ + + + + + +L + EL +
Sbjct: 188 LRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSA-LGPAIHHLPKLEELDLRG-CTALRN 244
Query: 284 L-AFIRDMKSLSILELRNNNISDSIPSNIGEYRSLQHLDLSFNNLGGSIPDSLFNLSSLT 342
L L L++ + ++P +I L+ LDL +P + L +
Sbjct: 245 YPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANC 304
Query: 343 HLFLGNNKLNGTLPAR 358
+ + + R
Sbjct: 305 IILVPPHLQAQLDQHR 320
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 1e-37
Identities = 53/236 (22%), Positives = 89/236 (37%), Gaps = 13/236 (5%)
Query: 115 IPDELWNLTSLFNLNLGQNYLTGPLSPSVGNLTAMQYLNLAINALSGELPKELGQLTELL 174
PD+ + L+ L ++ + L L ++ ++ L LA N L LP + L L
Sbjct: 96 FPDQAFRLSHLQHMTIDAAGLME-LPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLR 153
Query: 175 ILGIGTNNFSGPLPSELGS---------LSKLQELYIDSAGVSGEIPSSFANLQSLTKWW 225
L I LP L S L LQ L ++ G+ +P+S ANLQ+L
Sbjct: 154 ELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLK 212
Query: 226 ASDTRLTGRIPDFIGNWSKLTALRFQGNSFNGPIPSSFSNLTSVTELRISDLSNGSSKLA 285
++ L+ + I + KL L +G + P F + L + D SN +
Sbjct: 213 IRNSPLSA-LGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPL 271
Query: 286 FIRDMKSLSILELRNNNISDSIPSNIGEYRSLQHLDLSFNNLGGSIPDSLFNLSSL 341
I + L L+LR +PS I + + + + + +
Sbjct: 272 DIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQAQLDQHRPVARPAE 327
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 5e-33
Identities = 49/319 (15%), Positives = 93/319 (29%), Gaps = 30/319 (9%)
Query: 112 VGVIPDELWNLTSLFNLNL-GQNYLTGPLSPSVGNLTAMQYLNLAINALSGELPKELGQL 170
+G + + NL G L P + +
Sbjct: 1 MGSSHHHHHHSSGRENLYFQGSTALR-PYHDVLSQWQRHYNADRNRW----HSAWRQANS 55
Query: 171 TELLILGIGTNNFSGPLPSELGSLS--KLQELYIDSAGVSGEIPSSFANLQSLTKWWASD 228
I L + L + S + + P L L
Sbjct: 56 NNPQIETRTGRALKA-TADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDA 113
Query: 229 TRLTGRIPDFIGNWSKLTALRFQGNSFNGPIPSSFSNLTSVTELRISDLSN--------- 279
L +PD + ++ L L N +P+S ++L + EL I
Sbjct: 114 AGLM-ELPDTMQQFAGLETLTLARNPLRA-LPASIASLNRLRELSIRACPELTELPEPLA 171
Query: 280 GSSKLAFIRDMKSLSILELRNNNISDSIPSNIGEYRSLQHLDLSFNNLGGSIPDSLFNLS 339
+ + + +L L L I S+P++I ++L+ L + + L ++ ++ +L
Sbjct: 172 STDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPL-SALGPAIHHLP 229
Query: 340 SLTHLFLGNNKLNGTLPARKSPL--LLNIDVSYNNLQGNLPSWINGQQNLQINLVANNLT 397
L L L P L + + + LP I+ L+ + +
Sbjct: 230 KLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVN 289
Query: 398 IRSSDNSVLPRGLICLQRN 416
+ LP + L N
Sbjct: 290 LSR-----LPSLIAQLPAN 303
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 56.5 bits (137), Expect = 2e-08
Identities = 16/94 (17%), Positives = 30/94 (31%), Gaps = 2/94 (2%)
Query: 102 TQLKVYALNVVGVIPDELWNLTSLFNLNL-GQNYLTGPLSPSVGNLTAMQYLNLAINALS 160
+L + + P L L L + L L + LT ++ L+L
Sbjct: 232 EELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLT-LPLDIHRLTQLEKLDLRGCVNL 290
Query: 161 GELPKELGQLTELLILGIGTNNFSGPLPSELGSL 194
LP + QL I+ + + + +
Sbjct: 291 SRLPSLIAQLPANCIILVPPHLQAQLDQHRPVAR 324
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 164 bits (416), Expect = 2e-42
Identities = 51/319 (15%), Positives = 94/319 (29%), Gaps = 42/319 (13%)
Query: 113 GVIPDELWNLTSLFNLNLGQNYLTGPLSPSVGNLTAMQYLNLAINALSGELPKELGQLTE 172
I D LT++ + +L + Q+L L +L L
Sbjct: 272 DDIIDLFNCLTNVSSFSLVSVTIERV--KDFSYNFGWQHLELVNCKFGQFPTLKLKSLKR 329
Query: 173 LLILGIGTNN---------------------FSGPLPSELGSLSKLQELYIDSAGVSGEI 211
L N F G + L+ L + GV +
Sbjct: 330 LTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-M 388
Query: 212 PSSFANLQSLTKWWASDTRLTGRIP-DFIGNWSKLTALRFQGNSFNGPIPSSFSNLTSVT 270
S+F L+ L + L + L L F+ L+S+
Sbjct: 389 SSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLE 448
Query: 271 ELRISDLSN----GSSKLAFIRDMKSLSILELRNNNISDSIPSNIGEYRSLQHLDLSFNN 326
L ++ + ++++L+ L+L + P+ SLQ L++S NN
Sbjct: 449 VL---KMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNN 505
Query: 327 LGGSIPDSLFNLSSLTHLFLGNNKLNGTLPARKSPL---LLNIDVSYNNLQGNLPS---- 379
L+SL L N + + L ++++ N+
Sbjct: 506 FFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFL 565
Query: 380 -WINGQQNLQINLVANNLT 397
WI Q+ L + + +
Sbjct: 566 QWIKDQRQLLVEV--ERME 582
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 3e-38
Identities = 54/327 (16%), Positives = 101/327 (30%), Gaps = 52/327 (15%)
Query: 89 CDCSSQNGTV----CHITQLKVYALNVVGVIPDELWNLTSLFNLNLGQNYLTGPLSPSVG 144
C N T + + IPD L S NL+L N L S S
Sbjct: 3 CVEVVPNITYQCMELNFYK-----------IPDNL--PFSTKNLDLSFNPLRHLGSYSFF 49
Query: 145 NLTAMQYLNLAINALSGELPKELGQLTELLILGIGTNNFSGPLPSELGSLSKLQELYIDS 204
+ +Q L+L+ + L+ L L + N LS LQ+L
Sbjct: 50 SFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVE 109
Query: 205 AGVSGEIPSSFANLQSLTKWWASDTRLTG-RIPDFIGNWSKLTALRFQGNSFNGPIPSSF 263
++ +L++L + + + ++P++ N + L L N +
Sbjct: 110 TNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDL 169
Query: 264 SNLTSVTELRISDLSNGSSKLAFIRDMKSLSILELRNNNISDSIPSNIGEYRSLQHLDLS 323
L + L +S L+L N ++ I + L L L
Sbjct: 170 RVLHQMPLLNLS--------------------LDLSLNPMN-FIQPGAFKEIRLHKLTLR 208
Query: 324 FNNLGGSIPDSLF-NLSSLTHLFLGNNKLNG----------TLPARKSPLLLNIDVSYNN 372
N ++ + L+ L L + L + + ++Y +
Sbjct: 209 NNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLD 268
Query: 373 LQGN-LPSWINGQQNLQ-INLVANNLT 397
+ + N N+ +LV+ +
Sbjct: 269 YYLDDIIDLFNCLTNVSSFSLVSVTIE 295
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 149 bits (377), Expect = 1e-37
Identities = 43/309 (13%), Positives = 96/309 (31%), Gaps = 16/309 (5%)
Query: 113 GVIPDELWNLTSLFNLNLGQNYLTGPLSPSVGNLTAMQYLNLAINALSGELPKELGQLTE 172
+ ++ L L+L + + + +L+ + L L N + L+
Sbjct: 42 HLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSS 101
Query: 173 LLILGIGTNNFSGPLPSELGSLSKLQELYIDS-AGVSGEIPSSFANLQSLTKWWASDTRL 231
L L N + +G L L+EL + S ++P F+NL +L S ++
Sbjct: 102 LQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKI 161
Query: 232 TGRIPDFIGNWSKLTA----LRFQGNSFNGPIPSSFSNLTSVTELRISD-LSNGSSKLAF 286
+ ++ L N N P +F + + +L + + + +
Sbjct: 162 QSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEI-RLHKLTLRNNFDSLNVMKTC 220
Query: 287 IRDMKSLSILELRNN------NISDSIPSNIGEYRSLQHLDLSFNNL---GGSIPDSLFN 337
I+ + L + L N+ S + +L + L I D
Sbjct: 221 IQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNC 280
Query: 338 LSSLTHLFLGNNKLNGTLPARKSPLLLNIDVSYNNLQGNLPSWINGQQNLQINLVANNLT 397
L++++ L + + + ++++ + + L
Sbjct: 281 LTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNA 340
Query: 398 IRSSDNSVL 406
D L
Sbjct: 341 FSEVDLPSL 349
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 4e-36
Identities = 55/290 (18%), Positives = 90/290 (31%), Gaps = 56/290 (19%)
Query: 109 LNVVGVIPDELWNLTSLFNLNLGQNYLTGPLSPSVGNLTAMQYLNLAINALSGELPKE-L 167
L+ G + TSL L+L N + +S + L +++L+ + L
Sbjct: 359 LSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVF 417
Query: 168 GQLTELLILGIGTNNFSGPLPSELGSLSKLQELYIDSAGVSGEIPSSFANLQSLTKWWAS 227
L L+ L I + LS L+ L + +
Sbjct: 418 LSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKM------------------------A 453
Query: 228 DTRLTGRI-PDFIGNWSKLTALRFQGNSFNGPIPSSFSNLTSVTELRISDLSNGSSKLAF 286
PD LT L P++F++L+S+ L ++S
Sbjct: 454 GNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVL---NMS-------- 502
Query: 287 IRDMKSLSILELRNNNISDSIPSNIGEYRSLQHLDLSFNNLGGSIPDSLFNL-SSLTHLF 345
+NN SLQ LD S N++ S L + SSL L
Sbjct: 503 -------------HNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLN 549
Query: 346 LGNNKLNGTLPARKSPLLLN----IDVSYNNLQGNLPSWINGQQNLQINL 391
L N T + + + V ++ PS G L +N+
Sbjct: 550 LTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATPSDKQGMPVLSLNI 599
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 5e-42
Identities = 59/345 (17%), Positives = 97/345 (28%), Gaps = 38/345 (11%)
Query: 102 TQLKVYALNVVGVIPDELWNLTSLFNLNLGQNYLTGPLSPSVGNLTAMQYLNLAINALSG 161
NL L ++ L L + +L +Q LN+A N
Sbjct: 470 EDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGIS 529
Query: 162 ---------ELPKELGQLTELLILGIGTNNFSG-PLPSELGSLSKLQELYIDSAGVSG-- 209
L + ++ I +G NN P + L + KL L
Sbjct: 530 AAQLKADWTRLADDEDTGPKIQIFYMGYNNLEEFPASASLQKMVKLGLLD-----CVHNK 584
Query: 210 -EIPSSFANLQSLTKWWASDTRLTGRIPDFIGNW-SKLTALRFQGNSFNG-PIPSSFSNL 266
+F LT ++ IP+ + ++ L F N P + ++
Sbjct: 585 VRHLEAFGTNVKLTDLKLDYNQIEE-IPEDFCAFTDQVEGLGFSHNKLKYIPNIFNAKSV 643
Query: 267 TSVTEL-----RISDLSNGSSKLAFIRDMKSLSILELRNNNISDSIPSNIGEYRSLQHLD 321
+ + +I S + S + L N I + +
Sbjct: 644 YVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTII 703
Query: 322 LSFNNLG-------GSIPDSLFNLSSLTHLFLGNNKLNG---TLPARKSPLLLNIDVSYN 371
LS N + + N LT + L NKL A P L N+DVSYN
Sbjct: 704 LSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLTSLSDDFRATTLPYLSNMDVSYN 763
Query: 372 NLQGNLPSWINGQQNLQ-INLVANNLTIRSSDNSVLPRGLICLQR 415
P+ L+ + + P G+
Sbjct: 764 CFSS-FPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPS 807
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 7e-38
Identities = 58/354 (16%), Positives = 115/354 (32%), Gaps = 34/354 (9%)
Query: 68 TGAALDDSIVFDNTDYNPFIKCDCSSQNGTVC----HITQLKVYALNVVGVIPDELWNLT 123
++++I N ++N + Q G +T L + G +PD + LT
Sbjct: 289 YSGTINNTIHSLNWNFNKEL-DMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLT 347
Query: 124 SLFNLNLGQNYLTGPLSPSVGNLTAMQYLNLAINALSGELPKELG------QLTELLILG 177
L L+ G + T + + K L++LL
Sbjct: 348 ELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDA 407
Query: 178 IGTNNFSGPLPSELGSLSKLQELYIDSAGVSGEIPSSFANLQSLTKWWASDTRLTGRIPD 237
I N P+ + K ++ + ++ I + L L + +++ T
Sbjct: 408 INRNPEMKPIKKDSRISLKDTQIGNLTNRITF-ISKAIQRLTKLQIIYFANSPFTYDNIA 466
Query: 238 FIGNWSKLTALRFQGNSFNGPIPSSFSNLTSVTELRISDLSNGSSKLAFIRDMKSLSILE 297
S+SNL +T++ + + N + F+ D+ L L
Sbjct: 467 -----VDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLN 521
Query: 298 LRNNNISD---------SIPSNIGEYRSLQHLDLSFNNLGGSIPDS--LFNLSSLTHLFL 346
+ N + + +Q + +NNL P S L + L L
Sbjct: 522 IACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNL-EEFPASASLQKMVKLGLLDC 580
Query: 347 GNNKLNGTLPA-RKSPLLLNIDVSYNNLQGNLPSWI-NGQQNLQ-INLVANNLT 397
+NK+ L A + L ++ + YN ++ +P ++ + N L
Sbjct: 581 VHNKVR-HLEAFGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLK 632
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 135 bits (340), Expect = 2e-32
Identities = 41/319 (12%), Positives = 84/319 (26%), Gaps = 54/319 (16%)
Query: 115 IPDELWNLTSLFNLNLGQNYLTGPLSPSVG-NLTAMQYLNLAINALSGELPK--ELGQLT 171
+ L +L L N + + ++ L + N L +P +
Sbjct: 587 HLEAFGTNVKLTDLKLDYNQIEE-IPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKSVY 644
Query: 172 ELLILGIGTNNFSGPLPSELGS------LSKLQELYIDSAGVSGEIPSSFANLQSLTKWW 225
+ + N + + + + FA ++
Sbjct: 645 VMGSVDFSYNKIGS-EGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTII 703
Query: 226 ASDTRLT-------GRIPDFIGNWSKLTALRFQGNSFNG-PIPSSFSNLTSVTELRISDL 277
S+ +T N LT + + N + L ++ + +S
Sbjct: 704 LSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLTSLSDDFRATTLPYLSNMDVS-- 761
Query: 278 SNGSSKL-AFIRDMKSLSILELR------NNNISDSIPSNIGEYRSLQHLDLSFNNLGGS 330
N S + L +R N I P+ I SL L + N++
Sbjct: 762 YNCFSSFPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDI-RK 820
Query: 331 IPDSLFNLSSLTHLFLGNNKLNGTLPARKSPLLLNIDVSYNNLQGNLPSWINGQQNLQIN 390
+ + L L L + +N + ++ S +
Sbjct: 821 VDEKL--TPQLYILDIADNPN---------------------ISIDVTSVCPYIEAGMYV 857
Query: 391 LVANNLT-IRSSDNSVLPR 408
L+ + IR D + R
Sbjct: 858 LLYDKTQDIRGCDALGIER 876
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 7e-32
Identities = 44/304 (14%), Positives = 87/304 (28%), Gaps = 24/304 (7%)
Query: 113 GVIPDELWNLTSLFNLNLGQNYLTGPLSPSVGNLTAMQYLNLAINALSGELPKELGQLTE 172
+ + + N N + + N + L+LA G +P +GQLTE
Sbjct: 290 SGTINNTIHSLNW-NFNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTE 348
Query: 173 LLILGIGTNNFSGPLPSELGSLSKLQELYIDSAGVSGEIPSSF----ANLQSLTKWWASD 228
L +L GT++ + + F L +
Sbjct: 349 LKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAI 408
Query: 229 TRLTGRIPDFIGNWSKLTALRFQGNSFN-GPIPSSFSNLTSVTELRISDLSNGSSKLAFI 287
R P + L + + I + LT + + ++ S +
Sbjct: 409 NRNPEMKPIKKDSRISLKDTQIGNLTNRITFISKAIQRLTKLQIIYFAN-----SPFTYD 463
Query: 288 RDMKSLSILELRNNNISDSIPSNIGEYRSLQHLDLSFNNLGGSIPDSLFNLSSLTHLFLG 347
++ + + L ++L +PD L++L L L +
Sbjct: 464 NIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIA 523
Query: 348 NNKLNGTLPARKS-----------PLLLNIDVSYNNLQGNLPSWINGQ-QNLQ-INLVAN 394
N+ + P + + YNNL+ S + L ++ V N
Sbjct: 524 CNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLEEFPASASLQKMVKLGLLDCVHN 583
Query: 395 NLTI 398
+
Sbjct: 584 KVRH 587
|
| >2jwp_A Malectin, MGC80075; sugar binding, sugar binding protein; NMR {Xenopus laevis} PDB: 2k46_A* 2kr2_A* Length = 174 | Back alignment and structure |
|---|
Score = 147 bits (371), Expect = 9e-41
Identities = 40/192 (20%), Positives = 67/192 (34%), Gaps = 32/192 (16%)
Query: 429 FAIKSGGPQIRSSNGVVYERDNATLGPATYYVTDSNKWGVSNVGLFTGSNNPQYKSSSLS 488
+A+ +GG +G+ Y +D Y
Sbjct: 8 WAVNAGGESHVDVHGIHYRKDPLEGR---------------------VGRASDYGMKLPI 46
Query: 489 QFTNTLDSELFQTARLSASSLRYYGLGLENGNYTVLLQFAEMAILDTNRWESLGRRVFDV 548
+N D L+QT R + S Y E G Y ++L+FAE+ + ++VFDV
Sbjct: 47 LRSNPEDQVLYQTERYNEDSFGYDIPIKEEGEYVLVLKFAEVY------FAQSQQKVFDV 100
Query: 549 YIQGNRVLKDFDIKREAGGVSKRAIQREIKTRVSENYLEIHLF---WAGKGTCCVPAQGT 605
+ G+ V+KD DI G A I + + L + + GK +
Sbjct: 101 RVNGHTVVKDLDIFDRVGH--STAHDEIIPISIKKGKLSVQGEVSTFTGKLSVEFVKGYY 158
Query: 606 YGPSISAIRVTP 617
P + A+ +
Sbjct: 159 DNPKVCALFIMK 170
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 1e-40
Identities = 71/283 (25%), Positives = 116/283 (40%), Gaps = 30/283 (10%)
Query: 699 NKLGEGGFGPVYKGKL-----GDGRAIAVKQLSVASRQGKSQFVAEIATISAVQHRNLVK 753
+LG+G FG V + G +AVK+L ++ + F EI + ++QH N+VK
Sbjct: 16 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 75
Query: 754 LHGCCIEGAER--LLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEES 811
G C R L+ EYL SL L + +D + S + +G+ YL +
Sbjct: 76 YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKE-RIDHIKLLQYTSQICKGMEYL--GT 132
Query: 812 RVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVAGT--IGYLAPEYAMR 869
+ R IHRD+ N+L++ + KI DFGL K+ K + G I + APE
Sbjct: 133 K-RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTE 191
Query: 870 GHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEIELADPKLIE 929
+ +DV++FGV+ E + S E + IE L++
Sbjct: 192 SKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIE-----LLK 246
Query: 930 FNE---------EEVKRLIGVALLCTQTLPSLRPSMSRVVAML 963
N +E+ ++ C + RPS + +
Sbjct: 247 NNGRLPRPDGCPDEIYMIM---TECWNNNVNQRPSFRDLALRV 286
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 2e-40
Identities = 71/283 (25%), Positives = 117/283 (41%), Gaps = 30/283 (10%)
Query: 699 NKLGEGGFGPVYKGKL-----GDGRAIAVKQLSVASRQGKSQFVAEIATISAVQHRNLVK 753
+LG+G FG V + G +AVK+L ++ + F EI + ++QH N+VK
Sbjct: 47 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 106
Query: 754 LHGCCIEGAER--LLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEES 811
G C R L+ EYL SL L + +D + S + +G+ YL +
Sbjct: 107 YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKE-RIDHIKLLQYTSQICKGMEYL--GT 163
Query: 812 RVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVAGT--IGYLAPEYAMR 869
+ R IHRD+ N+L++ + KI DFGL K+ K + + G I + APE
Sbjct: 164 K-RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTE 222
Query: 870 GHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEIELADPKLIE 929
+ +DV++FGV+ E + S E + IE L++
Sbjct: 223 SKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIE-----LLK 277
Query: 930 FNE---------EEVKRLIGVALLCTQTLPSLRPSMSRVVAML 963
N +E+ ++ C + RPS + +
Sbjct: 278 NNGRLPRPDGCPDEIYMIM---TECWNNNVNQRPSFRDLALRV 317
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 8e-40
Identities = 77/284 (27%), Positives = 119/284 (41%), Gaps = 33/284 (11%)
Query: 699 NKLGEGGFGPVYKGKL-----GDGRAIAVKQLSVASRQGKSQFVAEIATISAVQHRNLVK 753
++LG+G FG V + G +AVKQL + + F EI + A+ +VK
Sbjct: 29 SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVK 88
Query: 754 LHGCCIEGAER--LLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEES 811
G + LV EYL + L L R+ LD + S + +G+ YL S
Sbjct: 89 YRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRA-RLDASRLLLYSSQICKGMEYL--GS 145
Query: 812 RVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVAGT--IGYLAPEYAMR 869
R R +HRD+ A N+L++++ KI+DFGLAKL K + R G I + APE
Sbjct: 146 R-RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSD 204
Query: 870 GHLTEKTDVFAFGVLALETVS-GRPNSDPSLDEEKLYLLEWAWHLHENNQEIELADPKLI 928
+ ++DV++FGV+ E + + + + +L+
Sbjct: 205 NIFSRQSDVWSFGVVLYELFTYCDK---SCSPSAEFLRMMGCERDVPALSRL----LELL 257
Query: 929 EFNE---------EEVKRLIGVALLCTQTLPSLRPSMSRVVAML 963
E + EV L+ LC P RPS S + L
Sbjct: 258 EEGQRLPAPPACPAEVHELM---KLCWAPSPQDRPSFSALGPQL 298
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 2e-39
Identities = 72/311 (23%), Positives = 119/311 (38%), Gaps = 51/311 (16%)
Query: 661 RRKRPQHDDDEELLGMDARPYTFSYAELKTATENFSPSNK-------LGEGGFGPVYKGK 713
+ +R Q DD E EL+T S + +G G F VYKG
Sbjct: 1 QEERNQQQDDIE--------------ELETKAVGMSNDGRFLKFDIEIGRGSFKTVYKGL 46
Query: 714 -LGDGRAIAVKQLSVA--SRQGKSQFVAEIATISAVQHRNLVKLHGCCI---EGAERLLV 767
+A +L ++ + +F E + +QH N+V+ + +G + +++
Sbjct: 47 DTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL 106
Query: 768 Y-EYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVL 826
E + + +L L +R + C + +GL +LH + IIHRD+K N+
Sbjct: 107 VTELMTSGTLKTYL--KRFKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIF 163
Query: 827 LDAD--LVPKISDFGLAKLYDDKKTHISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVL 884
+ V KI D GLA L V GT ++APE + E DV+AFG+
Sbjct: 164 ITGPTGSV-KIGDLGLATLKRASFAK---AVIGTPEFMAPEMYEEKY-DESVDVYAFGMC 218
Query: 885 ALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEIELADPKLIEFNEEEVKRLIGVALL 944
LE + P + + + + + K+ EVK +I
Sbjct: 219 MLEMATSEY---PYSECQNAA----QIYRRVTSGVKPASFDKVA---IPEVKEII---EG 265
Query: 945 CTQTLPSLRPS 955
C + R S
Sbjct: 266 CIRQNKDERYS 276
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 2e-39
Identities = 68/286 (23%), Positives = 119/286 (41%), Gaps = 36/286 (12%)
Query: 699 NKLGEGGFGPVYKGKL-----GDGRAIAVKQL-SVASRQGKSQFVAEIATISAVQHRNLV 752
LGEG FG V + G +AVK L + + EI + + H N+V
Sbjct: 27 RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 86
Query: 753 KLHGCCIEGAER--LLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEE 810
K G C E L+ E+L + SL + L ++ ++ + + + +G+ YL
Sbjct: 87 KYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKN-KINLKQQLKYAVQICKGMDYL--G 143
Query: 811 SRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVAGT--IGYLAPEYAM 868
SR + +HRD+ A NVL++++ KI DFGL K + K + + + + + APE M
Sbjct: 144 SR-QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLM 202
Query: 869 RGHLTEKTDVFAFGVLALETVS-GRPNSDPSLDEEKLYLLE-WAWHLHENNQEIELADPK 926
+ +DV++FGV E ++ +S P K+ +
Sbjct: 203 QSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQM----TVTRL----VN 254
Query: 927 LIEFNE---------EEVKRLIGVALLCTQTLPSLRPSMSRVVAML 963
++ + +EV +L+ C + PS R S ++
Sbjct: 255 TLKEGKRLPCPPNCPDEVYQLM---RKCWEFQPSNRTSFQNLIEGF 297
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 3e-39
Identities = 79/288 (27%), Positives = 119/288 (41%), Gaps = 42/288 (14%)
Query: 699 NKLGEGGFGPVYKGKL-----GDGRAIAVKQL-SVASRQGKSQFVAEIATISAVQHRNLV 752
LGEG FG V G G +AVK L + A Q +S + EI + + H +++
Sbjct: 37 RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHII 96
Query: 753 KLHGCCIEGAER--LLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEE 810
K GCC + LV EY+ SL L ++ A + G+AYL
Sbjct: 97 KYKGCCEDAGAASLQLVMEYVPLGSLRDYL---PRHSIGLAQLLLFAQQICEGMAYL--H 151
Query: 811 SRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVAGT--IGYLAPEYAM 868
++ IHRD+ A NVLLD D + KI DFGLAK + + R G + + APE
Sbjct: 152 AQ-HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLK 210
Query: 869 RGHLTEKTDVFAFGVLALETVS-GRPNSDPSLDEEKLYLLEWAWHLHENNQEIELADPKL 927
+DV++FGV E ++ + P +L + ++ +L
Sbjct: 211 EYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQG----------QMTVLRL 260
Query: 928 IEFNEE------------EVKRLIGVALLCTQTLPSLRPSMSRVVAML 963
E E EV L+ C +T S RP+ ++ +L
Sbjct: 261 TELLERGERLPRPDKCPAEVYHLM---KNCWETEASFRPTFENLIPIL 305
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 3e-39
Identities = 65/260 (25%), Positives = 112/260 (43%), Gaps = 15/260 (5%)
Query: 115 IPDELWNLTSLFNLNLGQNYLTGPLSPSVGNLTAMQYLNLAINALSGELPKELGQLTELL 174
L NLT+L L L ++ ++ + NLT M LNL N L +T L
Sbjct: 102 DISALQNLTNLRELYLNEDNISDI--SPLANLTKMYSLNLGANHNLS-DLSPLSNMTGLN 158
Query: 175 ILGIGTNNFSGPLPSELGSLSKLQELYIDSAGVSGEIPSSFANLQSLTKWWASDTRLTGR 234
L + + + + +L+ L L ++ + P A+L SL + A ++T
Sbjct: 159 YLTVTESKVKDV--TPIANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDI 214
Query: 235 IPDFIGNWSKLTALRFQGNSFNGPIPSSFSNLTSVTELRISDLSNGSSKLAFIRDMKSLS 294
P + N ++L +L+ N P +NL+ +T L I N S + ++D+ L
Sbjct: 215 TP--VANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGT--NQISDINAVKDLTKLK 268
Query: 295 ILELRNNNISDSIPSNIGEYRSLQHLDLSFNNLGGSIPDSLFNLSSLTHLFLGNNKLNGT 354
+L + +N ISD S + L L L+ N LG + + L++LT LFL N +
Sbjct: 269 MLNVGSNQISD--ISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDI 326
Query: 355 LPARKSPLLLNIDVSYNNLQ 374
P + + D + ++
Sbjct: 327 RPLASLSKMDSADFANQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 9e-36
Identities = 65/282 (23%), Positives = 121/282 (42%), Gaps = 18/282 (6%)
Query: 117 DELWNLTSLFNLNLGQNYLTGPLSPSVGNLTAMQYLNLAINALSGELPKELGQLTELLIL 176
+ LT+L LNL N +T + NL + L + N ++ L LT L L
Sbjct: 60 QGIEYLTNLEYLNLNGNQITDI--SPLSNLVKLTNLYIGTNKITD--ISALQNLTNLREL 115
Query: 177 GIGTNNFSGPLPSELGSLSKLQELYIDSAGVSGEIPSSFANLQSLTKWWASDTRLTGRIP 236
+ +N S S L +L+K+ L + + S +N+ L +++++ P
Sbjct: 116 YLNEDNISDI--SPLANLTKMYSLNLGANHNLS-DLSPLSNMTGLNYLTVTESKVKDVTP 172
Query: 237 DFIGNWSKLTALRFQGNSFNGPIPSSFSNLTSVTELRISDLSNGSSKLAFIRDMKSLSIL 296
I N + L +L N P ++LTS+ N + + + +M L+ L
Sbjct: 173 --IANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYV--NQITDITPVANMTRLNSL 226
Query: 297 ELRNNNISDSIPSNIGEYRSLQHLDLSFNNLGGSIPDSLFNLSSLTHLFLGNNKLNGTLP 356
++ NN I+D P + L L++ N + S +++ +L+ L L +G+N+++
Sbjct: 227 KIGNNKITDLSP--LANLSQLTWLEIGTNQI--SDINAVKDLTKLKMLNVGSNQISDISV 282
Query: 357 ARKSPLLLNIDVSYNNLQGNLPSWINGQQNLQ-INLVANNLT 397
L ++ ++ N L I G NL + L N++T
Sbjct: 283 LNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHIT 324
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 2e-35
Identities = 60/297 (20%), Positives = 122/297 (41%), Gaps = 22/297 (7%)
Query: 102 TQLKVYALNVVGVIPDELWNLTSLFNLNLGQNYLTGPLSPSVGNLTAMQYLNLAINALSG 161
L + + PD +L L + +T + L ++ L +A ++
Sbjct: 3 ATLATLPAPINQIFPDA--DLAEGIRAVLQKASVTDV--VTQEELESITKLVVAGEKVAS 58
Query: 162 ELPKELGQLTELLILGIGTNNFSGPLPSELGSLSKLQELYIDSAGVSGEIPSSFANLQSL 221
+ + LT L L + N + S L +L KL LYI + ++ S+ NL +L
Sbjct: 59 --IQGIEYLTNLEYLNLNGNQITDI--SPLSNLVKLTNLYIGTNKIT--DISALQNLTNL 112
Query: 222 TKWWASDTRLTGRIPDFIGNWSKLTALRFQGNSFNGPIPSSFSNLTSVTELRISDLSNGS 281
+ + ++ ++ + N +K+ +L N S SN+T + L +++ +
Sbjct: 113 RELYLNEDNISD--ISPLANLTKMYSLNLGANHNLS-DLSPLSNMTGLNYLTVTE--SKV 167
Query: 282 SKLAFIRDMKSLSILELRNNNISDSIPSNIGEYRSLQHLDLSFNNLGGSIPDSLFNLSSL 341
+ I ++ L L L N I D P + SL + N + P + N++ L
Sbjct: 168 KDVTPIANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP--VANMTRL 223
Query: 342 THLFLGNNKLNGTLPARKSPLLLNIDVSYNNLQGNLPSWINGQQNLQ-INLVANNLT 397
L +GNNK+ P L +++ N + ++ + + L+ +N+ +N ++
Sbjct: 224 NSLKIGNNKITDLSPLANLSQLTWLEIGTNQIS-DINA-VKDLTKLKMLNVGSNQIS 278
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 93.0 bits (232), Expect = 2e-20
Identities = 30/181 (16%), Positives = 69/181 (38%), Gaps = 15/181 (8%)
Query: 218 LQSLTKWWASDTRLTGRIPDFIGNWSKLTALRFQGNSFNGPIPSSFSNLTSVTELRISDL 277
+L + PD + ++ Q S + L S+T+L ++
Sbjct: 2 AATLA---TLPAPINQIFPD--ADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAG- 53
Query: 278 SNGSSKLAFIRDMKSLSILELRNNNISDSIPSNIGEYRSLQHLDLSFNNLGGSIPDSLFN 337
+ + I + +L L L N I+D P + L +L + N + + +L N
Sbjct: 54 -EKVASIQGIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKI--TDISALQN 108
Query: 338 LSSLTHLFLGNNKLNGTLPARKSPLLLNIDVSYNNLQGNLPSWINGQQNLQI-NLVANNL 396
L++L L+L + ++ P + ++++ N+ + S ++ L + + +
Sbjct: 109 LTNLRELYLNEDNISDISPLANLTKMYSLNLGANHNLSD-LSPLSNMTGLNYLTVTESKV 167
Query: 397 T 397
Sbjct: 168 K 168
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 5e-39
Identities = 60/286 (20%), Positives = 100/286 (34%), Gaps = 15/286 (5%)
Query: 115 IPDELWNLTSLFNLNLGQNYLTGPLSPSVGNLTAMQYLNLAINALSGELPKE-LGQLTEL 173
+P L L++L L L N S N ++ +L++ N EL L L L
Sbjct: 293 LPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENL 352
Query: 174 LILGIGTNN--FSGPLPSELGSLSKLQELYIDSAGVSGEIPSSFANLQSLTKWWASDTRL 231
L + ++ S +L +LS LQ L + +F L + TRL
Sbjct: 353 RELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRL 412
Query: 232 TGRIPD-FIGNWSKLTALRFQGNSFNGPIPSSFSNLTSVTELRISD---LSNGSSKLAFI 287
+ N L L + + F L ++ L + K +
Sbjct: 413 KVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSL 472
Query: 288 RDMKSLSILELRNNNISDSIPSNIGEYRSLQHLDLSFNNLGGSIPDSLFNLSSLTHLFLG 347
+ + L IL L ++S + + H+DLS N L S ++L +L + L L
Sbjct: 473 QTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGIY-LNLA 531
Query: 348 NNKLNGTLPARKSPL--LLNIDVSYNNLQGN-----LPSWINGQQN 386
+N ++ LP+ L I++ N L W
Sbjct: 532 SNHISIILPSLLPILSQQRTINLRQNPLDCTCSNIYFLEWYKENMQ 577
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 6e-39
Identities = 65/318 (20%), Positives = 125/318 (39%), Gaps = 14/318 (4%)
Query: 92 SSQNGTVCHITQLKVYALNVVGVIPDELWNL--TSLFNLNLGQNYLTGPLSPSVGNLTAM 149
+N T+ + ++ + P L S+ ++NL ++Y S + + +
Sbjct: 221 GLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGL 280
Query: 150 QYLNLAINALSGELPKELGQLTELLILGIGTNNFSGPLPSELGSLSKLQELYIDSAGVSG 209
Q L+L LS ELP L L+ L L + N F + L L I
Sbjct: 281 QELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRL 339
Query: 210 EIPS-SFANLQSLTKWWASDTRLT--GRIPDFIGNWSKLTALRFQGNSFNGPIPSSFSNL 266
E+ + NL++L + S + + N S L +L N +F
Sbjct: 340 ELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKEC 399
Query: 267 TSVTELRISD--LSNGSSKLAFIRDMKSLSILELRNNNISDSIPSNIGEYRSLQHLDLSF 324
+ L ++ L ++ F +++ L +L L ++ + S +LQHL+L
Sbjct: 400 PQLELLDLAFTRLKVKDAQSPF-QNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQG 458
Query: 325 NNLGGSI---PDSLFNLSSLTHLFLGNNKLNGTLPARKSPL--LLNIDVSYNNLQGNLPS 379
N+ +SL L L L L L+ + L + ++D+S+N L +
Sbjct: 459 NHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIE 518
Query: 380 WINGQQNLQINLVANNLT 397
++ + + +NL +N+++
Sbjct: 519 ALSHLKGIYLNLASNHIS 536
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 2e-38
Identities = 61/309 (19%), Positives = 109/309 (35%), Gaps = 14/309 (4%)
Query: 100 HITQLKVYALNVVGVIPDELWNLTSLFNLNLGQNYLTGPLSPSVGNLTAMQYLNLAINAL 159
+ + + + + + L L+L +L+ L + L+ ++ L L+ N
Sbjct: 255 SVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLSE-LPSGLVGLSTLKKLVLSANKF 313
Query: 160 SGELPKELGQLTELLILGIGTNNFSGPLPSE-LGSLSKLQELYIDS--AGVSGEIPSSFA 216
L L I N L + L +L L+EL + S
Sbjct: 314 ENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLR 373
Query: 217 NLQSLTKWWASDTRLTGRIPDFIGNWSKLTALRFQGNSFNG-PIPSSFSNLTSVTELRIS 275
NL L S + +L L S F NL + L +S
Sbjct: 374 NLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLS 433
Query: 276 D--LSNGSSKLAFIRDMKSLSILELRNNNISDSI---PSNIGEYRSLQHLDLSFNNLGGS 330
L S +L + +L L L+ N+ +++ L+ L LSF +L
Sbjct: 434 HSLLDISSEQL--FDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSI 491
Query: 331 IPDSLFNLSSLTHLFLGNNKLNGTLPARKSPL-LLNIDVSYNNLQGNLPSWINGQQNLQ- 388
+ +L + H+ L +N+L + S L + ++++ N++ LPS + +
Sbjct: 492 DQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGIYLNLASNHISIILPSLLPILSQQRT 551
Query: 389 INLVANNLT 397
INL N L
Sbjct: 552 INLRQNPLD 560
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 1e-37
Identities = 56/306 (18%), Positives = 103/306 (33%), Gaps = 22/306 (7%)
Query: 113 GVIPDELWNLTSLFNLNLGQNYLTGPLSPSVGNLTAMQYLNLAINALSGELPKELGQLTE 172
+ L +L +L Q ++ + N ++ L L N +S + +
Sbjct: 95 FMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEK 154
Query: 173 LLILGIGTNNFSGPLPSELGSLSKLQELYIDSAGVS-GEIPSSFANLQSLTKWWASDTRL 231
L +L N ++ SL + L ++ G I + T+
Sbjct: 155 LKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAGIEPGAFDSAVFQSLNFGGTQN 214
Query: 232 TGRIPDFIGN--WSKLTALRFQGNSFNGPIPSSFSNL--TSVTEL-----RISDLSNGSS 282
I + N L F+ P+ F L SV + ++S+ +
Sbjct: 215 LLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNT- 273
Query: 283 KLAFIRDMKSLSILELRNNNISDSIPSNIGEYRSLQHLDLSFNNLGGSIPDSLFNLSSLT 342
L L+L ++S +PS + +L+ L LS N S N SLT
Sbjct: 274 ----FHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLT 328
Query: 343 HLFLGNNKLNGTLPA---RKSPLLLNIDVSYNNLQ--GNLPSWINGQQNLQ-INLVANNL 396
HL + N L L +D+S+++++ + +LQ +NL N
Sbjct: 329 HLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEP 388
Query: 397 TIRSSD 402
++
Sbjct: 389 LSLKTE 394
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 5e-33
Identities = 55/322 (17%), Positives = 92/322 (28%), Gaps = 26/322 (8%)
Query: 88 KCDCSSQNGTV----CHITQLKVYALNVVGVIPDELWNLTSLFNLNLGQNYLTGPLSPSV 143
KC N T + + IP L S L N L + +
Sbjct: 7 KCIEKEVNKTYNCENLGLNE-----------IPGTL--PNSTECLEFSFNVLPTIQNTTF 53
Query: 144 GNLTAMQYLNLAINALSGELPKELGQLTELLILGIGTNNFSGPLPSELGSLSKLQELYID 203
L + +L+L + L L + N + L L+ L+
Sbjct: 54 SRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFI 113
Query: 204 SAGVSGEIPSSFANLQSLTKWWASDTRLTGRIPDFIGNWSKLTALRFQGNSFNGPIPSSF 263
G+S N ++L + ++ KL L FQ N+ +
Sbjct: 114 QTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDM 173
Query: 264 SNLTSVTELRISDLSNGSSKL-AFIRDMKSLSILELRNNNISDSIPSNIG--EYRSLQHL 320
S+L T L ++ N + + D L I + +SL
Sbjct: 174 SSLQQATNLSLNLNGNDIAGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLG 233
Query: 321 DLSFNNLGGSIPDSLFNLS--SLTHLFLGNNKLNGTLPARKSPL--LLNIDVSYNNLQGN 376
+ P L S+ + L + L +D++ +L
Sbjct: 234 TFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-E 292
Query: 377 LPSWINGQQNLQI-NLVANNLT 397
LPS + G L+ L AN
Sbjct: 293 LPSGLVGLSTLKKLVLSANKFE 314
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 1e-22
Identities = 41/250 (16%), Positives = 79/250 (31%), Gaps = 53/250 (21%)
Query: 109 LNVVGVIPDELWNLTSLFNLNLGQNYLTGPLSPSVGNLTAMQYLNLAINALSGELPKE-L 167
+ +L NL+ L +LNL N + + ++ L+LA L + +
Sbjct: 362 IETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPF 421
Query: 168 GQLTELLILGIGTNNFSGPLPSELGSLSKLQELYIDS---AGVSGEIPSSFANLQSLTKW 224
L L +L + + L LQ L + + + +S L L
Sbjct: 422 QNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEI- 480
Query: 225 WASDTRLTGRIPDFIGNWSKLTALRFQGNSFNGPIPSSFSNLTSVTELRISDLSNGSSKL 284
L + +F++L + + DLS
Sbjct: 481 -----------------------LVLSFCDLSSIDQHAFTSLKMMNHV---DLS------ 508
Query: 285 AFIRDMKSLSILELRNNNISDSIPSNIGEYRSLQHLDLSFNNLGGSIPDSLFNLSSLTHL 344
+N ++ S + + + +L+L+ N++ +P L LS +
Sbjct: 509 ---------------HNRLTSSSIEALSHLKGI-YLNLASNHISIILPSLLPILSQQRTI 552
Query: 345 FLGNNKLNGT 354
L N L+ T
Sbjct: 553 NLRQNPLDCT 562
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 1e-38
Identities = 53/193 (27%), Positives = 91/193 (47%), Gaps = 5/193 (2%)
Query: 699 NKLGEGGFGPVYKGKL-GDGRAIAVKQLSVASRQGKSQFVAEIATISAVQHRNLVKLHGC 757
+KLG G +G VY+G +AVK L + + +F+ E A + ++H NLV+L G
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 284
Query: 758 CIEGAERLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIH 817
C ++ E++ +L L + + + ++ + YL E + IH
Sbjct: 285 CTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL--EKK-NFIH 341
Query: 818 RDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVAGTIGYLAPEYAMRGHLTEKTD 877
R++ A N L+ + + K++DFGL++L I + APE + K+D
Sbjct: 342 RNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSD 401
Query: 878 VFAFGVLALETVS 890
V+AFGVL E +
Sbjct: 402 VWAFGVLLWEIAT 414
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 143 bits (364), Expect = 2e-38
Identities = 57/211 (27%), Positives = 93/211 (44%), Gaps = 22/211 (10%)
Query: 699 NKLGEGGFGPVYKGKL-GDGRAIAVKQLSVASRQGKSQFVAEIATISAVQHRNLVKLHGC 757
+KLG G +G VY+G +AVK L + + +F+ E A + ++H NLV+L G
Sbjct: 19 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 77
Query: 758 CIEGAERLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIH 817
C ++ E++ +L L + + + ++ + YL E + IH
Sbjct: 78 CTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL--EKK-NFIH 134
Query: 818 RDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVAGTIGYL-----APEYAMRGHL 872
RD+ A N L+ + + K++DFGL++L T A APE
Sbjct: 135 RDLAARNCLVGENHLVKVADFGLSRLMTG-----DTYTAHAGAKFPIKWTAPESLAYNKF 189
Query: 873 TEKTDVFAFGVLALETVS-------GRPNSD 896
+ K+DV+AFGVL E + G S
Sbjct: 190 SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ 220
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 5e-38
Identities = 68/215 (31%), Positives = 99/215 (46%), Gaps = 20/215 (9%)
Query: 693 ENFSPSNKLGEGGFGPVYKGKLGDGRAIAVKQLSVASRQGKSQFVAEIATISAVQHRNLV 752
E + +LG G FG V GK +AVK + S + +F E T+ + H LV
Sbjct: 8 EEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLV 66
Query: 753 KLHGCCIEGAERLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESR 812
K +G C + +V EY+ N L L L+ + E+C V G+A+L
Sbjct: 67 KFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGK-GLEPSQLLEMCYDVCEGMAFL---ES 122
Query: 813 VRIIHRDVKASNVLLDADLVPKISDFGLAK-LYDDKKTHISTRVAGT---IGYLAPEYAM 868
+ IHRD+ A N L+D DL K+SDFG+ + + DD GT + + APE
Sbjct: 123 HQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDD----QYVSSVGTKFPVKWSAPEVFH 178
Query: 869 RGHLTEKTDVFAFGVLALETVS-------GRPNSD 896
+ K+DV+AFG+L E S NS+
Sbjct: 179 YFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSE 213
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 6e-38
Identities = 61/209 (29%), Positives = 95/209 (45%), Gaps = 20/209 (9%)
Query: 699 NKLGEGGFGPVYKGKLGDGRAIAVKQLSVASRQGKSQFVAEIATISAVQHRNLVKLHGCC 758
+LG G FG V GK +A+K + S + +F+ E + + H LV+L+G C
Sbjct: 30 KELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS-EDEFIEEAKVMMNLSHEKLVQLYGVC 88
Query: 759 IEGAERLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHR 818
+ ++ EY+ N L L R E+C V + YL + +HR
Sbjct: 89 TKQRPIFIITEYMANGCLLNYLREMRH-RFQTQQLLEMCKDVCEAMEYL---ESKQFLHR 144
Query: 819 DVKASNVLLDADLVPKISDFGLAK-LYDDKKTHISTRVAGT---IGYLAPEYAMRGHLTE 874
D+ A N L++ V K+SDFGL++ + DD T G+ + + PE M +
Sbjct: 145 DLAARNCLVNDQGVVKVSDFGLSRYVLDD----EYTSSVGSKFPVRWSPPEVLMYSKFSS 200
Query: 875 KTDVFAFGVLALETVS-------GRPNSD 896
K+D++AFGVL E S NS+
Sbjct: 201 KSDIWAFGVLMWEIYSLGKMPYERFTNSE 229
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 141 bits (359), Expect = 7e-38
Identities = 66/209 (31%), Positives = 102/209 (48%), Gaps = 20/209 (9%)
Query: 699 NKLGEGGFGPVYKGKLGDGRAIAVKQLSVASRQGKSQFVAEIATISAVQHRNLVKLHGCC 758
++G G FG V+ G + +A+K + + + F+ E + + H LV+L+G C
Sbjct: 14 QEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVC 72
Query: 759 IEGAERLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHR 818
+E A LV E++E+ L L QR T +C V G+AYL E +IHR
Sbjct: 73 LEQAPICLVTEFMEHGCLSDYLRTQRG-LFAAETLLGMCLDVCEGMAYL--EEA-CVIHR 128
Query: 819 DVKASNVLLDADLVPKISDFGLAK-LYDDKKTHISTRVAGT---IGYLAPEYAMRGHLTE 874
D+ A N L+ + V K+SDFG+ + + DD T GT + + +PE +
Sbjct: 129 DLAARNCLVGENQVIKVSDFGMTRFVLDD----QYTSSTGTKFPVKWASPEVFSFSRYSS 184
Query: 875 KTDVFAFGVLALETVS-------GRPNSD 896
K+DV++FGVL E S R NS+
Sbjct: 185 KSDVWSFGVLMWEVFSEGKIPYENRSNSE 213
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 2e-37
Identities = 68/208 (32%), Positives = 105/208 (50%), Gaps = 18/208 (8%)
Query: 699 NKLGEGGFGPVYKGKLGDGRAIAVKQLSVASRQGKSQFVAEIATISAVQHRNLVKLHGCC 758
+LG G FG V+ G +AVK L S F+AE + +QH+ LV+L+
Sbjct: 19 ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS-PDAFLAEANLMKQLQHQRLVRLYAVV 77
Query: 759 IEGAERLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHR 818
+ ++ EY+EN SL L + L ++ + +A G+A++ E R IHR
Sbjct: 78 TQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI--EER-NYIHR 133
Query: 819 DVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVAGT---IGYLAPEYAMRGHLTEK 875
D++A+N+L+ L KI+DFGLA+L +D + T G I + APE G T K
Sbjct: 134 DLRAANILVSDTLSCKIADFGLARLIED---NEYTAREGAKFPIKWTAPEAINYGTFTIK 190
Query: 876 TDVFAFGVLALETVS-------GRPNSD 896
+DV++FG+L E V+ G N +
Sbjct: 191 SDVWSFGILLTEIVTHGRIPYPGMTNPE 218
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 2e-37
Identities = 59/212 (27%), Positives = 102/212 (48%), Gaps = 19/212 (8%)
Query: 699 NKLGEGGFGPVYKGKL---GDGRAI--AVKQLSV-ASRQGKSQFVAEIATISAVQHRNLV 752
LG G FG VYKG G+ I A+K+L S + + + E +++V + ++
Sbjct: 21 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 753 KLHGCCIEGAERLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESR 812
+L G C+ L+ + + L + + + C +A+G+ YL E R
Sbjct: 81 RLLGICLTS-TVQLITQLMPFGCLLDYVREHKD-NIGSQYLLNWCVQIAKGMNYL--EDR 136
Query: 813 VRIIHRDVKASNVLLDADLVPKISDFGLAK-LYDDKKTHISTRVAGTIGYLAPEYAMRGH 871
R++HRD+ A NVL+ KI+DFGLAK L ++K + + I ++A E +
Sbjct: 137 -RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 195
Query: 872 LTEKTDVFAFGVLALETVS-------GRPNSD 896
T ++DV+++GV E ++ G P S+
Sbjct: 196 YTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 227
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 3e-37
Identities = 57/199 (28%), Positives = 101/199 (50%), Gaps = 12/199 (6%)
Query: 700 KLGEGGFGPVYKGKLGDGRA-----IAVKQLSV-ASRQGKSQFVAEIATISAVQHRNLVK 753
+G G FG VYKG L +A+K L + + + F+ E + H N+++
Sbjct: 51 VIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIR 110
Query: 754 LHGCCIEGAERLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRV 813
L G + +++ EY+EN +LD+ L + + G+A G+ YL + +
Sbjct: 111 LEGVISKYKPMMIITEYMENGALDKFLREKDG-EFSVLQLVGMLRGIAAGMKYL---ANM 166
Query: 814 RIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVAGT--IGYLAPEYAMRGH 871
+HRD+ A N+L++++LV K+SDFGL+++ +D T G I + APE
Sbjct: 167 NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRK 226
Query: 872 LTEKTDVFAFGVLALETVS 890
T +DV++FG++ E ++
Sbjct: 227 FTSASDVWSFGIVMWEVMT 245
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 5e-37
Identities = 60/195 (30%), Positives = 94/195 (48%), Gaps = 15/195 (7%)
Query: 699 NKLGEGGFGPVYKGKLGDGRAIAVKQLSVASRQGKSQ--FVAEIATISAVQHRNLVKLHG 756
+G+G FG V G G +AVK + + + F+AE + ++ ++H NLV+L G
Sbjct: 199 QTIGKGEFGDVMLGDY-RGNKVAVKCI----KNDATAQAFLAEASVMTQLRHSNLVQLLG 253
Query: 757 CCIEGAERL-LVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRI 815
+E L +V EY+ SL L + L + V + YL E
Sbjct: 254 VIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL--EGN-NF 310
Query: 816 IHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVAGTIGYLAPEYAMRGHLTEK 875
+HRD+ A NVL+ D V K+SDFGL K + T + ++ + + APE + K
Sbjct: 311 VHRDLAARNVLVSEDNVAKVSDFGLTK--EASSTQDTGKLP--VKWTAPEALREKKFSTK 366
Query: 876 TDVFAFGVLALETVS 890
+DV++FG+L E S
Sbjct: 367 SDVWSFGILLWEIYS 381
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 6e-37
Identities = 62/208 (29%), Positives = 96/208 (46%), Gaps = 22/208 (10%)
Query: 699 NKLGEGGFGPVYKGKLGDGRAIAVKQLSVASRQGKSQ--FVAEIATISAVQHRNLVKLHG 756
+G+G FG V G G +AVK + + + F+AE + ++ ++H NLV+L G
Sbjct: 27 QTIGKGEFGDVMLGDY-RGNKVAVKCI----KNDATAQAFLAEASVMTQLRHSNLVQLLG 81
Query: 757 CCIEGAERL-LVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRI 815
+E L +V EY+ SL L + L + V + YL E
Sbjct: 82 VIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL--EGN-NF 138
Query: 816 IHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVAGTIGYLAPEYAMRGHLTEK 875
+HRD+ A NVL+ D V K+SDFGL K + T + ++ + + APE + K
Sbjct: 139 VHRDLAARNVLVSEDNVAKVSDFGLTK--EASSTQDTGKLP--VKWTAPEALREKKFSTK 194
Query: 876 TDVFAFGVLALETVS-------GRPNSD 896
+DV++FG+L E S P D
Sbjct: 195 SDVWSFGILLWEIYSFGRVPYPRIPLKD 222
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 7e-37
Identities = 56/313 (17%), Positives = 103/313 (32%), Gaps = 27/313 (8%)
Query: 115 IPDELWNLTSLFNLNLGQNYLTGPLSPSVGNLTAMQYLNLAINALSGELPKELGQLTELL 174
I + N + + L L+ + ++ L+L+ N LS +L T+L
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 175 ILGIGTNNFSGPLPSELGSLSKLQELYIDSAGVSGEIPSSFANLQSLTKWWASDTRLTGR 234
+L + +N +L SLS L+ L + + S+ A++ ++ R
Sbjct: 62 LLNLSSNVLYE--TLDLESLSTLRTLDL-----NNNYVQELLVGPSIETLHAANNNIS-R 113
Query: 235 IPDFIGNWSKLTALRFQGNSFNGPIPSSFSNLTSVTEL-----RISDLSNGSSKLAFIRD 289
+ + N + V L I ++
Sbjct: 114 VS--CSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFA----ELAAS 167
Query: 290 MKSLSILELRNNNISDSIPSNIGEYRSLQHLDLSFNNLGGSIPDSLFNLSSLTHLFLGNN 349
+L L L+ N I + + L+ LDLS N L + + + +T + L NN
Sbjct: 168 SDTLEHLNLQYNFIY-DVKGQVVF-AKLKTLDLSSNKL-AFMGPEFQSAAGVTWISLRNN 224
Query: 350 KLNGTLPA--RKSPLLLNIDVSYNNLQ-GNLPSWINGQQNLQINLVANNLTIRSSDNSVL 406
KL + R S L + D+ N G L + + Q +Q + + + N
Sbjct: 225 KLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQ-TVAKQTVKKLTGQNEEE 282
Query: 407 PRGLICLQRNFPC 419
C
Sbjct: 283 CTVPTLGHYGAYC 295
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 2e-07
Identities = 14/96 (14%), Positives = 35/96 (36%), Gaps = 7/96 (7%)
Query: 306 SIPSNIGEYRSLQHLDLSFNNLGGSIPDSLFNLSSLTHLFLGNNKLNGTLPA---RKSPL 362
+I + ++ ++L ++ + ++ L L N L+ + A
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLS-QISAADLAPFTK 59
Query: 363 LLNIDVSYNNLQGNLPSWINGQQNLQ-INLVANNLT 397
L +++S N L + L+ ++L N +
Sbjct: 60 LELLNLSSNVLY-ETLD-LESLSTLRTLDLNNNYVQ 93
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 9e-37
Identities = 60/199 (30%), Positives = 98/199 (49%), Gaps = 11/199 (5%)
Query: 699 NKLGEGGFGPVYKGKL----GDGRAIAVKQLSV-ASRQGKSQFVAEIATISAVQHRNLVK 753
+G G G V G+L +A+K L + + + F++E + + H N+++
Sbjct: 55 KIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIR 114
Query: 754 LHGCCIEGAERLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRV 813
L G G ++V EY+EN SLD L + GV G+ YL S +
Sbjct: 115 LEGVVTRGRLAMIVTEYMENGSLDTFLRTHDG-QFTIMQLVGMLRGVGAGMRYL---SDL 170
Query: 814 RIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVAGT--IGYLAPEYAMRGH 871
+HRD+ A NVL+D++LV K+SDFGL+++ +D T G I + APE
Sbjct: 171 GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRT 230
Query: 872 LTEKTDVFAFGVLALETVS 890
+ +DV++FGV+ E ++
Sbjct: 231 FSSASDVWSFGVVMWEVLA 249
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 9e-37
Identities = 69/283 (24%), Positives = 123/283 (43%), Gaps = 19/283 (6%)
Query: 116 PDELWNLTSLFNLNLGQNYLTGPLSPSVGNLTAMQYLNLAINALSGELPKELGQLTELLI 175
L LTSL L+ G N +T + NLT ++ L+++ N +S L +LT L
Sbjct: 149 ISALSGLTSLQQLSFG-NQVTDL--KPLANLTTLERLDISSNKVSD--ISVLAKLTNLES 203
Query: 176 LGIGTNNFSGPLPSELGSLSKLQELYIDSAGVSGEIPSSFANLQSLTKWWASDTRLTGRI 235
L N S + LG L+ L EL ++ + + A+L +LT ++ +++
Sbjct: 204 LIATNNQISDI--TPLGILTNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLA 259
Query: 236 PDFIGNWSKLTALRFQGNSFNGPIPSSFSNLTSVTELRISDLSNGSSKLAFIRDMKSLSI 295
P + +KLT L+ N + P + LT++T L +++ N ++ I ++K+L+
Sbjct: 260 P--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNE--NQLEDISPISNLKNLTY 313
Query: 296 LELRNNNISDSIPSNIGEYRSLQHLDLSFNNLGGSIPDSLFNLSSLTHLFLGNNKLNGTL 355
L L NNISD P + LQ L N + S SL NL+++ L G+N+++
Sbjct: 314 LTLYFNNISDISP--VSSLTKLQRLFFYNNKV--SDVSSLANLTNINWLSAGHNQISDLT 369
Query: 356 PARKSPLLLNIDVSYNNLQGNLPSWINGQQNLQINLVANNLTI 398
P + + ++ ++ I
Sbjct: 370 PLANLTRITQLGLNDQAWTNAPVNYKANVSIPNTVKNVTGALI 412
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 2e-35
Identities = 65/281 (23%), Positives = 110/281 (39%), Gaps = 18/281 (6%)
Query: 116 PDELWNLTSLFNLNLGQNYLTGPLSPSVGNLTAMQYLNLAINALSGELPKELGQLTELLI 175
L NLT+L L++ N ++ + LT ++ L N +S P LG LT L
Sbjct: 170 LKPLANLTTLERLDISSNKVSDI--SVLAKLTNLESLIATNNQISDITP--LGILTNLDE 225
Query: 176 LGIGTNNFSGPLPSELGSLSKLQELYIDSAGVSGEIPSSFANLQSLTKWWASDTRLTGRI 235
L + N L SL+ L +L + + +S P + L LT+ +++
Sbjct: 226 LSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNIS 281
Query: 236 PDFIGNWSKLTALRFQGNSFNGPIPSSFSNLTSVTELRISDLSNGSSKLAFIRDMKSLSI 295
P + + LT L N P SNL ++T L + N S ++ + + L
Sbjct: 282 P--LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLY--FNNISDISPVSSLTKLQR 335
Query: 296 LELRNNNISDSIPSNIGEYRSLQHLDLSFNNLGGSIPDSLFNLSSLTHLFLGNNKLNGTL 355
L NN +SD S++ ++ L N + P L NL+ +T L L +
Sbjct: 336 LFFYNNKVSD--VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTNAP 391
Query: 356 PARKSPLLLNIDVSYNNLQGNLPSWINGQQNLQINLVANNL 396
K+ + + V P+ I+ + + NL
Sbjct: 392 VNYKANVSIPNTVKNVTGALIAPATISDGGSYTEPDITWNL 432
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 7e-34
Identities = 60/278 (21%), Positives = 117/278 (42%), Gaps = 22/278 (7%)
Query: 121 NLTSLFNLNLGQNYLTGPLSPSVGNLTAMQYLNLAINALSGELPKELGQLTELLILGIGT 180
L LG+ +T S +L + L + + L L +
Sbjct: 22 ALAEKMKTVLGKTNVTDT--VSQTDLDQVTTLQADRLGIKS--IDGVEYLNNLTQINFSN 77
Query: 181 NNFSGPLPSELGSLSKLQELYIDSAGVSGEIPSSFANLQSLTKWWASDTRLTGRIPDFIG 240
N + + L +L+KL ++ +++ ++ P ANL +LT + ++T P +
Sbjct: 78 NQLTDI--TPLKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQITDIDP--LK 131
Query: 241 NWSKLTALRFQGNSFNGPIPSSFSNLTSVTELRISDLSNGSSKLAFIRDMKSLSILELRN 300
N + L L N+ + S+ S LTS+ +L N + L + ++ +L L++ +
Sbjct: 132 NLTNLNRLELSSNTISDI--SALSGLTSLQQL---SFGNQVTDLKPLANLTTLERLDISS 186
Query: 301 NNISDSIPSNIGEYRSLQHLDLSFNNLGGSIPDSLFNLSSLTHLFLGNNKLNGTLPARKS 360
N +SD S + + +L+ L + N + P L L++L L L N+L
Sbjct: 187 NKVSD--ISVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDIGTLASL 242
Query: 361 PLLLNIDVSYNNLQGNLPSWINGQQNLQ-INLVANNLT 397
L ++D++ N + P ++G L + L AN ++
Sbjct: 243 TNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQIS 278
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 2e-27
Identities = 60/262 (22%), Positives = 104/262 (39%), Gaps = 37/262 (14%)
Query: 117 DELWNLTSLFNLNLGQNYLTGPLSPSVGNLTAMQYLNLAINALSGELPKELGQLTELLIL 176
L LT+L L+L N L ++ +LT + L+LA N +S P L LT+L L
Sbjct: 215 TPLGILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTEL 270
Query: 177 GIGTNNFSGPLPSELGSLSKLQELYIDSAGVSGEIPSSFANLQSLTKWWASDTRLTGRIP 236
+G N S S L L+ L L ++ + S +NL++LT ++ P
Sbjct: 271 KLGANQISNI--SPLAGLTALTNLELNENQLED--ISPISNLKNLTYLTLYFNNISDISP 326
Query: 237 DFIGNWSKLTALRFQGNSFNGPIPSSFSNLTSVTELRISDLSNGSSKLAFIRDMKSLSIL 296
+ + +KL L F N + SS +NLT++ L N S L + ++ ++ L
Sbjct: 327 --VSSLTKLQRLFFYNNKVSDV--SSLANLTNINWLSAGH--NQISDLTPLANLTRITQL 380
Query: 297 ELRNNNISD----------------------SIPSNIGEYRSLQHLDLSFNNLGGSIPDS 334
L + ++ P+ I + S D+++N +
Sbjct: 381 GLNDQAWTNAPVNYKANVSIPNTVKNVTGALIAPATISDGGSYTEPDITWNLP-SYTNEV 439
Query: 335 LFNLSSLTHLFLGNNKLNGTLP 356
+ S + G +GT+
Sbjct: 440 SYTFSQPVTIGKGTTTFSGTVT 461
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 2e-10
Identities = 21/131 (16%), Positives = 49/131 (37%), Gaps = 8/131 (6%)
Query: 268 SVTELRISDLSNGSSKLAFIRDMKSLSILELRNNNISDSIPSNIGEYRSLQHLDLSFNNL 327
+ I+ +++ + L N++D++ + + L +
Sbjct: 2 PLGSATITQ-DTPINQIFTDTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGI 58
Query: 328 GGSIPDSLFNLSSLTHLFLGNNKLNGTLPARKSPLLLNIDVSYNNLQGNLPSWINGQQNL 387
D + L++LT + NN+L P + L++I ++ N + + + NL
Sbjct: 59 --KSIDGVEYLNNLTQINFSNNQLTDITPLKNLTKLVDILMNNNQIAD--ITPLANLTNL 114
Query: 388 Q-INLVANNLT 397
+ L N +T
Sbjct: 115 TGLTLFNNQIT 125
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 1e-36
Identities = 58/199 (29%), Positives = 101/199 (50%), Gaps = 11/199 (5%)
Query: 699 NKLGEGGFGPVYKGKL----GDGRAIAVKQLSV-ASRQGKSQFVAEIATISAVQHRNLVK 753
+G G FG V G+L ++A+K L V + + + F+ E + + H N+++
Sbjct: 51 KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 110
Query: 754 LHGCCIEGAERLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRV 813
L G + ++V EY+EN SLD L + + G+A G+ YL S +
Sbjct: 111 LEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA-QFTVIQLVGMLRGIASGMKYL---SDM 166
Query: 814 RIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVAGT--IGYLAPEYAMRGH 871
+HRD+ A N+L++++LV K+SDFGL ++ +D T G I + +PE
Sbjct: 167 GYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRK 226
Query: 872 LTEKTDVFAFGVLALETVS 890
T +DV+++G++ E +S
Sbjct: 227 FTSASDVWSYGIVLWEVMS 245
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 2e-36
Identities = 56/213 (26%), Positives = 99/213 (46%), Gaps = 24/213 (11%)
Query: 699 NKLGEGGFGPVYKGKL------GDGRAIAVKQLSVASRQGKSQFVAEIATISAVQHRNLV 752
+LGEG FG V+ + D +AVK L + + F E ++ +QH ++V
Sbjct: 21 RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIV 80
Query: 753 KLHGCCIEGAERLLVYEYLENKSLDQALFGQRSLTLDWATRYE--------------ICS 798
K +G C +G ++V+EY+++ L++ L + I S
Sbjct: 81 KFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIAS 140
Query: 799 GVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAK-LYDDKKTHISTRVAG 857
+A G+ YL + +HRD+ N L+ A+L+ KI DFG+++ +Y +
Sbjct: 141 QIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTML 197
Query: 858 TIGYLAPEYAMRGHLTEKTDVFAFGVLALETVS 890
I ++ PE M T ++DV++FGV+ E +
Sbjct: 198 PIRWMPPESIMYRKFTTESDVWSFGVILWEIFT 230
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 2e-36
Identities = 63/205 (30%), Positives = 103/205 (50%), Gaps = 12/205 (5%)
Query: 699 NKLGEGGFGPVYKGKLGDGRAIAVKQLSVASRQGKSQFVAEIATISAVQHRNLVKLHGCC 758
KLG+G FG V+ G +A+K L + F+ E + ++H LV+L+
Sbjct: 190 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVV 248
Query: 759 IEGAERLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHR 818
E +V EY+ SL L G+ L ++ + +A G+AY+ E +HR
Sbjct: 249 SEEP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYV--ERM-NYVHR 304
Query: 819 DVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVAGTIGYLAPEYAMRGHLTEKTDV 878
D++A+N+L+ +LV K++DFGLA+L +D + I + APE A+ G T K+DV
Sbjct: 305 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 364
Query: 879 FAFGVLALETVS-------GRPNSD 896
++FG+L E + G N +
Sbjct: 365 WSFGILLTELTTKGRVPYPGMVNRE 389
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 3e-36
Identities = 56/197 (28%), Positives = 94/197 (47%), Gaps = 11/197 (5%)
Query: 700 KLGEGGFGPVYKGKLGDGR---AIAVKQLSV-ASRQGKSQFVAEIATISAVQHRNLVKLH 755
+LG G FG V +G + +A+K L + + + E + + + +V+L
Sbjct: 17 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 76
Query: 756 GCCIEGAERLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRI 815
G C + +LV E L + L G+R + + E+ V+ G+ YL E +
Sbjct: 77 GVC-QAEALMLVMEMAGGGPLHKFLVGKRE-EIPVSNVAELLHQVSMGMKYL--EEK-NF 131
Query: 816 IHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVAGT--IGYLAPEYAMRGHLT 873
+HRD+ A NVLL KISDFGL+K ++ + R AG + + APE +
Sbjct: 132 VHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFS 191
Query: 874 EKTDVFAFGVLALETVS 890
++DV+++GV E +S
Sbjct: 192 SRSDVWSYGVTMWEALS 208
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 4e-36
Identities = 60/212 (28%), Positives = 100/212 (47%), Gaps = 23/212 (10%)
Query: 699 NKLGEGGFGPVYKGKL------GDGRAIAVKQLSVASRQGKSQFVAEIATISAVQHRNLV 752
+LGEG FG V+ + D +AVK L AS + F E ++ +QH+++V
Sbjct: 47 WELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIV 106
Query: 753 KLHGCCIEGAERLLVYEYLENKSLDQALFGQRSLTLDWATRYE-------------ICSG 799
+ G C EG L+V+EY+ + L++ L A + + S
Sbjct: 107 RFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQ 166
Query: 800 VARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAK-LYDDKKTHISTRVAGT 858
VA G+ YL + + +HRD+ N L+ LV KI DFG+++ +Y + R
Sbjct: 167 VAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLP 223
Query: 859 IGYLAPEYAMRGHLTEKTDVFAFGVLALETVS 890
I ++ PE + T ++DV++FGV+ E +
Sbjct: 224 IRWMPPESILYRKFTTESDVWSFGVVLWEIFT 255
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 4e-36
Identities = 66/280 (23%), Positives = 123/280 (43%), Gaps = 36/280 (12%)
Query: 693 ENFSPSNKLGEGGFGPVYKGK-LGDGRAIAVKQLSVA---SRQGKSQFVAEIATISAVQH 748
NF K+G G F VY+ L DG +A+K++ + + ++ + EI + + H
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 749 RNLVKLHGCCIEGAERLLVYEYLENKSLDQAL--FGQRSLTLDWATRYEICSGVARGLAY 806
N++K + IE E +V E + L + + F ++ + T ++ + L +
Sbjct: 92 PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEH 151
Query: 807 LHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVAGTIGYLAPEY 866
+H R++HRD+K +NV + A V K+ D GL + + K T + V GT Y++PE
Sbjct: 152 MHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPER 207
Query: 867 AMRGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQE-----IE 921
K+D+++ G L E + + ++ + N IE
Sbjct: 208 IHENGYNFKSDIWSLGCLLYEMAALQS----------------PFYGDKMNLYSLCKKIE 251
Query: 922 LADPKLIEFNE--EEVKRLIGVALLCTQTLPSLRPSMSRV 959
D + + EE+++L+ +C P RP ++ V
Sbjct: 252 QCDYPPLPSDHYSEELRQLV---NMCINPDPEKRPDVTYV 288
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 4e-36
Identities = 54/215 (25%), Positives = 91/215 (42%), Gaps = 22/215 (10%)
Query: 699 NKLGEGGFGPVYKGKLGDGR----AIAVKQL-SVASRQGKSQFVAEIATISAVQHRNLVK 753
+G+G FG VY G+ D A+K L + Q F+ E + + H N++
Sbjct: 27 RVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLA 86
Query: 754 LHGCCIEGAERLL-VYEYLENKSLDQALFGQR-SLTLDWATRYEICSGVARGLAYLHEES 811
L G + + Y+ + L Q + + + T+ VARG+ YL
Sbjct: 87 LIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTV--KDLISFGLQVARGMEYL--AE 142
Query: 812 RVRIIHRDVKASNVLLDADLVPKISDFGLAK-LYDDKKTHISTRVAGT--IGYLAPEYAM 868
+ + +HRD+ A N +LD K++DFGLA+ + D + + + + A E
Sbjct: 143 Q-KFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQ 201
Query: 869 RGHLTEKTDVFAFGVLALETVS-------GRPNSD 896
T K+DV++FGVL E ++ D
Sbjct: 202 TYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFD 236
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 4e-36
Identities = 66/208 (31%), Positives = 101/208 (48%), Gaps = 18/208 (8%)
Query: 699 NKLGEGGFGPVYKGKLGDGRAIAVKQLSVASRQGKSQFVAEIATISAVQHRNLVKLHGCC 758
KLG G FG V+ +AVK + S F+AE + +QH LVKLH
Sbjct: 194 KKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS-VEAFLAEANVMKTLQHDKLVKLHAVV 252
Query: 759 IEGAERLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHR 818
+ ++ E++ SL L + + +A G+A++ E R IHR
Sbjct: 253 TKEP-IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFI--EQR-NYIHR 308
Query: 819 DVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVAGT---IGYLAPEYAMRGHLTEK 875
D++A+N+L+ A LV KI+DFGLA++ +D + T G I + APE G T K
Sbjct: 309 DLRAANILVSASLVCKIADFGLARVIEDNEY---TAREGAKFPIKWTAPEAINFGSFTIK 365
Query: 876 TDVFAFGVLALETVS-------GRPNSD 896
+DV++FG+L +E V+ G N +
Sbjct: 366 SDVWSFGILLMEIVTYGRIPYPGMSNPE 393
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 143 bits (361), Expect = 7e-36
Identities = 61/192 (31%), Positives = 100/192 (52%), Gaps = 5/192 (2%)
Query: 699 NKLGEGGFGPVYKGKLGDGRAIAVKQLSVASRQGKSQFVAEIATISAVQHRNLVKLHGCC 758
KLG+G FG V+ G +A+K L + F+ E + ++H LV+L+
Sbjct: 273 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVV 331
Query: 759 IEGAERLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHR 818
E +V EY+ SL L G+ L ++ + +A G+AY+ E +HR
Sbjct: 332 SEEP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYV--ERM-NYVHR 387
Query: 819 DVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVAGTIGYLAPEYAMRGHLTEKTDV 878
D++A+N+L+ +LV K++DFGLA+L +D + I + APE A+ G T K+DV
Sbjct: 388 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 447
Query: 879 FAFGVLALETVS 890
++FG+L E +
Sbjct: 448 WSFGILLTELTT 459
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 1e-35
Identities = 61/198 (30%), Positives = 89/198 (44%), Gaps = 13/198 (6%)
Query: 700 KLGEGGFGPVYKGKL-GDGRAI--AVKQL--SVASRQGKSQFVAEIATISAVQHRNLVKL 754
+LG G FG V KG AVK L K + +AE + + + +V++
Sbjct: 24 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83
Query: 755 HGCCIEGAERLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVR 814
G C E +LV E E L++ L R + E+ V+ G+ YL E
Sbjct: 84 IGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKD--KNIIELVHQVSMGMKYL--EES-N 137
Query: 815 IIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVAGT--IGYLAPEYAMRGHL 872
+HRD+ A NVLL KISDFGL+K + + + G + + APE
Sbjct: 138 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKF 197
Query: 873 TEKTDVFAFGVLALETVS 890
+ K+DV++FGVL E S
Sbjct: 198 SSKSDVWSFGVLMWEAFS 215
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 1e-35
Identities = 52/231 (22%), Positives = 105/231 (45%), Gaps = 13/231 (5%)
Query: 667 HDDDEELLGMDARPYTFSYAELKTATENFSPSNKLGEGGFGPVYKGK-LGDGRAIAVKQL 725
H G+D + + E + K+GEG FG K DGR +K++
Sbjct: 2 HHHHHHSSGVDLGTENLYFQSM----EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEI 57
Query: 726 SVA--SRQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLVYEYLENKSLDQALFGQ 783
+++ S + + + E+A ++ ++H N+V+ E +V +Y E L + + Q
Sbjct: 58 NISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQ 117
Query: 784 RSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKL 843
+ + + + L ++H+ +I+HRD+K+ N+ L D ++ DFG+A++
Sbjct: 118 KGVLFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARV 174
Query: 844 YDDKKTHISTRVAGTIGYLAPE-YAMRGHLTEKTDVFAFGVLALETVSGRP 893
+ + GT YL+PE + + K+D++A G + E + +
Sbjct: 175 LNSTVELARACI-GTPYYLSPEICENKPY-NNKSDIWALGCVLYELCTLKH 223
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 3e-35
Identities = 59/212 (27%), Positives = 102/212 (48%), Gaps = 19/212 (8%)
Query: 699 NKLGEGGFGPVYKGKL---GDGRAI--AVKQLSV-ASRQGKSQFVAEIATISAVQHRNLV 752
LG G FG VYKG G+ I A+K+L S + + + E +++V + ++
Sbjct: 21 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 753 KLHGCCIEGAERLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESR 812
+L G C+ L+ + + L + + + C +A+G+ YL E R
Sbjct: 81 RLLGICLTS-TVQLITQLMPFGCLLDYVREHKD-NIGSQYLLNWCVQIAKGMNYL--EDR 136
Query: 813 VRIIHRDVKASNVLLDADLVPKISDFGLAK-LYDDKKTHISTRVAGTIGYLAPEYAMRGH 871
R++HRD+ A NVL+ KI+DFGLAK L ++K + + I ++A E +
Sbjct: 137 -RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 195
Query: 872 LTEKTDVFAFGVLALETVS-------GRPNSD 896
T ++DV+++GV E ++ G P S+
Sbjct: 196 YTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 227
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 3e-35
Identities = 57/212 (26%), Positives = 96/212 (45%), Gaps = 19/212 (8%)
Query: 699 NKLGEGGFGPVYKGKL---GDGRAI--AVKQL-SVASRQGKSQFVAEIATISAVQHRNLV 752
LG G FG V+KG G+ I +K + + RQ + I ++ H ++V
Sbjct: 19 KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIV 78
Query: 753 KLHGCCIEGAERLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESR 812
+L G C + LV +YL SL + R L +A+G+ YL E
Sbjct: 79 RLLGLCPG-SSLQLVTQYLPLGSLLDHVRQHRG-ALGPQLLLNWGVQIAKGMYYL--EEH 134
Query: 813 VRIIHRDVKASNVLLDADLVPKISDFGLAK-LYDDKKTHISTRVAGTIGYLAPEYAMRGH 871
++HR++ A NVLL + +++DFG+A L D K + + I ++A E G
Sbjct: 135 -GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGK 193
Query: 872 LTEKTDVFAFGVLALETVS-------GRPNSD 896
T ++DV+++GV E ++ G ++
Sbjct: 194 YTHQSDVWSYGVTVWELMTFGAEPYAGLRLAE 225
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 3e-35
Identities = 52/216 (24%), Positives = 91/216 (42%), Gaps = 28/216 (12%)
Query: 693 ENFSPSNKLGEGGFGPVYKGKL------GDGRAI--AVKQLSVASRQGKSQFVAEIATIS 744
E+ + LG+G F ++KG G +K L A R F + +S
Sbjct: 8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMS 67
Query: 745 AVQHRNLVKLHGCCIEGAERLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGL 804
+ H++LV +G C+ G E +LV E+++ SLD L ++ ++ + E+ +A +
Sbjct: 68 KLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKN-CINILWKLEVAKQLAAAM 126
Query: 805 AYLHEESRVRIIHRDVKASNVLLDAD--------LVPKISDFGLAK-LYDDKKTHISTRV 855
+L E +IH +V A N+LL + K+SD G++ +
Sbjct: 127 HFL--EEN-TLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIP- 182
Query: 856 AGTIGYLAPE-YAMRGHLTEKTDVFAFGVLALETVS 890
++ PE +L TD ++FG E S
Sbjct: 183 -----WVPPECIENPKNLNLATDKWSFGTTLWEICS 213
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 6e-35
Identities = 63/216 (29%), Positives = 99/216 (45%), Gaps = 26/216 (12%)
Query: 699 NKLGEGGFGPVYKGKL-GDGRAI--AVKQL-SVASRQGKSQFVAEIATISAV-QHRNLVK 753
+ +GEG FG V K ++ DG + A+K++ AS+ F E+ + + H N++
Sbjct: 31 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 90
Query: 754 LHGCCIEGAERLLVYEYLENKSLDQALFGQRSLTLDWATRYE--------------ICSG 799
L G C L EY + +L L R L D A +
Sbjct: 91 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 150
Query: 800 VARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVAGTI 859
VARG+ YL + + IHRD+ A N+L+ + V KI+DFGL++ + R+ +
Sbjct: 151 VARGMDYL--SQK-QFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLP--V 205
Query: 860 GYLAPEYAMRGHLTEKTDVFAFGVLALETVS--GRP 893
++A E T +DV+++GVL E VS G P
Sbjct: 206 RWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 241
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 7e-35
Identities = 56/197 (28%), Positives = 94/197 (47%), Gaps = 11/197 (5%)
Query: 700 KLGEGGFGPVYKGKL-GDGRAI--AVKQLSV-ASRQGKSQFVAEIATISAVQHRNLVKLH 755
+LG G FG V +G + I A+K L + + + E + + + +V+L
Sbjct: 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 402
Query: 756 GCCIEGAERLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRI 815
G C + +LV E L + L G+R + + E+ V+ G+ YL E +
Sbjct: 403 GVC-QAEALMLVMEMAGGGPLHKFLVGKRE-EIPVSNVAELLHQVSMGMKYL--EEK-NF 457
Query: 816 IHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVAGT--IGYLAPEYAMRGHLT 873
+HR++ A NVLL KISDFGL+K ++ + R AG + + APE +
Sbjct: 458 VHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFS 517
Query: 874 EKTDVFAFGVLALETVS 890
++DV+++GV E +S
Sbjct: 518 SRSDVWSYGVTMWEALS 534
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 8e-35
Identities = 56/315 (17%), Positives = 104/315 (33%), Gaps = 27/315 (8%)
Query: 115 IPDELWNLTSLFNLNLGQNYLTGPLSPSVGNLTAMQYLNLAINALSGELPKELGQLTELL 174
I + N + + L L+ + ++ L+L+ N LS +L T+L
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 175 ILGIGTNNFSGPLPSELGSLSKLQELYIDSAGVSGEIPSSFANLQSLTKWWASDTRLTGR 234
+L + +N +L SLS L+ L + + S+ A++ ++ R
Sbjct: 62 LLNLSSNVLYE--TLDLESLSTLRTLDL-----NNNYVQELLVGPSIETLHAANNNIS-R 113
Query: 235 IPDFIGNWSKLTALRFQGNSFNGPIPSSFSNLTSVTEL-----RISDLSNGSSKLAFIRD 289
+ + N + V L I ++
Sbjct: 114 VS--CSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFA----ELAAS 167
Query: 290 MKSLSILELRNNNISDSIPSNIGEYRSLQHLDLSFNNLGGSIPDSLFNLSSLTHLFLGNN 349
+L L L+ N I + + + L+ LDLS N L + + + +T + L NN
Sbjct: 168 SDTLEHLNLQYNFIY-DVKGQVV-FAKLKTLDLSSNKL-AFMGPEFQSAAGVTWISLRNN 224
Query: 350 KLNGTLPA--RKSPLLLNIDVSYNNLQ-GNLPSWINGQQNLQINLVANNLTIRSSDNSVL 406
KL + R S L + D+ N G L + + Q +Q + + + N
Sbjct: 225 KLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQ-TVAKQTVKKLTGQNEEE 282
Query: 407 PRGLICLQRNFPCNR 421
C
Sbjct: 283 CTVPTLGHYGAYCCE 297
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 2e-32
Identities = 43/296 (14%), Positives = 93/296 (31%), Gaps = 15/296 (5%)
Query: 114 VIPDELWNLTSLFNLNLGQNYLTGPLSPSVGNLTAMQYLNLAINALSGELPKELGQLTEL 173
+ + ++ L+L N L+ + + T ++ LNL+ N L E +L L+ L
Sbjct: 25 ALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLY-ETL-DLESLSTL 82
Query: 174 LILGIGTNNFSGPLPSELGSLSKLQELYIDSAGVSGEIPSSFANLQSLTKWWASDTRLTG 233
L + N EL ++ L+ + +S S +++ + ++ ++T
Sbjct: 83 RTLDLNNNYVQ-----ELLVGPSIETLHAANNNISRVSCSRGQGKKNI---YLANNKITM 134
Query: 234 RIPDFIGNWSKLTALRFQGNSFNG-PIPSSFSNLTSVTELRISDLSNGSSKLAFIRDMKS 292
G S++ L + N + ++ ++ L + N +
Sbjct: 135 LRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQY--NFIYDVKGQVVFAK 192
Query: 293 LSILELRNNNISDSIPSNIGEYRSLQHLDLSFNNLGGSIPDSLFNLSSLTHLFLGNNKLN 352
L L+L +N ++ + + + L N L I +L +L H L N +
Sbjct: 193 LKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFH 250
Query: 353 GTLPARKSPLLLNIDVSYNNLQGNLPSWINGQQNLQINLVANNLTIRSSDNSVLPR 408
+ L + + R
Sbjct: 251 CGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADR 306
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 5e-26
Identities = 34/284 (11%), Positives = 85/284 (29%), Gaps = 15/284 (5%)
Query: 114 VIPDELWNLTSLFNLNLGQNYLTG-PLSPSVGNLTAMQYLNLAINALSGELPKELGQLTE 172
+ + + + L+L N + + + +++LNL N + ++ ++ +
Sbjct: 135 LRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQV-VFAK 192
Query: 173 LLILGIGTNNFSGPLPSELGSLSKLQELYIDSAGVSGEIPSSFANLQSLTKWWASDTRL- 231
L L + +N + + E S + + + + + + I + Q+L +
Sbjct: 193 LKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFH 250
Query: 232 TGRIPDFIGNWSKLTALRFQGNSFNGPIPSSFSNLTSVTELRISDLSNGSSKLAFIR--- 288
G + DF ++ + + + T T F
Sbjct: 251 CGTLRDFFSKNQRVQTV--AKQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLI 308
Query: 289 --DMKSLSILELRNNNISDSIPSNIGEYRSLQHLDLSFNNLGGSIPDSLFNLSSLTHLFL 346
K ++L + + + + +D I + L
Sbjct: 309 ALKRKEHALLSGQGSETE-RLECERENQARQREIDALKEQYRTVIDQVTLRKQAKITLEQ 367
Query: 347 GNNKLNGTLP-ARKSPLLLNIDVSYNNLQGNLPSWINGQQNLQI 389
L+ + R++ L+ + Q L Q LQ+
Sbjct: 368 KKKALDEQVSNGRRAHAELDGTLQQAVGQIELQHATEEQSPLQL 411
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 4e-24
Identities = 39/295 (13%), Positives = 90/295 (30%), Gaps = 18/295 (6%)
Query: 110 NVVGVIPDELWNLTSLFNLNLGQNYLTGPLSPSVGNLTAMQYLNLAINALSG-ELPKELG 168
N + + N+ L N +T G + +QYL+L +N + +
Sbjct: 109 NNISRVSCS--RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAA 166
Query: 169 QLTELLILGIGTNNFSGPLPSELGSLSKLQELYIDSAGVSGEIPSSFANLQSLTKWWASD 228
L L + N + ++ +KL+ L + S ++ + F + +T +
Sbjct: 167 SSDTLEHLNLQYNFIYD-VKGQV-VFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRN 223
Query: 229 TRLTGRIPDFIGNWSKLTALRFQGNSFN-GPIPSSFSNLTSVTELRISDLSNGSSKLAFI 287
+L I + L +GN F+ G + FS V + + + +
Sbjct: 224 NKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQN--E 280
Query: 288 RDMKSLSILELRNNNISDSIPSNIGEYRSLQHLDLSFNNLGGS----IPDSLFNLSSLTH 343
+ ++ D +L+ + + + GS + N +
Sbjct: 281 EECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQRE 340
Query: 344 LFLGNNKLNGTLPA---RKSPLLLNIDVSYNNLQGNLPSWINGQQNLQINLVANN 395
+ + T+ + + ++ L + + L L
Sbjct: 341 IDALKEQYR-TVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQAV 394
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 54.5 bits (131), Expect = 1e-07
Identities = 25/255 (9%), Positives = 61/255 (23%), Gaps = 27/255 (10%)
Query: 115 IPDELWNLTSLFNLNLGQNYL-TGPLSPSVGNLTAMQYLNLAINALSGELPKELGQLTEL 173
I L +L + +L N G L +Q + +E + L
Sbjct: 229 IEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTL 288
Query: 174 LILGI--------------------------GTNNFSGPLPSELGSLSKLQELYIDSAGV 207
G G + + L E + ++ +E+
Sbjct: 289 GHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQREIDALKEQY 348
Query: 208 SGEIPSSFANLQSLTKWWASDTRLTGRIPDFIGNWSKLTALRFQGNSFNGPIPSSFSNLT 267
I Q+ L ++ + ++L Q ++
Sbjct: 349 RTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQAVGQIELQHATEEQSP 408
Query: 268 SVTELRISDLSNGSSKLAFIRDMKSLSILELRNNNISDSIPSNIGEYRSLQHLDLSFNNL 327
I ++ ++ + + N + DL+ +
Sbjct: 409 LQLLRAIVKRYEEMYVEQQSVQNNAIRDWDMYQHKETQLAEENARLKKLNGEADLALASA 468
Query: 328 GGSIPDSLFNLSSLT 342
++ + + +L
Sbjct: 469 NATLQELVVREQNLA 483
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 52.2 bits (125), Expect = 6e-07
Identities = 15/95 (15%), Positives = 35/95 (36%), Gaps = 5/95 (5%)
Query: 306 SIPSNIGEYRSLQHLDLSFNNLGGSIPDSLFNLSSLTHLFLGNNKLNGTLPARKSPL--L 363
+I + ++ ++L ++ + ++ L L N L+ A +P L
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 364 LNIDVSYNNLQGNLPSWINGQQNLQI-NLVANNLT 397
+++S N L + L+ +L N +
Sbjct: 61 ELLNLSSNVLY-ETLD-LESLSTLRTLDLNNNYVQ 93
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 8e-35
Identities = 55/206 (26%), Positives = 94/206 (45%), Gaps = 16/206 (7%)
Query: 693 ENFSPSNKLGEGGFGPVYKGKL----GDGRAIAVKQLSV-ASRQGKSQFVAEIATISAVQ 747
E+ + LGEG FG VY+G G+ +AVK + K +F++E + +
Sbjct: 12 EDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLD 71
Query: 748 HRNLVKLHGCCIEGAERLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYL 807
H ++VKL G E ++ E L L ++ +L T + + +AYL
Sbjct: 72 HPHIVKLIGIIEEEP-TWIIMELYPYGELGHYLERNKN-SLKVLTLVLYSLQICKAMAYL 129
Query: 808 HEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVAGT---IGYLAP 864
ES +HRD+ N+L+ + K+ DFGL++ +D+ + + T I +++P
Sbjct: 130 --ESI-NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDY---YKASVTRLPIKWMSP 183
Query: 865 EYAMRGHLTEKTDVFAFGVLALETVS 890
E T +DV+ F V E +S
Sbjct: 184 ESINFRRFTTASDVWMFAVCMWEILS 209
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 8e-35
Identities = 61/214 (28%), Positives = 97/214 (45%), Gaps = 20/214 (9%)
Query: 699 NKLGEGGFGPVYKGKL--GDGRAI--AVKQL-SVASRQGKSQFVAEIATISAVQHRNLVK 753
+G G FG VY G L DG+ I AVK L + SQF+ E + H N++
Sbjct: 31 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 90
Query: 754 LHGCCIEGAE-RLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESR 812
L G C+ L+V Y+++ L + + VA+G+ YL S+
Sbjct: 91 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH-NPTVKDLIGFGLQVAKGMKYL--ASK 147
Query: 813 VRIIHRDVKASNVLLDADLVPKISDFGLAK-LYDDKKTHISTRVAGT--IGYLAPEYAMR 869
+ +HRD+ A N +LD K++DFGLA+ +YD + + + + ++A E
Sbjct: 148 -KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 206
Query: 870 GHLTEKTDVFAFGVLALETVS-------GRPNSD 896
T K+DV++FGVL E ++ D
Sbjct: 207 QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD 240
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 8e-35
Identities = 53/213 (24%), Positives = 91/213 (42%), Gaps = 29/213 (13%)
Query: 699 NKLGEGGFGPVYKGKL------GDGRAIAVKQL-SVASRQGKSQFVAEIATISAVQHRNL 751
+LG+G FG VY+G +A+K + AS + + +F+ E + + ++
Sbjct: 31 RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 90
Query: 752 VKLHGCCIEGAERLLVYEYLENKSLDQALFGQRSLTLDWATRYE--------ICSGVARG 803
V+L G +G L++ E + L L R + + +A G
Sbjct: 91 VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADG 150
Query: 804 LAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLA-KLYDDKKTHISTRVAGTIGYL 862
+AYL + + +HRD+ A N ++ D KI DFG+ +Y+ G G L
Sbjct: 151 MAYL--NAN-KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYET-----DYYRKGGKGLL 202
Query: 863 -----APEYAMRGHLTEKTDVFAFGVLALETVS 890
+PE G T +DV++FGV+ E +
Sbjct: 203 PVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 235
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 9e-35
Identities = 60/225 (26%), Positives = 99/225 (44%), Gaps = 34/225 (15%)
Query: 699 NKLGEGGFGPVYKGKL----GDGRAIAVKQLSV--ASRQGKSQFVAEIATISAVQHRNLV 752
LGEG FG V +G L G +AVK + + +S++ +F++E A + H N++
Sbjct: 40 KILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVI 99
Query: 753 KLHGCCIEG-----AERLLVYEYLENKSLDQALFGQR----SLTLDWATRYEICSGVARG 803
+L G CIE + +++ +++ L L R + T + +A G
Sbjct: 100 RLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALG 159
Query: 804 LAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVAGTIGYL- 862
+ YL +R +HRD+ A N +L D+ ++DFGL+K + G I +
Sbjct: 160 MEYL--SNR-NFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYY----RQGRIAKMP 212
Query: 863 ----APEYAMRGHLTEKTDVFAFGVLALETVS-------GRPNSD 896
A E T K+DV+AFGV E + G N +
Sbjct: 213 VKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHE 257
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 1e-34
Identities = 59/213 (27%), Positives = 106/213 (49%), Gaps = 13/213 (6%)
Query: 692 TENFSPSNKLGEGGFGPVYKGK-LGDGRAIAVKQLSVASRQGKSQFVAEIATISAVQHRN 750
+ ++ K+G+G G VY + G+ +A++Q+++ + K + EI + ++ N
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 751 LVKLHGCCIEGAERLLVYEYLENKSLDQALFGQRSLTLDW-ATRYEICSGVARGLAYLHE 809
+V + G E +V EYL SL + + + A +C + L +LH
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSL-TDVVTETCMDEGQIAA---VCRECLQALEFLHS 134
Query: 810 ESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVAGTIGYLAPEYAMR 869
++IHRD+K+ N+LL D K++DFG +++ ST V GT ++APE R
Sbjct: 135 N---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTR 190
Query: 870 GHLTEKTDVFAFGVLALETVSGRPNSDPSLDEE 902
K D+++ G++A+E + G P P L+E
Sbjct: 191 KAYGPKVDIWSLGIMAIEMIEGEP---PYLNEN 220
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 1e-34
Identities = 58/201 (28%), Positives = 90/201 (44%), Gaps = 16/201 (7%)
Query: 700 KLGEGGFGPVYKGKL----GDGRAIAVKQL---SVASRQGKSQFVAEIATISAVQHRNLV 752
KLG+G FG V +G+ G ++AVK L ++ + F+ E+ + ++ HRNL+
Sbjct: 25 KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 84
Query: 753 KLHGCCIEGAERL-LVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEES 811
+L+G + + +V E SL L + T VA G+ YL ES
Sbjct: 85 RLYGVVLT--PPMKMVTELAPLGSLLDRLRKHQG-HFLLGTLSRYAVQVAEGMGYL--ES 139
Query: 812 RVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVAGT--IGYLAPEYAMR 869
+ R IHRD+ A N+LL + KI DFGL + H + + APE
Sbjct: 140 K-RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT 198
Query: 870 GHLTEKTDVFAFGVLALETVS 890
+ +D + FGV E +
Sbjct: 199 RTFSHASDTWMFGVTLWEMFT 219
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 1e-34
Identities = 66/286 (23%), Positives = 120/286 (41%), Gaps = 50/286 (17%)
Query: 693 ENFSPSNKLGEGGFGPVYKGK-LGDGRAIAVKQLSVASRQGKSQFVAEIATISAVQHRNL 751
+F +G GGFG V+K K DG+ +K++ + + + E+ ++ + H N+
Sbjct: 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAER----EVKALAKLDHVNI 66
Query: 752 VKLHGCCIEGAERL----------------LVYEYLENKSLDQALFGQRSLTLDWATRYE 795
V +GC + E+ + +L+Q + +R LD E
Sbjct: 67 VHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALE 126
Query: 796 ICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRV 855
+ + +G+ Y+H + ++I+RD+K SN+ L KI DFGL + TR
Sbjct: 127 LFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKR--TRS 181
Query: 856 AGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHE 915
GT+ Y++PE ++ D++A G++ E LL E
Sbjct: 182 KGTLRYMSPEQISSQDYGKEVDLYALGLILAE------------------LLHVCDTAFE 223
Query: 916 NNQEIELADPKLI--EFNEEEVKRLIGVALLCTQTLPSLRPSMSRV 959
++ +I F+++E K L+ LL + P RP+ S +
Sbjct: 224 TSKFFTDLRDGIISDIFDKKE-KTLLQ-KLLSKK--PEDRPNTSEI 265
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 2e-34
Identities = 56/219 (25%), Positives = 93/219 (42%), Gaps = 35/219 (15%)
Query: 699 NKLGEGGFGPVYKGKL------GDGRAIAVKQL-SVASRQGKSQFVAEIATISAVQHRNL 751
+LGE FG VYKG L +A+A+K L A + +F E + +QH N+
Sbjct: 15 EELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNV 74
Query: 752 VKLHGCCIEGAERLLVYEYLENKSLDQALFGQRSLTLDWATRYE--------------IC 797
V L G + +++ Y + L + L + + +T + +
Sbjct: 75 VCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLV 134
Query: 798 SGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLA-KLYDDKKTHISTRVA 856
+ +A G+ YL S ++H+D+ NVL+ L KISD GL ++Y
Sbjct: 135 AQIAAGMEYL--SSH-HVVHKDLATRNVLVYDKLNVKISDLGLFREVYAA-----DYYKL 186
Query: 857 GTIGYL-----APEYAMRGHLTEKTDVFAFGVLALETVS 890
L APE M G + +D++++GV+ E S
Sbjct: 187 LGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 225
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 2e-34
Identities = 55/196 (28%), Positives = 92/196 (46%), Gaps = 10/196 (5%)
Query: 700 KLGEGGFGPVYKGKL----GDGRAIAVKQLSV-ASRQGKSQFVAEIATISAVQHRNLVKL 754
+GEG FG V++G A+A+K S + +F+ E T+ H ++VKL
Sbjct: 22 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 81
Query: 755 HGCCIEGAERLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVR 814
G E ++ E L L ++ +LD A+ ++ LAYL R
Sbjct: 82 IGVITENP-VWIIMELCTLGELRSFLQVRKY-SLDLASLILYAYQLSTALAYL---ESKR 136
Query: 815 IIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVAGTIGYLAPEYAMRGHLTE 874
+HRD+ A NVL+ ++ K+ DFGL++ +D + +++ I ++APE T
Sbjct: 137 FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTS 196
Query: 875 KTDVFAFGVLALETVS 890
+DV+ FGV E +
Sbjct: 197 ASDVWMFGVCMWEILM 212
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 3e-34
Identities = 56/226 (24%), Positives = 92/226 (40%), Gaps = 35/226 (15%)
Query: 699 NKLGEGGFGPVYKGKL----GDGRAIAVKQL--SVASRQGKSQFVAEIATISAVQHRNLV 752
LG+G FG V + +L G +AVK L + + +F+ E A + H ++
Sbjct: 29 RMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVA 88
Query: 753 KLHGCCIEGAER------LLVYEYLENKSLDQALFGQR----SLTLDWATRYEICSGVAR 802
KL G + + +++ ++++ L L R L T +A
Sbjct: 89 KLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIAC 148
Query: 803 GLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVAGTIGYL 862
G+ YL SR IHRD+ A N +L D+ ++DFGL++ + G L
Sbjct: 149 GMEYL--SSR-NFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYY----RQGCASKL 201
Query: 863 -----APEYAMRGHLTEKTDVFAFGVLALETVS-------GRPNSD 896
A E T +DV+AFGV E ++ G N++
Sbjct: 202 PVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAE 247
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 3e-34
Identities = 60/213 (28%), Positives = 101/213 (47%), Gaps = 13/213 (6%)
Query: 692 TENFSPSNKLGEGGFGPVYKGK-LGDGRAIAVKQLSVASRQGKSQFVAEIATISAVQHRN 750
K+GEG G V + GR +AVK + + +Q + E+ + QH N
Sbjct: 44 RLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFN 103
Query: 751 LVKLHGCCIEGAERLLVYEYLENKSLDQALFGQRSLTLDW-ATRYEICSGVARGLAYLHE 809
+V+++ + G E ++ E+L+ +L + Q L + AT +C V + LAYLH
Sbjct: 104 VVEMYKSYLVGEELWVLMEFLQGGAL-TDIVSQVRLNEEQIAT---VCEAVLQALAYLHA 159
Query: 810 ESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVAGTIGYLAPEYAMR 869
+ +IHRD+K+ ++LL D K+SDFG + V GT ++APE R
Sbjct: 160 Q---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV-GTPYWMAPEVISR 215
Query: 870 GHLTEKTDVFAFGVLALETVSGRPNSDPSLDEE 902
+ D+++ G++ +E V G P P +
Sbjct: 216 SLYATEVDIWSLGIMVIEMVDGEP---PYFSDS 245
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 4e-34
Identities = 65/241 (26%), Positives = 100/241 (41%), Gaps = 19/241 (7%)
Query: 659 VRRRKRPQHDDDEELLGMDARPYTFSYAELKTATENFSPSNKLGEGGFGPVYKGK-LGDG 717
++R D++ LL +P + Y E + ++G G FG V++ K G
Sbjct: 27 LQRLGPETEDNEGVLLTEKLKPVDYEYRE---EVHWMTHQPRVGRGSFGEVHRMKDKQTG 83
Query: 718 RAIAVKQLSVASRQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLVYEYLENKSLD 777
AVK++ + + + E+ + + +V L+G EG + E LE SL
Sbjct: 84 FQCAVKKVRLEVFRVE-----ELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLG 138
Query: 778 QALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVP-KIS 836
Q + L D A Y GL YLH RI+H DVKA NVLL +D +
Sbjct: 139 QLIKQMGCLPEDRALYY--LGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALC 193
Query: 837 DFGLAKLYDDKKTHISTR----VAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGR 892
DFG A S + GT ++APE M K D+++ + L ++G
Sbjct: 194 DFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGC 253
Query: 893 P 893
Sbjct: 254 H 254
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 6e-34
Identities = 68/300 (22%), Positives = 121/300 (40%), Gaps = 59/300 (19%)
Query: 692 TENFSPSNKLGEGGFGPVYKGK-LGDGRAIAVKQLSVASRQGKSQFVAEIATISAVQHRN 750
+F LG+G FG V K + D R A+K++ + S ++E+ ++++ H+
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEK-LSTILSEVMLLASLNHQY 63
Query: 751 LVKLHGCCIEGAERL-------------LVYEYLENKSL-----DQALFGQRSLTLDWAT 792
+V+ + +E + + EY EN +L + L QR
Sbjct: 64 VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFR 123
Query: 793 RYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHIS 852
+I ++ Y+H + IIHRD+K N+ +D KI DFGLAK +
Sbjct: 124 --QILEALS----YIHSQ---GIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILK 174
Query: 853 -------------TRVAGTIGYLAPE-YAMRGHLTEKTDVFAFGVLALETVSGRPNSDPS 898
T GT Y+A E GH EK D+++ G++ E + S
Sbjct: 175 LDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP-----FS 229
Query: 899 LDEEKLYLLEWAWHLHENNQEIELADPKLIEFNE-EEVKRLIGVALLCTQTLPSLRPSMS 957
E++ +L + + + + P + N+ + K++I L+ P+ RP
Sbjct: 230 TGMERVNIL-------KKLRSVSIEFPPDFDDNKMKVEKKIIR-LLIDHD--PNKRPGAR 279
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 6e-34
Identities = 60/214 (28%), Positives = 97/214 (45%), Gaps = 20/214 (9%)
Query: 699 NKLGEGGFGPVYKGKL--GDGRAI--AVKQL-SVASRQGKSQFVAEIATISAVQHRNLVK 753
+G G FG VY G L DG+ I AVK L + SQF+ E + H N++
Sbjct: 95 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 154
Query: 754 LHGCCIEGAE-RLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESR 812
L G C+ L+V Y+++ L + + VA+G+ +L S+
Sbjct: 155 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH-NPTVKDLIGFGLQVAKGMKFL--ASK 211
Query: 813 VRIIHRDVKASNVLLDADLVPKISDFGLAK-LYDDKKTHISTRVAGT--IGYLAPEYAMR 869
+ +HRD+ A N +LD K++DFGLA+ +YD + + + + ++A E
Sbjct: 212 -KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT 270
Query: 870 GHLTEKTDVFAFGVLALETVS-------GRPNSD 896
T K+DV++FGVL E ++ D
Sbjct: 271 QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD 304
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 7e-34
Identities = 69/226 (30%), Positives = 94/226 (41%), Gaps = 36/226 (15%)
Query: 699 NKLGEGGFGPVYKGKL----GDGRAI--AVKQL-SVASRQGKSQFVAEIATISAVQHRNL 751
LG G FG VY+G++ D + AVK L V S Q + F+ E IS H+N+
Sbjct: 36 RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 95
Query: 752 VKLHGCCIEGAERLLVYEYLENKSLDQALFGQR-----SLTLDWATRYEICSGVARGLAY 806
V+ G ++ R ++ E + L L R +L + +A G Y
Sbjct: 96 VRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 155
Query: 807 LHEESRVRIIHRDVKASNVLLDA---DLVPKISDFGLAK-LYDDKKTHISTRVAGTIGYL 862
L E IHRD+ A N LL V KI DFG+A+ +Y S G L
Sbjct: 156 L--EEN-HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA-----SYYRKGGCAML 207
Query: 863 -----APEYAMRGHLTEKTDVFAFGVLALETVS-------GRPNSD 896
PE M G T KTD ++FGVL E S + N +
Sbjct: 208 PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE 253
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 2e-33
Identities = 67/218 (30%), Positives = 91/218 (41%), Gaps = 34/218 (15%)
Query: 699 NKLGEGGFGPVYKGKL------GDGRAIAVKQL-SVASRQGKSQFVAEIATISAV-QHRN 750
LG G FG V + +AVK L S A K ++E+ +S + QH N
Sbjct: 52 KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHEN 111
Query: 751 LVKLHGCCIEGAERLLVYEYLENKSL------------DQALFGQRSLTLDWATRYEICS 798
+V L G C G L++ EY L F + T S
Sbjct: 112 IVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSS 171
Query: 799 GVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLA-KLYDDKKTHISTRVAG 857
VA+G+A+L S+ IHRDV A NVLL V KI DFGLA + +D S +
Sbjct: 172 QVAQGMAFL--ASK-NCIHRDVAARNVLLTNGHVAKIGDFGLARDIMND-----SNYIVK 223
Query: 858 TIGYL-----APEYAMRGHLTEKTDVFAFGVLALETVS 890
L APE T ++DV+++G+L E S
Sbjct: 224 GNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 2e-33
Identities = 68/214 (31%), Positives = 104/214 (48%), Gaps = 15/214 (7%)
Query: 692 TENFSPSNKLGEGGFGPVYKGK-LGDGRAIAVKQLSVASRQGKSQFVAEIATISAVQHRN 750
E F KLGEG +G VYK G+ +A+KQ+ V S + + EI+ + +
Sbjct: 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD--LQEIIKEISIMQQCDSPH 85
Query: 751 LVKLHGCCIEGAERLLVYEYLENKSL-DQALFGQRSLTLDW-ATRYEICSGVARGLAYLH 808
+VK +G + + +V EY S+ D ++LT D AT I +GL YLH
Sbjct: 86 VVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIAT---ILQSTLKGLEYLH 142
Query: 809 EESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVAGTIGYLAPEYAM 868
R IHRD+KA N+LL+ + K++DFG+A D +T + GT ++APE
Sbjct: 143 FM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVI-GTPFWMAPEVIQ 198
Query: 869 RGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEE 902
D+++ G+ A+E G+P P D
Sbjct: 199 EIGYNCVADIWSLGITAIEMAEGKP---PYADIH 229
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 2e-33
Identities = 59/227 (25%), Positives = 94/227 (41%), Gaps = 43/227 (18%)
Query: 699 NKLGEGGFGPVYKGKL------GDGRAIAVKQL-SVASRQGKSQFVAEIATISAVQHRNL 751
LGEG FG V K +AVK L AS ++E + V H ++
Sbjct: 29 KTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHV 88
Query: 752 VKLHGCCIEGAERLLVYEYLENKSLDQALFGQRSLTLDWATRYE---------------- 795
+KL+G C + LL+ EY + SL L R + +
Sbjct: 89 IKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALT 148
Query: 796 ------ICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLA-KLYDDKK 848
+++G+ YL +++HRD+ A N+L+ KISDFGL+ +Y++
Sbjct: 149 MGDLISFAWQISQGMQYL--AEM-KLVHRDLAARNILVAEGRKMKISDFGLSRDVYEE-- 203
Query: 849 THISTRVAGTIGYL-----APEYAMRGHLTEKTDVFAFGVLALETVS 890
+ V + G + A E T ++DV++FGVL E V+
Sbjct: 204 ---DSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 2e-33
Identities = 55/221 (24%), Positives = 95/221 (42%), Gaps = 22/221 (9%)
Query: 688 LKTATENFSPSNKLGEGGFGPVYKGK-LGDGRAIAVKQLSVA--SRQGKSQFVAEIATIS 744
+ + E++ +G G +G K + DG+ + K+L + K V+E+ +
Sbjct: 1 MPSRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLR 60
Query: 745 AVQHRNLVKLHGCCIEGAERLL--VYEYLENKSLDQALFGQR--------SLTLDWATRY 794
++H N+V+ + I+ L V EY E L + L T
Sbjct: 61 ELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMT-- 118
Query: 795 EICSGVARGLAYLHE--ESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHIS 852
++ L H + ++HRD+K +NV LD K+ DFGLA++ + +
Sbjct: 119 QLTLA----LKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAK 174
Query: 853 TRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRP 893
T V GT Y++PE R EK+D+++ G L E + P
Sbjct: 175 TFV-GTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMP 214
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 3e-33
Identities = 54/210 (25%), Positives = 84/210 (40%), Gaps = 22/210 (10%)
Query: 693 ENFSPSNKLGEGGFGPVYKG-KLGDGRAIAVKQ--LSVASRQGKSQFVAEIATISAV-QH 748
++F ++LG G +G V+K DGR AVK+ + +++ +AE+ + V QH
Sbjct: 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQH 116
Query: 749 RNLVKLHGCCIEGAERLLVYEYLENKSLDQAL--FGQR---SLTLDWATRYEICSGVARG 803
V+L EG L E SL Q +G + + +
Sbjct: 117 PCCVRLEQAWEEGGILYLQTELCG-PSLQQHCEAWGASLPEAQVWGYLR--DTLLA---- 169
Query: 804 LAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVAGTIGYLA 863
LA+LH + ++H DVK +N+ L K+ DFGL G Y+A
Sbjct: 170 LAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEV--QEGDPRYMA 224
Query: 864 PEYAMRGHLTEKTDVFAFGVLALETVSGRP 893
PE + DVF+ G+ LE
Sbjct: 225 PELLQGSY-GTAADVFSLGLTILEVACNME 253
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 3e-33
Identities = 61/222 (27%), Positives = 99/222 (44%), Gaps = 38/222 (17%)
Query: 699 NKLGEGGFGPVYKGKL--------GDGRAIAVKQL-SVASRQGKSQFVAEIATISAV-QH 748
LGEG FG V + + +AVK L A+ + S V+E+ + + +H
Sbjct: 41 KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 749 RNLVKLHGCCIEGAERLLVYEYLENKSLDQALFGQRSLTLDWATRYE------------- 795
+N++ L G C + ++ EY +L + L +R ++++
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 796 -ICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLA-KLYDDKKTHIST 853
+ARG+ YL S+ + IHRD+ A NVL+ + V KI+DFGLA + +
Sbjct: 161 SCTYQLARGMEYL--ASQ-KCIHRDLAARNVLVTENNVMKIADFGLARDINNI-----DY 212
Query: 854 RVAGTIGYL-----APEYAMRGHLTEKTDVFAFGVLALETVS 890
T G L APE T ++DV++FGVL E +
Sbjct: 213 YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 3e-33
Identities = 77/310 (24%), Positives = 128/310 (41%), Gaps = 66/310 (21%)
Query: 699 NKLGEGGFGPVYKGKL--------GDGRAIAVKQL-SVASRQGKSQFVAEIATISAV-QH 748
LGEG FG V + + +AVK L A+ + S V+E+ + + +H
Sbjct: 87 KPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 146
Query: 749 RNLVKLHGCCIEGAERLLVYEYLENKSLDQALFGQRSLTLDWATRYE------------- 795
+N++ L G C + ++ EY +L + L +R ++++
Sbjct: 147 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 206
Query: 796 -ICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLA-KLYDDKKTHIST 853
+ARG+ YL S+ + IHRD+ A NVL+ + V KI+DFGLA + +
Sbjct: 207 SCTYQLARGMEYL--ASQ-KCIHRDLAARNVLVTENNVMKIADFGLARDINNI-----DY 258
Query: 854 RVAGTIGYL-----APEYAMRGHLTEKTDVFAFGVLALETVS-------GRPNSDPSLDE 901
T G L APE T ++DV++FGVL E + G P E
Sbjct: 259 YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV------E 312
Query: 902 EKLYLLEWAWHLHENNQEIELADPKLIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVA 961
E LL+ + + P E+ ++ C +PS RP+ ++V
Sbjct: 313 ELFKLLK---------EGHRMDKP---ANCTNELYMMM---RDCWHAVPSQRPTFKQLVE 357
Query: 962 MLCGDMEVST 971
L + ++T
Sbjct: 358 DLDRILTLTT 367
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 4e-33
Identities = 58/291 (19%), Positives = 114/291 (39%), Gaps = 46/291 (15%)
Query: 693 ENFSPSNKLGEGGFGPVYKGK-LGDGRAIAVKQLSVASRQ-GKSQFVAEIATISAVQHRN 750
+F P LG GGFG V++ K D A+K++ + +R+ + + + E+ ++ ++H
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64
Query: 751 LVKLHGCCIEG---------AERLLVY---EYLENKSLDQALFGQRSLT-LDWATRYEIC 797
+V+ +E + ++ +Y + ++L + G+ ++ + + I
Sbjct: 65 IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIF 124
Query: 798 SGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVA- 856
+A + +LH + ++HRD+K SN+ D V K+ DFGL D + +
Sbjct: 125 LQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPM 181
Query: 857 ----------GTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYL 906
GT Y++PE + K D+F+ G++ E + P S L
Sbjct: 182 PAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL--YPFSTQMERVRTLTD 239
Query: 907 LEWAWHLHENNQEIELADPKLIEFNEEEVKRLIGVALLCTQTLPSLRPSMS 957
+ N + P L ++ P RP
Sbjct: 240 V--------RNLKF----PPLFTQKYPCEYVMV---QDMLSPSPMERPEAI 275
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 5e-33
Identities = 63/221 (28%), Positives = 93/221 (42%), Gaps = 37/221 (16%)
Query: 699 NKLGEGGFGPVYKGKL------GDGRAIAVKQL-SVASRQGKSQFVAEIATISAV-QHRN 750
LG G FG V + R +AVK L A+ ++E+ + + H N
Sbjct: 33 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 92
Query: 751 LVKLHGCC-IEGAERLLVYEYLENKSLDQALFGQRSLTLDWATRYE-------------- 795
+V L G C G +++ E+ + +L L +R+ + + E
Sbjct: 93 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 152
Query: 796 ICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLA-KLYDDKKTHISTR 854
VA+G+ +L SR + IHRD+ A N+LL V KI DFGLA +Y D
Sbjct: 153 YSFQVAKGMEFL--ASR-KCIHRDLAARNILLSEKNVVKICDFGLARDIYKD-----PDY 204
Query: 855 VAGTIGYL-----APEYAMRGHLTEKTDVFAFGVLALETVS 890
V L APE T ++DV++FGVL E S
Sbjct: 205 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 5e-33
Identities = 68/226 (30%), Positives = 93/226 (41%), Gaps = 36/226 (15%)
Query: 699 NKLGEGGFGPVYKGKL----GDGRAI--AVKQL-SVASRQGKSQFVAEIATISAVQHRNL 751
LG G FG VY+G++ D + AVK L V S Q + F+ E IS H+N+
Sbjct: 77 RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 136
Query: 752 VKLHGCCIEGAERLLVYEYLENKSLDQALFGQR-----SLTLDWATRYEICSGVARGLAY 806
V+ G ++ R ++ E + L L R +L + +A G Y
Sbjct: 137 VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 196
Query: 807 LHEESRVRIIHRDVKASNVLLDA---DLVPKISDFGLAK-LYDDKKTHISTRVAGTIGYL 862
L E IHRD+ A N LL V KI DFG+A+ +Y G L
Sbjct: 197 L--EEN-HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA-----GYYRKGGCAML 248
Query: 863 -----APEYAMRGHLTEKTDVFAFGVLALETVS-------GRPNSD 896
PE M G T KTD ++FGVL E S + N +
Sbjct: 249 PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE 294
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 6e-33
Identities = 60/201 (29%), Positives = 94/201 (46%), Gaps = 15/201 (7%)
Query: 701 LGEGGFGPVYKGK-LGDGRAIAVKQLSVASRQGKSQFVAEIATISAVQHRNLVKLHGCCI 759
LG+G +G VY G+ L + IA+K++ + EIA ++H+N+V+ G
Sbjct: 30 LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 89
Query: 760 EGAERLLVYEYLENKSLDQAL---FGQRSLTLDWATRYEICSGVARGLAYLHEESRVRII 816
E + E + SL L +G Y + GL YLH+ +I+
Sbjct: 90 ENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFY--TKQILEGLKYLHDN---QIV 144
Query: 817 HRDVKASNVLLDADL-VPKISDFGLAKLYDDKKTHISTRVAGTIGYLAPE---YAMRGHL 872
HRD+K NVL++ V KISDFG +K T GT+ Y+APE RG+
Sbjct: 145 HRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET-FTGTLQYMAPEIIDKGPRGY- 202
Query: 873 TEKTDVFAFGVLALETVSGRP 893
+ D+++ G +E +G+P
Sbjct: 203 GKAADIWSLGCTIIEMATGKP 223
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 6e-33
Identities = 55/210 (26%), Positives = 94/210 (44%), Gaps = 15/210 (7%)
Query: 692 TENFSPSNKLGEGGFGPVYKGK-LGDGRAIAVKQLSVASRQGKSQFVAEIATISAVQHRN 750
E + +LG+G FG VYK K G A K + S + ++ EI ++ H
Sbjct: 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPY 77
Query: 751 LVKLHGCCIEGAERLLVYEYLENKSL-DQALFGQRSLTLDW-ATRYEICSGVARGLAYLH 808
+VKL G + ++ E+ ++ L R LT +C + L +LH
Sbjct: 78 IVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQV---VCRQMLEALNFLH 134
Query: 809 EESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVAGTIGYLAPEYAM 868
+ RIIHRD+KA NVL+ + +++DFG++ + + GT ++APE M
Sbjct: 135 SK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI-GTPYWMAPEVVM 190
Query: 869 RGHLTE-----KTDVFAFGVLALETVSGRP 893
+ + K D+++ G+ +E P
Sbjct: 191 CETMKDTPYDYKADIWSLGITLIEMAQIEP 220
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 8e-33
Identities = 50/324 (15%), Positives = 100/324 (30%), Gaps = 35/324 (10%)
Query: 99 CHITQLKVYALNVVGVIPDELWNLTSLFNLNLGQNYLTGPLSPSVGNLTAMQYLNLAINA 158
I + ++ N + L ++ ++L + V Q L++
Sbjct: 261 VTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKYL--EDVPKHFKWQSLSIIRCQ 318
Query: 159 LSGELPKELGQLTEL-----LILGIGTN----------------NFSGPLPSELGSLSKL 197
L +L L L +FSG + L
Sbjct: 319 LKQFPTLDLPFLKSLTLTMNKGSISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSL 378
Query: 198 QELYIDSAGVSGEIPSSFANLQSLTKWWASDTRLTGRIP-DFIGNWSKLTALRFQGNSFN 256
+ L + G + ++F L+ L + L + KL L +
Sbjct: 379 RHLDLSFNGAI-IMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTK 437
Query: 257 GPIPSSFSNLTSVTELRISD--LSNGSSKLAFIRDMKSLSILELRNNNISDSIPSNIGEY 314
F LTS+ L+++ + + F + +L+ L+L +
Sbjct: 438 IDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVF-ANTTNLTFLDLSKCQLEQISWGVFDTL 496
Query: 315 RSLQHLDLSFNNLGGSIPDSLFNLSSLTHLFLGNNKLNGTLPARKSPL--LLNIDVSYNN 372
LQ L++S NNL L SL+ L N++ + + L +++ N+
Sbjct: 497 HRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNS 556
Query: 373 LQ-----GNLPSWINGQQNLQINL 391
+ W+ Q+ +N+
Sbjct: 557 VACICEHQKFLQWVKEQKQFLVNV 580
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 1e-32
Identities = 52/324 (16%), Positives = 98/324 (30%), Gaps = 45/324 (13%)
Query: 88 KCDCSSQNGTV-CHITQLKVYALNVVGVIPDELWNLTSLFNLNLGQNYLTGPLSPSVGNL 146
C N T C +L +PD++ +S N++L N L S S N
Sbjct: 6 PCIEVVPNITYQCMDQKLSK--------VPDDI--PSSTKNIDLSFNPLKILKSYSFSNF 55
Query: 147 TAMQYLNLAINALSGELPKELGQLTELLILGIGTNNFSGPLPSELGSLSKLQELYIDSAG 206
+ +Q+L+L+ + K L L L + N P L+ L+ L
Sbjct: 56 SELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETK 115
Query: 207 VSGEIPSSFANLQSLTKWWASDTRLTG-RIPDFIGNWSKLTALRFQGNSFNGPIPSSFSN 265
++ L +L K + + ++P + N + L + N +
Sbjct: 116 LASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQF 175
Query: 266 LTSVTELRISDLSNGSSKLAFIRDMKSLSILELRNNNISDSIPSNIGEYRSLQHLDLSFN 325
L + L++ N I I + L L L N
Sbjct: 176 LRENP--------------------QVNLSLDMSLNPID-FIQDQAFQGIKLHELTLRGN 214
Query: 326 NLGGSIPDSLF-NLSSLTHLFLGNNKL----------NGTLPARKSPLLLNIDVSYNNLQ 374
+I + NL+ L L + + + ++Y N
Sbjct: 215 FNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDF 274
Query: 375 GNLPSWINGQQNLQ-INLVANNLT 397
+ + N+ ++L ++
Sbjct: 275 SDDIVKFHCLANVSAMSLAGVSIK 298
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 8e-33
Identities = 57/225 (25%), Positives = 97/225 (43%), Gaps = 15/225 (6%)
Query: 676 MDARPYTFSYAELKTATENFSPSN-----KLGEGGFGPVYKG--KLGDGRAI--AVKQLS 726
+ +Y T +GEG FG V++G + A+ A+K
Sbjct: 368 AEIIDEEDTYTMPSTRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCK 427
Query: 727 V-ASRQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLVYEYLENKSLDQALFGQRS 785
S + +F+ E T+ H ++VKL G E ++ E L L ++
Sbjct: 428 NCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRKF 486
Query: 786 LTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYD 845
+LD A+ ++ LAYL R +HRD+ A NVL+ ++ K+ DFGL++ +
Sbjct: 487 -SLDLASLILYAYQLSTALAYL---ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME 542
Query: 846 DKKTHISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVS 890
D + +++ I ++APE T +DV+ FGV E +
Sbjct: 543 DSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILM 587
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 8e-33
Identities = 64/222 (28%), Positives = 99/222 (44%), Gaps = 38/222 (17%)
Query: 699 NKLGEGGFGPVYKGKL--------GDGRAIAVKQL-SVASRQGKSQFVAEIATISAV-QH 748
LGEG FG V + +AVK L S A+ + S ++E+ + + +H
Sbjct: 75 KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 134
Query: 749 RNLVKLHGCCIEGAERLLVYEYLENKSLDQALFGQRSLTLDWATRYE------------- 795
+N++ L G C + ++ EY +L + L +R L+++
Sbjct: 135 KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 194
Query: 796 -ICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLA-KLYDDKKTHIST 853
VARG+ YL S+ + IHRD+ A NVL+ D V KI+DFGLA ++
Sbjct: 195 SCAYQVARGMEYL--ASK-KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHI-----DY 246
Query: 854 RVAGTIGYL-----APEYAMRGHLTEKTDVFAFGVLALETVS 890
T G L APE T ++DV++FGVL E +
Sbjct: 247 YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 288
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 9e-33
Identities = 64/242 (26%), Positives = 97/242 (40%), Gaps = 40/242 (16%)
Query: 699 NKLGEGGFGPVYKGKL------GDGRAIAVKQL-SVASRQGKSQFVAEIATISAV-QHRN 750
LG G FG V + +AVK L A + ++E+ +S + H N
Sbjct: 29 KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMN 88
Query: 751 LVKLHGCCIEGAERLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSG----------- 799
+V L G C G L++ EY L L +R + T I
Sbjct: 89 IVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLL 148
Query: 800 -----VARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLA-KLYDDKKTHIST 853
VA+G+A+L S+ IHRD+ A N+LL + KI DFGLA + +D S
Sbjct: 149 SFSYQVAKGMAFL--ASK-NCIHRDLAARNILLTHGRITKICDFGLARDIKND-----SN 200
Query: 854 RVAGTIGYL-----APEYAMRGHLTEKTDVFAFGVLALETVS--GRPNSDPSLDEEKLYL 906
V L APE T ++DV+++G+ E S P +D + +
Sbjct: 201 YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKM 260
Query: 907 LE 908
++
Sbjct: 261 IK 262
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 1e-32
Identities = 60/227 (26%), Positives = 95/227 (41%), Gaps = 43/227 (18%)
Query: 699 NKLGEGGFGPVYKGKL------GDGRAIAVKQL-SVASRQGKSQFVAEIATISAVQHRNL 751
+GEG FG V++ + +AVK L AS ++ F E A ++ + N+
Sbjct: 53 RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNI 112
Query: 752 VKLHGCCIEGAERLLVYEYLENKSLDQALFGQRSLTLDWATRYE---------------- 795
VKL G C G L++EY+ L++ L T+ + +
Sbjct: 113 VKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLS 172
Query: 796 ------ICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLA-KLYDDKK 848
I VA G+AYL R + +HRD+ N L+ ++V KI+DFGL+ +Y
Sbjct: 173 CAEQLCIARQVAAGMAYL--SER-KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSA-- 227
Query: 849 THISTRVAGTIGYL-----APEYAMRGHLTEKTDVFAFGVLALETVS 890
A + PE T ++DV+A+GV+ E S
Sbjct: 228 ---DYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 271
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 2e-32
Identities = 49/210 (23%), Positives = 84/210 (40%), Gaps = 21/210 (10%)
Query: 693 ENFSPSNKLGEGGFGPVYKGK-LGDGRAIAVKQLSVASRQGKSQFVAEIATISAVQHRNL 751
+++ KLGEGGF V + L DG A+K++ +Q + + E H N+
Sbjct: 29 KHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNI 88
Query: 752 VKLHGCCIE----GAERLLVYEYLENKSLDQAL--FGQRSLTLDWATRYEICSGVARGLA 805
++L C+ E L+ + + +L + + L + G+ RGL
Sbjct: 89 LRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLE 148
Query: 806 YLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVA--------G 857
+H + HRD+K +N+LL + P + D G +
Sbjct: 149 AIHAK---GYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRC 205
Query: 858 TIGYLAPE---YAMRGHLTEKTDVFAFGVL 884
TI Y APE + E+TDV++ G +
Sbjct: 206 TISYRAPELFSVQSHCVIDERTDVWSLGCV 235
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 3e-32
Identities = 59/219 (26%), Positives = 99/219 (45%), Gaps = 22/219 (10%)
Query: 692 TENFSPSNKLGEGGFGPVYKGK-LGDGRAIAVKQLSVASRQGK---SQFVAEIATISAVQ 747
+ FS ++G G FG VY + + + +A+K++S + +Q + E+ + ++
Sbjct: 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 112
Query: 748 HRNLVKLHGCCIEGAERLLVYEYLENKSLDQALFGQRSLTLDW-ATRYEICSGVARGLAY 806
H N ++ GC + LV EY + D ++ L A + G +GLAY
Sbjct: 113 HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAA---VTHGALQGLAY 169
Query: 807 LHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVAGTIGYLAPE- 865
LH +IHRDVKA N+LL + K+ DFG A + + + GT ++APE
Sbjct: 170 LHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFV-----GTPYWMAPEV 221
Query: 866 --YAMRGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEE 902
G K DV++ G+ +E +P P +
Sbjct: 222 ILAMDEGQYDGKVDVWSLGITCIELAERKP---PLFNMN 257
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 4e-32
Identities = 74/310 (23%), Positives = 113/310 (36%), Gaps = 60/310 (19%)
Query: 699 NKLGEGGFGPVYKGKL------GDGRAIAVKQL-SVASRQGKSQFVAEIATISAV-QHRN 750
LG G FG V G +AVK L A + ++E+ ++ + H N
Sbjct: 51 KVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHEN 110
Query: 751 LVKLHGCCIEGAERLLVYEYLENKSLDQALFGQRSLTLDWATRYE--------------- 795
+V L G C L++EY L L +R + YE
Sbjct: 111 IVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLT 170
Query: 796 ------ICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLA-KLYDDKK 848
VA+G+ +L E + +HRD+ A NVL+ V KI DFGLA + D
Sbjct: 171 FEDLLCFAYQVAKGMEFL--EFK-SCVHRDLAARNVLVTHGKVVKICDFGLARDIMSD-- 225
Query: 849 THISTRVAGTIGYL-----APEYAMRGHLTEKTDVFAFGVLALETVS--GRPNSDPSLDE 901
S V L APE G T K+DV+++G+L E S P +D
Sbjct: 226 ---SNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDA 282
Query: 902 EKLYLLEWAWHLHENNQEIELADPKLIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVA 961
L++ ++ P + EE+ ++ C RPS + +
Sbjct: 283 NFYKLIQ---------NGFKMDQP---FYATEEIYIIM---QSCWAFDSRKRPSFPNLTS 327
Query: 962 MLCGDMEVST 971
L + +
Sbjct: 328 FLGCQLADAE 337
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 5e-32
Identities = 63/297 (21%), Positives = 105/297 (35%), Gaps = 43/297 (14%)
Query: 115 IPDELWNLTSLFNLNLGQNYLTGPLSPSVGNLTAM-------------QYLNLAINALSG 161
+P E N+ S + P G M L L LS
Sbjct: 26 MPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLS- 84
Query: 162 ELPKELGQLTELLILGIGTNNFSGPLPSELGSLSKLQELYIDSAGVSGEIPSSFANLQSL 221
LP+ L L+ N+ + LP SL L + + L+ L
Sbjct: 85 SLPELPPHLESLVASC---NSLT-ELPELPQSLKSLLVDNNNLK----ALSDLPPLLEYL 136
Query: 222 TKWWASDTRLTGRIPDFIGNWSKLTALRFQGNSFNGPIPSSFSNLTSVTELRISDLSNGS 281
S+ +L ++P+ + N S L + NS +P +L + + N
Sbjct: 137 ---GVSNNQLE-KLPE-LQNSSFLKIIDVDNNSLKK-LPDLPPSL---EFIAAGN--NQL 185
Query: 282 SKLAFIRDMKSLSILELRNNNISDSIPSNIGEYRSLQHLDLSFNNLGGSIPDSLFNLSSL 341
+L ++++ L+ + NN++ +P SL+ + N L L NL L
Sbjct: 186 EELPELQNLPFLTAIYADNNSLK-KLPDLPL---SLESIVAGNNIL--EELPELQNLPFL 239
Query: 342 THLFLGNNKLNGTLPARKSPLLLNIDVSYNNLQGNLPSWINGQQNLQI-NLVANNLT 397
T ++ NN L TLP P L ++V N L +LP L + + + L+
Sbjct: 240 TTIYADNNLLK-TLPD-LPPSLEALNVRDNYLT-DLPELPQSLTFLDVSENIFSGLS 293
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 2e-29
Identities = 50/311 (16%), Positives = 100/311 (32%), Gaps = 56/311 (18%)
Query: 115 IPDELWNLTSLFNLNLGQNYLTGPLSPSVGNLTAMQYLNLAINALSGELPKELGQLTELL 174
+PD +L + G N L P + NL + + N+L +LP L ++
Sbjct: 168 LPDLPPSLEFI---AAGNNQLEEL--PELQNLPFLTAIYADNNSLK-KLPDLPLSLESIV 221
Query: 175 ILGIGTNNFSGPLPSELGSLSKLQELYIDSAGVSGEIPSSFANLQSLTKWWASDTRLTGR 234
N EL +L L +Y D+ + +P +L++L D LT
Sbjct: 222 AGN---NILE--ELPELQNLPFLTTIYADNNLLK-TLPDLPPSLEALN---VRDNYLT-D 271
Query: 235 IPDFIGNWSKLTALRFQGNSFNGPIPSSFSNLTS--VTELRISDLSNGSSKLAFI----- 287
+P+ + + L + + NL + I L + L +
Sbjct: 272 LPELPQSLTFLDVSENIFSG----LSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNN 327
Query: 288 ------RDMKSLSILELRNNNISDSIPSNIGEYRSLQHLDLSFNNLGGSIPDSLFNL--- 338
L L N+++ +P +L+ L + +N L PD ++
Sbjct: 328 KLIELPALPPRLERLIASFNHLA-EVPELPQ---NLKQLHVEYNPLR-EFPDIPESVEDL 382
Query: 339 -------------SSLTHLFLGNNKLNGTLPARKSPLLLNIDVSYNNLQGNLPSWINGQQ 385
+L L + N L P + ++ ++ +
Sbjct: 383 RMNSHLAEVPELPQNLKQLHVETNPLR-EFPD-IPESVEDLRMNSERVVDPYEFAHETTD 440
Query: 386 NLQINLVANNL 396
L+ ++ ++
Sbjct: 441 KLEDDVFEHHH 451
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 2e-28
Identities = 63/274 (22%), Positives = 107/274 (39%), Gaps = 41/274 (14%)
Query: 139 LSPSVGNLTAMQYLNLAINALSGELPKELGQLTELLILGIGTNNFSGPLPSELGSLS--- 195
++P + T +Q + L+ E+P E + + + P G
Sbjct: 3 INPRNVSNTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMA 61
Query: 196 ----------KLQELYIDSAGVSGEIPSSFANLQSLTKWWASDTRLTGRIPDFIGNWSKL 245
+ EL +++ G+S +P +L+SL AS LT +P+ + L
Sbjct: 62 VSRLRDCLDRQAHELELNNLGLS-SLPELPPHLESLV---ASCNSLT-ELPELPQS---L 113
Query: 246 TALRFQGNSFNGPIPSSFSNLTSVTELRISDLSNGSSKLAFIRDMKSLSILELRNNNISD 305
+L N+ + L L +S+ N KL +++ L I+++ NN++
Sbjct: 114 KSLLVDNNNLK-ALSDLPPLL---EYLGVSN--NQLEKLPELQNSSFLKIIDVDNNSLK- 166
Query: 306 SIPSNIGEYRSLQHLDLSFNNLGGSIPDSLFNLSSLTHLFLGNNKLNGTLPARKSPL-LL 364
+P SL+ + N L +P+ L NL LT ++ NN L LP PL L
Sbjct: 167 KLPDLPP---SLEFIAAGNNQL-EELPE-LQNLPFLTAIYADNNSLK-KLP--DLPLSLE 218
Query: 365 NIDVSYNNLQGNLPSWINGQQNLQ-INLVANNLT 397
+I N L+ LP + L I N L
Sbjct: 219 SIVAGNNILE-ELPE-LQNLPFLTTIYADNNLLK 250
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 2e-27
Identities = 62/309 (20%), Positives = 118/309 (38%), Gaps = 61/309 (19%)
Query: 122 LTSLFNLNLGQNYLTGPLSPSVGNLTAMQYLNLAINALSGELPKELGQLTELLILGIGTN 181
L L L+ L +L + L + N+L+ ELP+ L LL+
Sbjct: 70 DRQAHELELNNLGLS-SLPELPPHL---ESLVASCNSLT-ELPELPQSLKSLLVDNNNLK 124
Query: 182 NFSGPLPS---------------ELGSLSKLQELYIDSAGVSGEIPSSFANLQSLTKWWA 226
S P EL + S L+ + +D+ + ++P +L+ + A
Sbjct: 125 ALSDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLK-KLPDLPPSLEFIA---A 180
Query: 227 SDTRLTGRIPDFIGNWSKLTALRFQGNSFNGPIPSSFSNLTSVTELRISDLSNGSSKLAF 286
+ +L +P+ N LTA+ NS +P +L + + N +L
Sbjct: 181 GNNQLE-ELPEL-QNLPFLTAIYADNNSLKK-LPDLPLSLE---SIVAGN--NILEELPE 232
Query: 287 IRDMKSLSILELRNNNISDSIPSNIGEYRSLQHLDLSFNNLGGSIPDSLFNL-------- 338
++++ L+ + NN + ++P SL+ L++ N L +P+ +L
Sbjct: 233 LQNLPFLTTIYADNNLLK-TLPDLPP---SLEALNVRDNYLT-DLPELPQSLTFLDVSEN 287
Query: 339 ---------SSLTHLFLGNNKLNGTLPARKSPLLLNIDVSYNNLQGNLPSWINGQQNLQ- 388
+L +L +N++ +L P L ++VS N L LP+ L+
Sbjct: 288 IFSGLSELPPNLYYLNASSNEIR-SLCD-LPPSLEELNVSNNKLI-ELPALP---PRLER 341
Query: 389 INLVANNLT 397
+ N+L
Sbjct: 342 LIASFNHLA 350
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 4e-24
Identities = 42/266 (15%), Positives = 79/266 (29%), Gaps = 50/266 (18%)
Query: 115 IPDELWNLTSLFNLNLGQNYLTGPLSPSVGNLTAMQYLNLAINALSGELPKELGQLTELL 174
+PD +L ++ G N L P + NL + + N L LP L L
Sbjct: 210 LPDLPLSLE---SIVAGNNILEEL--PELQNLPFLTTIYADNNLLK-TLPDLPPSLEALN 263
Query: 175 ILGIGTNNFSGPLPSELGSLSKLQELYIDSAGVSG----------------EIPSSFANL 218
+ +N+ LP SL+ L +G+S + +L
Sbjct: 264 VR----DNYLTDLPELPQSLTFLDVSENIFSGLSELPPNLYYLNASSNEIRSLCDLPPSL 319
Query: 219 QSLTKWWASDTRLTGRIPDFIGNWSKLTALRFQGNSFNGPIPSSFSNLTS--VTELRISD 276
+ L S+ +L +P L L N +P NL V + +
Sbjct: 320 EEL---NVSNNKLI-ELPALPPR---LERLIASFNHLAE-VPELPQNLKQLHVEYNPLRE 371
Query: 277 LSNGSSKL----------AFIRDMKSLSILELRNNNISDSIPSNIGEYRSLQHLDLSFNN 326
+ + ++L L + N + P S++ L ++
Sbjct: 372 FPDIPESVEDLRMNSHLAEVPELPQNLKQLHVETNPLR-EFPDIPE---SVEDLRMNSER 427
Query: 327 LGGSIPDSLFNLSSLTHLFLGNNKLN 352
+ + L ++ +
Sbjct: 428 VVDPYEFAHETTDKLEDDVFEHHHHH 453
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 4e-08
Identities = 25/137 (18%), Positives = 44/137 (32%), Gaps = 25/137 (18%)
Query: 291 KSLSILELRNNNISDSIPSNIGEYRSLQHLDLSFNNLGGSIPDSLFNLS----------- 339
L ++N++ +P +S +++ + P
Sbjct: 11 TFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCL 69
Query: 340 --SLTHLFLGNNKLNGTLPARKSPLLLNIDVSYNNLQGNLPSWINGQQNLQI-NLVANNL 396
L L N L+ +LP P L ++ S N+L LP ++L + N L
Sbjct: 70 DRQAHELELNNLGLS-SLPE-LPPHLESLVASCNSLT-ELPELPQSLKSLLVDNNNLKAL 126
Query: 397 TIRSSDNSVLPRGLICL 413
+ LP L L
Sbjct: 127 SD-------LPPLLEYL 136
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 6e-32
Identities = 58/201 (28%), Positives = 98/201 (48%), Gaps = 15/201 (7%)
Query: 700 KLGEGGFGPVYKGKLGD---GRAIAVKQLSVASRQGKSQFVA----EIATISAVQHRNLV 752
KLG GG VY + D +A+K + + K + + E+ S + H+N+V
Sbjct: 18 KLGGGGMSTVYLAE--DTILNIKVAIKAIF-IPPREKEETLKRFEREVHNSSQLSHQNIV 74
Query: 753 KLHGCCIEGAERLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESR 812
+ E LV EY+E +L + + L++D A + + G+ + H
Sbjct: 75 SMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAI--NFTNQILDGIKHAH---D 129
Query: 813 VRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVAGTIGYLAPEYAMRGHL 872
+RI+HRD+K N+L+D++ KI DFG+AK + + V GT+ Y +PE A
Sbjct: 130 MRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEAT 189
Query: 873 TEKTDVFAFGVLALETVSGRP 893
E TD+++ G++ E + G P
Sbjct: 190 DECTDIYSIGIVLYEMLVGEP 210
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 9e-32
Identities = 62/205 (30%), Positives = 100/205 (48%), Gaps = 11/205 (5%)
Query: 692 TENFSPSNKLGEGGFGPVYKGK-LGDGRAIAVKQLSVASRQGKSQ-FVAEIATISAVQHR 749
E F+ K+G+G FG V+KG + +A+K + + + + + EI +S
Sbjct: 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 80
Query: 750 NLVKLHGCCIEGAERLLVYEYLENKSLDQALFGQRSLTLDW-ATRYEICSGVARGLAYLH 808
+ K +G ++ + ++ EYL S L L AT I + +GL YLH
Sbjct: 81 YVTKYYGSYLKDTKLWIIMEYLGGGSA-LDLLEPGPLDETQIAT---ILREILKGLDYLH 136
Query: 809 EESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVAGTIGYLAPEYAM 868
E + IHRD+KA+NVLL K++DFG+A D + +T V GT ++APE
Sbjct: 137 SE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIK 192
Query: 869 RGHLTEKTDVFAFGVLALETVSGRP 893
+ K D+++ G+ A+E G P
Sbjct: 193 QSAYDSKADIWSLGITAIELARGEP 217
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 2e-31
Identities = 69/269 (25%), Positives = 117/269 (43%), Gaps = 36/269 (13%)
Query: 701 LGEGGFGPVYKGK-LGDGRAIAVKQL---SVASRQGKSQFVAEIATISAVQHRNLVKLHG 756
LG+GGF ++ A K + + + + EI+ ++ H+++V HG
Sbjct: 23 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82
Query: 757 CCIEGAERL-LVYEYLENKSLDQALFGQRSLTLDWATRY--EICSGVARGLAYLHEESRV 813
E + + +V E +SL + +++LT A Y +I G YLH
Sbjct: 83 F-FEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQ----YLHRN--- 134
Query: 814 RIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVAGTIGYLAPEYAM-RGHL 872
R+IHRD+K N+ L+ DL KI DFGLA + + GT Y+APE +GH
Sbjct: 135 RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-LCGTPNYIAPEVLSKKGH- 192
Query: 873 TEKTDVFAFGVLALETVSGR-PNSDPSLDEEKLYLLEWAWHLHENNQEIELADPKLIEFN 931
+ + DV++ G + + G+ P L E Y I+ + + +
Sbjct: 193 SFEVDVWSIGCIMYTLLVGKPPFETSCLKE--TY------------LRIKKNEYSIPKHI 238
Query: 932 EEEVKRLIGVALLCTQTLPSLRPSMSRVV 960
LI +L QT P+ RP+++ ++
Sbjct: 239 NPVAASLIQ-KML--QTDPTARPTINELL 264
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 2e-31
Identities = 75/277 (27%), Positives = 121/277 (43%), Gaps = 40/277 (14%)
Query: 693 ENFSPSNKLGEGGFGPVYKGK-LGDGRAIAVKQLS---VASRQGKSQFVAEIATISAVQH 748
E+F LG+G FG VY + +A+K L + + Q E+ S ++H
Sbjct: 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 68
Query: 749 RNLVKLHGCCIEGAERL-LVYEYLENKSLDQALFGQRSLTLDWATRY--EICSGVARGLA 805
N+++L+G A R+ L+ EY ++ + L Y E+ + L+
Sbjct: 69 PNILRLYGY-FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA----LS 123
Query: 806 YLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVAGTIGYLAPE 865
Y H + R+IHRD+K N+LL + KI+DFG + + + GT+ YL PE
Sbjct: 124 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT--D-LCGTLDYLPPE 177
Query: 866 YAM-RGHLTEKTDVFAFGVLALETVSGRPNSDP--SLDEEKLYLLEWAWHLHENNQEIEL 922
R H EK D+++ GVL E + G+P P + ++ Y + I
Sbjct: 178 MIEGRMH-DEKVDLWSLGVLCYEFLVGKP---PFEANTYQETY------------KRISR 221
Query: 923 ADPKLIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRV 959
+ +F E + LI LL + PS RP + V
Sbjct: 222 VEFTFPDFVTEGARDLIS-RLL--KHNPSQRPMLREV 255
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 3e-31
Identities = 69/269 (25%), Positives = 117/269 (43%), Gaps = 36/269 (13%)
Query: 701 LGEGGFGPVYKGK-LGDGRAIAVKQLS---VASRQGKSQFVAEIATISAVQHRNLVKLHG 756
LG+GGF ++ A K + + + + EI+ ++ H+++V HG
Sbjct: 49 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108
Query: 757 CCIEGAERL-LVYEYLENKSLDQALFGQRSLTLDWATRY--EICSGVARGLAYLHEESRV 813
E + + +V E +SL + +++LT A Y +I G YLH
Sbjct: 109 F-FEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQ----YLHRN--- 160
Query: 814 RIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVAGTIGYLAPEYAM-RGHL 872
R+IHRD+K N+ L+ DL KI DFGLA + + GT Y+APE +GH
Sbjct: 161 RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-LCGTPNYIAPEVLSKKGH- 218
Query: 873 TEKTDVFAFGVLALETVSGR-PNSDPSLDEEKLYLLEWAWHLHENNQEIELADPKLIEFN 931
+ + DV++ G + + G+ P L E Y I+ + + +
Sbjct: 219 SFEVDVWSIGCIMYTLLVGKPPFETSCLKE--TY------------LRIKKNEYSIPKHI 264
Query: 932 EEEVKRLIGVALLCTQTLPSLRPSMSRVV 960
LI +L QT P+ RP+++ ++
Sbjct: 265 NPVAASLIQ-KML--QTDPTARPTINELL 290
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 3e-31
Identities = 64/292 (21%), Positives = 104/292 (35%), Gaps = 56/292 (19%)
Query: 692 TENFSPSNKLGEGGFGPVYKG-KLGDGRAIAVKQ--LSVASRQGKSQFVAEIATISAV-Q 747
T F K+G G FG V+K K DG A+K+ +A + + E+ + + Q
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69
Query: 748 HRNLVKLHGCCIEGAERLLVYEYLENKSLDQAL--FGQRSLTLDWATRYEICSGVARGLA 805
H ++V+ E L+ EY SL A+ + A ++ V RGL
Sbjct: 70 HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLR 129
Query: 806 YLHEESRVRIIHRDVKASNVLLDADLVP-------------------KISDFGLAKLYDD 846
Y+H ++H D+K SN+ + +P KI D G
Sbjct: 130 YIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISS 186
Query: 847 KKTHISTRVAGTIGYLAPEYAM--RGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKL 904
+ G +LA E HL K D+FA + + P P ++
Sbjct: 187 PQVEE-----GDSRFLANEVLQENYTHLP-KADIFALALTVVCAAGAEP--LPRNGDQ-- 236
Query: 905 YLLEWAWH-LHENNQEIELADPKLIEFNEEEVKRLIGVALLCTQTLPSLRPS 955
WH + + P++ + +E L+ + P RPS
Sbjct: 237 ------WHEIRQGRL------PRIPQVLSQEFTELL---KVMIHPDPERRPS 273
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 5e-31
Identities = 55/236 (23%), Positives = 102/236 (43%), Gaps = 20/236 (8%)
Query: 662 RKRPQHDDDEELLGMDARPYTFSYAELKTATENFSPSNKLGEGGFGPVYKGKL-GDGRAI 720
Q E L + + + ++LG G G V+K G +
Sbjct: 9 LDEQQRKRLEAFLTQKQKVGELKDDDFEKI-------SELGAGNGGVVFKVSHKPSGLVM 61
Query: 721 AVKQLSV-ASRQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLVYEYLENKSLDQA 779
A K + + ++Q + E+ + +V +G E + E+++ SLDQ
Sbjct: 62 ARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQV 121
Query: 780 LFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFG 839
L + + + V +GL YL E+ + I+HRDVK SN+L+++ K+ DFG
Sbjct: 122 LKKAGRIPEQILGK--VSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFG 177
Query: 840 LA-KLYDDK-KTHISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRP 893
++ +L D + + GT Y++PE H + ++D+++ G+ +E GR
Sbjct: 178 VSGQLIDSMANSFV-----GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRY 228
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 5e-31
Identities = 63/279 (22%), Positives = 103/279 (36%), Gaps = 35/279 (12%)
Query: 694 NFSPSNKLGEGGFGPVYKGKLGDGRAIAVKQLSVASRQGKSQFVAEIATISAV-QHRNLV 752
+F P + LG G G + + D R +AVK++ + E+ + +H N++
Sbjct: 25 SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFADR---EVQLLRESDEHPNVI 81
Query: 753 KLHGCCIEGAERL-LVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEES 811
+ C + + + E +L + Q+ + GLA+LH
Sbjct: 82 RYF-CTEKDRQFQYIAIELCA-ATLQE-YVEQKDFAHLGLEPITLLQQTTSGLAHLHSL- 137
Query: 812 RVRIIHRDVKASNVLL-----DADLVPKISDFGLAKLYDDKKTHISTR--VAGTIGYLAP 864
I+HRD+K N+L+ + ISDFGL K + S R V GT G++AP
Sbjct: 138 --NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAP 195
Query: 865 EY---AMRGHLTEKTDVFAFGVLALETVS-GRPNSDPSLDEEKLYLLEWAWHLHENNQEI 920
E + + T D+F+ G + +S G SL + L
Sbjct: 196 EMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANIL----------LGAC 245
Query: 921 ELADPKLIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRV 959
L + + + LI P RPS V
Sbjct: 246 SLDCLHPEKHEDVIARELI---EKMIAMDPQKRPSAKHV 281
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 6e-31
Identities = 54/202 (26%), Positives = 83/202 (41%), Gaps = 17/202 (8%)
Query: 700 KLGEGGFGPVYKGKLGD---GRAIAVKQLSVASRQGKSQFVA----EIATISAVQHRNLV 752
+G GG G VY+ + D R +A+K +S + F E T +Q ++V
Sbjct: 41 LVGRGGMGDVYEAE--DTVRERIVALKLMS-ETLSSDPVFRTRMQREARTAGRLQEPHVV 97
Query: 753 KLHGCCIEGAERLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESR 812
+H + + + L L Q L A I + L H
Sbjct: 98 PIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVA--IVRQIGSALDAAH---A 152
Query: 813 VRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKK-THISTRVAGTIGYLAPEYAMRGH 871
HRDVK N+L+ AD + DFG+A D+K T + GT+ Y+APE H
Sbjct: 153 AGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGN-TVGTLYYMAPERFSESH 211
Query: 872 LTEKTDVFAFGVLALETVSGRP 893
T + D++A + E ++G P
Sbjct: 212 ATYRADIYALTCVLYECLTGSP 233
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 7e-31
Identities = 43/203 (21%), Positives = 85/203 (41%), Gaps = 24/203 (11%)
Query: 700 KLGEGGFGPVYKGK---LGDGRAIAVKQLSVAS-RQGKSQFVAEIATISAVQHRNLVKLH 755
+ GG G +Y + +GR + +K L + + ++ +AE ++ V H ++V++
Sbjct: 87 CIAHGGLGWIYLALDRNV-NGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIF 145
Query: 756 --GCCIEGAERLLVY---EYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEE 810
+ + Y EY+ +SL ++ + L + A + L+YLH
Sbjct: 146 NFVEHTDRHGDPVGYIVMEYVGGQSLKRSK--GQKLPVAEAIA--YLLEILPALSYLH-- 199
Query: 811 SRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVAGTIGYLAPEYAMRG 870
+ +++ D+K N++L + + K+ D G + + GT G+ APE R
Sbjct: 200 -SIGLVYNDLKPENIMLTEEQL-KLIDLGAVSRINS-----FGYLYGTPGFQAPEIV-RT 251
Query: 871 HLTEKTDVFAFGVLALETVSGRP 893
T TD++ G P
Sbjct: 252 GPTVATDIYTVGRTLAALTLDLP 274
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 2e-30
Identities = 60/310 (19%), Positives = 122/310 (39%), Gaps = 42/310 (13%)
Query: 667 HDDDEELLGMDARPYTFSYAELKTATENFSPSNKLGEGGFGPVYKGKLGDGRAIAVKQLS 726
H G+D + + +S ++G GG V++ + A+K ++
Sbjct: 2 HHHHHHSSGVDLGTENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVN 61
Query: 727 VASRQGKS--QFVAEIATISAVQHRNL--VKLHGCCIEGAERLLVYEYLENKSLDQALFG 782
+ ++ + EIA ++ +Q + ++L+ I +V E N L+ L
Sbjct: 62 LEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKK 120
Query: 783 QRSLTLDWATRY--EICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGL 840
++S+ Y + V +H+ I+H D+K +N L+ ++ K+ DFG+
Sbjct: 121 KKSIDPWERKSYWKNMLEAV----HTIHQH---GIVHSDLKPANFLIVDGML-KLIDFGI 172
Query: 841 AKLYDDKKTHISTR-VAGTIGYLAPE-----------YAMRGHLTEKTDVFAFGVLALET 888
A T + GT+ Y+ PE + ++ K+DV++ G +
Sbjct: 173 ANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYM 232
Query: 889 VSGR-PNSDPSLDEEKLYLLEWAWHLHENNQEIELADPKLIEFNEEEVKRLIGVALLCTQ 947
G+ P KL+ + + N EIE P + E++++ ++ C +
Sbjct: 233 TYGKTPFQQIINQISKLH------AIIDPNHEIEF--PDIP---EKDLQDVL---KCCLK 278
Query: 948 TLPSLRPSMS 957
P R S+
Sbjct: 279 RDPKQRISIP 288
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 3e-30
Identities = 65/313 (20%), Positives = 106/313 (33%), Gaps = 46/313 (14%)
Query: 100 HITQLKVYALNVVGVIPDELWNLTSLFNLNLGQNYLTGPLSPSVGNLTAMQYLNLAINAL 159
HIT L + N + +P L L + N LT L L + + +
Sbjct: 62 HITTLVIPD-NNLTSLPALPPELR---TLEVSGNQLTS-LPVLPPGLLELSIFSNPLT-- 114
Query: 160 SGELPKELGQLTELLILGIGTNNFSGPLPSELGSLSKLQELYIDSAGVSGEIPSSFANLQ 219
LP L +L I G N + LP L QEL + ++ +P+ + L
Sbjct: 115 --HLPALPSGLCKLWIFG---NQLTS-LPVLPPGL---QELSVSDNQLA-SLPALPSELC 164
Query: 220 SLTKWWASDTRLTGRIPDFIGNWSKLTALRFQGNSFNGPIPSSFSNLTSVTEL--RISDL 277
L WA + +LT +P L L N +P+ S L + R++ L
Sbjct: 165 KL---WAYNNQLT-SLPMLPSG---LQELSVSDNQLAS-LPTLPSELYKLWAYNNRLTSL 216
Query: 278 SNGSSKLAFIR-----------DMKSLSILELRNNNISDSIPSNIGEYRSLQHLDLSFNN 326
S L + L L + N ++ S+P L L + N
Sbjct: 217 PALPSGLKELIVSGNRLTSLPVLPSELKELMVSGNRLT-SLPMLPS---GLLSLSVYRNQ 272
Query: 327 LGGSIPDSLFNLSSLTHLFLGNNKLNGTLPARKSPLLLNIDVSYNNL--QGNLPSWINGQ 384
L +P+SL +LSS T + L N L+ + + + + + +
Sbjct: 273 LT-RLPESLIHLSSETTVNLEGNPLS-ERTLQALREITSAPGYSGPIIRFDMAGASAPRE 330
Query: 385 QNLQINLVANNLT 397
A+ L
Sbjct: 331 TRALHLAAADWLV 343
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 8e-25
Identities = 69/300 (23%), Positives = 106/300 (35%), Gaps = 51/300 (17%)
Query: 118 ELWNLTSLFNLNLGQNYLTGPLSPSVGNLTAMQYLNLAINALSGELPKELGQLTELLILG 177
LN+G++ LT L + + L + N L+ LP +L L + G
Sbjct: 35 RACLNNGNAVLNVGESGLTT-LPDCLP--AHITTLVIPDNNLT-SLPALPPELRTLEVSG 90
Query: 178 IGTNNFSGPLPSELGSLSKLQELYIDSAGVSGEIPSSFANLQSLTKWWASDTRLTGRIPD 237
N + LP L +L +P+ + L L W +LT +P
Sbjct: 91 ---NQLTS-LPVLPPGLLELSIFSNPLT----HLPALPSGLCKL---WIFGNQLT-SLPV 138
Query: 238 FIGNWSKLTALRFQGNSFNGPIPSSFSNLTS--VTELRISDLSNGSSKLAFIRDMKSLSI 295
L L N +P+ S L +++ L L
Sbjct: 139 LPPG---LQELSVSDNQLAS-LPALPSELCKLWAYNNQLTSLPM---------LPSGLQE 185
Query: 296 LELRNNNISDSIPSNIGEYRSLQHLDLSFNNLGGSIPDSLFNLSSLTHLFLGNNKLNGTL 355
L + +N ++ S+P+ L L N L S+P S L L + N+L +L
Sbjct: 186 LSVSDNQLA-SLPTLPS---ELYKLWAYNNRL-TSLPAL---PSGLKELIVSGNRLT-SL 236
Query: 356 PARKSPLLLNIDVSYNNLQGNLPSWINGQQNLQINLVANNLTIRSSDNSVLPRGLICLQR 415
P S L + VS N L +LP +G +L ++ N LT LP LI L
Sbjct: 237 PVLPS-ELKELMVSGNRLT-SLPMLPSGLLSL--SVYRNQLT-------RLPESLIHLSS 285
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 6e-30
Identities = 58/207 (28%), Positives = 96/207 (46%), Gaps = 21/207 (10%)
Query: 700 KLGEGGFGPVYKGKLGD---GRAIAVKQLSVASRQGKSQFVA----EIATISAVQHRNLV 752
LG GG V+ + D R +AVK L A F E +A+ H +V
Sbjct: 19 ILGFGGMSEVHLAR--DLRDHRDVAVKVLR-ADLARDPSFYLRFRREAQNAAALNHPAIV 75
Query: 753 KLH--GCCIEGAERL--LVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLH 808
++ G A L +V EY++ +L + + +T A E+ + + L + H
Sbjct: 76 AVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAI--EVIADACQALNFSH 133
Query: 809 EESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHI--STRVAGTIGYLAPEY 866
+ IIHRDVK +N+++ A K+ DFG+A+ D + + V GT YL+PE
Sbjct: 134 ---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQ 190
Query: 867 AMRGHLTEKTDVFAFGVLALETVSGRP 893
A + ++DV++ G + E ++G P
Sbjct: 191 ARGDSVDARSDVYSLGCVLYEVLTGEP 217
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 1e-29
Identities = 54/231 (23%), Positives = 93/231 (40%), Gaps = 19/231 (8%)
Query: 676 MDARPYTFSYAELKTATENFSPSNKLGEGGFGPVYKGK-LGDGRAIAVKQLSVASRQGK- 733
M ++ +++ +G G V +A+K++++ Q
Sbjct: 1 MSEDSSALPWS---INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSM 57
Query: 734 SQFVAEIATISAVQHRNLVKLHGCCIEGAERLLVYEYLENKSLDQALFGQRSLTLDWATR 793
+ + EI +S H N+V + + E LV + L S+ + + +
Sbjct: 58 DELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGV 117
Query: 794 YE------ICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGL-AKLYDD 846
+ I V GL YLH+ IHRDVKA N+LL D +I+DFG+ A L
Sbjct: 118 LDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATG 174
Query: 847 KKTHISTR---VAGTIGYLAPEYAMRGHL-TEKTDVFAFGVLALETVSGRP 893
+ GT ++APE + K D+++FG+ A+E +G
Sbjct: 175 GDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAA 225
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 2e-29
Identities = 69/269 (25%), Positives = 110/269 (40%), Gaps = 40/269 (14%)
Query: 701 LGEGGFGPVYKGK-LGDGRAIAVKQLS---VASRQGKSQFVAEIATISAVQHRNLVKLHG 756
LG+G FG VY + + +A+K L + + Q EI S ++H N+++++
Sbjct: 22 LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYN 81
Query: 757 CCIEGAERL-LVYEYLENKSLDQALFGQRSLTLDWATRY--EICSGVARGLAYLHEESRV 813
+R+ L+ E+ L + L + + E+ L Y HE
Sbjct: 82 Y-FHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADA----LHYCHER--- 133
Query: 814 RIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVAGTIGYLAPEYAM-RGHL 872
++IHRD+K N+L+ KI+DFG + + T + GT+ YL PE + H
Sbjct: 134 KVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRR--T-MCGTLDYLPPEMIEGKTH- 189
Query: 873 TEKTDVFAFGVLALETVSGRPNSDP--SLDEEKLYLLEWAWHLHENNQEIELADPKLIEF 930
EK D++ GVL E + G P P S + + + I D K F
Sbjct: 190 DEKVDLWCAGVLCYEFLVGMP---PFDSPSHTETH------------RRIVNVDLKFPPF 234
Query: 931 NEEEVKRLIGVALLCTQTLPSLRPSMSRV 959
+ K LI LL P R + V
Sbjct: 235 LSDGSKDLIS-KLLRYH--PPQRLPLKGV 260
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 2e-29
Identities = 55/279 (19%), Positives = 115/279 (41%), Gaps = 44/279 (15%)
Query: 699 NKLGEGGFGPVYKGKLGDGRAIAVKQLSVASRQGKS--QFVAEIATISAVQHRNL--VKL 754
++G GG V++ + A+K +++ ++ + EIA ++ +Q + ++L
Sbjct: 15 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74
Query: 755 HGCCIEGAERL-LVYEYLENKSLDQALFGQRSLTLDWATRY--EICSGVARGLAYLHEES 811
+ + + +V E N L+ L ++S+ Y + V +H+
Sbjct: 75 YD-YEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAV----HTIHQH- 127
Query: 812 RVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTR-VAGTIGYLAPE----- 865
I+H D+K +N L+ ++ K+ DFG+A T + GT+ Y+ PE
Sbjct: 128 --GIVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDM 184
Query: 866 ------YAMRGHLTEKTDVFAFGVLALETVSGR-PNSDPSLDEEKLYLLEWAWHLHENNQ 918
+ ++ K+DV++ G + G+ P KL+ + + N
Sbjct: 185 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLH------AIIDPNH 238
Query: 919 EIELADPKLIEFNEEEVKRLIGVALLCTQTLPSLRPSMS 957
EIE P + E++++ ++ C + P R S+
Sbjct: 239 EIEF--PDIP---EKDLQDVL---KCCLKRDPKQRISIP 269
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 2e-29
Identities = 67/268 (25%), Positives = 118/268 (44%), Gaps = 35/268 (13%)
Query: 701 LGEGGFGPVYKGK-LGDGRAIAVKQLS---VASRQGKSQFVAEIATISAVQHRNLVKLHG 756
LG+G F VY+ + + G +A+K + + + E+ ++H ++++L+
Sbjct: 19 LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYN 78
Query: 757 CCIEGAERL-LVYEYLENKSL-DQALFGQRSLTLDWATRY--EICSGVARGLAYLHEESR 812
E + + LV E N + + + + A + +I +G+ YLH
Sbjct: 79 Y-FEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGML----YLHSH-- 131
Query: 813 VRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVAGTIGYLAPEYAMRGHL 872
I+HRD+ SN+LL ++ KI+DFGLA T + GT Y++PE A R
Sbjct: 132 -GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT-LCGTPNYISPEIATRSAH 189
Query: 873 TEKTDVFAFGVLALETVSGR-PNSDPSLDEEKLYLLEWAWHLHENNQEIELADPKLIEFN 931
++DV++ G + + GR P ++ ++ LAD ++ F
Sbjct: 190 GLESDVWSLGCMFYTLLIGRPPFDTDTVKN--TL------------NKVVLADYEMPSFL 235
Query: 932 EEEVKRLIGVALLCTQTLPSLRPSMSRV 959
E K LI LL + P+ R S+S V
Sbjct: 236 SIEAKDLIH-QLL--RRNPADRLSLSSV 260
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 3e-29
Identities = 56/275 (20%), Positives = 107/275 (38%), Gaps = 31/275 (11%)
Query: 110 NVVGVIPDE-LWNLTSLFNLNLGQNYLTGPLSPSV-GNLTAMQYLNLAINALSGELPKEL 167
N + +P N+ L L L +N L+ L + N + L+++ N L + +
Sbjct: 103 NAIRYLPPHVFQNVPLLTVLVLERNDLSS-LPRGIFHNTPKLTTLSMSNNNLE-RIEDDT 160
Query: 168 GQ-LTELLILGIGTNNFSGPLPSELGSLSKLQELYIDSAGVSGEIPSSFANLQSLTKWWA 226
Q T L L + +N + + L + L + S + S+ A ++ + A
Sbjct: 161 FQATTSLQNLQLSSNRLTH-VD--LSLIPSLFHANV-----SYNLLSTLAIPIAVEELDA 212
Query: 227 SDTRLTGRIPDFIGNWSKLTALRFQGNSFNGPIPSSFSNLTSVTEL-----RISDLSNGS 281
S + + +LT L+ Q N+ + N + E+ + +
Sbjct: 213 SHNSIN-VVRG--PVNVELTILKLQHNNLTDT--AWLLNYPGLVEVDLSYNELEKIMYH- 266
Query: 282 SKLAFIRDMKSLSILELRNNNISDSIPSNIGEYRSLQHLDLSFNNLGGSIPDSLFNLSSL 341
F M+ L L + NN + ++ +L+ LDLS N+L + + L
Sbjct: 267 ---PF-VKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRL 320
Query: 342 THLFLGNNKLNGTLPARKSPLLLNIDVSYNNLQGN 376
+L+L +N + TL L N+ +S+N+ N
Sbjct: 321 ENLYLDHNSIV-TLKLSTHHTLKNLTLSHNDWDCN 354
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 6e-26
Identities = 55/305 (18%), Positives = 104/305 (34%), Gaps = 31/305 (10%)
Query: 115 IPDELWNLTSLFNLNLGQNYLTGPLSPSVGNLTAMQYLNLAINALSGELPKE-LGQLTEL 173
I L +++++ L + + + + +LP L ++
Sbjct: 13 IDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQV 71
Query: 174 LILGIGTNNFSGPLPSELGSLSKLQELYIDSAGVSGEIPSSFANLQSLTKWWASDTRLTG 233
+L + +Q+LY+ + P F N+ LT L+
Sbjct: 72 ELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS- 130
Query: 234 RIPDFI-GNWSKLTALRFQGNSFNGPIPSSFSNLTSVTEL-----RISDLSNG------- 280
+P I N KLT L N+ +F TS+ L R++ +
Sbjct: 131 SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVDLSLIPSLFH 190
Query: 281 ----SSKLAFIRDMKSLSILELRNNNISDSIPSNIGEYRSLQHLDLSFNNLGGSIPDSLF 336
+ L+ + ++ L+ +N+I+ + + L L L NNL + L
Sbjct: 191 ANVSYNLLSTLAIPIAVEELDASHNSIN-VVRGPV--NVELTILKLQHNNL--TDTAWLL 245
Query: 337 NLSSLTHLFLGNNKLNGTLPA---RKSPLLLNIDVSYNNLQGNLPSWINGQQNLQI-NLV 392
N L + L N+L + K L + +S N L L + L++ +L
Sbjct: 246 NYPGLVEVDLSYNELE-KIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLS 303
Query: 393 ANNLT 397
N+L
Sbjct: 304 HNHLL 308
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 5e-04
Identities = 10/97 (10%), Positives = 32/97 (32%), Gaps = 7/97 (7%)
Query: 306 SIPSNIGEYRSLQHLDLSFNNLGGSIPDSLFNLSSLTHLFLGNNKLNGTLPA---RKSPL 362
I SN+ + + L++ + N+ + LPA
Sbjct: 12 CIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQ 70
Query: 363 LLNIDVSYNNLQGNLPSWI-NGQQNLQ-INLVANNLT 397
+ ++++ ++ + ++ +Q + + N +
Sbjct: 71 VELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIR 106
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 1e-28
Identities = 60/220 (27%), Positives = 98/220 (44%), Gaps = 28/220 (12%)
Query: 692 TENFSPSNKLGEGGFGPVYKGK-LGDGRAIAVKQLSVASRQGKSQFVAEIATISAV-QHR 749
F +G G +G VYKG+ + G+ A+K + V + + EI + HR
Sbjct: 23 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHR 81
Query: 750 NLVKLHGCCIEGAERL------LVYEYLENKSLDQALFGQRSLTLDWATRYE-----ICS 798
N+ +G I+ LV E+ S+ + + TL E IC
Sbjct: 82 NIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLK-----EEWIAYICR 136
Query: 799 GVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVAGT 858
+ RGL++LH+ ++IHRD+K NVLL + K+ DFG++ D +T GT
Sbjct: 137 EILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT-FIGT 192
Query: 859 IGYLAPEYAMRGHLTE-----KTDVFAFGVLALETVSGRP 893
++APE + K+D+++ G+ A+E G P
Sbjct: 193 PYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAP 232
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 1e-28
Identities = 45/213 (21%), Positives = 86/213 (40%), Gaps = 27/213 (12%)
Query: 699 NKLGEGGFGPVYKGKLGDGRAIAVKQ--LSVASRQGKSQFVAEIATISAVQHRNL--VKL 754
++G GG V++ + A+K L A Q + EIA ++ +Q + ++L
Sbjct: 62 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 121
Query: 755 HGCCIEGAERLLVYEYLENKSLDQALFGQRSLTLDWATRY--EICSGVARGLAYLHEESR 812
+ I +V E N L+ L ++S+ Y + V +H+
Sbjct: 122 YDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAV----HTIHQH-- 174
Query: 813 VRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTR-VAGTIGYLAPE------ 865
I+H D+K +N L+ ++ K+ DFG+A T + G + Y+ PE
Sbjct: 175 -GIVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMS 232
Query: 866 -----YAMRGHLTEKTDVFAFGVLALETVSGRP 893
+ ++ K+DV++ G + G+
Sbjct: 233 SSRENGKSKSKISPKSDVWSLGCILYYMTYGKT 265
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 1e-28
Identities = 50/216 (23%), Positives = 98/216 (45%), Gaps = 16/216 (7%)
Query: 688 LKTATENFSPSNKLGEGGFGPVYKGK-LGDGRAIAVKQLSV-ASRQGKSQFVAEIATI-S 744
++ ++ P +LG G +G V K + + G+ +AVK++ + Q + + + ++
Sbjct: 2 MEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMR 61
Query: 745 AVQHRNLVKLHGCCIEGAERLLVYEYLE---NKSLDQALFGQRSLTLDWATRYEICSGVA 801
V V +G + + E ++ +K Q + +++ D + I +
Sbjct: 62 TVDCPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGK--IAVSIV 119
Query: 802 RGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVAGTIGY 861
+ L +LH + +IHRDVK SNVL++A K+ DFG++ D AG Y
Sbjct: 120 KALEHLHSKLS--VIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAK--DIDAGCKPY 175
Query: 862 LAPE----YAMRGHLTEKTDVFAFGVLALETVSGRP 893
+APE + + K+D+++ G+ +E R
Sbjct: 176 MAPERINPELNQKGYSVKSDIWSLGITMIELAILRF 211
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 5e-28
Identities = 52/219 (23%), Positives = 93/219 (42%), Gaps = 19/219 (8%)
Query: 687 ELKTATENFSPSNKLGEGGFGPVYKGK-LGDGRAIAVKQLSV-ASRQGKSQFVAEIATI- 743
E+ ++G G +G V K G+ +AVK++ + + Q + ++ +
Sbjct: 16 HWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVM 75
Query: 744 SAVQHRNLVKLHGCCIEGAERLLVYEYLENKSLDQAL-----FGQRSLTLDWATRYEICS 798
+ +V+ +G + + E + + S D+ + + + I
Sbjct: 76 RSSDCPYIVQFYGALFREGDCWICMELM-STSFDKFYKYVYSVLDDVIPEEILGK--ITL 132
Query: 799 GVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVAGT 858
+ L +L E + IIHRD+K SN+LLD K+ DFG++ D TR AG
Sbjct: 133 ATVKALNHLKENLK--IIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAK--TRDAGC 188
Query: 859 IGYLAPE----YAMRGHLTEKTDVFAFGVLALETVSGRP 893
Y+APE A R ++DV++ G+ E +GR
Sbjct: 189 RPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRF 227
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 116 bits (291), Expect = 7e-28
Identities = 38/215 (17%), Positives = 77/215 (35%), Gaps = 16/215 (7%)
Query: 692 TENFSPSNKLGEG--GFGPVYKGK-LGDGRAIAVKQLSV--ASRQGKSQFVAEIATISAV 746
+ +G+G V + G + V+++++ S + + E+
Sbjct: 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLF 83
Query: 747 QHRNLVKLHGCCIEGAERLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAY 806
H N+V I E +V ++ S + ++ I GV + L Y
Sbjct: 84 NHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDY 143
Query: 807 LHEESRVRIIHRDVKASNVLLDADLVPKISDFG-LAKLYDDKK-----THISTRVAGTIG 860
+H +HR VKAS++L+ D +S + + +
Sbjct: 144 IHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLP 200
Query: 861 YLAPEYAMRGHL--TEKTDVFAFGVLALETVSGRP 893
+L+PE + K+D+++ G+ A E +G
Sbjct: 201 WLSPEVLQQNLQGYDAKSDIYSVGITACELANGHV 235
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 118 bits (296), Expect = 2e-27
Identities = 62/318 (19%), Positives = 121/318 (38%), Gaps = 36/318 (11%)
Query: 110 NVVGVIPDEL-WNLTSLFNLNLGQNYLTGPLSPSV-GNLTAMQYLNLAINALSGELPKEL 167
N + +P + N+ L L L +N L+ L + N + L+++ N L + +
Sbjct: 109 NAIRYLPPHVFQNVPLLTVLVLERNDLSS-LPRGIFHNTPKLTTLSMSNNNLE-RIEDDT 166
Query: 168 GQ-LTELLILGIGTNNFSGPLPSELGSLSKLQELYIDSAGVSGEIPSSFANLQSLTKWWA 226
Q T L L + +N + + L + L + S + S+ A ++ + A
Sbjct: 167 FQATTSLQNLQLSSNRLTH-VD--LSLIPSLFHANV-----SYNLLSTLAIPIAVEELDA 218
Query: 227 SDTRLTGRIPDFIGNWSKLTALRFQGNSFNGPIPSSFSNLTSVTEL-----RISDLSNGS 281
S + + +LT L+ Q N+ + N + E+ + +
Sbjct: 219 SHNSIN-VVRG--PVNVELTILKLQHNNLTDT--AWLLNYPGLVEVDLSYNELEKIMYHP 273
Query: 282 SKLAFIRDMKSLSILELRNNNISDSIPSNIGEYRSLQHLDLSFNNLGGSIPDSLFNLSSL 341
M+ L L + NN + ++ +L+ LDLS N+L + + L
Sbjct: 274 -----FVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRL 326
Query: 342 THLFLGNNKLNGTLPARKSPLLLNIDVSYNNLQGN-LPSWINGQQNLQINLVANNLTIRS 400
+L+L +N + TL L N+ +S+N+ N L + ++ + I
Sbjct: 327 ENLYLDHNSIV-TLKLSTHHTLKNLTLSHNDWDCNSLRALFRNVARPAVDDADQHCKI-- 383
Query: 401 SDNSVLPRGLICLQRNFP 418
+ L GL C + + P
Sbjct: 384 --DYQLEHGLCCKESDKP 399
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 3e-23
Identities = 57/287 (19%), Positives = 106/287 (36%), Gaps = 18/287 (6%)
Query: 115 IPDELWNLTSLFNLNLGQNYLTGPLSPSVGNLTAMQYLNLAINALSGELPKE-LGQLTEL 173
I L +++++ L + + + + +LP L ++
Sbjct: 19 IDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQV 77
Query: 174 LILGIGTNNFSGPLPSELGSLSKLQELYIDSAGVSGEIPSSFANLQSLTKWWASDTRLTG 233
+L + +Q+LY+ + P F N+ LT L+
Sbjct: 78 ELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS- 136
Query: 234 RIPDFI-GNWSKLTALRFQGNSFNGPIPSSFSNLTSVTELRISDLSNGSSKLAFIRDMKS 292
+P I N KLT L N+ +F TS+ L++S SN + + + S
Sbjct: 137 SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLS--SNRLTHVDL-SLIPS 193
Query: 293 LSILELRNNNISDSIPSNIGEYRSLQHLDLSFNNLGGSIPDSLFNLSSLTHLFLGNNKLN 352
L + N +S ++ I +++ LD S N++ + + LT L L +N L
Sbjct: 194 LFHANVSYNLLS-TLAIPI----AVEELDASHNSI-NVVRGPVN--VELTILKLQHNNLT 245
Query: 353 GTLPA-RKSPLLLNIDVSYNNLQGNLPSWINGQQNLQ-INLVANNLT 397
P L+ +D+SYN L+ + Q L+ + + N L
Sbjct: 246 -DTAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV 291
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 2e-27
Identities = 49/209 (23%), Positives = 90/209 (43%), Gaps = 14/209 (6%)
Query: 693 ENFSPSNKLGEGGFGPVYKGK-LGDGRAIAVKQLSV-ASRQGKSQFVAEIATI-SAVQHR 749
+ ++G G G V+K + G IAVKQ+ +++ + + ++ + +
Sbjct: 25 NDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCP 84
Query: 750 NLVKLHGCCIEGAERLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHE 809
+V+ G I + + E + + Q + + + + + L YL E
Sbjct: 85 YIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGK--MTVAIVKALYYLKE 142
Query: 810 ESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVAGTIGYLAPE---- 865
+ +IHRDVK SN+LLD K+ DFG++ D K R AG Y+APE
Sbjct: 143 KHG--VIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAK--DRSAGCAAYMAPERIDP 198
Query: 866 -YAMRGHLTEKTDVFAFGVLALETVSGRP 893
+ + DV++ G+ +E +G+
Sbjct: 199 PDPTKPDYDIRADVWSLGISLVELATGQF 227
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 8e-27
Identities = 37/300 (12%), Positives = 78/300 (26%), Gaps = 63/300 (21%)
Query: 701 LGEGGFGPVYKGK-LGDGRAIAVKQLSVASRQGKS------------------------- 734
LG+ + G + V R +
Sbjct: 86 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 145
Query: 735 QFVAEIATISAVQHRNLVKLHGCCIEGAERLLVYEYL-------ENKSLDQALF--GQRS 785
+ I V+ K+ ++ + ++ + ++ + L
Sbjct: 146 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 205
Query: 786 LTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYD 845
+L R ++ V R LA LH ++H ++ +++LD ++ F
Sbjct: 206 KSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG 262
Query: 846 DKKTHISTRVAGTIGYLAPE-----YAMRGHLTEKTDVFAFGVLALETVSGRPNSDPSLD 900
R A +T D + G+ P+ D
Sbjct: 263 ASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADL---PNTD 319
Query: 901 EEKLYLLEWAWHLHENNQEIELADPKLIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVV 960
+ L EW + + + I P + V+ L+ L R + +
Sbjct: 320 DAALGGSEW---IFRSCKNI----P-------QPVRALL-EGFLRYP--KEDRLLPLQAM 362
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 8e-27
Identities = 45/237 (18%), Positives = 88/237 (37%), Gaps = 43/237 (18%)
Query: 700 KLGEGGFGPVYKGKLGDGRAIAVKQLS-----------------VASRQGKSQFVAEIAT 742
L +G F + + D + A+K+ ++ + F E+
Sbjct: 38 TLNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQI 96
Query: 743 ISAVQHRNLVKLHGCCIEGAERL-LVYEYLEN--------KSLDQALFGQRSLTLDWATR 793
I+ +++ + G I + + ++YEY+EN + +
Sbjct: 97 ITDIKNEYCLTCEGI-ITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKC 155
Query: 794 Y--EICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHI 851
+ + + Y+H + I HRDVK SN+L+D + K+SDFG ++ DKK
Sbjct: 156 IIKSVLNSFS----YIH--NEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIKG 209
Query: 852 STRVAGTIGYLAPEYAMRGHLT---EKTDVFAFGVLALETVSGRPNSDPSLDEEKLY 905
S GT ++ PE + K D+++ G+ + +L+
Sbjct: 210 S---RGTYEFMPPE-FFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELF 262
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 1e-26
Identities = 53/213 (24%), Positives = 82/213 (38%), Gaps = 33/213 (15%)
Query: 700 KLGEGGFGPVYKGK-LGDGRAIAVKQLSVASRQGKSQFVAEIATISAVQ-HRNLVKLHGC 757
L EGGF VY+ + +G GR A+K+L + + E+ + + H N+V+
Sbjct: 35 VLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSA 94
Query: 758 CIEGAER-------LLVYEYLENKSLDQALFGQRS---LTLDWATR--YEICSGVARGLA 805
G E L+ L L + L S L+ D + Y+ C V
Sbjct: 95 ASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQ---- 150
Query: 806 YLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVA--------- 856
++H + IIHRD+K N+LL K+ DFG A + +
Sbjct: 151 HMHR-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEIT 209
Query: 857 --GTIGYLAPE---YAMRGHLTEKTDVFAFGVL 884
T Y PE + EK D++A G +
Sbjct: 210 RNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCI 242
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 2e-26
Identities = 55/238 (23%), Positives = 98/238 (41%), Gaps = 21/238 (8%)
Query: 658 IVRRRKRPQHDDDEELLGMDARPYTFSYAELKTA--TENFSPSNKLGEGGFGPVYKGK-L 714
+ + P+ +D ++ + Y E+K + + +LG G FG V++
Sbjct: 14 VRGKYDGPKINDYDKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEK 73
Query: 715 GDGRAIAVKQLSVASRQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLVYEYLENK 774
GR K ++ K EI+ ++ + H L+ LH + E +L+ E+L
Sbjct: 74 ATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGG 133
Query: 775 SL-DQALFGQRSLTLDWATRY--EICSGVARGLAYLHEESRVRIIHRDVKASNVLL---- 827
L D+ ++ Y + C G+ ++HE I+H D+K N++
Sbjct: 134 ELFDRIAAEDYKMSEAEVINYMRQACEGL----KHMHEH---SIVHLDIKPENIMCETKK 186
Query: 828 DADLVPKISDFGLAKLYDDKKTHISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLA 885
+ + KI DFGLA + + T + APE R + TD++A GVL
Sbjct: 187 ASSV--KIIDFGLATKLNPDEIV--KVTTATAEFAAPEIVDREPVGFYTDMWAIGVLG 240
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 111 bits (278), Expect = 2e-26
Identities = 30/298 (10%), Positives = 67/298 (22%), Gaps = 52/298 (17%)
Query: 701 LGEGGFGPVYKGK-LGDGRAIAVKQLSVASRQGKS---QFVAEIATISAVQHRNLVKLHG 756
L G V+ + + A+K ++ + +S + + + + +
Sbjct: 70 LRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARD 129
Query: 757 CC--------------------------IEGAERLLVYEY----LENKSLDQALFGQRSL 786
A LL+ LE
Sbjct: 130 RRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRG 189
Query: 787 TLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDD 846
+ + + + R A L ++H N+ + D + D
Sbjct: 190 DEGILALHILTAQLIRLAANLQ---SKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGT 246
Query: 847 KKTHISTRVAGTIGYLAPEYAMRGHL--TEKTDVFAFGVLALETVSGR-PNSDPSLDEEK 903
+ + + Y E+ T + + G+ P + +
Sbjct: 247 R----GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKG 302
Query: 904 LYLLEWAWHLHENNQEIELADPKLIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVA 961
+ + + + VK LIG L R +
Sbjct: 303 SWKRPSLRVPGT--DSLAFGSCTPL---PDFVKTLIG-RFLNFD--RRRRLLPLEAME 352
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 6e-26
Identities = 56/218 (25%), Positives = 97/218 (44%), Gaps = 24/218 (11%)
Query: 701 LGEGGFGPVYKG-KLGDGRAIAVKQLS---VASRQGKSQFVAE---IATISAVQHRNLVK 753
+G GGFG VY K G+ A+K L + +QG++ + E ++ +S +V
Sbjct: 197 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 256
Query: 754 LHGCCIEGAERL-LVYEYLENKSLDQALFGQRSLTLDWATRY--EICSGVARGLAYLHEE 810
+ ++L + + + L L + Y EI G L ++H
Sbjct: 257 MS-YAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILG----LEHMHNR 311
Query: 811 SRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVAGTIGYLAPEYAMRG 870
+++RD+K +N+LLD +ISD GLA + KK H V GT GY+APE +G
Sbjct: 312 ---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH--ASV-GTHGYMAPEVLQKG 365
Query: 871 HLTEKT-DVFAFGVLALETVSGRP--NSDPSLDEEKLY 905
+ + D F+ G + + + G + D+ ++
Sbjct: 366 VAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID 403
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 6e-26
Identities = 37/230 (16%), Positives = 71/230 (30%), Gaps = 28/230 (12%)
Query: 687 ELKTATENFSPSNKLGEGGFGPVYKGKLGD------GRAIAVKQLSVASRQGKSQFVAEI 740
E + ++ + LGEG F VY+ GD + +K A+ +
Sbjct: 59 EFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLM 118
Query: 741 ATISAVQHRNLVKLHGCCIEGAERLLVYEYLENKSLDQAL-----FGQRSLTLDWATRYE 795
+ +K + + +LV E +L A+ ++ + +
Sbjct: 119 ERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFA 178
Query: 796 ICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVP-----------KISDFGLAK-L 843
+ + + +H+ IIH D+K N +L + + D G + +
Sbjct: 179 MR--MLYMIEQVHD---CEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDM 233
Query: 844 YDDKKTHISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRP 893
K I T T G+ E + D F + G
Sbjct: 234 KLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTY 283
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 9e-26
Identities = 52/239 (21%), Positives = 90/239 (37%), Gaps = 28/239 (11%)
Query: 689 KTATENFSPSNKLGEGGFGPVYKGK-LGDGRAIAVKQLSVASRQGKSQFVA-EIATISAV 746
T+ + S+ LG+G V++G+ G A+K + S E + +
Sbjct: 5 STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKL 64
Query: 747 QHRNLVKLHGCCIEGAERLLVY---EYLENKSLDQALF-GQRSLTLDWATRYEICSGVAR 802
H+N+VKL E E+ SL L + L + + V
Sbjct: 65 NHKNIVKLFAI-EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVG 123
Query: 803 GLAYLHEESRVRIIHRDVKASNVLL----DADLVPKISDFGLAKLYDDKKTHISTRVAGT 858
G+ +L E I+HR++K N++ D V K++DFG A+ +D + GT
Sbjct: 124 GMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELED-DEQFVSLY-GT 178
Query: 859 IGYLAPE--------YAMRGHLTEKTDVFAFGVLALETVSGRP----NSDPSLDEEKLY 905
YL P+ + D+++ GV +G P ++E +Y
Sbjct: 179 EEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMY 237
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 1e-25
Identities = 60/241 (24%), Positives = 107/241 (44%), Gaps = 27/241 (11%)
Query: 661 RRKRPQHDDDEELLGMD--ARPYTFSYAELKTATENFS------PSNKLGEGGFGPVYKG 712
+ P L +D A P F + + + + LG G FG V+K
Sbjct: 49 TERMPVKSKRTSALAVDIPAPPAPFDHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHKC 108
Query: 713 K-LGDGRAIAVKQLSVASRQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLVYEYL 771
+ G +A K + + K + EI+ ++ + H NL++L+ + +LV EY+
Sbjct: 109 EETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYV 168
Query: 772 ENKSL-DQALFGQRSLTLDWATRY--EICSGVARGLAYLHEESRVRIIHRDVKASNVLL- 827
+ L D+ + +LT + +IC G+ ++H+ I+H D+K N+L
Sbjct: 169 DGGELFDRIIDESYNLTELDTILFMKQICEGI----RHMHQM---YILHLDLKPENILCV 221
Query: 828 ---DADLVPKISDFGLAKLYDDKKTHISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVL 884
+ KI DFGLA+ Y ++ + GT +LAPE ++ TD+++ GV+
Sbjct: 222 NRDAKQI--KIIDFGLARRYKPREK-LKVNF-GTPEFLAPEVVNYDFVSFPTDMWSVGVI 277
Query: 885 A 885
A
Sbjct: 278 A 278
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 2e-25
Identities = 63/303 (20%), Positives = 106/303 (34%), Gaps = 64/303 (21%)
Query: 695 FSPSNKLGEGGFGPVYKGKLGDGRAIAVKQLSVASRQGKSQFVAEIATISAV-QHRNLVK 753
LG G G V GR +AVK++ + EI ++ H N+++
Sbjct: 17 VVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIALM---EIKLLTESDDHPNVIR 73
Query: 754 LHGCCIEGAERL-LVYEY----LENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLH 808
+ C L + E L++ + + + + +A G+A+LH
Sbjct: 74 YY-CSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH 132
Query: 809 EESRVRIIHRDVKASNVLLD-------------ADLVPKISDFGLAKLYDDKKTHISTR- 854
+IIHRD+K N+L+ +L ISDFGL K D ++ T
Sbjct: 133 SL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNL 189
Query: 855 --VAGTIGYLAPE-------YAMRGHLTEKTDVFAFGVLALETVSG--RPNSDPSLDEEK 903
+GT G+ APE + LT D+F+ G + +S P D E
Sbjct: 190 NNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESN 249
Query: 904 -------LYLLEWAWHLHENNQEIELADPKLIEFNEEEVKRLIGVALLCTQTLPSLRPSM 956
L ++ + +L + ++I P RP+
Sbjct: 250 IIRGIFSLDEMKCLHDRSLIAEATDL------------ISQMI-------DHDPLKRPTA 290
Query: 957 SRV 959
+V
Sbjct: 291 MKV 293
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 3e-25
Identities = 63/225 (28%), Positives = 99/225 (44%), Gaps = 15/225 (6%)
Query: 676 MDARPYTFSYAELKTATENFSPSNKLGEGGFGPVYKGK-LGDGRAIAVKQLS---VASRQ 731
+ A P F ++ + LG+G FG V K G+ AVK +S V +
Sbjct: 9 LHATPGMFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKT 68
Query: 732 GKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLVYEYLENKSLDQALFGQRSLTLDWA 791
K + E+ + + H N++KL+ + LV E L + ++ + A
Sbjct: 69 DKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDA 128
Query: 792 TRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLL---DADLVPKISDFGLAKLYDDKK 848
I V G+ Y+H+ I+HRD+K N+LL D +I DFGL+ ++ K
Sbjct: 129 A--RIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASK 183
Query: 849 THISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRP 893
GT Y+APE + G EK DV++ GV+ +SG P
Sbjct: 184 KM--KDKIGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSGCP 225
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 108 bits (270), Expect = 4e-25
Identities = 52/239 (21%), Positives = 90/239 (37%), Gaps = 28/239 (11%)
Query: 689 KTATENFSPSNKLGEGGFGPVYKGK-LGDGRAIAVKQLSVASRQGKSQFVA-EIATISAV 746
T+ + S+ LG+G V++G+ G A+K + S E + +
Sbjct: 5 STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKL 64
Query: 747 QHRNLVKLHGCCIEGAERLLVY---EYLENKSLDQALFG-QRSLTLDWATRYEICSGVAR 802
H+N+VKL E E+ SL L + L + + V
Sbjct: 65 NHKNIVKLF-AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVG 123
Query: 803 GLAYLHEESRVRIIHRDVKASNVLL----DADLVPKISDFGLAKLYDDKKTHISTRVAGT 858
G+ +L E I+HR++K N++ D V K++DFG A+ +D + GT
Sbjct: 124 GMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELED-DEQFVSLY-GT 178
Query: 859 IGYLAPE--------YAMRGHLTEKTDVFAFGVLALETVSGRP----NSDPSLDEEKLY 905
YL P+ + D+++ GV +G P ++E +Y
Sbjct: 179 EEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMY 237
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 5e-25
Identities = 40/306 (13%), Positives = 87/306 (28%), Gaps = 74/306 (24%)
Query: 701 LGEGGFGPVYKGK-LGDGRAIAVKQLSVASRQGKS------------------------- 734
LG+ + G + V R +
Sbjct: 81 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 140
Query: 735 ---QFVAEIATISAVQHRNLVKLHGCC--IEGAERLLVYEYLENKSLD--QALF--GQRS 785
+F+ + Q + ++++ + R +Y +++ + L
Sbjct: 141 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 200
Query: 786 LTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYD 845
+L R ++ V R LA LH ++H ++ +++LD ++ F
Sbjct: 201 KSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG 257
Query: 846 DKKTHISTRVAGTIGYLAPEY-----------AMRGHLTEKTDVFAFGVLALETVSGRPN 894
+ + + G+ PE R +T D +A G++
Sbjct: 258 ARVV-----SSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADL- 311
Query: 895 SDPSLDEEKLYLLEWAWHLHENNQEIELADPKLIEFNEEEVKRLIGVALLCTQTLPSLRP 954
P + L EW + + + I P + V+ L+ L R
Sbjct: 312 --PITKDAALGGSEW---IFRSCKNI----P-------QPVRALLE-GFLRYP--KEDRL 352
Query: 955 SMSRVV 960
+ +
Sbjct: 353 LPLQAM 358
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 5e-25
Identities = 74/346 (21%), Positives = 128/346 (36%), Gaps = 53/346 (15%)
Query: 562 KREAGGVSKRAIQREIKTRVSENYLEIHLFWAGKGTCCVPAQGTYGPS----ISAIRVTP 617
KREA G S L + + A+ +G S +A + P
Sbjct: 48 KREAMGGSWS----PCAKSRYTYTTIEGLRAGKQYEFRIIAENKHGQSKPCEPTAPVLIP 103
Query: 618 DFTPTVRPPKEKDNNRTGLIVGIVVGVGVATFLSVLAIFCIVRRRKRPQHDDDEELLGMD 677
R + D + R K + + +
Sbjct: 104 GDERKRRRGYDVDEQGK------------------------IVRGKGTVSSNYDNYVFDI 139
Query: 678 ARPYTFSYAELKTA--TENFSPSNKLGEGGFGPVYKGK-LGDGRAIAVKQLSVASRQGKS 734
+ Y E+K +++ +LG G FG V++ G A K + K
Sbjct: 140 WKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKE 199
Query: 735 QFVAEIATISAVQHRNLVKLHGCCIEGAERLLVYEYLENKSL-DQALFGQRSLTLDWATR 793
EI T+S ++H LV LH + E +++YE++ L ++ ++ D A
Sbjct: 200 TVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVE 259
Query: 794 Y--EICSGVARGLAYLHEESRVRIIHRDVKASNVLL----DADLVPKISDFGLAKLYDDK 847
Y ++C G+ ++HE + +H D+K N++ +L K+ DFGL D K
Sbjct: 260 YMRQVCKGL----CHMHENN---YVHLDLKPENIMFTTKRSNEL--KLIDFGLTAHLDPK 310
Query: 848 KTHISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRP 893
++ GT + APE A + TD+++ GVL+ +SG
Sbjct: 311 QSV--KVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLS 354
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 7e-25
Identities = 65/242 (26%), Positives = 99/242 (40%), Gaps = 24/242 (9%)
Query: 679 RPYTFSYAELKTAT-ENFSPSNKLGEGGFGPVYKGKL-GDGRAIAVKQLS---VASRQGK 733
R + + E + + F LG GGFG V+ ++ G+ A K+L+ + R+G
Sbjct: 170 RFLQWKWLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGY 229
Query: 734 SQFVAEIATISAVQHRNLVKLHGCCIEGAERL-LVYEYLENKSL----DQALFGQRSLTL 788
+ E ++ V R +V L E L LV + +
Sbjct: 230 QGAMVEKKILAKVHSRFIVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQE 288
Query: 789 DWATRY--EICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDD 846
A Y +I SG L +LH+ II+RD+K NVLLD D +ISD GLA
Sbjct: 289 PRAIFYTAQIVSG----LEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKA 341
Query: 847 KKTHISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRP---NSDPSLDEEK 903
+T GT G++APE + D FA GV E ++ R ++ ++
Sbjct: 342 GQTKTKGYA-GTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKE 400
Query: 904 LY 905
L
Sbjct: 401 LK 402
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 1e-24
Identities = 59/208 (28%), Positives = 98/208 (47%), Gaps = 14/208 (6%)
Query: 692 TENFSPSNKLGEGGFGPVYKGK-LGDGRAIAVKQLSVA--SRQGKSQFVAEIATISAVQH 748
+E + KLG G +G V + A+K + S S+ + E+A + + H
Sbjct: 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDH 95
Query: 749 RNLVKLHGCCIEGAERLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLH 808
N++KL+ + LV E + L + + A I V G+ YLH
Sbjct: 96 PNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAA--VIIKQVLSGVTYLH 153
Query: 809 EESRVRIIHRDVKASNVLL---DADLVPKISDFGLAKLYDDKKTHISTRVAGTIGYLAPE 865
+ + I+HRD+K N+LL + D + KI DFGL+ +++++K GT Y+APE
Sbjct: 154 KHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKM--KERLGTAYYIAPE 208
Query: 866 YAMRGHLTEKTDVFAFGVLALETVSGRP 893
+R EK DV++ GV+ ++G P
Sbjct: 209 -VLRKKYDEKCDVWSIGVILFILLAGYP 235
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 1e-24
Identities = 60/324 (18%), Positives = 108/324 (33%), Gaps = 29/324 (8%)
Query: 122 LTSLFNLNLGQNYLTGPLSPSV-GNLTAMQYLNLAINALSGELPKELGQLTELLILGIGT 180
+S+ +L+L ++ L+ V L ++ LNLA N ++ + L L +L +
Sbjct: 265 RSSVRHLDLSHGFVFS-LNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSY 323
Query: 181 NNFSGPLPSELGSLSKLQELYIDSAGVSGEIPSSFANLQSLTKWWASDTRLTG------- 233
N S L K+ + + ++ +F L+ L D LT
Sbjct: 324 NLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTTIHFIPSI 383
Query: 234 --------RIPDFIGNWSKLTALRFQGNSFNG-PIPSSFSNLTSVTELRISDLSNGS-SK 283
++ + N I + + L ++ S S
Sbjct: 384 PDIFLSGNKLVTLPKINLTANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSG 443
Query: 284 LAFIRDMKSLSILELRNNNISDSIPSNIGEY-----RSLQHLDLSFNNLGGSIPDSLF-N 337
+ SL L L N + + + + LQ L L+ N L S+P +F +
Sbjct: 444 DQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYL-NSLPPGVFSH 502
Query: 338 LSSLTHLFLGNNKLNGTLPARKSPLLLNIDVSYNNLQGNLPSWINGQQNLQINLVANNLT 397
L++L L L +N+L L +D+S N L P +L + + +N
Sbjct: 503 LTALRGLSLNSNRLTVLSHNDLPANLEILDISRNQLLAPNPDVF---VSLSVLDITHNKF 559
Query: 398 IRSSDNSVLPRGLICLQRNFPCNR 421
I + S L
Sbjct: 560 ICECELSTFINWLNHTNVTIAGPP 583
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 2e-24
Identities = 58/321 (18%), Positives = 104/321 (32%), Gaps = 33/321 (10%)
Query: 91 CSSQNGTV-CHITQLKVYALNVVGVIPDELWNLTSLFNLNLGQNYLTGPLSPSVGNLTAM 149
CS L +P L + L L NY+ + S L +
Sbjct: 2 CSFDGRIAFYRFCNLTQ--------VPQ---VLNTTERLLLSFNYIRTVTASSFPFLEQL 50
Query: 150 QYLNLAINALSGELPKE-LGQLTELLILGIGTNNFSGPLPSELGSLSKLQELYIDSAGVS 208
Q L L + KE L L IL +G++ P L L EL + G+S
Sbjct: 51 QLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLS 110
Query: 209 GEI--PSSFANLQSLTKWWASDTRLTG-RIPDFIGNWSKLTALRFQGNSFNGPIPSSFSN 265
+ F NL++LT+ S ++ + G + L ++ F N
Sbjct: 111 DAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEP 170
Query: 266 LTSVTELRISDLSNGS----SKLAFIRDMKSLSILELRNNNISDSIPSNIGEYRSLQHLD 321
L T L L+ S + + + M + L ++S + ++
Sbjct: 171 LQGKT-LSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGN-------GWTVDITG 222
Query: 322 LSFNNLGGSIPDSLFNLSSLTHLFLGNNKL----NGTLPARKSPLLLNIDVSYNNLQGNL 377
N + S SL + G + + T + ++D+S+ +
Sbjct: 223 NFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLN 282
Query: 378 PSWINGQQNLQ-INLVANNLT 397
++L+ +NL N +
Sbjct: 283 SRVFETLKDLKVLNLAYNKIN 303
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 4e-24
Identities = 60/317 (18%), Positives = 110/317 (34%), Gaps = 39/317 (12%)
Query: 109 LNVVGVIPDELWNLTSLFNLNLGQNYLTG-PLSPSVGNLTAMQYLNLAINALSGELPKEL 167
L+ + NL +L L+L +N + L PS G L +++ ++ + N + EL
Sbjct: 109 LSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHEL 168
Query: 168 GQLT--ELLILGIGTNNFSGPLPSELGSLSK------LQELYIDSAGVSGEIPSSFAN-- 217
L L + N+ + + G L+ L + G + +I +F+N
Sbjct: 169 EPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAI 228
Query: 218 ----------LQSLTKWWASDTRLTGRIPDFIGNW--SKLTALRFQGNSFNGPIPSSFSN 265
+ + + S + L F
Sbjct: 229 SKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFET 288
Query: 266 LTSVTEL-----RISDLSNGSSKLAFIRDMKSLSILELRNNNISDSIPSNIGEYRSLQHL 320
L + L +I+ +++ AF + +L +L L N + + SN + ++
Sbjct: 289 LKDLKVLNLAYNKINKIADE----AF-YGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYI 343
Query: 321 DLSFNNLGGSIPDSLFNLSSLTHLFLGNNKLNGTLPARKSPLLLNIDVSYNNLQGNLPSW 380
DL N++ + L L L L +N L T+ P + +I +S N L LP
Sbjct: 344 DLQKNHIAIIQDQTFKFLEKLQTLDLRDNALT-TIHF--IPSIPDIFLSGNKLV-TLPK- 398
Query: 381 INGQQNLQINLVANNLT 397
I+L N L
Sbjct: 399 -INLTANLIHLSENRLE 414
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 4e-22
Identities = 50/307 (16%), Positives = 105/307 (34%), Gaps = 24/307 (7%)
Query: 100 HITQLKVYALNVVGVIPDELWNLTSLFNLNLGQNYLTGPLSPSVGNLTAMQYLNLAINAL 159
+ L + + + + + L +L LNL N L S + L + Y++L N +
Sbjct: 291 DLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHI 350
Query: 160 SGELPKELGQLTELLILGIGTNNFSGPLPSELGSLSKLQELYIDSAGVSGEIPSSFANLQ 219
+ + L +L L + N + + + + ++++ + +P
Sbjct: 351 AIIQDQTFKFLEKLQTLDLRDNAL-----TTIHFIPSIPDIFLSGNKLV-TLPKINLTAN 404
Query: 220 SLTKWWASDTRLTG-RIPDFIGNWSKLTALRFQGNSFNG-PIPSSFSNLTSVTEL----- 272
+ S+ RL I F+ L L N F+ + S S+ +L
Sbjct: 405 LI---HLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGEN 461
Query: 273 RISDLSNGSSKLAFIRDMKSLSILELRNNNISDSIPSNIGEYRSLQHLDLSFNNLGGSIP 332
+ + L +L L +N ++ P +L+ L L+ N L +
Sbjct: 462 MLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRL-TVLS 520
Query: 333 DSLFNLSSLTHLFLGNNKLNGTLPARKSPLLLNIDVSYNNLQ-----GNLPSWINGQQNL 387
+ ++L L + N+L L +D+++N +W+N
Sbjct: 521 HNDL-PANLEILDISRNQLL-APNPDVFVSLSVLDITHNKFICECELSTFINWLNHTNVT 578
Query: 388 QINLVAN 394
A+
Sbjct: 579 IAGPPAD 585
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 1e-24
Identities = 75/289 (25%), Positives = 111/289 (38%), Gaps = 33/289 (11%)
Query: 700 KLGEGGFGPVYKGK-LGDGRAIAVKQLSVASRQGKSQFVA-EIATISAVQHRNLVKLHGC 757
+LG GGFG V + G +A+KQ + EI + + H N+V
Sbjct: 21 RLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAR-E 79
Query: 758 CIEGAERL-------LVYEYLENKSLDQALFG-QRSLTLDWATRYEICSGVARGLAYLHE 809
+G ++L L EY E L + L + L + S ++ L YLHE
Sbjct: 80 VPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHE 139
Query: 810 ESRVRIIHRDVKASNVLLDA---DLVPKISDFGLAKLYDDKKTHISTRVAGTIGYLAPEY 866
RIIHRD+K N++L L+ KI D G AK D + V GT+ YLAPE
Sbjct: 140 N---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQ-GELCTEFV-GTLQYLAPEL 194
Query: 867 AMRGHLTEKTDVFAFGVLALETVSGRP----NSDPSLD----EEKLYLLEWAWHLHENNQ 918
+ T D ++FG LA E ++G N P EK +
Sbjct: 195 LEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTGAV 254
Query: 919 EI--ELADP-KLIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVAMLC 964
+ L P L +++R + L R + + + C
Sbjct: 255 KFSSVLPTPNHLSGILAGKLERWLQCML---MWHQRQRGTDPQNPNVGC 300
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 2e-24
Identities = 67/320 (20%), Positives = 115/320 (35%), Gaps = 52/320 (16%)
Query: 89 CDCSSQNGTV-CHITQLKVYALNVVGVIPDELWNLTSLFNLNLGQNYLTGPLSPSVGNLT 147
C+CS+Q+ V CH + +P+ + T L+LG+N + +
Sbjct: 7 CECSAQDRAVLCHRKRFVA--------VPEGI--PTETRLLDLGKNRIKTLNQDEFASFP 56
Query: 148 AMQYLNLAINALSGELPKELGQLTELLILGIGTNNFSGPLPSELGSLSKLQELYIDSAGV 207
++ L L N +S P L L LG+ +N LS L +L I +
Sbjct: 57 HLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKI 116
Query: 208 SGEIPSSFANLQSLTKWWASDTRLTGRIPDFIGNWSKLTALRFQGNSFNGPIPSSFSNLT 267
+ F +L +L D L I +FS L
Sbjct: 117 VILLDYMFQDLYNLKSLEVGDNDLV-YIS-----------------------HRAFSGLN 152
Query: 268 SVTEL-----RISDLSNGSSKLAFIRDMKSLSILELRNNNISDSIPSNI-GEYRSLQHLD 321
S+ +L ++ + A + L +L LR+ NI+ +I L+ L+
Sbjct: 153 SLEQLTLEKCNLTSIPTE----AL-SHLHGLIVLRLRHLNIN-AIRDYSFKRLYRLKVLE 206
Query: 322 LSFNNLGGSIPDSLFNLSSLTHLFLGNNKLNGTLPA---RKSPLLLNIDVSYNNLQGNLP 378
+S ++ + +LT L + + L +P R L +++SYN +
Sbjct: 207 ISHWPYLDTMTPNCLYGLNLTSLSITHCNLT-AVPYLAVRHLVYLRFLNLSYNPISTIEG 265
Query: 379 SWINGQQNLQ-INLVANNLT 397
S ++ LQ I LV L
Sbjct: 266 SMLHELLRLQEIQLVGGQLA 285
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 7e-23
Identities = 57/272 (20%), Positives = 102/272 (37%), Gaps = 24/272 (8%)
Query: 116 PDELWNLTSLFNLNLGQNYLTGPLSPSV-GNLTAMQYLNLAINALSGELPKELGQLTELL 174
P NL +L L L N L + V L+ + L+++ N + L L L
Sbjct: 73 PGAFNNLFNLRTLGLRSNRLKL-IPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLK 131
Query: 175 ILGIGTNNFSGPLPSELGSLSKLQELYIDSAGVSGEIPS-SFANLQSLTKWWASDTRLTG 233
L +G N+ L+ L++L ++ ++ IP+ + ++L L +
Sbjct: 132 SLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLT-SIPTEALSHLHGLIVLRLRHLNIN- 189
Query: 234 RIPDFIGNWSKLTALRF---QGNSFNGPIPSSFSNLTSVTELRISDLSNGSSKL---AFI 287
I D ++ +L L+ + + + ++T L I+ + + A
Sbjct: 190 AIRD--YSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITH--CNLTAVPYLAV- 244
Query: 288 RDMKSLSILELRNNNISDSIPSNI-GEYRSLQHLDLSFNNLGGSIPDSLF-NLSSLTHLF 345
R + L L L N IS +I ++ E LQ + L L + F L+ L L
Sbjct: 245 RHLVYLRFLNLSYNPIS-TIEGSMLHELLRLQEIQLVGGQLA-VVEPYAFRGLNYLRVLN 302
Query: 346 LGNNKLNGTLPAR---KSPLLLNIDVSYNNLQ 374
+ N+L TL L + + N L
Sbjct: 303 VSGNQLT-TLEESVFHSVGNLETLILDSNPLA 333
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 3e-24
Identities = 53/282 (18%), Positives = 94/282 (33%), Gaps = 30/282 (10%)
Query: 117 DELWNLTSLFNLNLGQNYLTGPLSPSVGNLTAMQYLNLAINALSGELPKELGQLTELLIL 176
+ LT L L N +T + + T + YL N L+ L + LT+L L
Sbjct: 58 TGIEKLTGLTKLICTSNNIT---TLDLSQNTNLTYLACDSNKLT-NLD--VTPLTKLTYL 111
Query: 177 GIGTNNFSGPLPSELGSLSKLQELYIDSAGVSGEIPSSFANLQSLTKWWASDTRLTGRIP 236
TN + ++ L L ++ EI ++ LT+ + ++
Sbjct: 112 NCDTNKLT---KLDVSQNPLLTYLNCARNTLT-EID--VSHNTQLTELDCHLNKKITKLD 165
Query: 237 DFIGNWSKLTALRFQGNSFNGPIPSSFSNLTSVTELRISDLSNGSSKLAFIRDMKSLSIL 296
+ ++LT L N S + L N +KL L+ L
Sbjct: 166 --VTPQTQLTTLDCSFNKITE---LDVSQNKLLNRLNCDT--NNITKLDL-NQNIQLTFL 217
Query: 297 ELRNNNISDSIPSNIGEYRSLQHLDLSFNNLGGSIPDSLFNLSSLTHLFLGNNKLNGTLP 356
+ +N +++ ++ L + D S N L + S LS LT L L +
Sbjct: 218 DCSSNKLTE---IDVTPLTQLTYFDCSVNPL-TELDVS--TLSKLTTLHCIQTDLL-EID 270
Query: 357 ARKSPLLLNIDVSYNNLQGNLPSWINGQQNLQ-INLVANNLT 397
+ L+ L + L ++ A +T
Sbjct: 271 LTHNTQLIYFQAEGCRKIKELD--VTHNTQLYLLDCQAAGIT 310
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 3e-23
Identities = 54/295 (18%), Positives = 95/295 (32%), Gaps = 31/295 (10%)
Query: 118 ELWNLTSLFNLNLGQNYLTGPLSPSVGNLTAMQYLNLAINALSGELPKELGQLTELLILG 177
++ + T L L+ N V T + L+ + N ++ EL + Q L L
Sbjct: 143 DVSHNTQLTELDCHLNKKIT--KLDVTPQTQLTTLDCSFNKIT-ELD--VSQNKLLNRLN 197
Query: 178 IGTNNFSGPLPSELGSLSKLQELYIDSAGVSGEIPSSFANLQSLTKWWASDTRLTGRIPD 237
TNN + +L +L L S ++ EI L LT + S LT +
Sbjct: 198 CDTNNITKL---DLNQNIQLTFLDCSSNKLT-EID--VTPLTQLTYFDCSVNPLT-ELD- 249
Query: 238 FIGNWSKLTALRFQGNSFNGPIPSSFSNLTSVTELRISDLSNGSSKLAFIRDMKSLSILE 297
+ SKLT L ++ T + + K + L +L+
Sbjct: 250 -VSTLSKLTTLHCIQTDLLE---IDLTHNTQLIYFQAEGCRK--IKELDVTHNTQLYLLD 303
Query: 298 LRNNNISDSIPSNIGEYRSLQHLDLSFNNLGGSIPDSLFNLSSLTHLFLGNNKLNGTLPA 357
+ I+ + + + L +L L+ L + S + + L L N +
Sbjct: 304 CQAAGIT-ELD--LSQNPKLVYLYLNNTELT-ELDVS--HNTKLKSLSCVNAHIQDFSSV 357
Query: 358 RKSPLLLNIDVSYNNLQGNLPSWINGQQNL------QINLVANNLTIRSSDNSVL 406
K P L N + + ++ N + I D V
Sbjct: 358 GKIPALNNNFEAEGQTITMPKETLTNNSLTIAVSPDLLDQFGNPMNIEPGDGGVY 412
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 1e-22
Identities = 48/284 (16%), Positives = 97/284 (34%), Gaps = 28/284 (9%)
Query: 116 PDELWNLTSLFNLNLGQNYLTGPLSPSVGNLTAMQYLNLAINALSGELPKELGQLTELLI 175
++ T L L+ N +T V + LN N ++ +L L Q +L
Sbjct: 163 KLDVTPQTQLTTLDCSFNKIT---ELDVSQNKLLNRLNCDTNNIT-KLD--LNQNIQLTF 216
Query: 176 LGIGTNNFSGPLPSELGSLSKLQELYIDSAGVSGEIPSSFANLQSLTKWWASDTRLTGRI 235
L +N + ++ L++L ++ S+ + L +L T L I
Sbjct: 217 LDCSSNKLTE---IDVTPLTQLTYFDCSVNPLTELDVSTLSKLTTLH---CIQTDLL-EI 269
Query: 236 PDFIGNWSKLTALRFQGNSFNGPIPSSFSNLTSVTELRISDLSNGSSKLAFIRDMKSLSI 295
+ + ++L + +G + ++ T + L G ++L L
Sbjct: 270 D--LTHNTQLIYFQAEGCRKIKELD--VTHNTQLYLLDCQA--AGITELDL-SQNPKLVY 322
Query: 296 LELRNNNISDSIPSNIGEYRSLQHLDLSFNNLGGSIPDSLFNLSSLTHLFLGNNKLNGTL 355
L L N ++ + + L+ L ++ S+ + +L + F +
Sbjct: 323 LYLNNTELT-ELD--VSHNTKLKSLSCVNAHI-QDFS-SVGKIPALNNNFEAEGQTITMP 377
Query: 356 PARKSPLLLNIDVSYNNLQ--GNLPSWINGQQNLQINLVANNLT 397
+ L I VS + L GN + I + N +T
Sbjct: 378 KETLTNNSLTIAVSPDLLDQFGNPMN-IEPGDGGVYDQATNTIT 420
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 1e-22
Identities = 56/285 (19%), Positives = 99/285 (34%), Gaps = 32/285 (11%)
Query: 114 VIPDELWNLTSLFNLNLGQNYLTGPLSPSVGNLTAMQYLNLAINALSGELPKELGQLTEL 173
PD+ N S + S L + L+ ++++ ++ + +LT L
Sbjct: 14 WFPDD--NFASEVAAAFEMQATD---TISEEQLATLTSLDCHNSSIT-DMT-GIEKLTGL 66
Query: 174 LILGIGTNNFSGPLPSELGSLSKLQELYIDSAGVSGEIPSSFANLQSLTKWWASDTRLTG 233
L +NN + +L + L L DS ++ + L LT +LT
Sbjct: 67 TKLICTSNNITTL---DLSQNTNLTYLACDSNKLT-NLD--VTPLTKLTYLNCDTNKLTK 120
Query: 234 RIPDFIGNWSKLTALRFQGNSFNGPIPSSFSNLTSVTELRISDLSNGSSKLAFIRDMKSL 293
+ + LT L N+ S+ T +TEL N + L
Sbjct: 121 -LD--VSQNPLLTYLNCARNTLTEI---DVSHNTQLTELDCHL--NKKITKLDVTPQTQL 172
Query: 294 SILELRNNNISDSIPSNIGEYRSLQHLDLSFNNLGGSIPDSLFNLSSLTHLFLGNNKLNG 353
+ L+ N I++ ++ + + L L+ NN+ + L LT L +NKL
Sbjct: 173 TTLDCSFNKITE---LDVSQNKLLNRLNCDTNNI-TKLD--LNQNIQLTFLDCSSNKLT- 225
Query: 354 TLPARKSPLLLNIDVSYNNLQGNLPSWINGQQNLQ-INLVANNLT 397
+ L D S N L L L ++ + +L
Sbjct: 226 EIDVTPLTQLTYFDCSVNPLT-ELDVSTL--SKLTTLHCIQTDLL 267
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 2e-17
Identities = 47/265 (17%), Positives = 93/265 (35%), Gaps = 29/265 (10%)
Query: 121 NLTSLFNLNLGQNYLTGPLSPSVGNLTAMQYLNLAINALSGELPKELGQLTELLILGIGT 180
L LN N +T + + +L+ + N L+ E+ + LT+L
Sbjct: 189 QNKLLNRLNCDTNNIT---KLDLNQNIQLTFLDCSSNKLT-EID--VTPLTQLTYFDCSV 242
Query: 181 NNFSGPLPSELGSLSKLQELYIDSAGVSGEIPSSFANLQSLTKWWASDTRLTGRIPDFIG 240
N + L + +LSKL L+ + EI + + L + A R + +
Sbjct: 243 NPLT-ELD--VSTLSKLTTLHCIQTDLL-EIDLT--HNTQLIYFQAEGCRKIKELD--VT 294
Query: 241 NWSKLTALRFQGNSFNGPIPSSFSNLTSVTELRISDLSNGSSKLAFIRDMKSLSILELRN 300
+ ++L L Q S + L +++ ++L + L L N
Sbjct: 295 HNTQLYLLDCQAAGIT---ELDLSQNPKLVYLYLNN--TELTELD-VSHNTKLKSLSCVN 348
Query: 301 NNISDSIPSNIGEYRSLQHLDLSFNNLGGSIPDSLFNLSSLTHLFLGN------NKLNGT 354
+I D S +G+ +L + + ++P +SLT + N +N
Sbjct: 349 AHIQD-FSS-VGKIPALNNNFEAEGQT-ITMPKETLTNNSLTIAVSPDLLDQFGNPMNIE 405
Query: 355 LPARKSPLLLNIDVSYNNLQGNLPS 379
+++ NL + P+
Sbjct: 406 PGDGGVYDQATNTITWENLSTDNPA 430
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 2e-12
Identities = 30/193 (15%), Positives = 55/193 (28%), Gaps = 36/193 (18%)
Query: 226 ASDTRLTGRIPDFIGNWSKLTALRFQGNSFNGPIPSSFSNLTSVTELRISDLSNGSSKLA 285
PD + S L ++T L ++ + +
Sbjct: 6 GQTQSFNDWFPD-----DNFASEVAAAFEMQATDTISEEQLATLTSLDCH--NSSITDMT 58
Query: 286 FIRDMKSLSILELRNNNISD--------------------SIPSNIGEYRSLQHLDLSFN 325
I + L+ L +NNI+ ++ + L +L+ N
Sbjct: 59 GIEKLTGLTKLICTSNNITTLDLSQNTNLTYLACDSNKLTNLD--VTPLTKLTYLNCDTN 116
Query: 326 NLGGSIPDSLFNLSSLTHLFLGNNKLNGTLPARKSPLLLNIDVSYNNLQGNLPSWINGQQ 385
L + S LT+L N L + + L +D N L + Q
Sbjct: 117 KL-TKLDVS--QNPLLTYLNCARNTLT-EIDVSHNTQLTELDCHLNKKITKLD--VTPQT 170
Query: 386 NLQ-INLVANNLT 397
L ++ N +T
Sbjct: 171 QLTTLDCSFNKIT 183
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 3e-24
Identities = 69/217 (31%), Positives = 100/217 (46%), Gaps = 22/217 (10%)
Query: 701 LGEGGFGPVYKGKL-GDGRAIAVKQLS---VASRQGKSQFVAEIATISAVQHRNLVKLHG 756
LG+GGFG V ++ G+ A K+L + R+G++ + E + V R +V L
Sbjct: 192 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLA- 250
Query: 757 CCIEGAERL-LVYEYLENKSLDQAL--FGQRSLTLDWATRY--EICSGVARGLAYLHEES 811
E + L LV + L + GQ A Y EIC G L LH E
Sbjct: 251 YAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCG----LEDLHRE- 305
Query: 812 RVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVAGTIGYLAPEYAMRGH 871
RI++RD+K N+LLD +ISD GLA + +T I RV GT+GY+APE
Sbjct: 306 --RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT-IKGRV-GTVGYMAPEVVKNER 361
Query: 872 LTEKTDVFAFGVLALETVSGRP---NSDPSLDEEKLY 905
T D +A G L E ++G+ + E++
Sbjct: 362 YTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVE 398
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 3e-24
Identities = 58/343 (16%), Positives = 105/343 (30%), Gaps = 52/343 (15%)
Query: 89 CDCSSQNGTV-C---HITQLKVYALNVVGVIPDELWNLTSLFNLNLGQNYLTGPLSPSVG 144
C N T C + + IPD L S NL+L N L S S
Sbjct: 3 CVEVVPNITYQCMELNFYK-----------IPDNL--PFSTKNLDLSFNPLRHLGSYSFF 49
Query: 145 NLTAMQYLNLAINALSGELPKELGQLTELLILGIGTNNFSGPLPSELGSLSKLQELYIDS 204
+ +Q L+L+ + L+ L L + N LS LQ+L
Sbjct: 50 SFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVE 109
Query: 205 AGVSGEIPSSFANLQSLTKWWASDTRLT-GRIPDFIGNWSKLTALRFQGNSFNGPIPSSF 263
++ +L++L + + + ++P++ N + L L N +
Sbjct: 110 TNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDL 169
Query: 264 SNLTSVTELRISDLSNGSSKLAFIRDMKSLSILELRNNNISDSIPSNIGEYRSLQHLDLS 323
L + L +S L+L N ++ I + L L L
Sbjct: 170 RVLHQMPLLNLS--------------------LDLSLNPMN-FIQPGAFKEIRLHKLTLR 208
Query: 324 FNNLGGSIPDSLF-NLSSLTHL------FLGNNKL----NGTLPARKSPLLLNIDVSYNN 372
N ++ + L+ L F L L + + ++Y +
Sbjct: 209 NNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLD 268
Query: 373 LQGN-LPSWINGQQNLQINLVANNLTIRSSDNSVLPRGLICLQ 414
+ + N N+ + + TI + G L+
Sbjct: 269 YYLDDIIDLFNCLTNVSSFSLVSV-TIERVKDFSYNFGWQHLE 310
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 6e-24
Identities = 47/246 (19%), Positives = 90/246 (36%), Gaps = 21/246 (8%)
Query: 119 LWNLTSLFNLNLGQNYLTGPLSPSVGNLTAMQYLNLAINALSGELPKELGQLTELLILGI 178
+ L +N L +++ L N E+ L L L +
Sbjct: 303 NFGWQHLELVNCKFGQFPT------LKLKSLKRLTFTSNKGG-NAFSEVD-LPSLEFLDL 354
Query: 179 GTN--NFSGPLPSELGSLSKLQELYIDSAGVSGEIPSSFANLQSLTKWWASDTRLTGRIP 236
N +F G + L+ L + GV + S+F L+ L + L ++
Sbjct: 355 SRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLK-QMS 412
Query: 237 D--FIGNWSKLTALRFQGNSFNGPIPSSFSNLTSVTELRISD--LSNGSSKLAFIRDMKS 292
+ + L L F+ L+S+ L+++ F ++++
Sbjct: 413 EFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIF-TELRN 471
Query: 293 LSILELRNNNISDSIPSNI-GEYRSLQHLDLSFNNLGGSIPDSLF-NLSSLTHLFLGNNK 350
L+ L+L + + SLQ L+++ N L S+PD +F L+SL ++L N
Sbjct: 472 LTFLDLSQCQLE-QLSPTAFNSLSSLQVLNMASNQL-KSVPDGIFDRLTSLQKIWLHTNP 529
Query: 351 LNGTLP 356
+ + P
Sbjct: 530 WDCSCP 535
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 5e-22
Identities = 54/324 (16%), Positives = 103/324 (31%), Gaps = 39/324 (12%)
Query: 110 NVVGVIPDELWNLTSLFNLNLGQNYLTGPLSPSV-GNLTAMQYLNLAINALSGE------ 162
N + I + L L L N+ + + + L ++ L + E
Sbjct: 187 NPMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKF 246
Query: 163 ---LPKELGQLTELLILGIGTNNFSGPLPSELGSLSKLQELYIDSAGVSGEIPSSF-ANL 218
+ L LT + + + L+ + + S + S+
Sbjct: 247 DKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGW 306
Query: 219 QSLTKWWASDTRLT-----------------GRIPDFIGNWSKLTALRFQGNSFN--GPI 259
Q L + G + L L N + G
Sbjct: 307 QHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDL-PSLEFLDLSRNGLSFKGCC 365
Query: 260 PSSFSNLTSVTELRISDLSNGSSKL-AFIRDMKSLSILELRNNNISDSIPSNI-GEYRSL 317
S TS+ L +S NG + + ++ L L+ +++N+ ++ R+L
Sbjct: 366 SQSDFGTTSLKYLDLS--FNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNL 423
Query: 318 QHLDLSFNNLGGSIPDSLFNLSSLTHLFLGNNKLNGTLPA---RKSPLLLNIDVSYNNLQ 374
+LD+S + + LSSL L + N + L +D+S L+
Sbjct: 424 IYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE 483
Query: 375 GNLPSWINGQQNLQ-INLVANNLT 397
P+ N +LQ +N+ +N L
Sbjct: 484 QLSPTAFNSLSSLQVLNMASNQLK 507
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 3e-24
Identities = 62/309 (20%), Positives = 120/309 (38%), Gaps = 27/309 (8%)
Query: 96 GTVCHITQLKVYALNVVGVIPDELWNLTSLFNLNLGQNYLTGPLSPSVGNLTAMQYLNLA 155
G++ T + V + PD L + + G++ +T + +L + L+
Sbjct: 1 GSITQPTAINV-------IFPDP--ALANAIKIAAGKSNVTDT--VTQADLDGITTLSAF 49
Query: 156 INALSGELPKELGQLTELLILGIGTNNFSGPLPSELGSLSKLQELYIDSAGVSGEIPSSF 215
++ + + L L+ L + N + + L +L+K+ EL + + S+
Sbjct: 50 GTGVT-TIE-GVQYLNNLIGLELKDNQITDL--APLKNLTKITELELSGNPLK--NVSAI 103
Query: 216 ANLQSLTKWWASDTRLTGRIPDFIGNWSKLTALRFQGNSFNGPIPSSFSNLTSVTELRIS 275
A LQS+ + T++T + S L L N S + LT++ L I
Sbjct: 104 AGLQSIKTLDLTSTQITD--VTPLAGLSNLQVLYLDLNQITNI--SPLAGLTNLQYLSIG 159
Query: 276 DLSNGSSKLAFIRDMKSLSILELRNNNISDSIPSNIGEYRSLQHLDLSFNNLGGSIPDSL 335
+ S L + ++ L+ L+ +N ISD S + +L + L N + S L
Sbjct: 160 N--AQVSDLTPLANLSKLTTLKADDNKISDI--SPLASLPNLIEVHLKNNQI--SDVSPL 213
Query: 336 FNLSSLTHLFLGNNKLNGTLPARKSPLLLNIDVSYNNLQGNLPSWINGQQNLQINLVANN 395
N S+L + L N + + L++ V + P+ I+ + N
Sbjct: 214 ANTSNLFIVTLTNQTITNQPVFYNNNLVVPNVVKGPSGAPIAPATISDNGTYASPNLTWN 273
Query: 396 LTIRSSDNS 404
LT ++ S
Sbjct: 274 LTSFINNVS 282
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 5e-24
Identities = 42/229 (18%), Positives = 87/229 (37%), Gaps = 6/229 (2%)
Query: 124 SLFNLNLGQNYLTGPLSPSVGNLTAMQYLNLAINALSGELPKELGQLTELLILGIGTNNF 183
+++NL + + + S L ++ ++ E+ I + ++
Sbjct: 282 NIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDT 341
Query: 184 SGPLPSELGSLSKLQELYIDSAGVSGEIPSSFANLQSLTKWWASDTRLTGRIPDFIGNWS 243
S S L + + + L+ L L
Sbjct: 342 PFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLK-NFFKVALMTK 400
Query: 244 KLTALRFQGNSFNGPIPSSFSNLTSVTE-LRISDLS-NGSSKLAFIRDMKSLSILELRNN 301
+++L S N ++ + E + + +LS N + F + +L+L NN
Sbjct: 401 NMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLPPKVKVLDLHNN 460
Query: 302 NISDSIPSNIGEYRSLQHLDLSFNNLGGSIPDSLF-NLSSLTHLFLGNN 349
I SIP ++ ++LQ L+++ N L S+PD +F L+SL +++L +N
Sbjct: 461 RIM-SIPKDVTHLQALQELNVASNQL-KSVPDGVFDRLTSLQYIWLHDN 507
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 72.2 bits (177), Expect = 4e-13
Identities = 45/337 (13%), Positives = 98/337 (29%), Gaps = 46/337 (13%)
Query: 89 CDCSSQNGTVCHITQLKVYALNVVGVIPDELWNLTSLFNLNLGQNYLTGPLSPSV-GNLT 147
S++ ++ + + +P +L L+L QN ++ L L+
Sbjct: 26 TPFSNELESMVDYSNRNLTH------VPKDL--PPRTKALSLSQNSISE-LRMPDISFLS 76
Query: 148 AMQYLNLAINALSGELPKEL-GQLTELLILGIGTNNFSGPLPSELGSLSKLQELY----- 201
++ L L+ N + L + +L L + N + ++ L+ L
Sbjct: 77 ELRVLRLSHNRIR-SLDFHVFLFNQDLEYLDVSHNRLQN-ISC--CPMASLRHLDLSFND 132
Query: 202 IDSAGVSGEIPSSFANLQSLTKWWASDTRLTGRIP--DFIGNWSKLTALRFQGNSFNGPI 259
D V E F NL LT S + ++ L G
Sbjct: 133 FDVLPVCKE----FGNLTKLTFLGLSAAKFR-QLDLLPVAHLHLSCILLDLVSYHIKGGE 187
Query: 260 PSSFSNLTSVTELRISDLSNGSSKLAFIRDMKSLSILELRNNNIS-----DSIPSNIGEY 314
S + T L + N + + +L L+L N ++ +
Sbjct: 188 TESLQIP-NTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELT 246
Query: 315 RSLQHLDLSFNNLGGSIPD-----SLFNLSSLTHLFLGNNKLNGTLPARKSPLLLNI--- 366
R L+++ ++ + F + +L + N + + +
Sbjct: 247 RGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKS 306
Query: 367 ----DVSYNNLQGNLPSWINGQQNLQI-NLVANNLTI 398
V + + + + I L ++
Sbjct: 307 LMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPF 343
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 70.3 bits (172), Expect = 2e-12
Identities = 59/331 (17%), Positives = 116/331 (35%), Gaps = 32/331 (9%)
Query: 100 HITQLKVYALNVVGVIPDELWNL-TSLFNLNLGQNYL-TGPLSPSVGNLTAMQYLNLAIN 157
L + + ++ G + L T++ +L N L + ++ SV L +Q N+ +N
Sbjct: 172 SCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLN 231
Query: 158 ALSG----ELPKELGQLTELLILGIGTNNFSGPLPSELGSL---SKLQELYID-----SA 205
+ EL + LL + + + +L ++ L I
Sbjct: 232 DENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITER 291
Query: 206 GVSGEIPSSFANLQSLTKWWASDTRLTGRIPDFIGNWSKLTALRFQGNSFNGPIPSSFSN 265
E S L+SL + ++++ + +
Sbjct: 292 IDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPS 351
Query: 266 LTSVTELRISDLSNGSSKLAF--IRDMKSLSILELRNNNISDSIPSNIGEYRSLQHL--- 320
+S T L + N + F +K L L L+ N + + +++ L
Sbjct: 352 PSSFTFLNFTQ--NVFTDSVFQGCSTLKRLQTLILQRNGLK-NFFKVALMTKNMSSLETL 408
Query: 321 DLSFNNLGGSIPDSLFNL-SSLTHLFLGNNKLNGTLPARKSPLLLNIDVSYNNLQGNLPS 379
D+S N+L D S+ L L +N L G++ P + +D+ N + ++P
Sbjct: 409 DVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLPPKVKVLDLHNNRIM-SIPK 467
Query: 380 WINGQQNLQ-INLVANNLTIRSSDNSVLPRG 409
+ Q LQ +N+ +N L +P G
Sbjct: 468 DVTHLQALQELNVASNQLKS-------VPDG 491
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 64.9 bits (158), Expect = 7e-11
Identities = 58/302 (19%), Positives = 95/302 (31%), Gaps = 29/302 (9%)
Query: 121 NLTSLFNLNLGQNYLT-GPLSPSVGNLTAMQYLNLAINALSGELPKELGQL-TELLILGI 178
NLT L L L L P + L+L + G + L T +L L
Sbjct: 144 NLTKLTFLGLSAAKFRQLDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVF 203
Query: 179 GTNN-FSGPLPSELGSLSKLQELYIDSAGVSGEIPSSF-------ANLQSLTKWWASDTR 230
N+ FS + + +L LQ I + + +F L ++T T
Sbjct: 204 HPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTW 263
Query: 231 LTGRIPDFIGNW-SKLTALRFQGNSFNGPIPSSF--SNLTSVTELRISDLSNGSSKLAFI 287
+ F W + L + I + T++ L I + N F
Sbjct: 264 -KCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQ--VFLFS 320
Query: 288 RD-----MKSLSILELRNNNISDSIPSNIGEYRSLQHLDLSFNNLGGSIPDSLFNLSSLT 342
++ ++I L ++ S L+ + N S+ L L
Sbjct: 321 KEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQ 380
Query: 343 HLFLGNNKLNGTLPARKSPL-----LLNIDVSYNNLQ-GNLPSWINGQQNLQI-NLVANN 395
L L N L L +DVS N+L +++ + NL +N
Sbjct: 381 TLILQRNGLK-NFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNM 439
Query: 396 LT 397
LT
Sbjct: 440 LT 441
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 5e-24
Identities = 50/314 (15%), Positives = 104/314 (33%), Gaps = 33/314 (10%)
Query: 115 IPDE-LWNLTSLFNLNLGQNYLTG-PLSPSVGNLTAMQYLNLAINALSGELPKE-LGQLT 171
+ L+SL LNL N ++ NLT +Q L + E+ + LT
Sbjct: 89 LSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLT 148
Query: 172 ELLILGIGTNNFSGPLPSELGSLSKLQELYIDSAGVSGEIPSSFANLQSLTKWWASDTRL 231
L L I + L S+ + L + + + + L S+ DT L
Sbjct: 149 SLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNL 208
Query: 232 TGRIPDFIGNWSKLTALRFQGNSFNGPIPSSFSNLT-------SVTELRISDLS------ 278
+ + ++ + SF+ L ++E+ D +
Sbjct: 209 ARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGD 268
Query: 279 ------NGSSKLAFIRDMKSLSILELRNNNISDSIPSNIGEYRSLQHLDLSFNNLGGSIP 332
+ S+L + ++ L + + + + ++ + + + + +P
Sbjct: 269 FNPSESDVVSELGKVE-TVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKV-FLVP 326
Query: 333 DSLF-NLSSLTHLFLGNNKL-----NGTLPARKSPLLLNIDVSYNNLQ--GNLPSWINGQ 384
S +L SL L L N + + P L + +S N+L+ +
Sbjct: 327 CSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTL 386
Query: 385 QNLQ-INLVANNLT 397
+NL +++ N
Sbjct: 387 KNLTSLDISRNTFH 400
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 2e-23
Identities = 61/307 (19%), Positives = 108/307 (35%), Gaps = 38/307 (12%)
Query: 100 HITQLKVYALNVVGVIPDELWNLTSLFNLNLGQNYLTGPLSPSVGNLTAMQYLNLAINAL 159
+ L + N + + + L+ + + N L N + + +
Sbjct: 231 RGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLG--------------DFNPSESDV 276
Query: 160 SGELPKELGQLTELLILGIGTNNFSGPLPSELGSLSKLQELYIDSAGVSGEIPSSFANLQ 219
EL K + + L I L + L K++ + ++++ V S +L+
Sbjct: 277 VSELGKV--ETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLK 334
Query: 220 SLTKWWASDTRLTGRI---PDFIGNWSKLTALRFQGNSFN--GPIPSSFSNLTSVTELRI 274
SL S+ + G W L L N L ++T L
Sbjct: 335 SLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSL-- 392
Query: 275 SDLSNGSSKLAFIRD----MKSLSILELRNNNISDSIPSNIGEYRSLQHLDLSFNNLGGS 330
D+S + + D + + L L + I + + I ++L+ LD+S NNL S
Sbjct: 393 -DISR--NTFHPMPDSCQWPEKMRFLNLSSTGIR-VVKTCI--PQTLEVLDVSNNNLD-S 445
Query: 331 IPDSLFNLSSLTHLFLGNNKLNGTLPARKSPLLLNIDVSYNNLQGNLPSWINGQQNLQ-I 389
L L L++ NKL A P+LL + +S N L+ + +LQ I
Sbjct: 446 FS---LFLPRLQELYISRNKLKTLPDASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKI 502
Query: 390 NLVANNL 396
L N
Sbjct: 503 WLHTNPW 509
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 1e-22
Identities = 51/322 (15%), Positives = 100/322 (31%), Gaps = 30/322 (9%)
Query: 100 HITQLKVYALNVVGVIPDELWNLTSLFNLNLGQNYLTGPLSPSVGNLTAMQYLNLAINAL 159
+ +L++ AL++ L ++ + +L L + L L++++YL L L
Sbjct: 149 SLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNL 208
Query: 160 SGELPKELGQLTELLILGIGTNNFSGPLPSELGSLSKLQEL------------------Y 201
+ L + S L KL
Sbjct: 209 ARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGD 268
Query: 202 IDSAGVSGEIPSSFANLQSLTKWWASDTRLTGRIPDFIGNWSKLTALRFQGNSFNGPIPS 261
+ + ++ + L + K+ + + + S
Sbjct: 269 FNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCS 328
Query: 262 SFSNLTSVTELRISD---LSNGSSKLAFIRDMKSLSILELRNNNISD--SIPSNIGEYRS 316
+L S+ L +S+ + A SL L L N++ + ++
Sbjct: 329 FSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKN 388
Query: 317 LQHLDLSFNNLGGSIPDSLFNLSSLTHLFLGNNKLNGTLPARKSPLLLNIDVSYNNLQGN 376
L LD+S N +PDS + L L + + + L +DVS NNL +
Sbjct: 389 LTSLDISRNTF-HPMPDSCQWPEKMRFLNLSSTGIR-VVKTCIPQTLEVLDVSNNNLD-S 445
Query: 377 LPSWINGQQNLQ-INLVANNLT 397
++ LQ + + N L
Sbjct: 446 FSLFL---PRLQELYISRNKLK 464
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 97.9 bits (244), Expect = 3e-21
Identities = 53/333 (15%), Positives = 106/333 (31%), Gaps = 43/333 (12%)
Query: 89 CDCSSQNGTVCHITQLKVYALNVVGVIPDELWNLTSLFNLNLGQNYLTGPLSPSVGNLTA 148
CD S++ T IP L ++ +L+L N +T +
Sbjct: 10 CDGRSRS-----FTS-----------IPSGL--TAAMKSLDLSFNKITYIGHGDLRACAN 51
Query: 149 MQYLNLAINALSGELPKE-LGQLTELLILGIGTNNFSGPLPSELGSLSKLQELYIDSAG- 206
+Q L L + ++ + + L L L + N+ S S G LS L+ L +
Sbjct: 52 LQVLILKSSRIN-TIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPY 110
Query: 207 VSGEIPSSFANLQSLTKWWASDTRLTGRIP-DFIGNWSKLTALRFQGNSFNGPIPSSFSN 265
+ + S F NL +L + I + L L + S S +
Sbjct: 111 QTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKS 170
Query: 266 LTSVTELRISDLSNGSSKLAFIRDMKSLSILELRNNNISDSIPSNIGEYRSLQHLDLSFN 325
+ + L + + F + S+ LELR+ N++ S + +
Sbjct: 171 IRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAF 230
Query: 326 NLG-------GSIPDSLFNLSSLTHLFLGNNKLNGTLPARKSPL-------------LLN 365
+ L + L+ + + LNG S +
Sbjct: 231 RGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRR 290
Query: 366 IDVSYNNLQGNLPSWINGQQNLQ-INLVANNLT 397
+ + L +L + + + ++ I + + +
Sbjct: 291 LHIPQFYLFYDLSTVYSLLEKVKRITVENSKVF 323
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 97.5 bits (243), Expect = 4e-21
Identities = 49/256 (19%), Positives = 105/256 (41%), Gaps = 9/256 (3%)
Query: 152 LNLAINALSGELPKELGQLTELLILGIGTNNFSGPLPSELGSLSKLQELYIDSAGVSGEI 211
+ + + +P L + L + N + +L + + LQ L + S+ ++
Sbjct: 10 CDGRSRSFT-SIPSGL--TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIE 66
Query: 212 PSSFANLQSLTKWWASDTRLTGRIPDFIGNWSKLTALRFQGNSFNG-PIPSSFSNLTSVT 270
+F +L SL SD L+ + G S L L GN + + S F NLT++
Sbjct: 67 GDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQ 126
Query: 271 ELRISDLSNGSSKL--AFIRDMKSLSILELRNNNISDSIPSNIGEYRSLQHLDLSFNNLG 328
LRI + S++ + SL+ LE++ ++ + ++ R + HL L +
Sbjct: 127 TLRIGN-VETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSES- 184
Query: 329 GSIPDSLFN-LSSLTHLFLGNNKLNGTLPARKSPLLLNIDVSYNNLQGNLPSWINGQQNL 387
+ + + LSS+ +L L + L + ++ + +G++ + + + L
Sbjct: 185 AFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELL 244
Query: 388 QINLVANNLTIRSSDN 403
++ L+ D+
Sbjct: 245 KLLRYILELSEVEFDD 260
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 97.5 bits (243), Expect = 5e-21
Identities = 47/239 (19%), Positives = 86/239 (35%), Gaps = 19/239 (7%)
Query: 121 NLTSLFNLNLGQNYLTGPLSPSVGNLTAMQYLNLAINALSGELPKELGQ-LTELLILGIG 179
++ L++ Q YL LS L ++ + + + + +P Q L L L +
Sbjct: 284 ETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVF-LVPCSFSQHLKSLEFLDLS 342
Query: 180 TNNFS---GPLPSELGSLSKLQELYIDSAGVS--GEIPSSFANLQSLTKWWASDTRLTGR 234
N + G+ LQ L + + + L++LT S
Sbjct: 343 ENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-P 401
Query: 235 IPDFIGNWSKLTALRFQGNSFNGPIPSSFSNLTSVTELRISDLSNGSSKLAFIRDMKSLS 294
+PD K+ L L + D+SN + +F + L
Sbjct: 402 MPDSCQWPEKMRFLNLSSTGIRVVKTCIPQTLEVL------DVSNNNLD-SFSLFLPRLQ 454
Query: 295 ILELRNNNISDSIPSNIGEYRSLQHLDLSFNNLGGSIPDSLF-NLSSLTHLFLGNNKLN 352
L + N + ++P + L + +S N L S+PD +F L+SL ++L N +
Sbjct: 455 ELYISRNKLK-TLPDASL-FPVLLVMKISRNQL-KSVPDGIFDRLTSLQKIWLHTNPWD 510
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 8e-24
Identities = 62/262 (23%), Positives = 104/262 (39%), Gaps = 37/262 (14%)
Query: 658 IVRRRKRPQHDDDEELLGMDARPYTFSYAELKTATENFSPSN---------KLGEGGFGP 708
+ + ++RP +++ E L +R F + +L ++ P LG G G
Sbjct: 92 VGKGKRRPLNNNSEIALS-LSRNKVFVFFDLTVDDQSVYPKALRDEYIMSKTLGSGACGE 150
Query: 709 VYKGK-LGDGRAIAVKQLS--------VASRQGKSQFVAEIATISAVQHRNLVKLHGCCI 759
V + +A++ +S EI + + H ++K+
Sbjct: 151 VKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNF-F 209
Query: 760 EGAERLLVYEYLENKSLDQALFGQRSLTLDWATR--YEICSGVARGLAYLHEESRVRIIH 817
+ + +V E +E L + G + L Y++ V YLHE IIH
Sbjct: 210 DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQ----YLHEN---GIIH 262
Query: 818 RDVKASNVLL---DADLVPKISDFGLAKLYDDKKTHISTRVAGTIGYLAPE---YAMRGH 871
RD+K NVLL + D + KI+DFG +K+ + + T GT YLAPE
Sbjct: 263 RDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL-MRTLC-GTPTYLAPEVLVSVGTAG 320
Query: 872 LTEKTDVFAFGVLALETVSGRP 893
D ++ GV+ +SG P
Sbjct: 321 YNRAVDCWSLGVILFICLSGYP 342
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 1e-23
Identities = 63/208 (30%), Positives = 98/208 (47%), Gaps = 14/208 (6%)
Query: 692 TENFSPSNKLGEGGFGPVYKGK-LGDGRAIAVKQLSVASRQGK--SQFVAEIATISAVQH 748
E ++ LG+G FG V K K + AVK ++ AS + K S + E+ + + H
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 749 RNLVKLHGCCIEGAERLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLH 808
N++KL + + +V E L + ++ + A R I V G+ Y+H
Sbjct: 81 PNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAAR--IIKQVFSGITYMH 138
Query: 809 EESRVRIIHRDVKASNVLL---DADLVPKISDFGLAKLYDDKKTHISTRVAGTIGYLAPE 865
+ I+HRD+K N+LL + D KI DFGL+ + GT Y+APE
Sbjct: 139 KH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM--KDRIGTAYYIAPE 193
Query: 866 YAMRGHLTEKTDVFAFGVLALETVSGRP 893
+RG EK DV++ GV+ +SG P
Sbjct: 194 -VLRGTYDEKCDVWSAGVILYILLSGTP 220
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 1e-23
Identities = 52/213 (24%), Positives = 94/213 (44%), Gaps = 21/213 (9%)
Query: 692 TENFSPSNKLGEGGFGPVYKGK-LGDGRAIAVKQLSVASRQGKSQFVA-EIATISAVQHR 749
+ F KLG G FG V+ + G +K ++ Q + + EI + ++ H
Sbjct: 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHP 80
Query: 750 NLVKLHGCCIEGAERLLVYEYLENKSL----DQALFGQRSLTLDWATRY--EICSGVARG 803
N++K+ + +V E E L A ++L+ + ++ + +A
Sbjct: 81 NIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALA-- 138
Query: 804 LAYLHEESRVRIIHRDVKASNVLL---DADLVPKISDFGLAKLYDDKKTHISTRVAGTIG 860
Y H + ++H+D+K N+L KI DFGLA+L+ + T AGT
Sbjct: 139 --YFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHS--TNAAGTAL 191
Query: 861 YLAPEYAMRGHLTEKTDVFAFGVLALETVSGRP 893
Y+APE + +T K D+++ GV+ ++G
Sbjct: 192 YMAPE-VFKRDVTFKCDIWSAGVVMYFLLTGCL 223
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 1e-23
Identities = 40/202 (19%), Positives = 81/202 (40%), Gaps = 20/202 (9%)
Query: 692 TENFSPSNKLGEGGFGPVYKGK-LGDGRAIAVKQLSVASRQGKSQFVAEIATISAVQHRN 750
E + + LG G FG V++ + K + V + EI+ ++ +HRN
Sbjct: 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKV-KGTDQVLVKKEISILNIARHRN 62
Query: 751 LVKLHGCCIEGAERLLVYEYLENKSL-DQALFGQRSLTLDWATRY--EICSGVARGLAYL 807
++ LH E ++++E++ + ++ L Y ++C + +L
Sbjct: 63 ILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEAL----QFL 118
Query: 808 HEESRVRIIHRDVKASNVLL----DADLVPKISDFGLAKLYDDKKTHISTRVAGTIGYLA 863
H + I H D++ N++ + + KI +FG A+ + Y A
Sbjct: 119 HSHN---IGHFDIRPENIIYQTRRSSTI--KIIEFGQARQLKPGDNF--RLLFTAPEYYA 171
Query: 864 PEYAMRGHLTEKTDVFAFGVLA 885
PE ++ TD+++ G L
Sbjct: 172 PEVHQHDVVSTATDMWSLGTLV 193
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 1e-23
Identities = 52/209 (24%), Positives = 88/209 (42%), Gaps = 26/209 (12%)
Query: 692 TENFSPSNKLGEGGFGPVYKGK-LGDGRAIAVKQLSVASRQGKSQFVA------EIATIS 744
+ + +LG G F V K + G A K + + + V E++ +
Sbjct: 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILR 70
Query: 745 AVQHRNLVKLHGCCIEGAERLLVYEYLENKSLDQALFGQRSLTLDWATRY--EICSGVAR 802
V H N++ LH + +L+ E + L L + SL+ + AT + +I GV
Sbjct: 71 QVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVN- 129
Query: 803 GLAYLHEESRVRIIHRDVKASNVLL------DADLVPKISDFGLAKLYDDKKTHISTRVA 856
YLH + I H D+K N++L + K+ DFGLA +D +
Sbjct: 130 ---YLHTKK---IAHFDLKPENIMLLDKNIPIPHI--KLIDFGLAHEIEDGVEF--KNIF 179
Query: 857 GTIGYLAPEYAMRGHLTEKTDVFAFGVLA 885
GT ++APE L + D+++ GV+
Sbjct: 180 GTPEFVAPEIVNYEPLGLEADMWSIGVIT 208
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-23
Identities = 52/209 (24%), Positives = 89/209 (42%), Gaps = 26/209 (12%)
Query: 692 TENFSPSNKLGEGGFGPVYKGK-LGDGRAIAVKQLSVASRQGKSQFVA------EIATIS 744
+ + +LG G F V K + G A K + + + V+ E++ +
Sbjct: 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILR 70
Query: 745 AVQHRNLVKLHGCCIEGAERLLVYEYLENKSLDQALFGQRSLTLDWATRY--EICSGVAR 802
V H N++ LH + +L+ E + L L + SL+ + AT + +I GV
Sbjct: 71 QVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVN- 129
Query: 803 GLAYLHEESRVRIIHRDVKASNVLL------DADLVPKISDFGLAKLYDDKKTHISTRVA 856
YLH + I H D+K N++L + K+ DFGLA +D +
Sbjct: 130 ---YLHTKK---IAHFDLKPENIMLLDKNIPIPHI--KLIDFGLAHEIEDGVEF--KNIF 179
Query: 857 GTIGYLAPEYAMRGHLTEKTDVFAFGVLA 885
GT ++APE L + D+++ GV+
Sbjct: 180 GTPEFVAPEIVNYEPLGLEADMWSIGVIT 208
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 3e-23
Identities = 49/200 (24%), Positives = 83/200 (41%), Gaps = 16/200 (8%)
Query: 700 KLGEGGFGPVYKGK-LGDGRAIAVKQLSVASRQGKSQFVAEIATISAVQHRNLVKLHGCC 758
+G G +G V G A K++ + +F EI + ++ H N+++L+
Sbjct: 16 TIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETF 75
Query: 759 IEGAERLLVYEYLENKSLDQALFGQRSLTLDWATRY--EICSGVARGLAYLHEESRVRII 816
+ + LV E L + + +R A R ++ S V AY H+ +
Sbjct: 76 EDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAV----AYCHKL---NVA 128
Query: 817 HRDVKASNVLL---DADLVPKISDFGLAKLYDDKKTHISTRVAGTIGYLAPEYAMRGHLT 873
HRD+K N L D K+ DFGLA + K GT Y++P+ + G
Sbjct: 129 HRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMM--RTKVGTPYYVSPQ-VLEGLYG 185
Query: 874 EKTDVFAFGVLALETVSGRP 893
+ D ++ GV+ + G P
Sbjct: 186 PECDEWSAGVMMYVLLCGYP 205
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 4e-23
Identities = 53/181 (29%), Positives = 93/181 (51%), Gaps = 9/181 (4%)
Query: 690 TATENFSPSNKLGEGGFGPVYKGK-LGDGRAIAVKQLSVASRQGK-SQFVAEIATISAVQ 747
+++ F KLG G + VYKG G +A+K++ + S +G S + EI+ + ++
Sbjct: 2 SSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELK 61
Query: 748 HRNLVKLHGCCIEGAERLLVYEYLEN---KSLDQALFGQRSLTLDWATRYEICSGVARGL 804
H N+V+L+ + LV+E+++N K +D G L+ + +GL
Sbjct: 62 HENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGL 121
Query: 805 AYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVAGTIGYLAP 864
A+ HE +I+HRD+K N+L++ K+ DFGLA+ + S+ V T+ Y AP
Sbjct: 122 AFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVV-TLWYRAP 177
Query: 865 E 865
+
Sbjct: 178 D 178
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 4e-23
Identities = 56/333 (16%), Positives = 109/333 (32%), Gaps = 85/333 (25%)
Query: 693 ENFSPSNKLGEGGFGPVYKGK-LGDGRAIAVKQLSVASRQGKSQFVA-EIATISAVQHRN 750
+F P +G GGFG V++ K D A+K++ + +R+ + V E+ ++ ++H
Sbjct: 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 65
Query: 751 LVKLHGCCIEGAERLLVYEYLENKSLDQALFGQRSLTLDWATRY---------------- 794
+V+ +E E E D++ S
Sbjct: 66 IVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVG 125
Query: 795 ---------------EICSG-------VARGLAYLHEESRVR-----------------I 815
++C R E +
Sbjct: 126 QLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGL 185
Query: 816 IHRDVKASNVLLDADLVPKISDFGLAKL----YDDKKTHIS-------TRVAGTIGYLAP 864
+HRD+K SN+ D V K+ DFGL +++ T GT Y++P
Sbjct: 186 MHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSP 245
Query: 865 EYAMRGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEIELAD 924
E + + K D+F+ G++ E + S E++ ++ + + ++
Sbjct: 246 EQIHGNNYSHKVDIFSLGLILFELLYS-----FSTQMERVRII-------TDVRNLKF-- 291
Query: 925 PKLIEFNEEEVKRLIGVALLCTQTLPSLRPSMS 957
P L + ++ P+ RP +
Sbjct: 292 PLLFTQKYPQEHMMV---QDMLSPSPTERPEAT 321
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 98.8 bits (247), Expect = 8e-23
Identities = 53/209 (25%), Positives = 93/209 (44%), Gaps = 26/209 (12%)
Query: 692 TENFSPSNKLGEGGFGPVYKGK-LGDGRAIAVKQLSVASRQGKSQFVA------EIATIS 744
+++ +LG G F V K + G G+ A K + + V+ E+ +
Sbjct: 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILR 63
Query: 745 AVQHRNLVKLHGCCIEGAERLLVYEYLENKSLDQALFGQRSLTLDWATRY--EICSGVAR 802
++H N++ LH + +L+ E + L L + SLT D AT++ +I GV
Sbjct: 64 EIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVH- 122
Query: 803 GLAYLHEESRVRIIHRDVKASNVLL------DADLVPKISDFGLAKLYDDKKTHISTRVA 856
YLH + RI H D+K N++L + + K+ DFG+A + +
Sbjct: 123 ---YLHSK---RIAHFDLKPENIMLLDKNVPNPRI--KLIDFGIAHKIEAGNEF--KNIF 172
Query: 857 GTIGYLAPEYAMRGHLTEKTDVFAFGVLA 885
GT ++APE L + D+++ GV+
Sbjct: 173 GTPEFVAPEIVNYEPLGLEADMWSIGVIT 201
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 8e-23
Identities = 63/304 (20%), Positives = 94/304 (30%), Gaps = 45/304 (14%)
Query: 89 CDCSSQNGTV-CHITQLKVYALNVVGVIPDEL-WNLTSLFNLNLGQNYLTGPLSPSV-GN 145
C C + V C LK +P E+ + T L +L N ++ L
Sbjct: 31 CHCHLR--VVQCSDLGLKA--------VPKEISPDTTLL---DLQNNDISE-LRKDDFKG 76
Query: 146 LTAMQYLNLAINALSGELPKELGQLTELLILGIGTNNFSGPLPSELGSLSKLQELYIDSA 205
L + L L N +S K L +L L I N+ +P L S L EL I
Sbjct: 77 LQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNHLVE-IPPNL--PSSLVELRIHDN 133
Query: 206 GVSGEIPSSFANLQSLTKWWASDTRLT-GRIPDFIGNWSKLTALRFQGNSFNGPIPSSFS 264
+ F+ L+++ L + KL LR G
Sbjct: 134 RIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLTGIPKDLPE 193
Query: 265 NLTSVTEL-----RISDLSNGSSKLAFIRDMKSLSILELRNNNISDSIPSNI-GEYRSLQ 318
L EL +I + L L L +N I I + +L+
Sbjct: 194 TLN---ELHLDHNKIQAIELE----DL-LRYSKLYRLGLGHNQIR-MIENGSLSFLPTLR 244
Query: 319 HLDLSFNNLGGSIPDSLFNLSSLTHLFLGNNKLN--------GTLPARKSPLLLNIDVSY 370
L L N L +P L +L L ++L N + K I +
Sbjct: 245 ELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGISLFN 303
Query: 371 NNLQ 374
N +
Sbjct: 304 NPVP 307
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 2e-20
Identities = 53/273 (19%), Positives = 91/273 (33%), Gaps = 50/273 (18%)
Query: 116 PDELWNLTSLFNLNLGQNYLTGPLSPSV-GNLTAMQYLNLAINALSGELPKELGQLTELL 174
D+ L L+ L L N ++ + L +Q L ++ N L E+P L + L+
Sbjct: 71 KDDFKGLQHLYALVLVNNKISK-IHEKAFSPLRKLQKLYISKNHLV-EIPPNL--PSSLV 126
Query: 175 ILGIGTNNFSGPLPSELGSLSKLQELY-----IDSAGVSGEIPSSFANLQSLTKWWASDT 229
L I N L + + ++++G P +F L L S+
Sbjct: 127 ELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFE---PGAFDGL-KLNYLRISEA 182
Query: 230 RLTGRIPDFIGNWSKLTALRFQGNSFNGPIPSSFSNLTSVTEL-----RISDLSNGS--- 281
+LT IP L L N + + L +I + NGS
Sbjct: 183 KLT-GIPK--DLPETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSF 239
Query: 282 -SKL--------------AFIRDMKSLSILELRNNNISDSIPSNI-------GEYRSLQH 319
L A + D+K L ++ L NNI+ + N +
Sbjct: 240 LPTLRELHLDNNKLSRVPAGLPDLKLLQVVYLHTNNIT-KVGVNDFCPVGFGVKRAYYNG 298
Query: 320 LDLSFNNLG-GSIPDSLF-NLSSLTHLFLGNNK 350
+ L N + + + F ++ + GN K
Sbjct: 299 ISLFNNPVPYWEVQPATFRCVTDRLAIQFGNYK 331
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 103 bits (257), Expect = 8e-23
Identities = 45/298 (15%), Positives = 86/298 (28%), Gaps = 48/298 (16%)
Query: 115 IPDELW----NLTSLFNLNLGQNYLTGPLSPSVGNLTAMQYLNLAINALSGELPKELGQL 170
+ + +N + L L LS LP L
Sbjct: 25 TYADYFSAWDKWEKQALPGENRNEAVS--LLKECLINQFSELQLNRLNLS-SLPDNLPP- 80
Query: 171 TELLILGIGTNNFSGPLPSELGSLSKLQELYIDSAGVSG----EIPSSFANLQSLTKWWA 226
++ +L I N LP SL L +P A+L+ L
Sbjct: 81 -QITVLEITQNALI-SLPELPASLEYLD--------ACDNRLSTLPELPASLKHL---DV 127
Query: 227 SDTRLTGRIPDFIGNWSKLTALRFQGNSFNGPIPSSFSNLTSVTELRISDLSNGSSKLAF 286
+ +LT +P+ L + N +P ++L L + + +L F
Sbjct: 128 DNNQLT-MLPELPAL---LEYINADNNQLTM-LPELPTSLE---VLSVRNN-----QLTF 174
Query: 287 IRD-MKSLSILELRNNNISDSIPSNIGEYRSLQ----HLDLSFNNLGGSIPDSLFNLSSL 341
+ + +SL L++ N + S+P+ + N + IP+++ +L
Sbjct: 175 LPELPESLEALDVSTNLLE-SLPAVPVRNHHSEETEIFFRCRENRIT-HIPENILSLDPT 232
Query: 342 THLFLGNNKLNGTLPARKSPLLLNIDVSYNNLQG--NLPSWINGQQNLQINLVANNLT 397
+ L +N L+ + + N + V
Sbjct: 233 CTIILEDNPLS-SRIRESLSQQTAQPDYHGPRIYFSMSDGQQNTLHRPLADAVTAWFP 289
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 1e-22
Identities = 52/279 (18%), Positives = 96/279 (34%), Gaps = 27/279 (9%)
Query: 110 NVVGVIPDELWNLTSLFNLNLGQNYLTGPLSPSVGNLTAMQYLNLAINALSGELPKELGQ 169
V ++ + L + L L + L+ L ++ + L + NAL LP+
Sbjct: 48 EAVSLLKECL--INQFSELQLNRLNLSS-LPDNLP--PQITVLEITQNALI-SLPELPAS 101
Query: 170 LTELLILGIGTNNFSGPLPSELGSLSKLQELYIDSAGVSGEIPSSFANLQSLTKWWASDT 229
L L N S LP SL + L +D+ ++ +P A L+ + A +
Sbjct: 102 LEYLDACD---NRLST-LPELPASL---KHLDVDNNQLT-MLPELPALLEYI---NADNN 150
Query: 230 RLTGRIPDFIGNWSKLTALRFQGNSFNGPIPSSFSNLT--SVTELRISDLSNGSSKLAFI 287
+LT +P+ + L L + N +P +L V+ + L +
Sbjct: 151 QLT-MLPELPTS---LEVLSVRNNQLTF-LPELPESLEALDVSTNLLESLPAVPVRNHHS 205
Query: 288 RDMKSLSILELRNNNISDSIPSNIGEYRSLQHLDLSFNNLGGSIPDSLFNLSSLTHLFLG 347
++ R N I+ IP NI + L N L I +SL ++
Sbjct: 206 E--ETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGP 262
Query: 348 NNKLNGTLPARKSPLLLNIDVSYNNLQGNLPSWINGQQN 386
+ + + + D N S ++ +
Sbjct: 263 RIYFSMSDGQQNTLHRPLADAVTAWFPENKQSDVSQIWH 301
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 98.8 bits (247), Expect = 8e-23
Identities = 59/200 (29%), Positives = 95/200 (47%), Gaps = 18/200 (9%)
Query: 692 TENFSPSNKLGEGGFGPVYKGK-LGDGRAIAVKQLSVASRQGK--SQFVAEIATISAVQH 748
E ++ LG+G FG V K K + AVK ++ AS + K S + E+ + + H
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 749 RNLVKLHGCCIEGAERLLVYEYLENKSLDQALFGQRSLTLDWATRY--EICSGVARGLAY 806
N++KL + + +V E L + ++ + A R ++ SG+ Y
Sbjct: 81 PNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGIT----Y 136
Query: 807 LHEESRVRIIHRDVKASNVLL---DADLVPKISDFGLAKLYDDKKTHISTRVAGTIGYLA 863
+H+ + I+HRD+K N+LL + D KI DFGL+ + GT Y+A
Sbjct: 137 MHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM--KDRIGTAYYIA 191
Query: 864 PEYAMRGHLTEKTDVFAFGV 883
PE +RG EK DV++ GV
Sbjct: 192 PE-VLRGTYDEKCDVWSAGV 210
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 1e-22
Identities = 57/219 (26%), Positives = 94/219 (42%), Gaps = 25/219 (11%)
Query: 692 TENFSPSNKLGEGGFGPVYKGK-LGDGRAIAVKQLS-------------VASRQGKSQFV 737
E++ KLG G +G V K A+K + + +
Sbjct: 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIY 94
Query: 738 AEIATISAVQHRNLVKLHGCCIEGAERLLVYEYLENKSLDQALFGQRSLTLDWATRYEIC 797
EI+ + ++ H N++KL + LV E+ E L + + + A I
Sbjct: 95 NEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAA--NIM 152
Query: 798 SGVARGLAYLHEESRVRIIHRDVKASNVLL---DADLVPKISDFGLAKLYDDKKTHISTR 854
+ G+ YLH+ + I+HRD+K N+LL ++ L KI DFGL+ + K +
Sbjct: 153 KQILSGICYLHKHN---IVHRDIKPENILLENKNSLLNIKIVDFGLSSFF--SKDYKLRD 207
Query: 855 VAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRP 893
GT Y+APE ++ EK DV++ GV+ + G P
Sbjct: 208 RLGTAYYIAPE-VLKKKYNEKCDVWSCGVIMYILLCGYP 245
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 1e-22
Identities = 47/184 (25%), Positives = 82/184 (44%), Gaps = 24/184 (13%)
Query: 700 KLGEGGFGPVYKGK---LGDGRAIAVKQLSVASRQGKSQFVAEIATISAVQHRNLVKLHG 756
K+G G +G VYK K D + A+KQ+ + EIA + ++H N++ L
Sbjct: 28 KVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSA--CREIALLRELKHPNVISLQK 85
Query: 757 CCIEGAERL--LVYEYLEN---KSLDQALFGQRSLTLDWATRYEICSGVA---RGLAYLH 808
+ A+R L+++Y E+ + + + R + S + G+ YLH
Sbjct: 86 VFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH 145
Query: 809 EESRVRIIHRDVKASNVLLDADLVP----KISDFGLAKLYDD---KKTHISTRVAGTIGY 861
++HRD+K +N+L+ + KI+D G A+L++ + V T Y
Sbjct: 146 AN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV-TFWY 201
Query: 862 LAPE 865
APE
Sbjct: 202 RAPE 205
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 98.0 bits (245), Expect = 2e-22
Identities = 51/196 (26%), Positives = 84/196 (42%), Gaps = 12/196 (6%)
Query: 692 TENFSPSNKLGEGGFGPVYKGK-LGDGRAIAVKQLSVASRQGKSQFVAEIATISAVQHRN 750
+ F LG G F V+ K G+ A+K + + S EIA + ++H N
Sbjct: 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHEN 67
Query: 751 LVKLHGCCIEGAERLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEE 810
+V L LV + + L + + T A+ + V + YLHE
Sbjct: 68 IVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDAS--LVIQQVLSAVKYLHEN 125
Query: 811 SRVRIIHRDVKASNVLL---DADLVPKISDFGLAKLYDDKKTHISTRVAGTIGYLAPEYA 867
I+HRD+K N+L + + I+DFGL+K+ + + GT GY+APE
Sbjct: 126 ---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIM---STACGTPGYVAPEVL 179
Query: 868 MRGHLTEKTDVFAFGV 883
+ ++ D ++ GV
Sbjct: 180 AQKPYSKAVDCWSIGV 195
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 3e-22
Identities = 54/209 (25%), Positives = 89/209 (42%), Gaps = 26/209 (12%)
Query: 692 TENFSPSNKLGEGGFGPVYKGK-LGDGRAIAVKQLSVASRQGKSQFVA------EIATIS 744
+ + +LG G F V K + G A K + + + V+ E++ +
Sbjct: 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69
Query: 745 AVQHRNLVKLHGCCIEGAERLLVYEYLENKSLDQALFGQRSLTLDWATRY--EICSGVAR 802
+QH N++ LH + +L+ E + L L + SLT + AT + +I +GV
Sbjct: 70 EIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVY- 128
Query: 803 GLAYLHEESRVRIIHRDVKASNVLL------DADLVPKISDFGLAKLYDDKKTHISTRVA 856
YLH I H D+K N++L + KI DFGLA D +
Sbjct: 129 ---YLHSLQ---IAHFDLKPENIMLLDRNVPKPRI--KIIDFGLAHKIDFGNEF--KNIF 178
Query: 857 GTIGYLAPEYAMRGHLTEKTDVFAFGVLA 885
GT ++APE L + D+++ GV+
Sbjct: 179 GTPEFVAPEIVNYEPLGLEADMWSIGVIT 207
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 3e-22
Identities = 67/273 (24%), Positives = 109/273 (39%), Gaps = 49/273 (17%)
Query: 116 PDELWNLTSLFNLNLGQNYLTGPLSPSV-GNLTAMQYLNLAINALSGELPKELGQLTELL 174
+ NL +L L L N ++ +SP L ++ L L+ N L ELP+++ L
Sbjct: 69 DGDFKNLKNLHTLILINNKISK-ISPGAFAPLVKLERLYLSKNQLK-ELPEKM--PKTLQ 124
Query: 175 ILGIGTNNFSGPLPSELGSLSKLQELY-----IDSAGVSGEIPSSFANLQSLTKWWASDT 229
L + N + S L+++ + + S+G+ +F ++ L+ +DT
Sbjct: 125 ELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIE---NGAFQGMKKLSYIRIADT 181
Query: 230 RLTGRIPDFIGNWSKLTALRFQGNSFNGPIPSSFSNLTSVTEL-----RISDLSNGS--- 281
+T IP G LT L GN +S L ++ +L IS + NGS
Sbjct: 182 NIT-TIPQ--GLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLAN 238
Query: 282 -----------SKLAFI----RDMKSLSILELRNNNISDSIPSN-------IGEYRSLQH 319
+KL + D K + ++ L NNNIS +I SN + S
Sbjct: 239 TPHLRELHLNNNKLVKVPGGLADHKYIQVVYLHNNNIS-AIGSNDFCPPGYNTKKASYSG 297
Query: 320 LDLSFNNLG-GSIPDSLF-NLSSLTHLFLGNNK 350
+ L N + I S F + + LGN K
Sbjct: 298 VSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNYK 330
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 1e-19
Identities = 54/273 (19%), Positives = 101/273 (36%), Gaps = 34/273 (12%)
Query: 147 TAMQYLNLAINALSGELPKELGQLTELLILGIGTNNFSGPLPSELGSLSKLQELYIDSAG 206
L+L N ++ + L L L + N S P L KL+ LY+
Sbjct: 52 PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQ 111
Query: 207 VSGEIPSS-FANLQSLTKWWASDTRLTGRIPDFIGNWSKLTALRF---QGNSF-NGPIPS 261
+ E+P LQ L + +T ++ ++ L + N + I +
Sbjct: 112 LK-ELPEKMPKTLQEL---RVHENEIT-KVRK--SVFNGLNQMIVVELGTNPLKSSGIEN 164
Query: 262 -SFSNLTSVTELRISDLSNGSSKLAFIRD--MKSLSILELRNNNISDSIPSNI-GEYRSL 317
+F + ++ +RI+D + I SL+ L L N I+ + + +L
Sbjct: 165 GAFQGMKKLSYIRIAD--T---NITTIPQGLPPSLTELHLDGNKIT-KVDAASLKGLNNL 218
Query: 318 QHLDLSFNNLGGSIPDSLF-NLSSLTHLFLGNNKLNGTLPA--RKSPLLLNIDVSYNNLQ 374
L LSFN++ ++ + N L L L NNKL +P + + + NN+
Sbjct: 219 AKLGLSFNSI-SAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNIS 276
Query: 375 G------NLPSWINGQQNLQ-INLVANNLTIRS 400
P + + + ++L +N +
Sbjct: 277 AIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWE 309
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 7e-22
Identities = 45/200 (22%), Positives = 83/200 (41%), Gaps = 18/200 (9%)
Query: 692 TENFSPSNKLGEGGFGPVYKG-KLGDGRAIAVKQLSVASRQGKSQFVAEIATI-SAVQHR 749
T+ + +G G + + AVK + + R EI + QH
Sbjct: 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTE----EIEILLRYGQHP 76
Query: 750 NLVKLHGCCIEGAERLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHE 809
N++ L +G +V E ++ L + Q+ + A+ + + + + YLH
Sbjct: 77 NIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASA--VLFTITKTVEYLHA 134
Query: 810 ESRVRIIHRDVKASNVLL-----DADLVPKISDFGLAKLYDDKKTHISTRVAGTIGYLAP 864
+ ++HRD+K SN+L + + + +I DFG AK + + T T ++AP
Sbjct: 135 Q---GVVHRDLKPSNILYVDESGNPESI-RICDFGFAKQLRAENGLLMTPC-YTANFVAP 189
Query: 865 EYAMRGHLTEKTDVFAFGVL 884
E R D+++ GVL
Sbjct: 190 EVLERQGYDAACDIWSLGVL 209
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 99.6 bits (248), Expect = 9e-22
Identities = 57/285 (20%), Positives = 102/285 (35%), Gaps = 25/285 (8%)
Query: 120 WNLTSLFNLNLGQNYLTGPLSPSVGNLTAMQYLNLAINALSGELPKELG-----QLTELL 174
+ +L N+ N L T + Y +++ L G+L L L
Sbjct: 222 LSNLTLNNIETTWNSFIRILQLV--WHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALS 279
Query: 175 ILGIGTNNFSGPLPSELGSLSKLQELYIDSAGVSGEIPSSFANLQSLTKWWASDTRLTGR 234
I + ++ F P S + +G + + S+ LT
Sbjct: 280 IHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDT 339
Query: 235 IPDFIGNWSKLTALRFQGNSFN--GPIPSSFSNLTSVTELRISD--LSNGSSKLAFIRDM 290
+ + G+ ++L L Q N I + + S+ +L IS +S K
Sbjct: 340 VFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSW-T 398
Query: 291 KSLSILELRNNNISDSIPSNIGEYRSLQHLDLSFNNLGGSIPDSLFNLSSLTHLFLGNNK 350
KSL L + +N ++D+I + ++ LDL N + SIP + L +L L + +N+
Sbjct: 399 KSLLSLNMSSNILTDTIFRCLP--PRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQ 455
Query: 351 LNGTLPA---RKSPLLLNIDVSYN------NLQGNLPSWINGQQN 386
L ++P + L I + N L W+N
Sbjct: 456 LK-SVPDGIFDRLTSLQKIWLHTNPWDCSCPRIDYLSRWLNKNSQ 499
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 79.9 bits (197), Expect = 2e-15
Identities = 37/296 (12%), Positives = 96/296 (32%), Gaps = 25/296 (8%)
Query: 114 VIPDELWNLTSLFNLNLGQNYLTGPLSPSVGNLTAMQYLNLAINALSGELPKELGQLTEL 173
++ L +L + T + +++ NL ++ + L
Sbjct: 152 GEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLS 211
Query: 174 LILGIGTNNFSGPLPSELGSLSKLQELYIDSAGVSGEIPSSFANLQSLTKWWASDTRLTG 233
++ + TN L + + I ++ + S+ +L G
Sbjct: 212 ILAKLQTNPKLSNLTLNNIETTWNSFIRI----------LQLVWHTTVWYFSISNVKLQG 261
Query: 234 RIPDFIGNWS-----KLTALRFQGNSFNGPIPSSFSNLTSVTELRISDLSNGSSKLAFIR 288
++ ++S L+ + + F P + +++ + +
Sbjct: 262 QLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPS 321
Query: 289 DMKSLSILELRNNNISDSIPSNIGEYRSLQHLDLSFNNLGGSIPD--SLF-NLSSLTHLF 345
+ L+ NN ++D++ N G L+ L L N L + + + SL L
Sbjct: 322 KISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQL-KELSKIAEMTTQMKSLQQLD 380
Query: 346 LGNNKLNGTLPARKSPLLLNI---DVSYNNLQGNLPSWINGQQNLQI-NLVANNLT 397
+ N ++ ++ ++S N L + + +++ +L +N +
Sbjct: 381 ISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCL--PPRIKVLDLHSNKIK 434
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 76.1 bits (187), Expect = 2e-14
Identities = 60/337 (17%), Positives = 109/337 (32%), Gaps = 54/337 (16%)
Query: 89 CDCSSQNGTVCHITQLKVYALNVVGVIPDELWNLTSLFNLNLGQNYLTGPLSPSV-GNLT 147
D S + +P +L LN+ QNY++ L S +L+
Sbjct: 5 VDRSKNG-----LIH-----------VPKDL--SQKTTILNISQNYISE-LWTSDILSLS 45
Query: 148 AMQYLNLAINALSGELPKELGQLTELLILGIGTNNFSGPLPSELGSLSKLQELY-----I 202
++ L ++ N + EL L + N + L+ L
Sbjct: 46 KLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLVK-ISC--HPTVNLKHLDLSFNAF 102
Query: 203 DSAGVSGEIPSSFANLQSLTKWWASDTRLTGRIPDFIGNWSKLTALRFQGNSFNGPI-PS 261
D+ + E F N+ L S T L I + + L G ++ P
Sbjct: 103 DALPICKE----FGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDPE 158
Query: 262 SFSNLTSVTELRISDLSNGSSKLAFIRDMKSLSILELRN---------NNISDSIPSNIG 312
+ L I +N +K+++ LEL N + SI + +
Sbjct: 159 GLQDFN-TESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQ 217
Query: 313 EYRSLQHLDLSFNNLGGSIPDSLFNL---SSLTHLFLGNNKLNGTLPARKSPLL------ 363
L +L L+ + + L +++ + + N KL G L R
Sbjct: 218 TNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKA 277
Query: 364 LNIDVSYNNLQGNLPSWI-NGQQNLQI-NLVANNLTI 398
L+I +++ G S+I N+ I N + +
Sbjct: 278 LSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRM 314
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 59.1 bits (143), Expect = 4e-09
Identities = 43/275 (15%), Positives = 87/275 (31%), Gaps = 22/275 (8%)
Query: 147 TAMQYLNLAINALSGELPKELGQLTELLILGIGTNNFSGPLPSELGSLSKLQELYIDSAG 206
LN++ N +S ++ L++L IL I N S +L+ L +
Sbjct: 21 QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLS--- 77
Query: 207 VSGEIPS-SFANLQSLTKWWASDTRLTGRIPD--FIGNWSKLTALRFQGNSFNGPIPSSF 263
++ S +L S +P GN S+L L
Sbjct: 78 -HNKLVKISCHPTVNLKHLDLSFNAFD-ALPICKEFGNMSQLKFLGLSTTHLEKSSVLPI 135
Query: 264 SNLTSVTELRISDLSNGSSKLAFIRDMKSLSILELRNNNISDSIPSNIGEYRSLQHLDLS 323
++L +++++ + K ++ + L ++ I + +L
Sbjct: 136 AHL-NISKVLLVLGETYGEKEDP-EGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLE 193
Query: 324 FNNLGG-----------SIPDSLFNLSSLTHLFLGNNKLNGTLPARKSPLLLNIDVSYNN 372
+N+ SI L L++L L N + R L+ + V Y +
Sbjct: 194 LSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFS 253
Query: 373 LQGN-LPSWINGQQNLQINLVANNLTIRSSDNSVL 406
+ L ++ + L+I + V
Sbjct: 254 ISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVF 288
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 95.7 bits (238), Expect = 2e-21
Identities = 49/244 (20%), Positives = 78/244 (31%), Gaps = 18/244 (7%)
Query: 169 QLTELLILGIGTNNFSGPLPSELGSLSKLQELYIDSAGVSGEIPSSFANLQ--SLTKWWA 226
L L + + + +S LQEL +++ V+G P L
Sbjct: 69 SLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNL 128
Query: 227 SDTRLTGRIPDF--IGNWSK--LTALRFQGNSFNGPIPSSFSNLTSVTELRISD--LSNG 280
+ R + W K L L +++ L +SD
Sbjct: 129 RNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGE 188
Query: 281 SSKLAFI--RDMKSLSILELRNNN---ISDSIPSNIGEYRSLQHLDLSFNNLGGSIPDSL 335
++ + +L +L LRN S + LQ LDLS N+L +
Sbjct: 189 RGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPS 248
Query: 336 F-NLSSLTHLFLGNNKLNGTLPARKSPLLLNIDVSYNNLQGNLPSWINGQQNLQ-INLVA 393
S L L L L +P L +D+SYN L PS + + ++L
Sbjct: 249 CDWPSQLNSLNLSFTGLK-QVPKGLPAKLSVLDLSYNRLDR-NPS-PDELPQVGNLSLKG 305
Query: 394 NNLT 397
N
Sbjct: 306 NPFL 309
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 90.3 bits (224), Expect = 1e-19
Identities = 48/275 (17%), Positives = 87/275 (31%), Gaps = 44/275 (16%)
Query: 118 ELWNLTSLFNLNLGQNYLTGPLSPS---VGNLTAMQYLNLAINALSGELPKELGQLTELL 174
++ SL L + + + V ++ +Q L L ++G P L + T
Sbjct: 63 DIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPD 122
Query: 175 ILGIGTNNFS-GPLPSELGSLS-----KLQELYIDSAGVSGEIPSSFANLQSLTKWWASD 228
+ + N S + L L L+ L I A +L+ SD
Sbjct: 123 LNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSD 182
Query: 229 TRLTGRIP----DFIGNWSKLTALRFQGNSFN---GPIPSSFSNLTSVTELRISDLSNGS 281
G + L L + G + + + L DLS+
Sbjct: 183 NPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGL---DLSH-- 237
Query: 282 SKLAFIRDMKSLSILELRNNNISDSIPSNIGEY-RSLQHLDLSFNNLGGSIPDSLFNLSS 340
N++ D+ + ++ L L+LSF L +P L +
Sbjct: 238 -------------------NSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGLP--AK 275
Query: 341 LTHLFLGNNKLNGTLPARKSPLLLNIDVSYNNLQG 375
L+ L L N+L+ + P + N+ + N
Sbjct: 276 LSVLDLSYNRLDRNPSPDELPQVGNLSLKGNPFLD 310
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 81.5 bits (201), Expect = 1e-16
Identities = 45/228 (19%), Positives = 73/228 (32%), Gaps = 21/228 (9%)
Query: 118 ELWNLTSLFNLNLGQNYLTGPLSPSVGNLT--AMQYLNLAINALSGELPKELGQL----- 170
+ ++ L L L +TG P + T + LNL + + L +L
Sbjct: 90 RVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWAT-RDAWLAELQQWLK 148
Query: 171 TELLILGIGTNNFSGPLPSELGSLSKLQELYI-------DSAGVSGEIPSSFANLQSLTK 223
L +L I + ++ L L + + +S P F LQ L
Sbjct: 149 PGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLAL 208
Query: 224 WWASDTRLTGRIPDFIGNWSKLTALRFQGNSFNG-PIPSSFSNLTSVTELRISDLSNGSS 282
A +G +L L NS S + + L +S G
Sbjct: 209 RNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLS--FTGLK 266
Query: 283 KLAFIRDMKSLSILELRNNNISDSIPSNIGEYRSLQHLDLSFNNLGGS 330
++ LS+L+L N + PS E + +L L N S
Sbjct: 267 QV-PKGLPAKLSVLDLSYNRLD-RNPS-PDELPQVGNLSLKGNPFLDS 311
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 57.2 bits (138), Expect = 8e-09
Identities = 34/189 (17%), Positives = 58/189 (30%), Gaps = 28/189 (14%)
Query: 254 SFNGPIPSSFSNLTSVTELRISDLSNGSSKLAFIRD-------------MKSLSI--LEL 298
+F+ P P S + + G S ++ +KSLS+ L +
Sbjct: 16 NFSDPKPDWSSAFNCLGAADVELYGGGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTV 75
Query: 299 RNNNISDSIPSNIGE---YRSLQHLDLSFNNLGGSIPDSLFNLS--SLTHLFLGNNKLNG 353
R I I LQ L L + G+ P L + L L L N
Sbjct: 76 RAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWAT 135
Query: 354 ------TLPARKSPLLLNIDVSYNNLQGNLPSWINGQQNLQINLVANNLTI--RSSDNSV 405
L P L + ++ + + L +++N + R +++
Sbjct: 136 RDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISAL 195
Query: 406 LPRGLICLQ 414
P LQ
Sbjct: 196 CPLKFPTLQ 204
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 57.2 bits (138), Expect = 1e-08
Identities = 30/167 (17%), Positives = 52/167 (31%), Gaps = 13/167 (7%)
Query: 100 HITQLKVYALNVVGVIPDELWNLTSLFNLNLGQNYLTGPL----SPSVGNLTAMQYLNLA 155
+ L + + + +++ +L L+L N G + +Q L L
Sbjct: 150 GLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALR 209
Query: 156 ---INALSGELPKELGQLTELLILGIGTNNFSGPLPSELGS-LSKLQELYIDSAGVSGEI 211
+ SG +L L + N+ + S+L L + G+
Sbjct: 210 NAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQVP 269
Query: 212 PSSFANLQSLTKWWASDTRLTGRIPDFIGNWSKLTALRFQGNSFNGP 258
A L L S RL R P ++ L +GN F
Sbjct: 270 KGLPAKLSVLD---LSYNRLD-RNP-SPDELPQVGNLSLKGNPFLDS 311
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 94.9 bits (237), Expect = 2e-21
Identities = 52/202 (25%), Positives = 90/202 (44%), Gaps = 21/202 (10%)
Query: 692 TENFSPSNKLGEGGFGPVYKG-KLGDGRAIAVKQLSVASRQGKSQ--FVAEIATISAVQH 748
++N+ +LG+G F V + G A K ++ + E +QH
Sbjct: 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 749 RNLVKLHGCCIEGAERLLVYEYLENKSLDQALFGQRSLTLDWATRY--EICSGVARGLAY 806
N+V+LH E + LV++ + L + + + + A+ +I +A Y
Sbjct: 65 PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIA----Y 120
Query: 807 LHEESRVRIIHRDVKASNVLL-----DADLVPKISDFGLAKLYDDKKTHISTRVAGTIGY 861
H I+HR++K N+LL A + K++DFGLA +D + AGT GY
Sbjct: 121 CHSN---GIVHRNLKPENLLLASKAKGAAV--KLADFGLAIEVNDSEAW--HGFAGTPGY 173
Query: 862 LAPEYAMRGHLTEKTDVFAFGV 883
L+PE + ++ D++A GV
Sbjct: 174 LSPEVLKKDPYSKPVDIWACGV 195
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 97.9 bits (244), Expect = 2e-21
Identities = 56/297 (18%), Positives = 107/297 (36%), Gaps = 54/297 (18%)
Query: 89 CDCSSQNGTV-CHITQLKVYALNVVGVIPDELWNLTSLFNLNLGQNYLTGPLSPSVGNLT 147
C CS+Q V C L +P + ++ LNL +N + + + +L
Sbjct: 50 CSCSNQFSKVVCTRRGLSE--------VPQGI--PSNTRYLNLMENNIQMIQADTFRHLH 99
Query: 148 AMQYLNLAINALSGELPKELGQLTELLILGIGTNNFSGPLPSELGSLSKLQELYIDSAGV 207
++ L L N++ I F+G L+ L L + +
Sbjct: 100 HLEVLQLGRNSIRQ----------------IEVGAFNG--------LASLNTLELFDNWL 135
Query: 208 SGEIPS-SFANLQSLTKWWASDTRLTGRIPDFIGNWSKLTALRF----QGNSFNGPIPSS 262
+ IPS +F L L + W + + IP ++++ +L + +
Sbjct: 136 T-VIPSGAFEYLSKLRELWLRNNPIE-SIPS--YAFNRVPSLMRLDLGELKKLEYISEGA 191
Query: 263 FSNLTSVTELRISDLSNGSSKLAFIRDMKSLSILELRNNNISDSIPSN-IGEYRSLQHLD 321
F L ++ L + + + + L LE+ N+ I SL+ L
Sbjct: 192 FEGLFNLKYLNLGM--CNIKDMPNLTPLVGLEELEMSGNHFP-EIRPGSFHGLSSLKKLW 248
Query: 322 LSFNNLGGSIPDSLF-NLSSLTHLFLGNNKLNGTLPA---RKSPLLLNIDVSYNNLQ 374
+ + + I + F L+SL L L +N L+ +LP L+ + + +N
Sbjct: 249 VMNSQV-SLIERNAFDGLASLVELNLAHNNLS-SLPHDLFTPLRYLVELHLHHNPWN 303
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 85.6 bits (212), Expect = 1e-17
Identities = 56/229 (24%), Positives = 94/229 (41%), Gaps = 26/229 (11%)
Query: 162 ELPKELGQLTELLILGIGTNNFSGPLPSELGSLSKLQELYIDSAGVSGEIPSSFANLQSL 221
E+P+ + T L L NN L L+ L + + +F L SL
Sbjct: 68 EVPQGIPSNTRYLNLM--ENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASL 125
Query: 222 TKWWASDTRLTGRIPD--FIGNWSKLTALRFQGNSFNGPIPSSFSNLTSVTEL------R 273
D LT IP F SKL L + N +F+ + S+ L +
Sbjct: 126 NTLELFDNWLT-VIPSGAFEYL-SKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKK 183
Query: 274 ISDLSNGSSKLAFIRDMKSLSILELRNNNISDSIPSNIGEYRSLQHLDLSFNNLGGSIPD 333
+ +S G AF + +L L L NI +P+ + L+ L++S N+ I
Sbjct: 184 LEYISEG----AF-EGLFNLKYLNLGMCNIK-DMPN-LTPLVGLEELEMSGNHF-PEIRP 235
Query: 334 SLF-NLSSLTHLFLGNNKLNGTLPA---RKSPLLLNIDVSYNNLQGNLP 378
F LSSL L++ N++++ + L+ +++++NNL +LP
Sbjct: 236 GSFHGLSSLKKLWVMNSQVS-LIERNAFDGLASLVELNLAHNNLS-SLP 282
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 2e-21
Identities = 48/215 (22%), Positives = 84/215 (39%), Gaps = 37/215 (17%)
Query: 692 TENFSPSNKLGEGGFGPVYKGK-LGDGRAIAVKQLSVASRQGKSQFVA-----EIATISA 745
+ + +G+G F V + G+ AVK + VA E +
Sbjct: 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHM 82
Query: 746 VQHRNLVKLHGCCIEGAERLLVYEYLE---------NKSLDQALFGQRSLTLDWATRY-- 794
++H ++V+L +V+E+++ ++ ++ + A+ Y
Sbjct: 83 LKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAV-----ASHYMR 137
Query: 795 EICSGVARGLAYLHEESRVRIIHRDVKASNVLL-----DADLVPKISDFGLAKLYDDKKT 849
+I + Y H+ IIHRDVK VLL A + K+ FG+A +
Sbjct: 138 QILEALR----YCHDN---NIIHRDVKPHCVLLASKENSAPV--KLGGFGVAIQLGESGL 188
Query: 850 HISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVL 884
RV GT ++APE R + DV+ GV+
Sbjct: 189 VAGGRV-GTPHFMAPEVVKREPYGKPVDVWGCGVI 222
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 96.1 bits (240), Expect = 2e-21
Identities = 52/186 (27%), Positives = 90/186 (48%), Gaps = 14/186 (7%)
Query: 687 ELKTATENFSPSNKLGEGGFGPVYKGK-LGDGRAIAVKQLSVASRQGKSQFVA-----EI 740
++K+ + + + LGEG F VYK + + +A+K++ + R + EI
Sbjct: 4 DVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREI 63
Query: 741 ATISAVQHRNLVKLHGCCIEGAERLLVYEYLENKSLD-QALFGQRSLTLDWATRYEICSG 799
+ + H N++ L + LV++++E D + + SL L +
Sbjct: 64 KLLQELSHPNIIGLLDAFGHKSNISLVFDFME---TDLEVIIKDNSLVLTPSHIKAYMLM 120
Query: 800 VARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVAGTI 859
+GL YLH+ I+HRD+K +N+LLD + V K++DFGLAK + + +V T
Sbjct: 121 TLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVV-TR 176
Query: 860 GYLAPE 865
Y APE
Sbjct: 177 WYRAPE 182
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 96.1 bits (239), Expect = 2e-21
Identities = 46/266 (17%), Positives = 77/266 (28%), Gaps = 54/266 (20%)
Query: 679 RPYTFSYAELKTATENFSPSNKLGEGGFGPVYKGK-LGDGRAIAVK-----QLSVASRQG 732
F L + + +G+G +G V A+K ++ + +
Sbjct: 12 ENLYFQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKD 71
Query: 733 KSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLVYEYLENKSL---------------- 776
+ E+ + + H N+ +L+ + LV E L
Sbjct: 72 VERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCA 131
Query: 777 ----------------DQALFGQRSLTLDWATRY------EICSGVARGLAYLHEESRVR 814
+ I + L YLH +
Sbjct: 132 MDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ---G 188
Query: 815 IIHRDVKASNVLL--DADLVPKISDFGLAKLYDDKKTHISTR---VAGTIGYLAPE--YA 867
I HRD+K N L + K+ DFGL+K + AGT ++APE
Sbjct: 189 ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNT 248
Query: 868 MRGHLTEKTDVFAFGVLALETVSGRP 893
K D ++ GVL + G
Sbjct: 249 TNESYGPKCDAWSAGVLLHLLLMGAV 274
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 96.0 bits (239), Expect = 2e-21
Identities = 59/318 (18%), Positives = 107/318 (33%), Gaps = 41/318 (12%)
Query: 89 CDCSSQNGTVCHITQLKVYALNVVGVIPDELWNLTSLFNLNLGQNYLTGPLSPSV-GNLT 147
C L IP L ++ +L+L N +T +S S
Sbjct: 28 LSCDRNGICKGSSGSLNS--------IPSGL--TEAVKSLDLSNNRITY-ISNSDLQRCV 76
Query: 148 AMQYLNLAINALSGELPKEL-GQLTELLILGIGTNNFSGPLPSEL-GSLSKLQELYIDSA 205
+Q L L N ++ + ++ L L L + N S L S LS L L +
Sbjct: 77 NLQALVLTSNGIN-TIEEDSFSSLGSLEHLDLSYNYLSN-LSSSWFKPLSSLTFLNLLGN 134
Query: 206 GVSGEIPSS-FANLQSLTKWWASDTRLTGRIPDFI-GNWSKLTALRFQGNSFNGPIPSSF 263
+S F++L L + +I + L L + P S
Sbjct: 135 PYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSL 194
Query: 264 SNLTSVTELRISDLSNGSSKL--AFIRDMKSLSILELRNNNISDSIPSNI--------GE 313
++ +V+ L + L F+ S+ LELR+ ++ S + +
Sbjct: 195 KSIQNVSHLILH--MKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIK 252
Query: 314 YRSLQHLDLSFNNLGGSIPDSLFNLSSLTHLFLGNNKLNGTLPAR---KSPLLLNIDVSY 370
+ +++ ++ +L + L +S L L N+L ++P + L I +
Sbjct: 253 KFTFRNVKITDESLF-QVMKLLNQISGLLELEFSRNQLK-SVPDGIFDRLTSLQKIWLHT 310
Query: 371 NNLQ------GNLPSWIN 382
N L W+N
Sbjct: 311 NPWDCSCPRIDYLSRWLN 328
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 3e-16
Identities = 51/250 (20%), Positives = 87/250 (34%), Gaps = 34/250 (13%)
Query: 171 TELLILGIGTNNFSGPLPSELGSLSKLQELYIDSAGVSGEIPS-SFANLQSLTKWWASDT 229
+ L + N + S+L LQ L + S G++ I SF++L SL S
Sbjct: 52 EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGIN-TIEEDSFSSLGSLEHLDLSYN 110
Query: 230 RLTGRIPD--FIGNWSKLTALRFQGNSFNG-PIPSSFSNLTSVTEL------RISDLSNG 280
L+ + F S LT L GN + S FS+LT + L + +
Sbjct: 111 YLS-NLSSSWFKPL-SSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRK 168
Query: 281 SSKLAFIRDMKSLSILELRNNNISDSIPSNI-GEYRSLQHLDLSFNNLGGSIPDSLF-NL 338
F + L LE+ +++ S +++ HL L + +
Sbjct: 169 ----DF-AGLTFLEELEIDASDLQ-SYEPKSLKSIQNVSHLILHMKQHI-LLLEIFVDVT 221
Query: 339 SSLTHLFLGNNKLNGT----LPA------RKSPLLLNIDVSYNNLQGNLPSWINGQQNLQ 388
SS+ L L + L+ L K N+ ++ +L + +N L
Sbjct: 222 SSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLF-QVMKLLNQISGLL 280
Query: 389 -INLVANNLT 397
+ N L
Sbjct: 281 ELEFSRNQLK 290
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 94.9 bits (237), Expect = 2e-21
Identities = 55/189 (29%), Positives = 88/189 (46%), Gaps = 34/189 (17%)
Query: 693 ENFSPSNKLGEGGFGPVYKGK-LGDGRAIAVKQL----------SVASRQGKSQFVAEIA 741
ENF K+GEG +G VYK + G +A+K++ S A R EI+
Sbjct: 3 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR--------EIS 54
Query: 742 TISAVQHRNLVKLHGCCIEGAERLLVYEYLEN---KSLDQALFGQRSLTLDWATRY--EI 796
+ + H N+VKL + LV+E+L K +D + L Y ++
Sbjct: 55 LLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDA--SALTGIPLPLIKSYLFQL 112
Query: 797 CSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVA 856
+GLA+ H R++HRD+K N+L++ + K++DFGLA+ + + V
Sbjct: 113 L----QGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV 165
Query: 857 GTIGYLAPE 865
T+ Y APE
Sbjct: 166 -TLWYRAPE 173
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 3e-21
Identities = 49/178 (27%), Positives = 84/178 (47%), Gaps = 14/178 (7%)
Query: 693 ENFSPSNKLGEGGFGPVYKGKLGD-GRAIAVKQLSVASRQGK-SQFVAEIATISAVQHRN 750
E + +KLGEG + VYKGK +A+K++ + +G + E++ + ++H N
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHAN 61
Query: 751 LVKLHGCCIEGAERLLVYEYLEN---KSLDQALFGQRSLTLDWATRYEICSGVARGLAYL 807
+V LH LV+EYL+ + LD ++ + RGLAY
Sbjct: 62 IVTLHDIIHTEKSLTLVFEYLDKDLKQYLDD-----CGNIINMHNVKLFLFQLLRGLAYC 116
Query: 808 HEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVAGTIGYLAPE 865
H + +++HRD+K N+L++ K++DFGLA+ V T+ Y P+
Sbjct: 117 HRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVV-TLWYRPPD 170
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 3e-21
Identities = 54/193 (27%), Positives = 90/193 (46%), Gaps = 28/193 (14%)
Query: 691 ATENFSPSNKLGEGGFGPVYKGK-LGDGRAIAVKQLSV-ASRQGKSQF----VAEIAT-- 742
AT + P ++G G +G VYK + G +A+K + V G V E+A
Sbjct: 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLR 66
Query: 743 -ISAVQHRNLVKL----HGCCIEGAERL-LVYEYLENKSLDQALFGQRSLTLDWATR--- 793
+ A +H N+V+L + ++ LV+E+++ + L L L T
Sbjct: 67 RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDL 125
Query: 794 -YEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHIS 852
+ RGL +LH I+HRD+K N+L+ + K++DFGLA++Y + ++
Sbjct: 126 MRQFL----RGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMA-LT 177
Query: 853 TRVAGTIGYLAPE 865
V T+ Y APE
Sbjct: 178 PVVV-TLWYRAPE 189
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 3e-21
Identities = 54/218 (24%), Positives = 90/218 (41%), Gaps = 45/218 (20%)
Query: 701 LGEGGFGPVYKGK-LGDGRAIAVKQLS---VASRQGKSQFVA------------------ 738
+G+G +G V D A+K LS + + G +
Sbjct: 21 IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80
Query: 739 -----EIATISAVQHRNLVKLHGCCIEGAERL---LVYEYLENKSLDQALFGQRSLTLDW 790
EIA + + H N+VKL ++ +V+E + + + + L+ D
Sbjct: 81 EQVYQEIAILKKLDHPNVVKLV-EVLDDPNEDHLYMVFELVNQGPVMEVPTLKP-LSEDQ 138
Query: 791 ATRY--EICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKK 848
A Y ++ G+ YLH +IIHRD+K SN+L+ D KI+DFG++ +
Sbjct: 139 ARFYFQDLIKGIE----YLH---YQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSD 191
Query: 849 THISTRVAGTIGYLAPE---YAMRGHLTEKTDVFAFGV 883
+S GT ++APE + + DV+A GV
Sbjct: 192 ALLSN-TVGTPAFMAPESLSETRKIFSGKALDVWAMGV 228
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 3e-21
Identities = 57/219 (26%), Positives = 91/219 (41%), Gaps = 43/219 (19%)
Query: 692 TENFS-----PSNKLGEGGFGPVYKGK-LGDGRAIAVKQLSVASRQGK--SQFVAEIATI 743
ENF+ S +LG G F V + G+ A K L R ++ + EIA +
Sbjct: 23 MENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVL 82
Query: 744 SAVQHR-NLVKLHGCCIEGAERLLVYEYL---ENKSLDQALF------GQRSLTLDWATR 793
+ ++ LH +E +L+ EY E +F ++ + R
Sbjct: 83 ELAKSCPRVINLHEVYENTSEIILILEYAAGGE-------IFSLCLPELAEMVSENDVIR 135
Query: 794 Y--EICSGVARGLAYLHEESRVRIIHRDVKASNVLL-----DADLVPKISDFGLAKLYDD 846
+I GV YLH+ I+H D+K N+LL D+ KI DFG+++
Sbjct: 136 LIKQILEGVY----YLHQN---NIVHLDLKPQNILLSSIYPLGDI--KIVDFGMSRKIGH 186
Query: 847 KKTHISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLA 885
+ + GT YLAPE +T TD++ G++A
Sbjct: 187 ACE-LREIM-GTPEYLAPEILNYDPITTATDMWNIGIIA 223
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 4e-21
Identities = 61/322 (18%), Positives = 115/322 (35%), Gaps = 60/322 (18%)
Query: 88 KCDCSSQNGTV-CHITQLKVYALNVVGVIPDELWNLTSLFNLNLGQNYLTGPLSPSV-GN 145
+C CS + C+ L +P + +S L L N L L V
Sbjct: 4 RCSCSGT--EIRCNSKGLTS--------VPTGI--PSSATRLELESNKLQS-LPHGVFDK 50
Query: 146 LTAMQYLNLAINALSGELPKELGQLTELLILGIGTNNFSGPLPSELGSLSKLQELYIDSA 205
LT + L+L+ N LS G + + G + L+ L +
Sbjct: 51 LTQLTKLSLSSNGLS--------------FKGCCSQSDFG--------TTSLKYLDLSFN 88
Query: 206 GVSGEIPSSFANLQSLTKWWASDTRLTGRIPD---FIGNWSKLTALRFQGNSFNGPIPSS 262
GV + S+F L+ L + L ++ + F+ L L
Sbjct: 89 GVI-TMSSNFLGLEQLEHLDFQHSNLK-QMSEFSVFLSL-RNLIYLDISHTHTRVAFNGI 145
Query: 263 FSNLTSVTELRISD--LSNGSSKLAFIRDMKSLSILELRNNNISDSIPSNIGEY-RSLQH 319
F+ L+S+ L+++ F ++++L+ L+L + + SLQ
Sbjct: 146 FNGLSSLEVLKMAGNSFQENFLPDIF-TELRNLTFLDLSQCQLE-QLSPTAFNSLSSLQV 203
Query: 320 LDLSFNNLGGSIPDSLF-NLSSLTHLFLGNNKLNGTLPARK-SPLLLN---IDVSYNNLQ 374
L++S NN S+ + L+SL L N + T ++ + ++++ N+
Sbjct: 204 LNMSHNNF-FSLDTFPYKCLNSLQVLDYSLNHIM-TSKKQELQHFPSSLAFLNLTQNDFA 261
Query: 375 -----GNLPSWINGQQNLQINL 391
+ WI Q+ L + +
Sbjct: 262 CTCEHQSFLQWIKDQRQLLVEV 283
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 3e-16
Identities = 42/202 (20%), Positives = 76/202 (37%), Gaps = 24/202 (11%)
Query: 210 EIPSS-FANLQSLTKWWASDTRLTGRIPDFIGNWSKLTALRFQGN--SFNGPIPSSFSNL 266
+P+ ++ L +L ++LT L N SF G S
Sbjct: 21 SVPTGIPSSATRL---ELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGT 77
Query: 267 TSVTEL-----RISDLSNGSSKLAFIRDMKSLSILELRNNNISDSIPSNI-GEYRSLQHL 320
TS+ L + +S+ L + L L+ +++N+ ++ R+L +L
Sbjct: 78 TSLKYLDLSFNGVITMSSNFLGL------EQLEHLDFQHSNLKQMSEFSVFLSLRNLIYL 131
Query: 321 DLSFNNLGGSIPDSLF-NLSSLTHLFLGNNKLNGTLPA---RKSPLLLNIDVSYNNLQGN 376
D+S + + +F LSSL L + N + L +D+S L+
Sbjct: 132 DISHTHT-RVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQL 190
Query: 377 LPSWINGQQNLQ-INLVANNLT 397
P+ N +LQ +N+ NN
Sbjct: 191 SPTAFNSLSSLQVLNMSHNNFF 212
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 1e-12
Identities = 41/192 (21%), Positives = 68/192 (35%), Gaps = 30/192 (15%)
Query: 227 SDTRLTGRIPDFIGNWSKLTALRFQGNSFNGPIPSSFSNLTSVTELRISD--LSNGSSKL 284
+ LT +P I + T L + N F LT +T+L +S LS
Sbjct: 15 NSKGLT-SVPTGIPSS--ATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCS 71
Query: 285 AFIRDMKSLSILELRNNNISDSIPSNIGEYRSLQHLDLSFNNLGGSIPDSLF-NLSSLTH 343
SL L+L N + ++ SN L+HLD +NL S+F +L +L +
Sbjct: 72 QSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIY 130
Query: 344 LFLGNNKLNGTLPARKSPLLLNIDVSYNNLQGNLPSWINGQQNLQINLVANNLTIRSSDN 403
L + S+ + + NG +L++ +A N +
Sbjct: 131 LDI----------------------SHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLP 168
Query: 404 SVLPRGLICLQR 415
+ L L
Sbjct: 169 DIF-TELRNLTF 179
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 93.7 bits (234), Expect = 4e-21
Identities = 49/193 (25%), Positives = 86/193 (44%), Gaps = 44/193 (22%)
Query: 693 ENFSPSNKLGEGGFGPVYKGKLGDGRAIAVKQL----------SVASRQGKSQFVAEIAT 742
E + K+GEG +G VYK + G A+K++ S R EI+
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIR--------EISI 53
Query: 743 ISAVQHRNLVKLHGCCIEGAERLLVYEYLE----------NKSLDQALFGQRSLTLDWAT 792
+ ++H N+VKL+ +LV+E+L+ L+ +S
Sbjct: 54 LKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTA--KSFL----- 106
Query: 793 RYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHIS 852
++ G+AY H+ R++HRD+K N+L++ + KI+DFGLA+ + +
Sbjct: 107 -LQLL----NGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYT 158
Query: 853 TRVAGTIGYLAPE 865
+ T+ Y AP+
Sbjct: 159 HEIV-TLWYRAPD 170
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 4e-21
Identities = 53/188 (28%), Positives = 89/188 (47%), Gaps = 26/188 (13%)
Query: 689 KTATENFSPSNKLGEGGFGPVYKGKLGDGRAIAVKQL----------SVASRQGKSQFVA 738
+ E + K+GEG +G VYK K GR +A+K++ S A R
Sbjct: 17 QGLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIR-------- 68
Query: 739 EIATISAVQHRNLVKLHGCCIEGAERLLVYEYLENKSLD-QALFGQRSLTLDWATRYEIC 797
EI+ + + H N+V L LV+E++E D + + + L +
Sbjct: 69 EISLLKELHHPNIVSLIDVIHSERCLTLVFEFME---KDLKKVLDENKTGLQDSQIKIYL 125
Query: 798 SGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVAG 857
+ RG+A+ H+ RI+HRD+K N+L+++D K++DFGLA+ + + V
Sbjct: 126 YQLLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV- 181
Query: 858 TIGYLAPE 865
T+ Y AP+
Sbjct: 182 TLWYRAPD 189
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 5e-21
Identities = 64/228 (28%), Positives = 101/228 (44%), Gaps = 23/228 (10%)
Query: 689 KTATENFSPSNKLGEGGFGPVYKGKL-GDGRAIAVKQLSVAS--RQGKSQFV-AEIATIS 744
K E+F LGEG F V + R A+K L ++ K +V E +S
Sbjct: 26 KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS 85
Query: 745 AVQHRNLVKLHGCCIEGAERL-LVYEYLENKSLDQALFGQRSLTLDWATRY--EICSGVA 801
+ H VKL+ + E+L Y +N L + + S Y EI S
Sbjct: 86 RLDHPFFVKLYFTF-QDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSA-- 142
Query: 802 RGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTR-VAGTIG 860
L YLH + IIHRD+K N+LL+ D+ +I+DFG AK+ + GT
Sbjct: 143 --LEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQ 197
Query: 861 YLAPEYAM-RGHLTEKTDVFAFGVLALETVSGRPNSDP--SLDEEKLY 905
Y++PE + + +D++A G + + V+G P P + +E ++
Sbjct: 198 YVSPELLTEKSA-CKSSDLWALGCIIYQLVAGLP---PFRAGNEYLIF 241
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 93.4 bits (233), Expect = 6e-21
Identities = 46/185 (24%), Positives = 84/185 (45%), Gaps = 27/185 (14%)
Query: 693 ENFSPSNKLGEGGFGPVYKGK-LGDGRAIAVKQL----------SVASRQGKSQFVAEIA 741
+ + K+GEG +G V+K K +A+K++ S A R EI
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALR--------EIC 53
Query: 742 TISAVQHRNLVKLHGCCIEGAERLLVYEYLENKSLD-QALFGQRSLTLDWATRYEICSGV 800
+ ++H+N+V+LH + LV+E+ + D + F + LD +
Sbjct: 54 LLKELKHKNIVRLHDVLHSDKKLTLVFEFCD---QDLKKYFDSCNGDLDPEIVKSFLFQL 110
Query: 801 ARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVAGTIG 860
+GL + H ++HRD+K N+L++ + K+++FGLA+ + S V T+
Sbjct: 111 LKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVV-TLW 166
Query: 861 YLAPE 865
Y P+
Sbjct: 167 YRPPD 171
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 9e-21
Identities = 59/221 (26%), Positives = 101/221 (45%), Gaps = 38/221 (17%)
Query: 692 TENFSPSNKLGEGGFGPVYKGKLGDGRAIAVKQLSVASRQGKSQFVAEIATISAVQHRNL 751
++ +G G FG V++ KL + +A+K++ Q K E+ + V+H N+
Sbjct: 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKV----LQDKRFKNRELQIMRIVKHPNV 94
Query: 752 VKLHGCCIEGAERL------LVYEYLENKSLDQAL--FGQRSLTLDWAT----RYEICSG 799
V L ++ LV EY+ +++ +A + + T+ Y++
Sbjct: 95 VDLKAFFYSNGDKKDEVFLNLVLEYVP-ETVYRASRHYAKLKQTMPMLLIKLYMYQLL-- 151
Query: 800 VARGLAYLHEESRVRIIHRDVKASNVLLDADLVP-KISDFGLAKLY--DDKKTH-ISTRV 855
R LAY+H + I HRD+K N+LLD K+ DFG AK+ + I +R
Sbjct: 152 --RSLAYIH---SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSRY 206
Query: 856 AGTIGYLAPEYAMRG--HLTEKTDVFAFG-VLALETVSGRP 893
Y APE + G + T D+++ G V+A E + G+P
Sbjct: 207 -----YRAPE-LIFGATNYTTNIDIWSTGCVMA-ELMQGQP 240
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 94.4 bits (235), Expect = 9e-21
Identities = 50/239 (20%), Positives = 94/239 (39%), Gaps = 27/239 (11%)
Query: 663 KRPQHDDDEELLGMDARPYTFSYAELKTATENFSPSNKLGEGGFGPVYKGK-LGDGRAIA 721
+P+ ++ M +A K + + P + +G G V + G A
Sbjct: 64 AQPKGTENLYFQSMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFA 123
Query: 722 VKQLSVASRQGKSQFVA--------EIATISAV-QHRNLVKLHGCCIEGAERLLVYEYLE 772
VK + V + + + + E + V H +++ L + LV++ +
Sbjct: 124 VKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMR 183
Query: 773 NKSLDQALFGQRSLTLDWATR--YEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDAD 830
L L + +L+ + V+ +LH I+HRD+K N+LLD +
Sbjct: 184 KGELFDYLTEKVALSEKETRSIMRSLLEAVS----FLHAN---NIVHRDLKPENILLDDN 236
Query: 831 LVPKISDFGLAKLYDDKKTHISTRVAGTIGYLAPE------YAMRGHLTEKTDVFAFGV 883
+ ++SDFG + + + + GT GYLAPE ++ D++A GV
Sbjct: 237 MQIRLSDFGFSCHLEPGEK-LRELC-GTPGYLAPEILKCSMDETHPGYGKEVDLWACGV 293
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 93.0 bits (232), Expect = 1e-20
Identities = 49/194 (25%), Positives = 81/194 (41%), Gaps = 45/194 (23%)
Query: 693 ENFSPSNKLGEGGFGPVYKGK-LGDGRAIAVKQL----------SVASRQGKSQFVAEIA 741
E + K+GEG +G V+K + G+ +A+K+ +A R EI
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALR--------EIR 54
Query: 742 TISAVQHRNLVKLHGCCIEGAERLLVYEYLE----------NKSLDQALFGQRSLTLDWA 791
+ ++H NLV L LV+EY + + + + L +S+T
Sbjct: 55 MLKQLKHPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLV--KSIT---- 108
Query: 792 TRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHI 851
++ + + + H + IHRDVK N+L+ V K+ DFG A+L +
Sbjct: 109 --WQTL----QAVNFCH---KHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYY 159
Query: 852 STRVAGTIGYLAPE 865
VA T Y +PE
Sbjct: 160 DDEVA-TRWYRSPE 172
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 92.5 bits (230), Expect = 1e-20
Identities = 26/200 (13%), Positives = 51/200 (25%), Gaps = 43/200 (21%)
Query: 700 KLGEGGFGPVYKGKLGD---GRAIAVKQL---SVASRQGKSQFVAEIATISAVQHRNLVK 753
G ++ D R +A+ + V + ++ +S + + +
Sbjct: 38 FHGGVPPLQFWQAL--DTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95
Query: 754 LHGCCIEGAERLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRV 813
+ A L+V E++ SL + S + A R +A H R
Sbjct: 96 VLDVVHTRAGGLVVAEWIRGGSLQEVA--DTSPSPVGAIR--AMQSLAAAADAAH---RA 148
Query: 814 RIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVAGTIGYLAPEYAMRGHLT 873
+ S V + D G L +
Sbjct: 149 GVALSIDHPSRVRVSID--------GDVVL-------------AYPATMPDA-------N 180
Query: 874 EKTDVFAFGVLALETVSGRP 893
+ D+ G + R
Sbjct: 181 PQDDIRGIGASLYALLVNRW 200
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 95.2 bits (237), Expect = 1e-20
Identities = 61/297 (20%), Positives = 112/297 (37%), Gaps = 54/297 (18%)
Query: 89 CDCSSQNGTV-CHITQLKVYALNVVGVIPDELWNLTSLFNLNLGQNYLTGPLSPSVGNLT 147
C CS+Q V C L+ +PD + T+ LNL +N + S +L
Sbjct: 39 CSCSNQFSKVICVRKNLRE--------VPDGI--STNTRLLNLHENQIQIIKVNSFKHLR 88
Query: 148 AMQYLNLAINALSGELPKELGQLTELLILGIGTNNFSGPLPSELGSLSKLQELYIDSAGV 207
++ L L+ N + I F+G L+ L L + +
Sbjct: 89 HLEILQLSRNHIRT----------------IEIGAFNG--------LANLNTLELFDNRL 124
Query: 208 SGEIPS-SFANLQSLTKWWASDTRLTGRIPDFIGNWSKLTALRF----QGNSFNGPIPSS 262
+ IP+ +F L L + W + + IP ++++ +LR + + +
Sbjct: 125 T-TIPNGAFVYLSKLKELWLRNNPIE-SIPS--YAFNRIPSLRRLDLGELKRLSYISEGA 180
Query: 263 FSNLTSVTELRISDLSNGSSKLAFIRDMKSLSILELRNNNISDSIPSNI-GEYRSLQHLD 321
F L+++ L ++ ++ + + L L+L N++S +I LQ L
Sbjct: 181 FEGLSNLRYLNLAM--CNLREIPNLTPLIKLDELDLSGNHLS-AIRPGSFQGLMHLQKLW 237
Query: 322 LSFNNLGGSIPDSLF-NLSSLTHLFLGNNKLNGTLPAR---KSPLLLNIDVSYNNLQ 374
+ + + I + F NL SL + L +N L LP L I + +N
Sbjct: 238 MIQSQI-QVIERNAFDNLQSLVEINLAHNNLT-LLPHDLFTPLHHLERIHLHHNPWN 292
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 57.5 bits (139), Expect = 1e-08
Identities = 30/130 (23%), Positives = 50/130 (38%), Gaps = 11/130 (8%)
Query: 292 SLSILELRNNNISDSIPSNI-GEYRSLQHLDLSFNNLGGSIPDSLF-NLSSLTHLFLGNN 349
+ +L L N I I N R L+ L LS N++ +I F L++L L L +N
Sbjct: 65 NTRLLNLHENQIQ-IIKVNSFKHLRHLEILQLSRNHI-RTIEIGAFNGLANLNTLELFDN 122
Query: 350 KLNGTLPA---RKSPLLLNIDVSYNNLQGNLPSWINGQQNLQI-NLVANNLTIRSSDNSV 405
+L T+P L + + N ++ N +L+ +L +
Sbjct: 123 RLT-TIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKR-LSYISEGA 180
Query: 406 LPRGLICLQR 415
GL L+
Sbjct: 181 F-EGLSNLRY 189
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 1e-20
Identities = 54/216 (25%), Positives = 92/216 (42%), Gaps = 21/216 (9%)
Query: 678 ARPYTFSYAELKTATENFSPSNKLGEGGFGPVYKG-KLGDGRAIAVKQLSVASRQGKSQ- 735
R F ++N+ +LG+G F V + G A K ++ +
Sbjct: 14 GRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQ 73
Query: 736 -FVAEIATISAVQHRNLVKLHGCCIEGAERLLVYEYLENKSLDQALFGQRSLTLDWATRY 794
E +QH N+V+LH E + LV++ + L + + + + A+
Sbjct: 74 KLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHC 133
Query: 795 --EICSGVARGLAYLHEESRVRIIHRDVKASNVLL-----DADLVPKISDFGLAKLYDDK 847
+I +A Y H I+HR++K N+LL A + K++DFGLA +D
Sbjct: 134 IQQILESIA----YCHSNG---IVHRNLKPENLLLASKAKGAAV--KLADFGLAIEVNDS 184
Query: 848 KTHISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFGV 883
+ AGT GYL+PE + ++ D++A GV
Sbjct: 185 EAW--HGFAGTPGYLSPEVLKKDPYSKPVDIWACGV 218
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 1e-20
Identities = 48/211 (22%), Positives = 84/211 (39%), Gaps = 28/211 (13%)
Query: 692 TENFSPSNKLGEGGFGPVYKGK-LGDGRAIAVKQLSVASRQG---------KSQFVAEIA 741
EN+ P LG G V + + AVK + V + + E+
Sbjct: 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVD 75
Query: 742 TISAV-QHRNLVKLHGCCIEGAERLLVYEYLENKSLDQALFGQRSLTLDWATR--YEICS 798
+ V H N+++L LV++ ++ L L + +L+ + +
Sbjct: 76 ILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLE 135
Query: 799 GVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVAGT 858
+ LH+ I+HRD+K N+LLD D+ K++DFG + D + + GT
Sbjct: 136 VIC----ALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK-LREVC-GT 186
Query: 859 IGYLAPE------YAMRGHLTEKTDVFAFGV 883
YLAPE ++ D+++ GV
Sbjct: 187 PSYLAPEIIECSMNDNHPGYGKEVDMWSTGV 217
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 1e-20
Identities = 52/220 (23%), Positives = 86/220 (39%), Gaps = 37/220 (16%)
Query: 665 PQHDDDEELLGMDARPYTFSYAELKTATENFSPSNKLGEGGFGPVYKGK-LGDGRAIAVK 723
H E + S A T+ + + KLGEG +G VYK +A+K
Sbjct: 6 HHHMGTLEAQTQGPGSMSVSAAPSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIK 65
Query: 724 QL----------SVASRQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLVYEYLEN 773
++ A R E++ + +QHRN+++L L++EY E
Sbjct: 66 RIRLEHEEEGVPGTAIR--------EVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAE- 116
Query: 774 KSLDQALFGQRSLTLDWATRYEICSGVA---RGLAYLHEESRVRIIHRDVKASNVLLDAD 830
L + + +++ I S + G+ + H R +HRD+K N+LL
Sbjct: 117 NDLKKYMDKNPDVSMR-----VIKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVS 168
Query: 831 LVP-----KISDFGLAKLYDDKKTHISTRVAGTIGYLAPE 865
KI DFGLA+ + + + T+ Y PE
Sbjct: 169 DASETPVLKIGDFGLARAFGIPIRQFTHEII-TLWYRPPE 207
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 1e-20
Identities = 55/198 (27%), Positives = 87/198 (43%), Gaps = 17/198 (8%)
Query: 692 TENFSPSNKLGEGGFGPVYKGK-LGDGRAIAVKQLSVASRQGKSQFVAEIATISAVQHRN 750
++ F ++LG G VY+ K G + A+K + K EI + + H N
Sbjct: 52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALK--VLKKTVDKKIVRTEIGVLLRLSHPN 109
Query: 751 LVKLHGCCIEGAERLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEE 810
++KL E LV E + L + + + A + + +AYLHE
Sbjct: 110 IIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAA--DAVKQILEAVAYLHEN 167
Query: 811 SRVRIIHRDVKASNVLL-----DADLVPKISDFGLAKLYDDKKTHISTRVAGTIGYLAPE 865
I+HRD+K N+L DA L KI+DFGL+K+ + + V GT GY APE
Sbjct: 168 ---GIVHRDLKPENLLYATPAPDAPL--KIADFGLSKIVEHQVLM--KTVCGTPGYCAPE 220
Query: 866 YAMRGHLTEKTDVFAFGV 883
+ D+++ G+
Sbjct: 221 ILRGCAYGPEVDMWSVGI 238
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 2e-20
Identities = 53/203 (26%), Positives = 92/203 (45%), Gaps = 22/203 (10%)
Query: 700 KLGEGGFGPVYKG-KLGDGRAIAVKQLSVASRQGKSQFVAEIATISAVQ-HRNLVKLHGC 757
LGEG F K +A AVK +S ++ ++ EI + + H N+VKLH
Sbjct: 18 PLGEGSFSICRKCVHKKSNQAFAVKIIS---KRMEANTQKEITALKLCEGHPNIVKLHEV 74
Query: 758 CIEGAERLLVYEYLENKSLDQALFGQRSLTLDWATRY--EICSGVARGLAYLHEESRVRI 815
+ LV E L L + + ++ + A+ ++ S V+ ++H+ +
Sbjct: 75 FHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVS----HMHDVG---V 127
Query: 816 IHRDVKASNVLL-----DADLVPKISDFGLAKLYDDKKTHISTRVAGTIGYLAPEYAMRG 870
+HRD+K N+L + ++ KI DFG A+L + T T+ Y APE +
Sbjct: 128 VHRDLKPENLLFTDENDNLEI--KIIDFGFARLKPPDNQPLKTPC-FTLHYAAPELLNQN 184
Query: 871 HLTEKTDVFAFGVLALETVSGRP 893
E D+++ GV+ +SG+
Sbjct: 185 GYDESCDLWSLGVILYTMLSGQV 207
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 95.6 bits (237), Expect = 2e-20
Identities = 50/369 (13%), Positives = 114/369 (30%), Gaps = 22/369 (5%)
Query: 114 VIPDELWNLTSLFNLNLGQNYLTGPLSPSVGNLTAMQYLNLAINALSGELPKELGQLTEL 173
+ PD+ NL + +T + L ++ + + + + + + L +
Sbjct: 14 IFPDD--AFAETIKDNLKKKSVTDA--VTQNELNSIDQIIANNSDIK-SV-QGIQYLPNV 67
Query: 174 LILGIGTNNFSGPLPSELGSLSKLQELYIDSAGVSGEIPSSFANLQSLTKWWASDTRLTG 233
L + N + L +L L L++D + ++ SS +L+ L ++
Sbjct: 68 TKLFLNGNKLTDI--KPLTNLKNLGWLFLDENKIK-DL-SSLKDLKKLKSLSLEHNGIS- 122
Query: 234 RIPDFIGNWSKLTALRFQGNSFNGPIPSSFSNLTSVTELRISDLSNGSSKLAFIRDMKSL 293
I + + + +L +L N + S LT + L + N S + + + L
Sbjct: 123 DI-NGLVHLPQLESLYLGNNKIT--DITVLSRLTKLDTLSLE--DNQISDIVPLAGLTKL 177
Query: 294 SILELRNNNISDSIPSNIGEYRSLQHLDLSFNNLGGSIPDSLFNLSSLTHLFLGNNKLNG 353
L L N+ISD + ++L L+L + NL + + L
Sbjct: 178 QNLYLSKNHISD--LRALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVT 235
Query: 354 TLPARKSPLLLNIDVSYNNLQGNLPSWINGQQNLQINLVANNLTIRSSDNSVLPRGLICL 413
+V ++ + Q + I R P +
Sbjct: 236 PEIISDDGDYEKPNVKWHLPEFTNEVSFIFYQPVTI----GKAKARFHGRVTQPLKEVYT 291
Query: 414 QRNFPCNRGYAIYADFAIKSGGPQIRSSNGVVYERDNATLGPATYYVTDSNKWGVSNVGL 473
+ + P+ + G V++ + +++ ++ L
Sbjct: 292 VSYDVDGTVIKTKVEAGTRITAPKPPTKQGYVFKGWYTEKNGGHEWNFNTDYMSGNDFTL 351
Query: 474 FTGSNNPQY 482
+
Sbjct: 352 YAVFKAETT 360
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 57.0 bits (137), Expect = 2e-08
Identities = 20/129 (15%), Positives = 46/129 (35%), Gaps = 20/129 (15%)
Query: 273 RISDLSNGSSKLAFIRDMKSLSILELRNNNISDSIPSNIGEYRSLQHLDLSFNNLGGSIP 332
I + L+ +++D E S+ + + +++ S+
Sbjct: 10 PIKQIFP-------DDAFAETIKDNLKKKSVTD--AVTQNELNSIDQIIANNSDI-KSV- 58
Query: 333 DSLFNLSSLTHLFLGNNKLNGTLPARKSPLLLNIDVSYNNLQGNLPSWINGQQNL----Q 388
+ L ++T LFL NKL P L + + N + ++ ++L
Sbjct: 59 QGIQYLPNVTKLFLNGNKLTDIKPLTNLKNLGWLFLDENKI-----KDLSSLKDLKKLKS 113
Query: 389 INLVANNLT 397
++L N ++
Sbjct: 114 LSLEHNGIS 122
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 3e-20
Identities = 53/209 (25%), Positives = 82/209 (39%), Gaps = 27/209 (12%)
Query: 692 TENFSPSNKLGEGGFGPVYKGK-LGDGRAIAVKQLS--------VASRQGKSQFVAEIAT 742
+ + S LG G G V + +A+K +S EI
Sbjct: 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEI 68
Query: 743 ISAVQHRNLVKLHGCCIEGAERLLVYEYLENKSLDQALFGQRSLTLDWATRY--EICSGV 800
+ + H ++K+ + + +V E +E L + G + L Y ++ V
Sbjct: 69 LKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAV 127
Query: 801 ARGLAYLHEESRVRIIHRDVKASNVLL---DADLVPKISDFGLAKLYDDKKTHISTRVAG 857
YLHE IIHRD+K NVLL + D + KI+DFG +K+ + + T G
Sbjct: 128 Q----YLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL-MRTLC-G 178
Query: 858 TIGYLAPE---YAMRGHLTEKTDVFAFGV 883
T YLAPE D ++ GV
Sbjct: 179 TPTYLAPEVLVSVGTAGYNRAVDCWSLGV 207
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 4e-20
Identities = 55/226 (24%), Positives = 94/226 (41%), Gaps = 41/226 (18%)
Query: 692 TENFSPSNKLGEGGFGPVYKGKLGD-GRAIAVK----QLSVASRQGKSQFVAEIATISAV 746
+ F G+G FG V GK G ++A+K +R+ + + ++ +
Sbjct: 22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRE-----LQIMQDLAVL 76
Query: 747 QHRNLVKLHGCCIEGAER-------LLVYEYLE---NKSLDQALFGQRSLTLDWA--TRY 794
H N+V+L ER +V EY+ ++ Q + +
Sbjct: 77 HHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLF 136
Query: 795 EICSGVARGLAYLHEESRVRIIHRDVKASNVLLD-ADLVPKISDFGLAKLYDDKKTHIS- 852
++ R + LH S + HRD+K NVL++ AD K+ DFG AK + +++
Sbjct: 137 QLI----RSIGCLHLPSV-NVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAY 191
Query: 853 --TRVAGTIGYLAPEYAMRG--HLTEKTDVFAFG-VLALETVSGRP 893
+R Y APE + G H T D+++ G + A E + G P
Sbjct: 192 ICSRY-----YRAPEL-IFGNQHYTTAVDIWSVGCIFA-EMMLGEP 230
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 91.5 bits (228), Expect = 5e-20
Identities = 50/194 (25%), Positives = 77/194 (39%), Gaps = 45/194 (23%)
Query: 693 ENFSPSNKLGEGGFGPVYKGK-LGDGRAIAVKQL----------SVASRQGKSQFVAEIA 741
E + +GEG +G V K + GR +A+K+ +A R EI
Sbjct: 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMR--------EIK 76
Query: 742 TISAVQHRNLVKLHGCCIEGAERLLVYEYLE----------NKSLDQALFGQRSLTLDWA 791
+ ++H NLV L C + LV+E+++ LD + +
Sbjct: 77 LLKQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVV--QKYL---- 130
Query: 792 TRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHI 851
++I G+ + H IIHRD+K N+L+ V K+ DFG A+
Sbjct: 131 --FQII----NGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVY 181
Query: 852 STRVAGTIGYLAPE 865
VA T Y APE
Sbjct: 182 DDEVA-TRWYRAPE 194
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 93.3 bits (232), Expect = 5e-20
Identities = 71/252 (28%), Positives = 104/252 (41%), Gaps = 24/252 (9%)
Query: 665 PQHDDDEELLGMDARPYTFSYAELKTATENFSPSNKLGEGGFGPVYKGKL-GDGRAIAVK 723
+ + G + + + + + F LG+G FG V K GR A+K
Sbjct: 120 FRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMK 179
Query: 724 QLS---VASRQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERL-LVYEYLENKSLDQA 779
L + ++ + + E + +H L L + +RL V EY L
Sbjct: 180 ILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK-YSFQTHDRLCFVMEYANGGELFFH 238
Query: 780 LFGQRSLTLDWATRY--EICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISD 837
L +R + D A Y EI S L YLH S +++RD+K N++LD D KI+D
Sbjct: 239 LSRERVFSEDRARFYGAEIVSA----LDYLH--SEKNVVYRDLKLENLMLDKDGHIKITD 292
Query: 838 FGLAK--LYDDKKTHISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRPNS 895
FGL K + D T GT YLAPE D + GV+ E + GR
Sbjct: 293 FGLCKEGIKDGATM--KT-FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRL-- 347
Query: 896 DP--SLDEEKLY 905
P + D EKL+
Sbjct: 348 -PFYNQDHEKLF 358
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 5e-20
Identities = 39/230 (16%), Positives = 83/230 (36%), Gaps = 42/230 (18%)
Query: 103 QLKVYALNVVGVIPDELWNLTSLFNLNLGQNYLTGPLSPSVGNLTAMQYLNLA---INAL 159
Q + A IPD + N LGQ+ T ++ + + ++ Y+ LA + L
Sbjct: 5 QTGLKASQDNVNIPDS--TFKAYLNGLLGQS-STANITEA--QMNSLTYITLANINVTDL 59
Query: 160 SGELPKELGQLTELLILGIGTNNFSGPLPSELGSLSKLQELYIDSAGVSGEIPSSFANLQ 219
+G + + L I + + + + LS L+ L I V+ + + + L
Sbjct: 60 TG-----IEYAHNIKDLTINNIHATNY--NPISGLSNLERLRIMGKDVTSDKIPNLSGL- 111
Query: 220 SLTKWWASDTRLTGRIPDFIGNWSKLTALRFQGNSFNGPIPSSFSNLTSVTELRISDLSN 279
+ LT L ++ + I + + L V + +S +
Sbjct: 112 -----------------------TSLTLLDISHSAHDDSILTKINTLPKVNSIDLSY-NG 147
Query: 280 GSSKLAFIRDMKSLSILELRNNNISDSIPSNIGEYRSLQHLDLSFNNLGG 329
+ + ++ + L L ++ + + D I ++ L L +GG
Sbjct: 148 AITDIMPLKTLPELKSLNIQFDGVHDY--RGIEDFPKLNQLYAFSQTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 5e-16
Identities = 23/157 (14%), Positives = 60/157 (38%), Gaps = 8/157 (5%)
Query: 243 SKLTALRFQGNSFNGPIPSSFSNLTSVTELRISDLSNGSSKLAFIRDMKSLSILELRNNN 302
+ LT + + + + ++ +L I++ ++ I + +L L + +
Sbjct: 44 NSLTYITLANINVTD-L-TGIEYAHNIKDLTINN--IHATNYNPISGLSNLERLRIMGKD 99
Query: 303 ISDSIPSNIGEYRSLQHLDLSFNNLGGSIPDSLFNLSSLTHLFLGNNKLNGTLPARKS-P 361
++ N+ SL LD+S + SI + L + + L N + K+ P
Sbjct: 100 VTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIMPLKTLP 159
Query: 362 LLLNIDVSYNNLQGNLPSWINGQQNLQ-INLVANNLT 397
L ++++ ++ + + I L + + +
Sbjct: 160 ELKSLNIQFDGVH-DY-RGIEDFPKLNQLYAFSQTIG 194
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 1e-12
Identities = 26/163 (15%), Positives = 59/163 (36%), Gaps = 32/163 (19%)
Query: 235 IPDFIGNWSKLTALRFQGNSFNGPIPSSFSNLTSVTELRISDLSNGSSKLAFIRDMKSLS 294
IPD + +S I + + + S+T + +++ + L I ++
Sbjct: 17 IPD--STFKAYLNGLLGQSS-TANI--TEAQMNSLTYITLAN--INVTDLTGIEYAHNIK 69
Query: 295 ILELRNNNISDSIPSNIGEYRSLQHLDLSFNNLGGSIPDSLFNLSSLTHLFLGNNKLNGT 354
L + N + ++ + I +L+ L + ++ +L L+SLT L +
Sbjct: 70 DLTINNIHATNY--NPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDI-------- 119
Query: 355 LPARKSPLLLNIDVSYNNLQGNLPSWINGQQNLQ-INLVANNL 396
S++ ++ + IN + I+L N
Sbjct: 120 --------------SHSAHDDSILTKINTLPKVNSIDLSYNGA 148
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 53.8 bits (130), Expect = 4e-08
Identities = 23/109 (21%), Positives = 43/109 (39%), Gaps = 3/109 (2%)
Query: 102 TQLKVYALNVVGVIPDELWNLTSLFNLNLGQNYLTGPLSPSVGNLTAMQYLNLAINALSG 161
+L++ +V L LTSL L++ + + + L + ++L+ N
Sbjct: 91 ERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAIT 150
Query: 162 ELPKELGQLTELLILGIGTNNFSGPLPSELGSLSKLQELYIDSAGVSGE 210
++ L L EL L I + + KL +LY S + G+
Sbjct: 151 DI-MPLKTLPELKSLNIQFDGVHD--YRGIEDFPKLNQLYAFSQTIGGK 196
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 91.5 bits (228), Expect = 6e-20
Identities = 54/200 (27%), Positives = 88/200 (44%), Gaps = 45/200 (22%)
Query: 693 ENFSPSNKLGEGGFGPVYKGK-LGDGRAIAVKQL----------SVASRQGKSQFVAEIA 741
+ K+G+G FG V+K + G+ +A+K++ A R EI
Sbjct: 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALR--------EIK 68
Query: 742 TISAVQHRNLVKLHGCCIEGAERL--------LVYEYLENKSLD-QALFGQRSLTLDWAT 792
+ ++H N+V L C A LV+++ E+ D L + +
Sbjct: 69 ILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH---DLAGLLSNVLVKFTLSE 125
Query: 793 RYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKK---- 848
+ + GL Y+H +I+HRD+KA+NVL+ D V K++DFGLA+ + K
Sbjct: 126 IKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQP 182
Query: 849 ---THISTRVAGTIGYLAPE 865
T+ RV T+ Y PE
Sbjct: 183 NRYTN---RVV-TLWYRPPE 198
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 6e-20
Identities = 47/202 (23%), Positives = 89/202 (44%), Gaps = 20/202 (9%)
Query: 692 TENFSPSNKLGEGGFGPVYKGK-LGDGRAIAVKQLSVA--SRQGKSQFVAEIATISAVQH 748
TE + +LG+G F V + + G+ A ++ S + + E ++H
Sbjct: 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKH 69
Query: 749 RNLVKLHGCCIEGAERLLVYEYLENKSLDQALFGQRSLTLDWATRY--EICSGVARGLAY 806
N+V+LH E L+++ + L + + + + A+ +I V +
Sbjct: 70 PNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVL----H 125
Query: 807 LHEESRVRIIHRDVKASNVLL-----DADLVPKISDFGLAKLYDDKKTHISTRVAGTIGY 861
H+ ++HR++K N+LL A + K++DFGLA + ++ GT GY
Sbjct: 126 CHQMG---VVHRNLKPENLLLASKLKGAAV--KLADFGLAIEVEGEQQAWFGFA-GTPGY 179
Query: 862 LAPEYAMRGHLTEKTDVFAFGV 883
L+PE + + D++A GV
Sbjct: 180 LSPEVLRKDPYGKPVDLWACGV 201
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 6e-20
Identities = 63/221 (28%), Positives = 100/221 (45%), Gaps = 37/221 (16%)
Query: 692 TENFSPSNKLGEGGFGPVYKGKLGD-GRAIAVKQLSVASRQGKSQFVAEIATISAVQHRN 750
+++ + +G G FG VY+ KL D G +A+K++ Q K E+ + + H N
Sbjct: 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV----LQDKRFKNRELQIMRKLDHCN 108
Query: 751 LVKLHGCCIEGAERL------LVYEYLE---NKSLDQALFGQRSLTLDWAT--RYEICSG 799
+V+L E+ LV +Y+ + +++L + + Y++
Sbjct: 109 IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF-- 166
Query: 800 VARGLAYLHEESRVRIIHRDVKASNVLLDADLVP-KISDFGLAKLY--DDKKTH-ISTRV 855
R LAY+H I HRD+K N+LLD D K+ DFG AK + I +R
Sbjct: 167 --RSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY 221
Query: 856 AGTIGYLAPEYAMRG--HLTEKTDVFAFG-VLALETVSGRP 893
Y APE + G T DV++ G VLA E + G+P
Sbjct: 222 -----YRAPE-LIFGATDYTSSIDVWSAGCVLA-ELLLGQP 255
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 6e-20
Identities = 64/273 (23%), Positives = 100/273 (36%), Gaps = 53/273 (19%)
Query: 89 CDCSSQNGTV-CHITQLKVYALNVVGVIPDELWNLTSLFNLNLGQNYLTGPLSPSV-GNL 146
C N T C IPD L S NL+L N L L +
Sbjct: 3 CVEVVPNITYQCMELNFYK--------IPDNL--PFSTKNLDLSFNPLRH-LGSYSFFSF 51
Query: 147 TAMQYLNLAINALSGELPKELGQLTELLILGIGTNNFSGPLPSELGSLSKLQELYIDSAG 206
+Q L+L+ + + + LS L L +
Sbjct: 52 PELQVLDLSRCEIQ-TIE---------------DGAYQS--------LSHLSTLILTGNP 87
Query: 207 VSGEIPS-SFANLQSLTKWWASDTRLTGRIPDFI-GNWSKLTALRFQGNSF-NGPIPSSF 263
+ + +F+ L SL K A +T L + +F G+ L L N + +P F
Sbjct: 88 IQ-SLALGAFSGLSSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHNLIQSFKLPEYF 145
Query: 264 SNLTSVTEL-----RISDLSNGSSKLAFIRDMKSLSI-LELRNNNISDSIPSNIGEYRSL 317
SNLT++ L +I + L + M L++ L+L N ++ I + L
Sbjct: 146 SNLTNLEHLDLSSNKIQSIYCTD--LRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRL 202
Query: 318 QHLDLSFNNLGGSIPDSLF-NLSSLTHLFLGNN 349
+ L L N L S+PD +F L+SL ++L N
Sbjct: 203 KELALDTNQL-KSVPDGIFDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 1e-11
Identities = 41/204 (20%), Positives = 82/204 (40%), Gaps = 27/204 (13%)
Query: 210 EIPSS-FANLQSLTKWWASDTRLTGRIPDFIGNWSKLTALRFQGNSFNGPIPSSFSNLTS 268
+IP + + ++L S L ++ +L L ++ +L+
Sbjct: 21 KIPDNLPFSTKNL---DLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSH 77
Query: 269 VTEL-----RISDLSNGSSKLAFIRDMKSLSILELRNNNISDSIPSNI-GEYRSLQHLDL 322
++ L I L+ G AF + SL L N++ S+ + G ++L+ L++
Sbjct: 78 LSTLILTGNPIQSLALG----AF-SGLSSLQKLVAVETNLA-SLENFPIGHLKTLKELNV 131
Query: 323 SFNNLGGSIPDSLF-NLSSLTHLFLGNNKLNGTLPARK-------SPLLLNIDVSYNNLQ 374
+ N + F NL++L HL L +NK+ ++ L L++D+S N +
Sbjct: 132 AHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQ-SIYCTDLRVLHQMPLLNLSLDLSLNPMN 190
Query: 375 GNLPSWINGQQNLQ-INLVANNLT 397
+ + L+ + L N L
Sbjct: 191 -FIQPGAFKEIRLKELALDTNQLK 213
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 91.1 bits (227), Expect = 7e-20
Identities = 49/197 (24%), Positives = 92/197 (46%), Gaps = 42/197 (21%)
Query: 693 ENFSPSNKLGEGGFGPVYKGK--LGDGRAIAVKQL----------SVASRQGKSQFVAEI 740
+ + ++GEG +G V+K + GR +A+K++ R E+
Sbjct: 11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIR--------EV 62
Query: 741 AT---ISAVQHRNLVKL----HGCCIEGAERL-LVYEYLENKSLDQALFGQRSLTLDWAT 792
A + +H N+V+L + +L LV+E+++ + L L + T
Sbjct: 63 AVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTET 121
Query: 793 R----YEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKK 848
+++ RGL +LH R++HRD+K N+L+ + K++DFGLA++Y +
Sbjct: 122 IKDMMFQLL----RGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM 174
Query: 849 THISTRVAGTIGYLAPE 865
+++ V T+ Y APE
Sbjct: 175 A-LTSVVV-TLWYRAPE 189
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 9e-20
Identities = 56/191 (29%), Positives = 83/191 (43%), Gaps = 17/191 (8%)
Query: 701 LGEGGFGPVYKGK-LGDGRAIAVKQLSVASRQGKSQFVA-EIATISAVQHRNLVKLHGCC 758
LGEG +G V A+AVK + + + + EI + H N+VK +G
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH- 73
Query: 759 IEGAERL-LVYEYLENKSLDQALFGQRSLTLDWATRY--EICSGVARGLAYLHEESRVRI 815
L EY L + + A R+ ++ +GV YLH + I
Sbjct: 74 RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV----YLH---GIGI 126
Query: 816 IHRDVKASNVLLDADLVPKISDFGLAKLYDDKKT--HISTRVAGTIGYLAPE-YAMRGHL 872
HRD+K N+LLD KISDFGLA ++ ++ GT+ Y+APE R
Sbjct: 127 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAPELLKRREFH 185
Query: 873 TEKTDVFAFGV 883
E DV++ G+
Sbjct: 186 AEPVDVWSCGI 196
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 1e-19
Identities = 53/204 (25%), Positives = 85/204 (41%), Gaps = 22/204 (10%)
Query: 701 LGEGGFGPVYKG-KLGDGRAIAVKQLS---VASRQGKSQFVAEIATISAVQHRNLVKLHG 756
+G+G FG V K + A+K ++ R E+ + ++H LV L
Sbjct: 23 IGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLW- 81
Query: 757 CCIEGAERL-LVYEYLENKSLDQALFGQRSLTLDWATRY--EICSGVARGLAYLHEESRV 813
+ E + +V + L L L + + E+ L YL +
Sbjct: 82 YSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMA----LDYLQNQ--- 134
Query: 814 RIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVAGTIGYLAPE----YAMR 869
RIIHRD+K N+LLD I+DF +A + + + +AGT Y+APE
Sbjct: 135 RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITT--MAGTKPYMAPEMFSSRKGA 192
Query: 870 GHLTEKTDVFAFGVLALETVSGRP 893
G+ + D ++ GV A E + GR
Sbjct: 193 GY-SFAVDWWSLGVTAYELLRGRR 215
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 3e-19
Identities = 67/216 (31%), Positives = 94/216 (43%), Gaps = 25/216 (11%)
Query: 701 LGEGGFGPVYKGKL-GDGRAIAVKQLS---VASRQGKSQFVAEIATISAVQHRNLVKLHG 756
LG+G FG V + GR A+K L + ++ + V E + +H L L
Sbjct: 13 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK- 71
Query: 757 CCIEGAERL-LVYEYLENKSLDQALFGQRSLTLDWATRY--EICSGVARGLAYLHEESRV 813
+ +RL V EY L L +R T + A Y EI S L YLH
Sbjct: 72 YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSA----LEYLHSRD-- 125
Query: 814 RIIHRDVKASNVLLDADLVPKISDFGLAK--LYDDKKTHISTRVAGTIGYLAPEYAMRGH 871
+++RD+K N++LD D KI+DFGL K + D T GT YLAPE
Sbjct: 126 -VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM--KT-FCGTPEYLAPEVLEDND 181
Query: 872 LTEKTDVFAFGVLALETVSGRPNSDP--SLDEEKLY 905
D + GV+ E + GR P + D E+L+
Sbjct: 182 YGRAVDWWGLGVVMYEMMCGRL---PFYNQDHERLF 214
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 91.0 bits (226), Expect = 3e-19
Identities = 62/296 (20%), Positives = 110/296 (37%), Gaps = 54/296 (18%)
Query: 678 ARPYTFSYAELKTATENFSPSNKLGEGGFGPVYKGKL-GDGRAIAVKQLS---VASRQGK 733
A+P+T +++ E+F +G G FG V KL + A+K L+ + R
Sbjct: 59 AKPFTSKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAET 118
Query: 734 SQFVAEIATISAVQHRNLVKLHGCCIEGAERL-LVYEYL---ENKSLDQALF-----GQR 784
+ F E + + + LH + L LV +Y + L +
Sbjct: 119 ACFREERDVLVNGDSKWITTLH-YAFQDDNNLYLVMDYYVGGD-------LLTLLSKFED 170
Query: 785 SLTLDWATRY--EICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAK 842
L + A Y E+ + +H+ +HRD+K N+L+D + +++DFG
Sbjct: 171 RLPEEMARFYLAEMVIA----IDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCL 223
Query: 843 LYDDKKTHISTRVAGTIGYLAPE------YAMRGHLTEKTDVFAFGVLALETVSGRPNSD 896
+ T S+ GT Y++PE + + D ++ GV E + G
Sbjct: 224 KLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRY-GPECDWWSLGVCMYEMLYGET--- 279
Query: 897 P--SLDEEKLYLLEWAWHLHEN--NQEIELADPKLIEFNEEEVKRLIGVALLCTQT 948
P + + Y N + P + E K LI L+C++
Sbjct: 280 PFYAESLVETY---------GKIMNHKERFQFPTQVTDVSENAKDLIR-RLICSRE 325
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 92.0 bits (228), Expect = 3e-19
Identities = 69/267 (25%), Positives = 106/267 (39%), Gaps = 38/267 (14%)
Query: 657 CIVRRRKRPQHDDDEELLGMDARPYTFSYAELKTATENFSPSNKLGEGGFGPVYKGKL-G 715
R + EE + + + +F+ LG+G FG V + G
Sbjct: 305 KFERAKIGQGTKAPEEKTANTISKFDNNGNRDRMKLTDFNFLMVLGKGSFGKVMLSERKG 364
Query: 716 DGRAIAVKQLSVASRQGKSQFVA--EIATI--------SAVQHRNLVKLHGCCIEGAERL 765
AVK L K + ++ + L +LH C + +RL
Sbjct: 365 TDELYAVKILK------KDVVIQDDDVECTMVEKRVLALPGKPPFLTQLH-SCFQTMDRL 417
Query: 766 -LVYEYLENKSLDQALFGQRSLTLDWATRY--EICSGVARGLAYLHEESRVRIIHRDVKA 822
V EY+ L + A Y EI G L +L + II+RD+K
Sbjct: 418 YFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIG----LFFLQSKG---IIYRDLKL 470
Query: 823 SNVLLDADLVPKISDFGLAK--LYDDKKTHISTRVAGTIGYLAPEYAMRGHLTEKTDVFA 880
NV+LD++ KI+DFG+ K ++D T T GT Y+APE + D +A
Sbjct: 471 DNVMLDSEGHIKIADFGMCKENIWDGVTT--KT-FCGTPDYIAPEIIAYQPYGKSVDWWA 527
Query: 881 FGVLALETVSGRPNSDP--SLDEEKLY 905
FGVL E ++G+ P DE++L+
Sbjct: 528 FGVLLYEMLAGQA---PFEGEDEDELF 551
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 3e-19
Identities = 72/288 (25%), Positives = 109/288 (37%), Gaps = 42/288 (14%)
Query: 678 ARPYTFSYAELKTATENFSPSNKLGEGGFGPVYKGKL-GDGRAIAVKQLS---VASRQGK 733
A P E++ ++F +G G F V K+ G+ A+K ++ + R
Sbjct: 46 AEPIVVRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEV 105
Query: 734 SQFVAEIATISAVQHRNLVKLHGCCIEGAERL-LVYEYLENKSLDQAL--FGQRSLTLDW 790
S F E + R + +LH + L LV EY L L FG+R + +
Sbjct: 106 SCFREERDVLVNGDRRWITQLH-FAFQDENYLYLVMEYYVGGDLLTLLSKFGER-IPAEM 163
Query: 791 ATRY--EICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKK 848
A Y EI + +H +HRD+K N+LLD +++DFG
Sbjct: 164 ARFYLAEIVMA----IDSVHRLG---YVHRDIKPDNILLDRCGHIRLADFGSCLKLRADG 216
Query: 849 THISTRVAGTIGYLAPE-------YAMRGHLTEKTDVFAFGVLALETVSGRPNSDP--SL 899
T S GT YL+PE G + D +A GV A E G+ P +
Sbjct: 217 TVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQT---PFYAD 273
Query: 900 DEEKLYLLEWAWHLHEN--NQEIELADPKLIEFNEEEVKRLIGVALLC 945
+ Y + + L+ P + E EE + I LLC
Sbjct: 274 STAETY---------GKIVHYKEHLSLPLVDEGVPEEARDFI-QRLLC 311
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 89.1 bits (222), Expect = 3e-19
Identities = 64/219 (29%), Positives = 103/219 (47%), Gaps = 29/219 (13%)
Query: 701 LGEGGFGPVY----KGKLGDGRAIAVKQLSVASRQGKSQF--VAEIATISAVQHRNLVKL 754
LG+G FG V+ + A+K L A+ + + + E + V H +VKL
Sbjct: 32 LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKL 91
Query: 755 HGCCIEGAERL-LVYEYLENKSLDQALFGQRSLTLDWATRY--EICSGVARGLAYLHEES 811
H + +L L+ ++L L L + T + Y E+ L +LH
Sbjct: 92 H-YAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALA----LDHLHSLG 146
Query: 812 RVRIIHRDVKASNVLLDADLVPKISDFGLAK--LYDDKKTHISTRVAGTIGYLAPEYAMR 869
II+RD+K N+LLD + K++DFGL+K + +KK + + GT+ Y+APE R
Sbjct: 147 ---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAY--S-FCGTVEYMAPEVVNR 200
Query: 870 -GHLTEKTDVFAFGVLALETVSGRPNSDP--SLDEEKLY 905
GH T+ D ++FGVL E ++G P D ++
Sbjct: 201 RGH-TQSADWWSFGVLMFEMLTGTL---PFQGKDRKETM 235
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 3e-19
Identities = 46/199 (23%), Positives = 79/199 (39%), Gaps = 26/199 (13%)
Query: 701 LGEGGFGPVYKGK-LGDGRAIAVKQLS----VASRQGKSQFVAEIATISAVQHRNLVKLH 755
LGEG +G V + AVK L G++ EI + ++H+N+++L
Sbjct: 13 LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLV 72
Query: 756 GCCIEGAERL---LVYEYLENKSLDQALFG---QRSLTLDWATRY--EICSGVARGLAYL 807
+ E+ +V EY + + ++ + A Y ++ G+ YL
Sbjct: 73 DV-LYNEEKQKMYMVMEYCVCGMQE--MLDSVPEKRFPVCQAHGYFCQLIDGLE----YL 125
Query: 808 HEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKT-HISTRVAGTIGYLAPEY 866
H I+H+D+K N+LL KIS G+A+ G+ + PE
Sbjct: 126 H---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEI 182
Query: 867 AM--RGHLTEKTDVFAFGV 883
A K D+++ GV
Sbjct: 183 ANGLDTFSGFKVDIWSAGV 201
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 4e-19
Identities = 56/191 (29%), Positives = 83/191 (43%), Gaps = 17/191 (8%)
Query: 701 LGEGGFGPVYKGK-LGDGRAIAVKQLSVASRQGKSQFVA-EIATISAVQHRNLVKLHGCC 758
LGEG +G V A+AVK + + + + EI + H N+VK +G
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH- 73
Query: 759 IEGAERL-LVYEYLENKSLDQALFGQRSLTLDWATRY--EICSGVARGLAYLHEESRVRI 815
L EY L + + A R+ ++ +GV YLH + I
Sbjct: 74 RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV----YLH---GIGI 126
Query: 816 IHRDVKASNVLLDADLVPKISDFGLAKLYDDKKT--HISTRVAGTIGYLAPE-YAMRGHL 872
HRD+K N+LLD KISDFGLA ++ ++ GT+ Y+APE R
Sbjct: 127 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAPELLKRREFH 185
Query: 873 TEKTDVFAFGV 883
E DV++ G+
Sbjct: 186 AEPVDVWSCGI 196
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 5e-19
Identities = 45/178 (25%), Positives = 69/178 (38%), Gaps = 20/178 (11%)
Query: 701 LGEGGFGPVYKGK-LGDGRAIAVKQLSVASRQGKSQFVAEIATISAVQ-HRNLVKLHGCC 758
LGEG V L + AVK + +S+ E+ + Q HRN+++L
Sbjct: 21 LGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFF 80
Query: 759 IEGAERLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHR 818
E LV+E + S+ + +R A+ + VA L +LH + I HR
Sbjct: 81 EEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASV--VVQDVASALDFLHNK---GIAHR 135
Query: 819 DVKASNVLL-----DADLVPKISDFGLAKLYDDKKTHISTR------VAGTIGYLAPE 865
D+K N+L + + KI DF L G+ Y+APE
Sbjct: 136 DLKPENILCEHPNQVSPV--KICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPE 191
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 5e-19
Identities = 47/209 (22%), Positives = 78/209 (37%), Gaps = 46/209 (22%)
Query: 701 LGEGGFGPVYKGK-LGDGRAIAVKQL--------SVASRQGKSQFVAEIATISAVQHRNL 751
LG G FG V+ + + VK + + EIA +S V+H N+
Sbjct: 32 LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91
Query: 752 VKLHG-------------CCIEGAERLLVYEYLENKSLDQALFGQRSLTLDWATRY--EI 796
+K+ G + ++ +++ L A+ ++
Sbjct: 92 IKVLDIFENQGFFQLVMEKHGSGLD---LFAFIDRHP---------RLDEPLASYIFRQL 139
Query: 797 CSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVA 856
S V YL IIHRD+K N+++ D K+ DFG A + K T
Sbjct: 140 VSAVG----YLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGK-LFYT-FC 190
Query: 857 GTIGYLAPE-YAMRGHLTEKTDVFAFGVL 884
GTI Y APE + + ++++ GV
Sbjct: 191 GTIEYCAPEVLMGNPYRGPELEMWSLGVT 219
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 88.4 bits (220), Expect = 5e-19
Identities = 66/221 (29%), Positives = 100/221 (45%), Gaps = 31/221 (14%)
Query: 701 LGEGGFGPVY----KGKLGDGRAIAVKQLSVASRQGKSQFVAEIAT----ISAVQHRNLV 752
LG+GG+G V+ G+ A+K L A ++ A + V+H +V
Sbjct: 25 LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIV 84
Query: 753 KLHGCCIEGAERL-LVYEYLENKSLDQALFGQRSLTLDWATRY--EICSGVARGLAYLHE 809
L + +L L+ EYL L L + D A Y EI L +LH+
Sbjct: 85 DLI-YAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMA----LGHLHQ 139
Query: 810 ESRVRIIHRDVKASNVLLDADLVPKISDFGLAK--LYDDKKTHISTRVAGTIGYLAPEYA 867
+ II+RD+K N++L+ K++DFGL K ++D TH T GTI Y+APE
Sbjct: 140 KG---IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTH--T-FCGTIEYMAPEIL 193
Query: 868 MR-GHLTEKTDVFAFGVLALETVSGRPNSDP--SLDEEKLY 905
MR GH D ++ G L + ++G P P + +K
Sbjct: 194 MRSGH-NRAVDWWSLGALMYDMLTGAP---PFTGENRKKTI 230
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 8e-19
Identities = 49/211 (23%), Positives = 80/211 (37%), Gaps = 21/211 (9%)
Query: 150 QYLNLAINALSGELPKELGQLTELLILGIGTNNFSGPLPSELGSLSKLQELYIDSAGVSG 209
Q + L N +S L IL + +N + + L+ L++L +
Sbjct: 35 QRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLR 94
Query: 210 EIPSS-FANLQSLTKWWASDTRLTGRIPD--FIGNWSKLTALRFQGNSFNGPIPS-SFSN 265
+ + F L L L + F G + L L Q N+ +P +F +
Sbjct: 95 SVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGL-AALQYLYLQDNALQA-LPDDTFRD 151
Query: 266 LTSVTEL-----RISDLSNGSSKLAFIRDMKSLSILELRNNNISDSIPSNIGEY-RSLQH 319
L ++T L RIS + AF R + SL L L N ++ + + L
Sbjct: 152 LGNLTHLFLHGNRISSVPER----AF-RGLHSLDRLLLHQNRVA-HVHPHAFRDLGRLMT 205
Query: 320 LDLSFNNLGGSIPDSLF-NLSSLTHLFLGNN 349
L L NNL ++P L +L +L L +N
Sbjct: 206 LYLFANNL-SALPTEALAPLRALQYLRLNDN 235
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 2e-08
Identities = 28/113 (24%), Positives = 40/113 (35%), Gaps = 10/113 (8%)
Query: 292 SLSILELRNNNISDSIPSNI-GEYRSLQHLDLSFNNLGGSIPDSLF-NLSSLTHLFLGNN 349
+ + L N IS +P+ R+L L L N L I + F L+ L L L +N
Sbjct: 33 ASQRIFLHGNRIS-HVPAASFRACRNLTILWLHSNVL-ARIDAAAFTGLALLEQLDLSDN 90
Query: 350 KLNGTLPA---RKSPLLLNIDVSYNNLQGNLPS-WINGQQNLQI-NLVANNLT 397
++ L + + LQ L G LQ L N L
Sbjct: 91 AQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNALQ 142
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 5e-06
Identities = 23/99 (23%), Positives = 41/99 (41%), Gaps = 10/99 (10%)
Query: 305 DSIPSNIGEYRSLQHLDLSFNNLGGSIPDSLF-NLSSLTHLFLGNNKLNGTLPA---RKS 360
++P I + Q + L N + +P + F +LT L+L +N L + A
Sbjct: 24 QAVPVGI--PAASQRIFLHGNRI-SHVPAASFRACRNLTILWLHSNVL-ARIDAAAFTGL 79
Query: 361 PLLLNIDVSYNNLQGNLPS-WINGQQNLQ-INLVANNLT 397
LL +D+S N ++ +G L ++L L
Sbjct: 80 ALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ 118
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 9e-19
Identities = 51/203 (25%), Positives = 82/203 (40%), Gaps = 34/203 (16%)
Query: 701 LGEGGFGPVYKGK-LGDGRAIAVK-----QLSVASRQGKSQFVA-EIATISAVQHR--NL 751
LG GGFG VY G + D +A+K ++S V E+ + V +
Sbjct: 51 LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 110
Query: 752 VKLHGCCIEGAERL-LVYEYLENKSLDQALF----GQRSLTLDWATRY--EICSGVARGL 804
++L E + L+ E E Q LF + +L + A + ++ V
Sbjct: 111 IRLLDW-FERPDSFVLILERPEPV---QDLFDFITERGALQEELARSFFWQVLEAVR--- 163
Query: 805 AYLHEESRVRIIHRDVKASNVLLDAD-LVPKISDFGLAKLYDDKKTHISTRVAGTIGYLA 863
+ H ++HRD+K N+L+D + K+ DFG L D GT Y
Sbjct: 164 -HCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDF---DGTRVYSP 216
Query: 864 PEYAMRGHLTE--KTDVFAFGVL 884
PE+ +R H V++ G+L
Sbjct: 217 PEW-IRYHRYHGRSAAVWSLGIL 238
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 1e-18
Identities = 50/291 (17%), Positives = 104/291 (35%), Gaps = 42/291 (14%)
Query: 114 VIPDELWNLTSLFNLNLGQNYLTGPLSPSVGNLTAMQYLNLAINALSGELPKELGQLTEL 173
+ D+ NL + +T + L ++ + + + + + + L +
Sbjct: 17 IFSDD--AFAETIKDNLKKKSVTDA--VTQNELNSIDQIIANNSDIK-SV-QGIQYLPNV 70
Query: 174 LILGIGTNNFSGPLPSELGSLSKLQELYIDSAGVSGEIPSSFANLQSLTKWWASDTRLTG 233
L + N + L +L L L++D V ++L+ L
Sbjct: 71 TKLFLNGNKLTD--IKPLANLKNLGWLFLDENKV-----KDLSSLKDLK----------- 112
Query: 234 RIPDFIGNWSKLTALRFQGNSFNGPIPSSFSNLTSVTELRISDLSNGSSKLAFIRDMKSL 293
KL +L + N + + +L + L + + N + + + + L
Sbjct: 113 ----------KLKSLSLEHNGIS--DINGLVHLPQLESLYLGN--NKITDITVLSRLTKL 158
Query: 294 SILELRNNNISDSIPSNIGEYRSLQHLDLSFNNLGGSIPDSLFNLSSLTHLFLGNNKLNG 353
L L +N ISD + LQ+L LS N++ S +L L +L L L + +
Sbjct: 159 DTLSLEDNQISD--IVPLAGLTKLQNLYLSKNHI--SDLRALAGLKNLDVLELFSQECLN 214
Query: 354 TLPARKSPLLLNIDVSYNNLQGNLPSWINGQQNLQINLVANNLTIRSSDNS 404
+S L++ V + P I+ + + V +L +++ S
Sbjct: 215 KPINHQSNLVVPNTVKNTDGSLVTPEIISDDGDYEKPNVKWHLPEFTNEVS 265
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 4e-17
Identities = 48/243 (19%), Positives = 94/243 (38%), Gaps = 26/243 (10%)
Query: 167 LGQLTELLILGIGTNNFSGPLPSELGSLSKLQELYIDSAGVSGEIPSSFANLQSLTKWWA 226
E + + + + + L+ + ++ +++ + + L ++TK +
Sbjct: 20 DDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SV-QGIQYLPNVTKLFL 75
Query: 227 SDTRLTGRIPDFIGNWSKLTALRFQGNSFNGPIP--SSFSNLTSVTELRISDLSNGSSKL 284
+ +LT I + N L L N + SS +L + L + NG S +
Sbjct: 76 NGNKLT-DIKP-LANLKNLGWLFLDEN----KVKDLSSLKDLKKLKSLSLE--HNGISDI 127
Query: 285 AFIRDMKSLSILELRNNNISDSIPSNIGEYRSLQHLDLSFNNLGGSIPDSLFNLSSLTHL 344
+ + L L L NN I+D + + L L L N + S L L+ L +L
Sbjct: 128 NGLVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQI--SDIVPLAGLTKLQNL 183
Query: 345 FLGNNKLNGTLPARKSPLLLNIDVSYNNLQGNLPSWINGQQNLQINLVANNLTIRSSDNS 404
+L N ++ L +++ +N N Q NLV N T++++D S
Sbjct: 184 YLSKNHISDLRALAGLKNLDVLELFSQEC-------LNKPINHQSNLVVPN-TVKNTDGS 235
Query: 405 VLP 407
++
Sbjct: 236 LVT 238
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 3e-07
Identities = 19/124 (15%), Positives = 46/124 (37%), Gaps = 13/124 (10%)
Query: 278 SNGSSKLAFIRDMKSLSILELRNNNISDSIPSNIGEYRSLQHLDLSFNNLGGSIPDSLFN 337
++ L+ +++D E S+ + + +++ S+ +
Sbjct: 11 PTPIKQIFSDDAFAETIKDNLKKKSVTD--AVTQNELNSIDQIIANNSDI-KSV-QGIQY 66
Query: 338 LSSLTHLFLGNNKLNGTLPARKSPLLLNIDVSYNNLQGNLPSWINGQQNL----QINLVA 393
L ++T LFL NKL P L + + N + ++ ++L ++L
Sbjct: 67 LPNVTKLFLNGNKLTDIKPLANLKNLGWLFLDENKV-----KDLSSLKDLKKLKSLSLEH 121
Query: 394 NNLT 397
N ++
Sbjct: 122 NGIS 125
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 2e-18
Identities = 69/261 (26%), Positives = 108/261 (41%), Gaps = 33/261 (12%)
Query: 663 KRPQHDDDEELLGMDARPYTFSYAELKTATENFSPSN----K-LGEGGFGPVYKGKL-GD 716
+PQ + + ++ + PS+ K +G+G FG V + +
Sbjct: 3 SQPQEPELMNANPAPPPAPSQQINLGPSSNPHAKPSDFHFLKVIGKGSFGKVLLARHKAE 62
Query: 717 GRAIAVKQLSVASRQGKSQFVAEIAT-----ISAVQHRNLVKLHGCCIEGAERL-LVYEY 770
AVK L + K + I + + V+H LV LH + A++L V +Y
Sbjct: 63 EVFYAVKVLQKKAILKKKE-EKHIMSERNVLLKNVKHPFLVGLH-FSFQTADKLYFVLDY 120
Query: 771 LENKSLDQALFGQRSLTLDWATRY--EICSGVARGLAYLHEESRVRIIHRDVKASNVLLD 828
+ L L +R A Y EI S L YLH + I++RD+K N+LLD
Sbjct: 121 INGGELFYHLQRERCFLEPRARFYAAEIASA----LGYLHSLN---IVYRDLKPENILLD 173
Query: 829 ADLVPKISDFGLAK--LYDDKKTHISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLAL 886
+ ++DFGL K + + T ST GT YLAPE + D + G +
Sbjct: 174 SQGHIVLTDFGLCKENIEHNSTT--ST-FCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLY 230
Query: 887 ETVSGRPNSDP--SLDEEKLY 905
E + G P P S + ++Y
Sbjct: 231 EMLYGLP---PFYSRNTAEMY 248
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 2e-18
Identities = 54/191 (28%), Positives = 89/191 (46%), Gaps = 17/191 (8%)
Query: 701 LGEGGFGPVYKGK-LGDGRAIAVKQL--SVASRQGKSQFVAEIATISAVQHRNLVKLHGC 757
+G+G F V + + GR +A+K + + + + E+ + + H N+VKL
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82
Query: 758 CIEGAERL-LVYEYLENKSLDQALFGQRSLTLDWATRY--EICSGVARGLAYLHEESRVR 814
IE + L L+ EY + L + A +I S V Y H + R
Sbjct: 83 -IETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQ----YCH---QKR 134
Query: 815 IIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVAGTIGYLAPE-YAMRGHLT 873
I+HRD+KA N+LLDAD+ KI+DFG + + + G Y APE + + +
Sbjct: 135 IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG-KLDAFC-GAPPYAAPELFQGKKYDG 192
Query: 874 EKTDVFAFGVL 884
+ DV++ GV+
Sbjct: 193 PEVDVWSLGVI 203
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 2e-18
Identities = 69/223 (30%), Positives = 100/223 (44%), Gaps = 38/223 (17%)
Query: 701 LGEGGFGPVYKGKL-GDGRAIAVKQLSVASRQGKSQFVA--EIA-TIS-------AVQHR 749
LG+G FG V+ + + A+K L K + ++ T+ A +H
Sbjct: 25 LGKGSFGKVFLAEFKKTNQFFAIKALK------KDVVLMDDDVECTMVEKRVLSLAWEHP 78
Query: 750 NLVKLHGCCIEGAERL-LVYEYLENKSLDQALFGQRSLTLDWATRY--EICSGVARGLAY 806
L + C + E L V EYL L + L AT Y EI G L +
Sbjct: 79 FLTHMF-CTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILG----LQF 133
Query: 807 LHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAK--LYDDKKTHISTRVAGTIGYLAP 864
LH + I++RD+K N+LLD D KI+DFG+ K + D KT +T GT Y+AP
Sbjct: 134 LHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT--NT-FCGTPDYIAP 187
Query: 865 EYAMRGHLTEKTDVFAFGVLALETVSGRPNSDP--SLDEEKLY 905
E + D ++FGVL E + G+ P DEE+L+
Sbjct: 188 EILLGQKYNHSVDWWSFGVLLYEMLIGQS---PFHGQDEEELF 227
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 4e-18
Identities = 48/204 (23%), Positives = 80/204 (39%), Gaps = 34/204 (16%)
Query: 701 LGEGGFGPVYKGK-LGDGRAIAVKQL------SVASRQGKSQFVAEIATISAV----QHR 749
LG+GGFG V+ G L D +A+K + + E+A + V H
Sbjct: 39 LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98
Query: 750 NLVKLHGCCIEGAERL-LVYEYLENKSLDQALF----GQRSLTLDWATRY--EICSGVAR 802
+++L E E LV E Q LF + L + + ++ + +
Sbjct: 99 GVIRLLDW-FETQEGFMLVLERPLP---AQDLFDYITEKGPLGEGPSRCFFGQVVAAIQ- 153
Query: 803 GLAYLHEESRVRIIHRDVKASNVLLDAD-LVPKISDFGLAKLYDDKKTHISTRVAGTIGY 861
+ H ++HRD+K N+L+D K+ DFG L D+ GT Y
Sbjct: 154 ---HCH---SRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDF---DGTRVY 204
Query: 862 LAPEY-AMRGHLTEKTDVFAFGVL 884
PE+ + + V++ G+L
Sbjct: 205 SPPEWISRHQYHALPATVWSLGIL 228
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 86.1 bits (214), Expect = 4e-18
Identities = 66/224 (29%), Positives = 93/224 (41%), Gaps = 31/224 (13%)
Query: 701 LGEGGFGPVYKGKL-GDGRAIAVKQLSVASRQGKSQFVAEIAT-----ISAVQHRNLVKL 754
+G G + V +L R A+K + + + T A H LV L
Sbjct: 17 IGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDED-IDWVQTEKHVFEQASNHPFLVGL 75
Query: 755 HGCCIEGAERL-LVYEYLENKSLDQALFGQRSLTLDWATRY--EICSGVARGLAYLHEES 811
H C + RL V EY+ L + QR L + A Y EI L YLHE
Sbjct: 76 H-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLA----LNYLHERG 130
Query: 812 RVRIIHRDVKASNVLLDADLVPKISDFGLAK--LYDDKKTHISTRVAGTIGYLAPEYAMR 869
II+RD+K NVLLD++ K++D+G+ K L T T GT Y+APE
Sbjct: 131 ---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTS--T-FCGTPNYIAPEILRG 184
Query: 870 GHLTEKTDVFAFGVLALETVSGRP--------NSDPSLDEEKLY 905
D +A GVL E ++GR ++ E+ L+
Sbjct: 185 EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLF 228
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 86.1 bits (214), Expect = 4e-18
Identities = 65/218 (29%), Positives = 93/218 (42%), Gaps = 28/218 (12%)
Query: 701 LGEGGFGPVYKGKL-GDGRAIAVKQLSVASRQGKSQFVAEIAT-----ISAVQHRNLVKL 754
LG+G FG V + G AVK L V + L +L
Sbjct: 28 LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDD-VECTMVEKRVLALPGKPPFLTQL 86
Query: 755 HGCCIEGAERL-LVYEYLENKSLDQALFGQRSLTLDWATRY--EICSGVARGLAYLHEES 811
H C + +RL V EY+ L + A Y EI G L +L +
Sbjct: 87 H-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIG----LFFLQSK- 140
Query: 812 RVRIIHRDVKASNVLLDADLVPKISDFGLAK--LYDDKKTHISTRVAGTIGYLAPEYAMR 869
II+RD+K NV+LD++ KI+DFG+ K ++D T T GT Y+APE
Sbjct: 141 --GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTK--T-FCGTPDYIAPEIIAY 195
Query: 870 GHLTEKTDVFAFGVLALETVSGRPNSDP--SLDEEKLY 905
+ D +AFGVL E ++G+ P DE++L+
Sbjct: 196 QPYGKSVDWWAFGVLLYEMLAGQA---PFEGEDEDELF 230
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 87.1 bits (216), Expect = 5e-18
Identities = 58/278 (20%), Positives = 87/278 (31%), Gaps = 44/278 (15%)
Query: 121 NLTSLFNLNLGQNYLTGPLSPSV--GNLTAMQYLNLAINALSGELPKELGQLTELL---- 174
LTSL L L N + + P+ N+ L+L N + ++L
Sbjct: 127 PLTSLEMLVLRDNNIKK-IQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLL 185
Query: 175 ------ILGIGTNNFSGPLPSELGSLSKLQELYIDSAGVSGEIPSSFANLQSLTKWWASD 228
+ + + + L + G + F + + TK
Sbjct: 186 RLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTK----- 240
Query: 229 TRLTGRIPDFIGNWSKLTALRFQGNSFNGPIPSSFSNL--TSVTEL-----RISDLSNGS 281
I I + S F +F P +F L + V +I L
Sbjct: 241 ------IQSLILSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKS- 293
Query: 282 SKLAFIRDMKSLSILELRNNNISDSIPSNI-GEYRSLQHLDLSFNNLGGSIPDSLF-NLS 339
F L L L N I+ I N L L+LS N LG SI +F NL
Sbjct: 294 ---VF-SHFTDLEQLTLAQNEIN-KIDDNAFWGLTHLLKLNLSQNFLG-SIDSRMFENLD 347
Query: 340 SLTHLFLGNNKLNGTLPAR---KSPLLLNIDVSYNNLQ 374
L L L N + L + P L + + N L+
Sbjct: 348 KLEVLDLSYNHI-RALGDQSFLGLPNLKELALDTNQLK 384
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 86.0 bits (213), Expect = 1e-17
Identities = 60/307 (19%), Positives = 112/307 (36%), Gaps = 43/307 (14%)
Query: 116 PDELWNLTSLFNLNLGQNYLTG-PLSPSV-GNLTAMQYLNLAINALSGELPKEL-GQLTE 172
L +L L L Q L G LS + LT+++ L L N + P +
Sbjct: 96 TGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRR 155
Query: 173 LLILGIGTNNFSGPLPSELGSLSKLQELYIDSAGVSGEIPSSFANLQSLTKWWASDTRLT 232
+L + N +L + + + + LQ + ++W
Sbjct: 156 FHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSI---------TLQDMNEYWLGWE--- 203
Query: 233 GRIPDFIGNWSKLTALRFQGNSFNGPIPSSFSNLTSVTELRISDLSNGSSKLAFIRDMK- 291
+ + N + +T L GN F + F + + T+++ LSN + +
Sbjct: 204 -KCGNPFKN-TSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNF 261
Query: 292 --------------SLSILELRNNNISDSIPSNI-GEYRSLQHLDLSFNNLGGSIPDSLF 336
+ +L + I ++ ++ + L+ L L+ N + I D+ F
Sbjct: 262 KDPDNFTFKGLEASGVKTCDLSKSKIF-ALLKSVFSHFTDLEQLTLAQNEI-NKIDDNAF 319
Query: 337 -NLSSLTHLFLGNNKLNGTLPA---RKSPLLLNIDVSYNNLQGNLPSWI-NGQQNLQ-IN 390
L+ L L L N L G++ + L +D+SYN+++ L G NL+ +
Sbjct: 320 WGLTHLLKLNLSQNFL-GSIDSRMFENLDKLEVLDLSYNHIR-ALGDQSFLGLPNLKELA 377
Query: 391 LVANNLT 397
L N L
Sbjct: 378 LDTNQLK 384
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 76.3 bits (188), Expect = 1e-14
Identities = 50/307 (16%), Positives = 95/307 (30%), Gaps = 42/307 (13%)
Query: 116 PDELWNLTSLFNLNLGQNYLTGPLSPSV-GNLTAMQYLNLAINALSGELPKE-LGQLTEL 173
L L L + Q + + L+++ L L N +L L L
Sbjct: 47 ETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFL-QLETGAFNGLANL 105
Query: 174 LILGIGTNNF-SGPLPSEL-GSLSKLQELYIDSAGVSGEIPSS-FANLQSLTKWWASDTR 230
+L + N L L+ L+ L + + P+S F N++ + +
Sbjct: 106 EVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNK 165
Query: 231 LTGRIPDFIGNWSKLTALRFQGNSFNGPIPSSFSNLTSVTELRISDLSNGSSKLAFIRDM 290
+ I + + F L+S+T +++ G K
Sbjct: 166 VK-SICE--EDLLNFQGKHFTLL-----------RLSSITLQDMNEYWLGWEKCGNPFKN 211
Query: 291 KSLSILELRNNNISDSIPS---NIGEYRSLQHLDLSFN---------NLGGSIPDSLFN- 337
S++ L+L N +S+ + +Q L LS + + F
Sbjct: 212 TSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFKG 271
Query: 338 --LSSLTHLFLGNNKLNGTLPA---RKSPLLLNIDVSYNNLQGNLPSWI-NGQQNLQ-IN 390
S + L +K+ L L + ++ N + + G +L +N
Sbjct: 272 LEASGVKTCDLSKSKIF-ALLKSVFSHFTDLEQLTLAQNEIN-KIDDNAFWGLTHLLKLN 329
Query: 391 LVANNLT 397
L N L
Sbjct: 330 LSQNFLG 336
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 72.5 bits (178), Expect = 2e-13
Identities = 38/205 (18%), Positives = 74/205 (36%), Gaps = 24/205 (11%)
Query: 227 SDTRLTGRIPDFIGNWSKLTALRFQGNSFNGPIPSSFSNLTSVTELRISD--LSNGSSKL 284
+ L ++P+ + + + NS +SFS L + L++
Sbjct: 18 INRGLH-QVPELPAH---VNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNN 73
Query: 285 AFIRDMKSLSILELRNNNISDSIPSNI-GEYRSLQHLDLSFNNL-GGSIPDSLF-NLSSL 341
F R + SL IL+L N + + +L+ L L+ NL G + + F L+SL
Sbjct: 74 TF-RGLSSLIILKLDYNQFL-QLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSL 131
Query: 342 THLFLGNNKLNGTLPAR---KSPLLLNIDVSYNNLQGNLPSWI----NGQQNLQINLVAN 394
L L +N + PA +D+++N ++ ++ G+ + L +
Sbjct: 132 EMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVK-SICEEDLLNFQGKHFTLLRLSSI 190
Query: 395 NLT-----IRSSDNSVLPRGLICLQ 414
L + P +
Sbjct: 191 TLQDMNEYWLGWEKCGNPFKNTSIT 215
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 70.2 bits (172), Expect = 1e-12
Identities = 46/285 (16%), Positives = 101/285 (35%), Gaps = 36/285 (12%)
Query: 147 TAMQYLNLAINALSGELPKELGQLTELLILGIGTNNFSGPLPSEL-GSLSKLQELYIDSA 205
+ Y++L++N+++ +L +L L + + + LS L L +D
Sbjct: 30 AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYN 89
Query: 206 GVSGEIPSS-FANLQSLTKWWASDTRLTGRI--PDFIGNWSKLTALRFQGNSFNGPIPSS 262
++ + F L +L + L G + +F + L L + N+ P+S
Sbjct: 90 QFL-QLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPAS 148
Query: 263 -FSNLTSVTEL-----RISDLSNGS----SKLAFIR-DMKSLSILELRNNNISDSIPSNI 311
F N+ L ++ + F + S+++ ++ + N
Sbjct: 149 FFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNP 208
Query: 312 GEYRSLQHLDLSFNNLGGSIPDSLFNLSSLTHL-------------FLGNNKL----NGT 354
+ S+ LDLS N S+ F+ + T + G+ N T
Sbjct: 209 FKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFT 268
Query: 355 LPARKSPLLLNIDVSYNNLQGNLPSWI-NGQQNLQ-INLVANNLT 397
++ + D+S + + L + + +L+ + L N +
Sbjct: 269 FKGLEASGVKTCDLSKSKIF-ALLKSVFSHFTDLEQLTLAQNEIN 312
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 5e-18
Identities = 68/265 (25%), Positives = 104/265 (39%), Gaps = 36/265 (13%)
Query: 665 PQHDDDEELLGMDARPYTFSYAELKTATENFSPSN----K-LGEGGFGPVYKGKL-GDGR 718
+ G++ + E A+ + + + +G G + V +L R
Sbjct: 19 NLYFQGAMGSGIEEEKEAMNTRESGKASSSLGLQDFDLLRVIGRGSYAKVLLVRLKKTDR 78
Query: 719 AIAVKQLSVASRQGKSQFVAEIAT-----ISAVQHRNLVKLHGCCIEGAERL-LVYEYLE 772
A++ + + + T A H LV LH C + RL V EY+
Sbjct: 79 IYAMRVVKKELVNDDED-IDWVQTEKHVFEQASNHPFLVGLH-SCFQTESRLFFVIEYVN 136
Query: 773 NKSLDQALFGQRSLTLDWATRY--EICSGVARGLAYLHEESRVRIIHRDVKASNVLLDAD 830
L + QR L + A Y EI L YLHE II+RD+K NVLLD++
Sbjct: 137 GGDLMFHMQRQRKLPEEHARFYSAEISLA----LNYLHERG---IIYRDLKLDNVLLDSE 189
Query: 831 LVPKISDFGLAK--LYDDKKTHISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALET 888
K++D+G+ K L T T GT Y+APE D +A GVL E
Sbjct: 190 GHIKLTDYGMCKEGLRPGDTTS--T-FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEM 246
Query: 889 VSGRP--------NSDPSLDEEKLY 905
++GR ++ E+ L+
Sbjct: 247 MAGRSPFDIVGSSDNPDQNTEDYLF 271
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 6e-18
Identities = 44/194 (22%), Positives = 74/194 (38%), Gaps = 20/194 (10%)
Query: 700 KLGEGGFGPVYKG-KLGDGRAIAVKQLSVASRQGKSQFVAEIATISAVQ-HRNLVKLHGC 757
LG G G V + G+ A+K L + + + E+ ++V +
Sbjct: 36 VLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQ-----EVDHHWQASGGPHIVCILDV 90
Query: 758 CIEGAER----LLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRV 813
L++ E +E L + + EI + + +LH +
Sbjct: 91 YENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHN-- 148
Query: 814 RIIHRDVKASNVLL---DADLVPKISDFGLAKLYDDKKTHISTRVAGTIGYLAPEYAMRG 870
I HRDVK N+L + D V K++DFG AK + T T Y+APE
Sbjct: 149 -IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA--LQTPC-YTPYYVAPEVLGPE 204
Query: 871 HLTEKTDVFAFGVL 884
+ D+++ GV+
Sbjct: 205 KYDKSCDMWSLGVI 218
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 1e-17
Identities = 66/218 (30%), Positives = 94/218 (43%), Gaps = 28/218 (12%)
Query: 701 LGEGGFGPVYKGKL-GDGRAIAVKQLSVASRQGKSQFVAEIAT-----ISAVQHRNLVKL 754
LG+G FG V ++ G AVK L V T A H L +L
Sbjct: 31 LGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDD-VECTMTEKRILSLARNHPFLTQL 89
Query: 755 HGCCIEGAERL-LVYEYLENKSLDQALFGQRSLTLDWATRY--EICSGVARGLAYLHEES 811
CC + +RL V E++ L + R A Y EI S L +LH++
Sbjct: 90 F-CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISA----LMFLHDKG 144
Query: 812 RVRIIHRDVKASNVLLDADLVPKISDFGLAK--LYDDKKTHISTRVAGTIGYLAPEYAMR 869
II+RD+K NVLLD + K++DFG+ K + + T +T GT Y+APE
Sbjct: 145 ---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTT--AT-FCGTPDYIAPEILQE 198
Query: 870 GHLTEKTDVFAFGVLALETVSGRPNSDP--SLDEEKLY 905
D +A GVL E + G P + +E+ L+
Sbjct: 199 MLYGPAVDWWAMGVLLYEMLCGHA---PFEAENEDDLF 233
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 83.0 bits (206), Expect = 2e-17
Identities = 58/193 (30%), Positives = 90/193 (46%), Gaps = 20/193 (10%)
Query: 701 LGEGGFGPVYKGK-LGDGRAIAVKQLS---VASRQGKSQFVAEIATISAVQHRNLVKLHG 756
LG G FG V G+ G +AVK L+ + S + EI + +H +++KL+
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 757 CCIEGAERL-LVYEYLENKSLDQALFGQRSLTLDWATRY--EICSGVARGLAYLHEESRV 813
I +V EY+ L + + A R +I S V Y H R
Sbjct: 79 V-ISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVD----YCH---RH 130
Query: 814 RIIHRDVKASNVLLDADLVPKISDFGLAKLY-DDKKTHISTRVAGTIGYLAPE-YAMRGH 871
++HRD+K NVLLDA + KI+DFGL+ + D + S G+ Y APE + R +
Sbjct: 131 MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTS---CGSPNYAAPEVISGRLY 187
Query: 872 LTEKTDVFAFGVL 884
+ D+++ GV+
Sbjct: 188 AGPEVDIWSCGVI 200
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 2e-17
Identities = 47/172 (27%), Positives = 72/172 (41%), Gaps = 19/172 (11%)
Query: 701 LGEGGFGPVYKGK-LGDGRAIAVKQLSVASRQGKSQFVAEIATISAVQHRNLVKLHGCCI 759
+G G FG + +AVK + EI +++H N+V+ I
Sbjct: 28 IGSGNFGVARLMRDKLTKELVAVKYIE-RGAAIDENVQREIINHRSLRHPNIVRFKEV-I 85
Query: 760 EGAERL-LVYEYLENKSLDQALFGQRSLTLDWATRY--EICSGVARGLAYLHEESRVRII 816
L ++ EY L + + + D A + ++ SGV+ Y H ++I
Sbjct: 86 LTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVS----YCH---SMQIC 138
Query: 817 HRDVKASNVLLDADLVP--KISDFGLAKLY-DDKKTHISTRVAGTIGYLAPE 865
HRD+K N LLD P KI DFG +K + + V GT Y+APE
Sbjct: 139 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK--STV-GTPAYIAPE 187
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 2e-17
Identities = 67/263 (25%), Positives = 102/263 (38%), Gaps = 41/263 (15%)
Query: 662 RKRPQHDDDEELLGMDARPYTFSYAELKTAT---ENFSPSNKLGEGGFGPVYKGKL-GDG 717
+K + + +E L + + T + F LG G FG V K G
Sbjct: 7 KKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESG 66
Query: 718 RAIAVKQLSVASRQGKSQFV---------AEIATISAVQHRNLVKLHGCCIEGAERL-LV 767
A+K L K + V E + AV LVKL + L +V
Sbjct: 67 NHYAMKILD------KQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSF-KDNSNLYMV 119
Query: 768 YEYLENKSLDQALFGQRSLTLDWATRY--EICSGVARGLAYLHEESRVRIIHRDVKASNV 825
EY+ + L + A Y +I YLH +I+RD+K N+
Sbjct: 120 MEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLT----FEYLHSLD---LIYRDLKPENL 172
Query: 826 LLDADLVPKISDFGLAKLYDDKKTHISTRVAGTIGYLAPEYAM-RGHLTEKTDVFAFGVL 884
L+D +++DFG AK +T T + GT LAPE + +G+ + D +A GVL
Sbjct: 173 LIDQQGYIQVTDFGFAK-RVKGRTW--T-LCGTPEALAPEIILSKGY-NKAVDWWALGVL 227
Query: 885 ALETVSGRPNSDP--SLDEEKLY 905
E +G P P + ++Y
Sbjct: 228 IYEMAAGYP---PFFADQPIQIY 247
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 84.8 bits (210), Expect = 2e-17
Identities = 52/228 (22%), Positives = 86/228 (37%), Gaps = 20/228 (8%)
Query: 677 DARPYTFSYAELKTATENFSPSNKLGEGGFGPVYKGKL-GDGRAIAVKQLS---VASRQG 732
+ +L+ E++ +G G FG V + + A+K LS + R
Sbjct: 53 RYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSD 112
Query: 733 KSQFVAEIATISAVQHRNLVKLHGCCIEGAERL-LVYEYLENKSLDQALFGQRSLTLDWA 791
+ F E ++ +V+L + L +V EY+ L + + WA
Sbjct: 113 SAFFWEERDIMAFANSPWVVQLF-YAFQDDRYLYMVMEYMPGGDLVNLMSNYD-VPEKWA 170
Query: 792 TRY--EICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKT 849
Y E+ L +H IHRDVK N+LLD K++DFG + +
Sbjct: 171 RFYTAEVVLA----LDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGM 223
Query: 850 HISTRVAGTIGYLAPE----YAMRGHLTEKTDVFAFGVLALETVSGRP 893
GT Y++PE G+ + D ++ GV E + G
Sbjct: 224 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDT 271
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 5e-17
Identities = 62/261 (23%), Positives = 105/261 (40%), Gaps = 27/261 (10%)
Query: 663 KRPQHDDDEELLGMDARPYTFSYAELKTATENFSPSNKLGEGGFGPVY----KGKLGDGR 718
+ + + R + K ENF LG G +G V+ G+
Sbjct: 24 DGGDGGEQLLTVKHELRTANLTGHAEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGK 83
Query: 719 AIAVKQLSVASRQGKSQFVAEIAT----ISAVQHRN-LVKLHGCCIEGAERL-LVYEYLE 772
A+K L A+ K++ T + ++ LV LH + +L L+ +Y+
Sbjct: 84 LYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLH-YAFQTETKLHLILDYIN 142
Query: 773 NKSLDQALFGQRSLTLDWATRY--EICSGVARGLAYLHEESRVRIIHRDVKASNVLLDAD 830
L L + T Y EI L +LH+ II+RD+K N+LLD++
Sbjct: 143 GGELFTHLSQRERFTEHEVQIYVGEIVLA----LEHLHKLG---IIYRDIKLENILLDSN 195
Query: 831 LVPKISDFGLAKLYDDKKTHISTRVAGTIGYLAPE---YAMRGHLTEKTDVFAFGVLALE 887
++DFGL+K + +T + GTI Y+AP+ GH + D ++ GVL E
Sbjct: 196 GHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGH-DKAVDWWSLGVLMYE 254
Query: 888 TVSGRP---NSDPSLDEEKLY 905
++G + ++
Sbjct: 255 LLTGASPFTVDGEKNSQAEIS 275
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 81.9 bits (202), Expect = 1e-16
Identities = 53/175 (30%), Positives = 82/175 (46%), Gaps = 21/175 (12%)
Query: 800 VARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAK-LYDDKKTHISTRVAGT 858
VA+G+ +L SR + IHRD+ A N+LL V KI DFGLA+ +Y D
Sbjct: 202 VAKGMEFL--ASR-KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 258
Query: 859 IGYLAPEYAMRGHLTEKTDVFAFGVLALETVS--GRPNSDPSLDEEKLYLLEWAWHLHEN 916
+ ++APE T ++DV++FGVL E S P +DEE L+ E
Sbjct: 259 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLK------EG 312
Query: 917 NQEIELADPKLIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVAMLCGDMEVST 971
+ + P ++ E+ + + L C PS RP+ S +V L ++ +
Sbjct: 313 TR---MRAP---DYTTPEMYQTM---LDCWHGEPSQRPTFSELVEHLGNLLQANA 358
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 58.4 bits (141), Expect = 5e-09
Identities = 40/189 (21%), Positives = 64/189 (33%), Gaps = 26/189 (13%)
Query: 665 PQHDDDEELLGMDARPYTFSYAELKTATENFSPSNKLGEGGFGPVYKGKL------GDGR 718
P + E L PY S E + LG G FG V + R
Sbjct: 2 PLDEHCERL------PYDASKWEF--PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCR 53
Query: 719 AIAVKQL-SVASRQGKSQFVAEIATISAV-QHRNLVKLHGCCI-EGAERLLVYEYLENKS 775
+AVK L A+ ++E+ + + H N+V L G C G +++ E+ + +
Sbjct: 54 TVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGN 113
Query: 776 LDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKI 835
L L + R E +G + + V I D+K + +
Sbjct: 114 LSTYL---------RSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSAS 164
Query: 836 SDFGLAKLY 844
S F K
Sbjct: 165 SGFVEEKSL 173
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 80.3 bits (199), Expect = 2e-16
Identities = 65/221 (29%), Positives = 101/221 (45%), Gaps = 38/221 (17%)
Query: 701 LGEGGFGPVYKGKL-GDGRAIAVKQLSVASRQGKSQFV---------AEIATISAVQHRN 750
LG G FG V+ + +GR A+K L K V E +S V H
Sbjct: 14 LGTGSFGRVHLIRSRHNGRYYAMKVLK------KEIVVRLKQVEHTNDERLMLSIVTHPF 67
Query: 751 LVKLHGCCIEGAERL-LVYEYLENKSLDQALFGQRSLTLDWATRY--EICSGVARGLAYL 807
++++ G + A+++ ++ +Y+E L L + A Y E+C L YL
Sbjct: 68 IIRMWGTF-QDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLA----LEYL 122
Query: 808 HEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVAGTIGYLAPEYA 867
H + II+RD+K N+LLD + KI+DFG AK D T+ T + GT Y+APE
Sbjct: 123 HSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPD-VTY--T-LCGTPDYIAPEVV 175
Query: 868 MR-GHLTEKTDVFAFGVLALETVSGRPNSDP--SLDEEKLY 905
+ + D ++FG+L E ++G P + K Y
Sbjct: 176 STKPY-NKSIDWWSFGILIYEMLAGYT---PFYDSNTMKTY 212
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 82.1 bits (203), Expect = 3e-16
Identities = 56/173 (32%), Positives = 81/173 (46%), Gaps = 19/173 (10%)
Query: 701 LGEGGFGPVYKGK-LGDGRAIAVKQLS---VASRQGKSQFVAEIATISAVQHRNLVKLHG 756
LG G FG V GK G +AVK L+ + S + EI + +H +++KL+
Sbjct: 24 LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83
Query: 757 CCIEGAERL-LVYEYLENKSLDQALFGQRSLTLDWATRY--EICSGVARGLAYLHEESRV 813
I + +V EY+ L + L + R +I SGV Y H R
Sbjct: 84 V-ISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVD----YCH---RH 135
Query: 814 RIIHRDVKASNVLLDADLVPKISDFGLAKLY-DDKKTHISTRVAGTIGYLAPE 865
++HRD+K NVLLDA + KI+DFGL+ + D + S G+ Y APE
Sbjct: 136 MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTS---CGSPNYAAPE 185
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 81.3 bits (201), Expect = 3e-16
Identities = 50/205 (24%), Positives = 79/205 (38%), Gaps = 41/205 (20%)
Query: 700 KLGEGGFGPVYKG-KLGDGRAIAVKQLSVASRQGKSQFVAEIATISAVQ-HRNLVKLHGC 757
LG G G V + A+K L + + E+ ++V++
Sbjct: 69 VLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARR-----EVELHWRASQCPHIVRIVDV 123
Query: 758 CIEGAER----LLVYEYL---ENKSLDQALF------GQRSLTLDWATRYEICSGVARGL 804
L+V E L E LF G ++ T A+ EI + +
Sbjct: 124 YENLYAGRKCLLIVMECLDGGE-------LFSRIQDRGDQAFTEREAS--EIMKSIGEAI 174
Query: 805 AYLHEESRVRIIHRDVKASNVLL-----DADLVPKISDFGLAKLYDDKKTHISTRVAGTI 859
YLH + I HRDVK N+L +A L K++DFG AK + ++T T
Sbjct: 175 QYLHSIN---IAHRDVKPENLLYTSKRPNAIL--KLTDFGFAKETTSHNS-LTTPC-YTP 227
Query: 860 GYLAPEYAMRGHLTEKTDVFAFGVL 884
Y+APE + D+++ GV+
Sbjct: 228 YYVAPEVLGPEKYDKSCDMWSLGVI 252
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 79.8 bits (197), Expect = 3e-16
Identities = 41/185 (22%), Positives = 65/185 (35%), Gaps = 16/185 (8%)
Query: 171 TELLILGIGTNNFSGPLPSELGSLSKLQELYIDSAGVSGEIPSSFANLQSLTKWWASDTR 230
+ IL + N + L ++L +L +D A ++ ++ L L S +
Sbjct: 31 KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQV-DGTLPVLGTLDLSHNQ 88
Query: 231 LTGRIPDFIGNWSKLTALRFQGNSFNGPIPSSFSNLTSVTEL-----RISDLSNGSSKLA 285
L +P LT L N + L + EL + L G
Sbjct: 89 LQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPG----L 143
Query: 286 FIRDMKSLSILELRNNNISDSIPSNI-GEYRSLQHLDLSFNNLGGSIPDSLFNLSSLTHL 344
L L L NNN++ +P+ + +L L L N+L +IP F L
Sbjct: 144 L-TPTPKLEKLSLANNNLT-ELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFA 200
Query: 345 FLGNN 349
FL N
Sbjct: 201 FLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 66.3 bits (162), Expect = 7e-12
Identities = 41/204 (20%), Positives = 62/204 (30%), Gaps = 37/204 (18%)
Query: 197 LQELYIDSAGVSGEIPSSFANLQSLTKWWASDTRLTGRIPDFIGNWSKLTALRFQGNSFN 256
L++ + ++ LT+ LT ++ G L L N
Sbjct: 33 TTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQVD-GTLPVLGTLDLSHNQLQ 90
Query: 257 GPIPSSFSNLTSVTELRISDLSNGSSKLAFIRDMKSLSILELRNNNISDSIPSNI-GEYR 315
+P L ++T L + N ++ S+P
Sbjct: 91 S-LPLLGQTLPALTVLD------------------------VSFNRLT-SLPLGALRGLG 124
Query: 316 SLQHLDLSFNNLGGSIPDSLF-NLSSLTHLFLGNNKLNGTLPA---RKSPLLLNIDVSYN 371
LQ L L N L ++P L L L L NN L LPA L + + N
Sbjct: 125 ELQELYLKGNELK-TLPPGLLTPTPKLEKLSLANNNLT-ELPAGLLNGLENLDTLLLQEN 182
Query: 372 NLQGNLPSWINGQQNLQ-INLVAN 394
+L +P G L L N
Sbjct: 183 SLY-TIPKGFFGSHLLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 50.5 bits (121), Expect = 1e-06
Identities = 27/109 (24%), Positives = 47/109 (43%), Gaps = 9/109 (8%)
Query: 292 SLSILELRNNNISDSIPSNIGEYRSLQHLDLSFNNLGGSIPDSLF-NLSSLTHLFLGNNK 350
S + N++ ++P ++ + L LS N L + + + LT L L +
Sbjct: 11 SHLEVNCDKRNLT-ALPPDL--PKDTTILHLSENLLY-TFSLATLMPYTRLTQLNLDRAE 66
Query: 351 LNGTLPA-RKSPLLLNIDVSYNNLQGNLPSWINGQQNLQI-NLVANNLT 397
L L P+L +D+S+N LQ +LP L + ++ N LT
Sbjct: 67 LT-KLQVDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLT 113
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 1e-04
Identities = 33/141 (23%), Positives = 44/141 (31%), Gaps = 29/141 (20%)
Query: 115 IPDELWNLTSLFNLNLGQNYLTGPLSPSV-GNLTAMQYLNLAINALSGELPKEL-GQLTE 172
+P L +L L++ N LT L L +Q L L N L LP L +
Sbjct: 92 LPLLGQTLPALTVLDVSFNRLTS-LPLGALRGLGELQELYLKGNELK-TLPPGLLTPTPK 149
Query: 173 LLILGIGTNNFSGPLPSELGSLSKLQELYIDSAGVSGEIPSSFANLQSLTKWWASDTRLT 232
L L + N L EL AG+ L++L + L
Sbjct: 150 LEKLSLANN--------------NLTEL---PAGL-------LNGLENLDTLLLQENSLY 185
Query: 233 GRIPDFIGNWSKLTALRFQGN 253
IP L GN
Sbjct: 186 -TIPKGFFGSHLLPFAFLHGN 205
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 1e-15
Identities = 53/193 (27%), Positives = 93/193 (48%), Gaps = 21/193 (10%)
Query: 701 LGEGGFGPVYKGK-LGDGRAIAVKQLS---VASRQGKSQFVAEIATISAVQHRNLVKLHG 756
LGEG FG V + +A+K +S + + EI+ + ++H +++KL+
Sbjct: 17 LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76
Query: 757 CCIEGAERL-LVYEYLENKSLDQALFGQRSLTLDWATRY--EICSGVARGLAYLHEESRV 813
I + +V EY + D + ++ +T D R+ +I + Y H R
Sbjct: 77 V-ITTPTDIVMVIEYAGGELFDY-IVEKKRMTEDEGRRFFQQIICAIE----YCH---RH 127
Query: 814 RIIHRDVKASNVLLDADLVPKISDFGLAKLY-DDKKTHISTRVAGTIGYLAPE-YAMRGH 871
+I+HRD+K N+LLD +L KI+DFGL+ + D S G+ Y APE + +
Sbjct: 128 KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTS---CGSPNYAAPEVINGKLY 184
Query: 872 LTEKTDVFAFGVL 884
+ DV++ G++
Sbjct: 185 AGPEVDVWSCGIV 197
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 5e-15
Identities = 47/237 (19%), Positives = 75/237 (31%), Gaps = 40/237 (16%)
Query: 170 LTELLILGIGTNNFSGPLPSELGSLSKLQELYIDSAGVSGEIPS-SFANLQSLTKWWASD 228
L + + +L + +Y+ ++ S SF NL +T +
Sbjct: 30 PPSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRN 89
Query: 229 TRLTGRIPDFIGNWSKLTALRFQGNSFNGPIPSSFSNLTSVTELRISDLSNGSSKL---A 285
TR I P + L + L I + G
Sbjct: 90 TRNLTYID-----------------------PDALKELPLLKFLGIFN--TGLKMFPDLT 124
Query: 286 FIRDMKSLSILELRNNNISDSIPSNI--GEYRSLQHLDLSFNNLGGSIPDSLFNLSSLTH 343
+ ILE+ +N SIP N G L L N S+ FN + L
Sbjct: 125 KVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDA 183
Query: 344 LFLGNNKLNGTLPAR----KSPLLLNIDVSYNNLQGNLPSWINGQQNLQINLVANNL 396
++L NK + +DVS ++ LPS G ++L+ L+A N
Sbjct: 184 VYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVT-ALPS--KGLEHLK-ELIARNT 236
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 2e-13
Identities = 41/286 (14%), Positives = 76/286 (26%), Gaps = 82/286 (28%)
Query: 89 CDCSSQNGTVCH-------------ITQLKVYALNVVGVIPDELWNLTSLFNLNLGQNYL 135
C+C + LK+ ++ + NL ++ + + +
Sbjct: 8 CECHQEEDFRVTCKDIQRIPSLPPSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSID-- 65
Query: 136 TGPLSPSVGNLTAMQYLNLAINALSGELPKELGQLTELLILGIGTNNFSGPLPSELGSLS 195
L + + +++F LS
Sbjct: 66 --------------------------------VTLQQ-----LESHSFYN--------LS 80
Query: 196 KLQELYIDSAGVSGEIPSS-FANLQSLTKWWASDTRLTGRIPD--FIGNWSKLTALRFQG 252
K+ + I + I L L +T L PD + + L
Sbjct: 81 KVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITD 139
Query: 253 NSFNGPIPS-SFSNLTSVTEL------RISDLSNGSSKLAFIRDMKSLSILELRNNNISD 305
N + IP +F L + T + + AF + L + L N
Sbjct: 140 NPYMTSIPVNAFQGLCNETLTLKLYNNGFTSVQGY----AF--NGTKLDAVYLNKNKYLT 193
Query: 306 SIPSNI--GEYRSLQHLDLSFNNLGGSIPDSLFNLSSLTHLFLGNN 349
I + G Y LD+S ++ ++P L L N
Sbjct: 194 VIDKDAFGGVYSGPSLLDVSQTSV-TALPSKGL--EHLKELIARNT 236
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 77.1 bits (190), Expect = 6e-15
Identities = 55/261 (21%), Positives = 102/261 (39%), Gaps = 77/261 (29%)
Query: 688 LKTATENFSPSNKLGEGGFGPVYKGKLGD-GRAIAVKQL----SVASRQGKSQFVAEIAT 742
L+T+++ +S LG G FG V + + G+ A+K++ +R E+
Sbjct: 2 LETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNR--------ELDI 53
Query: 743 ISAVQHRNLVKLHGCCIEGAERL------------------------------------- 765
+ + H N++KL +
Sbjct: 54 MKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYL 113
Query: 766 -LVYEYLE---NKSLDQALFGQRSLTLDWA--TRYEICSGVARGLAYLHEESRVRIIHRD 819
++ EY+ +K L + RS+ ++ Y++ R + ++H + I HRD
Sbjct: 114 NVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLF----RAVGFIHS---LGICHRD 166
Query: 820 VKASNVLLDA-DLVPKISDFGLAKLYDDKKTHIS---TRVAGTIGYLAPEYAMRG--HLT 873
+K N+L+++ D K+ DFG AK + ++ +R Y APE M G T
Sbjct: 167 IKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRF-----YRAPEL-MLGATEYT 220
Query: 874 EKTDVFAFG-VLALETVSGRP 893
D+++ G V E + G+P
Sbjct: 221 PSIDLWSIGCVFG-ELILGKP 240
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 1e-14
Identities = 53/245 (21%), Positives = 93/245 (37%), Gaps = 39/245 (15%)
Query: 675 GMDARPYTFSYAELKTA---TENFSPSNKLGEGGFGPVYKGKLGDGRAIAVKQLSVASRQ 731
GM A+ + ++ + G +G V G +G +A+K++
Sbjct: 1 GMQAKGEAAMRDLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSD 60
Query: 732 GKSQFVA-----------EIATISAVQHRNLVKLHGCCIEGAERL-----LVYEYLENKS 775
G++ + EI ++ H N++ L + E LV E +
Sbjct: 61 GRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-D 119
Query: 776 LDQALF-GQRSLTLDWATR--YEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLV 832
L Q + + ++ Y I GL LHE ++HRD+ N+LL +
Sbjct: 120 LAQVIHDQRIVISPQHIQYFMYHIL----LGLHVLHE---AGVVHRDLHPGNILLADNND 172
Query: 833 PKISDFGLAKLY--DDKKT-HISTRVAGTIGYLAPEYAM-RGHLTEKTDVFAFGVLALET 888
I DF LA+ D KT +++ R Y APE M T+ D+++ G + E
Sbjct: 173 ITICDFNLAREDTADANKTHYVTHRW-----YRAPELVMQFKGFTKLVDMWSAGCVMAEM 227
Query: 889 VSGRP 893
+ +
Sbjct: 228 FNRKA 232
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 1e-14
Identities = 49/184 (26%), Positives = 86/184 (46%), Gaps = 28/184 (15%)
Query: 692 TENFSPSNKLGEGGFGPVYKGK-LGDGRAIAVKQLSVASRQGKSQFVAEIATISAVQ-HR 749
+++ KLG G + V++ + + + VK L ++ + EI + ++
Sbjct: 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKK---KIKREIKILENLRGGP 91
Query: 750 NLVKLHGCCIEGAER--LLVYEYLENKSLDQALFGQRSLTLDWATR---YEICSGVARGL 804
N++ L + R LV+E++ N Q ++LT D+ R YEI + L
Sbjct: 92 NIITLADIVKDPVSRTPALVFEHVNNTDFKQLY---QTLT-DYDIRFYMYEIL----KAL 143
Query: 805 AYLHEESRVRIIHRDVKASNVLLDA---DLVPKISDFGLAKLYDDKKTHISTRVAGTIGY 861
Y H S I+HRDVK NV++D L ++ D+GLA+ Y + + + RVA + +
Sbjct: 144 DYCH--SM-GIMHRDVKPHNVMIDHEHRKL--RLIDWGLAEFYHPGQEY-NVRVA-SRYF 196
Query: 862 LAPE 865
PE
Sbjct: 197 KGPE 200
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 73.4 bits (179), Expect = 6e-14
Identities = 39/211 (18%), Positives = 64/211 (30%), Gaps = 50/211 (23%)
Query: 679 RPYTFSYAELKTATENFSPSNKLGEGGFGPVYKGKLGDGRAIAVKQLSVAS--------R 730
P FS+ TE K+GEG FG V++ D +A+K +++ +
Sbjct: 9 GPVPFSHC---LPTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQ 64
Query: 731 QGKSQFVAEIATISAVQ---------HRNLVKLHGCCI---EGAERLL------------ 766
+ + + EI + + L+ LL
Sbjct: 65 KTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGS 124
Query: 767 ------------VYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVR 814
++ LE + L R+ AT I + LA +R
Sbjct: 125 ANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEA--SLR 182
Query: 815 IIHRDVKASNVLLDADLVPKISDFGLAKLYD 845
HRD+ NVLL + K+ K
Sbjct: 183 FEHRDLHWGNVLLKKTSLKKLHYTLNGKSST 213
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 74.1 bits (182), Expect = 8e-14
Identities = 53/217 (24%), Positives = 92/217 (42%), Gaps = 31/217 (14%)
Query: 692 TENFSPSNKLGEGGFGPVYKGK-LGDGRAIAVKQLSVASRQGKSQFVA-----EIATISA 745
+ + +G G G V R +A+K+LS + +Q A E+ +
Sbjct: 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ---NQTHAKRAYRELVLMKC 117
Query: 746 VQHRNLVKLH-----GCCIEGAERL-LVYEYLE---NKSLDQALFGQRSLTLDWATRYEI 796
V H+N++ L +E + + LV E ++ + + L +R Y +
Sbjct: 118 VNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHER-------MSYLL 170
Query: 797 CSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVA 856
+ G+ +LH IIHRD+K SN+++ +D KI DFGLA+ + + T
Sbjct: 171 YQML-CGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT--SFMMTPYV 224
Query: 857 GTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRP 893
T Y APE + E D+++ G + E V +
Sbjct: 225 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKI 261
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 1e-13
Identities = 53/217 (24%), Positives = 91/217 (41%), Gaps = 31/217 (14%)
Query: 692 TENFSPSNKLGEGGFGPVYKGK-LGDGRAIAVKQLSVASRQGKSQFVA-----EIATISA 745
+ + +G G G V R +A+K+LS + +Q A E+ +
Sbjct: 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQ---NQTHAKRAYRELVLMKC 80
Query: 746 VQHRNLVKLH------GCCIEGAERLLVYEYLE---NKSLDQALFGQRSLTLDWATRYEI 796
V H+N++ L E + +V E ++ + + L +R L Y++
Sbjct: 81 VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYL----LYQM 136
Query: 797 CSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVA 856
G+ +LH IIHRD+K SN+++ +D KI DFGLA+ + + T
Sbjct: 137 L----CGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGT--SFMMTPYV 187
Query: 857 GTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRP 893
T Y APE + E D+++ G + E + G
Sbjct: 188 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGV 224
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 72.6 bits (178), Expect = 1e-13
Identities = 51/247 (20%), Positives = 85/247 (34%), Gaps = 43/247 (17%)
Query: 162 ELPKELGQLTELLILGIGTNNFSGPLPSELGSLSKLQELYIDSAGVSGEIPSS-FANLQS 220
E+P +L + L L+++ I V I + F+NL
Sbjct: 23 EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPK 80
Query: 221 LTKWWASDTRLTGRIPDFIGNWSKLTALRFQGNSFNGPIPSSFSNLTSVTELRISDLSNG 280
L + I + L + P +F NL ++ L IS+ G
Sbjct: 81 LH-------EI------RIEKANNLLYIN----------PEAFQNLPNLQYLLISN--TG 115
Query: 281 SSKL---AFIRDMKSLSILELRNNNISDSIPSNI--GEYRSLQHLDLSFNNLGGSIPDSL 335
L I +L++++N +I N G L L+ N + I +S
Sbjct: 116 IKHLPDVHKI-HSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGI-QEIHNSA 173
Query: 336 FNLSSLTHL-FLGNNKLNGTLPA---RKSPLLLNIDVSYNNLQGNLPSWI-NGQQNLQIN 390
FN + L L NN L LP + + +D+S + +LPS+ + L+
Sbjct: 174 FNGTQLDELNLSDNNNLE-ELPNDVFHGASGPVILDISRTRIH-SLPSYGLENLKKLRA- 230
Query: 391 LVANNLT 397
NL
Sbjct: 231 RSTYNLK 237
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 71.8 bits (176), Expect = 3e-13
Identities = 49/276 (17%), Positives = 80/276 (28%), Gaps = 48/276 (17%)
Query: 89 CDCSSQNGTV------CHITQLKVYALNVVGVIPDELWNLTSLFNLNLGQNYLTGPLSPS 142
C T + +L+ + + L + + QN + +
Sbjct: 14 FLCQESKVTEIPSDLPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEA- 72
Query: 143 VGNLTAMQYLNLAINALSGELPKELGQLTELLILGIGTNNFSGPLPSELGSLSKLQELYI 202
+ S L +L E+ I NN P +L LQ L I
Sbjct: 73 --------------DVFSN-----LPKLHEIRIE--KANNLLYINPEAFQNLPNLQYLLI 111
Query: 203 DSAGVSGEIPS-SFANLQSLTKWWASDTRLTGRIPD--FIGNWSKLTALRFQGNSFNGPI 259
+ G+ +P + D I F+G + L N I
Sbjct: 112 SNTGIK-HLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQE-I 169
Query: 260 PSSFSNLTSVTEL------RISDLSNGSSKLAFIRDMKSLSILELRNNNISDSIPSNIGE 313
+S N T + EL + +L N F IL++ I S+PS
Sbjct: 170 HNSAFNGTQLDELNLSDNNNLEELPND----VF-HGASGPVILDISRTRIH-SLPSYG-- 221
Query: 314 YRSLQHLDLSFNNLGGSIPDSLFNLSSLTHLFLGNN 349
+L+ L +P +L L +L L
Sbjct: 222 LENLKKLRARSTYNLKKLP-TLEKLVALMEASLTYP 256
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 55.2 bits (133), Expect = 6e-08
Identities = 38/233 (16%), Positives = 72/233 (30%), Gaps = 11/233 (4%)
Query: 116 PDELWNLTSLFNLNLGQNYLTGPLSPSVGNLTAMQYLNLAINALSGELPKEL--GQLTEL 173
P+ NL +L L + + + L++ N + + G E
Sbjct: 97 PEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFES 156
Query: 174 LILGIGTNNFSGPLPSELGSLSKLQELYIDSAGVSGEIPS-SFANLQSLTKWWASDTRLT 232
+IL + N + + + ++L EL + E+P+ F S TR+
Sbjct: 157 VILWLNKNGIQE-IHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIH 215
Query: 233 GRIPDFIGNWSKLTALRFQGNSFNGPIPSSFSNLTSVTELRISDLSNGSSKLAFIRDMKS 292
+P L LR + +P+ L + L + L+ S AF +
Sbjct: 216 -SLPS--YGLENLKKLRARSTYNLKKLPT-LEKLVA---LMEASLTYPSHCCAFANWRRQ 268
Query: 293 LSILELRNNNISDSIPSNIGEYRSLQHLDLSFNNLGGSIPDSLFNLSSLTHLF 345
+S L N + Q L+ +N + +
Sbjct: 269 ISELHPICNKSILRQEVDYMTQARGQRSSLAEDNESSYSRGFDMTYTEFDYDL 321
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 2e-13
Identities = 53/220 (24%), Positives = 95/220 (43%), Gaps = 38/220 (17%)
Query: 692 TENFSPSNKLGEGGFGPVYKGK-LGDGRAIAVKQLSVASRQGKSQFVA-----EIATISA 745
+ + +G G +G V G +A+K+LS + S+ A E+ +
Sbjct: 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQ---SEIFAKRAYRELLLLKH 79
Query: 746 VQHRNLVKLHGCCIEGAERL-------LVYEYLE---NKSLDQALFGQRSLTLDWATRYE 795
+QH N++ L A L LV +++ K + ++ L Y+
Sbjct: 80 MQHENVIGLLDV-FTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQYL----VYQ 134
Query: 796 ICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTH-ISTR 854
+ +GL Y+H ++HRD+K N+ ++ D KI DFGLA+ D + T + TR
Sbjct: 135 ML----KGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTR 187
Query: 855 VAGTIGYLAPEYAM-RGHLTEKTDVFAFGVLALETVSGRP 893
Y APE + H + D+++ G + E ++G+
Sbjct: 188 W-----YRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKT 222
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 2e-13
Identities = 51/220 (23%), Positives = 91/220 (41%), Gaps = 37/220 (16%)
Query: 692 TENFSPSNKLGEGGFGPVYKGK-LGDGRAIAVKQLSVASRQGKSQFVA-----EIATISA 745
+ +G G +G V G +A+K+L + S+ A E+ +
Sbjct: 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQ---SELFAKRAYRELRLLKH 80
Query: 746 VQHRNLVKLHGCCIEGAERL------LVYEYLENKSLDQALFGQRSLTLDWATR----YE 795
++H N++ L LV ++ L + + + L Y+
Sbjct: 81 MRHENVIGLLDVFTPDETLDDFTDFYLVMPFMG-TDLGKLM---KHEKLGEDRIQFLVYQ 136
Query: 796 ICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKT-HISTR 854
+ +GL Y+H IIHRD+K N+ ++ D KI DFGLA+ D + T ++ TR
Sbjct: 137 ML----KGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVTR 189
Query: 855 VAGTIGYLAPEYAM-RGHLTEKTDVFAFGVLALETVSGRP 893
Y APE + T+ D+++ G + E ++G+
Sbjct: 190 W-----YRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKT 224
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 2e-13
Identities = 54/174 (31%), Positives = 77/174 (44%), Gaps = 20/174 (11%)
Query: 700 KLGEGGFGPVYKGK-LGDGRAIAVKQLSVASRQGKSQFVAEIATISAVQH-RNLVKLHGC 757
K+G G FG +Y G + G +A+K V ++ Q E +Q + + C
Sbjct: 16 KIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWC 73
Query: 758 CIEGAERLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIH 817
EG ++V E L SL+ LF S T + + + Y+H ++ IH
Sbjct: 74 GAEGDYNVMVMELL-GPSLED-LFNFCSRKFSLKTVLLLADQMISRIEYIHSKN---FIH 128
Query: 818 RDVKASNVLL----DADLVPKISDFGLAKLYDDKKT--HISTR----VAGTIGY 861
RDVK N L+ +LV I DFGLAK Y D +T HI R + GT Y
Sbjct: 129 RDVKPDNFLMGLGKKGNLV-YIIDFGLAKKYRDARTHQHIPYRENKNLTGTARY 181
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 72.2 bits (177), Expect = 3e-13
Identities = 41/202 (20%), Positives = 77/202 (38%), Gaps = 30/202 (14%)
Query: 692 TENFSPSNKLGEGGFGPVYKGK-LGDGRAIAVKQLSVASRQGKSQFVA-----EIATISA 745
+ + + +G G +G V + + R +A+K++ EIA ++
Sbjct: 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFE---DLIDCKRILREIAILNR 108
Query: 746 VQHRNLVKLHGCCI-EGAERL----LVYEYLENKSLDQALFGQRSLTLDWATR--YEICS 798
+ H ++VK+ I + E+ +V E + + LT Y +
Sbjct: 109 LNHDHVVKVLDIVIPKDVEKFDELYVVLEIAD-SDFKKLFRTPVYLTELHIKTLLYNLL- 166
Query: 799 GVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVAG- 857
G+ Y+H I+HRD+K +N L++ D K+ DFGLA+ D + S
Sbjct: 167 ---VGVKYVHS---AGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISP 220
Query: 858 -----TIGYLAPEYAMRGHLTE 874
+ ++ LT
Sbjct: 221 REDDMNLVTFPHTKNLKRQLTG 242
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 4e-13
Identities = 60/271 (22%), Positives = 89/271 (32%), Gaps = 77/271 (28%)
Query: 89 CDCSSQNGTV-CHITQLKVYALNVVGVIPDELWNLTSLFNLNLGQNYLTGPLSPSV-GNL 146
C C++ +V C +L + IP L+L N L+ L L
Sbjct: 12 CSCNNNKNSVDCSSKKLTA----IPSNIP------ADTKKLDLQSNKLSS-LPSKAFHRL 60
Query: 147 TAMQYLNLAINALSGELPKELGQLTELLILGIGTNNFSGPLPSELGSLSKLQELYIDSAG 206
T ++ L L N +L L AG
Sbjct: 61 TKLRLLYLNDN-----------KLQTL------------------------------PAG 79
Query: 207 VSGEIPSSFANLQSLTKWWASDTRLTGRIPDFIGNW-SKLTALRFQGNSFNGPIPSSFSN 265
+ F L++L W +D +L +P + + L LR N P F +
Sbjct: 80 I-------FKELKNLETLWVTDNKLQ-ALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDS 131
Query: 266 LTSVTEL-----RISDLSNGSSKLAFIRDMKSLSILELRNNNISDSIPSNIGEY-RSLQH 319
LT +T L + L G F + SL L L NN + +P + L+
Sbjct: 132 LTKLTYLSLGYNELQSLPKG----VF-DKLTSLKELRLYNNQLK-RVPEGAFDKLTELKT 185
Query: 320 LDLSFNNLGGSIPDSLF-NLSSLTHLFLGNN 349
L L N L +P+ F +L L L L N
Sbjct: 186 LKLDNNQLK-RVPEGAFDSLEKLKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 2e-12
Identities = 42/165 (25%), Positives = 70/165 (42%), Gaps = 21/165 (12%)
Query: 245 LTALRFQGNSFNGPIPSSFSNLTSVTEL-----RISDLSNGSSKLAFIRDMKSLSILELR 299
L Q N + +F LT + L ++ L G F +K+L L +
Sbjct: 39 TKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAG----IFKE-LKNLETLWVT 93
Query: 300 NNNISDSIPSNIGEY-RSLQHLDLSFNNLGGSIPDSLF-NLSSLTHLFLGNNKLNGTLPA 357
+N + ++P + + +L L L N L S+P +F +L+ LT+L LG N+L +LP
Sbjct: 94 DNKLQ-ALPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNELQ-SLPK 150
Query: 358 ---RKSPLLLNIDVSYNNLQGNLPSWI-NGQQNLQI-NLVANNLT 397
K L + + N L+ +P + L+ L N L
Sbjct: 151 GVFDKLTSLKELRLYNNQLK-RVPEGAFDKLTELKTLKLDNNQLK 194
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 7e-13
Identities = 61/218 (27%), Positives = 97/218 (44%), Gaps = 33/218 (15%)
Query: 692 TENFSPSNKLGEGGFGPVYKGK-LGDGRAIAVKQLSVASRQGKSQFVA-----EIATISA 745
E + + +G G +G V G +AVK+LS + S A E+ +
Sbjct: 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ---SIIHAKRTYRELRLLKH 84
Query: 746 VQHRNLVKLHGCCIEGAERL------LVYEYLENKSLDQALFGQRSLTLDWAT--RYEIC 797
++H N++ L LV + L+ + Q+ LT D Y+I
Sbjct: 85 MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQK-LTDDHVQFLIYQIL 142
Query: 798 SGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKT-HISTRVA 856
RGL Y+H IIHRD+K SN+ ++ D KI DFGLA+ D+ T +++TR
Sbjct: 143 ----RGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVATRW- 194
Query: 857 GTIGYLAPEYAM-RGHLTEKTDVFAFGVLALETVSGRP 893
Y APE + H + D+++ G + E ++GR
Sbjct: 195 ----YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 228
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 7e-13
Identities = 43/175 (24%), Positives = 72/175 (41%), Gaps = 20/175 (11%)
Query: 700 KLGEGGFGPVYKGK-LGDGRAIAVKQLSVASRQGKSQFVAEIATISAVQH-RNLVKLHGC 757
++GEG FG +++G L + + +A+K S Q E T + + ++
Sbjct: 17 RIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYF 74
Query: 758 CIEGAERLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIH 817
EG +LV + L SL+ L T + + +HE+S +++
Sbjct: 75 GQEGLHNVLVIDLL-GPSLED-LLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS---LVY 129
Query: 818 RDVKASNVLLDADLVPK-----ISDFGLAKLYDDKKT--HISTR----VAGTIGY 861
RD+K N L+ + DFG+ K Y D T HI R ++GT Y
Sbjct: 130 RDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARY 184
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 1e-12
Identities = 64/235 (27%), Positives = 105/235 (44%), Gaps = 28/235 (11%)
Query: 676 MDARPYTFSYAELKTA---TENFSPSNKLGEGGFGPVYKGK-LGDGRAIAVKQLSVASRQ 731
M A ++ + +GEG +G V + +A+K++S Q
Sbjct: 7 MAAAAAAGPEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQ 66
Query: 732 GKSQFVA-EIATISAVQHRNLVKLHGCCI-EGAERL----LVYEYLENKSLDQALFGQRS 785
Q EI + +H N++ ++ E++ +V + +E L + L Q
Sbjct: 67 TYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLME-TDLYKLLKTQH- 124
Query: 786 LTLDWAT--RYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKL 843
L+ D Y+I RGL Y+H ++HRD+K SN+LL+ KI DFGLA++
Sbjct: 125 LSNDHICYFLYQIL----RGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARV 177
Query: 844 YD---DKKTHISTRVAGTIGYLAPEYAM-RGHLTEKTDVFAFG-VLALETVSGRP 893
D D ++ VA T Y APE + T+ D+++ G +LA E +S RP
Sbjct: 178 ADPDHDHTGFLTEYVA-TRWYRAPEIMLNSKGYTKSIDIWSVGCILA-EMLSNRP 230
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 68.6 bits (168), Expect = 2e-12
Identities = 49/175 (28%), Positives = 71/175 (40%), Gaps = 20/175 (11%)
Query: 700 KLGEGGFGPVYKGK-LGDGRAIAVKQLSVASRQGKSQFVAEIATISAVQH-RNLVKLHGC 757
K+G G FG + GK L +A+K + SR Q E + + +++
Sbjct: 16 KIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYF 73
Query: 758 CIEGAERLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIH 817
G +V E L SL+ LF T T I + + Y+H ++ +I+
Sbjct: 74 GPCGKYNAMVLELL-GPSLED-LFDLCDRTFSLKTVLMIAIQLISRMEYVHSKN---LIY 128
Query: 818 RDVKASNVLLDADLVPK-----ISDFGLAKLYDDKKT--HISTR----VAGTIGY 861
RDVK N L+ I DF LAK Y D +T HI R + GT Y
Sbjct: 129 RDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARY 183
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 4e-12
Identities = 49/283 (17%), Positives = 91/283 (32%), Gaps = 65/283 (22%)
Query: 114 VIPDELWNLTSLFNLNLGQNYLTGPLSPSVGNLTAMQYLNLAINALSGELPKELGQLTEL 173
V PD L + NLG+ +T S L+ +Q N + + L
Sbjct: 12 VFPDP--GLANAVKQNLGKQSVTDL--VSQKELSGVQNFNGDNS-----------NIQSL 56
Query: 174 LILGIGTNNFSGPLPSELGSLSKLQELYIDSAGVSGEIPSSFANLQSLTKWWASDTRLTG 233
+ + + L+EL++ +S ++ S +L L + + RL
Sbjct: 57 ---------------AGMQFFTNLKELHLSHNQIS-DL-SPLKDLTKLEELSVNRNRLK- 98
Query: 234 RIPDFIGNWSKLTALRFQGNSFNGPIPSSFSNLTSVTELRISDLSNGSSKLAFIRDMKSL 293
+ + L+ L N + D + + +K+L
Sbjct: 99 NLNGI--PSACLSRLFLDNN-------------------ELRDTDS-------LIHLKNL 130
Query: 294 SILELRNNNISDSIPSNIGEYRSLQHLDLSFNNLGGSIPDSLFNLSSLTHLFLGNNKLNG 353
IL +RNN + +G L+ LDL N + + L L + + L K
Sbjct: 131 EILSIRNNKLKS--IVMLGFLSKLEVLDLHGNEI--TNTGGLTRLKKVNWIDLTGQKCVN 186
Query: 354 TLPARKSPLLLNIDVSYNNLQGNLPSWINGQQNLQINLVANNL 396
+ L + V + + P +I+ + V L
Sbjct: 187 EPVKYQPELYITNTVKDPDGRWISPYYISNGGSYVDGCVLWEL 229
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 8e-12
Identities = 43/208 (20%), Positives = 72/208 (34%), Gaps = 29/208 (13%)
Query: 216 ANLQSLTKWWASDTRLTGRIPDFIGNWSKLTALRFQGNSFNGPIPSSFSNLTSVTELRIS 275
L + K +T + S + ++ S + + T L+
Sbjct: 16 PGLANAVKQNLGKQSVTDLVS--QKELSGVQNFNGDNSNI-----QSLAGMQFFTNLKEL 68
Query: 276 DLS-NGSSKLAFIRDMKSLSILELRNNNISDSIPSNIGEYRSLQHLDLSFNNLGGSIPDS 334
LS N S L+ ++D+ L L + N + + + I L L L N L DS
Sbjct: 69 HLSHNQISDLSPLKDLTKLEELSVNRNRLKN--LNGI-PSACLSRLFLDNNEL--RDTDS 123
Query: 335 LFNLSSLTHLFLGNNKLNGTLPARKSPLLLNIDVSYNNLQ-----GNLPS----WINGQQ 385
L +L +L L + NNKL + L +D+ N + L + GQ+
Sbjct: 124 LIHLKNLEILSIRNNKLKSIVMLGFLSKLEVLDLHGNEITNTGGLTRLKKVNWIDLTGQK 183
Query: 386 ------NLQINLVANNLTIRSSDNSVLP 407
Q L N T++ D +
Sbjct: 184 CVNEPVKYQPELYITN-TVKDPDGRWIS 210
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 1e-07
Identities = 31/190 (16%), Positives = 56/190 (29%), Gaps = 13/190 (6%)
Query: 117 DELWNLTSLFNLNLGQNYLTGPLSPSVGNLTAMQYLNLAINALSGELPKELGQLTELLIL 176
+ T+L L+L N ++ LSP + +LT ++ L++ N L L+ L
Sbjct: 57 AGMQFFTNLKELHLSHNQISD-LSP-LKDLTKLEELSVNRNRLKNLNGIPSACLSRLF-- 112
Query: 177 GIGTNNFSGPLPSELGSLSKLQELYIDSAGVSGEIPSSFANLQSLTKWWASDTRLTGRIP 236
+ N L L L+ L I + + I L L +T
Sbjct: 113 -LDNNELRD--TDSLIHLKNLEILSIRNNKLK-SI-VMLGFLSKLEVLDLHGNEITN--T 165
Query: 237 DFIGNWSKLTALRFQGNSFNGPIPSSFSNLTSVTELRISDLSNGSSKLAFIRDMKSLSIL 296
+ K+ + G L + D +I + S
Sbjct: 166 GGLTRLKKVNWIDLTGQKCVNEPVKYQPELYI--TNTVKDPDGRWISPYYISNGGSYVDG 223
Query: 297 ELRNNNISDS 306
+ +
Sbjct: 224 CVLWELPVYT 233
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 2e-07
Identities = 20/128 (15%), Positives = 47/128 (36%), Gaps = 19/128 (14%)
Query: 273 RISDLSNGSSKLAFIRDMKSLSILELRNNNISDSIPSNIGEYRSLQHLDLSFNNLGGSIP 332
I+ + + + L +++D + E +Q+ + +N+
Sbjct: 8 PINQVFP-------DPGLANAVKQNLGKQSVTD--LVSQKELSGVQNFNGDNSNI--QSL 56
Query: 333 DSLFNLSSLTHLFLGNNKLNGTLPARKSPLLLNIDVSYNNLQGNLPSWINGQQNLQI--- 389
+ ++L L L +N+++ P + L + V+ N L+ +NG + +
Sbjct: 57 AGMQFFTNLKELHLSHNQISDLSPLKDLTKLEELSVNRNRLKN-----LNGIPSACLSRL 111
Query: 390 NLVANNLT 397
L N L
Sbjct: 112 FLDNNELR 119
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 67.5 bits (165), Expect = 8e-12
Identities = 42/198 (21%), Positives = 82/198 (41%), Gaps = 27/198 (13%)
Query: 692 TENFSPSNKLGEGGFGPVYKGK-LGDGRAIAVKQLSVASRQGKSQFVA-----EIATISA 745
+N+ + +G G +G VY + +A+K+++ EI ++
Sbjct: 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFE---DLIDCKRILREITILNR 81
Query: 746 VQHRNLVKLHGCCI-EGAERL----LVYEYLENKSLDQALFGQRSLTLDWATR---YEIC 797
++ +++L+ I + + +V E + L + LT + + Y +
Sbjct: 82 LKSDYIIRLYDLIIPDDLLKFDELYIVLEIAD-SDLKKLFKTPIFLT-EEHIKTILYNLL 139
Query: 798 SGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYD-DKKTHISTRVA 856
G ++HE IIHRD+K +N LL+ D K+ DFGLA+ + +K T+I +
Sbjct: 140 ----LGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLE 192
Query: 857 GTIGYLAPEYAMRGHLTE 874
++ LT
Sbjct: 193 ENEEPGPHNKNLKKQLTS 210
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 67.0 bits (163), Expect = 2e-11
Identities = 49/173 (28%), Positives = 75/173 (43%), Gaps = 18/173 (10%)
Query: 700 KLGEGGFGPVYKGK-LGDGRAIAVKQLSVASRQGKSQFVAEIATISAVQHRNLV-KLHGC 757
K+G G FG +Y G + +A+K +V ++ Q + E +Q + +
Sbjct: 14 KIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWF 71
Query: 758 CIEGAERLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIH 817
+EG +LV + L SL+ LF S L T + + + ++H +S +H
Sbjct: 72 GVEGDYNVLVMDLL-GPSLED-LFNFCSRKLSLKTVLMLADQMINRVEFVHSKS---FLH 126
Query: 818 RDVKASNVLLDADLVPK---ISDFGLAKLYDDKKT--HISTR----VAGTIGY 861
RD+K N L+ I DFGLAK Y D T HI R + GT Y
Sbjct: 127 RDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARY 179
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 65.9 bits (161), Expect = 2e-11
Identities = 28/178 (15%), Positives = 60/178 (33%), Gaps = 32/178 (17%)
Query: 699 NKLGEGGFGPVYKGK---------LGDGRAIAVK----------QLSVASRQGKSQFVAE 739
+ G +Y+ + ++K + + R K V +
Sbjct: 48 SFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNK 107
Query: 740 IATISAVQHRNLVKLHGC-CIEGAERLLVYEYLENKSLDQALF---GQRSLTLDWATRYE 795
+ + + G + R LV L +SL Q+ + L+ + +
Sbjct: 108 WKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSL-QSALDVSPKHVLSER--SVLQ 163
Query: 796 ICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKI--SDFGLAKLYDDKKTHI 851
+ + L +LHE +H +V A N+ +D + ++ + +G A Y H+
Sbjct: 164 VACRLLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHV 218
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 65.7 bits (161), Expect = 2e-11
Identities = 51/222 (22%), Positives = 93/222 (41%), Gaps = 30/222 (13%)
Query: 692 TENFSPSNKLGEGGFGPVYKGK-LGDGRAIAVKQLSVASRQGKSQFVA-EIATISAVQHR 749
+ +F + LGEG +G V G +A+K++ + + EI + +H
Sbjct: 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHE 69
Query: 750 NLVKLHGCCI-EGAERL----LVYEYLENKSLDQALFGQRSLTLDWATR---YEICSGVA 801
N++ + + E ++ E ++ L + + Q L+ D + Y+
Sbjct: 70 NIITIFNIQRPDSFENFNEVYIIQELMQ-TDLHRVISTQM-LS-DDHIQYFIYQTL---- 122
Query: 802 RGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVAGTIG- 860
R + LH +IHRD+K SN+L++++ K+ DFGLA++ D+ S G
Sbjct: 123 RAVKVLHG---SNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGM 179
Query: 861 --------YLAPEYAM-RGHLTEKTDVFAFGVLALETVSGRP 893
Y APE + + DV++ G + E RP
Sbjct: 180 VEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRP 221
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 3e-11
Identities = 32/113 (28%), Positives = 55/113 (48%), Gaps = 14/113 (12%)
Query: 246 TALRFQGNSFNGPIPSSFSNLTSVTEL-----RISDLSNGSSKLAFIRDMKSLSILELRN 300
T +R + N+ P +FS + + +IS+L+ AF + ++SL+ L L
Sbjct: 35 TEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPD----AF-QGLRSLNSLVLYG 89
Query: 301 NNISDSIPSNI-GEYRSLQHLDLSFNNLGGSIPDSLF-NLSSLTHLFLGNNKL 351
N I+ +P ++ SLQ L L+ N + + F +L +L L L +NKL
Sbjct: 90 NKIT-ELPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNKL 140
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 4e-08
Identities = 27/114 (23%), Positives = 45/114 (39%), Gaps = 14/114 (12%)
Query: 243 SKLTALRFQGNSFNGPIPSSFSNLTSVTEL-----RISDLSNGSSKLAFIRDMKSLSILE 297
KL + N + P +F L S+ L +I++L F + SL +L
Sbjct: 56 KKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKITELPKS----LF-EGLFSLQLLL 110
Query: 298 LRNNNISDSIPSNIGEY-RSLQHLDLSFNNLGGSIPDSLF-NLSSLTHLFLGNN 349
L N I+ + + + +L L L N L +I F L ++ + L N
Sbjct: 111 LNANKIN-CLRVDAFQDLHNLNLLSLYDNKLQ-TIAKGTFSPLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 4e-07
Identities = 35/173 (20%), Positives = 62/173 (35%), Gaps = 19/173 (10%)
Query: 88 KCDCSSQNGTV-CHITQLKVYALNVVGVIPDELWNLTSLFNLNLGQNYLTGPLSPSV-GN 145
C CS N V C L + +P ++ + L QN + + P
Sbjct: 8 ACTCS--NNIVDCRGKGLT----EIPTNLP------ETITEIRLEQNTIKV-IPPGAFSP 54
Query: 146 LTAMQYLNLAINALSGELPKEL-GQLTELLILGIGTNNFSGPLPSEL-GSLSKLQELYID 203
++ ++L+ N +S EL + L L L + N + LP L L LQ L ++
Sbjct: 55 YKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGNKITE-LPKSLFEGLFSLQLLLLN 112
Query: 204 SAGVSGEIPSSFANLQSLTKWWASDTRLTGRIPDFIGNWSKLTALRFQGNSFN 256
+ ++ +F +L +L D +L + + N F
Sbjct: 113 ANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFI 165
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 7e-05
Identities = 18/78 (23%), Positives = 32/78 (41%), Gaps = 9/78 (11%)
Query: 306 SIPSNIGEYRSLQHLDLSFNNLGGSIPDSLF-NLSSLTHLFLGNNKLNGTLPAR---KSP 361
IP+N+ E ++ + L N + IP F L + L NN+++ L
Sbjct: 25 EIPTNLPE--TITEIRLEQNTIK-VIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLR 80
Query: 362 LLLNIDVSYNNLQGNLPS 379
L ++ + N + LP
Sbjct: 81 SLNSLVLYGNKIT-ELPK 97
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 3e-11
Identities = 37/111 (33%), Positives = 52/111 (46%), Gaps = 15/111 (13%)
Query: 246 TALRFQGNSFNGPIPSSFSNLTSVTEL-----RISDLSNGSSKLAFIRDMKSLSILELRN 300
T L GN F +P SN +T + RIS LSN +F M L L L
Sbjct: 34 TELYLDGNQFTL-VPKELSNYKHLTLIDLSNNRISTLSNQ----SFSN-MTQLLTLILSY 87
Query: 301 NNISDSIPSNI-GEYRSLQHLDLSFNNLGGSIPDSLF-NLSSLTHLFLGNN 349
N + IP +SL+ L L N++ +P+ F +LS+L+HL +G N
Sbjct: 88 NRLR-CIPPRTFDGLKSLRLLSLHGNDIS-VVPEGAFNDLSALSHLAIGAN 136
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 65.9 bits (160), Expect = 4e-11
Identities = 41/218 (18%), Positives = 74/218 (33%), Gaps = 15/218 (6%)
Query: 119 LWNLTSLFNLNLGQNYLTGPLSPSVGNLTAMQYLNLAINALSGELPKELGQLTELLILGI 178
L + + + + SV T +Q + L P+ L + IL +
Sbjct: 334 LKDRPECWCRDSATDEQLFRCELSVEKSTVLQSELESCKELQELEPENKWCLLTI-ILLM 392
Query: 179 GTNNFSGPLPSELGSLSKLQELYIDSAGVSGEIPSSFANLQSLTKWWASDTR-------- 230
+ L S L+ + A ++ S F S+ K +D R
Sbjct: 393 RALDPLLYEKETLQYFSTLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKD 452
Query: 231 LTGRIPDFIGNWSKLTALRFQGNSFNGPIPSSFSNLTSVTELRISDLSNGSSKLAFIRDM 290
LT + + +T L N +P + + L + L+ SD N + + ++
Sbjct: 453 LT-VLC-HLEQLLLVTHLDLSHNRLRA-LPPALAALRCLEVLQASD--NALENVDGVANL 507
Query: 291 KSLSILELRNNNISD-SIPSNIGEYRSLQHLDLSFNNL 327
L L L NN + + + L L+L N+L
Sbjct: 508 PRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSL 545
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 65.9 bits (160), Expect = 4e-11
Identities = 37/247 (14%), Positives = 67/247 (27%), Gaps = 27/247 (10%)
Query: 114 VIPDELWNLTSLFNLNLGQNYLTGPLSPSVGNLTAMQYLNLAINALSGELPKELGQLTEL 173
S L + L++ + L EL EL
Sbjct: 317 TFRVIWTGSDSQKECVL-LKDRPECWCRDSATDEQLFRCELSVEKST-VLQSELESCKEL 374
Query: 174 LILGIGTNNFSGPLPSELGSLSKLQELYIDSAGVSGEIPSSFANLQSLTKWWASDTRL-- 231
L + + +L L E F+ L+++ A+
Sbjct: 375 QELEPENKWCLLTIILLMRALDPLLYE--------KETLQYFSTLKAVDPMRAAYLDDLR 426
Query: 232 ---TGRIPDFIGNWSKLTALRFQGNSFNGPIPSSFSNLTSVTELRISDLS-NGSSKL-AF 286
++ + L + +L + + DLS N L
Sbjct: 427 SKFLLENSVLKMEYADVRVLHLAHKDL-----TVLCHLEQLLLVTHLDLSHNRLRALPPA 481
Query: 287 IRDMKSLSILELRNNNISDSIPSNIGEYRSLQHLDLSFNNLGGSIPD--SLFNLSSLTHL 344
+ ++ L +L+ +N + ++ + LQ L L N L L + L L
Sbjct: 482 LAALRCLEVLQASDNALE-NVD-GVANLPRLQELLLCNNRLQ-QSAAIQPLVSCPRLVLL 538
Query: 345 FLGNNKL 351
L N L
Sbjct: 539 NLQGNSL 545
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 51.3 bits (122), Expect = 1e-06
Identities = 39/195 (20%), Positives = 71/195 (36%), Gaps = 24/195 (12%)
Query: 212 PSSFANLQSLTKWWASDTRLTGRIPDFIGNWSKLTALRFQGNSFNGPIPSSFSNLTSVTE 271
A + L + S + T + + + +L L + + LT +
Sbjct: 342 CRDSATDEQLFRCELSVEKST-VLQSELESCKELQEL---------EPENKWCLLTIILL 391
Query: 272 LR-ISDLSNGSSKLAFIRDMKSLSILELRNNNISDSI-----PSNIGEYRSLQHLDLSFN 325
+R + L L + +K++ + + S EY ++ L L+
Sbjct: 392 MRALDPLLYEKETLQYFSTLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHK 451
Query: 326 NLGGSIPDSLFNLSSLTHLFLGNNKLNGTLPARKSPL--LLNIDVSYNNLQGNLPSWING 383
+L ++ L L +THL L +N+L LP + L L + S N L+ N+ +
Sbjct: 452 DL--TVLCHLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVDG-VAN 506
Query: 384 QQNLQI-NLVANNLT 397
LQ L N L
Sbjct: 507 LPRLQELLLCNNRLQ 521
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 48.6 bits (115), Expect = 9e-06
Identities = 31/210 (14%), Positives = 66/210 (31%), Gaps = 33/210 (15%)
Query: 109 LNVVGVIPDELWNLTSLFNLNLGQNYLTGPLSPSVGNLTAMQYLNLAINALSGELPKELG 168
+ V+ EL + L L + L + + A+ L L +
Sbjct: 358 VEKSTVLQSELESCKELQELEPENKW---CLLTIILLMRALDPLLYEKETL-----QYFS 409
Query: 169 QLTELLILGIGT-----NNFSGPLPSELGSLSKLQELYIDSAGVSGEIPSSFANLQSLTK 223
L + + + F + ++ L++ ++ + L +T
Sbjct: 410 TLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLT--VLCHLEQLLLVTH 467
Query: 224 WWASDTRLTGRIPDFIGNWSKLTALRFQGN---SFNGPIPSSFSNLTSVTEL-----RIS 275
S RL +P + L L+ N + +G +NL + EL R+
Sbjct: 468 LDLSHNRLR-ALPPALAALRCLEVLQASDNALENVDG-----VANLPRLQELLLCNNRLQ 521
Query: 276 DLSNGSSKLAFIRDMKSLSILELRNNNISD 305
+ + + L +L L+ N++
Sbjct: 522 QSAA----IQPLVSCPRLVLLNLQGNSLCQ 547
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 4e-11
Identities = 59/224 (26%), Positives = 100/224 (44%), Gaps = 32/224 (14%)
Query: 692 TENFSPSNKLGEGGFGPVYKGK-LGDGRAIAVKQLSVASRQGKSQFVAEIATISAVQHRN 750
+ LG GG G V+ + +A+K++ + Q + EI I + H N
Sbjct: 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDN 69
Query: 751 LVKLH----------GCCIEGAERL----LVYEYLENKSLDQALFGQRSLTLDWATR--Y 794
+VK+ + L +V EY+E L L L + A Y
Sbjct: 70 IVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYME-TDLANVLEQGP-LLEEHARLFMY 127
Query: 795 EICSGVARGLAYLHEESRVRIIHRDVKASNVLLDA-DLVPKISDFGLAKLYD---DKKTH 850
++ RGL Y+H + ++HRD+K +N+ ++ DLV KI DFGLA++ D K H
Sbjct: 128 QLL----RGLKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGH 180
Query: 851 ISTRVAGTIGYLAPEYAMR-GHLTEKTDVFAFGVLALETVSGRP 893
+S + T Y +P + + T+ D++A G + E ++G+
Sbjct: 181 LSEGLV-TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKT 223
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 64.9 bits (158), Expect = 5e-11
Identities = 38/144 (26%), Positives = 54/144 (37%), Gaps = 18/144 (12%)
Query: 243 SKLTALRFQGNSFNGPIPSSFSNLTSVTELRISD-----LSNGSSKLAFIRDMKSLSILE 297
+ L +L N N +F + ++ L +S L F D+++L +L
Sbjct: 64 TNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSNHLHTLDEF----LF-SDLQALEVLL 118
Query: 298 LRNNNISDSIPSNIGEY-RSLQHLDLSFNNLGGSIPDSLF----NLSSLTHLFLGNNKLN 352
L NN+I + N E LQ L LS N + P L L L L L +NKL
Sbjct: 119 LYNNHIV-VVDRNAFEDMAQLQKLYLSQNQI-SRFPVELIKDGNKLPKLMLLDLSSNKLK 176
Query: 353 GTLPARKSPLLLNIDVSYNNLQGN 376
LP L + L N
Sbjct: 177 -KLPLTDLQKLPAWVKNGLYLHNN 199
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 56.8 bits (137), Expect = 2e-08
Identities = 37/197 (18%), Positives = 70/197 (35%), Gaps = 25/197 (12%)
Query: 88 KCDCSSQNGTV-CHITQLKVYALNVVGVIPDELWNLTSLFNLNLGQNYLTGPLSPSV--G 144
C C+S + C QL +P L + L+L N L+ L
Sbjct: 15 NCLCASN--ILSCSKQQLPN--------VPQSL--PSYTALLDLSHNNLSR-LRAEWTPT 61
Query: 145 NLTAMQYLNLAINALSGELPKE-LGQLTELLILGIGTNNFSGPLPSE-LGSLSKLQELYI 202
LT + L L+ N L+ + E + L L + +N+ L L L+ L +
Sbjct: 62 RLTNLHSLLLSHNHLN-FISSEAFVPVPNLRYLDLSSNHLHT-LDEFLFSDLQALEVLLL 119
Query: 203 DSAGVSGEIPS-SFANLQSLTKWWASDTRLTGRIPDFIGNWSKLTALRF---QGNSFNGP 258
+ + + +F ++ L K + S +++ + I + +KL L N
Sbjct: 120 YNNHIV-VVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLKKL 178
Query: 259 IPSSFSNLTSVTELRIS 275
+ L + + +
Sbjct: 179 PLTDLQKLPAWVKNGLY 195
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 63.6 bits (155), Expect = 1e-10
Identities = 33/175 (18%), Positives = 65/175 (37%), Gaps = 28/175 (16%)
Query: 700 KLGEGGFGPVYKGKLGDGRAIAVKQLSVA-----------------SRQGKSQFVAEIAT 742
+G+GGFG +Y + ++ V R K + + +
Sbjct: 42 PIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIR 101
Query: 743 ISAVQHRNLVKLHGCCIEGAE----RLLVYEYLENKSLDQALFGQRSLTLDWATRYEICS 798
+++ + K G + R ++ + L Q ++ + T ++
Sbjct: 102 TRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDL-QKIYEANAKRFSRKTVLQLSL 159
Query: 799 GVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKI--SDFGLAKLYDDKKTHI 851
+ L Y+HE +H D+KASN+LL+ ++ D+GLA Y + H
Sbjct: 160 RILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHK 211
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 63.2 bits (154), Expect = 1e-10
Identities = 33/173 (19%), Positives = 61/173 (35%), Gaps = 27/173 (15%)
Query: 700 KLGEGGFGPVYKGK-LGDGRAIAVKQLSVASRQ--------------GKSQFVAEIATIS 744
K+G GGFG +Y A + V ++ K + +
Sbjct: 44 KIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERK 103
Query: 745 AVQHRNLVKLHGC----CIEGAERLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGV 800
+ + + +G + R +V E L L + + T ++ +
Sbjct: 104 QLDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKS--TVLQLGIRM 160
Query: 801 ARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKI--SDFGLAKLYDDKKTHI 851
L Y+HE +H D+KA+N+LL ++ +D+GL+ Y H
Sbjct: 161 LDVLEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHK 210
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 2e-10
Identities = 39/163 (23%), Positives = 59/163 (36%), Gaps = 39/163 (23%)
Query: 700 KLGEGGFGPVYKGK-LGDGRAIAVKQLSVASRQGKSQFVAEIATISAV-QHRNLVKLHGC 757
LG G G V + A+K L + + E+ Q ++V++
Sbjct: 25 VLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARR-----EVELHWRASQCPHIVRIVDV 79
Query: 758 CIEGAER----LLVYEYL---ENKSLDQALF------GQRSLTLDWATR--YEICSGVAR 802
L+V E L E LF G ++ T A+ I +
Sbjct: 80 YENLYAGRKCLLIVMECLDGGE-------LFSRIQDRGDQAFTEREASEIMKSIGEAIQ- 131
Query: 803 GLAYLHEESRVRIIHRDVKASNVLL---DADLVPKISDFGLAK 842
YLH + I HRDVK N+L + + K++DFG AK
Sbjct: 132 ---YLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAK 168
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 3e-10
Identities = 26/109 (23%), Positives = 44/109 (40%), Gaps = 4/109 (3%)
Query: 243 SKLTALRFQGNSFN-GPIPSSFSNLTSVTELRISDLSNGSSKLAFIRDMKSLSILELRNN 301
S + L + N G + + L + G + +A + + L LEL +N
Sbjct: 17 SDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTIN--VGLTSIANLPKLNKLKKLELSDN 74
Query: 302 NISDSIPSNIGEYRSLQHLDLSFNNLGG-SIPDSLFNLSSLTHLFLGNN 349
+S + + +L HL+LS N + S + L L +L L L N
Sbjct: 75 RVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 4e-07
Identities = 23/89 (25%), Positives = 40/89 (44%), Gaps = 3/89 (3%)
Query: 265 NLTSVTELRISDLSNGSSKL-AFIRDMKSLSILELRNNNISDSIPSNIGEYRSLQHLDLS 323
+ V EL + + + KL + + L L N ++ I +N+ + L+ L+LS
Sbjct: 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTS-I-ANLPKLNKLKKLELS 72
Query: 324 FNNLGGSIPDSLFNLSSLTHLFLGNNKLN 352
N + G + +LTHL L NK+
Sbjct: 73 DNRVSGGLEVLAEKCPNLTHLNLSGNKIK 101
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 3e-10
Identities = 52/227 (22%), Positives = 85/227 (37%), Gaps = 52/227 (22%)
Query: 700 KLGEGGFGPVYKGK-LGDGRAIAVKQLSVASRQGKSQFVAEIATISAV------------ 746
KLG G F V+ K + + +A+K + + EI + V
Sbjct: 26 KLGWGHFSTVWLAKDMVNNTHVAMK-IVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMG 84
Query: 747 -----------QHRNLVKLHGCCIEGAERLLVYEYLENKSLDQAL--FGQRSLTLDWATR 793
H+ +H +V+E L ++L + + R + L +
Sbjct: 85 ANHILKLLDHFNHKGPNGVHVV--------MVFEVL-GENLLALIKKYEHRGIPLI-YVK 134
Query: 794 YEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVP------KISDFGLAKLYDDK 847
+I + GL Y+H IIH D+K NVL++ P KI+D G A YD+
Sbjct: 135 -QISKQLLLGLDYMHRR--CGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEH 191
Query: 848 KT-HISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRP 893
T I TR Y +PE + D+++ L E ++G
Sbjct: 192 YTNSIQTRE-----YRSPEVLLGAPWGCGADIWSTACLIFELITGDF 233
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 4e-10
Identities = 45/292 (15%), Positives = 88/292 (30%), Gaps = 55/292 (18%)
Query: 115 IPDELWNLTSLFNLNLGQNYLTGP----LSPSVGNLTAMQYLNLA---INALSGELPKEL 167
+ L S+ + L N + LS ++ + ++ + + E+P+ L
Sbjct: 24 VFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEAL 83
Query: 168 GQLTELLI-------LGIGTNNFSG----PLPSELGSLSKLQELY-----IDSAGV---- 207
L + L+ + + N F PL L + L+ LY +
Sbjct: 84 RLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIA 143
Query: 208 ----SGEIPSSFANLQSLTKWWASDTRLTGR----IPDFIGNWSKLTALRFQGNSFN--- 256
+ N L RL + L ++ N
Sbjct: 144 RALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEG 203
Query: 257 --GPIPSSFSNLTSVTELRISD---LSNGSSKLA-FIRDMKSLSILELRNNNISDSIPSN 310
+ + + L + D GSS LA ++ +L L L + +S +
Sbjct: 204 IEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAA 263
Query: 311 IGEY------RSLQHLDLSFNNLGG----SIPDSLF-NLSSLTHLFLGNNKL 351
+ + LQ L L +N + ++ + + L L L N+
Sbjct: 264 VVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRF 315
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 59.0 bits (143), Expect = 4e-09
Identities = 42/314 (13%), Positives = 94/314 (29%), Gaps = 67/314 (21%)
Query: 124 SLFNLNLGQNYLTG----PLSPSVGNLTAMQYLNLAINALS-------GELPKELGQLTE 172
S+ +L + +T + + +++ + L+ N + E L
Sbjct: 5 SIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEI 64
Query: 173 LLILGIGTNNFSGPLPSELGSLSK-------LQELY-----IDSAGVSGEIPSSFANLQS 220
I T +P L L + L + + +
Sbjct: 65 AEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEP-LIDFLSKHTP 123
Query: 221 LTKWWASDTRLT-------------GRIPDFIGNWSKLTALRFQGNSFNGP----IPSSF 263
L + + L + N L ++ N +F
Sbjct: 124 LEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTF 183
Query: 264 SNLTSVTELRISDLSNG------SSKLA-FIRDMKSLSILELRNNNISD----SIPSNIG 312
+ + +++ NG L + + L +L+L++N + ++ +
Sbjct: 184 QSHRLLHTVKMV--QNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALK 241
Query: 313 EYRSLQHLDLSFNNLGG----SIPDSLFNLS--SLTHLFLGNNKLN-------GTLPARK 359
+ +L+ L L+ L ++ D+ L L L L N++ T+ K
Sbjct: 242 SWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEK 301
Query: 360 SPLLLNIDVSYNNL 373
P LL ++++ N
Sbjct: 302 MPDLLFLELNGNRF 315
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 50.9 bits (122), Expect = 1e-06
Identities = 39/268 (14%), Positives = 68/268 (25%), Gaps = 59/268 (22%)
Query: 99 CHITQLKVYALNVVGVIPDELWNLTSLFNLNLGQNYLTG----PLSPSVGNLTAMQYLNL 154
++K + ++ L L + L N PL + T +++L L
Sbjct: 70 IFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYL 129
Query: 155 AINALSGE-------------LPKELGQLTELLILGIGTNNFSGP----LPSELGSLSKL 197
N L + + K+ L + G N S L
Sbjct: 130 HNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLL 189
Query: 198 QELY-----IDSAGVSGEIPSSFANLQSLTKWWASDTRLTGR----IPDFIGNWSKLTAL 248
+ I G+ + A Q L D T + + +W L L
Sbjct: 190 HTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLREL 249
Query: 249 RFQGNSFNGPIPSSFSNLTSVTELRISDLSNGSSKLA---FIRDMKSLSILELRNNNISD 305
+S G++ + + L L L+ N I
Sbjct: 250 GLNDC-------------------LLSA--RGAAAVVDAFSKLENIGLQTLRLQYNEIEL 288
Query: 306 SIPSNIGE-----YRSLQHLDLSFNNLG 328
+ L L+L+ N
Sbjct: 289 DAVRTLKTVIDEKMPDLLFLELNGNRFS 316
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 4e-10
Identities = 19/73 (26%), Positives = 37/73 (50%), Gaps = 3/73 (4%)
Query: 802 RGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVAGTIGY 861
+ + YLH ++HRD+K SN+LL+A+ K++DFGL++ + + + +
Sbjct: 120 KVIKYLHS---GGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINEN 176
Query: 862 LAPEYAMRGHLTE 874
+ LT+
Sbjct: 177 TENFDDDQPILTD 189
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 1e-09
Identities = 25/114 (21%), Positives = 47/114 (41%), Gaps = 15/114 (13%)
Query: 246 TALRFQGNSFNG-PIPSSFSNLTSVTEL-----RISDLSNGSSKLAFIRDMKSLSILELR 299
LR N F F L + ++ +I+D+ G AF ++ + L
Sbjct: 35 AELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEG----AF-EGASGVNEILLT 89
Query: 300 NNNISDSIPSNI-GEYRSLQHLDLSFNNLGGSIPDSLF-NLSSLTHLFLGNNKL 351
+N + ++ + SL+ L L N + + + F LSS+ L L +N++
Sbjct: 90 SNRLE-NVQHKMFKGLESLKTLMLRSNRIT-CVGNDSFIGLSSVRLLSLYDNQI 141
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 1e-09
Identities = 26/114 (22%), Positives = 49/114 (42%), Gaps = 14/114 (12%)
Query: 243 SKLTALRFQGNSFNGPIPSSFSNLTSVTEL-----RISDLSNGSSKLAFIRDMKSLSILE 297
+L + F N +F + V E+ R+ ++ + F + ++SL L
Sbjct: 57 PQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLENVQHK----MF-KGLESLKTLM 111
Query: 298 LRNNNISDSIPSNIGEY-RSLQHLDLSFNNLGGSIPDSLF-NLSSLTHLFLGNN 349
LR+N I+ + ++ S++ L L N + ++ F L SL+ L L N
Sbjct: 112 LRSNRIT-CVGNDSFIGLSSVRLLSLYDNQIT-TVAPGAFDTLHSLSTLNLLAN 163
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 57.1 bits (138), Expect = 2e-09
Identities = 26/109 (23%), Positives = 42/109 (38%), Gaps = 4/109 (3%)
Query: 243 SKLTALRFQGNSFN-GPIPSSFSNLTSVTELRISDLSNGSSKLAFIRDMKSLSILELRNN 301
+ + L N G I + ++ L + + G ++ + + L LEL N
Sbjct: 24 AAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLIN--VGLISVSNLPKLPKLKKLELSEN 81
Query: 302 NISDSIPSNIGEYRSLQHLDLSFNNLGG-SIPDSLFNLSSLTHLFLGNN 349
I + + +L HL+LS N L S + L L L L L N
Sbjct: 82 RIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNC 130
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 50.9 bits (122), Expect = 2e-07
Identities = 26/89 (29%), Positives = 42/89 (47%), Gaps = 3/89 (3%)
Query: 265 NLTSVTELRISDLSNGSSKL-AFIRDMKSLSILELRNNNISDSIPSNIGEYRSLQHLDLS 323
+V EL + + + K+ + +L L L N + S+ SN+ + L+ L+LS
Sbjct: 22 TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-SV-SNLPKLPKLKKLELS 79
Query: 324 FNNLGGSIPDSLFNLSSLTHLFLGNNKLN 352
N + G + L +LTHL L NKL
Sbjct: 80 ENRIFGGLDMLAEKLPNLTHLNLSGNKLK 108
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 40.5 bits (95), Expect = 8e-04
Identities = 29/143 (20%), Positives = 57/143 (39%), Gaps = 25/143 (17%)
Query: 193 SLSKLQELYIDSAGVS-GEIPSSFANLQSLTKWWASDTRLTGRIPDFIGNWSKLTALRFQ 251
+ + ++EL +D+ + G+I A +L + L + + KL L
Sbjct: 22 TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-SVSNLPKL-PKLKKLELS 79
Query: 252 GNSFNGPIPSSFSNLTSVTEL-----RISDLSNGSSKLAFIRDMKSLSILELRNNNISDS 306
N G + L ++T L ++ D+S L ++ ++ L L+L N +
Sbjct: 80 ENRIFGGLDMLAEKLPNLTHLNLSGNKLKDIST----LEPLKKLECLKSLDLFNCEV--- 132
Query: 307 IPSNIGEYR--------SLQHLD 321
+N+ +YR L +LD
Sbjct: 133 --TNLNDYRESVFKLLPQLTYLD 153
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 6e-09
Identities = 29/112 (25%), Positives = 44/112 (39%), Gaps = 12/112 (10%)
Query: 243 SKLTALRFQGNSFNGPIPSSFSNLTSV-TELRISDLS-NGSSKLAFIRDMKSLSILELRN 300
+ L +G NL + + D S N KL ++ L L + N
Sbjct: 19 VRDRELDLRGYKI-----PVIENLGATLDQFDAIDFSDNEIRKLDGFPLLRRLKTLLVNN 73
Query: 301 NNISDSIPSNIGEY-RSLQHLDLSFNNLG--GSIPDSLFNLSSLTHLFLGNN 349
N I I + + L L L+ N+L G + D L +L SLT+L + N
Sbjct: 74 NRIC-RIGEGLDQALPDLTELILTNNSLVELGDL-DPLASLKSLTYLCILRN 123
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 2e-06
Identities = 17/93 (18%), Positives = 32/93 (34%), Gaps = 5/93 (5%)
Query: 261 SSFSNLTSVTELRISDLSNGSSKLAFI-RDMKSLSILELRNNNISDSIPSNIGEYRSLQH 319
+ ++N EL + + + + ++ +N I + R L+
Sbjct: 13 AQYTNAVRDRELDLR--GYKIPVIENLGATLDQFDAIDFSDNEIR-KL-DGFPLLRRLKT 68
Query: 320 LDLSFNNLGGSIPDSLFNLSSLTHLFLGNNKLN 352
L ++ N + L LT L L NN L
Sbjct: 69 LLVNNNRICRIGEGLDQALPDLTELILTNNSLV 101
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 4e-04
Identities = 26/149 (17%), Positives = 50/149 (33%), Gaps = 31/149 (20%)
Query: 189 SELGSLSKLQELYIDSAGVSGEIPSSFANLQSLTKWWASDTRLTGRIPDFIGNWSKLTAL 248
++ + + +EL + + I + A L SD + + + L L
Sbjct: 13 AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRK-----LDGFPLLRRL 66
Query: 249 R---FQGNSFNGPIPSSFSNLTSVTEL-----RISDLSNGSSKLAFIRDMKSLSILELRN 300
+ N L +TEL + +L + L + +KSL+ L +
Sbjct: 67 KTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGD----LDPLASLKSLTYLCILR 122
Query: 301 NNISDSIPSNIGEYR--------SLQHLD 321
N + +N YR ++ LD
Sbjct: 123 NPV-----TNKKHYRLYVIYKVPQVRVLD 146
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 7e-09
Identities = 40/159 (25%), Positives = 63/159 (39%), Gaps = 14/159 (8%)
Query: 198 QELYIDSAGVSGEIPSSFANLQSLTKWWASDTRLTGRIPDFIGNWSKLTALRFQGNSFNG 257
++L + S G++ ++F L LT +L + ++L L N
Sbjct: 38 EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLAS 97
Query: 258 PIPSSFSNLTSVTELRISD-----LSNGSSKLAFIRDMKSLSILELRNNNISDSIPSNIG 312
F +LT + +L + L +G F R + L L L N + SIP+
Sbjct: 98 LPLGVFDHLTQLDKLYLGGNQLKSLPSG----VFDR-LTKLKELRLNTNQLQ-SIPAGAF 151
Query: 313 EY-RSLQHLDLSFNNLGGSIPDSLF-NLSSLTHLFLGNN 349
+ +LQ L LS N L S+P F L L + L N
Sbjct: 152 DKLTNLQTLSLSTNQLQ-SVPHGAFDRLGKLQTITLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 4e-07
Identities = 32/111 (28%), Positives = 45/111 (40%), Gaps = 10/111 (9%)
Query: 246 TALRFQGNSFNGPIPSSFSNLTSVTELRISDLSNGSSKL---AFIRDMKSLSILELRNNN 302
L Q ++F LT +T L + N L F D+ L L L NN
Sbjct: 38 EKLDLQSTGLATLSDATFRGLTKLTWLNLD--YNQLQTLSAGVF-DDLTELGTLGLANNQ 94
Query: 303 ISDSIPSNI-GEYRSLQHLDLSFNNLGGSIPDSLF-NLSSLTHLFLGNNKL 351
++ S+P + L L L N L S+P +F L+ L L L N+L
Sbjct: 95 LA-SLPLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKELRLNTNQL 143
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 57.4 bits (138), Expect = 9e-09
Identities = 21/109 (19%), Positives = 41/109 (37%), Gaps = 7/109 (6%)
Query: 270 TELRISDLSNGSSKLAFIRDMKSLSILELRNNNISDSIPSN-IGEYRSLQHLDLSFNNLG 328
+ LR + S L + ++L+ L + N + + L++L + + L
Sbjct: 11 SGLRCTRDGALDS-LHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGL- 68
Query: 329 GSIPDSLF-NLSSLTHLFLGNNKLNGTLPAR--KSPLLLNIDVSYNNLQ 374
+ F L+ L L N L +L + + L + +S N L
Sbjct: 69 RFVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLH 116
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 53.6 bits (128), Expect = 2e-07
Identities = 23/158 (14%), Positives = 49/158 (31%), Gaps = 11/158 (6%)
Query: 306 SIPSNIGEYRSLQHLDLSFNNLGGSIPDSLF-NLSSLTHLFLGNNKLNGTLPA---RKSP 361
++ +L L + + L L +L + + L + +P
Sbjct: 22 DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPDAFHFTP 80
Query: 362 LLLNIDVSYNNLQGNLPSWINGQQNLQINLVANNLT----IRSSDNSVLPRGLICLQRNF 417
L +++S+N L+ + G ++ L N L +R ++
Sbjct: 81 RLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKL 140
Query: 418 PCNRGYAIYADFAIKSGGPQI--RSSNGVVYERDNATL 453
C+ + G P + + N V D+ L
Sbjct: 141 QCHGQGPLAHMPNASCGVPTLKVQVPNASVDVGDDVLL 178
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 57.6 bits (139), Expect = 9e-09
Identities = 61/352 (17%), Positives = 111/352 (31%), Gaps = 106/352 (30%)
Query: 700 KLGEGGFGPVYKGK-LGDGRAIAVKQLSVASRQGKSQFVAEIATISAVQ--------HRN 750
KLG G F V+ + + +A+K + ++ + EI + +V+
Sbjct: 44 KLGWGHFSTVWLSWDIQGKKFVAMK-VVKSAEHYTETALDEIRLLKSVRNSDPNDPNREM 102
Query: 751 LVKLHGC-CIEGAE---RLLVYEYL-ENKSLDQALFGQRSLTLDWATRYEICSGVARGLA 805
+V+L I G +V+E L + + L L + I V +GL
Sbjct: 103 VVQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKK--IIQQVLQGLD 160
Query: 806 YLHEESRVRIIHRDVKASNVLLDAD----------------------------------- 830
YLH ++ RIIH D+K N+LL +
Sbjct: 161 YLH--TKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAG 218
Query: 831 --------------LVPKISDFGLAKLYDDKKTH-ISTRVAGTIGYLAPEYAMRGHLTEK 875
L KI+D G A T I TR Y + E +
Sbjct: 219 NFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQ-----YRSLEVLIGSGYNTP 273
Query: 876 TDVFAFGVLALETVSGRP------NSDPSLDEEKL-------------YLLEWAWHLHEN 916
D+++ +A E +G + + DE+ + ++ +
Sbjct: 274 ADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFF 333
Query: 917 NQEIELADPKLI-------------EFNEEEVKRLIGVALLCTQTLPSLRPS 955
++ +L + E+++EE L + +P R +
Sbjct: 334 TKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRAT 385
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 1e-08
Identities = 50/305 (16%), Positives = 95/305 (31%), Gaps = 51/305 (16%)
Query: 119 LWNLTSLFNLNLGQNYLTGP----LSPSVGNL-TAMQYLNLAINALSGE----LPKELGQ 169
L +L LNL N L + + +Q L+L L+G L L
Sbjct: 52 LRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRT 111
Query: 170 LTELLILGIGTNNFSGPLPSELGSL-----SKLQELYIDSAGVSGE----IPSSFANLQS 220
L L L + N L +L++L ++ +S + S
Sbjct: 112 LPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPD 171
Query: 221 LTKWWASDTRLTGR-----IPDFIGNWSKLTALRFQGNSFN----GPIPSSFSNLTSVTE 271
+ S+ + + +L AL+ + + ++ S+ E
Sbjct: 172 FKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRE 231
Query: 272 LRISD--LSNGSSKL---AFIRDMKSLSILELRNNNISD----SIPSNIGEYRSLQHLDL 322
L + L + + L L + I+ + + SL+ L L
Sbjct: 232 LALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSL 291
Query: 323 SFNNLGGS----IPDSLFN-LSSLTHLFLGNNKLNGT--------LPARKSPLLLNIDVS 369
+ N LG + ++L L L++ + L ++ LL + +S
Sbjct: 292 AGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVL--AQNRFLLELQIS 349
Query: 370 YNNLQ 374
N L+
Sbjct: 350 NNRLE 354
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 1e-08
Identities = 56/304 (18%), Positives = 105/304 (34%), Gaps = 51/304 (16%)
Query: 119 LWNLTSLFNLNLGQNYLTGP----LSPSVG-NLTAMQYLNLAINALSGE----LPKELGQ 169
L L +L L+L N L L + ++ L L +LS L L
Sbjct: 109 LRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRA 168
Query: 170 LTELLILGIGTNNFSGPLPSELG-----SLSKLQELYIDSAGVSGE----IPSSFANLQS 220
+ L + N+ + L S +L+ L ++S GV+ + + A+ S
Sbjct: 169 KPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKAS 228
Query: 221 LTKWWASDTRLTGR-----IPDFIGNWSKLTALRFQGNSFNGP----IPSSFSNLTSVTE 271
L + +L P + S+L L + S+ E
Sbjct: 229 LRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKE 288
Query: 272 LRIS--DLSNGSSKL---AFIRDMKSLSILELRNNNISD----SIPSNIGEYRSLQHLDL 322
L ++ +L + ++L + L L +++ + + S + + R L L +
Sbjct: 289 LSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQI 348
Query: 323 SFNNLGGS----IPDSL-FNLSSLTHLFLGNNKLNGT--------LPARKSPLLLNIDVS 369
S N L + + L S L L+L + ++ + L + L +D+S
Sbjct: 349 SNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATL--LANHSLRELDLS 406
Query: 370 YNNL 373
N L
Sbjct: 407 NNCL 410
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 1e-04
Identities = 27/126 (21%), Positives = 46/126 (36%), Gaps = 20/126 (15%)
Query: 267 TSVTELRISDLSNGSSKLA-FIRDMKSLSILELRNNNISD----SIPSNIGEYRSLQHLD 321
+ L I ++ A + ++ ++ L + +++ I S + +L L+
Sbjct: 3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 62
Query: 322 LSFNNLGGS----IPDSLFNLS-SLTHLFLGNNKLNG--------TLPARKSPLLLNIDV 368
L N LG + L S + L L N L G TL R P L + +
Sbjct: 63 LRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTL--RTLPTLQELHL 120
Query: 369 SYNNLQ 374
S N L
Sbjct: 121 SDNLLG 126
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 3e-04
Identities = 51/266 (19%), Positives = 85/266 (31%), Gaps = 56/266 (21%)
Query: 121 NLTSLFNLNLGQNYLT----GPLSPSVGNLTAMQYLNLAINALSGELPKELGQ-----LT 171
+ L L L +T L V + +++ L L N L EL +
Sbjct: 197 SPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSS 256
Query: 172 ELLILGIGTNNFSGP----LPSELGSLSKLQELYIDSAGVSGEIPSSFANLQSLTKWWAS 227
L L I + L L + L+EL + + E
Sbjct: 257 RLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPG---- 312
Query: 228 DTRLTGRIPDFIGNWSKLTALRFQGNSFNG----PIPSSFSNLTSVTELRISDLSN---- 279
+L +L + SF S + + EL +SN
Sbjct: 313 ---------------CQLESLWVKSCSFTAACCSHFSSVLAQNRFLLEL---QISNNRLE 354
Query: 280 --GSSKL--AFIRDMKSLSILELRNNNISD----SIPSNIGEYRSLQHLDLSFNNLGGS- 330
G +L + L +L L + ++SD S+ + + SL+ LDLS N LG +
Sbjct: 355 DAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAG 414
Query: 331 ---IPDSL-FNLSSLTHLFLGNNKLN 352
+ +S+ L L L + +
Sbjct: 415 ILQLVESVRQPGCLLEQLVLYDIYWS 440
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 2e-08
Identities = 46/233 (19%), Positives = 87/233 (37%), Gaps = 42/233 (18%)
Query: 123 TSLFNLNLGQNYLTGPLSPSVGNLTAMQYLNLAINALSGELPKELGQLTELLILGIGTNN 182
NL + +T + + L ++ + + + + L + L +G N
Sbjct: 19 AETIKANLKKKSVTD--AVTQNELNSIDQIIANNSDIKSVQG--IQYLPNVRYLALGGN- 73
Query: 183 FSGPLPSELGSLSKLQELYIDSAGVSGEIPSSFANLQSLTKWWASDTRLTGRIPDFIGNW 242
KL ++ L +LT + +L +P+ + +
Sbjct: 74 -------------KLHDI-----SA-------LKELTNLTYLILTGNQLQ-SLPNGVFDK 107
Query: 243 -SKLTALRFQGNSFNGPIPSSFSNLTSVTELRISDLSNGSSKL---AFIRDMKSLSILEL 298
+ L L N F LT++T L ++ N L F + L+ L+L
Sbjct: 108 LTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLA--HNQLQSLPKGVFDKLTN-LTELDL 164
Query: 299 RNNNISDSIPSNI-GEYRSLQHLDLSFNNLGGSIPDSLF-NLSSLTHLFLGNN 349
N + S+P + + L+ L L N L S+PD +F L+SL +++L +N
Sbjct: 165 SYNQLQ-SLPEGVFDKLTQLKDLRLYQNQLK-SVPDGVFDRLTSLQYIWLHDN 215
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 5e-06
Identities = 37/150 (24%), Positives = 68/150 (45%), Gaps = 15/150 (10%)
Query: 213 SSFANLQSLTKWWASDTRLTGRIPDFIGNWSKLTALRFQGNSFNGPIPSSFSNLTSVTEL 272
+ L S+ + A+++ + + + L GN + S+ LT++T L
Sbjct: 35 VTQNELNSIDQIIANNSDIK-SVQGI-QYLPNVRYLALGGNKLHDI--SALKELTNLTYL 90
Query: 273 RISDLSNGSSKL---AFIRDMKSLSILELRNNNISDSIPSNI-GEYRSLQHLDLSFNNLG 328
++ N L F + +L L L N + S+P + + +L +L+L+ N L
Sbjct: 91 ILT--GNQLQSLPNGVF-DKLTNLKELVLVENQLQ-SLPDGVFDKLTNLTYLNLAHNQLQ 146
Query: 329 GSIPDSLF-NLSSLTHLFLGNNKLNGTLPA 357
S+P +F L++LT L L N+L +LP
Sbjct: 147 -SLPKGVFDKLTNLTELDLSYNQLQ-SLPE 174
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 5e-08
Identities = 25/109 (22%), Positives = 49/109 (44%), Gaps = 6/109 (5%)
Query: 244 KLTALRFQGNSFNGPIPSSFSNLTSVTELRISDLSNGSSKLAFIRDMKSLSILELRNNNI 303
+ L + ++ S L + L +S +N K++ + M++L IL L N I
Sbjct: 26 EKVELHGMIPPIEK-MDATLSTLKACKHLALS--TNNIEKISSLSGMENLRILSLGRNLI 82
Query: 304 SDSIPSNIGEYRSLQHLDLSFNNLGGSIPDSLFNLSSLTHLFLGNNKLN 352
I + +L+ L +S+N + + + L +L L++ NNK+
Sbjct: 83 KK-IENLDAVADTLEELWISYNQI--ASLSGIEKLVNLRVLYMSNNKIT 128
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 1e-07
Identities = 30/122 (24%), Positives = 48/122 (39%), Gaps = 12/122 (9%)
Query: 234 RIPDFIGNWSKLTALRFQGNSFNGPIPSSFSNLTSVTELRISDLS-NGSSKLAFIRDM-K 291
++ + L N+ S+L+ + LRI L N K+ + +
Sbjct: 39 KMDATLSTLKACKHLALSTNNI-----EKISSLSGMENLRILSLGRNLIKKIENLDAVAD 93
Query: 292 SLSILELRNNNISDSIPSNIGEYRSLQHLDLSFNNLG--GSIPDSLFNLSSLTHLFLGNN 349
+L L + N I+ S I + +L+ L +S N + G I D L L L L L N
Sbjct: 94 TLEELWISYNQIAS--LSGIEKLVNLRVLYMSNNKITNWGEI-DKLAALDKLEDLLLAGN 150
Query: 350 KL 351
L
Sbjct: 151 PL 152
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 56.0 bits (134), Expect = 6e-08
Identities = 72/483 (14%), Positives = 135/483 (27%), Gaps = 139/483 (28%)
Query: 534 DTNRWESLGRRVFDVYIQGNRVLKDFDIK------REAGGVSKRAIQR--EIKTRVSENY 585
+T + + + V+ + +FD K + +SK I K VS
Sbjct: 10 ETGEHQYQYKDILSVFED--AFVDNFDCKDVQDMPKSI--LSKEEIDHIIMSKDAVSGTL 65
Query: 586 LEIHLFWAGKGTCCVPAQGTYGPSISAIRVTPDFTPTVRPPKEKDNNRTGLIVGIVVGVG 645
LFW + ++ + F V +
Sbjct: 66 R---LFW------TLLSKQE--------EMVQKF---VEEVLRINYK------------- 92
Query: 646 VATFL-SVLAIFCIVRRRKRPQHDDDEELLGMDAR---PYTFS----YAELKTATENFSP 697
FL S + + + + L D + Y S Y +L+ A P
Sbjct: 93 ---FLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQALLELRP 149
Query: 698 SNKL---GEGGFGPVYKGKLGDGRAIAVKQLSVASRQGKSQFVAEIATISAVQHRNLVKL 754
+ + G G G K+ ++ VQ + K+
Sbjct: 150 AKNVLIDGVLGSG-------------------------KTWVALDVCLSYKVQCKMDFKI 184
Query: 755 H----GCCIEGAERLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEE 810
C L E L+ L Q + +W +R + S + + + E
Sbjct: 185 FWLNLKNCNSPETVL---EMLQK------LLYQ--IDPNWTSRSDHSSNIKLRIHSIQAE 233
Query: 811 SRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDK-KTHISTRVAGTIGYLAPEYAMR 869
R + + + N LL V + ++ K ++TR +L+
Sbjct: 234 LRRLLKSKPYE--NCLLVLLNV---QNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTH 288
Query: 870 GHLTEKTDVF----AFGVLALETVSGRPNSDP-----------SLDEEKL--YLLEWAWH 912
L + +L + RP P S+ E + L W
Sbjct: 289 ISLDHHSMTLTPDEVKSLLLK-YLDCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDNW 347
Query: 913 LHENNQEIELADPKLIE-----FNEEEVKRL---IGV----ALLCTQTLPSLRPSMSRVV 960
H N ++ +IE E +++ + V A + T L + + +
Sbjct: 348 KHVNCDKLT----TIIESSLNVLEPAEYRKMFDRLSVFPPSAHIPTILLSLIWFDVIKSD 403
Query: 961 AML 963
M+
Sbjct: 404 VMV 406
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 52.5 bits (125), Expect = 7e-07
Identities = 56/413 (13%), Positives = 125/413 (30%), Gaps = 109/413 (26%)
Query: 38 PNEVRALNSIFQQWRISARQGQWNRSGDPCTGAALDDSIVFDNTDYNPFIKCDCSSQNGT 97
+ V +F W + ++Q + +++ +Y F+ ++
Sbjct: 58 KDAVSGTLRLF--WTLLSKQEE-------MVQKFVEEV---LRINY-KFLMSPIKTEQRQ 104
Query: 98 VCHITQLKVYALNVVGVIPDELWNLTSLF---NLNLGQNYLTGPLSPSVGNLTAMQYLN- 153
+T++ + D L+N +F N++ Q YL L ++ L + +
Sbjct: 105 PSMMTRMYIEQR-------DRLYNDNQVFAKYNVSRLQPYLK--LRQALLELRPAKNVLI 155
Query: 154 ----------LAINALSGELPKELGQLTELLI--LGIGTNNFSGPLPSELGSLSKLQELY 201
+A++ ++ + I L + N P + L LQ+L
Sbjct: 156 DGVLGSGKTWVALDVCL---SYKVQCKMDFKIFWLNLKNCN----SPETV--LEMLQKLL 206
Query: 202 IDSAGVSGEIPSSFANLQSLTKWWASDTRLTGRIPDFIGNWSKLTALRFQGNSFNGPIPS 261
+N++ + + + + L
Sbjct: 207 YQIDPNWTSRSDHSSNIKLRIHSIQA------ELRRLLKSKPYENCL------------- 247
Query: 262 SFSNLTSVTELRISDLSNGSSKLAFIRDMKSLSILELRNNNISDSIPSNIGEYRSLQHLD 321
L + ++ N + AF ++ +L R ++D + + + SL H
Sbjct: 248 ----------LVLLNVQNAKAWNAF--NLSCKILLTTRFKQVTDFLSAATTTHISLDHHS 295
Query: 322 LSFNNLGGSIPDSLFNLSSLTHLFLGNNKLNGTLP--ARK-SPLLLNIDVSYNNLQGNLP 378
++ PD + +L +L LP +P L+I +++ L
Sbjct: 296 MTLT------PDEVKSLLL---KYLDCRP--QDLPREVLTTNPRRLSIIAE--SIRDGLA 342
Query: 379 SWINGQQNLQINLVANNLTIRSSDNSVLPRGLICLQRNFPCNRGYAIYADFAI 431
+W +N I SS N + P R + ++
Sbjct: 343 TW---DNWKHVNCDKLTTIIESSLNVLEPAEY----------RKM--FDRLSV 380
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 49.9 bits (118), Expect = 5e-06
Identities = 62/419 (14%), Positives = 123/419 (29%), Gaps = 110/419 (26%)
Query: 74 DSIVFDNTDYNPFIKCDCSSQNGTVCHITQLKVY--ALNVVGVIPDELWNLTSL--FNLN 129
D +D++ IK S + + + K Y L ++ + N + FNL+
Sbjct: 210 DPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCL----LVLLNVQNAKAWNAFNLS 265
Query: 130 ----------------LGQNYLTGPLSPSVGNLTAMQYLNLAINALS---GELPKELGQL 170
L LT + +L + L +LP+E+
Sbjct: 266 CKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTT 325
Query: 171 TELLILGIGT---------NNFSGPLPSELG-----SLSKL-----QELYIDSA----GV 207
+ I +N+ +L SL+ L ++++ +
Sbjct: 326 NPRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSVFPPSA 385
Query: 208 SGEIPSSFANLQSLTKWWASDTRLTGRIPDFIGNWSKLTALRFQGNSFNGPIPSSFSNLT 267
IP+ L + W+ + + + +S L + + ++
Sbjct: 386 --HIPTIL--LSLI--WFDVIKSDVMVVVNKLHKYS-LVEKQPKESTI------------ 426
Query: 268 SVTELRISDLSNGSSKLAFIRDMKSL--SILE----LRNNNISDSIPSNIGEYRSLQHLD 321
I + + + +L SI++ + + D IP + +Y H+
Sbjct: 427 -----SIPSIY--LELKVKLENEYALHRSIVDHYNIPKTFDSDDLIPPYLDQY-FYSHIG 478
Query: 322 LSFNNLGGSIPDSLFNLSSLTHLFLGNNKLNGTLPARKSPLLLNIDVSYNNLQGNLP--- 378
N+ +LF + L FL K+ R N S N L
Sbjct: 479 HHLKNIEHPERMTLFRMVFLDFRFLE-QKI------RHDSTAWNASGSILNTLQQLKFYK 531
Query: 379 SWINGQQNL---QINLVANNL------TIRSSDNSVLPRGLICLQRNFPCNRGYAIYAD 428
+I +N + + L I S +L L+ AI+ +
Sbjct: 532 PYICDNDPKYERLVNAILDFLPKIEENLICSKYTDLLRIALM--------AEDEAIFEE 582
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 47.5 bits (112), Expect = 2e-05
Identities = 79/680 (11%), Positives = 178/680 (26%), Gaps = 212/680 (31%)
Query: 285 AFIRDMKSLSILELRNNNISDSIPSNI-GEYRSLQHLDLSFNNLGGSIPDSLFNLSSLTH 343
AF+ + + ++ + +S +I ++ F L L +
Sbjct: 28 AFVDNFDCKDVQDMPKSILSKEEIDHIIMSKDAVSGTLRLFWTL-------LSKQEEMVQ 80
Query: 344 LFLGNNKLNGTLPARKSPLLLNIDVSYNNL------QGNLPSWINGQQNLQINLVANNLT 397
F+ +L I+ Y L + PS + Q + + N+
Sbjct: 81 KFVEE--------------VLRIN--YKFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQ 124
Query: 398 IRSSDN-------SVLPRGLICLQRNFPCNRGYAIY----------ADFAIKSGGPQIRS 440
+ + N L + L+ L+ + I A S Q +
Sbjct: 125 VFAKYNVSRLQPYLKLRQALLELRPA----KNVLIDGVLGSGKTWVALDVCLSYKVQCKM 180
Query: 441 SNGVVY------ERDNATLGP--ATYYVTDSNKWGVSNVGLFTGSNNPQYKSSSLSQFTN 492
+ + L Y D N S+ S+N + + S+
Sbjct: 181 DFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSD-----HSSNIKLRIHSIQAE-- 233
Query: 493 TLDSELFQTARLSASSLRYYGLGLENGNYTVLLQFAEMAILDTNRWESLGRRVFDVYIQG 552
L ++ LL +L +V Q
Sbjct: 234 --LRRLLKSKPYENC----------------LL------VLL------------NV--QN 255
Query: 553 NRVLKDFDIK-------RE--------AGGVSKRAIQREIKTRVSENYLEIHLFWAGKGT 597
+ F++ R A + ++ T + + L +
Sbjct: 256 AKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRP 315
Query: 598 CCVPAQGTYGPSISAIRVTPDFTPTVRPPKEKDNNRTGLIVGIVVGVGVATFLSVLAIFC 657
+P + + P + I+ A +
Sbjct: 316 QDLPRE--------VLTTNP------------------RRLSII-----AESIRDGLA-- 342
Query: 658 IVRRRKRPQHDDDEELLGMDARPYTFSYAELKTATENFSPSNKLGEGGFGPVYKGKLG-- 715
+H + ++L + ++++ P+ + ++ +L
Sbjct: 343 ---TWDNWKHVNCDKLTTI-----------IESSLNVLEPAE------YRKMFD-RLSVF 381
Query: 716 -DGRAIAVKQLSV----ASRQGKSQFVAEIATISAVQHRN---LVKLHGCCIEGAERLLV 767
I LS+ + V ++ S V+ + + + +E +L
Sbjct: 382 PPSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTISIPSIYLELKVKLEN 441
Query: 768 YEYLENKSLDQ----ALFGQRSLTLDWATRYEICSGVARGLAYLHEESRV---------- 813
L +D F L + +Y S + L + R+
Sbjct: 442 EYALHRSIVDHYNIPKTFDSDDLIPPYLDQY-FYSHIGHHLKNIEHPERMTLFRMVFLDF 500
Query: 814 RIIHRDVKASNVLLDA--DLVPKISDFGLAKLYDDKKTHIS------TRVAGTIGYLAPE 865
R + + ++ + +A ++ + K Y K +I R+ I P+
Sbjct: 501 RFLEQKIRHDSTAWNASGSILNTLQQL---KFY---KPYICDNDPKYERLVNAILDFLPK 554
Query: 866 YAMRGHLTEKTDVFAFGVLA 885
++ TD+ ++A
Sbjct: 555 IEENLICSKYTDLLRIALMA 574
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 42.5 bits (99), Expect = 8e-04
Identities = 45/307 (14%), Positives = 97/307 (31%), Gaps = 63/307 (20%)
Query: 759 IEGAERLLVYEYLENKSLDQA-LFGQRSLTLD-------WATRYEICSGVARGLAYLHEE 810
+ G RL L +K + F + L ++ T S + R ++ E
Sbjct: 61 VSGTLRLF--WTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTR----MYIE 114
Query: 811 SRVRIIHRDVKASNVLLDADLVPKISDF-----GLAKLYDDKKTHISTRVAGTIGY---- 861
R R+ + D N + V ++ + L +L K + + G +G
Sbjct: 115 QRDRL-YND----NQVFAKYNVSRLQPYLKLRQALLELRPAKN--VL--IDGVLGSGKTW 165
Query: 862 LAPEYAMRGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEIE 921
+A + + + F + L + NS E L +L+ + + N
Sbjct: 166 VALD-VCLSYKVQ--CKMDFKIFWL-NL-KNCNSP----ETVLEMLQKLLYQIDPNWTSR 216
Query: 922 LADPKLIEFNEEEVKRLIGVALLCTQTLPS----LRP-SMSRVVAMLCGDMEVST-VTAK 975
I+ ++ + LL ++ + L ++ ++ +T +
Sbjct: 217 SDHSSNIKLRIHSIQAEL-RRLLKSKPYENCLLVLLNVQNAKAWNAF--NLSCKILLTTR 273
Query: 976 PGYLTDWKFDDITSFVRTDEATKGTDTSHYTSSSSTSIVA-----EAEHLSR---NGKPL 1027
+TD+ T+ + D + T S++ + L R P
Sbjct: 274 FKQVTDFLSAATTTHISLDHHSMT-----LTPDEVKSLLLKYLDCRPQDLPREVLTTNPR 328
Query: 1028 LHDLVGE 1034
++ E
Sbjct: 329 RLSIIAE 335
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 55.0 bits (131), Expect = 7e-08
Identities = 23/180 (12%), Positives = 53/180 (29%), Gaps = 22/180 (12%)
Query: 209 GEIPSSFANLQSLTKWWASDTRLTGRIPDFIGNWSKLTALRFQGNSFNGPIPSSF--SNL 266
++ + L + T + L +L + S+L
Sbjct: 162 VDLSPVLDAMPLLNNLK---IKGTNNLSIGKKPRPNLKSLEIISGGLPDSVVEDILGSDL 218
Query: 267 TSVTELRISDLSNGSSKLAFIRD---------MKSLSILELRNNNISDSIPSNIGEYR-- 315
++ +L + + +L L + + + + E
Sbjct: 219 PNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDIL 278
Query: 316 -SLQHLDLSFNNLGGS----IPDSLFNLSSLTHLFLGNNKLNGTLPAR-KSPLLLNIDVS 369
L+ +D+S L + D + + L + + N L+ + + L + IDVS
Sbjct: 279 PQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDEMKKELQKSLPMKIDVS 338
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 1e-07
Identities = 25/112 (22%), Positives = 42/112 (37%), Gaps = 15/112 (13%)
Query: 246 TALRFQGNSFNG-PIPSSFSNLTSVTEL-----RISDLSNGSSKLAFIRDMKSLSILELR 299
T L N F L + +L +++ + AF + L+L
Sbjct: 32 TELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPN----AFEG-ASHIQELQLG 86
Query: 300 NNNISDSIPSNI-GEYRSLQHLDLSFNNLGGSIPDSLF-NLSSLTHLFLGNN 349
N I I + + L+ L+L N + + F +L+SLT L L +N
Sbjct: 87 ENKIK-EISNKMFLGLHQLKTLNLYDNQIS-CVMPGSFEHLNSLTSLNLASN 136
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 1e-05
Identities = 27/95 (28%), Positives = 41/95 (43%), Gaps = 9/95 (9%)
Query: 259 IPSSFSNLTSVTELRISDLSNGSSKLAFIRDMKSLSILELRNNNISDSIPSNIGEY-RSL 317
IP T+ L ++L SS F + L LEL+ N ++ I N E +
Sbjct: 27 IPLH----TTELLLNDNELGRISSDGLF-GRLPHLVKLELKRNQLT-GIEPNAFEGASHI 80
Query: 318 QHLDLSFNNLGGSIPDSLFN-LSSLTHLFLGNNKL 351
Q L L N + I + +F L L L L +N++
Sbjct: 81 QELQLGENKIK-EISNKMFLGLHQLKTLNLYDNQI 114
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 50.5 bits (121), Expect = 7e-07
Identities = 43/149 (28%), Positives = 59/149 (39%), Gaps = 15/149 (10%)
Query: 205 AGVSGEIPSSFANLQSLTKWWASDTRLTGRIPDFIGNWSKLTALRFQGNSFNGPIPSSFS 264
A V IP++ L + D ++T P + L L N F
Sbjct: 32 ASVPAGIPTNAQIL------YLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFD 85
Query: 265 NLTSVTELRISDLSNGSSKL---AFIRDMKSLSILELRNNNISDSIPSNIGEYRSLQHLD 321
+LT +T L + N + L F R + L L + N ++ +P I L HL
Sbjct: 86 SLTQLTVLDLGT--NQLTVLPSAVFDRLVH-LKELFMCCNKLT-ELPRGIERLTHLTHLA 141
Query: 322 LSFNNLGGSIPDSLF-NLSSLTHLFLGNN 349
L N L SIP F LSSLTH +L N
Sbjct: 142 LDQNQLK-SIPHGAFDRLSSLTHAYLFGN 169
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 5e-05
Identities = 29/109 (26%), Positives = 48/109 (44%), Gaps = 7/109 (6%)
Query: 246 TALRFQGNSFNGPIPSSFSNLTSVTELRISDLSNGSSKL-AFIRD-MKSLSILELRNNNI 303
L N P F +L ++ EL + N L + D + L++L+L N +
Sbjct: 43 QILYLHDNQITKLEPGVFDSLINLKELYLGS--NQLGALPVGVFDSLTQLTVLDLGTNQL 100
Query: 304 SDSIPSNI-GEYRSLQHLDLSFNNLGGSIPDSLFNLSSLTHLFLGNNKL 351
+ +PS + L+ L + N L +P + L+ LTHL L N+L
Sbjct: 101 T-VLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQL 147
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 9e-05
Identities = 48/170 (28%), Positives = 69/170 (40%), Gaps = 20/170 (11%)
Query: 88 KCDCSSQNGTV-CHITQLKVYALNVVGVIPDELWNLTSLFNLNLGQNYLTGPLSPSVGNL 146
+C CS TV C + +V IP T+ L L N +T +L
Sbjct: 16 QCSCSGT--TVDCRSKRHA----SVPAGIP------TNAQILYLHDNQITKLEPGVFDSL 63
Query: 147 TAMQYLNLAINALSGELPKEL-GQLTELLILGIGTNNFSGPLPSEL-GSLSKLQELYIDS 204
++ L L N L LP + LT+L +L +GTN + LPS + L L+EL++
Sbjct: 64 INLKELYLGSNQLG-ALPVGVFDSLTQLTVLDLGTNQLTV-LPSAVFDRLVHLKELFMCC 121
Query: 205 AGVSGEIPSSFANLQSLTKWWASDTRLTGRIPDFI-GNWSKLTALRFQGN 253
++ E+P L LT +L IP S LT GN
Sbjct: 122 NKLT-ELPRGIERLTHLTHLALDQNQLK-SIPHGAFDRLSSLTHAYLFGN 169
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 4e-06
Identities = 49/221 (22%), Positives = 81/221 (36%), Gaps = 50/221 (22%)
Query: 699 NKLGEGGFGPVYKGK-LGDGRAIAVK--------------------QLSVASRQGKSQFV 737
+ +G+G FG V K + +A+K ++ + K V
Sbjct: 60 SLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIV 119
Query: 738 AEIATISAVQHRNLVKLHGCCIEGAERLLVYEYLENKSLDQAL--FGQRSLTLDWATRYE 795
RN H C LV+E L +L L R ++L+ TR +
Sbjct: 120 H---LKRHFMFRN----HLC--------LVFEMLS-YNLYDLLRNTNFRGVSLN-LTR-K 161
Query: 796 ICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVP--KISDFGLAKLYDDKK-THIS 852
+ L +L + IIH D+K N+LL KI DFG + + +I
Sbjct: 162 FAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQ 220
Query: 853 TRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRP 893
+R Y +PE + D+++ G + +E +G P
Sbjct: 221 SRF-----YRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEP 256
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 Length = 185 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 5e-06
Identities = 15/100 (15%), Positives = 41/100 (41%), Gaps = 13/100 (13%)
Query: 264 SNLTSVTELRISDLSN----GSSKLA-FIRDMKSLSILELRNNNISDSIPSNIGEY---- 314
+N + E+ ++++ N A ++ + + +D + + E
Sbjct: 33 NNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVN 92
Query: 315 RSLQHLDLSFNNLGG----SIPDSLFNLSSLTHLFLGNNK 350
+L+ L++ N + G ++ ++L + +SL L + N
Sbjct: 93 NTLKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQS 132
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 48.6 bits (116), Expect = 7e-06
Identities = 50/218 (22%), Positives = 87/218 (39%), Gaps = 50/218 (22%)
Query: 701 LGEGGFGPVYKGK-LGDGRAIAVKQLSVASRQGKS---QFVAEIATISAVQHR------N 750
+G+G FG V K + +A+K + R K Q EI + ++ + N
Sbjct: 105 IGKGSFGQVVKAYDHKVHQHVALKMV----RNEKRFHRQAAEEIRILEHLRKQDKDNTMN 160
Query: 751 LVKLHGC-------CI--EGAERLL---VYEYLENKSLDQALFGQRSLTLDWATRYEICS 798
++ + C+ E LL +YE ++ + +L R +
Sbjct: 161 VIHMLENFTFRNHICMTFE----LLSMNLYELIKKNKF-------QGFSLP-LVR-KFAH 207
Query: 799 GVARGLAYLHEESRVRIIHRDVKASNVLLDADLVP--KISDFGLAKLYDDKK-THISTRV 855
+ + L LH+ RIIH D+K N+LL K+ DFG + + T+I +R
Sbjct: 208 SILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTYIQSRF 264
Query: 856 AGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRP 893
Y APE + D+++ G + E ++G P
Sbjct: 265 -----YRAPEVILGARYGMPIDMWSLGCILAELLTGYP 297
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 1e-05
Identities = 40/150 (26%), Positives = 60/150 (40%), Gaps = 16/150 (10%)
Query: 205 AGVSGEIPSSFANLQSLTKWWASDTRLTGRIPDFIGNWSKLTALRFQGNSFNGPIPSSFS 264
V IP+ L L + LT L GN F+
Sbjct: 20 TSVPTGIPAQTTYL------DLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFN 73
Query: 265 NLTSVTELRISDLSNGSSKL---AFIRDMKSLSILELRNNNISDSIPSNI-GEYRSLQHL 320
LTS+T L +S +N L F + + L L L N + S+P + + L+ L
Sbjct: 74 KLTSLTYLNLS--TNQLQSLPNGVFDKLTQ-LKELALNTNQLQ-SLPDGVFDKLTQLKDL 129
Query: 321 DLSFNNLGGSIPDSLF-NLSSLTHLFLGNN 349
L N L S+PD +F L+SL +++L +N
Sbjct: 130 RLYQNQLK-SVPDGVFDRLTSLQYIWLHDN 158
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 4e-04
Identities = 41/176 (23%), Positives = 63/176 (35%), Gaps = 31/176 (17%)
Query: 88 KCDCSSQNGTV-CHITQLKVYALNVVGVIPDELWNLTSLFNLNLGQNYLTGPLSPSVGNL 146
+C CS TV C+ +V IP L+L N L + L
Sbjct: 4 RCSCSGT--TVECYSQGRT----SVPTGIP------AQTTYLDLETNSLKSLPNGVFDEL 51
Query: 147 TAMQYLNLAINALSGELPKELGQLTELLILGIGTNNFSGPLPSEL-GSLSKLQELYIDS- 204
T++ L L N L +LT L L + TN LP+ + L++L+EL +++
Sbjct: 52 TSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQS-LPNGVFDKLTQLKELALNTN 110
Query: 205 ------AGVSGEIPSSFANLQSLTKWWASDTRLTGRIPDFI-GNWSKLTALRFQGN 253
GV F L L +L +PD + + L + N
Sbjct: 111 QLQSLPDGV-------FDKLTQLKDLRLYQNQLK-SVPDGVFDRLTSLQYIWLHDN 158
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 7e-04
Identities = 34/121 (28%), Positives = 62/121 (51%), Gaps = 10/121 (8%)
Query: 259 IPSSFSNLTSVTELRISDLSNGSSKLAFIRDMKSLSILELRNNNISDSIPSNI-GEYRSL 317
+P+ T+ +L + L + + F ++ SL+ L L N + S+P+ + + SL
Sbjct: 22 VPTGIPAQTTYLDLETNSLKSLPNG-VF-DELTSLTQLYLGGNKLQ-SLPNGVFNKLTSL 78
Query: 318 QHLDLSFNNLGGSIPDSLFN-LSSLTHLFLGNNKLNGTLPAR---KSPLLLNIDVSYNNL 373
+L+LS N L S+P+ +F+ L+ L L L N+L +LP K L ++ + N L
Sbjct: 79 TYLNLSTNQLQ-SLPNGVFDKLTQLKELALNTNQLQ-SLPDGVFDKLTQLKDLRLYQNQL 136
Query: 374 Q 374
+
Sbjct: 137 K 137
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 2e-05
Identities = 26/118 (22%), Positives = 47/118 (39%), Gaps = 20/118 (16%)
Query: 276 DLSNGSSKLA-FIRDMKSLSILELRNNNISDSIPSNIGE-----YRSLQHLDLSFNNLG- 328
L GS+ + F ++ L+L NN+ + + S+ L+LS N+LG
Sbjct: 6 TLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGF 65
Query: 329 ---GSIPDSL-FNLSSLTHLFLGNNKLN--------GTLPARKSPLLLNIDVSYNNLQ 374
+ L +++T L L N L+ TL A + +D+ +N+
Sbjct: 66 KNSDELVQILAAIPANVTSLNLSGNFLSYKSSDELVKTLAAIPFT-ITVLDLGWNDFS 122
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 2e-04
Identities = 30/132 (22%), Positives = 52/132 (39%), Gaps = 22/132 (16%)
Query: 241 NWSKLTALRFQGNSFNGP-----IPSSF-SNLTSVTELRISD--LSNGSSKL---AFIRD 289
+ +T+L GNS G + + +VT L +S LS SS
Sbjct: 49 TPASVTSLNLSGNSL-GFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDELVKTLAAI 107
Query: 290 MKSLSILELRNNNISDSIPSNIGEY-----RSLQHLDLSFNNLGG----SIPDSLFNL-S 339
++++L+L N+ S S + S+ L+L N+LG + L + +
Sbjct: 108 PFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQILAAIPA 167
Query: 340 SLTHLFLGNNKL 351
++ L L N L
Sbjct: 168 NVNSLNLRGNNL 179
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 5e-05
Identities = 33/111 (29%), Positives = 52/111 (46%), Gaps = 14/111 (12%)
Query: 246 TALRFQGNSFNGPIPSSFSNLTSVTELRISD-----LSNGSSKLAFIRDMKSLSILELRN 300
T L + N F LT +T+L +S L +G F + + L+IL L
Sbjct: 31 TRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDG----VFDK-LTKLTILYLHE 85
Query: 301 NNISDSIPSNI-GEYRSLQHLDLSFNNLGGSIPDSLF-NLSSLTHLFLGNN 349
N + S+P+ + + L+ L L N L S+PD +F L+SL ++L N
Sbjct: 86 NKLQ-SLPNGVFDKLTQLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTN 134
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372 | Back alignment and structure |
|---|
Score = 45.5 bits (108), Expect = 6e-05
Identities = 26/133 (19%), Positives = 43/133 (32%), Gaps = 29/133 (21%)
Query: 266 LTSVTELRISD--LSNGSSKL---AFIRDMKSLSILELRNNNISDS--------IPSNIG 312
+L + L + K + D ++ L L NN ++ + + N
Sbjct: 125 FLRARKLGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLAGN-- 182
Query: 313 EYRSLQHLDLSFNNLG----GSIPDSLFNLSSLTHLFLGNNKLNGTLPA-------RKSP 361
S+ HL L LG + L L L + N G A R+ P
Sbjct: 183 --TSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGA-GDTAALALARAAREHP 239
Query: 362 LLLNIDVSYNNLQ 374
L + + +N L
Sbjct: 240 SLELLHLYFNELS 252
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594 | Back alignment and structure |
|---|
Score = 45.3 bits (107), Expect = 9e-05
Identities = 38/247 (15%), Positives = 83/247 (33%), Gaps = 19/247 (7%)
Query: 121 NLTSLFNLNLGQNYLTGPLSPSVGNLTAMQYLNLAINALSG-------ELPKELGQLTEL 173
N L L+ + + T L+ ++ L+L + + P L L
Sbjct: 131 NFKVL-VLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLVSL 189
Query: 174 LILGIGTN-NFSGPLPSELGSLSKLQELYIDSAGVSGEIPSSFANLQSLTK------WWA 226
I + + +FS L + L+ L ++ A ++ + L +
Sbjct: 190 NISCLASEVSFSA-LERLVTRCPNLKSLKLNRAVPLEKLATLLQRAPQLEELGTGGYTAE 248
Query: 227 SDTRLTGRIPDFIGNWSKLTALRFQGNSFNGPIPSSFSNLTSVTELRISDLSNGSSKL-A 285
+ + + +L L ++ +P+ +S + +T L +S + S L
Sbjct: 249 VRPDVYSGLSVALSGCKELRCLSGFWDAVPAYLPAVYSVCSRLTTLNLSYATVQSYDLVK 308
Query: 286 FIRDMKSLSILELRNNNISDSIPSNIGEY-RSLQHLDLSFNNLGGSIPDSLFNLSSLTHL 344
+ L L + + I D+ + + L+ L + + P+ L +
Sbjct: 309 LLCQCPKLQRLWVLDY-IEDAGLEVLASTCKDLRELRVFPSEPFVMEPNVALTEQGLVSV 367
Query: 345 FLGNNKL 351
+G KL
Sbjct: 368 SMGCPKL 374
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170 | Back alignment and structure |
|---|
Score = 42.6 bits (101), Expect = 1e-04
Identities = 24/59 (40%), Positives = 35/59 (59%), Gaps = 4/59 (6%)
Query: 293 LSILELRNNNISDSIPSNI-GEYRSLQHLDLSFNNLGGSIPDSLF-NLSSLTHLFLGNN 349
L+ L+L NN ++ +P+ + + L L L+ N L SIP F NL SLTH++L NN
Sbjct: 56 LTRLDLDNNQLT-VLPAGVFDKLTQLTQLSLNDNQLK-SIPRGAFDNLKSLTHIWLLNN 112
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174 | Back alignment and structure |
|---|
Score = 42.6 bits (101), Expect = 1e-04
Identities = 24/59 (40%), Positives = 35/59 (59%), Gaps = 4/59 (6%)
Query: 293 LSILELRNNNISDSIPSNI-GEYRSLQHLDLSFNNLGGSIPDSLF-NLSSLTHLFLGNN 349
L L +N ++ +IP+ + + L LDL+ N+L SIP F NL SLTH++L NN
Sbjct: 59 LQQLYFNSNKLT-AIPTGVFDKLTQLTQLDLNDNHLK-SIPRGAFDNLKSLTHIYLYNN 115
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 Length = 197 | Back alignment and structure |
|---|
Score = 42.9 bits (101), Expect = 1e-04
Identities = 20/102 (19%), Positives = 37/102 (36%), Gaps = 13/102 (12%)
Query: 264 SNLTSVTELRISDLSNGSSK--LAFIRDMK---SLSILELRNNNISDSIPSNIGEY---- 314
+ T + E+ I+++ S + + I + L N ISDS + E
Sbjct: 38 EDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETS 97
Query: 315 RSLQHLDLSFNNLGG----SIPDSLFNLSSLTHLFLGNNKLN 352
SL+ L++ N L + S S+ N + +
Sbjct: 98 PSLRVLNVESNFLTPELLARLLRSTLVTQSIVEFKADNQRQS 139
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* Length = 130 | Back alignment and structure |
|---|
Score = 41.3 bits (97), Expect = 2e-04
Identities = 14/48 (29%), Positives = 20/48 (41%), Gaps = 4/48 (8%)
Query: 306 SIPSNIGEYRSLQHLDLSFNNLGGSIPDSLF-NLSSLTHLFLGNNKLN 352
S+P+ L L+ NNL ++P L L +L LG N
Sbjct: 24 SLPTAF--PVDTTELVLTGNNLT-ALPPGLLDALPALRTAHLGANPWR 68
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* Length = 540 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 5e-04
Identities = 19/88 (21%), Positives = 35/88 (39%), Gaps = 15/88 (17%)
Query: 759 IEGAERLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHR 818
++ + ++ Y+ K + +I + + LH+ +IH
Sbjct: 409 VDLDNKRIMMSYINGKLAKDVI----------EDNLDIAYKIGEIVGKLHKN---DVIHN 455
Query: 819 DVKASNVLLDADLVPKISDFGLAKLYDD 846
D+ SN + D DL I DFGL K+ +
Sbjct: 456 DLTTSNFIFDKDLY--IIDFGLGKISNL 481
|
Structure Templates Detected by HHsearch 
Original result of HHsearch against PDB70 database
No hit with probability above 80.00
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| 1036 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 3e-70 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 1e-67 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 3e-65 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 4e-64 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 9e-64 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 3e-63 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 8e-63 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 3e-61 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 7e-61 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 1e-60 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 2e-60 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 1e-59 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 4e-58 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 1e-57 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 1e-57 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 1e-57 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 2e-57 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 6e-57 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 2e-56 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 2e-56 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 5e-56 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 1e-55 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 1e-55 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 3e-55 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 3e-55 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 4e-55 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 5e-55 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 1e-54 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 2e-53 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 2e-50 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 8e-50 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 1e-49 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 2e-48 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 2e-46 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 3e-46 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 2e-45 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 5e-45 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 5e-45 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 4e-44 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 7e-44 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 1e-43 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 2e-43 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 4e-43 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 2e-42 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 3e-42 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 4e-42 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 6e-42 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 2e-40 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 8e-40 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 6e-39 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 1e-38 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 9e-38 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 2e-37 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 7e-37 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 8e-37 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 5e-35 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 2e-33 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 8e-33 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 4e-31 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 9e-31 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 8e-30 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 3e-25 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 6e-25 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 2e-23 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 3e-22 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 5e-21 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 2e-13 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 1e-10 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 5e-21 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 4e-14 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 1e-11 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 9e-11 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 2e-08 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 5e-08 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 3e-07 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 6e-07 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 4e-04 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 4e-04 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 4e-19 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 4e-07 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 3e-06 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 2e-13 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 2e-07 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 1e-06 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 2e-11 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 0.002 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 2e-10 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 4e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 5e-09 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 5e-08 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-07 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 9e-05 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 5e-09 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 7e-06 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 4e-05 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 2e-04 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 7e-04 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 0.002 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 6e-08 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 2e-06 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 9e-05 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 0.003 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 5e-07 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 0.001 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 0.002 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 8e-07 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 4e-04 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 2e-06 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 7e-06 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 3e-04 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 0.002 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 9e-05 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 0.002 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 6e-04 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 7e-04 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 8e-04 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 8e-04 | |
| d2ifga3 | 156 | c.10.2.7 (A:36-191) High affinity nerve growth fac | 0.001 | |
| d1m9la_ | 198 | c.10.3.1 (A:) Outer arm dynein light chain 1 {Gree | 0.003 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 233 bits (595), Expect = 3e-70
Identities = 66/275 (24%), Positives = 125/275 (45%), Gaps = 19/275 (6%)
Query: 693 ENFSPSNKLGEGGFGPVYKGKLGDGRAIAVKQLSVASRQGKSQFVAEIATISAVQHRNLV 752
+ ++G G FG VYKGK A+ + ++ + Q F E+ + +H N++
Sbjct: 8 GQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 67
Query: 753 KLHGCCIEGAERLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESR 812
G + +V ++ E SL L + + +I A+G+ YLH +S
Sbjct: 68 LFMGYSTAP-QLAIVTQWCEGSSLYHHLHIIET-KFEMIKLIDIARQTAQGMDYLHAKS- 124
Query: 813 VRIIHRDVKASNVLLDADLVPKISDFGLAKLYD-DKKTHISTRVAGTIGYLAPEYAM--- 868
IIHRD+K++N+ L DL KI DFGLA + +H +++G+I ++APE
Sbjct: 125 --IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQD 182
Query: 869 RGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEIELADPKLI 928
+ + ++DV+AFG++ E ++G+ + +++ + +L P L
Sbjct: 183 KNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYL----------SPDLS 232
Query: 929 EFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVAML 963
+ K + + C + RP +++A +
Sbjct: 233 KVRSNCPKAMKRLMAECLKKKRDERPLFPQILASI 267
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 225 bits (575), Expect = 1e-67
Identities = 72/271 (26%), Positives = 121/271 (44%), Gaps = 19/271 (7%)
Query: 693 ENFSPSNKLGEGGFGPVYKGKLGDGRAIAVKQLSVASRQGKSQFVAEIATISAVQHRNLV 752
E +LG G FG V+ G +AVK L F+AE + +QH+ LV
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLV 71
Query: 753 KLHGCCIEGAERLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESR 812
+L+ + ++ EY+EN SL L + L ++ + +A G+A++ E +
Sbjct: 72 RLYAVVTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN- 129
Query: 813 VRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVAGTIGYLAPEYAMRGHL 872
IHRD++A+N+L+ L KI+DFGLA+L +D + I + APE G
Sbjct: 130 --YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTF 187
Query: 873 TEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEIELADPKLIEFNE 932
T K+DV++FG+L E V+ P + ++ L + +
Sbjct: 188 TIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQN--------------LERGYRMVRPD 233
Query: 933 EEVKRLIGVALLCTQTLPSLRPSMSRVVAML 963
+ L + LC + P RP+ + ++L
Sbjct: 234 NCPEELYQLMRLCWKERPEDRPTFDYLRSVL 264
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 218 bits (557), Expect = 3e-65
Identities = 71/272 (26%), Positives = 123/272 (45%), Gaps = 21/272 (7%)
Query: 693 ENFSPSNKLGEGGFGPVYKGKLGDGRAIAVKQLSVASRQGKSQFVAEIATISAVQHRNLV 752
+ ++G G FG V+ G + +A+K + + F+ E + + H LV
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLV 63
Query: 753 KLHGCCIEGAERLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESR 812
+L+G C+E A LV+E++E+ L + T +C V G+AYL E
Sbjct: 64 QLYGVCLEQAPICLVFEFMEHGCLSD-YLRTQRGLFAAETLLGMCLDVCEGMAYLEEA-- 120
Query: 813 VRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVAGTIGYLAPEYAMRGHL 872
+IHRD+ A N L+ + V K+SDFG+ + D + ST + + +PE
Sbjct: 121 -CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRY 179
Query: 873 TEKTDVFAFGVLALETVS-GRPNSDPSLDEEKLYLLEWAWHLHENNQEIELADPKLIEFN 931
+ K+DV++FGVL E S G+ + + E + + + L+ P+L
Sbjct: 180 SSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLY---------KPRLA--- 227
Query: 932 EEEVKRLIGVALLCTQTLPSLRPSMSRVVAML 963
V +++ C + P RP+ SR++ L
Sbjct: 228 STHVYQIM---NHCWKERPEDRPAFSRLLRQL 256
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 216 bits (551), Expect = 4e-64
Identities = 71/290 (24%), Positives = 129/290 (44%), Gaps = 21/290 (7%)
Query: 675 GMDARPYTFSYAELKTATENFSPSNKLGEGGFGPVYKGKL-GDGRAIAVKQLSVASRQGK 733
MD P + +Y + + + + +KLG G +G VY+G +AVK L + + +
Sbjct: 1 AMD--PSSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE 58
Query: 734 SQFVAEIATISAVQHRNLVKLHGCCIEGAERLLVYEYLENKSLDQALFGQRSLTLDWATR 793
+F+ E A + ++H NLV+L G C ++ E++ +L L +
Sbjct: 59 -EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVL 117
Query: 794 YEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHIST 853
+ + ++ + YL ++ IHRD+ A N L+ + + K++DFGL++L
Sbjct: 118 LYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA 174
Query: 854 RVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHL 913
I + APE + K+DV+AFGVL E + + P +D ++Y
Sbjct: 175 GAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY-------- 226
Query: 914 HENNQEIELADPKLIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVAML 963
E+ D ++ E E +++ + C Q PS RPS + +
Sbjct: 227 -----ELLEKDYRM-ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAF 270
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 214 bits (546), Expect = 9e-64
Identities = 60/271 (22%), Positives = 108/271 (39%), Gaps = 19/271 (7%)
Query: 693 ENFSPSNKLGEGGFGPVYKGKLGDGRAIAVKQLSVASRQGKSQFVAEIATISAVQHRNLV 752
++ + +LG G FG V GK +A+K + + +F+ E + + H LV
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLV 62
Query: 753 KLHGCCIEGAERLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESR 812
+L+G C + ++ EY+ N L L R E+C V + YL +
Sbjct: 63 QLYGVCTKQRPIFIITEYMANGCLLNYLREMRH-RFQTQQLLEMCKDVCEAMEYLESK-- 119
Query: 813 VRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVAGTIGYLAPEYAMRGHL 872
+ +HRD+ A N L++ V K+SDFGL++ D + S + + PE M
Sbjct: 120 -QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKF 178
Query: 873 TEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEIELADPKLIEFNE 932
+ K+D++AFGVL E S + +A +
Sbjct: 179 SSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEH--------------IAQGLRLYRPH 224
Query: 933 EEVKRLIGVALLCTQTLPSLRPSMSRVVAML 963
+++ + C RP+ +++ +
Sbjct: 225 LASEKVYTIMYSCWHEKADERPTFKILLSNI 255
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 213 bits (544), Expect = 3e-63
Identities = 71/271 (26%), Positives = 121/271 (44%), Gaps = 19/271 (7%)
Query: 693 ENFSPSNKLGEGGFGPVYKGKLGDGRAIAVKQLSVASRQGKSQFVAEIATISAVQHRNLV 752
E+ KLG+G FG V+ G +A+K L F+ E + ++H LV
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLV 75
Query: 753 KLHGCCIEGAERLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESR 812
+L+ E +V EY+ SL L G+ L ++ + +A G+AY+ R
Sbjct: 76 QLYAVVSEE-PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---R 131
Query: 813 VRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVAGTIGYLAPEYAMRGHL 872
+ +HRD++A+N+L+ +LV K++DFGLA+L +D + I + APE A+ G
Sbjct: 132 MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRF 191
Query: 873 TEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEIELADPKLIEFNE 932
T K+DV++FG+L E + P + ++ + +
Sbjct: 192 TIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQ--------------VERGYRMPCPP 237
Query: 933 EEVKRLIGVALLCTQTLPSLRPSMSRVVAML 963
E + L + C + P RP+ + A L
Sbjct: 238 ECPESLHDLMCQCWRKEPEERPTFEYLQAFL 268
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 213 bits (543), Expect = 8e-63
Identities = 69/301 (22%), Positives = 127/301 (42%), Gaps = 38/301 (12%)
Query: 682 TFSYAELKTATENFSPS---------NKLGEGGFGPVYKGKL----GDGRAIAVKQL-SV 727
F++ + A F+ +G G FG V G L +A+K L S
Sbjct: 6 PFTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSG 65
Query: 728 ASRQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLVYEYLENKSLDQALFGQRSLT 787
+ + + F++E + + H N++ L G + +++ E++EN SLD Q
Sbjct: 66 YTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDS-FLRQNDGQ 124
Query: 788 LDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDK 847
+ G+A G+ YL + +HRD+ A N+L++++LV K+SDFGL++ +D
Sbjct: 125 FTVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 181
Query: 848 KTHISTRVA----GTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVS-GRPNSDPSLDEE 902
+ + A I + APE T +DV+++G++ E +S G +++
Sbjct: 182 TSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQD 241
Query: 903 KLYLLEWAWHLHENNQEIELADPKLIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVAM 962
+ +E + L + L + L C Q + RP ++V
Sbjct: 242 VINAIEQDYRL---------------PPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNT 286
Query: 963 L 963
L
Sbjct: 287 L 287
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 209 bits (532), Expect = 3e-61
Identities = 77/310 (24%), Positives = 123/310 (39%), Gaps = 47/310 (15%)
Query: 684 SYAELKTATENFSPSNKLGEGGFGPVYKGKL------GDGRAIAVKQLSV-ASRQGKSQF 736
L+ N +GEG FG V++ + +AVK L AS ++ F
Sbjct: 4 KLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADF 63
Query: 737 VAEIATISAVQHRNLVKLHGCCIEGAERLLVYEYLENKSLDQALFGQRSLT--------- 787
E A ++ + N+VKL G C G L++EY+ L++ L T
Sbjct: 64 QREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDL 123
Query: 788 -------------LDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPK 834
L A + I VA G+AYL E + +HRD+ N L+ ++V K
Sbjct: 124 STRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVK 180
Query: 835 ISDFGLAK-LYDDKKTHISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRP 893
I+DFGL++ +Y A I ++ PE T ++DV+A+GV+ E S
Sbjct: 181 IADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGL 240
Query: 894 NSDPSLDEEKLYLLEWAWHLHENNQEIELADPKLIEFNEEEVKRLIGVALLCTQTLPSLR 953
+ E++ + D ++ E L + LC LP+ R
Sbjct: 241 QPYYGMAHEEVIYY--------------VRDGNILACPENCPLELYNLMRLCWSKLPADR 286
Query: 954 PSMSRVVAML 963
PS + +L
Sbjct: 287 PSFCSIHRIL 296
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 208 bits (531), Expect = 7e-61
Identities = 58/253 (22%), Positives = 108/253 (42%), Gaps = 11/253 (4%)
Query: 687 ELKTATENFSPSNKLGEGGFGPVYKGK-LGDGRAIAVKQLSVASRQG-KSQFVAEIATIS 744
ELK ++F ++LG G G V+K G +A K + + + ++Q + E+ +
Sbjct: 2 ELKD--DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLH 59
Query: 745 AVQHRNLVKLHGCCIEGAERLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGL 804
+V +G E + E+++ SLDQ L +++ + ++ V +GL
Sbjct: 60 ECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL--KKAGRIPEQILGKVSIAVIKGL 117
Query: 805 AYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVAGTIGYLAP 864
YL + +I+HRDVK SN+L+++ K+ DFG++ D GT Y++P
Sbjct: 118 TYLR--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA---NSFVGTRSYMSP 172
Query: 865 EYAMRGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEIELAD 924
E H + ++D+++ G+ +E GR P +E +
Sbjct: 173 ERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRT 232
Query: 925 PKLIEFNEEEVKR 937
P + R
Sbjct: 233 PGRPLSSYGMDSR 245
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (523), Expect = 1e-60
Identities = 65/272 (23%), Positives = 108/272 (39%), Gaps = 25/272 (9%)
Query: 693 ENFSPSNKLGEGGFGPVYKGKLGDGRAIAVKQLSVASRQGKSQFVAEIATISAVQHRNLV 752
+ +G+G FG V G G +AVK + + F+AE + ++ ++H NLV
Sbjct: 7 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIK--NDATAQAFLAEASVMTQLRHSNLV 63
Query: 753 KLHGCCIEGAERL-LVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEES 811
+L G +E L +V EY+ SL L + L + V + YL
Sbjct: 64 QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN- 122
Query: 812 RVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVAGTIGYLAPEYAMRGH 871
+HRD+ A NVL+ D V K+SDFGL K + + + APE
Sbjct: 123 --NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDT----GKLPVKWTAPEALREKK 176
Query: 872 LTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEIELADPKLIEFN 931
+ K+DV++FG+L E S P + + + + + +
Sbjct: 177 FSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV-----PRVEKGY------KMDAPDGC 225
Query: 932 EEEVKRLIGVALLCTQTLPSLRPSMSRVVAML 963
V ++ C ++RPS ++ L
Sbjct: 226 PPAVYEVM---KNCWHLDAAMRPSFLQLREQL 254
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 206 bits (525), Expect = 2e-60
Identities = 64/288 (22%), Positives = 110/288 (38%), Gaps = 29/288 (10%)
Query: 700 KLGEGGFGPVYKGKLGDGRAIAVKQLSVASRQGKSQFVAEIATISAVQHRNLVKLHGCCI 759
+G+G FG V++GK G +AVK S + AEI ++H N++
Sbjct: 10 SIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSW-FREAEIYQTVMLRHENILGFIAADN 67
Query: 760 EG----AERLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEE----- 810
+ + LV +Y E+ SL L T+ ++ A GLA+LH E
Sbjct: 68 KDNGTWTQLWLVSDYHEHGSLFDYL---NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQ 124
Query: 811 SRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHIS---TRVAGTIGYLAPEY- 866
+ I HRD+K+ N+L+ + I+D GLA +D I GT Y+APE
Sbjct: 125 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVL 184
Query: 867 -----AMRGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLY----LLEWAWHLHENN 917
++ D++A G++ E D + Y + +
Sbjct: 185 DDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKV 244
Query: 918 QEIELADPKLIE--FNEEEVKRLIGVALLCTQTLPSLRPSMSRVVAML 963
+ P + + E ++ + + C + R + R+ L
Sbjct: 245 VCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTL 292
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (519), Expect = 1e-59
Identities = 64/284 (22%), Positives = 114/284 (40%), Gaps = 26/284 (9%)
Query: 687 ELKTATENFSPSN-KLGEGGFGPVYKGKL---GDGRAIAVKQLSVASRQG-KSQFVAEIA 741
+L +N ++ +LG G FG V +G +A+K L + + + + E
Sbjct: 2 KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQ 61
Query: 742 TISAVQHRNLVKLHGCCIEGAERLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVA 801
+ + + +V+L G C + +LV E L + L G+R + + E+ V+
Sbjct: 62 IMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKRE-EIPVSNVAELLHQVS 119
Query: 802 RGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTR--VAGTI 859
G+ YL E++ +HRD+ A NVLL KISDFGL+K ++ + R +
Sbjct: 120 MGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPL 176
Query: 860 GYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQE 919
+ APE + ++DV+++GV E +S + ++
Sbjct: 177 KWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAF------------ 224
Query: 920 IELADPKLIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVAML 963
+ K +E E L + C RP V +
Sbjct: 225 --IEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRM 266
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (509), Expect = 4e-58
Identities = 68/304 (22%), Positives = 115/304 (37%), Gaps = 41/304 (13%)
Query: 693 ENFSPSNKLGEGGFGPVYKGKL------GDGRAIAVKQLSVASRQG-KSQFVAEIATISA 745
S LG G FG V + +AVK L ++ + ++E+ +S
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 746 V-QHRNLVKLHGCCIEGAERLLVYEYLENKSLDQALFGQR----------------SLTL 788
+ H N+V L G C G L++ EY L L +R L L
Sbjct: 83 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 789 DWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAK-LYDDK 847
D VA+G+A+L + IHRD+ A N+LL + KI DFGLA+ + +D
Sbjct: 143 DLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199
Query: 848 KTHISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLL 907
+ + ++APE T ++DV+++G+ E S + P + + +
Sbjct: 200 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYK 259
Query: 908 EWAWHLHENNQEIELADPKLIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVAMLCGDM 967
+ E + + C P RP+ ++V ++ +
Sbjct: 260 MIKEGFR-------------MLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQI 306
Query: 968 EVST 971
ST
Sbjct: 307 SEST 310
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (503), Expect = 1e-57
Identities = 67/272 (24%), Positives = 108/272 (39%), Gaps = 27/272 (9%)
Query: 699 NKLGEGGFGPVYKGKL---GDGRAIAVKQLSVASRQG--KSQFVAEIATISAVQHRNLVK 753
+LG G FG V KG + +AVK L + K + +AE + + + +V+
Sbjct: 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 72
Query: 754 LHGCCIEGAERLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRV 813
+ G C E +LV E E L++ L R + E+ V+ G+ YL E
Sbjct: 73 MIGIC-EAESWMLVMEMAELGPLNKYLQQNR--HVKDKNIIELVHQVSMGMKYLEES--- 126
Query: 814 RIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTR--VAGTIGYLAPEYAMRGH 871
+HRD+ A NVLL KISDFGL+K + + + + + APE
Sbjct: 127 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYK 186
Query: 872 LTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEIELADPKLIEFN 931
+ K+DV++FGVL E S + ++ + L + +
Sbjct: 187 FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAM--------------LEKGERMGCP 232
Query: 932 EEEVKRLIGVALLCTQTLPSLRPSMSRVVAML 963
+ + + LC RP + V L
Sbjct: 233 AGCPREMYDLMNLCWTYDVENRPGFAAVELRL 264
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (506), Expect = 1e-57
Identities = 70/279 (25%), Positives = 121/279 (43%), Gaps = 29/279 (10%)
Query: 694 NFSPSNKLGEGGFGPVYKGKL----GDGRAIAVKQLSVASRQGK-SQFVAEIATISAVQH 748
+F+ +G G FG VY G L G AVK L+ + G+ SQF+ E + H
Sbjct: 30 HFN--EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 87
Query: 749 RNLVKLHGCCIEG-AERLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYL 807
N++ L G C+ L+V Y+++ L + VA+G+ +L
Sbjct: 88 PNVLSLLGICLRSEGSPLVVLPYMKHGDLRN-FIRNETHNPTVKDLIGFGLQVAKGMKFL 146
Query: 808 HEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKK---THISTRVAGTIGYLAP 864
+ + +HRD+ A N +LD K++DFGLA+ DK+ H T + ++A
Sbjct: 147 ASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMAL 203
Query: 865 EYAMRGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEIELAD 924
E T K+DV++FGVL E ++ P ++ + +L + +
Sbjct: 204 ESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN-----TFDITVYLLQGRR------ 252
Query: 925 PKLIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVAML 963
E+ + + ++ L C +RPS S +V+ +
Sbjct: 253 LLQPEYCPDPLYEVM---LKCWHPKAEMRPSFSELVSRI 288
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (503), Expect = 1e-57
Identities = 63/279 (22%), Positives = 123/279 (44%), Gaps = 26/279 (9%)
Query: 693 ENFSPSNKLGEGGFGPVYKGKLGDG-----RAIAVKQLSVASRQG-KSQFVAEIATISAV 746
+ +G G FG VYKG L +A+K L + + F+ E +
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66
Query: 747 QHRNLVKLHGCCIEGAERLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAY 806
H N+++L G + +++ EY+EN +LD+ ++ + G+A G+ Y
Sbjct: 67 SHHNIIRLEGVISKYKPMMIITEYMENGALDK-FLREKDGEFSVLQLVGMLRGIAAGMKY 125
Query: 807 LHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLY--DDKKTHISTRVAGTIGYLAP 864
L + +HRD+ A N+L++++LV K+SDFGL+++ D + T+ ++ I + AP
Sbjct: 126 LA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAP 182
Query: 865 EYAMRGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEIELAD 924
E T +DV++FG++ E ++ L ++ + D
Sbjct: 183 EAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKA--------------IND 228
Query: 925 PKLIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVAML 963
+ + + + + C Q + RP + +V++L
Sbjct: 229 GFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSIL 267
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 198 bits (505), Expect = 2e-57
Identities = 67/277 (24%), Positives = 116/277 (41%), Gaps = 33/277 (11%)
Query: 692 TENFSPSNKLGEGGFGPVYKGK-LGDGRAIAVKQLSVASRQGKS---QFVAEIATISAVQ 747
+ FS ++G G FG VY + + + +A+K++S + +Q + E+ + ++
Sbjct: 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73
Query: 748 HRNLVKLHGCCIEGAERLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYL 807
H N ++ GC + LV EY + D ++ L + G +GLAYL
Sbjct: 74 HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKK--PLQEVEIAAVTHGALQGLAYL 131
Query: 808 HEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVAGTIGYLAPEYA 867
H +IHRDVKA N+LL + K+ DFG A + + + GT ++APE
Sbjct: 132 HSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFV-----GTPYWMAPEVI 183
Query: 868 M---RGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEIELAD 924
+ G K DV++ G+ +E +P LY + +
Sbjct: 184 LAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI------------AQNES 231
Query: 925 PKLIEFN-EEEVKRLIGVALLCTQTLPSLRPSMSRVV 960
P L + E + + C Q +P RP+ ++
Sbjct: 232 PALQSGHWSEYFRNFV---DSCLQKIPQDRPTSEVLL 265
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (497), Expect = 6e-57
Identities = 60/270 (22%), Positives = 107/270 (39%), Gaps = 28/270 (10%)
Query: 699 NKLGEGGFGPVYKGKL-GDGRAIAVKQLSV--ASRQGKSQFVAEIATISAVQHRNLVKLH 755
++G G F VYKG +A +L ++ + +F E + +QH N+V+ +
Sbjct: 15 IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFY 74
Query: 756 GCCIEGAER----LLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEES 811
+ +LV E + + +L L + + C + +GL +LH +
Sbjct: 75 DSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK--VMKIKVLRSWCRQILKGLQFLHTRT 132
Query: 812 RVRIIHRDVKASNVLLDA-DLVPKISDFGLAKLYDDKKTHISTRVAGTIGYLAPEYAMRG 870
IIHRD+K N+ + KI D GLA L K+ + V GT ++APE
Sbjct: 133 P-PIIHRDLKCDNIFITGPTGSVKIGDLGLATL---KRASFAKAVIGTPEFMAPEM-YEE 187
Query: 871 HLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEIELADPKLIEF 930
E DV+AFG+ LE + + ++Y + K F
Sbjct: 188 KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIY-------------RRVTSGVKPASF 234
Query: 931 NEEEVKRLIGVALLCTQTLPSLRPSMSRVV 960
++ + + + C + R S+ ++
Sbjct: 235 DKVAIPEVKEIIEGCIRQNKDERYSIKDLL 264
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (494), Expect = 2e-56
Identities = 69/271 (25%), Positives = 109/271 (40%), Gaps = 22/271 (8%)
Query: 693 ENFSPSNKLGEGGFGPVYKGK-LGDGRAIAVKQLSVA-SRQGKSQFVAEIATISAVQHRN 750
E++ LGEG +G V A+AVK + + + EI + H N
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 751 LVKLHGCCIEGAERLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEE 810
+VK +G EG + L EY L + + A R + G+ YLH
Sbjct: 65 VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR--FFHQLMAGVVYLHGI 122
Query: 811 SRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYD-DKKTHISTRVAGTIGYLAPEYAMR 869
I HRD+K N+LLD KISDFGLA ++ + + + ++ GT+ Y+APE R
Sbjct: 123 ---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 179
Query: 870 GHL-TEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEIELADPKLI 928
E DV++ G++ ++G D D + Y ++ L K I
Sbjct: 180 REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY-------SDWKEKKTYLNPWKKI 232
Query: 929 EFNEEEVKRLIGVALLCTQTLPSLRPSMSRV 959
+ L+ PS R ++ +
Sbjct: 233 ---DSAPLALL---HKILVENPSARITIPDI 257
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (493), Expect = 2e-56
Identities = 63/280 (22%), Positives = 112/280 (40%), Gaps = 25/280 (8%)
Query: 690 TATENFSPSNKLGEGGFGPVYKGK-LGDGRAIAVKQLSVAS--RQGKSQFVAEIATISAV 746
+ E++ +G G +G K + DG+ + K+L S K V+E+ + +
Sbjct: 1 SRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLREL 60
Query: 747 QHRNLVKLHGCCIEGAERLL--VYEYLENKSLDQALF--GQRSLTLDWATRYEICSGVAR 802
+H N+V+ + I+ L V EY E L + + LD + + +
Sbjct: 61 KHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTL 120
Query: 803 GLAYLHEESRV--RIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVAGTIG 860
L H S ++HRD+K +NV LD K+ DFGLA++ + T + GT
Sbjct: 121 ALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNH-DTSFAKAFVGTPY 179
Query: 861 YLAPEYAMRGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEI 920
Y++PE R EK+D+++ G L E + P +E +
Sbjct: 180 YMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKI------------R 227
Query: 921 ELADPKLIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVV 960
E ++ +E+ +I RPS+ ++
Sbjct: 228 EGKFRRIPYRYSDELNEII---TRMLNLKDYHRPSVEEIL 264
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (492), Expect = 5e-56
Identities = 60/274 (21%), Positives = 105/274 (38%), Gaps = 24/274 (8%)
Query: 692 TENFSPSNKLGEGGFGPVYKGK-LGDGRAIAVKQLSVASRQGKSQFVAEIATISAVQHRN 750
+ + +LG+G FG VYK + A K + S + ++ EI +++ H N
Sbjct: 11 EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPN 70
Query: 751 LVKLHGCCIEGAERLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEE 810
+VKL ++ E+ ++D + + L + +C L YLH+
Sbjct: 71 IVKLLDAFYYENNLWILIEFCAGGAVDA-VMLELERPLTESQIQVVCKQTLDALNYLHDN 129
Query: 811 SRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVAGTIGYLAPEYAM-- 868
+IIHRD+KA N+L D K++DFG++ + + GT ++APE M
Sbjct: 130 ---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI-GTPYWMAPEVVMCE 185
Query: 869 ---RGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEIELADP 925
K DV++ G+ +E P L ++ LA P
Sbjct: 186 TSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLL-------KIAKSEPPTLAQP 238
Query: 926 KLIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRV 959
K + C + R + S++
Sbjct: 239 SRW---SSNFKDFL---KKCLEKNVDARWTTSQL 266
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (488), Expect = 1e-55
Identities = 65/280 (23%), Positives = 111/280 (39%), Gaps = 27/280 (9%)
Query: 693 ENFSPSNKLGEGGFGPVYKGKL----GDGRAIAVKQLS---VASRQGKSQFVAEIATISA 745
++ KLG+G FG V +G+ G ++AVK L ++ + F+ E+ + +
Sbjct: 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67
Query: 746 VQHRNLVKLHGCCIEGAERLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLA 805
+ HRNL++L+G + + +V E SL + T VA G+
Sbjct: 68 LDHRNLIRLYGVVLTPPMK-MVTELAPLGSLLD-RLRKHQGHFLLGTLSRYAVQVAEGMG 125
Query: 806 YLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTH--ISTRVAGTIGYLA 863
YL + R IHRD+ A N+LL + KI DFGL + H + + A
Sbjct: 126 YLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCA 182
Query: 864 PEYAMRGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEIELA 923
PE + +D + FGV E + L+ ++ +I+
Sbjct: 183 PESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQIL------------HKIDKE 230
Query: 924 DPKLIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVAML 963
+L E+ + + V + C P RP+ + L
Sbjct: 231 GERL-PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFL 269
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (492), Expect = 1e-55
Identities = 71/301 (23%), Positives = 115/301 (38%), Gaps = 46/301 (15%)
Query: 693 ENFSPSNKLGEGGFGPVYKG------KLGDGRAIAVKQLSVASRQG-KSQFVAEIATISA 745
EN LG G FG V K G +AVK L + + ++E+ ++
Sbjct: 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96
Query: 746 V-QHRNLVKLHGCCIEGAERLLVYEYLENKSLDQALFGQRSL------------------ 786
+ H N+V L G C L++EY L L +R
Sbjct: 97 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156
Query: 787 ---TLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAK- 842
L + VA+G+ +L + +HRD+ A NVL+ V KI DFGLA+
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLARD 213
Query: 843 LYDDKKTHISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEE 902
+ D + + ++APE G T K+DV+++G+L E S N P + +
Sbjct: 214 IMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD 273
Query: 903 KLYLLEWAWHLHENNQEIELADPKLIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVAM 962
+ + L +N + + EE+ ++ C RPS + +
Sbjct: 274 ANF-----YKLIQNGFK-----MDQPFYATEEIYIIM---QSCWAFDSRKRPSFPNLTSF 320
Query: 963 L 963
L
Sbjct: 321 L 321
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (488), Expect = 3e-55
Identities = 64/292 (21%), Positives = 125/292 (42%), Gaps = 33/292 (11%)
Query: 693 ENFSPSNKLGEGGFGPVYKGKL------GDGRAIAVKQLS-VASRQGKSQFVAEIATISA 745
E + S +LG+G FG VY+G +A+K ++ AS + + +F+ E + +
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79
Query: 746 VQHRNLVKLHGCCIEGAERLLVYEYLENKSLDQALFGQRSL--------TLDWATRYEIC 797
++V+L G +G L++ E + L L R + ++
Sbjct: 80 FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139
Query: 798 SGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAK-LYDDKKTHISTRVA 856
+A G+AYL+ + +HRD+ A N ++ D KI DFG+ + +Y+ +
Sbjct: 140 GEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 196
Query: 857 GTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHEN 916
+ +++PE G T +DV++FGV+ E + L E++
Sbjct: 197 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRF--------- 247
Query: 917 NQEIELADPKLIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVAMLCGDME 968
+ + L++ + L + +C Q P +RPS +++ + +ME
Sbjct: 248 -----VMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (487), Expect = 3e-55
Identities = 70/290 (24%), Positives = 116/290 (40%), Gaps = 38/290 (13%)
Query: 693 ENFSPSNKLGEGGFGPVYKGKL---GDGRAIAVKQLS-VASRQGKSQFVAEIATISAV-Q 747
+ + +GEG FG V K ++ G A+K++ AS+ F E+ + +
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 748 HRNLVKLHGCCIEGAERLLVYEYLENKSLDQALFGQRSL--------------TLDWATR 793
H N++ L G C L EY + +L L R L TL
Sbjct: 70 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 794 YEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHIST 853
+ VARG+ YL ++ + IHRD+ A N+L+ + V KI+DFGL++ + T
Sbjct: 130 LHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKK--T 184
Query: 854 RVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHL 913
+ ++A E T +DV+++GVL E VS + +LY
Sbjct: 185 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEK------ 238
Query: 914 HENNQEIELADPKLIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVAML 963
L +E + + C + P RPS ++++ L
Sbjct: 239 --------LPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSL 280
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (486), Expect = 4e-55
Identities = 66/269 (24%), Positives = 116/269 (43%), Gaps = 21/269 (7%)
Query: 692 TENFSPSNKLGEGGFGPVYKGK-LGDGRAIAVKQLSVASRQGKSQFVAEIATISAVQHRN 750
+ ++ K+G+G G VY + G+ +A++Q+++ + K + EI + ++ N
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 751 LVKLHGCCIEGAERLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEE 810
+V + G E +V EYL SL + D +C + L +LH
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCM---DEGQIAAVCRECLQALEFLHSN 135
Query: 811 SRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVAGTIGYLAPEYAMRG 870
++IHRD+K+ N+LL D K++DFG +++ ST V GT ++APE R
Sbjct: 136 ---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRK 191
Query: 871 HLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEIELADPKLIEF 930
K D+++ G++A+E + G P LY L N EL +P+ +
Sbjct: 192 AYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY-------LIATNGTPELQNPEKL-- 242
Query: 931 NEEEVKRLIGVALLCTQTLPSLRPSMSRV 959
+ + C R S +
Sbjct: 243 -SAIFRDFL---NRCLDMDVEKRGSAKEL 267
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (483), Expect = 5e-55
Identities = 68/272 (25%), Positives = 115/272 (42%), Gaps = 28/272 (10%)
Query: 693 ENFSPSNKLGEGGFGPVYKGKL-GDGRAIAVKQLS---VASRQGKSQFVAEIATISAVQH 748
E+F LG+G FG VY + +A+K L + + Q E+ S ++H
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 749 RNLVKLHGCCIEGAERLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLH 808
N+++L+G + L+ EY ++ + L D + +A L+Y H
Sbjct: 66 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS--KFDEQRTATYITELANALSYCH 123
Query: 809 EESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVAGTIGYLAPEYAM 868
+ R+IHRD+K N+LL + KI+DFG + + + GT+ YL PE
Sbjct: 124 SK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT---TLCGTLDYLPPEMIE 177
Query: 869 RGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEIELADPKLI 928
EK D+++ GVL E + G+P + + +E + I +
Sbjct: 178 GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETY-------------KRISRVEFTFP 224
Query: 929 EFNEEEVKRLIGVALLCTQTLPSLRPSMSRVV 960
+F E + LI + PS RP + V+
Sbjct: 225 DFVTEGARDLI---SRLLKHNPSQRPMLREVL 253
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (480), Expect = 1e-54
Identities = 65/277 (23%), Positives = 111/277 (40%), Gaps = 26/277 (9%)
Query: 693 ENFSPSNKLGEGGFGPVYKGKL----GDGRAIAVKQLSVASRQG-KSQFVAEIATISAVQ 747
E +GEG FG V++G A+A+K + + +F+ E T+
Sbjct: 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 66
Query: 748 HRNLVKLHGCCIEGAERLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYL 807
H ++VKL G E ++ E L R +LD A+ ++ LAYL
Sbjct: 67 HPHIVKLIGVITEN-PVWIIMELCTLGELRS-FLQVRKYSLDLASLILYAYQLSTALAYL 124
Query: 808 HEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVAGTIGYLAPEYA 867
+ R +HRD+ A NVL+ ++ K+ DFGL++ +D + +++ I ++APE
Sbjct: 125 ESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESI 181
Query: 868 MRGHLTEKTDVFAFGVLALET-VSGRPNSDPSLDEEKLYLLEWAWHLHENNQEIELADPK 926
T +DV+ FGV E + G + + + +E
Sbjct: 182 NFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGER------------LP 229
Query: 927 LIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVAML 963
+ + L+ C PS RP + + A L
Sbjct: 230 MPPNCPPTLYSLM---TKCWAYDPSRRPRFTELKAQL 263
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (476), Expect = 2e-53
Identities = 62/286 (21%), Positives = 117/286 (40%), Gaps = 27/286 (9%)
Query: 686 AELKTATEN-FSPSNKLGEGGFGPVYKGK-LGDGR----AIAVKQLS-VASRQGKSQFVA 738
A L+ E F LG G FG VYKG + +G +A+K+L S + + +
Sbjct: 1 ALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILD 60
Query: 739 EIATISAVQHRNLVKLHGCCIEGAERLLVYEYLENKSLDQALFGQRSLTLDWATRYEICS 798
E +++V + ++ +L G C+ +L+ LD + + C
Sbjct: 61 EAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDY--VREHKDNIGSQYLLNWCV 118
Query: 799 GVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAK-LYDDKKTHISTRVAG 857
+A+G+ YL + R++HRD+ A NVL+ KI+DFGLAK L ++K + +
Sbjct: 119 QIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 175
Query: 858 TIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENN 917
I ++A E + T ++DV+++GV E ++ + ++ +
Sbjct: 176 PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI---------- 225
Query: 918 QEIELADPKLIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVAML 963
L + + + + + C RP ++
Sbjct: 226 ----LEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEF 267
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (451), Expect = 2e-50
Identities = 73/304 (24%), Positives = 125/304 (41%), Gaps = 42/304 (13%)
Query: 693 ENFSPSNKLGEGGFGPVYKGKL--------GDGRAIAVKQLSV-ASRQGKSQFVAEIATI 743
+ LGEG FG V + +AVK L A+ + S ++E+ +
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72
Query: 744 SAV-QHRNLVKLHGCCIEGAERLLVYEYLENKSLDQALFGQRSL--------------TL 788
+ +H+N++ L G C + ++ EY +L + L +R L
Sbjct: 73 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132
Query: 789 DWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKK 848
VARG+ YL + + IHRD+ A NVL+ D V KI+DFGLA+
Sbjct: 133 SSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 189
Query: 849 THISTRVA-GTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLL 907
+ T + ++APE T ++DV++FGVL E + + P + E+L+ L
Sbjct: 190 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKL 249
Query: 908 EWAWHLHENNQEIELADPKLIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVAMLCGDM 967
L + ++ L + C +PS RP+ ++V L +
Sbjct: 250 --------------LKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 295
Query: 968 EVST 971
+++
Sbjct: 296 ALTS 299
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (447), Expect = 8e-50
Identities = 73/302 (24%), Positives = 124/302 (41%), Gaps = 40/302 (13%)
Query: 693 ENFSPSNKLGEGGFGPVYKG------KLGDGRAIAVKQLSVASRQGKSQ-FVAEIATISA 745
+ LG G FG V + K R +AVK L + + + ++E+ +
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72
Query: 746 -VQHRNLVKLHGCCIE-GAERLLVYEYLENKSLDQALFGQRSL--------------TLD 789
H N+V L G C + G +++ E+ + +L L +R+ L
Sbjct: 73 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132
Query: 790 WATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAK-LYDDKK 848
VA+G+ +L + IHRD+ A N+LL V KI DFGLA+ +Y D
Sbjct: 133 LEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 189
Query: 849 THISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLE 908
+ ++APE T ++DV++FGVL E S + P + ++ E
Sbjct: 190 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE----E 245
Query: 909 WAWHLHENNQEIELADPKLIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVAMLCGDME 968
+ L E + ++ E+ + + L C PS RP+ S +V L ++
Sbjct: 246 FCRRLKEGT------RMRAPDYTTPEMYQTM---LDCWHGEPSQRPTFSELVEHLGNLLQ 296
Query: 969 VS 970
+
Sbjct: 297 AN 298
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 177 bits (450), Expect = 1e-49
Identities = 64/271 (23%), Positives = 111/271 (40%), Gaps = 23/271 (8%)
Query: 693 ENFSPSNKLGEGGFGPVYKGK-LGDGRAIAVKQLSVASRQGKSQFVAEIATISAVQHRNL 751
+++ +LG G FG V++ G A K + K EI T+S ++H L
Sbjct: 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 85
Query: 752 VKLHGCCIEGAERLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEES 811
V LH + E +++YE++ L + + + + + E V +GL ++HE
Sbjct: 86 VNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHN-KMSEDEAVEYMRQVCKGLCHMHEN- 143
Query: 812 RVRIIHRDVKASNVLLDADL--VPKISDFGLAKLYDDKKTHISTRVAGTIGYLAPEYAMR 869
+H D+K N++ K+ DFGL D K++ T GT + APE A
Sbjct: 144 --NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT--GTAEFAAPEVAEG 199
Query: 870 GHLTEKTDVFAFGVLALETVSGR-PNSDPSLDEEKLYLLEWAWHLHENNQEIELADPKLI 928
+ TD+++ GVL+ +SG P + DE + W++ D
Sbjct: 200 KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNM----------DDSAF 249
Query: 929 EFNEEEVKRLIGVALLCTQTLPSLRPSMSRV 959
E+ K I P+ R ++ +
Sbjct: 250 SGISEDGKDFI---RKLLLADPNTRMTIHQA 277
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (436), Expect = 2e-48
Identities = 61/276 (22%), Positives = 102/276 (36%), Gaps = 26/276 (9%)
Query: 689 KTATENFSPSNKLGEGGFGPVYKGK-LGDGRAIAVKQLS---VASRQGKSQFVAEIATIS 744
K E+F LGEG F V + L R A+K L + E +S
Sbjct: 4 KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS 63
Query: 745 AVQHRNLVKLHGCCIEGAERLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGL 804
+ H VKL+ + + Y +N L + + S Y A +
Sbjct: 64 RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFY-----TAEIV 118
Query: 805 AYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYD-DKKTHISTRVAGTIGYLA 863
+ L IIHRD+K N+LL+ D+ +I+DFG AK+ + K + GT Y++
Sbjct: 119 SALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVS 178
Query: 864 PEYAMRGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEIELA 923
PE + +D++A G + + V+G P A + + Q+I
Sbjct: 179 PELLTEKSACKSSDLWALGCIIYQLVAGLP-------------PFRAGNEYLIFQKIIKL 225
Query: 924 DPKLIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRV 959
+ E + + L+ + R +
Sbjct: 226 EYDFPEKFFPKARDLV---EKLLVLDATKRLGCEEM 258
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 168 bits (427), Expect = 2e-46
Identities = 61/277 (22%), Positives = 106/277 (38%), Gaps = 29/277 (10%)
Query: 693 ENFSPSNKLGEGGFGPVYKGK-LGDGRAIAVKQLS---VASRQGKSQFVAEIATISAVQ- 747
+FS +G GGFG VY + G+ A+K L + +QG++ + E +S V
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 748 --HRNLVKLHGCCIEGAERLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLA 805
+V + + + + + L L + Y + GL
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAE--IILGLE 121
Query: 806 YLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVAGTIGYLAPE 865
++H +++RD+K +N+LLD +ISD GLA + KK H S GT GY+APE
Sbjct: 122 HMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMAPE 175
Query: 866 YAMRG-HLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEIELAD 924
+G D F+ G + + + G ++K + +
Sbjct: 176 VLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM----------A 225
Query: 925 PKLIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVA 961
+L + E++ L+ Q + R A
Sbjct: 226 VELPDSFSPELRSLL---EGLLQRDVNRRLGCLGRGA 259
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 167 bits (425), Expect = 3e-46
Identities = 65/284 (22%), Positives = 106/284 (37%), Gaps = 23/284 (8%)
Query: 681 YTFSYAELKTAT--ENFSPSNKLGEGGFGPVYKGK-LGDGRAIAVKQLSVASRQGKSQFV 737
Y E+K + + + +LG G FG V++ GR K ++ K
Sbjct: 15 YVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVK 74
Query: 738 AEIATISAVQHRNLVKLHGCCIEGAERLLVYEYLENKSLDQALFGQRSLTLDWATRYEIC 797
EI+ ++ + H L+ LH + E +L+ E+L L + + A
Sbjct: 75 NEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIA-AEDYKMSEAEVINYM 133
Query: 798 SGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVP--KISDFGLAKLYDDKKTHISTRV 855
GL ++HE I+H D+K N++ + KI DFGLA + + T
Sbjct: 134 RQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT- 189
Query: 856 AGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHE 915
T + APE R + TD++A GVL +SG D E L ++
Sbjct: 190 -ATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVK------- 241
Query: 916 NNQEIELADPKLIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRV 959
+ E + + E K I Q P R ++
Sbjct: 242 -RCDWEFDEDAFSSVS-PEAKDFI---KNLLQKEPRKRLTVHDA 280
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 163 bits (414), Expect = 2e-45
Identities = 62/297 (20%), Positives = 103/297 (34%), Gaps = 32/297 (10%)
Query: 700 KLGEGGFGPVYKGK-LGDGRAIAVKQLSVASRQGKSQFVAEIATISAVQHRNLVK-LHGC 757
K+G G FG +Y G + G +A+K V ++ Q E +Q + + C
Sbjct: 14 KIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWC 71
Query: 758 CIEGAERLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIH 817
EG ++V E L D F R +L + + Y+H + IH
Sbjct: 72 GAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLL--ADQMISRIEYIHSK---NFIH 126
Query: 818 RDVKASNVL---LDADLVPKISDFGLAKLYDDKKTHI------STRVAGTIGYLAPEYAM 868
RDVK N L + I DFGLAK Y D +TH + + GT Y + +
Sbjct: 127 RDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHL 186
Query: 869 RGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEIELADPKLI 928
+ + D+ + G + + G K E +++ L
Sbjct: 187 GIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISE-----KKMSTPIEVLC 241
Query: 929 EFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVAMLCGDMEVSTVTAKPGYLTDWKFD 985
+ E + C +P S + + + + G+ D+ FD
Sbjct: 242 KGYPSEFATYL---NFCRSLRFDDKPDYSYLRQLF------RNLFHRQGFSYDYVFD 289
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 162 bits (412), Expect = 5e-45
Identities = 59/277 (21%), Positives = 107/277 (38%), Gaps = 18/277 (6%)
Query: 685 YAELKTATENFSPSNKLGEGGFGPVYKGK-LGDGRAIAVKQLSVASRQGK-SQFVAEIAT 742
+ + + + + + LG G F V + + +A+K ++ + +GK EIA
Sbjct: 1 WKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAV 60
Query: 743 ISAVQHRNLVKLHGCCIEGAERLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVAR 802
+ ++H N+V L G L+ + + L + + T A+R + V
Sbjct: 61 LHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASR--LIFQVLD 118
Query: 803 GLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVAGTIGYL 862
+ YLH+ V + LD D ISDFGL+K+ D + + GT GY+
Sbjct: 119 AVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDP--GSVLSTACGTPGYV 176
Query: 863 APEYAMRGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEIEL 922
APE + ++ D ++ GV+A + G P D + + E E
Sbjct: 177 APEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQIL--------KAEYEF 228
Query: 923 ADPKLIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRV 959
P + + + K I + P R + +
Sbjct: 229 DSPYWDDIS-DSAKDFI---RHLMEKDPEKRFTCEQA 261
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 161 bits (409), Expect = 5e-45
Identities = 61/284 (21%), Positives = 112/284 (39%), Gaps = 36/284 (12%)
Query: 693 ENFSPSNKLGEGGFGPVYKGK-LGDGRAIAVKQLSVAS---------RQGKSQFVAEIAT 742
EN+ P LG G V + + AVK + V ++ + + E+
Sbjct: 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62
Query: 743 ISAVQ-HRNLVKLHGCCIEGAERLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVA 801
+ V H N+++L LV++ ++ L L +TL +I +
Sbjct: 63 LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL--TEKVTLSEKETRKIMRALL 120
Query: 802 RGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVAGTIGY 861
+ LH+ I+HRD+K N+LLD D+ K++DFG + D + V GT Y
Sbjct: 121 EVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKL--REVCGTPSY 175
Query: 862 LAPEYAM------RGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHE 915
LAPE ++ D+++ GV+ ++G P P +++ +L
Sbjct: 176 LAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSP---PFWHRKQMLMLRMIM---- 228
Query: 916 NNQEIELADPKLIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRV 959
+ + P+ +++ + VK L+ P R +
Sbjct: 229 -SGNYQFGSPEWDDYS-DTVKDLV---SRFLVVQPQKRYTAEEA 267
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (406), Expect = 4e-44
Identities = 68/269 (25%), Positives = 106/269 (39%), Gaps = 27/269 (10%)
Query: 693 ENFSPSNKLGEGGFGPVYKGK-LGDGRAIAVKQLS---VASRQGKSQFVAEIATISAV-Q 747
E+F LG+G FG V+ + + A+K L V + E +S +
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 748 HRNLVKLHGCCIEGAERLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYL 807
H L + V EYL L + L AT Y + + GL +L
Sbjct: 62 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFY--AAEIILGLQFL 119
Query: 808 HEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVAGTIGYLAPEYA 867
H + I++RD+K N+LLD D KI+DFG+ K +T GT Y+APE
Sbjct: 120 HSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFC-GTPDYIAPEIL 175
Query: 868 MRGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEIELADPKL 927
+ D ++FGVL E + G+ P +++ L I + +P
Sbjct: 176 LGQKYNHSVDWWSFGVLLYEMLIGQS---PFHGQDEEELFHS----------IRMDNPFY 222
Query: 928 IEFNEEEVKRLIGVALLCTQTLPSLRPSM 956
+ E+E K L+ + P R +
Sbjct: 223 PRWLEKEAKDLL---VKLFVREPEKRLGV 248
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (402), Expect = 7e-44
Identities = 62/283 (21%), Positives = 119/283 (42%), Gaps = 20/283 (7%)
Query: 693 ENFSPSNKLGEGGFGPVYKGK-LGDGRAIAVKQL--SVASRQGKSQFVAEIATISAVQHR 749
ENF K+GEG +G VYK + G +A+K++ + S + EI+ + + H
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 750 NLVKLHGCCIEGAERLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHE 809
N+VKL + LV+E+L ++ L + + + + +GLA+ H
Sbjct: 62 NIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 810 ESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVAGTIGYLAPEYAMR 869
R++HRD+K N+L++ + K++DFGLA+ + + V
Sbjct: 121 H---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGC 177
Query: 870 GHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLL--------EWAWHLHENNQEIE 921
+ + D+++ G + E V+ R + ++L+ + E W + + +
Sbjct: 178 KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK 237
Query: 922 LADPKLIEFNEEEVKRLI---GVALL--CTQTLPSLRPSMSRV 959
+ PK + +V + G +LL P+ R S
Sbjct: 238 PSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 280
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (405), Expect = 1e-43
Identities = 61/292 (20%), Positives = 111/292 (38%), Gaps = 30/292 (10%)
Query: 692 TENFSPSNKLGEGGFGPVYKGK-LGDGRAIAVKQLSVASRQGKSQ-FVAEIATISAVQHR 749
++ + +GEG +G V + +A+K++S Q Q + EI + +H
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66
Query: 750 NLVKLHGCCIEGAERLLVYEYLENKSLDQALFG-QRSLTLDWATRYEICSGVARGLAYLH 808
N++ ++ + YL + L+ ++ L + RGL Y+H
Sbjct: 67 NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIH 126
Query: 809 EESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHIS--TRVAGTIGYLAPEY 866
++HRD+K SN+LL+ KI DFGLA++ D H T T Y APE
Sbjct: 127 SA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 183
Query: 867 AMRGHL-TEKTDVFAFGVLALETVSGRP------------------NSDPSLDEEKLYLL 907
+ T+ D+++ G + E +S RP S D + L
Sbjct: 184 MLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL 243
Query: 908 EWAWHLHENNQEIELADPKLIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRV 959
+ +L + ++ +L + + L+ P R + +
Sbjct: 244 KARNYLLSLPHKNKVPWNRLFPNADSKALDLL---DKMLTFNPHKRIEVEQA 292
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 158 bits (401), Expect = 2e-43
Identities = 69/273 (25%), Positives = 110/273 (40%), Gaps = 29/273 (10%)
Query: 693 ENFSPSNKLGEGGFGPVYKGK-LGDGRAIAVKQLS---VASRQGKSQFVAEIATISAVQH 748
++F LG G FG V+ + +GR A+K L V + E +S V H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 749 RNLVKLHGCCIEGAERLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLH 808
++++ G + + ++ +Y+E L L + A Y V L YLH
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAE--VCLALEYLH 121
Query: 809 EESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVAGTIGYLAPEYAM 868
+ II+RD+K N+LLD + KI+DFG AK D + GT Y+APE
Sbjct: 122 SK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT----YTLCGTPDYIAPEVVS 174
Query: 869 RGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEIELADPKLI 928
+ D ++FG+L E ++G P D + ++I A+ +
Sbjct: 175 TKPYNKSIDWWSFGILIYEMLAGYT---PFYDSNTMKTY----------EKILNAELRFP 221
Query: 929 EFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVA 961
F E+VK L+ S R +
Sbjct: 222 PFFNEDVKDLL---SRLITRDLSQRLGNLQNGT 251
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 156 bits (395), Expect = 4e-43
Identities = 61/282 (21%), Positives = 115/282 (40%), Gaps = 20/282 (7%)
Query: 693 ENFSPSNKLGEGGFGPVYKGKLGDGRAIAVKQLSVA--SRQGKSQFVAEIATISAVQHRN 750
E + K+GEG +G VYK + G A+K++ + S + EI+ + ++H N
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 751 LVKLHGCCIEGAERLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEE 810
+VKL+ +LV+E+L+ + L + T + G+AY H+
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGL--ESVTAKSFLLQLLNGIAYCHD- 118
Query: 811 SRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVAGTIGYLAPEYAMRG 870
R++HRD+K N+L++ + KI+DFGLA+ + + +
Sbjct: 119 --RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSK 176
Query: 871 HLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLY-----LLEWAWHLHENNQEIELADP 925
+ D+++ G + E V+G P + ++L L N E+ DP
Sbjct: 177 KYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDP 236
Query: 926 KLIEFNEEEVKRLI------GVALL--CTQTLPSLRPSMSRV 959
+ + + G+ LL + P+ R + +
Sbjct: 237 NFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQA 278
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (393), Expect = 2e-42
Identities = 48/270 (17%), Positives = 94/270 (34%), Gaps = 22/270 (8%)
Query: 693 ENFSPSNKLGEGGFGPVYKGK-LGDGRAIAVKQLSVASRQGKSQFVAEIATISAVQHRNL 751
E + + LG G FG V++ + K + V + EI+ ++ +HRN+
Sbjct: 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD-QVLVKKEISILNIARHRNI 63
Query: 752 VKLHGCCIEGAERLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEES 811
+ LH E ++++E++ + + + + L+ V L +LH
Sbjct: 64 LHLHESFESMEELVMIFEFISGLDIFERIN-TSAFELNEREIVSYVHQVCEALQFLHSH- 121
Query: 812 RVRIIHRDVKASNVLLDAD--LVPKISDFGLAKLYDDKKTHISTRVAGTIGYLAPEYAMR 869
I H D++ N++ KI +FG A+ Y APE
Sbjct: 122 --NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLF--TAPEYYAPEVHQH 177
Query: 870 GHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEIELADPKLIE 929
++ TD+++ G L +SG +++ + + N E + E
Sbjct: 178 DVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIM--------NAEYTFDEEAFKE 229
Query: 930 FNEEEVKRLIGVALLCTQTLPSLRPSMSRV 959
+ E + R + S
Sbjct: 230 IS-IEAMDFV---DRLLVKERKSRMTASEA 255
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 154 bits (389), Expect = 3e-42
Identities = 53/306 (17%), Positives = 101/306 (33%), Gaps = 34/306 (11%)
Query: 693 ENFSPSNKLGEGGFGPVYKGK-LGDGRAIAVKQLSVASRQGKSQFVAEIATISAVQHRN- 750
++ ++GEG FG +++G L + + +A+K R Q E T +
Sbjct: 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEP--RRSDAPQLRDEYRTYKLLAGCTG 62
Query: 751 LVKLHGCCIEGAERLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEE 810
+ ++ EG +LV + L D L T + + +HE+
Sbjct: 63 IPNVYYFGQEGLHNVLVIDLLGPSLED--LLDLCGRKFSVKTVAMAAKQMLARVQSIHEK 120
Query: 811 SRVRIIHRDVKASNVLLDADLVP-----KISDFGLAKLYDDKKTHI------STRVAGTI 859
+++RD+K N L+ + DFG+ K Y D T ++GT
Sbjct: 121 ---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTA 177
Query: 860 GYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQE 919
Y++ + + + D+ A G + + + G + + E Q
Sbjct: 178 RYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAAT---NKQKYERIGEKKQS 234
Query: 920 IELADPKLIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVAMLCGDMEVSTVTAKPGYL 979
L +L EE + + P + + +E +
Sbjct: 235 TPL--RELCAGFPEEFYKYM---HYARNLAFDATPDYDYLQGLFSKVLE------RLNTT 283
Query: 980 TDWKFD 985
D FD
Sbjct: 284 EDENFD 289
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 153 bits (387), Expect = 4e-42
Identities = 62/280 (22%), Positives = 116/280 (41%), Gaps = 27/280 (9%)
Query: 692 TENFSPSNKLGEGGFGPVYKGK-LGDGRAIAVKQLSVASRQGKS---QFVAEIATISAVQ 747
++ + LG GG V+ + L R +AVK L + S +F E +A+
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65
Query: 748 HRNLVKLHGCCIE----GAERLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARG 803
H +V ++ G +V EY++ +L + + +T E+ + +
Sbjct: 66 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMT--PKRAIEVIADACQA 123
Query: 804 LAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHI--STRVAGTIGY 861
L + H+ IIHRDVK +N+++ A K+ DFG+A+ D + + V GT Y
Sbjct: 124 LNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQY 180
Query: 862 LAPEYAMRGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEIE 921
L+PE A + ++DV++ G + E ++G P P + + + H+ E+
Sbjct: 181 LSPEQARGDSVDARSDVYSLGCVLYEVLTGEP---PFTGDSPVSVAY--QHVREDPIPPS 235
Query: 922 LADPKLIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVA 961
L ++ ++ L P R + +
Sbjct: 236 ARHEGL----SADLDAVV---LKALAKNPENRYQTAAEMR 268
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (388), Expect = 6e-42
Identities = 68/294 (23%), Positives = 122/294 (41%), Gaps = 33/294 (11%)
Query: 691 ATENFSPSNKLGEGGFGPVYKGK--LGDGRAIAVKQLSVASRQGKS-----QFVAEIATI 743
A + + ++GEG +G V+K + GR +A+K++ V + + + VA + +
Sbjct: 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64
Query: 744 SAVQHRNLVKLHGCCIEGAERLLVYEYLENKSLDQA----LFGQRSLTLDWATRYEICSG 799
+H N+V+L C L + +DQ L + T ++
Sbjct: 65 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 124
Query: 800 VARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVAGTI 859
+ RGL +LH R++HRD+K N+L+ + K++DFGLA++Y + T V T+
Sbjct: 125 LLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL--TSVVVTL 179
Query: 860 GYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLL----------EW 909
Y APE ++ D+++ G + E +P S D ++L + +W
Sbjct: 180 WYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW 239
Query: 910 AWHLHENNQEIELADP----KLIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRV 959
+ Q K + +E K L+ L C P+ R S
Sbjct: 240 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLL---LKCLTFNPAKRISAYSA 290
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (380), Expect = 2e-40
Identities = 67/286 (23%), Positives = 114/286 (39%), Gaps = 30/286 (10%)
Query: 694 NFSPSNKLGEGGFGPVYKGKL-GDGRAIAVKQLSVASRQGKSQFVAEIATISAVQHRNLV 752
+++ + +G G FG VY+ KL G +A+K++ Q K E+ + + H N+V
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV----LQDKRFKNRELQIMRKLDHCNIV 76
Query: 753 KLHGCCIEGAER------LLVYEYLENKSLDQALFGQRS-LTLDWATRYEICSGVARGLA 805
+L E+ LV +Y+ A R+ TL + R LA
Sbjct: 77 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136
Query: 806 YLHEESRVRIIHRDVKASNVLLDAD-LVPKISDFGLAKLYDDKKTHISTRVAGTIGYLAP 864
Y+H I HRD+K N+LLD D V K+ DFG AK + ++ + +
Sbjct: 137 YIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV-SYICSRYYRAPE 192
Query: 865 EYAMRGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLL---------EWAWHLHE 915
T DV++ G + E + G+P ++L + E ++
Sbjct: 193 LIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNP 252
Query: 916 NNQEIELADPKLIEFNEEEVKRLIGVAL-LCTQTL---PSLRPSMS 957
N E + K + + R A+ LC++ L P+ R +
Sbjct: 253 NYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPL 298
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (372), Expect = 8e-40
Identities = 64/283 (22%), Positives = 112/283 (39%), Gaps = 25/283 (8%)
Query: 699 NKLGEGGFGPVYKGK-LGDGRAIAVKQLSVASRQGKSQ-----FVAEIATISAVQHRNLV 752
+ LGEG F VYK + + +A+K++ + R + EI + + H N++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 753 KLHGCCIEGAERLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESR 812
L + LV++++E + SL L + +GL YLH+
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLEV--IIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH-- 119
Query: 813 VRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVAGTIGYLAPEYAMRGHL 872
I+HRD+K +N+LLD + V K++DFGLAK + + +V T Y APE +
Sbjct: 120 -WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQV-VTRWYRAPELLFGARM 177
Query: 873 -TEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLL----------EWA--WHLHENNQE 919
D++A G + E + P D ++L + +W L +
Sbjct: 178 YGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTF 237
Query: 920 IELADPKLIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVAM 962
L L+ + P R + ++ + M
Sbjct: 238 KSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 280
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (363), Expect = 6e-39
Identities = 57/271 (21%), Positives = 93/271 (34%), Gaps = 40/271 (14%)
Query: 700 KLGEGGFGPVYKGK-LGDGRAIAVKQLSVASRQGKS------QFVAEIATISAVQ--HRN 750
LG GGFG VY G + D +A+K + + E+ + V
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 751 LVKLHGCCIEGAERLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEE 810
+++L +L+ E E +R L V + + H
Sbjct: 71 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERG-ALQEELARSFFWQVLEAVRHCHNC 129
Query: 811 SRVRIIHRDVKASNVLLDAD-LVPKISDFGLAKLYDDKKTHISTRVAGTIGYLAPEYAM- 868
++HRD+K N+L+D + K+ DFG L D + T GT Y PE+
Sbjct: 130 ---GVLHRDIKDENILIDLNRGELKLIDFGSGALLKD---TVYTDFDGTRVYSPPEWIRY 183
Query: 869 RGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEIELADPKLI 928
+ V++ G+L + V G E+++EI
Sbjct: 184 HRYHGRSAAVWSLGILLYDMVCGDI-------------------PFEHDEEIIRGQVFFR 224
Query: 929 EFNEEEVKRLIGVALLCTQTLPSLRPSMSRV 959
+ E + LI C PS RP+ +
Sbjct: 225 QRVSSECQHLI---RWCLALRPSDRPTFEEI 252
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (365), Expect = 1e-38
Identities = 62/268 (23%), Positives = 100/268 (37%), Gaps = 27/268 (10%)
Query: 701 LGEGGFGPVYKGK-LGDGRAIAVKQLSVASRQGKSQFVAEIATIS-AVQHRNLVKLHGCC 758
LG G G V + A+K L Q + E+ A Q ++V++
Sbjct: 20 LGLGINGKVLQIFNKRTQEKFALKML-----QDCPKARREVELHWRASQCPHIVRIVDVY 74
Query: 759 IEGAER----LLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVR 814
L+V E L+ L + + EI + + YLH
Sbjct: 75 ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---N 131
Query: 815 IIHRDVKASNVLLDA---DLVPKISDFGLAKLYDDKKTHISTRVAGTIGYLAPEYAMRGH 871
I HRDVK N+L + + + K++DFG AK + + T Y+APE
Sbjct: 132 IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY--TPYYVAPEVLGPEK 189
Query: 872 LTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEIELADPKLIEFN 931
+ D+++ GV+ + G P P L + Q E +P+ E +
Sbjct: 190 YDKSCDMWSLGVIMYILLCGYP---PFYSNHGLAISPGMKTRIRMGQ-YEFPNPEWSEVS 245
Query: 932 EEEVKRLIGVALLCTQTLPSLRPSMSRV 959
EEVK LI +T P+ R +++
Sbjct: 246 -EEVKMLI---RNLLKTEPTQRMTITEF 269
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (356), Expect = 9e-38
Identities = 63/278 (22%), Positives = 104/278 (37%), Gaps = 30/278 (10%)
Query: 693 ENFSPSNKLGEGGFGPVYKGK-LGDGRAIAVKQLSVASRQG------KSQFVAEIATISA 745
+ + +LG G F V K + G A K + + + E++ +
Sbjct: 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69
Query: 746 VQHRNLVKLHGCCIEGAERLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLA 805
+QH N++ LH + +L+ E + L L + SLT + AT + + G+
Sbjct: 70 IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEF--LKQILNGVY 127
Query: 806 YLHEESRVRIIHRDVKASNVLLDADLVP----KISDFGLAKLYDDKKTHISTRVAGTIGY 861
YLH +I H D+K N++L VP KI DFGLA D + GT +
Sbjct: 128 YLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF--KNIFGTPEF 182
Query: 862 LAPEYAMRGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEIE 921
+APE L + D+++ GV+ +SG +E L + + E
Sbjct: 183 VAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANV--------SAVNYE 234
Query: 922 LADPKLIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRV 959
D + K I P R ++
Sbjct: 235 FEDEYFSNTS-ALAKDFI---RRLLVKDPKKRMTIQDS 268
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (354), Expect = 2e-37
Identities = 64/298 (21%), Positives = 122/298 (40%), Gaps = 36/298 (12%)
Query: 693 ENFSPSNKLGEGGFGPVYKGK-LGDGRAIAVKQLSVASRQGKS--QFVAEIATISAVQHR 749
+ K+G+G FG V+K + G+ +A+K++ + + + + EI + ++H
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69
Query: 750 NLVKLHGCCIEGAER--------LLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVA 801
N+V L C A LV+++ E+ TL R + +
Sbjct: 70 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKR--VMQMLL 127
Query: 802 RGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKT---HISTRVAGT 858
GL Y+H +I+HRD+KA+NVL+ D V K++DFGLA+ + K + T T
Sbjct: 128 NGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVT 184
Query: 859 IGYLAPEYAMRGHL-TEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWA------- 910
+ Y PE + D++ G + E + P + ++ +L L+
Sbjct: 185 LWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPE 244
Query: 911 -------WHLHENNQEIELADPKLIEFNEEEVKRLIGVALL--CTQTLPSLRPSMSRV 959
+ L+E + ++ K+ + + V+ + L+ P+ R
Sbjct: 245 VWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDA 302
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (349), Expect = 7e-37
Identities = 51/284 (17%), Positives = 102/284 (35%), Gaps = 22/284 (7%)
Query: 693 ENFSPSNKLGEGGFGPVYKGK-LGDGRAIAVKQLSVA--SRQGKSQFVAEIATISAVQHR 749
+ + K+GEG +G V+K K +A+K++ + S + EI + ++H+
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 750 NLVKLHGCCIEGAERLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHE 809
N+V+LH + LV+E+ + L + + + + L L
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSF-----LFQLLKGLGF 116
Query: 810 ESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVAGTIGYLAPEYAMR 869
++HRD+K N+L++ + K+++FGLA+ + S V
Sbjct: 117 CHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGA 176
Query: 870 GHLTEKTDVFAFGVLALETVSGRPNSDPSLDE----EKLYLLEWAWHLHENNQEIELADP 925
+ D+++ G + E + P D ++++ L + +L D
Sbjct: 177 KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDY 236
Query: 926 KLIEFNEEEVKRLIGVALL----------CTQTLPSLRPSMSRV 959
K + V L + P R S
Sbjct: 237 KPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEA 280
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (352), Expect = 8e-37
Identities = 67/277 (24%), Positives = 101/277 (36%), Gaps = 26/277 (9%)
Query: 689 KTATENFSPSNKLGEGGFGPVYKGK-LGDGRAIAVKQLS---VASRQGKSQFVAEIATIS 744
K +F LG+G FG V + GR A+K L + ++ + V E +
Sbjct: 1 KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 60
Query: 745 AVQHRNLVKLHGCCIEGAERLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGL 804
+H L L V EY L L +R T + A Y A +
Sbjct: 61 NTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFY-----GAEIV 115
Query: 805 AYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVAGTIGYLAP 864
+ L +++RD+K N++LD D KI+DFGL K + T GT YLAP
Sbjct: 116 SALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC-GTPEYLAP 174
Query: 865 EYAMRGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEIELAD 924
E D + GV+ E + GR + D E+L+ + I + +
Sbjct: 175 EVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF-YNQDHERLF------------ELILMEE 221
Query: 925 PKLIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVA 961
+ E K L+ + P R A
Sbjct: 222 IRFPRTLSPEAKSLL---AGLLKKDPKQRLGGGPSDA 255
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 134 bits (339), Expect = 5e-35
Identities = 57/224 (25%), Positives = 88/224 (39%), Gaps = 16/224 (7%)
Query: 693 ENFSPSNKLGEGGFGPVYKGK-LGDGRAIAVKQLS---VASRQGKSQFVAEIATISAVQH 748
+ F LG G FG V K G A+K L V + + E + AV
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 749 RNLVKLHGCCIEGAERLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLH 808
LVKL + + +V EY+ + L + A Y + + YLH
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFY--AAQIVLTFEYLH 158
Query: 809 EESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVAGTIGYLAPEYAM 868
+I+RD+K N+L+D +++DFG AK + + GT LAPE +
Sbjct: 159 SL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLC----GTPEALAPEIIL 211
Query: 869 RGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWH 912
+ D +A GVL E +G P P ++ + + E
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYP---PFFADQPIQIYEKIVS 252
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (327), Expect = 2e-33
Identities = 49/225 (21%), Positives = 86/225 (38%), Gaps = 25/225 (11%)
Query: 683 FSYAELKTAT----ENFSPSNKLGEGGFGPVYKGK-LGDGRAIAVKQL--SVASRQGKSQ 735
F E+ + +G G +G V G +A+K+L S +
Sbjct: 4 FYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKR 63
Query: 736 FVAEIATISAVQHRNLVKLHGCCIEG------AERLLVYEYLENKSLDQALFGQRSLTLD 789
E+ + ++H N++ L + LV ++ + L
Sbjct: 64 AYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKL----MKHEKLG 119
Query: 790 WATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKT 849
+ + +GL Y+H IIHRD+K N+ ++ D KI DFGLA+ D + T
Sbjct: 120 EDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMT 176
Query: 850 HISTRVAGTIGYLAPEYAM-RGHLTEKTDVFAFGVLALETVSGRP 893
T Y APE + T+ D+++ G + E ++G+
Sbjct: 177 GY----VVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKT 217
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (321), Expect = 8e-33
Identities = 62/280 (22%), Positives = 105/280 (37%), Gaps = 28/280 (10%)
Query: 693 ENFSPSNKLGEGGFGPVYKGKL----GDGRAIAVKQLS----VASRQGKSQFVAEIATIS 744
ENF LG G +G V+ + G+ A+K L V + E +
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 745 AVQHR-NLVKLHGCCIEGAERLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARG 803
++ LV LH + L+ +Y+ L L + T Y V
Sbjct: 84 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIY-----VGEI 138
Query: 804 LAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHISTRVAGTIGYLA 863
+ L ++ II+RD+K N+LLD++ ++DFGL+K + +T + GTI Y+A
Sbjct: 139 VLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMA 198
Query: 864 PEYAMRGH--LTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEIE 921
P+ G + D ++ GVL E ++G ++ + ++ I
Sbjct: 199 PDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEI---------SRRIL 249
Query: 922 LADPKLIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVA 961
++P + K LI P R A
Sbjct: 250 KSEPPYPQEMSALAKDLI---QRLLMKDPKKRLGCGPRDA 286
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 123 bits (308), Expect = 4e-31
Identities = 42/221 (19%), Positives = 85/221 (38%), Gaps = 19/221 (8%)
Query: 693 ENFSPSNKLGEGGFGPVYKGK-LGDGRAIAVKQLSVASRQGKSQFVAEIATISAVQ-HRN 750
+++ KLG G + V++ + + + VK L ++ + EI + ++ N
Sbjct: 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKK---KIKREIKILENLRGGPN 91
Query: 751 LVKLHGCCIEGAERL--LVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLH 808
++ L + R LV+E++ N Q TL + + L Y H
Sbjct: 92 IITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ-----TLTDYDIRFYMYEILKALDYCH 146
Query: 809 EESRVRIIHRDVKASNVLLDAD-LVPKISDFGLAKLYDDKKTHISTRVAGTIGYLAPEYA 867
I+HRDVK NV++D + ++ D+GLA+ Y + + + + PE
Sbjct: 147 SM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY--NVRVASRYFKGPELL 201
Query: 868 MR-GHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLL 907
+ D+++ G + + + D +
Sbjct: 202 VDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVR 242
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (307), Expect = 9e-31
Identities = 51/223 (22%), Positives = 86/223 (38%), Gaps = 20/223 (8%)
Query: 681 YTFSYAELK-TATENFSPSNKLGEGGFGPVYKGK-LGDGRAIAVKQLS--VASRQGKSQF 736
Y+ + T + + +G G G V R +A+K+LS ++ +
Sbjct: 4 YSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRA 63
Query: 737 VAEIATISAVQHRNLVKLHGCCI------EGAERLLVYEYLENKSLDQALFGQRSLTLDW 790
E+ + V H+N++ L E + LV E ++ D
Sbjct: 64 YRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL-----DH 118
Query: 791 ATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTH 850
+ + G+ +LH IIHRD+K SN+++ +D KI DFGLA+
Sbjct: 119 ERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM 175
Query: 851 ISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRP 893
T T Y APE + E D+++ G + E V +
Sbjct: 176 --TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKI 216
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (299), Expect = 8e-30
Identities = 70/307 (22%), Positives = 118/307 (38%), Gaps = 39/307 (12%)
Query: 679 RPYTFSYAELKTA----TENFSPSNKLGEGGFGPVYKGK-LGDGRAIAVKQLS--VASRQ 731
RP TF EL E + + +G G +G V G +AVK+LS S
Sbjct: 1 RP-TFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII 59
Query: 732 GKSQFVAEIATISAVQHRNLVKLHGCCIEGA-----ERLLVYEYLENKSLDQALFGQRSL 786
+ E+ + ++H N++ L + + +L L+ + Q+
Sbjct: 60 HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK-- 117
Query: 787 TLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDD 846
L + + RGL Y+H IIHRD+K SN+ ++ D KI DFGLA+ DD
Sbjct: 118 -LTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDD 173
Query: 847 KKTHISTRVAGTIGYLAPEYAMR-GHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLY 905
+ T T Y APE + H + D+++ G + E ++GR + ++L
Sbjct: 174 EMTGYVA----TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLK 229
Query: 906 LL----------EWAWHLHENNQEIELADPKLIEFNEEEVKRLI---GVALL--CTQTLP 950
L+ E+ + + ++ + N V V LL
Sbjct: 230 LILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDS 289
Query: 951 SLRPSMS 957
R + +
Sbjct: 290 DKRITAA 296
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 106 bits (264), Expect = 3e-25
Identities = 44/252 (17%), Positives = 82/252 (32%), Gaps = 24/252 (9%)
Query: 700 KLGEGGFGPVYKGK-LGDGRAIAVKQLSVASRQGKSQFVAEIATISAVQHRNLVKLHGCC 758
KLG G F V+ K + + +A+K + + EI + V + K
Sbjct: 20 KLGWGHFSTVWLAKDMVNNTHVAMKIVR-GDKVYTEAAEDEIKLLQRVNDADNTKEDSMG 78
Query: 759 IEGAERLLVYEYLENKSL--------------DQALFGQRSLTLDWATRYEICSGVARGL 804
+LL + + + + + +I + GL
Sbjct: 79 ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGL 138
Query: 805 AYLHEESRVRIIHRDVKASNVLLDA-DLVPKISDFGLAKLYDDKKTHISTR-VAGTIGYL 862
Y+H R IIH D+K NVL++ D + +A L + T Y
Sbjct: 139 DYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYR 196
Query: 863 APEYAMRGHLTEKTDVFAFGVLALETVSGRP----NSDPSLDEEKLYLLEWAWHLHENNQ 918
+PE + D+++ L E ++G + S ++ ++ + L E
Sbjct: 197 SPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPS 256
Query: 919 EIELADPKLIEF 930
+ F
Sbjct: 257 YLLRNGKYTRTF 268
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 104 bits (259), Expect = 6e-25
Identities = 86/324 (26%), Positives = 130/324 (40%), Gaps = 23/324 (7%)
Query: 37 DPNEVRALNSIFQQWRISARQGQWNRSGDPCTGAALDDSIVFDNTDYNPFIKCDCSSQNG 96
+P + +AL I + W + D C + CD +
Sbjct: 4 NPQDKQALLQIKKDLGNPTTLSSWLPTTDCCNRTW-------------LGVLCD---TDT 47
Query: 97 TVCHITQLKVYALNVVGV--IPDELWNLTSLFNLNLGQNY-LTGPLSPSVGNLTAMQYLN 153
+ L + LN+ IP L NL L L +G L GP+ P++ LT + YL
Sbjct: 48 QTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLY 107
Query: 154 LAINALSGELPKELGQLTELLILGIGTNNFSGPLPSELGSLSKLQELYIDSAGVSGEIPS 213
+ +SG +P L Q+ L+ L N SG LP + SL L + D +SG IP
Sbjct: 108 ITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPD 167
Query: 214 SFANLQSLTK-WWASDTRLTGRIPDFIGNWSKLTALRFQGNSFNGPIPSSFSNLTSVTEL 272
S+ + L S RLTG+IP N + + S+ T+
Sbjct: 168 SYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSD--KNTQK 225
Query: 273 RISDLSNGSSKLAFIRDMKSLSILELRNNNISDSIPSNIGEYRSLQHLDLSFNNLGGSIP 332
++ + L + K+L+ L+LRNN I ++P + + + L L++SFNNL G IP
Sbjct: 226 IHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP 285
Query: 333 DSLFNLSSLTHLFLGNNKLNGTLP 356
NL NNK P
Sbjct: 286 -QGGNLQRFDVSAYANNKCLCGSP 308
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 96.8 bits (240), Expect = 2e-23
Identities = 29/157 (18%), Positives = 48/157 (30%), Gaps = 19/157 (12%)
Query: 699 NKLGEGGFGPVYKGKLGDGRAIAVKQLSVASR----------QGKSQFVAEIATISAVQH 748
+GEG V+ VK V G F + +
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 749 RNLVKLHGCCIEGAERLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLH 808
R L KL G + VY + N L + + + + E+ + +A +
Sbjct: 66 RALQKLQGLAVPK-----VYAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFY 120
Query: 809 EESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYD 845
I+H D+ NVL+ + I DF +
Sbjct: 121 HR---GIVHGDLSQYNVLVS-EEGIWIIDFPQSVEVG 153
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 96.3 bits (238), Expect = 3e-22
Identities = 60/295 (20%), Positives = 105/295 (35%), Gaps = 48/295 (16%)
Query: 89 CDCSSQNGTVCHITQLKVYALNVVGVIPDELWNLTSLFNLNLGQNYLTGPLSPSVGNLTA 148
C C + C L+ +P +L L+L N +T NL
Sbjct: 8 CQCHLR-VVQCSDLGLEK--------VPKDL--PPDTALLDLQNNKITEIKDGDFKNLKN 56
Query: 149 MQYLNLAINALSGELPKELGQLTELLILGIGTNNFSGPLPSELG---------------- 192
+ L L N +S P L +L L + N LP ++
Sbjct: 57 LHTLILINNKISKISPGAFAPLVKLERLYLSKNQLKE-LPEKMPKTLQELRVHENEITKV 115
Query: 193 --------SLSKLQELYIDSAGVSGEIPSSFANLQSLTKWWASDTRLTGRIPDFIGNWSK 244
+ + EL + SG +F ++ L+ +DT +T IP G
Sbjct: 116 RKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQ--GLPPS 172
Query: 245 LTALRFQGNSFNGPIPSSFSNLTSVTELRISDLSNGSSKLAFIRDMKSLSILELRNNNIS 304
LT L GN +S L ++ +L +S S + + + L L L NN +
Sbjct: 173 LTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKL- 231
Query: 305 DSIPSNIGEYRSLQHLDLSFNNLGGSIPDSLF-------NLSSLTHLFLGNNKLN 352
+P + +++ +Q + L NN+ +I + F +S + + L +N +
Sbjct: 232 VKVPGGLADHKYIQVVYLHNNNI-SAIGSNDFCPPGYNTKKASYSGVSLFSNPVQ 285
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 92.8 bits (229), Expect = 5e-21
Identities = 57/258 (22%), Positives = 101/258 (39%), Gaps = 12/258 (4%)
Query: 162 ELPKELGQLTELLILGIGTNNFSGPLPSELGSLSKLQELYIDSAGVSGEIPSSFANLQSL 221
++PK+L T LL L N + + +L L L + + +S P +FA L L
Sbjct: 24 KVPKDLPPDTALLDLQ--NNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKL 81
Query: 222 TKWWASDTRLTGRIPDFIGNWSKLTALRFQGNSFNGPIPSSFSNLTSVTELRISDLSNGS 281
+ + S +L +P+ + + LR N S F+ L + + + S
Sbjct: 82 ERLYLSKNQLKE-LPEKMPKTLQE--LRVHENEITKVRKSVFNGLNQMIVVELGTNPLKS 138
Query: 282 SK--LAFIRDMKSLSILELRNNNISDSIPSNIGEYRSLQHLDLSFNNLGGSIPDSLFNLS 339
S + MK LS + + + NI+ +IP + SL L L N + SL L+
Sbjct: 139 SGIENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKITKVDAASLKGLN 195
Query: 340 SLTHLFLGNNKLNGTLPA--RKSPLLLNIDVSYNNLQGNLPSWINGQQNLQINLVANNLT 397
+L L L N ++ +P L + ++ N L + + + L NN++
Sbjct: 196 NLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKYIQVVYLHNNNIS 255
Query: 398 IRSSDNSVLPRGLICLQR 415
S++ P
Sbjct: 256 AIGSNDFCPPGYNTKKAS 273
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 70.1 bits (170), Expect = 2e-13
Identities = 26/186 (13%), Positives = 54/186 (29%), Gaps = 27/186 (14%)
Query: 227 SDTRLTGRIPDFIGNWSKLTALRFQGNSFNGPIPSSFSNLTSVTELRISDLSNGSSKLAF 286
SD L ++P + L Q N F NL ++ L + +
Sbjct: 18 SDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGA 74
Query: 287 IRDMKSLSILELRNNNISDSIPSNIGEYRSLQHLDLSFNNL------------------- 327
+ L L L N + + + L+ + +
Sbjct: 75 FAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTN 134
Query: 328 ----GGSIPDSLFNLSSLTHLFLGNNKLNGTLPARKSPLLLNIDVSYNNLQGNLPSWING 383
G + + L+++ + + + T+P P L + + N + + + G
Sbjct: 135 PLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGLPPSLTELHLDGNKITKVDAASLKG 193
Query: 384 QQNLQI 389
NL
Sbjct: 194 LNNLAK 199
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 61.6 bits (148), Expect = 1e-10
Identities = 28/130 (21%), Positives = 51/130 (39%), Gaps = 1/130 (0%)
Query: 291 KSLSILELRNNNISDSIPSNIGEYRSLQHLDLSFNNLGGSIPDSLFNLSSLTHLFLGNNK 350
++L+L+NN I++ + ++L L L N + P + L L L+L N+
Sbjct: 31 PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQ 90
Query: 351 LNGTLPARKSPLLLNIDVSYNNLQGNLPSWINGQQNLQINLVANNLTIRSSDNSVLPRGL 410
L LP + L + V N + S NG + + + N S + +G+
Sbjct: 91 LK-ELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGM 149
Query: 411 ICLQRNFPCN 420
L +
Sbjct: 150 KKLSYIRIAD 159
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 94.3 bits (233), Expect = 5e-21
Identities = 49/204 (24%), Positives = 91/204 (44%), Gaps = 14/204 (6%)
Query: 168 GQLTELLILGIGTNNFSGPLPSELGSLSKLQELYIDSAGVSGEIPSSFANLQSLTKWWAS 227
+LT L L N S P + + L EL ++ + + A+L +LT +
Sbjct: 194 AKLTNLESLIATNNQISDITPLGILT--NLDELSLNGNQLKD--IGTLASLTNLTDLDLA 249
Query: 228 DTRLTGRIPDFIGNWSKLTALRFQGNSFNGPIPSSFSNLTSVTELRISDLSNGSSKLAFI 287
+ +++ P + +KLT L+ N + P + LT++T + N ++ I
Sbjct: 250 NNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTN--LELNENQLEDISPI 303
Query: 288 RDMKSLSILELRNNNISDSIPSNIGEYRSLQHLDLSFNNLGGSIPDSLFNLSSLTHLFLG 347
++K+L+ L L NNISD P + LQ L + N + S SL NL+++ L G
Sbjct: 304 SNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKV--SDVSSLANLTNINWLSAG 359
Query: 348 NNKLNGTLPARKSPLLLNIDVSYN 371
+N+++ P + + ++
Sbjct: 360 HNQISDLTPLANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 73.1 bits (178), Expect = 4e-14
Identities = 43/184 (23%), Positives = 77/184 (41%), Gaps = 28/184 (15%)
Query: 215 FANLQSLTKWWASDTRLTGRIPDFIGNWSKLTALRFQGNSFNGPIPSSFSNLTSVTELRI 274
A L +L A++ +++ P I + L L GN + ++LT++T+L +
Sbjct: 193 LAKLTNLESLIATNNQISDITPLGI--LTNLDELSLNGNQLKDI--GTLASLTNLTDLDL 248
Query: 275 SDLSNGSSKLAFIRDMKSLSILELRNNNISDSIP--------------------SNIGEY 314
++ N S LA + + L+ L+L N IS+ P S I
Sbjct: 249 AN--NQISNLAPLSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISPISNL 306
Query: 315 RSLQHLDLSFNNLGGSIPDSLFNLSSLTHLFLGNNKLNGTLPARKSPLLLNIDVSYNNLQ 374
++L +L L FNN+ P + +L+ L LF NNK++ + + +N +
Sbjct: 307 KNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSDVSSLANLTNINWLSAGHNQIS 364
Query: 375 GNLP 378
P
Sbjct: 365 DLTP 368
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 65.0 bits (157), Expect = 1e-11
Identities = 57/315 (18%), Positives = 103/315 (32%), Gaps = 44/315 (13%)
Query: 117 DELWNLTSLFNLNLGQNYLTGPLSPSVGNLTAMQYLNLAINALSGELPKELGQLTELLIL 176
D + L +L +N N LT + NLT + + + N ++ P L L
Sbjct: 60 DGVEYLNNLTQINFSNNQLTDI--TPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTL 117
Query: 177 GIGTNNFSGPLP------------SELGSLSKLQELYIDSAGVSGEIPSSFANLQSLTKW 224
PL + + +S L L G + L +LT
Sbjct: 118 FNNQITDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTL 177
Query: 225 W-ASDTRLTGRIPDFIGNWSKLTALRFQGNSFNGPIPSSFSNLTSVTELRISDLSNGSSK 283
+ + + L +L N + P T++ EL ++ N
Sbjct: 178 ERLDISSNKVSDISVLAKLTNLESLIATNNQISDITPLGIL--TNLDELSLNG--NQLKD 233
Query: 284 LAFIRDMKSLSILELRNNNISDSIPSNIGEYRSLQHLDLSFNNLGGSIP----------- 332
+ + + +L+ L+L NN IS+ P + L L L N + P
Sbjct: 234 IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALTNLE 291
Query: 333 ---------DSLFNLSSLTHLFLGNNKLNGTLPARKSPLLLNIDVSYNNLQGNLPSWING 383
+ NL +LT+L L N ++ P L + + N + S +
Sbjct: 292 LNENQLEDISPISNLKNLTYLTLYFNNISDISPVSSLTKLQRLFFANNKVSD--VSSLAN 349
Query: 384 QQNLQ-INLVANNLT 397
N+ ++ N ++
Sbjct: 350 LTNINWLSAGHNQIS 364
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 62.7 bits (151), Expect = 9e-11
Identities = 57/302 (18%), Positives = 109/302 (36%), Gaps = 28/302 (9%)
Query: 110 NVVGVIP-DELWNLTSLFNLNLGQNYLTGPLSPSVGNLTAMQYLNLAINALSGELPKELG 168
NV + +L +T+L LG + G V L + +N + N L+ P L
Sbjct: 33 NVTDTVSQTDLDQVTTLQADRLGIKSIDG-----VEYLNNLTQINFSNNQLTDITP--LK 85
Query: 169 QLTELLILGIGTNNFSGPLPSELGSLSKLQELYIDSAGVSGEIPSSFA---------NLQ 219
LT+L+ + + N + P + L+ + + + +
Sbjct: 86 NLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNRLELSSNTIS 145
Query: 220 SLTKWWASDTRLTGRIPDFIGNWSKLTALRFQGNSF----NGPIPSSFSNLTSVTELRIS 275
++ + + + + L L S + LT++ L +
Sbjct: 146 DISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLAKLTNLESLIAT 205
Query: 276 DLSNGSSKLAFIRDMKSLSILELRNNNISDSIPSNIGEYRSLQHLDLSFNNLGGSIPDSL 335
+ N S + + + +L L L N + D + +L LDL+ N + P L
Sbjct: 206 N--NQISDITPLGILTNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP--L 259
Query: 336 FNLSSLTHLFLGNNKLNGTLPARKSPLLLNIDVSYNNLQGNLPSWINGQQNLQINLVANN 395
L+ LT L LG N+++ P L N++++ N L+ P + L NN
Sbjct: 260 SGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISPISNLKNLTY-LTLYFNN 318
Query: 396 LT 397
++
Sbjct: 319 IS 320
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 55.0 bits (131), Expect = 2e-08
Identities = 39/133 (29%), Positives = 59/133 (44%), Gaps = 10/133 (7%)
Query: 96 GTVCHITQLKVYALNVVGVIPDELWNLTSLFNLNLGQNYLTGPLSPSVGNLTAMQYLNLA 155
+ +T+LK+ A + + P L LT+L NL L +N L + NL + YL L
Sbjct: 260 SGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDI--SPISNLKNLTYLTLY 315
Query: 156 INALSGELPKELGQLTELLILGIGTNNFSGPLPSELGSLSKLQELYIDSAGVSGEIPSSF 215
N +S P + LT+L L N S S L +L+ + L +S P
Sbjct: 316 FNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQISDLTP--L 369
Query: 216 ANLQSLTKWWASD 228
ANL +T+ +D
Sbjct: 370 ANLTRITQLGLND 382
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 53.9 bits (128), Expect = 5e-08
Identities = 24/99 (24%), Positives = 43/99 (43%), Gaps = 6/99 (6%)
Query: 83 YNPFIKCDCSSQNGTVCHITQLKVYALNVVGVIPDELWNLTSLFNLNLGQNYLTGPLSPS 142
+ + S + ++T L +Y N+ + P + +LT L L N ++ S
Sbjct: 291 ELNENQLEDISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSDV--SS 346
Query: 143 VGNLTAMQYLNLAINALSGELPKELGQLTELLILGIGTN 181
+ NLT + +L+ N +S P L LT + LG+
Sbjct: 347 LANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 51.5 bits (122), Expect = 3e-07
Identities = 16/90 (17%), Positives = 30/90 (33%), Gaps = 8/90 (8%)
Query: 258 PIPSSF--SNLTSVTELRISDLSNGSSKLAFIRDMKSLSILELRNNNISDSIPSNIGEYR 315
PI F + L + + + D+ ++ L+ I +
Sbjct: 11 PINQIFTDTALAEKMKTVLGK--TNVTDTVSQTDLDQVTTLQADRLGIKS--IDGVEYLN 66
Query: 316 SLQHLDLSFNNLGGSIPDSLFNLSSLTHLF 345
+L ++ S N L P L NL+ L +
Sbjct: 67 NLTQINFSNNQLTDITP--LKNLTKLVDIL 94
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 50.4 bits (119), Expect = 6e-07
Identities = 42/289 (14%), Positives = 86/289 (29%), Gaps = 49/289 (16%)
Query: 114 VIPDELWNLTSLFNLNLGQNYLTGPLSPSVGNLTAMQYLNLAINALSGELPKELGQLTEL 173
+ D L LG+ +T +S + +L Q+T L
Sbjct: 15 IFTDT--ALAEKMKTVLGKTNVTDTVSQT-----------------------DLDQVTTL 49
Query: 174 LILGIGTNNFSGPLPSELGSLSKLQELYIDSAGVSGEIPSSFANLQSLTKWWASDTRLTG 233
+G + G + L+ L ++ + ++ P NL L ++ ++
Sbjct: 50 QADRLGIKSIDG-----VEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIAD 102
Query: 234 RIP------DFIGNWSKLTALRFQGNSFNGPIPSSFSNLTSVTELRISDLSNGSSKLAFI 287
P + + +++++ +L+F
Sbjct: 103 ITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQLSFG 162
Query: 288 RDMKSLSILELRNNNISDSIPSNIGEY-------RSLQHLDLSFNNLGGSIPDSLFNLSS 340
+ L L I SN +L+ L + N + P L++
Sbjct: 163 NQVTDLKPLANLTTLERLDISSNKVSDISVLAKLTNLESLIATNNQISDITPL--GILTN 220
Query: 341 LTHLFLGNNKLNGTLPARKSPLLLNIDVSYNNLQGNLPSWINGQQNLQI 389
L L L N+L L ++D++ N + P ++G L
Sbjct: 221 LDELSLNGNQLKDIGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTE 267
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 41.5 bits (96), Expect = 4e-04
Identities = 13/43 (30%), Positives = 20/43 (46%), Gaps = 2/43 (4%)
Query: 116 PDELWNLTSLFNLNLGQNYLTGPLSPSVGNLTAMQYLNLAINA 158
L NLT++ L+ G N ++ + NLT + L L A
Sbjct: 344 VSSLANLTNINWLSAGHNQISD--LTPLANLTRITQLGLNDQA 384
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 41.5 bits (96), Expect = 4e-04
Identities = 45/241 (18%), Positives = 84/241 (34%), Gaps = 25/241 (10%)
Query: 170 LTELLILGIGTNNFSGPLPSELGSLSKLQELYIDSAGVSGEIPSSFANLQSLTKWWASDT 229
L E + +G N + + L ++ L D G+ L +LT+ S+
Sbjct: 21 LAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIKS--IDGVEYLNNLTQINFSNN 76
Query: 230 RLTGRIPDFIGNWSKLTALRFQGN---------------SFNGPIPSSFSNLTSVTELRI 274
+LT P + N +KL + N +
Sbjct: 77 QLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNL 134
Query: 275 SDLSNGSSKLAFIRDMKSLSILELRNNNISDSIPSNIGEYRSLQHLDLSFNNLGGSIPDS 334
+ L S+ ++ I + L+ L+ + + + +L+ LD+S N S
Sbjct: 135 NRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNK--VSDISV 192
Query: 335 LFNLSSLTHLFLGNNKLNGTLPARKSPLLLNIDVSYNNLQGNLPSWINGQQNLQINLVAN 394
L L++L L NN+++ P L + ++ N L+ + NL +AN
Sbjct: 193 LAKLTNLESLIATNNQISDITPLGILTNLDELSLNGNQLKD--IGTLASLTNLTDLDLAN 250
Query: 395 N 395
N
Sbjct: 251 N 251
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 86.8 bits (213), Expect = 4e-19
Identities = 61/288 (21%), Positives = 103/288 (35%), Gaps = 11/288 (3%)
Query: 89 CDCSSQNGTVCHITQLKVYALNVVGVIPDELWNLTSLFNLNLGQNYLTGPLSPSVGNLTA 148
C C ++ Q + A +P + + + L N ++ + S
Sbjct: 6 CVCYNEPKVTTSCPQQGLQA------VPVGI--PAASQRIFLHGNRISHVPAASFRACRN 57
Query: 149 MQYLNLAINALSGELPKELGQLTELLILGIGTNNFSGPL-PSELGSLSKLQELYIDSAGV 207
+ L L N L+ L L L + N + P+ L +L L++D G+
Sbjct: 58 LTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGL 117
Query: 208 SGEIPSSFANLQSLTKWWASDTRLTGRIPDFIGNWSKLTALRFQGNSFNGPIPSSFSNLT 267
P F L +L + D L D + LT L GN + +F L
Sbjct: 118 QELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLH 177
Query: 268 SVTELRISDLSNGSSKLAFIRDMKSLSILELRNNNISDSIPSNIGEYRSLQHLDLSFNNL 327
S+ L + RD+ L L L NN+S + R+LQ+L L+ N
Sbjct: 178 SLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPW 237
Query: 328 GGSIPDSLFNLSSLTHLFLGNNKLNGTLPARKSPLLLNIDVSYNNLQG 375
+ L ++++ +LP R + L ++ N+LQG
Sbjct: 238 VCDCRARPL-WAWLQKFRGSSSEVPCSLPQRLAGRDL-KRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 50.6 bits (119), Expect = 4e-07
Identities = 35/197 (17%), Positives = 57/197 (28%), Gaps = 11/197 (5%)
Query: 227 SDTRLTGRIPDFIGNWSKLTALRFQGNSFNGPIPSSFSNLTSVTELRISDLSNGSS-KLA 285
L +P I + + GN + +SF ++T L + A
Sbjct: 19 PQQGLQ-AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAA 75
Query: 286 FIRDMKSLSILELRNNNISDSIPSNIGEYRSLQHLDLSFNNLGGSIPDSLFNLSSLTHLF 345
F + N + P+ L L L L P L++L +L+
Sbjct: 76 FTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLY 135
Query: 346 LGNNKLNGTLPA--RKSPLLLNIDVSYNNLQGNLPSWINGQQNLQINLVANNLTIRSSDN 403
L +N L R L ++ + N + G +L L+ N
Sbjct: 136 LQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQN-----RVA 190
Query: 404 SVLPRGLICLQRNFPCN 420
V P L R
Sbjct: 191 HVHPHAFRDLGRLMTLY 207
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.9 bits (112), Expect = 3e-06
Identities = 34/197 (17%), Positives = 61/197 (30%), Gaps = 26/197 (13%)
Query: 83 YNPFIKCDCSSQNGTVCHITQLKVYALNVVGVIPDELWNLTSLFNLNLGQNYLTGPLSPS 142
++ + + L + + + D +L +L +L L N ++ +
Sbjct: 113 DRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERA 172
Query: 143 VGNLTAMQYLNLAINALSGELPKELGQLTELLILGIGTNNFSGPLPSELGSLSKLQELYI 202
L ++ L L N ++ P L L+ L + NN S L L LQ L +
Sbjct: 173 FRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRL 232
Query: 203 DSAGVSGEIPSSFANLQSLTKWWASDTRLTGRIPDFIGNWSKLTALRFQGNSFNGPIPSS 262
+ N W D R W+ L R + +P
Sbjct: 233 ND------------N------PWVCDCRA-------RPLWAWLQKFRGSSSEVPCSLPQR 267
Query: 263 FSNLTSVTELRISDLSN 279
+ + L +DL
Sbjct: 268 LAGR-DLKRLAANDLQG 283
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 69.0 bits (167), Expect = 2e-13
Identities = 39/211 (18%), Positives = 65/211 (30%), Gaps = 7/211 (3%)
Query: 142 SVGNLTAMQYLNLAINALSGELPKELGQLTELLILGIGTNNFSGPLPSELGSLSKLQELY 201
V + + +N L+ LP +L + T +L L N + L ++L +L
Sbjct: 5 EVSKVASHLEVNCDKRNLT-ALPPDLPKDTTILHLS--ENLLYTFSLATLMPYTRLTQLN 61
Query: 202 IDSAGVSGEIPSSFANLQSLTKWWASDTRLTGRIPDFIGNWSKLTALRFQGNSFNGPIPS 261
+D L L S +L + N
Sbjct: 62 LDR--AELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVL-DVSFNRLTSLPLG 118
Query: 262 SFSNLTSVTELRISDLSNGSSKLAFIRDMKSLSILELRNNNISDSIPSNIGEYRSLQHLD 321
+ L + EL + + + L L L NNN+++ + +L L
Sbjct: 119 ALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLL 178
Query: 322 LSFNNLGGSIPDSLFNLSSLTHLFLGNNKLN 352
L N+ +IP F L FL N
Sbjct: 179 LQENS-LYTIPKGFFGSHLLPFAFLHGNPWL 208
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 51.3 bits (121), Expect = 2e-07
Identities = 16/77 (20%), Positives = 30/77 (38%), Gaps = 3/77 (3%)
Query: 287 IRDMKSLSILELRNNNISDSIPSNIGEYRSLQHLDLSFNNLGGSIPDSLFNLSSLTHLFL 346
+ + S + N++ ++P ++ + L LS N L +L + LT L L
Sbjct: 6 VSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNL 62
Query: 347 GNNKLNGTLPARKSPLL 363
+L P+L
Sbjct: 63 DRAELTKLQVDGTLPVL 79
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 48.6 bits (114), Expect = 1e-06
Identities = 39/242 (16%), Positives = 71/242 (29%), Gaps = 41/242 (16%)
Query: 89 CDCSSQNGTV---CHITQLKVYALNVVGVIPDELWNLTSLFNLNLGQNYLTGPLSPSVGN 145
C+ S + C L +P +L L+L +N L ++
Sbjct: 4 CEVSKVASHLEVNCDKRNLTA--------LPPDL--PKDTTILHLSENLLYTFSLATLMP 53
Query: 146 LTAMQYLNLAINALSGELPKELGQLTELLILGIGTNNFSGPLPSELGSLSKLQELYIDSA 205
T + LNL + G+L L L +
Sbjct: 54 YTRLTQLNL--------------------------DRAELTKLQVDGTLPVLGTLDLSHN 87
Query: 206 GVSGEIPSSFANLQSLTKWWASDTRLTGRIPDFIGNWSKLTALRFQGNSFNGPIPSSFSN 265
+ +LT S RLT + +L L +GN P +
Sbjct: 88 QLQSLPLLGQTL-PALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTP 146
Query: 266 LTSVTELRISDLSNGSSKLAFIRDMKSLSILELRNNNISDSIPSNIGEYRSLQHLDLSFN 325
+ +L +++ + + +++L L L+ N++ +IP L L N
Sbjct: 147 TPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGN 205
Query: 326 NL 327
Sbjct: 206 PW 207
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 63.6 bits (153), Expect = 2e-11
Identities = 45/256 (17%), Positives = 85/256 (33%), Gaps = 21/256 (8%)
Query: 116 PDELWNLTS--LFNLNLGQNYLTGPLSPSVGNLTAMQYLNLAINALSGE-LPKELGQLTE 172
PD L S + ++++ PL + +Q+++L+ + + L L Q ++
Sbjct: 14 PDVTGRLLSQGVIAFRCPRSFMDQPL-AEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSK 72
Query: 173 LLILGIGTNNFSGPLPSELGSLSKLQELYIDS-----AGVSGEIPSSFANLQSLTKWWAS 227
L L + S P+ + L S L L + + SS + L L W
Sbjct: 73 LQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCF 132
Query: 228 DTRLTGRIPDFIGNWSKLTALRFQGNSFNGPIPSSFSNLTSVTELRISDLSN-------G 280
D +T L G N + + L DLS+
Sbjct: 133 DFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDC 192
Query: 281 SSKLAFIRDMKSLSILELRNNNISDSIPSNIGEYRSLQHLDLSFNNLGGSIPDSLFNLSS 340
+ + ++ LS+ R +I +GE +L+ L + G++ +
Sbjct: 193 FQEFFQLNYLQHLSLS--RCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQLL---KEA 247
Query: 341 LTHLFLGNNKLNGTLP 356
L HL + +
Sbjct: 248 LPHLQINCSHFTTIAR 263
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.3 bits (90), Expect = 0.002
Identities = 17/101 (16%), Positives = 38/101 (37%), Gaps = 11/101 (10%)
Query: 318 QHLDLSFNNLGGSIPDSLFNLSSLTHLFLGNNKLNGTLPARKSPL-LLNIDVSYNNLQGN 376
Q LDL+ NL + L + + + ++ L SP + ++D+S + ++ +
Sbjct: 3 QTLDLTGKNLHPDVTGRLLSQ-GVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVS 61
Query: 377 -LPSWINGQQNLQINLVANNLTIRSSDNSVLPRGLICLQRN 416
L ++ LQ + + + L +N
Sbjct: 62 TLHGILSQCSKLQ--------NLSLEGLRLSDPIVNTLAKN 94
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 60.0 bits (144), Expect = 2e-10
Identities = 35/235 (14%), Positives = 77/235 (32%), Gaps = 20/235 (8%)
Query: 114 VIPDELWNLTSLFNLNLGQNYLTGPLSPSVGNLTAMQYLNLAINALSGELPKELGQLTEL 173
+ PD L + + G++ +T ++ + +L + L+ ++ + + L L
Sbjct: 12 IFPDP--ALANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVTTI--EGVQYLNNL 65
Query: 174 LILGIGTNNFSGPLPSELGSLSKLQELYIDSAGVSGEIPSSFANLQSLTKWWASDTRLTG 233
+ L + N + P + + EL + I +
Sbjct: 66 IGLELKDNQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPL 125
Query: 234 RIPDFIGNWSKLTALRFQGNSFNGPIPSSFSNLTSVTELRISDLSNGSSKLAFIRDMKSL 293
+ + G + ++ + ++ L+N + L
Sbjct: 126 AGLSNLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLAN----------LSKL 175
Query: 294 SILELRNNNISDSIPSNIGEYRSLQHLDLSFNNLGGSIPDSLFNLSSLTHLFLGN 348
+ L+ +N ISD P + +L + L N + P L N S+L + L N
Sbjct: 176 TTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTN 226
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 40.8 bits (94), Expect = 4e-04
Identities = 38/221 (17%), Positives = 70/221 (31%), Gaps = 16/221 (7%)
Query: 169 QLTELLILGIGTNNFSGPLPSELGSLSKLQELYIDSAGVSGEIPSSFANLQSLTKWWASD 228
L + + G +N + + L + L GV+ L +L D
Sbjct: 17 ALANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKD 72
Query: 229 TRLTGRIPDFIGNWSKLTALRFQGNSFNGPIPSSFSNLTSVTELRISDLSNGSSKLAFIR 288
++ K + P+ + + + + S + + +
Sbjct: 73 NQI------TDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLA 126
Query: 289 DMKSLSILELRNNNISDSIPSNIGEYRSLQHLDLSFNNLGGSIPDSLFNLSSLTHLFLGN 348
+ +L +L L N I++ P N S L NLS LT L +
Sbjct: 127 GLSNLQVLYLDLNQITNISPLAGLTNLQYLS----IGNAQVSDLTPLANLSKLTTLKADD 182
Query: 349 NKLNGTLPARKSPLLLNIDVSYNNLQGNLPSWINGQQNLQI 389
NK++ P P L+ + + N + P + NL I
Sbjct: 183 NKISDISPLASLPNLIEVHLKNNQISDVSP--LANTSNLFI 221
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 57.3 bits (136), Expect = 5e-09
Identities = 21/99 (21%), Positives = 38/99 (38%), Gaps = 13/99 (13%)
Query: 285 AFIRDMKSLSILELRNNNISD----SIPSNIGEYRSLQHLDLSFNNLGGSIPDSLF---- 336
+ L +L L + ++SD S+ + + SL+ LDLS N LG + L
Sbjct: 363 GLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVR 422
Query: 337 -NLSSLTHLFLGNNKLNGTLPARKSPLLLNIDVSYNNLQ 374
L L L + + + L ++ +L+
Sbjct: 423 QPGCLLEQLVLYDIYWSEEME----DRLQALEKDKPSLR 457
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 54.2 bits (128), Expect = 5e-08
Identities = 20/134 (14%), Positives = 39/134 (29%), Gaps = 5/134 (3%)
Query: 292 SLSILELRNNNISDSIPSNIGEY-RSLQHLDLSFNNLGG----SIPDSLFNLSSLTHLFL 346
+ L+++ +SD+ + + + Q + L L I +L +L L L
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 347 GNNKLNGTLPARKSPLLLNIDVSYNNLQGNLPSWINGQQNLQINLVANNLTIRSSDNSVL 406
+N+L L L + + + T++ S
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDN 122
Query: 407 PRGLICLQRNFPCN 420
G LQ
Sbjct: 123 LLGDAGLQLLCEGL 136
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 52.3 bits (123), Expect = 2e-07
Identities = 14/92 (15%), Positives = 32/92 (34%), Gaps = 10/92 (10%)
Query: 268 SVTELRISDLSNGSSKLA-FIRDMKSLSILELRNNNISDSIPSNIGEY----RSLQHLDL 322
+ L I ++ A + ++ ++ L + ++++ +I +L L+L
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 323 SFNNLGGSIPDSLF-----NLSSLTHLFLGNN 349
N LG + + L L N
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNC 94
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.8 bits (101), Expect = 9e-05
Identities = 17/118 (14%), Positives = 40/118 (33%), Gaps = 9/118 (7%)
Query: 88 KCDCSSQNGTVCHITQLKVYALNVVGVIPDELWNLTSLFNLNLGQNYLTG----PLSPSV 143
++ I+ ++ V + + L L L ++ L+ ++
Sbjct: 334 SVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATL 393
Query: 144 GNLTAMQYLNLAINALSGELPKELGQ-----LTELLILGIGTNNFSGPLPSELGSLSK 196
+++ L+L+ N L +L + L L + +S + L +L K
Sbjct: 394 LANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEEMEDRLQALEK 451
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 56.8 bits (135), Expect = 5e-09
Identities = 24/93 (25%), Positives = 36/93 (38%), Gaps = 7/93 (7%)
Query: 298 LRNNNISDSIPSNIGEYRSLQHLDLSFNNLGGSIPDSLFNLSSLTHLFLGNNKLNGTLPA 357
N S+ I S SL+ L++S N L +P L L N L +P
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNKL-IELPAL---PPRLERLIASFNHLA-EVP- 320
Query: 358 RKSPLLLNIDVSYNNLQGNLPSWINGQQNLQIN 390
L + V YN L+ P ++L++N
Sbjct: 321 ELPQNLKQLHVEYNPLRE-FPDIPESVEDLRMN 352
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 47.1 bits (110), Expect = 7e-06
Identities = 19/79 (24%), Positives = 29/79 (36%), Gaps = 9/79 (11%)
Query: 120 WNLTSLFNLNLGQNYLTGPLSPSVGNLTAMQYLNLAINALSGELPKELGQLTELLILGIG 179
SL LN+ N L L L + L + N L+ E+P+ L +L +
Sbjct: 281 DLPPSLEELNVSNNKLIE-LPALPPRL---ERLIASFNHLA-EVPELPQNLKQLHVEY-- 333
Query: 180 TNNFSGPLPSELGSLSKLQ 198
N P S+ L+
Sbjct: 334 -NPLRE-FPDIPESVEDLR 350
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 44.8 bits (104), Expect = 4e-05
Identities = 18/66 (27%), Positives = 27/66 (40%), Gaps = 5/66 (7%)
Query: 291 KSLSILELRNNNISDSIPSNIGEYRSLQHLDLSFNNLGGSIPDSLFNLSSLTHLFLGNNK 350
+ LEL N +S S+P L+ L S N+L +P+ +L SL
Sbjct: 38 RQAHELELNNLGLS-SLPELPP---HLESLVASCNSL-TELPELPQSLKSLLVDNNNLKA 92
Query: 351 LNGTLP 356
L+ P
Sbjct: 93 LSDLPP 98
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 42.1 bits (97), Expect = 2e-04
Identities = 15/101 (14%), Positives = 30/101 (29%), Gaps = 14/101 (13%)
Query: 224 WWASDTRLTGRIPDFIGNWSKLTALRFQGNSFNGPIPSSFSNLTSVTELRISDLSNGSSK 283
+ I L L N +P+ L + S +
Sbjct: 265 NLYYLNASSNEIRSLCDLPPSLEELNVSNNKLIE-LPALPPRLERL------IASF--NH 315
Query: 284 LAFIRD-MKSLSILELRNNNISDSIPSNIGEYRSLQHLDLS 323
LA + + ++L L + N + P S++ L ++
Sbjct: 316 LAEVPELPQNLKQLHVEYNPLR-EFPDIPE---SVEDLRMN 352
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 40.6 bits (93), Expect = 7e-04
Identities = 21/95 (22%), Positives = 36/95 (37%), Gaps = 12/95 (12%)
Query: 181 NNFSGPLPSELGSLSKLQELYIDSAGVSGEIPSSFANLQSLTKWWASDTRLTGRIPDFIG 240
N S + S L+EL + + + E+P+ L+ L AS L +P+
Sbjct: 270 NASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLERL---IASFNHLA-EVPELPQ 324
Query: 241 NWSKLTALRFQGNSFNGPIPSSFSNLTSVTELRIS 275
N L L + N P ++ LR++
Sbjct: 325 N---LKQLHVEYNPLRE-FPDIPESVED---LRMN 352
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 39.0 bits (89), Expect = 0.002
Identities = 23/81 (28%), Positives = 32/81 (39%), Gaps = 7/81 (8%)
Query: 318 QHLDLSFNNLGGSIPDSLFNLSSLTHLFLGNNKLNGTLPARKSPLLLNIDVSYNNLQGNL 377
N I SL L + NNKL LPA P L + S+N+L +
Sbjct: 263 PPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPA-LPPRLERLIASFNHLA-EV 319
Query: 378 PSWINGQQNLQ-INLVANNLT 397
P QNL+ +++ N L
Sbjct: 320 PELP---QNLKQLHVEYNPLR 337
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 50.1 bits (119), Expect = 6e-08
Identities = 28/123 (22%), Positives = 46/123 (37%), Gaps = 5/123 (4%)
Query: 295 ILELRNNNISDSIPSNIGEYRSLQHLDLSFNNLGGSIPDSLFNLSSLTHLFLGNNKLNGT 354
+L L + +++ + ++ + + HLDLS N L P +L L L L +N L
Sbjct: 2 VLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNALENV 58
Query: 355 LPARKSPLLLNIDVSYNNLQG-NLPSWINGQQNLQ-INLVANNLTIRSSDNSVLPRGLIC 412
P L + + N LQ + L +NL N+L L L
Sbjct: 59 DGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPS 118
Query: 413 LQR 415
+
Sbjct: 119 VSS 121
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 45.5 bits (107), Expect = 2e-06
Identities = 20/80 (25%), Positives = 36/80 (45%), Gaps = 2/80 (2%)
Query: 318 QHLDLSFNNLGGSIPDSLFNLSSLTHLFLGNNKLNGTLPARKSPLLLNIDVSYNNLQGNL 377
+ L L+ +L ++ L L +THL L +N+L PA + L + + +N N+
Sbjct: 1 RVLHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALENV 58
Query: 378 PSWINGQQNLQINLVANNLT 397
N + ++ L N L
Sbjct: 59 DGVANLPRLQELLLCNNRLQ 78
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 40.9 bits (95), Expect = 9e-05
Identities = 21/112 (18%), Positives = 36/112 (32%), Gaps = 5/112 (4%)
Query: 115 IPDELWNLTSLFNLNLGQNYLTGPLSPSVGNLTAMQYLNLAINALSGELPKELGQLTELL 174
+ L L + +L+L N L P++ L ++ L + NAL + L
Sbjct: 12 VLCHLEQLLLVTHLDLSHNRLRAL-PPALAALRCLEVLQASDNALENVDGVANLPRLQEL 70
Query: 175 ILGIGTNNFSGPLPSELGSLSKLQELYIDS---AGVSGEIPSSFANLQSLTK 223
+L L S +L L + G L S++
Sbjct: 71 LLC-NNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSS 121
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 36.6 bits (84), Expect = 0.003
Identities = 18/114 (15%), Positives = 36/114 (31%), Gaps = 5/114 (4%)
Query: 210 EIPSSFANLQSLTKWWASDTRLTGRIPDFIGNWSKLTALRFQGNSFNGPIPSSFSNLTSV 269
+ L +T S RL P L L+ N+ +
Sbjct: 11 TVLCHLEQLLLVTHLDLSHNRLRALPPAL-AALRCLEVLQASDNALENVDGVANLPRLQE 69
Query: 270 TELRISDLSNGSSKLAFIRDMKSLSILELRNNNIS--DSIPSNIGEY-RSLQHL 320
L + L ++ + + L +L L+ N++ + I + E S+ +
Sbjct: 70 LLLCNNRLQQSAA-IQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSI 122
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 49.2 bits (116), Expect = 5e-07
Identities = 30/210 (14%), Positives = 65/210 (30%), Gaps = 18/210 (8%)
Query: 114 VIPDELWNLTSLFNLNLGQNYLTGPLSPSVGNLTAMQYLNLAINALSGELPKELGQLTEL 173
+ D+ NL + +T ++ + L ++ + + + + L +
Sbjct: 17 IFSDD--AFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKSVQG--IQYLPNV 70
Query: 174 LILGIGTNNFSGPLPSELGSLSKLQELYIDSAGVSGEIPSSFANLQSLTKWWASDTRLTG 233
L + N + P L+ L+ L + S S
Sbjct: 71 TKLFLNGNKLTDIKP-----LANLKNLGWLFLDENKVKDLSSLKDLK-KLKSLSLEHNGI 124
Query: 234 RIPDFIGNWSKLTALRFQGNSFNGPIPSSFSNLTSVTELRISDLSNGSSKLAFIRDMKSL 293
+ + + +L +L N S L + +S+ + + + L
Sbjct: 125 SDINGLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISD----IVPLAGLTKL 180
Query: 294 SILELRNNNISDSIPSNIGEYRSLQHLDLS 323
L L N+ISD + ++L L+L
Sbjct: 181 QNLYLSKNHISD--LRALAGLKNLDVLELF 208
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 39.2 bits (90), Expect = 0.001
Identities = 23/183 (12%), Positives = 61/183 (33%), Gaps = 14/183 (7%)
Query: 169 QLTELLILGIGTNNFSGPLPSELGSLSKLQELYIDSAGVSGEIPSSFANLQSLTKWWASD 228
E + + + + + L+ + ++ +++ + L ++TK + +
Sbjct: 22 AFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLNG 77
Query: 229 TRLTGRIPDFIGNWSKLTALRFQGNSFNGPIPSSFSNLTSVTELRISDLSNGSSKLAFIR 288
+LT + L L + N S + + + S +
Sbjct: 78 NKLTDIK-----PLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDINGLVH 132
Query: 289 DMKSLSILELRNNNISDSIPSNIGEYRSLQHLDLSFNNLGGSIPDSLFNLSSLTHLFLGN 348
+ S+ N ++ S + + +L D +++ L L+ L +L+L
Sbjct: 133 LPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDI-----VPLAGLTKLQNLYLSK 187
Query: 349 NKL 351
N +
Sbjct: 188 NHI 190
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 38.8 bits (89), Expect = 0.002
Identities = 11/85 (12%), Positives = 32/85 (37%), Gaps = 10/85 (11%)
Query: 298 LRNNNISDSIPSNIGEY------RSLQHLDLSFNNLGGSIPDSLFNLSSLTHLFLGNNKL 351
L + I+ +P+ I + +L ++ ++ + L+S+ + N+ +
Sbjct: 3 LGSETIT--VPTPIKQIFSDDAFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDI 58
Query: 352 NGTLPARKSPLLLNIDVSYNNLQGN 376
+ P + + ++ N L
Sbjct: 59 KSVQGIQYLPNVTKLFLNGNKLTDI 83
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 48.5 bits (114), Expect = 8e-07
Identities = 31/208 (14%), Positives = 70/208 (33%), Gaps = 20/208 (9%)
Query: 114 VIPDELWNLTSLFNLNLGQNYLTGPLSPS-VGNLTAMQYLNLAINALSGELPKELGQLTE 172
+ D L LG+ +T +S + + +T +Q L I ++ G + L
Sbjct: 11 IFTDT--ALAEKMKTVLGKTNVTDTVSQTDLDQVTTLQADRLGIKSIDG-----VEYLNN 63
Query: 173 LLILGIGTNNFSGPLPSELGSLSKLQELYIDSAGVSGEIPSSFANLQSLTKWWASDTRLT 232
L + N + P + + + + +I +
Sbjct: 64 LTQINFSNNQLTDITPLKNLTKLVDILMNNN------QIADITPLANLTNLTGLTLFNNQ 117
Query: 233 GRIPDFIGNWSKLTALRFQGNSFNGPIPSSFSNLTSVTELRISDLSNGSSKLAFIRDMKS 292
D + N + L L N+ + S + +++ L + ++ +
Sbjct: 118 ITDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQLNFSSNQVTD----LKPLANLTT 173
Query: 293 LSILELRNNNISDSIPSNIGEYRSLQHL 320
L L++ +N +SD S + + +L+ L
Sbjct: 174 LERLDISSNKVSD--ISVLAKLTNLESL 199
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 40.4 bits (93), Expect = 4e-04
Identities = 33/184 (17%), Positives = 63/184 (34%), Gaps = 14/184 (7%)
Query: 170 LTELLILGIGTNNFSGPLPSELGSLSKLQELYIDSAGVSGEIPSSFANLQSLTKWWASDT 229
L E + +G N + + L ++ L D G+ L +LT+ S+
Sbjct: 17 LAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIKS--IDGVEYLNNLTQINFSNN 72
Query: 230 RLTGRIPDFIGNWSKLTALRFQGNSFNGPIPSSFSNLTSVTELRISDLSNGSSKLAFIRD 289
+LT + L L + + + +
Sbjct: 73 QLTD--------ITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPL 124
Query: 290 MKSLSILELRNNNISDSIPSNIGEYRSLQHLDLSFNNLGGSIPDSLFNLSSLTHLFLGNN 349
++ L ++ + S S + SLQ L+ S N + P L NL++L L + +N
Sbjct: 125 KNLTNLNRLELSSNTISDISALSGLTSLQQLNFSSNQVTDLKP--LANLTTLERLDISSN 182
Query: 350 KLNG 353
K++
Sbjct: 183 KVSD 186
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 48.3 bits (113), Expect = 2e-06
Identities = 12/65 (18%), Positives = 22/65 (33%), Gaps = 11/65 (16%)
Query: 298 LRNNNISDSIPSNIGEY------RSLQHLDLSFNNLGGSIPDSLF-----NLSSLTHLFL 346
L + +S + + + LQ L L +N + +L + L L L
Sbjct: 250 LNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLEL 309
Query: 347 GNNKL 351
N+
Sbjct: 310 NGNRF 314
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 47.2 bits (110), Expect = 7e-06
Identities = 11/69 (15%), Positives = 28/69 (40%), Gaps = 8/69 (11%)
Query: 292 SLSILELRNNNISD----SIPSNIGEYRSLQHLDLSFNNLGG----SIPDSLFNLSSLTH 343
S+ L+ + I+ S+ + + E S++ + LS N +G + +++ + L
Sbjct: 4 SIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEI 63
Query: 344 LFLGNNKLN 352
+
Sbjct: 64 AEFSDIFTG 72
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 42.2 bits (97), Expect = 3e-04
Identities = 17/87 (19%), Positives = 31/87 (35%), Gaps = 6/87 (6%)
Query: 272 LRISDLSNGSSK--LAFIRDMKSLSILELRNNNISD----SIPSNIGEYRSLQHLDLSFN 325
L++ ++ K A + + S+ + L N I + NI + L+ + S
Sbjct: 10 LKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDI 69
Query: 326 NLGGSIPDSLFNLSSLTHLFLGNNKLN 352
G + L L L KL+
Sbjct: 70 FTGRVKDEIPEALRLLLQALLKCPKLH 96
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 39.1 bits (89), Expect = 0.002
Identities = 10/56 (17%), Positives = 17/56 (30%), Gaps = 7/56 (12%)
Query: 290 MKSLSILELRNNNISDSIPSNIGE-----YRSLQHLDLSFNNLG--GSIPDSLFNL 338
L L L+ N I + L L+L+ N + D + +
Sbjct: 272 NIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEEDDVVDEIREV 327
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.7 bits (97), Expect = 9e-05
Identities = 20/105 (19%), Positives = 41/105 (39%), Gaps = 2/105 (1%)
Query: 251 QGNSFNGPIPSSFSNLTSVTELRIS--DLSNGSSKLAFIRDMKSLSILELRNNNISDSIP 308
+ +S + N+ + L +S L + ++ +L IL L N +
Sbjct: 49 RRSSMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERE 108
Query: 309 SNIGEYRSLQHLDLSFNNLGGSIPDSLFNLSSLTHLFLGNNKLNG 353
+ + L+ L L N+L + D +S++ F +L+G
Sbjct: 109 LDKIKGLKLEELWLDGNSLSDTFRDQSTYISAIRERFPKLLRLDG 153
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.9 bits (87), Expect = 0.002
Identities = 22/103 (21%), Positives = 37/103 (35%), Gaps = 7/103 (6%)
Query: 261 SSFSNLTSVTELRISDLSNGSSKLAFI-----RDMKSLSILELRNNNISD--SIPSNIGE 313
+ + I + N S +A ++ L L L NN + + S + +
Sbjct: 30 KGLRSDPDLVAQNIDVVLNRRSSMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQK 89
Query: 314 YRSLQHLDLSFNNLGGSIPDSLFNLSSLTHLFLGNNKLNGTLP 356
+L+ L+LS N L L L+L N L+ T
Sbjct: 90 APNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFR 132
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.3 bits (92), Expect = 6e-04
Identities = 11/42 (26%), Positives = 13/42 (30%), Gaps = 3/42 (7%)
Query: 315 RSLQHLDLSFNNLGGSIPDSLFNLSSLTHLFLGNNKLNGTLP 356
LD+S + L NL L N K LP
Sbjct: 201 SGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK---KLP 239
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.3 bits (92), Expect = 7e-04
Identities = 8/55 (14%), Positives = 19/55 (34%), Gaps = 3/55 (5%)
Query: 292 SLSILELRNNNISDSIPSNIGEYRSLQHLDLSFNNLGGSIPDSLFNLSSLTHLFL 346
S + + + ++ IPS++ R+ L L + L + +
Sbjct: 9 SNRVFLCQESKVT-EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEI 60
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.2 bits (90), Expect = 8e-04
Identities = 16/102 (15%), Positives = 30/102 (29%), Gaps = 3/102 (2%)
Query: 289 DMKSLSILELRNNNISDSIPSNIGEYRSLQHLDLSFNNLGGSIPDSLFNLSSLTHLFLGN 348
+ L+LR I I + +D S N + L L L + N
Sbjct: 16 NAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKLDGFP--LLRRLKTLLVNN 72
Query: 349 NKLNGTLPARKSPLLLNIDVSYNNLQGNLPSWINGQQNLQIN 390
N++ L ++ N ++ +L+
Sbjct: 73 NRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSL 114
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 39.4 bits (90), Expect = 8e-04
Identities = 32/173 (18%), Positives = 61/173 (35%), Gaps = 5/173 (2%)
Query: 162 ELPKELGQLTELLILGIGTNNFSGPLPSELGSLSKLQELYIDSAGVSGEIPSSFANLQSL 221
E+P+++ T L+L G L L +L + ++G P++F +
Sbjct: 22 EIPRDIPLHTTELLLN-DNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHI 80
Query: 222 TKWWASDTRLTGRIPDFIGNWSKLTALRFQGNSFNGPIPSSFSNLTSVTELRISDLSNGS 281
+ + ++ +L L N + +P SF +L S+T L ++
Sbjct: 81 QELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNC 140
Query: 282 SKLAFIRDMKSLSILELRNNNISDSIPSNIGEYRSLQHLDLSFNNLGGSIPDS 334
+ + L L PS + R +Q DL + S +S
Sbjct: 141 NCHLAWF-AEWLRKKSLNGGAARCGAPSKV---RDVQIKDLPHSEFKCSSENS 189
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.2 bits (87), Expect = 0.001
Identities = 14/106 (13%), Positives = 30/106 (28%), Gaps = 3/106 (2%)
Query: 292 SLSILELRNNNISDSIPSNIGEYRSLQHLDLSFNNLGGSIPDSLF-NLSSLTHLFLGNNK 350
S L + ++ +L L + + L L +L + +
Sbjct: 9 GSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSG 67
Query: 351 LNGTLPARKSPLLLNIDVSY-NNLQGNLPSWINGQQNLQINLVANN 395
L P ++ N +L +LQ +++ N
Sbjct: 68 LRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGN 113
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} Length = 198 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Score = 37.7 bits (86), Expect = 0.003
Identities = 15/68 (22%), Positives = 27/68 (39%), Gaps = 8/68 (11%)
Query: 284 LAFIRDMKSLSILELRNNNISDSIP------SNIGEYRSLQHLDLSFNNLGGSIPDSLFN 337
+ + KS+ E + IP + + ++ +HL LS NN+ SL
Sbjct: 11 IRIFEERKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNI--EKISSLSG 68
Query: 338 LSSLTHLF 345
+ +L L
Sbjct: 69 MENLRILS 76
|
Homologous Domains Detected by HHsearch 
Original result of HHsearch against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 1036 | |||
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 100.0 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 100.0 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 100.0 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 100.0 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 100.0 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 100.0 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 100.0 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 100.0 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.96 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.95 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.94 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.94 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.94 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.93 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.93 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.91 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.91 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.91 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.9 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.9 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.9 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.89 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.87 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.87 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.86 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.85 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.83 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.76 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.72 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.69 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.69 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.65 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.61 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.61 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 99.27 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.86 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.79 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 98.58 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 98.38 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 98.29 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 98.29 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 98.08 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 97.85 |
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=0 Score=387.40 Aligned_cols=262 Identities=26% Similarity=0.388 Sum_probs=217.1
Q ss_pred HHCCCCCCCCCCCCCCEEEEEEEEC-CCCEEEEEECCCCCHHCHHHHHHHHHHHHHHCCCCCCEEEEEEECCCEEEEEEE
Q ss_conf 7239999893035897889996828-993899999241033209999999999874015884316858870832289998
Q 001658 691 ATENFSPSNKLGEGGFGPVYKGKLG-DGRAIAVKQLSVASRQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLVYE 769 (1036)
Q Consensus 691 ~~~~~~~~~~iG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 769 (1036)
..++|++.+.||+|+||+||+|+.. +++.||||+++... ...++|.+|+.++++++|||||+++|+|.+.+..++|||
T Consensus 15 ~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E 93 (287)
T d1opja_ 15 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 93 (287)
T ss_dssp CGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred CHHHEEEEEEEEECCCEEEEEEEECCCCEEEEEEEECCCC-CHHHHHHHHHHHHHHCCCCCEECCCCCEEECCEEEEEEE
T ss_conf 5799398659820888089999999999699999977761-039999999999986799988267752745785478763
Q ss_pred ECCCCCHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCEEECCCCCEEEEECCCCEEECCCCC
Q ss_conf 34799944563218877757677999999999999998761896501134578858846998449997474114158987
Q 001658 770 YLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKT 849 (1036)
Q Consensus 770 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~ 849 (1036)
|+++|+|.+++.......+++..++.|+.|+++||+|||+++ |+||||||+|||+++++.+||+|||+|+.......
T Consensus 94 ~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~ 170 (287)
T d1opja_ 94 FMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY 170 (287)
T ss_dssp CCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSS
T ss_pred CCCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCEEEECCCCCEEECCCCCEEECCCCCC
T ss_conf 146760677753035541579999999999999788898789---30576045768998999289832445465378872
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCCCC
Q ss_conf 42235433567457100023878942467868999999982999999998156778999999874049531125852436
Q 001658 850 HISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEIELADPKLIE 929 (1036)
Q Consensus 850 ~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~ 929 (1036)
.......|++.|+|||++.+..++.++|||||||++|||++|+.|+.......... +.+ ..+ ..+...
T Consensus 171 ~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~--~~i----~~~-----~~~~~~- 238 (287)
T d1opja_ 171 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY--ELL----EKD-----YRMERP- 238 (287)
T ss_dssp EEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH--HHH----HTT-----CCCCCC-
T ss_pred EEECCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHH--HHH----HCC-----CCCCCC-
T ss_conf 21035566546669278727999810430217899999986799887742599999--998----558-----888887-
Q ss_pred CCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCCCC
Q ss_conf 79999999999999810449999999899999964055887
Q 001658 930 FNEEEVKRLIGVALLCTQTLPSLRPSMSRVVAMLCGDMEVS 970 (1036)
Q Consensus 930 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~ 970 (1036)
......+.+++..||+.+|.+|||++|+++.|+......
T Consensus 239 --~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~~~ 277 (287)
T d1opja_ 239 --EGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES 277 (287)
T ss_dssp --TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTSSS
T ss_pred --CCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHHC
T ss_conf --433099999999975779768939999999999998757
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=0 Score=384.00 Aligned_cols=267 Identities=25% Similarity=0.415 Sum_probs=213.3
Q ss_pred CCHHHHHHHHC---------CCCCCCCCCCCCCEEEEEEEEC-CC---CEEEEEECCCC-CHHCHHHHHHHHHHHHHHCC
Q ss_conf 59899998723---------9999893035897889996828-99---38999992410-33209999999999874015
Q 001658 683 FSYAELKTATE---------NFSPSNKLGEGGFGPVYKGKLG-DG---RAIAVKQLSVA-SRQGKSQFVAEIATISAVQH 748 (1036)
Q Consensus 683 ~~~~~l~~~~~---------~~~~~~~iG~G~fG~Vy~~~~~-~g---~~vAvK~l~~~-~~~~~~~f~~Ei~~l~~l~H 748 (1036)
++++++..++. +|++.+.||+|+||+||+|+.. ++ ..||||.+... .....+.|.+|+.++++++|
T Consensus 7 ~t~~d~~~a~~~f~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H 86 (299)
T d1jpaa_ 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDH 86 (299)
T ss_dssp GGSSSHHHHHHHHSCBCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCC
T ss_pred CCHHHHHHHHHHHCHHHCHHHCEEEEEEEECCCEEEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCC
T ss_conf 88798999996046220800427856980278829999999579978899999997844598999999999999985799
Q ss_pred CCCCEEEEEEECCCEEEEEEEECCCCCHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCEEEC
Q ss_conf 88431685887083228999834799944563218877757677999999999999998761896501134578858846
Q 001658 749 RNLVKLHGCCIEGAERLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLD 828 (1036)
Q Consensus 749 ~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NILl~ 828 (1036)
||||+++|+|.+.+..++||||+++|+|.+++... ...++|..++.|+.|+|+||+|||+.+ |+||||||+|||++
T Consensus 87 pnIv~l~g~~~~~~~~~iv~Ey~~~g~L~~~~~~~-~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~ 162 (299)
T d1jpaa_ 87 PNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQN-DGQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVN 162 (299)
T ss_dssp TTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHTT-TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEC
T ss_pred CCCCCEEEEEEECCEEEEEEEECCCCCCEEEECCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCEEEEC
T ss_conf 88861899996288779999722798530021045-679999999999999999889885279---83576150448988
Q ss_pred CCCCEEEEECCCCEEECCCCCCC----CCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHH-CCCCCCCCCHHHH
Q ss_conf 99844999747411415898742----235433567457100023878942467868999999982-9999999981567
Q 001658 829 ADLVPKISDFGLAKLYDDKKTHI----STRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVS-GRPNSDPSLDEEK 903 (1036)
Q Consensus 829 ~~~~~kl~DFGla~~~~~~~~~~----~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvil~ellt-G~~p~~~~~~~~~ 903 (1036)
.++.+||+|||+++.+....... .....||+.|||||++.++.++.++|||||||++|||+| |++||......+.
T Consensus 163 ~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~ 242 (299)
T d1jpaa_ 163 SNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDV 242 (299)
T ss_dssp TTCCEEECCC-----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH
T ss_pred CCCCEEECCCCCCEECCCCCCCCEEEECCCCCCCCCCCCHHHHHCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHHHH
T ss_conf 99919988844315756777765365025666883003878883699786121445357899998679999999999999
Q ss_pred HHHHHHHHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCC
Q ss_conf 78999999874049531125852436799999999999998104499999998999999640558
Q 001658 904 LYLLEWAWHLHENNQEIELADPKLIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVAMLCGDME 968 (1036)
Q Consensus 904 ~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 968 (1036)
...+. .+. .+ ..+.+....+.+++.+||+.+|.+||||.||++.|++.+.
T Consensus 243 ~~~i~-------~~~-----~~---~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~ 292 (299)
T d1jpaa_ 243 INAIE-------QDY-----RL---PPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR 292 (299)
T ss_dssp HHHHH-------TTC-----CC---CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred HHHHH-------CCC-----CC---CCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHC
T ss_conf 99997-------378-----89---9974226999999999758797689299999999999841
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=383.96 Aligned_cols=256 Identities=28% Similarity=0.428 Sum_probs=211.1
Q ss_pred CCCCCCCCCCCCCCEEEEEEEECCCCEEEEEECCCCCHHCHHHHHHHHHHHHHHCCCCCCEEEEEEECCCEEEEEEEECC
Q ss_conf 39999893035897889996828993899999241033209999999999874015884316858870832289998347
Q 001658 693 ENFSPSNKLGEGGFGPVYKGKLGDGRAIAVKQLSVASRQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLVYEYLE 772 (1036)
Q Consensus 693 ~~~~~~~~iG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~ 772 (1036)
++|++.+.||+|+||+||+|++.+++.||||+++.. ....++|.+|+.++++++|||||+++|+|.+.+..++||||++
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~ 83 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 83 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSS-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred HHCEEEEEEEECCCEEEEEEEECCCCEEEEEEECCC-CCCHHHHHHHHHHHHHCCCCCCCCCCCEECCCCCEEEEEEECC
T ss_conf 995888898208882999999889999999998788-6768999999999996689975653524315993379998369
Q ss_pred CCCHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCEEECCCCCEEEEECCCCEEECCCCCCCC
Q ss_conf 99944563218877757677999999999999998761896501134578858846998449997474114158987422
Q 001658 773 NKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHIS 852 (1036)
Q Consensus 773 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 852 (1036)
+|+|.+++... ...+++..++.|+.|+|+||+|||+.+ |+||||||+|||+++++.+||+|||+++..........
T Consensus 84 ~g~L~~~l~~~-~~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~ 159 (263)
T d1sm2a_ 84 HGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSS 159 (263)
T ss_dssp TCBHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC-------------
T ss_pred CCCHHHHHHCC-CCCCCHHHHHHHHHHHHHHHHHHHCCC---EEECCCCHHHEEECCCCCEEECCCCHHEECCCCCCEEE
T ss_conf 99189975201-347889999999999999877653164---31044315326666887768655321002368873350
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHC-CCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCC
Q ss_conf 354335674571000238789424678689999999829-9999999815677899999987404953112585243679
Q 001658 853 TRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSG-RPNSDPSLDEEKLYLLEWAWHLHENNQEIELADPKLIEFN 931 (1036)
Q Consensus 853 ~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvil~elltG-~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~ 931 (1036)
....||+.|+|||++.+..++.++|||||||++|||+|+ ++|+......+....+. . +. ....|.
T Consensus 160 ~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~---~----~~--~~~~p~----- 225 (263)
T d1sm2a_ 160 TGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIS---T----GF--RLYKPR----- 225 (263)
T ss_dssp -----CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHH---H----TC--CCCCCT-----
T ss_pred CCEECCCCCCCHHHHCCCCCCCHHHHCCHHHHHHHHHHCCCCCCCCCCHHHHHHHHH---H----CC--CCCCCC-----
T ss_conf 430017666785786079998403321059999999878988877899999999998---0----68--889954-----
Q ss_pred HHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCC
Q ss_conf 9999999999998104499999998999999640558
Q 001658 932 EEEVKRLIGVALLCTQTLPSLRPSMSRVVAMLCGDME 968 (1036)
Q Consensus 932 ~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 968 (1036)
.....+.+++..||+.+|.+||||+||++.|+++.+
T Consensus 226 -~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~e 261 (263)
T d1sm2a_ 226 -LASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE 261 (263)
T ss_dssp -TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -CCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHH
T ss_conf -367999999999765797689199999999999985
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=384.35 Aligned_cols=256 Identities=29% Similarity=0.437 Sum_probs=209.3
Q ss_pred HCCCCCCCCCCCCCCEEEEEEEECCCCEEEEEECCCCCHHCHHHHHHHHHHHHHHCCCCCCEEEEEEECCCEEEEEEEEC
Q ss_conf 23999989303589788999682899389999924103320999999999987401588431685887083228999834
Q 001658 692 TENFSPSNKLGEGGFGPVYKGKLGDGRAIAVKQLSVASRQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLVYEYL 771 (1036)
Q Consensus 692 ~~~~~~~~~iG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~ 771 (1036)
.++|++.+.||+|+||.||+|.+++++.||||+++... ...+.|.+|+.++++++|||||+++|++.+ +..++||||+
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~ 89 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYM 89 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred HHHEEEEEEEECCCCCEEEEEEECCCCEEEEEEECCCC-CCHHHHHHHHHHHHHCCCCCEEEEEEEECC-CCEEEEEEEC
T ss_conf 89938867981079828999999999999999986476-888999999999986799988578731045-9769999957
Q ss_pred CCCCHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCEEECCCCCEEEEECCCCEEECCCCCCC
Q ss_conf 79994456321887775767799999999999999876189650113457885884699844999747411415898742
Q 001658 772 ENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHI 851 (1036)
Q Consensus 772 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 851 (1036)
++|+|.+++.......+++..+++|+.||++||.|||+.+ |+||||||+|||+++++.+||+|||+|+.........
T Consensus 90 ~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~~ 166 (272)
T d1qpca_ 90 ENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTA 166 (272)
T ss_dssp TTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEEC
T ss_pred CCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHEEEECCCCEEECCCCCEEECCCCCCCC
T ss_conf 8982888875147898878899999999999999997489---5467564225156202440423410147735886442
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCC
Q ss_conf 23543356745710002387894246786899999998299999999815677899999987404953112585243679
Q 001658 852 STRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEIELADPKLIEFN 931 (1036)
Q Consensus 852 ~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~ 931 (1036)
.....||+.|+|||++.++.++.++|||||||++|||+||+.|+......... ...+ ..+ ..+....
T Consensus 167 ~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~--~~~i----~~~-----~~~~~p~-- 233 (272)
T d1qpca_ 167 REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEV--IQNL----ERG-----YRMVRPD-- 233 (272)
T ss_dssp CTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH--HHHH----HTT-----CCCCCCT--
T ss_pred CCCCCCCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCHHHH--HHHH----HHC-----CCCCCCC--
T ss_conf 03567744445828983799982456452579999999689888888899999--9999----706-----8888965--
Q ss_pred HHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCC
Q ss_conf 99999999999981044999999989999996405
Q 001658 932 EEEVKRLIGVALLCTQTLPSLRPSMSRVVAMLCGD 966 (1036)
Q Consensus 932 ~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 966 (1036)
.....+.+++.+||+.+|++||||+||+++|+..
T Consensus 234 -~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ 267 (272)
T d1qpca_ 234 -NCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF 267 (272)
T ss_dssp -TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -CCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHH
T ss_conf -5719999999997588976893999999986113
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=380.73 Aligned_cols=260 Identities=27% Similarity=0.434 Sum_probs=209.7
Q ss_pred HCCCCCCCCCCCCCCEEEEEEEECCCCEEEEEECCCC--CHHCHHHHHHHHHHHHHHCCCCCCEEEEEEECCCEEEEEEE
Q ss_conf 2399998930358978899968289938999992410--33209999999999874015884316858870832289998
Q 001658 692 TENFSPSNKLGEGGFGPVYKGKLGDGRAIAVKQLSVA--SRQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLVYE 769 (1036)
Q Consensus 692 ~~~~~~~~~iG~G~fG~Vy~~~~~~g~~vAvK~l~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 769 (1036)
.++|++.+.||+|+||+||+|+++. .||||+++.. +....+.|.+|+.++++++|||||+++|++.+ +..++|||
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~E 83 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQ 83 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESSS--EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred CCCEEEEEEEEECCCCEEEEEEECC--EEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEC-CEEEEEEE
T ss_conf 4518998898307885899999999--89999997346998999999999999984799878645679715-58999996
Q ss_pred ECCCCCHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCEEECCCCCEEEEECCCCEEECCCCC
Q ss_conf 34799944563218877757677999999999999998761896501134578858846998449997474114158987
Q 001658 770 YLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKT 849 (1036)
Q Consensus 770 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~ 849 (1036)
|+++|+|.+++... ...+++..++.|+.|+++||+|||+++ |+||||||+|||++.++.+||+|||+|+.......
T Consensus 84 y~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~ 159 (276)
T d1uwha_ 84 WCEGSSLYHHLHII-ETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSG 159 (276)
T ss_dssp CCCEEEHHHHHHTS-CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSCC------
T ss_pred CCCCCCHHHHHHHC-CCCCCHHHHHHHHHHHHHHHHHHHCCC---EECCCCCHHHEEECCCCCEEECCCCCEEECCCCCC
T ss_conf 58998889998523-578999999999999999988875099---95161478997981899788750022133355677
Q ss_pred -CCCCCCCCCCCCCCCCCCCC---CCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCC
Q ss_conf -42235433567457100023---87894246786899999998299999999815677899999987404953112585
Q 001658 850 -HISTRVAGTIGYLAPEYAMR---GHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEIELADP 925 (1036)
Q Consensus 850 -~~~~~~~gt~~y~APE~~~~---~~~~~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 925 (1036)
.......||+.|||||++.+ ..++.++|||||||++|||+||+.||............ .. . ....+
T Consensus 160 ~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~--~~----~----~~~~p 229 (276)
T d1uwha_ 160 SHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFM--VG----R----GYLSP 229 (276)
T ss_dssp ------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHH--HH----H----TSCCC
T ss_pred CCCCCCCCCCCCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHH--HH----C----CCCCC
T ss_conf 63125665574317999995056899995315163599999999788998998969999999--96----5----88898
Q ss_pred CCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCC
Q ss_conf 2436799999999999998104499999998999999640558
Q 001658 926 KLIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVAMLCGDME 968 (1036)
Q Consensus 926 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 968 (1036)
............+.+++.+||+.+|.+||||.|+++.|+....
T Consensus 230 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~ 272 (276)
T d1uwha_ 230 DLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLAR 272 (276)
T ss_dssp CGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCHHCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHH
T ss_conf 6000365554999999999758897689299999999999997
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=373.80 Aligned_cols=249 Identities=25% Similarity=0.439 Sum_probs=207.9
Q ss_pred CCCCCCCCCCCCCCEEEEEEEE-CCCCEEEEEECCCCCHHCHHHHHHHHHHHHHHCCCCCCEEEEEEECCCEEEEEEEEC
Q ss_conf 3999989303589788999682-899389999924103320999999999987401588431685887083228999834
Q 001658 693 ENFSPSNKLGEGGFGPVYKGKL-GDGRAIAVKQLSVASRQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLVYEYL 771 (1036)
Q Consensus 693 ~~~~~~~~iG~G~fG~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~ 771 (1036)
++|+..+.||+|+||.||+|+. .+|+.||+|++........+.+.+|+.++++++|||||++++++.+.+..++||||+
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 99 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred CCCEEEEEEECCCCCEEEEEEECCCCCEEEEEEEECCCCHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEEEEC
T ss_conf 05388789812858299999998999899999984301727999999999998679998805857798899989999703
Q ss_pred CCCCHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCEEECCCCCEEEEECCCCEEECCCCCCC
Q ss_conf 79994456321887775767799999999999999876189650113457885884699844999747411415898742
Q 001658 772 ENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHI 851 (1036)
Q Consensus 772 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 851 (1036)
++|+|.+++.. ..+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+|+.+..... .
T Consensus 100 ~gg~L~~~~~~---~~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~-~ 172 (293)
T d1yhwa1 100 AGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-K 172 (293)
T ss_dssp TTCBHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC-C
T ss_pred CCCCHHHHHHC---CCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHEEECCCCCEEECCCHHHEEECCCCC-C
T ss_conf 79808988641---59999999999999999999999879---72267768886887899686425156413213666-4
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCC
Q ss_conf 23543356745710002387894246786899999998299999999815677899999987404953112585243679
Q 001658 852 STRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEIELADPKLIEFN 931 (1036)
Q Consensus 852 ~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~ 931 (1036)
.....||+.|+|||++.+..++.++||||+||++|||+||+.||......+...... ... .+.+ ...
T Consensus 173 ~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~------~~~------~~~~-~~~ 239 (293)
T d1yhwa1 173 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIA------TNG------TPEL-QNP 239 (293)
T ss_dssp BCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH------HHC------SCCC-SSG
T ss_pred CCCCCCCCCCCCHHHHCCCCCCCHHCEEHHHHHHHHHHHCCCCCCCCCHHHHHHHHH------HCC------CCCC-CCC
T ss_conf 444444777368266447998801203137299999804889989979999999998------579------9988-885
Q ss_pred HHHHHHHHHHHHHHCCCCCCCCCCHHHHHH
Q ss_conf 999999999999810449999999899999
Q 001658 932 EEEVKRLIGVALLCTQTLPSLRPSMSRVVA 961 (1036)
Q Consensus 932 ~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 961 (1036)
......+.+++.+||+.||.+|||+.|+++
T Consensus 240 ~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 240 EKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp GGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred CCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf 537999999999986699668909999964
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=376.66 Aligned_cols=259 Identities=28% Similarity=0.434 Sum_probs=212.9
Q ss_pred CCCCCCCCCCCCCCEEEEEEEECCCCEEEEEECCCCCHHCHHHHHHHHHHHHHHCCCCCCEEEEEEECCCEEEEEEEECC
Q ss_conf 39999893035897889996828993899999241033209999999999874015884316858870832289998347
Q 001658 693 ENFSPSNKLGEGGFGPVYKGKLGDGRAIAVKQLSVASRQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLVYEYLE 772 (1036)
Q Consensus 693 ~~~~~~~~iG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~ 772 (1036)
++|++.+.||+|+||.||+|+..+++.||||+++.. ....+.|.+|+.++++++|+|||+++|+|.+ +..++||||++
T Consensus 17 ~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~~ 94 (285)
T d1fmka3 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMS 94 (285)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCT
T ss_pred HHEEEEEEEEECCCEEEEEEEECCCCEEEEEEECCC-CCCHHHHHHHHHHHHHCCCCCEEEEEEEEEC-CCEEEEEEECC
T ss_conf 997984699307980999999999999999998804-4888999999999986666788689999823-97599999447
Q ss_pred CCCHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCEEECCCCCEEEEECCCCEEECCCCCCCC
Q ss_conf 99944563218877757677999999999999998761896501134578858846998449997474114158987422
Q 001658 773 NKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHIS 852 (1036)
Q Consensus 773 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 852 (1036)
+|+|.+++.......++|..++.|+.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++..........
T Consensus 95 ~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 171 (285)
T d1fmka3 95 KGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTAR 171 (285)
T ss_dssp TCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC----------
T ss_pred CCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHHHH---EECCCCCCEEEEECCCCCEEECCCCHHHHCCCCCCEEE
T ss_conf 994354200003553059999999999999999875411---43353123079998999299844255542568873352
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCC-HHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCC
Q ss_conf 35433567457100023878942467868999999982999999998-15677899999987404953112585243679
Q 001658 853 TRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRPNSDPSL-DEEKLYLLEWAWHLHENNQEIELADPKLIEFN 931 (1036)
Q Consensus 853 ~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvil~elltG~~p~~~~~-~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~ 931 (1036)
....||+.|+|||++..+.++.++||||||+++|||++|+.|+.... ..+....+. .+ ..+.. .
T Consensus 172 ~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~-------~~-----~~~~~---~ 236 (285)
T d1fmka3 172 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE-------RG-----YRMPC---P 236 (285)
T ss_dssp ----CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH-------TT-----CCCCC---C
T ss_pred CCCCCCCCCCCHHHHHCCCCCCHHHHHCCHHHHHHHHHCCCCCCCCCCHHHHHHHHH-------HC-----CCCCC---C
T ss_conf 454556654580898379989177413235899999868999998888999999998-------26-----89999---8
Q ss_pred HHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCCCCC
Q ss_conf 9999999999998104499999998999999640558876
Q 001658 932 EEEVKRLIGVALLCTQTLPSLRPSMSRVVAMLCGDMEVST 971 (1036)
Q Consensus 932 ~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~~ 971 (1036)
......+.+++.+||+.+|++||+|.+|+++|+.......
T Consensus 237 ~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~ 276 (285)
T d1fmka3 237 PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE 276 (285)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSC
T ss_pred CCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHCCCC
T ss_conf 3237999999999756697589199999998766623899
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=370.59 Aligned_cols=253 Identities=25% Similarity=0.413 Sum_probs=213.7
Q ss_pred CCCCCCCCCCCCCCEEEEEEEECCCCEEEEEECCCCCHHCHHHHHHHHHHHHHHCCCCCCEEEEEEECCCEEEEEEEECC
Q ss_conf 39999893035897889996828993899999241033209999999999874015884316858870832289998347
Q 001658 693 ENFSPSNKLGEGGFGPVYKGKLGDGRAIAVKQLSVASRQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLVYEYLE 772 (1036)
Q Consensus 693 ~~~~~~~~iG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~ 772 (1036)
++|+..++||+|+||.||+|+.++++.||||+++... ...++|.+|+.++++++||||++++|+|.+.+..++|+||++
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~-~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~ 82 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA 82 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSS-SCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred HHCEEEEEEECCCCEEEEEEEECCCCEEEEEEECCCC-CCHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCEEEEEECCC
T ss_conf 9979968982078839999998899899999987475-778999999999996689860158899850781699997048
Q ss_pred CCCHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCEEECCCCCEEEEECCCCEEECCCCCCCC
Q ss_conf 99944563218877757677999999999999998761896501134578858846998449997474114158987422
Q 001658 773 NKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHIS 852 (1036)
Q Consensus 773 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 852 (1036)
+|+|.+++... ...+++..+.+|+.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++.+........
T Consensus 83 ~g~l~~~~~~~-~~~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~ 158 (258)
T d1k2pa_ 83 NGCLLNYLREM-RHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSS 158 (258)
T ss_dssp TEEHHHHHHSG-GGCCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCCC
T ss_pred CCCHHHHHHCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCEEEEECCCCCEEECCCHHHEECCCCCCEEE
T ss_conf 99388864102-467768999999999999999875468---43466541358876998479886144202357872252
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHH-CCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCC
Q ss_conf 35433567457100023878942467868999999982-99999999815677899999987404953112585243679
Q 001658 853 TRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVS-GRPNSDPSLDEEKLYLLEWAWHLHENNQEIELADPKLIEFN 931 (1036)
Q Consensus 853 ~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~ 931 (1036)
....||+.|+|||++....++.++||||||+++|||+| |+.||......+....+. .+. ....|
T Consensus 159 ~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~-------~~~--~~~~p------ 223 (258)
T d1k2pa_ 159 VGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIA-------QGL--RLYRP------ 223 (258)
T ss_dssp CCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHH-------TTC--CCCCC------
T ss_pred CCCCCCCCCCCCHHHCCCCCCCCEEECCCCHHHHHHHHCCCCCCCCCCHHHHHHHHH-------HCC--CCCCC------
T ss_conf 465788775780786379988521033643246739755999988999999999998-------079--78996------
Q ss_pred HHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHC
Q ss_conf 9999999999998104499999998999999640
Q 001658 932 EEEVKRLIGVALLCTQTLPSLRPSMSRVVAMLCG 965 (1036)
Q Consensus 932 ~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~ 965 (1036)
......+.+++.+||+.+|.+|||+.|+++.|..
T Consensus 224 ~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 224 HLASEKVYTIMYSCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred CCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHC
T ss_conf 5465999999999766897689399999987418
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=373.49 Aligned_cols=257 Identities=26% Similarity=0.369 Sum_probs=207.7
Q ss_pred HCCCCCCCCCCCCCCEEEEEEEECC-C-----CEEEEEECCCC-CHHCHHHHHHHHHHHHHH-CCCCCCEEEEEEECCCE
Q ss_conf 2399998930358978899968289-9-----38999992410-332099999999998740-15884316858870832
Q 001658 692 TENFSPSNKLGEGGFGPVYKGKLGD-G-----RAIAVKQLSVA-SRQGKSQFVAEIATISAV-QHRNLVKLHGCCIEGAE 763 (1036)
Q Consensus 692 ~~~~~~~~~iG~G~fG~Vy~~~~~~-g-----~~vAvK~l~~~-~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~ 763 (1036)
.++|++.+.||+|+||+||+|+... + ..||+|.+... .......+.+|+.++.++ +|||||++++++.+.+.
T Consensus 36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~ 115 (325)
T d1rjba_ 36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP 115 (325)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHEEEEEEEEECCCEEEEEEEECCCCCCCCEEEEEEEEECCCCCHHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCE
T ss_conf 89939701983078819999998578855420499999966335878999999999999971589968687788862995
Q ss_pred EEEEEEECCCCCHHHHHHCCCC---------------------CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCC
Q ss_conf 2899983479994456321887---------------------7757677999999999999998761896501134578
Q 001658 764 RLLVYEYLENKSLDQALFGQRS---------------------LTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKA 822 (1036)
Q Consensus 764 ~~lV~E~~~~gsL~~~l~~~~~---------------------~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp 822 (1036)
.++||||+++|+|.++++..+. ..+++..++.|+.|+++||+|||+++ |+||||||
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiHRDlKp 192 (325)
T d1rjba_ 116 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAA 192 (325)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCSG
T ss_pred EEEEEECCCCCCHHHHHHHCCCCCCCHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCCCH
T ss_conf 899997279995999998625777510221000012220012577899999999999999999997399---05052703
Q ss_pred CCEEECCCCCEEEEECCCCEEECCCCCC-CCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHH-CCCCCCCCCH
Q ss_conf 8588469984499974741141589874-2235433567457100023878942467868999999982-9999999981
Q 001658 823 SNVLLDADLVPKISDFGLAKLYDDKKTH-ISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVS-GRPNSDPSLD 900 (1036)
Q Consensus 823 ~NILl~~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvil~ellt-G~~p~~~~~~ 900 (1036)
+|||++.++.+||+|||+|+........ ......||+.|||||++.++.++.++|||||||++|||+| |++||.....
T Consensus 193 ~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~ 272 (325)
T d1rjba_ 193 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV 272 (325)
T ss_dssp GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred HCCCCCCCCEEEEEECCCCCCCCCCCCEEEECCCCCCCCCCCHHHHCCCCCCCCEECCCHHHHHHHHHHCCCCCCCCCCH
T ss_conf 21443459828985142222045778615623435787657838872799996330300039999998389999999898
Q ss_pred HHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHC
Q ss_conf 56778999999874049531125852436799999999999998104499999998999999640
Q 001658 901 EEKLYLLEWAWHLHENNQEIELADPKLIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVAMLCG 965 (1036)
Q Consensus 901 ~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~ 965 (1036)
....... ...+ ..+.. +......+.+++.+||+.+|++|||++||+++|..
T Consensus 273 ~~~~~~~------~~~~-----~~~~~---p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~ 323 (325)
T d1rjba_ 273 DANFYKL------IQNG-----FKMDQ---PFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGC 323 (325)
T ss_dssp SHHHHHH------HHTT-----CCCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHHHHH------HHCC-----CCCCC---CCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHC
T ss_conf 9999999------8569-----98998---87678999999999758896689399999999748
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=369.73 Aligned_cols=255 Identities=24% Similarity=0.353 Sum_probs=205.5
Q ss_pred CCCCCCC-CCCCCCCEEEEEEEEC---CCCEEEEEECCCC-CHHCHHHHHHHHHHHHHHCCCCCCEEEEEEECCCEEEEE
Q ss_conf 3999989-3035897889996828---9938999992410-332099999999998740158843168588708322899
Q 001658 693 ENFSPSN-KLGEGGFGPVYKGKLG---DGRAIAVKQLSVA-SRQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLV 767 (1036)
Q Consensus 693 ~~~~~~~-~iG~G~fG~Vy~~~~~---~g~~vAvK~l~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV 767 (1036)
++|.+.+ +||+|+||.||+|... ++..||||+++.. .....+.|.+|++++++++|||||+++|+|.. +..++|
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv 86 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV 86 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred CCEEECCCEEECCCCEEEEEEEEECCCCCEEEEEEEECHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECC-CEEEEE
T ss_conf 4718878487306080999999960897689999998820397899999999999986799888068656036-807999
Q ss_pred EEECCCCCHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCEEECCCCCEEEEECCCCEEECCC
Q ss_conf 98347999445632188777576779999999999999987618965011345788588469984499974741141589
Q 001658 768 YEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDK 847 (1036)
Q Consensus 768 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~ 847 (1036)
|||+++|+|.+++... ...+++..+..|+.|+++||+|||+++ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 87 mE~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~ 162 (285)
T d1u59a_ 87 MEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGAD 162 (285)
T ss_dssp EECCTTEEHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTTC
T ss_pred EEECCCCCHHHHHHCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEECCCCCEEECCCHHHHCCCCC
T ss_conf 9807899689975212-569999999999999999878998688---105767646604546885420331342115543
Q ss_pred CCCC--CCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHH-CCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCC
Q ss_conf 8742--235433567457100023878942467868999999982-9999999981567789999998740495311258
Q 001658 848 KTHI--STRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVS-GRPNSDPSLDEEKLYLLEWAWHLHENNQEIELAD 924 (1036)
Q Consensus 848 ~~~~--~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 924 (1036)
.... .....||+.|+|||++..+.++.++|||||||++|||+| |+.||......+....+. .+. .
T Consensus 163 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~-------~~~-----~ 230 (285)
T d1u59a_ 163 DSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE-------QGK-----R 230 (285)
T ss_dssp SCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHH-------TTC-----C
T ss_pred CCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCHHHCCHHHHHHHHHCCCCCCCCCCHHHHHHHHH-------CCC-----C
T ss_conf 4321135621137433586887279999541232201789999938999999979999999998-------189-----9
Q ss_pred CCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCC
Q ss_conf 5243679999999999999810449999999899999964055
Q 001658 925 PKLIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVAMLCGDM 967 (1036)
Q Consensus 925 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~ 967 (1036)
+.. +...+..+.+++.+||+.+|++||+|.+|++.|+...
T Consensus 231 ~~~---p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~ 270 (285)
T d1u59a_ 231 MEC---PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACY 270 (285)
T ss_dssp CCC---CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCC---CCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHH
T ss_conf 999---9767899999999975779768909999999999999
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=370.24 Aligned_cols=259 Identities=24% Similarity=0.414 Sum_probs=207.7
Q ss_pred CCCCCCCCCCCCCCEEEEEEEECCC-----CEEEEEECCCC-CHHCHHHHHHHHHHHHHHCCCCCCEEEEEEECCCEEEE
Q ss_conf 3999989303589788999682899-----38999992410-33209999999999874015884316858870832289
Q 001658 693 ENFSPSNKLGEGGFGPVYKGKLGDG-----RAIAVKQLSVA-SRQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLL 766 (1036)
Q Consensus 693 ~~~~~~~~iG~G~fG~Vy~~~~~~g-----~~vAvK~l~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l 766 (1036)
..|+..++||+|+||.||+|.+... ..||||++... ......+|.+|+.++++++|||||+++|++.+.+..++
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~ 86 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 86 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHEEEEEEEEECCCEEEEEEEEECCCCEEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCEEE
T ss_conf 99686159811779099999996899878799999998844596899999999999985689878323677833880389
Q ss_pred EEEECCCCCHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCEEECCCCCEEEEECCCCEEECC
Q ss_conf 99834799944563218877757677999999999999998761896501134578858846998449997474114158
Q 001658 767 VYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDD 846 (1036)
Q Consensus 767 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~ 846 (1036)
|+||+.+|++.+++... ...++|..++.|+.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+..
T Consensus 87 v~e~~~~~~l~~~~~~~-~~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~ 162 (283)
T d1mqba_ 87 ITEYMENGALDKFLREK-DGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLED 162 (283)
T ss_dssp EEECCTTEEHHHHHHHT-TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred EEEECCCCCCHHHHHCC-CCCCCHHHHHHHHHHHHHHHHHCCCCC---CCCCCCCCCEEEECCCCEEEECCCCHHHCCCC
T ss_conf 99721357402221023-454208999999999998541212123---42576564427888998499845510300357
Q ss_pred CCCC--CCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCC
Q ss_conf 9874--22354335674571000238789424678689999999829999999981567789999998740495311258
Q 001658 847 KKTH--ISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEIELAD 924 (1036)
Q Consensus 847 ~~~~--~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 924 (1036)
.... ......||+.|+|||++.++.++.++|||||||++|||++++.|+......... ...+ ..+ ..
T Consensus 163 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~--~~~i----~~~-----~~ 231 (283)
T d1mqba_ 163 DPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEV--MKAI----NDG-----FR 231 (283)
T ss_dssp -----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH--HHHH----HTT-----CC
T ss_pred CCCCCEEECCCCCCCCCCCHHHHCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHHHH--HHHH----HCC-----CC
T ss_conf 876526742677773434888870499997355634489899999679886556899999--9998----635-----78
Q ss_pred CCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCCC
Q ss_conf 524367999999999999981044999999989999996405588
Q 001658 925 PKLIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVAMLCGDMEV 969 (1036)
Q Consensus 925 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~ 969 (1036)
+. .+.+.+..+.+++.+||+.+|++||+|.||+++|++.+..
T Consensus 232 ~~---~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~ 273 (283)
T d1mqba_ 232 LP---TPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 273 (283)
T ss_dssp CC---CCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred CC---CCHHHHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHC
T ss_conf 99---8504579999999997767976893999999999998669
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=370.23 Aligned_cols=265 Identities=29% Similarity=0.416 Sum_probs=214.4
Q ss_pred HHHHHHHCCCCCCCCCCCCCCEEEEEEEEC------CCCEEEEEECCCC-CHHCHHHHHHHHHHHHHHCCCCCCEEEEEE
Q ss_conf 999987239999893035897889996828------9938999992410-332099999999998740158843168588
Q 001658 686 AELKTATENFSPSNKLGEGGFGPVYKGKLG------DGRAIAVKQLSVA-SRQGKSQFVAEIATISAVQHRNLVKLHGCC 758 (1036)
Q Consensus 686 ~~l~~~~~~~~~~~~iG~G~fG~Vy~~~~~------~g~~vAvK~l~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~ 758 (1036)
.+++...++|++.+.||+|+||+||+|+.. +++.||||+++.. .....++|.+|+.++++++||||++++++|
T Consensus 6 ~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~ 85 (301)
T d1lufa_ 6 LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVC 85 (301)
T ss_dssp HHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred HHCCCCHHHCEEEEEEEECCCEEEEEEEECCCCCCCCCEEEEEEEECHHCCHHHHHHHHHHHHHHHHCCCCCCCCCEEEE
T ss_conf 31138988938867982078839999998887657788299999988210857999999999999966899765524666
Q ss_pred ECCCEEEEEEEECCCCCHHHHHHCCC----------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCC
Q ss_conf 70832289998347999445632188----------------------77757677999999999999998761896501
Q 001658 759 IEGAERLLVYEYLENKSLDQALFGQR----------------------SLTLDWATRYEICSGVARGLAYLHEESRVRII 816 (1036)
Q Consensus 759 ~~~~~~~lV~E~~~~gsL~~~l~~~~----------------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iv 816 (1036)
...+..++|+||+++|+|.+++.... ...+++..++.|+.|++.||+|||+.+ |+
T Consensus 86 ~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---iv 162 (301)
T d1lufa_ 86 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FV 162 (301)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CC
T ss_pred CCCCCEEEEEEECCCCCHHHHHHHCCCCCCCCCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCC---EE
T ss_conf 059803899981589929999985275542100001110012103467889899999999999999855413578---68
Q ss_pred CCCCCCCCEEECCCCCEEEEECCCCEEECCCCC-CCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHCC-CC
Q ss_conf 134578858846998449997474114158987-4223543356745710002387894246786899999998299-99
Q 001658 817 HRDVKASNVLLDADLVPKISDFGLAKLYDDKKT-HISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGR-PN 894 (1036)
Q Consensus 817 H~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvil~elltG~-~p 894 (1036)
||||||+|||++.++.+||+|||+++....... .......|++.|+|||++.+..++.++|||||||++|||++|. +|
T Consensus 163 HrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p 242 (301)
T d1lufa_ 163 HRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP 242 (301)
T ss_dssp CSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred EEEECCCCEEECCCCCEEECCCHHHEECCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCHHHHHCCCHHHHHHHHCCCCCC
T ss_conf 54884011689899928983314421136776411157777676767989972688980563025236299998068999
Q ss_pred CCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCC
Q ss_conf 99998156778999999874049531125852436799999999999998104499999998999999640558
Q 001658 895 SDPSLDEEKLYLLEWAWHLHENNQEIELADPKLIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVAMLCGDME 968 (1036)
Q Consensus 895 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 968 (1036)
|......+....+. .+.. +. .+...+.++.+++..||+.+|++||||.||+++|+++.+
T Consensus 243 ~~~~~~~e~~~~v~-------~~~~-----~~---~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~~ 301 (301)
T d1lufa_ 243 YYGMAHEEVIYYVR-------DGNI-----LA---CPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE 301 (301)
T ss_dssp TTTSCHHHHHHHHH-------TTCC-----CC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred CCCCCHHHHHHHHH-------CCCC-----CC---CCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHCC
T ss_conf 99989999999997-------3997-----88---873252999999999748896579399999999998429
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=371.72 Aligned_cols=252 Identities=25% Similarity=0.358 Sum_probs=203.6
Q ss_pred HCCCCCCCCCCCCCCEEEEEEEEC-CCCEEEEEECCCCC-HHCHHHHHHHHHHHHHHCCCCCCEEEEEEECCCEEEEEEE
Q ss_conf 239999893035897889996828-99389999924103-3209999999999874015884316858870832289998
Q 001658 692 TENFSPSNKLGEGGFGPVYKGKLG-DGRAIAVKQLSVAS-RQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLVYE 769 (1036)
Q Consensus 692 ~~~~~~~~~iG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 769 (1036)
.++|++.+.||+|+||+||+|+.. +++.||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE 83 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 83 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCEEEEEEE
T ss_conf 74608998972174809999999999979999998456641279999999999985799888469654046743679886
Q ss_pred ECCCCCHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCEEECCCCCEEEEECCCCEEECCCC-
Q ss_conf 3479994456321887775767799999999999999876189650113457885884699844999747411415898-
Q 001658 770 YLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKK- 848 (1036)
Q Consensus 770 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~- 848 (1036)
|+++|+|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+|+......
T Consensus 84 y~~gg~L~~~l~~--~~~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~ 158 (271)
T d1nvra_ 84 YCSGGELFDRIEP--DIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 158 (271)
T ss_dssp CCTTEEGGGGSBT--TTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred CCCCCCHHHHHHC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHEEECCCCCEEECCCHHHEEECCCCC
T ss_conf 4589808999753--799999999999999999999999759---83575468997887899879832314224046886
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCC-CCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCC
Q ss_conf 742235433567457100023878-9424678689999999829999999981567789999998740495311258524
Q 001658 849 THISTRVAGTIGYLAPEYAMRGHL-TEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEIELADPKL 927 (1036)
Q Consensus 849 ~~~~~~~~gt~~y~APE~~~~~~~-~~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~ 927 (1036)
.......+||+.|||||++.+..+ +.++||||+||++|||+||++||............ +. .... ..
T Consensus 159 ~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~-~~-----~~~~---~~--- 226 (271)
T d1nvra_ 159 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSD-WK-----EKKT---YL--- 226 (271)
T ss_dssp ECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHH-HH-----TTCT---TS---
T ss_pred CCCCCCEEECCCCCCHHHHCCCCCCCCCEEEEHHHHHHHHHHHCCCCCCCCCHHHHHHHH-HH-----CCCC---CC---
T ss_conf 531113255747428728618999997101617379999998299788889859999999-86-----3888---78---
Q ss_pred CCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHH
Q ss_conf 3679999999999999810449999999899999
Q 001658 928 IEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVA 961 (1036)
Q Consensus 928 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 961 (1036)
.........+.+++.+|++.||.+|||++|+++
T Consensus 227 -~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 227 -NPWKKIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp -TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred -CCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf -864469999999999976799668909999961
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=372.07 Aligned_cols=261 Identities=23% Similarity=0.330 Sum_probs=205.3
Q ss_pred HHCCCCCCCCCCCCCCEEEEEEEE-CCCCEEEEEECCCC-CHHCHHHHHHHHHHHHHHCCCCCCEEEEEEECCCEEEEEE
Q ss_conf 723999989303589788999682-89938999992410-3320999999999987401588431685887083228999
Q 001658 691 ATENFSPSNKLGEGGFGPVYKGKL-GDGRAIAVKQLSVA-SRQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLVY 768 (1036)
Q Consensus 691 ~~~~~~~~~~iG~G~fG~Vy~~~~-~~g~~vAvK~l~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 768 (1036)
..++|++.+.||+|+||+||+|+. .+|+.||+|+++.. .......+.+|+.++++++|||||++++++.+.+..++||
T Consensus 4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVm 83 (322)
T d1s9ja_ 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 83 (322)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCCCCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEEE
T ss_conf 75688897897127780999999989996999999875409789999999999998679999994999999899999999
Q ss_pred EECCCCCHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHC-CCCCCCCCCCCCCCEEECCCCCEEEEECCCCEEECCC
Q ss_conf 834799944563218877757677999999999999998761-8965011345788588469984499974741141589
Q 001658 769 EYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEE-SRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDK 847 (1036)
Q Consensus 769 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~ 847 (1036)
||+++|+|.+++... ..+++..+..++.|++.||.|||+. + |+||||||+|||++.++.+||+|||+|+.+.+.
T Consensus 84 Ey~~gg~L~~~l~~~--~~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~ 158 (322)
T d1s9ja_ 84 EHMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 158 (322)
T ss_dssp ECCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH
T ss_pred ECCCCCCHHHHHHHC--CCCCHHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEECCCCCEEEEECCCCCCCCCC
T ss_conf 767998689987424--999999999999999999999998599---971445779946878998999548776256788
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHH-HHHHHHC--------CC
Q ss_conf 87422354335674571000238789424678689999999829999999981567789999-9987404--------95
Q 001658 848 KTHISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEW-AWHLHEN--------NQ 918 (1036)
Q Consensus 848 ~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~-~~~~~~~--------~~ 918 (1036)
. ....+||+.|+|||++.+..++.++||||+||++|||++|+.||.............. ....... ..
T Consensus 159 ~---~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (322)
T d1s9ja_ 159 M---ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGR 235 (322)
T ss_dssp T---C---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC--------------------
T ss_pred C---CCCCCCCCCCCCCHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCCC
T ss_conf 6---2111377141194687589989488899899999999988899899887899999988751775457742123332
Q ss_pred CC--C-------------------CCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHH
Q ss_conf 31--1-------------------2585243679999999999999810449999999899999
Q 001658 919 EI--E-------------------LADPKLIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVA 961 (1036)
Q Consensus 919 ~~--~-------------------~~d~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 961 (1036)
.. . ...+.+. .......+.+++.+|++.||.+|||++|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~ 297 (322)
T d1s9ja_ 236 PLSSYGMDSRPPMAIFELLDYIVNEPPPKLP--SGVFSLEFQDFVNKCLIKNPAERADLKQLMV 297 (322)
T ss_dssp ----------CCCCHHHHHHHHHTSCCCCCC--BTTBCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCCCCCCCCCCCHHHHHHHHHHHCCCCCCCC--CCCCCHHHHHHHHHHCCCCHHHCCCHHHHHH
T ss_conf 2111122235413477887665026876676--4448999999999986899467908999960
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=0 Score=367.25 Aligned_cols=254 Identities=23% Similarity=0.325 Sum_probs=209.2
Q ss_pred HHCCCCCCCCCCCCCCEEEEEEEE-CCCCEEEEEECCCCCHHCHHHHHHHHHHHHHHCCCCCCEEEEEEECCCEEEEEEE
Q ss_conf 723999989303589788999682-8993899999241033209999999999874015884316858870832289998
Q 001658 691 ATENFSPSNKLGEGGFGPVYKGKL-GDGRAIAVKQLSVASRQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLVYE 769 (1036)
Q Consensus 691 ~~~~~~~~~~iG~G~fG~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 769 (1036)
..++|++.+.||+|+||.||+|+. .+|+.||||++........+.+.+|+.++++++|||||++++++.+.+..++|||
T Consensus 24 il~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE 103 (350)
T d1koaa2 24 VLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYE 103 (350)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEEC
T ss_pred CCCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEEEE
T ss_conf 86575898898407681999999889998999999845243169999999999986799799929999998999999998
Q ss_pred ECCCCCHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCEEECC--CCCEEEEECCCCEEECCC
Q ss_conf 347999445632188777576779999999999999987618965011345788588469--984499974741141589
Q 001658 770 YLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDA--DLVPKISDFGLAKLYDDK 847 (1036)
Q Consensus 770 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NILl~~--~~~~kl~DFGla~~~~~~ 847 (1036)
|+++|+|.+++... ...+++..+..|+.||+.||+|||+.+ |+||||||+|||++. ++.+||+|||+++.+...
T Consensus 104 ~~~gg~L~~~l~~~-~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~ 179 (350)
T d1koaa2 104 FMSGGELFEKVADE-HNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK 179 (350)
T ss_dssp CCCSCBHHHHHTCT-TSCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT
T ss_pred CCCCCCHHHHHHHH-CCCCCHHHHHHHHHHHHHHHHHHHHCC---CEEEEECHHHEEECCCCCCEEEEEECCHHEECCCC
T ss_conf 57998899999762-378999999999999999999997569---76000154673641688986999545210442565
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCC
Q ss_conf 87422354335674571000238789424678689999999829999999981567789999998740495311258524
Q 001658 848 KTHISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEIELADPKL 927 (1036)
Q Consensus 848 ~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~ 927 (1036)
.. .....||+.|||||++.+..++.++||||+||++|||++|+.||......+....+. .... ......
T Consensus 180 ~~--~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~------~~~~---~~~~~~ 248 (350)
T d1koaa2 180 QS--VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVK------SCDW---NMDDSA 248 (350)
T ss_dssp SC--EEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH------HTCC---CSCCGG
T ss_pred CC--CCEECCCCCCCCHHHHCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHH------HCCC---CCCCCC
T ss_conf 43--200068624218899758998726765546599999985989989979999999998------4788---989422
Q ss_pred CCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH
Q ss_conf 36799999999999998104499999998999999
Q 001658 928 IEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVAM 962 (1036)
Q Consensus 928 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 962 (1036)
. ......+.+++.+|++.||.+|||++|+++.
T Consensus 249 ~---~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 249 F---SGISEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp G---GGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred C---CCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 3---5899999999999756896679089998629
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=371.96 Aligned_cols=251 Identities=23% Similarity=0.346 Sum_probs=205.1
Q ss_pred CCCCCCCCCCCCCCEEEEEEEEC-CCCEEEEEECCCCCHHCHHHHHHHHHHHHHHCCCCCCEEEEEEECCCEEEEEEEEC
Q ss_conf 39999893035897889996828-99389999924103320999999999987401588431685887083228999834
Q 001658 693 ENFSPSNKLGEGGFGPVYKGKLG-DGRAIAVKQLSVASRQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLVYEYL 771 (1036)
Q Consensus 693 ~~~~~~~~iG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~ 771 (1036)
+.|++.+.||+|+||.||+|+.. +++.||+|++........+.+.+|++++++++|||||++++++.+.+..++||||+
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred CCEEEEEEEEECCCCEEEEEEECCCCEEEEEEEECCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEEECC
T ss_conf 37598479930778199999999999399999987289999999999999998679999884988980099589999627
Q ss_pred CCCCHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCEEECCCCCEEEEECCCCEEECCCCCCC
Q ss_conf 79994456321887775767799999999999999876189650113457885884699844999747411415898742
Q 001658 772 ENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHI 851 (1036)
Q Consensus 772 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 851 (1036)
++|+|.+++... ...+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+|+....... .
T Consensus 92 ~~g~L~~~~~~~-~~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~-~ 166 (288)
T d2jfla1 92 AGGAVDAVMLEL-ERPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ-R 166 (288)
T ss_dssp TTEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECHHHHH-H
T ss_pred CCCCHHHHHHHC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---EEEEECCHHHEEECCCCCEEEEECHHHHCCCCCCC-C
T ss_conf 998188999862-899999999999999999999999889---88714070031487899989971612303577864-1
Q ss_pred CCCCCCCCCCCCCCCCC-----CCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCC
Q ss_conf 23543356745710002-----3878942467868999999982999999998156778999999874049531125852
Q 001658 852 STRVAGTIGYLAPEYAM-----RGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEIELADPK 926 (1036)
Q Consensus 852 ~~~~~gt~~y~APE~~~-----~~~~~~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 926 (1036)
.....||+.|+|||++. ...++.++||||+||++|||+||+.||......+....+. .. . .+.
T Consensus 167 ~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~------~~-~-----~~~ 234 (288)
T d2jfla1 167 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIA------KS-E-----PPT 234 (288)
T ss_dssp HTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHH------HS-C-----CCC
T ss_pred CCCCCCCCCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHH------CC-C-----CCC
T ss_conf 00102562647999983202578888806657878999999820889999989999999997------07-9-----987
Q ss_pred CCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHH
Q ss_conf 43679999999999999810449999999899999
Q 001658 927 LIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVA 961 (1036)
Q Consensus 927 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 961 (1036)
+ ..+......+.+++.+||+.||.+|||+.|+++
T Consensus 235 ~-~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 235 L-AQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp C-SSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred C-CCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf 7-765669999999999976699668919999962
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=370.69 Aligned_cols=254 Identities=23% Similarity=0.348 Sum_probs=205.8
Q ss_pred HCCCCCCCCCCCCCCEEEEEEEE-CCCCEEEEEECCCC--CHHCHHHHHHHHHHHHHHCCCCCCEEEEEEEC--CCEEEE
Q ss_conf 23999989303589788999682-89938999992410--33209999999999874015884316858870--832289
Q 001658 692 TENFSPSNKLGEGGFGPVYKGKL-GDGRAIAVKQLSVA--SRQGKSQFVAEIATISAVQHRNLVKLHGCCIE--GAERLL 766 (1036)
Q Consensus 692 ~~~~~~~~~iG~G~fG~Vy~~~~-~~g~~vAvK~l~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~--~~~~~l 766 (1036)
.++|++.+.||+|+||.||+|+. .+|+.||+|++... .+...+.+.+|++++++++|||||++++++.+ ....++
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~i 82 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 82 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEE
T ss_pred CHHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEEE
T ss_conf 33379967983088919999999999979999998746579799999999999999778999824899999178998999
Q ss_pred EEEECCCCCHHHHHHCC--CCCCCCHHHHHHHHHHHHHHHHHHHHCCC--CCCCCCCCCCCCEEECCCCCEEEEECCCCE
Q ss_conf 99834799944563218--87775767799999999999999876189--650113457885884699844999747411
Q 001658 767 VYEYLENKSLDQALFGQ--RSLTLDWATRYEICSGVARGLAYLHEESR--VRIIHRDVKASNVLLDADLVPKISDFGLAK 842 (1036)
Q Consensus 767 V~E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~~L~yLH~~~~--~~ivH~Dikp~NILl~~~~~~kl~DFGla~ 842 (1036)
||||+++|+|.+++... ....+++..++.++.|++.||+|||+.+. .+|+||||||+|||++.++.+||+|||+++
T Consensus 83 vmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~ 162 (269)
T d2java1 83 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 162 (269)
T ss_dssp EEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHH
T ss_pred EEECCCCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCHHHCCCCCCCCEEEEECCCEE
T ss_conf 99568999389999851545789999999999999999999999716778878858676542574788857980010003
Q ss_pred EECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCC
Q ss_conf 41589874223543356745710002387894246786899999998299999999815677899999987404953112
Q 001658 843 LYDDKKTHISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEIEL 922 (1036)
Q Consensus 843 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 922 (1036)
.+..... ......||+.|+|||++.+..++.++|||||||++|||+||+.||......+....+. .+..
T Consensus 163 ~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~-------~~~~--- 231 (269)
T d2java1 163 ILNHDTS-FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIR-------EGKF--- 231 (269)
T ss_dssp HC------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH-------HTCC---
T ss_pred ECCCCCC-CCCCCCCCCCCCCHHHHCCCCCCHHHHHHHHCHHHHHHHHCCCCCCCCCHHHHHHHHH-------CCCC---
T ss_conf 2245777-5566778823279999839999938988752789999801889989989999999997-------1899---
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHH
Q ss_conf 585243679999999999999810449999999899999
Q 001658 923 ADPKLIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVA 961 (1036)
Q Consensus 923 ~d~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 961 (1036)
+.+ +......+.+++.+||+.||.+|||++|+++
T Consensus 232 --~~~---~~~~s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 232 --RRI---PYRYSDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp --CCC---CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred --CCC---CCCCCHHHHHHHHHHCCCCHHHCCCHHHHHH
T ss_conf --889---7435999999999976799557918999972
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=366.18 Aligned_cols=247 Identities=28% Similarity=0.365 Sum_probs=201.0
Q ss_pred CCCCCCCCEEEEEEEEC---CCCEEEEEECCCC--CHHCHHHHHHHHHHHHHHCCCCCCEEEEEEECCCEEEEEEEECCC
Q ss_conf 93035897889996828---9938999992410--332099999999998740158843168588708322899983479
Q 001658 699 NKLGEGGFGPVYKGKLG---DGRAIAVKQLSVA--SRQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLVYEYLEN 773 (1036)
Q Consensus 699 ~~iG~G~fG~Vy~~~~~---~g~~vAvK~l~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~ 773 (1036)
++||+|+||.||+|.+. .++.||||+++.. +....+.|.+|+.++++++|||||+++|+|.. +..++||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCCCCCCCEEEEEEEECCCCCCEEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEECC-CCEEEEEECCCC
T ss_conf 7834587829999998169738599999988010898999999999999986799898527777505-977999974788
Q ss_pred CCHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCEEECCCCCEEEEECCCCEEECCCCCCC--
Q ss_conf 994456321887775767799999999999999876189650113457885884699844999747411415898742--
Q 001658 774 KSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHI-- 851 (1036)
Q Consensus 774 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~-- 851 (1036)
|+|.+++.. ...+++..++.|+.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++.+.......
T Consensus 92 g~L~~~l~~--~~~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~ 166 (277)
T d1xbba_ 92 GPLNKYLQQ--NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKA 166 (277)
T ss_dssp EEHHHHHHH--CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC
T ss_pred CCHHHHHHH--CCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCHHHCCCCCCCCCCCCHHHHHHCCCCCCCCCC
T ss_conf 968999752--257899999999999999976687479---556777611310235675123413453313432344322
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHH-CCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCC
Q ss_conf 235433567457100023878942467868999999982-9999999981567789999998740495311258524367
Q 001658 852 STRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVS-GRPNSDPSLDEEKLYLLEWAWHLHENNQEIELADPKLIEF 930 (1036)
Q Consensus 852 ~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~ 930 (1036)
.....||+.|+|||++.+..++.++|||||||++|||+| |+.||......+....+. .+. .+..
T Consensus 167 ~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~-------~~~-----~~~~--- 231 (277)
T d1xbba_ 167 QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE-------KGE-----RMGC--- 231 (277)
T ss_dssp ----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH-------TTC-----CCCC---
T ss_pred CCCCCCCCEECCCHHHCCCCCCCHHHHCCCHHHHHHHHHCCCCCCCCCCHHHHHHHHH-------CCC-----CCCC---
T ss_conf 4456778420391665379998434430340313289658999999989999999998-------289-----9999---
Q ss_pred CHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCC
Q ss_conf 999999999999981044999999989999996405
Q 001658 931 NEEEVKRLIGVALLCTQTLPSLRPSMSRVVAMLCGD 966 (1036)
Q Consensus 931 ~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 966 (1036)
+...+..+.+++.+||+.+|.+|||+++|+++|+..
T Consensus 232 p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~ 267 (277)
T d1xbba_ 232 PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 267 (277)
T ss_dssp CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred CCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHCH
T ss_conf 865679999999997588976890989999985288
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=0 Score=364.85 Aligned_cols=253 Identities=24% Similarity=0.297 Sum_probs=208.5
Q ss_pred HCCCCCCCCCCCCCCEEEEEEEE-CCCCEEEEEECCCCCHHCHHHHHHHHHHHHHHCCCCCCEEEEEEECCCEEEEEEEE
Q ss_conf 23999989303589788999682-89938999992410332099999999998740158843168588708322899983
Q 001658 692 TENFSPSNKLGEGGFGPVYKGKL-GDGRAIAVKQLSVASRQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLVYEY 770 (1036)
Q Consensus 692 ~~~~~~~~~iG~G~fG~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~ 770 (1036)
.++|++.+.||+|+||.||+|+. .+|+.||+|+++.........+.+|+.++++++|||||++++++.+.+..++||||
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 107 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 107 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEEEEC
T ss_conf 40359989993177829999999899979999998872646799999999999867997989199999989999999982
Q ss_pred CCCCCHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCEEEC--CCCCEEEEECCCCEEECCCC
Q ss_conf 4799944563218877757677999999999999998761896501134578858846--99844999747411415898
Q 001658 771 LENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLD--ADLVPKISDFGLAKLYDDKK 848 (1036)
Q Consensus 771 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NILl~--~~~~~kl~DFGla~~~~~~~ 848 (1036)
+++|+|.+++... ...+++.....|+.||+.||+|||+.+ |+||||||+|||++ .++.+||+|||+|+.+....
T Consensus 108 ~~gg~L~~~~~~~-~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~ 183 (352)
T d1koba_ 108 LSGGELFDRIAAE-DYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE 183 (352)
T ss_dssp CCCCBHHHHTTCT-TCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS
T ss_pred CCCCHHHHHHHHC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCCCCCCCCCCCCCCCEEEEEECCCCEECCCCC
T ss_conf 8998088889863-899899999999999999999999779---265131445531134678848995256303437887
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCCC
Q ss_conf 74223543356745710002387894246786899999998299999999815677899999987404953112585243
Q 001658 849 THISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEIELADPKLI 928 (1036)
Q Consensus 849 ~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~ 928 (1036)
. .....||+.|+|||++.+..++.++||||+||++|||+||+.||......+....+. .... . ...
T Consensus 184 ~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~------~~~~--~-~~~--- 249 (352)
T d1koba_ 184 I--VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVK------RCDW--E-FDE--- 249 (352)
T ss_dssp C--EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHH------HCCC--C-CCS---
T ss_pred C--EEECCCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHH------HCCC--C-CCC---
T ss_conf 2--010047645348999747998976333898999999996889989979999999998------4788--9-893---
Q ss_pred CCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH
Q ss_conf 6799999999999998104499999998999999
Q 001658 929 EFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVAM 962 (1036)
Q Consensus 929 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 962 (1036)
.........+.+++.+|++.||.+|||+.|+++.
T Consensus 250 ~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~H 283 (352)
T d1koba_ 250 DAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 283 (352)
T ss_dssp STTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred CCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 0024799999999999756996689189999609
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=364.94 Aligned_cols=245 Identities=27% Similarity=0.389 Sum_probs=205.0
Q ss_pred CCCCCCCCCCCCCCEEEEEEEEC-CCCEEEEEECCCC---CHHCHHHHHHHHHHHHHHCCCCCCEEEEEEECCCEEEEEE
Q ss_conf 39999893035897889996828-9938999992410---3320999999999987401588431685887083228999
Q 001658 693 ENFSPSNKLGEGGFGPVYKGKLG-DGRAIAVKQLSVA---SRQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLVY 768 (1036)
Q Consensus 693 ~~~~~~~~iG~G~fG~Vy~~~~~-~g~~vAvK~l~~~---~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 768 (1036)
++|++.+.||+|+||.||+|+.. +++.||+|++... .......+.+|+.++++++||||+++++++.+.+..++||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEE
T ss_conf 37699889851778589999998999499999981688567689999999999998568888885999999899989998
Q ss_pred EECCCCCHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCEEECCCCCEEEEECCCCEEECCCC
Q ss_conf 83479994456321887775767799999999999999876189650113457885884699844999747411415898
Q 001658 769 EYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKK 848 (1036)
Q Consensus 769 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~ 848 (1036)
||+++|+|.+++.. ...+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+|+......
T Consensus 86 Ey~~~g~L~~~l~~--~~~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~ 160 (263)
T d2j4za1 86 EYAPLGTVYRELQK--LSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR 160 (263)
T ss_dssp ECCTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCC
T ss_pred EECCCCCHHHHHHH--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EEEEEECCCCCEECCCCCEEECCCCEEEECCCCC
T ss_conf 50479858988750--489999999999999999999999889---4652202344146689987115556335448885
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCCC
Q ss_conf 74223543356745710002387894246786899999998299999999815677899999987404953112585243
Q 001658 849 THISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEIELADPKLI 928 (1036)
Q Consensus 849 ~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~ 928 (1036)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||......+....+. . ..+.+.
T Consensus 161 ---~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~-------~------~~~~~p 224 (263)
T d2j4za1 161 ---RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRIS-------R------VEFTFP 224 (263)
T ss_dssp ---CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH-------T------TCCCCC
T ss_pred ---CCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHH-------C------CCCCCC
T ss_conf ---235578876349999758998931440467599999832999988899999999997-------1------899998
Q ss_pred CCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHH
Q ss_conf 679999999999999810449999999899999
Q 001658 929 EFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVA 961 (1036)
Q Consensus 929 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 961 (1036)
.. ....+.+++.+|++.||.+|||+.|+++
T Consensus 225 ~~---~s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 225 DF---VTEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp TT---SCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CC---CCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf 66---8999999999976479768909999971
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=363.83 Aligned_cols=253 Identities=22% Similarity=0.301 Sum_probs=205.8
Q ss_pred HHCCCCCCCCCCCCCCEEEEEEEEC-CCCEEEEEECCCCC-HHCHHHHHHHHHHHHHHCCCCCCEEEEEEECCCEEEEEE
Q ss_conf 7239999893035897889996828-99389999924103-320999999999987401588431685887083228999
Q 001658 691 ATENFSPSNKLGEGGFGPVYKGKLG-DGRAIAVKQLSVAS-RQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLVY 768 (1036)
Q Consensus 691 ~~~~~~~~~~iG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 768 (1036)
..+.|++.+.||+|+||+||+|+.. +++.||||++.... ......+.+|+.++++++|||||++++++.+.+..++||
T Consensus 7 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvm 86 (307)
T d1a06a_ 7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIM 86 (307)
T ss_dssp GGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCCCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECHHHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEEE
T ss_conf 76666998899406583999999999998999999815773128999999999998679989991989999899888988
Q ss_pred EECCCCCHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCEEEC---CCCCEEEEECCCCEEEC
Q ss_conf 834799944563218877757677999999999999998761896501134578858846---99844999747411415
Q 001658 769 EYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLD---ADLVPKISDFGLAKLYD 845 (1036)
Q Consensus 769 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NILl~---~~~~~kl~DFGla~~~~ 845 (1036)
||+++|+|.+++.. ...+++.....++.|++.||+|||+.+ |+||||||+|||+. +++.+||+|||+++...
T Consensus 87 E~~~gg~L~~~l~~--~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~ 161 (307)
T d1a06a_ 87 QLVSGGELFDRIVE--KGFYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED 161 (307)
T ss_dssp CCCCSCBHHHHHHT--CSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC-------
T ss_pred ECCCCCCHHHHHHC--CCCCCHHHHHHHHHHHHHHHHHHHHCE---EEEEEECCCCEEECCCCCCCEEEEECCCEEEECC
T ss_conf 52689848886530--367887899999999999987524130---5568704630011046888249983154358725
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCC
Q ss_conf 89874223543356745710002387894246786899999998299999999815677899999987404953112585
Q 001658 846 DKKTHISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEIELADP 925 (1036)
Q Consensus 846 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 925 (1036)
.... .....||+.|||||++.+..++.++||||+||++|||++|+.||......+....+. ... .. ...
T Consensus 162 ~~~~--~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~------~~~--~~-~~~ 230 (307)
T d1a06a_ 162 PGSV--LSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQIL------KAE--YE-FDS 230 (307)
T ss_dssp -------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH------TTC--CC-CCT
T ss_pred CCCE--EEEEEECCCCCCCHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHH------CCC--CC-CCC
T ss_conf 8970--440032842259188737999807873451599999985979999989999999986------168--77-787
Q ss_pred CCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH
Q ss_conf 2436799999999999998104499999998999999
Q 001658 926 KLIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVAM 962 (1036)
Q Consensus 926 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 962 (1036)
. ........+.+++.+|++.||.+|||+.|+++.
T Consensus 231 ~---~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 264 (307)
T d1a06a_ 231 P---YWDDISDSAKDFIRHLMEKDPEKRFTCEQALQH 264 (307)
T ss_dssp T---TTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred C---CCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 6---666789999999999760897579189998629
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=360.03 Aligned_cols=255 Identities=24% Similarity=0.373 Sum_probs=206.4
Q ss_pred CCCCCCCCCCCCCCEEEEEEEEC-CCC----EEEEEECCCC-CHHCHHHHHHHHHHHHHHCCCCCCEEEEEEECCCEEEE
Q ss_conf 39999893035897889996828-993----8999992410-33209999999999874015884316858870832289
Q 001658 693 ENFSPSNKLGEGGFGPVYKGKLG-DGR----AIAVKQLSVA-SRQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLL 766 (1036)
Q Consensus 693 ~~~~~~~~iG~G~fG~Vy~~~~~-~g~----~vAvK~l~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l 766 (1036)
.+|+..+.||+|+||+||+|... +|+ .||+|+++.. +....+.|.+|+.++++++|||||+++|+|.+. ..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred HHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECC-CEEE
T ss_conf 999783198208992999999958998898999999965134979999999999999867998881589999619-8369
Q ss_pred EEEECCCCCHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCEEECCCCCEEEEECCCCEEECC
Q ss_conf 99834799944563218877757677999999999999998761896501134578858846998449997474114158
Q 001658 767 VYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDD 846 (1036)
Q Consensus 767 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~ 846 (1036)
++|++.+|+|.+++... ...+++..+++|+.|||+||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 88 v~e~~~~~~l~~~~~~~-~~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~ 163 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 163 (317)
T ss_dssp EEECCTTCBHHHHHHHT-SSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSHHHHTTT
T ss_pred EEEECCCCCCCCCCCCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCHHHCCEECCCCCEEEECCCCCEECCC
T ss_conf 99842687401011133-457999999999999999999998769---50476212031167998758602552223354
Q ss_pred CCCCC-CCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHH-CCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCC
Q ss_conf 98742-235433567457100023878942467868999999982-9999999981567789999998740495311258
Q 001658 847 KKTHI-STRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVS-GRPNSDPSLDEEKLYLLEWAWHLHENNQEIELAD 924 (1036)
Q Consensus 847 ~~~~~-~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 924 (1036)
..... .....||+.|+|||++.++.++.++|||||||++|||+| |++||......+....+. .+. .
T Consensus 164 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~-------~~~-----~ 231 (317)
T d1xkka_ 164 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE-------KGE-----R 231 (317)
T ss_dssp TCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHH-------HTC-----C
T ss_pred CCCCCCCCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHH-------CCC-----C
T ss_conf 4453223651058644670887469998356544079999999977999999999899999997-------599-----8
Q ss_pred CCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCC
Q ss_conf 5243679999999999999810449999999899999964055
Q 001658 925 PKLIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVAMLCGDM 967 (1036)
Q Consensus 925 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~ 967 (1036)
+. .+......+.+++.+||+.+|.+|||+.|+++.|....
T Consensus 232 ~~---~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~ 271 (317)
T d1xkka_ 232 LP---QPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 271 (317)
T ss_dssp CC---CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CC---CCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHH
T ss_conf 99---98556899999999847899346919999999999987
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=361.24 Aligned_cols=245 Identities=27% Similarity=0.449 Sum_probs=199.5
Q ss_pred CCCCCCCCCCCCCCEEEEEEEE-CCCCEEEEEECCCCC---HHCHHHHHHHHHHHHHHCCCCCCEEEEEEECCCEEEEEE
Q ss_conf 3999989303589788999682-899389999924103---320999999999987401588431685887083228999
Q 001658 693 ENFSPSNKLGEGGFGPVYKGKL-GDGRAIAVKQLSVAS---RQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLVY 768 (1036)
Q Consensus 693 ~~~~~~~~iG~G~fG~Vy~~~~-~~g~~vAvK~l~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 768 (1036)
+.|+..+.||+|+||.||+|+. .+++.||||++.... ....+.+.+|+.++++++|||||++++++.+.+..++||
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEE
T ss_conf 85676279701888099999998999399999984444358899999999999999778999823899999899889999
Q ss_pred EECCCCCHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCEEECCCCCEEEEECCCCEEECCCC
Q ss_conf 83479994456321887775767799999999999999876189650113457885884699844999747411415898
Q 001658 769 EYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKK 848 (1036)
Q Consensus 769 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~ 848 (1036)
||+++|+|..++.. ...+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+|+.....
T Consensus 95 E~~~~g~l~~~~~~--~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~- 168 (309)
T d1u5ra_ 95 EYCLGSASDLLEVH--KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA- 168 (309)
T ss_dssp ECCSEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB-
T ss_pred EECCCCCHHHHHHH--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCCCEEEECCCCCEEEEECCCCCCCCCC-
T ss_conf 80699945789973--799999999999999999999998689---766678842179879997898443653346778-
Q ss_pred CCCCCCCCCCCCCCCCCCCCC---CCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCC
Q ss_conf 742235433567457100023---87894246786899999998299999999815677899999987404953112585
Q 001658 849 THISTRVAGTIGYLAPEYAMR---GHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEIELADP 925 (1036)
Q Consensus 849 ~~~~~~~~gt~~y~APE~~~~---~~~~~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 925 (1036)
....||+.|||||++.+ +.++.++|||||||++|||++|+.||......+....+ ... ..+
T Consensus 169 ----~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i------~~~------~~~ 232 (309)
T d1u5ra_ 169 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI------AQN------ESP 232 (309)
T ss_dssp ----CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH------HHS------CCC
T ss_pred ----CCCCCCCCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHH------HHC------CCC
T ss_conf ----7313476636889983467888672145455899999998788999997999999999------828------999
Q ss_pred CCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHH
Q ss_conf 243679999999999999810449999999899999
Q 001658 926 KLIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVA 961 (1036)
Q Consensus 926 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 961 (1036)
... .......+.+++.+||+.||.+|||++|+++
T Consensus 233 ~~~--~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 233 ALQ--SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp CCS--CTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCC--CCCCCHHHHHHHHHHCCCCHHHCCCHHHHHH
T ss_conf 888--7888999999999977379657918999971
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=358.93 Aligned_cols=246 Identities=23% Similarity=0.354 Sum_probs=194.6
Q ss_pred CCCCCCCCCCCEEEEEEEEC-CCCEEEEEECCCC--CHHCHHHHHHHHHHHHHHCCCCCCEEEEEEEC----CCEEEEEE
Q ss_conf 99893035897889996828-9938999992410--33209999999999874015884316858870----83228999
Q 001658 696 SPSNKLGEGGFGPVYKGKLG-DGRAIAVKQLSVA--SRQGKSQFVAEIATISAVQHRNLVKLHGCCIE----GAERLLVY 768 (1036)
Q Consensus 696 ~~~~~iG~G~fG~Vy~~~~~-~g~~vAvK~l~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~----~~~~~lV~ 768 (1036)
+..++||+|+||+||+|... +++.||+|++... .....+.|.+|++++++++|||||++++++.+ ....++||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EEEEEEECCCCCEEEEEEECCCCEEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCCCEEEEEE
T ss_conf 85169700828499999999999599999985122798999999999999985799985069999840334588899999
Q ss_pred EECCCCCHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCEEEC-CCCCEEEEECCCCEEECCC
Q ss_conf 834799944563218877757677999999999999998761896501134578858846-9984499974741141589
Q 001658 769 EYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLD-ADLVPKISDFGLAKLYDDK 847 (1036)
Q Consensus 769 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NILl~-~~~~~kl~DFGla~~~~~~ 847 (1036)
||+++|+|.+++.. ...+++..+..++.|+++||+|||+++ ++|+||||||+|||++ +++.+||+|||+|+.....
T Consensus 92 E~~~~g~L~~~l~~--~~~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~~ 168 (270)
T d1t4ha_ 92 ELMTSGTLKTYLKR--FKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS 168 (270)
T ss_dssp ECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTT
T ss_pred ECCCCCCHHHHHHC--CCCCCHHHHHHHHHHHHHHHHHHHHCC-CCEEECCCCHHHCEEECCCCCEEEEECCCCEECCCC
T ss_conf 57898948999751--355469999999999999999999789-979968767435116679998898005765423687
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCC
Q ss_conf 87422354335674571000238789424678689999999829999999981567789999998740495311258524
Q 001658 848 KTHISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEIELADPKL 927 (1036)
Q Consensus 848 ~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~ 927 (1036)
......||+.|||||++.+ .++.++|||||||++|||++|+.||.......... .. ...+ ...+.+
T Consensus 169 ---~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~--~~----i~~~----~~~~~~ 234 (270)
T d1t4ha_ 169 ---FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIY--RR----VTSG----VKPASF 234 (270)
T ss_dssp ---SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHH--HH----HTTT----CCCGGG
T ss_pred ---CCCCCCCCCCCCCHHHHCC-CCCCCCCHHHHHHHHHHHHHCCCCCCCCCCHHHHH--HH----HHCC----CCCCCC
T ss_conf ---6677553813008988478-99986711007999999987889998765599999--99----9738----998656
Q ss_pred CCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHH
Q ss_conf 3679999999999999810449999999899999
Q 001658 928 IEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVA 961 (1036)
Q Consensus 928 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 961 (1036)
... ....+.+++.+||+.+|++|||+.|+++
T Consensus 235 ~~~---~~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 235 DKV---AIPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp GGC---CCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCC---CCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf 755---7899999999976379758929999967
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=363.21 Aligned_cols=249 Identities=22% Similarity=0.282 Sum_probs=206.3
Q ss_pred CCCCCCCCCCCCCCEEEEEEEE-CCCCEEEEEECCCC---CHHCHHHHHHHHHHHHHHCCCCCCEEEEEEECCCEEEEEE
Q ss_conf 3999989303589788999682-89938999992410---3320999999999987401588431685887083228999
Q 001658 693 ENFSPSNKLGEGGFGPVYKGKL-GDGRAIAVKQLSVA---SRQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLVY 768 (1036)
Q Consensus 693 ~~~~~~~~iG~G~fG~Vy~~~~-~~g~~vAvK~l~~~---~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 768 (1036)
++|++.+.||+|+||.||+|+. .+++.||||++... .....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEE
T ss_conf 87789889850879099999998999799999986577557778999999999998768888617999999899889999
Q ss_pred EECCCCCHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCEEECCCCCEEEEECCCCEEECCCC
Q ss_conf 83479994456321887775767799999999999999876189650113457885884699844999747411415898
Q 001658 769 EYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKK 848 (1036)
Q Consensus 769 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~ 848 (1036)
||+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+|+.+....
T Consensus 88 Ey~~gg~L~~~~~~~--~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~ 162 (288)
T d1uu3a_ 88 SYAKNGELLKYIRKI--GSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 162 (288)
T ss_dssp CCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred ECCCCCCHHHHHHCC--CCCCHHHHHHHHHHHHHHHHHHCCCC---EECCCCCCCCCCCCCCCEEEECCCCCCEECCCCC
T ss_conf 704898777765315--99999999999999999997621650---8847677412366888538860321024225677
Q ss_pred C-CCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCC
Q ss_conf 7-422354335674571000238789424678689999999829999999981567789999998740495311258524
Q 001658 849 T-HISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEIELADPKL 927 (1036)
Q Consensus 849 ~-~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~ 927 (1036)
. .......||+.|+|||++.+..++.++||||+||++|||++|+.||......+....+ .. ..+.+
T Consensus 163 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i------~~-------~~~~~ 229 (288)
T d1uu3a_ 163 KQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKI------IK-------LEYDF 229 (288)
T ss_dssp -------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH------HT-------TCCCC
T ss_pred CCCCCCCCCCCCCCCCCEEECCCCCCCCCCEEHHHHHHHHHHHCCCCCCCCCHHHHHHHH------HC-------CCCCC
T ss_conf 643335556775525844002689896662304569999980388998995999999999------71-------89999
Q ss_pred CCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH
Q ss_conf 36799999999999998104499999998999999
Q 001658 928 IEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVAM 962 (1036)
Q Consensus 928 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 962 (1036)
.. .....+.+++.+|++.||.+|||++|+++.
T Consensus 230 p~---~~s~~~~~li~~~L~~dP~~R~t~~e~~~~ 261 (288)
T d1uu3a_ 230 PE---KFFPKARDLVEKLLVLDATKRLGCEEMEGY 261 (288)
T ss_dssp CT---TCCHHHHHHHHTTSCSSGGGSTTSGGGTCH
T ss_pred CC---CCCHHHHHHHHHHCCCCHHHCCCHHHHCCC
T ss_conf 85---479999999999855797689197897377
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=359.29 Aligned_cols=257 Identities=26% Similarity=0.348 Sum_probs=210.2
Q ss_pred HCCCCCCCCCCCCCCEEEEEEEECC----CCEEEEEECCCC-CHHCHHHHHHHHHHHHHHCCCCCCEEEEEEECCCEEEE
Q ss_conf 2399998930358978899968289----938999992410-33209999999999874015884316858870832289
Q 001658 692 TENFSPSNKLGEGGFGPVYKGKLGD----GRAIAVKQLSVA-SRQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLL 766 (1036)
Q Consensus 692 ~~~~~~~~~iG~G~fG~Vy~~~~~~----g~~vAvK~l~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l 766 (1036)
.++|++.+.||+|+||.||+|+... +..||||.++.. .....+.|.+|+.++++++||||++++|++. .+..++
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~i 84 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 84 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred HHHEEEEEEEEECCCCEEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEE-CCEEEE
T ss_conf 8996987799307882999999936996449999999365668799999999999998689999856988995-374799
Q ss_pred EEEECCCCCHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCEEECCCCCEEEEECCCCEEECC
Q ss_conf 99834799944563218877757677999999999999998761896501134578858846998449997474114158
Q 001658 767 VYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDD 846 (1036)
Q Consensus 767 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~ 846 (1036)
||||+++|+|.+++... ...+++..++.++.|+++||.|||+.+ |+||||||+||+++.++.+||+|||+++....
T Consensus 85 v~E~~~~g~l~~~~~~~-~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~ 160 (273)
T d1mp8a_ 85 IMELCTLGELRSFLQVR-KYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMED 160 (273)
T ss_dssp EEECCTTEEHHHHHHHT-TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC---------
T ss_pred EEEECCCCCHHHHHHCC-CCCCCHHHHHHHHHHHHHHHHHHCCCC---EECCCCCHHHEEECCCCCEEECCCHHHEECCC
T ss_conf 99840698077654224-789999999999999987752302267---44141026553206789678765034213367
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHH-CCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCC
Q ss_conf 98742235433567457100023878942467868999999982-99999999815677899999987404953112585
Q 001658 847 KKTHISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVS-GRPNSDPSLDEEKLYLLEWAWHLHENNQEIELADP 925 (1036)
Q Consensus 847 ~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 925 (1036)
..........||+.|+|||++.+..++.++|||||||++|||+| |++||......+....+. .+. .+
T Consensus 161 ~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~-------~~~-----~~ 228 (273)
T d1mp8a_ 161 STYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE-------NGE-----RL 228 (273)
T ss_dssp ----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH-------TTC-----CC
T ss_pred CCCEECCCEECCCCCCHHHHHCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHHHHHHHHH-------CCC-----CC
T ss_conf 762330540058310326675169988745244424789999826999988899999999998-------189-----99
Q ss_pred CCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCC
Q ss_conf 2436799999999999998104499999998999999640558
Q 001658 926 KLIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVAMLCGDME 968 (1036)
Q Consensus 926 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 968 (1036)
.. +......+.+++..||+.+|.+|||+.||++.|+.+++
T Consensus 229 ~~---~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~ 268 (273)
T d1mp8a_ 229 PM---PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 268 (273)
T ss_dssp CC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CC---CCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHH
T ss_conf 89---87779999999999768797689299999999999977
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=358.30 Aligned_cols=261 Identities=24% Similarity=0.409 Sum_probs=211.1
Q ss_pred HCCCCCCCCCCCCCCEEEEEEEEC------CCCEEEEEECCCC-CHHCHHHHHHHHHHHHHHCCCCCCEEEEEEECCCEE
Q ss_conf 239999893035897889996828------9938999992410-332099999999998740158843168588708322
Q 001658 692 TENFSPSNKLGEGGFGPVYKGKLG------DGRAIAVKQLSVA-SRQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAER 764 (1036)
Q Consensus 692 ~~~~~~~~~iG~G~fG~Vy~~~~~------~g~~vAvK~l~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~ 764 (1036)
.++|+..+.||+|+||+||+|.+. +++.||||+++.. .......|.+|+.++++++||||++++|+|...+..
T Consensus 19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~ 98 (308)
T d1p4oa_ 19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT 98 (308)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSC
T ss_pred HHHEEEEEEEEECCCEEEEEEEECCCCCCCCCCEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCE
T ss_conf 89918835982078818999998786447789689999987012868999999999999976999884125478428810
Q ss_pred EEEEEECCCCCHHHHHHCCC--------CCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCEEECCCCCEEEE
Q ss_conf 89998347999445632188--------7775767799999999999999876189650113457885884699844999
Q 001658 765 LLVYEYLENKSLDQALFGQR--------SLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKIS 836 (1036)
Q Consensus 765 ~lV~E~~~~gsL~~~l~~~~--------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~ 836 (1036)
++|+||+++|+|.++++..+ ...+++..+.+++.|+|+||.|||+.+ |+||||||+|||+++++.+||+
T Consensus 99 ~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld~~~~~Kl~ 175 (308)
T d1p4oa_ 99 LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIG 175 (308)
T ss_dssp EEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCEEEC
T ss_pred EEEEEECCCCCHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECEECCCCEEECCCCEEEEE
T ss_conf 6777604899889998750332113444688799999999999999999876479---6543286775403599649994
Q ss_pred ECCCCEEECCCCCC-CCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHCC-CCCCCCCHHHHHHHHHHHHHHH
Q ss_conf 74741141589874-223543356745710002387894246786899999998299-9999998156778999999874
Q 001658 837 DFGLAKLYDDKKTH-ISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGR-PNSDPSLDEEKLYLLEWAWHLH 914 (1036)
Q Consensus 837 DFGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvil~elltG~-~p~~~~~~~~~~~l~~~~~~~~ 914 (1036)
|||+++........ ......|++.|+|||.+.++.++.++||||||+++|||+||+ +|+......+....+.
T Consensus 176 DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~------ 249 (308)
T d1p4oa_ 176 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVM------ 249 (308)
T ss_dssp CTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHH------
T ss_pred ECCCCEECCCCCCEEECCCEECCCCCCCHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHHHHH------
T ss_conf 24542023577630313402316323788887369988333444378999999968999999989999999998------
Q ss_pred HCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCCCC
Q ss_conf 04953112585243679999999999999810449999999899999964055887
Q 001658 915 ENNQEIELADPKLIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVAMLCGDMEVS 970 (1036)
Q Consensus 915 ~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~ 970 (1036)
.+. ....+......+.+++.+||+.+|.+||||.||+++|++.++..
T Consensus 250 -~~~--------~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~~ 296 (308)
T d1p4oa_ 250 -EGG--------LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPG 296 (308)
T ss_dssp -TTC--------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTT
T ss_pred -HCC--------CCCCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHCCCC
T ss_conf -088--------88886335399999999975779658939999999978761778
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=357.84 Aligned_cols=257 Identities=26% Similarity=0.351 Sum_probs=206.8
Q ss_pred CCCCCCCCCCCCCCEEEEEEEEC-CCC--EEEEEECCCC-CHHCHHHHHHHHHHHHHH-CCCCCCEEEEEEECCCEEEEE
Q ss_conf 39999893035897889996828-993--8999992410-332099999999998740-158843168588708322899
Q 001658 693 ENFSPSNKLGEGGFGPVYKGKLG-DGR--AIAVKQLSVA-SRQGKSQFVAEIATISAV-QHRNLVKLHGCCIEGAERLLV 767 (1036)
Q Consensus 693 ~~~~~~~~iG~G~fG~Vy~~~~~-~g~--~vAvK~l~~~-~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV 767 (1036)
++|++.++||+|+||.||+|++. ++. .||||++... .....+.|.+|++++.++ +|||||+++|+|.+.+..++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHCEEEEEEEECCCCEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCEEEEE
T ss_conf 99688779820788289999998999699999999782338579999999999998622899883678888418736999
Q ss_pred EEECCCCCHHHHHHCC--------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCEEECCCCCE
Q ss_conf 9834799944563218--------------87775767799999999999999876189650113457885884699844
Q 001658 768 YEYLENKSLDQALFGQ--------------RSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVP 833 (1036)
Q Consensus 768 ~E~~~~gsL~~~l~~~--------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NILl~~~~~~ 833 (1036)
+||+++|+|.++++.. ....+++..++.++.|||+||.|+|+.+ |+||||||+|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred EEECCCCCHHHHHHHCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCC---CCCCCCCCCEEEECCCCCE
T ss_conf 9802898699998640355555123101234578999999999999999987663089---5455505204898688763
Q ss_pred EEEECCCCEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHCCC-CCCCCCHHHHHHHHHHHHH
Q ss_conf 999747411415898742235433567457100023878942467868999999982999-9999981567789999998
Q 001658 834 KISDFGLAKLYDDKKTHISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRP-NSDPSLDEEKLYLLEWAWH 912 (1036)
Q Consensus 834 kl~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvil~elltG~~-p~~~~~~~~~~~l~~~~~~ 912 (1036)
||+|||+++....... .....||..|+|||.+.++.++.++||||||+++|||++|.. ||......+... .+
T Consensus 167 kl~DfG~a~~~~~~~~--~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~---~i-- 239 (309)
T d1fvra_ 167 KIADFGLSRGQEVYVK--KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYE---KL-- 239 (309)
T ss_dssp EECCTTCEESSCEECC--C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHH---HG--
T ss_pred EECCCCCCCCCCCCCC--CCCEECCCCCCCHHHHCCCCCCCCCEEEHHHHHHHHHHHCCCCCCCCCCHHHHHH---HH--
T ss_conf 8743443224442234--5530137755553875269999622153138899999836899999999999999---99--
Q ss_pred HHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCCC
Q ss_conf 740495311258524367999999999999981044999999989999996405588
Q 001658 913 LHENNQEIELADPKLIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVAMLCGDMEV 969 (1036)
Q Consensus 913 ~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~ 969 (1036)
..+ ..+.. +......+.+++.+||+.+|++||||.||++.|++..+.
T Consensus 240 --~~~-----~~~~~---~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~ 286 (309)
T d1fvra_ 240 --PQG-----YRLEK---PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 286 (309)
T ss_dssp --GGT-----CCCCC---CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred --HHC-----CCCCC---CCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHC
T ss_conf --826-----88888---766789999999997678966894999999999999861
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=355.85 Aligned_cols=252 Identities=22% Similarity=0.278 Sum_probs=205.5
Q ss_pred HHCCCCCCCCCCCCCCEEEEEEEE-CCCCEEEEEECCCCC------HHCHHHHHHHHHHHHHHCCCCCCEEEEEEECCCE
Q ss_conf 723999989303589788999682-899389999924103------3209999999999874015884316858870832
Q 001658 691 ATENFSPSNKLGEGGFGPVYKGKL-GDGRAIAVKQLSVAS------RQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAE 763 (1036)
Q Consensus 691 ~~~~~~~~~~iG~G~fG~Vy~~~~-~~g~~vAvK~l~~~~------~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~ 763 (1036)
..++|++.+.||+|+||.||+|+. .+|+.||||++.... ....+.+.+|+.++++++|||||++++++.+.+.
T Consensus 8 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~ 87 (293)
T d1jksa_ 8 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTD 87 (293)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred CCCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCE
T ss_conf 55677982798117895999999999998999999875663213406899999999999986799899938899997998
Q ss_pred EEEEEEECCCCCHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCEEECCCC----CEEEEECC
Q ss_conf 28999834799944563218877757677999999999999998761896501134578858846998----44999747
Q 001658 764 RLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADL----VPKISDFG 839 (1036)
Q Consensus 764 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NILl~~~~----~~kl~DFG 839 (1036)
.++||||+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++ .+|++|||
T Consensus 88 ~~iv~E~~~gg~L~~~i~~~--~~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~vkl~DfG 162 (293)
T d1jksa_ 88 VILILELVAGGELFDFLAEK--ESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFG 162 (293)
T ss_dssp EEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEEECCCCCCCCCHHCCC--CCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCCCCCEEEEECCCCCCCCEEECCHH
T ss_conf 99999867786431001035--64215578999999999987666254---22113330127982589866646964334
Q ss_pred CCEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCC
Q ss_conf 41141589874223543356745710002387894246786899999998299999999815677899999987404953
Q 001658 840 LAKLYDDKKTHISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQE 919 (1036)
Q Consensus 840 la~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 919 (1036)
+++....... .....||+.|+|||++.+..++.++||||+||++|||++|+.||......+....+. ...
T Consensus 163 ~a~~~~~~~~--~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~------~~~-- 232 (293)
T d1jksa_ 163 LAHKIDFGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVS------AVN-- 232 (293)
T ss_dssp TCEECTTSCB--CSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH------TTC--
T ss_pred HHHHCCCCCC--CCCCCCCCCCCCHHHHCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCHHHHHHHHH------HCC--
T ss_conf 4210577763--122477774309999818999976652214099999970889988999999999998------168--
Q ss_pred CCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHH
Q ss_conf 112585243679999999999999810449999999899999
Q 001658 920 IELADPKLIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVA 961 (1036)
Q Consensus 920 ~~~~d~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 961 (1036)
.. ..+... ......+.+++.+||+.||.+|||++|+++
T Consensus 233 ~~-~~~~~~---~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 233 YE-FEDEYF---SNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp CC-CCHHHH---TTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CC-CCCHHC---CCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf 88-870104---788999999999986389668919999961
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=359.46 Aligned_cols=250 Identities=26% Similarity=0.364 Sum_probs=205.8
Q ss_pred CCCCCCCCCCCCCCEEEEEEEECCCCEEEEEECCCCCHHCHHHHHHHHHHHHHHCCCCCCEEEEEEECC-CEEEEEEEEC
Q ss_conf 399998930358978899968289938999992410332099999999998740158843168588708-3228999834
Q 001658 693 ENFSPSNKLGEGGFGPVYKGKLGDGRAIAVKQLSVASRQGKSQFVAEIATISAVQHRNLVKLHGCCIEG-AERLLVYEYL 771 (1036)
Q Consensus 693 ~~~~~~~~iG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~-~~~~lV~E~~ 771 (1036)
++|++.+.||+|+||.||+|+. .|+.||||+++.. ...+.|.+|++++++++||||++++|+|.+. +..++||||+
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~ 83 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 83 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred HHEEEEEEEECCCCEEEEEEEE-CCEEEEEEEECCH--HHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEEEEECC
T ss_conf 9948857982079808999999-9909999998857--779999999999986789898549878872389289999636
Q ss_pred CCCCHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCEEECCCCCEEEEECCCCEEECCCCCCC
Q ss_conf 79994456321887775767799999999999999876189650113457885884699844999747411415898742
Q 001658 772 ENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHI 851 (1036)
Q Consensus 772 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 851 (1036)
++|+|.+++.......++|..+++|+.|++.||.|||+.+ |+||||||+|||++.++.+|++|||+++......
T Consensus 84 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~~--- 157 (262)
T d1byga_ 84 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--- 157 (262)
T ss_dssp TTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC-----------
T ss_pred CCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHCCCCCCCC---EECCCCCHHHHEECCCCCEEECCCCCCEECCCCC---
T ss_conf 9998999987457888899999999999985232113376---5536665676014689977632456003447877---
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHH-CCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCC
Q ss_conf 235433567457100023878942467868999999982-9999999981567789999998740495311258524367
Q 001658 852 STRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVS-GRPNSDPSLDEEKLYLLEWAWHLHENNQEIELADPKLIEF 930 (1036)
Q Consensus 852 ~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~ 930 (1036)
....++..|+|||++.++.++.++||||||+++|||+| |++|+......+....+ ..+ ..+.+
T Consensus 158 -~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i-------~~~-----~~~~~--- 221 (262)
T d1byga_ 158 -DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV-------EKG-----YKMDA--- 221 (262)
T ss_dssp -----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHH-------TTT-----CCCCC---
T ss_pred -CCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHH-------HCC-----CCCCC---
T ss_conf -65566646778178727988858877757999999997899999999999999999-------808-----99999---
Q ss_pred CHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCC
Q ss_conf 9999999999999810449999999899999964055
Q 001658 931 NEEEVKRLIGVALLCTQTLPSLRPSMSRVVAMLCGDM 967 (1036)
Q Consensus 931 ~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~ 967 (1036)
+......+.+++.+||+.||.+||||.|++++|+.+.
T Consensus 222 ~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~ 258 (262)
T d1byga_ 222 PDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK 258 (262)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHH
T ss_conf 7657999999999975669768939999999999998
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=357.42 Aligned_cols=262 Identities=25% Similarity=0.341 Sum_probs=206.7
Q ss_pred HHHCCCCCCCCCCCCCCEEEEEEEEC------CCCEEEEEECCCC-CHHCHHHHHHHHHHHHHH-CCCCCCEEEEEEECC
Q ss_conf 87239999893035897889996828------9938999992410-332099999999998740-158843168588708
Q 001658 690 TATENFSPSNKLGEGGFGPVYKGKLG------DGRAIAVKQLSVA-SRQGKSQFVAEIATISAV-QHRNLVKLHGCCIEG 761 (1036)
Q Consensus 690 ~~~~~~~~~~~iG~G~fG~Vy~~~~~------~g~~vAvK~l~~~-~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~ 761 (1036)
...++|++.+.||+|+||.||+|... +++.||||+++.. .....+.+..|...+.++ +|+||+.+++++...
T Consensus 10 i~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~ 89 (299)
T d1ywna1 10 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP 89 (299)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST
T ss_pred CCHHHEEEEEEEEECCCEEEEEEEECCCCCCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCEEEEEEEEECCC
T ss_conf 16799798449841678399999986777555783999999860017178999999999988614998499741154047
Q ss_pred -CEEEEEEEECCCCCHHHHHHCCC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCEE
Q ss_conf -32289998347999445632188--------------777576779999999999999987618965011345788588
Q 001658 762 -AERLLVYEYLENKSLDQALFGQR--------------SLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVL 826 (1036)
Q Consensus 762 -~~~~lV~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIL 826 (1036)
...++||||+++|+|.++++... ...+++..+..++.|+++||+|||+++ |+||||||+|||
T Consensus 90 ~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrDlKp~NIL 166 (299)
T d1ywna1 90 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNIL 166 (299)
T ss_dssp TSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEE
T ss_pred CCEEEEEEEECCCCCHHHHHHHCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCCEE
T ss_conf 97579999845899299999853666665322202332146899999999999999999887379---717867731065
Q ss_pred ECCCCCEEEEECCCCEEECCCCCC-CCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHCC-CCCCCCCHHHHH
Q ss_conf 469984499974741141589874-223543356745710002387894246786899999998299-999999815677
Q 001658 827 LDADLVPKISDFGLAKLYDDKKTH-ISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGR-PNSDPSLDEEKL 904 (1036)
Q Consensus 827 l~~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvil~elltG~-~p~~~~~~~~~~ 904 (1036)
++.++.+||+|||+|+........ ......||+.|+|||++.+..++.++|||||||++|||+||. +||......+..
T Consensus 167 l~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~ 246 (299)
T d1ywna1 167 LSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF 246 (299)
T ss_dssp ECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHH
T ss_pred ECCCCCEEECCCCCHHHCCCCCCCCCCCCEEECCCCCCHHHHHCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCHHHHH
T ss_conf 77998289845752001135665222475166721020368646889966322136789999986889999899989999
Q ss_pred HHHHHHHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCC
Q ss_conf 8999999874049531125852436799999999999998104499999998999999640558
Q 001658 905 YLLEWAWHLHENNQEIELADPKLIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVAMLCGDME 968 (1036)
Q Consensus 905 ~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 968 (1036)
. . ....+. .+.... .....+.+++.+||+.||.+|||+.|++++|+..++
T Consensus 247 ~--~----~~~~~~-----~~~~~~---~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq 296 (299)
T d1ywna1 247 C--R----RLKEGT-----RMRAPD---YTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 296 (299)
T ss_dssp H--H----HHHHTC-----CCCCCT---TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred H--H----HHHCCC-----CCCCCC---CCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHH
T ss_conf 9--9----996389-----888886---578999999999767796679199999999979986
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=353.04 Aligned_cols=248 Identities=23% Similarity=0.257 Sum_probs=204.8
Q ss_pred HCCCCCCCCCCCCCCEEEEEEEE-CCCCEEEEEECCCC---CHHCHHHHHHHHHHHHHHCCCCCCEEEEEEECCCEEEEE
Q ss_conf 23999989303589788999682-89938999992410---332099999999998740158843168588708322899
Q 001658 692 TENFSPSNKLGEGGFGPVYKGKL-GDGRAIAVKQLSVA---SRQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLV 767 (1036)
Q Consensus 692 ~~~~~~~~~iG~G~fG~Vy~~~~-~~g~~vAvK~l~~~---~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV 767 (1036)
.++|++.+.||+|+||.||+|+. .+++.||+|+++.. .....+.+.+|+.+|++++||||+++++++.+.+..++|
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv 83 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred HHHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCCCCC
T ss_conf 47428988983176849999999899989999998156544979999999999999867999887787640356421110
Q ss_pred EEECCCCCHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCEEECCCCCEEEEECCCCEEECCC
Q ss_conf 98347999445632188777576779999999999999987618965011345788588469984499974741141589
Q 001658 768 YEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDK 847 (1036)
Q Consensus 768 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~ 847 (1036)
|||+++|+|.+++... ..+++.....++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+|+.....
T Consensus 84 ~ey~~gg~L~~~~~~~--~~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~ 158 (337)
T d1o6la_ 84 MEYANGGELFFHLSRE--RVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISD 158 (337)
T ss_dssp EECCTTCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred EECCCCCCHHHHHHCC--CCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHEEECCCCCEEEEECCCCCCCCCC
T ss_conf 0035798605555325--67759999999999965211343159---622464777847658998888205652003567
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCC
Q ss_conf 87422354335674571000238789424678689999999829999999981567789999998740495311258524
Q 001658 848 KTHISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEIELADPKL 927 (1036)
Q Consensus 848 ~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~ 927 (1036)
.. .....+||+.|+|||++.+..++.++||||+||++|||++|++||......+...... . ..+.+
T Consensus 159 ~~-~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~------~-------~~~~~ 224 (337)
T d1o6la_ 159 GA-TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELIL------M-------EEIRF 224 (337)
T ss_dssp TC-CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH------H-------CCCCC
T ss_pred CC-CCCCCEECHHHHHHHHCCCCCCCHHHCCCCHHHHHHHHHHCCCCCCCCCHHHHHHHHH------C-------CCCCC
T ss_conf 86-2055100889966665048988833310223067889987899999969999999985------2-------89989
Q ss_pred CCCCHHHHHHHHHHHHHHCCCCCCCCCC-----HHHHHH
Q ss_conf 3679999999999999810449999999-----899999
Q 001658 928 IEFNEEEVKRLIGVALLCTQTLPSLRPS-----MSRVVA 961 (1036)
Q Consensus 928 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt-----~~evl~ 961 (1036)
.. .....+.+++..|++.||.+||+ +.|+++
T Consensus 225 p~---~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 225 PR---TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp CT---TSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred CC---CCCHHHHHHHHHHCCCCCHHHCCCCCCCHHHHHC
T ss_conf 86---6899999999866638934422565234999972
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=354.54 Aligned_cols=259 Identities=25% Similarity=0.409 Sum_probs=209.5
Q ss_pred HCCCCCCCCCCCCCCEEEEEEEE------CCCCEEEEEECCCC-CHHCHHHHHHHHHHHHHH-CCCCCCEEEEEEECCCE
Q ss_conf 23999989303589788999682------89938999992410-332099999999998740-15884316858870832
Q 001658 692 TENFSPSNKLGEGGFGPVYKGKL------GDGRAIAVKQLSVA-SRQGKSQFVAEIATISAV-QHRNLVKLHGCCIEGAE 763 (1036)
Q Consensus 692 ~~~~~~~~~iG~G~fG~Vy~~~~------~~g~~vAvK~l~~~-~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~ 763 (1036)
.++|++.+.||+|+||.||+|++ ..++.||||+++.. .......|.+|+.++.++ +|||||+++|+|.+.+.
T Consensus 22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~ 101 (311)
T d1t46a_ 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (311)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHEEEEEEEEECCCEEEEEEEEECCCCCCCCEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEECCE
T ss_conf 89969854982068829999998066447788699999987424877999999999998762699988789989831997
Q ss_pred EEEEEEECCCCCHHHHHHCCC----------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCEEE
Q ss_conf 289998347999445632188----------------7775767799999999999999876189650113457885884
Q 001658 764 RLLVYEYLENKSLDQALFGQR----------------SLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLL 827 (1036)
Q Consensus 764 ~~lV~E~~~~gsL~~~l~~~~----------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NILl 827 (1036)
.++||||+++|+|.++++... ...+++..+..++.||++||+|||+++ |+||||||+||++
T Consensus 102 ~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp~NIl~ 178 (311)
T d1t46a_ 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILL 178 (311)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred EEEEEECCCCCCHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCCCCCCCCC
T ss_conf 8999973799879999985356654444453322233458899999999999999999887579---2666241021000
Q ss_pred CCCCCEEEEECCCCEEECCCCC-CCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHC-CCCCCCCCHHHHHH
Q ss_conf 6998449997474114158987-422354335674571000238789424678689999999829-99999998156778
Q 001658 828 DADLVPKISDFGLAKLYDDKKT-HISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSG-RPNSDPSLDEEKLY 905 (1036)
Q Consensus 828 ~~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvil~elltG-~~p~~~~~~~~~~~ 905 (1036)
+.++.+|++|||+++....... .......||+.|+|||++..+.++.++||||||+++|||+|+ .+|+......+...
T Consensus 179 ~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~~ 258 (311)
T d1t46a_ 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFY 258 (311)
T ss_dssp ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHH
T ss_pred CCCCCCCCCCCCHHEECCCCCCCEEEEECCCCHHHCCHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHH
T ss_conf 02575210234010233678861586201359687677886179999740010258999999858998877899899999
Q ss_pred -HHHHHHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCC
Q ss_conf -999999874049531125852436799999999999998104499999998999999640558
Q 001658 906 -LLEWAWHLHENNQEIELADPKLIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVAMLCGDME 968 (1036)
Q Consensus 906 -l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 968 (1036)
.+. .+ ..+.. +......+.+++.+||+.||.+||||+||+++|++.+.
T Consensus 259 ~~i~-------~~-----~~~~~---~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~ 307 (311)
T d1t46a_ 259 KMIK-------EG-----FRMLS---PEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS 307 (311)
T ss_dssp HHHH-------HT-----CCCCC---CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHH-------CC-----CCCCC---CCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHC
T ss_conf 9986-------68-----98898---54365999999999757796579299999999987653
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=352.88 Aligned_cols=253 Identities=28% Similarity=0.431 Sum_probs=202.7
Q ss_pred CCCCCCCCCEEEEEEEECCC----CEEEEEECCCC-CHHCHHHHHHHHHHHHHHCCCCCCEEEEEEEC-CCEEEEEEEEC
Q ss_conf 89303589788999682899----38999992410-33209999999999874015884316858870-83228999834
Q 001658 698 SNKLGEGGFGPVYKGKLGDG----RAIAVKQLSVA-SRQGKSQFVAEIATISAVQHRNLVKLHGCCIE-GAERLLVYEYL 771 (1036)
Q Consensus 698 ~~~iG~G~fG~Vy~~~~~~g----~~vAvK~l~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~-~~~~~lV~E~~ 771 (1036)
.++||+|+||+||+|++.++ ..||||+++.. +....++|.+|++++++++||||++++|++.+ ....++||||+
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred CEEEEECCCEEEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEEEEEEE
T ss_conf 66981368809999999779987999999998843697899999999999986789998678678980699438999874
Q ss_pred CCCCHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCEEECCCCCEEEEECCCCEEECCCCCC-
Q ss_conf 7999445632188777576779999999999999987618965011345788588469984499974741141589874-
Q 001658 772 ENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTH- 850 (1036)
Q Consensus 772 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~- 850 (1036)
++|+|.+++... ....++..+++++.|+++||.|+|+.+ |+||||||+|||+++++.+||+|||+++........
T Consensus 112 ~~g~l~~~~~~~-~~~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~ 187 (311)
T d1r0pa_ 112 KHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDS 187 (311)
T ss_dssp TTCBHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCC
T ss_pred ECCCHHHHHCCC-CCCCHHHHHHHHHHHHHHHHHHHCCCC---CCCCCCCHHHEEECCCCCEEEECCCCHHHCCCCCCCC
T ss_conf 067414421013-454048999999999887652003367---6257766875767799988991065232255665553
Q ss_pred --CCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCCC
Q ss_conf --223543356745710002387894246786899999998299999999815677899999987404953112585243
Q 001658 851 --ISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEIELADPKLI 928 (1036)
Q Consensus 851 --~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~ 928 (1036)
......||..|+|||++..+.++.++||||||+++|||+||+.||........ ...+. .. +. ....|
T Consensus 188 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~--~~~~i---~~-g~--~~~~p--- 256 (311)
T d1r0pa_ 188 VHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD--ITVYL---LQ-GR--RLLQP--- 256 (311)
T ss_dssp TTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC--------CHHHH---HT-TC--CCCCC---
T ss_pred CEECCCCCCCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCHHH--HHHHH---HC-CC--CCCCC---
T ss_conf 1002565556455676887437999745746619999999978999988899999--99999---80-89--88996---
Q ss_pred CCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCC
Q ss_conf 6799999999999998104499999998999999640558
Q 001658 929 EFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVAMLCGDME 968 (1036)
Q Consensus 929 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 968 (1036)
.. ....+.+++.+||+.||.+||+|.||++.|+++..
T Consensus 257 ~~---~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~ 293 (311)
T d1r0pa_ 257 EY---CPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 293 (311)
T ss_dssp TT---CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CC---CCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHH
T ss_conf 44---75999999999768897689399999999999997
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=0 Score=354.17 Aligned_cols=248 Identities=23% Similarity=0.280 Sum_probs=196.8
Q ss_pred CCCCCCCCCCCCCCEEEEEEEEC-CCCEEEEEECCCC---CHHCHHHHHHH---HHHHHHHCCCCCCEEEEEEECCCEEE
Q ss_conf 39999893035897889996828-9938999992410---33209999999---99987401588431685887083228
Q 001658 693 ENFSPSNKLGEGGFGPVYKGKLG-DGRAIAVKQLSVA---SRQGKSQFVAE---IATISAVQHRNLVKLHGCCIEGAERL 765 (1036)
Q Consensus 693 ~~~~~~~~iG~G~fG~Vy~~~~~-~g~~vAvK~l~~~---~~~~~~~f~~E---i~~l~~l~H~nIv~l~g~~~~~~~~~ 765 (1036)
++|++.+.||+|+||.||+|+.. +|+.||+|++... .......+.+| +.+++.++|||||++++++.+.+..+
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEECCEEE
T ss_conf 76851018842889099999999999799999984587542667999999999999985089985889999999899889
Q ss_pred EEEEECCCCCHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCEEECCCCCEEEEECCCCEEEC
Q ss_conf 99983479994456321887775767799999999999999876189650113457885884699844999747411415
Q 001658 766 LVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYD 845 (1036)
Q Consensus 766 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~ 845 (1036)
+||||+++|+|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+|+.+.
T Consensus 84 ivmE~~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DFGla~~~~ 158 (364)
T d1omwa3 84 FILDLMNGGDLHYHLSQH--GVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFS 158 (364)
T ss_dssp EEECCCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCCTTCEECS
T ss_pred EEEEECCCCCHHHHHHHC--CCCCHHHHHHHHHHHHHHHHHHHHCC---CCCEEECCCEEEECCCCCEEEEEECEEEECC
T ss_conf 999914898389998732--55327899999999999999999779---6220444221678588967982201023337
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCC-CCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCC
Q ss_conf 898742235433567457100023-8789424678689999999829999999981567789999998740495311258
Q 001658 846 DKKTHISTRVAGTIGYLAPEYAMR-GHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEIELAD 924 (1036)
Q Consensus 846 ~~~~~~~~~~~gt~~y~APE~~~~-~~~~~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 924 (1036)
.... ....||+.|+|||++.. ..++.++||||+||++|||+||+.||......+...+... .....
T Consensus 159 ~~~~---~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~----------~~~~~ 225 (364)
T d1omwa3 159 KKKP---HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM----------TLTMA 225 (364)
T ss_dssp SSCC---CSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHH----------SSSCC
T ss_pred CCCC---CCCCCCCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHH----------CCCCC
T ss_conf 8864---3311345542168760389998441046778999999859998888998999999986----------04688
Q ss_pred CCCCCCCHHHHHHHHHHHHHHCCCCCCCCCC-----HHHHHH
Q ss_conf 5243679999999999999810449999999-----899999
Q 001658 925 PKLIEFNEEEVKRLIGVALLCTQTLPSLRPS-----MSRVVA 961 (1036)
Q Consensus 925 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt-----~~evl~ 961 (1036)
+.... .....+.+++.+|++.||.+||| ++|+++
T Consensus 226 ~~~~~---~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 226 VELPD---SFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp CCCCS---SSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred CCCCC---CCCHHHHHHHHHHCCCCHHHHCCCCCCCHHHHHC
T ss_conf 87887---7899999999998566988808874357999974
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=353.34 Aligned_cols=259 Identities=28% Similarity=0.396 Sum_probs=209.6
Q ss_pred HCCCCCCCCCCCCCCEEEEEEEECC--------CCEEEEEECCCCC-HHCHHHHHHHHHHHHHH-CCCCCCEEEEEEECC
Q ss_conf 2399998930358978899968289--------9389999924103-32099999999998740-158843168588708
Q 001658 692 TENFSPSNKLGEGGFGPVYKGKLGD--------GRAIAVKQLSVAS-RQGKSQFVAEIATISAV-QHRNLVKLHGCCIEG 761 (1036)
Q Consensus 692 ~~~~~~~~~iG~G~fG~Vy~~~~~~--------g~~vAvK~l~~~~-~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~ 761 (1036)
.++|.+.+.||+|+||.||+|+... +..||||+++... ......+.+|...+.++ +|||||+++++|.+.
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~ 91 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 91 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHHEEEEEEEEECCCCEEEEEEECCCCCCCCCCCEEEEEEEECCCCCHHHHHHHHHHHHHHHHHCCCCEEEECCCCCCCC
T ss_conf 89969700985167828999998578755566754999999881128688999999999999813999697346522018
Q ss_pred CEEEEEEEECCCCCHHHHHHCCC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCEEE
Q ss_conf 32289998347999445632188--------------7775767799999999999999876189650113457885884
Q 001658 762 AERLLVYEYLENKSLDQALFGQR--------------SLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLL 827 (1036)
Q Consensus 762 ~~~~lV~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NILl 827 (1036)
+..++||||+++|+|.+++.... ...+++..+++++.|++.||+|||+.+ |+||||||+|||+
T Consensus 92 ~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~NiLl 168 (299)
T d1fgka_ 92 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV 168 (299)
T ss_dssp SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred CEEEEEEECCCCCCHHHHHHHHCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEEEEECCCCEEE
T ss_conf 8689999736999099999860677643222334574346799999999999999998766379---7863022102245
Q ss_pred CCCCCEEEEECCCCEEECCCCCC-CCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHH-CCCCCCCCCHHHHHH
Q ss_conf 69984499974741141589874-2235433567457100023878942467868999999982-999999998156778
Q 001658 828 DADLVPKISDFGLAKLYDDKKTH-ISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVS-GRPNSDPSLDEEKLY 905 (1036)
Q Consensus 828 ~~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~ 905 (1036)
+.++.+||+|||+++........ ......|++.|+|||.+.++.++.++||||||+++|||++ |++||..........
T Consensus 169 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~~~ 248 (299)
T d1fgka_ 169 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK 248 (299)
T ss_dssp CTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHH
T ss_pred CCCCCEEECCCHHHCCCCCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCHHHHHH
T ss_conf 47897676221110113555554314667888466326675179888255547758888874017989899999999999
Q ss_pred HHHHHHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCC
Q ss_conf 999999874049531125852436799999999999998104499999998999999640558
Q 001658 906 LLEWAWHLHENNQEIELADPKLIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVAMLCGDME 968 (1036)
Q Consensus 906 l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 968 (1036)
.+ ..+. .+... ......+.+++.+||+.+|.+|||+.||+++|++++.
T Consensus 249 ~i-------~~~~-----~~~~p---~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a 296 (299)
T d1fgka_ 249 LL-------KEGH-----RMDKP---SNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 296 (299)
T ss_dssp HH-------HTTC-----CCCCC---SSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HH-------HCCC-----CCCCC---CCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHH
T ss_conf 99-------7288-----88987---4352999999999766797679399999999988860
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=357.23 Aligned_cols=268 Identities=24% Similarity=0.269 Sum_probs=201.8
Q ss_pred HCCCCCCCCCCCCCCEEEEEEEECCCCEEEEEECCCCCHHCHHHHHHHHHHHHHHCCCCCCEEEEEEECCC----EEEEE
Q ss_conf 23999989303589788999682899389999924103320999999999987401588431685887083----22899
Q 001658 692 TENFSPSNKLGEGGFGPVYKGKLGDGRAIAVKQLSVASRQGKSQFVAEIATISAVQHRNLVKLHGCCIEGA----ERLLV 767 (1036)
Q Consensus 692 ~~~~~~~~~iG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~----~~~lV 767 (1036)
.++|...+.||+|+||.||+|+. +|+.||||+++..... ...++.|+..+.+++||||++++|+|.+.+ ..++|
T Consensus 2 ~~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~~~-~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv 79 (303)
T d1vjya_ 2 ARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV 79 (303)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred CCEEEEEEEEEECCCEEEEEEEE-CCEEEEEEEECCCCHH-HHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCCEEEEEE
T ss_conf 86899988982078819999999-9989999998720046-799999999996279986832688998379860489999
Q ss_pred EEECCCCCHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC-----CCCCCCCCCCCCCEEECCCCCEEEEECCCCE
Q ss_conf 98347999445632188777576779999999999999987618-----9650113457885884699844999747411
Q 001658 768 YEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEES-----RVRIIHRDVKASNVLLDADLVPKISDFGLAK 842 (1036)
Q Consensus 768 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~-----~~~ivH~Dikp~NILl~~~~~~kl~DFGla~ 842 (1036)
|||+++|+|.++++. ..++|..+++++.|+|.||+|+|+.+ .++|+||||||+|||++.++.+||+|||+++
T Consensus 80 ~Ey~~~g~L~~~l~~---~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~ 156 (303)
T d1vjya_ 80 SDYHEHGSLFDYLNR---YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 156 (303)
T ss_dssp EECCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred EECCCCCCHHHHHHC---CCCCHHHHHHHHHHHHHHHHHHHHHHHHHCCCCCEECCCCCCCCEEECCCCCEEEEECCCCC
T ss_conf 964669898999865---89998999999999999999988766520468986615317313578688776887638662
Q ss_pred EECCCCCC---CCCCCCCCCCCCCCCCCCCC------CCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHH--------H
Q ss_conf 41589874---22354335674571000238------7894246786899999998299999999815677--------8
Q 001658 843 LYDDKKTH---ISTRVAGTIGYLAPEYAMRG------HLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKL--------Y 905 (1036)
Q Consensus 843 ~~~~~~~~---~~~~~~gt~~y~APE~~~~~------~~~~ksDVwSlGvil~elltG~~p~~~~~~~~~~--------~ 905 (1036)
........ ......||+.|+|||++... .++.++|||||||++|||+||..|+......... .
T Consensus 157 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~ 236 (303)
T d1vjya_ 157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 236 (303)
T ss_dssp EEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred CCCCCCCCEECCCCCEECCCCCCCHHHCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHCCCCCC
T ss_conf 34677762001355250354767822105654546777675012201599999996289988766311241012255643
Q ss_pred HHHHHHHHHHCCCCCCCCCCCCCC--CCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCC
Q ss_conf 999999874049531125852436--799999999999998104499999998999999640558
Q 001658 906 LLEWAWHLHENNQEIELADPKLIE--FNEEEVKRLIGVALLCTQTLPSLRPSMSRVVAMLCGDME 968 (1036)
Q Consensus 906 l~~~~~~~~~~~~~~~~~d~~~~~--~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 968 (1036)
.......... ....+|.+.. ...+....+.+++.+||+.||.+||||.||+++|++..+
T Consensus 237 ~~~~~~~~~~----~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~ 297 (303)
T d1vjya_ 237 SVEEMRKVVC----EQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 297 (303)
T ss_dssp CHHHHHHHHT----TSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHHH----CCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHH
T ss_conf 0999999875----024688877655776899999999999760698589599999999998888
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=354.04 Aligned_cols=255 Identities=25% Similarity=0.374 Sum_probs=205.3
Q ss_pred CCCCCCCCCCCCCCEEEEEEEEC--CC--CEEEEEECCCC---CHHCHHHHHHHHHHHHHHCCCCCCEEEEEEECCCEEE
Q ss_conf 39999893035897889996828--99--38999992410---3320999999999987401588431685887083228
Q 001658 693 ENFSPSNKLGEGGFGPVYKGKLG--DG--RAIAVKQLSVA---SRQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERL 765 (1036)
Q Consensus 693 ~~~~~~~~iG~G~fG~Vy~~~~~--~g--~~vAvK~l~~~---~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~ 765 (1036)
++|++.+.||+|+||.||+|+.. ++ ..||||++... .....++|.+|+.++++++||||++++|+|.+ +..+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred HHEEEEEEEECCCCEEEEEEEEECCCCCEEEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEE-CCHH
T ss_conf 891997898038883999999988999079999999983555798999999999999986899998789877740-1001
Q ss_pred EEEEECCCCCHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCEEECCCCCEEEEECCCCEEEC
Q ss_conf 99983479994456321887775767799999999999999876189650113457885884699844999747411415
Q 001658 766 LVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYD 845 (1036)
Q Consensus 766 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~ 845 (1036)
+|+||+++|++.+++... ...+++..++.++.|+|+||.|||+++ |+||||||+||+++.++.+||+|||+++...
T Consensus 87 lv~e~~~~~~l~~~~~~~-~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfGl~~~~~ 162 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRKH-QGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALP 162 (273)
T ss_dssp EEEECCTTCBHHHHHHHH-GGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred EEEEEECCCCHHHHHHCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---EEEEEECHHHHCCCCCCCEEECCCHHHHHCC
T ss_conf 146542386125444212-689999999999999999998752178---7520566888156556543325611555303
Q ss_pred CCCCC--CCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHH-CCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCC
Q ss_conf 89874--2235433567457100023878942467868999999982-99999999815677899999987404953112
Q 001658 846 DKKTH--ISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVS-GRPNSDPSLDEEKLYLLEWAWHLHENNQEIEL 922 (1036)
Q Consensus 846 ~~~~~--~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 922 (1036)
..... ......|+..|+|||++.+..++.++||||||+++|||+| |+.||......+....+ ...+.
T Consensus 163 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i------~~~~~---- 232 (273)
T d1u46a_ 163 QNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKI------DKEGE---- 232 (273)
T ss_dssp C-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHH------HTSCC----
T ss_pred CCCCCCEECCCCCCCCCCCCHHHHHCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHH------HHCCC----
T ss_conf 58875265476325731079999837999942156614899999996899999996999999999------84799----
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCC
Q ss_conf 58524367999999999999981044999999989999996405
Q 001658 923 ADPKLIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVAMLCGD 966 (1036)
Q Consensus 923 ~d~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 966 (1036)
.+. .....+..+.+++.+||+.||.+||||.||+++|.++
T Consensus 233 -~~~---~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 233 -RLP---RPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp -CCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -CCC---CCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHC
T ss_conf -999---8544539999999997688966792999999999964
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=0 Score=349.51 Aligned_cols=245 Identities=24% Similarity=0.288 Sum_probs=203.0
Q ss_pred CCCCCCCCCCCCCCEEEEEEEE-CCCCEEEEEECCCC---CHHCHHHHHHHHHHHHHHCCCCCCEEEEEEECCCEEEEEE
Q ss_conf 3999989303589788999682-89938999992410---3320999999999987401588431685887083228999
Q 001658 693 ENFSPSNKLGEGGFGPVYKGKL-GDGRAIAVKQLSVA---SRQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLVY 768 (1036)
Q Consensus 693 ~~~~~~~~iG~G~fG~Vy~~~~-~~g~~vAvK~l~~~---~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 768 (1036)
++|++.+.||+|+||+||+|+. .+|+.||||+++.. .....+.+.+|+.++++++|||||++++++.+.+..++||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred HHEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCHHHEEEEEEECCEEEEEE
T ss_conf 47088889720768089999998999799999984577548899999999999998636967533035685288005676
Q ss_pred EECCCCCHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCEEECCCCCEEEEECCCCEEECCCC
Q ss_conf 83479994456321887775767799999999999999876189650113457885884699844999747411415898
Q 001658 769 EYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKK 848 (1036)
Q Consensus 769 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~ 848 (1036)
||+++|+|..++... ..+++.....++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+|+......
T Consensus 84 E~~~gg~l~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~~ 158 (316)
T d1fota_ 84 DYIEGGELFSLLRKS--QRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT 158 (316)
T ss_dssp CCCCSCBHHHHHHHT--SSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSSCB
T ss_pred EECCCCCCCCCCCCC--CCCCCCHHHHHHHHHHHHHHHHCCCC---EECCCCCCHHEEECCCCCEEEECCCCCEEECCCC
T ss_conf 503786322343222--21110079999999987655412476---7705568105038689988983175216712456
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCCC
Q ss_conf 74223543356745710002387894246786899999998299999999815677899999987404953112585243
Q 001658 849 THISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEIELADPKLI 928 (1036)
Q Consensus 849 ~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~ 928 (1036)
....||+.|+|||++.+..++.++||||+||++|||++|+.||......+....+. .. ...+.
T Consensus 159 ----~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~------~~-------~~~~p 221 (316)
T d1fota_ 159 ----YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKIL------NA-------ELRFP 221 (316)
T ss_dssp ----CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH------HC-------CCCCC
T ss_pred ----CCCCCCCCCCCHHHHCCCCCCCHHHCCCCCHHHHHHHHCCCCCCCCCHHHHHHHHH------CC-------CCCCC
T ss_conf ----43457634359999838999804304653336899975989999969999999997------08-------98899
Q ss_pred CCCHHHHHHHHHHHHHHCCCCCCCCC-----CHHHHHHH
Q ss_conf 67999999999999981044999999-----98999999
Q 001658 929 EFNEEEVKRLIGVALLCTQTLPSLRP-----SMSRVVAM 962 (1036)
Q Consensus 929 ~~~~~~~~~l~~l~~~Cl~~dP~~RP-----t~~evl~~ 962 (1036)
......+.+++.+|++.+|.+|+ +++|+++.
T Consensus 222 ---~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H 257 (316)
T d1fota_ 222 ---PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 257 (316)
T ss_dssp ---TTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred ---CCCCHHHHHHHHHHHHHCHHHCCCCCHHHHHHHHCC
T ss_conf ---778999999999995449976664310219999819
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=0 Score=349.15 Aligned_cols=244 Identities=23% Similarity=0.246 Sum_probs=203.4
Q ss_pred CCCCCCCCCCCCCCEEEEEEEEC-CCCEEEEEECCCC---CHHCHHHHHHHHHHHHHHCCCCCCEEEEEEECCCEEEEEE
Q ss_conf 39999893035897889996828-9938999992410---3320999999999987401588431685887083228999
Q 001658 693 ENFSPSNKLGEGGFGPVYKGKLG-DGRAIAVKQLSVA---SRQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLVY 768 (1036)
Q Consensus 693 ~~~~~~~~iG~G~fG~Vy~~~~~-~g~~vAvK~l~~~---~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 768 (1036)
++|++.+.||+|+||.||+|+.. +|+.||||++... .....+.+.+|+.+++.++|||||++++++.+....++|+
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCCCCCCCCC
T ss_conf 37089889611768089999998999899999982677458899999999999999748772740344443222223222
Q ss_pred EECCCCCHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCEEECCCCCEEEEECCCCEEECCCC
Q ss_conf 83479994456321887775767799999999999999876189650113457885884699844999747411415898
Q 001658 769 EYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKK 848 (1036)
Q Consensus 769 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~ 848 (1036)
||+.+|+|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+|+.+....
T Consensus 121 e~~~~g~l~~~l~~~--~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~~ 195 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT 195 (350)
T ss_dssp ECCTTCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSCB
T ss_pred CCCCCCCHHHHHHHC--CCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHCCCCCCCCEEEEECEEEEECCCCC
T ss_conf 233466226667515--89899999999999999899998599---8617679999360778978861010333225666
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCCC
Q ss_conf 74223543356745710002387894246786899999998299999999815677899999987404953112585243
Q 001658 849 THISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEIELADPKLI 928 (1036)
Q Consensus 849 ~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~ 928 (1036)
....||+.|||||++.+..++.++||||+||++|||+||+.||...........+. .. .+...
T Consensus 196 ----~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~------~~-------~~~~p 258 (350)
T d1rdqe_ 196 ----WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIV------SG-------KVRFP 258 (350)
T ss_dssp ----CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH------HC-------CCCCC
T ss_pred ----CCCCCCCCCCCHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCHHHHHHHHH------CC-------CCCCC
T ss_conf ----43367635678899717998853311450078999975889989959999999986------17-------98897
Q ss_pred CCCHHHHHHHHHHHHHHCCCCCCCCC-----CHHHHHH
Q ss_conf 67999999999999981044999999-----9899999
Q 001658 929 EFNEEEVKRLIGVALLCTQTLPSLRP-----SMSRVVA 961 (1036)
Q Consensus 929 ~~~~~~~~~l~~l~~~Cl~~dP~~RP-----t~~evl~ 961 (1036)
......+.+++.+|++.||.+|+ +++|+++
T Consensus 259 ---~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 259 ---SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp ---TTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred ---CCCCHHHHHHHHHHHHHCHHHCCCCCCCCHHHHHC
T ss_conf ---66899999999998340998606553454999971
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=349.69 Aligned_cols=253 Identities=20% Similarity=0.220 Sum_probs=200.1
Q ss_pred HHCCCCCCC-CCCCCCCEEEEEEEE-CCCCEEEEEECCCCCHHCHHHHHHHHHHHHHH-CCCCCCEEEEEEEC----CCE
Q ss_conf 723999989-303589788999682-89938999992410332099999999998740-15884316858870----832
Q 001658 691 ATENFSPSN-KLGEGGFGPVYKGKL-GDGRAIAVKQLSVASRQGKSQFVAEIATISAV-QHRNLVKLHGCCIE----GAE 763 (1036)
Q Consensus 691 ~~~~~~~~~-~iG~G~fG~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~----~~~ 763 (1036)
..++|.+.+ .||+|+||.||+|+. .+++.||||+++. ...+.+|+.++.++ +|||||++++++.+ ...
T Consensus 9 i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~ 83 (335)
T d2ozaa1 9 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKC 83 (335)
T ss_dssp GGGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred CCCCEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECC-----CHHHHHHHHHHHHHCCCCCCCEEEEEEEECCCCCCE
T ss_conf 014879810796545486999999889998999999897-----477999999999866999978298999503468978
Q ss_pred EEEEEEECCCCCHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCEEECC---CCCEEEEECCC
Q ss_conf 289998347999445632188777576779999999999999987618965011345788588469---98449997474
Q 001658 764 RLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDA---DLVPKISDFGL 840 (1036)
Q Consensus 764 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NILl~~---~~~~kl~DFGl 840 (1036)
.++||||+++|+|.+++.......+++..+..|+.|++.||+|||+.+ |+||||||+|||++. ++.+||+|||+
T Consensus 84 ~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~Kl~DFG~ 160 (335)
T d2ozaa1 84 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGF 160 (335)
T ss_dssp EEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEEEEECCCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCCCCCCCCCCCCCCCCCCCCE
T ss_conf 999997789984999998627877579999999999999999999769---86444100220113555566311354551
Q ss_pred CEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCC
Q ss_conf 11415898742235433567457100023878942467868999999982999999998156778999999874049531
Q 001658 841 AKLYDDKKTHISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEI 920 (1036)
Q Consensus 841 a~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 920 (1036)
|+....... .....||+.|+|||++.+..++.++||||+||++|||+||++||............. ..+
T Consensus 161 a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~---------~~i 229 (335)
T d2ozaa1 161 AKETTSHNS--LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMK---------TRI 229 (335)
T ss_dssp CEECCCCCC--CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-----------------CC
T ss_pred EEECCCCCC--CCCCCCCCCCCCCHHHCCCCCCHHHHHHHHCHHHHHHHHCCCCCCCCCHHHHHHHHH---------HHH
T ss_conf 233368886--432267756379277748988888888764516778865889988988778899999---------998
Q ss_pred CCCCCCCCC-CCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH
Q ss_conf 125852436-799999999999998104499999998999999
Q 001658 921 ELADPKLIE-FNEEEVKRLIGVALLCTQTLPSLRPSMSRVVAM 962 (1036)
Q Consensus 921 ~~~d~~~~~-~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 962 (1036)
......+.. ........+.+++.+|++.||++|||+.|+++.
T Consensus 230 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 272 (335)
T d2ozaa1 230 RMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 272 (335)
T ss_dssp CSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HCCCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 5388888985434699999999999756996579099999709
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=347.04 Aligned_cols=253 Identities=18% Similarity=0.238 Sum_probs=205.6
Q ss_pred HHCCCCCCCCCCCCCCEEEEEEEEC-CCCEEEEEECCCCCHHCHHHHHHHHHHHHHHCCCCCCEEEEEEECCCEEEEEEE
Q ss_conf 7239999893035897889996828-993899999241033209999999999874015884316858870832289998
Q 001658 691 ATENFSPSNKLGEGGFGPVYKGKLG-DGRAIAVKQLSVASRQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLVYE 769 (1036)
Q Consensus 691 ~~~~~~~~~~iG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 769 (1036)
..++|.+.+.||+|+||+||+|... +++.||+|+++.... ....+.+|+++|+.++|||||++++++.+.+..++|||
T Consensus 3 ~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~-~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE 81 (321)
T d1tkia_ 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT-DQVLVKKEISILNIARHRNILHLHESFESMEELVMIFE 81 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH-HHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred CCCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCCC-CHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEEE
T ss_conf 70105887898317783999999989996999999757866-59999999999985799798909899988998899995
Q ss_pred ECCCCCHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCEEECCC--CCEEEEECCCCEEECCC
Q ss_conf 3479994456321887775767799999999999999876189650113457885884699--84499974741141589
Q 001658 770 YLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDAD--LVPKISDFGLAKLYDDK 847 (1036)
Q Consensus 770 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NILl~~~--~~~kl~DFGla~~~~~~ 847 (1036)
|+++|+|.+++... ...+++..+..|+.|++.||+|||+.+ |+||||||+|||++.+ ..+||+|||+++.....
T Consensus 82 ~~~gg~L~~~i~~~-~~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~ 157 (321)
T d1tkia_ 82 FISGLDIFERINTS-AFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG 157 (321)
T ss_dssp CCCCCBHHHHHTSS-SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred CCCCCCHHHHHHHC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCCEEECCCCCEEEEECCCCHHHCCCCC
T ss_conf 38998088998753-899999999999999999999998769---97513554443443788518997644111003467
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCC
Q ss_conf 87422354335674571000238789424678689999999829999999981567789999998740495311258524
Q 001658 848 KTHISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEIELADPKL 927 (1036)
Q Consensus 848 ~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~ 927 (1036)
. ......|++.|+|||...+..++.++||||+||++|||++|+.||......+....+. ... ...+...
T Consensus 158 ~--~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~------~~~---~~~~~~~ 226 (321)
T d1tkia_ 158 D--NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIM------NAE---YTFDEEA 226 (321)
T ss_dssp C--EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH------HTC---CCCCHHH
T ss_pred C--CCCCCCCCCCCCCCHHCCCCCCCCHHHCCCHHHHHHHHHHCCCCCCCCCHHHHHHHHH------HCC---CCCCHHH
T ss_conf 7--5321223322234021048777840113027999999982899999989999999998------389---9988022
Q ss_pred CCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH
Q ss_conf 36799999999999998104499999998999999
Q 001658 928 IEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVAM 962 (1036)
Q Consensus 928 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 962 (1036)
.. .....+.+++.+|++.||.+|||+.|+++.
T Consensus 227 ~~---~~s~~~~~li~~~L~~dp~~R~s~~eil~h 258 (321)
T d1tkia_ 227 FK---EISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp HT---TSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred CC---CCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 36---789999999999866996689099999639
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=0 Score=347.98 Aligned_cols=259 Identities=24% Similarity=0.323 Sum_probs=207.9
Q ss_pred HHCCCCCCCCCCCCCCEEEEEEEE-CCCCEEEEEECCCC---CHHCHHHHHHHHHHHHHHCCCCCCEEEEEEECCC----
Q ss_conf 723999989303589788999682-89938999992410---3320999999999987401588431685887083----
Q 001658 691 ATENFSPSNKLGEGGFGPVYKGKL-GDGRAIAVKQLSVA---SRQGKSQFVAEIATISAVQHRNLVKLHGCCIEGA---- 762 (1036)
Q Consensus 691 ~~~~~~~~~~iG~G~fG~Vy~~~~-~~g~~vAvK~l~~~---~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~---- 762 (1036)
..++|++.+.||+|+||.||+|+. .+++.||+|+++.. +......|.+|+.++++++||||+++++++...+
T Consensus 5 l~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~ 84 (277)
T d1o6ya_ 5 LSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP 84 (277)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSE
T ss_pred CCCEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCEEEECCCCCC
T ss_conf 06206986899608992999999999998999999855664698999999999999985699988731143543268876
Q ss_pred EEEEEEEECCCCCHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCEEECCCCCEEEEECCCCE
Q ss_conf 22899983479994456321887775767799999999999999876189650113457885884699844999747411
Q 001658 763 ERLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAK 842 (1036)
Q Consensus 763 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~ 842 (1036)
..++||||+++++|.+++... ..+++..+..|+.|++.||+|||+.+ |+||||||+|||++.++..+++|||.+.
T Consensus 85 ~~~lvmE~~~g~~L~~~~~~~--~~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~d~~~~~ 159 (277)
T d1o6ya_ 85 LPYIVMEYVDGVTLRDIVHTE--GPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIAR 159 (277)
T ss_dssp EEEEEEECCCEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEECCCTTCE
T ss_pred EEEEEEECCCCCEEHHHHCCC--CCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCCCCCCCCCCCEEEHHHHHH
T ss_conf 699999778898710112035--89999999999999999999998579---5276346755665754320100344432
Q ss_pred EECCCCC--CCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCC
Q ss_conf 4158987--42235433567457100023878942467868999999982999999998156778999999874049531
Q 001658 843 LYDDKKT--HISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEI 920 (1036)
Q Consensus 843 ~~~~~~~--~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 920 (1036)
....... .......||+.|+|||++.+..++.++||||+||++|||+||++||......+.... .......
T Consensus 160 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~------~~~~~~~- 232 (277)
T d1o6ya_ 160 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQ------HVREDPI- 232 (277)
T ss_dssp ECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH------HHHCCCC-
T ss_pred HHCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCEECCCCHHHHHHHHHCCCCCCCCCHHHHHHH------HHHCCCC-
T ss_conf 212354433334642576243699998399999663202652899999769799899699999999------9846999-
Q ss_pred CCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCC-CHHHHHHHHHCC
Q ss_conf 1258524367999999999999981044999999-989999996405
Q 001658 921 ELADPKLIEFNEEEVKRLIGVALLCTQTLPSLRP-SMSRVVAMLCGD 966 (1036)
Q Consensus 921 ~~~d~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-t~~evl~~L~~~ 966 (1036)
.+. .........+.+++.+|++.||.+|| +++++.+.|.+.
T Consensus 233 ---~~~--~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~ 274 (277)
T d1o6ya_ 233 ---PPS--ARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 274 (277)
T ss_dssp ---CGG--GTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred ---CCC--HHCCCCCHHHHHHHHHHCCCCHHHCHHHHHHHHHHHHHH
T ss_conf ---971--003478999999999986679767773999999999997
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=342.68 Aligned_cols=259 Identities=25% Similarity=0.292 Sum_probs=198.6
Q ss_pred CCCCCCCCCEEEEEEEE-CCCCEEEEEECCCCCHH-----CHHHHHHHHHHHHHHCCCCCCEEEEEEECCCEEEEEEEEC
Q ss_conf 89303589788999682-89938999992410332-----0999999999987401588431685887083228999834
Q 001658 698 SNKLGEGGFGPVYKGKL-GDGRAIAVKQLSVASRQ-----GKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLVYEYL 771 (1036)
Q Consensus 698 ~~~iG~G~fG~Vy~~~~-~~g~~vAvK~l~~~~~~-----~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~ 771 (1036)
.++||+|+||+||+|+. .+|+.||||+++..... ..+.+.+|+.++++++|||||++++++.+.+..++||||+
T Consensus 3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~ 82 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM 82 (299)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred CEEECCCCCEEEEEEEECCCCCEEEEEEEEHHHHHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCEEEHHHHH
T ss_conf 63851272829999999999969999998420212456799999999999998679999868985422587402204553
Q ss_pred CCCCHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCEEECCCCCEEEEECCCCEEECCCCCCC
Q ss_conf 79994456321887775767799999999999999876189650113457885884699844999747411415898742
Q 001658 772 ENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTHI 851 (1036)
Q Consensus 772 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 851 (1036)
+++++..+.. ....+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++........
T Consensus 83 ~~~~~~~~~~--~~~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~- 156 (299)
T d1ua2a_ 83 ETDLEVIIKD--NSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA- 156 (299)
T ss_dssp SEEHHHHHTT--CCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCC-
T ss_pred CCHHHHHHHH--CCCCCCHHHHHHHHHHHHHHHHHHHCCC---EECCCCCCCEEEECCCCCCCCCCCCCCCCCCCCCCC-
T ss_conf 4507765541--2667789999999999999998863163---550357762588537784114657610005787554-
Q ss_pred CCCCCCCCCCCCCCCCCCC-CCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCC---CCCCC---
Q ss_conf 2354335674571000238-7894246786899999998299999999815677899999987404953---11258---
Q 001658 852 STRVAGTIGYLAPEYAMRG-HLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQE---IELAD--- 924 (1036)
Q Consensus 852 ~~~~~gt~~y~APE~~~~~-~~~~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~---~~~~d--- 924 (1036)
.....||+.|+|||++... .++.++||||+||++|||+||++||....+.+....+............ .....
T Consensus 157 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~ 236 (299)
T d1ua2a_ 157 YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVT 236 (299)
T ss_dssp CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCC
T ss_pred CCCEECCHHHCCHHHHCCCCCCCHHHHHHHCCHHHHHHHHCCCCCCCCCHHHHHHHHHHHCCCCCHHHCCCHHCCCHHHH
T ss_conf 33020473336399972677888056436304289999859699999999999999998518997254521000213443
Q ss_pred -CCCCCCC-----HHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH
Q ss_conf -5243679-----9999999999998104499999998999999
Q 001658 925 -PKLIEFN-----EEEVKRLIGVALLCTQTLPSLRPSMSRVVAM 962 (1036)
Q Consensus 925 -~~~~~~~-----~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 962 (1036)
....... ......+.+++.+|++.||++|||+.|+++.
T Consensus 237 ~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~H 280 (299)
T d1ua2a_ 237 FKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 280 (299)
T ss_dssp CCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred HCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 03478988678565689999999999763894569089999679
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=346.05 Aligned_cols=247 Identities=24% Similarity=0.330 Sum_probs=201.4
Q ss_pred CCCCCCCCCCCCCCEEEEEEEEC-CCCEEEEEECCCC---CHHCHHHHHHHHHHHH-HHCCCCCCEEEEEEECCCEEEEE
Q ss_conf 39999893035897889996828-9938999992410---3320999999999987-40158843168588708322899
Q 001658 693 ENFSPSNKLGEGGFGPVYKGKLG-DGRAIAVKQLSVA---SRQGKSQFVAEIATIS-AVQHRNLVKLHGCCIEGAERLLV 767 (1036)
Q Consensus 693 ~~~~~~~~iG~G~fG~Vy~~~~~-~g~~vAvK~l~~~---~~~~~~~f~~Ei~~l~-~l~H~nIv~l~g~~~~~~~~~lV 767 (1036)
++|.+.+.||+|+||+||+|+.. +++.||||+++.. .....+.+..|..++. .++|||||++++++.+++..++|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCEEEE
T ss_conf 97188658940878289999999999899999980555338489999999999999847999687898897049831677
Q ss_pred EEECCCCCHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCEEECCCCCEEEEECCCCEEECCC
Q ss_conf 98347999445632188777576779999999999999987618965011345788588469984499974741141589
Q 001658 768 YEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDK 847 (1036)
Q Consensus 768 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~ 847 (1036)
|||+++|+|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 82 mEy~~~g~L~~~i~~~--~~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~ 156 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSC--HKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLG 156 (320)
T ss_dssp EECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred EEECCCCCHHHHHHCC--CCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCCCCCCEEECCCCCEECCCCCHHHHCCCC
T ss_conf 7503798089986404--78999999999999999999998689---340347654044448996301555302323566
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCC
Q ss_conf 87422354335674571000238789424678689999999829999999981567789999998740495311258524
Q 001658 848 KTHISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEIELADPKL 927 (1036)
Q Consensus 848 ~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~ 927 (1036)
.. ......||+.|+|||++.+..++.++||||+||++|||++|+.||......+....+. ...+.+
T Consensus 157 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~-------------~~~~~~ 222 (320)
T d1xjda_ 157 DA-KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIR-------------MDNPFY 222 (320)
T ss_dssp TC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH-------------HCCCCC
T ss_pred CC-CCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHH-------------CCCCCC
T ss_conf 53-3454578777689999827998832320112278989873889999989999999997-------------189989
Q ss_pred CCCCHHHHHHHHHHHHHHCCCCCCCCCCHH-HHHH
Q ss_conf 367999999999999981044999999989-9999
Q 001658 928 IEFNEEEVKRLIGVALLCTQTLPSLRPSMS-RVVA 961 (1036)
Q Consensus 928 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~-evl~ 961 (1036)
... ....+.+++.+|++.+|.+||++. |+++
T Consensus 223 p~~---~s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 223 PRW---LEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp CTT---SCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred CCC---CCHHHHHHHHHHCCCCCCCCCCHHHHHHH
T ss_conf 756---79999999999654489878388999980
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=0 Score=342.27 Aligned_cols=250 Identities=24% Similarity=0.327 Sum_probs=203.2
Q ss_pred CCCCCCCCCCCCCCEEEEEEEE-CCCCEEEEEECCCCC---------HHCHHHHHHHHHHHHHHC-CCCCCEEEEEEECC
Q ss_conf 3999989303589788999682-899389999924103---------320999999999987401-58843168588708
Q 001658 693 ENFSPSNKLGEGGFGPVYKGKL-GDGRAIAVKQLSVAS---------RQGKSQFVAEIATISAVQ-HRNLVKLHGCCIEG 761 (1036)
Q Consensus 693 ~~~~~~~~iG~G~fG~Vy~~~~-~~g~~vAvK~l~~~~---------~~~~~~f~~Ei~~l~~l~-H~nIv~l~g~~~~~ 761 (1036)
++|++.+.||+|+||+||+|+. .+++.||||++.... +...+.+.+|+.++++++ ||||+++++++.+.
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred CCCEECEEEECCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEECCCC
T ss_conf 63888528841768499999999999899999996244641147888999999999999999850799747997621467
Q ss_pred CEEEEEEEECCCCCHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCEEECCCCCEEEEECCCC
Q ss_conf 32289998347999445632188777576779999999999999987618965011345788588469984499974741
Q 001658 762 AERLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLA 841 (1036)
Q Consensus 762 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla 841 (1036)
+..++||||+++|+|.+++.. ...+++..+..++.||++||+|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~--~~~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a 157 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTE--KVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFS 157 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred CCEEEEEECCCCCHHHHHHHH--CCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCEEEECCCCCEEECCCHHE
T ss_conf 605999976898668999986--599999999999999999999998759---943234625489868998387124031
Q ss_pred EEECCCCCCCCCCCCCCCCCCCCCCCCC------CCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHH
Q ss_conf 1415898742235433567457100023------8789424678689999999829999999981567789999998740
Q 001658 842 KLYDDKKTHISTRVAGTIGYLAPEYAMR------GHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHE 915 (1036)
Q Consensus 842 ~~~~~~~~~~~~~~~gt~~y~APE~~~~------~~~~~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~ 915 (1036)
+...... ......||..|+|||++.+ ..++.++||||+||++|||++|+.||......+....+. .
T Consensus 158 ~~~~~~~--~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~------~ 229 (277)
T d1phka_ 158 CQLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIM------S 229 (277)
T ss_dssp EECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH------H
T ss_pred EECCCCC--CEEEEECCCCCCCHHHHHCCCCCCCCCCCCHHEECCCCHHHHHHCCCCCCCCCCCHHHHHHHHH------H
T ss_conf 6726887--2134524678889888605344567889923318565602310322888988999999999998------1
Q ss_pred CCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHH
Q ss_conf 4953112585243679999999999999810449999999899999
Q 001658 916 NNQEIELADPKLIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVA 961 (1036)
Q Consensus 916 ~~~~~~~~d~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 961 (1036)
.. .....+... .....+.+++.+|++.+|.+||++.|+++
T Consensus 230 ~~--~~~~~~~~~----~~s~~~~~li~~~L~~~p~~R~s~~eil~ 269 (277)
T d1phka_ 230 GN--YQFGSPEWD----DYSDTVKDLVSRFLVVQPQKRYTAEEALA 269 (277)
T ss_dssp TC--CCCCTTTGG----GSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred CC--CCCCCCCCC----CCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf 89--888985434----68999999999976589668919999973
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=340.87 Aligned_cols=265 Identities=23% Similarity=0.312 Sum_probs=204.8
Q ss_pred CCCCCCCCCCCCCCEEEEEEEE-CCCCEEEEEECCCCC--HHCHHHHHHHHHHHHHHCCCCCCEEEEEEECCCEEEEEEE
Q ss_conf 3999989303589788999682-899389999924103--3209999999999874015884316858870832289998
Q 001658 693 ENFSPSNKLGEGGFGPVYKGKL-GDGRAIAVKQLSVAS--RQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLVYE 769 (1036)
Q Consensus 693 ~~~~~~~~iG~G~fG~Vy~~~~-~~g~~vAvK~l~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 769 (1036)
++|++.+.||+|+||+||+|+. .+++.||+|+++... ......+.+|++++++++|||||++++++.+.+..++|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEECCEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCCCCEEEEEE
T ss_conf 99776517723768099999999999799999980222575899999999999986799838874453322432037886
Q ss_pred ECCCCCHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCEEECCCCCEEEEECCCCEEECCCCC
Q ss_conf 34799944563218877757677999999999999998761896501134578858846998449997474114158987
Q 001658 770 YLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKT 849 (1036)
Q Consensus 770 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~ 849 (1036)
|+.+ ++.+++.......+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+|+.......
T Consensus 82 ~~~~-~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~ 157 (298)
T d1gz8a_ 82 FLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR 157 (298)
T ss_dssp CCSE-EHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSB
T ss_pred ECCC-CHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHCCC---EECCCCCCHHEEECCCCCCEECCCCCCEECCCCCC
T ss_conf 2377-4455544202568888999999999999999865288---99213571140113467621035786134368864
Q ss_pred CCCCCCCCCCCCCCCCCCCCCC-CCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCC-CC---
Q ss_conf 4223543356745710002387-894246786899999998299999999815677899999987404953112-58---
Q 001658 850 HISTRVAGTIGYLAPEYAMRGH-LTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEIEL-AD--- 924 (1036)
Q Consensus 850 ~~~~~~~gt~~y~APE~~~~~~-~~~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~-~d--- 924 (1036)
......||+.|+|||...... ++.++||||+||++|||++|+.||......+.............+...... ..
T Consensus 158 -~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 236 (298)
T d1gz8a_ 158 -TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 236 (298)
T ss_dssp -CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTC
T ss_pred -CCEEECCCCEEEEHHHHCCCCCCCCCCCCCCCCHHHHHHHHCCCCCCCCCHHHHHHHHHHHCCCCCHHHCCCCCCCCCC
T ss_conf -1001036521541122136657774221033331342796687998988999999999983289833314442224212
Q ss_pred ----CCCCCC-----CHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH
Q ss_conf ----524367-----99999999999998104499999998999999
Q 001658 925 ----PKLIEF-----NEEEVKRLIGVALLCTQTLPSLRPSMSRVVAM 962 (1036)
Q Consensus 925 ----~~~~~~-----~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 962 (1036)
+..... .......+.+++.+|++.||.+|||+.|+++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H 283 (298)
T d1gz8a_ 237 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283 (298)
T ss_dssp CTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 43454322220444166789999999999763995579189999678
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=0 Score=335.73 Aligned_cols=263 Identities=24% Similarity=0.325 Sum_probs=204.0
Q ss_pred CCCCCCCCCCCCCCEEEEEEEECCCCEEEEEECCCC--CHHCHHHHHHHHHHHHHHCCCCCCEEEEEEECCCEEEEEEEE
Q ss_conf 399998930358978899968289938999992410--332099999999998740158843168588708322899983
Q 001658 693 ENFSPSNKLGEGGFGPVYKGKLGDGRAIAVKQLSVA--SRQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLVYEY 770 (1036)
Q Consensus 693 ~~~~~~~~iG~G~fG~Vy~~~~~~g~~vAvK~l~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~ 770 (1036)
++|+..+.||+|+||+||+|+.++++.||||++... .....+.+.+|+.++++++||||+++++++...+..++++|+
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCCEECCEEECCCCCEEEEEEECCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEECCCCCCEEEEEEE
T ss_conf 99634318722778189999968999999999812326858999999999999867998687660120467731589974
Q ss_pred CCCCCHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCEEECCCCCEEEEECCCCEEECCCCCC
Q ss_conf 47999445632188777576779999999999999987618965011345788588469984499974741141589874
Q 001658 771 LENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKTH 850 (1036)
Q Consensus 771 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~ 850 (1036)
+.++.+..+.. ....+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+|++|||.+........
T Consensus 82 ~~~~~~~~~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~- 155 (286)
T d1ob3a_ 82 LDQDLKKLLDV--CEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVR- 155 (286)
T ss_dssp CSEEHHHHHHT--STTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC----
T ss_pred EHHHHHHHHHH--HCCCCCHHHHHHHHHHHHHHHHHHCCCC---EEECCCCCCEEEECCCCCEEECCCCCCEECCCCCC-
T ss_conf 00456789986--0477514456899999999999860574---88267877505686899787323664301146765-
Q ss_pred CCCCCCCCCCCCCCCCCCC-CCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCC---CC--CCC
Q ss_conf 2235433567457100023-87894246786899999998299999999815677899999987404953---11--258
Q 001658 851 ISTRVAGTIGYLAPEYAMR-GHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQE---IE--LAD 924 (1036)
Q Consensus 851 ~~~~~~gt~~y~APE~~~~-~~~~~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~---~~--~~d 924 (1036)
......|++.|+|||.+.+ ..++.++||||+||++|||++|+.||......+....+............ .. ...
T Consensus 156 ~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 235 (286)
T d1ob3a_ 156 KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYD 235 (286)
T ss_dssp ------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCC
T ss_pred CCCEECCCCHHHHHHHHHCCCCCCCCEEEHHCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHHCCCCHHHCCCHHHHHHCC
T ss_conf 41010243110137887178888841002111758999977979989889899999999863899711042123332214
Q ss_pred CCC--------CCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHH
Q ss_conf 524--------3679999999999999810449999999899999
Q 001658 925 PKL--------IEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVA 961 (1036)
Q Consensus 925 ~~~--------~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 961 (1036)
... ..........+.+++.+|++.||++|||+.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 236 PNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp TTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf 333335676466651258999999999986689668909999856
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=333.79 Aligned_cols=266 Identities=23% Similarity=0.339 Sum_probs=198.3
Q ss_pred HHCCCCCCCCCCCCCCEEEEEEEE-CC-CCEEEEEECCCCC--HHCHHHHHHHHHHHHHH---CCCCCCEEEEEEEC---
Q ss_conf 723999989303589788999682-89-9389999924103--32099999999998740---15884316858870---
Q 001658 691 ATENFSPSNKLGEGGFGPVYKGKL-GD-GRAIAVKQLSVAS--RQGKSQFVAEIATISAV---QHRNLVKLHGCCIE--- 760 (1036)
Q Consensus 691 ~~~~~~~~~~iG~G~fG~Vy~~~~-~~-g~~vAvK~l~~~~--~~~~~~f~~Ei~~l~~l---~H~nIv~l~g~~~~--- 760 (1036)
..++|++.+.||+|+||+||+|+. .+ ++.||||+++... ......+.+|+.+++.+ +||||+++++++..
T Consensus 5 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~ 84 (305)
T d1blxa_ 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 84 (305)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred CCCCEEEEEEEECCCCEEEEEEEEECCCCEEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHHHCCCCCCCEEEEEECCCCC
T ss_conf 75897988899215586999999988899899999980232451679999999999998742589880236632214666
Q ss_pred --CCEEEEEEEECCCCCHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCEEECCCCCEEEEEC
Q ss_conf --832289998347999445632188777576779999999999999987618965011345788588469984499974
Q 001658 761 --GAERLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDF 838 (1036)
Q Consensus 761 --~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DF 838 (1036)
....++++|+++++.+.... ......+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+||
T Consensus 85 ~~~~~~~~~~e~~~~~~~~~~~-~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~~kl~df 160 (305)
T d1blxa_ 85 DRETKLTLVFEHVDQDLTTYLD-KVPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADF 160 (305)
T ss_dssp SSEEEEEEEEECCSCBHHHHHH-HSCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECSC
T ss_pred CCCCEEEEEEEECCCCCHHHHH-HCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCCCCCEEEECCCCCEEECCH
T ss_conf 6674699999740587144444-303789998999999999999999997588---983579862789858997542100
Q ss_pred CCCEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHCC-
Q ss_conf 7411415898742235433567457100023878942467868999999982999999998156778999999874049-
Q 001658 839 GLAKLYDDKKTHISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENN- 917 (1036)
Q Consensus 839 Gla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~- 917 (1036)
|+++..... .......||+.|+|||++.+..++.++||||+||++|||++|++||......+....+..........
T Consensus 161 g~~~~~~~~--~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 238 (305)
T d1blxa_ 161 GLARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED 238 (305)
T ss_dssp CSCCCCCGG--GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGG
T ss_pred HHHHHHCCC--CCCCCCCCCHHHCCCCHHCCCCCCHHEHHHCHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHCCCCHHC
T ss_conf 010110023--457776548511483100179888111000328999999878799899898999999998407996110
Q ss_pred CCCC----------CCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH
Q ss_conf 5311----------25852436799999999999998104499999998999999
Q 001658 918 QEIE----------LADPKLIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVAM 962 (1036)
Q Consensus 918 ~~~~----------~~d~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 962 (1036)
.... ................+.+++.+|++.||.+|||+.|+++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H 293 (305)
T d1blxa_ 239 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 293 (305)
T ss_dssp SCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred CCCCCCCHHHHHCCCCCCCHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 5321111033302234564544044589999999999874896679189999669
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=331.10 Aligned_cols=266 Identities=21% Similarity=0.268 Sum_probs=200.8
Q ss_pred HHCCCCCCCCCCCCCCEEEEEEEE-CCCCEEEEEECCCC-CHHCHHHHHHHHHHHHHHCCCCCCEEEEEEECCC----EE
Q ss_conf 723999989303589788999682-89938999992410-3320999999999987401588431685887083----22
Q 001658 691 ATENFSPSNKLGEGGFGPVYKGKL-GDGRAIAVKQLSVA-SRQGKSQFVAEIATISAVQHRNLVKLHGCCIEGA----ER 764 (1036)
Q Consensus 691 ~~~~~~~~~~iG~G~fG~Vy~~~~-~~g~~vAvK~l~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~----~~ 764 (1036)
.+.+|++.+.||+|+||+||+|+. .+|+.||||++... .....+.+.+|+.+|++++||||+++++++.... ..
T Consensus 6 i~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~ 85 (345)
T d1pmea_ 6 VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 85 (345)
T ss_dssp CCTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred CCCCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHCCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCCCCE
T ss_conf 38985997899406480999999999994999999803109589999999999999768989885888995056455414
Q ss_pred EEEEEECCCCCHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCEEECCCCCEEEEECCCCEEE
Q ss_conf 89998347999445632188777576779999999999999987618965011345788588469984499974741141
Q 001658 765 LLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLY 844 (1036)
Q Consensus 765 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~ 844 (1036)
+++++++.+|+|.+++.. ..+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 86 ~~l~~~~~~g~L~~~l~~---~~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~DfG~a~~~ 159 (345)
T d1pmea_ 86 VYLVTHLMGADLYKLLKT---QHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVA 159 (345)
T ss_dssp EEEEEECCCEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEEEECCCCHHHHHHC---CCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCEEEECCCCCEEECCCCCEEEC
T ss_conf 999996259865664405---89999999999999999999999789---867778764378879997787545705650
Q ss_pred CCCCCC--CCCCCCCCCCCCCCCCCCC-CCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHCCC---
Q ss_conf 589874--2235433567457100023-8789424678689999999829999999981567789999998740495---
Q 001658 845 DDKKTH--ISTRVAGTIGYLAPEYAMR-GHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQ--- 918 (1036)
Q Consensus 845 ~~~~~~--~~~~~~gt~~y~APE~~~~-~~~~~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~--- 918 (1036)
...... ......||+.|+|||++.. ..++.++||||+||++|||++|+.||......+................
T Consensus 160 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (345)
T d1pmea_ 160 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC 239 (345)
T ss_dssp CGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHT
T ss_pred CCCCCCCEEECCCCCCCEECHHHHHHCCCCCCCHHHHHCCCCEEHHHHHCCCCCCCCCHHHHHHHHHHHCCCCCHHHHHH
T ss_conf 47776410101102652000387860478887410100467013377669799788888999998765206997566423
Q ss_pred -------CCCCCCCCCCCCC-----HHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH
Q ss_conf -------3112585243679-----9999999999998104499999998999999
Q 001658 919 -------EIELADPKLIEFN-----EEEVKRLIGVALLCTQTLPSLRPSMSRVVAM 962 (1036)
Q Consensus 919 -------~~~~~d~~~~~~~-----~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 962 (1036)
......+...... .....++.+++.+|++.||.+|||+.|+++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 240 IINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp CCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHHHHHCCCCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 43322220244677557787778378999999999999764895679089998619
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=328.87 Aligned_cols=261 Identities=21% Similarity=0.254 Sum_probs=200.9
Q ss_pred HHCCCCCCCCCCCCCCEEEEEEEE-CCCCEEEEEECCCC--CHHCHHHHHHHHHHHHHHCCCCCCEEEEEEECCC-----
Q ss_conf 723999989303589788999682-89938999992410--3320999999999987401588431685887083-----
Q 001658 691 ATENFSPSNKLGEGGFGPVYKGKL-GDGRAIAVKQLSVA--SRQGKSQFVAEIATISAVQHRNLVKLHGCCIEGA----- 762 (1036)
Q Consensus 691 ~~~~~~~~~~iG~G~fG~Vy~~~~-~~g~~vAvK~l~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~----- 762 (1036)
..++|++.+.||+|+||+||+|.. .+|+.||||+++.. .....+.+.+|+.+|++++|||||++++++...+
T Consensus 16 ~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~ 95 (346)
T d1cm8a_ 16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 95 (346)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred CCCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCCCCC
T ss_conf 47718998898017781999999999998999999852225969999999999999866898754799986357655554
Q ss_pred -EEEEEEEECCCCCHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCEEECCCCCEEEEECCCC
Q ss_conf -2289998347999445632188777576779999999999999987618965011345788588469984499974741
Q 001658 763 -ERLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLA 841 (1036)
Q Consensus 763 -~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla 841 (1036)
..++||||+ +.+|..+... ..+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+|++|||++
T Consensus 96 ~~~~lv~e~~-~~~l~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl~Dfg~a 168 (346)
T d1cm8a_ 96 TDFYLVMPFM-GTDLGKLMKH---EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLA 168 (346)
T ss_dssp CCCEEEEECC-SEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred CEEEEEEECC-CCCHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCHHHCCCCCCCCCCCCCCE
T ss_conf 1599998405-5218999874---02269999999999999999987378---764566851111210012211343102
Q ss_pred EEECCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHH-----H
Q ss_conf 1415898742235433567457100023-878942467868999999982999999998156778999999874-----0
Q 001658 842 KLYDDKKTHISTRVAGTIGYLAPEYAMR-GHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLH-----E 915 (1036)
Q Consensus 842 ~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~-----~ 915 (1036)
+...... +...||+.|+|||++.+ ..++.++||||+||++|||++|++||................... .
T Consensus 169 ~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (346)
T d1cm8a_ 169 RQADSEM----TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQ 244 (346)
T ss_dssp EECCSSC----CSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred ECCCCCC----CCCCCCCCCCCHHHHCCCCCCCCCCHHHCCHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCCCHHHHH
T ss_conf 2068763----102455333588998178789965010300389999997869988897689999998503788488886
Q ss_pred CCC----------CCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH
Q ss_conf 495----------31125852436799999999999998104499999998999999
Q 001658 916 NNQ----------EIELADPKLIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVAM 962 (1036)
Q Consensus 916 ~~~----------~~~~~d~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 962 (1036)
... ...................+.+++.+|++.||.+|||+.|+++.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~H 301 (346)
T d1cm8a_ 245 RLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 301 (346)
T ss_dssp TCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHCCHHHHHHHCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 530003443311578666556677556899999999999772995579299999639
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=326.11 Aligned_cols=266 Identities=21% Similarity=0.282 Sum_probs=201.7
Q ss_pred HCCCCCCCCCCCCCCEEEEEEEE-CCCCEEEEEECCCC--CHHCHHHHHHHHHHHHHHCCCCCCEEEEEEEC--------
Q ss_conf 23999989303589788999682-89938999992410--33209999999999874015884316858870--------
Q 001658 692 TENFSPSNKLGEGGFGPVYKGKL-GDGRAIAVKQLSVA--SRQGKSQFVAEIATISAVQHRNLVKLHGCCIE-------- 760 (1036)
Q Consensus 692 ~~~~~~~~~iG~G~fG~Vy~~~~-~~g~~vAvK~l~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~-------- 760 (1036)
.++|++.+.||+|+||+||+|+. .+|+.||||++... ......++.+|+.+|++++|+||+++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHHCCCCCCCEEEEEECCCCCCCCC
T ss_conf 27988999972274829999999899979999998422246378999999999999835999660676540246544445
Q ss_pred CCEEEEEEEECCCCCHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCEEECCCCCEEEEECCC
Q ss_conf 83228999834799944563218877757677999999999999998761896501134578858846998449997474
Q 001658 761 GAERLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGL 840 (1036)
Q Consensus 761 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGl 840 (1036)
.+..++|+||++++.+..... ....+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+|++|||+
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~~--~~~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~kl~dfg~ 163 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLSN--VLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGL 163 (318)
T ss_dssp --CEEEEEECCCEEHHHHHTC--TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTT
T ss_pred CCEEEEEEECCCCCCCCHHHH--CCCCCCCHHHHHHHHHHHHHHHHHCCCC---EEECCCCCHHEEECCCCCEEEEECCE
T ss_conf 763899985357874101222--0344330899999999999998852299---88567672220366899687631350
Q ss_pred CEEECCCCCC---CCCCCCCCCCCCCCCCCCCC-CCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHC
Q ss_conf 1141589874---22354335674571000238-7894246786899999998299999999815677899999987404
Q 001658 841 AKLYDDKKTH---ISTRVAGTIGYLAPEYAMRG-HLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHEN 916 (1036)
Q Consensus 841 a~~~~~~~~~---~~~~~~gt~~y~APE~~~~~-~~~~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~ 916 (1036)
++.+...... ......||+.|+|||++.+. .++.++||||+||++|||++|+.||....+................
T Consensus 164 ~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~ 243 (318)
T d3blha1 164 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP 243 (318)
T ss_dssp CEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred EEECCCCCCCCCCCCCCEECCHHHHHHHHHCCCCCCCCHHHCCCCCCEEEEHHHCCCCCCCCCHHHHHHHHHHHCCCCCH
T ss_conf 02235544432113566024978742899707999891787006786466174487998998999999999984189982
Q ss_pred CCCCCCCCC---------CCCCCCHH-------HHHHHHHHHHHHCCCCCCCCCCHHHHHHH
Q ss_conf 953112585---------24367999-------99999999998104499999998999999
Q 001658 917 NQEIELADP---------KLIEFNEE-------EVKRLIGVALLCTQTLPSLRPSMSRVVAM 962 (1036)
Q Consensus 917 ~~~~~~~d~---------~~~~~~~~-------~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 962 (1036)
......... ........ ....+.+++.+|++.||++|||+.|+++.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H 305 (318)
T d3blha1 244 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305 (318)
T ss_dssp TTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHCCCCCHHHHHHHHCCCCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 55344320344433201334455503340444599899999999873896589099999749
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=335.57 Aligned_cols=240 Identities=21% Similarity=0.307 Sum_probs=192.8
Q ss_pred HCCCCCCCCCCCCCCEEEEEEEE-CCCCEEEEEECCCCCH------HCHHHHHHHHHHHHHHC--CCCCCEEEEEEECCC
Q ss_conf 23999989303589788999682-8993899999241033------20999999999987401--588431685887083
Q 001658 692 TENFSPSNKLGEGGFGPVYKGKL-GDGRAIAVKQLSVASR------QGKSQFVAEIATISAVQ--HRNLVKLHGCCIEGA 762 (1036)
Q Consensus 692 ~~~~~~~~~iG~G~fG~Vy~~~~-~~g~~vAvK~l~~~~~------~~~~~f~~Ei~~l~~l~--H~nIv~l~g~~~~~~ 762 (1036)
.++|++.+.||+|+||.||+|+. .+++.||||++..... ....++.+|+.++++++ |||||++++++.+.+
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CCEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEEECC
T ss_conf 88379967984087839999999999979999998568844334556799999999999974358988127999983099
Q ss_pred EEEEEEEECCC-CCHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCEEECCC-CCEEEEECCC
Q ss_conf 22899983479-994456321887775767799999999999999876189650113457885884699-8449997474
Q 001658 763 ERLLVYEYLEN-KSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDAD-LVPKISDFGL 840 (1036)
Q Consensus 763 ~~~lV~E~~~~-gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NILl~~~-~~~kl~DFGl 840 (1036)
..++|+||+.+ +++.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.+ +.+||+|||+
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~~--~~~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~vkl~DFG~ 157 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFITE--RGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGS 157 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred EEEEEEEECCCCCHHHHHHHC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCCEEEECCCCEEEECCCCC
T ss_conf 689999833686228999861--589999999999999999999998779---755667611147744788489775465
Q ss_pred CEEECCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCC
Q ss_conf 11415898742235433567457100023878-94246786899999998299999999815677899999987404953
Q 001658 841 AKLYDDKKTHISTRVAGTIGYLAPEYAMRGHL-TEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQE 919 (1036)
Q Consensus 841 a~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~-~~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 919 (1036)
|+...... .....||+.|+|||++.+..+ +.++||||+||++|||++|+.||.... . .. ..
T Consensus 158 a~~~~~~~---~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~---~--i~-------~~--- 219 (273)
T d1xwsa_ 158 GALLKDTV---YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE---E--II-------RG--- 219 (273)
T ss_dssp CEECCSSC---BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH---H--HH-------HC---
T ss_pred CEECCCCC---CCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCEEEEHHHHHCCCCCCCCH---H--HH-------HC---
T ss_conf 35324445---5665658774799998489978865332554034536756889988736---7--76-------15---
Q ss_pred CCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHH
Q ss_conf 112585243679999999999999810449999999899999
Q 001658 920 IELADPKLIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVA 961 (1036)
Q Consensus 920 ~~~~d~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 961 (1036)
...+... ...++.+++.+|++.||.+|||+.|+++
T Consensus 220 ----~~~~~~~---~s~~~~~li~~~L~~dp~~R~s~~eil~ 254 (273)
T d1xwsa_ 220 ----QVFFRQR---VSSECQHLIRWCLALRPSDRPTFEEIQN 254 (273)
T ss_dssp ----CCCCSSC---CCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ----CCCCCCC---CCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf ----4477877---9999999999976089758939999853
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=325.22 Aligned_cols=260 Identities=25% Similarity=0.300 Sum_probs=192.9
Q ss_pred CCCCCCCCCCCCCEEEEEEEEC-CCCEEEEEECCCCCHHCHHHHHHHHHHHHHHCCCCCCEEEEEEECC------CEEEE
Q ss_conf 9999893035897889996828-9938999992410332099999999998740158843168588708------32289
Q 001658 694 NFSPSNKLGEGGFGPVYKGKLG-DGRAIAVKQLSVASRQGKSQFVAEIATISAVQHRNLVKLHGCCIEG------AERLL 766 (1036)
Q Consensus 694 ~~~~~~~iG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~------~~~~l 766 (1036)
+|+..++||+|+||+||+|+.. +++.||||++..... .+.+|+.++++++|+||+++++++... ...++
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CCEEEEEEEECCCEEEEEEEECCCCCEEEEEEECCCCH----HHHHHHHHHHHCCCCCCCCEEEEEEECCCCCCCEEEEE
T ss_conf 76751698217683999999999997999999881606----89999999986689898738789974476577318999
Q ss_pred EEEECCCCCHHHHHHC-CCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCEEECCCC-CEEEEECCCCEEE
Q ss_conf 9983479994456321-8877757677999999999999998761896501134578858846998-4499974741141
Q 001658 767 VYEYLENKSLDQALFG-QRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADL-VPKISDFGLAKLY 844 (1036)
Q Consensus 767 V~E~~~~gsL~~~l~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NILl~~~~-~~kl~DFGla~~~ 844 (1036)
||||++++.+...... .....+++..+..++.|++.||+|||+.+ |+||||||+|||++.++ .+||+|||+++..
T Consensus 97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~ 173 (350)
T d1q5ka_ 97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173 (350)
T ss_dssp EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred EEECCCCCCHHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCEEEEECCCCCEEEECCCCHHHC
T ss_conf 9841688607888863103689999999999999999999998668---7645788603787358971167336605440
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHH--------HHHHH
Q ss_conf 5898742235433567457100023-87894246786899999998299999999815677899999--------98740
Q 001658 845 DDKKTHISTRVAGTIGYLAPEYAMR-GHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWA--------WHLHE 915 (1036)
Q Consensus 845 ~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~--------~~~~~ 915 (1036)
..... .....|+..|+|||.+.+ ..++.++||||+||++|||++|++||......+....+... +....
T Consensus 174 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~ 251 (350)
T d1q5ka_ 174 VRGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN 251 (350)
T ss_dssp CTTSC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHC
T ss_pred CCCCC--CCCCCCCCCCCCHHHHHCCCCCCCCEEECCCCEEEEEHHHCCCCCCCCCHHHHHHHHHHHHCCCHHHHHHHHC
T ss_conf 47765--3200255555682776404688821000246527785502879989879999999999974898177654306
Q ss_pred CC-CCCCCCC---CCC-CCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH
Q ss_conf 49-5311258---524-36799999999999998104499999998999999
Q 001658 916 NN-QEIELAD---PKL-IEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVAM 962 (1036)
Q Consensus 916 ~~-~~~~~~d---~~~-~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 962 (1036)
.. ....... ... ..........+.+++.+|++.||.+|||+.|+++.
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 303 (350)
T d1q5ka_ 252 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 303 (350)
T ss_dssp C---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CCHHHCCCCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 2101103554456744443156899999999999765895579299999669
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=326.75 Aligned_cols=262 Identities=22% Similarity=0.273 Sum_probs=200.1
Q ss_pred HCCCCCCCCCCCCCCEEEEEEEE-CCCCEEEEEECCCCCHHCHHHHHHHHHHHHHHCCCCCCE-EEEEEECCCEEEEEEE
Q ss_conf 23999989303589788999682-899389999924103320999999999987401588431-6858870832289998
Q 001658 692 TENFSPSNKLGEGGFGPVYKGKL-GDGRAIAVKQLSVASRQGKSQFVAEIATISAVQHRNLVK-LHGCCIEGAERLLVYE 769 (1036)
Q Consensus 692 ~~~~~~~~~iG~G~fG~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~-l~g~~~~~~~~~lV~E 769 (1036)
.++|++.+.||+|+||.||+|+. .+++.||||++..... ..++..|+++++.++|+|++. +.++..+.+..++|+|
T Consensus 6 g~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme 83 (299)
T d1ckia_ 6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 83 (299)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCEEEEEEEEEECCCCEEEEEEECCCCCEEEEEEECHHCC--CHHHHHHHHHHHHCCCCCCCCEEEEEEECCCEEEEEEE
T ss_conf 8889996898507880999999988998999999721005--88899999999970389960179999951987789998
Q ss_pred ECCCCCHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCEEECC---CCCEEEEECCCCEEECC
Q ss_conf 347999445632188777576779999999999999987618965011345788588469---98449997474114158
Q 001658 770 YLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDA---DLVPKISDFGLAKLYDD 846 (1036)
Q Consensus 770 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NILl~~---~~~~kl~DFGla~~~~~ 846 (1036)
|+ +++|.+.+... ...+++..+..++.|++.||+|||+++ |+||||||+|||++. +..+|++|||+|+.+..
T Consensus 84 ~~-~~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~ 158 (299)
T d1ckia_ 84 LL-GPSLEDLFNFC-SRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 158 (299)
T ss_dssp CC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSSCEECBC
T ss_pred EC-CCCHHHHHHHC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCCCHHHCCCCCCCCCCEEEEECCCCCEECCC
T ss_conf 73-87133324430-688768999999999999999999799---44266787660643357776156504675134255
Q ss_pred CCCC------CCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCC
Q ss_conf 9874------2235433567457100023878942467868999999982999999998156778999999874049531
Q 001658 847 KKTH------ISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEI 920 (1036)
Q Consensus 847 ~~~~------~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 920 (1036)
.... ......||+.|+|||++.+..++.++|||||||++|||+||+.||.....................
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~---- 234 (299)
T d1ckia_ 159 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS---- 234 (299)
T ss_dssp TTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHH----
T ss_pred CCCCCCEECCCCCCCCCCCCCCCHHHHHCCCCCCHHHEEECCHHHHHHHHCCCCCCCCCHHHHHHHHHHHHCCCCC----
T ss_conf 4455410001357767873532999991899898321886177899998498766553057799999985235678----
Q ss_pred CCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCC
Q ss_conf 125852436799999999999998104499999998999999640558
Q 001658 921 ELADPKLIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVAMLCGDME 968 (1036)
Q Consensus 921 ~~~d~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 968 (1036)
...+.+ ....+..+.+++..||+.+|.+||+++++.+.|+....
T Consensus 235 -~~~~~~---~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~ 278 (299)
T d1ckia_ 235 -TPIEVL---CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 278 (299)
T ss_dssp -SCHHHH---TTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHH
T ss_pred -CCHHHH---CCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHH
T ss_conf -983575---34788999999999843995579199999999999999
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=0 Score=323.86 Aligned_cols=264 Identities=18% Similarity=0.211 Sum_probs=206.2
Q ss_pred HCCCCCCCCCCCCCCEEEEEEEEC-CCCEEEEEECCCCCHHCHHHHHHHHHHHHHHCC-CCCCEEEEEEECCCEEEEEEE
Q ss_conf 239999893035897889996828-993899999241033209999999999874015-884316858870832289998
Q 001658 692 TENFSPSNKLGEGGFGPVYKGKLG-DGRAIAVKQLSVASRQGKSQFVAEIATISAVQH-RNLVKLHGCCIEGAERLLVYE 769 (1036)
Q Consensus 692 ~~~~~~~~~iG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~f~~Ei~~l~~l~H-~nIv~l~g~~~~~~~~~lV~E 769 (1036)
.++|++.+.||+|+||+||+|+.. +++.||||++..... ...+.+|++.+..++| +|++.+++++......++|||
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme 81 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 81 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCCC--CHHHHHHHHHHHHHCCCCCCCEEEEEEECCCCCEEEEE
T ss_conf 9806997998417882999999988997999999750258--29999999999996489998779999601881179999
Q ss_pred ECCCCCHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCEEECC-----CCCEEEEECCCCEEE
Q ss_conf 347999445632188777576779999999999999987618965011345788588469-----984499974741141
Q 001658 770 YLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDA-----DLVPKISDFGLAKLY 844 (1036)
Q Consensus 770 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NILl~~-----~~~~kl~DFGla~~~ 844 (1036)
|+ +++|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+|||++. ++.+||+|||+|+.+
T Consensus 82 ~~-~~~l~~~~~~~-~~~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~ 156 (293)
T d1csna_ 82 LL-GPSLEDLLDLC-GRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 156 (293)
T ss_dssp CC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred EC-CCCHHHHHHHH-CCCHHHHHHHHHHHHHHHHHHHHHHCC---CEECCCCCCCEEECCCCCCCCCCEEECCCCEEEEC
T ss_conf 64-88879999752-031106899999999999999999779---66266771315234754344795687236605771
Q ss_pred CCCCCC------CCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHCCC
Q ss_conf 589874------22354335674571000238789424678689999999829999999981567789999998740495
Q 001658 845 DDKKTH------ISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQ 918 (1036)
Q Consensus 845 ~~~~~~------~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 918 (1036)
...... ......||+.|||||++.+..++.++||||||+++|||+||+.||.......................
T Consensus 157 ~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 236 (293)
T d1csna_ 157 RDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTP 236 (293)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSC
T ss_pred CCCCCCCCEEECCCCCEEECHHHCCHHHHCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHCCCCCC
T ss_conf 46766541110246762775102679896488888699989831999999869876788530219999999970567999
Q ss_pred CCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCCCC
Q ss_conf 3112585243679999999999999810449999999899999964055887
Q 001658 919 EIELADPKLIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVAMLCGDMEVS 970 (1036)
Q Consensus 919 ~~~~~d~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~ 970 (1036)
.+.+ ....+..+.+++..|+..+|++||+++.+.+.|++.++..
T Consensus 237 -----~~~l---~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~ 280 (293)
T d1csna_ 237 -----LREL---CAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERL 280 (293)
T ss_dssp -----HHHH---TTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred -----HHHH---CCCCCHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHC
T ss_conf -----5896---5799899999999984399300859999999999999975
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=100.00 E-value=0 Score=322.17 Aligned_cols=281 Identities=28% Similarity=0.482 Sum_probs=211.4
Q ss_pred CCCHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCEEEEEEEEEEECCCCC-
Q ss_conf 8998799999999986045767999889999987988898610278999993110159999943567599984032466-
Q 001658 35 TTDPNEVRALNSIFQQWRISARQGQWNRSGDPCTGAALDDSIVFDNTDYNPFIKCDCSSQNGTVCHITQLKVYALNVVG- 113 (1036)
Q Consensus 35 ~~~~~~~~aL~~~~~~~~~~~~~~sW~~~~d~C~~~~~~~~~~~~~~~~~~~~~~~C~~~~~~~~~~~~L~l~~~~l~~- 113 (1036)
.|+|+|++||++||+++.++..+++|+.++|||.. .|.||.|+..+ .+.+|+.|++.++++.+
T Consensus 2 ~c~~~e~~aLl~~k~~~~~~~~l~sW~~~~d~C~~---------------~w~gv~C~~~~-~~~~v~~L~L~~~~l~g~ 65 (313)
T d1ogqa_ 2 LCNPQDKQALLQIKKDLGNPTTLSSWLPTTDCCNR---------------TWLGVLCDTDT-QTYRVNNLDLSGLNLPKP 65 (313)
T ss_dssp CSCHHHHHHHHHHHHHTTCCGGGTTCCTTSCTTTT---------------CSTTEEECCSS-SCCCEEEEEEECCCCSSC
T ss_pred CCCHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCC---------------CCCCEEEECCC-CCEEEEEEECCCCCCCCC
T ss_conf 98989999999999977999867788999999889---------------48896974899-947988998989988888
Q ss_pred -CCCCCCCCCCCCCEEECCC-CCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCC
Q ss_conf -6981125999998999238-88999896111377767765211433668764011399998699831677988894124
Q 001658 114 -VIPDELWNLTSLFNLNLGQ-NYLTGPLSPSVGNLTAMQYLNLAINALSGELPKELGQLTELLILGIGTNNFSGPLPSEL 191 (1036)
Q Consensus 114 -~ip~~l~~l~~L~~L~L~~-n~l~~~~p~~~~~L~~L~~L~L~~n~l~~~~p~~l~~L~~L~~L~Ls~N~l~~~~p~~l 191 (1036)
.+|++++++++|++|+|++ |.++|.+|.+|++|++|++|+|++|++.+..+..+..+.+|+.++++.|.+.+.+|..+
T Consensus 66 ~~lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~N~~~~~~p~~l 145 (313)
T d1ogqa_ 66 YPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSI 145 (313)
T ss_dssp EECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGG
T ss_pred CCCCHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCHHH
T ss_conf 87984784675335202026543330024311454200110203564344332222201110011112245555685122
Q ss_pred CCCCCCCEEECCCCCCCCCCCCCCCCCCCC-CEEECCCCCCCCCCHHHHCCCCCCCEEEEECCCCCCCCCCCCCCCCCCC
Q ss_conf 788668777475644778897320287789-6786468747887702103999999999008868887872234999988
Q 001658 192 GSLSKLQELYIDSAGVSGEIPSSFANLQSL-TKWWASDTRLTGRIPDFIGNWSKLTALRFQGNSFNGPIPSSFSNLTSVT 270 (1036)
Q Consensus 192 ~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L-~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~ 270 (1036)
..+++|+.+++++|.+.+.+|..+..+..+ +.++++.|++.+..+..+..+.. ..+++..+.+.+.+|..+..+.
T Consensus 146 ~~l~~L~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~-~~l~l~~~~~~~~~~~~~~~~~--- 221 (313)
T d1ogqa_ 146 SSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNL-AFVDLSRNMLEGDASVLFGSDK--- 221 (313)
T ss_dssp GGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCC-SEEECCSSEEEECCGGGCCTTS---
T ss_pred CCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCCCCCCCCCCCCCCCCC---
T ss_conf 067400000023553356203121443112323102246435332433222222-2333333433222222222222---
Q ss_pred EEECCCCCCCCCCHHHHCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHCCCCCCCCEEECCCCC
Q ss_conf 99846888999840200399999899831776686655121289986599177988999992000599886579744761
Q 001658 271 ELRISDLSNGSSKLAFIRDMKSLSILELRNNNISDSIPSNIGEYRSLQHLDLSFNNLGGSIPDSLFNLSSLTHLFLGNNK 350 (1036)
Q Consensus 271 ~L~L~~n~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~ip~~l~~l~~L~~L~Ls~N~L~g~ip~~l~~l~~L~~L~Ls~N~ 350 (1036)
+|+.|++++|.+.+.++ .+..+++|+.|+|++|+++|.+|..+.++++|+.|+|++|+
T Consensus 222 ---------------------~l~~l~~~~~~l~~~~~-~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~ 279 (313)
T d1ogqa_ 222 ---------------------NTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNN 279 (313)
T ss_dssp ---------------------CCSEEECCSSEECCBGG-GCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSE
T ss_pred ---------------------CCCCCCCCCCCCCCCCC-CCCCCCCCCCCCCCCCEECCCCCHHHHCCCCCCEEECCCCC
T ss_conf ---------------------21112222222222222-22245544444476570666087688479999989795883
Q ss_pred CCCCCCC
Q ss_conf 6666888
Q 001658 351 LNGTLPA 357 (1036)
Q Consensus 351 l~g~~p~ 357 (1036)
|+|.+|.
T Consensus 280 l~g~iP~ 286 (313)
T d1ogqa_ 280 LCGEIPQ 286 (313)
T ss_dssp EEEECCC
T ss_pred CCCCCCC
T ss_conf 5166898
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=325.76 Aligned_cols=252 Identities=23% Similarity=0.295 Sum_probs=201.0
Q ss_pred CCCCCCCCCCCCCCEEEEEEEE----CCCCEEEEEECCCC----CHHCHHHHHHHHHHHHHHCC-CCCCEEEEEEECCCE
Q ss_conf 3999989303589788999682----89938999992410----33209999999999874015-884316858870832
Q 001658 693 ENFSPSNKLGEGGFGPVYKGKL----GDGRAIAVKQLSVA----SRQGKSQFVAEIATISAVQH-RNLVKLHGCCIEGAE 763 (1036)
Q Consensus 693 ~~~~~~~~iG~G~fG~Vy~~~~----~~g~~vAvK~l~~~----~~~~~~~f~~Ei~~l~~l~H-~nIv~l~g~~~~~~~ 763 (1036)
++|++.+.||+|+||+||+|+. .+|+.||+|+++.. .....+.+.+|++++++++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred HCEEEEEEEECCCCEEEEEEEECCCCCCCCEEEEEEEEHHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCC
T ss_conf 02599989832878399999987658879489999983677210168999999999999864679839996200024873
Q ss_pred EEEEEEECCCCCHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCEEECCCCCEEEEECCCCEE
Q ss_conf 28999834799944563218877757677999999999999998761896501134578858846998449997474114
Q 001658 764 RLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKL 843 (1036)
Q Consensus 764 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~ 843 (1036)
.++|+||+.+|+|.+++...+ .+.+.....++.|++.|++|+|+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~~--~~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~DFG~a~~ 178 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQRE--RFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKE 178 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred EEEEEECCCCCHHHHHHHHCC--CCCHHHHHHHHHHHHHHHHHHHCCC---EEECCCCCCCEEECCCCCEEEEECCCHHH
T ss_conf 001231234117999987304--5437888888999999998851499---89654773201246999888741320222
Q ss_pred ECCCCCCCCCCCCCCCCCCCCCCCCCC--CCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCC
Q ss_conf 158987422354335674571000238--789424678689999999829999999981567789999998740495311
Q 001658 844 YDDKKTHISTRVAGTIGYLAPEYAMRG--HLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHENNQEIE 921 (1036)
Q Consensus 844 ~~~~~~~~~~~~~gt~~y~APE~~~~~--~~~~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 921 (1036)
+............|++.|+|||.+... .++.++||||+||++|||++|+.||......+....+.... ..
T Consensus 179 ~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~--~~------ 250 (322)
T d1vzoa_ 179 FVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRI--LK------ 250 (322)
T ss_dssp CCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHH--HH------
T ss_pred HCCCCCCCCCCCCCCCCCCHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHC--CC------
T ss_conf 0344443221222333331068760577688713251777799999976899988887777999999833--56------
Q ss_pred CCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCC-----HHHHHH
Q ss_conf 2585243679999999999999810449999999-----899999
Q 001658 922 LADPKLIEFNEEEVKRLIGVALLCTQTLPSLRPS-----MSRVVA 961 (1036)
Q Consensus 922 ~~d~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt-----~~evl~ 961 (1036)
..+.+ +......+.+++.+|++.+|.+||+ ++|+++
T Consensus 251 -~~~~~---~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 251 -SEPPY---PQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp -CCCCC---CTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred -CCCCC---CCCCCHHHHHHHHHHCCCCHHHCCCCCCCCHHHHHC
T ss_conf -89988---654799999999997445898819997450999974
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=319.73 Aligned_cols=262 Identities=22% Similarity=0.258 Sum_probs=199.2
Q ss_pred HHCCCCCCCCCCCCCCEEEEEEEE-CCCCEEEEEECCCC--CHHCHHHHHHHHHHHHHHCCCCCCEEEEEEECC-----C
Q ss_conf 723999989303589788999682-89938999992410--332099999999998740158843168588708-----3
Q 001658 691 ATENFSPSNKLGEGGFGPVYKGKL-GDGRAIAVKQLSVA--SRQGKSQFVAEIATISAVQHRNLVKLHGCCIEG-----A 762 (1036)
Q Consensus 691 ~~~~~~~~~~iG~G~fG~Vy~~~~-~~g~~vAvK~l~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~-----~ 762 (1036)
..++|++.+.||+|+||+||+|+. .+|+.||||+++.. +....+++.+|+.++++++|+|||++++++... .
T Consensus 16 ~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~ 95 (348)
T d2gfsa1 16 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 95 (348)
T ss_dssp EETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTC
T ss_pred CCCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCCCC
T ss_conf 89871888898317883999999999997999999882002868999999999999866898742599999634645668
Q ss_pred EEEEEEEECCCCCHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCEEECCCCCEEEEECCCCE
Q ss_conf 22899983479994456321887775767799999999999999876189650113457885884699844999747411
Q 001658 763 ERLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAK 842 (1036)
Q Consensus 763 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~ 842 (1036)
..+++++++.+|+|.+++.. ..+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+|++|||++.
T Consensus 96 ~~~~i~~~~~gg~L~~~~~~---~~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~dfg~a~ 169 (348)
T d2gfsa1 96 NDVYLVTHLMGADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 169 (348)
T ss_dssp CCCEEEEECCSEEHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC----
T ss_pred CEEEEEEEECCCCHHHHCCC---CCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCCCCCCCCCCCCCCCCCHHC
T ss_conf 64999996258862320022---45309999999999999999997388---7651667763345543220013210001
Q ss_pred EECCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHC-----
Q ss_conf 4158987422354335674571000238-7894246786899999998299999999815677899999987404-----
Q 001658 843 LYDDKKTHISTRVAGTIGYLAPEYAMRG-HLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAWHLHEN----- 916 (1036)
Q Consensus 843 ~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~~~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~----- 916 (1036)
..... .....|+..|+|||...+. .++.++||||+||++|||++|++||...........+.........
T Consensus 170 ~~~~~----~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~ 245 (348)
T d2gfsa1 170 HTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKK 245 (348)
T ss_dssp CCTGG----GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTT
T ss_pred CCCCC----CCCCCCCCCCCCCHHHCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHCCCCCHHHHHH
T ss_conf 25754----44434543555835533775678551243205899999768899788988999999997307997577320
Q ss_pred C----------CCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH
Q ss_conf 9----------531125852436799999999999998104499999998999999
Q 001658 917 N----------QEIELADPKLIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVAM 962 (1036)
Q Consensus 917 ~----------~~~~~~d~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 962 (1036)
. .........+..........+.+++.+|++.||.+|||+.|+++.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~H 301 (348)
T d2gfsa1 246 ISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 301 (348)
T ss_dssp CCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CCCHHHHHHHHHCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 01024454443035578755566267899999999999775883459389998559
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=0 Score=313.81 Aligned_cols=256 Identities=17% Similarity=0.230 Sum_probs=194.9
Q ss_pred CCCCCCCCCCCCCCEEEEEEEE-CCCCEEEEEECCCCCHHCHHHHHHHHHHHHHHC-CCCCCEEEEEEECC--CEEEEEE
Q ss_conf 3999989303589788999682-899389999924103320999999999987401-58843168588708--3228999
Q 001658 693 ENFSPSNKLGEGGFGPVYKGKL-GDGRAIAVKQLSVASRQGKSQFVAEIATISAVQ-HRNLVKLHGCCIEG--AERLLVY 768 (1036)
Q Consensus 693 ~~~~~~~~iG~G~fG~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~f~~Ei~~l~~l~-H~nIv~l~g~~~~~--~~~~lV~ 768 (1036)
++|++.++||+|+||+||+|+. .+++.||+|+++.. ..+++.+|+.+|.+++ ||||+++++++... ...++||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~ 111 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 111 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred CCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHHCCCCCCCCEEEEEEEECCCCCEEEEE
T ss_conf 6718978983174819999998899979999998889---9999999999998515799876799999816877126888
Q ss_pred EECCCCCHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCEEECCCC-CEEEEECCCCEEECCC
Q ss_conf 834799944563218877757677999999999999998761896501134578858846998-4499974741141589
Q 001658 769 EYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADL-VPKISDFGLAKLYDDK 847 (1036)
Q Consensus 769 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NILl~~~~-~~kl~DFGla~~~~~~ 847 (1036)
||+++++|..+. ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++ .+||+|||+|+.....
T Consensus 112 e~~~~~~L~~~~-----~~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~ 183 (328)
T d3bqca1 112 EHVNNTDFKQLY-----QTLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG 183 (328)
T ss_dssp ECCCSCBGGGTT-----TSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGCEECCTT
T ss_pred EECCCCCHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCCEEECCCCCEEEECCCCCCEECCCC
T ss_conf 631798589974-----68999999999999999998876433---4434564412377489983664156542664688
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCC-CCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHH-HH----------HHHHHHHH
Q ss_conf 87422354335674571000238-78942467868999999982999999998156778-99----------99998740
Q 001658 848 KTHISTRVAGTIGYLAPEYAMRG-HLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLY-LL----------EWAWHLHE 915 (1036)
Q Consensus 848 ~~~~~~~~~gt~~y~APE~~~~~-~~~~ksDVwSlGvil~elltG~~p~~~~~~~~~~~-l~----------~~~~~~~~ 915 (1036)
.. .....||..|+|||.+.+. .++.++||||+|+++|||++|+.||....+..... .. .+......
T Consensus 184 ~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~ 261 (328)
T d3bqca1 184 QE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNI 261 (328)
T ss_dssp CC--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTC
T ss_pred CC--CCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHCCCHHHHHHHHCCC
T ss_conf 74--4432248642476102688888845232335455587604889998876018999999998788415555542254
Q ss_pred CCC-C-CCCC--CC-----CC-C-CCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHH
Q ss_conf 495-3-1125--85-----24-3-679999999999999810449999999899999
Q 001658 916 NNQ-E-IELA--DP-----KL-I-EFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVA 961 (1036)
Q Consensus 916 ~~~-~-~~~~--d~-----~~-~-~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 961 (1036)
... . .... .+ .. . ........++.+++.+|++.||.+|||++|+++
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 262 ELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp CCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCCCCCCHHCCCCCCCCHHHCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf 447430000033343311211552112448999999999986699568908999964
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=316.88 Aligned_cols=261 Identities=23% Similarity=0.252 Sum_probs=200.2
Q ss_pred HCCCCCCCCCCCCCCEEEEEEEEC-CCCEEEEEECCCC--CHHCHHHHHHHHHHHHHHCCCCCCEEEEEEEC------CC
Q ss_conf 239999893035897889996828-9938999992410--33209999999999874015884316858870------83
Q 001658 692 TENFSPSNKLGEGGFGPVYKGKLG-DGRAIAVKQLSVA--SRQGKSQFVAEIATISAVQHRNLVKLHGCCIE------GA 762 (1036)
Q Consensus 692 ~~~~~~~~~iG~G~fG~Vy~~~~~-~g~~vAvK~l~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~------~~ 762 (1036)
.++|++.++||+|+||+||+|+.. +|+.||||++... +.....++.+|+.++++++||||+++++++.. ..
T Consensus 16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~ 95 (355)
T d2b1pa1 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 95 (355)
T ss_dssp ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCCCCCC
T ss_conf 37759988962175859999999999989999998823369799999999999998648987648998970256434576
Q ss_pred EEEEEEEECCCCCHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCEEECCCCCEEEEECCCCE
Q ss_conf 22899983479994456321887775767799999999999999876189650113457885884699844999747411
Q 001658 763 ERLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAK 842 (1036)
Q Consensus 763 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~ 842 (1036)
..++|+||+.++ +.+.+. ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+|++|||+++
T Consensus 96 ~~~iv~Ey~~~~-l~~~~~----~~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~df~~~~ 167 (355)
T d2b1pa1 96 DVYLVMELMDAN-LCQVIQ----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR 167 (355)
T ss_dssp EEEEEEECCSEE-HHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred EEEEEEECCCHH-HHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCCCCCCCCCCEEEECHHHHH
T ss_conf 269998414467-787650----38999999999999999998865221---1245677632113654431320102321
Q ss_pred EECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHH-----------
Q ss_conf 415898742235433567457100023878942467868999999982999999998156778999999-----------
Q 001658 843 LYDDKKTHISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEKLYLLEWAW----------- 911 (1036)
Q Consensus 843 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~----------- 911 (1036)
...... ......||+.|+|||++.+..++.++||||+||+++||++|++||...........+....
T Consensus 168 ~~~~~~--~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~ 245 (355)
T d2b1pa1 168 TAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 245 (355)
T ss_dssp ---------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTS
T ss_pred CCCCCC--CCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHCCCCCHHHHHHH
T ss_conf 146665--533221465555813314777787743335662578986598998889778899999972058987999876
Q ss_pred -----HHHHCC-CCC-----CCCCCCC----CCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH
Q ss_conf -----874049-531-----1258524----36799999999999998104499999998999999
Q 001658 912 -----HLHENN-QEI-----ELADPKL----IEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVAM 962 (1036)
Q Consensus 912 -----~~~~~~-~~~-----~~~d~~~----~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 962 (1036)
...... ... ....... ..........+.+++.+|++.||++|||++|+++.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 246 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp CHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 566777764175435666421264333543210133379999999999876994579089999669
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=315.95 Aligned_cols=263 Identities=20% Similarity=0.270 Sum_probs=202.5
Q ss_pred CCCCCCCCCCCCCCEEEEEEEE-CCCCEEEEEECCCC--CHHCHHHHHHHHHHHHHHCCCCCCEEEEEEECCCEEEEEEE
Q ss_conf 3999989303589788999682-89938999992410--33209999999999874015884316858870832289998
Q 001658 693 ENFSPSNKLGEGGFGPVYKGKL-GDGRAIAVKQLSVA--SRQGKSQFVAEIATISAVQHRNLVKLHGCCIEGAERLLVYE 769 (1036)
Q Consensus 693 ~~~~~~~~iG~G~fG~Vy~~~~-~~g~~vAvK~l~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 769 (1036)
++|++.+.||+|+||+||+|+. .+++.||||+++.. ......++.+|+.+++.++|+||+++++++.+....++|+|
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCCCCEEEEEE
T ss_conf 99786269712868199999999999699999980321786899999999999985675788821354444431158863
Q ss_pred ECCCCCHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCEEECCCCCEEEEECCCCEEECCCCC
Q ss_conf 34799944563218877757677999999999999998761896501134578858846998449997474114158987
Q 001658 770 YLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDFGLAKLYDDKKT 849 (1036)
Q Consensus 770 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~ 849 (1036)
++.+++|..++.. ...+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||.++.......
T Consensus 82 ~~~~~~l~~~~~~--~~~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~ 156 (292)
T d1unla_ 82 FCDQDLKKYFDSC--NGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR 156 (292)
T ss_dssp CCSEEHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSCCS
T ss_pred ECCCCCCCCCCCC--CCCCCHHHHHHHHHHHHHHHHHHHCCC---EEEECCCCCCCCCCCCCCEEEEECCHHHCCCCCCC
T ss_conf 0233222112123--565403678999999999987743399---86001467612113378266520460110468875
Q ss_pred CCCCCCCCCCCCCCCCCCCCCC-CCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHH-HHHHHHHHHHHHCCCC---CCCC-
Q ss_conf 4223543356745710002387-89424678689999999829999999981567-7899999987404953---1125-
Q 001658 850 HISTRVAGTIGYLAPEYAMRGH-LTEKTDVFAFGVLALETVSGRPNSDPSLDEEK-LYLLEWAWHLHENNQE---IELA- 923 (1036)
Q Consensus 850 ~~~~~~~gt~~y~APE~~~~~~-~~~ksDVwSlGvil~elltG~~p~~~~~~~~~-~~l~~~~~~~~~~~~~---~~~~- 923 (1036)
. .....++..|+|||++.... ++.++||||+||++|||++|+.||....+... ...+............ ....
T Consensus 157 ~-~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (292)
T d1unla_ 157 C-YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPD 235 (292)
T ss_dssp C-CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTT
T ss_pred C-CEEECCCCCHHHHHHHCCCCCCCCHHHCCCCCHHHHHHHHCCCCCCCCCCHHHHHHHHHHHCCCCCHHHHHHHHHCCC
T ss_conf 1-001034431014667506988880444026541889985189999889999999999986118997355134432221
Q ss_pred ---------CCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHH
Q ss_conf ---------85243679999999999999810449999999899999
Q 001658 924 ---------DPKLIEFNEEEVKRLIGVALLCTQTLPSLRPSMSRVVA 961 (1036)
Q Consensus 924 ---------d~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 961 (1036)
..............+.+++.+|++.||.+|||++|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~ 282 (292)
T d1unla_ 236 YKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp CCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred CCCCCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf 13344454431043306568999999999986499668909999964
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=0 Score=285.60 Aligned_cols=262 Identities=21% Similarity=0.216 Sum_probs=192.1
Q ss_pred CCCCCCCCCCCCCCEEEEEEEE-CCCCEEEEEECCCCCHHCHHHHHHHHHHHHHHC-----------CCCCCEEEEEEEC
Q ss_conf 3999989303589788999682-899389999924103320999999999987401-----------5884316858870
Q 001658 693 ENFSPSNKLGEGGFGPVYKGKL-GDGRAIAVKQLSVASRQGKSQFVAEIATISAVQ-----------HRNLVKLHGCCIE 760 (1036)
Q Consensus 693 ~~~~~~~~iG~G~fG~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~f~~Ei~~l~~l~-----------H~nIv~l~g~~~~ 760 (1036)
.+|++.++||+|+||+||+|+. .+|+.||||+++.... ..+.+.+|+.+++.++ |+||+++++++..
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~-~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~ 91 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV-YTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 91 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHH-HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEECCCC-CHHHHHHHHHHHHHHCCHHHHHHHHCCCCCEEEEEEEEEE
T ss_conf 857998997507781899999999997999999834313-3689999999999840145555542276764789987631
Q ss_pred C--CEEEEEEEECCCC-CHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCCCCCCCCCCCCCEEECCCC-----
Q ss_conf 8--3228999834799-94456321887775767799999999999999876-1896501134578858846998-----
Q 001658 761 G--AERLLVYEYLENK-SLDQALFGQRSLTLDWATRYEICSGVARGLAYLHE-ESRVRIIHRDVKASNVLLDADL----- 831 (1036)
Q Consensus 761 ~--~~~~lV~E~~~~g-sL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~-~~~~~ivH~Dikp~NILl~~~~----- 831 (1036)
. ...+++++++..+ .............+++..+..++.|++.||+|||+ .+ |+||||||+|||++.++
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDlKp~NIll~~~~~~~~~ 168 (362)
T d1q8ya_ 92 KGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPENL 168 (362)
T ss_dssp EETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTTTE
T ss_pred CCCCCEEEEEEECCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHEEEECCCCCCCC
T ss_conf 2565202343200035420000012234678689999999999999888764058---6465677057056305765644
Q ss_pred -CEEEEECCCCEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHH----HHH
Q ss_conf -449997474114158987422354335674571000238789424678689999999829999999981567----789
Q 001658 832 -VPKISDFGLAKLYDDKKTHISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLALETVSGRPNSDPSLDEEK----LYL 906 (1036)
Q Consensus 832 -~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvil~elltG~~p~~~~~~~~~----~~l 906 (1036)
.++++|||.+....... ....||+.|+|||++....++.++|+||+||+++||++|+.||.+...... ..+
T Consensus 169 ~~~kl~dfg~s~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~ 244 (362)
T d1q8ya_ 169 IQIKIADLGNACWYDEHY----TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHI 244 (362)
T ss_dssp EEEEECCCTTCEETTBCC----CSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHH
T ss_pred CEEEEEECCCCCCCCCCC----CCCCCCCCCCCHHHCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCCHHHHH
T ss_conf 305675314421234454----2236652105713214667776432012378999998788998987554321026899
Q ss_pred HHHHHHHHH-------C----------CCC-CCCCC----------CCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHH
Q ss_conf 999998740-------4----------953-11258----------5243679999999999999810449999999899
Q 001658 907 LEWAWHLHE-------N----------NQE-IELAD----------PKLIEFNEEEVKRLIGVALLCTQTLPSLRPSMSR 958 (1036)
Q Consensus 907 ~~~~~~~~~-------~----------~~~-~~~~d----------~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~e 958 (1036)
.......-. . ... ..... +............+.+++.+|++.||.+|||+.|
T Consensus 245 ~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e 324 (362)
T d1q8ya_ 245 AQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGG 324 (362)
T ss_dssp HHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHH
T ss_pred HHHHHHHCCCCHHHHHCCCCCCCCCCCCHHHHCCCCCCCCCHHHHCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHH
T ss_conf 99999837998788624532200013201220243235776444210001567435899999999987799457908999
Q ss_pred HHHH
Q ss_conf 9999
Q 001658 959 VVAM 962 (1036)
Q Consensus 959 vl~~ 962 (1036)
+++.
T Consensus 325 ~L~H 328 (362)
T d1q8ya_ 325 LVNH 328 (362)
T ss_dssp HHTC
T ss_pred HHCC
T ss_conf 9669
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=100.00 E-value=1.4e-45 Score=255.98 Aligned_cols=277 Identities=30% Similarity=0.479 Sum_probs=234.7
Q ss_pred EEECCC--CCCCCEEEEEEEEEEECCCCCCCCCCCCCCCCCCEEECCCCCCCC--CCCCCCCCCCCCCEEECCC-CCCCC
Q ss_conf 110159--999943567599984032466698112599999899923888999--8961113777677652114-33668
Q 001658 87 IKCDCS--SQNGTVCHITQLKVYALNVVGVIPDELWNLTSLFNLNLGQNYLTG--PLSPSVGNLTAMQYLNLAI-NALSG 161 (1036)
Q Consensus 87 ~~~~C~--~~~~~~~~~~~L~l~~~~l~~~ip~~l~~l~~L~~L~L~~n~l~~--~~p~~~~~L~~L~~L~L~~-n~l~~ 161 (1036)
.+-+|+ .|.|+.|+-. ....+++.|+|++|.++| .+|.++++|++|++|+|++ |++.|
T Consensus 29 ~~~d~C~~~w~gv~C~~~-----------------~~~~~v~~L~L~~~~l~g~~~lp~~l~~L~~L~~L~Ls~~N~l~g 91 (313)
T d1ogqa_ 29 PTTDCCNRTWLGVLCDTD-----------------TQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVG 91 (313)
T ss_dssp TTSCTTTTCSTTEEECCS-----------------SSCCCEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEES
T ss_pred CCCCCCCCCCCCEEEECC-----------------CCCEEEEEEECCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCCC
T ss_conf 999998894889697489-----------------994798899898998888887984784675335202026543330
Q ss_pred CCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCHHHHCC
Q ss_conf 76401139999869983167798889412478866877747564477889732028778967864687478877021039
Q 001658 162 ELPKELGQLTELLILGIGTNNFSGPLPSELGSLSKLQELYIDSAGVSGEIPSSFANLQSLTKWWASDTRLTGRIPDFIGN 241 (1036)
Q Consensus 162 ~~p~~l~~L~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~ 241 (1036)
.+|..|++|++|++|+|++|++.+..+..+..+.+|+.++++.|.+.+.+|..+..++.|+.+++++|.+.+.+|..+..
T Consensus 92 ~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~l~~~ip~~~~~ 171 (313)
T d1ogqa_ 92 PIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGS 171 (313)
T ss_dssp CCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGC
T ss_pred CCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCHHHCCCCCCCEEECCCCCCCCCCCCCCCC
T ss_conf 02431145420011020356434433222220111001111224555568512206740000002355335620312144
Q ss_pred CCCC-CEEEEECCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCHHHHCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEE
Q ss_conf 9999-999900886888787223499998899846888999840200399999899831776686655121289986599
Q 001658 242 WSKL-TALRFQGNSFNGPIPSSFSNLTSVTELRISDLSNGSSKLAFIRDMKSLSILELRNNNISDSIPSNIGEYRSLQHL 320 (1036)
Q Consensus 242 l~~L-~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~n~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~ip~~l~~l~~L~~L 320 (1036)
+..+ +.++++.|++++..|..+..+ .+..++++++.+.+.+|..+..+++|+.|
T Consensus 172 l~~l~~~l~~~~n~l~~~~~~~~~~l-------------------------~~~~l~l~~~~~~~~~~~~~~~~~~l~~l 226 (313)
T d1ogqa_ 172 FSKLFTSMTISRNRLTGKIPPTFANL-------------------------NLAFVDLSRNMLEGDASVLFGSDKNTQKI 226 (313)
T ss_dssp CCTTCCEEECCSSEEEEECCGGGGGC-------------------------CCSEEECCSSEEEECCGGGCCTTSCCSEE
T ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCC-------------------------CCCCCCCCCCCCCCCCCCCCCCCCCCCCC
T ss_conf 31123231022464353324332222-------------------------22233333343322222222222221112
Q ss_pred ECCCCCCCCCCCHHCCCCCCCCEEECCCCCCCCCCCCCCC--CCCCEEEEECCCCCCCCCHHHHCCCCCCEEEECCCCCC
Q ss_conf 1779889999920005998865797447616666888867--98658982076289998143313679623450688200
Q 001658 321 DLSFNNLGGSIPDSLFNLSSLTHLFLGNNKLNGTLPARKS--PLLLNIDVSYNNLQGNLPSWINGQQNLQINLVANNLTI 398 (1036)
Q Consensus 321 ~Ls~N~L~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~~~~--~~L~~Ldls~N~l~g~~p~~l~~l~~L~~~~~~nn~~~ 398 (1036)
++++|.+.+.+| .+..+++|+.|+|++|+++|.+|..+. +.|+.|||++|+|+|.+|. +..+++|+.+.+.+|..
T Consensus 227 ~~~~~~l~~~~~-~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~-~~~L~~L~~l~l~~N~~- 303 (313)
T d1ogqa_ 227 HLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ-GGNLQRFDVSAYANNKC- 303 (313)
T ss_dssp ECCSSEECCBGG-GCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCC-STTGGGSCGGGTCSSSE-
T ss_pred CCCCCCCCCCCC-CCCCCCCCCCCCCCCCEECCCCCHHHHCCCCCCEEECCCCCCCCCCCC-CCCCCCCCHHHHCCCCC-
T ss_conf 222222222222-222455444444765706660876884799999897958835166898-66679989788688950-
Q ss_pred CCCCCCCCCCCCCCCCCCCCCC
Q ss_conf 3899974575410013567557
Q 001658 399 RSSDNSVLPRGLICLQRNFPCN 420 (1036)
Q Consensus 399 ~~~~~~~~p~~~~~~~~~~~c~ 420 (1036)
+|+.++++|.
T Consensus 304 ------------l~g~plp~c~ 313 (313)
T d1ogqa_ 304 ------------LCGSPLPACT 313 (313)
T ss_dssp ------------EESTTSSCCC
T ss_pred ------------CCCCCCCCCC
T ss_conf ------------0198988989
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=2e-36 Score=206.68 Aligned_cols=265 Identities=22% Similarity=0.266 Sum_probs=220.8
Q ss_pred EEEEEEEEECCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECC
Q ss_conf 67599984032466698112599999899923888999896111377767765211433668764011399998699831
Q 001658 100 HITQLKVYALNVVGVIPDELWNLTSLFNLNLGQNYLTGPLSPSVGNLTAMQYLNLAINALSGELPKELGQLTELLILGIG 179 (1036)
Q Consensus 100 ~~~~L~l~~~~l~~~ip~~l~~l~~L~~L~L~~n~l~~~~p~~~~~L~~L~~L~L~~n~l~~~~p~~l~~L~~L~~L~Ls 179 (1036)
..+.++..+.+++ .+|..+. +.+++|+|++|.|+...+.+|.++++|++|++++|.+....|..|.++++|+.|+++
T Consensus 11 ~~~~~~C~~~~L~-~lP~~l~--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l~ 87 (305)
T d1xkua_ 11 HLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLS 87 (305)
T ss_dssp ETTEEECTTSCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred CCCEEEECCCCCC-CCCCCCC--CCCCEEECCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCEECCC
T ss_conf 5999985599988-5198889--997989784991898696576046565231123443445235665279855783156
Q ss_pred CCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCC--CCCHHHHCCCCCCCEEEEECCCCCC
Q ss_conf 67798889412478866877747564477889732028778967864687478--8770210399999999900886888
Q 001658 180 TNNFSGPLPSELGSLSKLQELYIDSAGVSGEIPSSFANLQSLTKWWASDTRLT--GRIPDFIGNWSKLTALRFQGNSFNG 257 (1036)
Q Consensus 180 ~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~--~~~~~~l~~l~~L~~L~L~~N~l~~ 257 (1036)
+|+++ .+|..+ ...|..|.+.+|.+....+..+.....+..+....|... ...+..+..+++|+.+++.+|.+.
T Consensus 88 ~n~l~-~l~~~~--~~~l~~L~~~~n~l~~l~~~~~~~~~~~~~l~~~~n~~~~~~~~~~~~~~l~~L~~l~l~~n~l~- 163 (305)
T d1xkua_ 88 KNQLK-ELPEKM--PKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT- 163 (305)
T ss_dssp SSCCS-BCCSSC--CTTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCC-
T ss_pred CCCCC-CCCCCH--HHHHHHHHCCCCCHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-
T ss_conf 87567-676400--11132321024610234444540133110000123333346777642234565671203467745-
Q ss_pred CCCCCCCCCCCCCEEECCCCCCCCCCHHHHCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHCCC
Q ss_conf 78722349999889984688899984020039999989983177668665512128998659917798899999200059
Q 001658 258 PIPSSFSNLTSVTELRISDLSNGSSKLAFIRDMKSLSILELRNNNISDSIPSNIGEYRSLQHLDLSFNNLGGSIPDSLFN 337 (1036)
Q Consensus 258 ~~p~~l~~l~~L~~L~L~~n~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~ip~~l~~l~~L~~L~Ls~N~L~g~ip~~l~~ 337 (1036)
.+|..+ .++|+.|++++|.........+..++.++.|++++|.+.+..+..+..+++|++|+|++|+|+ .+|.++..
T Consensus 164 ~l~~~~--~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~-~lp~~l~~ 240 (305)
T d1xkua_ 164 TIPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLAD 240 (305)
T ss_dssp SCCSSC--CTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTT
T ss_pred CCCCCC--CCCCCEEECCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEEECCCCCCC-CCCCCCCC
T ss_conf 167101--776678989788677888267641341330154455332223454334433224302554002-46311033
Q ss_pred CCCCCEEECCCCCCCCCCCCCC--------CCCCCEEEEECCCCC
Q ss_conf 9886579744761666688886--------798658982076289
Q 001658 338 LSSLTHLFLGNNKLNGTLPARK--------SPLLLNIDVSYNNLQ 374 (1036)
Q Consensus 338 l~~L~~L~Ls~N~l~g~~p~~~--------~~~L~~Ldls~N~l~ 374 (1036)
+++|+.|+|++|+|+......+ .+.|+.|++++|.++
T Consensus 241 l~~L~~L~Ls~N~i~~i~~~~f~~~~~~~~~~~L~~L~L~~N~~~ 285 (305)
T d1xkua_ 241 HKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQ 285 (305)
T ss_dssp CSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSC
T ss_pred CCCCCEEECCCCCCCCCCHHHCCCCCHHCCCCCCCEEECCCCCCC
T ss_conf 467898989898657638100267210021588897889899576
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=100.00 E-value=4.3e-36 Score=204.96 Aligned_cols=276 Identities=24% Similarity=0.321 Sum_probs=172.2
Q ss_pred EEEEEEEEECCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECC
Q ss_conf 67599984032466698112599999899923888999896111377767765211433668764011399998699831
Q 001658 100 HITQLKVYALNVVGVIPDELWNLTSLFNLNLGQNYLTGPLSPSVGNLTAMQYLNLAINALSGELPKELGQLTELLILGIG 179 (1036)
Q Consensus 100 ~~~~L~l~~~~l~~~ip~~l~~l~~L~~L~L~~n~l~~~~p~~~~~L~~L~~L~L~~n~l~~~~p~~l~~L~~L~~L~Ls 179 (1036)
+++.|++.++++... +.+..+++|++|+|++|.|++. + .|+++++|++|++++|.+.+.. .++.+++|+.|+++
T Consensus 45 ~l~~L~l~~~~I~~l--~gl~~L~nL~~L~Ls~N~l~~l-~-~l~~L~~L~~L~L~~n~i~~i~--~l~~l~~L~~L~~~ 118 (384)
T d2omza2 45 QVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLTDI-T-PLKNLTKLVDILMNNNQIADIT--PLANLTNLTGLTLF 118 (384)
T ss_dssp TCCEEECCSSCCCCC--TTGGGCTTCCEEECCSSCCCCC-G-GGTTCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECC
T ss_pred CCCEEECCCCCCCCC--CCCCCCCCCCEEECCCCCCCCC-C-CCCCCCCCCCCCCCCCCCCCCC--CCCCCCCCCCCCCC
T ss_conf 878998999898776--2424589999896818817988-6-3347711010301343332222--11123343334433
Q ss_pred CCCCCCCCCCCCCCCCCCCEEECCCCCCCC-----------------------------------------CCCCCCCCC
Q ss_conf 677988894124788668777475644778-----------------------------------------897320287
Q 001658 180 TNNFSGPLPSELGSLSKLQELYIDSAGVSG-----------------------------------------EIPSSFANL 218 (1036)
Q Consensus 180 ~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~-----------------------------------------~~p~~l~~l 218 (1036)
+|.+.+..+. .....+..+....|.+.. .....+..+
T Consensus 119 ~~~~~~~~~~--~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 196 (384)
T d2omza2 119 NNQITDIDPL--KNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLAKL 196 (384)
T ss_dssp SSCCCCCGGG--TTCTTCSEEEEEEEEECCCGGGTTCTTCSEEEEEESCCCCGGGTTCTTCCEEECCSSCCCCCGGGGGC
T ss_pred CCCCCCCCCC--CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCC
T ss_conf 2222222222--22222211213466313100232222112222212322011112454211011222433321100223
Q ss_pred CCCCEEECCCCCCCCCCHHHHCCCCCCCEEEEECCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCHHHHCCCCCCCEEEC
Q ss_conf 78967864687478877021039999999990088688878722349999889984688899984020039999989983
Q 001658 219 QSLTKWWASDTRLTGRIPDFIGNWSKLTALRFQGNSFNGPIPSSFSNLTSVTELRISDLSNGSSKLAFIRDMKSLSILEL 298 (1036)
Q Consensus 219 ~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~n~~~~~~~~~l~~l~~L~~L~L 298 (1036)
++++.+++++|.+++..+ +..+++|+.|++++|.++. + ..+..+++|+.|++++|.+..... +..+++|+.|++
T Consensus 197 ~~~~~l~l~~n~i~~~~~--~~~~~~L~~L~l~~n~l~~-~-~~l~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l 270 (384)
T d2omza2 197 TNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKD-I-GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKL 270 (384)
T ss_dssp TTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCC-C-GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEEC
T ss_pred CCCCEEECCCCCCCCCCC--CCCCCCCCEEECCCCCCCC-C-CHHHCCCCCCHHCCCCCCCCCCCC--CCCCCCCCEEEC
T ss_conf 532333035774478786--4445778788887777789-6-134325653410044674478775--355466877545
Q ss_pred CCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHCCCCCCCCEEECCCCCCCCCCCCCCCCCCCEEEEECCCCCCCCC
Q ss_conf 17766866551212899865991779889999920005998865797447616666888867986589820762899981
Q 001658 299 RNNNISDSIPSNIGEYRSLQHLDLSFNNLGGSIPDSLFNLSSLTHLFLGNNKLNGTLPARKSPLLLNIDVSYNNLQGNLP 378 (1036)
Q Consensus 299 s~N~l~~~ip~~l~~l~~L~~L~Ls~N~L~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~L~~Ldls~N~l~g~~p 378 (1036)
++|.+++.. .+..++.++.++++.|.+.+ + ..+..+++++.|++++|++++..+....+.|+.|++++|++++ ++
T Consensus 271 ~~~~l~~~~--~~~~~~~l~~l~~~~n~l~~-~-~~~~~~~~l~~L~ls~n~l~~l~~l~~l~~L~~L~L~~n~l~~-l~ 345 (384)
T d2omza2 271 GANQISNIS--PLAGLTALTNLELNENQLED-I-SPISNLKNLTYLTLYFNNISDISPVSSLTKLQRLFFANNKVSD-VS 345 (384)
T ss_dssp CSSCCCCCG--GGTTCTTCSEEECCSSCCSC-C-GGGGGCTTCSEEECCSSCCSCCGGGGGCTTCCEEECCSSCCCC-CG
T ss_pred CCCCCCCCC--CCCCCCCCCCCCCCCCCCCC-C-CCCCHHCCCCEEECCCCCCCCCCCCCCCCCCCEEECCCCCCCC-CH
T ss_conf 674457877--32356522223323233333-2-2100002467677778877898453668988989898998999-74
Q ss_pred HHHHCCCCCCEEEECCC
Q ss_conf 43313679623450688
Q 001658 379 SWINGQQNLQINLVANN 395 (1036)
Q Consensus 379 ~~l~~l~~L~~~~~~nn 395 (1036)
.+.++++|+.+.+.+|
T Consensus 346 -~l~~l~~L~~L~l~~N 361 (384)
T d2omza2 346 -SLANLTNINWLSAGHN 361 (384)
T ss_dssp -GGGGCTTCCEEECCSS
T ss_pred -HHCCCCCCCEEECCCC
T ss_conf -6708999998989799
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-37 Score=213.46 Aligned_cols=265 Identities=21% Similarity=0.217 Sum_probs=158.9
Q ss_pred EEECCCCCCCCEEEEEEEEEEECCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCC
Q ss_conf 11015999994356759998403246669811259999989992388899989611137776776521143366876401
Q 001658 87 IKCDCSSQNGTVCHITQLKVYALNVVGVIPDELWNLTSLFNLNLGQNYLTGPLSPSVGNLTAMQYLNLAINALSGELPKE 166 (1036)
Q Consensus 87 ~~~~C~~~~~~~~~~~~L~l~~~~l~~~ip~~l~~l~~L~~L~L~~n~l~~~~p~~~~~L~~L~~L~L~~n~l~~~~p~~ 166 (1036)
.+|.|..... ..+...+.+++ .+|..+. ..+++|+|++|.|+...+.+|.++++|++|++++|.+....+..
T Consensus 4 ~~C~C~~~~~-----~~v~c~~~~L~-~iP~~ip--~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~ 75 (284)
T d1ozna_ 4 GACVCYNEPK-----VTTSCPQQGLQ-AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAA 75 (284)
T ss_dssp TTCEEECSSS-----CEEECCSSCCS-SCCTTCC--TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTT
T ss_pred CCCEECCCCC-----EEEECCCCCCC-CCCCCCC--CCCCEEECCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCC
T ss_conf 9889869999-----69984799989-4497889--99888977488179879778641421300001344543321112
Q ss_pred CCCCCCCCEEECC-CCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCHHHHCCCCCC
Q ss_conf 1399998699831-677988894124788668777475644778897320287789678646874788770210399999
Q 001658 167 LGQLTELLILGIG-TNNFSGPLPSELGSLSKLQELYIDSAGVSGEIPSSFANLQSLTKWWASDTRLTGRIPDFIGNWSKL 245 (1036)
Q Consensus 167 l~~L~~L~~L~Ls-~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L 245 (1036)
+..+..+..+... .|.+....+..+.++++|++|++++|.+....+..+....+|+.+++++|.+++..+..|
T Consensus 76 ~~~~~~~~~l~~~~~~~~~~l~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f------ 149 (284)
T d1ozna_ 76 FTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTF------ 149 (284)
T ss_dssp TTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTT------
T ss_pred CCCCCCCCCCCCCCCCCCCCCCCHHHCCCCCCCEEECCCCCCCCCCCCCCCHHCCCCHHHHCCCCCCCCCHHHH------
T ss_conf 12222222222221022354462010101027787568854432013533200012110200143144580574------
Q ss_pred CEEEEECCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCHHHHCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCC
Q ss_conf 99990088688878722349999889984688899984020039999989983177668665512128998659917798
Q 001658 246 TALRFQGNSFNGPIPSSFSNLTSVTELRISDLSNGSSKLAFIRDMKSLSILELRNNNISDSIPSNIGEYRSLQHLDLSFN 325 (1036)
Q Consensus 246 ~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~n~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~ip~~l~~l~~L~~L~Ls~N 325 (1036)
..+.+|+.|++++|.+..++...|.++++|+.|++++|++++..|..|..+++|+.|++++|
T Consensus 150 ------------------~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N 211 (284)
T d1ozna_ 150 ------------------RDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFAN 211 (284)
T ss_dssp ------------------TTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred ------------------CCCCCHHHCCCCCCCCCCCCHHHHCCCCCCCHHHHHHCCCCCCCHHHHHHHHHCCCCCCCCC
T ss_conf ------------------04340502231417656625666546563413142114346628167665320002333335
Q ss_pred CCCCCCCHHCCCCCCCCEEECCCCCCCCCCCCC-CCCCCCEEEEECCCCCCCCCHHHHC
Q ss_conf 899999200059988657974476166668888-6798658982076289998143313
Q 001658 326 NLGGSIPDSLFNLSSLTHLFLGNNKLNGTLPAR-KSPLLLNIDVSYNNLQGNLPSWING 383 (1036)
Q Consensus 326 ~L~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~~-~~~~L~~Ldls~N~l~g~~p~~l~~ 383 (1036)
++.+..+..+..+++|+.|+|++|.+.+..+.. +...++.+....+++....|..+.+
T Consensus 212 ~i~~~~~~~~~~~~~L~~L~l~~N~l~C~C~~~~l~~~l~~~~~~~~~~~C~~p~~l~g 270 (284)
T d1ozna_ 212 NLSALPTEALAPLRALQYLRLNDNPWVCDCRARPLWAWLQKFRGSSSEVPCSLPQRLAG 270 (284)
T ss_dssp CCSCCCHHHHTTCTTCCEEECCSSCEECSGGGHHHHHHHHHCCSEECCCBEEESGGGTT
T ss_pred CCCCCCCCCCCCCCCCCEEEECCCCCCCCCCCHHHHHHHHHCCCCCCCEEECCCHHHCC
T ss_conf 22100000235546568898119988787564699999986738888667479669849
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-36 Score=205.98 Aligned_cols=205 Identities=20% Similarity=0.180 Sum_probs=116.1
Q ss_pred CCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECC-CCCCCCCCHHHHCCCCCCCEEEEE
Q ss_conf 8699831677988894124788668777475644778897320287789678646-874788770210399999999900
Q 001658 173 LLILGIGTNNFSGPLPSELGSLSKLQELYIDSAGVSGEIPSSFANLQSLTKWWAS-DTRLTGRIPDFIGNWSKLTALRFQ 251 (1036)
Q Consensus 173 L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~-~N~l~~~~~~~l~~l~~L~~L~L~ 251 (1036)
+++|+|++|+|+...+..|.++++|++|++++|++....+..+..+..++.+... .|.+....+..|.++++|+.|+++
T Consensus 34 ~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~~l~~L~~L~l~ 113 (284)
T d1ozna_ 34 SQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLD 113 (284)
T ss_dssp CSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEECT
T ss_pred CCEEECCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHCCCCCCCEEECC
T ss_conf 88897748817987977864142130000134454332111212222222222221022354462010101027787568
Q ss_pred CCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCHHHHCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCC
Q ss_conf 88688878722349999889984688899984020039999989983177668665512128998659917798899999
Q 001658 252 GNSFNGPIPSSFSNLTSVTELRISDLSNGSSKLAFIRDMKSLSILELRNNNISDSIPSNIGEYRSLQHLDLSFNNLGGSI 331 (1036)
Q Consensus 252 ~N~l~~~~p~~l~~l~~L~~L~L~~n~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~ip~~l~~l~~L~~L~Ls~N~L~g~i 331 (1036)
+|.+....+..+....+|+.+++++|.+..++...|..+++|+.|++++|++++..+..|..+++|+.|++++|++.+..
T Consensus 114 ~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i~ 193 (284)
T d1ozna_ 114 RCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVH 193 (284)
T ss_dssp TSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEEC
T ss_pred CCCCCCCCCCCCCHHCCCCHHHHCCCCCCCCCHHHHCCCCCHHHCCCCCCCCCCCCHHHHCCCCCCCHHHHHHCCCCCCC
T ss_conf 85443201353320001211020014314458057404340502231417656625666546563413142114346628
Q ss_pred CHHCCCCCCCCEEECCCCCCCCCCCCCC--CCCCCEEEEECCCCCCCC
Q ss_conf 2000599886579744761666688886--798658982076289998
Q 001658 332 PDSLFNLSSLTHLFLGNNKLNGTLPARK--SPLLLNIDVSYNNLQGNL 377 (1036)
Q Consensus 332 p~~l~~l~~L~~L~Ls~N~l~g~~p~~~--~~~L~~Ldls~N~l~g~~ 377 (1036)
|..|..+++|+.|++++|++.+..+..+ .+.|+.|++++|.+...-
T Consensus 194 ~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~C 241 (284)
T d1ozna_ 194 PHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDC 241 (284)
T ss_dssp TTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSG
T ss_pred HHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCC
T ss_conf 167665320002333335221000002355465688981199887875
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=4e-34 Score=194.56 Aligned_cols=262 Identities=19% Similarity=0.245 Sum_probs=144.0
Q ss_pred CCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECC
Q ss_conf 99899923888999896111377767765211433668764011399998699831677988894124788668777475
Q 001658 124 SLFNLNLGQNYLTGPLSPSVGNLTAMQYLNLAINALSGELPKELGQLTELLILGIGTNNFSGPLPSELGSLSKLQELYID 203 (1036)
Q Consensus 124 ~L~~L~L~~n~l~~~~p~~~~~L~~L~~L~L~~n~l~~~~p~~l~~L~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls 203 (1036)
.++.++-++++++ .+|..+. +.+++|+|++|+|+...+..|.++++|++|++++|.+....|..|.++++|+.|+++
T Consensus 11 ~~~~~~C~~~~L~-~lP~~l~--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l~ 87 (305)
T d1xkua_ 11 HLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLS 87 (305)
T ss_dssp ETTEEECTTSCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred CCCEEEECCCCCC-CCCCCCC--CCCCEEECCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCEECCC
T ss_conf 5999985599988-5198889--997989784991898696576046565231123443445235665279855783156
Q ss_pred CCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCHHHHCCCCCCCEEEEECCCCCC--CCCCCCCCCCCCCEEECCCCCCCC
Q ss_conf 644778897320287789678646874788770210399999999900886888--787223499998899846888999
Q 001658 204 SAGVSGEIPSSFANLQSLTKWWASDTRLTGRIPDFIGNWSKLTALRFQGNSFNG--PIPSSFSNLTSVTELRISDLSNGS 281 (1036)
Q Consensus 204 ~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~--~~p~~l~~l~~L~~L~L~~n~~~~ 281 (1036)
+|++.. +|..+ ...+..|.+.+|.+....+..+.....+..++...|.... ..+..+..+++|+.+++++|.+..
T Consensus 88 ~n~l~~-l~~~~--~~~l~~L~~~~n~l~~l~~~~~~~~~~~~~l~~~~n~~~~~~~~~~~~~~l~~L~~l~l~~n~l~~ 164 (305)
T d1xkua_ 88 KNQLKE-LPEKM--PKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITT 164 (305)
T ss_dssp SSCCSB-CCSSC--CTTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCCS
T ss_pred CCCCCC-CCCCH--HHHHHHHHCCCCCHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
T ss_conf 875676-76400--111323210246102344445401331100001233333467776422345656712034677451
Q ss_pred CCHHHHCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHCCCCCCCCEEECCCCCCCCCCCCCCC-
Q ss_conf 8402003999998998317766866551212899865991779889999920005998865797447616666888867-
Q 001658 282 SKLAFIRDMKSLSILELRNNNISDSIPSNIGEYRSLQHLDLSFNNLGGSIPDSLFNLSSLTHLFLGNNKLNGTLPARKS- 360 (1036)
Q Consensus 282 ~~~~~l~~l~~L~~L~Ls~N~l~~~ip~~l~~l~~L~~L~Ls~N~L~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~~~~- 360 (1036)
++... +++|+.|++++|.+.+..+..|..++.++.|++++|.+.+..+..+..+++|++|+|++|+|+ .+|..+.
T Consensus 165 l~~~~---~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~-~lp~~l~~ 240 (305)
T d1xkua_ 165 IPQGL---PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLAD 240 (305)
T ss_dssp CCSSC---CTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTT
T ss_pred CCCCC---CCCCCEEECCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEEECCCCCCC-CCCCCCCC
T ss_conf 67101---776678989788677888267641341330154455332223454334433224302554002-46311033
Q ss_pred -CCCCEEEEECCCCCCCCCHHH------HCCCCCCEEEECCC
Q ss_conf -986589820762899981433------13679623450688
Q 001658 361 -PLLLNIDVSYNNLQGNLPSWI------NGQQNLQINLVANN 395 (1036)
Q Consensus 361 -~~L~~Ldls~N~l~g~~p~~l------~~l~~L~~~~~~nn 395 (1036)
+.|+.|++++|+++......+ ....+|+.+.+.+|
T Consensus 241 l~~L~~L~Ls~N~i~~i~~~~f~~~~~~~~~~~L~~L~L~~N 282 (305)
T d1xkua_ 241 HKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSN 282 (305)
T ss_dssp CSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSS
T ss_pred CCCCCEEECCCCCCCCCCHHHCCCCCHHCCCCCCCEEECCCC
T ss_conf 467898989898657638100267210021588897889899
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=100.00 E-value=1.1e-32 Score=186.94 Aligned_cols=277 Identities=24% Similarity=0.323 Sum_probs=211.7
Q ss_pred EEEEEEEEEECCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEEC
Q ss_conf 56759998403246669811259999989992388899989611137776776521143366876401139999869983
Q 001658 99 CHITQLKVYALNVVGVIPDELWNLTSLFNLNLGQNYLTGPLSPSVGNLTAMQYLNLAINALSGELPKELGQLTELLILGI 178 (1036)
Q Consensus 99 ~~~~~L~l~~~~l~~~ip~~l~~l~~L~~L~L~~n~l~~~~p~~~~~L~~L~~L~L~~n~l~~~~p~~l~~L~~L~~L~L 178 (1036)
.+++.|++.++.+.+.. .+..+++|++|++++|.+++.. .++++++|+.|+++.+.+++..+ ......+..+..
T Consensus 66 ~nL~~L~Ls~N~l~~l~--~l~~L~~L~~L~L~~n~i~~i~--~l~~l~~L~~L~~~~~~~~~~~~--~~~~~~~~~~~~ 139 (384)
T d2omza2 66 NNLTQINFSNNQLTDIT--PLKNLTKLVDILMNNNQIADIT--PLANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLEL 139 (384)
T ss_dssp TTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCCCGG--GTTCTTCSEEEE
T ss_pred CCCCEEECCCCCCCCCC--CCCCCCCCCCCCCCCCCCCCCC--CCCCCCCCCCCCCCCCCCCCCCC--CCCCCCCCCCCC
T ss_conf 99998968188179886--3347711010301343332222--11123343334433222222222--222222211213
Q ss_pred CCCCCC-----------------------------------------CCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCC
Q ss_conf 167798-----------------------------------------889412478866877747564477889732028
Q 001658 179 GTNNFS-----------------------------------------GPLPSELGSLSKLQELYIDSAGVSGEIPSSFAN 217 (1036)
Q Consensus 179 s~N~l~-----------------------------------------~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~ 217 (1036)
..|.+. ......+..+++++.+++++|.+.+..+ +..
T Consensus 140 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~l~~n~i~~~~~--~~~ 217 (384)
T d2omza2 140 SSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLAKLTNLESLIATNNQISDITP--LGI 217 (384)
T ss_dssp EEEEECCCGGGTTCTTCSEEEEEESCCCCGGGTTCTTCCEEECCSSCCCCCGGGGGCTTCSEEECCSSCCCCCGG--GGG
T ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCC--CCC
T ss_conf 466313100232222112222212322011112454211011222433321100223532333035774478786--444
Q ss_pred CCCCCEEECCCCCCCCCCHHHHCCCCCCCEEEEECCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCHHHHCCCCCCCEEE
Q ss_conf 77896786468747887702103999999999008868887872234999988998468889998402003999998998
Q 001658 218 LQSLTKWWASDTRLTGRIPDFIGNWSKLTALRFQGNSFNGPIPSSFSNLTSVTELRISDLSNGSSKLAFIRDMKSLSILE 297 (1036)
Q Consensus 218 l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~n~~~~~~~~~l~~l~~L~~L~ 297 (1036)
.++|++|++++|.++.. ..+..+++|+.|++++|.+++.. .+..+++|+.|+++.+.+..... +..++.++.+.
T Consensus 218 ~~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~--~~~~~~~L~~L~l~~~~l~~~~~--~~~~~~l~~l~ 291 (384)
T d2omza2 218 LTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLA--PLSGLTKLTELKLGANQISNISP--LAGLTALTNLE 291 (384)
T ss_dssp CTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCG--GGTTCTTCSEEECCSSCCCCCGG--GTTCTTCSEEE
T ss_pred CCCCCEEECCCCCCCCC--CHHHCCCCCCHHCCCCCCCCCCC--CCCCCCCCCEEECCCCCCCCCCC--CCCCCCCCCCC
T ss_conf 57787888877777896--13432565341004467447877--53554668775456744578773--23565222233
Q ss_pred CCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHCCCCCCCCEEECCCCCCCCCCCCCCCCCCCEEEEECCCCCCCC
Q ss_conf 31776686655121289986599177988999992000599886579744761666688886798658982076289998
Q 001658 298 LRNNNISDSIPSNIGEYRSLQHLDLSFNNLGGSIPDSLFNLSSLTHLFLGNNKLNGTLPARKSPLLLNIDVSYNNLQGNL 377 (1036)
Q Consensus 298 Ls~N~l~~~ip~~l~~l~~L~~L~Ls~N~L~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~L~~Ldls~N~l~g~~ 377 (1036)
++.|.+.+ + ..+..+++++.|++++|++++ ++ .+..+++|+.|++++|++++.......+.|+.|++++|++++..
T Consensus 292 ~~~n~l~~-~-~~~~~~~~l~~L~ls~n~l~~-l~-~l~~l~~L~~L~L~~n~l~~l~~l~~l~~L~~L~l~~N~l~~l~ 367 (384)
T d2omza2 292 LNENQLED-I-SPISNLKNLTYLTLYFNNISD-IS-PVSSLTKLQRLFFANNKVSDVSSLANLTNINWLSAGHNQISDLT 367 (384)
T ss_dssp CCSSCCSC-C-GGGGGCTTCSEEECCSSCCSC-CG-GGGGCTTCCEEECCSSCCCCCGGGGGCTTCCEEECCSSCCCBCG
T ss_pred CCCCCCCC-C-CCCCHHCCCCEEECCCCCCCC-CC-CCCCCCCCCEEECCCCCCCCCHHHCCCCCCCEEECCCCCCCCCH
T ss_conf 23233333-2-210000246767777887789-84-53668988989898998999746708999998989799589980
Q ss_pred CHHHHCCCCCCEEEECCC
Q ss_conf 143313679623450688
Q 001658 378 PSWINGQQNLQINLVANN 395 (1036)
Q Consensus 378 p~~l~~l~~L~~~~~~nn 395 (1036)
| +.++++|+.+.+.+|
T Consensus 368 ~--l~~l~~L~~L~L~~N 383 (384)
T d2omza2 368 P--LANLTRITQLGLNDQ 383 (384)
T ss_dssp G--GTTCTTCSEEECCCE
T ss_pred H--HCCCCCCCEEECCCC
T ss_conf 0--003999999639789
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-32 Score=186.37 Aligned_cols=199 Identities=23% Similarity=0.238 Sum_probs=112.9
Q ss_pred CCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECC
Q ss_conf 99899923888999896111377767765211433668764011399998699831677988894124788668777475
Q 001658 124 SLFNLNLGQNYLTGPLSPSVGNLTAMQYLNLAINALSGELPKELGQLTELLILGIGTNNFSGPLPSELGSLSKLQELYID 203 (1036)
Q Consensus 124 ~L~~L~L~~n~l~~~~p~~~~~L~~L~~L~L~~n~l~~~~p~~l~~L~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls 203 (1036)
.+..++.++++|+ .+|..+. ++|++|+|++|.|++..+..|.++++|++|+|++|+++ .++ .++.+++|+.|+|+
T Consensus 11 ~~~~v~C~~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~-~l~-~~~~l~~L~~L~Ls 85 (266)
T d1p9ag_ 11 SHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQ-VDGTLPVLGTLDLS 85 (266)
T ss_dssp TCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCC-EEE-CCSCCTTCCEEECC
T ss_pred CCEEEECCCCCCC-EECCCCC--CCCCEEECCCCCCCCCCHHHHHCCCCCCCCCCCCCCCC-CCC-CCCCCCCCCCCCCC
T ss_conf 9869980699988-6196757--68898988499289859778634565522135665444-431-11112232111112
Q ss_pred CCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCHHHHCCCCCCCEEEEECCCCCCCCCCCCCCCCCCCEEECCCCCCCCCC
Q ss_conf 64477889732028778967864687478877021039999999990088688878722349999889984688899984
Q 001658 204 SAGVSGEIPSSFANLQSLTKWWASDTRLTGRIPDFIGNWSKLTALRFQGNSFNGPIPSSFSNLTSVTELRISDLSNGSSK 283 (1036)
Q Consensus 204 ~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~n~~~~~~ 283 (1036)
+|++. . .+..+..+++|+.|++++|.+....+..+..+.+++.|.+++|.+..++
T Consensus 86 ~N~l~-~------------------------~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~ 140 (266)
T d1p9ag_ 86 HNQLQ-S------------------------LPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLP 140 (266)
T ss_dssp SSCCS-S------------------------CCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCC
T ss_pred CCCCC-C------------------------CCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEC
T ss_conf 22221-1------------------------1112122222222222223110110011222211112212434210221
Q ss_pred HHHHCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHCCCCCCCCEEECCCCCCCC
Q ss_conf 0200399999899831776686655121289986599177988999992000599886579744761666
Q 001658 284 LAFIRDMKSLSILELRNNNISDSIPSNIGEYRSLQHLDLSFNNLGGSIPDSLFNLSSLTHLFLGNNKLNG 353 (1036)
Q Consensus 284 ~~~l~~l~~L~~L~Ls~N~l~~~ip~~l~~l~~L~~L~Ls~N~L~g~ip~~l~~l~~L~~L~Ls~N~l~g 353 (1036)
...+..+++|+.|++++|++++..+..|..+++|++|+|++|+|+ .+|..+..+++|+.|+|++|.+..
T Consensus 141 ~~~~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np~~C 209 (266)
T d1p9ag_ 141 PGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLC 209 (266)
T ss_dssp TTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCC
T ss_pred CCCCCCCCCCHHCCCCCCCCCCCCCCCCCCCCCCCEEECCCCCCC-CCCHHHCCCCCCCEEEECCCCCCC
T ss_conf 233322111000000015652237200134212423430139785-568667778889999836999878
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.9e-32 Score=182.67 Aligned_cols=197 Identities=23% Similarity=0.208 Sum_probs=95.0
Q ss_pred CCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCHHHHCCCCCCCEEEE
Q ss_conf 99869983167798889412478866877747564477889732028778967864687478877021039999999990
Q 001658 171 TELLILGIGTNNFSGPLPSELGSLSKLQELYIDSAGVSGEIPSSFANLQSLTKWWASDTRLTGRIPDFIGNWSKLTALRF 250 (1036)
Q Consensus 171 ~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L 250 (1036)
..+..++.+++.++ .+|..+. ++|++|+|++|++++..+..|..+++|++|+|++|+++. ++ .+..+++|+.|+|
T Consensus 10 ~~~~~v~C~~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~~-l~-~~~~l~~L~~L~L 84 (266)
T d1p9ag_ 10 ASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTK-LQ-VDGTLPVLGTLDL 84 (266)
T ss_dssp TTCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCE-EE-CCSCCTTCCEEEC
T ss_pred CCCEEEECCCCCCC-EECCCCC--CCCCEEECCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCC-CC-CCCCCCCCCCCCC
T ss_conf 89869980699988-6196757--688989884992898597786345655221356654444-31-1111223211111
Q ss_pred ECCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCHHHHCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCC
Q ss_conf 08868887872234999988998468889998402003999998998317766866551212899865991779889999
Q 001658 251 QGNSFNGPIPSSFSNLTSVTELRISDLSNGSSKLAFIRDMKSLSILELRNNNISDSIPSNIGEYRSLQHLDLSFNNLGGS 330 (1036)
Q Consensus 251 ~~N~l~~~~p~~l~~l~~L~~L~L~~n~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~ip~~l~~l~~L~~L~Ls~N~L~g~ 330 (1036)
++|+++ ..+..+..+++|+.|+++++.+.......+..+.+++.|++++|.+....+..+..+++|+.|++++|+|++.
T Consensus 85 s~N~l~-~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~~ 163 (266)
T d1p9ag_ 85 SHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTEL 163 (266)
T ss_dssp CSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCC
T ss_pred CCCCCC-CCCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEECCCCCCCCCCCHHCCCCCCCCCCC
T ss_conf 222221-1111212222222222222311011001122221111221243421022123332211100000001565223
Q ss_pred CCHHCCCCCCCCEEECCCCCCCCCCCCCCC--CCCCEEEEECCCCC
Q ss_conf 920005998865797447616666888867--98658982076289
Q 001658 331 IPDSLFNLSSLTHLFLGNNKLNGTLPARKS--PLLLNIDVSYNNLQ 374 (1036)
Q Consensus 331 ip~~l~~l~~L~~L~Ls~N~l~g~~p~~~~--~~L~~Ldls~N~l~ 374 (1036)
.+..+..+++|+.|+|++|+|+ .+|..+. +.|+.|+|++|.+.
T Consensus 164 ~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np~~ 208 (266)
T d1p9ag_ 164 PAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWL 208 (266)
T ss_dssp CTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBC
T ss_pred CCCCCCCCCCCCEEECCCCCCC-CCCHHHCCCCCCCEEEECCCCCC
T ss_conf 7200134212423430139785-56866777888999983699987
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.96 E-value=1.4e-29 Score=170.45 Aligned_cols=169 Identities=16% Similarity=0.114 Sum_probs=120.1
Q ss_pred CCCCCCCCCCEEEEEEEECCCCEEEEEECCCCCH------------------HCHHHHHHHHHHHHHHCCCCCCEEEEEE
Q ss_conf 9893035897889996828993899999241033------------------2099999999998740158843168588
Q 001658 697 PSNKLGEGGFGPVYKGKLGDGRAIAVKQLSVASR------------------QGKSQFVAEIATISAVQHRNLVKLHGCC 758 (1036)
Q Consensus 697 ~~~~iG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~------------------~~~~~f~~Ei~~l~~l~H~nIv~l~g~~ 758 (1036)
+.++||+|+||.||+|+..+|+.||||+++.... .....+..|...+.++.|.+++..+++.
T Consensus 4 vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~~ 83 (191)
T d1zara2 4 IGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAWE 83 (191)
T ss_dssp EEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEEE
T ss_pred HCCEEEECCCEEEEEEECCCCCEEEEEEEECCCCHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHCCCCCCCEEEEEC
T ss_conf 27780248565999999799999999998604434666556563000888999999778999999981699914499862
Q ss_pred ECCCEEEEEEEECCCCCHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCEEECCCCCEEEEEC
Q ss_conf 70832289998347999445632188777576779999999999999987618965011345788588469984499974
Q 001658 759 IEGAERLLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEESRVRIIHRDVKASNVLLDADLVPKISDF 838 (1036)
Q Consensus 759 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DF 838 (1036)
..+++|||++++.+.+ ++.....+++.|++++++|||+.+ |+||||||+|||++++ .++|+||
T Consensus 84 ----~~~lvme~~~~~~~~~---------l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~-~~~liDF 146 (191)
T d1zara2 84 ----GNAVLMELIDAKELYR---------VRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEE-GIWIIDF 146 (191)
T ss_dssp ----TTEEEEECCCCEEGGG---------CCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETT-EEEECCC
T ss_pred ----CCEEEEEEECCCCCCC---------HHHHHHHHHHHHHHHHHHHHHHCC---EEECCCCHHHEEEECC-CEEEEEC
T ss_conf ----8889999504565420---------015789999999999999982688---8983689036114289-8999877
Q ss_pred CCCEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHH
Q ss_conf 741141589874223543356745710002387894246786899999
Q 001658 839 GLAKLYDDKKTHISTRVAGTIGYLAPEYAMRGHLTEKTDVFAFGVLAL 886 (1036)
Q Consensus 839 Gla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvil~ 886 (1036)
|.|........... ....... -.+.+ ...|+.++|+||..--++
T Consensus 147 G~a~~~~~~~~~~~--l~rd~~~-~~~~f-~r~y~~~~d~~s~~~~~~ 190 (191)
T d1zara2 147 PQSVEVGEEGWREI--LERDVRN-IITYF-SRTYRTEKDINSAIDRIL 190 (191)
T ss_dssp TTCEETTSTTHHHH--HHHHHHH-HHHHH-HHHHCCCCCHHHHHHHHH
T ss_pred CCCCCCCCCCCHHH--HHHHHHH-HHHHH-CCCCCCCCCHHHHHHHHH
T ss_conf 88430899870999--9877999-99997-578998446899999874
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.95 E-value=2.5e-25 Score=147.89 Aligned_cols=97 Identities=24% Similarity=0.272 Sum_probs=70.2
Q ss_pred EEEEEEEEECCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECC
Q ss_conf 67599984032466698112599999899923888999896111377767765211433668764011399998699831
Q 001658 100 HITQLKVYALNVVGVIPDELWNLTSLFNLNLGQNYLTGPLSPSVGNLTAMQYLNLAINALSGELPKELGQLTELLILGIG 179 (1036)
Q Consensus 100 ~~~~L~l~~~~l~~~ip~~l~~l~~L~~L~L~~n~l~~~~p~~~~~L~~L~~L~L~~n~l~~~~p~~l~~L~~L~~L~Ls 179 (1036)
+++.|++.+++++. +|+. .++|++|+|++|.|+ .+|.. +.+|+.|++++|+++ .++.. .+.|++|+++
T Consensus 39 ~l~~LdLs~~~L~~-lp~~---~~~L~~L~Ls~N~l~-~lp~~---~~~L~~L~l~~n~l~-~l~~l---p~~L~~L~L~ 106 (353)
T d1jl5a_ 39 QAHELELNNLGLSS-LPEL---PPHLESLVASCNSLT-ELPEL---PQSLKSLLVDNNNLK-ALSDL---PPLLEYLGVS 106 (353)
T ss_dssp TCSEEECTTSCCSC-CCSC---CTTCSEEECCSSCCS-SCCCC---CTTCCEEECCSSCCS-CCCSC---CTTCCEEECC
T ss_pred CCCEEEECCCCCCC-CCCC---CCCCCEEECCCCCCC-CCCCC---HHHHHHHHHHHCCCC-HHHHH---CCCCCCCCCC
T ss_conf 99899937999887-8898---789888989999796-33620---332033266551432-03210---2211111334
Q ss_pred CCCCCCCCCCCCCCCCCCCEEECCCCCCCCC
Q ss_conf 6779888941247886687774756447788
Q 001658 180 TNNFSGPLPSELGSLSKLQELYIDSAGVSGE 210 (1036)
Q Consensus 180 ~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ 210 (1036)
+|.+. .+|. ++.+++|+.|+++++.+...
T Consensus 107 ~n~l~-~lp~-~~~l~~L~~L~l~~~~~~~~ 135 (353)
T d1jl5a_ 107 NNQLE-KLPE-LQNSSFLKIIDVDNNSLKKL 135 (353)
T ss_dssp SSCCS-SCCC-CTTCTTCCEEECCSSCCSCC
T ss_pred CCCCC-CCCC-HHHHCCCEEECCCCCCCCCC
T ss_conf 55432-2210-01101312311356510013
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.94 E-value=1.6e-26 Score=154.22 Aligned_cols=160 Identities=17% Similarity=0.181 Sum_probs=92.2
Q ss_pred CEEECCCCCCCCEEEEEEEEEEECCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCC-
Q ss_conf 3110159999943567599984032466698112599999899923888999896111377767765211433668764-
Q 001658 86 FIKCDCSSQNGTVCHITQLKVYALNVVGVIPDELWNLTSLFNLNLGQNYLTGPLSPSVGNLTAMQYLNLAINALSGELP- 164 (1036)
Q Consensus 86 ~~~~~C~~~~~~~~~~~~L~l~~~~l~~~ip~~l~~l~~L~~L~L~~n~l~~~~p~~~~~L~~L~~L~L~~n~l~~~~p- 164 (1036)
...|+|.. +.++..+.+++ .+|+.+. +++++|+|++|.|+...+.+|.++++|++|+|++|.+...++
T Consensus 3 ~~~C~C~~--------~~i~c~~~~l~-~iP~~l~--~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~ 71 (242)
T d1xwdc1 3 HRICHCSN--------RVFLCQESKVT-EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEA 71 (242)
T ss_dssp CSSEEECS--------SEEEEESCSCS-SCCSCSC--SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECS
T ss_pred CCCCCCCC--------CEEEEECCCCC-CCCCCCC--CCCCEEECCCCCCCCCCHHHHHCCCHHHHHHHCCCCCCCEEEC
T ss_conf 98288739--------99998189988-7688889--9889998769918964966861464323211022112420100
Q ss_pred CCCCCCCCCCEEECCC-CCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCC-CCCCCCCCCEEECCCCCCCCCCHHHHCCC
Q ss_conf 0113999986998316-779888941247886687774756447788973-20287789678646874788770210399
Q 001658 165 KELGQLTELLILGIGT-NNFSGPLPSELGSLSKLQELYIDSAGVSGEIPS-SFANLQSLTKWWASDTRLTGRIPDFIGNW 242 (1036)
Q Consensus 165 ~~l~~L~~L~~L~Ls~-N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~-~l~~l~~L~~L~L~~N~l~~~~~~~l~~l 242 (1036)
..|..++.++.|.+.. |.+....+..+..+++|+.|++++|++....+. .+..+..+..+...++.+....+..|.++
T Consensus 72 ~~f~~l~~l~~l~~~~~n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~ 151 (242)
T d1xwdc1 72 DVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGL 151 (242)
T ss_dssp SSEESCTTCCEEEEECCTTCCEECTTSEECCTTCCEEEEESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEECTTSSTTS
T ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
T ss_conf 11222222222111112343222222122222222223421111255433322211112222222121112222222222
Q ss_pred C-CCCEEEEECCCCC
Q ss_conf 9-9999990088688
Q 001658 243 S-KLTALRFQGNSFN 256 (1036)
Q Consensus 243 ~-~L~~L~L~~N~l~ 256 (1036)
+ .+..|++.+|+++
T Consensus 152 ~~~l~~L~l~~n~l~ 166 (242)
T d1xwdc1 152 SFESVILWLNKNGIQ 166 (242)
T ss_dssp BSSCEEEECCSSCCC
T ss_pred CCCCEEEECCCCCCC
T ss_conf 331001220012333
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.94 E-value=1e-25 Score=149.91 Aligned_cols=202 Identities=22% Similarity=0.316 Sum_probs=93.3
Q ss_pred EECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCC
Q ss_conf 99238889998961113777677652114336687640113999986998316779888941247886687774756447
Q 001658 128 LNLGQNYLTGPLSPSVGNLTAMQYLNLAINALSGELPKELGQLTELLILGIGTNNFSGPLPSELGSLSKLQELYIDSAGV 207 (1036)
Q Consensus 128 L~L~~n~l~~~~p~~~~~L~~L~~L~L~~n~l~~~~p~~l~~L~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l 207 (1036)
++++.+.+++.. .++.+.+|++|++.+|+|+. ++ .+..+++|++|++++|.+.+..+ +..+++|+.+++++|.+
T Consensus 24 ~~l~~~~~~d~~--~~~~l~~L~~L~l~~~~i~~-l~-~l~~l~~L~~L~ls~n~i~~~~~--l~~l~~l~~l~~~~n~~ 97 (227)
T d1h6ua2 24 IAAGKSNVTDTV--TQADLDGITTLSAFGTGVTT-IE-GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPL 97 (227)
T ss_dssp HHTTCSSTTSEE--CHHHHHTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCC
T ss_pred HHHCCCCCCCCC--CHHHCCCCCEEECCCCCCCC-CH-HHHCCCCCCEEECCCCEEECCCC--CCCCCCCCCCCCCCCCC
T ss_conf 984888767757--98784886899777999976-64-57448888376357853202543--11233432012111222
Q ss_pred CCCCCCCCCCCCCCCEEECCCCCCCCCCHHHHCCCCCCCEEEEECCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCHHHH
Q ss_conf 78897320287789678646874788770210399999999900886888787223499998899846888999840200
Q 001658 208 SGEIPSSFANLQSLTKWWASDTRLTGRIPDFIGNWSKLTALRFQGNSFNGPIPSSFSNLTSVTELRISDLSNGSSKLAFI 287 (1036)
Q Consensus 208 ~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~n~~~~~~~~~l 287 (1036)
+. + ..+..+++|+.+.++.+...+. ..+...+.+..+.+.++.+... ..+...++|+.|.+++|.+..... +
T Consensus 98 ~~-i-~~l~~l~~L~~l~l~~~~~~~~--~~~~~~~~~~~l~~~~~~~~~~--~~~~~~~~L~~L~l~~n~~~~~~~--l 169 (227)
T d1h6ua2 98 KN-V-SAIAGLQSIKTLDLTSTQITDV--TPLAGLSNLQVLYLDLNQITNI--SPLAGLTNLQYLSIGNAQVSDLTP--L 169 (227)
T ss_dssp SC-C-GGGTTCTTCCEEECTTSCCCCC--GGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCCEEECCSSCCCCCGG--G
T ss_pred CC-C-CCCCCCCCCCCCCCCCCCCCCC--CHHCCCCCHHHHHCHHHHHCHH--HHHCCCCCCCCCCCCCCCCCCCHH--H
T ss_conf 22-2-2222222221221222443311--0000023012220000000000--000102111002333333331001--0
Q ss_pred CCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHCCCCCCCCEEECC
Q ss_conf 399999899831776686655121289986599177988999992000599886579744
Q 001658 288 RDMKSLSILELRNNNISDSIPSNIGEYRSLQHLDLSFNNLGGSIPDSLFNLSSLTHLFLG 347 (1036)
Q Consensus 288 ~~l~~L~~L~Ls~N~l~~~ip~~l~~l~~L~~L~Ls~N~L~g~ip~~l~~l~~L~~L~Ls 347 (1036)
..+++|+.|+|++|++++ ++ .+..+++|++|+|++|+++ .++ .+.++++|+.|+|+
T Consensus 170 ~~l~~L~~L~Ls~n~l~~-l~-~l~~l~~L~~L~Ls~N~lt-~i~-~l~~l~~L~~L~ls 225 (227)
T d1h6ua2 170 ANLSKLTTLKADDNKISD-IS-PLASLPNLIEVHLKNNQIS-DVS-PLANTSNLFIVTLT 225 (227)
T ss_dssp TTCTTCCEEECCSSCCCC-CG-GGGGCTTCCEEECTTSCCC-BCG-GGTTCTTCCEEEEE
T ss_pred CCCCCCEECCCCCCCCCC-CH-HHCCCCCCCEEECCCCCCC-CCC-CCCCCCCCCEEEEE
T ss_conf 564633564458884177-85-3447999998979599689-980-20369998989712
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.94 E-value=5.5e-25 Score=146.08 Aligned_cols=210 Identities=16% Similarity=0.238 Sum_probs=142.3
Q ss_pred CCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEE
Q ss_conf 77767765211433668764011399998699831677988894124788668777475644778897320287789678
Q 001658 145 NLTAMQYLNLAINALSGELPKELGQLTELLILGIGTNNFSGPLPSELGSLSKLQELYIDSAGVSGEIPSSFANLQSLTKW 224 (1036)
Q Consensus 145 ~L~~L~~L~L~~n~l~~~~p~~l~~L~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L 224 (1036)
.|.++..++++.+++++.. .+..+.+|+.|++.+|.++. ++ .+..+++|+.|++++|.+.+..+ +..+++|+.+
T Consensus 17 ~l~~~~~~~l~~~~~~d~~--~~~~l~~L~~L~l~~~~i~~-l~-~l~~l~~L~~L~ls~n~i~~~~~--l~~l~~l~~l 90 (227)
T d1h6ua2 17 ALANAIKIAAGKSNVTDTV--TQADLDGITTLSAFGTGVTT-IE-GVQYLNNLIGLELKDNQITDLAP--LKNLTKITEL 90 (227)
T ss_dssp HHHHHHHHHTTCSSTTSEE--CHHHHHTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEE
T ss_pred HHHHHHHHHHCCCCCCCCC--CHHHCCCCCEEECCCCCCCC-CH-HHHCCCCCCEEECCCCEEECCCC--CCCCCCCCCC
T ss_conf 9999999984888767757--98784886899777999976-64-57448888376357853202543--1123343201
Q ss_pred ECCCCCCCCCCHHHHCCCCCCCEEEEECCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCHHHHCCCCCCCEEECCCCCCC
Q ss_conf 64687478877021039999999990088688878722349999889984688899984020039999989983177668
Q 001658 225 WASDTRLTGRIPDFIGNWSKLTALRFQGNSFNGPIPSSFSNLTSVTELRISDLSNGSSKLAFIRDMKSLSILELRNNNIS 304 (1036)
Q Consensus 225 ~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~n~~~~~~~~~l~~l~~L~~L~Ls~N~l~ 304 (1036)
++++|.++. + ..+..+++|+.++++++...+. ..+.....+..+.++.+.+..... +..+++|+.|++++|.+.
T Consensus 91 ~~~~n~~~~-i-~~l~~l~~L~~l~l~~~~~~~~--~~~~~~~~~~~l~~~~~~~~~~~~--~~~~~~L~~L~l~~n~~~ 164 (227)
T d1h6ua2 91 ELSGNPLKN-V-SAIAGLQSIKTLDLTSTQITDV--TPLAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVS 164 (227)
T ss_dssp ECCSCCCSC-C-GGGTTCTTCCEEECTTSCCCCC--GGGTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCC
T ss_pred CCCCCCCCC-C-CCCCCCCCCCCCCCCCCCCCCC--CHHCCCCCHHHHHCHHHHHCHHHH--HCCCCCCCCCCCCCCCCC
T ss_conf 211122222-2-2222222221221222443311--000002301222000000000000--010211100233333333
Q ss_pred CCCCCCCCCCCCCCEEECCCCCCCCCCCHHCCCCCCCCEEECCCCCCCCCCCCCCCCCCCEEEEEC
Q ss_conf 665512128998659917798899999200059988657974476166668888679865898207
Q 001658 305 DSIPSNIGEYRSLQHLDLSFNNLGGSIPDSLFNLSSLTHLFLGNNKLNGTLPARKSPLLLNIDVSY 370 (1036)
Q Consensus 305 ~~ip~~l~~l~~L~~L~Ls~N~L~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~L~~Ldls~ 370 (1036)
+.. .+..+++|+.|+|++|+++ .++. +..+++|++|+|++|++++..|....+.|+.|++++
T Consensus 165 ~~~--~l~~l~~L~~L~Ls~n~l~-~l~~-l~~l~~L~~L~Ls~N~lt~i~~l~~l~~L~~L~lsn 226 (227)
T d1h6ua2 165 DLT--PLANLSKLTTLKADDNKIS-DISP-LASLPNLIEVHLKNNQISDVSPLANTSNLFIVTLTN 226 (227)
T ss_dssp CCG--GGTTCTTCCEEECCSSCCC-CCGG-GGGCTTCCEEECTTSCCCBCGGGTTCTTCCEEEEEE
T ss_pred CCH--HHCCCCCCEECCCCCCCCC-CCHH-HCCCCCCCEEECCCCCCCCCCCCCCCCCCCEEEEEC
T ss_conf 100--1056463356445888417-7853-447999998979599689980203699989897129
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.93 E-value=1.4e-25 Score=149.19 Aligned_cols=211 Identities=18% Similarity=0.137 Sum_probs=105.9
Q ss_pred CEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCC-CCCCCCCCCCCEEECC-
Q ss_conf 89992388899989611137776776521143366876401139999869983167798889-4124788668777475-
Q 001658 126 FNLNLGQNYLTGPLSPSVGNLTAMQYLNLAINALSGELPKELGQLTELLILGIGTNNFSGPL-PSELGSLSKLQELYID- 203 (1036)
Q Consensus 126 ~~L~L~~n~l~~~~p~~~~~L~~L~~L~L~~n~l~~~~p~~l~~L~~L~~L~Ls~N~l~~~~-p~~l~~l~~L~~L~Ls- 203 (1036)
+.++.++.+++ .+|..+. +++++|+|++|.|+...+..|.++++|++|++++|.+...+ +..+..+++++++.+.
T Consensus 11 ~~i~c~~~~l~-~iP~~l~--~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~ 87 (242)
T d1xwdc1 11 RVFLCQESKVT-EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEK 87 (242)
T ss_dssp SEEEEESCSCS-SCCSCSC--SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEEC
T ss_pred CEEEEECCCCC-CCCCCCC--CCCCEEECCCCCCCCCCHHHHHCCCHHHHHHHCCCCCCCEEECCCCCCCCCCCCCCCCC
T ss_conf 99998189988-7688889--98899987699189649668614643232110221124201001122222222211111
Q ss_pred CCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCH-HHHCCCCCCCEEEEECCCCCCCCCCCCCCCCCCCEEECCCCCCCCC
Q ss_conf 644778897320287789678646874788770-2103999999999008868887872234999988998468889998
Q 001658 204 SAGVSGEIPSSFANLQSLTKWWASDTRLTGRIP-DFIGNWSKLTALRFQGNSFNGPIPSSFSNLTSVTELRISDLSNGSS 282 (1036)
Q Consensus 204 ~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~-~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~n~~~~~ 282 (1036)
.|++....+..|..+++|++|++++|.+....+ ..+..+..+..+...++. +..+
T Consensus 88 ~n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~------------------------l~~i 143 (242)
T d1xwdc1 88 ANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNIN------------------------IHTI 143 (242)
T ss_dssp CTTCCEECTTSEECCTTCCEEEEESCCCCSCCCCTTTCBSSCEEEEEESCTT------------------------CCEE
T ss_pred CCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCCCCCCCCC------------------------CCCC
T ss_conf 2343222222122222222223421111255433322211112222222121------------------------1122
Q ss_pred CHHHHCCC-CCCCEEECCCCCCCCCCCCCCCCCCCCCE-EECCCCCCCCCCC-HHCCCCCCCCEEECCCCCCCCCCCCCC
Q ss_conf 40200399-99989983177668665512128998659-9177988999992-000599886579744761666688886
Q 001658 283 KLAFIRDM-KSLSILELRNNNISDSIPSNIGEYRSLQH-LDLSFNNLGGSIP-DSLFNLSSLTHLFLGNNKLNGTLPARK 359 (1036)
Q Consensus 283 ~~~~l~~l-~~L~~L~Ls~N~l~~~ip~~l~~l~~L~~-L~Ls~N~L~g~ip-~~l~~l~~L~~L~Ls~N~l~g~~p~~~ 359 (1036)
....|.++ ..+..|++++|+++ .++.......+++. +++++|+++ .+| ..|.++++|+.|+|++|+++ .+|...
T Consensus 144 ~~~~~~~~~~~l~~L~l~~n~l~-~i~~~~~~~~~l~~~~~l~~n~l~-~l~~~~f~~l~~L~~L~Ls~N~l~-~l~~~~ 220 (242)
T d1xwdc1 144 ERNSFVGLSFESVILWLNKNGIQ-EIHNCAFNGTQLDELNLSDNNNLE-ELPNDVFHGASGPVILDISRTRIH-SLPSYG 220 (242)
T ss_dssp CTTSSTTSBSSCEEEECCSSCCC-EECTTTTTTCCEEEEECTTCTTCC-CCCTTTTTTSCCCSEEECTTSCCC-CCCSSS
T ss_pred CCCCCCCCCCCCEEEECCCCCCC-CCCCCCCCCHHHHCCCCCCCCCCC-CCCHHHHCCCCCCCEEECCCCCCC-CCCHHH
T ss_conf 22222222331001220012333-322222220111012123543246-424788668999998989799289-459779
Q ss_pred CCCCCEE
Q ss_conf 7986589
Q 001658 360 SPLLLNI 366 (1036)
Q Consensus 360 ~~~L~~L 366 (1036)
+..+..|
T Consensus 221 ~~~l~~L 227 (242)
T d1xwdc1 221 LENLKKL 227 (242)
T ss_dssp CTTCCEE
T ss_pred HCCCCCC
T ss_conf 7377134
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.93 E-value=2.7e-22 Score=131.81 Aligned_cols=249 Identities=25% Similarity=0.297 Sum_probs=128.1
Q ss_pred EEEEEEEEECCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECC
Q ss_conf 67599984032466698112599999899923888999896111377767765211433668764011399998699831
Q 001658 100 HITQLKVYALNVVGVIPDELWNLTSLFNLNLGQNYLTGPLSPSVGNLTAMQYLNLAINALSGELPKELGQLTELLILGIG 179 (1036)
Q Consensus 100 ~~~~L~l~~~~l~~~ip~~l~~l~~L~~L~L~~n~l~~~~p~~~~~L~~L~~L~L~~n~l~~~~p~~l~~L~~L~~L~Ls 179 (1036)
+++.|++.+++++ .+|..+ .+|+.|++++|.++ .++. + .+.|++|+|++|.+. .+|. ++.+++|+.|+++
T Consensus 59 ~L~~L~Ls~N~l~-~lp~~~---~~L~~L~l~~n~l~-~l~~-l--p~~L~~L~L~~n~l~-~lp~-~~~l~~L~~L~l~ 128 (353)
T d1jl5a_ 59 HLESLVASCNSLT-ELPELP---QSLKSLLVDNNNLK-ALSD-L--PPLLEYLGVSNNQLE-KLPE-LQNSSFLKIIDVD 128 (353)
T ss_dssp TCSEEECCSSCCS-SCCCCC---TTCCEEECCSSCCS-CCCS-C--CTTCCEEECCSSCCS-SCCC-CTTCTTCCEEECC
T ss_pred CCCEEECCCCCCC-CCCCCH---HHHHHHHHHHCCCC-HHHH-H--CCCCCCCCCCCCCCC-CCCC-HHHHCCCEEECCC
T ss_conf 9888989999796-336203---32033266551432-0321-0--221111133455432-2210-0110131231135
Q ss_pred CCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCH------------------HHHCC
Q ss_conf 677988894124788668777475644778897320287789678646874788770------------------21039
Q 001658 180 TNNFSGPLPSELGSLSKLQELYIDSAGVSGEIPSSFANLQSLTKWWASDTRLTGRIP------------------DFIGN 241 (1036)
Q Consensus 180 ~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~------------------~~l~~ 241 (1036)
+|.+.. .+.. ...+..+.+..+... ....+..++.++.+.+.+|....... ..+..
T Consensus 129 ~~~~~~-~~~~---~~~l~~l~~~~~~~~--~~~~l~~l~~l~~L~l~~n~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 202 (353)
T d1jl5a_ 129 NNSLKK-LPDL---PPSLEFIAAGNNQLE--ELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPELQN 202 (353)
T ss_dssp SSCCSC-CCCC---CTTCCEEECCSSCCS--SCCCCTTCTTCCEEECCSSCCSSCCCCCTTCCEEECCSSCCSSCCCCTT
T ss_pred CCCCCC-CCCC---CCCCCCHHHCCCCCC--CCCCCCCCCCCEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
T ss_conf 651001-3223---333210000122222--3332000122200111233443222212222223344432222122345
Q ss_pred CCCCCEEEEECCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCHHHHCCCCCCCEEECCCCCCCCC---------------
Q ss_conf 99999999008868887872234999988998468889998402003999998998317766866---------------
Q 001658 242 WSKLTALRFQGNSFNGPIPSSFSNLTSVTELRISDLSNGSSKLAFIRDMKSLSILELRNNNISDS--------------- 306 (1036)
Q Consensus 242 l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~n~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~--------------- 306 (1036)
++.|+.+++++|... ..+. ...++..+.+.++.+..... ....+..+++..+.+.+.
T Consensus 203 l~~L~~l~l~~n~~~-~~~~---~~~~l~~~~~~~~~~~~~~~----~~~~l~~~~~~~~~~~~l~~l~~~~~~~~~~~~ 274 (353)
T d1jl5a_ 203 LPFLTTIYADNNLLK-TLPD---LPPSLEALNVRDNYLTDLPE----LPQSLTFLDVSENIFSGLSELPPNLYYLNASSN 274 (353)
T ss_dssp CTTCCEEECCSSCCS-SCCS---CCTTCCEEECCSSCCSCCCC----CCTTCCEEECCSSCCSEESCCCTTCCEEECCSS
T ss_pred CCCCCCCCCCCCCCC-CCCC---CCCCCCCCCCCCCCCCCCCC----CCCCCCCCCCCCCCCCCCCCCCCHHCCCCCCCC
T ss_conf 553331222542223-4553---23343332223333344433----344322222222333222345300012333357
Q ss_pred -CCCCCCCCCCCCEEECCCCCCCCCCCHHCCCCCCCCEEECCCCCCCCCCCCCCCCCCCEEEEECCCCCCCCCH
Q ss_conf -5512128998659917798899999200059988657974476166668888679865898207628999814
Q 001658 307 -IPSNIGEYRSLQHLDLSFNNLGGSIPDSLFNLSSLTHLFLGNNKLNGTLPARKSPLLLNIDVSYNNLQGNLPS 379 (1036)
Q Consensus 307 -ip~~l~~l~~L~~L~Ls~N~L~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~L~~Ldls~N~l~g~~p~ 379 (1036)
++.....+++|++|+|++|+|. .+|.. +++|+.|+|++|+|+ .+|. ..+.|+.|++++|+++ .+|.
T Consensus 275 ~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~---~~~L~~L~L~~N~L~-~l~~-~~~~L~~L~L~~N~L~-~lp~ 341 (353)
T d1jl5a_ 275 EIRSLCDLPPSLEELNVSNNKLI-ELPAL---PPRLERLIASFNHLA-EVPE-LPQNLKQLHVEYNPLR-EFPD 341 (353)
T ss_dssp CCSEECCCCTTCCEEECCSSCCS-CCCCC---CTTCCEEECCSSCCS-CCCC-CCTTCCEEECCSSCCS-SCCC
T ss_pred CCCCCCCCCCCCCEEECCCCCCC-CCCCC---CCCCCEEECCCCCCC-CCCC-CCCCCCEEECCCCCCC-CCCC
T ss_conf 53234566898898979799168-35665---487998989999687-5453-2288898987699189-7776
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.91 E-value=4.8e-24 Score=141.11 Aligned_cols=164 Identities=20% Similarity=0.317 Sum_probs=77.2
Q ss_pred CCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCHHHHCCCCCCCEEEE
Q ss_conf 99869983167798889412478866877747564477889732028778967864687478877021039999999990
Q 001658 171 TELLILGIGTNNFSGPLPSELGSLSKLQELYIDSAGVSGEIPSSFANLQSLTKWWASDTRLTGRIPDFIGNWSKLTALRF 250 (1036)
Q Consensus 171 ~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L 250 (1036)
.+|+.|++++|.+.. ++ .+..+++|++|++++|++++.. .++.+++|+.|++++|+++. ++ .+..+++|+.|++
T Consensus 46 ~~L~~L~l~~~~i~~-l~-~l~~l~~L~~L~L~~n~i~~l~--~~~~l~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~l 119 (210)
T d1h6ta2 46 NSIDQIIANNSDIKS-VQ-GIQYLPNVTKLFLNGNKLTDIK--PLANLKNLGWLFLDENKVKD-LS-SLKDLKKLKSLSL 119 (210)
T ss_dssp HTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCEEEC
T ss_pred CCCCEEECCCCCCCC-CH-HHHHCCCCCEEECCCCCCCCCC--CCCCCCCCCCCCCCCCCCCC-CC-CCCCCCCCCCCCC
T ss_conf 484589782798887-44-4764899898769896025860--11358621201433333212-22-1212221112234
Q ss_pred ECCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCHHHHCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCC
Q ss_conf 08868887872234999988998468889998402003999998998317766866551212899865991779889999
Q 001658 251 QGNSFNGPIPSSFSNLTSVTELRISDLSNGSSKLAFIRDMKSLSILELRNNNISDSIPSNIGEYRSLQHLDLSFNNLGGS 330 (1036)
Q Consensus 251 ~~N~l~~~~p~~l~~l~~L~~L~L~~n~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~ip~~l~~l~~L~~L~Ls~N~L~g~ 330 (1036)
++|.+.. + ..+..++.++.++++.|.+.... .+..+++|+.+++++|++++ ++ .+..+++|+.|+|++|+++ .
T Consensus 120 ~~~~~~~-~-~~l~~l~~l~~l~~~~n~l~~~~--~~~~l~~L~~l~l~~n~l~~-i~-~l~~l~~L~~L~Ls~N~i~-~ 192 (210)
T d1h6ta2 120 EHNGISD-I-NGLVHLPQLESLYLGNNKITDIT--VLSRLTKLDTLSLEDNQISD-IV-PLAGLTKLQNLYLSKNHIS-D 192 (210)
T ss_dssp TTSCCCC-C-GGGGGCTTCCEEECCSSCCCCCG--GGGGCTTCSEEECCSSCCCC-CG-GGTTCTTCCEEECCSSCCC-B
T ss_pred CCCCCCC-C-CCCCCCCCCCCCCCCCCCCCCCC--CCCCCCCCCCCCCCCCCCCC-CC-CCCCCCCCCEEECCCCCCC-C
T ss_conf 5653221-1-22011111222112223334543--10001332100134643025-64-5367898999989799899-8
Q ss_pred CCHHCCCCCCCCEEECCC
Q ss_conf 920005998865797447
Q 001658 331 IPDSLFNLSSLTHLFLGN 348 (1036)
Q Consensus 331 ip~~l~~l~~L~~L~Ls~ 348 (1036)
++ .+..+++|+.|+|++
T Consensus 193 l~-~l~~l~~L~~L~Ls~ 209 (210)
T d1h6ta2 193 LR-ALAGLKNLDVLELFS 209 (210)
T ss_dssp CG-GGTTCTTCSEEEEEE
T ss_pred CH-HHCCCCCCCEEECCC
T ss_conf 72-116999989997118
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.91 E-value=2.5e-23 Score=137.27 Aligned_cols=165 Identities=18% Similarity=0.265 Sum_probs=72.7
Q ss_pred CCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEE
Q ss_conf 77677652114336687640113999986998316779888941247886687774756447788973202877896786
Q 001658 146 LTAMQYLNLAINALSGELPKELGQLTELLILGIGTNNFSGPLPSELGSLSKLQELYIDSAGVSGEIPSSFANLQSLTKWW 225 (1036)
Q Consensus 146 L~~L~~L~L~~n~l~~~~p~~l~~L~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~ 225 (1036)
+.+|++|++++|.++. ++ .+..+++|++|+|++|++++ ++ .+..+++|+.|++++|++++ ++ .+..+++|+.|+
T Consensus 45 L~~L~~L~l~~~~i~~-l~-~l~~l~~L~~L~L~~n~i~~-l~-~~~~l~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~ 118 (210)
T d1h6ta2 45 LNSIDQIIANNSDIKS-VQ-GIQYLPNVTKLFLNGNKLTD-IK-PLANLKNLGWLFLDENKVKD-LS-SLKDLKKLKSLS 118 (210)
T ss_dssp HHTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCC-CG-GGTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCEEE
T ss_pred HCCCCEEECCCCCCCC-CH-HHHHCCCCCEEECCCCCCCC-CC-CCCCCCCCCCCCCCCCCCCC-CC-CCCCCCCCCCCC
T ss_conf 5484589782798887-44-47648998987698960258-60-11358621201433333212-22-121222111223
Q ss_pred CCCCCCCCCCHHHHCCCCCCCEEEEECCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCHHHHCCCCCCCEEECCCCCCCC
Q ss_conf 46874788770210399999999900886888787223499998899846888999840200399999899831776686
Q 001658 226 ASDTRLTGRIPDFIGNWSKLTALRFQGNSFNGPIPSSFSNLTSVTELRISDLSNGSSKLAFIRDMKSLSILELRNNNISD 305 (1036)
Q Consensus 226 L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~n~~~~~~~~~l~~l~~L~~L~Ls~N~l~~ 305 (1036)
+++|.+.. ...+..++.|+.+++++|.+++ +..+..+++|+.+++++|.+..+.. +.++++|+.|+|++|.++
T Consensus 119 l~~~~~~~--~~~l~~l~~l~~l~~~~n~l~~--~~~~~~l~~L~~l~l~~n~l~~i~~--l~~l~~L~~L~Ls~N~i~- 191 (210)
T d1h6ta2 119 LEHNGISD--INGLVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHIS- 191 (210)
T ss_dssp CTTSCCCC--CGGGGGCTTCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCC-
T ss_pred CCCCCCCC--CCCCCCCCCCCCCCCCCCCCCC--CCCCCCCCCCCCCCCCCCCCCCCCC--CCCCCCCCEEECCCCCCC-
T ss_conf 45653221--1220111112221122233345--4310001332100134643025645--367898999989799899-
Q ss_pred CCCCCCCCCCCCCEEECCC
Q ss_conf 6551212899865991779
Q 001658 306 SIPSNIGEYRSLQHLDLSF 324 (1036)
Q Consensus 306 ~ip~~l~~l~~L~~L~Ls~ 324 (1036)
.++ .+..+++|++|+|++
T Consensus 192 ~l~-~l~~l~~L~~L~Ls~ 209 (210)
T d1h6ta2 192 DLR-ALAGLKNLDVLELFS 209 (210)
T ss_dssp BCG-GGTTCTTCSEEEEEE
T ss_pred CCH-HHCCCCCCCEEECCC
T ss_conf 872-116999989997118
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.91 E-value=1.6e-23 Score=138.27 Aligned_cols=161 Identities=20% Similarity=0.348 Sum_probs=67.4
Q ss_pred CCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCHHHHCCCCCCCEEE
Q ss_conf 99986998316779888941247886687774756447788973202877896786468747887702103999999999
Q 001658 170 LTELLILGIGTNNFSGPLPSELGSLSKLQELYIDSAGVSGEIPSSFANLQSLTKWWASDTRLTGRIPDFIGNWSKLTALR 249 (1036)
Q Consensus 170 L~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~ 249 (1036)
+.+|+.|++++|.+.. + ..+..+++|++|++++|++++..+ +..+++|++|++++|.+... + .+..++.|+.|+
T Consensus 39 l~~l~~L~l~~~~i~~-l-~~l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~l~~n~~~~~-~-~l~~l~~L~~L~ 112 (199)
T d2omxa2 39 LDQVTTLQADRLGIKS-I-DGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADI-T-PLANLTNLTGLT 112 (199)
T ss_dssp HTTCCEEECTTSCCCC-C-TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCC-G-GGTTCTTCSEEE
T ss_pred HCCCCEEECCCCCCCC-C-CCCCCCCCCCCCCCCCCCCCCCCC--CCCCCCCCCCCCCCCCCCCC-C-CCCCCCCCCCCC
T ss_conf 4687899899999977-5-202137886757545655667640--16775223111122222222-1-111122322211
Q ss_pred EECCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCHHHHCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCC
Q ss_conf 00886888787223499998899846888999840200399999899831776686655121289986599177988999
Q 001658 250 FQGNSFNGPIPSSFSNLTSVTELRISDLSNGSSKLAFIRDMKSLSILELRNNNISDSIPSNIGEYRSLQHLDLSFNNLGG 329 (1036)
Q Consensus 250 L~~N~l~~~~p~~l~~l~~L~~L~L~~n~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~ip~~l~~l~~L~~L~Ls~N~L~g 329 (1036)
+++|.+... ..+..+++|+.|++++|.+...+ .+..+++|+.|++++|++++ ++ .+..+++|+.|++++|+++
T Consensus 113 l~~~~~~~~--~~~~~l~~L~~L~l~~n~l~~~~--~l~~~~~L~~L~l~~n~l~~-l~-~l~~l~~L~~L~ls~N~i~- 185 (199)
T d2omxa2 113 LFNNQITDI--DPLKNLTNLNRLELSSNTISDIS--ALSGLTSLQQLNFSSNQVTD-LK-PLANLTTLERLDISSNKVS- 185 (199)
T ss_dssp CCSSCCCCC--GGGTTCTTCSEEECCSSCCCCCG--GGTTCTTCSEEECCSSCCCC-CG-GGTTCTTCCEEECCSSCCC-
T ss_pred CCCCCCCCC--CCCCHHHHHHHHHHHHHHHCCCC--CCCCCCCCCCCCCCCCCCCC-CC-CCCCCCCCCEEECCCCCCC-
T ss_conf 122222232--10001223677643111100234--33321111112234555567-70-1167998999978799799-
Q ss_pred CCCHHCCCCCCCCEE
Q ss_conf 992000599886579
Q 001658 330 SIPDSLFNLSSLTHL 344 (1036)
Q Consensus 330 ~ip~~l~~l~~L~~L 344 (1036)
.++ .+..+++|+.|
T Consensus 186 ~i~-~l~~L~~L~~L 199 (199)
T d2omxa2 186 DIS-VLAKLTNLESL 199 (199)
T ss_dssp CCG-GGGGCTTCSEE
T ss_pred CCC-CCCCCCCCCCC
T ss_conf 881-01278998949
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.90 E-value=1.7e-22 Score=132.85 Aligned_cols=162 Identities=23% Similarity=0.369 Sum_probs=70.2
Q ss_pred CCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEE
Q ss_conf 77767765211433668764011399998699831677988894124788668777475644778897320287789678
Q 001658 145 NLTAMQYLNLAINALSGELPKELGQLTELLILGIGTNNFSGPLPSELGSLSKLQELYIDSAGVSGEIPSSFANLQSLTKW 224 (1036)
Q Consensus 145 ~L~~L~~L~L~~n~l~~~~p~~l~~L~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L 224 (1036)
.+.+|++|++++|.+.. + ..+..+++|++|++++|++++..+ +.++++|+.|++++|.+... + .+..++.|+.|
T Consensus 38 ~l~~l~~L~l~~~~i~~-l-~~l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~l~~n~~~~~-~-~l~~l~~L~~L 111 (199)
T d2omxa2 38 DLDQVTTLQADRLGIKS-I-DGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADI-T-PLANLTNLTGL 111 (199)
T ss_dssp HHTTCCEEECTTSCCCC-C-TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCC-G-GGTTCTTCSEE
T ss_pred HHCCCCEEECCCCCCCC-C-CCCCCCCCCCCCCCCCCCCCCCCC--CCCCCCCCCCCCCCCCCCCC-C-CCCCCCCCCCC
T ss_conf 94687899899999977-5-202137886757545655667640--16775223111122222222-1-11112232221
Q ss_pred ECCCCCCCCCCHHHHCCCCCCCEEEEECCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCHHHHCCCCCCCEEECCCCCCC
Q ss_conf 64687478877021039999999990088688878722349999889984688899984020039999989983177668
Q 001658 225 WASDTRLTGRIPDFIGNWSKLTALRFQGNSFNGPIPSSFSNLTSVTELRISDLSNGSSKLAFIRDMKSLSILELRNNNIS 304 (1036)
Q Consensus 225 ~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~n~~~~~~~~~l~~l~~L~~L~Ls~N~l~ 304 (1036)
++++|.+... ..+..+++|+.|++++|++.. ++ .+..+++|+.|++.+|.+..+.+ +.++++|+.|++++|+++
T Consensus 112 ~l~~~~~~~~--~~~~~l~~L~~L~l~~n~l~~-~~-~l~~~~~L~~L~l~~n~l~~l~~--l~~l~~L~~L~ls~N~i~ 185 (199)
T d2omxa2 112 TLFNNQITDI--DPLKNLTNLNRLELSSNTISD-IS-ALSGLTSLQQLNFSSNQVTDLKP--LANLTTLERLDISSNKVS 185 (199)
T ss_dssp ECCSSCCCCC--GGGTTCTTCSEEECCSSCCCC-CG-GGTTCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCC
T ss_pred CCCCCCCCCC--CCCCHHHHHHHHHHHHHHHCC-CC-CCCCCCCCCCCCCCCCCCCCCCC--CCCCCCCCEEECCCCCCC
T ss_conf 1122222232--100012236776431111002-34-33321111112234555567701--167998999978799799
Q ss_pred CCCCCCCCCCCCCCEE
Q ss_conf 6655121289986599
Q 001658 305 DSIPSNIGEYRSLQHL 320 (1036)
Q Consensus 305 ~~ip~~l~~l~~L~~L 320 (1036)
+ ++ .+..+++|+.|
T Consensus 186 ~-i~-~l~~L~~L~~L 199 (199)
T d2omxa2 186 D-IS-VLAKLTNLESL 199 (199)
T ss_dssp C-CG-GGGGCTTCSEE
T ss_pred C-CC-CCCCCCCCCCC
T ss_conf 8-81-01278998949
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.90 E-value=4.1e-26 Score=152.07 Aligned_cols=296 Identities=18% Similarity=0.159 Sum_probs=157.4
Q ss_pred EEEEEEEEECCCCCCC-CCCCCCCCCCCEEECCCCCCCC----CCCCCCCCCCCCCEEECCCCCCCCC----CCCCCC-C
Q ss_conf 6759998403246669-8112599999899923888999----8961113777677652114336687----640113-9
Q 001658 100 HITQLKVYALNVVGVI-PDELWNLTSLFNLNLGQNYLTG----PLSPSVGNLTAMQYLNLAINALSGE----LPKELG-Q 169 (1036)
Q Consensus 100 ~~~~L~l~~~~l~~~i-p~~l~~l~~L~~L~L~~n~l~~----~~p~~~~~L~~L~~L~L~~n~l~~~----~p~~l~-~ 169 (1036)
+++.|++..+++++.- ..-+..+++++.|+|++|+++. .+...+..+++|++|||++|.|+.. +...+. .
T Consensus 3 ~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~ 82 (460)
T d1z7xw1 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTP 82 (460)
T ss_dssp EEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCST
T ss_pred CCCEEEEECCCCCHHHHHHHHHHCCCCCEEEECCCCCCHHHHHHHHHHHHCCCCCCEEECCCCCCCHHHHHHHHHHHHCC
T ss_conf 87779820895886899999976779999982899998899999999985399988897959859728999999998437
Q ss_pred CCCCCEEECCCCCCCCC----CCCCCCCCCCCCEEECCCCCCCCCCCC--------------------------------
Q ss_conf 99986998316779888----941247886687774756447788973--------------------------------
Q 001658 170 LTELLILGIGTNNFSGP----LPSELGSLSKLQELYIDSAGVSGEIPS-------------------------------- 213 (1036)
Q Consensus 170 L~~L~~L~Ls~N~l~~~----~p~~l~~l~~L~~L~Ls~N~l~~~~p~-------------------------------- 213 (1036)
..+|+.|+|++|+++.. ++..+..+++|++|++++|.++.....
T Consensus 83 ~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (460)
T d1z7xw1 83 SCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLA 162 (460)
T ss_dssp TCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHH
T ss_pred CCCCCEEECCCCCCCCCCCCCCCCHHHCCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCHHHHCCCC
T ss_conf 88778877888775432210121100003432002444332023455554430135543332222223222001100112
Q ss_pred -CCCCCCCCCEEECCCCC-----------------------------CCCCC----HHHHCCCCCCCEEEEECCCCCC--
Q ss_conf -20287789678646874-----------------------------78877----0210399999999900886888--
Q 001658 214 -SFANLQSLTKWWASDTR-----------------------------LTGRI----PDFIGNWSKLTALRFQGNSFNG-- 257 (1036)
Q Consensus 214 -~l~~l~~L~~L~L~~N~-----------------------------l~~~~----~~~l~~l~~L~~L~L~~N~l~~-- 257 (1036)
.+.....++.+.++.+. +.... ...+...+.++.+++..|.+..
T Consensus 163 ~~l~~~~~~~~~~ls~~~~~~~~~~~~~~~l~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~~l~~~~n~~~~~~ 242 (460)
T d1z7xw1 163 SVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVG 242 (460)
T ss_dssp HHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHHH
T ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCHHHCCCCCCC
T ss_conf 22333322222332222124555543234332112210012411245421011012233222222100100211223344
Q ss_pred ---CCCCCCCCCCCCCEEECCCCCCCCCCH----HHHCCCCCCCEEECCCCCCCCCCCCCC-----CCCCCCCEEECCCC
Q ss_conf ---787223499998899846888999840----200399999899831776686655121-----28998659917798
Q 001658 258 ---PIPSSFSNLTSVTELRISDLSNGSSKL----AFIRDMKSLSILELRNNNISDSIPSNI-----GEYRSLQHLDLSFN 325 (1036)
Q Consensus 258 ---~~p~~l~~l~~L~~L~L~~n~~~~~~~----~~l~~l~~L~~L~Ls~N~l~~~ip~~l-----~~l~~L~~L~Ls~N 325 (1036)
.....+.....++.+++++|.+..... ..+...+.++.+++++|.+.......+ .....|+.+++++|
T Consensus 243 ~~~~~~~~~~~~~~l~~l~l~~n~i~~~~~~~~~~~l~~~~~l~~l~l~~n~i~~~~~~~l~~~l~~~~~~L~~l~l~~~ 322 (460)
T d1z7xw1 243 MAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSC 322 (460)
T ss_dssp HHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTS
T ss_pred CCHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHCCCCCCCCCCCCCCCCCC
T ss_conf 20110001111111000013454332123343322111234333444443332245642111012333444333323334
Q ss_pred CCCCCCCHHC----CCCCCCCEEECCCCCCCCC----CCCC---CCCCCCEEEEECCCCCCC----CCHHHHCCCCCCEE
Q ss_conf 8999992000----5998865797447616666----8888---679865898207628999----81433136796234
Q 001658 326 NLGGSIPDSL----FNLSSLTHLFLGNNKLNGT----LPAR---KSPLLLNIDVSYNNLQGN----LPSWINGQQNLQIN 390 (1036)
Q Consensus 326 ~L~g~ip~~l----~~l~~L~~L~Ls~N~l~g~----~p~~---~~~~L~~Ldls~N~l~g~----~p~~l~~l~~L~~~ 390 (1036)
.+.......+ ...++|++|+|++|++... ++.. ..+.|+.|++++|.++.. +...+..+++|+.+
T Consensus 323 ~l~~~~~~~l~~~~~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~L 402 (460)
T d1z7xw1 323 SFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLREL 402 (460)
T ss_dssp CCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEE
T ss_pred CHHHHHHHHCCCCCCCCCCHHHHHEEEECCCCCCCCHHHHHHHCCCCCCCEEECCCCCCCHHHHHHHHHHHHCCCCCCEE
T ss_conf 10233443213322110111132012101357664001112204567778898979979759999999999629988989
Q ss_pred EECCC
Q ss_conf 50688
Q 001658 391 LVANN 395 (1036)
Q Consensus 391 ~~~nn 395 (1036)
.+.+|
T Consensus 403 ~Ls~N 407 (460)
T d1z7xw1 403 DLSNN 407 (460)
T ss_dssp ECCSS
T ss_pred ECCCC
T ss_conf 89999
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.90 E-value=1.4e-23 Score=138.71 Aligned_cols=106 Identities=25% Similarity=0.268 Sum_probs=38.7
Q ss_pred CCCEEECCCCCCCCCC-CCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEEC
Q ss_conf 9989992388899989-611137776776521143366876401139999869983167798889412478866877747
Q 001658 124 SLFNLNLGQNYLTGPL-SPSVGNLTAMQYLNLAINALSGELPKELGQLTELLILGIGTNNFSGPLPSELGSLSKLQELYI 202 (1036)
Q Consensus 124 ~L~~L~L~~n~l~~~~-p~~~~~L~~L~~L~L~~n~l~~~~p~~l~~L~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L 202 (1036)
++++|+|++|.|+..+ +..|.++++|+.|+|++|.+....+..+..+++|++|+|++|++....+..|.++++|++|+|
T Consensus 30 ~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N~l~~l~~~~F~~l~~L~~L~L 109 (192)
T d1w8aa_ 30 HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNL 109 (192)
T ss_dssp TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEEC
T ss_pred CCCEEEECCCCCCCCCCCCCCCCCCEEEEEECCCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCHHHHHCCCCCCCCCC
T ss_conf 87889848987755302002578762721301363221212122211222210100355344349799807974655245
Q ss_pred CCCCCCCCCCCCCCCCCCCCEEECCCC
Q ss_conf 564477889732028778967864687
Q 001658 203 DSAGVSGEIPSSFANLQSLTKWWASDT 229 (1036)
Q Consensus 203 s~N~l~~~~p~~l~~l~~L~~L~L~~N 229 (1036)
++|+|++..+..|..+++|++|+|++|
T Consensus 110 ~~N~l~~i~~~~f~~l~~L~~l~L~~N 136 (192)
T d1w8aa_ 110 YDNQISCVMPGSFEHLNSLTSLNLASN 136 (192)
T ss_dssp CSSCCCEECTTSSTTCTTCCEEECTTC
T ss_pred CCCCCCCCCHHHHCCCCCCCCCCCCCC
T ss_conf 774535359778568753342000364
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.89 E-value=2e-23 Score=137.82 Aligned_cols=126 Identities=21% Similarity=0.277 Sum_probs=65.9
Q ss_pred EECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCC-CCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCC
Q ss_conf 992388899989611137776776521143366876-4011399998699831677988894124788668777475644
Q 001658 128 LNLGQNYLTGPLSPSVGNLTAMQYLNLAINALSGEL-PKELGQLTELLILGIGTNNFSGPLPSELGSLSKLQELYIDSAG 206 (1036)
Q Consensus 128 L~L~~n~l~~~~p~~~~~L~~L~~L~L~~n~l~~~~-p~~l~~L~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~ 206 (1036)
++.++++++ .+|..+. +++++|+|++|.|+..+ +..|..+++|+.|+|++|.+....+..+..+++|++|+|++|+
T Consensus 13 v~Cs~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N~ 89 (192)
T d1w8aa_ 13 VDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENK 89 (192)
T ss_dssp EECTTSCCS-SCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCC
T ss_pred EEEECCCCC-CCCCCCC--CCCCEEEECCCCCCCCCCCCCCCCCCEEEEEECCCCCCCCCCCCCCCCCCCCCEEEECCCC
T ss_conf 997089967-0298989--7878898489877553020025787627213013632212121222112222101003553
Q ss_pred CCCCCCCCCCCCCCCCEEECCCCCCCCCCHHHHCCCCCCCEEEEECCCCC
Q ss_conf 77889732028778967864687478877021039999999990088688
Q 001658 207 VSGEIPSSFANLQSLTKWWASDTRLTGRIPDFIGNWSKLTALRFQGNSFN 256 (1036)
Q Consensus 207 l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~ 256 (1036)
+....+..|.++++|++|+|++|+|++..++.|..+++|++|+|++|.+.
T Consensus 90 l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~ 139 (192)
T d1w8aa_ 90 IKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFN 139 (192)
T ss_dssp CCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBC
T ss_pred CCCCCHHHHHCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCC
T ss_conf 44349799807974655245774535359778568753342000364434
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.87 E-value=1.4e-23 Score=138.68 Aligned_cols=181 Identities=19% Similarity=0.207 Sum_probs=83.7
Q ss_pred CCCCCCEEECCCCCCCCC-CCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCC-CCCCCC-HHHHCCCCCC
Q ss_conf 999986998316779888-9412478866877747564477889732028778967864687-478877-0210399999
Q 001658 169 QLTELLILGIGTNNFSGP-LPSELGSLSKLQELYIDSAGVSGEIPSSFANLQSLTKWWASDT-RLTGRI-PDFIGNWSKL 245 (1036)
Q Consensus 169 ~L~~L~~L~Ls~N~l~~~-~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N-~l~~~~-~~~l~~l~~L 245 (1036)
...+|++|||+++.+... +...+..+++|++|+|.++.+....+..++.+++|++|+++++ .++... ...+..+++|
T Consensus 44 ~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L 123 (284)
T d2astb2 44 SPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRL 123 (284)
T ss_dssp CCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTC
T ss_pred CCCCCCEEECCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCCCHHHHHHHCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHC
T ss_conf 67878878898984577799999974877651452346798678999851899757151001341235540365788743
Q ss_pred CEEEEECC-CCCCC-CCCCCCC-CCCCCEEECCCCC--CCCCCH-HHHCCCCCCCEEECCCC-CCCCCCCCCCCCCCCCC
Q ss_conf 99990088-68887-8722349-9998899846888--999840-20039999989983177-66866551212899865
Q 001658 246 TALRFQGN-SFNGP-IPSSFSN-LTSVTELRISDLS--NGSSKL-AFIRDMKSLSILELRNN-NISDSIPSNIGEYRSLQ 318 (1036)
Q Consensus 246 ~~L~L~~N-~l~~~-~p~~l~~-l~~L~~L~L~~n~--~~~~~~-~~l~~l~~L~~L~Ls~N-~l~~~ip~~l~~l~~L~ 318 (1036)
++|+++++ .++.. +...+.. .++|+.|+++++. +..... ..+..+++|+.|++++| .+++.....+.++++|+
T Consensus 124 ~~L~ls~c~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~ 203 (284)
T d2astb2 124 DELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQ 203 (284)
T ss_dssp CEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCC
T ss_pred CCCCCCCCCCCCCCCCHHHHCCCCCCCCHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHCCCCCCC
T ss_conf 56522453323332200010001111101221355424444434342323222123553223477830333321357687
Q ss_pred EEECCCC-CCCCCCCHHCCCCCCCCEEECCCC
Q ss_conf 9917798-899999200059988657974476
Q 001658 319 HLDLSFN-NLGGSIPDSLFNLSSLTHLFLGNN 349 (1036)
Q Consensus 319 ~L~Ls~N-~L~g~ip~~l~~l~~L~~L~Ls~N 349 (1036)
+|+|+++ .+++.....+..+++|+.|+++++
T Consensus 204 ~L~L~~C~~i~~~~l~~L~~~~~L~~L~l~~~ 235 (284)
T d2astb2 204 HLSLSRCYDIIPETLLELGEIPTLKTLQVFGI 235 (284)
T ss_dssp EEECTTCTTCCGGGGGGGGGCTTCCEEECTTS
T ss_pred EEECCCCCCCCHHHHHHHHCCCCCCEEEEECC
T ss_conf 79899999787378999726999898964488
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.87 E-value=6.4e-25 Score=145.74 Aligned_cols=277 Identities=20% Similarity=0.196 Sum_probs=142.5
Q ss_pred EEEEEEEEECCCCC----CCCCCCCCCCCCCEEECCCCCCCCCC----CCCCC-CCCCCCEEECCCCCCCCC----CCCC
Q ss_conf 67599984032466----69811259999989992388899989----61113-777677652114336687----6401
Q 001658 100 HITQLKVYALNVVG----VIPDELWNLTSLFNLNLGQNYLTGPL----SPSVG-NLTAMQYLNLAINALSGE----LPKE 166 (1036)
Q Consensus 100 ~~~~L~l~~~~l~~----~ip~~l~~l~~L~~L~L~~n~l~~~~----p~~~~-~L~~L~~L~L~~n~l~~~----~p~~ 166 (1036)
+++.|++.+++++. .+...+...++|+.|+|++|.|+... ...+. ...+|+.|+|++|++++. ++..
T Consensus 28 ~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~it~~~~~~l~~~ 107 (460)
T d1z7xw1 28 QCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSST 107 (460)
T ss_dssp TCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCSTTCCCCEEECTTSCCBGGGHHHHHHH
T ss_pred CCCEEEECCCCCCHHHHHHHHHHHHCCCCCCEEECCCCCCCHHHHHHHHHHHHCCCCCCCEEECCCCCCCCCCCCCCCCH
T ss_conf 99999828999988999999999853999888979598597289999999984378877887788877543221012110
Q ss_pred CCCCCCCCEEECCCCCCCCCCCC---------------------------------CCCCCCCCCEEECCCCCCC-----
Q ss_conf 13999986998316779888941---------------------------------2478866877747564477-----
Q 001658 167 LGQLTELLILGIGTNNFSGPLPS---------------------------------ELGSLSKLQELYIDSAGVS----- 208 (1036)
Q Consensus 167 l~~L~~L~~L~Ls~N~l~~~~p~---------------------------------~l~~l~~L~~L~Ls~N~l~----- 208 (1036)
+..+++|++|+|++|.+...... .+.....++.+.++.+.+.
T Consensus 108 l~~~~~L~~L~L~~N~i~~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ls~~~~~~~~~~ 187 (460)
T d1z7xw1 108 LRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVR 187 (460)
T ss_dssp TTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCTTCCEEECCSSBCHHHHHH
T ss_pred HHCCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
T ss_conf 00034320024443320234555544301355433322222232220011001122233332222233222212455554
Q ss_pred ------------------------CC----CCCCCCCCCCCCEEECCCCCCCCC-----CHHHHCCCCCCCEEEEECCCC
Q ss_conf ------------------------88----973202877896786468747887-----702103999999999008868
Q 001658 209 ------------------------GE----IPSSFANLQSLTKWWASDTRLTGR-----IPDFIGNWSKLTALRFQGNSF 255 (1036)
Q Consensus 209 ------------------------~~----~p~~l~~l~~L~~L~L~~N~l~~~-----~~~~l~~l~~L~~L~L~~N~l 255 (1036)
.. ....+.....++.+++..|.+... ..........++.+++++|.+
T Consensus 188 ~~~~~l~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~~l~~~~n~~~~~~~~~~~~~~~~~~~~l~~l~l~~n~i 267 (460)
T d1z7xw1 188 VLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGI 267 (460)
T ss_dssp HHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCC
T ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCHHHCCCCCCCCCHHHCCCCCCCCCCCCCCCCCCCC
T ss_conf 32343321122100124112454210110122332222221001002112233442011000111111100001345433
Q ss_pred CCC----CCCCCCCCCCCCEEECCCCCCCCCCHHHH-----CCCCCCCEEECCCCCCCCCCCC----CCCCCCCCCEEEC
Q ss_conf 887----87223499998899846888999840200-----3999998998317766866551----2128998659917
Q 001658 256 NGP----IPSSFSNLTSVTELRISDLSNGSSKLAFI-----RDMKSLSILELRNNNISDSIPS----NIGEYRSLQHLDL 322 (1036)
Q Consensus 256 ~~~----~p~~l~~l~~L~~L~L~~n~~~~~~~~~l-----~~l~~L~~L~Ls~N~l~~~ip~----~l~~l~~L~~L~L 322 (1036)
... ....+...+.++.+++++|.+.......+ .....|+.+++++|.++..... .+...++|+.|+|
T Consensus 268 ~~~~~~~~~~~l~~~~~l~~l~l~~n~i~~~~~~~l~~~l~~~~~~L~~l~l~~~~l~~~~~~~l~~~~~~~~~L~~L~L 347 (460)
T d1z7xw1 268 TAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQI 347 (460)
T ss_dssp CHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEEC
T ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHCCCCCCCCCCCCCCCCCCCHHHHHHHHCCCCCCCCCCHHHHHE
T ss_conf 21233433221112343334444433322456421110123334443333233341023344321332211011113201
Q ss_pred CCCCCCCC----CCHHCC-CCCCCCEEECCCCCCCCC----CCCC--CCCCCCEEEEECCCCCCC
Q ss_conf 79889999----920005-998865797447616666----8888--679865898207628999
Q 001658 323 SFNNLGGS----IPDSLF-NLSSLTHLFLGNNKLNGT----LPAR--KSPLLLNIDVSYNNLQGN 376 (1036)
Q Consensus 323 s~N~L~g~----ip~~l~-~l~~L~~L~Ls~N~l~g~----~p~~--~~~~L~~Ldls~N~l~g~ 376 (1036)
++|++.+. ++..+. ..+.|+.|+|++|+++.. +... ..+.|+.||+++|+++..
T Consensus 348 s~N~i~~~g~~~l~~~l~~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~N~i~~~ 412 (460)
T d1z7xw1 348 SNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDA 412 (460)
T ss_dssp CSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCCHH
T ss_pred EEECCCCCCCCHHHHHHHCCCCCCCEEECCCCCCCHHHHHHHHHHHHCCCCCCEEECCCCCCCHH
T ss_conf 21013576640011122045677788989799797599999999996299889898999969879
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.86 E-value=2.3e-23 Score=137.48 Aligned_cols=250 Identities=16% Similarity=0.178 Sum_probs=115.7
Q ss_pred CCCCCCCCCCCEEECCCCCCCCCC----CCCCCCCCCCCEEECCCCCCCCC----------CCCCCCCCCCCCEEECCCC
Q ss_conf 811259999989992388899989----61113777677652114336687----------6401139999869983167
Q 001658 116 PDELWNLTSLFNLNLGQNYLTGPL----SPSVGNLTAMQYLNLAINALSGE----------LPKELGQLTELLILGIGTN 181 (1036)
Q Consensus 116 p~~l~~l~~L~~L~L~~n~l~~~~----p~~~~~L~~L~~L~L~~n~l~~~----------~p~~l~~L~~L~~L~Ls~N 181 (1036)
...+.....++.|+|++|.++... ...+...++|+.|+++.+.+... +...+...++|+.|+|++|
T Consensus 24 ~~~L~~~~~l~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~l~l~~~~~~~~~~~~~~~~~~l~~~l~~~~~L~~L~L~~n 103 (344)
T d2ca6a1 24 FAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDN 103 (344)
T ss_dssp SHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSC
T ss_pred HHHHHHCCCCCEEECCCCCCCHHHHHHHHHHHHHCCCCCEEECCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCC
T ss_conf 99996389978897849837789999999999858998888887775433454210678799988754777563300001
Q ss_pred CCCCCC----CCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCHHHHCCCCCCCEEEEECCCCCC
Q ss_conf 798889----4124788668777475644778897320287789678646874788770210399999999900886888
Q 001658 182 NFSGPL----PSELGSLSKLQELYIDSAGVSGEIPSSFANLQSLTKWWASDTRLTGRIPDFIGNWSKLTALRFQGNSFNG 257 (1036)
Q Consensus 182 ~l~~~~----p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~ 257 (1036)
.+.... ...+...++|+.|++++|.+.......++. .|..+ .........+.|+.+.+++|.++.
T Consensus 104 ~i~~~~~~~l~~~l~~~~~L~~L~l~~n~l~~~~~~~l~~--~l~~~---------~~~~~~~~~~~L~~l~l~~n~i~~ 172 (344)
T d2ca6a1 104 AFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIAR--ALQEL---------AVNKKAKNAPPLRSIICGRNRLEN 172 (344)
T ss_dssp CCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHH--HHHHH---------HHHHHHHTCCCCCEEECCSSCCTG
T ss_pred CCCCCCCCCHHHHHCCCCCCHHEECCCCCCCCCCCCCCCC--CCCCC---------CCCCCCCCCCCCCEEECCCCCCCC
T ss_conf 3455433310111002343210000024666654311112--12222---------110001467642111013650135
Q ss_pred C----CCCCCCCCCCCCEEECCCCCCCCCC-----HHHHCCCCCCCEEECCCCCCCCC----CCCCCCCCCCCCEEECCC
Q ss_conf 7----8722349999889984688899984-----02003999998998317766866----551212899865991779
Q 001658 258 P----IPSSFSNLTSVTELRISDLSNGSSK-----LAFIRDMKSLSILELRNNNISDS----IPSNIGEYRSLQHLDLSF 324 (1036)
Q Consensus 258 ~----~p~~l~~l~~L~~L~L~~n~~~~~~-----~~~l~~l~~L~~L~Ls~N~l~~~----ip~~l~~l~~L~~L~Ls~ 324 (1036)
. +...+.....|+.|+++.|.+.... ...+...++|+.|+|++|.++.. +...+..+++|+.|+|++
T Consensus 173 ~~~~~l~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~Ls~ 252 (344)
T d2ca6a1 173 GSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLND 252 (344)
T ss_dssp GGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTT
T ss_pred CCCCCCCCHHHHHHHHCCCCCCCCCCCCCCCCCCHHHHHCCHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHC
T ss_conf 54332211112333213354333222222232002433211012112223333222222223444332322111103004
Q ss_pred CCCCCCCCHHC----C--CCCCCCEEECCCCCCCCC----CCCC---CCCCCCEEEEECCCCCCC
Q ss_conf 88999992000----5--998865797447616666----8888---679865898207628999
Q 001658 325 NNLGGSIPDSL----F--NLSSLTHLFLGNNKLNGT----LPAR---KSPLLLNIDVSYNNLQGN 376 (1036)
Q Consensus 325 N~L~g~ip~~l----~--~l~~L~~L~Ls~N~l~g~----~p~~---~~~~L~~Ldls~N~l~g~ 376 (1036)
|.|.+.....+ . ....|+.|++++|++... +... ..+.|+.|++++|++...
T Consensus 253 n~i~~~g~~~l~~~l~~~~~~~L~~L~ls~N~i~~~~~~~l~~~l~~~~~~L~~L~l~~N~~~~~ 317 (344)
T d2ca6a1 253 CLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEE 317 (344)
T ss_dssp CCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCTT
T ss_pred CCCCCHHHHHHHHHHHHCCCCCCCEEECCCCCCCHHHHHHHHHHHHCCCCCCCEEECCCCCCCCC
T ss_conf 75671566788877631568888989898986980899999999970389999897879808986
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.85 E-value=1.6e-22 Score=133.06 Aligned_cols=241 Identities=15% Similarity=0.146 Sum_probs=138.5
Q ss_pred CCCCCCCCCCCCEEECCCCCCCCC----CCCCCCCCCCCCEEECCCCCCCCCC---CCCCCCCCCCCEEECCCCCCCCCC
Q ss_conf 961113777677652114336687----6401139999869983167798889---412478866877747564477889
Q 001658 139 LSPSVGNLTAMQYLNLAINALSGE----LPKELGQLTELLILGIGTNNFSGPL---PSELGSLSKLQELYIDSAGVSGEI 211 (1036)
Q Consensus 139 ~p~~~~~L~~L~~L~L~~n~l~~~----~p~~l~~L~~L~~L~Ls~N~l~~~~---p~~l~~l~~L~~L~Ls~N~l~~~~ 211 (1036)
+...+.+...|+.|+|++|.+... +...+...++|+.|+++++...... +..+. .+
T Consensus 23 l~~~L~~~~~l~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~l~l~~~~~~~~~~~~~~~~~-----------------~l 85 (344)
T d2ca6a1 23 VFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALR-----------------LL 85 (344)
T ss_dssp TSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHH-----------------HH
T ss_pred HHHHHHHCCCCCEEECCCCCCCHHHHHHHHHHHHHCCCCCEEECCCCCCCCCCCCCCHHHH-----------------HH
T ss_conf 9999963899788978498377899999999998589988888877754334542106787-----------------99
Q ss_pred CCCCCCCCCCCEEECCCCCCCCCC----HHHHCCCCCCCEEEEECCCCCCCC-------------CCCCCCCCCCCEEEC
Q ss_conf 732028778967864687478877----021039999999990088688878-------------722349999889984
Q 001658 212 PSSFANLQSLTKWWASDTRLTGRI----PDFIGNWSKLTALRFQGNSFNGPI-------------PSSFSNLTSVTELRI 274 (1036)
Q Consensus 212 p~~l~~l~~L~~L~L~~N~l~~~~----~~~l~~l~~L~~L~L~~N~l~~~~-------------p~~l~~l~~L~~L~L 274 (1036)
...+...++|+.|+|++|.+.... ...+...++|++|++++|.+.... .........|+.+.+
T Consensus 86 ~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~~~~~~~~~~L~~l~l 165 (344)
T d2ca6a1 86 LQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIIC 165 (344)
T ss_dssp HHHHTTCTTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEEC
T ss_pred HHHHHHCCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCHHEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEEC
T ss_conf 98875477756330000134554333101110023432100000246666543111121222211000146764211101
Q ss_pred CCCCCCCCCHHH----HCCCCCCCEEECCCCCCCCC-----CCCCCCCCCCCCEEECCCCCCCCC----CCHHCCCCCCC
Q ss_conf 688899984020----03999998998317766866-----551212899865991779889999----92000599886
Q 001658 275 SDLSNGSSKLAF----IRDMKSLSILELRNNNISDS-----IPSNIGEYRSLQHLDLSFNNLGGS----IPDSLFNLSSL 341 (1036)
Q Consensus 275 ~~n~~~~~~~~~----l~~l~~L~~L~Ls~N~l~~~-----ip~~l~~l~~L~~L~Ls~N~L~g~----ip~~l~~l~~L 341 (1036)
++|.+....... +...+.|+.|+|++|.+... +...+..+++|+.|+|++|.++.. +...+...++|
T Consensus 166 ~~n~i~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L 245 (344)
T d2ca6a1 166 GRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNL 245 (344)
T ss_dssp CSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTC
T ss_pred CCCCCCCCCCCCCCCHHHHHHHHCCCCCCCCCCCCCCCCCCHHHHHCCHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCC
T ss_conf 36501355433221111233321335433322222223200243321101211222333322222222344433232211
Q ss_pred CEEECCCCCCCCCC--------CCCCCCCCCEEEEECCCCCCCC----CHHHH-CCCCCCEEEECCCC
Q ss_conf 57974476166668--------8886798658982076289998----14331-36796234506882
Q 001658 342 THLFLGNNKLNGTL--------PARKSPLLLNIDVSYNNLQGNL----PSWIN-GQQNLQINLVANNL 396 (1036)
Q Consensus 342 ~~L~Ls~N~l~g~~--------p~~~~~~L~~Ldls~N~l~g~~----p~~l~-~l~~L~~~~~~nn~ 396 (1036)
++|+|++|.+.+.- .....+.|+.||+++|+++..- ...+. .+++|+.+.+.+|.
T Consensus 246 ~~L~Ls~n~i~~~g~~~l~~~l~~~~~~~L~~L~ls~N~i~~~~~~~l~~~l~~~~~~L~~L~l~~N~ 313 (344)
T d2ca6a1 246 RELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNR 313 (344)
T ss_dssp CEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSB
T ss_pred HHHHHHCCCCCCHHHHHHHHHHHHCCCCCCCEEECCCCCCCHHHHHHHHHHHHCCCCCCCEEECCCCC
T ss_conf 11030047567156678887763156888898989898698089999999997038999989787980
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.83 E-value=1e-21 Score=128.72 Aligned_cols=178 Identities=20% Similarity=0.221 Sum_probs=68.1
Q ss_pred CCCCCEEECCCCCCCCC-CCCCCCCCCCCCEEECCCCCCCCCCHHHHCCCCCCCEEEEECC-CCCCC-CCCCCCCCCCCC
Q ss_conf 86687774756447788-9732028778967864687478877021039999999990088-68887-872234999988
Q 001658 194 LSKLQELYIDSAGVSGE-IPSSFANLQSLTKWWASDTRLTGRIPDFIGNWSKLTALRFQGN-SFNGP-IPSSFSNLTSVT 270 (1036)
Q Consensus 194 l~~L~~L~Ls~N~l~~~-~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N-~l~~~-~p~~l~~l~~L~ 270 (1036)
..+|++|+++++.+... +...+..+++|++|.++++.+.......+..+++|++|+++++ .++.. +...+..+++|+
T Consensus 45 ~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L~ 124 (284)
T d2astb2 45 PFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLD 124 (284)
T ss_dssp CBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCC
T ss_pred CCCCCEEECCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCCCHHHHHHHCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHCC
T ss_conf 78788788989845777999999748776514523467986789998518997571510013412355403657887435
Q ss_pred EEECCCCC-CCCCC--HHHHCCCCCCCEEECCCC--CCCCC-CCCCCCCCCCCCEEECCCC-CCCCCCCHHCCCCCCCCE
Q ss_conf 99846888-99984--020039999989983177--66866-5512128998659917798-899999200059988657
Q 001658 271 ELRISDLS-NGSSK--LAFIRDMKSLSILELRNN--NISDS-IPSNIGEYRSLQHLDLSFN-NLGGSIPDSLFNLSSLTH 343 (1036)
Q Consensus 271 ~L~L~~n~-~~~~~--~~~l~~l~~L~~L~Ls~N--~l~~~-ip~~l~~l~~L~~L~Ls~N-~L~g~ip~~l~~l~~L~~ 343 (1036)
+|+++++. +.... .......++|+.|+++++ .++.. +...+..+++|+.|++++| .+++..+..+..+++|++
T Consensus 125 ~L~ls~c~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~ 204 (284)
T d2astb2 125 ELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQH 204 (284)
T ss_dssp EEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCE
T ss_pred CCCCCCCCCCCCCCCHHHHCCCCCCCCHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHCCCCCCCE
T ss_conf 65224533233322000100011111012213554244444343423232221235532234778303333213576877
Q ss_pred EECCCC-CCCCCCCC--CCCCCCCEEEEECC
Q ss_conf 974476-16666888--86798658982076
Q 001658 344 LFLGNN-KLNGTLPA--RKSPLLLNIDVSYN 371 (1036)
Q Consensus 344 L~Ls~N-~l~g~~p~--~~~~~L~~Ldls~N 371 (1036)
|+|+++ .+++.... ...+.|+.|+++++
T Consensus 205 L~L~~C~~i~~~~l~~L~~~~~L~~L~l~~~ 235 (284)
T d2astb2 205 LSLSRCYDIIPETLLELGEIPTLKTLQVFGI 235 (284)
T ss_dssp EECTTCTTCCGGGGGGGGGCTTCCEEECTTS
T ss_pred EECCCCCCCCHHHHHHHHCCCCCCEEEEECC
T ss_conf 9899999787378999726999898964488
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.76 E-value=1.2e-18 Score=112.50 Aligned_cols=130 Identities=15% Similarity=0.100 Sum_probs=0.0
Q ss_pred CCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCC
Q ss_conf 61113777677652114336687640113999986998316779888941247886687774756447788973202877
Q 001658 140 SPSVGNLTAMQYLNLAINALSGELPKELGQLTELLILGIGTNNFSGPLPSELGSLSKLQELYIDSAGVSGEIPSSFANLQ 219 (1036)
Q Consensus 140 p~~~~~L~~L~~L~L~~n~l~~~~p~~l~~L~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~ 219 (1036)
...|.+..+|++|+|++|+|+ .++..+..+++|+.|+|++|.+... +.+..+++|+.|++++|++....+..+..++
T Consensus 11 ~~~~~n~~~lr~L~L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~~l--~~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~ 87 (162)
T d1a9na_ 11 AAQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALP 87 (162)
T ss_dssp SCEEECTTSCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCT
T ss_pred HHHCCCCCCCCEEECCCCCCC-CCCCCCCCCCCCCEEECCCCCCCCC--CCCCCCCCHHHHHCCCCCCCCCCCCCCCCCC
T ss_conf 175168574848978899788-6576200414599898979978764--7744576130643102134577763223345
Q ss_pred CCCEEECCCCCCCCCCH-HHHCCCCCCCEEEEECCCCCCCCCC----CCCCCCCCCEEE
Q ss_conf 89678646874788770-2103999999999008868887872----234999988998
Q 001658 220 SLTKWWASDTRLTGRIP-DFIGNWSKLTALRFQGNSFNGPIPS----SFSNLTSVTELR 273 (1036)
Q Consensus 220 ~L~~L~L~~N~l~~~~~-~~l~~l~~L~~L~L~~N~l~~~~p~----~l~~l~~L~~L~ 273 (1036)
+|++|++++|.+..... ..+..+++|+.|++++|.++ ..|. .+..+++|+.|+
T Consensus 88 ~L~~L~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~-~~~~~r~~~i~~lp~L~~LD 145 (162)
T d1a9na_ 88 DLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVT-NKKHYRLYVIYKVPQVRVLD 145 (162)
T ss_dssp TCCEEECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGG-GSTTHHHHHHHHCTTCSEET
T ss_pred CCCCCEECCCCCCCCCCCCCCCCCCCCCHHHCCCCCCC-CCCCHHHHHHHHCCCCCEEC
T ss_conf 34434203000166542110013653206640799634-56106999998789958337
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.72 E-value=3.4e-17 Score=104.82 Aligned_cols=100 Identities=24% Similarity=0.303 Sum_probs=40.9
Q ss_pred EEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCC
Q ss_conf 99923888999896111377767765211433668764011399998699831677988894124788668777475644
Q 001658 127 NLNLGQNYLTGPLSPSVGNLTAMQYLNLAINALSGELPKELGQLTELLILGIGTNNFSGPLPSELGSLSKLQELYIDSAG 206 (1036)
Q Consensus 127 ~L~L~~n~l~~~~p~~~~~L~~L~~L~L~~n~l~~~~p~~l~~L~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~ 206 (1036)
+|+|++|+++ .++ .+..+++|++|++++|.|+ .+|..++.+++|+.|++++|+++. +| .+..+++|+.|++++|+
T Consensus 2 ~L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~-l~-~~~~l~~L~~L~l~~N~ 76 (124)
T d1dcea3 2 VLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNR 76 (124)
T ss_dssp EEECTTSCCS-SCC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSC
T ss_pred EEECCCCCCC-CCC-CCCCCCCCCEEECCCCCCC-CCHHHHHHHHCCCCCCCCCCCCCC-CC-CCCCCCCCCEEECCCCC
T ss_conf 8986899898-871-0105898898979787168-652156554313545324321123-57-41233555768888986
Q ss_pred CCCCCC-CCCCCCCCCCEEECCCCCC
Q ss_conf 778897-3202877896786468747
Q 001658 207 VSGEIP-SSFANLQSLTKWWASDTRL 231 (1036)
Q Consensus 207 l~~~~p-~~l~~l~~L~~L~L~~N~l 231 (1036)
+..... ..+..+++|+.|++++|.+
T Consensus 77 i~~~~~~~~l~~~~~L~~L~l~~N~i 102 (124)
T d1dcea3 77 LQQSAAIQPLVSCPRLVLLNLQGNSL 102 (124)
T ss_dssp CCSSSTTGGGGGCTTCCEEECTTSGG
T ss_pred CCCCCCCHHHCCCCCCCEEECCCCCC
T ss_conf 58888825653799999998979968
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.69 E-value=2.3e-19 Score=116.29 Aligned_cols=115 Identities=23% Similarity=0.351 Sum_probs=65.0
Q ss_pred CCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCC
Q ss_conf 89611137776776521143366876401139999869983167798889412478866877747564477889732028
Q 001658 138 PLSPSVGNLTAMQYLNLAINALSGELPKELGQLTELLILGIGTNNFSGPLPSELGSLSKLQELYIDSAGVSGEIPSSFAN 217 (1036)
Q Consensus 138 ~~p~~~~~L~~L~~L~L~~n~l~~~~p~~l~~L~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~ 217 (1036)
.++.++..|++|++|+|++|+|+ .++ .+..+++|+.|+|++|.+. .++.....+++|+.|++++|+++.. ..+..
T Consensus 39 ~l~~sl~~L~~L~~L~Ls~n~I~-~i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~~l--~~~~~ 113 (198)
T d1m9la_ 39 KMDATLSTLKACKHLALSTNNIE-KIS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIASL--SGIEK 113 (198)
T ss_dssp CCHHHHHHTTTCCEEECSEEEES-CCC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECCCH--HHHHH
T ss_pred HHHHHHHCCCCCCEEECCCCCCC-CCC-CCCCCCCCCCHHHCCCCCC-CCCCCCCCCCCCCCCCCCCCCCCCC--CCCCC
T ss_conf 02467762604615199446899-864-4247825357341353432-1000033221233333333222222--22222
Q ss_pred CCCCCEEECCCCCCCCCCH-HHHCCCCCCCEEEEECCCCCC
Q ss_conf 7789678646874788770-210399999999900886888
Q 001658 218 LQSLTKWWASDTRLTGRIP-DFIGNWSKLTALRFQGNSFNG 257 (1036)
Q Consensus 218 l~~L~~L~L~~N~l~~~~~-~~l~~l~~L~~L~L~~N~l~~ 257 (1036)
+++|+.|++++|+++.... ..+..+++|+.|++++|.+..
T Consensus 114 l~~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~~ 154 (198)
T d1m9la_ 114 LVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYN 154 (198)
T ss_dssp HHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSSHHHH
T ss_pred CCCCCCCCCCCCHHCCCCCCCCCCCCCCCCEEECCCCCCCC
T ss_conf 22341112341021255422123677763023427984346
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.69 E-value=1e-16 Score=102.27 Aligned_cols=41 Identities=27% Similarity=0.362 Sum_probs=14.3
Q ss_pred CCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCC
Q ss_conf 139999869983167798889412478866877747564477
Q 001658 167 LGQLTELLILGIGTNNFSGPLPSELGSLSKLQELYIDSAGVS 208 (1036)
Q Consensus 167 l~~L~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~ 208 (1036)
+..+++|++|++++|++. .+|..++.+++|+.|++++|.++
T Consensus 16 l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~ 56 (124)
T d1dcea3 16 LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE 56 (124)
T ss_dssp GGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCC
T ss_pred CCCCCCCCEEECCCCCCC-CCHHHHHHHHCCCCCCCCCCCCC
T ss_conf 105898898979787168-65215655431354532432112
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.65 E-value=1.2e-18 Score=112.43 Aligned_cols=13 Identities=23% Similarity=0.401 Sum_probs=4.0
Q ss_pred CCCCCEEECCCCC
Q ss_conf 7767765211433
Q 001658 146 LTAMQYLNLAINA 158 (1036)
Q Consensus 146 L~~L~~L~L~~n~ 158 (1036)
+++|++|+|++|.
T Consensus 69 l~~L~~L~Ls~N~ 81 (198)
T d1m9la_ 69 MENLRILSLGRNL 81 (198)
T ss_dssp HTTCCEEECCEEE
T ss_pred CCCCCCHHHCCCC
T ss_conf 8253573413534
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.61 E-value=1.3e-15 Score=96.39 Aligned_cols=49 Identities=24% Similarity=0.286 Sum_probs=17.2
Q ss_pred CCCCHHHHCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCC
Q ss_conf 9984020039999989983177668665512128998659917798899
Q 001658 280 GSSKLAFIRDMKSLSILELRNNNISDSIPSNIGEYRSLQHLDLSFNNLG 328 (1036)
Q Consensus 280 ~~~~~~~l~~l~~L~~L~Ls~N~l~~~ip~~l~~l~~L~~L~Ls~N~L~ 328 (1036)
..++...|.++++|+.|+|++|+|+...+..|..+++|+.|+|++|+|+
T Consensus 45 ~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~N~l~ 93 (156)
T d2ifga3 45 QHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALE 93 (156)
T ss_dssp CEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSCCS
T ss_pred CCCCCHHHCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCEECCCCCCC
T ss_conf 4369212256666672162021247742011124554333322678785
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.61 E-value=1.7e-15 Score=95.76 Aligned_cols=92 Identities=16% Similarity=0.095 Sum_probs=45.4
Q ss_pred CCCCCCCCCCCCEEECCCC-CCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCC
Q ss_conf 9811259999989992388-899989611137776776521143366876401139999869983167798889412478
Q 001658 115 IPDELWNLTSLFNLNLGQN-YLTGPLSPSVGNLTAMQYLNLAINALSGELPKELGQLTELLILGIGTNNFSGPLPSELGS 193 (1036)
Q Consensus 115 ip~~l~~l~~L~~L~L~~n-~l~~~~p~~~~~L~~L~~L~L~~n~l~~~~p~~l~~L~~L~~L~Ls~N~l~~~~p~~l~~ 193 (1036)
+|..+..+++|+.|++++| .|+.+.+.+|.++++|+.|+|++|+|+...+..|..+++|++|+|++|++....+..+ .
T Consensus 23 ~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~-~ 101 (156)
T d2ifga3 23 SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTV-Q 101 (156)
T ss_dssp TTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSCCSCCCSTTT-C
T ss_pred CCCCCCCCCCCCEEECCCCCCCCCCCCHHHCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCEECCCCCCCCCCHHHH-C
T ss_conf 860025765657431689866443692122566666721620212477420111245543333226787851574563-3
Q ss_pred CCCCCEEECCCCCC
Q ss_conf 86687774756447
Q 001658 194 LSKLQELYIDSAGV 207 (1036)
Q Consensus 194 l~~L~~L~Ls~N~l 207 (1036)
..+|+.|+|++|.+
T Consensus 102 ~~~l~~L~L~~Np~ 115 (156)
T d2ifga3 102 GLSLQELVLSGNPL 115 (156)
T ss_dssp SCCCCEEECCSSCC
T ss_pred CCCCCCCCCCCCCC
T ss_conf 53212433579863
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=99.27 E-value=4.9e-11 Score=72.15 Aligned_cols=150 Identities=14% Similarity=0.066 Sum_probs=102.7
Q ss_pred HHHHHHHCCCCCCCCCCCCCCEEEEEEEECCCCEEEEEECCCCCHHCHHHHHHHHHHHHHHC-CCCCCEEEEEEECCCEE
Q ss_conf 99998723999989303589788999682899389999924103320999999999987401-58843168588708322
Q 001658 686 AELKTATENFSPSNKLGEGGFGPVYKGKLGDGRAIAVKQLSVASRQGKSQFVAEIATISAVQ-HRNLVKLHGCCIEGAER 764 (1036)
Q Consensus 686 ~~l~~~~~~~~~~~~iG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~f~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~ 764 (1036)
.+++...+.|+..+..+.+....||+... ++..+.+|+...........+.+|...+..+. +--+.+++.++.+.+..
T Consensus 7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~ 85 (263)
T d1j7la_ 7 PELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWS 85 (263)
T ss_dssp HHHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEE
T ss_pred HHHHHHHHCEEEEECCCCCCCCCEEEEEE-CCCEEEEEECCCCCCCCHHHHHHHHHHHHHHHCCCCCCCEEEEEECCCCE
T ss_conf 99997513527997678998771899990-89869999848876532556999999999876069987289997508964
Q ss_pred EEEEEECCCCCHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHC----------------------------------
Q ss_conf 8999834799944563218877757677999999999999998761----------------------------------
Q 001658 765 LLVYEYLENKSLDQALFGQRSLTLDWATRYEICSGVARGLAYLHEE---------------------------------- 810 (1036)
Q Consensus 765 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~---------------------------------- 810 (1036)
++||+++++..+.+.... ......++.++++.++.||+.
T Consensus 86 ~lv~~~l~G~~~~~~~~~-------~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (263)
T d1j7la_ 86 NLLMSEADGVLCSEEYED-------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENW 158 (263)
T ss_dssp EEEEECCSSEEHHHHTTT-------CSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGG
T ss_pred EEEEEECCCCCCCCCCCC-------CCCHHHHHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHHCC
T ss_conf 999986043343543344-------0269999998999999985568421435764465655577899877655554303
Q ss_pred ----------------------CCCCCCCCCCCCCCEEECCCCCEEEEECCCCEE
Q ss_conf ----------------------896501134578858846998449997474114
Q 001658 811 ----------------------SRVRIIHRDVKASNVLLDADLVPKISDFGLAKL 843 (1036)
Q Consensus 811 ----------------------~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~ 843 (1036)
.+..++|+|+.+.||+++++..+-|+||+.+..
T Consensus 159 ~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 159 EEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp STTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred CCCCCCHHHHHHHHHHHHCCCCCCCEEEEEECCCCCEEECCCCEEEEEECHHCCC
T ss_conf 3232005799999999844986781789860047642364996599960231441
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.86 E-value=9e-11 Score=70.76 Aligned_cols=122 Identities=16% Similarity=0.090 Sum_probs=0.0
Q ss_pred CCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCHHHHCCCCCCCEEEEECCCCCCC--CCCCCCCCCCCCEE
Q ss_conf 6687774756447788973202877896786468747887702103999999999008868887--87223499998899
Q 001658 195 SKLQELYIDSAGVSGEIPSSFANLQSLTKWWASDTRLTGRIPDFIGNWSKLTALRFQGNSFNGP--IPSSFSNLTSVTEL 272 (1036)
Q Consensus 195 ~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~--~p~~l~~l~~L~~L 272 (1036)
...+.|++++.... ..+..+..+..+...++... .++..+..+++|++|+|++|+++.. ++..+..+++|+.|
T Consensus 22 ~~~~~Ldls~l~~~----~~l~~~~~~~~l~~~~~~~~-~l~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L 96 (162)
T d1koha1 22 GSQQALDLKGLRSD----PDLVAQNIDVVLNRRSSMAA-TLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKIL 96 (162)
T ss_dssp SSSCCBCCCCCSSC----TTTTTTTCCCCTTSHHHHHH-HHHHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCC
T ss_pred HHHCEEECCCCCCC----CHHHHCCCHHHCCHHHHHHH-HHHHHHHHCCCCCEEECCCCCCCCCCHHHHHHHHCCCCCCC
T ss_conf 33086534359898----21554664011225556766-60788974878788637776666773158898658856100
Q ss_pred ECCCCCCCCCCHHHHCCCCCCCEEECCCCCCCCCCCCC-------CCCCCCCCEEE
Q ss_conf 84688899984020039999989983177668665512-------12899865991
Q 001658 273 RISDLSNGSSKLAFIRDMKSLSILELRNNNISDSIPSN-------IGEYRSLQHLD 321 (1036)
Q Consensus 273 ~L~~n~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~ip~~-------l~~l~~L~~L~ 321 (1036)
++++|.+..+....+....+|+.|++++|.+....... +..+|+|+.||
T Consensus 97 ~Ls~N~i~~l~~l~~l~~~~L~~L~L~~Npl~~~~~~~~~y~~~i~~~~P~L~~LD 152 (162)
T d1koha1 97 NLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTYISAIRERFPKLLRLD 152 (162)
T ss_dssp CCTTSCCCCGGGHHHHTTCCCSSCCCTTSTTSSSSSSHHHHHHHHHTTSTTCCEET
T ss_pred CCCCCCCCCCHHHHHHHCCCCCEEECCCCCCCCCCCCCHHHHHHHHHHCCCCCEEC
T ss_conf 04357213423442220331042664899767676661569999999889978799
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.79 E-value=7.6e-08 Score=55.23 Aligned_cols=131 Identities=16% Similarity=0.152 Sum_probs=84.0
Q ss_pred CCCCCCC-EEEEEEEECCCCEEEEEECCCCCHHCHHHHHHHHHHHHHHCCC--CCCEEEEEEECCCEEEEEEEECCCCCH
Q ss_conf 3035897-8899968289938999992410332099999999998740158--843168588708322899983479994
Q 001658 700 KLGEGGF-GPVYKGKLGDGRAIAVKQLSVASRQGKSQFVAEIATISAVQHR--NLVKLHGCCIEGAERLLVYEYLENKSL 776 (1036)
Q Consensus 700 ~iG~G~f-G~Vy~~~~~~g~~vAvK~l~~~~~~~~~~f~~Ei~~l~~l~H~--nIv~l~g~~~~~~~~~lV~E~~~~gsL 776 (1036)
.+..|.. ..||+....++..+++|....... ..+..|...++.+... .+.++++++.+.+..++|++++++..+
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~---~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL---NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCTT---SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred ECCCCCCCCEEEEEEECCCCEEEEEECCCCCH---HHHHHHHHHHHHHHHCCCCCCCEEEECCCCCCEEEEEEEEECCCC
T ss_conf 76786547758999938987899995896677---689999999999986599988613222456615999874413554
Q ss_pred HHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHH------------------------------------------------
Q ss_conf 45632188777576779999999999999987------------------------------------------------
Q 001658 777 DQALFGQRSLTLDWATRYEICSGVARGLAYLH------------------------------------------------ 808 (1036)
Q Consensus 777 ~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH------------------------------------------------ 808 (1036)
.+.. .. ...++.++++.|+-||
T Consensus 94 ~~~~-------~~---~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (255)
T d1nd4a_ 94 LSSH-------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFA 163 (255)
T ss_dssp TTSC-------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHH
T ss_pred CCCC-------CC---HHHHHHHHHHHHHHHCCCCHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCHHHHHHHHHHHH
T ss_conf 3221-------26---8999999999999873688544887554124688999999875411011340112137999999
Q ss_pred ---HC----CCCCCCCCCCCCCCEEECCCCCEEEEECCCCEE
Q ss_conf ---61----896501134578858846998449997474114
Q 001658 809 ---EE----SRVRIIHRDVKASNVLLDADLVPKISDFGLAKL 843 (1036)
Q Consensus 809 ---~~----~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~ 843 (1036)
.. .++.++|+|+.+.|||++++..+.|+||+.+..
T Consensus 164 ~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 164 RLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 205 (255)
T ss_dssp HHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHHCCCCCCCEEEECCCCCCCEEEECCCEEEEEECHHCCC
T ss_conf 998718765795678678887635773796589998533265
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=98.58 E-value=2.8e-07 Score=52.25 Aligned_cols=76 Identities=16% Similarity=0.177 Sum_probs=49.1
Q ss_pred CCCCCCCCEEEEEEEECC-CCEEEEEECCCCC-------HHCHHHHHHHHHHHHHHC-C--CCCCEEEEEEECCCEEEEE
Q ss_conf 930358978899968289-9389999924103-------320999999999987401-5--8843168588708322899
Q 001658 699 NKLGEGGFGPVYKGKLGD-GRAIAVKQLSVAS-------RQGKSQFVAEIATISAVQ-H--RNLVKLHGCCIEGAERLLV 767 (1036)
Q Consensus 699 ~~iG~G~fG~Vy~~~~~~-g~~vAvK~l~~~~-------~~~~~~f~~Ei~~l~~l~-H--~nIv~l~g~~~~~~~~~lV 767 (1036)
+.||.|....||+....+ ++.|++|.-.... .....+...|.+.+..+. + ..+++++.+ +.+..++|
T Consensus 32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~lv 109 (392)
T d2pula1 32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV 109 (392)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred EEECCCCEEEEEEEEECCCCEEEEEECCCCHHCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCEEEEE--CCCCCEEE
T ss_conf 9807985276899995799848999617713034677788877899999999998650579885528998--59887798
Q ss_pred EEECCCCCH
Q ss_conf 983479994
Q 001658 768 YEYLENKSL 776 (1036)
Q Consensus 768 ~E~~~~gsL 776 (1036)
||++++..+
T Consensus 110 mE~L~~~~~ 118 (392)
T d2pula1 110 MEDLSHLKI 118 (392)
T ss_dssp ECCCTTSEE
T ss_pred EECCCCCCC
T ss_conf 713577653
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=98.38 E-value=1.9e-07 Score=53.16 Aligned_cols=10 Identities=10% Similarity=0.112 Sum_probs=3.3
Q ss_pred CCCEEECCCC
Q ss_conf 8659917798
Q 001658 316 SLQHLDLSFN 325 (1036)
Q Consensus 316 ~L~~L~Ls~N 325 (1036)
.|+.|+|++|
T Consensus 101 sL~~L~l~~n 110 (167)
T d1pgva_ 101 SIVEFKADNQ 110 (167)
T ss_dssp CCSEEECCCC
T ss_pred CCCEEECCCC
T ss_conf 3898778877
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=98.29 E-value=5.9e-06 Score=45.21 Aligned_cols=135 Identities=16% Similarity=0.133 Sum_probs=75.4
Q ss_pred CEEEEEEEECCCCEEEEEECCCCCHHCHHHHHHHHHHHHHHCCCCCC--EEEE-----EEECCCEEEEEEEECCCCCHHH
Q ss_conf 78899968289938999992410332099999999998740158843--1685-----8870832289998347999445
Q 001658 706 FGPVYKGKLGDGRAIAVKQLSVASRQGKSQFVAEIATISAVQHRNLV--KLHG-----CCIEGAERLLVYEYLENKSLDQ 778 (1036)
Q Consensus 706 fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv--~l~g-----~~~~~~~~~lV~E~~~~gsL~~ 778 (1036)
--.||++...+|+.+++|+.+.. ....+++..|...+..+....+. ..+. .....+..+.++++++|..+..
T Consensus 35 EN~vy~v~~~dg~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~ 113 (325)
T d1zyla1 35 ENRVYQFQDEDRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEA 113 (325)
T ss_dssp SSEEEEECCTTCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCS
T ss_pred CCEEEEEECCCCCEEEEEEECCC-CCCHHHHHHHHHHHHHHHHCCCCCCCCEECCCCEEEEEEEEEEEEEEECCCCCCCC
T ss_conf 20269998389997999984787-78899999999999999855998787520689805665347999986527768899
Q ss_pred -----H---------HHC----CC---CCCCCHH-------------------HHHHHHHHHHHHHHHHHH----CCCCC
Q ss_conf -----6---------321----88---7775767-------------------799999999999999876----18965
Q 001658 779 -----A---------LFG----QR---SLTLDWA-------------------TRYEICSGVARGLAYLHE----ESRVR 814 (1036)
Q Consensus 779 -----~---------l~~----~~---~~~l~~~-------------------~~~~i~~~ia~~L~yLH~----~~~~~ 814 (1036)
+ +|. .. ....++. .+-.+...+.+.++.+.. ..+..
T Consensus 114 ~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~ 193 (325)
T d1zyla1 114 DNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVL 193 (325)
T ss_dssp SCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCE
T ss_pred CCHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHHCCCCCCCE
T ss_conf 99999999899999988630357865567789788766568999874769988989999999999999998454568712
Q ss_pred CCCCCCCCCCEEECCCCCEEEEECCCCEE
Q ss_conf 01134578858846998449997474114
Q 001658 815 IIHRDVKASNVLLDADLVPKISDFGLAKL 843 (1036)
Q Consensus 815 ivH~Dikp~NILl~~~~~~kl~DFGla~~ 843 (1036)
++|+|+.+.|||++++ ..++||+-+..
T Consensus 194 liHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 194 RLHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp ECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred EECCCCCCCCEEEECC--CEEEECHHCCC
T ss_conf 0247888042878389--35886520146
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=98.29 E-value=6.7e-06 Score=44.92 Aligned_cols=73 Identities=19% Similarity=0.271 Sum_probs=47.9
Q ss_pred CCCCCCCCEEEEEEEECC--------CCEEEEEECCCCCHHCHHHHHHHHHHHHHHCCCCCC-EEEEEEECCCEEEEEEE
Q ss_conf 930358978899968289--------938999992410332099999999998740158843-16858870832289998
Q 001658 699 NKLGEGGFGPVYKGKLGD--------GRAIAVKQLSVASRQGKSQFVAEIATISAVQHRNLV-KLHGCCIEGAERLLVYE 769 (1036)
Q Consensus 699 ~~iG~G~fG~Vy~~~~~~--------g~~vAvK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv-~l~g~~~~~~~~~lV~E 769 (1036)
+.|+.|-.-.+|++...+ .+.|.+++... ........+|..+++.+.-.++. ++++++.+ .+|+|
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~--~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~e 121 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN--PETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE 121 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS--CCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred EECCCCCCCCEEEEEECCCCCCCCCCCCCEEEEECCC--CCHHHHHHHHHHHHHHHHHCCCCCEEEEECCC----CEEEE
T ss_conf 9917853343489996887754457898179996599--61165899999999999757999808998189----56999
Q ss_pred ECCCCCHH
Q ss_conf 34799944
Q 001658 770 YLENKSLD 777 (1036)
Q Consensus 770 ~~~~gsL~ 777 (1036)
|+++..+.
T Consensus 122 fi~g~~l~ 129 (395)
T d1nw1a_ 122 YIPSRPLS 129 (395)
T ss_dssp CCCEEECC
T ss_pred EECCCCCC
T ss_conf 73455488
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=98.08 E-value=0.00012 Score=38.35 Aligned_cols=33 Identities=27% Similarity=0.306 Sum_probs=28.1
Q ss_pred CCCCCCCCCCCCCCEEECCCCCEEEEECCCCEE
Q ss_conf 896501134578858846998449997474114
Q 001658 811 SRVRIIHRDVKASNVLLDADLVPKISDFGLAKL 843 (1036)
Q Consensus 811 ~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~ 843 (1036)
.+..++|+|+.+.||+++.+...-|.||+.+..
T Consensus 181 L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 181 LPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 213 (316)
T ss_dssp SCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred CCCCCCCCCCCHHHHHCCCCCCEEEECCCCCCC
T ss_conf 545033378636564020454126742221236
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=97.85 E-value=2.5e-06 Score=47.19 Aligned_cols=111 Identities=10% Similarity=0.122 Sum_probs=0.0
Q ss_pred CCCCCCCEEECCC-CCCCCCCHHHHC----CCCCCCEEEEECCCCCC----CCCCCCCCCCCCCEEECCCCCCCCCCH--
Q ss_conf 2877896786468-747887702103----99999999900886888----787223499998899846888999840--
Q 001658 216 ANLQSLTKWWASD-TRLTGRIPDFIG----NWSKLTALRFQGNSFNG----PIPSSFSNLTSVTELRISDLSNGSSKL-- 284 (1036)
Q Consensus 216 ~~l~~L~~L~L~~-N~l~~~~~~~l~----~l~~L~~L~L~~N~l~~----~~p~~l~~l~~L~~L~L~~n~~~~~~~-- 284 (1036)
.+.++|++|++++ +.++......+. ..+.|++|++++|.++. .+...+.....++.++++++.++....
T Consensus 14 ~~~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~~ 93 (166)
T d1io0a_ 14 NNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILA 93 (166)
T ss_dssp TTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHH
T ss_pred HCCCCCCEEECCCCCCCCHHHHHHHHHHHHCCCCCCEEECCCCCCCHHHHHHHHHHHHHCCCCHHHHHCCCCCCCHHHHH
T ss_conf 55999868876899998989999999888419825743015896117789999987752122101210254322014788
Q ss_pred --HHHCCCCCCCE--EECCCCCCCC----CCCCCCCCCCCCCEEECCCCC
Q ss_conf --20039999989--9831776686----655121289986599177988
Q 001658 285 --AFIRDMKSLSI--LELRNNNISD----SIPSNIGEYRSLQHLDLSFNN 326 (1036)
Q Consensus 285 --~~l~~l~~L~~--L~Ls~N~l~~----~ip~~l~~l~~L~~L~Ls~N~ 326 (1036)
..+...++|+. |++++|.+.. .+...+...++|+.|+++.+.
T Consensus 94 l~~~l~~~~~L~~l~L~l~~n~i~~~~~~~La~~L~~n~~L~~L~l~~~~ 143 (166)
T d1io0a_ 94 LVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQ 143 (166)
T ss_dssp HHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSS
T ss_pred HHHHHHHCCCCCEEEECCCCCCCCHHHHHHHHHHHHHCCCCCEEECCCCC
T ss_conf 99999848652477321677867679999999999849984788581898
|